PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Adhikary, A; Chakraborty, S; Mazumdar, M; Ghosh, S; Mukherjee, S; Manna, A; Mohanty, S; Nakka, KK; Joshi, S; De, A; Chattopadhyay, S; Sa, G; Das, T				Adhikary, Arghya; Chakraborty, Samik; Mazumdar, Minakshi; Ghosh, Swatilekha; Mukherjee, Shravanti; Manna, Argha; Mohanty, Suchismita; Nakka, Kiran Kumar; Joshi, Shruti; De, Abhijit; Chattopadhyay, Samit; Sa, Gaurisankar; Das, Tanya			Inhibition of Epithelial to Mesenchymal Transition by E-cadherin Up-regulation via Repression of Slug Transcription and Inhibition of E-cadherin Degradation DUAL ROLE OF SCAFFOLD/MATRIX ATTACHMENT REGION-BINDING PROTEIN 1 (SMAR1) IN BREAST CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC-SIGNIFICANCE; ATTACHMENT REGIONS; TUMOR PROGRESSION; GENE-EXPRESSION; INVASION; PROTEIN; MDM2; METASTASIS; ADHESION; SNAIL	The evolution of the cancer cell into a metastatic entity is the major cause of death in patients with cancer. It has been acknowledged that aberrant activation of a latent embryonic program, known as the epithelial-mesenchymal transition (EMT), can endow cancer cells with the migratory and invasive capabilities associated with metastatic competence for which E-cadherin switch is a well-established hallmark. Discerning the molecular mechanisms that regulate E-cadherin expression is therefore critical for understanding tumor invasiveness and metastasis. Here we report that SMAR1 overexpression inhibits EMT and decelerates the migratory potential of breast cancer cells by up-regulating E-cadherin in a bidirectional manner. While SMAR1-dependent transcriptional repression of Slug by direct recruitment of SMAR1/HDAC1 complex to the matrix attachment region site present in the Slug promoter restores E-cadherin expression, SMAR1 also hinders E-cadherin-MDM2 interaction thereby reducing ubiquitination and degradation of E-cadherin protein. Consistently, siRNA knockdown of SMAR1 expression in these breast cancer cells results in a coordinative action of Slug-mediated repression of E-cadherin transcription, as well as degradation of E-cadherin protein through MDM2, up-regulating breast cancer cell migration. These results indicate a crucial role for SMAR1 in restraining breast cancer cell migration and suggest the candidature of this scaffold matrix-associated region-binding protein as a tumor suppressor.	[Adhikary, Arghya; Chakraborty, Samik; Mazumdar, Minakshi; Ghosh, Swatilekha; Mukherjee, Shravanti; Manna, Argha; Mohanty, Suchismita; Sa, Gaurisankar; Das, Tanya] Bose Inst, Div Mol Med, Kolkata 700054, W Bengal, India; [Nakka, Kiran Kumar; Joshi, Shruti; Chattopadhyay, Samit] NCCS, Pune 411007, Maharashtra, India; [De, Abhijit] ACTREC, Tata Mem Ctr, Mol Funct Imaging Lab, Bombay 410210, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Das, T (corresponding author), Bose Inst, Div Mol Med, P-1-12 Calcutta Improvement Trust Scheme 7 M, Kolkata 700054, W Bengal, India.	tanya@jcbose.ac.in	Nakka, Kiran/CAJ-3374-2022; DE, ABHIJIT/AAR-5631-2021; Chakraborty, Samik/Q-1779-2018	DE, ABHIJIT/0000-0002-5818-0206; Nakka, Kiran/0000-0002-8418-9343; Chakraborty, Samik/0000-0002-5232-0474	DST; CSIR; UGC, Govt of India	DST(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC, Govt of India(University Grants Commission, India)	This work was supported by grants from DST, CSIR, and UGC, Govt of India.	Adhikary A, 2010, FEBS LETT, V584, P7, DOI 10.1016/j.febslet.2009.10.081; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Cheng JC, 2013, ONCOGENE, V32, P1041, DOI 10.1038/onc.2012.127; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Hajra KM, 2002, CANCER RES, V62, P1613; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Hsieh CY, 2013, TOXICOL IN VITRO, V27, P1, DOI 10.1016/j.tiv.2012.10.001; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Lukas J, 2001, CANCER RES, V61, P3212; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Mathew R, 2002, EUR J CANCER, V38, P832, DOI 10.1016/S0959-8049(02)00007-2; Moll UM, 2003, MOL CANCER RES, V1, P1001; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pavithra L, 2009, J MOL BIOL, V388, P691, DOI 10.1016/j.jmb.2009.03.033; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P1079; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Singh K, 2009, J BIOL CHEM, V284, P1267, DOI 10.1074/jbc.M801088200; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Strathdee G, 2002, SEMIN CANCER BIOL, V12, P373, DOI 10.1016/S1044-579X(02)00057-3; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06	40	72	73	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25431	25444		10.1074/jbc.M113.527267	http://dx.doi.org/10.1074/jbc.M113.527267			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086032	Green Published, hybrid			2022-12-25	WOS:000342130800004
J	Briganti, S; Flori, E; Bellei, B; Picardo, M				Briganti, Stefania; Flori, Enrica; Bellei, Barbara; Picardo, Mauro			Modulation of PPAR gamma Provides New Insights in a Stress Induced Premature Senescence Model	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; INDUCED OXIDATIVE DAMAGE; TRANSCRIPTION FACTOR; CELLULAR SENESCENCE; INDUCED APOPTOSIS; SKIN FIBROBLASTS; UVA RADIATION; IN-VITRO; ACID; ULTRAVIOLET	Peroxisome proliferator-activated receptor gamma (PPAR gamma) may be involved in a key mechanism of the skin aging process, influencing several aspects related to the age-related degeneration of skin cells, including antioxidant unbalance. Therefore, we investigated whether the up-modulation of this nuclear receptor exerts a protective effect in a stress-induced premature senescence (SIPS) model based on a single exposure of human dermal fibroblasts to 8-methoxypsoralen plus + ultraviolet-A-irradiation (PUVA). Among possible PPAR gamma modulators, we selected 2,4,6-octatrienoic acid (Octa), a member of the parrodiene family, previously reported to promote melanogenesis and antioxidant defense in normal human melanocytes through a mechanism involving PPAR gamma activation. Exposure to PUVA induced an early and significant decrease in PPAR gamma expression and activity. PPAR gamma up-modulation counteracted the antioxidant imbalance induced by PUVA and reduced the expression of stress response genes with a synergistic increase of different components of the cell antioxidant network, such as catalase and reduced glutathione. PUVA-treated fibroblasts grown in the presence of Octa are partially but significantly rescued from the features of the cellular senescence-like phenotype, such as cytoplasmic enlargement, the expression of senescence-associated-beta-galactosidase, matrix-metalloproteinase-1, and cell cycle proteins. Moreover, the alterations in the cell membrane lipids, such as the decrease in the polyunsaturated fatty acid content of phospholipids and the increase in cholesterol levels, which are typical features of cell aging, were prevented. Our data suggest that PPAR gamma is one of the targets of PUVA-SIPS and that its pharmacological up-modulation may represent a novel therapeutic approach for the photooxidative skin damage.	[Briganti, Stefania; Flori, Enrica; Bellei, Barbara; Picardo, Mauro] Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Picardo, M (corresponding author), Ist Ricovero & Cura Carattere Sci, San Gallicano Dermatol Inst, Lab Cutaneous Physiopathol, Rome, Italy.	picardo@ifo.it	Briganti, Stefania/AAY-2136-2021; briganti, stefania/J-3185-2016; Flori, Enrica/H-4417-2014; Bellei, Barbara/K-5288-2016; Picardo, Mauro/A-6978-2011	Briganti, Stefania/0000-0003-2000-006X; briganti, stefania/0000-0003-2000-006X; Flori, Enrica/0000-0002-9275-1041; Bellei, Barbara/0000-0002-3883-5500; Picardo, Mauro/0000-0003-4899-6639	Giuliani Pharma, Milan, Italy	Giuliani Pharma, Milan, Italy	This work has been partly supported by a research grant provided by Giuliani Pharma, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding received for this study.	Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; Andre M, 2003, FEBS LETT, V546, P223, DOI 10.1016/S0014-5793(03)00576-3; Anticoli S, 2010, J CELL PHYSIOL, V222, P586, DOI 10.1002/jcp.21972; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; BAYREUTHER K, 1992, ARCH GERONTOL GERIAT, P47, DOI 10.1016/S0167-4943(05)80006-8; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Brenneisen P, 2002, ANN NY ACAD SCI, V973, P31, DOI 10.1111/j.1749-6632.2002.tb04602.x; Briganti S, 2008, FREE RADICAL BIO MED, V45, P636, DOI 10.1016/j.freeradbiomed.2008.05.006; Briganti S, 2013, EXP DERMATOL, V22, P41, DOI 10.1111/exd.12066; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V39, P63, DOI 10.1111/j.1751-1097.1984.tb03405.x; Camera E, 2001, J CHROMATOGR B, V757, P69, DOI 10.1016/S0378-4347(01)00081-0; Canton M, 2002, FEBS LETT, V522, P168, DOI 10.1016/S0014-5793(02)02926-5; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chiba Y, 2005, J GERONTOL A-BIOL, V60, P1087, DOI 10.1093/gerona/60.9.1087; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; CUNNINGHAM M L, 1985, Journal of Free Radicals in Biology and Medicine, V1, P381, DOI 10.1016/0748-5514(85)90150-3; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; dos Santos DJVA, 2006, BIOPHYS J, V91, P2464, DOI 10.1529/biophysj.105.077156; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; El-Domyati M, 2002, EXP DERMATOL, V11, P398, DOI 10.1034/j.1600-0625.2002.110502.x; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Feingold KR, 2011, DERM-ENDOCRINOL, V3, P113, DOI 10.4161/derm.3.2.14996; Flori E, 2011, PIGM CELL MELANOMA R, V24, P618, DOI 10.1111/j.1755-148X.2011.00887.x; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grabacka M, 2008, PIGM CELL MELANOMA R, V21, P388, DOI 10.1111/j.1755-148X.2008.00460.x; Gruber F, 2010, FASEB J, V24, P39, DOI 10.1096/fj.09-133520; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Ham SA, 2013, J INVEST DERMATOL, V133, P2593, DOI 10.1038/jid.2013.202; Hanson KM, 2002, PHOTOCHEM PHOTOBIOL, V76, P57, DOI 10.1562/0031-8655(2002)076<0057:OAQOUI>2.0.CO;2; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herrmann G, 1998, J CELL SCI, V111, P759; Jurzak M, 2008, ACTA POL PHARM, V65, P85; Kim BH, 2003, TOXICOL LETT, V146, P65, DOI 10.1016/j.toxlet.2003.09.001; Koziel R, 2011, J INVEST DERMATOL, V131, P594, DOI 10.1038/jid.2010.383; Kurien BT, 2003, LIFE SCI, V73, P1655, DOI 10.1016/S0024-3205(03)00475-2; Kwak BR, 2002, DRUG NEWS PERSPECT, V15, P325, DOI 10.1358/dnp.2002.15.6.701652; Lee YH, 2010, CELL BIOCHEM FUNCT, V28, P490, DOI 10.1002/cbf.1681; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009; McCarty MF, 2009, MED HYPOTHESES, V72, P29, DOI 10.1016/j.mehy.2008.07.043; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Morelli R, 2003, DRUG EXP CLIN RES, V29, P95; Naru E, 2005, BRIT J DERMATOL, V153, P6, DOI 10.1111/j.1365-2133.2005.06964.x; Nejati Reza, 2013, Expert Rev Dermatol, V8, P581; Okuno Y, 2010, ENDOCR J, V57, P303, DOI 10.1507/endocrj.K09E-113; Palozza P, 2011, J NUTR BIOCHEM, V22, P259, DOI 10.1016/j.jnutbio.2010.02.003; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Park H, 2008, EXP DERMATOL, V17, P829, DOI 10.1111/j.1600-0625.2008.00708.x; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; Picardo M, 1996, J INVEST DERMATOL, V107, P322, DOI 10.1111/1523-1747.ep12363163; Pini E, 2004, DRUG EXP CLIN RES, V30, P203; Pinnell SR, 2003, J AM ACAD DERMATOL, V48, P1, DOI 10.1067/mjd.2003.16; Polvani S, 2012, PPAR RES, V2012, DOI 10.1155/2012/641087; Raval CM, 2012, FREE RADICAL BIO MED, V52, P227, DOI 10.1016/j.freeradbiomed.2011.10.494; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Saito Y, 2007, FEBS LETT, V581, P4349, DOI 10.1016/j.febslet.2007.08.010; Santamaria AB, 2002, CELL DEATH DIFFER, V9, P549, DOI 10.1038/sj/cdd/4401007; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Shin MH, 2005, J INVEST DERMATOL, V125, P221, DOI 10.1111/j.0022-202X.2005.23823.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; STOCKS J, 1971, BRIT J HAEMATOL, V20, P95, DOI 10.1111/j.1365-2141.1971.tb00790.x; Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Tanaka H, 2009, J INVEST DERM SYMP P, V14, P60, DOI 10.1038/jidsymp.2009.2; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Tian FF, 2011, BIOSCI TRENDS, V5, P23, DOI 10.5582/bst.2011.v5.1.23; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; WALDMAN T, 1995, CANCER RES, V55, P5187; WEISS JS, 1988, J AM ACAD DERMATOL, V19, P169, DOI 10.1016/S0190-9622(88)70161-9; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; Yasui H, 2003, EXP DERMATOL, V12, P655, DOI 10.1034/j.1600-0625.2003.00033.x; Zhong JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P18, DOI 10.1039/b9pp00068b	80	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104045	10.1371/journal.pone.0104045	http://dx.doi.org/10.1371/journal.pone.0104045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101957	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900033
J	Gustine, DD; Barboza, PS; Adams, LG; Wolf, NB				Gustine, David D.; Barboza, Perry S.; Adams, Layne G.; Wolf, Nathan B.			Environmental and Physiological Influences to Isotopic Ratios of N and Protein Status in a Montane Ungulate in Winter	PLOS ONE			English	Article							STABLE-ISOTOPES; MATERNAL CHARACTERISTICS; MILK-PRODUCTION; REPRODUCTIVE ALLOCATION; POPULATION-DYNAMICS; RANGIFER-TARANDUS; WOODLAND CARIBOU; BODY CONDITION; AMINO-ACIDS; BIRTH-DATE	Winter severity can influence large herbivore populations through a reduction in maternal proteins available for reproduction. Nitrogen (N) isotopes in blood fractions can be used to track the use of body proteins in northern and montane ungulates. We studied 113 adult female caribou for 13 years throughout a series of severe winters that reduced population size and offspring mass. After these severe winters, offspring mass increased but the size of the population remained low. We devised a conceptual model for routing of isotopic N in blood in the context of the severe environmental conditions experienced by this population. We measured delta N-15 in three blood fractions and predicted the relative mobilization of dietary and body proteins. The delta N-15 of the body protein pool varied by 4 parts per thousand and 46% of the variance was associated with year. Annual variation in delta N-15 of body protein likely reflected the fall/early winter diet and winter locations, yet 15% of the isotopic variation in amino acid N was due to body proteins. Consistent isotopic differences among blood N pools indicated that animals tolerated fluxes in diet and body stores. Conservation of body protein in caribou is the result of active exchange among diet and body N pools. Adult females were robust to historically severe winter conditions and prioritized body condition and survival over early investment in offspring. For a vagile ungulate residing at low densities in a predator-rich environment, protein restrictions in winter may not be the primary limiting factor for reproduction.	[Gustine, David D.; Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Barboza, Perry S.] Univ Alaska Fairbanks, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK USA; [Wolf, Nathan B.] Univ Alaska Anchorage, Environm & Nat Resources Inst, Anchorage, AK USA	United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Anchorage	Gustine, DD (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	dgustine@usgs.gov		Barboza, Perry/0000-0002-1489-6448	United States Geological Survey; National Park Service	United States Geological Survey(United States Geological Survey); National Park Service	This work was funded by the United States Geological Survey and the National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2010, ECOL APPL, V20, P251, DOI 10.1890/08-1437.1; Adams LG, 2005, J MAMMAL, V86, P506, DOI 10.1644/1545-1542(2005)86[506:EOMCAC]2.0.CO;2; ADAMS LG, 1995, J WILDLIFE MANAGE, V59, P584, DOI 10.2307/3802467; Adams LG, 2003, J WILDLIFE MANAGE, V67, P20, DOI 10.2307/3803057; Adams LG, 1998, J WILDLIFE MANAGE, V62, P1184, DOI 10.2307/3801982; Adams LG, 2006, ALASKA PARK SCI, V5, P36; Adams LG, 1995, OCCASIONAL PUBLICATI, P245; ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; Barboza PS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P835, DOI 10.1086/590414; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P628, DOI 10.1086/502811; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bardsen BJ, 2011, OIKOS, V120, P245, DOI 10.1111/j.1600-0706.2010.18597.x; Bartz KK, 2005, ECOSYSTEMS, V8, P529, DOI 10.1007/s10021-005-0064-z; Ben-David M, 2001, ALCES-N AM MOOSE CON, V37, P421; Ben-David M, 2012, J MAMMAL, V93, P399, DOI 10.1644/11-MAMM-S-168.1; BOERTJE RD, 1984, ARCTIC, V37, P161; CHANMCLEOD ACA, 1994, CAN J ZOOL, V72, P938, DOI DOI 10.1139/z94-127; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DRENT RH, 1980, ARDEA, V68, P225; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; Festa-Bianchet M, 1998, BEHAV ECOL, V9, P144, DOI 10.1093/beheco/9.2.144; Finstad GL, 2011, ARCT ANTARCT ALP RES, V43, P543, DOI 10.1657/1938-4246-43.4.543; Fischer LA, 2005, CAN J ZOOL, V83, P1162, DOI 10.1139/Z05-117; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Gustine DD, 2011, J WILDLIFE MANAGE, V75, P178, DOI 10.1002/jwmg.11; Gustine DD, 2010, PHYSIOL BIOCHEM ZOOL, V83, P687, DOI 10.1086/652729; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; Hamel S, 2009, OECOLOGIA, V161, P421, DOI 10.1007/s00442-009-1377-y; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Huber PJ, 2009, WILEY SERIES PROBABI; Joly K, 2007, CAN FIELD NAT, V121, P379, DOI 10.22621/cfn.v121i4.509; Karasov WH., 2007, PHYSL ECOLOGY ANIMAL, P741; Landete-Castillejos T, 2001, J ANIM SCI, V79, P1085; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Lesage L, 2001, OECOLOGIA, V126, P30, DOI 10.1007/s004420000499; Lobley Gerald E., 1994, P147; Martin JGA, 2010, AM NAT, V176, P414, DOI 10.1086/656267; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Milakovic B, 2011, J MAMMAL, V92, P295, DOI 10.1644/10-MAMM-A-038.1; MILLER FL, 1974, J WILDLIFE MANAGE, V38, P47, DOI 10.2307/3800199; Milner JM, 2003, CAN J ZOOL, V81, P1566, DOI [10.1139/z03-152, 10.1139/Z03-152]; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NOLAN JV, 1972, BRIT J NUTR, V27, P177, DOI 10.1079/BJN19720081; O'Brien DM, 2005, PHYSIOL BIOCHEM ZOOL, V78, P819, DOI 10.1086/431191; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Oftedal O.T., 1985, BIOENERGETICS WILD H, V10, P215; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Podlesak DW, 2006, PHYSIOL BIOCHEM ZOOL, V79, P534, DOI 10.1086/502813; Popp BN, 2007, TERR ECOL SER, V1, P173; Quillfeldt P, 2008, MAR BIOL, V155, P593, DOI 10.1007/s00227-008-1048-2; ROBBINS CT, 1981, J WILDLIFE MANAGE, V45, P172, DOI 10.2307/3807885; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Russell DE, 1993, RANGIFER, V8, P1, DOI DOI 10.7557/2.13.5.1057; Stephens PA, 2014, ECOLOGY, V95, P882, DOI 10.1890/13-1434.1; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Taillon J, 2013, ECOLOGY, V94, P1815, DOI 10.1890/12-1424.1; Tyler NJC, 2008, ECOLOGY, V89, P1675, DOI 10.1890/07-0416.1; Wang GM, 2006, ECOLOGY, V87, P95, DOI 10.1890/05-0355; Waterlow JC, 1999, NUTR RES REV, V12, P25, DOI 10.1079/095442299108728857; White R.G., 1984, Symposia of the Zoological Society of London, P215; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; WHITTEN KR, 1995, J WILDLIFE MANAGE, V59, P273, DOI 10.2307/3808940; Zar JH, 1999, BIOSTATISTICAL ANAL	78	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103471	10.1371/journal.pone.0103471	http://dx.doi.org/10.1371/journal.pone.0103471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102057	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900019
J	Michaud, L; Lo Giudice, A; Mysara, M; Monsieurs, P; Raffa, C; Leys, N; Amalfitano, S; Van Houdt, R				Michaud, Luigi; Lo Giudice, Angelina; Mysara, Mohamed; Monsieurs, Pieter; Raffa, Carmela; Leys, Natalie; Amalfitano, Stefano; Van Houdt, Rob			Snow Surface Microbiome on the High Antarctic Plateau (DOME C)	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TARGETED OLIGONUCLEOTIDE PROBES; CATALYZED REPORTER DEPOSITION; GRAM-POSITIVE BACTERIA; DIVERSITY; IDENTIFICATION; MICROORGANISMS; SEQUENCES; COMMUNITY; PROTEOBACTERIA	The cryosphere is an integral part of the global climate system and one of the major habitable ecosystems of Earth's biosphere. These permanently frozen environments harbor diverse, viable and metabolically active microbial populations that represent almost all the major phylogenetic groups. In this study, we investigated the microbial diversity in the surface snow surrounding the Concordia Research Station on the High Antarctic Plateau through a polyphasic approach, including direct prokaryotic quantification by flow cytometry and catalyzed reporter deposition fluorescence in situ hybridization (CARD-FISH), and phylogenetic identification by 16S RNA gene clone library sequencing and 454 16S amplicon pyrosequencing. Although the microbial abundance was low (<10(3) cells/ml of snowmelt), concordant results were obtained with the different techniques. The microbial community was mainly composed of members of the Alpha-proteobacteria class (e.g. Kiloniellaceae and Rhodobacteraceae), which is one of the most well-represented bacterial groups in marine habitats, Bacteroidetes (e.g. Cryomorphaceae and Flavobacteriaceae) and Cyanobacteria. Based on our results, polar microorganisms could not only be considered as deposited airborne particles, but as an active component of the snowpack ecology of the High Antarctic Plateau.	[Michaud, Luigi; Lo Giudice, Angelina; Raffa, Carmela] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Mysara, Mohamed; Monsieurs, Pieter; Leys, Natalie; Van Houdt, Rob] Belgian Nucl Res Ctr SCK CEN, Microbiol Unit, Mol, Belgium; [Mysara, Mohamed] Vrije Univ Brussel, Dept Biosci Engn, Brussels, Belgium; [Amalfitano, Stefano] Natl Res Council IRSA CNR, Water Res Inst, Rome, Italy	University of Messina; Belgian Nuclear Research Centre (SCK-CEN); Vrije Universiteit Brussel; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sulle Acque (IRSA-CNR)	Lo Giudice, A (corresponding author), Univ Messina, Dept Biol & Environm Sci, Messina, Italy.	alogiudice@unime.it	Monsieurs, Pieter/W-3916-2019; Monsieurs, Pieter/A-2917-2009; Mysara, Mohamed/AAH-4242-2019; Leys, Natalie M.E.J./P-2761-2017; Van Houdt, Rob/B-8599-2011; Amalfitano, Stefano/C-6737-2012	Monsieurs, Pieter/0000-0003-2214-6652; Mysara, Mohamed/0000-0001-5746-4330; Van Houdt, Rob/0000-0002-7459-496X; Amalfitano, Stefano/0000-0002-6148-1472	European Space Agency (ESA-PRODEX); EXANAM project [C90359]	European Space Agency (ESA-PRODEX)(European Space Agency); EXANAM project	This work was supported by the European Space Agency (ESA-PRODEX) and the Belgian Science Policy (Belspo) through the EXANAM project (C90359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller JY, 2005, J AEROSOL SCI, V36, P801, DOI 10.1016/j.jaerosci.2004.10.012; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amato P, 2007, FEMS MICROBIOL ECOL, V59, P255, DOI 10.1111/j.1574-6941.2006.00198.x; Amoroso A, 2010, ENVIRON SCI TECHNOL, V44, P714, DOI 10.1021/es9027309; BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Clarke A, 2013, PLOS ONE, V8, P1; Cowan DA, 2011, TRENDS MICROBIOL, V19, P540, DOI 10.1016/j.tim.2011.07.008; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Donachie SP, 2005, INT J SYST EVOL MICR, V55, P1271, DOI 10.1099/ijs.0.63581-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Harding T, 2011, APPL ENVIRON MICROB, V77, P3234, DOI 10.1128/AEM.02611-10; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Junge K, 2004, APPL ENVIRON MICROB, V70, P550, DOI 10.1128/AEM.70.1.550-557.2004; La Cono V, 2013, ENVIRON MICROBIOL, V15, P1717, DOI 10.1111/1462-2920.12060; Larose C, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035004; Liu YQ, 2006, CHINESE SCI BULL, V51, P1476, DOI 10.1007/s11434-006-1476-7; Liu YQ, 2009, EXTREMOPHILES, V13, P411, DOI 10.1007/s00792-009-0227-5; Lopatina A, 2013, RES MICROBIOL, V164, P949, DOI 10.1016/j.resmic.2013.08.005; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lugg D, 1999, ACTA ASTRONAUT, V44, P693, DOI 10.1016/S0094-5765(99)00068-5; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Michaud L, 2012, FEMS MICROBIOL ECOL, V82, P391, DOI 10.1111/j.1574-6941.2012.01394.x; Miteva V, 2007, GEOMICROBIOL J, V24, P451, DOI 10.1080/01490450701437693; Miteva Vanya, 2008, P31, DOI 10.1007/978-3-540-74335-4_3; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Neef A, 1997, THESIS MUNICH; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Pyne SJ, 2007, SPACE POLICY, V23, P147, DOI 10.1016/j.spacepol.2007.06.006; Quesada A., 2012, ECOLOGY CYANOBACTERI, P387, DOI DOI 10.1007/978-94-007-3855-3_14; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schonhuber W, 1999, APPL ENVIRON MICROB, V65, P1259; Sowers T, 2001, J GEOPHYS RES-ATMOS, V106, P31903, DOI 10.1029/2000JD900707; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Tindall BJ, 2004, MICROB ECOL, V47, P271, DOI 10.1007/s00248-003-1050-7; Van Houdt R, 2013, EXTREMOPHILES, V17, P565, DOI 10.1007/s00792-013-0539-3; Velazquez D, 2011, POLAR BIOL, V34, P1045, DOI 10.1007/s00300-011-0964-7; Vincent Warwick F., 2007, V11; Vincent WF, 2000, ANTARCT SCI, V12, P374, DOI 10.1017/S0954102000000420; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yan PY, 2012, EXTREMOPHILES, V16, P345, DOI 10.1007/s00792-012-0434-3; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	60	26	27	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104505	10.1371/journal.pone.0104505	http://dx.doi.org/10.1371/journal.pone.0104505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101779	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900071
J	Schmid, MR; Anderl, I; Vesala, L; Vanha-aho, LM; Deng, XJ; Ramet, M; Hultmark, D				Schmid, Martin R.; Anderl, Ines; Vesala, Laura; Vanha-aho, Leena-Maija; Deng, Xiao-Juan; Ramet, Mika; Hultmark, Dan			Control of Drosophila Blood Cell Activation via Toll Signaling in the Fat Body	PLOS ONE			English	Article							IMMUNE-RESPONSE; TUMOR-SUPPRESSOR; GENE-EXPRESSION; MELANOGASTER; PATHWAY; HEMATOPOIESIS; HEMOCYTES; PROTEIN; DORSAL; LEPTOPILINA	The Toll signaling pathway, first discovered in Drosophila, has a well-established role in immune responses in insects as well as in mammals. In Drosophila, the Toll-dependent induction of antimicrobial peptide production has been intensely studied as a model for innate immune responses in general. Besides this humoral immune response, Toll signaling is also known to activate blood cells in a reaction that is similar to the cellular immune response to parasite infections, but the mechanisms of this response are poorly understood. Here we have studied this response in detail, and found that Toll signaling in several different tissues can activate a cellular immune defense, and that this response does not require Toll signaling in the blood cells themselves. Like in the humoral immune response, we show that Toll signaling in the fat body (analogous to the liver in vertebrates) is of major importance in the Toll-dependent activation of blood cells. However, this Toll-dependent mechanism of blood cell activation contributes very little to the immune response against the parasitoid wasp, Leptopilina boulardi, probably because the wasp is able to suppress Toll induction. Other redundant pathways may be more important in the defense against this pathogen.	[Schmid, Martin R.; Anderl, Ines; Deng, Xiao-Juan; Hultmark, Dan] Umea Univ, Dept Mol Biol, Umea, Sweden; [Anderl, Ines; Vesala, Laura; Vanha-aho, Leena-Maija; Ramet, Mika; Hultmark, Dan] Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland; [Deng, Xiao-Juan] South China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Umea University; Tampere University; South China Agricultural University; Tampere University; Tampere University Hospital	Hultmark, D (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	dan.hultmark@ucmp.umu.se	Hultmark, Dan/C-5058-2013; Schmid, Martin/M-3802-2014	Hultmark, Dan/0000-0002-6506-5855; Vanha-aho, Leena-Maija/0000-0001-7933-7711	Swedish Research Council; Swedish Cancer Society; Sigrid Juselius Foundation; Academy of Finland; Tampere University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Tampere University Hospital	This work was supported by the Swedish Research Council, the Swedish Cancer Society and the Sigrid Juselius Foundation to DH, the Academy of Finland to DH and MR, and Competitive Research Funding of the Tampere University Hospital to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres A.J., 1994, DROSOPHILA MELANOGAS, P565; Asha H, 2003, GENETICS, V163, P203; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; ERDELYI M, 1989, GENETICS, V122, P111; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; GERTTULA S, 1988, GENETICS, V119, P123; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Imler JL, 2014, DEV COMP IMMUNOL, V42, P3, DOI 10.1016/j.dci.2013.08.018; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Kroeger PT, 2012, GENESIS, V50, P41, DOI 10.1002/dvg.20787; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lindsay SA, 2014, DEV COMP IMMUNOL, V42, P16, DOI 10.1016/j.dci.2013.04.011; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Maxton-Kuchenmeister J, 1999, MECH DEVELOP, V83, P107, DOI 10.1016/S0925-4773(99)00041-6; Parisi F, 2014, CELL REP, V6, P855, DOI 10.1016/j.celrep.2014.01.039; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Qiu P, 1998, DEVELOPMENT, V125, P1909; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2004, GENETICS, V166, P1343, DOI 10.1534/genetics.166.3.1343; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	41	48	48	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102568	10.1371/journal.pone.0102568	http://dx.doi.org/10.1371/journal.pone.0102568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102059	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900003
J	Carreiras, JMB; Jones, J; Lucas, RM; Gabriel, C				Carreiras, Joao M. B.; Jones, Joshua; Lucas, Richard M.; Gabriel, Cristina			Land Use and Land Cover Change Dynamics across the Brazilian Amazon: Insights from Extensive Time-Series Analysis of Remote Sensing Data	PLOS ONE			English	Article							TAPAJOS NATIONAL FOREST; UPPER RIO NEGRO; TROPICAL FOREST; LANDSCAPE DYNAMICS; ABANDONED PASTURES; SECONDARY FORESTS; BIODIVERSITY LOSS; BURN AGRICULTURE; EASTERN AMAZONIA; CARBON-CYCLE	Throughout the Amazon region, the age of forests regenerating on previously deforested land is determined, in part, by the periods of active land use prior to abandonment and the frequency of reclearance of regrowth, both of which can be quantified by comparing time-series of Landsat sensor data. Using these time-series of near annual data from 1973-2011 for an area north of Manaus (in Amazonas state), from 1984-2010 for south of Santarem (Parastate) and 1984-2011 near Machadinho d'Oeste (Rondonia state), the changes in the area of primary forest, non-forest and secondary forest were documented from which the age of regenerating forests, periods of active land use and the frequency of forest reclearance were derived. At Manaus, and at the end of the time-series, over 50% of regenerating forests were older than 16 years, whilst at Santarem and Machadinho d'Oeste, 57% and 41% of forests respectively were aged 6-15 years, with the remainder being mostly younger forests. These differences were attributed to the time since deforestation commenced but also the greater frequencies of reclearance of forests at the latter two sites with short periods of use in the intervening periods. The majority of clearance for agriculture was also found outside of protected areas. The study suggested that a) the history of clearance and land use should be taken into account when protecting deforested land for the purpose of restoring both tree species diversity and biomass through natural regeneration and b) a greater proportion of the forested landscape should be placed under protection, including areas of regrowth.	[Carreiras, Joao M. B.; Gabriel, Cristina] Trop Res Inst IICT, Lisbon, Portugal; [Carreiras, Joao M. B.] Univ Sheffield, Ctr Terr Carbon Dynam, Natl Ctr Earth Observat, Sheffield, S Yorkshire, England; [Jones, Joshua; Lucas, Richard M.] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth, Ceredigion, Wales; [Lucas, Richard M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia	Universidade de Lisboa; University of Sheffield; Aberystwyth University; University of New South Wales Sydney	Carreiras, JMB (corresponding author), Trop Res Inst IICT, Lisbon, Portugal.	j.carreiras@sheffield.ac.uk	Carreiras, Joao M B/B-4520-2008; Jones, Joshua/U-1494-2017	Carreiras, Joao M B/0000-0003-2737-9420; Jones, Joshua/0000-0001-9047-9147; Lucas, Richard/0000-0003-3010-3302	"REGROWTH-BR - Remote sensing of regenerating tropical forests in Brazil: mapping and retrieving biophysical parameters" project [PTDC/AGR-CFL/114908/2009]; Foundation for Science and Technology (FCT), Portugal; NERC National Centre for Earth Observation [R8/H12/82]; NERC [nceo020005, earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003, nceo020005] Funding Source: researchfish	"REGROWTH-BR - Remote sensing of regenerating tropical forests in Brazil: mapping and retrieving biophysical parameters" project; Foundation for Science and Technology (FCT), Portugal(Portuguese Foundation for Science and Technology); NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the "REGROWTH-BR - Remote sensing of regenerating tropical forests in Brazil: mapping and retrieving biophysical parameters" project (Ref. PTDC/AGR-CFL/114908/2009), funded by the Foundation for Science and Technology (FCT, http://www.fct.pt/index.phtml.en), Portugal. J.M.B. Carreiras' work was partially funded by NERC National Centre for Earth Observation (Ref: R8/H12/82). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Batistella Mateus, 2005, Acta Amaz., V35, P239, DOI 10.1590/S0044-59672005000200014; Bierregaard R., 2001, LESSONS AMAZONIA ECO; Brazil INPE (Instituto Nacional de Pesquisas Espaciais), 2013, PROJ PRODES MON FLOR; Brondizio ES, 2012, POPUL ENVIRON, V34, P69, DOI 10.1007/s11111-011-0159-8; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; BUSCHBACHER R, 1988, J ECOL, V76, P682, DOI 10.2307/2260567; Bacha CJC, 2007, ECOL ECON, V63, P70, DOI 10.1016/j.ecolecon.2006.09.024; Cardille JA, 2003, REMOTE SENS ENVIRON, V87, P551, DOI 10.1016/j.rse.2002.09.001; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carreiras JMB, 2006, REMOTE SENS ENVIRON, V101, P283, DOI 10.1016/j.rse.2005.12.017; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Cochrane MA, 1998, INT J REMOTE SENS, V19, P3433, DOI 10.1080/014311698214109; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Espírito-Santo Fernando Del Bon, 2005, Acta Amaz., V35, P155, DOI 10.1590/S0044-59672005000200006; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Fearnside PM, 1996, FOREST ECOL MANAG, V80, P21, DOI 10.1016/0378-1127(95)03647-4; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; Ferraz SFD, 2005, FOREST ECOL MANAG, V204, P67, DOI 10.1016/j.foreco.2004.07.073; Gallego FJ, 2004, INT J REMOTE SENS, V25, P3019, DOI 10.1080/01431160310001619607; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Goulding M, 2003, SMITHSONIAN ATLAS AM; Hastie T., 2009, UNSUPERVISED LEARNIN; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Keller M, 2005, EARTH INTERACT, V9; Kimes DS, 1999, INT J REMOTE SENS, V20, P3625, DOI 10.1080/014311699211246; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Kuplich TM, 2006, FOREST ECOL MANAG, V234, P1, DOI 10.1016/j.foreco.2006.05.066; Laurance SGW, 2010, J VEG SCI, V21, P96, DOI 10.1111/j.1654-1103.2009.01122.x; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lederer M, 2011, ECOL ECON, V70, P1900, DOI 10.1016/j.ecolecon.2011.02.003; Lillesand T.M., 2000, REMOTE SENSING IMAGE, V4th ed.; Lu DS, 2003, REMOTE SENS ENVIRON, V87, P456, DOI 10.1016/j.rse.2002.06.001; Lucas RM, 2000, INT J REMOTE SENS, V21, P2855, DOI 10.1080/01431160050121285; Lucas RM, 2002, INT J REMOTE SENS, V23, P965, DOI 10.1080/01431160110069791; Lucas RM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013375; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Miranda EE, 2013, SUSTENTABILIDADE AGR; Navulur K., 2007, MULTISPECTRAL IMAGE; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Nepstad DC, 2011, CONSERV BIOL, V25, P1113, DOI 10.1111/j.1523-1739.2011.01784.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nolte C, 2013, P NATL ACAD SCI USA, V110, P4956, DOI 10.1073/pnas.1214786110; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pacheco P, 2009, WORLD DEV, V37, P1337, DOI 10.1016/j.worlddev.2008.08.019; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; PEREIRA MC, 1993, INT J REMOTE SENS, V14, P2061, DOI 10.1080/01431169308954022; Perz SG, 2003, SOC SCI RES, V32, P25, DOI 10.1016/S0049-089X(02)00012-1; Prates-Clark CD, 2009, CAN J REMOTE SENS, V35, P534; Prates-Clark CC, 2004, THESIS U WALES ABERY; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Raupach MR, 2011, NAT CLIM CHANGE, V1, P148, DOI 10.1038/nclimate1123; Roberts DA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000374; Rosa IMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077231; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Scatena FN, 1996, ECOL ECON, V18, P29, DOI 10.1016/0921-8009(95)00055-0; SCHROEDER PE, 1995, FOREST ECOL MANAG, V75, P87, DOI 10.1016/0378-1127(95)03533-G; Silva JMN, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016056; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; STONE TA, 1994, PHOTOGRAMM ENG REM S, V60, P541; TENENBEI.A, 1972, TECHNOMETRICS, V14, P187, DOI 10.2307/1266930; UHL C, 1984, ECOLOGY, V65, P1476, DOI 10.2307/1939128; UHL C, 1981, J ECOL, V69, P631, DOI 10.2307/2259689; UHL C, 1987, J ECOL, V75, P377, DOI 10.2307/2260425; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; van Gardingen PR, 2006, FOREST ECOL MANAG, V231, P184, DOI 10.1016/j.foreco.2006.05.047; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; WALSH TA, 1993, REMOTE SENS ENVIRON, V46, P281, DOI 10.1016/0034-4257(93)90048-3; Zarin DJ, 2001, ECOSYSTEMS, V4, P658, DOI 10.1007/s10021-001-0035-y	81	41	43	1	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104144	10.1371/journal.pone.0104144	http://dx.doi.org/10.1371/journal.pone.0104144			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25099362	Green Published, gold, Green Accepted			2022-12-25	WOS:000339995100051
J	Fukushima, M; Jutagate, T; Grudpan, C; Phomikong, P; Nohara, S				Fukushima, Michio; Jutagate, Tuantong; Grudpan, Chaiwut; Phomikong, Pisit; Nohara, Seiichi			Potential Effects of Hydroelectric Dam Development in the Mekong River Basin on the Migration of Siamese Mud Carp (Henicorhynchus siamensis and H-lobatus) Elucidated by Otolith Microchemistry	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; DESCRIBE MOVEMENTS; FISH OTOLITHS; CHEMISTRY; WATER; TEMPERATURE; SIGNATURES; STRONTIUM; RESERVOIR; HISTORY	The migration of Siamese mud carp (Henicorhynchus siamensis and H. lobatus), two of the most economically important fish species in the Mekong River, was studied using an otolith microchemistry technique. Fish and river water samples were collected in seven regions throughout the whole basin in Thailand, Laos and Cambodia over a 4 year study period. There was coherence between the elements in the ambient water and on the surface of the otoliths, with strontium (Sr) and barium (Ba) showing the strongest correlation. The partition coefficients were 0.409-0.496 for Sr and 0.055 for Ba. Otolith Sr-Ba profiles indicated extensive synchronized migrations with similar natal origins among individuals within the same region. H. siamensis movement has been severely suppressed in a tributary system where a series of irrigation dams has blocked their migration. H. lobatus collected both below and above the Khone Falls in the mainstream Mekong exhibited statistically different otolith surface elemental signatures but similar core elemental signatures. This result suggests a population originating from a single natal origin but bypassing the waterfalls through a passable side channel where a major hydroelectric dam is planned. The potential effects of damming in the Mekong River are discussed.	[Fukushima, Michio; Nohara, Seiichi] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Jutagate, Tuantong; Grudpan, Chaiwut; Phomikong, Pisit] Ubon Ratchathani Univ, Fac Agr, Dept Fisheries, Ubon Ratchathani, Thailand	National Institute for Environmental Studies - Japan; Ubon Ratchathani University	Fukushima, M (corresponding author), Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan.	michio@nies.go.jp			Mitsui & Co., Ltd. Environment Fund [R08-B034]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4D-1202]; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund [Ph.D./0236/2551]	Mitsui & Co., Ltd. Environment Fund; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by the Mitsui & Co., Ltd. Environment Fund (R08-B034) to MF and TJ, the Environment Research and Technology Development Fund (4D-1202) of the Ministry of the Environment, Japan to MF, and the Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund (Ph.D./0236/2551) to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2009, J FISH BIOL, V75, P1371, DOI 10.1111/j.1095-8649.2009.02369.x; Amarasinghe, 2009, STATUS RESERVOIR FIS, P96; [Anonymous], 2004, DISTRIBUTION ECOLOG; Baird Ian G., 2003, Natural History Bulletin of the Siam Society, V51, P5; Baird IG, 1996, CATCH CULTURE MEKONG, V2, P2; Baran E., 2010, ICEM 2010 MEKONG RIV; Baran E., 2001, FISH RESOURCE HYDROB; Baran E., 2006, FISH MIGRATION TRIGG; Baran E., 2005, FISHERIES BIOECOLOGY; Barlow C, 2008, CATCH CULTURE, V14, P16; Barthem R., 1997, CATFISH CONNECTION E; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campbell IC, 2009, AQUAT ECOL-SAN DIEGO, P251, DOI 10.1016/B978-0-12-374026-7.00010-3; Chheng P, 2005, BIOL REV IMPORTANT C; Clarke AD, 2007, J APPL ECOL, V44, P1156, DOI 10.1111/j.1365-2664.2007.01350.x; Coghlan SM, 2007, N AM J FISH MANAGE, V27, P531, DOI 10.1577/M06-118.1; Collingsworth PD, 2010, CAN J FISH AQUAT SCI, V67, P1187, DOI 10.1139/F10-050; Crook DA, 2006, RIVER RES APPL, V22, P871, DOI 10.1002/rra.941; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2003, MAR ECOL PROG SER, V260, P263, DOI 10.3354/meps260263; Ferguson JW, 2011, ENVIRON MANAGE, V47, P141, DOI 10.1007/s00267-010-9563-6; Fukushima M, 2012, J JAPAN SOC WATER EN, V35, P53; Gibson-Reinemer DK, 2009, CAN J FISH AQUAT SCI, V66, P513, DOI 10.1139/F09-015; Halden NM, 2008, MINERAL MAG, V72, P593, DOI 10.1180/minmag.2008.072.2.593; Hale R, 2008, MAR ECOL PROG SER, V354, P229, DOI 10.3354/meps07251; Hoff GR, 1997, T AM FISH SOC, V126, P488, DOI 10.1577/1548-8659(1997)126<0488:NOMAIV>2.3.CO;2; Hogan Z, 2007, J FISH BIOL, V71, P818, DOI 10.1111/j.1095-8649.2007.01549.x; Hortle KG, 2009, AQUAT ECOL-SAN DIEGO, P197, DOI 10.1016/B978-0-12-374026-7.00009-7; Hurwood DA, 2008, ECOL FRESHW FISH, V17, P272; Jackson D., 2001, DAMS; Jutagat T, 2005, FISHERIES MANAG ECOL, V12, P57, DOI 10.1111/j.1365-2400.2004.00419.x; Jutagate T, 2007, RIVER RES APPL, V23, P87, DOI 10.1002/rra.945; Lamberts D, 2001, FAO REGIONAL OFFICE; Lieng S, 1995, ASIAN FISH, V8, P255; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Martin GB, 2004, CAN J FISH AQUAT SCI, V61, P34, DOI 10.1139/F03-143; Miller JA, 2011, J EXP MAR BIOL ECOL, V405, P42, DOI 10.1016/j.jembe.2011.05.017; Milton DA, 2001, J EXP MAR BIOL ECOL, V264, P47, DOI 10.1016/S0022-0981(01)00301-X; MUGIYA Y, 1995, FISHERIES SCI, V61, P29, DOI 10.2331/fishsci.61.29; Muhlfeld CC, 2005, T AM FISH SOC, V134, P945, DOI 10.1577/T04-029.1; Muhlfeld CC, 2012, CAN J FISH AQUAT SCI, V69, P906, DOI 10.1139/F2012-033; Northcote TG, 1998, FISH MIGRATION AND FISH BYPASSES, P3; Pangle KL, 2010, CAN J FISH AQUAT SCI, V67, P1475, DOI 10.1139/F10-076; Phomikong P, 2014, RIVER RES A IN PRESS; Pongsri C, 2008, 10 DEP FISH; Puangchareon S, 2006, P 44 KAS U ANN C FIS, P21; Rainboth W.J., 1996, FAO SPECIES IDENTIFI; Roberts Tyson R., 1997, Natural History Bulletin of the Siam Society, V45, P171; Roberts Tyson R., 1995, Natural History Bulletin of the Siam Society, V43, P219; Sanchez-Jerez P, 2002, J FISH BIOL, V61, P801, DOI 10.1006/jfbi.2002.2109; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Suntornratana U, 2002, MRC C SERIES, P270; Suvarnaraksha A, 2011, J APPL ICHTHYOL, V27, P995, DOI 10.1111/j.1439-0426.2010.01619.x; Termvidchakorn A., 2013, 38 MRC; van Zalinge N., 2004, P 2 INT S MANAGEMENT, V1, P335; Welcomme RL, 2001, INLAND FISHERIES ECO; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Yen NTH, 2009, J GREAT LAKES RES, V35, P169, DOI 10.1016/j.jglr.2008.11.014; Zimmerman CE, 2009, T AM FISH SOC, V138, P280, DOI 10.1577/T08-044.1	61	23	23	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103722	10.1371/journal.pone.0103722	http://dx.doi.org/10.1371/journal.pone.0103722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099147	Green Submitted, gold, Green Published			2022-12-25	WOS:000339995100029
J	Nigro, D; Blanco, A; Anderson, OD; Gadaleta, A				Nigro, Domenica; Blanco, Antonio; Anderson, Olin D.; Gadaleta, Agata			Characterization of Ferredoxin-Dependent Glutamine-Oxoglutarate Amidotransferase (Fd-GOGAT) Genes and Their Relationship with Grain Protein Content QTL in Wheat	PLOS ONE			English	Article							AMMONIUM ASSIMILATION; SYNTHASE; NITROGEN; SYNTHETASE; METABOLISM; QUALITY; PLANTS; PHOTORESPIRATION; PURIFICATION; EXPRESSION	Background: In higher plants, inorganic nitrogen is assimilated via the glutamate synthase cycle or GS-GOGAT pathway. GOGAT enzyme occurs in two distinct forms that use NADH (NADH-GOGAT) or Fd (Fd-GOGAT) as electron carriers. The goal of the present study was to characterize wheat Fd-GOGAT genes and to assess the linkage with grain protein content (GPC), an important quantitative trait controlled by multiple genes. Results: We report the complete genomic sequences of the three homoeologous A, B and D Fd-GOGAT genes from hexaploid wheat (Triticum aestivum) and their localization and characterization. The gene is comprised of 33 exons and 32 introns for all the three homoeologues genes. The three genes show the same exon/intron number and size, with the only exception of a series of indels in intronic regions. The partial sequence of the Fd-GOGAT gene located on A genome was determined in two durum wheat (Triticum turgidum ssp. durum) cvs Ciccio and Svevo, characterized by different grain protein content. Genomic differences allowed the gene mapping in the centromeric region of chromosome 2A. QTL analysis was conducted in the Svevo xCiccio RIL mapping population, previously evaluated in 5 different environments. The study co-localized the Fd-GOGAT-A gene with the marker GWM-339, identifying a significant major QTL for GPC. Conclusions: The wheat Fd-GOGAT genes are highly conserved; both among the three homoeologous hexaploid wheat genes and in comparison with other plants. In durum wheat, an association was shown between the Fd-GOGAT allele of cv Svevo with increasing GPC - potentially useful in breeding programs.	[Nigro, Domenica; Blanco, Antonio; Gadaleta, Agata] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy; [Anderson, Olin D.] USDA ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, Albany, CA USA	Universita degli Studi di Bari Aldo Moro; United States Department of Agriculture (USDA)	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy.	agata.gadaleta@uniba.it	Gadaleta, Agata/H-2627-2012	Gadaleta, Agata/0000-0002-6312-249X; BLANCO, ANTONIO/0000-0002-2222-1133	Ministero dell'Istruzione, dell'Universita' e della Ricerca ['PON01_01145-ISCOCEM]; USDA Agricultural Research Service	Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca, projects 'PON01_01145-ISCOCEM' and 'PRIN-2010-2011, and by USDA Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA C, 1993, PLANTA, V189, P475, DOI 10.1007/BF00198209; Bernard SM, 2008, PLANT MOL BIOL, V67, P89, DOI 10.1007/s11103-008-9303-y; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Boisson M, 2005, THEOR APPL GENET, V110, P932, DOI 10.1007/s00122-004-1913-4; Bordes J, 2011, J CEREAL SCI, V54, P137, DOI 10.1016/j.jcs.2011.03.004; Campbell KG, 2001, CROP SCI, V41, P1275, DOI 10.2135/cropsci2001.4141275x; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Ferrario-Mery S, 2002, PLANTA, V214, P877, DOI 10.1007/s00425-001-0692-2; Ferrario-Mery S, 2002, PLANT SCI, V163, P59, DOI 10.1016/S0168-9452(02)00058-4; Fontaine JX, 2009, THEOR APPL GENET, V119, P645, DOI 10.1007/s00122-009-1076-4; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; Gadaleta A, 2011, FUNCT INTEGR GENOMIC, V11, P665, DOI 10.1007/s10142-011-0235-2; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; JOPPA LR, 1990, CROP SCI, V30, P1059, DOI 10.2135/cropsci1990.0011183X003000050021x; Khan IA, 2000, CROP SCI, V40, P518, DOI 10.2135/cropsci2000.402518x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KRAMER T, 1979, EUPHYTICA, V28, P209, DOI 10.1007/BF00056577; Lancien M, 2002, PLANT J, V29, P347, DOI 10.1046/j.1365-313X.2002.01218.x; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lea PJ, 2003, PLANT PHYSIOL BIOCH, V41, P555, DOI 10.1016/S0981-9428(03)00060-3; LEEGOOD RC, 1995, J EXP BOT, V46, P1397, DOI 10.1093/jxb/46.special_issue.1397; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; MARQUEZ AJ, 1988, PLANT PHYSIOL BIOCH, V26, P645; Miflin BJ, 1980, BIOCH PLANTS, V5; Nakayama T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-35; Nigro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073751; Prasad M, 1999, THEOR APPL GENET, V99, P341, DOI 10.1007/s001220051242; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Raman R, 2009, MOL BREEDING, V24, P153, DOI 10.1007/s11032-009-9280-0; SAKAKIBARA H, 1992, PLANT CELL PHYSIOL, V33, P49; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Suprayogi Y, 2009, THEOR APPL GENET, V119, P437, DOI 10.1007/s00122-009-1050-1; Suzuki A, 2005, PHOTOSYNTH RES, V83, P191, DOI 10.1007/s11120-004-3478-0; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Till BJ, 2004, NUCLEIC ACIDS RES, V32, P2632, DOI 10.1093/nar/gkh599; Till BJ, 2004, BMC PLANT BIOL, P4; Tobin AK, 2001, J EXP BOT, V52, P591, DOI 10.1093/jexbot/52.356.591; Trepp GB, 1999, PLANT PHYSIOL, V119, P829, DOI 10.1104/pp.119.3.829; Triboi E, 2002, EUR J AGRON, V16, P163, DOI 10.1016/S1161-0301(01)00146-0; Voorrips, 2001, JOINMAP VERSION 3 0; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; ZEHNACKER C, 1992, PLANTA, V187, P266, DOI 10.1007/BF00201950; Zhang L, 2008, PLANT SOIL, V303, P55, DOI 10.1007/s11104-007-9442-y	55	27	30	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103869	10.1371/journal.pone.0103869	http://dx.doi.org/10.1371/journal.pone.0103869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099972	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100036
J	Aberg, CH; Haubek, D; Kwamin, F; Johansson, A; Claesson, R				Aberg, Carola Hoglund; Haubek, Dorte; Kwamin, Francis; Johansson, Anders; Claesson, Rolf			Leukotoxic Activity of Aggregatibacter actinomycetemcomitans and Periodontal Attachment Loss	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; JP2 CLONE; AGGRESSIVE PERIODONTITIS; LONGITUDINAL COHORT; EXPRESSION; STRAINS; SEROTYPE; GENE; ADOLESCENTS; GENOTYPE	Aggregatibacter actinomycetemcomitans is a Gram-negative periodontitis-associated bacterium that expresses a toxin that selectively affects leukocytes. This leukotoxin is encoded by an operon belonging to the core genome of this bacterial species. Variations in the expression of the leukotoxin have been reported, and a well-characterized specific clonal type (JP2) of this bacterium with enhanced leukotoxin expression has been isolated. In particular, the presence of the JP2 genotype significantly increases the risk for the progression of periodontal attachment loss (AL). Based on these findings we hypothesized that variations in the leukotoxicity are linked to disease progression in infected individuals. In the present study, the leukotoxicity of 239 clinical isolates of A. actinomycetemcomitans was analysed with different bioassays, and the genetic peculiarities of the isolates were related to their leukotoxicity based on examination with molecular techniques. The periodontal status of the individuals sampled for the presence of A. actinomycetemcomitans was examined longitudinally, and the importance of the observed variations in leukotoxicity was evaluated in relation to disease progression. Our data show that high leukotoxicity correlates with an enhanced risk for the progression of AL. The JP2 genotype isolates were all highly leukotoxic, while the isolates with an intact leukotoxin promoter (non-JP2 genotypes) showed substantial variation in leukotoxicity. Genetic characterization of the non-JP2 genotype isolates indicated the presence of highly leukotoxic genotypes of serotype b with similarities to the JP2 genotype. Based on these results, we conclude that A. actinomycetemcomitans harbours other highly virulent genotypes besides the previously described JP2 genotype. In addition, the results from the present study further highlight the importance of the leukotoxin as a key virulence factor in aggressive forms of periodontitis.	[Aberg, Carola Hoglund; Johansson, Anders] Umea Univ, Dept Odontol, Fac Med, Div Mol Periodontol, Umea, Sweden; [Haubek, Dorte] Aarhus Univ, Dept Dent, Sect Pediat Dent, Aarhus, Denmark; [Kwamin, Francis] Univ Ghana, Sch Dent, Accra, Ghana; [Claesson, Rolf] Umea Univ, Dept Odontol, Fac Med, Umea, Sweden	Umea University; Aarhus University; University of Ghana; Umea University	Claesson, R (corresponding author), Umea Univ, Dept Odontol, Fac Med, Umea, Sweden.	rolf.claesson@odont.umu.se			Swedish National Graduate School in Odontological Science; Research Fund (TUA); County of Vasterbotten, Sweden; Swedish Dental Association, Sweden; Ingeborg and Leo Dannins Foundation; Aarhus University Research Foundation [F-2009-SUN-1-57]; Danish Dental Association	Swedish National Graduate School in Odontological Science; Research Fund (TUA); County of Vasterbotten, Sweden; Swedish Dental Association, Sweden; Ingeborg and Leo Dannins Foundation; Aarhus University Research Foundation; Danish Dental Association	This study was supported by the Swedish National Graduate School in Odontological Science, the Research Fund (TUA), County of Vasterbotten, Sweden, the Swedish Dental Association, Sweden, Ingeborg and Leo Dannins Foundation, Aarhus University Research Foundation (F-2009-SUN-1-57), funds from the Danish Dental Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2014, J CLIN PERIODONTOL, V41, P232, DOI 10.1111/jcpe.12209; Aberg CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065781; Aberg CH, 2012, J PERIODONTOL, V83, P1520, DOI 10.1902/jop.2012.110699; Balashova NV, 2006, INFECT IMMUN, V74, P2015, DOI 10.1128/IAI.74.4.2015-2021.2006; BROGAN JM, 1994, INFECT IMMUN, V62, P501, DOI 10.1128/IAI.62.2.501-508.1994; Claesson R, 2002, J PERIODONTAL RES, V37, P353, DOI 10.1034/j.1600-0765.2002.00365.x; Claesson R, 2011, J CLIN PERIODONTOL, V38, P115, DOI 10.1111/j.1600-051X.2010.01643.x; Dogan B, 1999, ORAL MICROBIOL IMMUN, V14, P98, DOI 10.1034/j.1399-302X.1999.140204.x; Eriksen KT, 2005, MICROBIOL-SGM, V151, P3371, DOI 10.1099/mic.0.28193-0; Feuerbacher LA, 2011, MICROB PATHOGENESIS, V51, P133, DOI 10.1016/j.micpath.2011.04.009; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Guthmiller JM, 2001, CRIT REV ORAL BIOL M, V12, P116, DOI 10.1177/10454411010120020201; Haubek D, 1997, J CLIN MICROBIOL, V35, P3037, DOI 10.1128/JCM.35.12.3037-3042.1997; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Haubek D, 2007, INFECT IMMUN, V75, P3080, DOI 10.1128/IAI.01734-06; Haubek D, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2010.02665.x; He T, 1998, J PERIODONTOL, V69, P69, DOI 10.1902/jop.1998.69.1.69; He T, 1999, J PERIODONTOL, V70, P1261, DOI 10.1902/jop.1999.70.11.1261; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Inoue T, 2001, MICROBIOL-SGM, V147, P2749, DOI 10.1099/00221287-147-10-2749; Jentsch H, 2012, CLIN ORAL INVEST, V16, P1589, DOI 10.1007/s00784-012-0672-x; Johansson A, 2000, J PERIODONTAL RES, V35, P85, DOI 10.1034/j.1600-0765.2000.035002085.x; Johansson A, 2011, TOXINS, V3, P242, DOI 10.3390/toxins3030242; Kelk P, 2003, INFECT IMMUN, V71, P4448, DOI 10.1128/IAI.71.8.4448-4455.2003; Kelk P, 2008, INT J MED MICROBIOL, V298, P529, DOI 10.1016/j.ijmm.2007.06.005; Kolodrubetz D, 2003, RES MICROBIOL, V154, P645, DOI 10.1016/j.resmic.2003.09.001; KOLODRUBETZ D, 1989, INFECT IMMUN, V57, P1465, DOI 10.1128/IAI.57.5.1465-1469.1989; Kolodrubetz D, 1996, INFECT IMMUN, V64, P3451, DOI 10.1128/IAI.64.9.3451-3460.1996; KRAIG E, 1990, INFECT IMMUN, V58, P920, DOI 10.1128/IAI.58.4.920-929.1990; LALLY ET, 1989, BIOCHEM BIOPH RES CO, V159, P256, DOI 10.1016/0006-291X(89)92431-5; Macheleidt A, 1999, Clin Oral Investig, V3, P161, DOI 10.1007/s007840050096; Mitchell C, 2003, INFECT IMMUN, V71, P5640, DOI 10.1128/IAI.71.10.5640-5649.2003; Paju S, 1998, J CLIN MICROBIOL, V36, P2019, DOI 10.1128/JCM.36.7.2019-2022.1998; Paju S, 2000, J CLIN MICROBIOL, V38, P79; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Poulsen K, 2003, J CLIN MICROBIOL, V41, P4829, DOI 10.1128/JCM.41.10.4829-4832.2003; Reinholdt J, 2013, BBA-PROTEINS PROTEOM, V1834, P546, DOI 10.1016/j.bbapap.2012.12.004; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; SPITZNAGEL J, 1991, INFECT IMMUN, V59, P1394, DOI 10.1128/IAI.59.4.1394-1401.1991; Van der Velden U, 2006, J CLIN PERIODONTOL, V33, P540, DOI 10.1111/j.1600-051X.2006.00953.x; Yang HW, 2004, J PERIODONTOL, V75, P592, DOI 10.1902/jop.2004.75.4.592; ZAMBON JJ, 1983, INFECT IMMUN, V41, P19, DOI 10.1128/IAI.41.1.19-27.1983	42	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104095	10.1371/journal.pone.0104095	http://dx.doi.org/10.1371/journal.pone.0104095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093857	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200065
J	Gersten, M; Zhou, D; Azad, P; Haddad, GG; Subramaniam, S				Gersten, Merril; Zhou, Dan; Azad, Priti; Haddad, Gabriel G.; Subramaniam, Shankar			Wnt Pathway Activation Increases Hypoxia Tolerance during Development	PLOS ONE			English	Article							BETA-CATENIN; GENE-EXPRESSION; EXPERIMENTAL SELECTION; SIGNALING PATHWAYS; DROSOPHILA; NOTCH; ADAPTATION; ONTOLOGY; CELLS; STEM	Adaptation to hypoxia, defined as a condition of inadequate oxygen supply, has enabled humans to successfully colonize high altitude regions. The mechanisms attempted by organisms to cope with short-term hypoxia include increased ATP production via anaerobic respiration and stabilization of Hypoxia Inducible Factor 1 alpha (HIF-1 alpha). However, less is known about the means through which populations adapt to chronic hypoxia during the process of development within a life time or over generations. Here we show that signaling via the highly conserved Wnt pathway impacts the ability of Drosophila melanogaster to complete its life cycle under hypoxia. We identify this pathway through analyses of genome sequencing and gene expression of a Drosophila melanogaster population adapted over >180 generations to tolerate a concentration of 3.5-4% O-2 in air. We then show that genetic activation of the Wnt canonical pathway leads to increased rates of adult eclosion in low O-2. Our results indicate that a previously unsuspected major developmental pathway, Wnt, plays a significant role in hypoxia tolerance.	[Gersten, Merril; Subramaniam, Shankar] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Zhou, Dan; Azad, Priti; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu; shankar@ucsd.edu	Zhou, Dan/T-7203-2017	Azad, Priti/0000-0002-7615-9507; Zhou, Dan/0000-0001-6401-9040	Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [5P01HD032573]; National Heart, Lung, and Blood Institute [1P01HL098053, 5 R33 HL087375-02]; National Institute of Neurological Disorders and Stroke [5R01NS037756]; American Heart Association [0835188N]; National Science Foundation (NSF) [DBI-0641037]; NSF Collaborative Grant [DBI-0835541]; National Institute of Health/National Institute of General Medical Sciences Grant [GM078005-05]; NSF [STC-0939370]; Div Of Biological Infrastructure [0835541] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087375, P01HL098053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Collaborative Grant; National Institute of Health/National Institute of General Medical Sciences Grant; NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 5P01HD032573 (GGH), National Heart, Lung, and Blood Institute Grant 1P01HL098053 (GGH), National Institute of Neurological Disorders and Stroke Grant 5R01NS037756 (GGH), American Heart Association Award 0835188N (DZ), National Heart, Lung and Blood Institute Grant 5 R33 HL087375-02 (S. S.), National Science Foundation (NSF) Grant DBI-0641037 (S. S.), NSF Collaborative Grant DBI-0835541 (S. S.), National Institute of Health/National Institute of General Medical Sciences Grant GM078005-05 (S. S.), and NSF Collaborative Grant STC-0939370 (S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Affymetrix, 2005, TECHN NOT GUID PROB; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Archbold HC, 2011, ACTA PHYSL OXF; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Azad P, 2011, FREE RADICAL BIO MED, V51, P530, DOI 10.1016/j.freeradbiomed.2011.05.005; Costello JC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r97; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De Strooper B, 2001, J CELL BIOL, V152, pF17, DOI 10.1083/jcb.152.4.F17; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fauvarque MO, 2011, J CELL SCI, V124, P1373, DOI 10.1242/jcs.064592; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Komiya Yuko, 2008, Organogenesis, V4, P68; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Munoz-Descalzo S., 2010, FLY AUSTIN, V4; Polakis P, 2000, GENE DEV, V14, P1837; R Core Team, 2012, R LANG ENV STAT COMP; Rademakers SE, 2008, MOL ONCOL, V2, P41, DOI 10.1016/j.molonc.2008.03.006; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106; Scherbakov AM, 2013, EXP CELL RES, V319, P3150, DOI 10.1016/j.yexcr.2013.08.019; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Streiner DL, 1996, CAN J PSYCHIAT, V41, P498, DOI 10.1177/070674379604100805; Takemaru K. -I., 2008, V186, P261, DOI 10.1007/978-3-540-72843-6_11; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Williams MJ, 2007, J CELL SCI, V120, P502, DOI 10.1242/jcs.03341; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	67	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103292	10.1371/journal.pone.0103292	http://dx.doi.org/10.1371/journal.pone.0103292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093834	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200019
J	Kamiya, K; Hori, M; Miyajima, M; Nakajima, M; Suzuki, Y; Kamagata, K; Suzuki, M; Arai, H; Ohtomo, K; Aoki, S				Kamiya, Kouhei; Hori, Masaaki; Miyajima, Masakazu; Nakajima, Madoka; Suzuki, Yuriko; Kamagata, Koji; Suzuki, Michimasa; Arai, Hajime; Ohtomo, Kuni; Aoki, Shigeki			Axon Diameter and Intra-Axonal Volume Fraction of the Corticospinal Tract in Idiopathic Normal Pressure Hydrocephalus Measured by Q-Space Imaging	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; PYRAMIDAL TRACT; SPINAL-CORD; TENSOR; TRACTOGRAPHY; MICROSTRUCTURE; MANAGEMENT; DIAGNOSIS	Purpose: Previous studies suggest that compression and stretching of the corticospinal tract (CST) potentially cause treatable gait disturbance in patients with idiopathic normal pressure hydrocephalus (iNPH). Measurement of axon diameter with diffusion MRI has recently been used to investigate microstructural alterations in neurological diseases. In this study, we investigated alterations in the axon diameter and intra-axonal fraction of the CST in iNPH by q-space imaging (QSI) analysis. Methods: Nineteen patients with iNPH and 10 age-matched controls were recruited. QSI data were obtained with a 3-T system by using a single-shot echo planar imaging sequence with the diffusion gradient applied parallel to the anteroposterior axis. By using a two-component low-q fit model, the root mean square displacements of intra-axonal space (= axon diameter) and intra-axonal volume fraction of the CST were calculated at the levels of the internal capsule and body of the lateral ventricle, respectively. Results: Wilcoxon's rank-sum test revealed a significant increase in CST intra-axonal volume fraction at the paraventricular level in patients (p<0.001), whereas no significant difference was observed in the axon diameter. At the level of the internal capsule, neither axon diameter nor intra-axonal volume fraction differed significantly between the two groups. Conclusion: Our results suggest that in patients with iNPH, the CST does not undergo irreversible axonal damage but is rather compressed and/or stretched owing to pressure from the enlarged ventricle. These analyses of axon diameter and intra-axonal fraction yield insights into microstructural alterations of the CST in iNPH.	[Kamiya, Kouhei; Hori, Masaaki; Suzuki, Yuriko; Kamagata, Koji; Suzuki, Michimasa; Aoki, Shigeki] Juntendo Univ Grad Sch Med, Dept Radiol, Tokyo, Japan; [Miyajima, Masakazu; Nakajima, Madoka; Arai, Hajime] Juntendo Univ Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Suzuki, Yuriko] Philips Elect Japan Ltd, Tokyo, Japan; [Kamiya, Kouhei; Ohtomo, Kuni] Univ Tokyo, Dept Radiol, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Philips; University of Tokyo	Kamiya, K (corresponding author), Juntendo Univ Grad Sch Med, Dept Radiol, Tokyo, Japan.	kkamiya-tky@umin.ac.jp	Hori, Masaaki/G-1235-2010; Nakajima, Madoka/AAU-6505-2021	Hori, Masaaki/0000-0002-1791-8032; Kamagata, Koji/0000-0001-5028-218X; Suzuki, Yuriko/0000-0002-4851-7872	Ministry of Health, Labor and Welfare of Japan [2011-Nanchi-018]; Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a Research Grant from the Ministry of Health, Labor and Welfare of Japan (2011-Nanchi-018) and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; AKAI K, 1987, ACTA PATHOL JAPON, V37, P97; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2006, AM J NEURORADIOL, V27, P1717; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Assaf Y, 2013, NEUROIMAGE, V80, P273, DOI 10.1016/j.neuroimage.2013.05.055; Bar-Shir A, 2008, J MAGN RESON, V194, P230, DOI 10.1016/j.jmr.2008.07.009; Barazany D., 2011, PROC 19 ANN M ISMRM, P76; BRADLEY WG, 1991, AM J NEURORADIOL, V12, P31; Cluskey S, 2001, J CLIN PATHOL-MOL PA, V54, P386; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Conturo TE, 2008, J INT NEUROPSYCH SOC, V14, P933, DOI 10.1017/S1355617708081381; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; DIROCCO C, 1977, J NEUROL SCI, V33, P437, DOI 10.1016/0022-510X(77)90139-3; Dyrby TB, 2013, MAGN RESON MED, V70, P711, DOI 10.1002/mrm.24501; Farrell JAD, 2010, MAGN RESON MED, V63, P1323, DOI 10.1002/mrm.22389; Hakim S, 1976, Surg Neurol, V5, P187; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hattori T, 2012, AM J NEURORADIOL, V33, P97, DOI 10.3174/ajnr.A2706; Hattori T, 2011, AM J NEURORADIOL, V32, P1681, DOI 10.3174/ajnr.A2570; Holodny AI, 2005, RADIOLOGY, V234, P649, DOI 10.1148/radiol.2343032087; Hori M, 2012, MAGN RESON MED SCI, V11, P221, DOI 10.2463/mrms.11.221; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Jang SH, 2011, J NEUROIMAGING, V21, P69, DOI 10.1111/j.1552-6569.2009.00394.x; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jurcoane A, 2013, NEURORADIOLOGY; Kim JS, 2005, NEUROLOGY, V64, P1438, DOI 10.1212/01.WNL.0000158656.09335.E7; Kim MJ, 2011, AM J NEURORADIOL, V32, P1496, DOI 10.3174/ajnr.A2531; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Marmarou A, 2005, J NEUROSURG, V102, P987, DOI 10.3171/jns.2005.102.6.0987; Mayzel-Oreg O, 2007, J NEUROL SCI, V257, P105, DOI 10.1016/j.jns.2007.01.048; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Meier U, 2006, ACTA NEUROCHIR SUPPL, V96, P377; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Morozov D, 2013, NMR BIOMED, V26, P1787, DOI 10.1002/nbm.3018; Nakanishi A, 2013, NEURORADIOLOGY, V55, P971, DOI 10.1007/s00234-013-1201-6; Ong HH, 2010, NEUROIMAGE, V51, P1360, DOI 10.1016/j.neuroimage.2010.03.063; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; RITCHIE JM, 1982, PROC R SOC SER B-BIO, V217, P29, DOI 10.1098/rspb.1982.0092; Sasaki M, 2008, NEURORADIOLOGY, V50, P117, DOI 10.1007/s00234-007-0318-x; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Scheel M, 2012, ACTA NEUROCHIR, V154, P1699, DOI 10.1007/s00701-012-1377-2; Shemesh N, 2009, J MAGN RESON, V198, P15, DOI 10.1016/j.jmr.2009.01.004; Shizukuishi T, 2013, MAGN RESON MED SCI, V12, P153, DOI 10.2463/mrms.2012-0082; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yamada K, 2007, J MAGN RESON IMAGING, V26, P519, DOI 10.1002/jmri.21006; Zolal A, 2012, ACTA NEUROCHIR, V154, P1097, DOI 10.1007/s00701-012-1326-0	53	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103842	10.1371/journal.pone.0103842	http://dx.doi.org/10.1371/journal.pone.0103842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093733	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200035
J	Qin, YJ; Chu, KO; Yip, YWY; Li, WY; Yang, YP; Chan, KP; Ren, JL; Chan, SO; Pang, CP				Qin, Yong Jie; Chu, Kai On; Yip, Yolanda Wong Ying; Li, Wai Ying; Yang, Ya Ping; Chan, Kwok Ping; Ren, Jia Lin; Chan, Sun On; Pang, Chi Pui			Green Tea Extract Treatment Alleviates Ocular Inflammation in a Rat Model of Endotoxin-Induced Uveitis	PLOS ONE			English	Article							EPIGALLOCATECHIN GALLATE; SIGNALING PATHWAYS; TNF-ALPHA; EXPRESSION; RECOGNITION; MECHANISMS; CYTOKINES; (-)-EPIGALLOCATECHIN-3-GALLATE; POLYPHENOLS; CATECHINS	Green tea extract (GTE) ingested by rats exerted anti-oxidative activities in various ocular tissues as shown in our previous studies. The present work investigated anti-inflammatory effects of GTE on endotoxin-induced uveitis (EIU). EIU was generated in adult rats by a footpad injection of 1 mg/kg lipopolysaccharide (LPS). Oral administration of GTE (550 mg/kg) was given one, two or four times after LPS injection. Twenty-four hours later, LPS produced severe hyperemia and edema in the iris. Immunocytochemical examinations showed an accumulation of infiltrating cells in the aqueous humor that were immunopositive for cluster of differentiation 43 (CD43) and CD68, markers for leucocytes and macrophages, respectively. Analyses of the aqueous humor showed an increase in pro-inflammatory mediators including tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1). GTE treatments improved the clinical manifestations and reduced infiltrating cells and protein exudation in the aqueous humor, which were not observed under half dose of GTE (275 mg/kg). The number of CD68 positive macrophages residing in the iris and ciliary was also reduced. GTE suppressed production of TNF-alpha, IL-6 and MCP-1 in the aqueous humor, which was associated with a down-regulation of LPS receptor complex subunits, Toll-like receptor 4 (TLR-4) and CD14, and suppression of nuclear factor-kappa Bp65 (NF-kappa Bp65) in the iris and ciliary body. Our findings show that GTE is a potent anti-inflammatory agent against the inflammation of EIU, and suggest a potential use in treatment of acute uveitis.	[Qin, Yong Jie; Chu, Kai On; Yip, Yolanda Wong Ying; Li, Wai Ying; Yang, Ya Ping; Chan, Kwok Ping; Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Ren, Jia Lin; Chan, Sun On] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, SO (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	sunonchan@cuhk.edu.hk; cppang@cuhk.edu.hk	Chan, Sun-On/R-6547-2018; Chan, Kwok Ping/E-6044-2016	Chan, Sun-On/0000-0002-3221-3786; Chan, Kwok Ping/0000-0003-2416-1995; Qin, Yong Jie/0000-0003-3117-0865	University Grants Committee Hong Kong, a GRF Grant [CUHK461612]; Lui Che Woo Institute of Innovative Medicine [8303107]; Endowment Fund for Lim Por-Yen Eye Genetics Research Centre, Hong Kong	University Grants Committee Hong Kong, a GRF Grant; Lui Che Woo Institute of Innovative Medicine; Endowment Fund for Lim Por-Yen Eye Genetics Research Centre, Hong Kong	This work was supported in part by a block grant of the University Grants Committee Hong Kong, a GRF Grant (Project No. CUHK461612), a seed grant from Lui Che Woo Institute of Innovative Medicine (Project No. 8303107) and the Endowment Fund for Lim Por-Yen Eye Genetics Research Centre, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3368; BHATTACHERJEE P, 1983, INVEST OPHTH VIS SCI, V24, P196; Brito BE, 2004, EXP EYE RES, V79, P203, DOI 10.1016/j.exer.2004.03.012; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Cavet ME, 2011, MOL VIS, V17, P533; Chertin B, 2003, EUR UROL, V44, P144, DOI 10.1016/S0302-2838(03)00190-8; Chu KO, 2010, J AGR FOOD CHEM, V58, P1523, DOI 10.1021/jf9032602; da Silva PS, 2011, MOL VIS, V17, P1310; de Visser L, 2009, INFECTIOUS UVEITIS N, P148; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; GREWAL HP, 1994, AM J SURG, V167, P214, DOI 10.1016/0002-9610(94)90076-0; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Heiligenhaus A, 2010, GRAEF ARCH CLIN EXP, V248, P1531, DOI 10.1007/s00417-010-1485-8; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kalariya NM, 2011, INVEST OPHTH VIS SCI, V52, P5144, DOI 10.1167/iovs.10-7047; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koizumi K, 2003, INVEST OPHTH VIS SCI, V44, P2184, DOI 10.1167/iovs.02-0589; Lee FF, 2010, EXPERT OPIN PHARMACO, V11, P1135, DOI 10.1517/14656561003713534; Lee HS, 2011, CORNEA, V30, P1465, DOI 10.1097/ICO.0b013e31821c9b5a; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; Masukawa Y, 2006, J CHROMATOGR B, V834, P26, DOI 10.1016/j.jchromb.2006.02.008; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Nguyen QD, 2006, RETINA-J RET VIT DIS, P1; Nguyen QD, 2011, OPHTHALMOLOGY, V118, P184, DOI 10.1016/j.ophtha.2010.03.029; Ohgami K, 2005, INVEST OPHTH VIS SCI, V46, P275, DOI 10.1167/iovs.04-0715; OKUMURA A, 1990, INT OPHTHALMOL, V14, P31, DOI 10.1007/BF00131166; OKUMURA A, 1988, JPN J OPHTHALMOL, V32, P457; Ooi KGJ, 2006, CLIN MED RES, V4, P294, DOI 10.3121/cmr.4.4.294; Piazza M, 2009, J MED CHEM, V52, P1209, DOI 10.1021/jm801333m; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pooran N, 2003, J CLIN GASTROENTEROL, V37, P263, DOI 10.1097/00004836-200309000-00013; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Pouvreau I, 1998, J NEUROIMMUNOL, V86, P171, DOI 10.1016/S0165-5728(98)00042-3; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Siddique SS, 2011, EXPERT OPIN INV DRUG, V20, P1497, DOI 10.1517/13543784.2011.617741; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; Stangl V, 2007, CARDIOVASC RES, V73, P348, DOI 10.1016/j.cardiores.2006.08.022; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tuaillon N, 2002, INVEST OPHTH VIS SCI, V43, P1493; VANKESSEL KPM, 1991, J IMMUNOL, V147, P3862; Wakefield D, 2010, BRIT J OPHTHALMOL, V94, P271, DOI 10.1136/bjo.2008.146753; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029155; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021	50	25	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103995	10.1371/journal.pone.0103995	http://dx.doi.org/10.1371/journal.pone.0103995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093862	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200056
J	Sang, TT; Cao, Q; Wang, YQ; Liu, F; Chen, SY				Sang, Tiantian; Cao, Qing; Wang, Yuqiang; Liu, Fang; Chen, Shuyan			Overexpression or Silencing of FOXO3a Affects Proliferation of Endothelial Progenitor Cells and Expression of Cell Cycle Regulatory Proteins	PLOS ONE			English	Article							ACTIVATION; INHIBITOR; THERAPY; CANCER; AKT; P27; SENESCENCE; P27(KIP1)	Endothelial dysfunction is involved in the pathogenesis of many cardiovascular diseases such as atherosclerosis. Endothelial progenitor cells (EPCs) have been considered to be of great significance in therapeutic angiogenesis. Furthermore, the Forkhead box O (FOXO) transcription factors are known to be important regulators of cell cycle. Therefore, we investigated the effects of changes in FOXO3a activity on cell proliferation and cell cycle regulatory proteins in EPCs. The constructed recombinant adenovirus vectors Ad-TM (triple mutant)-FOXO3a, Ad-shRNA-FOXO3a and the control Ad-GFP were transfected into EPCs derived from human umbilical cord blood. Assessment of transfection efficiency using an inverted fluorescence microscope and flow cytometry indicated a successful transfection. Additionally, the expression of FOXO3a was markedly increased in the Ad-TM-FOXO3a group but was inhibited in the Ad-shRNA-FOXO3a group as seen by western blotting. Overexpression of FOXO3a suppressed EPC proliferation and modulated expression of the cell cycle regulatory proteins including upregulation of the cell cycle inhibitor p27(kip1) and downregulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 and proliferating cell nuclear antigen (PCNA). In the Ad-shRNA-FOXO3a group, the results were counterproductive. Furthermore, flow cytometry for cell cycle analysis suggested that the active mutant of FOXO3a caused a noticeable increase in G1- and S-phase frequencies, while a decrease was observed after FOXO3a silencing. In conclusion, these data demonstrated that FOXO3a could possibly inhibit EPC proliferation via cell cycle arrest involving upregulation of p27(kip1) and downregulation of CDK2, cyclin D1 and PCNA.	[Sang, Tiantian; Cao, Qing; Wang, Yuqiang; Liu, Fang; Chen, Shuyan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gerontol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Liu, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gerontol, Shanghai 200030, Peoples R China.	Fangliucn@163.com; shuyanchencn@hotmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Sang, Tiantian/GPT-0103-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; 	National Natural Science Foundation of China [30973152, 81270205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 30973152 and 81270205). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; Balestrieri ML, 2013, DIABETOLOGIA, V56, P162, DOI 10.1007/s00125-012-2749-0; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Chen SW, 2009, J ELECTRON MATER, V38, P1, DOI 10.1007/s11664-008-0572-7; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; Fillies T, 2007, ONCOL REP, V17, P355; Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6; Jahn SC, 2013, BIOCHEMISTRY; Lau CJ, 2009, CANCER RES, V69, P5433, DOI 10.1158/0008-5472.CAN-08-4540; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wang F., 2013, MICROVASC RES; Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhong S, 2013, CHEM-BIOL INTERACT, V206, P222, DOI 10.1016/j.cbi.2013.09.008; Zhu JH, 2006, J MOL CELL CARDIOL, V40, P648, DOI 10.1016/j.yjmcc.2006.01.011; Zhu SK, 2008, CIRCULATION, V118, P2156, DOI 10.1161/CIRCULATIONAHA.108.787200	29	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101703	10.1371/journal.pone.0101703	http://dx.doi.org/10.1371/journal.pone.0101703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093499	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200005
J	Vecoli, C; Novelli, M; Pippa, A; Giacopelli, D; Beffy, P; Masiello, P; L'Abbate, A; Neglia, D				Vecoli, Cecilia; Novelli, Michela; Pippa, Anna; Giacopelli, Daniela; Beffy, Pascale; Masiello, Pellegrino; L'Abbate, Antonio; Neglia, Danilo			Partial Deletion of eNOS Gene Causes Hyperinsulinemic State, Unbalance of Cardiac Insulin Signaling Pathways and Coronary Dysfunction Independently of High Fat Diet	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MICE LACKING; ENDOTHELIAL DYSFUNCTION; ARTERY-DISEASE; RESISTANCE; HYPERTENSION; POLYMORPHISM; EXPRESSION; RISK; AKT	Abnormalities in eNOS gene, possibly interacting with high fat diet (HFD), affect peripheral vascular function and glucose metabolism. The relative role of eNOS gene, HFD and metabolic derangement on coronary function has not been fully elucidated. We test whether eNOS gene deficiency per se or in association with HFD modulates coronary function through mechanisms involving molecular pathways related to insulin signaling. Wild type (WT), eNOS(-/-) and eNOS(+/-) mice were studied. WT and eNOS(+/-) mice were fed with either standard or HF diet for 16 weeks and compared with standard diet fed eNOS(-/-). Glucose and insulin tolerance tests were performed during the last week of diet. Coronary resistance (CR) was measured at baseline and during infusions of acetylcholine (Ach) or sodium-nitroprusside (SNP) to evaluate endothelium-dependent or independent vasodilation, in the Langendorff isolated hearts. Cardiac expression of Akt and ERK genes as evaluation of two major insulin-regulated signaling pathways involved in the control of vascular tone were assessed by western blot. HFD-fed mice developed an overt diabetic state. Conversely, chow-fed genetically modified mice (in particular eNOS(-/-)) showed a metabolic pattern characterized by normoglycemia and hyperinsulinemia with a limited degree of insulin resistance. CR was significantly higher in animals with eNOS gene deletions than in WT, independently of diet. Percent decrease in CR, during Ach infusion, was significantly lower in both eNOS(-/-) and eNOS(+/-) mice than in WT, independently of diet. SNP reduced CR in all groups except eNOS(-/-). The cardiac ERK1-2/Akt ratio, increased in animals with eNOS gene deletions compared with WT, independently of diet. These results suggest that the eNOS genetic deficiency, associated or not with HFD, has a relevant effect on coronary vascular function, possibly mediated by increase in blood insulin levels and unbalance in insulin-dependent signaling in coronary vessels, consistent with a shift towards a vasoconstrictive pattern.	[Vecoli, Cecilia; Giacopelli, Daniela; Beffy, Pascale; L'Abbate, Antonio; Neglia, Danilo] Clin CNR, Ist Fisiol, Pisa, Italy; [Novelli, Michela; Masiello, Pellegrino] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Pippa, Anna; L'Abbate, Antonio] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Neglia, Danilo] Fdn Toscana G Monasterio CNR, Pisa, Italy	University of Pisa; Scuola Superiore Sant'Anna	Neglia, D (corresponding author), Clin CNR, Ist Fisiol, Pisa, Italy.	dneglia@ifc.cnr.it	Vecoli, Cecilia/K-8613-2016; Neglia, Danilo/AAR-6384-2020	Vecoli, Cecilia/0000-0002-5921-3604; Neglia, Danilo/0000-0003-0016-9538	Scuola Superiore Sant'Anna; IFC-CNR	Scuola Superiore Sant'Anna; IFC-CNR(Consiglio Nazionale delle Ricerche (CNR))	Scuola Superiore Sant'Anna and IFC-CNR internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai H, 1999, J MOL MED, V77, P511, DOI 10.1007/s001099900020; Cao J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00160; Cardillo C, 1999, CIRCULATION, V100, P820, DOI 10.1161/01.CIR.100.8.820; Contreras C, 2011, ATHEROSCLEROSIS, V217, P331, DOI 10.1016/j.atherosclerosis.2011.03.036; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Cook S, 2003, SWISS MED WKLY, V133, P360; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Godecke A, 1998, CIRC RES, V82, P186; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Kaneko YK, 2013, J PHARMACOL SCI, V123, P295, DOI 10.1254/jphs.13R10CP; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kubis N, 2002, J HYPERTENS, V20, P1581, DOI 10.1097/00004872-200208000-00021; Kubis N, 2002, J HYPERTENS, V20, P273, DOI 10.1097/00004872-200202000-00017; L'Abbate A, 2007, AM J PHYSIOL-HEART C, V293, pH3532, DOI 10.1152/ajpheart.00826.2007; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Leuwerke SM, 2002, AM J PHYSIOL-LUNG C, V282, pL1272, DOI 10.1152/ajplung.00490.2001; LUCAS CP, 1985, HYPERTENSION, V7, P702, DOI 10.1161/01.HYP.7.5.702; Mashimo H, 1999, AM J PHYSIOL-GASTR L, V277, pG745, DOI 10.1152/ajpgi.1999.277.4.G745; Matsa LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070523; Miyamoto Y, 1998, HYPERTENSION, V32, P3, DOI 10.1161/01.HYP.32.1.3; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Monti LD, 2003, DIABETES, V52, P1270, DOI 10.2337/diabetes.52.5.1270; Nagareddy PR, 2005, AM J PHYSIOL-HEART C, V289, pH2144, DOI 10.1152/ajpheart.00591.2005; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024266; RADOMSKI MW, 1993, THROMB HAEMOSTASIS, V70, P36; Sartori C, 1999, J HYPERTENS, V17, P1517, DOI 10.1097/00004872-199917110-00003; Scherrer U, 2000, EUR J ENDOCRINOL, V142, P315, DOI 10.1530/eje.0.1420315; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Shimasaki Y, 1998, J AM COLL CARDIOL, V31, P1506, DOI 10.1016/S0735-1097(98)00167-3; Shoji M, 2000, LIFE SCI, V66, P2557, DOI 10.1016/S0024-3205(00)00589-0; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Vecoli C, 2011, J CELL BIOCHEM, V112, P2616, DOI 10.1002/jcb.23188; Vecoli C, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-92; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	46	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104156	10.1371/journal.pone.0104156	http://dx.doi.org/10.1371/journal.pone.0104156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093405	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200076
J	Xu, J; Barinas-Mitchell, E; Kuller, LH; Youk, AO; Catov, JM				Xu, Jia; Barinas-Mitchell, Emma; Kuller, Lewis H.; Youk, Ada O.; Catov, Janet M.			Maternal Hypertension after a Low-Birth-Weight Delivery Differs by Race/Ethnicity: Evidence from the National Health and Nutrition Examination Survey (NHANES) 1999-2006	PLOS ONE			English	Article							GESTATIONAL-AGE; PRETERM BIRTH; PREGNANCY COMPLICATIONS; RETROSPECTIVE COHORT; FETAL-GROWTH; DISEASE; MORTALITY; RISK	Studies have suggested an increase in maternal morbidity and mortality due to cardiovascular diseases in women with a prior low-birth-weight (LBW, <2,500 grams) delivery. This study evaluated blood pressure and hypertension in women who reported a prior preterm or small-for-gestational-age (SGA) LBW delivery in the National Health and Nutrition Examination Survey 1999-2006 (n = 6,307). This study also aimed to explore if race/ethnicity, menopause status, and years since last pregnancy modified the above associations. A total of 3,239 white, 1,350 black, and 1,718 Hispanics were assessed. Linear regression models were used to evaluate blood pressure by birth characteristics (preterm-LBW, SGA-LBW, and birthweight >= 2,500). Logistic regression models estimated the odds ratios (OR) of hypertension among women who reported a preterm-LBW or SGA-LBW delivery compared with women who reported an infant with birthweight >= 2,500 at delivery. Overall, there was a positive association between a preterm-LBW delivery and hypertension (adjusted OR = 1.39, 95% confidence interval (CI) 1.02-1.90). Prior SGA-LBW also increased the odds of hypertension, but the estimate did not reach statistical significance (adjusted OR = 1.21, 95% CI 0.76-1.92). Race/ethnicity modified the above associations. Only black women had increased risk of hypertension following SGA-LBW delivery (adjusted OR = 2.09, 95% CI 1.12-3.90). Black women were at marginally increased risk of hypertension after delivery of a preterm-LBW (adjusted OR = 1.49, 95% CI 0.93-2.38). Whites and Hispanics had increased, but not statistically significant, risk of hypertension after a preterm-LBW (whites: adjusted OR = 1.39, 95% CI 0.92-2.10; Hispanics: adjusted OR = 1.22, 95% CI 0.62-2.38). Stratified analysis indicated that the associations were stronger among women who were premenopausal and whose last pregnancy were more recent. The current study suggests that in a representative United States population, women with a history of preterm- or SGA-LBW deliveries have increased odds of hypertension and this risk appears to be higher for black women and younger women.	[Xu, Jia; Barinas-Mitchell, Emma; Kuller, Lewis H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Youk, Ada O.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Catov, Janet M.] Univ Pittsburgh, Dept OB GYN, Pittsburgh, PA 15260 USA; [Catov, Janet M.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Catov, JM (corresponding author), Univ Pittsburgh, Dept OB GYN, Pittsburgh, PA 15260 USA.	catovjm@mail.magee.edu		Youk, Ada/0000-0001-6912-9759; Barinas-Mitchell, Emma/0000-0002-7280-7781	National Institutes of Health's National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award [5K12 HD43441-09]; Women and Infant Study of Healthy Hearts (WISH) Fetal Growth Restriction and Maternal Cardiovascular Risk Grant [RO1HL76532-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076532] Funding Source: NIH RePORTER	National Institutes of Health's National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award; Women and Infant Study of Healthy Hearts (WISH) Fetal Growth Restriction and Maternal Cardiovascular Risk Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by The National Institutes of Health's National Institute of Child Health and Human Development Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award Grant 5K12 HD43441-09, and Women and Infant Study of Healthy Hearts (WISH) Fetal Growth Restriction and Maternal Cardiovascular Risk Grant RO1HL76532-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Ananth CV, 2008, CLIN PERINATOL, V35, P53, DOI 10.1016/j.clp.2007.11.001; Axt R., 1999, Clinical and Experimental Obstetrics and Gynecology, V26, P195; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Catov JM, 2008, OBSTET GYNECOL, V112, P290, DOI 10.1097/AOG.0b013e31817f589b; Catov JM, 2007, INT J EPIDEMIOL, V36, P412, DOI 10.1093/ije/dyl271; Catov JM, 2011, OBSTET GYNECOL, V117, P225, DOI 10.1097/AOG.0b013e3182075626; Catov JM, 2010, ANN EPIDEMIOL, V20, P604, DOI 10.1016/j.annepidem.2010.05.007; Chaturvedi S, 2004, NATL MED J INDIA, V17, P227; Curtin Lester R, 2012, Vital Health Stat 2, P1; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Hastie CE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.080; Hauck FR, 2011, SEMIN PERINATOL, V35, P209, DOI 10.1053/j.semperi.2011.02.018; Klein RJ, 2001, HLTH PEOPLE 2010 STA, V20, P1; Lin CC, 1998, OBSTET GYNECOL, V92, P1044, DOI 10.1016/S0029-7844(98)00328-7; Magnussen EB, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.016; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2005, EPIDEMIOLOGY, V16, P563, DOI 10.1097/01.ede.0000164790.96316.c0; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Watson T, 2008, ANTIOXID REDOX SIGN, V10, P1079, DOI 10.1089/ars.2007.1998	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104149	10.1371/journal.pone.0104149	http://dx.doi.org/10.1371/journal.pone.0104149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093324	gold, Green Published, Green Accepted			2022-12-25	WOS:000341357200075
J	Zhang, JX; Li, Y; Chen, XT; Pan, YQ; Zhang, SW; Wang, YH				Zhang, Jingxiao; Li, Yan; Chen, Xuetong; Pan, Yanqiu; Zhang, Shuwei; Wang, Yonghua			Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action for Herbal Medicines in Stroke Treatment and Prevention	PLOS ONE			English	Article							SALVIANOLIC ACID B; DRUG DISCOVERY; PLATELET-AGGREGATION; THERAPEUTIC TARGET; AQUEOUS SOLUBILITY; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; GINKGO-BILOBA; BRAIN; INHIBITION	Annually, tens of millions of first-ever strokes occur in the world; however, currently there is lack of effective and widely applicable pharmacological treatments for stroke patients. Herbal medicines, characterized as multi-constituent, multi-target and multi-effect, have been acknowledged with conspicuous effects in treating stroke, and attract extensive interest of researchers although the mechanism of action is yet unclear. In this work, we introduce an innovative systems-pharmacology method that combines pharmacokinetic prescreening, target fishing and network analysis to decipher the mechanisms of action of 10 herbal medicines like Salvia miltiorrhizae, Ginkgo biloba and Ephedrae herba which are efficient in stroke treatment and prevention. Our systematic analysis results display that, in these anti-stroke herbal medicines, 168 out of 1285 constituents with the favorable pharmacokinetic profiles might be implicated in stroke therapy, and the systematic use of these compounds probably acts through multiple mechanisms to synergistically benefit patients with stroke, which can roughly be classified as preventing ischemic inflammatory response, scavenging free radicals and inhibiting neuronal apoptosis against ischemic cerebral damage, as well as exhibiting lipid-lowering, anti-diabetic, anti-thrombotic and antiplatelet effects to decrease recurrent strokes. Relying on systems biology-based analysis, we speculate that herbal medicines, being characterized as the classical combination therapies, might be not only engaged in multiple mechanisms of action to synergistically improve the stroke outcomes, but also might be participated in reducing the risk factors for recurrent strokes.	[Zhang, Jingxiao; Li, Yan; Pan, Yanqiu; Zhang, Shuwei] Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Key Lab Ind Ecol & Environm Engn, MOE, Dalian, Liaoning, Peoples R China; [Chen, Xuetong; Wang, Yonghua] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Chen, Xuetong; Wang, Yonghua] Northwest A&F Univ, Ctr Bioinformat, Yangling, Shaanxi, Peoples R China	Dalian University of Technology; Northwest A&F University - China; Northwest A&F University - China	Li, Y (corresponding author), Dalian Univ Technol, Fac Chem Environm & Biol Sci & Technol, Key Lab Ind Ecol & Environm Engn, MOE, Dalian, Liaoning, Peoples R China.	yanli@dlut.edu.cn; yh_wang@nwsuaf.edu.cn	Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022		National Natural Science Foundation of China [11201049, 31170796, 81373892]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research is financially supported by the National Natural Science Foundation of China (Grant No. 11201049, 31170796 and 81373892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2003, STROKE, V34, P1333, DOI 10.1161/01.STR.0000069266.99057.BF; Arnott JA, 2012, EXPERT OPIN DRUG DIS, V7, P863, DOI 10.1517/17460441.2012.714363; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Broussalis E, 2012, DRUG DISCOV TODAY, V17, P296, DOI 10.1016/j.drudis.2011.11.005; Chang CP, 2007, NEUROPHARMACOLOGY, V52, P1024, DOI 10.1016/j.neuropharm.2006.10.018; CHEN CX, 1992, ACTA PHARM SINIC, V13, P126; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Choi MY, 2008, ARCH PHARM RES, V31, P1166, DOI 10.1007/s12272-001-1284-4; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; Di Napoli M, 2003, STROKE, V34, P2922, DOI 10.1161/01.STR.0000099124.84425.BB; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Gao DY, 2009, ARCH PHARM RES, V32, P773, DOI 10.1007/s12272-009-1517-2; Geraets L, 2007, J NUTR, V137, P2190, DOI 10.1093/jn/137.10.2190; Gim SangA, 2013, Laboratory Animal Research, V29, P63; Gong XD, 1999, TRENDS PHARMACOL SCI, V20, P191, DOI 10.1016/S0165-6147(98)01276-0; Ha SK, 2012, NEUROCHEM RES, V37, P1560, DOI 10.1007/s11064-012-0751-z; The HP, 2011, MOL INFORM, V30, P376, DOI 10.1002/minf.201000118; Hou TJ, 2002, J MOL MODEL, V8, P337, DOI 10.1007/s00894-002-0101-1; Huang C., 2013, BRIEF BIOINFORM; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Jeon SJ, 2011, NEUROSCI RES, V69, P214, DOI 10.1016/j.neures.2010.11.008; Jin DZ, 2006, EUR J PHARMACOL, V549, P166, DOI 10.1016/j.ejphar.2006.07.055; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jorgensen WL, 2002, ADV DRUG DELIVER REV, V54, P355, DOI 10.1016/S0169-409X(02)00008-X; Kam A, 2012, CURR MED CHEM, V19, P1830, DOI 10.2174/092986712800099794; Karmin O, 2001, LIFE SCI, V68, P903, DOI 10.1016/S0024-3205(00)00989-9; Kawai Mari, 2007, Allergol Int, V56, P113; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kim EJ, 2007, MOL PHARMACOL, V72, P62, DOI 10.1124/mol.107.034447; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Kuo PL, 2005, LIFE SCI, V77, P2964, DOI 10.1016/j.lfs.2005.05.026; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lee S, 2010, NEUROCHEM RES, V35, P1725, DOI 10.1007/s11064-010-0235-y; [李兰婷 LI Lanting], 2007, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V17, P221; [李兰婷 LI Lanting], 2007, [分子科学学报, Journal of Molecular Science], V23, P286; Li M, 2004, CLIN HEMORHEOL MICRO, V31, P97; Li XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043918; Lin Tsai-Hui, 2010, Chin Med, V5, P22, DOI 10.1186/1749-8546-5-22; Liu CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001321; Liu H, 2013, J ETHNOPHARMACOL, V146, P773, DOI 10.1016/j.jep.2013.02.004; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; MELDRUM BS, 1995, CURR OPIN NEUROL, V8, P15, DOI 10.1097/00019052-199502000-00004; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mueller M, 2008, J AGR FOOD CHEM, V56, P11621, DOI 10.1021/jf802298w; O'Collins VE, 2012, J CEREBR BLOOD F MET, V32, P585, DOI 10.1038/jcbfm.2011.203; Pang KS, 2003, DRUG METAB DISPOS, V31, P1507, DOI 10.1124/dmd.31.12.1507; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi C, 2010, INT J MOL SCI, V11, P107, DOI 10.3390/ijms11010107; Shi JS, 2003, ACTA PHARMACOL SIN, V24, P97; Shuaib A, 2002, J CEREBR BLOOD F MET, V22, P215, DOI 10.1097/00004647-200202000-00009; Suh SJ, 2006, BIOCHEM PHARMACOL, V72, P1680, DOI 10.1016/j.bcp.2006.08.013; Suk K, 2002, LIFE SCI, V70, P2467, DOI 10.1016/S0024-3205(02)01534-5; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tetko IV, 2004, J PHARM SCI-US, V93, P3103, DOI 10.1002/jps.20217; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1488, DOI 10.1021/ci000392t; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Wang JM, 2007, J CHEM INF MODEL, V47, P1395, DOI 10.1021/ci700096r; Wang X, 2013, INTEGR BIOL-UK, V5, P351, DOI 10.1039/c2ib20204b; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; WU B, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004295.PUB3; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Ye H, 2011, NUCLEIC ACIDS RES, V39, pD1055, DOI 10.1093/nar/gkq1165; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zeng X, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003691.pub2; Zhang FY, 2009, EXP BRAIN RES, V193, P109, DOI 10.1007/s00221-008-1600-9; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zhou JY, 2012, FITOTERAPIA, V83, P617, DOI 10.1016/j.fitote.2012.02.010; Zhou JY, 2010, J ETHNOPHARMACOL, V132, P15, DOI 10.1016/j.jep.2010.08.041; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	76	35	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102506	10.1371/journal.pone.0102506	http://dx.doi.org/10.1371/journal.pone.0102506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093322	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200012
J	Abe, E; Ikeda, K; Nutahara, E; Hayashi, M; Yamashita, A; Taguchi, R; Doi, K; Honda, D; Okino, N; Ito, M				Abe, Eriko; Ikeda, Kazutaka; Nutahara, Eri; Hayashi, Masahiro; Yamashita, Atsushi; Taguchi, Ryo; Doi, Kosaku; Honda, Daiske; Okino, Nozomu; Ito, Makoto			Novel Lysophospholipid Acyltransferase PLAT1 of Aurantiochytrium limacinum F26-b Responsible for Generation of Palmitate-Docosahexaenoate-Phosphatidylcholine and Phosphatidylethanolamine	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACYL-COA; SCHIZOCHYTRIUM; METABOLISM; EXPRESSION; CLONING; FAMILY; CELLS; THRAUSTOCHYTRIDS; IDENTIFICATION	N-3 polyunsaturated fatty acids (PUFA), such as docosahexaenoic acid (DHA, 22:6n-3), have been reported to play roles in preventing cardiovascular diseases. The major source of DHA is fish oils but a recent increase in the global demand of DHA and decrease in fish stocks require a substitute. Thraustochytrids, unicellular marine protists belonging to the Chromista kingdom, can synthesize large amounts of DHA, and, thus, are expected to be an alternative to fish oils. DHA is found in the acyl chain(s) of phospholipids as well as triacylglycerols in thraustochytrids; however, how thraustochytrids incorporate DHA into phospholipids remains unknown. We report here a novel lysophospholipid acyltransferase (PLAT1), which is responsible for the generation of DHA-containing phosphatidylcholine and phosphatidylethanolamine in thraustochytrids. The PLAT1 gene, which was isolated from the genomic DNA of Aurantiochytrium limacinum F26-b, was expressed in Saccharomyces cerevisiae, and the FLAG-tagged recombinant enzyme was characterized after purification with anti-FLAG affinity gel. PLAT1 shows wide specificity for donor substrates as well as acceptor substrates in vitro, i.e, the enzyme can adopt lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylserine and lysophosphatidylinositol as acceptor substrates, and 15:0/16:0-CoA and DHA-CoA as donor substrates. In contrast to the in vitro experiment, only lysophosphatidylcholine acyltransferase and lysophosphatidylethanolamine acyltransferase activities were decreased in plat1-knockout mutants, resulting in a decrease of 16:0-DHA-phosphatidylcholine (PC) [PC(38:6)] and 16:0-DHA-phosphatidylethanolamine (PE) [PE(38:6)], which are two major DHA-containing phospholipids in A. limacinum F26-b. However, the amounts of other phospholipid species including DHA-DHA-PC [PC(44:12)] and DHA-DHA-PE [PE(44:12)] were almost the same in plat-knockout mutants and the wild-type. These results indicate that PLAT1 is the enzyme responsible for the generation of 16:0-DHA-PC and 16:0-DHA-PE in the thraustochytrid.	[Abe, Eriko; Nutahara, Eri; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Hayashi, Masahiro] Miyazaki Univ, Fac Agr, Miyazaki 88921, Japan; [Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Tokyo 173, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Doi, Kosaku] Konan Univ, Grad Sch Nat Sci, Higashinada Ku, Kobe, Hyogo, Japan; [Doi, Kosaku; Honda, Daiske] Konan Univ, Inst Integrat Neurobiol, Higashinada Ku, Kobe, Hyogo, Japan; [Honda, Daiske] Konan Univ, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo, Japan; [Ito, Makoto] Kyushu Univ, Bioarchtechture Ctr, Fukuoka 812, Japan	Kyushu University; Keio University; University of Miyazaki; Teikyo University; Chubu University; Konan University; Konan University; Konan University; Kyushu University	Ito, M (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	ito, Makoto/0000-0003-3159-7818; Yamashita, Atsushi/0000-0002-2544-2134; Honda, Daiske/0000-0002-3436-4561	Japanese Ministry of Education, Culture, Science and Technology [24380058]; Grants-in-Aid for Scientific Research [24619007] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Basic research B (24380058) from the Japanese Ministry of Education, Culture, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2006, J BIOCHEM, V140, P247, DOI 10.1093/jb/mvj145; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Harris WS, 2013, POSTGRAD MED, V125, P100, DOI 10.3810/pgm.2013.11.2717; Hayashi M, 2007, BIOSCI BIOTECH BIOCH, V71, P222, DOI 10.1271/bbb.60308; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Honda D, 1998, MYCOL RES, V102, P439, DOI 10.1017/S0953756297005170; Ikeda K, 2011, ANAL BIOANAL CHEM, V400, P1853, DOI 10.1007/s00216-011-4703-2; Kobayashi T, 2011, APPL ENVIRON MICROB, V77, P3870, DOI 10.1128/AEM.02664-10; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; Martins DA, 2013, MAR DRUGS, V11, P2259, DOI 10.3390/md11072259; Matsuda T, 2012, J LIPID RES, V53, P1210, DOI 10.1194/jlr.M024935; Miyamoto E, 2007, J NUTR SCI VITAMINOL, V53, P471, DOI 10.3177/jnsv.53.471; Nagano N, 2009, J OLEO SCI, V58, P623, DOI 10.5650/jos.58.623; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ohara J, 2013, MAR BIOTECHNOL, V15, P476, DOI 10.1007/s10126-013-9496-1; Raghukumar S, 2008, MAR BIOTECHNOL, V10, P631, DOI 10.1007/s10126-008-9135-4; Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834; Sakaguchi K, 2012, APPL ENVIRON MICROB, V78, P3193, DOI 10.1128/AEM.07129-11; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; von Schacky C, 2007, CARDIOVASC RES, V73, P310, DOI 10.1016/j.cardiores.2006.08.019; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0	39	12	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102377	10.1371/journal.pone.0102377	http://dx.doi.org/10.1371/journal.pone.0102377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090090	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700006
J	Bennett, TM; Mackay, DS; Siegfried, CJ; Shiels, A				Bennett, Thomas M.; Mackay, Donna S.; Siegfried, Carla J.; Shiels, Alan			Mutation of the Melastatin-Related Cation Channel, TRPM3, Underlies Inherited Cataract and Glaucoma	PLOS ONE			English	Article							ANTERIOR SEGMENT DYSGENESIS; STATIONARY NIGHT BLINDNESS; CONGENITAL CATARACT; GENE-EXPRESSION; N-TERMINUS; PROTEIN; MOUSE; DOMAIN; LOCUS; COMPLEX	Inherited forms of cataract are a clinically important and genetically heterogeneous cause of visual impairment that usually present at an early age with or without systemic and/or other ocular abnormalities. Here we have identified a new locus for inherited cataract and high-tension glaucoma with variable anterior segment defects, and characterized an underlying mutation in the gene coding for transient receptor potential cation channel, subfamily M, member-3 (TRPM3, melastatin-2). Genome-wide linkage analysis mapped the ocular disease locus to the pericentric region of human chromosome 9. Whole exome and custom-target next-generation sequencing detected a heterozygous A-to-G transition in exon-3 of TRPM3 that co-segregated with disease. As a consequence of alternative splicing this missense mutation was predicted to result in the substitution of isoleucine-to-methionine at codon 65 (c.195A>G; p.I65 M) of TRPM3 transcript variant 9, and at codon 8 (c.24A>G; p.18 M) of a novel TRPM3 transcript variant expressed in human lens. In both transcript variants the I-to-M substitution was predicted in silico to exert damaging effects on protein function. Furthermore, transient expression studies of a recombinant TRPM3-GFP reporter product predicted that the I-to-M substitution introduced an alternative translation start-site located 89 codons upstream from the native initiator methionine found in eight other TRPM3 transcript variants (1-8). Collectively, these studies have provided the first evidence that TRPM3 is associated with inherited ocular disease in humans, and further provide support for the important role of this cation channel in normal eye development.	[Bennett, Thomas M.; Mackay, Donna S.; Siegfried, Carla J.; Shiels, Alan] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA.	shiels@vision.wustl.edu		Mackay, Donna/0000-0002-2499-1203	National Institutes of Health/National Eye Institute (NIH/NEI) [EY012284, EY02687]; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY012284, P30EY002687] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health/National Eye Institute (NIH/NEI) grants EY012284 (to AS), and EY02687 (Core Grant for Vision Research), and by an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (RPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amaya L, 2003, SURV OPHTHALMOL, V48, P125, DOI 10.1016/S0039-6257(02)00462-9; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Banka S, 2012, EUR J HUM GENET, V20, P381, DOI 10.1038/ejhg.2011.220; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Everett KV, 2011, ADV EXP MED BIOL, V704, P1011, DOI 10.1007/978-94-007-0265-3_52; Forshew T, 2005, HUM GENET, V117, P452, DOI 10.1007/s00439-005-1309-9; Fruhwald J, 2012, J BIOL CHEM, V287, P36663, DOI 10.1074/jbc.M112.396663; Gilliam JC, 2011, VISION RES, V51, P2440, DOI 10.1016/j.visres.2011.10.009; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kluijt I, 2000, Ophthalmic Genet, V21, P51, DOI 10.1076/1381-6810(200003)21:1;1-I;FT051; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kuniba H, 2009, J HUM GENET, V54, P304, DOI 10.1038/jhg.2009.30; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lambert SR, 2013, AM J OPHTHALMOL, V156, P355, DOI 10.1016/j.ajo.2013.03.013; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee H, 2008, ACTA OPHTHALMOL, V86, P708, DOI 10.1111/j.1755-3768.2008.01427.x; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Moiseenkova-Bell V, 2011, ADV EXP MED BIOL, V704, P25, DOI 10.1007/978-94-007-0265-3_2; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Rahi JS, 2001, INVEST OPHTH VIS SCI, V42, P1444; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Rhodes JD, 2009, EXP EYE RES, V88, P226, DOI 10.1016/j.exer.2008.10.025; Sandmeyer LS, 2012, VET OPHTHALMOL, V15, P18, DOI 10.1111/j.1463-5224.2011.00903.x; Shaham O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003357; Shiels A, 2013, CLIN GENET, V84, P120, DOI 10.1111/cge.12182; Shiels A, 2010, MOL VIS, V16, P2007; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Toro CA, 2011, CURR PHARM BIOTECHNO, V12, P12; Trumler AA, 2011, CURR OPIN OPHTHALMOL, V22, P365, DOI 10.1097/ICU.0b013e32834994dc; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wang FE, 2010, FASEB J, V24, P1552, DOI 10.1096/fj.08-125856; Wang Y, 2013, INVEST OPHTH VIS SCI, V54, P323, DOI 10.1167/iovs.12-10904; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zetterstrom C, 2005, J CATARACT REFR SURG, V31, P824, DOI 10.1016/j.jcrs.2005.01.012	64	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104000	10.1371/journal.pone.0104000	http://dx.doi.org/10.1371/journal.pone.0104000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090642	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700076
J	Lin, M; Jiao, JW; Zhan, XH; Zhan, XF; Pan, MC; Wang, JL; Wang, CF; Zhong, TY; Zhang, Q; Yu, X; Wu, JR; Yang, HT; Lin, F; Tong, X; Yang, H; Zha, GC; Wang, Q; Zheng, L; Wen, YF; Yang, LY				Lin, Min; Jiao, Ji-Wei; Zhan, Xiu-Hui; Zhan, Xiao-Fen; Pan, Mei-Chen; Wang, Jun-Li; Wang, Chun-Fang; Zhong, Tian-Yu; Zhang, Qin; Yu, Xia; Wu, Jiao-Ren; Yang, Hui-Tian; Lin, Fen; Tong, Xin; Yang, Hui; Zha, Guang-Cai; Wang, Qian; Zheng, Lei; Wen, Ying-Fang; Yang, Li-Ye			High Resolution Melting Analysis: A Rapid Screening and Typing Tool for Common beta-Thalassemia Mutation in Chinese Population	PLOS ONE			English	Article							SYBR GREEN1; HEMOGLOBINOPATHIES; IDENTIFICATION; PCR; ALPHA; ASSAY	beta-thalassemia is a common inherited disorder worldwide including southern China, and at least 45 distinct beta-thalassemia mutations have been identified in China. High-resolution melting (HRM) assay was recently introduced as a rapid, inexpensive and effective method for genotyping. However, there was no systemic study on the diagnostic capability of HRM to identify beta-thalassemia. Here, we used an improved HRM method to screen and type 12 common beta-thalassemia mutations in Chinese, and the rapidity and reliability of this method was investigated. The whole PCR and HRM procedure could be completed in 40 min. The heterozygous mutations and 4 kinds of homozygous mutations could be readily differentiated from the melting curve except c.-78A>G heterozygote and c.-79A>G heterozygote. The diagnostic reliability of this HRM assay was evaluated on 756 pre-typed genomic DNA samples and 50 cases of blood spots on filter paper, which were collected from seven high prevalent provinces in southern China. If c.-78A>G heterozygote and c.-79A>G heterozygote were classified into the same group (c.-78&79 A>G heterozygote), the HRM method was in complete concordance with the reference method (reverse dot blot/DNA-sequencing). In a conclusion, the HRM method appears to be an accurate and sensitive method for the rapid screening and identification of beta-thalassemia mutations. In the future, we suggest this technology to be used in neonatal blood spot screening program. It could enlarge the coverage of beta-thalassemia screening program in China. At the same time, its value should be confirmed in prospectively clinical and epidemiological studies.	[Lin, Min; Zhan, Xiao-Fen; Wu, Jiao-Ren; Yang, Hui-Tian; Lin, Fen; Tong, Xin; Yang, Hui; Yang, Li-Ye] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Lin, Min; Pan, Mei-Chen] Shantou Univ, Coll Med, Affiliated Hosp 1, Med Lab, Shantou, Guangdong, Peoples R China; [Jiao, Ji-Wei; Zhan, Xiu-Hui; Zha, Guang-Cai] Hanshan Normal Univ, Dept Biol, Chaozhou, Guangdong, Peoples R China; [Wang, Jun-Li; Wang, Chun-Fang] Hosp Youjiang Med Univ Nationalities, Dept Lab Med, Baise, Guangxi Provinc, Peoples R China; [Zhong, Tian-Yu] Gannan Med Univ, Affiliated Hosp 1, Med Lab, Ganzhou, Jiangxi, Peoples R China; [Zhang, Qin] Peoples Hosp Yunan Prov, Lab Med Ctr, Kunming, Yunnan Province, Peoples R China; [Yu, Xia] Chengdu Womens & Childrens Cent Hosp, Dept Lab Med, Chengdu, Sichuan Provinc, Peoples R China; [Yang, Hui; Wang, Qian; Zheng, Lei] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wen, Ying-Fang] Meixian Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China	Southern Medical University - China; Shantou University; Hanshan Normal University; Youjiang Medical University for Nationalities; Gannan Medical University; Southern Medical University - China	Yang, LY (corresponding author), Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com		Zhong, Tianyu/0000-0003-1934-0032	National Natural Science Foundation of China [81101329]; Social Development Program of Guangdong Province [2011B031800329]; Natural Science Foundation for Young Scientists of Jiangxi Province [20122BAB215006]; Foundation of the Health Department of Guangxi Province, China [2012713, Z2012085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Program of Guangdong Province; Natural Science Foundation for Young Scientists of Jiangxi Province; Foundation of the Health Department of Guangxi Province, China	This work was partially supported by the National Natural Science Foundation of China (contract/grant number 81101329 to Min Lin), Social Development Program of Guangdong Province (contract/grant number 2011B031800329 to Min Lin), Natural Science Foundation for Young Scientists of Jiangxi Province (contract/grant number 20122BAB215006 to Tian-Yu Zhong) and Foundation of the Health Department of Guangxi Province, China (contract/grant number 2012713 and Z2012085 to Jun-Li Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borbely N, 2013, J CLIN PATHOL, V66, P29, DOI 10.1136/jclinpath-2012-200946; CHAN V, 1987, AM J HUM GENET, V41, P678; Chen GM, 2012, INT J PEDIATR OTORHI, V76, P1771, DOI 10.1016/j.ijporl.2012.08.021; Chen JT, 2013, J MOL DIAGN THER, V5, P225; Cui GL, 2013, GENE, V514, P125, DOI 10.1016/j.gene.2012.11.004; Er TK, 2012, CLIN CHIM ACTA, V413, P1781, DOI 10.1016/j.cca.2012.06.033; Feng Shan-wei, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P223, DOI 10.3760/cma.j.issn.1003-9406.2011.02.023; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Gu Xue-fan, 2005, Zhonghua Er Ke Za Zhi, V43, P321; He XA, 2010, GENET TEST MOL BIOMA, V14, P851, DOI 10.1089/gtmb.2010.0048; Li DZ, 2009, PRENATAL DIAG, V29, P637, DOI 10.1002/pd.2251; Li Q, 2008, CLIN BIOCHEM, V41, P681, DOI 10.1016/j.clinbiochem.2008.02.008; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; Lin M, 2012, BLOOD CELL MOL DIS, V48, P86, DOI 10.1016/j.bcmd.2011.12.001; Pornprasert S, 2008, EUR J HAEMATOL, V80, P510, DOI 10.1111/j.1600-0609.2008.01055.x; Pornprasert S, 2012, HEMOGLOBIN, V36, P491, DOI 10.3109/03630269.2012.709896; Pornprasert S, 2011, KOREAN J LAB MED, V31, P138, DOI 10.3343/kjlm.2011.31.3.138; Reichert VCD, 2008, ANN HEMATOL, V87, P381, DOI 10.1007/s00277-007-0418-z; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Shih HC, 2009, CLIN BIOCHEM, V42, P1667, DOI 10.1016/j.clinbiochem.2009.07.017; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xiong F, 2011, J MOL DIAGN, V13, P427, DOI 10.1016/j.jmoldx.2011.03.005; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	25	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102243	10.1371/journal.pone.0102243	http://dx.doi.org/10.1371/journal.pone.0102243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089872	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700004
J	Martens, A; Rojas, SV; Baraki, H; Rathert, C; Schecker, N; Hernandez, SR; Schwanke, K; Zweigerdt, R; Martin, U; Saito, S; Haverich, A; Kutschka, I				Martens, Andreas; Rojas, Sebastian V.; Baraki, Hassina; Rathert, Christian; Schecker, Natalie; Hernandez, Sara Rojas; Schwanke, Kristin; Zweigerdt, Robert; Martin, Ulrich; Saito, Shunsuke; Haverich, Axel; Kutschka, Ingo			Macroscopic Fluorescence Imaging: A Novel Technique to Monitor Retention and Distribution of Injected Microspheres in an Experimental Model of Ischemic Heart Failure	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EMBRYONIC STEM-CELLS; INTRAMYOCARDIAL INJECTION; CARDIAC REPAIR; DELIVERY	Background: The limited effectiveness of cardiac cell therapy has generated concern regarding its clinical relevance. Experimental studies show that cell retention and engraftment are low after injection into ischemic myocardium, which may restrict therapy effectiveness significantly. Surgical aspects and mechanical loss are suspected to be the main culprits behind this phenomenon. As current techniques of monitoring intramyocardial injections are complex and time-consuming, the aim of the study was to develop a fast and simple model to study cardiac retention and distribution following intramyocardial injections. For this purpose, our main hypothesis was that macroscopic fluorescence imaging could adequately serve as a detection method for intramyocardial injections. Methods and Results: A total of 20 mice underwent ligation of the left anterior descending artery (LAD) for myocardial infarction. Fluorescent microspheres with cellular dimensions were used as cell surrogates. Particles (5 x 10(5)) were injected into the infarcted area of explanted resting hearts (Ex vivo myocardial injetions EVMI, n = 10) and in vivo into beating hearts (In vivo myocardial injections IVMI, n = 10). Microsphere quantification was performed by fluorescence imaging of explanted organs. Measurements were repeated after a reduction to homogenate dilutions. Cardiac microsphere retention was 2.78 x 10(5) +/- 0.31 x 10(5) in the EVMI group. In the IVMI group, cardiac retention of microspheres was significantly lower (0.74 x 10(5) +/- 0.18 x 10(5); p<0.05). Direct fluorescence imaging revealed venous drainage through the coronary sinus, resulting in a microsphere accumulation in the left (0.90 x 10(5) +/- 0.20 x 10(5)) and the right (1.07 x 10(5) +/- 0.17 x 10(5)) lung. Processing to homogenates involved further particle loss (p<0.05) in both groups. Conclusions: We developed a fast and simple direct fluorescence imaging method for biodistribution analysis which enabled the quantification of fluorescent microspheres after intramyocardial delivery using macroscopic fluorescence imaging. This new technique showed massive early particle loss and venous drainage into the right atrium leading to substantial accumulation of graft particles in both lungs.	[Martens, Andreas; Rojas, Sebastian V.; Baraki, Hassina; Saito, Shunsuke; Haverich, Axel; Kutschka, Ingo] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Martens, Andreas; Rojas, Sebastian V.; Rathert, Christian; Schecker, Natalie; Schwanke, Kristin; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Kutschka, Ingo] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs, Hannover, Germany; [Hernandez, Sara Rojas] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Rojas, SV (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany.	rojas.sebastian@mh-hannover.de	Martin, Ulrich/F-4888-2017; Haverich, Axel/AAC-7552-2022; Rojas, Sebastian V/AFR-1536-2022; Martens, Andreas/AAG-2746-2020	Martin, Ulrich/0000-0003-1058-4540; Rojas, Sebastian V/0000-0002-9505-1358; Martens, Andreas/0000-0002-7953-2645				Al Kindi A, 2008, FRONT BIOSCI-LANDMRK, V13, P2421, DOI 10.2741/2855; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Anderl JN, 2009, J BIOMED MATER RES A, V88A, P704, DOI 10.1002/jbm.a.31917; Azene N, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-7; Behfar A, 2013, CIRC-CARDIOVASC INTE, V6, P710, DOI 10.1161/CIRCINTERVENTIONS.112.000422; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bonios M, 2011, J NUCL CARDIOL, V18, P443, DOI 10.1007/s12350-011-9369-9; Clifford DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037373; Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011; Fu Yingli, 2011, Imaging Med, V3, P473; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Kutschka I, 2007, J HEART LUNG TRANSPL, V26, P273, DOI 10.1016/j.healun.2006.11.604; Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297; Kutschka I, 2006, CIRCULATION, V114, pI174, DOI 10.1161/CIRCULATIONAHA.105.001370; Lang C, 2013, EUR J NUCL MED MOL I, V40, P1730, DOI 10.1007/s00259-013-2480-1; Leri A, 2008, CURR PROB CARDIOLOGY, V33, P91, DOI 10.1016/j.cpcardiol.2007.11.002; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688; Martens A, 2014, ARTIF ORGANS, V38, P978, DOI 10.1111/aor.12268; Martens A, 2011, CYTOTHERAPY, V13, P864, DOI 10.3109/14653249.2011.571247; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Mignone JL, 2010, CIRC J, V74, P2517, DOI 10.1253/circj.CJ-10-0958; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Stamm C, 2012, LANCET, V379, P891, DOI 10.1016/S0140-6736(12)60385-7; Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034; Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zweigerdt R, 2007, SEMIN CELL DEV BIOL, V18, P794, DOI 10.1016/j.semcdb.2007.09.014	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e101775	10.1371/journal.pone.0101775	http://dx.doi.org/10.1371/journal.pone.0101775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089764	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700003
J	Nuruddin, S; Syverstad, GHE; Lillehaug, S; Leergaard, TB; Nilsson, LNG; Ropstad, E; Krogenaes, A; Haraldsen, IRH; Torp, R				Nuruddin, Syed; Syverstad, Gry Helen Enger; Lillehaug, Sveinung; Leergaard, Trygve B.; Nilsson, Lars N. G.; Ropstad, Erik; Krogenaes, Anette; Haraldsen, Ira Ronit Hebold; Torp, Reidun			Elevated mRNA-Levels of Gonadotropin-Releasing Hormone and Its Receptor in Plaque-Bearing Alzheimer's Disease Transgenic Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE; COGNITIVE FUNCTION; BETA; MEN; EXPRESSION; REGULATOR; DEMENTIA; ACETATE; PROTEIN; BRAIN	Research on Alzheimer's disease (AD) has indicated an association between hormones of the hypothalamic-pituitary-gonadal (HPG) axis and cognitive senescence, indicating that post meno-/andropausal changes in HPG axis hormones are implicated in the neuropathology of AD. Studies of transgenic mice with AD pathologies have led to improved understanding of the pathophysiological processes underlying AD. The aims of this study were to explore whether mRNA-levels of gonadotropin-releasing hormone (Gnrh) and its receptor (Gnrhr) were changed in plaque-bearing Alzheimer's disease transgenic mice and to investigate whether these levels and amyloid plaque deposition were downregulated by treatment with a gonadotropin-releasing hormone analog (Gnrh-a; Leuprorelin acetate). The study was performed on mice carrying the Arctic and Swedish amyloid-b precursor protein (AbPP) mutations (tgArcSwe). At 12 months of age, female tgArcSwe mice showed a twofold higher level of Gnrh mRNA and more than 1.5 higher level of Gnrhr mRNA than age matched controls. Male tgArcSwe mice showed the same pattern of changes, albeit more pronounced. In both sexes, Gnrha treatment caused significant down-regulation of Gnrh and Gnrhr mRNA expression. Immunohistochemistry combined with quantitative image analysis revealed no significant changes in the plaque load after Gnrh-a treatment in hippocampus and thalamus. However, plaque load in the cerebral cortex of treated females tended to be lower than in female vehicle-treated mice. The present study points to the involvement of hormonal changes in AD mice models and demonstrates that these changes can be effectively counteracted by pharmacological treatment. Although known to increase in normal aging, our study shows that Gnrh/Gnrhr mRNA expression increases much more dramatically in tgArcSwe mice. Treatment with Leuprorelin acetate successfully abolished the transgene specific effects on Gnrh/Gnrhr mRNA expression. The present experimental approach should serve as a platform for further studies on the usefulness of Gnrh-a treatment in suppressing plaque development in AD.	[Nuruddin, Syed; Ropstad, Erik; Krogenaes, Anette] Norwegian Sch Vet Sci, Oslo, Norway; [Syverstad, Gry Helen Enger; Lillehaug, Sveinung; Leergaard, Trygve B.; Torp, Reidun] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Haraldsen, Ira Ronit Hebold] Oslo Univ Hosp, Rikshosp, Div Surg & Clin Neurosci, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway; [Nilsson, Lars N. G.] Univ Oslo, Dept Pharmacol, Oslo, Norway; [Nilsson, Lars N. G.] Oslo Univ Hosp, Oslo, Norway; [Nilsson, Lars N. G.] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden	Norwegian University of Life Sciences; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Uppsala University	Torp, R (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	torp@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018; Nuruddin, Syed/Q-2398-2018; Haraldsen, Ira Hebold/AAY-4300-2021	Nuruddin, Syed/0000-0002-6779-8315; Leergaard, Trygve B./0000-0001-5965-8470; nilsson, lars/0000-0002-8362-1042; Krogenaes, Anette/0000-0001-6280-5697	Letten Centre, IMB, UiO; Nasjonalforeningen for folkehelsen	Letten Centre, IMB, UiO; Nasjonalforeningen for folkehelsen	The authors would also like to thank Letten Centre, IMB, UiO for support to Reidun Torp, CIVITAN Norge Alzheimer foundation, and Nasjonalforeningen for folkehelsen for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADR M, 1988, PEPTIDES, V9, P441, DOI 10.1016/0196-9781(88)90283-5; Barron AM, 2006, ENDOCRINE, V29, P257, DOI 10.1385/ENDO:29:2:257; Bowen RL, 2001, JAMA-J AM MED ASSOC, V286, P790, DOI 10.1001/jama.286.7.790; Bowen RL, 2004, J BIOL CHEM, V279, P20539, DOI 10.1074/jbc.M311993200; Bryan KJ, 2010, J NEUROCHEM, V112, P870, DOI 10.1111/j.1471-4159.2009.06502.x; Casadesus G, 2006, BBA-MOL BASIS DIS, V1762, P447, DOI 10.1016/j.bbadis.2006.01.008; Cherrier MM, 2003, J UROLOGY, V170, P1808, DOI 10.1097/01.ju.0000091640.59812.83; D'Amico AV, 2010, ALZ DIS ASSOC DIS, V24, P85, DOI 10.1097/WAD.0b013e31819cb8f4; Ehlers K, 2013, GONADOTROPIN RELEASI; Evans NP, 2012, PSYCHONEUROENDOCRINO, V37, P1876, DOI 10.1016/j.psyneuen.2012.03.020; Francis PT, 2012, EXPERT REV NEUROTHER, V12, P1351, DOI [10.1586/ern.12.124, 10.1586/ERN.12.124]; Gault PM, 2003, J NEUROENDOCRINOL, V15, P831, DOI 10.1046/j.1365-2826.2003.01065.x; Green HJ, 2002, BJU INT, V90, P427, DOI 10.1046/j.1464-410X.2002.02917.x; Grigorova M, 2006, PSYCHONEUROENDOCRINO, V31, P935, DOI 10.1016/j.psyneuen.2006.05.004; He DQ, 1999, BRAIN RES, V820, P71, DOI 10.1016/S0006-8993(98)01358-4; Hogervorst E, 2004, EXP GERONTOL, V39, P1633, DOI 10.1016/j.exger.2004.06.019; Lillehaug S, 2014, NEUROBIOL AGING, V35, P556, DOI 10.1016/j.neurobiolaging.2013.09.013; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lu F, 1999, CHINESE J PHYSIOL, V42, P67; Marlatt MW, 2005, CURR MED CHEM, V12, P1137, DOI 10.2174/0929867053764644; Meethal SV, 2005, ENDOCRINE, V26, P317, DOI 10.1385/ENDO:26:3:317; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Nogami H, 2007, J NEUROENDOCRINOL, V19, P583, DOI 10.1111/j.1365-2826.2007.01565.x; Nuruddin S, 2013, PSYCHONEURO IN PRESS; Nuruddin S, 2013, BEHAV BRAIN RES, V242, P9, DOI 10.1016/j.bbr.2012.12.027; Rodrigues MA, 2008, J ALZHEIMERS DIS, V13, P267; Schally AV, 2001, FRONT NEUROENDOCRIN, V22, P248, DOI 10.1006/frne.2001.0217; SEDGEWICK J, 2008, SCI IMAGING PHOTOSHO; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sherwin BB, 2003, J MOL NEUROSCI, V20, P385, DOI 10.1385/JMN:20:3:385; Simpkins James W, 2009, Ther Adv Neurol Disord, V2, P31, DOI 10.1177/1756285608100427; Skinner DC, 2009, J NEUROENDOCRINOL, V21, P282, DOI 10.1111/j.1365-2826.2009.01842.x; Stevenson TJ, 2012, FRONT NEUROENDOCRIN, V33, P287, DOI 10.1016/j.yfrne.2012.09.001; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verdile G, 2014, MOL PSYCHIATR, V19, P69, DOI 10.1038/mp.2012.147; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Wang LY, 2010, CNS NEUROL DISORD-DR, V9, P651, DOI 10.2174/187152710793361559; Wilson AC, 2006, J ENDOCRINOL, V191, P651, DOI 10.1677/joe.1.07047; Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wojniusz S, 2011, HORM BEHAV, V59, P22, DOI 10.1016/j.yhbeh.2010.09.010; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	45	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103607	10.1371/journal.pone.0103607	http://dx.doi.org/10.1371/journal.pone.0103607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089901	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700037
J	Sagnia, B; Fedeli, D; Casetti, R; Montesano, C; Falcioni, G; Colizzi, V				Sagnia, Bertrand; Fedeli, Donatella; Casetti, Rita; Montesano, Carla; Falcioni, Giancarlo; Colizzi, Vittorio			Antioxidant and Anti-Inflammatory Activities of Extracts from Cassia alata, Eleusine indica, Eremomastax speciosa, Carica papaya and Polyscias fulva Medicinal Plants Collected in Cameroon	PLOS ONE			English	Article							FREE-RADICALS; IN-VITRO; OXIDATIVE STRESS; DENDRITIC CELLS; AQUEOUS EXTRACT; ASSAY; ACID; GLUTATHIONE; TRITERPENE; LEAVES	Background: The vast majority of the population around the world has always used medicinal plants as first source of health care to fight infectious and non infectious diseases. Most of these medicinal plants may have scientific evidence to be considered in general practice. Objective: The aim of this work was to investigate the antioxidant capacities and anti-inflammatory activities of ethanol extracts of leaves of Cassia alata, Eleusine indica, Carica papaya, Eremomastax speciosa and the stem bark of Polyscias fulva, collected in Cameroon. Methods: Chemiluminescence was used to analyze the antioxidant activities of plant extracts against hydrogen peroxide or superoxide anion. Comet assays were used to analyze the protection against antioxidant-induced DNA damage induced in white blood cells after treating with hydrogen peroxide. Flow cytometry was used to measure gamma delta T cells proliferation and anti-inflammatory activity of gamma delta T cells and of immature dendritic cells (imDC) in the presence of different concentrations of plant extracts. Results: Ethanol extracts showed strong antioxidant properties against both hydrogen peroxide and superoxide anion. Cassia alata showed the highest antioxidant activity. The effect of plant extracts on gamma delta T cells and imDC was evidenced by the dose dependent reduction in TNF-alpha production in the presence of Cassia alata, Carica papaya, Eremomastax speciosa Eleusine indica, and Polyscias fulva. gamma delta T cells proliferation was affected to the greatest extent by Polyscias fulva. Conclusion: These results clearly show the antioxidant capacity and anti-inflammatory activities of plant extracts collected in Cameroon. These properties of leaves and stem bark extracts may contribute to the value for these plants in traditional medicine and in general medical practice.	[Sagnia, Bertrand] Chantal BIYA Int Reference Ctr Res Prevent & Mana, Lab Microbiol & Immunol, Yaounde, Cameroon; [Fedeli, Donatella; Falcioni, Giancarlo] Univ Camerino, Sch Pharm, I-62032 Camerino, MC, Italy; [Casetti, Rita; Colizzi, Vittorio] Natl Inst Infect Dis Lazzaro Spallanzani, Cellular Immunol Lab, Rome, Italy; [Montesano, Carla; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Camerino; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata	Sagnia, B (corresponding author), Chantal BIYA Int Reference Ctr Res Prevent & Mana, Lab Microbiol & Immunol, Yaounde, Cameroon.	bertrandsagnia@yahoo.fr	Casetti, Rita/K-8631-2016	Casetti, Rita/0000-0002-7574-8780; Montesano, Carla/0000-0002-9865-6619	School of Advanced Studies, University of Camerino, Italy; University of Rome Tor Vergata, Italy	School of Advanced Studies, University of Camerino, Italy; University of Rome Tor Vergata, Italy	This work was supported by the School of Advanced Studies, University of Camerino, Italy, and the University of Rome Tor Vergata, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi IS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-262; Aruoma OI, 2010, TOXICOLOGY, V278, P6, DOI 10.1016/j.tox.2010.09.006; Bedir E, 2001, J NAT PROD, V64, P95, DOI 10.1021/np0003589; Birdi T, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-33; Brusotti G, 2013, J PHARM BIOMED ANAL; Cesari I, 2013, J ETHNOPHARMACOL, V146, P264, DOI 10.1016/j.jep.2012.12.041; Cheynier V, 2013, PLANT PHYSL BIOCH; Cunningham AL, 2013, ADV EXP MED BIOL, V762, P1, DOI 10.1007/978-1-4614-4433-6_1; De Melo GO, 2005, PLANTA MED, V71, P362, DOI 10.1055/s-2005-864104; Dunne MR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/704941; Ettebong EO, 2012, ASIAN PAC J TROP MED, V5, P673, DOI 10.1016/S1995-7645(12)60105-9; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; FLOYD RA, 1990, FASEB J, V4, P2587, DOI 10.1096/fasebj.4.9.2189775; Focho DA, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-17; Gabbianelli R, 2004, COMP BIOCHEM PHYS C, V137, P355, DOI 10.1016/j.cca.2004.03.006; Gabbianelli R, 2003, ARCH ENVIRON CON TOX, V45, P350, DOI 10.1007/s00244-003-2171-1; Ghoti H, 2011, ANN HEMATOL, V90, P509, DOI 10.1007/s00277-010-1110-2; Huang LF, 2011, EUR J PHARMACOL, V672, P169, DOI 10.1016/j.ejphar.2011.09.175; Huang SS, 2013, J ETHNOPHARMACOL, V147, P395, DOI 10.1016/j.jep.2013.03.025; Iqbal Mohammad, 2012, Environmental Health and Preventive Medicine, V17, P307, DOI 10.1007/s12199-011-0255-5; Iweala EEJ, 2010, AFR J TRADIT COMPLEM, V7, P113; Khan M, 2012, J PHARMACEUT BIOMED, V59, P162, DOI 10.1016/j.jpba.2011.09.025; KIRKPATRICK D T, 1986, Journal of Biochemical Toxicology, V1, P93, DOI 10.1002/jbt.2570010110; Kisangau DP, 2007, AFR J TRADIT COMPLEM, V4, P510; Kumar H, 2012, CNS NEUROL DISORD-DR, V11, P1015; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Mitchelmore CL, 1998, ECOTOX ENVIRON SAFE, V41, P51, DOI 10.1006/eesa.1998.1666; Momo CEN, 2006, ANN TROP MED PARASIT, V100, P69, DOI 10.1179/136485906X78517; Morris D, 2013, BBA-GEN SUBJECTS, V1830, P3329, DOI 10.1016/j.bbagen.2012.10.012; Njateng GSS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-95; Nussbaumer O, 2011, BLOOD, V118, P2743, DOI 10.1182/blood-2011-01-328526; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ouedraogo M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/162651; Rao Chandana Venkateswara, 2007, Acta Pharmaceutica (Zagreb), V57, P491, DOI 10.2478/v10007-007-0039-z; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Sen TA, 2010, ANADOLU KARDIYOL DER, V10, P465, DOI 10.5152/akd.2010.149; Sripanidkulchai B, 2001, J ETHNOPHARMACOL, V75, P185, DOI 10.1016/S0378-8741(01)00173-8; Tan PV, 1996, J ETHNOPHARMACOL, V54, P139, DOI 10.1016/S0378-8741(96)01461-4; Thomas E, 2009, J ETHNOPHARMACOL, V122, P60, DOI 10.1016/j.jep.2008.11.021; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Varghese GK, 2013, PHARM BIOL, V51, P345, DOI 10.3109/13880209.2012.729066; World Health Organization, 2002, WHO TRAD MED STRAT 2	45	50	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103999	10.1371/journal.pone.0103999	http://dx.doi.org/10.1371/journal.pone.0103999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090613	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700075
J	Sun, CS; Wang, CYH; Chen, BPW; He, RY; Liu, GCH; Wang, CH; Chen, WL; Chern, Y; Huang, JJT				Sun, Chia-Sui; Wang, Cindy Yu-Hsiang; Chen, Bryan Po-Wen; He, Ruei-Yu; Liu, Gerard Chun-Hao; Wang, Chih-Hsien; Chen, Wenlung; Chern, Yijuang; Huang, Joseph Jen-Tse			The Influence of Pathological Mutations and Proline Substitutions in TDP-43 Glycine-Rich Peptides on Its Amyloid Properties and Cellular Toxicity	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN 43; DNA-BINDING; ALZHEIMER-DISEASE; ION CHANNELS; AGGREGATION; ALS; INCLUSIONS; SCLEROSIS; NEURODEGENERATION	TAR DNA-binding protein (TDP-43) was identified as the major ubiquitinated component deposited in the inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) in 2006. Later on, numerous ALS-related mutations were found in either the glycine or glutamine/asparagine-rich region on the TDP-43 C-terminus, which hinted on the importance of mutations on the disease pathogenesis. However, how the structural conversion was influenced by the mutations and the biological significance of these peptides remains unclear. In this work, various peptides bearing pathogenic or de novo designed mutations were synthesized and displayed their ability to form twisted amyloid fibers, cause liposome leakage, and mediate cellular toxicity as confirmed by transmission electron microscopy (TEM), circular dichroism (CD), Thioflavin T (ThT) assay, Raman spectroscopy, calcein leakage assay, and cell viability assay. We have also shown that replacing glycines with prolines, known to obstruct beta-sheet formation, at the different positions in these peptides may influence the amyloidogenesis process and neurotoxicity. In these cases, GGG308PPP mutant was not able to form beta-amyloid, cause liposome leakage, nor jeopardized cell survival, which hinted on the importance of the glycines (308-310) during amyloidogenesis.	[Sun, Chia-Sui] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei 112, Taiwan; [Sun, Chia-Sui] Acad Sinica, Taipei 115, Taiwan; [Sun, Chia-Sui; Wang, Cindy Yu-Hsiang; Chen, Bryan Po-Wen; He, Ruei-Yu; Liu, Gerard Chun-Hao; Huang, Joseph Jen-Tse] Acad Sinica, Inst Chem, Taipei, Taiwan; [Sun, Chia-Sui; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Sun, Chia-Sui] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Cindy Yu-Hsiang; Liu, Gerard Chun-Hao] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Wang, Chih-Hsien; Chen, Wenlung] Natl Chiayi Univ, Dept Appl Chem, Chiayi, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Chiayi University	Huang, JJT (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.	jthuang@gate.sinica.edu.tw	chern, yijuang/S-7013-2018; Huang, Joseph Jen-Tse/E-4918-2015	chern, yijuang/0000-0002-5842-5429; Huang, Joseph Jen-Tse/0000-0003-4847-7126	Academia Sinica; National Science Council, Taiwan [AS-100-TP2-B02, NSC 100-2113-M-001-013-MY2, NSC 102-2113-M-001-007]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica (http://www.sinica.edu.tw/index.shtml) and the National Science Council, Taiwan. (http://web1.most.gov.tw/) Grant number: AS-100-TP2-B02, NSC 100-2113-M-001-013-MY2, and NSC 102-2113-M-001-007. RYH was supported by the postdoctoral fellowship from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Gendron TF, 2013, J ALZHEIMERS DIS, V33, pS35, DOI 10.3233/JAD-2012-129036; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu GCH, 2013, CHEM COMMUN, V49, P11212, DOI 10.1039/c3cc46762g; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Malchiodi-Albedi Fiorella, 2011, Int J Alzheimers Dis, V2011, P906964, DOI 10.4061/2011/906964; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wigley WC, 2002, NAT STRUCT BIOL, V9, P381, DOI 10.1038/nsb784; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	48	26	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103644	10.1371/journal.pone.0103644	http://dx.doi.org/10.1371/journal.pone.0103644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090004	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700038
J	Li, XF; Lytton, J				Li, Xiao-Fang; Lytton, Jonathan			An Essential Role for the K+-dependent Na+/Ca2+-exchanger, NCKX4, in Melanocortin-4-receptor-dependent Satiety	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; INTRACELLULAR FREE CALCIUM; MELANOCORTIN-4 RECEPTOR; NA+/CA2+ EXCHANGERS; CA2+ CLEARANCE; FOOD-INTAKE; MICE; ACTIVATION; HOMEOSTASIS; MUTATIONS	K+-dependent Na+/Ca2+-exchangers are broadly expressed in various tissues, and particularly enriched in neurons of the brain. The distinct physiological roles for the different members of this Ca2+ transporter family are, however, not well described. Here we show that gene-targeted mice lacking the K+-dependent Na+/Ca2+-exchanger, NCKX4 (gene slc24a4 or Nckx4), display a remarkable anorexia with severe hypophagia and weight loss. Feeding and satiety are coordinated centrally by melanocortin-4 receptors (MC4R) in neurons of the hypothalamic paraventricular nucleus (PVN). The hypophagic response of Nckx4 knock-out mice is accompanied by hyperactivation of neurons in the PVN, evidenced by high levels of c-Fos expression. The activation of PVN neurons in both fasted Nckx4 knock-out and glucose-injected wild-type animals is blocked by Ca2+ removal and MC4R antagonists. In cultured hypothalamic neurons, melanocyte stimulating hormone induces an MC4R-dependent and sustained Ca2+ signal, which requires phospholipase C activity and plasma membrane Ca2+ entry. The Ca2+ signal is enhanced in hypothalamic neurons from Nckx4 knock-out animals, and is depressed in cells in which NCKX4 is overexpressed. Finally, MC4R-dependent oxytocin expression in the PVN, a key essential step in satiety, is prevented by blocking phospholipase C activation or Ca2+ entry. These findings highlight an essential, and to our knowledge previously unknown, role for Ca2+ signaling in the MC4R pathway that leads to satiety, and a novel non-redundant role for NCKX4-mediated Ca2+ extrusion in controlling MC4R signaling and feeding behavior. Together, these findings highlight a novel pathway that potentially could be exploited to develop much needed new therapeutics to tackle eating disorders and obesity.	Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4Z6, Canada; Univ Calgary, Fac Med, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4Z6, Canada	University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Lytton, J (corresponding author), Univ Calgary, Hlth Res Innovat Ctr, Rm GAC64,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jlytton@ucalgary.ca		Lytton, Jonathan/0000-0003-4770-2512	Canadian Institutes of Health Research [FRN 97876]; Tier 1 Canada Research Chair; Alberta Innovates-Health Solutions Medical Scientist award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); Alberta Innovates-Health Solutions Medical Scientist award	This work was supported in part by Canadian Institutes of Health Research Grant FRN 97876 (to J. L.).; Supported by a Tier 1 Canada Research Chair and an Alberta Innovates-Health Solutions Medical Scientist award. To whom correspondence should be addressed: University of Calgary, Health Research Innovation Centre, Rm. GAC64, 3280 Hospital Dr. NW, Calgary, AB T2N 4Z6, Canada.	Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Ausubel FM, 2012, CURRENT PROTOCOLS MO; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Chen M, 2012, ENDOCRINOLOGY, V153, P4256, DOI 10.1210/en.2012-1113; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chiappini F, 2011, J BIOL CHEM, V286, P8094, DOI 10.1074/jbc.M110.178186; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Ghamari-Langroudi M, 2011, P NATL ACAD SCI USA, V108, P355, DOI 10.1073/pnas.1016785108; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Kim MH, 2003, J NEUROSCI, V23, P11673; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lee SH, 2002, J NEUROSCI, V22, P6891; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Marth JD, 1996, J CLIN INVEST, V97, P1999, DOI 10.1172/JCI118634; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mountjoy KG, 2001, PHYSIOL GENOMICS, V5, P11, DOI 10.1152/physiolgenomics.2001.5.1.11; Neumann S, 2005, ENDOCRINOLOGY, V146, P477, DOI 10.1210/en.2004-1045; Newman EA, 2006, J SURG RES, V132, P201, DOI 10.1016/j.jss.2006.02.003; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Sabatier Nancy, 2013, Front Endocrinol (Lausanne), V4, P35, DOI 10.3389/fendo.2013.00035; Schnetkamp PPM, 2004, PFLUG ARCH EUR J PHY, V447, P683, DOI 10.1007/s00424-003-1069-0; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Singru PS, 2007, ENDOCRINOLOGY, V148, P638, DOI 10.1210/en.2006-1233; Sokolow S, 2004, J CLIN INVEST, V113, P265, DOI 10.1172/JCI200418688; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jc.80.2.573; Tateyama M, 2006, P NATL ACAD SCI USA, V103, P1124, DOI 10.1073/pnas.0505925103; Tsuzuki T, 1998, NUCLEIC ACIDS RES, V26, P988, DOI 10.1093/nar/26.4.988; Visser F, 2007, PHYSIOLOGY, V22, P185, DOI 10.1152/physiol.00001.2007; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yang X, 2013, BIOSCIENCE REP, V33, P939, DOI 10.1042/BSR20130099; Zhang Hai, 2013, PLoS One, V8, pe61477, DOI 10.1371/journal.pone.0061477	55	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25445	25459		10.1074/jbc.M114.564450	http://dx.doi.org/10.1074/jbc.M114.564450			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25096581	Green Published, hybrid			2022-12-25	WOS:000342130800005
J	Smith, MH; Rodriguez, EH; Weissman, JS				Smith, Melanie H.; Rodriguez, Edwin H.; Weissman, Jonathan S.			Misfolded Proteins Induce Aggregation of the Lectin Yos9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; STAPHYLOCOCCAL NUCLEASE; UNFOLDED PROTEIN; 131-RESIDUE FRAGMENT; MOLECULAR CHAPERONE; BINDING-SPECIFICITY; PEPTIDE-BINDING	A substantial fraction of nascent proteins delivered into the endoplasmic reticulum (ER) never reach their native conformations. Eukaryotes use a series of complementary pathways to efficiently recognize and dispose of these terminally misfolded proteins. In this process, collectively termed ER-associated degradation (ERAD), misfolded proteins are retrotranslocated to the cytosol, polyubiquitinated, and degraded by the proteasome. Although there has been great progress in identifying ERAD components, how these factors accurately identify substrates remains poorly understood. The targeting of misfolded glycoproteins in the ER lumen for ERAD requires the lectin Yos9, which recognizes the glycan species found on terminally misfolded proteins. In a role that remains poorly characterized, Yos9 also binds the protein component of ERAD substrates. Here, we identified a 45-kDa domain of Yos9, consisting of residues 22-421, that is proteolytically stable, highly structured, and able to fully support ERAD in vivo. In vitro binding studies show that Yos9(22-421) exhibits sequence-specific recognition of linear peptides from the ERAD substrate, carboxypeptidase Y G255R (CPY*), and binds a model unfolded peptide Delta EspP and protein Delta 131 Delta in solution. Binding of Yos9 to these substrates results in their cooperative aggregation. Although the physiological consequences of this substrate-induced aggregation remain to be seen, it has the potential to play a role in the regulation of ERAD.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biosci, Grad Grp Biophys,Ctr RNA Syst Biol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Calif Inst Quantitat Biosci, Ctr RNA Syst Biol, 1700 4th St, San Francisco, CA 94158 USA.	Jonathan.Weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Smith, Melanie/0000-0003-2464-8429	National Institutes of Health [U01 GM098254]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, U01GM098254, T32GM008284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 GM098254 (to J. S. W.).	ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004; Benitez EM, 2011, FEBS LETT, V585, P3015, DOI 10.1016/j.febslet.2011.08.021; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; Carter John Mark, 2004, Curr Protoc Immunol, VChapter 9, DOI 10.1002/0471142735.im0904s60; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dam TK, 2004, METHOD ENZYMOL, V379, P107; deCrouyChanel A, 1996, J BIOL CHEM, V271, P15486, DOI 10.1074/jbc.271.26.15486; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hanna J, 2012, J BIOL CHEM, V287, P8633, DOI 10.1074/jbc.M111.317644; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Izawa T, 2012, MOL BIOL CELL, V23, P1283, DOI 10.1091/mbc.E11-08-0722; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; Plemper RK, 1999, J CELL SCI, V112, P4123; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Wang Y, 1995, BIOCHEMISTRY-US, V34, P15895, DOI 10.1021/bi00049a004; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	45	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25670	25677		10.1074/jbc.M114.583344	http://dx.doi.org/10.1074/jbc.M114.583344			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086047	Green Published, hybrid			2022-12-25	WOS:000342130800026
J	Escobar-Nino, A; Luna, C; Luna, D; Marcos, AT; Canovas, D; Mellado, E				Escobar-Nino, Almudena; Luna, Carlos; Luna, Diego; Marcos, Ana T.; Canovas, David; Mellado, Encarnacion			Selection and Characterization of Biofuel-Producing Environmental Bacteria Isolated from Vegetable Oil-Rich Wastes	PLOS ONE			English	Article							SOLID BY-PRODUCT; BIODIESEL PRODUCTION; ENZYMATIC PRODUCTION; OLIVE OIL; SP NOV.; LIPASE; TRANSESTERIFICATION; TERRIBACILLUS; ALPERUJO; PROPOSAL	Fossil fuels are consumed so rapidly that it is expected that the planet resources will be soon exhausted. Therefore, it is imperative to develop alternative and inexpensive new technologies to produce sustainable fuels, for example biodiesel. In addition to hydrolytic and esterification reactions, lipases are capable of performing transesterification reactions useful for the production of biodiesel. However selection of the lipases capable of performing transesterification reactions is not easy and consequently very few biodiesel producing lipases are currently available. In this work we first isolated 1,016 lipolytic microorganisms by a qualitative plate assay. In a second step, lipolytic bacteria were analyzed using a colorimetric assay to detect the transesterification activity. Thirty of the initial lipolytic strains were selected for further characterization. Phylogenetic analysis revealed that 23 of the bacterial isolates were Gram negative and 7 were Gram positive, belonging to different clades. Biofuel production was analyzed and quantified by gas chromatography and revealed that 5 of the isolates produced biofuel with yields higher than 80% at benchtop scale. Chemical and viscosity analysis of the produced biofuel revealed that it differed from biodiesel. This bacterial-derived biofuel does not require any further downstream processing and it can be used directly in engines. The freeze-dried bacterial culture supernatants could be used at least five times for biofuel production without diminishing their activity. Therefore, these 5 isolates represent excellent candidates for testing biofuel production at industrial scale.	[Escobar-Nino, Almudena; Marcos, Ana T.; Canovas, David] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Escobar-Nino, Almudena; Mellado, Encarnacion] Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain; [Luna, Carlos; Luna, Diego] Univ Cordoba, Dept Organ Chem, Cordoba, Spain	University of Sevilla; University of Sevilla; Universidad de Cordoba	Canovas, D (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	davidc@us.es; emellado@us.es	Cánovas, David/L-7628-2014; MELLADO, ENCARNACIÓN/K-8665-2014; NIÑO, ALMUDENA ESCOBAR/Y-3315-2019; Luna, Diego/I-1059-2015	Cánovas, David/0000-0002-7293-7332; MELLADO, ENCARNACIÓN/0000-0002-7135-1428; NIÑO, ALMUDENA ESCOBAR/0000-0001-5637-1474; Marcos, Ana Teresa/0000-0002-0263-7473; Luna, Diego/0000-0003-1478-7476	Junta de Andalucia [P08-RNM-03515, P11-CVI-7427 MO, P11-TEP-7723]; Spanish Ministry of Economy and Competitiveness [ENE 2011-27017]; FEDER funds	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER funds(European Commission)	This work was supported by grants from Junta de Andalucia (P08-RNM-03515, P11-CVI-7427 MO and P11-TEP-7723), as well as Spanish Ministry of Economy and Competitiveness (Project ENE 2011-27017) and FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alburquerque JA, 2004, BIORESOURCE TECHNOL, V91, P195, DOI 10.1016/S0960-8524(03)00177-9; Alburquerque JA, 2006, CHEMOSPHERE, V64, P470, DOI 10.1016/j.chemosphere.2005.10.055; An SY, 2007, INT J SYST EVOL MICR, V57, P51, DOI 10.1099/ijs.0.64340-0; Bajaj A, 2010, J MOL CATAL B-ENZYM, V62, P9, DOI 10.1016/j.molcatb.2009.09.018; BRISOU J, 1954, ANN I PASTEUR PARIS, V86, P722; Cowan ST, 2004, MANUAL IDENTIFICATIO; de la Fuente C, 2008, ECOTOX ENVIRON SAFE, V70, P207, DOI 10.1016/j.ecoenv.2007.05.021; Elomari M, 1996, INT J SYST BACTERIOL, V46, P1138, DOI 10.1099/00207713-46-4-1138; Green MR, 2012, MOL CLONING LAB MANU; Heyrman J, 2005, INT J SYST EVOL MICR, V55, P119, DOI 10.1099/ijs.0.63221-0; Hoffmann H, 2005, SYST APPL MICROBIOL, V28, P206, DOI 10.1016/j.syapm.2004.12.009; Ilham Z, 2010, BIORESOURCE TECHNOL, V101, P2735, DOI 10.1016/j.biortech.2009.10.053; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; Krishnamurthi S, 2008, INT J SYST EVOL MICR, V58, P2287, DOI 10.1099/ijs.0.65579-0; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Luna C, 2013, ENERGIES, V6, P3879, DOI 10.3390/en6083879; Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002; Meyer A, 1901, ZENTRALBL BAKTERIOL, V7, P680; Modi MK, 2007, BIORESOURCE TECHNOL, V98, P1260, DOI 10.1016/j.biortech.2006.05.006; Moreno MD, 2009, FEMS MICROBIOL ECOL, V68, P59, DOI 10.1111/j.1574-6941.2009.00651.x; MORGAN FJ, 1979, J APPL BACTERIOL, V46, P291, DOI 10.1111/j.1365-2672.1979.tb00823.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Ognjanovic N, 2009, BIORESOURCE TECHNOL, V100, P5146, DOI 10.1016/j.biortech.2009.05.068; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Porta Casanellas J., 1986, TECNICAS EXPT EDAFOL; Ranganathan SV, 2008, BIORESOURCE TECHNOL, V99, P3975, DOI 10.1016/j.biortech.2007.04.060; Ribeiro Bernardo Dias, 2011, Enzyme Res, V2011, P615803, DOI 10.4061/2011/615803; Robles-Medina A, 2009, BIOTECHNOL ADV, V27, P398, DOI 10.1016/j.biotechadv.2008.10.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SILVERMAN MP, 1959, J BACTERIOL, V77, P642, DOI 10.1128/JB.77.5.642-647.1959; Sumner M. E., 1996, Methods of soil analysis. Part 3 - chemical methods., P1201; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng Y, 2007, ANAL BIOCHEM, V363, P297, DOI 10.1016/j.ab.2007.01.026; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verdugo C, 2010, BIORESOURCE TECHNOL, V101, P6657, DOI 10.1016/j.biortech.2010.03.089; Zhang Y, 2003, BIORESOURCE TECHNOL, V89, P1, DOI 10.1016/S0960-8524(03)00040-3	38	14	14	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104063	10.1371/journal.pone.0104063	http://dx.doi.org/10.1371/journal.pone.0104063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099150	Green Published, gold			2022-12-25	WOS:000339995100049
J	Lim, J; Sabandal, PR; Fernandez, A; Sabandal, JM; Lee, HG; Evans, P; Han, KA				Lim, Junghwa; Sabandal, Paul R.; Fernandez, Ana; Sabandal, John Martin; Lee, Hyun-Gwan; Evans, Peter; Han, Kyung-An			The Octopamine Receptor Oct beta 2R Regulates Ovulation in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN-KINASE-II; PHARMACOLOGICAL CHARACTERIZATION; FRUIT-FLY; EXPRESSION; OAMB; SYSTEM; ROLES; GENE; IMMUNOREACTIVITY; IDENTIFICATION	Oviposition is induced upon mating in most insects. Ovulation is a primary step in oviposition, representing an important target to control insect pests and vectors, but limited information is available on the underlying mechanism. Here we report that the beta adrenergic-like octopamine receptor Oct beta 2R serves as a key signaling molecule for ovulation and recruits protein kinase A and Ca2+/calmodulin-sensitive kinase II as downstream effectors for this activity. We found that the oct beta 2r homozygous mutant females are sterile. They displayed normal courtship, copulation, sperm storage and post-mating rejection behavior but were unable to lay eggs. We have previously shown that octopamine neurons in the abdominal ganglion innervate the oviduct epithelium. Consistently, restored expression of Oct beta 2R in oviduct epithelial cells was sufficient to reinstate ovulation and full fecundity in the oct beta 2r mutant females, demonstrating that the oviduct epithelium is a major site of Oct beta 2R's function in oviposition. We also found that overexpression of the protein kinase A catalytic subunit or Ca2+/calmodulin-sensitive protein kinase U led to partial rescue of oct beta 2r's sterility. This suggests that Oct beta 2R activates cAMP as well as additional effectors including Ca2+ /calmodulin-sensitive protein kinase II for oviposition. All three known beta adrenergic-like octopamine receptors stimulate cAMP production in vitro. Oct beta 1R, when ectopically expressed in the oct beta 2r's oviduct epithelium, fully reinstated ovulation and fecundity. Ectopically expressed Oct beta 3R, on the other hand, partly restored ovulation and fecundity while OAMB-K3 and OAMB-AS that increase Ca2+ levels yielded partial rescue of ovulation but not fecundity deficit. These observations suggest that Oct beta 2R have distinct signaling capacities in vivo and activate multiple signaling pathways to induce egg laying. The findings reported here narrow the knowledge gap and offer insight into novel strategies for insect control.	[Lim, Junghwa; Sabandal, Paul R.; Fernandez, Ana; Sabandal, John Martin; Lee, Hyun-Gwan; Han, Kyung-An] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr Neurosci & Metab Disorders, El Paso, TX 79968 USA; [Evans, Peter] Babraham Inst, Inositide Lab, Cambridge, England	University of Texas System; University of Texas El Paso; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Han, KA (corresponding author), Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr Neurosci & Metab Disorders, El Paso, TX 79968 USA.	khan@utep.edu			United States Department of Agriculture [NIFA2010-65105-20625]; National Institute on Minority Health and Health Disparities [8G12MD007592]; Babraham Institute; Biotechnology and Biological Sciences Research Council [BBS/E/B/00001194, BBS/E/B/0000C194] Funding Source: researchfish; BBSRC [BBS/E/B/0000C194] Funding Source: UKRI; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by United States Department of Agriculture NIFA2010-65105-20625 (K.-A.H.) and National Institute on Minority Health and Health Disparities 8G12MD007592 (BBRC/K.-A.H.) grants, and BBSRC funding through the Babraham Institute (P.D.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew AJ, 2012, BRIT J PHARMACOL, V166, P327, DOI 10.1111/j.1476-5381.2011.01761.x; AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Akbari OS, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-8; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BOOTH TF, 1989, EXP APPL ACAROL, V7, P259, DOI 10.1007/BF01197920; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; Chen X, 2010, INSECT BIOCHEM MOLEC, V40, P476, DOI 10.1016/j.ibmb.2010.04.007; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Cossio-Bayugar R, 2012, J INSECT PHYSIOL, V58, P628, DOI 10.1016/j.jinsphys.2012.01.006; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Drazen DL, 1999, NITRIC OXIDE-BIOL CH, V3, P366, DOI 10.1006/niox.1999.0251; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Farooqui T, 2003, J NEUROSCI, V23, P5370; Gabler M, 2005, GENETICS, V169, P723, DOI 10.1534/genetics.103.020842; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Han KA, 1998, J NEUROSCI, V18, P3650; HELM G, 1982, ACTA PHYSIOL SCAND, V114, P425, DOI 10.1111/j.1748-1716.1982.tb07005.x; Isaac RE, 2010, P ROY SOC B-BIOL SCI, V277, P65, DOI 10.1098/rspb.2009.1236; Jones RJ, 2007, AM J PHYSIOL-HEART C, V292, pH2634, DOI 10.1152/ajpheart.01247.2006; Kapelnikov A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-114; Khan I, 2005, PHARMACOLOGY, V74, P157, DOI 10.1159/000084615; Kiger JA, 1999, GENETICS, V152, P281; Kim YC, 2007, GENES BRAIN BEHAV, V6, P201, DOI 10.1111/j.1601-183X.2006.00241.x; Kim YC, 2013, J NEUROSCI, V33, P1672, DOI 10.1523/JNEUROSCI.3042-12.2013; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004716; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Nykamp DA, 2000, J INSECT PHYSIOL, V46, P809, DOI 10.1016/S0022-1910(99)00170-5; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Rezaval C, 2012, CURR BIOL, V22, P1155, DOI 10.1016/j.cub.2012.04.062; Ribeiro C, 2010, CURR BIOL, V20, P1000, DOI 10.1016/j.cub.2010.03.061; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Schneider JC, 2003, AM J PHYSIOL-HEART C, V284, pH2311, DOI 10.1152/ajpheart.00932.2001; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Tay JI, 1997, HUM REPROD, V12, P2451, DOI 10.1093/humrep/12.11.2451; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Wu SF, 2012, J EXP BIOL, V215, P2646, DOI 10.1242/jeb.068932; Yamane T, 2010, J INSECT PHYSIOL, V56, P271, DOI 10.1016/j.jinsphys.2009.10.011; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012	51	33	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104441	10.1371/journal.pone.0104441	http://dx.doi.org/10.1371/journal.pone.0104441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099506	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100072
J	Carver, J; Dexheimer, TS; Hsu, D; Weng, MT; Smith, JL; Guha, R; Jadhav, A; Simeonov, A; Luo, J				Carver, Joseph; Dexheimer, Thomas S.; Hsu, Dennis; Weng, Meng-Tzu; Smith, Jordan L.; Guha, Rajarshi; Jadhav, Ajit; Simeonov, Anton; Luo, Ji			A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein	PLOS ONE			English	Article							RAS ONCOGENES; IN-VITRO; K-RAS; INHIBITION; PROTEIN; DEGRADATION; CANCER; LOCALIZATION; TRAFFICKING; ACTIVATION	Mutations in the Ras family of small GTPases, particularly KRAS, occur at high frequencies in cancer and represent a major unmet therapeutic need due to the lack of effective targeted therapies. Past efforts directed at inhibiting the activity of the Ras oncoprotein have proved difficult. We propose an alternative approach to target Ras by eliminating Ras protein from cells with pharmacological means. In this study, we developed a cell-based, high-content screening platform to identify small molecules that could promote the degradation of the KRAS oncoprotein. We generated an EGFP-KRAS(G12V) fluorescence reporter system and implemented it for automated screening in 1536-well plates using high-throughput cellular imaging. We screened a library of clinically relevant compounds at wide dose range and identified Ponatinib and AMG-47a as two candidate compounds that selectively reduced the levels of EGFP-KRAS(G12V) protein but did not affect EGFP protein in cells. This proof-of-principle study demonstrates that it is feasible to use a high-throughput screen to identify compounds that promote the degradation of the Ras oncoprotein as a new approach to target Ras.	[Carver, Joseph; Hsu, Dennis; Weng, Meng-Tzu; Smith, Jordan L.; Luo, Ji] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Dexheimer, Thomas S.; Guha, Rajarshi; Jadhav, Ajit; Simeonov, Anton] Natl Ctr Adv Translat Sci, Div Preclin Innovat, Natl Inst Hlth Chem Genom Ctr, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Simeonov, A (corresponding author), Natl Ctr Adv Translat Sci, Div Preclin Innovat, Natl Inst Hlth Chem Genom Ctr, Bethesda, MD 20894 USA.	asimeono@mail.nih.gov; ji.luo@nih.gov	Smith, Jordan/GVU-3480-2022	Smith, Jordan/0000-0003-0460-0647; Jadhav, Ajit/0000-0001-7955-1451	National Cancer Institute (NCI) Center for Cancer Research-Johns Hopkins University Master in Biotechnology Fellowship; Howard Hughes Medical Institute-National Institutes of Health Research Scholar Fellowship; Liver Disease Prevention and Treatment Research Foundation (Taiwan) Fellowship; NCI Intramural Program; Division of Preclinical Innovation at the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Center for Cancer Research-Johns Hopkins University Master in Biotechnology Fellowship; Howard Hughes Medical Institute-National Institutes of Health Research Scholar Fellowship; Liver Disease Prevention and Treatment Research Foundation (Taiwan) Fellowship; NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Preclinical Innovation at the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by an National Cancer Institute (NCI) Center for Cancer Research-Johns Hopkins University Master in Biotechnology Fellowship to J.C.; by a Howard Hughes Medical Institute-National Institutes of Health Research Scholar Fellowship to D. H.; by a Liver Disease Prevention and Treatment Research Foundation (Taiwan) Fellowship to M. T. W.; by the NCI Intramural Program to J.L.; and by the Division of Preclinical Innovation at the National Center for Advancing Translational Sciences to T. S. D., R. G., A.J. and A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Cho KJ, 2012, J BIOL CHEM, V287, P43573, DOI 10.1074/jbc.M112.424457; Cox Adrienne D, 2010, Small GTPases, V1, P2; Friedland JC, 2014, INVEST NEW DRUG, V32, P14, DOI 10.1007/s10637-013-9971-6; Grade M, 2011, INT J CANCER, V128, P1069, DOI 10.1002/ijc.25453; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Khvalevsky EZ, 2013, P NATL ACAD SCI USA, V110, P20723, DOI 10.1073/pnas.1314307110; Ma YH, 2013, MOL CANCER THER, V12, P286, DOI 10.1158/1535-7163.MCT-12-0650; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raina K, 2010, J BIOL CHEM, V285, P11057, DOI 10.1074/jbc.R109.078105; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Rodriguez-Gonzalez A, 2008, ONCOGENE, V27, P7201, DOI 10.1038/onc.2008.320; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; ULSH LS, 1984, MOL CELL BIOL, V4, P1647, DOI 10.1128/MCB.4.8.1647; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	33	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103836	10.1371/journal.pone.0103836	http://dx.doi.org/10.1371/journal.pone.0103836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093678	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200034
J	Konda, K; Konishi, K; Yamochi, T; Ito, YM; Nozawa, H; Tojo, M; Shinmura, K; Kogo, M; Katagiri, A; Kubota, Y; Muramoto, T; Yano, Y; Kobayashi, Y; Kihara, T; Tagawa, T; Makino, R; Takimoto, M; Imawari, M; Yoshida, H				Konda, Kenichi; Konishi, Kazuo; Yamochi, Toshiko; Ito, Yoichi M.; Nozawa, Hisako; Tojo, Masayuki; Shinmura, Kensuke; Kogo, Mari; Katagiri, Atsushi; Kubota, Yutaro; Muramoto, Takashi; Yano, Yuichiro; Kobayashi, Yoshiya; Kihara, Toshihiro; Tagawa, Teppei; Makino, Reiko; Takimoto, Masafumi; Imawari, Michio; Yoshida, Hitoshi			Distinct Molecular Features of Different Macroscopic Subtypes of Colorectal Neoplasms	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; LATERALLY-SPREADING TUMORS; POPULATION-BASED SERIES; K-RAS; DNA METHYLATION; PIK3CA MUTATION; SERRATED PATHWAY; FLAT; ADENOMAS; CANCER	Background: Colorectal adenoma develops into cancer with the accumulation of genetic and epigenetic changes. We studied the underlying molecular and clinicopathological features to better understand the heterogeneity of colorectal neoplasms (CRNs). Methods: We evaluated both genetic (mutations of KRAS, BRAF, TP53, and PIK3CA, and microsatellite instability [MSI]) and epigenetic (methylation status of nine genes or sequences, including the CpG island methylator phenotype [CIMP] markers) alterations in 158 CRNs including 56 polypoid neoplasms (PNs), 25 granular type laterally spreading tumors (LST-Gs), 48 non-granular type LSTs (LST-NGs), 19 depressed neoplasms (DNs) and 10 small flat-elevated neoplasms (S-FNs) on the basis of macroscopic appearance. Results: S-FNs showed few molecular changes except SFRP1 methylation. Significant differences in the frequency of KRAS mutations were observed among subtypes (68% for LST-Gs, 36% for PNs, 16% for DNs and 6% for LST-NGs) (P<0.001). By contrast, the frequency of TP53 mutation was higher in DNs than PNs or LST-Gs (32% vs. 5% or 0%, respectively) (P<0.007). We also observed significant differences in the frequency of CIMP between LST-Gs and LST-NGs or PNs (32% vs. 6% or 5%, respectively) (P<0.005). Moreover, the methylation level of LINE-1 was significantly lower in DNs or LST-Gs than in PNs (58.3% or 60.5% vs. 63.2%, P<0.05). PIK3CA mutations were detected only in LSTs. Finally, multivariate analyses showed that macroscopic morphologies were significantly associated with an increased risk of molecular changes (PN or LST-G for KRAS mutation, odds ratio [OR] 9.11; LST-NG or DN for TP53 mutation, OR 5.30; LST-G for PIK3CA mutation, OR 26.53; LST-G or DN for LINE-1 hypomethylation, OR 3.41). Conclusion: We demonstrated that CRNs could be classified into five macroscopic subtypes according to clinicopathological and molecular differences, suggesting that different mechanisms are involved in the pathogenesis of colorectal tumorigenesis.	[Konda, Kenichi; Konishi, Kazuo; Nozawa, Hisako; Tojo, Masayuki; Shinmura, Kensuke; Katagiri, Atsushi; Kubota, Yutaro; Muramoto, Takashi; Yano, Yuichiro; Kobayashi, Yoshiya; Kihara, Toshihiro; Tagawa, Teppei; Imawari, Michio; Yoshida, Hitoshi] Showa Univ Sch Med, Dept Med, Div Gastroenterol, Tokyo, Japan; [Yamochi, Toshiko; Takimoto, Masafumi] Showa Univ Sch Med, Dept Pathol, Tokyo, Japan; [Makino, Reiko] Showa Univ Sch Med, Clin Collaborating Lab, Tokyo, Japan; [Kogo, Mari] Showa Univ Sch Pharm, Dept Hosp Pharmaceut, Tokyo, Japan; [Ito, Yoichi M.] Hokkaido Univ Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Showa University; Showa University; Showa University; Hokkaido University	Konishi, K (corresponding author), Showa Univ Sch Med, Dept Med, Div Gastroenterol, Tokyo, Japan.	konishimd@med.showa-u.ac.jp		Ito, Yoichi M./0000-0001-5073-0827	Japanese Ministry of Education, Culture, Sports, Science and Technology of Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (C) and Supported Program for the Strategic Research Foundation at Private Universities from Japanese Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1991, DIS COLON RECTUM, V34, P981, DOI 10.1007/BF02049961; An B, 2010, INT J CANCER, V127, P2095, DOI 10.1002/ijc.25225; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Beggs AD, 2013, J PATHOL, V229, P697, DOI 10.1002/path.4132; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; FUJIMORI T, 1994, INT J CANCER, V57, P51, DOI 10.1002/ijc.2910570110; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hiraoka S, 2006, GASTROENTEROLOGY, V131, P379, DOI 10.1053/j.gastro.2006.04.027; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kaji E, 2011, J GASTROEN HEPATOL, V26, P599, DOI 10.1111/j.1440-1746.2010.06485.x; Kaneko K, 2000, GASTROINTEST ENDOSC, V51, P443, DOI 10.1016/S0016-5107(00)70446-9; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Konishi K, 2004, CLIN CANCER RES, V10, P3082, DOI 10.1158/1078-0432.CCR-03-0334; Konishi K, 2006, BRIT J CANCER, V94, P311, DOI 10.1038/sj.bjc.6602911; Konishi K, 2007, GASTROENTEROLOGY, V132, P1254, DOI 10.1053/j.gastro.2007.01.035; Konishi K, 2007, CANCER J, V13, P49, DOI 10.1097/PPO.0b013e31803c72fe; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Kudo S, 1997, WORLD J SURG, V21, P694, DOI 10.1007/s002689900293; Kudo S, 2000, WORLD J SURG, V24, P1081, DOI 10.1007/s002680010154; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; MINAMOTO T, 1994, CANCER RES, V54, P2841; MINAMOTO T, 1994, GASTROENTEROLOGY, V106, P1436, DOI 10.1016/0016-5085(94)90395-6; Mollevi DG, 2007, CARCINOGENESIS, V28, P1241, DOI 10.1093/carcin/bgm012; Morita T, 2002, GASTROINTEST ENDOSC, V56, P663, DOI 10.1067/mge.2002.129087; MORSON BC, 1968, BRIT J SURG, V55, P725, DOI 10.1002/bjs.1800551003; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; O'Brien MJ, 2004, CLIN GASTROENTEROL H, V2, P905, DOI 10.1016/S1542-3565(04)00392-1; Ogino S, 2005, CLIN CANCER RES, V11, P6650, DOI 10.1158/1078-0432.CCR-05-0738; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P1789, DOI 10.1093/jnci/djt298; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Richter H, 2003, AM J PATHOL, V163, P287, DOI 10.1016/S0002-9440(10)63652-8; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Saito Y, 2001, ENDOSCOPY, V33, P682, DOI 10.1055/s-2001-16213; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Sugimoto T, 2010, INT J CANCER, V127, P1562, DOI 10.1002/ijc.25180; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Takahashi T, 2007, MODERN PATHOL, V20, P139, DOI 10.1038/modpathol.3800722; Voorham QJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041963; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; YAMAGATA S, 1994, JPN J CANCER RES, V85, P147, DOI 10.1111/j.1349-7006.1994.tb02075.x; Yamamoto E, 2012, AM J PATHOL, V181, P1847, DOI 10.1016/j.ajpath.2012.08.007; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yano Y, 2011, AM J GASTROENTEROL, V106, P1351, DOI 10.1038/ajg.2011.76; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164	55	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103822	10.1371/journal.pone.0103822	http://dx.doi.org/10.1371/journal.pone.0103822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093594	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200033
J	Ye, Q; Hu, YF; Jin, CW				Ye, Qian; Hu, Yunfei; Jin, Changwen			Conformational Dynamics of Escherichia coli Flavodoxins in Apo- and Holo-States by Solution NMR Spectroscopy	PLOS ONE			English	Article							CLOSTRIDIUM-BEIJERINCKII FLAVODOXIN; TORSION ANGLE DYNAMICS; BACKBONE DYNAMICS; BIOTIN SYNTHASE; ANABAENA APOFLAVODOXIN; DIFFERENTIATING LOOP; VULGARIS FLAVODOXIN; OXIDIZED FLAVODOXIN; SECONDARY STRUCTURE; ELECTRON-TRANSFER	Flavodoxins are a family of small FMN-binding proteins that commonly exist in prokaryotes. They utilize a non-covalently bound FMN molecule to act as the redox center during the electron transfer processes in various important biological pathways. Although extensive investigations were performed, detailed molecular mechanisms of cofactor binding and electron transfer remain elusive. Herein we report the solution NMR studies on Escherichia coli flavodoxins FldA and YqcA, belonging to the long-chain and short-chain flavodoxin subfamilies respectively. Our structural studies demonstrate that both proteins show the typical flavodoxin fold, with extensive conformational exchanges observed near the FMN binding pocket in their apo-forms. Cofactor binding significantly stabilizes both proteins as revealed by the extension of secondary structures in the holo-forms, and the overall rigidity shown by the backbone dynamics data. However, the 50 s loops of both proteins in the holo-form still show conformational exchanges on the mu s-ms timescales, which appears to be a common feature in the flavodoxin family, and might play an important role in structural fine-tuning during the electron transfer reactions.	[Ye, Qian; Hu, Yunfei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Ye, Qian; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Hu, YF (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei@pku.edu.cn; changwen@pku.edu.cn			National Natural Science Foundation of China [31100525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Grant 31100525 from the National Natural Science Foundation of China to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti Y, 2004, J AM CHEM SOC, V126, P8001, DOI 10.1021/ja0496470; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; Birch OM, 2000, J BIOL CHEM, V275, P32277, DOI 10.1074/jbc.M004497200; BIRCH OM, 1995, J BIOL CHEM, V270, P19158, DOI 10.1074/jbc.270.32.19158; Bollen YJM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2010; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang FC, 1999, BIOCHEMISTRY-US, V38, P7168, DOI 10.1021/bi982203u; Chen HC, 2008, BIOCHEMISTRY-US, V47, P13788, DOI 10.1021/bi800954h; de la Pena TC, 2013, J APPL MICROBIOL, V115, P236, DOI 10.1111/jam.12224; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cremades N, 2005, BIOPHYS CHEM, V115, P267, DOI 10.1016/j.bpc.2004.12.045; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fischer MWF, 1998, P NATL ACAD SCI USA, V95, P8016, DOI 10.1073/pnas.95.14.8016; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoover DM, 1997, PROTEIN SCI, V6, P2525; Hrovat A, 1997, J BIOMOL NMR, V10, P53, DOI 10.1023/A:1018380509735; Hu YF, 2006, J BIOL CHEM, V281, P35454, DOI 10.1074/jbc.M607336200; Inda LA, 2003, PHYTOCHEMISTRY, V63, P303, DOI 10.1016/S0031-9422(03)00160-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kasim M, 2000, BIOCHEMISTRY-US, V39, P15322, DOI 10.1021/bi001519a; Kasim M, 2001, BIOCHEMISTRY-US, V40, P13548, DOI 10.1021/bi011587c; KNIGHT E, 1967, J BIOL CHEM, V242, P1370; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Langdon GM, 2001, PROTEINS, V43, P476, DOI 10.1002/prot.1059; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47177, DOI 10.1074/jbc.M405792200; Lostao A, 2003, J BIOL CHEM, V278, P24053, DOI 10.1074/jbc.M301049200; Lostao A, 2000, J BIOL CHEM, V275, P9518, DOI 10.1074/jbc.275.13.9518; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Martinez-Julvez M, 2007, PROTEINS, V69, P581, DOI 10.1002/prot.21410; Mayhew SG, 1996, BIOCHEM SOC T, V24, P122, DOI 10.1042/bst0240122; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; O'Farrell PA, 1998, BIOCHEMISTRY-US, V37, P8405, DOI 10.1021/bi973193k; OSBORNE C, 1991, J BACTERIOL, V173, P1729, DOI 10.1128/jb.173.5.1729-1737.1991; Ponstingl H, 1997, EUR J BIOCHEM, V244, P384, DOI 10.1111/j.1432-1033.1997.00384.x; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sanyal I, 1996, ARCH BIOCHEM BIOPHYS, V326, P48, DOI 10.1006/abbi.1996.0045; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sawers G, 1998, MOL MICROBIOL, V29, P945, DOI 10.1046/j.1365-2958.1998.00941.x; Sibille N, 2005, BIOCHEMISTRY-US, V44, P9086, DOI 10.1021/bi050437p; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; Ye Q, 2013, BIOMOL NMR ASSIGN; Zhang PL, 1997, J MOL BIOL, V272, P443, DOI 10.1006/jmbi.1997.1266	56	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103936	10.1371/journal.pone.0103936	http://dx.doi.org/10.1371/journal.pone.0103936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093851	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200047
J	Heggemann, F; Hamm, K; Brade, J; Streitner, F; Doesch, C; Papavassiliu, T; Borggrefe, M; Haghi, D				Heggemann, Felix; Hamm, Karsten; Brade, Joachim; Streitner, Florian; Doesch, Christina; Papavassiliu, Theano; Borggrefe, Martin; Haghi, Dariusch			Right Ventricular Function Quantification in Takotsubo Cardiomyopathy Using Two-Dimensional Strain Echocardiography	PLOS ONE			English	Article							APICAL BALLOONING SYNDROME; HEART-FAILURE; LONGITUDINAL STRAIN; PLEURAL EFFUSIONS; SPECKLE TRACKING; PROGNOSTIC VALUE; HYPERTENSION; INVOLVEMENT; DYSFUNCTION; ADULTS	Aims: This study sought to characterize global and regional right ventricular (RV) myocardial function in patients with Takotsubo cardiomyopathy (TC) using 2D strain imaging. Methods: We compared various parameters of RV and left ventricular (LV) systolic function between 2 groups of consecutive patients with TC at initial presentation and upon follow-up. Group 1 had RV involvement and group 2 did not have RV involvement. Results: At initial presentation, RV peak systolic longitudinal strain (RVPSS) and RV fractional area change (RVFAC) were significantly lower in group 1 (-13.2 +/- 8.6% vs. -21.8 +/- 5.4%, p = 0.001; 30.7 +/- 9.3% vs. 43.5 +/- 6.3%, p = 0.001) and improved significantly upon follow-up. Tricuspid annular plane systolic excursion (TAPSE) did not differ significantly at initial presentation between both groups (14.8 +/- 4.1 mm vs. 17.9 +/- 3.5 mm, p = 0.050). Differences in regional systolic RV strain were only observed in the mid and apical segments. LV ejection fraction (LVEF) and LV global strain were significantly lower in group 1 (36 +/- 8% vs. 46 +/- 10%, p = 0.006 and -5.5 +/- 4.8% vs. -10.2 > 6.2%, p = 0.040) at initial presentation. None of the parameters were significantly different between the 2 groups upon follow-up. A RVPSS cut-off value of >-19.1% had a sensitivity of 85% and a specificity of 71% to discriminate between the 2 groups. Conclusion: In TC, RVFAC, RVPSS, LVEF and LV global strain differed significantly between patients with and without RV dysfunction, whereas TAPSE did not. 2 D strain imaging was feasible for the assessment of RV dysfunction in TC and could discriminate between patients with and without RV involvement in a clinically meaningful way.	[Heggemann, Felix; Streitner, Florian; Doesch, Christina; Papavassiliu, Theano; Borggrefe, Martin; Haghi, Dariusch] Heidelberg Univ, Univ Med Ctr Mannheim, Med Dept 1, Mannheim, Germany; [Hamm, Karsten] Ctr Cardiovasc Med, Dept Cardiol, Bad Neustadt an der Saale, Germany; [Brade, Joachim] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Biometr & Stat, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Heggemann, F (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Dept 1, Mannheim, Germany.	felixheggemann@gmx.de		Hamm, Karsten/0000-0001-5808-5842				Aneq MA, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-37; Brixey AG, 2011, CURR OPIN PULM MED, V17, P226, DOI 10.1097/MCP.0b013e32834702fb; Brown SB, 2011, CHEST, V140, P27, DOI 10.1378/chest.10-1136; Burgdorf C, 2011, CLIN RES CARDIOL, V100, P617, DOI 10.1007/s00392-011-0293-4; Cameli M, 2012, TRANSPL P, V44, P2013, DOI 10.1016/j.transproceed.2012.06.018; Diller GP, 2012, AM HEART J, V163, P859, DOI 10.1016/j.ahj.2012.01.038; Dote K, 1991, J Cardiol, V21, P203; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Giusca S, 2010, HEART, V96, P281, DOI 10.1136/hrt.2009.171728; Guendouz S, 2012, CIRC J, V76, P127, DOI 10.1253/circj.CJ-11-0778; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; Haghi D, 2007, INT J CARDIOL, V120, P205, DOI 10.1016/j.ijcard.2006.09.019; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Hanekom L, 2007, EUR HEART J, V28, P1765, DOI 10.1093/eurheartj/ehm188; Heggemann F, 2009, EUR J ECHOCARDIOGR, V10, P760, DOI 10.1093/ejechocard/jep062; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Kempny A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-32; Kurisu S, 2005, INTERNAL MED, V44, P727, DOI 10.2169/internalmedicine.44.727; Mrdovic I, 2010, J AM COLL CARDIOL, V55, P1750, DOI 10.1016/j.jacc.2009.02.098; Natanzon A, 2009, AM J MED SCI, V338, P211, DOI 10.1097/MAJ.0b013e3181a3936f; Nishikawa S, 2004, CIRC J, V68, P1076, DOI 10.1253/circj.68.1076; Nyui N, 2000, JPN CIRC J, V64, P715, DOI 10.1253/jcj.64.715; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Stahli BE, 2011, EUR HEART J, V32, P1821, DOI 10.1093/eurheartj/ehr079; Ternacle J, 2013, J AM SOC ECHOCARDIOG, V26, P721, DOI 10.1016/j.echo.2013.03.021; Teske AJ, 2009, J AM SOC ECHOCARDIOG, V22, P920, DOI 10.1016/j.echo.2009.05.014; Teske PR, 2009, MOL ECOL RESOUR, V9, P1162, DOI 10.1111/j.1755-0998.2009.02595.x	27	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103717	10.1371/journal.pone.0103717	http://dx.doi.org/10.1371/journal.pone.0103717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089702	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700046
J	Jia, SX; Keilberg, D; Hot, E; Thanbichler, M; Sogaard-Andersen, L; Lenz, P				Jia, Shuxin; Keilberg, Daniela; Hot, Edina; Thanbichler, Martin; Sogaard-Andersen, Lotte; Lenz, Peter			Effect of the Min System on Timing of Cell Division in Escherichia coli	PLOS ONE			English	Article							TO-POLE OSCILLATION; CHROMOSOME-REPLICATION; FTSZ RING; TOPOLOGICAL REGULATION; ASSEMBLY DYNAMICS; BACILLUS-SUBTILIS; STOCHASTIC-MODEL; SEPTUM FORMATION; INHIBITOR MINC; RAPID POLE	In Escherichia coli the Min protein system plays an important role in positioning the division site. We show that this system also has an effect on timing of cell division. We do this in a quantitative way by measuring the cell division waiting time (defined as time difference between appearance of a division site and the division event) and the Z-ring existence time. Both quantities are found to be different in WT and cells without functional Min system. We develop a series of theoretical models whose predictions are compared with the experimental findings. Continuous improvement leads to a final model that is able to explain all relevant experimental observations. In particular, it shows that the chromosome segregation defect caused by the absence of Min proteins has an important influence on timing of cell division. Our results indicate that the Min system affects the septum formation rate. In the absence of the Min proteins this rate is reduced, leading to the observed strongly randomized cell division events and the longer division waiting times.	[Jia, Shuxin; Lenz, Peter] Univ Marburg, Dept Phys, D-35032 Marburg, Germany; [Jia, Shuxin; Keilberg, Daniela; Thanbichler, Martin; Sogaard-Andersen, Lotte; Lenz, Peter] Univ Marburg, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Keilberg, Daniela; Hot, Edina; Thanbichler, Martin; Sogaard-Andersen, Lotte] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Thanbichler, Martin] Univ Marburg, Dept Biol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Max Planck Society; Philipps University Marburg	Lenz, P (corresponding author), Univ Marburg, Dept Phys, D-35032 Marburg, Germany.	peter.lenz@Physik.Uni-Marburg.DE		Sogaard-Andersen, Lotte/0000-0002-0674-0013; Lenz, Peter/0000-0001-7705-3950	German Research Council within the framework of the Graduate School "Intra- and Intercellular Transport and Communication"; Max Planck Society; LOEWE Research Center for Synthetic Microbiology	German Research Council within the framework of the Graduate School "Intra- and Intercellular Transport and Communication"; Max Planck Society(Max Planck SocietyFoundation CELLEX); LOEWE Research Center for Synthetic Microbiology	This work was supported by the German Research Council within the framework of the Graduate School "Intra- and Intercellular Transport and Communication", the Max Planck Society, and the LOEWE Research Center for Synthetic Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1992, MOL MICROBIOL, V6, P2073, DOI 10.1111/j.1365-2958.1992.tb01380.x; Akerlund T, 2002, MICROBIOL-SGM, V148, P3213, DOI 10.1099/00221287-148-10-3213; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; BI E, 1990, J BACTERIOL, V172, P2765, DOI 10.1128/jb.172.5.2765-2768.1990; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; Boye E, 2003, EMBO REP, V4, P757, DOI 10.1038/sj.embor.embor895; Browning ST, 2004, BIOTECHNOL BIOENG, V88, P575, DOI 10.1002/bit.20223; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Creutziger M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/095016; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Di Ventura B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.44; Di Ventura B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.111; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Drew DA, 2005, P NATL ACAD SCI USA, V102, P6114, DOI 10.1073/pnas.0502037102; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016009; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Fried L, 2012, J MICROBIOL METH, V91, P537, DOI 10.1016/j.mimet.2012.09.023; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; Howard M, 2005, J CELL BIOL, V168, P533, DOI 10.1083/jcb.200411122; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; JAFFE A, 1988, J BACTERIOL, V170, P3094, DOI 10.1128/jb.170.7.3094-3101.1988; Jenal U, 2009, RES MICROBIOL, V160, P687, DOI 10.1016/j.resmic.2009.09.006; Johnson JE, 2002, J BACTERIOL, V184, P2951, DOI 10.1128/JB.184.11.2951-2962.2002; Kerr RA, 2006, P NATL ACAD SCI USA, V103, P347, DOI 10.1073/pnas.0505825102; Koch AL, 2002, CRIT REV MICROBIOL, V28, P61, DOI 10.1080/1040-840291046696; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lenz P, 2011, NAT REV MICROBIOL, V9, P565, DOI 10.1038/nrmicro2612; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; Lutkenhaus J, 2002, CURR OPIN MICROBIOL, V5, P548, DOI 10.1016/S1369-5274(02)00376-4; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; MAHAFFY JM, 1989, J THEOR BIOL, V140, P453, DOI 10.1016/S0022-5193(89)80109-2; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Migocki MD, 2002, EMBO REP, V3, P1163, DOI 10.1093/embo-reports/kvf233; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MULDER E, 1990, MOL GEN GENET, V221, P87, DOI 10.1007/BF00280372; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NORDSTROM K, 1991, MOL MICROBIOL, V5, P769, DOI 10.1111/j.1365-2958.1991.tb00747.x; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Sun Q, 1998, MOL MICROBIOL, V29, P491, DOI 10.1046/j.1365-2958.1998.00942.x; TEATHER RM, 1974, J BACTERIOL, V118, P407, DOI 10.1128/JB.118.2.407-413.1974; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Tostevin F, 2006, PHYS BIOL, V3, P1, DOI 10.1088/1478-3975/3/1/001; VINELLA D, 1995, BIOESSAYS, V17, P527, DOI 10.1002/bies.950170609; Wery M, 2001, BIOCHIMIE, V83, P193, DOI 10.1016/S0300-9084(01)01254-8; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	88	8	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103863	10.1371/journal.pone.0103863	http://dx.doi.org/10.1371/journal.pone.0103863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090009	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700060
J	Strom, A; Yutzy, B; Kruip, C; Ooms, M; Schloot, NC; Roden, M; Scott, FW; Loewer, J; Holznagel, E				Strom, Alexander; Yutzy, Barbara; Kruip, Carina; Ooms, Mark; Schloot, Nanette C.; Roden, Michael; Scott, Fraser W.; Loewer, Johannes; Holznagel, Edgar			Foodborne Transmission of Bovine Spongiform Encephalopathy to Non-Human Primates Results in Preclinical Rapid-Onset Obesity	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; VARIANT CJD; BRAIN; GUT; MICE; CATTLE; AGENT; CELLS; COMMUNICATION; INFECTION	Obesity has become one of the largest public health challenges worldwide. Recently, certain bacterial and viral pathogens have been implicated in the pathogenesis of obesity. In the present study, we retrospectively analyzed clinical data, plasma samples and post-mortem tissue specimens derived from a risk assessment study in bovine spongiform encephalopathy (BSE)-infected female cynomolgus monkeys (Macaca fascicularis). The original study design aimed to determine minimal infectious doses after oral or intracerebral (i.c.) infection of macaques to assess the risk for humans. High-dose exposures resulted in 100% attack rates and a median incubation time of 4.7 years as described previously. Retrospective analyses of clinical data from high-dosed macaques revealed that foodborne BSE transmission caused rapid weight gain within 1.5 years post infection (beta = 0.915; P<0.0001) which was not seen in age-and sex-matched control animals or i.c. infected animals. The rapid-onset obesity was not associated with impaired pancreatic islet function or glucose metabolism. In the early preclinical phase of oral transmission associated with body weight gain, prion accumulation was confined to the gastrointestinal tract. Intriguingly, immunohistochemical findings suggest that foodborne BSE transmission has a pathophysiological impact on gut endocrine cells which may explain rapid weight gain. To our knowledge, this is the first experimental model which clearly demonstrates that foodborne pathogens can induce obesity.	[Strom, Alexander; Ooms, Mark; Schloot, Nanette C.; Roden, Michael] Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Yutzy, Barbara; Kruip, Carina; Loewer, Johannes; Holznagel, Edgar] Fed Agcy Vaccines & Biomed, Paul Ehrlich Inst, Langen, Germany; [Roden, Michael] Univ Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Scott, Fraser W.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON, Canada	Deutsches Diabetes-Zentrum (DDZ); Paul Ehrlich Institute; Heinrich Heine University Dusseldorf; University of Ottawa; Ottawa Hospital Research Institute	Strom, A (corresponding author), Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	alexander.strom@ddz.uni-duesseldorf.de; Edgar.Holznagel@pei.de	Roden, Michael/AAD-3843-2019		European Union [QLK1-2002-01096]; German Ministry of Health, Bonn/Berlin	European Union(European Commission); German Ministry of Health, Bonn/Berlin	This study was performed in partial fulfillment of the study 'BSE in primates' supported by the European Union [QLK1-2002-01096] and by the German Ministry of Health, Bonn/Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041652; Amselgruber WM, 2006, HISTOCHEM CELL BIOL, V125, P441, DOI 10.1007/s00418-005-0089-6; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Beekes M, 2007, FEBS J, V274, P588, DOI 10.1111/j.1742-4658.2007.05631.x; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brown KL, 2000, MICROSC RES TECHNIQ, V50, P40, DOI 10.1002/1097-0029(20000701)50:1<40::AID-JEMT7>3.0.CO;2-M; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; CARP RI, 1989, J GEN VIROL, V70, P827, DOI 10.1099/0022-1317-70-4-827; CARP RI, 1990, J INFECT DIS, V161, P462, DOI 10.1093/infdis/161.3.462; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; DAWSON M, 1990, VET REC, V126, P112; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Holst JJ, 2013, INT J OBESITY, V37, P1161, DOI 10.1038/ijo.2012.208; Holznagel E, 2013, EMERG INFECT DIS, V19, P712, DOI 10.3201/eid1905.120274; Kaatz M, 2012, AM J PATHOL, V181, P515, DOI 10.1016/j.ajpath.2012.05.001; KIM YS, 1987, J INFECT DIS, V156, P402, DOI 10.1093/infdis/156.2.402; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; Lawson VA, 2010, GUT, V59, P1643, DOI 10.1136/gut.2010.222620; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; LYONS MJ, 1982, SCIENCE, V216, P82, DOI 10.1126/science.7038878; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Miranda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018422; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SJOLUND K, 1983, GASTROENTEROLOGY, V85, P1120; Steinacker P, 2010, AM J PATHOL, V176, P1409, DOI 10.2353/ajpath.2010.090355; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Strom A, 2013, VET PATHOL, V50, P909, DOI 10.1177/0300985813476057; Strom A, 2007, LAB INVEST, V87, P139, DOI 10.1038/labinvest.3700500; Strom A, 2011, EUR J CELL BIOL, V90, P414, DOI 10.1016/j.ejcb.2010.11.015; Strom A, 2011, PANCREAS, V40, P229, DOI 10.1097/MPA.0b013e3181f7e547; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wells GAH, 2007, J GEN VIROL, V88, P1363, DOI 10.1099/vir.0.82421-0; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yi CX, 2012, DIS MODEL MECH, V5, P583, DOI 10.1242/dmm.009902; Yutzy B, 2007, J GEN VIROL, V88, P3469, DOI 10.1099/vir.0.83128-0; Zinn AR, 2010, AM J MED SCI, V340, P481, DOI 10.1097/MAJ.0b013e3181ccb980	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104343	10.1371/journal.pone.0104343	http://dx.doi.org/10.1371/journal.pone.0104343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090610	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700118
J	Sue, YM; Chou, HC; Chang, CC; Yang, NJ; Chou, Y; Juan, SH				Sue, Yuh-Mou; Chou, Hsiu-Chu; Chang, Chih-Cheng; Yang, Nian-Jie; Chou, Ying; Juan, Shu-Hui			L-Carnitine Protects against Carboplatin-Mediated Renal Injury: AMPK- and PPAR alpha-Dependent Inactivation of NFAT3	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; SPONTANEOUSLY HYPERTENSIVE-RATS; PROPIONYL-L-CARNITINE; NF-KAPPA-B; GENE-EXPRESSION; MUSCLE-CELLS; INDUCTION; CISPLATIN; MECHANISM; APOPTOSIS	We have previously shown that carboplatin induces inflammation and apoptosis in renal tubular cells (RTCs) through the activation of the nuclear factor of activated T cells-3 (NFAT3) protein by reactive oxygen species (ROS), and that the ROS-mediated activation of NFAT3 is prevented by N-acetyl cysteine and heme oxygenase-1 treatment. In the current study, we investigated the underlying molecular mechanisms of the protective effect of L-carnitine on carboplatin-mediated renal injury. Balb/c mice and RTCs were used as model systems. Carboplatin-induced apoptosis in RTCs was examined using terminal-deoxynucleotidyl-transferase-mediated dUTP nick end labeling. We evaluated the effects of the overexpression of the peroxisome-proliferator-activated receptor alpha (PPAR alpha) protein, the knockdown of PPAR alpha gene, and the blockade of AMPK activation and PPAR alpha to investigate the underlying mechanisms of the protective effect of L-carnitine on carboplatin-mediated renal injury. Carboplatin reduced the nuclear translocation, phosphorylation, and peroxisome proliferator responsive element transactivational activity of PPAR alpha. These carboplatin-mediated effects were prevented by L-carnitine through a mechanism dependent on AMPK phosphorylation and subsequent PPAR alpha activation. The activation of PPAR alpha induced cyclooxygenase 2 (COX-2) and prostacyclin (PGI2) synthase expression that formed a positive feedback loop to further activate PPAR alpha. The coimmunoprecipitation of the nuclear factor (NF) kappa B proteins increased following the induction of PPAR alpha by L-carnitine, which reduced NF kappa B transactivational activity and cytokine expression. The in vivo study showed that the inactivation of AMPK suppressed the protective effect of L-carnitine in carboplatin-treated mice, indicating that AMPK phosphorylation is required for PPAR alpha activation in the L-carnitine-mediated protection of RTC apoptosis caused by carboplatin. The results of our study provide molecular evidence that L-carnitine prevents carboplatin-mediated apoptosis through AMPK-mediated PPAR alpha activation.	[Sue, Yuh-Mou] Taipei Med Univ, Wan Fang Hosp, Dept Nephrol, Taipei, Taiwan; [Chou, Hsiu-Chu] Taipei Med Univ, Coll Med, Sch Med, Dept Anat, Taipei, Taiwan; [Chang, Chih-Cheng; Yang, Nian-Jie; Chou, Ying; Juan, Shu-Hui] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Chih-Cheng; Yang, Nian-Jie; Chou, Ying; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Juan, SH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.	juansh@tmu.edu.tw			Wan Fang Hospital; Taipei Medical University [100TMU-WFH-06, 101TMU-WFH-09]; National Science Council, Taiwan [NSC100-2320-B-038-016-MY2(1-2), NSC102-2320-B-038-030-MY3(1-3)]	Wan Fang Hospital; Taipei Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by grants from Wan Fang Hospital and Taipei Medical University (100TMU-WFH-06 and 101TMU-WFH-09) and the National Science Council, Taiwan (NSC100-2320-B-038-016-MY2(1-2) and NSC102-2320-B-038-030-MY3(1-3)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1995, SEMIN ONCOL, V22, P88; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Best CJM, 1999, IN VITRO CELL DEV-AN, V35, P205, DOI 10.1007/s11626-999-0028-2; Bueno R, 2005, LIFE SCI, V77, P2082, DOI 10.1016/j.lfs.2005.01.035; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Chen HH, 2009, NEPHROL DIAL TRANSPL, V24, P3042, DOI 10.1093/ndt/gfp258; Cipolla MJ, 1999, J VASC SURG, V29, P1097, DOI 10.1016/S0741-5214(99)70251-X; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Fujiwara K, 2003, GYNECOL ONCOL, V90, P637, DOI 10.1016/S0090-8258(03)00377-9; GARRELDS IM, 1994, BRIT J NUTR, V72, P785, DOI 10.1079/BJN19940080; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Herrera MD, 2002, J PHARM PHARMACOL, V54, P1423, DOI 10.1211/002235702760345536; Husain K, 2001, HEARING RES, V151, P71, DOI 10.1016/S0300-2977(00)00081-4; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Juge-Aubry CE, 1999, J BIOL CHEM, V274, P10505, DOI 10.1074/jbc.274.15.10505; Kockx M, 1999, BLOOD, V93, P2991; Lee FP, 2010, J CELL PHYSIOL, V224, P837, DOI 10.1002/jcp.22192; Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000; Lim H, 2002, ENDOCRINOLOGY, V143, P3207, DOI 10.1210/en.2002-220159; Lin H, 2010, BRIT J PHARMACOL, V161, P1661, DOI 10.1111/j.1476-5381.2010.00989.x; Lin H, 2010, AM J PATHOL, V177, P1697, DOI 10.2353/ajpath.2010.090789; MacAulay K, 2005, J BIOL CHEM, V280, P9509, DOI 10.1074/jbc.M411648200; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Miguel-Carrasco JL, 2010, EUR J PHARMACOL, V632, P65, DOI 10.1016/j.ejphar.2010.01.017; Neve BP, 2001, CIRCULATION, V103, P207; Ning WH, 2013, VASCUL PHARM; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Pisano C, CLIN CANC RES, V16, P3944; Santana-Davila R, 2014, J THORAC ONCOL, V9, P702, DOI 10.1097/JTO.0000000000000146; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Sue YM, 2011, BRIT J PHARMACOL, V162, P1716, DOI 10.1111/j.1476-5381.2010.01189.x	41	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104079	10.1371/journal.pone.0104079	http://dx.doi.org/10.1371/journal.pone.0104079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090113	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700094
J	Wang, ZL; Fang, Q; Han, ZL; Pan, JX; Li, XH; Li, N; Tang, HH; Wang, P; Zheng, T; Chang, XM; Wang, R				Wang, Zi-long; Fang, Quan; Han, Zheng-lan; Pan, Jia-xin; Li, Xu-hui; Li, Ning; Tang, Hong-hai; Wang, Pei; Zheng, Ting; Chang, Xue-mei; Wang, Rui			Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice	PLOS ONE			English	Article							RAT DORSAL RAPHE; PHARMACOLOGICAL CHARACTERIZATION; DIFFERENTIAL MECHANISMS; SPINAL ANTINOCICEPTION; MAMMALIAN NEUROPEPTIDE; POSSIBLE INVOLVEMENT; MODULATING PEPTIDES; RECEPTOR ANTAGONIST; MORPHINE ANALGESIA; OPIOID ACTIVITIES	Neuropeptide FF (NPFF) is known to be an endogenous opioid-modulating peptide. Nevertheless, very few researches focused on the interaction between NPFF and endogenous opioid peptides. In the present study, we have investigated the effects of NPFF system on the supraspinal antinociceptive effects induced by the endogenous m-opioid receptor agonists, endomorphin-1 (EM-1) and endomorphin-2 (EM-2). In the mouse tail-flick assay, intracerebroventricular injection of EM-1 induced antinociception via mu-opioid receptor while the antinociception of intracerebroventricular injected EM-2 was mediated by both mu- and kappa-opioid receptors. In addition, central administration of NPFF significantly reduced EM-1-induced central antinociception, but enhanced EM-2-induced central antinociception. The results using the selective NPFF1 and NPFF2 receptor agonists indicated that the EM-1-modulating action of NPFF was mainly mediated by NPFF2 receptor, while NPFF potentiated EM-2-induecd antinociception via both NPFF1 and NPFF2 receptors. To further investigate the roles of mu- and kappa-opioid systems in the opposite effects of NPFF on central antinociception of endomprphins, the mu- and kappa-opioid receptors selective agonists DAMGO and U69593, respectively, were used. Our results showed that NPFF could reduce the central antinociception of DAMGO via NPFF2 receptor and enhance the central antinociception of U69593 via both NPFF1 and NPFF2 receptors. Taken together, our data demonstrate that NPFF exerts opposite effects on central antinociception of endomorphins and provide the first evidence that NPFF potentiate antinociception of EM-2, which might result from the interaction between NPFF and kappa-opioid systems.	[Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; Lanzhou Univ, Sch Basic Med Sci, Inst Physiol, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Wang, R (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China.	wangrui@lzu.edu.cn	Wang, Zilong/AAB-4143-2019; Wang, Zilong/AEY-8544-2022; Wang, Zilong/P-7047-2017; Li, Xuhui/V-2692-2019	Wang, Zilong/0000-0001-7473-0354; Wang, Zilong/0000-0001-7473-0354; Li, Xuhui/0000-0003-4376-6252; Fang, Quan/0000-0003-0381-6796	National Natural Science Foundation of China [81273355]; Key National S&T Program of the Ministry of Science and Technology [2012ZX09504001-003]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1137]; Program for New Century Excellent Talents in University [NCET-13-0257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program of the Ministry of Science and Technology; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by the grants from the National Natural Science Foundation of China (No. 81273355), the Key National S&T Program of the Ministry of Science and Technology (2012ZX09504001-003), Program for Changjiang Scholars and Innovative Research Team in University (IRT1137), and Program for New Century Excellent Talents in University (NCET-13-0257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Brown RM, 2012, DRUG ALCOHOL DEPEN, V123, P264, DOI 10.1016/j.drugalcdep.2011.11.002; Desprat C, 1997, NEUROPEPTIDES, V31, P1, DOI 10.1016/S0143-4179(97)90010-X; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Fang Q, 2008, REGUL PEPTIDES, V147, P45, DOI 10.1016/j.regpep.2007.12.007; Fang Q, 2012, NEUROPHARMACOLOGY, V62, P855, DOI 10.1016/j.neuropharm.2011.09.013; Fang Q, 2011, PROTEIN PEPTIDE LETT, V18, P403, DOI 10.2174/092986611794654012; GICQUEL S, 1993, PEPTIDES, V14, P749, DOI 10.1016/0196-9781(93)90108-S; Goldberg IE, 1998, J PHARMACOL EXP THER, V286, P1007; Gouarderes C, 2007, NEUROPHARMACOLOGY, V52, P376, DOI 10.1016/j.neuropharm.2006.07.034; GOUARDERES C, 1993, EUR J PHARMACOL, V237, P73, DOI 10.1016/0014-2999(93)90095-Y; Han ZL, 2013, BEHAV BRAIN RES, V248, P51, DOI 10.1016/j.bbr.2013.03.046; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Kersante F, 2006, PEPTIDES, V27, P980, DOI 10.1016/j.peptides.2005.07.025; KONTINEN VK, 1995, PEPTIDES, V16, P973, DOI 10.1016/0196-9781(95)00068-U; Leitermann RJ, 2004, EUR J PHARMACOL, V504, P177, DOI 10.1016/j.ejphar.2004.10.006; Liu QY, 2001, J BIOL CHEM, V276, P36961, DOI 10.1074/jbc.M105308200; Mizoguchi H, 2006, J PHARMACOL EXP THER, V317, P362, DOI 10.1124/jpet.105.098293; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mollereau C, 2002, EUR J PHARMACOL, V451, P245, DOI 10.1016/S0014-2999(02)02224-0; Mouledous L, 2010, BIOFACTORS, V36, P423, DOI 10.1002/biof.116; OBERLING P, 1993, PEPTIDES, V14, P919, DOI 10.1016/0196-9781(93)90067-Q; Ohsawa M, 2000, J PHARMACOL EXP THER, V294, P1106; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; Picker MJ, 2011, BEHAV PHARMACOL, V22, P785, DOI 10.1097/FBP.0b013e32834d13a2; Quelven I, 2005, EUR J PHARMACOL, V508, P107, DOI 10.1016/j.ejphar.2004.12.002; RAFFA RB, 1989, PEPTIDES, V10, P873, DOI 10.1016/0196-9781(89)90127-7; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Roumy M, 1999, BRAIN RES, V845, P208, DOI 10.1016/S0006-8993(99)01965-4; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Roumy M, 2003, NEUROSCI LETT, V348, P159, DOI 10.1016/S0304-3940(03)00791-2; Roumy M, 2007, J BIOL CHEM, V282, P8332, DOI 10.1074/jbc.M606946200; Roussin A, 2005, BIOCHEM BIOPH RES CO, V336, P197, DOI 10.1016/j.bbrc.2005.08.060; Sakurada S, 1999, EUR J PHARMACOL, V372, P25, DOI 10.1016/S0014-2999(99)00181-8; Sakurada S, 2008, PEPTIDES, V29, P1554, DOI 10.1016/j.peptides.2008.04.012; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Spetea M, 1998, BIOCHEM BIOPH RES CO, V250, P720, DOI 10.1006/bbrc.1998.9395; Stone LS, 1997, NEUROREPORT, V8, P3131, DOI 10.1097/00001756-199709290-00025; Terashvili M, 2005, J PHARMACOL EXP THER, V312, P1257, DOI 10.1124/jpet.104.076224; Tseng LF, 2002, JPN J PHARMACOL, V89, P216, DOI 10.1254/jjp.89.216; Tseng LF, 2000, J PHARMACOL EXP THER, V292, P576; Vilim FS, 1999, MOL PHARMACOL, V55, P804; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	48	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103773	10.1371/journal.pone.0103773	http://dx.doi.org/10.1371/journal.pone.0103773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090615	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700053
J	Zhang, Y; Kim, JY; Horst, O; Nakano, Y; Zhu, L; Radlanski, RJ; Ho, S; Den Besten, PK				Zhang, Yan; Kim, Ji-Yeon; Horst, Orapin; Nakano, Yukiko; Zhu, Li; Radlanski, Ralf J.; Ho, Sunita; Den Besten, Pamela K.			Fluorosed Mouse Ameloblasts Have Increased SATB1 Retention and G alpha q Activity	PLOS ONE			English	Article							CELLS IN-VITRO; DEVELOPING DENTAL ENAMEL; SODIUM-FLUORIDE; BINDING PROTEIN; MATRIX; GENES; DIFFERENTIATION; AMELOGENESIS; MODULATION; MECHANISMS	Dental fluorosis is characterized by subsurface hypomineralization and increased porosity of enamel, associated with a delay in the removal of enamel matrix proteins. To investigate the effects of fluoride on ameloblasts, A/J mice were given 50 ppm sodium fluoride in drinking water for four weeks, resulting serum fluoride levels of 4.5 mu M, a four-fold increase over control mice with no fluoride added to drinking water. MicroCT analyses showed delayed and incomplete mineralization of fluorosed incisor enamel as compared to control enamel. A microarray analysis of secretory and maturation stage ameloblasts microdissected from control and fluorosed mouse incisors showed that genes clustered with Mmp20 appeared to be less downregulated in maturation stage ameloblasts of fluorosed incisors as compared to control maturation ameloblasts. One of these Mmp20 co-regulated genes was the global chromatin organizer, special AT-rich sequence-binding protein-1 (SATB1). Immunohistochemical analysis showed increased SATB1 protein present in fluorosed ameloblasts compared to controls. In vitro, exposure of human ameloblast-lineage cells to micromolar levels of both NaF and AlF3 led to a significantly increase in SATB1 protein content, but not levels of Satb1 mRNA, suggesting a fluoride-induced mechanism protecting SABT1 from degradation. Consistent with this possibility, we used immunohistochemistry and Western blot to show that fluoride exposed ameloblasts had increased phosphorylated PKC alpha both in vivo and in vitro. This kinase is known to phosphorylate SATB1, and phosphorylation is known to protect SATB1 from degradation by caspase-6. In addition, production of cellular diacylglycerol (DAG) was significantly increased in fluorosed ameloblasts, suggesting that the increased phosphorylation of SATB1 may be related to an effect of fluoride to enhance G alpha q activity of secretory ameloblasts.	[Zhang, Yan; Nakano, Yukiko; Zhu, Li; Den Besten, Pamela K.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Kim, Ji-Yeon] Pusan Natl Univ, Dent Res Inst, Dept Pediat Dent, Pusan 609735, South Korea; [Horst, Orapin; Ho, Sunita] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Radlanski, Ralf J.] Free Univ Berlin, Ctr Dent & Craniofacial Sci, Dept Craniofacial Dev Biol, Charite Campus Benjamin Franklin, Berlin, Germany	University of California System; University of California San Francisco; Pusan National University; University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Den Besten, PK (corresponding author), Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA.	Pamela.denbesten@ucsf.edu	Nakano, Yukiko/E-1019-2015; Ho, Sunita P/B-1084-2008	Radlanski, Ralf Johannes/0000-0001-7090-5225; Nakano, Yukiko/0000-0002-1799-1205	NIH/NIDCR [R56 DE13508]; Department of Orofacial Sciences at UCSF; NIH S10 Shared Instrumentation Grant [S10RR026645]; Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, School of Dentistry at UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE022377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE013508] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Orofacial Sciences at UCSF; NIH S10 Shared Instrumentation Grant; Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, School of Dentistry at UCSF; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIH/NIDCR grants R56 DE13508 to Pamela K. Den Besten, and the funds from the Department of Orofacial Sciences at UCSF. The Micro-CT Imaging facility was supported by NIH S10 Shared Instrumentation Grant (S10RR026645) and Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, School of Dentistry at UCSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2005, J DENT RES, V84, P832, DOI 10.1177/154405910508400910; BAWDEN JW, 1989, J DENT RES, V68, P1169, DOI 10.1177/00220345890680070601; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; DenBesten P K, 1989, Adv Dent Res, V3, P199; DenBesten P, 2011, MONOGR ORAL SCI, V22, P81, DOI 10.1159/000327028; DenBesten PK, 2011, EUR J ORAL SCI, V119, P3, DOI 10.1111/j.1600-0722.2011.00903.x; DENBESTEN PK, 1985, J DENT RES, V64, P1365, DOI 10.1177/00220345850640120701; Everett ET, 2011, EUR J ORAL SCI, V119, P8, DOI 10.1111/j.1600-0722.2011.00868.x; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; He PP, 2010, MATRIX BIOL, V29, P411, DOI 10.1016/j.matbio.2010.03.001; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; KIERDORF U, 1993, ARCH ORAL BIOL, V38, P1071, DOI 10.1016/0003-9969(93)90169-M; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; Li Y, 2005, ARCH ORAL BIOL, V50, P681, DOI 10.1016/j.archoralbio.2004.11.021; Matsuo S, 1996, ARCH TOXICOL, V70, P420, DOI 10.1007/s002040050294; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Ribeiro DA, 2006, J MOL HISTOL, V37, P361, DOI 10.1007/s10735-006-9065-2; Shimizu D, 2008, ANAT REC, V291, P175, DOI 10.1002/ar.20633; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SMID JR, 1990, ARCH ORAL BIOL, V35, P671, DOI 10.1016/0003-9969(90)90035-9; SMITH CE, 1993, ANAT RECORD, V237, P243, DOI 10.1002/ar.1092370212; Smith CE, 2011, EUR J ORAL SCI, V119, P125, DOI 10.1111/j.1600-0722.2011.00871.x; SUCKLING G, 1984, ARCH ORAL BIOL, V29, P165, DOI 10.1016/0003-9969(84)90050-5; Takano Y, 2006, EUR J ORAL SCI, V114, P52, DOI 10.1111/j.1600-0722.2006.00295.x; Tan J.A., MOL CELL BIOL, V30, P2823; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; TAVES DR, 1968, TALANTA, V15, P1015, DOI 10.1016/0039-9140(68)80109-2; Toker A, 2004, PROTEIN KINASE C, P64; WALTON RE, 1974, ARCH ORAL BIOL, V19, P171, DOI 10.1016/0003-9969(74)90212-X; Yan Q, 2007, J DENT RES, V86, P336, DOI 10.1177/154405910708600407; Yan QM, 2006, EUR J ORAL SCI, V114, P154, DOI 10.1111/j.1600-0722.2006.00304.x; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang Y, 2006, EUR J ORAL SCI, V114, P105, DOI 10.1111/j.1600-0722.2006.00303.x	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103994	10.1371/journal.pone.0103994	http://dx.doi.org/10.1371/journal.pone.0103994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090413	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700074
J	Alam, M; Chen, X; Zhang, ZC; Li, Y; He, JF				Alam, Monzurul; Chen, Xi; Zhang, Zicong; Li, Yan; He, Jufang			A Brain-Machine-Muscle Interface for Restoring Hindlimb Locomotion after Complete Spinal Transection in Rats	PLOS ONE			English	Article							CORD-INJURY; MOTOR CORTEX; STIMULATION; NEURONS; REHABILITATION; TETRAPLEGIA; MOVEMENTS	A brain-machine interface (BMI) is a neuroprosthetic device that can restore motor function of individuals with paralysis. Although the feasibility of BMI control of upper-limb neuroprostheses has been demonstrated, a BMI for the restoration of lower-limb motor functions has not yet been developed. The objective of this study was to determine if gait-related information can be captured from neural activity recorded from the primary motor cortex of rats, and if this neural information can be used to stimulate paralysed hindlimb muscles after complete spinal cord transection. Neural activity was recorded from the hindlimb area of the primary motor cortex of six female Sprague Dawley rats during treadmill locomotion before and after mid-thoracic transection. Before spinal transection there was a strong association between neural activity and the step cycle. This association decreased after spinal transection. However, the locomotive state (standing vs. walking) could still be successfully decoded from neural recordings made after spinal transection. A novel BMI device was developed that processed this neural information in real-time and used it to control electrical stimulation of paralysed hindlimb muscles. This system was able to elicit hindlimb muscle contractions that mimicked forelimb stepping. We propose this lower-limb BMI as a future neuroprosthesis for human paraplegics.	[Alam, Monzurul; Chen, Xi; Zhang, Zicong; Li, Yan; He, Jufang] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Chen, Xi; He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; City University of Hong Kong	Alam, M (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	malam@mednet.ucla.edu; jufanghe@cityu.edu.hk	Zhang, Zicong/V-7853-2019	Zhang, Zicong/0000-0002-6453-5528; Alam, Monzurul/0000-0003-0987-1999; HE, Jufang/0000-0002-4288-5957; CHEN, Xi/0000-0002-2144-6584	Hong Kong Research Grants Council [PolyU5614/10M]; Ministry of Science and Technology of China [2012CB966300]; Charlie Lee Charitable Foundation; Fong Shu Fook Tong Foundation; Fong's Family Foundation; P. K. Yu Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Charlie Lee Charitable Foundation; Fong Shu Fook Tong Foundation; Fong's Family Foundation; P. K. Yu Foundation	This work was supported by Hong Kong Research Grants Council (PolyU5614/10M) and Ministry of Science and Technology of China (2012CB966300), The Charlie Lee Charitable Foundation, Fong Shu Fook Tong Foundation, and Fong's Family Foundation. M Alam was supported by the P. K. Yu Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alam M, 2013, CONVERGING CLIN ENG, P35; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; CROZIER KS, 1991, ARCH PHYS MED REHAB, V72, P119; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; Drew T, 1991, Curr Opin Neurobiol, V1, P652, DOI 10.1016/S0959-4388(05)80044-3; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Gerasimenko Yu P, 2003, Neurosci Behav Physiol, V33, P247, DOI 10.1023/A:1022199214515; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gibson S, 2008, IEEE ENG MED BIO, P5015, DOI 10.1109/IEMBS.2008.4650340; Giszter SF, 2010, ANN NY ACAD SCI, V1198, P279, DOI 10.1111/j.1749-6632.2010.05534.x; Gorska T, 1999, ACTA NEUROBIOL EXP, V59, P131; He JP, 2008, P IEEE, V96, P1152, DOI 10.1109/JPROC.2008.922593; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ichiyama RM, 2005, NEUROSCI LETT, V383, P339, DOI 10.1016/j.neulet.2005.04.049; Jung W., 2005, OP AMP APPL HDB; Lebedev MA, 2011, CLINICS, V66, P25, DOI 10.1590/S1807-59322011001300004; Lebedev Mikhail A., 2008, P219; Luo Peng, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P1416; Manohar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052173; Marin Cristina, 2010, Front Neuroeng, V3, P8, DOI 10.3389/fneng.2010.00008; Moritz CT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025017; Motchenbacher CD, 1993, LOW NOISE ELECT SYST; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nicolelis M, 2007, METHODS NEURAL ENSEM, DOI DOI 10.1201/9781420006414; Orlovskii GN., 1999, NEURONAL CONTROL LOC; SCI-recovery, 2013, SPIN CORD INJ; Scott SH, 2008, NAT NEUROSCI, V11, P1245, DOI 10.1038/nn1108-1245; Song WG, 2009, IEEE T BIO-MED ENG, V56, P2712, DOI 10.1109/TBME.2009.2026284; Thakor NV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007303; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; VANHEUNINGEN R, 1984, MED BIOL ENG COMPUT, V22, P77, DOI 10.1007/BF02443749; Wahnoun R, 2006, J NEURAL ENG, V3, P162, DOI 10.1088/1741-2560/3/2/010; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; WATERS RL, 1991, PARAPLEGIA, V29, P573, DOI 10.1038/sc.1991.85; Wattanapanitch W, 2007, IEEE T BIOMED CIRC S, V1, P136, DOI 10.1109/TBCAS.2007.907868; Xiao-qin Liu, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P854, DOI 10.1109/BMEI.2011.6098451; Zacksenhouse Miriam, 2008, P57; Zelenin PV, 2011, J NEUROSCI, V31, P4636, DOI 10.1523/JNEUROSCI.6511-10.2011	45	11	11	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103764	10.1371/journal.pone.0103764	http://dx.doi.org/10.1371/journal.pone.0103764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084446	gold, Green Published			2022-12-25	WOS:000339819800077
J	Grorud-Colvert, K; Claudet, J; Tissot, BN; Caselle, JE; Carr, MH; Day, JC; Friedlander, AM; Lester, SE; De Loma, TL; Malone, D; Walsh, WJ				Grorud-Colvert, Kirsten; Claudet, Joachim; Tissot, Brian N.; Caselle, Jennifer E.; Carr, Mark H.; Day, Jon C.; Friedlander, Alan M.; Lester, Sarah E.; De Loma, Thierry Lison; Malone, Daniel; Walsh, William J.			Marine Protected Area Networks: Assessing Whether the Whole Is Greater than the Sum of Its Parts	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; RESERVE NETWORKS; HAWAIIAN-ISLANDS; REEF FISHES; POPULATIONS; CONNECTIVITY; SIZE; CONSERVATION; ABUNDANCE; DESIGN	Anthropogenic impacts are increasingly affecting the world's oceans. Networks of marine protected areas (MPAs) provide an option for increasing the ecological and economic benefits often provided by single MPAs. It is vital to empirically assess the effects of MPA networks and to prioritize the monitoring data necessary to explain those effects. We summarize the types of MPA networks based on their intended management outcomes and illustrate a framework for evaluating whether a connectivity network is providing an outcome greater than the sum of individual MPA effects. We use an analysis of an MPA network in Hawai'i to compare networked MPAs to non-networked MPAs to demonstrate results consistent with a network effect. We assert that planning processes for MPA networks should identify their intended outcomes while also employing coupled field monitoring-simulation modeling approaches, a powerful way to prioritize the most relevant monitoring data for empirically assessing MPA network performance.	[Grorud-Colvert, Kirsten] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Claudet, Joachim] Univ Perpignan, Natl Ctr Sci Res CNRS, F-66025 Perpignan, France; [Claudet, Joachim] Lab Excellence CORAIL, Perpignan, France; [Tissot, Brian N.] Humboldt State Univ, Marine Lab, Trinidad, CA USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Carr, Mark H.] Univ Calif Santa Cruz, Long Marine Lab, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Day, Jon C.] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Honolulu, HI USA; [Lester, Sarah E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA USA; [De Loma, Thierry Lison] CRIOBE, Moorea, Iceland; [Malone, Daniel] Univ Calif Santa Cruz, Long Marine Lab, Inst Marine Sci, Santa Cruz, CA USA; [Walsh, William J.] Hawaii Div Aquat Resources, Kailua, HI USA	Oregon State University; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; California State University System; California State Polytechnic University, Humboldt; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; University of Hawaii System; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz	Grorud-Colvert, K (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	grorudck@science.oregonstate.edu	Day, Jon C/H-3276-2016; Claudet, Joachim/C-6335-2008	Day, Jon C/0000-0003-3906-0759; Claudet, Joachim/0000-0001-6295-1061; Tissot, Brian/0000-0003-0398-2241	David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; EU FP7 COCONET; biodivERsA BUFFER; Hawaii Coral Reef Initiative Research Program (HCRI-RP) under the National Oceanic and Atmospheric Administration (NOAA); Coral Reef Monitoring Grants under NOAA's Coral Reef Conservation Program	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); EU FP7 COCONET; biodivERsA BUFFER; Hawaii Coral Reef Initiative Research Program (HCRI-RP) under the National Oceanic and Atmospheric Administration (NOAA); Coral Reef Monitoring Grants under NOAA's Coral Reef Conservation Program	Funding was provided by the David and Lucille Packard Foundation (http://www.packard.org/), Gordon and Betty Moore Foundation (http://www.moore.org/), EU FP7 COCONET (http://www.coconet-fp7.eu/), biodivERsA BUFFER (http://www.biodiversa.org/518), Hawaii Coral Reef Initiative Research Program (HCRI-RP, http://www.cop.noaa.gov/ecosystems/coralreefs/current/hcri-factsheet-cr.aspx) under the National Oceanic and Atmospheric Administration (NOAA), and Coral Reef Monitoring Grants under NOAA's Coral Reef Conservation Program (http://coralreef.noaa.gov/aboutcrcp/workwithus/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2006, AQUAT CONSERV, V16, P349, DOI 10.1002/aqc.730; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Browman HI, 2004, MAR ECOL PROG SER, V274, P271; Carr MH, 2011, FRONT ECOL ENVIRON, V9, P342, DOI 10.1890/090096; CDFG (California Department of Fish and Game), 2008, CAL MAR LIF PROT ACT; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2004, AQUAT LIVING RESOUR, V17, P129, DOI 10.1051/alr:2004017; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Day J, 2002, WORLD C AQUATIC PROT, P401; Edgar GJ, 2004, ENVIRON CONSERV, V31, P212, DOI 10.1017/S0376892904001584; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; GBRMPA, 2002, BIOPH OP PRINC REC S; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Grorud-Colvert K., 2011, MARINE PROTECTED ARE, P293; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; IUCN World Commission on Protected Areas, 2008, EST RES MAR PROT AR; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Joseph LN, 2009, ECOL APPL, V19, P631, DOI 10.1890/07-2107.1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; McInerney CE, 2012, BIOL CONSERV, V152, P262, DOI 10.1016/j.biocon.2012.03.009; Miller I, 2012, MAR ENVIRON RES, V79, P167, DOI 10.1016/j.marenvres.2012.05.008; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; NRC, 2001, MAR PROT AR TOOLS SU; Parrish JD, 2000, INTERACTIONS NONINDI; Pelletier D, 2008, CAN J FISH AQUAT SCI, V65, P765, DOI 10.1139/F08-026; Pillay D, 2010, MAR ECOL PROG SER, V415, P35, DOI 10.3354/meps08733; Rassweiler A, 2012, P NATL ACAD SCI US; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Schumacher BD, 2011, THESIS U HAWAII; Shanks AL, 2003, ECOL APPL, V13, pS159; Stevenson TC, 2013, MAR POLICY, V39, P215, DOI 10.1016/j.marpol.2012.11.003; Stevenson TC, 2011, ICES J MAR SCI, V68, P813, DOI 10.1093/icesjms/fsr020; SWEATMAN H, 2001, 5 AUSTR I MAR SCI; Tissot Brian N., 2004, Pacific Science, V58, P175, DOI 10.1353/psc.2004.0024; Tissot BN, 2009, COAST MANAGE, V37, P255, DOI 10.1080/08920750902851096; Walsh W, 2013, LONG TERM MONITORING; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x; White JW, 2013, CONSERV LETT, V6, P180, DOI 10.1111/j.1755-263X.2012.00295.x; White JW, 2011, FRONT ECOL ENVIRON, V9, P390, DOI 10.1890/100138; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	55	70	70	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102298	10.1371/journal.pone.0102298	http://dx.doi.org/10.1371/journal.pone.0102298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084458	Green Published, gold			2022-12-25	WOS:000339819800008
J	Skeldon, AC; Dijk, DJ; Derks, G				Skeldon, Anne C.; Dijk, Derk-Jan; Derks, Gianne			Mathematical Models for Sleep-Wake Dynamics: Comparison of the Two-Process Model and a Mutual Inhibition Neuronal Model	PLOS ONE			English	Article							BORDER-COLLISION BIFURCATIONS; QUANTITATIVE MODEL; DURATION; METAANALYSIS; FATIGUE	Sleep is essential for the maintenance of the brain and the body, yet many features of sleep are poorly understood and mathematical models are an important tool for probing proposed biological mechanisms. The most well-known mathematical model of sleep regulation, the two-process model, models the sleep-wake cycle by two oscillators: a circadian oscillator and a homeostatic oscillator. An alternative, more recent, model considers the mutual inhibition of sleep promoting neurons and the ascending arousal system regulated by homeostatic and circadian processes. Here we show there are fundamental similarities between these two models. The implications are illustrated with two important sleep-wake phenomena. Firstly, we show that in the two-process model, transitions between different numbers of daily sleep episodes can be classified as grazing bifurcations. This provides the theoretical underpinning for numerical results showing that the sleep patterns of many mammals can be explained by the mutual inhibition model. Secondly, we show that when sleep deprivation disrupts the sleep-wake cycle, ostensibly different measures of sleepiness in the two models are closely related. The demonstration of the mathematical similarities of the two models is valuable because not only does it allow some features of the two-process model to be interpreted physiologically but it also means that knowledge gained from study of the two-process model can be used to inform understanding of the behaviour of the mutual inhibition model. This is important because the mutual inhibition model and its extensions are increasingly being used as a tool to understand a diverse range of sleep-wake phenomena such as the design of optimal shift-patterns, yet the values it uses for parameters associated with the circadian and homeostatic processes are very different from those that have been experimentally measured in the context of the two-process model.	[Skeldon, Anne C.; Derks, Gianne] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England; [Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Surrey	Skeldon, AC (corresponding author), Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England.	a.skeldon@surrey.ac.uk		Skeldon, Anne/0000-0001-6387-4766; Derks, Gianne/0000-0002-2437-1813	Engineering and Physical Sciences Research Council [EP/I000992/1]; Royal Society of Medicine; EPSRC [EP/I000992/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society of Medicine(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by the Engineering and Physical Sciences Research Council (grant number EP/I000992/1) www.epsrc.ac.uk and by the Royal Society of Medicine www.rsm.ac.uk (DJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; AKERSTEDT T, 2014, J SLEEP RES, V23, P240; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Avinash D., 2005, SLEEP WAKE RES NETHE, V16, P39; Avrutin V, 2006, NONLINEARITY, V19, P1875, DOI 10.1088/0951-7715/19/8/007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Behn CGD, 2012, SIAM J APPL DYN SYST, V11, P212, DOI 10.1137/110832823; Behn CGD, 2010, J NEUROPHYSIOL, V103, P1937, DOI 10.1152/jn.00795.2009; Booth V, 2014, MATH BIOSCI, V250, P54, DOI 10.1016/j.mbs.2014.01.012; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Coombes S, 2000, PHYS REV E, V62, P4057, DOI 10.1103/PhysRevE.62.4057; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; Fulcher BD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051920; Hagenauer MH, 2013, HORM BEHAV, V64, P270, DOI 10.1016/j.yhbeh.2013.01.013; Jain P, 2003, INT J BIFURCAT CHAOS, V13, P3341, DOI 10.1142/S0218127403008533; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kronholm E, 2011, J SLEEP RES, V20, P288, DOI 10.1111/j.1365-2869.2010.00899.x; LoFaro T, 1996, MATH COMPUT MODEL, V24, P27, DOI 10.1016/0895-7177(96)00105-7; LoFaro T, 1999, J MATH BIOL, V38, P479, DOI 10.1007/s002850050157; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Moller-Levet CS, 2013, P NATL ACCADEMY SCI; Moore-Ede MC., 1984, MATH MODELS CIRCADIA; Nakao M, 1997, METHOD INFORM MED, V36, P282; Nakao M, 1998, PSYCHIAT CLIN NEUROS, V52, P131, DOI 10.1111/j.1440-1819.1998.tb00990.x; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; NUSSE HE, 1992, PHYSICA D, V57, P39, DOI 10.1016/0167-2789(92)90087-4; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2010, J BIOL RHYTHM, V25, P217, DOI 10.1177/0748730410369208; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Phillips AJK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000826; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Puckeridge M, 2011, J THEOR BIOL, V273, P44, DOI 10.1016/j.jtbi.2010.12.018; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005	43	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103877	10.1371/journal.pone.0103877	http://dx.doi.org/10.1371/journal.pone.0103877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084361	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800096
J	Zhang, X; Ma, W; Cui, J; Yao, H; Zhou, H; Ge, Y; Xiao, L; Hu, X; Liu, BH; Yang, J; Li, YY; Chen, S; Eaves, CJ; Wu, D; Zhao, Y				Zhang, X.; Ma, W.; Cui, J.; Yao, H.; Zhou, H.; Ge, Y.; Xiao, L.; Hu, X.; Liu, B-H; Yang, J.; Li, Y-Y; Chen, S.; Eaves, C. J.; Wu, D.; Zhao, Y.			Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ACUTE LYMPHOBLASTIC-LEUKEMIA; HELIX TRANSCRIPTION FACTOR; ADULT HEMATOPOIETIC STEM; SAETHRE-CHOTZEN SYNDROME; MYELODYSPLASTIC SYNDROMES; GENE-EXPRESSION; CELLS; PROTEIN; CANCER	TWIST2 has a dual function in tumors. Its implication in the initiation and metastasis of various solid tumors is well established, and its tumor-suppressor role in murine osteosarcoma cells has been reported recently. However, the function of TWIST2 and its underlying mechanisms in human normal and malignant hematopoiesis remain unclear. In the present study, we found that TWIST2 directly regulated p21 in human hematopoietic cells and whose silence promoted cell proliferation and cell cycle progression. Hypermethylation of TWIST2 occurred to 23 out of the 75 adult acute myeloid leukemia (AML) patients and resulted in the impaired expression of both TWIST2 and p21. Conversely, TWIST2 overexpression inhibited the growth of AML cells partially through its direct activation of p21 with intact HLH (helix-loop-helix) domain. The microarray data and gene expression validation showed that TWIST2 was sufficient to activate known tumor-suppressor genes, whereas suppress known oncogenes, which further supported its inhibitory effect against AML cells. Taken together, our data have identified a novel TWIST2-p21 axis that modulates the cell cycle of both normal and leukemic cells and demonstrated that the direct regulation of p21 by TWIST2 has a role in its tumor-suppressor function in AML.	[Zhang, X.; Ma, W.; Cui, J.; Yao, H.; Ge, Y.; Xiao, L.; Zhao, Y.] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, X.; Ma, W.; Chen, S.; Wu, D.; Zhao, Y.] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215123, Jiangsu, Peoples R China; [Cui, J.; Yao, H.; Zhou, H.; Hu, X.; Chen, S.; Wu, D.] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostatis, Suzhou 215123, Jiangsu, Peoples R China; [Liu, B-H; Yang, J.; Li, Y-Y] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Eaves, C. J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	Soochow University - China; Soochow University - China; Soochow University - China; Chinese Academy of Sciences; British Columbia Cancer Agency	Wu, D (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostatis, Suzhou 215123, Jiangsu, Peoples R China.	wudepei@medmail.com.cn; zhaoy@suda.edu.cn		, Yun/0000-0002-0065-4675; Eaves, Connie/0000-0002-3452-1926	National Natural Science Foundation of China [31170755]; National Key Scientific Project of China (973 Program) [2011CB933501]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20113201120017]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province's Key Medical Center [ZX201102]; National Public Health Grand Research Foundation [201202017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Project of China (973 Program); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Province's Key Medical Center; National Public Health Grand Research Foundation	This work was funded by National Natural Science Foundation of China (no. 31170755), National Key Scientific Project of China (973 Program no. 2011CB933501), Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP, no. 20113201120017), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Jiangsu Province's Key Medical Center (ZX201102) and National Public Health Grand Research Foundation (No. 201202017).	Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; APLAN PD, 1992, BLOOD, V79, P1327; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cosset E, 2011, BLOOD, V117, P1673, DOI 10.1182/blood-2009-11-254680; Duriez C, 2002, GENE, V282, P207, DOI 10.1016/S0378-1119(01)00825-3; ElGhouzzi V, 1997, NAT GENET, V15, P42; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Ishikawa T, 2013, CANCER SCI, V104, P880, DOI 10.1111/cas.12163; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kennah E, 2009, BLOOD, V113, P4646, DOI 10.1182/blood-2008-08-174037; Kim MS, 2013, MOL CELLS, V36, P177, DOI 10.1007/s10059-013-0061-6; Ko J, 2008, P NATL ACAD SCI USA, V105, P12967, DOI 10.1073/pnas.0805073105; Li X, 2013, HAEMATOLOGICA, V98, P414, DOI 10.3324/haematol.2012.071753; Li XA, 2010, BLOOD, V116, P2304, DOI 10.1182/blood-2009-09-242313; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu JH, 2004, LEUKEMIA LYMPHOMA, V45, P2419, DOI 10.1080/10428190400003317; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Meng YS, 2005, LEUKEMIA, V19, P1941, DOI 10.1038/sj.leu.2403836; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Piccinin S, 2012, CANCER CELL, V22, P404, DOI 10.1016/j.ccr.2012.08.003; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Raval A, 2005, J CLIN ONCOL, V23, P3877, DOI 10.1200/JCO.2005.02.196; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Shiota M, 2008, ONCOGENE, V27, P5543, DOI 10.1038/onc.2008.176; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thathia SH, 2012, HAEMATOL-HEMATOL J, V97, P371, DOI 10.3324/haematol.2011.049593; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; Wang M, 2009, LEUKEMIA, V23, P1320, DOI 10.1038/leu.2009.19; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yin B, 2009, BLOOD, V113, P1075, DOI 10.1182/blood-2008-03-144436; Zhang WQ, 2014, BIOMATERIALS, V35, P567, DOI 10.1016/j.biomaterials.2013.09.102; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhou HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086195	57	20	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3000	3010		10.1038/onc.2014.241	http://dx.doi.org/10.1038/onc.2014.241			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25088197				2022-12-25	WOS:000356100500006
J	Saura, M; Marquez, S; Reventun, P; Olea-Herrero, N; Arenas, MI; Moreno-Gomez-Toledano, R; Gomez-Parrizas, M; Munoz-Moreno, C; Gonzalez-Santander, M; Zaragoza, C; Bosch, RJ				Saura, Marta; Marquez, Susana; Reventun, Paula; Olea-Herrero, Nuria; Isabel Arenas, Maria; Moreno-Gomez-Toledano, Rafael; Gomez-Parrizas, Monica; Munoz-Moreno, Carmen; Gonzalez-Santander, Marta; Zaragoza, Carlos; Bosch, Ricardo J.			Oral administration of bisphenol A induces high blood pressure through angiotensin II/CaMKII-dependent uncoupling of eNOS	FASEB JOURNAL			English	Article						BPA; hypertension; endothelial dysfunction; superoxide; AngII	NITRIC-OXIDE SYNTHASE; ENDOTHELIAL NO SYNTHASE; CAM KINASE-II; GENE-EXPRESSION; REACTIVE OXYGEN; ACTIVATION; ESTROGEN; ASSOCIATION; RECEPTOR; URINARY	Bisphenol A (BPA) is found in human urine and fat tissue. Higher urinary BPA concentrations are associated with arterial hypertension. To shed light on the underlying mechanism, we orally administered BPA (4 nM to 400 M in drinking water) to 8-wk-old CD11 mice over 30 d. Mice developed dosage-dependent high blood pressure (systolic 130 +/- 12 vs. 170 +/- 12 mmHg; EC50 0.4 M), impairment of acetylcholine (AcH)-induced carotid relaxation (0.66 +/- 0.08 vs. 0.44 +/- 0.1 mm), a 1.7-fold increase in arterial angiotensin II (AngII), an 8.7-fold increase in eNOS mRNA and protein, and significant eNOS-dependent superoxide and peroxynitrite accumulation. AngII inhibition with 0.5 mg/ml losartan reduced oxidative stress and normalized blood pressure and endothelium-dependent relaxation, which suggests that AngII uncouples eNOS and contributes to the BPA-induced endothelial dysfunction by promoting oxidative and nitrosative stress. Microarray analysis of mouse aortic endothelial cells revealed a 2.5-fold increase in expression of calcium/calmodulin-dependent protein kinase II- (CaMKII-) in response to 10 nM BPA, with increased expression of phosphorylated-CaMKII- in carotid rings of BPA-exposed mice, whereas CaMKII- inhibition with 100 nM autocamptide-2-related inhibitor peptide (AIP) reduced BPA-mediated increase of superoxide. Administration of CaMKII- inhibitor KN 93 reduced BPA-induced blood pressure and carotid blood velocity in mice, and reverted BPA-mediated carotid constriction in response to treatment with AcH. Given that CaMKII- inhibition prevents BPA-mediated high blood pressure, our data suggest that BPA regulates blood pressure by inducing AngII/CaMKII- uncoupling of eNOS.Saura, M., Marquez, S., Reventun, P., Olea-Herrero, N., Arenas, M.I., Moreno-Gomez-Toledano, R., Gomez-Parrizas, M., Munoz-Moreno, C., Gonzalez-Santander, M., Zaragoza, C., Bosch, R.J. Oral administration of bisphenol A induces high blood pressure through angiotensin II/CaMKII-dependent uncoupling of eNOS.	[Saura, Marta; Marquez, Susana; Reventun, Paula] Univ Alcala de Henares, Lab Pathophysiol Vasc Wall, E-28801 Alcala De Henares, Spain; [Saura, Marta; Marquez, Susana; Reventun, Paula; Olea-Herrero, Nuria; Moreno-Gomez-Toledano, Rafael; Munoz-Moreno, Carmen; Bosch, Ricardo J.] Univ Alcala de Henares, Dept Syst Biol, Physiol Unit, E-28801 Alcala De Henares, Spain; [Olea-Herrero, Nuria; Isabel Arenas, Maria; Moreno-Gomez-Toledano, Rafael; Munoz-Moreno, Carmen; Gonzalez-Santander, Marta; Bosch, Ricardo J.] Univ Alcala de Henares, Lab Renal Physiol & Expt Nephrol, E-28801 Alcala De Henares, Spain; [Isabel Arenas, Maria] Univ Alcala de Henares, Dept Biomed & Biotechnol, Cell Biol Unit, E-28801 Alcala De Henares, Spain; [Gonzalez-Santander, Marta] Univ Alcala de Henares, Dept Med & Med Specialties, E-28801 Alcala De Henares, Spain; [Gomez-Parrizas, Monica; Zaragoza, Carlos] Natl Ctr Cardiovasc Res CNIC, Madrid, Spain; [Zaragoza, Carlos] Univ Francisco de Vitoria, Sch Med, Joint Translat Res Unit, Lab Cardiovasc Pathophysiol, Madrid, Spain; [Zaragoza, Carlos] Univ Hosp Ramon & Cajal, Div Cardiol, Madrid, Spain	Universidad de Alcala; Universidad de Alcala; Universidad de Alcala; Universidad de Alcala; Universidad de Alcala; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Francisco de Vitoria; Hospital Universitario Ramon y Cajal	Zaragoza, C (corresponding author), Univ Francisco de Vitoria, Sch Med, Lab Cardiovasc Pathophysiol, Madrid, Spain.	c.zaragoza.prof@ufv.es	Moreno-Gómez-Toledano, Rafael/Q-6662-2018; Bosch, Ricardo José/S-7828-2017; Moreno, Carmen Muñoz/N-2952-2016; Reventun, Paula/AAK-9265-2020; Zaragoza, Carlos/AAH-9275-2019; Reventun, Paula/C-7764-2018; Marta, Gonzalez-Santander Martinez/N-2987-2016	Moreno-Gómez-Toledano, Rafael/0000-0002-4834-289X; Bosch, Ricardo José/0000-0002-9094-1204; Moreno, Carmen Muñoz/0000-0002-7105-1628; Reventun, Paula/0000-0002-6221-8780; Reventun, Paula/0000-0002-6221-8780; Arenas, Maria I/0000-0002-7825-0654; Zaragoza, Carlos/0000-0002-1706-8592; Marta, Gonzalez-Santander Martinez/0000-0002-8901-1077	Ministerio de Ciencia e Innovacion [SAF2009-12009-C02-01]; Instituto de Salud Carlos III [PI12/02825]; Eugenio Rodriguez Pascual Foundation; Ministerio de Economia y Competitividad [SAF 2012-35141, SAF 2008-04629, SAF 2011-28375]; Spanish Society of Nephrology; Comunidad Autonoma de Madrid-Programa de Actividavies I+D in Biociencias [S2010/BMD-2378]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Eugenio Rodriguez Pascual Foundation; Ministerio de Economia y Competitividad(Spanish Government); Spanish Society of Nephrology; Comunidad Autonoma de Madrid-Programa de Actividavies I+D in Biociencias	The authors thank Dr. Irene Cuadrado-Berrocal for her technical assistance. This Work was supported in part by grants from the Ministerio de Ciencia e Innovacion (SAF2009-12009-C02-01), Instituto de Salud Carlos III (PI12/02825), and Eugenio Rodriguez Pascual Foundation to R.B.; Ministerio de Economia y Competitividad (SAF 2012-35141), Spanish Society of Nephrology 2012, to M.S.; and Ministerio de Economia y Competitividad (SAF 2008-04629 and SAF 2011-28375) to C.Z. N.O. is the recipient of a research contract from Comunidad Autonoma de Madrid-Programa de Actividavies I+D in Biociencias 2010 (S2010/BMD-2378). The authors declare no conflicts of interest.	Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Babu S, 2012, BIOCHEM BIOPH RES CO, V426, P215, DOI 10.1016/j.bbrc.2012.08.065; Bae S, 2012, HYPERTENSION, V60, P786, DOI 10.1161/HYPERTENSIONAHA.112.197715; Bodin J, 2014, TOXICOL SCI, V137, P311, DOI 10.1093/toxsci/kft242; Brunner H, 2005, J HYPERTENS, V23, P233, DOI 10.1097/00004872-200502000-00001; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Carwile JL, 2011, JAMA-J AM MED ASSOC, V306, P2218, DOI 10.1001/jama.2011.1721; Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102; Chou Wei-Chun, 2011, Environ Health, V10, P94, DOI 10.1186/1476-069X-10-94; Gong H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054198; Gonzalez-Parra E, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/437857; GORDON MS, 1992, J HYPERTENS, V10, P361, DOI 10.1097/00004872-199204000-00007; Herranz B, 2012, CIRC RES, V110, P439, DOI 10.1161/CIRCRESAHA.111.253948; Kabuto H, 2003, ENVIRON RES, V93, P31, DOI 10.1016/S0013-9351(03)00062-8; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kobayashi T, 2012, CLIN SCI, V123, P375, DOI 10.1042/CS20110621; Kotchen TA, 2008, AM J HYPERTENS, V21, P1074, DOI 10.1038/ajh.2008.257; Kurosawa T, 2002, ENDOCR J, V49, P465, DOI 10.1507/endocrj.49.465; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Landmesser U, 2007, CURR OPIN CARDIOL, V22, P316, DOI 10.1097/HCO.0b013e3281ca710d; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102; MICHEL T, 1992, J CARDIOVASC PHARM, V20, pS45, DOI 10.1097/00005344-199204002-00014; Muthalif MM, 2002, HYPERTENSION, V39, P704, DOI 10.1161/hy0202.103823; Nishio S, 2012, J MOL CELL CARDIOL, V52, P1103, DOI 10.1016/j.yjmcc.2012.02.006; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; Richter CA, 2007, ENVIRON HEALTH PERSP, V115, P902, DOI 10.1289/ehp.9804; Rodrigo R, 2011, HYPERTENS RES, V34, P431, DOI 10.1038/hr.2010.264; Sag CM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0385-6; Sangai NP, 2014, TOXICOL IND HEALTH, V30, P581, DOI 10.1177/0748233712457438; Saura M, 2002, CIRC RES, V91, P806, DOI 10.1161/01.RES.0000040397.23817.E5; Shankar Anoop, 2012, J Environ Public Health, V2012, P481641, DOI 10.1155/2012/481641; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Spary EJ, 2009, J CHEM NEUROANAT, V38, P185, DOI 10.1016/j.jchemneu.2009.05.008; Sriphrapradang C, 2013, ENDOCRINE, V44, P441, DOI 10.1007/s12020-013-9889-y; Tabima DM, 2012, FREE RADICAL BIO MED, V52, P1970, DOI 10.1016/j.freeradbiomed.2012.02.041; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Teeguarden JG, 2011, TOXICOL SCI, V123, P48, DOI 10.1093/toxsci/kfr160; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zhao YY, 1998, ACTA BIOCH BIOPH SIN, V30, P445	48	65	66	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4719	4728		10.1096/fj.14-252460	http://dx.doi.org/10.1096/fj.14-252460			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25103225				2022-12-25	WOS:000344050900013
J	Solsona, C; Kahn, TB; Badilla, CL; Alvarez-Zaldiernas, C; Blasi, J; Fernandez, JM; Alegre-Cebollada, J				Solsona, Carles; Kahn, Thomas B.; Badilla, Carmen L.; Alvarez-Zaldiernas, Cristina; Blasi, Juan; Fernandez, Julio M.; Alegre-Cebollada, Jorge			Altered Thiol Chemistry in Human Amyotrophic Lateral Sclerosis-linked Mutants of Superoxide Dismutase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND; WILD-TYPE; CU,ZN-SUPEROXIDE DISMUTASE; FAMILIAL ALS; BIOPHYSICAL PROPERTIES; PROTEIN IMPORT; SINGLE PROTEIN; MOTOR-NEURONS; METAL-IONS; SOD1	Neurodegenerative diseases share a common characteristic, the presence of intracellular or extracellular deposits of protein aggregates in nervous tissues. Amyotrophic Lateral Sclerosis (ALS) is a severe and fatal neurodegenerative disorder, which affects preferentially motoneurons. Changes in the redox state of superoxide dismutase 1 (SOD1) are associated with the onset and development of familial forms of ALS. In human SOD1 (hSOD1), a conserved disulfide bond and two free cysteine residues can engage in anomalous thiol/disulfide exchange resulting in non-native disulfides, a hallmark of ALS that is related to protein misfolding and aggregation. Because of the many competing reaction pathways, traditional bulk techniques fall short at quantifying individual thiol/disulfide exchange reactions. Here, we adapt recently developed single-bond chemistry techniques to study individual disulfide isomerization reactions in hSOD1. Mechanical unfolding of hSOD1 leads to the formation of a polypeptide loop held by the disulfide. This loop behaves as a molecular jump rope that brings reactive Cys-111 close to the disulfide. Using force-clamp spectroscopy, we monitor nucleophilic attack of Cys-111 at either sulfur of the disulfide and determine the selectivity of the reaction. Disease-causing mutations G93A and A4V show greatly altered reactivity patterns, which may contribute to the progression of familial ALS.	[Solsona, Carles; Alvarez-Zaldiernas, Cristina; Blasi, Juan] Univ Barcelona, Lab Cellular & Mol Neurobiol, Dept Pathol & Expt Therapeut, Fac Med, Barcelona 08907, Spain; [Solsona, Carles; Alvarez-Zaldiernas, Cristina; Blasi, Juan] Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain; [Kahn, Thomas B.] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kahn, Thomas B.; Badilla, Carmen L.; Fernandez, Julio M.; Alegre-Cebollada, Jorge] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Alegre-Cebollada, Jorge] CNIC, Vasc Biol & Inflammat Dept, Madrid 28029, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Columbia University; Columbia University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Solsona, C (corresponding author), Univ Barcelona, Lab Cellular & Mol Neurobiol, Dept Pathol & Expt Therapeut, Fac Med, Campus Bellvitge,Feixa Llarga S-N, Barcelona 08907, Spain.	solsona@ub.edu	Blasi, Juan/K-7943-2014; Alegre-Cebollada, Jorge/I-4301-2014	Blasi, Juan/0000-0002-0482-9444; Alegre-Cebollada, Jorge/0000-0003-0542-0170	National Institutes of Health [HL66030, HL61228]; Spanish Ministry of Economy and Competitiveness [SAF2011-28485, SAF2011-27566]; European Union FEDER from the Spanish Ministry of Education [PR2011-0339]; Government of Catalonia [SGR2009/152]; National Institutes of Health Training Program in Molecular Biophysics [T32GM008281]; European Union FEDER; National Institutes of Health Grant [AI106072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI106072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union FEDER from the Spanish Ministry of Education; Government of Catalonia(Generalitat de Catalunya); National Institutes of Health Training Program in Molecular Biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union FEDER(European Commission); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.) and Grants SAF2011-28485 from the Spanish Ministry of Economy and Competitiveness and European Union FEDER PR2011-0339 from the Spanish Ministry of Education, and Government of Catalonia SGR2009/152 (to C. S.).; Supported by the National Institutes of Health Training Program in Molecular Biophysics (T32GM008281).; Recipient of Grant SAF2011-27566, Spanish Ministry of Economy and Competitiveness and European Union FEDER.; Supported by National Institutes of Health Grant AI106072.	Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056; Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bouldin SD, 2012, BIOCHEM J, V446, P59, DOI 10.1042/BJ20120075; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Das A, 2013, J MOL BIOL, V425, P850, DOI 10.1016/j.jmb.2012.12.022; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Galaleldeen A, 2009, ARCH BIOCHEM BIOPHYS, V492, P40, DOI 10.1016/j.abb.2009.09.020; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Juneja T, 1997, NEUROLOGY, V48, P55, DOI 10.1212/WNL.48.1.55; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Kosuri P, 2012, CELL, V151, P794, DOI 10.1016/j.cell.2012.09.036; Liang J, 2009, ACS NANO, V3, P1628, DOI 10.1021/nn900294n; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Nordlund A, 2006, P NATL ACAD SCI USA, V103, P10218, DOI 10.1073/pnas.0601696103; Pickles S, 2012, AMYOTROPH LATERAL SC, V13, P333, DOI 10.3109/17482968.2012.648645; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Shariff K, 2004, BIOPHYS J, V86, P3647, DOI 10.1529/biophysj.104.040865; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; You Z, 2010, BIOCHEMISTRY-US, V49, P1191, DOI 10.1021/bi901844d; Zimmermann JL, 2010, NAT PROTOC, V5, P975, DOI 10.1038/nprot.2010.49	65	13	13	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26722	26732		10.1074/jbc.M114.565333	http://dx.doi.org/10.1074/jbc.M114.565333			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096579	Green Published, hybrid			2022-12-25	WOS:000342853900005
J	Aghazadeh, Y; Ye, XY; Blonder, J; Papadopoulos, V				Aghazadeh, Yasaman; Ye, Xiaoying; Blonder, Josip; Papadopoulos, Vassilios			Protein Modifications Regulate the Role of 14-3-3 gamma Adaptor Protein in cAMP-induced Steroidogenesis in MA-10 Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-BIOSYNTHESIS; FUNCTIONAL SPECIFICITY; CHOLESTEROL TRANSPORT; CRYSTAL-STRUCTURE; LIGAND-BINDING; IN-VIVO; PHOSPHORYLATION; ISOFORM; 14-3-3-PROTEINS; ACTIVATION	The 14-3-3 protein family comprises adaptors and scaffolds that regulate intracellular signaling pathways. The 14-3-3 gamma isoform is a negative regulator of steroidogenesis that is hormonally induced and transiently functions at the initiation of steroidogenesis by delaying maximal steroidogenesis in MA-10 mouse tumor Leydig cells. Treatment of MA-10 cells with the cAMP analog 8-bromo-cAMP (8-Br-cAMP), which stimulates steroidogenesis, triggers the interaction of 14-3-3 gamma with the steroidogenic acute regulatory protein (STAR) in the cytosol, limiting STAR activity to basal levels. Over time, this interaction ceases, allowing for a 2-fold induction in STAR activity and maximal increase in the rate of steroid formation. The 14-3-3 gamma/ STAR pattern of interaction was found to be opposite that of the 14-3-3 gamma homodimerization pattern. Phosphorylation and acetylation of 14-3-3 gamma showed similar patterns to homodimerization and STAR binding, respectively. 14-3-3 gamma Ser(58) phosphorylation and 14-3-3 gamma Lys(49) acetylation were blocked using trans-activator of HIV transcription factor 1 peptides coupled to 14-3-3 gamma sequences containing Ser(58) or Lys(49). Blocking either one of these modifications further induced 8-Br-cAMP-induced steroidogenesis while reducing lipid storage, suggesting that the stored cholesterol is used for steroid formation. Taken together, these results indicate that Ser(58) phosphorylation and Lys(49) acetylation of 14-3-3 gamma occur in a coordinated time-dependent manner to regulate 14-3-3 gamma homodimerization. 14-3-3 gamma Ser(58) phosphorylation is required for STAR interactions under control conditions, and 14-3-3 gamma Lys(49) acetylation is important for the cAMP-dependent induction of these interactions.	[Aghazadeh, Yasaman; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Aghazadeh, Yasaman; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Ye, Xiaoying; Blonder, Josip] NCI, Prot Characterizat Lab, Canc Res Technol Program, Leidos Biomed Res Inc,Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	McGill University; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1650 Cedar Ave,C10-148, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	Le Fonds de la recherche du Quebec-Sante	Le Fonds de la recherche du Quebec-Sante	We thank Dr. Mario Ascoli (University of Iowa, Iowa City, IA) for supplying the MA-10 cell line and Dr. Buck Hales (Southern Illinois University) for supplying the STAR antibody. The Research Institute of McGill University Health Centre was supported by a center grant from Le Fonds de la recherche du Quebec-Sante.	Aghazadeh Y, 2012, J BIOL CHEM, V287, P15380, DOI 10.1074/jbc.M112.339580; Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1998, ENDOCR RES, V24, P463, DOI 10.3109/07435809809032634; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Cheah PS, 2012, MOL PSYCHIATR, V17, P451, DOI 10.1038/mp.2011.158; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069702; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Hamaguchi A, 2003, J BIOL CHEM, V278, P41557, DOI 10.1074/jbc.M305294200; Han DD, 2010, BIOCHEM BIOPH RES CO, V396, P401, DOI 10.1016/j.bbrc.2010.04.104; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003; Jagemann LR, 2008, J BIOL CHEM, V283, P17450, DOI 10.1074/jbc.M709185200; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kramer B, 1997, PROTEINS, P221; Liang XB, 2008, J BIOL CHEM, V283, P27418, DOI 10.1074/jbc.M803687200; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Manna P. R., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P93, DOI 10.2174/1568008053174714; MARAIS R, 1995, STRUCTURE, V3, P751, DOI 10.1016/S0969-2126(01)00209-X; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Uhart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055703; Wang C, 2009, J ANDROL, V30, P1, DOI 10.2164/jandrol.108.006486; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Xiao B, 1996, ACTA CRYSTALLOGR D, V52, P203, DOI 10.1107/S0907444995009516; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	49	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26542	26553		10.1074/jbc.M114.569079	http://dx.doi.org/10.1074/jbc.M114.569079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086053	Green Published, hybrid			2022-12-25	WOS:000342128800045
J	Cai, MJ; Liu, W; Pei, XY; Li, XR; He, HJ; Wang, JX; Zhao, XF				Cai, Mei-Juan; Liu, Wen; Pei, Xu-Yang; Li, Xiang-Ru; He, Hong-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan			Juvenile Hormone Prevents 20-Hydroxyecdysone-induced Metamorphosis by Regulating the Phosphorylation of a Newly Identified Broad Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STATUS-QUO ACTION; RED FLOUR BEETLE; TRANSCRIPTION FACTORS; INSECT METAMORPHOSIS; TRIBOLIUM-CASTANEUM; MANDUCA-SEXTA; DROSOPHILA METAMORPHOSIS; HELICOVERPA-ARMIGERA; METHOPRENE-TOLERANT	The steroid hormone 20-hydroxyecdysone (20E) initiates insect molting and metamorphosis. By contrast, juvenile hormone (JH) prevents metamorphosis. However, the mechanism by which JH inhibits metamorphosis remains unclear. In this study, we propose that JH induces the phosphorylation of Broad isoform Z7 (BrZ7), a newly identified protein, to inhibit 20E-mediated metamorphosis in the lepidopteran insect Helicoverpa armigera. The knockdown of BrZ7 in larvae inhibited metamorphosis by repressing the expression of the 20E response gene. BrZ7 was weakly expressed and phosphorylated during larval growth but highly expressed and non-phosphorylated during metamorphosis. JH regulated the rapid phosphorylation of BrZ7 via a G-protein-coupled receptor-, phospholipase C-, and protein kinase C-triggered pathway. The phosphorylated BrZ7 bound to the 5'-regulatory region of calponin to regulate its expression in the JH pathway. Exogenous JH induced BrZ7 phosphorylation to prevent metamorphosis by suppressing 20E-related gene transcription. JH promoted non-phosphorylated calponin interacting with ultraspiracle protein to activate the JH pathway and antagonize the 20E pathway. This study reveals one of the possible mechanisms by which JH counteracts 20E-regulated metamorphosis by inducing the phosphorylation of BrZ7.	[Cai, Mei-Juan; Liu, Wen; Pei, Xu-Yang; Li, Xiang-Ru; He, Hong-Juan; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Shandong Prov Key Lab Anim Cells & Dev Biol,Minis, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Liu, Wen/S-8027-2019; Zhao, Xiao-Fan/AGW-9886-2022	Liu, Wen/0000-0002-4985-0618; Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [31230067]; National Basic Research Program of China (973 Program) [2012CB114101]; Ph.D. Programs Foundation of the Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grant 31230067, National Basic Research Program of China (973 Program) Grant 2012CB114101, and Ph.D. Programs Foundation of the Ministry of Education of China Grant 20120131110025.	Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Cai MJ, 2012, APOPTOSIS, V17, P1327, DOI 10.1007/s10495-012-0761-y; Deng H, 2011, INSECT MOL BIOL, V20, P45, DOI 10.1111/j.1365-2583.2010.01041.x; DIBELLO PR, 1991, GENETICS, V129, P385; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EMERY IF, 1994, DEVELOPMENT, V120, P3275; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Fang F, 2005, FEBS J, V272, P1577, DOI 10.1111/j.1742-4658.2005.04578.x; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; Gorelick-Feldman J, 2010, STEROIDS, V75, P632, DOI 10.1016/j.steroids.2010.03.008; Ijiro T, 2004, INSECT BIOCHEM MOLEC, V34, P963, DOI 10.1016/j.ibmb.2004.06.005; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KARIM FD, 1993, DEVELOPMENT, V118, P977; Kim Y, 1999, INSECT BIOCHEM MOLEC, V29, P943, DOI 10.1016/S0965-1748(99)00070-3; KISS I, 1988, GENETICS, V118, P247; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; RANE SG, 1989, NEURON, V3, P239, DOI 10.1016/0896-6273(89)90037-8; Rauch P, 1998, INSECT BIOCHEM MOLEC, V28, P265, DOI 10.1016/S0965-1748(98)00026-5; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; RIDDIFORD LM, 1993, RECEPTOR, V3, P203; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Schooley D.A., 1984, P373; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wang CX, 2012, AMINO ACIDS, V43, P963, DOI 10.1007/s00726-011-1159-9; Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Wu Y, 2006, MECH DEVELOP, V123, P530, DOI 10.1016/j.mod.2006.05.005; Yang DT, 2008, MOL BIOL REP, V35, P405, DOI 10.1007/s11033-007-9100-8; Yang XH, 2011, MOL CELL ENDOCRINOL, V333, P172, DOI 10.1016/j.mce.2010.12.029; Zhao WL, 2014, J MOL ENDOCRINOL, V53, P93, DOI 10.1530/JME-14-0019; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhou BH, 1998, DEV BIOL, V193, P127, DOI 10.1006/dbio.1997.8798; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	49	31	33	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26630	26641		10.1074/jbc.M114.581876	http://dx.doi.org/10.1074/jbc.M114.581876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25096576	Green Published, hybrid			2022-12-25	WOS:000342128800053
J	Minett, MS; Eijkelkamp, N; Wood, JN				Minett, Michael S.; Eijkelkamp, Niels; Wood, John N.			Significant Determinants of Mouse Pain Behaviour	PLOS ONE			English	Article							SENSORY NEURONS; MOLECULAR-BASIS; NOCICEPTION; COLD; DELETION; TRPA1; RECOMBINATION; HERITABILITY; HYPERALGESIA; EXPRESSION	Transgenic mouse behavioural analysis has furthered our understanding of the molecular and cellular mechanisms underlying damage sensing and pain. However, it is not unusual for conflicting data on the pain phenotypes of knockout mice to be generated by reputable groups. Here we focus on some technical aspects of measuring mouse pain behaviour that are often overlooked, which may help explain discrepancies in the pain literature. We examined touch perception using von Frey hairs and mechanical pain thresholds using the Randall-Selitto test. Thermal pain thresholds were measured using the Hargreaves apparatus and a thermal place preference test. Sodium channel Nav1.7 knockout mice show a mechanical deficit in the hairy skin, but not the paw, whilst shaving the abdominal hair abolished this phenotype. Nav1.7, Nav1.8 and Nav1.9 knockout mice show deficits in noxious mechanosensation in the tail, but not the paw. TRPA1 knockout mice, however, have a loss of noxious mechanosensation in the paw but not the tail. Studies of heat and cold sensitivity also show variability depending on the intensity of the stimulus. Deleting Nav1.7, Nav1.8 or Nav1.9 in Nav1.8-positive sensory neurons attenuates responses to slow noxious heat ramps, whilst responses to fast noxious heat ramps are only reduced when Nav1.7 is lost in large diameter sensory neurons. Deleting Nav1.7 from all sensory neurons attenuates responses to noxious cooling but not extreme cold. Finally, circadian rhythms dramatically influence behavioural outcome measures such as von Frey responses, which change by 80% over the day. These observations demonstrate that fully characterising the phenotype of a transgenic mouse strain requires a range of behavioural pain models. Failure to conduct behavioural tests at different anatomical locations, stimulus intensities, and at different points in the circadian cycle may lead to a pain behavioural phenotype being misinterpreted, or missed altogether.	[Minett, Michael S.; Eijkelkamp, Niels; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Eijkelkamp, Niels] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands	University of London; University College London; Utrecht University; Utrecht University Medical Center	Wood, JN (corresponding author), UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, Gower St, London, England.	j.wood@ucl.ac.uk		Eijkelkamp, Niels/0000-0003-0039-7063	Medical Research Council [G0901905]; Wellcome Trust [101054/Z/13/Z]; Rubicon Trust; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Versus Arthritis [20200] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Rubicon Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This study was supported by JNW Medical Research Council G0901905, JNW MSM Wellcome Trust 101054/Z/13/Z, NE Rubicon Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Callahan BL, 2008, J PAIN, V9, P174, DOI 10.1016/j.jpain.2007.10.011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chassard D, 2004, ANESTHESIOLOGY, V100, P413; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; FREDERICKSON RCA, 1977, SCIENCE, V198, P756, DOI 10.1126/science.561998; Gautron L, 2011, J COMP NEUROL, V519, P3085, DOI 10.1002/cne.22667; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Kusunose N, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-83; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Minett Michael S, 2011, Curr Protoc Mouse Biol, V1, P383, DOI 10.1002/9780470942390.mo110116; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Mogil JS, 2010, PAIN, V151, P12, DOI 10.1016/j.pain.2010.07.015; Mogil JS, 1999, PAIN, V80, P83, DOI 10.1016/S0304-3959(98)00196-1; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-33; Ostman JAR, 2008, J PHYSIOL-LONDON, V586, P1077, DOI 10.1113/jphysiol.2007.147942; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Thompson SJ, 2012, NEUROSCI LETT, V520, P131, DOI 10.1016/j.neulet.2012.03.015; Zhou X, 2010, P NATL ACAD SCI USA, V107, P9424, DOI 10.1073/pnas.0914725107	39	68	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104458	10.1371/journal.pone.0104458	http://dx.doi.org/10.1371/journal.pone.0104458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101983	Green Published, gold			2022-12-25	WOS:000339993900066
J	Swale, DR; Sun, BN; Tong, F; Bloomquist, JR				Swale, Daniel R.; Sun, Baonan; Tong, Fan; Bloomquist, Jeffrey R.			Neurotoxicity and Mode of Action of N,N-Diethyl-Meta-Toluamide (DEET)	PLOS ONE			English	Article							INSECT REPELLENT; ANOPHELES-GAMBIAE; FIREFLY LANTERN; NEURAL-CONTROL; AEDES-AEGYPTI; OCTOPAMINE; N,N-DIETHYL-M-TOLUAMIDE; CHOLINESTERASES; TRANSMITTER; PESTICIDES	Recent studies suggest that N,N-diethyl-meta-toluamide (DEET) is an acetylcholinesterase inhibitor and that this action may result in neurotoxicity and pose a risk to humans from its use as an insect repellent. We investigated the mode of action of DEET neurotoxicity in order to define the specific neuronal targets related to its acute toxicity in insects and mammals. Although toxic to mosquitoes (LD50 ca. 1.5 mu g/mg), DEET was a poor acetylcholinesterase inhibitor (<10% inhibition), even at a concentration of 10 mM. IC50 values for DEET against Drosophila melanogaster, Musca domestica, and human acetylcholinesterases were 6-12 mM. Neurophysiological recordings showed that DEET had excitatory effects on the housefly larval central nervous system (EC50: 120 mu M), but was over 300-fold less potent than propoxur, a standard anticholinesterase insecticide. Phentolamine, an octopamine receptor antagonist, completely blocked the central neuroexcitation by DEET and octopamine, but was essentially ineffective against hyperexcitation by propoxur and 4-aminopyridine, a potassium channel blocker. DEET was found to illuminate the firefly light organ, a tissue utilizing octopamine as the principal neurotransmitter. Additionally, DEET was shown to increase internal free calcium via the octopamine receptors of Sf21 cells, an effect blocked by phentolamine. DEET also blocked Na+ and K+ channels in patch clamped rat cortical neurons, with IC50 values in the micromolar range. These findings suggest DEET is likely targeting octopaminergic synapses to induce neuroexcitation and toxicity in insects, while acetylcholinesterase in both insects and mammals has low (mM) sensitivity to DEET. The ion channel blocking action of DEET in neurons may contribute to the numbness experienced after inadvertent application to the lips or mouth of humans.	[Swale, Daniel R.; Sun, Baonan; Tong, Fan; Bloomquist, Jeffrey R.] Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Bloomquist, JR (corresponding author), Univ Florida, Emerging Pathogens Inst, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	jbquist@epi.ufl.edu			Deployed War Fighter Research Program under USDA [58-0208-0-068]	Deployed War Fighter Research Program under USDA	This study was financially supported by the Deployed War Fighter Research Program under USDA Specific Cooperative Agreement 58-0208-0-068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bloomquist JR, 1996, TOXICON, V34, P1072, DOI 10.1016/0041-0101(96)00028-1; BLOOMQUIST JR, 1991, PESTIC SCI, V32, P463, DOI 10.1002/ps.2780320408; Bonnet J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-17; BOOTH GM, 1971, B WORLD HEALTH ORGAN, V44, P91; Carlier PR, 2008, CHEM-BIOL INTERACT, V175, P368, DOI 10.1016/j.cbi.2008.04.037; CASIDA JE, 1970, J AGR FOOD CHEM, V18, P753, DOI 10.1021/jf60171a013; CLEM JR, 1993, ANN PHARMACOTHER, V27, P289, DOI 10.1177/106002809302700305; Coats JR., 1982, INSECTICIDE MODE ACT, P198; Colhoun E. H., 1963, P1; COPELAND J, 1982, COMP BIOCHEM PHYS C, V72, P125, DOI 10.1016/0306-4492(82)90217-9; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Ellenhorn M.J, 1997, ELLENHORNS MED TOXIC, V2nd; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; HOLLINGWORTH RM, 1980, SCIENCE, V208, P74, DOI 10.1126/science.208.4439.74; Jaffe RA, 1996, ANESTHESIOLOGY, V84, P1455, DOI 10.1097/00000542-199606000-00022; Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x; LIPSCOMB JW, 1992, ANN EMERG MED, V21, P315, DOI 10.1016/S0196-0644(05)80896-0; Macko J, 1980, PHASE 6 ACUTE TOXICI; Moore Sarah J., 2007, P3; Moss JI, 1996, J ECON ENTOMOL, V89, P1151, DOI 10.1093/jee/89.5.1151; NATHANSON JA, 1979, J EXP ZOOL, V208, P255, DOI 10.1002/jez.1402080213; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; ORR N, 1992, INSECT BIOCHEM MOLEC, V22, P591, DOI 10.1016/0965-1748(92)90036-E; Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2; REUVENI H, 1982, ARCH DERMATOL, V118, P582, DOI 10.1001/archderm.118.8.582; ROBERTSON HA, 1976, J EXP ZOOL, V195, P159, DOI 10.1002/jez.1401950116; SALGADO VL, 1992, ARCH INSECT BIOCHEM, V21, P239, DOI 10.1002/arch.940210307; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Scior TRF, 2009, J RECEPT LIGAND CH R, V2, P1; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; World Health Organization, 1981, 81805 WHOVBC; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103	34	58	58	5	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103713	10.1371/journal.pone.0103713	http://dx.doi.org/10.1371/journal.pone.0103713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101788	Green Published, gold			2022-12-25	WOS:000339993900023
J	Wang, Y; Zeng, XB; Yao, FJ; Wu, F; Su, C; Fan, ZG; Zhu, Z; Tao, J; Huang, YJ				Wang, Yan; Zeng, Xian-bo; Yao, Feng-juan; Wu, Fang; Su, Chen; Fan, Zhen-guo; Zhu, Zhu; Tao, Jun; Huang, Yi-jun			Endurance Capacity Is Not Correlated with Endothelial Function in Male University Students	PLOS ONE			English	Article							MICROPARTICLES CORRELATE; V+ MICROPARTICLES; PHYSICAL-ACTIVITY; PROGENITOR CELLS; OXYGEN-UPTAKE; DYSFUNCTION; YOUNG; INCREASES; MEN	Background: Endurance capacity, assessed by 1000-meter (1000 m) run of male university students, is an indicator of cardiovascular fitness in Chinese students physical fitness surveillance. Although cardiovascular fitness is related to endothelial function closely in patients with cardiovascular diseases, it remains unclear whether endurance capacity correlates with endothelial function, especially with circulating endothelial microparticles (EMPs), a new sensitive marker of endothelial dysfunction in young students. The present study aimed to investigate the relationship between endurance capacity and endothelial function in male university students. Methods: Forty-seven healthy male university students (mean age, 20.1 +/- 0.6 years; mean height, 172.4 +/- 6.3 cm; and mean weight, 60.0 +/- 8.2 kg) were recruited in this study. The measurement procedure of 1000 m run time was followed to Chinese national students Constitutional Health Criterion. Endothelium function was assessed by flow-mediated vasodilation (FMD) in the brachial artery measured by ultrasonic imaging, and the level of circulating EMPs was measured by flow cytometry. Cardiovascular fitness indicator - maximal oxygen uptake (VO2 max) - was also measured on a cycle ergometer using a portable gas analyzer. Results: 1000 m run time was correlated with VO(2)max (r = -0.399, p < 0.05). However, there were no correlations between VO(2)max and FMD or levels of circulating CD31+/CD42- microparticles. Similarly, no correlations were found between 1000 m run time and FMD, and levels of circulating CD31+/CD42- microparticles in these male university students (p > 0.05). Conclusion: The correlations between endurance capacity or cardiovascular fitness and endothelial function were not found in healthy Chinese male university students. These results suggest that endurance capacity may not reflect endothelial function in healthy young adults with well preserved FMD and low level of circulating CD31+/CD42-EMPs.	[Wang, Yan] Sun Yat Sen Univ, Affiliated Hosp 1, Phys Examinat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Xian-bo; Fan, Zhen-guo] Sun Yat Sen Univ, Sch Educ, Guangzhou 510275, Guangdong, Peoples R China; [Yao, Feng-juan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Ultrason, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Fang; Su, Chen; Tao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Zhu; Huang, Yi-jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tao, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou 510275, Guangdong, Peoples R China.	taojungz@yahoo.com; huangyj@mail.sysu.edu.cn			National Natural Scientific Foundation of China [81200095]; Guangdong National Science Foundation [S2011010004852]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong National Science Foundation	This study is financially supported by the grants from National Natural Scientific Foundation of China (81200095, http://isisn.nsfc.gov.cn/egrantweb/) and Guangdong National Science Foundation (S2011010004852, http://pro.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis,	Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Babbitt DM, 2013, INT J HYPER IN PRESS; Boyle LJ, 2013, J APPL PHYSIOL, V115, P1519, DOI 10.1152/japplphysiol.00837.2013; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Bulut D, 2009, EUR J CLIN INVEST, V39, P17, DOI 10.1111/j.1365-2362.2008.02058.x; Bulut D, 2008, J CARD FAIL, V14, P336, DOI 10.1016/j.cardfail.2007.11.002; Buscemi S, 2013, ACTA DIABETOL, V50, P135, DOI 10.1007/s00592-010-0229-x; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cheng F, 2013, INT J CARDIOL, V167, P936, DOI 10.1016/j.ijcard.2012.03.090; Chinese National Survey on Students of Constitution and Health Association, 2012, REP 2010 PHYS FITN H; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Duffield R, 2004, J SCI MED SPORT, V7, P11, DOI 10.1016/S1440-2440(04)80039-2; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Franzoni F, 2005, AM J HYPERTENS, V18, P510, DOI 10.1016/j.amjhyper.2004.11.006; Guazzi M, 2007, EUR J CLIN INVEST, V37, P454, DOI 10.1111/j.1365-2362.2007.01805.x; Jenkins NT, 2011, J PHYSIOL-LONDON, V589, P5539, DOI 10.1113/jphysiol.2011.215277; Klinkner DB, 2006, SHOCK, V25, P575, DOI 10.1097/01.shk.0000209558.69575.80; Lee ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035713; Moe IT, 2005, VASC MED, V10, P97, DOI 10.1191/1358863x05vm592oa; Peterson D. Fred, 2003, Journal of the American Osteopathic Association, V103, P361; Rognmo O, 2008, J STRENGTH COND RES, V22, P535, DOI 10.1519/JSC.0b013e31816354b1; Schmidt JF, 2013, MED SCI SPORT EXER, V45, P2223, DOI 10.1249/MSS.0b013e31829ab43c; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Sossdorf M, 2011, MED SCI SPORT EXER, V43, P1169, DOI 10.1249/MSS.0b013e3182068645; Strohacker K, 2012, APPL PHYSIOL NUTR ME, V37, P530, DOI [10.1139/h2012-034, 10.1139/H2012-034]; Tjonna AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065382; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Wang JM, 2007, AM J HYPERTENS, V20, P957, DOI 10.1016/j.amjhyper.2007.04.005; Wang JM, 2009, EUR J PHARMACOL, V614, P77, DOI 10.1016/j.ejphar.2009.04.037; Wilkinson DM, 1999, J SPORT SCI, V17, P413, DOI 10.1080/026404199365939; Xia WH, 2012, AGING CELL, V11, P111, DOI 10.1111/j.1474-9726.2011.00758.x; Yang Z, 2007, J HUM HYPERTENS, V21, P452, DOI 10.1038/sj.jhh.1002171	33	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103814	10.1371/journal.pone.0103814	http://dx.doi.org/10.1371/journal.pone.0103814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101975	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900025
J	Yamaguchi, S; Machida, J; Kamamoto, M; Kimura, M; Shibata, A; Tatematsu, T; Miyachi, H; Higashi, Y; Jezewski, P; Nakayama, A; Shimozato, K; Tokita, Y				Yamaguchi, Seishi; Machida, Junichiro; Kamamoto, Munefumi; Kimura, Masashi; Shibata, Akio; Tatematsu, Tadashi; Miyachi, Hitoshi; Higashi, Yujiro; Jezewski, Peter; Nakayama, Atsuo; Shimozato, Kazuo; Tokita, Yoshihito			Characterization of Novel MSX1 Mutations Identified in Japanese Patients with Nonsyndromic Tooth Agenesis	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPODONTIA; BONE MORPHOGENETIC PROTEIN; CLEFT-LIP; NONSENSE MUTATION; CRYSTAL-STRUCTURE; EXPRESSION; PAX9; HAPLOINSUFFICIENCY; DIFFERENTIATION; TRANSCRIPTION	Since MSX1 and PAX9 are linked to the pathogenesis of nonsyndromic tooth agenesis, we performed detailed mutational analysis of these two genes sampled from Japanese patients. We identified two novel MSX1 variants with an amino acid substitution within the homeodomain; Thr174Ile (T174I) from a sporadic hypodontia case and Leu205Arg (L205R) from a familial oligodontia case. Both the Thr174 and Leu205 residues in the MSX1 homeodomain are highly conserved among different species. To define possible roles of mutations at these amino acids in the pathogenesis of nonsyndromic tooth agenesis, we performed several functional analyses. It has been demonstrated that MSX1 plays a pivotal role in hard tissue development as a suppressor for mesenchymal cell differentiation. To evaluate the suppression activity of the variants in mesenchymal cells, we used the myoD-promoter, which is one of convenient reporter assay system for MSX1. Although the gene products of these MSX1 variants are stable and capable of normal nuclear localization, they do not suppress myoD-promoter activity in differentiated C2C12 cells. To clarify the molecular mechanisms underlying our results, we performed further analyses including electrophoretic mobility shift assays, and co-immunoprecipitation assays to survey the molecular interactions between the mutant MSX1 proteins and the oligonucleotide DNA with MSX1 consensus binding motif or EZH2 methyltransferase. Since EZH2 is reported to interact with MSX1 and regulate MSX1 mediated gene suppression, we hypothesized that the T174I and L205R substitutions would impair this interaction. We conclude from the results of our experiments that the DNA binding ability of MSX1 is abolished by these two amino acid substitutions. This illustrates a causative role of the T174I and L205R MSX1 homeodomain mutations in tooth agenesis, and suggests that they may influence cell proliferation and differentiation resulting in lesser tooth germ formation in vivo.	[Yamaguchi, Seishi; Machida, Junichiro; Kamamoto, Munefumi; Kimura, Masashi; Shibata, Akio; Tatematsu, Tadashi; Miyachi, Hitoshi; Shimozato, Kazuo; Tokita, Yoshihito] Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, Nagoya, Aichi 464, Japan; [Yamaguchi, Seishi] Aichi Childrens Hlth & Med Ctr, Dept Dent & Oral Surg, Aichi, Japan; [Yamaguchi, Seishi; Kimura, Masashi; Shibata, Akio; Tatematsu, Tadashi; Higashi, Yujiro; Tokita, Yoshihito] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi, Japan; [Nakayama, Atsuo] Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan; [Kamamoto, Munefumi] Himeji Hosp, Japanese Red Cross Soc, Dept Oral & Maxillofacial Surg, Himeji, Hyogo, Japan; [Jezewski, Peter] Univ Alabama Birmingham, Birmingham Sch Dent, Inst Oral Hlth Res, Dept Periodontol, Birmingham, AL USA; [Machida, Junichiro] Toyota Mem Hosp, Dept Oral & Maxillofacial Surg, Toyota, Aichi, Japan	Aichi Gakuin University; University of Alabama System; University of Alabama Birmingham	Tokita, Y (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Maxillofacial Surg, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	tokita@inst-hsc.jp			Institute for Developmental Research; Aichi-Human Service Center; Aichi-Gakuin University, School of Dentistry; Grants-in-Aid for Scientific Research [23591524] Funding Source: KAKEN	Institute for Developmental Research; Aichi-Human Service Center; Aichi-Gakuin University, School of Dentistry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Institute for Developmental Research, Aichi-Human Service Center (YT), and from the Aichi-Gakuin University, School of Dentistry (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YP, 1996, DEVELOPMENT, V122, P3035; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Feng XY, 2013, EUR J ORAL SCI, V121, P412, DOI 10.1111/eos.12078; Finnerty JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-18; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; Honda T, 2010, MOL BIOL CELL, V21, P3269, DOI 10.1091/mbc.E10-02-0117; Hu GZ, 1998, MOL CELL BIOL, V18, P6044, DOI 10.1128/MCB.18.10.6044; ILER N, 1995, MECH DEVELOP, V53, P87, DOI 10.1016/0925-4773(95)00427-0; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Kamamoto M, 2011, INT J ORAL MAX SURG, V40, P434, DOI 10.1016/j.ijom.2010.09.025; Kamamoto M, 2011, EUR J HUM GENET, V19, P844, DOI 10.1038/ejhg.2011.47; Kimura M, 2013, EUR J ORAL IN PRESS; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lee H, 2006, GENE DEV, V20, P784, DOI 10.1101/gad.1392006; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Letra A, 2007, J DENT RES, V86, P986, DOI 10.1177/154405910708601013; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4; Li H, 1997, PROTEIN SCI, V6, P956, DOI 10.1002/pro.5560060502; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Lidral AC, 1998, AM J HUM GENET, V63, P557, DOI 10.1086/301956; Mostowska A, 2013, CLIN GENET, V84, P429, DOI 10.1111/cge.12061; Mostowska A, 2012, ARCH ORAL BIOL, V57, P790, DOI 10.1016/j.archoralbio.2012.01.003; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakayama A, 2003, J BIOL CHEM, V278, P233, DOI 10.1074/jbc.M209574200; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Suzuki Y, 2004, GENET MED, V6, P117, DOI 10.1097/01.GIM.0000127275.52925.05; Tokita Y, 2001, J NEUROSCI, V21, P1257; URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Vieira AR, 2003, J DENT RES, V82, P289, DOI 10.1177/154405910308200409; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Wang Y, 2011, J DENT RES, V90, P311, DOI 10.1177/0022034510387430; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; WOLOSHIN P, 1995, CELL, V82, P611, DOI 10.1016/0092-8674(95)90033-0; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	43	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102944	10.1371/journal.pone.0102944	http://dx.doi.org/10.1371/journal.pone.0102944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101640	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900013
J	Zhang, ZY; Li, CY; Zug, C; Schluesener, HJ				Zhang, Zhi-Yuan; Li, Chaoyun; Zug, Caroline; Schluesener, Hermann J.			Icariin Ameliorates Neuropathological Changes, TGF-beta 1 Accumulation and Behavioral Deficits in a Mouse Model of Cerebral Amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSFORMING GROWTH-FACTOR-BETA-1; FUNCTIONAL RECOVERY; TRANSGENIC MICE; IV COLLAGEN; INFLAMMATION; NEUROINFLAMMATION; INHIBITOR; NEURONS; DIFFERENTIATION	Icariin, a major constituent of flavonoids from the Chinese medicinal herb Epimedium brevicornum, exhibits multiple biological properties, including anti-inflammatory, neuroregulatory and neuroprotective activities. Therefore, Icariin might be applied in treatment of neurodegenerative disorders, including Alzheimer's disease (AD), which is neuropathologically characterized by beta-amyloid aggregation, hyperphosphorylated tau and neuroinflammation. Potential therapeutic effects of Icariin were investigated in an animal model of cerebral amyloidosis for AD, transgenic APP/PS1 mouse. Icariin was suspended in carboxymethylcellulose and given orally to APP/PS1 mice. Therapeutic effects were monitored by behavioral tests, namely nesting assay, before and during the experimental treatment. Following an oral treatment of 10 days, Icariin significantly attenuated A beta deposition, microglial activation and TGF-beta 1 immunoreactivity at amyloid plaques in cortex and hippocampus of transgenic mice 5 months of age, and restored impaired nesting ability. Our results suggest that Icariin might be considered a promising therapeutic option for human AD.	[Zhang, Zhi-Yuan; Li, Chaoyun; Zug, Caroline; Schluesener, Hermann J.] Univ Tubingen, Inst Pathol & Neuropathol, Div Immunopathol Nervous Syst, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Zhang, ZY (corresponding author), Univ Tubingen, Inst Pathol & Neuropathol, Div Immunopathol Nervous Syst, Tubingen, Germany.	zhiyuan.zhang@medizin.uni-tuebingen.de	zhang, zhiyuan/GRS-2141-2022	Zhang, Zhi-Yuan/0000-0001-9067-0670	China Scholarship Council (CSC); Deutsche Forschungsgemeinschaft (German Research Foundation); Tuebingen University	China Scholarship Council (CSC)(China Scholarship Council); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Tuebingen University	Chaoyun Li is supported and financed by the Chinese government scholarship from the China Scholarship Council (CSC). The authors also acknowledge support by Deutsche Forschungsgemeinschaft (German Research Foundation) and Open Access Publishing Fund of Tuebingen University, for the open access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alexander G, 2011, BEHAV BRAIN RES, V216, P77, DOI 10.1016/j.bbr.2010.07.016; BRANDAN E, 1993, GEN PHARMACOL, V24, P1063, DOI 10.1016/0306-3623(93)90350-7; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Chen Y, 2011, MOLECULES, V16, P1336, DOI 10.3390/molecules16021336; Cheng YF, 2010, PSYCHOPHARMACOLOGY, V212, P181, DOI 10.1007/s00213-010-1943-3; Gengler S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009764; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; GRAY CW, 1993, MOL BRAIN RES, V19, P251, DOI 10.1016/0169-328X(93)90037-P; Guo J, 2010, PHYTOMEDICINE, V17, P950, DOI 10.1016/j.phymed.2010.03.007; Herrmann N, 2011, CURRENT EMERGING DRU; Ho Christopher C K, 2011, Curr Urol Rep, V12, P470, DOI 10.1007/s11934-011-0217-x; Huang J, 2007, LIFE SCI, V81, P832, DOI 10.1016/j.lfs.2007.07.015; Kuroda M, 2000, PLANTA MED, V66, P575, DOI 10.1055/s-2000-8611; Lesne S, 2003, J BIOL CHEM, V278, P18408, DOI 10.1074/jbc.M300819200; Li L, 2005, CHINESE MED J-PEKING, V118, P1637; Li YC, 2013, CLIN EXP PHARMACOL P, V40, P635, DOI 10.1111/1440-1681.12143; Lippa CF, 1998, NEUROBIOL AGING, V19, P527, DOI 10.1016/S0197-4580(98)00089-X; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Luo Y, 2007, CLIN EXP PHARMACOL P, V34, P792, DOI 10.1111/j.1440-1681.2007.04647.x; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Ming LG, 2013, J CELL PHYSIOL, V228, P513, DOI 10.1002/jcp.24158; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Nie J, 2010, EUR J PHARMACOL, V626, P213, DOI 10.1016/j.ejphar.2009.09.039; Ning HX, 2006, UROLOGY, V68, P1350, DOI 10.1016/j.urology.2006.09.031; Ownby RL, 2010, CURR PSYCHIAT REP, V12, P39, DOI 10.1007/s11920-009-0082-1; Pan Y, 2005, PHARMACOL BIOCHEM BE, V82, P686, DOI 10.1016/j.pbb.2005.11.010; Pan Y, 2007, PHARMACOL BIOCHEM BE, V87, P130, DOI 10.1016/j.pbb.2007.04.009; PERESS NS, 1995, J NEUROPATH EXP NEUR, V54, P802, DOI 10.1097/00005072-199511000-00007; Pietropaolo S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.012; Qi MY, 2011, J ETHNOPHARMACOL, V138, P731, DOI 10.1016/j.jep.2011.10.015; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sha DJ, 2009, NEUROREPORT, V20, P1564, DOI 10.1097/WNR.0b013e328332d345; Sun PJ, 2013, PHYTOMEDICINE, V20, P975, DOI 10.1016/j.phymed.2013.04.019; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; VANDERWAL EA, 1993, NEUROREPORT, V4, P69, DOI 10.1097/00001756-199301000-00018; Wang Z, 2007, NEUROSCIENCE, V145, P911, DOI 10.1016/j.neuroscience.2006.12.059; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Wu JF, 2012, INT IMMUNOPHARMACOL, V12, P74, DOI 10.1016/j.intimp.2011.10.015; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Wyss-Coray Tony, 2006, Current Alzheimer Research, V3, P191, DOI 10.2174/156720506777632916; WyssCoray T, 1997, NATURE, V389, P603, DOI 10.1038/39321; Xie J, 2007, NAT PROD RES, V21, P600, DOI 10.1080/14786410701369680; Xin ZC, 2003, ASIAN J ANDROL, V5, P15; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zeng KW, 2010, INT IMMUNOPHARMACOL, V10, P668, DOI 10.1016/j.intimp.2010.03.010; Zhang DW, 2012, BIOCHIMIE, V94, P2514, DOI 10.1016/j.biochi.2012.06.033; Zhang HY, 2012, MOL MED REP, V6, P967, DOI 10.3892/mmr.2012.1041; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang ZY, 2013, J NEUROPATH EXP NEUR, V72, P178, DOI 10.1097/NEN.0b013e318283114a; Zhang Z, 2008, EXP NEUROL, V210, P681, DOI 10.1016/j.expneurol.2007.12.025; Zhao J, 2010, NEUROPHARMACOLOGY, V58, P774, DOI 10.1016/j.neuropharm.2009.12.008	58	18	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104616	10.1371/journal.pone.0104616	http://dx.doi.org/10.1371/journal.pone.0104616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101849	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900080
J	Blask, DE; Dauchy, RT; Dauchy, EM; Mao, L; Hill, SM; Greene, MW; Belancio, VP; Sauer, LA; Davidson, L				Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Greene, Michael W.; Belancio, Victoria P.; Sauer, Leonard A.; Davidson, Leslie			Light Exposure at Night Disrupts Host/Cancer Circadian Regulatory Dynamics: Impact on the Warburg Effect, Lipid Signaling and Tumor Growth Prevention	PLOS ONE			English	Article							BREAST-CANCER XENOGRAFTS; HEPATOMA 7288CTC; CELL METABOLISM; MELATONIN; ACID; CLOCK; HIF-1-ALPHA; INHIBITION; EXPRESSION; DIETARY	The central circadian clock within the suprachiasmatic nucleus (SCN) plays an important role in temporally organizing and coordinating many of the processes governing cancer cell proliferation and tumor growth in synchrony with the daily light/dark cycle which may contribute to endogenous cancer prevention. Bioenergetic substrates and molecular intermediates required for building tumor biomass each day are derived from both aerobic glycolysis (Warburg effect) and lipid metabolism. Using tissue-isolated human breast cancer xenografts grown in nude rats, we determined that circulating systemic factors in the host and the Warburg effect, linoleic acid uptake/metabolism and growth signaling activities in the tumor are dynamically regulated, coordinated and integrated within circadian time structure over a 24-hour light/dark cycle by SCN-driven nocturnal pineal production of the anticancer hormone melatonin. Dim light at night (LAN)-induced melatonin suppression disrupts this circadian-regulated host/cancer balance among several important cancer preventative signaling mechanisms, leading to hyperglycemia and hyperinsulinemia in the host and runaway aerobic glycolysis, lipid signaling and proliferative activity in the tumor.	[Blask, David E.; Dauchy, Robert T.; Sauer, Leonard A.] Tulane Univ, Sch Med, Lab Chrononeuroendocrine Oncol, New Orleans, LA 70112 USA; [Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Belancio, Victoria P.] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA; [Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Belancio, Victoria P.] Tulane Canc Ctr, New Orleans, LA USA; [Blask, David E.; Dauchy, Robert T.; Dauchy, Erin M.; Mao, Lulu; Hill, Steven M.; Belancio, Victoria P.] Louisiana Canc Res Consortium, New Orleans, LA USA; [Greene, Michael W.; Davidson, Leslie] Mary Imogene Bassett Hosp, Bassett Res Inst, Cooperstown, NY 13326 USA	Tulane University; Tulane University; Tulane University	Blask, DE (corresponding author), Tulane Univ, Sch Med, Lab Chrononeuroendocrine Oncol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	dblask@tulane.edu	Greene, Michael/L-6174-2019	Greene, Michael/0000-0002-6443-8269	American Association for Laboratory Animal Science; National Institutes of Health [R21CA129875, R01CA054152]; Tulane University School of Medicine; Louisiana Cancer Research Consortium [631455]; NATIONAL CANCER INSTITUTE [R21CA129875, R01CA054152] Funding Source: NIH RePORTER	American Association for Laboratory Animal Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University School of Medicine; Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by the American Association for Laboratory Animal Science (www.aalas.org) Grants for Laboratory Animal Science (GLAS) Award to RTD, National Institutes of Health (www.nih.gov) grant R21CA129875 to DEB, Tulane University School of Medicine (www.tulane.edu) and Louisiana Cancer Research Consortium (www.louisianacancercenter.org) Startup Grant 631455 to DEB and National Institutes of Health grant R01CA054152 to SMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Blask DE, 2011, J PINEAL RES, V51, P259, DOI 10.1111/j.1600-079X.2011.00888.x; Blask DE, 1999, CANCER RES, V59, P4693; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Canaple L, 2003, CANCER RES, V63, P7545; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Dauchy RT, 2004, CANCER LETT, V209, P7, DOI 10.1016/j.canlet.2003.12.012; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; GLASGOW WC, 1994, ARCH BIOCHEM BIOPHYS, V311, P286, DOI 10.1006/abbi.1994.1239; Glasgow WC, 1997, J BIOL CHEM, V272, P19269, DOI 10.1074/jbc.272.31.19269; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hrushesky WJM, 2001, J CONTROL RELEASE, V74, P27, DOI 10.1016/S0168-3659(01)00307-8; Hrushesky WJM, 2000, JPN J CLIN ONCOL, V30, P529, DOI 10.1093/jjco/hyd134; Hsi LC, 2002, J BIOL CHEM, V277, P40549, DOI 10.1074/jbc.M203522200; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Kalsbeek A, 1998, PHYSIOL BEHAV, V63, P553, DOI 10.1016/S0031-9384(97)00493-9; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; REITER RJ, 1994, LAB MED, V25, P438, DOI 10.1093/labmed/25.7.438; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Reiter RJ, 2012, ANN MED, V44, P564, DOI 10.3109/07853890.2011.586365; Sauer LA, 1999, CANCER RES, V59, P4688; SAUER LA, 1992, BRIT J CANCER, V66, P297, DOI 10.1038/bjc.1992.260; Sauer LA, 1997, J NUTR, V127, P1412, DOI 10.1093/jn/127.7.1412; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Warburg O., 1925, KLIN WOCHENSCHR, V4, P534, DOI DOI 10.1007/BF01726151; Wu JH, 2011, CANCER RES, V71, P2622, DOI 10.1158/0008-5472.CAN-10-3837; Xiang S, 2012, BREAST CANCER-BASIC, V6, P137, DOI 10.4137/BCBCR.S9673; Yang XM, 2009, BREAST CANCER RES TR, V117, P423, DOI 10.1007/s10549-008-0133-z; Zhao YH, 2011, FRONT BIOSCI-LANDMRK, V16, P1844, DOI 10.2741/3826	39	77	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102776	10.1371/journal.pone.0102776	http://dx.doi.org/10.1371/journal.pone.0102776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099274	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100011
J	Cao, LL; Kawai, H; Sasatani, M; Iizuka, D; Masuda, Y; Inaba, T; Suzuki, K; Ootsuyama, A; Umata, T; Kamiya, K; Suzuki, F				Cao, Lili; Kawai, Hidehiko; Sasatani, Megumi; Iizuka, Daisuke; Masuda, Yuji; Inaba, Toshiya; Suzuki, Keiji; Ootsuyama, Akira; Umata, Toshiyuki; Kamiya, Kenji; Suzuki, Fumio			A Novel ATM/TP53/p21-Mediated Checkpoint Only Activated by Chronic gamma-Irradiation	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; DOSE RATE; IN-VIVO; P53; CELLS; RADIATION; INSTABILITY; GROWTH; CANCER	Different levels or types of DNA damage activate distinct signaling pathways that elicit various cellular responses, including cell-cycle arrest, DNA repair, senescence, and apoptosis. Whereas a range of DNA-damage responses have been characterized, mechanisms underlying subsequent cell-fate decision remain elusive. Here we exposed cultured cells and mice to different doses and dose rates of gamma-irradiation, which revealed cell-type-specific sensitivities to chronic, but not acute, gamma-irradiation. Among tested cell types, human fibroblasts were associated with the highest levels of growth inhibition in response to chronic gamma-irradiation. In this context, fibroblasts exhibited a reversible G1 cell-cycle arrest or an irreversible senescence-like growth arrest, depending on the irradiation dose rate or the rate of DNA damage. Remarkably, when the same dose of gamma-irradiation was delivered chronically or acutely, chronic delivery induced considerably more cellular senescence. A similar effect was observed with primary cells isolated from irradiated mice. We demonstrate a critical role for the ataxia telangiectasia mutated (ATM)/tumor protein p53 (TP53)/p21 pathway in regulating DNA-damage-associated cell fate. Indeed, blocking the ATM/TP53/p21 pathway deregulated DNA damage responses, leading to micronucleus formation in chronically irradiated cells. Together these results provide insights into the mechanisms governing cell-fate determination in response to different rates of DNA damage.	[Cao, Lili; Sasatani, Megumi; Iizuka, Daisuke; Masuda, Yuji; Kamiya, Kenji] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Expt Oncol, Hiroshima, Japan; [Cao, Lili; Kawai, Hidehiko; Suzuki, Fumio] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima, Japan; [Masuda, Yuji] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Chikusa Ku, Nagoya, Aichi 464, Japan; [Inaba, Toshiya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima, Japan; [Inaba, Toshiya] Hiroshima Univ, Res Inst Radiat Biol & Med, Leukemia Program Project, Hiroshima, Japan; [Suzuki, Keiji] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan; [Ootsuyama, Akira] Univ Occupat & Environm Hlth, Sch Med, Dept Radiat Biol & Hlth, Kitakyushu, Fukuoka 807, Japan; [Umata, Toshiyuki] Univ Occupat & Environm Hlth, Radioisotope Res Ctr, Kitakyushu, Fukuoka 807, Japan	Hiroshima University; Hiroshima University; Nagoya University; Hiroshima University; Hiroshima University; Nagasaki University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Kawai, H (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima, Japan.	kawaih@hiroshima-u.ac.jp	Masuda, Yuji/I-6315-2014	Masuda, Yuji/0000-0002-6229-1988; IIZUKA, Daisuke/0000-0003-3990-4800; Kawai, Hidehiko/0000-0003-2213-7166	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [25281020, 26340024] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by the Ministry of Education, Science, Sports and Culture of Japan (to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; GONDO Y, 1994, BIOCHEM BIOPH RES CO, V202, P830, DOI 10.1006/bbrc.1994.2005; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; HALL EJ, 1986, INT J RADIAT ONCOL, V12, P655, DOI 10.1016/0360-3016(86)90076-3; Harfouche G, 2010, MUTAT RES-REV MUTAT, V704, P167, DOI 10.1016/j.mrrev.2010.01.007; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Illa-Bochaca I, 2010, METHODS MOL BIOL, V621, P29, DOI 10.1007/978-1-60761-063-2_2; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; MARIN G, 1966, EXP CELL RES, V43, P413, DOI 10.1016/0014-4827(66)90068-1; Martin M, 2012, MUTAT RES; MCMILLAN TJ, 1992, EUR J CANCER, V28A, P267, DOI 10.1016/0959-8049(92)90430-A; MICHALOWSKI A, 1981, RADIAT ENVIRON BIOPH, V19, P157, DOI 10.1007/BF01324183; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Norimura T, 1996, NAT MED, V2, P577, DOI 10.1038/nm0596-577; Nussenzweig A, 2007, CELL CYCLE, V6, P2339, DOI 10.4161/cc.6.19.4995; Ojima M, 2004, J RADIAT RES, V45, P105, DOI 10.1269/jrr.45.105; Panganiban RAM, 2013, INT J MOL SCI, V14, P15931, DOI 10.3390/ijms140815931; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Santoro R, 2010, CELL CYCLE, V9, P4262, DOI 10.4161/cc.9.21.13853; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smith LE, 2003, HEALTH PHYS, V85, P23, DOI 10.1097/00004032-200307000-00006; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; SUZUKI F, 1992, RADIAT RES, V131, P290, DOI 10.2307/3578418; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wagner J, 2005, IEE P SYST BIOL, V152, P109, DOI 10.1049/ip-syb:20050025; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401	43	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104279	10.1371/journal.pone.0104279	http://dx.doi.org/10.1371/journal.pone.0104279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093836	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200091
J	de Freitas, FAD; Bernardo, V; Gomgnimbou, MK; Sola, C; Siqueira, HR; Pereira, MAS; Fandinho, FCO; Gomes, H; Araujo, MEI; Suffys, PN; Marques, EA; Albano, RM				de Freitas, Flavia A. D.; Bernardo, Vagner; Gomgnimbou, Michel K.; Sola, Christophe; Siqueira, Helio R.; Pereira, Marcia A. S.; Fandinho, Fatima C. O.; Gomes, HarrisonM.; Araujo, Marcelo E. I.; Suffys, Philip N.; Marques, Elizabeth A.; Albano, Rodolpho M.			Multidrug Resistant Mycobacterium tuberculosis: A Retrospective katG and rpoB Mutation Profile Analysis in Isolates from a Reference Center in Brazil	PLOS ONE			English	Article							DRUG-RESISTANCE; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; RIFAMPICIN; STRAINS; SUBSTITUTION; PREVALENCE	Background: Multidrug resistance is a critical factor in tuberculosis control. To gain better understanding of multidrug resistant tuberculosis in Brazil, a retrospective study was performed to compare genotypic diversity and drug resistance associated mutations in Mycobacterium tuberculosis isolates from a national reference center. Methods and Findings: Ninety-nine multidrug resistant isolates from 12 Brazilian states were studied. Drug-resistance patterns were determined and the rpoB and katG genes were screened for mutations. Genotypic diversity was investigated by IS6110-RFLP and Luminex 47 spoligotyping. Mutations in rpoB and katG were seen in 91% and 93% of the isolates, respectively. Codon 315 katG mutations occurred in 82.8% of the isolates with a predominance of the Ser315Thr substitution. Twenty-five isolates were clustered in 11 groups with identical IS6110-RFLP patterns while 74 showed unique patterns with no association between mutation frequencies or susceptibility profiles. The most prevalent spoligotyping lineages were LAM (47%), T (17%) and Haarlen (12%). The Haarlen lineage showed a higher frequency of codon 516 rpoB mutations while codon 531 mutations prevailed in the other isolates. Conclusions: Our data suggest that there were no major multidrug resistant M. tuberculosis strains transmitted among patients referred to the reference center, indicating an independent acquisition of resistance. In addition, drug resistance associated mutation profiles were well established among the main spoligotyping lineages found in these Brazilian multidrug resistant isolates, providing useful data for patient management and treatment.	[de Freitas, Flavia A. D.; Bernardo, Vagner; Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil; [Gomgnimbou, Michel K.; Sola, Christophe] Univ Paris 11, CNRS, Inst Genet & Microbiol, Infect Genet Emerging Pathogens Evolut Team, F-91405 Orsay, France; [Siqueira, Helio R.; Marques, Elizabeth A.] Univ Estado Rio de Janeiro, Fac Ciencias Med, BR-20550011 Rio De Janeiro, Brazil; [Pereira, Marcia A. S.; Fandinho, Fatima C. O.] Fundacao Oswaldo Cruz, Ctr Referencia Prof Helio Fraga, Rio De Janeiro, Brazil; [Gomes, HarrisonM.; Araujo, Marcelo E. I.; Suffys, Philip N.] Fundacao Oswaldo Cruz, Lab Biol Mol Aplicada Micobacteria, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Albano, RM (corresponding author), Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil.	albano@uerj.br	Sola, Christophe/A-7992-2016; Bernardo, Vagner G/H-7924-2012; Marques, Elizabeth/AAL-8002-2021; suffys, philip/E-3009-2013	Sola, Christophe/0000-0003-4672-2140; Bernardo, Vagner G/0000-0003-2844-0924; Albano, Rodolpho/0000-0002-0643-901X; Fandinho, Fatima Cristina Onofre/0000-0003-3896-3526	Fundacao Carlos Chagas de Amparo a Pesquisa (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Carlos Chagas de Amparo a Pesquisa (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Some of the authors received funding for this work. RMA received funding from the following Brazilian Agencies: Fundacao Carlos Chagas de Amparo a Pesquisa (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev MV, 2007, J ANTIMICROB CHEMOTH, V59, P1057, DOI 10.1093/jac/dkm086; da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Araya P, 2011, REV MED CHILE, V139, P467, DOI /S0034-98872011000400008; Baranov AA, 2009, INT J TUBERC LUNG D, V13, P1288; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Cave MD, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P33; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Dalcolmo MP, 2007, REV SAUDE PUBL, V41; Dalcomo M. P., 2012, PULMAO RJ, V21, P55; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; de Siqueira HR, 2009, J BRAS PNEUMOL, V35, P773, DOI 10.1590/S1806-37132009000800009; Doroudchi M, 2000, SCAND J INFECT DIS, V32, P663, DOI 10.1080/003655400459595; Durmaz R, 2007, INFECT GENET EVOL, V7, P513, DOI 10.1016/j.meegid.2007.03.003; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gomgnimbou MK, 2012, J CLIN MICROBIOL, V50, P3172, DOI 10.1128/JCM.00976-12; Hofling CC, 2005, INT J TUBERC LUNG D, V9, P87; Jackson AD, 2009, INT J TUBERC LUNG D, V13, P486; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P314; Kisa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030331; Koch A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.17; Kozhamkulov U, 2011, JPN J INFECT DIS, V64, P253; Lipin MY, 2007, CLIN MICROBIOL INFEC, V13, P620, DOI 10.1111/j.1469-0691.2007.01711.x; Marttila HJ, 1998, ANTIMICROB AGENTS CH, V42, P2443, DOI 10.1128/AAC.42.9.2443; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; O'Sullivan DM, 2005, J ANTIMICROB CHEMOTH, V55, P674, DOI 10.1093/jac/dki069; Perizzolo PF, 2012, TUBERCULOSIS, V92, P56, DOI 10.1016/j.tube.2011.09.008; Portugal I, 1999, J CLIN MICROBIOL, V37, P3022, DOI 10.1128/JCM.37.9.3022-3024.1999; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Santos LC, 2010, INFECT GENET EVOL, V10, P1052, DOI 10.1016/j.meegid.2010.06.018; Siu GKH, 2011, DIAGN MICR INFEC DIS, V69, P51, DOI 10.1016/j.diagmicrobio.2010.08.021; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Valim ARM, 2000, J CLIN MICROBIOL, V38, P3119, DOI 10.1128/JCM.38.8.3119-3122.2000; Valvatne H, 2009, J ANTIMICROB CHEMOTH, V64, P694, DOI 10.1093/jac/dkp292; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; World Health Organization, 2019, 10 HLTH ISS WHO WILL, DOI DOI 10.1016/S2213-2600(19)30418-7; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003; Zumarraga MJ, 1999, J CLIN MICROBIOL, V37, P296	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104100	10.1371/journal.pone.0104100	http://dx.doi.org/10.1371/journal.pone.0104100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093512	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200068
J	Hartley, DEH; Isaiah, A				Hartley, Douglas E. H.; Isaiah, Amal			Envelope Enhancement Increases Cortical Sensitivity to Interaural Envelope Delays with Acoustic and Electric Hearing	PLOS ONE			English	Article							BILATERAL COCHLEAR IMPLANTS; SUPERIOR OLIVARY COMPLEX; HIGH-FREQUENCY NEURONS; INFERIOR COLLICULUS NEURONS; TIME DIFFERENCES; SOUND LOCALIZATION; AUDITORY-CORTEX; BINAURAL SENSITIVITY; TEMPORAL DISPARITIES; GUINEA-PIG	Evidence from human psychophysical and animal electrophysiological studies suggests that sensitivity to interaural time delay (ITD) in the modulating envelope of a high-frequency carrier can be enhanced using half-wave rectified stimuli. Recent evidence has shown potential benefits of equivalent electrical stimuli to deaf individuals with bilateral cochlear implants (CIs). In the current study we assessed the effects of envelope shape on ITD sensitivity in the primary auditory cortex of normal-hearing ferrets, and profoundly-deaf animals with bilateral CIs. In normal-hearing animals, cortical sensitivity to ITDs (+/- 1 ms in 0.1-ms steps) was assessed in response to dichotically-presented i) sinusoidal amplitude-modulated (SAM) and ii) half-wave rectified (HWR) tones (100-ms duration; 70 dB SPL) presented at the best-frequency of the unit over a range of modulation frequencies. In separate experiments, adult ferrets were deafened with neomycin administration and bilaterally-implanted with intra-cochlear electrode arrays. Electrically-evoked auditory brainstem responses (EABRs) were recorded in response to bipolar electrical stimulation of the apical pair of electrodes with singe biphasic current pulses (40 mu s per phase) over a range of current levels to measure hearing thresholds. Subsequently, we recorded cortical sensitivity to ITDs (+/- 800 mu s in 80-mu s steps) within the envelope of SAM and HWR biphasic-pulse trains (40 mu s per phase; 6000 pulses per second, 100-ms duration) over a range of modulation frequencies. In normal-hearing animals, nearly a third of cortical neurons were sensitive to envelope-ITDs in response to SAM tones. In deaf animals with bilateral CI, the proportion of ITD-sensitive cortical neurons was approximately a fifth in response to SAM pulse trains. In normal-hearing and deaf animals with bilateral CI the proportion of ITD sensitive units and neural sensitivity to ITDs increased in response to HWR, compared with SAM stimuli. Consequently, novel stimulation strategies based on envelope enhancement may prove beneficial to individuals with bilateral cochlear implants.	[Hartley, Douglas E. H.] NIHR Natl Biomed Res Unit Hearing, Nottingham, England; [Hartley, Douglas E. H.] Univ Nottingham, Dept Otolaryngol, Sch Clin Sci, Nottingham NG7 2RD, England; [Hartley, Douglas E. H.] MRC, Inst Hearing Res, Nottingham, England; [Hartley, Douglas E. H.; Isaiah, Amal] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Nottingham; University of Nottingham; University of Oxford	Hartley, DEH (corresponding author), NIHR Natl Biomed Res Unit Hearing, Ropewalk House, Nottingham, England.	Douglas.Hartley@nottingham.ac.uk		Hartley, Douglas/0000-0001-9803-4169; Isaiah, Amal/0000-0003-3064-6964	National Institute for Health Research; Wellcome Trust; Rhodes Trust	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust	This work was supported by the National Institute for Health Research, the Wellcome Trust through a Clinician Scientist Fellowship to DEHH and the Rhodes Trust through a Scholarship to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra R, 1997, J NEUROPHYSIOL, V78, P1237, DOI 10.1152/jn.1997.78.3.1237; Batra R, 1997, J NEUROPHYSIOL, V78, P1222, DOI 10.1152/jn.1997.78.3.1222; BERNSTEIN LR, 1982, J ACOUST SOC AM, V71, P147, DOI 10.1121/1.387254; Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; BERNSTEIN LR, 1994, J ACOUST SOC AM, V95, P3561, DOI 10.1121/1.409973; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Coffey CS, 2006, HEARING RES, V221, P1, DOI 10.1016/j.heares.2006.06.005; Darwin C. J., 1995, P387, DOI 10.1016/B978-012505626-7/50013-3; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; DOMNITZ RH, 1976, J ACOUST SOC AM, V59, P598, DOI 10.1121/1.380904; Dreyer A, 2006, J NEUROPHYSIOL, V96, P2327, DOI 10.1152/jn.00326.2006; Fitzpatrick DC, 2001, J NEUROSCI, V21, P4844, DOI 10.1523/JNEUROSCI.21-13-04844.2001; Green T, 2004, J ACOUST SOC AM, V116, P2298, DOI 10.1121/1.1785611; Griffin SJ, 2005, J NEUROPHYSIOL, V93, P3463, DOI 10.1152/jn.00794.2004; Hancock KE, 2004, J NEUROSCI, V24, P7110, DOI 10.1523/JNEUROSCI.0762-04.2004; Hartley DEH, 2011, J NEUROPHYSIOL, V106, P30, DOI 10.1152/jn.01070.2010; Hartley DEH, 2010, J NEUROSCI METH, V190, P214, DOI 10.1016/j.jneumeth.2010.05.014; IRVINE DRF, 1995, HEARING RES, V85, P127, DOI 10.1016/0378-5955(95)00040-B; Ison JR, 2003, J ACOUST SOC AM, V114, P522, DOI 10.1121/1.1577553; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 1996, J NEUROPHYSIOL, V76, P2137, DOI 10.1152/jn.1996.76.4.2137; Joris PX, 1998, J NEUROPHYSIOL, V79, P253, DOI 10.1152/jn.1998.79.1.253; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; Joris PX, 2003, J NEUROSCI, V23, P6345; KAVANAGH GL, 1987, J NEUROPHYSIOL, V57, P1746, DOI 10.1152/jn.1987.57.6.1746; KELLY JB, 1991, HEARING RES, V55, P39, DOI 10.1016/0378-5955(91)90089-R; Klein-Hennig M, 2011, J ACOUST SOC AM, V129, P3856, DOI 10.1121/1.3585847; Laback B, 2004, EAR HEARING, V25, P488, DOI 10.1097/01.aud.0000145124.85517.e8; Laback B, 2011, J ACOUST SOC AM, V130, P1515, DOI 10.1121/1.3613704; Long CJ, 2003, J ACOUST SOC AM, V114, P1565, DOI 10.1121/1.1603765; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Monaghan JJM, 2013, J ACOUST SOC AM, V133, P2288, DOI 10.1121/1.4793270; Moore BCJ, 1997, INTRO PSYCHOL HEARIN, P213; PELIZZONE M, 1990, HEARING RES, V48, P287, DOI 10.1016/0378-5955(90)90069-2; Pind J, 1998, J ACOUST SOC AM, V103, P2117, DOI 10.1121/1.421357; REALE RA, 1990, J NEUROPHYSIOL, V64, P1247, DOI 10.1152/jn.1990.64.4.1247; Schlauch RS, 2001, J ACOUST SOC AM, V109, P2880, DOI 10.1121/1.1372913; Schnupp JWH, 2003, J ACOUST SOC AM, V113, P2021, DOI 10.1121/1.1547460; SHEPHERD RK, 1993, HEARING RES, V66, P108, DOI 10.1016/0378-5955(93)90265-3; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Smith ZM, 2008, J NEUROPHYSIOL, V99, P2390, DOI 10.1152/jn.00751.2007; Smith ZM, 2007, J NEUROSCI, V27, P6740, DOI 10.1523/JNEUROSCI.0052-07.2007; Smith ZM, 2007, JARO-J ASSOC RES OTO, V8, P134, DOI 10.1007/s10162-006-0069-0; Stecker GC, 2009, J ACOUST SOC AM, V125, P3914, DOI 10.1121/1.3124776; Tillein J, 2010, CEREB CORTEX, V20, P492, DOI 10.1093/cercor/bhp222; van Hoesel RJM, 2009, JARO-J ASSOC RES OTO, V10, P557, DOI 10.1007/s10162-009-0175-x; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; vandePar S, 1997, J ACOUST SOC AM, V101, P1671, DOI 10.1121/1.418151; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; YIN TCT, 1984, J ACOUST SOC AM, V76, P1401, DOI 10.1121/1.391457; YOST WA, 1971, J ACOUST SOC AM, V50, P1526, DOI 10.1121/1.1912806	52	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104097	10.1371/journal.pone.0104097	http://dx.doi.org/10.1371/journal.pone.0104097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093417	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200067
J	Rowan, F; Richards, M; Widya, M; Bayliss, R; Blagg, J				Rowan, Fiona; Richards, Meirion; Widya, Marcella; Bayliss, Richard; Blagg, Julian			Diverse Functionalization of Aurora-A Kinase at Specified Surface and Buried Sites by Native Chemical Modification	PLOS ONE			English	Article							UNNATURAL AMINO-ACIDS; CRYSTAL-STRUCTURE; GENERAL-METHOD; PROTEIN; CHEMISTRY; CYSTEINE; DEHYDROALANINE; CONVERSION; INSIGHTS; INSTALLATION	The ability to obtain a homogeneous sample of protein is invaluable when studying the effect of alterations such as post-translational modifications (PTMs). Selective functionalization of a protein to investigate the effect of PTMs on its structure or activity can be achieved by chemical modification of cysteine residues. We demonstrate here that one such technique, which involves conversion of cysteine to dehydroalanine followed by thiol nucleophile addition, is suitable for the site-specific installation of a wide range of chemical mimics of PTMs, including acetylated and dimethylated lysine, and other unnatural amino acids. These reactions, optimized for the clinically relevant kinase Aurora-A, readily proceed to completion as revealed by intact protein mass spectrometry. Moreover, these reactions proceed under non-denaturing conditions, which is desirable when working with large protein substrates. We have determined reactivity trends for a diverse range of thiol nucleophile addition reactions at two separate sites on Aurora-A, and we also highlight limitations when using thiol nucleophiles that contain basic functional groups. We show that chemical modification of cysteine residues is possible not only on a flexible surface-exposed loop, but also within a deep active site pocket at the conserved DFG motif, which reveals the potential use of this method in exploring enzyme function through modification of catalytic site residues.	[Rowan, Fiona; Richards, Meirion; Blagg, Julian] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Rowan, Fiona; Bayliss, Richard] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Widya, Marcella] Inst Canc Res, Prote Core Facil, London SW3 6JB, England; [Bayliss, Richard] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leicester	Rowan, F (corresponding author), Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England.	fiona.rowan@icr.ac.uk; julian.blagg@icr.ac.uk		Bayliss, Richard/0000-0003-0604-2773	Wellcome Trust [093986/Z/10/Z]; Cancer Research UK [C309/A11566, C24461/A12772]; Cancer Research UK [11566, 12772] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	FR is supported by The Wellcome Trust (www.wellcome.ac.uk) Ph.D. program in Mechanism-Based Drug Discovery at The Institute of Cancer Research, grant number 093986/Z/10/Z. MR and JB are supported by Cancer Research UK (www.cancerresearchuk.org) grant number C309/A11566. RB is a Royal Society Research Fellow and is supported by Cancer Research UK grant number C24461/A12772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Becker CFW, 2004, J MOL BIOL, V343, P747, DOI 10.1016/j.jmb.2004.08.062; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; Chalker JM, 2012, ANGEW CHEM INT EDIT, V51, P1835, DOI 10.1002/anie.201106432; Chalker JM, 2011, CHEM SCI, V2, P1666, DOI 10.1039/c1sc00185j; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Chooi KP, 2014, J AM CHEM SOC, V136, P1698, DOI 10.1021/ja4095318; de Graaf AJ, 2009, BIOCONJUGATE CHEM, V20, P1281, DOI 10.1021/bc800294a; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Fernandez-Gonzalez M, 2010, CHEM SCI, V1, P709, DOI 10.1039/c0sc00265h; Halkides CJ, 2000, BIOCHEMISTRY-US, V39, P5280, DOI 10.1021/bi9925524; Huang R, 2010, J AM CHEM SOC, V132, P9986, DOI 10.1021/ja103954u; Le DD, 2013, J AM CHEM SOC, V135, P2879, DOI 10.1021/ja3108214; Li FP, 2011, ANGEW CHEM INT EDIT, V50, P9611, DOI 10.1002/anie.201103754; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Rowan FC, 2013, ACS CHEM BIOL, V8, P2184, DOI 10.1021/cb400425t; Simard JR, 2009, J AM CHEM SOC, V131, P13286, DOI 10.1021/ja902010p; Simard JR, 2009, NAT CHEM BIOL, V5, P394, DOI 10.1038/nchembio.162; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Smith MEB, 2010, J AM CHEM SOC, V132, P1960, DOI 10.1021/ja908610s; Valkevich EM, 2012, J AM CHEM SOC, V134, P6916, DOI 10.1021/ja300500a; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023	26	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103935	10.1371/journal.pone.0103935	http://dx.doi.org/10.1371/journal.pone.0103935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093837	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200046
J	Das, JK; Felty, Q				Das, Jayanta K.; Felty, Quentin			PCB153-Induced Overexpression of ID3 Contributes to the Development of Microvascular Lesions	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; POLYCHLORINATED-BIPHENYLS; PULMONARY-HYPERTENSION; IN-VITRO; PLEXIFORM LESIONS; TYROSINE KINASE; PCB; CANCER	Microvascular lesions resulting from endothelial cell dysfunction are produced in the brain, lung, kidney, and retina of patients of complex chronic diseases. The environmental and molecular risk factors which may contribute in the development of microvascular damage are unclear. The mechanism(s) responsible for initiating microvascular damage remain poorly defined, although several inciting factors have been proposed, including environmental toxicants-induced oxidative stress. Enhanced neovascularization has been implicated in either the development or progression of proliferative vascular lesions. Here, we present evidence for how PCB-induced ROS may contribute to the development of a neovascular phenotype with the aim of elucidating the role of environmental toxicants in endothelial dysfunction with a specific focus on the inhibitor of differentiation protein ID3. We used a combination of phenotype and immunohistochemical analysis followed by validating with protein expression and post-translational modifications with Western Blot and MALDI-TOF/TOF analysis. We also looked for a correlation between ID3 expression in vascular tissue. Our results showed that PCB-induced ROS mediated a highly tube branched neovascular phenotype that also depended on ID3 and Pyk2; and PCB153 treatment increased the size of endothelial spheroids under conditions typically used for clonal selection of stem cell spheroids. High ID3 protein expression correlated with a greater degree of malignancy and oxidative DNA damage marker 8-OHdG in blood vessels from human subjects. PCB153 treatment increased both serine and tyrosine phosphorylation of endothelial ID3. Stable ID3 overexpression increased cell survival of human microvascular endothelial cell line hCMEC/D3. In summary, our data provide evidence that ID3 may play a critical role in regulating vascular endothelial cell survival and development of microvascular lesions induced by persistent environmental pollutants such as PCB153. Findings of this study are important because they provide a new paradigm by which PCBs may contribute to the growth of microvascular lesions.	[Das, Jayanta K.; Felty, Quentin] Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA	State University System of Florida; Florida International University	Felty, Q (corresponding author), Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA.	feltyq@fiu.edu	DAS, JAYANTA/E-2596-2015	DAS, JAYANTA/0000-0002-2840-1645; Felty, Quentin/0000-0002-7151-0441	National Institute of Health [1SC3GM084827-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084827] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health 1SC3GM084827-01A1: QF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2013, COMPR PHYSIOL, V3, P1011, DOI 10.1002/cphy.c120024; Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; Arzuaga X, 2007, CARDIOVASC TOXICOL, V7, P264, DOI 10.1007/s12012-007-9005-8; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Charlier CJ, 2004, CLIN CHIM ACTA, V347, P177, DOI 10.1016/j.cccn.2004.04.025; Cutchins A, 2012, ARTERIOSCL THROM VAS, V32, P317, DOI 10.1161/ATVBAHA.111.234856; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Eum SY, 2009, TOXICOL APPL PHARM, V240, P299, DOI 10.1016/j.taap.2009.07.022; Felty Q, 2008, ATHEROSCLEROSIS, V198, P12, DOI 10.1016/j.atherosclerosis.2007.12.048; Forrest S, 2004, ARTERIOSCL THROM VAS, V24, P2014, DOI 10.1161/01.ATV.0000143932.03151.ad; Forrest ST, 2004, CIRC RES, V95, P557, DOI 10.1161/01.RES.0000142735.67542.5a; Forrest ST, 2004, J BIOL CHEM, V279, P32897, DOI 10.1074/jbc.M404882200; Frank GD, 2000, BIOCHEM BIOPH RES CO, V270, P761, DOI 10.1006/bbrc.2000.2505; Friis T, 2006, APMIS, V114, P211, DOI 10.1111/j.1600-0463.2006.apm_189.x; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Ghosh S, 2007, INT J TOXICOL, V26, P203, DOI 10.1080/10915810701352648; Goncharov A, 2008, ENVIRON RES, V106, P226, DOI 10.1016/j.envres.2007.10.006; Gronning LM, 2006, AM J PHYSIOL-ENDOC M, V290, pE599, DOI 10.1152/ajpendo.00242.2005; Gustavsson P, 1997, AM J IND MED, V32, P234, DOI 10.1002/(SICI)1097-0274(199709)32:3<234::AID-AJIM8>3.3.CO;2-I; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; Hennig B, 2002, INT J HYG ENVIR HEAL, V205, P95, DOI 10.1078/1438-4639-00134; Inoue K, 2006, ENVIRON HEALTH PERSP, V114, P1179, DOI 10.1289/ehp.9032; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Matsumura ME, 2001, ARTERIOSCL THROM VAS, V21, P752, DOI 10.1161/01.ATV.21.5.752; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Nickenig G, 2002, FASEB J, V16, P1077, DOI 10.1096/fj.01-0570com; Noren K, 1999, ARCH ENVIRON CON TOX, V37, P408, DOI 10.1007/s002449900532; Norton JD, 2000, J CELL SCI, V113, P3897; Petrulis JR, 2000, J BIOCHEM MOL TOXIC, V14, P73, DOI 10.1002/(SICI)1099-0461(2000)14:2<73::AID-JBT2>3.0.CO;2-1; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramadass P, 2003, TOXICOL SCI, V76, P212, DOI 10.1093/toxsci/kfg227; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Rodriguez P, 2005, BIOTECHNOL LETT, V27, P1869, DOI 10.1007/s10529-005-3895-y; Rojiani AM, 1996, J NEUROSURG, V85, P1078, DOI 10.3171/jns.1996.85.6.1078; Sergeev AV, 2005, ENVIRON HEALTH PERSP, V113, P756, DOI 10.1289/ehp.7595; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Tanaka F, 2003, CANCER RES, V63, P6791; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Tokunaga Shoji, 2003, Fukuoka Acta Medica, V94, P110; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; TUDER RM, 1994, AM J PATHOL, V144, P275; Uemura H, 2009, ENVIRON HEALTH PERSP, V117, P568, DOI 10.1289/ehp.0800012; Wahlang B, 2013, J NUTR BIOCHEM, V24, P1587, DOI 10.1016/j.jnutbio.2013.01.009; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wice BM, 2001, DIABETOLOGIA, V44, P453, DOI 10.1007/s001250051643; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217	52	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104159	10.1371/journal.pone.0104159	http://dx.doi.org/10.1371/journal.pone.0104159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090023	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700104
J	Sun, CJ; Pan, YH; Wang, HB; Li, J; Nie, P; Wang, XM; Ma, H; Huo, FT				Sun, Chunjuan; Pan, Yinghua; Wang, Hongbo; Li, Jian; Nie, Pei; Wang, Ximing; Ma, Heng; Huo, Futao			Assessment of the Coronary Venous System Using 256-Slice Computed Tomography	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; MITRAL-VALVE ANNULUS; NONINVASIVE VISUALIZATION; ANATOMY; SINUS; VEINS; ANGIOGRAPHY	Purpose: To investigate the coronary venous system and its relation to adjacent structures using 256-slice computed tomography (CT). Materials and Methods: The study consisted of 102 patients who underwent coronary CT angiography (CTA) using 256-slice CT. For each patient, the coronary venous system and its relation to adjacent structures were evaluated. The appropriate locations and diameters of the posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV) and the left marginal vein (LMV) were detected. The paired student's t test was used to evaluate the difference between the diameter of the coronary sinus (CS) ostium in anteroposterior direction and that in superoinferior direction. Results: The CS, great cardiac vein (GCV), PIV, and anterior interventricular vein (AIV) were visualized in all cases. It was possible to evaluate at least one main vein with adequate caliber and regular course for cardiac resynchronization therapy (CRT) in 96.1% of these cases. The diameter of the CS ostium in superoinferior direction (11.7 +/- 2.1 mm) was larger than that in anteroposterior direction (9.0 +/- 2.0 mm) (t = 13.511, P < 0.05). For the majority of the cases, the CS-GCV was located above the level of the mitral valve annulus (MVA), while the left circumflex coronary artery (LCX) was coursed between the CS-GCV and the MVA. LMV had more intersection with the circumflex or circumflex marginal than PVLV. Conclusion: 256-slice CT provides superior noninvasive evaluation of the coronary venous system which has important clinical implications.	[Sun, Chunjuan; Nie, Pei; Wang, Ximing] Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China; [Sun, Chunjuan; Pan, Yinghua; Wang, Hongbo; Li, Jian; Ma, Heng; Huo, Futao] Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China	Shandong University	Wang, XM (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China.	wangximing369@126.com; mahengyhd@163.com			Shandong Province Natural Science Foundation [ZR2012HM013]; Yantai City Science and Technology Development Plan [2012090]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Yantai City Science and Technology Development Plan	Funding was received from the Shandong Province Natural Science Foundation (ZR2012HM013) and Yantai City Science and Technology Development Plan (2012090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara S, 2005, AM J ROENTGENOL, V185, P1001, DOI 10.2214/AJR.04.1382; Arbelo E, 2008, REV ESP CARDIOL, V61, P936, DOI 10.1016/S1885-5857(08)60254-6; Blendea D, 2007, HEART RHYTHM, V4, P1155, DOI 10.1016/j.hrthm.2007.05.023; Chiribiri A, 2008, AM J CARDIOL, V101, P407, DOI 10.1016/j.amjcard.2007.08.049; Echeverri D, 2013, J INVASIVE CARDIOL, V25, P98; Genc B, 2013, DIAGN INTERV RADIOL, V19, P286, DOI 10.5152/dir.2013.012; Hasdemir C, 2007, ANATOL J CARDIOL, V7, P53; Hosch W, 2011, EUR J RADIOL, V80, P127, DOI 10.1016/j.ejrad.2010.07.011; Jongbloed MRM, 2005, J AM COLL CARDIOL, V45, P749, DOI 10.1016/j.jacc.2004.11.035; Klass O, 2010, EUR RADIOL, V20, P1124, DOI 10.1007/s00330-009-1652-7; Knackstedt C, 2008, INT J CARDIOVAS IMAG, V24, P783, DOI 10.1007/s10554-008-9333-1; Koos R, 2004, AM J CARDIOL, V94, P59, DOI 10.1016/j.amjcard.2004.03.031; Loukas M, 2009, CLIN ANAT, V22, P129, DOI 10.1002/ca.20745; Ma H, 2011, INT J CARDIOVAS IMAG, V27, P1003, DOI 10.1007/s10554-010-9757-2; Malago R, 2012, EUR J RADIOL, V81, P3262, DOI 10.1016/j.ejrad.2012.03.007; Mao SS, 2005, AM HEART J, V150, P315, DOI 10.1016/j.ahj.2004.09.050; Maselli D, 2006, CIRCULATION, V114, P377, DOI 10.1161/CIRCULATIONAHA.105.609883; Mlynarski R, 2011, CIRC J, V75, P613, DOI 10.1253/circj.CJ-10-0736; Muhlenbruch G, 2005, AM J ROENTGENOL, V185, P1252, DOI 10.2214/AJR.04.1231; Saremi F, 2012, RADIOGRAPHICS, V32, pE1, DOI 10.1148/rg.321115014; Tada H, 2005, CIRC J, V69, P165, DOI 10.1253/circj.69.165; Tops LF, 2007, CIRCULATION, V115, P1426, DOI 10.1161/CIRCULATIONAHA.106.677880; Van de Veire NR, 2008, AM J CARDIOL, V101, P1023, DOI 10.1016/j.amjcard.2007.11.052; Van de Veire NR, 2006, J AM COLL CARDIOL, V48, P1832, DOI 10.1016/j.jacc.2006.07.042; Vaseghi M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P219, DOI 10.1161/CIRCEP.110.957332	25	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104246	10.1371/journal.pone.0104246	http://dx.doi.org/10.1371/journal.pone.0104246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089900	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700114
J	Wang, QS; Jan, E				Wang, Qing S.; Jan, Eric			Switch from Cap- to Factorless IRES-Dependent 0 and+1 Frame Translation during Cellular Stress and Dicistrovirus Infection	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; HOST PROTEIN-SYNTHESIS; METHIONINE-INDEPENDENT INITIATION; PARALYSIS VIRUS; MEDIATED TRANSLATION; OVERLAPPING GENE; C-VIRUS; RNA; ELEMENTS; SHUTOFF	Internal ribosome entry sites (IRES) are utilized by a subset of cellular and viral mRNAs to initiate translation during cellular stress and virus infection when canonical cap-dependent translation is compromised. The intergenic region (IGR) IRES of the Dicistroviridae uses a streamlined mechanism in which it can directly recruit the ribosome in the absence of initiation factors and initiates translation using a non-AUG codon. A subset of IGR IRESs including that from the honey bee viruses can also direct translation of an overlapping +1 frame gene. In this study, we systematically examined cellular conditions that lead to IGR IRES-mediated 0 and +1 frame translation in Drosophila S2 cells. Towards this, a novel bicistronic reporter that exploits the 2A ``stop-go'' peptide was developed to allow the detection of IRES-mediated translation in vivo. Both 0 and +1 frame translation by the IGR IRES are stimulated under a number of cellular stresses and in S2 cells infected by cricket paralysis virus, demonstrating a switch from cap-dependent to IRES-dependent translation. The regulation of the IGR IRES mechanism ensures that both 0 frame viral structural proteins and +1 frame ORFx protein are optimally expressed during virus infection.	[Wang, Qing S.; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Jan, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ej@mail.ubc.ca	Jan, Eric/O-1923-2019		Canadian Institute of Health Research [MOP-81244]; NSERC [RGPIN 341459-12]; Genome Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada)	This study was supported in part by the Canadian Institute of Health Research (MOP-81244), an NSERC Discovery Grant (RGPIN 341459-12), and Genome Canada to E.J. E.J. is a Michael Smith Foundation for Health Research Scholar and a CIHR New Investigator Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Brakier-Gingras L, 2012, EXPERT OPIN THER TAR, V16, P249, DOI 10.1517/14728222.2012.665879; Brown JD, 2010, NUCLEIC ACIDS MOL BI, V24, P101, DOI 10.1007/978-0-387-89382-2_5; Carter JR, 2008, J GEN VIROL, V89, P3150, DOI 10.1099/vir.0.2008/003921-0; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Doudna J.A., 2007, COLD SPRING HARB MON, V48, P129; Dulude D, 2006, VIROLOGY, V345, P127, DOI 10.1016/j.virol.2005.08.048; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Feng PH, 2005, J VIROL, V79, P9651, DOI 10.1128/JVI.79.15.9651-9664.2005; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Firth AE, 2012, J GEN VIROL; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-193; Garrey JL, 2010, J VIROL, V84, P1124, DOI 10.1128/JVI.02006-09; Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hertz MI, 2011, NUCLEIC ACIDS RES, V39, P7276, DOI 10.1093/nar/gkr427; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Jang CJ, 2010, RNA, V16, P1182, DOI 10.1261/rna.2044610; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; King HA, 2010, BIOCHEM SOC T, V38, P1581, DOI 10.1042/BST0381581; Koh CS, 2014, P NATL ACAD SCI US; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; MOORE NF, 1981, VIROLOGY, V112, P411, DOI 10.1016/0042-6822(81)90288-9; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; OROSKAR AA, 1989, J VIROL, V63, P1897, DOI 10.1128/JVI.63.5.1897-1906.1989; Perez C, 2011, J VIROL, V85, P156, DOI 10.1128/JVI.01778-10; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pfingsten JS, 2007, J MOL BIOL, V370, P856, DOI 10.1016/j.jmb.2007.04.076; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Pringle FM, 1999, J GEN VIROL, V80, P1855, DOI 10.1099/0022-1317-80-7-1855; Ren Q, 2012, P NATL ACAD SCI USA, V109, pE630, DOI 10.1073/pnas.1111303109; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Sabath N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-144; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Shibuya N, 2003, J VIROL, V77, P12002, DOI 10.1128/JVI.77.22.12002-12010.2003; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang QS, 2013, METHODS, V59, P167, DOI 10.1016/j.ymeth.2012.09.004; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000	59	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103601	10.1371/journal.pone.0103601	http://dx.doi.org/10.1371/journal.pone.0103601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089704	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700035
J	Yu, KR; Lee, JY; Kim, HS; Hong, IS; Choi, SW; Seo, Y; Kang, I; Kim, JJ; Lee, BC; Lee, S; Kurtz, A; Seo, KW; Kang, KS				Yu, Kyung-Rok; Lee, Jin Young; Kim, Hyung-Sik; Hong, In-Sun; Choi, Soon Won; Seo, Yoojin; Kang, Insung; Kim, Jae-Jun; Lee, Byung-Chul; Lee, SeungHee; Kurtz, Andreas; Seo, Kwang-Won; Kang, Kyung-Sun			A p38 MAPK-Mediated Alteration of COX-2/PGE(2) Regulates Immunomodulatory Properties in Human Mesenchymal Stem Cell Aging	PLOS ONE			English	Article							MARROW STROMAL CELLS; ACTIVATED PROTEIN-KINASE; IMMUNOSUPPRESSION; SENESCENCE; RESPONSES; COLITIS; PATHWAY; DISEASE; PROLIFERATION; MACROPHAGES	Because human mesenchymal stem cells (hMSC) have profound immunomodulatory effects, many attempts have been made to use hMSCs in preclinical and clinical trials. For hMSCs to be used in therapy, a large population of hMSCs must be generated by in vitro expansion. However, the immunomodulatory changes following the in vitro expansion of hMSCs have not been elucidated. In this study, we evaluated the effect of replicative senescence on the immunomodulatory ability of hMSCs in vitro and in vivo. Late-passage hMSCs showed impaired suppressive effect on mitogen-induced mononuclear cell proliferation. Strikingly, late-passage hMSCs had a significantly compromised protective effect against mouse experimental colitis, which was confirmed by gross and histologic examination. Among the anti-inflammatory cytokines, the production of prostaglandin E-2 (PGE(2)) and the expression of its primary enzyme, cyclooxygenase-2 (COX-2), were profoundly increased by pre-stimulation with interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha), and this response was significantly decreased with consecutive passages. We demonstrated that the impaired phosphorylation activity of p38 MAP kinase (p38 MAPK) in late-passage hMSCs led to a compromised immunomodulatory ability through the regulation of COX-2. In conclusion, our data indicate that the immunomodulatory ability of hMSCs gradually declines with consecutive passages via a p38-mediated alteration of COX-2 and PGE(2) levels.	[Yu, Kyung-Rok; Lee, Jin Young; Kim, Hyung-Sik; Hong, In-Sun; Choi, Soon Won; Seo, Yoojin; Kang, Insung; Kim, Jae-Jun; Lee, Byung-Chul; Lee, SeungHee; Kurtz, Andreas; Seo, Kwang-Won; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea; [Yu, Kyung-Rok; Lee, Jin Young; Hong, In-Sun; Choi, Soon Won; Seo, Yoojin; Kang, Insung; Kim, Jae-Jun; Lee, Byung-Chul; Kurtz, Andreas; Kang, Kyung-Sun] Seoul Natl Univ, Coll Vet Med, Vet Med Res Inst, Seoul, South Korea; [Kim, Hyung-Sik; Lee, SeungHee; Seo, Kwang-Won] Seoul Natl Univ, Biotechnol Incubating Ctr, Inst Stem Cell & Regenerat Med Kangstem Biotech, Seoul, South Korea; [Kurtz, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seo, KW (corresponding author), Seoul Natl Univ, Coll Vet Med, Adult Stem Cell Res Ctr, Seoul, South Korea.	kwang_wons@hotmail.com; kangpub@snu.ac.kr	Yu, Kyung-Rok/AAR-6227-2021; Kang, Kyung-Sun/G-6205-2013; Seo, Kwang Won/AAB-4821-2020; Choi, Soon Won/S-3052-2017	Yu, Kyung-Rok/0000-0002-4685-3223; Seo, Kwang Won/0000-0003-1025-6133; Choi, Soon Won/0000-0001-8642-6093; Kurtz, Andreas/0000-0003-3301-6546; Lee, Jin Young/0000-0001-8559-7077	National Research Foundation (NRF) - Korean government [2012M3A9C6049716]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120176]; Research Institute for Veterinary Science, Seoul National University	National Research Foundation (NRF) - Korean government(Korean Government); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Research Institute for Veterinary Science, Seoul National University	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (No. 2012M3A9C6049716), a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120176), and the Research Institute for Veterinary Science, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ANDRE C, 1981, GUT, V22, P571, DOI 10.1136/gut.22.7.571; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen BC, 1999, IMMUNOLOGY, V97, P124, DOI 10.1046/j.1365-2567.1999.00747.x; COOPER HS, 1993, LAB INVEST, V69, P238; Crisostomo PR, 2006, SHOCK, V26, P575, DOI 10.1097/01.shk.0000235087.45798.93; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P303, DOI 10.3109/10520295.2011.649785; Gu ZF, 2012, CELL SIGNAL, V24, P2307, DOI 10.1016/j.cellsig.2012.07.012; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kim HS, 2013, GASTROENTEROLOGY, V145, P1392, DOI 10.1053/j.gastro.2013.08.033; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176; Liu H, 2012, J CELL SCI, V125, P200, DOI 10.1242/jcs.093070; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Scruggs BA, 2013, STEM CELL TRANSL MED, V2, P797, DOI 10.5966/sctm.2013-0026; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Yu KR, 2013, J CELL SCI, V126, P5422, DOI 10.1242/jcs.133314; Yu KR, 2013, GERONTOLOGY, V59, P557, DOI 10.1159/000353857; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x	37	67	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102426	10.1371/journal.pone.0102426	http://dx.doi.org/10.1371/journal.pone.0102426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090227	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700007
J	Dago, AE; Stepansky, A; Carlsson, A; Luttgen, M; Kendall, J; Baslan, T; Kolatkar, A; Wigler, M; Bethel, K; Gross, ME; Hicks, J; Kuhn, P				Dago, Angel E.; Stepansky, Asya; Carlsson, Anders; Luttgen, Madelyn; Kendall, Jude; Baslan, Timour; Kolatkar, Anand; Wigler, Michael; Bethel, Kelly; Gross, Mitchell E.; Hicks, James; Kuhn, Peter			Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; SURVIVAL; EVOLUTION; PROGRESSION	Timely characterization of a cancer's evolution is required to predict treatment efficacy and to detect resistance early. High content analysis of single Circulating Tumor Cells (CTCs) enables sequential characterization of genotypic, morphometric and protein expression alterations in real time over the course of cancer treatment. This concept was investigated in a patient with castrate-resistant prostate cancer progressing through both chemotherapy and targeted therapy. In this case study, we integrate across four timepoints 41 genome-wide copy number variation (CNV) profiles plus morphometric parameters and androgen receptor (AR) protein levels. Remarkably, little change was observed in response to standard chemotherapy, evidenced by the fact that a unique clone (A), exhibiting highly rearranged CNV profiles and AR+ phenotype was found circulating before and after treatment. However, clinical response and subsequent progression after targeted therapy was associated with the drastic depletion of clone A, followed by the sequential emergence of two distinct CTC sub-populations that differed in both AR genotype and expression phenotype. While AR-cells with flat or pseudo-diploid CNV profiles (clone B) were identified at the time of response, a new tumor lineage of AR+ cells (clone C) with CNV altered profiles was detected during relapse. We showed that clone C, despite phylogenetically related to clone A, possessed a unique set of somatic CNV alterations, including MYC amplification, an event linked to hormone escape. Interesting, we showed that both clones acquired AR gene amplification by deploying different evolutionary paths. Overall, these data demonstrate the timeframe of tumor evolution in response to therapy and provide a framework for the multi-scale analysis of fluid biopsies to quantify and monitor disease evolution in individual patients.	[Dago, Angel E.; Carlsson, Anders; Luttgen, Madelyn; Kolatkar, Anand; Bethel, Kelly] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Stepansky, Asya; Kendall, Jude; Baslan, Timour; Wigler, Michael; Hicks, James] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Stepansky, Asya; Kendall, Jude] Skyline Genom, Roslyn Hts, NY USA; [Baslan, Timour] SUNY Stony Brook, Dept Mol & Cellular Biol, Stony Brook, NY USA; [Bethel, Kelly] Scripps Clin, Dept Pathol, La Jolla, CA USA; [Gross, Mitchell E.] Univ So Calif, Keck Sch Med, Los Angeles, CA USA; [Kuhn, Peter] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA USA	Scripps Research Institute; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Scripps Research Institute; University of Southern California; University of Southern California	Hicks, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	hicks@cshl.edu; pkuhn@usc.edu		Bethel, Kelly/0000-0002-7005-8641; Gross, Mitchell/0000-0002-1691-921X; Wigler, Michael/0000-0003-4396-1971	National Cancer Institute [U54CA143906]; National Cancer Institute (NCI) [PA-12-149-]; Swedish Research Council [Dnr 2012-235]; Dr. Marilyn Simons for cancer research at CSHL; Breast Cancer Research Foundation; Skyline Genomics; NATIONAL CANCER INSTITUTE [P30CA045508, U54CA143907, U54CA143906] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Dr. Marilyn Simons for cancer research at CSHL; Breast Cancer Research Foundation; Skyline Genomics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Award Number U54CA143906 from the National Cancer Institute. A. E. Dago is a recipient of a PA-12-149- Research Supplements to Promote Diversity in Health-Related Research awarded by the National Cancer Institute (NCI). A. Carlsson is funded by the Swedish Research Council, Dnr 2012-235. JH, JK, TB and MW were supported by a special grant from Dr. Marilyn Simons for cancer research at CSHL, a Breast Cancer Research Foundation grant, and research support from Skyline Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Asya Stepansky of Skyline Genomics had a significant role in developing the protocol for isolating DNA from HD-CTC cells and performed the Illumina library preparations. Skyline Genomics financially supported the Illumina sequencing at the Cold Spring Harbor Genome facility as a demonstration of their capabilities as a future service provider. The company did not have a role in design of the experiments or interpretation of the data.	Almendro V, 2014, CANCER RES, V74, P1338, DOI 10.1158/0008-5472.CAN-13-2357-T; Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goatly A, 2008, MODERN PATHOL, V21, P902, DOI 10.1038/modpathol.2008.74; Halir R, 1998, WSCG '98, VOL 1, P125; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Koivisto P, 1997, CANCER RES, V57, P314; Lazar DC, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016002; Li B, 2013, CLIN CANC RES; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nair VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067733; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Team RC, 2012, R LANG ENV STAT COMP; Toivanen R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005688	35	110	114	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e101777	10.1371/journal.pone.0101777	http://dx.doi.org/10.1371/journal.pone.0101777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084170	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000339819800005
J	Ge, ZW; Yang, ZL; Pfister, DH; Carbone, M; Bau, T; Smith, ME				Ge, Zai-Wei; Yang, Zhu L.; Pfister, Donald H.; Carbone, Matteo; Bau, Tolgor; Smith, Matthew E.			Multigene Molecular Phylogeny and Biogeographic Diversification of the Earth Tongue Fungi in the Genera Cudonia and Spathularia (Rhytismatales, Ascomycota)	PLOS ONE			English	Article							TRUE MORELS MORCHELLA; HISTORICAL BIOGEOGRAPHY; RIBOSOMAL DNA; SPECIES RECOGNITION; DIVERGENCE TIMES; EVOLUTION; TREE; HEMISPHERE; DISPERSAL; REVEALS	The family Cudoniaceae (Rhytismatales, Ascomycota) was erected to accommodate the "earth tongue fungi" in the genera Cudonia and Spathularia. There have been no recent taxonomic studies of these genera, and the evolutionary relationships within and among these fungi are largely unknown. Here we explore the molecular phylogenetic relationships within Cudonia and Spathularia using maximum likelihood and Bayesian inference analyses based on 111 collections from across the Northern Hemisphere. Phylogenies based on the combined data from ITS, nrLSU, rpb2 and tef-1 alpha sequences support the monophyly of three main clades, the /flavida, /velutipes, and /cudonia clades. The genus Cudonia and the family Cudoniaceae are supported as monophyletic groups, while the genus Spathularia is not monophyletic. Although Cudoniaceae is monophyletic, our analyses agree with previous studies that this family is nested within the Rhytismataceae. Our phylogenetic analyses circumscribes 32 species-level clades, including the putative recognition of 23 undescribed phylogenetic species. Our molecular phylogeny also revealed an unexpectedly high species diversity of Cudonia and Spathularia in eastern Asia, with 16 (out of 21) species-level clades of Cudonia and 8 (out of 11) species-level clades of Spathularia. We estimate that the divergence time of the Cudoniaceae was in the Paleogene approximately 28 Million years ago (Mya) and that the ancestral area for this group of fungi was in Eastern Asia based on the current data. We hypothesize that the large-scale geological and climatic events in Oligocene (e. g. the global cooling and the uplift of the Tibetan plateau) may have triggered evolutionary radiations in this group of fungi in East Asia. This work provides a foundation for future studies on the phylogeny, diversity, and evolution of Cudonia and Spathularia and highlights the need for more molecular studies on collections from Europe and North America.	[Ge, Zai-Wei; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Ge, Zai-Wei; Pfister, Donald H.] Harvard Univ, Harvard Univ Herbaria, Cambridge, MA 02138 USA; [Ge, Zai-Wei; Pfister, Donald H.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Ge, Zai-Wei; Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Bau, Tolgor] Jilin Agr Univ, Inst Mycol, Changchun, Jilin, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Harvard University; Harvard University; State University System of Florida; University of Florida; Jilin Agricultural University	Ge, ZW (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	zaiweige@gmail.com; fungi@mail.kib.ac.cn	Smith, Matthew E/A-8115-2012; Smith, Matthew E./ABC-3015-2020	Smith, Matthew E/0000-0002-0878-0932; Smith, Matthew E./0000-0002-0878-0932	National Natural Science Foundation of China [31270074, U1302263]; Yunnan Provincial Government [U1302263]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]; Farlow Fellowships from the Friends of Farlow; CAS/SAFEA International Partnership Program for Creative Research Teams; U. S. National Science Foundation [DEB-0321846]; University of Florida's Institute for Food and Agricultural Sciences (IFAS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Farlow Fellowships from the Friends of Farlow; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); U. S. National Science Foundation(National Science Foundation (NSF)); University of Florida's Institute for Food and Agricultural Sciences (IFAS)	This study was supported by the National Natural Science Foundation of China (No. 31270074), the Joint Funds of the National Natural Science Foundation of China and Yunnan Provincial Government (No. U1302263), the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-24), and the Farlow Fellowships from the Friends of Farlow to Zai-Wei Ge. Field work was jointly supported by the CAS/SAFEA International Partnership Program for Creative Research Teams and the U. S. National Science Foundation (No. DEB-0321846 to D. E. Boufford), and the University of Florida's Institute for Food and Agricultural Sciences (IFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; [Anonymous], 1973, FUNGI ADV TREATISE; AXELROD DI, 1983, ANN MO BOT GARD, V70, P629, DOI 10.2307/2398982; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Cai Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-143; Chung SL, 1998, NATURE, V394, P769, DOI 10.1038/29511; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Doring H, 1998, CRYPTOGAMIE BRYOL L, V19, P123; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Du XH, 2012, FUNGAL GENET BIOL, V49, P455, DOI 10.1016/j.fgb.2012.03.006; Duff GH, 1922, BOT GAZ, V74, P264, DOI 10.1086/333097; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Durand E.J., 1921, MYCOLOGIA, V13, P184; Durand EJ., 1908, ANN MYCOL, V6, P387; Fang MY, 2005, FLORA CHINA, V14, P260; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037567; Fries EM, 1849, DISCOMYCETES, V346, P259; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Ge ZW, 2010, FUNGAL DIVERS, V45, P81, DOI 10.1007/s13225-010-0062-0; Ge ZW, 2008, FUNGAL DIVERS, V32, P59; Geml J, 2006, MOL ECOL, V15, P225, DOI 10.1111/j.1365-294X.2005.02799.x; Gernandt DS, 2001, MYCOLOGIA, V93, P915, DOI 10.2307/3761757; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanso M, 2012, FOREST PATHOL, V42, P124, DOI 10.1111/j.1439-0329.2011.00728.x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hawksworth DL, 2005, FUNGAL COMMUNITY ITS, DOI DOI 10.1201/9781420027891.CH2; Hibbett DS, 1997, P NATL ACAD SCI USA, V94, P12002, DOI 10.1073/pnas.94.22.12002; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hintikka V., 1970, Metsatieteellisen tutkimuslaitoksen julkaisuja, V69, P68; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Hou CL, 2005, MYCOPATHOLOGIA, V159, P299, DOI 10.1007/s11046-004-5653-4; Imai S, 1955, SCI REPORTS YOKOHOMA; Imai S, 1941, J FAC AGR HOKKAIDO U, V45, P155; Jansen G, 2010, MOL PHYLOGENET EVOL, V56, P294, DOI 10.1016/j.ympev.2010.01.029; Jeandroz S, 2008, J BIOGEOGR, V35, P815, DOI 10.1111/j.1365-2699.2007.01851.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirk P, 2001, BISBYS DICT FUNGI; Kirk PM, 2008, DICT FUNGI; Kraatz BP, 2010, GEOLOGY, V38, P111, DOI 10.1130/G30619.1; Landvik Sara, 1993, Systema Ascomycetum, V11, P107; Lantz H, 2011, MYCOLOGIA, V103, P57, DOI 10.3852/10-060; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Lin Y. G., 1994, Acta Mycologica Sinica, V13, P8; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lloyd CG, 1916, GEOGLOSSACEAE; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; MAASGEESTERANUS RA, 1972, P K NED AKAD C BIOL, V75, P243; MAINS EB, 1955, MYCOLOGIA, V47, P846, DOI 10.2307/3755508; Mains EB, 1940, AM J BOT, V27, P322, DOI 10.2307/2436703; MAINS EB, 1956, MYCOLOGIA, V48, P694, DOI 10.2307/3755379; Manos PS, 2001, INT J PLANT SCI, V162, pS77, DOI 10.1086/323280; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Moncalvo JM, 2008, MYCOL RES, V112, P425, DOI 10.1016/j.mycres.2007.12.001; MUELLER GM, 2004, BIODIVERSITY FUNGI I; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Nannfeldt JA, 1942, ARK BOT A, V30A, P1; NYLANDER J.A.A., 2004, MRMODELTEST V2 3; O'Donnell K, 2011, FUNGAL GENET BIOL, V48, P252, DOI 10.1016/j.fgb.2010.09.006; Persoon CH, 1794, N MAG BOT IHREM GANZ, V1, P63; Platt JL, 2000, MYCOLOGIA, V92, P475, DOI 10.2307/3761506; Pringle A, 2009, MOL ECOL, V18, P817, DOI 10.1111/j.1365-294X.2008.04030.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rahm E, 1966, SCHWEIZ Z PILZK, V44, P165; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rehm H, 1904, HEDWIGIA, V44, P1; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoch CL, 2009, PERSOONIA, V22, P129, DOI 10.3767/003158509X461486; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schumacher HCF, 1803, ENUMERATIO PLANTARUM, V2, P1; Sharma M, 1983, INDIA J CRAMMERS BIB, V91, P203; Skrede I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-230; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Takamatsu S, 2006, MYCOL RES, V110, P1093, DOI 10.1016/j.mycres.2006.07.005; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang E, 2012, NAT GEOSCI, V5, P640, DOI [10.1038/ngeo1538, 10.1038/NGEO1538]; Wang Z, 2002, MYCOLOGIA, V94, P641, DOI 10.2307/3761715; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Wang Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004246; White T., 1990, PCR PROTOCOLS GUIDE, P315; Yang ZL, 2011, FUNGAL DIVERS, V50, P47, DOI 10.1007/s13225-011-0121-1; Yang ZL, 2005, EVOL GENET, V2, P35; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	106	19	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103457	10.1371/journal.pone.0103457	http://dx.doi.org/10.1371/journal.pone.0103457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084276	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800045
J	Saez-Laguna, E; Guevara, MA; Diaz, LM; Sanchez-Gomez, D; Collada, C; Aranda, I; Cervera, MT				Saez-Laguna, Enrique; Guevara, Maria-Angeles; Diaz, Luis-Manuel; Sanchez-Gomez, David; Collada, Carmen; Aranda, Ismael; Cervera, Maria-Teresa			Epigenetic Variability in the Genetically Uniform Forest Tree Species Pinus pinea L	PLOS ONE			English	Article							DNA METHYLATION POLYMORPHISM; CYTOSINE METHYLATION; CLIMATIC ADAPTATION; NATURAL VARIATION; POPULATIONS; DIVERGENCE; TRAITS; AFLP; TRANSCRIPTION; DEPAUPERATE	There is an increasing interest in understanding the role of epigenetic variability in forest species and how it may contribute to their rapid adaptation to changing environments. In this study we have conducted a genome-wide analysis of cytosine methylation pattern in Pinus pinea, a species characterized by very low levels of genetic variation and a remarkable degree of phenotypic plasticity. DNA methylation profiles of different vegetatively propagated trees from representative natural Spanish populations of P. pinea were analyzed with the Methylation Sensitive Amplified Polymorphism (MSAP) technique. A high degree of cytosine methylation was detected (64.36% of all scored DNA fragments). Furthermore, high levels of epigenetic variation were observed among the studied individuals. This high epigenetic variation found in P. pinea contrasted with the lack of genetic variation based on Amplified Fragment Length Polymorphism (AFLP) data. In this manner, variable epigenetic markers clearly discriminate individuals and differentiates two well represented populations while the lack of genetic variation revealed with the AFLP markers fail to differentiate at both, individual or population levels. In addition, the use of different replicated trees allowed identifying common polymorphic methylation sensitive MSAP markers among replicates of a given propagated tree. This set of MSAPs allowed discrimination of the 70% of the analyzed trees.	[Saez-Laguna, Enrique; Guevara, Maria-Angeles; Diaz, Luis-Manuel; Sanchez-Gomez, David; Aranda, Ismael; Cervera, Maria-Teresa] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Invest Forestal CIFOR, Dept Ecol & Genet, Madrid, Spain; [Saez-Laguna, Enrique; Guevara, Maria-Angeles; Diaz, Luis-Manuel; Collada, Carmen; Cervera, Maria-Teresa] UPM, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Unidad Mixta Genom & Ecofisiol Forestal, Madrid, Spain; [Collada, Carmen] UPM, ETSIM, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Cervera, MT (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Invest Forestal CIFOR, Dept Ecol & Genet, Madrid, Spain.	cervera@inia.es	Sanchez-Gomez, David/K-5653-2014; Collada, Carmen/H-1529-2015; Guevara, M Angeles/H-5858-2011; Cervera, M. Teresa/G-9181-2012; Aranda, Ismael/B-7050-2008	Sanchez-Gomez, David/0000-0002-0588-9713; Collada, Carmen/0000-0003-0236-1312; Guevara, M Angeles/0000-0001-7399-3136; Cervera, M. Teresa/0000-0001-6797-2347; Aranda, Ismael/0000-0001-9086-7940	EPINEA: Estudio de la variabilidad epigenetica de Pinus pinea y su papel para el control molecular de la repuestas adaptativa [SUM 2008-05]; PINCOxSEQ: Estudio multidisciplinar de la respuesta de Pinus pinaster a sequia bajo distintas concentraciones de CO2 atmosferico [AGL2012-35175]; ProCoGen: PROmoting a functional and COmparative understanding of the conifer GENome - implementing applied aspects for more productive and adapted forests [7FP-289841]; Predoctoral Fellowship ESL [BES-2010-039754]	EPINEA: Estudio de la variabilidad epigenetica de Pinus pinea y su papel para el control molecular de la repuestas adaptativa; PINCOxSEQ: Estudio multidisciplinar de la respuesta de Pinus pinaster a sequia bajo distintas concentraciones de CO2 atmosferico; ProCoGen: PROmoting a functional and COmparative understanding of the conifer GENome - implementing applied aspects for more productive and adapted forests; Predoctoral Fellowship ESL	This work was supported by the following: EPINEA: Estudio de la variabilidad epigenetica de Pinus pinea y su papel para el control molecular de la repuestas adaptativa (SUM 2008-05), www.inia.es; PINCOxSEQ: Estudio multidisciplinar de la respuesta de Pinus pinaster a sequia bajo distintas concentraciones de CO2 atmosferico (AGL2012-35175), www.mineco.gob.es; ProCoGen: PROmoting a functional and COmparative understanding of the conifer GENome - implementing applied aspects for more productive and adapted forests (7FP-289841), http://ec.europa.eu/research/fp7/; and Predoctoral Fellowship ESL (BES-2010-039754), www.mineco.gob.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Bucher E, 2012, CURR OPIN PLANT BIOL, V15, P503, DOI 10.1016/j.pbi.2012.08.006; BUTKUS V, 1987, NUCLEIC ACIDS RES, V15, P7091, DOI 10.1093/nar/15.17.7091; Carrasquinho I, 2013, TREE GENET GENOMES, V9, P855, DOI 10.1007/s11295-013-0603-2; Catalan G., 1997, REGIONES PROCEDENCIA; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Cervera MT, 1998, THEOR APPL GENET, V97, P51, DOI 10.1007/s001220050866; Cervera MT, 2000, CAN J FOREST RES, V30, P1608, DOI 10.1139/cjfr-30-10-1608; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fallour D, 1997, SILVAE GENET, V46, P201; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Food and Agriculture Organization of the United Nations [FAO], 2020, GLOBAL FOREST RESOUR; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gourcilleau D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009101; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Huang LC, 2012, PHYSIOL PLANTARUM, V145, P360, DOI 10.1111/j.1399-3054.2012.01606.x; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnsen O, 2005, PLANT CELL ENVIRON, V28, P1090, DOI 10.1111/j.1365-3040.2005.01356.x; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Lafon-Placette C, 2013, NEW PHYTOL, V197, P416, DOI 10.1111/nph.12026; Latzel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3875; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li A, 2011, PLANT MOL BIOL REP, V29, P784, DOI 10.1007/s11105-010-0280-3; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lisch D, 2011, CURR OPIN PLANT BIOL, V14, P156, DOI 10.1016/j.pbi.2011.01.003; Marfil CF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-21; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Monteuuis O, 2008, TREES-STRUCT FUNCT, V22, P779, DOI 10.1007/s00468-008-0238-3; Mougel C, 2002, INT J SYST EVOL MICR, V52, P573, DOI 10.1099/00207713-52-2-573; Mutke S, 2005, SILVAE GENET, V54, P189, DOI 10.1515/sg-2005-0028; Mutke S., 2013, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P73; Mutke S., 2000, NUCIS Newsletter, P50; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Pinzauti F, 2012, AM J BOT, V99, pE362, DOI 10.3732/ajb.1200064; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Richards CL, 2010, NEW PHYTOL, V187, P562, DOI 10.1111/j.1469-8137.2010.03369.x; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Richards CL, 2012, PLANT GENOME DIVERSI, V1; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Rohde A, 2008, NEW PHYTOL, V177, P2, DOI 10.1111/j.1469-8137.2007.02319.x; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Sanchez-Gomez D, 2011, ENVIRON EXP BOT, V70, P104, DOI 10.1016/j.envexpbot.2010.08.007; SCHULMAN E, 1958, NATL GEOGR, V113, P355; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vendramin GG, 2008, EVOLUTION, V62, P680, DOI 10.1111/j.1558-5646.2007.00294.x; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Vining Kelly J, 2012, BMC Genomics, V13, P27, DOI 10.1186/1471-2164-13-27; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yakovlev IA, 2014, TREE GENET GENOMES, V10, P355, DOI 10.1007/s11295-013-0691-z; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zonneveld BJM, 2012, NORD J BOT, V30, P490, DOI 10.1111/j.1756-1051.2012.01516.x	79	56	58	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103145	10.1371/journal.pone.0103145	http://dx.doi.org/10.1371/journal.pone.0103145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084460	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000339819800017
J	Thompson, A; Devine, S; Kattan, M; Muir, A				Thompson, Alex; Devine, Scott; Kattan, Mike; Muir, Andrew			Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2B/RIBAVIRIN P/RBV; SVR; RETREATMENT; TELAPREVIR; INFECTION; RATES	Aim: Sustained virologic response (SVR) can be attained with boceprevir plus peginterferon alfa and ribavirin (PR) in up to 68% of patients, and short duration therapy is possible if plasma HCV RNA levels are undetectable at treatment week 8 (TW8 response). We have developed predictive models for SVR, and TW8 response using data from boceprevir clinical trials. Methods: Regression models were built to predict TW8 response and SVR. Separate models were built for TW8 and SVR using baseline variables only, and compared to models with baseline variables plus HCV RNA change after 4 weeks of PR (TW4 delta). Predictive accuracy was assessed by c-statistics, calibration curves, and decision curve analyses. Nomograms were developed to create clinical decision support tools. Models were externally validated using independent data. Results: The models that included TW4 delta produced the best discrimination ability. The predictive factors for TW8 response (n = 856) were TW4 delta, race, platelet count and ALT. The predictive factors for SVR (n = 522) were TW4 delta, HCV-subtype, gender, BMI, RBV dose and platelet count. The discrimination abilities of these models were excellent (C-statistics = 0.88, 0.80 respectively). Baseline models for TW8 response (n = 444) and SVR (n = 197) had weaker discrimination ability (C-statistic = 0.76, 0.69). External validation confirmed the predictive accuracy of the week 4 models. Conclusions: Models incorporating baseline and treatment week 4 data provide excellent prediction of TW8 response and SVR, and support the clinical utility of the lead-in phase of PR. The nomograms are suitable for point-of-care use to inform individual patient and physician decision-making.	[Thompson, Alex] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Devine, Scott] Merck, Whitehouse Stn, NJ 08889 USA; [Kattan, Mike] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Muir, Andrew] Duke Univ, Sch Med, Durham, NC USA	St Vincent's Hospital Melbourne; Merck & Company; Cleveland Clinic Foundation; Duke University	Devine, S (corresponding author), Merck, Whitehouse Stn, NJ 08889 USA.	scott.devine@gmail.com	Kattan, Michael/AAF-9735-2021	Kattan, Michael/0000-0002-3840-4161	project (Merck)	project (Merck)	The funder of this project (Merck) provided support in the form of salaries for authors [SD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; Elefsiniotis IS, 2009, INTERVIROLOGY, V52, P247, DOI 10.1159/000228548; Flamm SL, 2013, CLIN GASTROENTEROL H, V11, P81, DOI 10.1016/j.cgh.2012.10.006; Harrell F. E., 2011, RMS REGRESSION MODEL; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell Jr F. E., 2011, HMISC HARRELL MISCEL; Harrell Jr FE, 2001, REGRESION MODELING S; Harrell Jr FE, 2011, VAL PROB VALIDATED P; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lawitz E, 2012, HEPATOLOGY, V56, p216A; Poordad F, 2012, HEPATOLOGY, V56, p269A; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Thompson A, 2011, HEPATOLOGY, V54; Thompson AJ, 2011, HEPATOLOGY, V54, p436A; Van Buuren S., 2011, MICE MULTIVARIATE IM; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103370	10.1371/journal.pone.0103370	http://dx.doi.org/10.1371/journal.pone.0103370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084272	gold, Green Published			2022-12-25	WOS:000339819800035
J	Singh, D; Vaughan, R; Kao, CC				Singh, Divyendu; Vaughan, Robert; Kao, C. Cheng			LL-37 Peptide Enhancement of Signal Transduction by Toll-like Receptor 3 Is Regulated by pH IDENTIFICATION OF A PEPTIDE ANTAGONIST OF LL-37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endosome; Innate Immunity; pH Regulation; RNA-binding Protein; Toll-like Receptor (TLR); pH	RESONANCE ENERGY-TRANSFER; DOUBLE-STRANDED-RNA; ANTIMICROBIAL PEPTIDE; CATHELICIDIN LL-37; VITAMIN-D; ASTHMA; RECOGNITION; MICROSCOPY; CATHEPSINS; CLEAVAGE	Background: How LL-37 delivers double-stranded RNA (dsRNA) to activate TLR3 signaling is poorly understood. Results: LL-37 was found to traffic to endosomes with RNA and releases the dsRNA upon endosome acidification. A peptide derived from LL-37 could antagonize LL-37dsRNA trafficking. Conclusion: LL-37 trafficking of dsRNA is regulated by pH. Significance: This work establishes the mechanism of LL-37 enhancement of dsRNA-activated TLR3 signaling. LL-37 is a peptide secreted by human epithelial cells that can lyse bacteria, suppress signaling by Toll-like receptor 4 (TLR4), and enhance signaling to double-stranded RNA (dsRNA) by TLR3. How LL-37 interacts with dsRNA to affect signal transduction by TLR3 is not completely understood. We determined that LL-37 binds dsRNA and traffics to endosomes and releases the dsRNA in a pH-dependent manner. Using dynamic light scattering spectroscopy and cell-based FRET experiments, LL-37 was found to form higher order complexes independent of dsRNA binding. Upon acidification LL-37 will dissociate from a larger complex. In cells, LL-37 has a half-live of approximate to 1 h. LL-37 half-life was increased by inhibiting endosome acidification or inhibiting cathepsins, which include proteases whose activity are activated by endosome acidification. Residues in LL-37 that contact poly(I:C) and facilitate oligomerization in vitro were mapped. Peptide LL-29, which contains the oligomerization region of LL-37, inhibited LL-37 enhancement of TLR3 signal transduction. LL-29 prevented LL-37poly(I:C) co-localization to endosomes containing TLR3. These results shed light on the requirements for LL-37 enhancement of TLR3 signaling.	[Singh, Divyendu; Vaughan, Robert; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu						Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Dombrowski Y, 2012, EXP DERMATOL, V21, P327, DOI 10.1111/j.1600-0625.2012.01459.x; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gambichler T, 2011, REGUL PEPTIDES, V167, P163, DOI 10.1016/j.regpep.2011.02.001; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kim SK, 2010, J KOREAN MED SCI, V25, P1506, DOI 10.3346/jkms.2010.25.10.1506; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li GM, 2009, INT ARCH ALLERGY IMM, V150, P122, DOI 10.1159/000218115; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Martin T John, 2014, J Bone Metab, V21, P8, DOI 10.11005/jbm.2014.21.1.8; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Perez-Vargas J, 2014, J VIROL, V88, P9287, DOI 10.1128/JVI.00935-14; Phelps MA, 2004, MOL PHARMACEUT, V1, P257, DOI 10.1021/mp0499510; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Rohde G, 2014, CLIN EXP ALLERGY, V44, P930, DOI 10.1111/cea.12313; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Singh D, 2013, J BIOL CHEM, V288, P8258, DOI 10.1074/jbc.M112.440883; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sun J, 2013, ALLERGY, V68, P304, DOI 10.1111/all.12087; Takiguchi T, 2014, BRIT J DERMATOL, V171, P492, DOI 10.1111/bjd.12942; Vaughan R, 2012, RNA, V18, P1541, DOI 10.1261/rna.031914.111; Wan M, 2014, J LEUKOCYTE BIOL, V95, P971, DOI 10.1189/jlb.0513304; Xhindoli D, 2014, BIOCHEM J, V457, P263, DOI 10.1042/BJ20131048	35	32	32	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27614	27624		10.1074/jbc.M114.582973	http://dx.doi.org/10.1074/jbc.M114.582973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25092290	Green Published, hybrid			2022-12-25	WOS:000342852800022
J	Kuge, H; Akahori, K; Yagyu, K; Honke, K				Kuge, Hideaki; Akahori, Kana; Yagyu, Ken-ichi; Honke, Koichi			Functional Compartmentalization of the Plasma Membrane of Neurons by a Unique Acyl Chain Composition of Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; DOPAMINE TRANSPORTER; DIFFUSION BARRIER; LIPIDS; METABOLISM; EXTRACTION; EXPRESSION	In neurons, the plasma membrane is functionally separated into several distinct segments. Neurons form these domains by delivering selected components to and by confining them within each segment of the membrane. Although some mechanisms of the delivery are elucidated, that of the confinement is unclear. We show here that 1-oleoyl-2-palmitoyl-phosphatidylcholine (OPPC), a unique molecular species of phospholipids, is concentrated at the protrusion tips of several neuronal culture cells and the presynaptic area of neuronal synapses of the mouse brain. In PC12 cells, NGF-stimulated neuronal differentiation induces a phospholipase A1 activity at the protrusion tips, which co-localizes with the OPPC domain. Inhibition of the phospholipase A1 activity leads to suppression of phospholipid remodeling in the tip membrane and results in disappearance of the OPPC at the tips. In these cells, confinement of dopamine transporter and G alpha(o) proteins to the tip was also disrupted. These findings link the lateral distribution of the molecular species of phospholipids to the formation of functional segments in the plasma membrane of neurons and to the mechanism of protein confinement at the synapse.	[Kuge, Hideaki; Akahori, Kana; Honke, Koichi] Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan; [Kuge, Hideaki; Honke, Koichi] Kochi Univ, Sch Med, Ctr Innovate & Translat Med, Nankoku, Kochi 7838505, Japan; [Yagyu, Ken-ichi] Kochi Univ, Sch Med, Ctr Sci Res, Nankoku, Kochi 7838505, Japan	Kochi University; Kochi University; Kochi University	Kuge, H (corresponding author), Kochi Univ, Sch Med, Dept Biochem, Nankoku, Kochi 7838505, Japan.	kugeh@kochi-u.ac.jp; khonke@kochi-u.ac.jp		Kuge, Hideaki/0000-0001-6202-9202	CREST, Japan Science and Technology Agency	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by CREST, Japan Science and Technology Agency (to K. H.).	Al-Saad KA, 2003, J AM SOC MASS SPECTR, V14, P373, DOI 10.1016/S1044-0305(03)00068-0; [Anonymous], 2000, PRACT APPROACH SER; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chaurand P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.004259; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Cvacka J, 2003, RAPID COMMUN MASS SP, V17, P2203, DOI 10.1002/rcm.1178; Darrow AL, 2011, J LIPID RES, V52, P374, DOI 10.1194/jlr.D007971; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; Imae R, 2010, MOL BIOL CELL, V21, P3114, DOI 10.1091/mbc.E10-03-0195; Kadota T, 1996, J HISTOCHEM CYTOCHEM, V44, P989, DOI 10.1177/44.9.8773564; Kanamori T, 2008, EMBO J, V27, P1647, DOI 10.1038/emboj.2008.102; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; Rahman MS, 2010, J BACTERIOL, V192, P3294, DOI 10.1128/JB.00155-10; Richmond GS, 2011, INT J MOL SCI, V12, P588, DOI 10.3390/ijms12010588; Santiago-Tirado FH, 2011, TRENDS CELL BIOL, V21, P515, DOI 10.1016/j.tcb.2011.05.005; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; SUTHERLAND CA, 1982, J BIOL CHEM, V257, P4006; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; TAMAKI H, 1994, J HISTOCHEM CYTOCHEM, V42, P1285, DOI 10.1177/42.9.8064136; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Winckler B, 1996, NATURE, V379, P213, DOI 10.1038/379213a0; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	40	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26783	26793		10.1074/jbc.M114.571075	http://dx.doi.org/10.1074/jbc.M114.571075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096572	Green Published, hybrid			2022-12-25	WOS:000342853900011
J	Sarell, CJ; Karamanos, TK; White, SJ; Bunka, DHJ; Kalverda, AP; Thompson, GS; Barker, AM; Stockley, PG; Radford, SE				Sarell, Claire J.; Karamanos, Theodoros K.; White, Simon J.; Bunka, David H. J.; Kalverda, Arnout P.; Thompson, Gary S.; Barker, Amy M.; Stockley, Peter G.; Radford, Sheena E.			Distinguishing Closely Related Amyloid Precursors Using an RNA Aptamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-MICROGLOBULIN; PROTEIN; FIBRILS; BETA-2-MICROGLOBULIN; STATE; SELECTION; DNA; POLYMERIZATION; SPECIFICITY; AGGREGATION	Although amyloid fibrils assembled in vitro commonly involve a single protein, fibrils formed in vivo can contain multiple protein sequences. The amyloidogenic protein human beta(2)-microglobulin (h beta(2)m) can co-polymerize with its N-terminally truncated variant (Delta N6) in vitro to form hetero-polymeric fibrils that differ from their homo-polymeric counterparts. Discrimination between the different assembly precursors, for example by binding of a biomolecule to one species in a mixture of conformers, offers an opportunity to alter the course of co-assembly and the properties of the fibrils formed. Here, using h beta(2)m and its amyloidogenic counterpart, Delta N6, we describe selection of a 2'F-modified RNA aptamer able to distinguish between these very similar proteins. SELEX with a N30 RNA pool yielded an aptamer (B6) that binds h beta(2)m with an EC50 of similar to 200 nM. NMR spectroscopy was used to assign the H-1-N-15 HSQC spectrum of the B6-h beta(2)m complex, revealing that the aptamer binds to the face of h beta(2)m containing the A, B, E, and D beta-strands. In contrast, binding of B6 to Delta N6 is weak and less specific. Kinetic analysis of the effect of B6 on co-polymerization of h beta(2)m and Delta N6 revealed that the aptamer alters the kinetics of co-polymerization of the two proteins. The results reveal the potential of RNA aptamers as tools for elucidating the mechanisms of co-assembly in amyloid formation and as reagents able to discriminate between very similar protein conformers with different amyloid propensity.	[Stockley, Peter G.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Stockley, Peter G.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Stockley, PG (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	p.g.stockley@leeds.ac.uk; s.e.radford@leeds.ac.uk	Barker, Amy/ABF-5790-2021; White, Simon/AAC-5819-2019	Barker, Amy/0000-0003-1626-0934; White, Simon/0000-0002-9227-9461; Stockley, Peter/0000-0002-1360-2751; Radford, Sheena/0000-0002-3079-8039; Karamanos, Theodoros/0000-0003-2297-540X	Wellcome Trust [094232]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank members of our research groups for helpful discussion and comments. We also acknowledge The Wellcome Trust for funding the NMR facility (094232).	ADAMS CJ, 1994, TETRAHEDRON LETT, V35, P765, DOI 10.1016/S0040-4039(00)75812-6; Baker CM, 2007, BIOPOLYMERS, V85, P456, DOI 10.1002/bip.20682; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Bunka DHJ, 2007, J BIOL CHEM, V282, P34500, DOI 10.1074/jbc.M703679200; Bunka DHJ, 2010, CURR OPIN PHARMACOL, V10, P557, DOI 10.1016/j.coph.2010.06.009; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chen CHB, 2008, P NATL ACAD SCI USA, V105, P15908, DOI 10.1073/pnas.0808360105; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Debelouchina GT, 2010, J AM CHEM SOC, V132, P10414, DOI 10.1021/ja102775u; Diomede L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052314; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Eichner T, 2009, J MOL BIOL, V386, P1312, DOI 10.1016/j.jmb.2009.01.013; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Farrar CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089901; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Hodkinson JP, 2012, RAPID COMMUN MASS SP, V26, P1783, DOI 10.1002/rcm.6282; Huang YZ, 2012, MOL PHARMACOL, V82, P623, DOI 10.1124/mol.112.078220; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Kupce E, 2003, PROG NUCL MAG RES SP, V42, P95, DOI 10.1016/S0079-6565(03)00022-0; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P54; Lee CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400580; Leontovich AM, 2002, BIOINFORMATICS, V18, P838, DOI 10.1093/bioinformatics/18.6.838; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Marcovitz A, 2011, P NATL ACAD SCI USA, V108, P17957, DOI 10.1073/pnas.1109594108; Mashima T, 2013, NUCLEIC ACIDS RES, V41, P1355, DOI 10.1093/nar/gks1132; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Montagna G, 2013, AMYLOID, V20, P173, DOI 10.3109/13506129.2013.803463; MURRAY JB, 1994, ANAL BIOCHEM, V218, P177, DOI 10.1006/abio.1994.1157; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Padilla R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf138; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; Rahimi F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007694; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Rhie A, 2003, J BIOL CHEM, V278, P39697, DOI 10.1074/jbc.M305297200; Rockey WM, 2011, BIOORGAN MED CHEM, V19, P4080, DOI 10.1016/j.bmc.2011.05.010; Sakata M, 2008, J MOL BIOL, V382, P1242, DOI 10.1016/j.jmb.2008.08.003; Sarell CJ, 2013, J BIOL CHEM, V288, P7327, DOI 10.1074/jbc.M112.447524; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Su YC, 2014, J AM CHEM SOC, V136, P6313, DOI 10.1021/ja4126092; Takahashi T, 2009, MOL BIOSYST, V5, P986, DOI 10.1039/b903391b; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zhou JH, 2009, NUCLEIC ACIDS RES, V37, P3094, DOI 10.1093/nar/gkp185; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	66	5	5	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26859	26871		10.1074/jbc.M114.595066	http://dx.doi.org/10.1074/jbc.M114.595066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100729	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000342853900017
J	Chu, LL; Huo, YD; Liu, X; Yao, P; Thomas, K; Jiang, H; Zhu, TG; Zhang, GL; Chaudhry, M; Adams, G; Thompson, W; Dou, Z; Jin, CJ; He, P; Yao, XB				Chu, Lingluo; Huo, Yuda; Liu, Xing; Yao, Phil; Thomas, Kelwyn; Jiang, Hao; Zhu, Tongge; Zhang, Guanglan; Chaudhry, Maryam; Adams, Gregory; Thompson, Winston; Dou, Zhen; Jin, Changjiang; He, Ping; Yao, Xuebiao			The Spatiotemporal Dynamics of Chromatin Protein HP1 alpha Is Essential for Accurate Chromosome Segregation during Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B; HISTONE H3; HETEROCHROMATIN PROTEIN-1; KINETOCHORE PROTEIN; MITOTIC CHECKPOINT; OUTER KINETOCHORE; INNER CENTROMERE; DNA-DAMAGE; HP1; PHOSPHORYLATION	Heterochromatin protein 1 alpha (HP1 alpha) is involved in regulation of chromatin plasticity, DNA damage repair, and centromere dynamics. HP1 alpha detects histone dimethylation and trimethylation of Lys-9 via its chromodomain. HP1 alpha localizes to heterochromatin in interphase cells but is liberated from chromosomal arms at the onset of mitosis. However, the structural determinants required for HP1 alpha localization in interphase and the regulation of HP1 alpha dynamics have remained elusive. Here we show that centromeric localization of HP1 alpha depends on histone H3 Lys-9 trimethyltransferase SUV39H1 activity in interphase but not in mitotic cells. Surprisingly, HP1 alpha liberates from chromosome arms in early mitosis. To test the role of this dissociation, we engineered an HP1 alpha construct that persistently localizes to chromosome arms. Interestingly, persistent localization of HP1 alpha to chromosome arms perturbs accurate kinetochore-microtubule attachment due to an aberrant distribution of chromosome passenger complex and Sgo1 from centromeres to chromosome arms that prevents resolution of sister chromatids. Further analyses showed that Mis14 and perhaps other PXVXL-containing proteins are involved in directing localization of HP1 alpha to the centromere in mitosis. Taken together, our data suggest a model in which spatiotemporal dynamics of HP1 alpha localization to centromere is governed by two distinct structural determinants. These findings reveal a previously unrecognized but essential link between HP1 alpha-interacting molecular dynamics and chromosome plasticity in promoting accurate cell division.	[Chu, Lingluo; Huo, Yuda; Liu, Xing; Jiang, Hao; Zhu, Tongge; Adams, Gregory; Dou, Zhen; Jin, Changjiang; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China; [Chu, Lingluo; Huo, Yuda; Liu, Xing; Jiang, Hao; Zhu, Tongge; Adams, Gregory; Dou, Zhen; Jin, Changjiang; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Xing; Yao, Phil; Zhu, Tongge; Chaudhry, Maryam; Adams, Gregory; Thompson, Winston; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Thomas, Kelwyn] Morehouse Sch Med, Dept Neurobiol, Atlanta, GA 30310 USA; [Zhang, Guanglan; He, Ping] Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China; [Yao, Phil] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Morehouse School of Medicine; Morehouse School of Medicine; University System of Georgia; University of Georgia	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China.	heping-20088@163.com; yaoxb@ustc.edu.cn	DOU, ZHEN/N-2022-2013; Liu, Xing/H-2989-2018; Yao, Xuebiao/P-5771-2014	Liu, Xing/0000-0002-7480-5085; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, G12RR03034]; Chinese 973 Project [2012CB917204, 2013CB911203, 2014CB964803]; Anhui Province Key Project [08040102005]; International Collaboration Grant [31320103904]; Chinese Natural Science Foundation [31171300, 31301120, 91313303, 31301121, 31301105, 31371363, 81270466, 90913016, MOE20113402130010]; Fundamental Research Funds for Central Universities [WK2060190018]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, and G12RR03034. This work was also supported by Chinese 973 Project Grants 2012CB917204, 2013CB911203, and 2014CB964803; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 31320103904; Chinese Natural Science Foundation Grants 31171300, 31301120, 91313303, 31301121, 31301105, 31371363, 81270466, 90913016, and MOE20113402130010; and Fundamental Research Funds for Central Universities Grant WK2060190018.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Al-Sady B, 2013, MOL CELL, V51, P80, DOI 10.1016/j.molcel.2013.06.013; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Ball AR, 2009, J CELL BIOL, V185, P573, DOI 10.1083/jcb.200904033; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Canzio D, 2013, NATURE, V496, P377, DOI 10.1038/nature12032; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fu GS, 2007, CELL RES, V17, P608, DOI 10.1038/cr.2007.55; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hayakawa T, 2003, J CELL SCI, V116, P3327, DOI 10.1242/jcs.00635; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Inoue A, 2008, MUTAT RES-GEN TOX EN, V657, P48, DOI 10.1016/j.mrgentox.2008.08.010; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Juang BT, 2013, CELL, V154, P1010, DOI 10.1016/j.cell.2013.08.006; Kang J, 2011, MOL BIOL CELL, V22, P1181, DOI 10.1091/mbc.E11-01-0009; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Kwon SH, 2010, GENE DEV, V24, P2133, DOI 10.1101/gad.1959110; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu X, 2014, J BIOL CHEM, V289, P20638, DOI 10.1074/jbc.M114.572842; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Studencka M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002940; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340	49	10	10	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26249	26262		10.1074/jbc.M114.581504	http://dx.doi.org/10.1074/jbc.M114.581504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104354	Green Published, hybrid			2022-12-25	WOS:000342128800020
J	Oleinik, NV; Helke, KL; Kistner-Griffin, E; Krupenko, NI; Krupenko, SA				Oleinik, Natalia V.; Helke, Kristi L.; Kistner-Griffin, Emily; Krupenko, Natalia I.; Krupenko, Sergey A.			Rho GTPases RhoA and Rac1 Mediate Effects of Dietary Folate on Metastatic Potential of A549 Cancer Cells through the Control of Cofilin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLIC-ACID SUPPLEMENTATION; MIGRATION; ACTIVATION; GENE; METHYLATION; DEFICIENCY; INVASION; REORGANIZATION; METABOLISM; INSIGHTS	Folate, an important nutrient in the human diet, has been implicated in cancer, but its role in metastasis is not established. We have shown previously that the withdrawal of medium folate leads to the inhibition of migration and invasion of A549 lung carcinoma cells. Here we have demonstrated that medium folate regulates the function of Rho GTPases by enabling their carboxyl methylation and translocation to plasma membrane. Conversely, the lack of folate leads to the retention of these proteins in endoplasmic reticulum. Folate also promoted the switch from inactive (GDP-bound) to active (GTP-bound) GTPases, resulting in the activation of downstream kinases p21-activated kinase and LIM kinase and phosphorylation of the actin-depolymerizing factor cofilin. We have further demonstrated that in A549 cells two GTPases, RhoA and Rac1, but not Cdc42, are immediate sensors of folate status: the siRNA silencing of RhoA or Rac1 blocked effects of folate on cofilin phosphorylation and cellular migration and invasion. The finding that folate modulates metastatic potential of cancer cells was confirmed in an animal model of lung cancer using tail vein injection of A549 cells in SCID mice. A folate-rich diet enhanced lung colonization and distant metastasis to lymph nodes and decreased overall survival (35 versus 63 days for mice on a folate-restricted diet). High folate also promoted epithelial-mesenchymal transition in cancer cells and experimental mouse tumors. Our study provides experimental evidence for a mechanism of metastasis promotion by dietary folate and highlights the interaction between nutrients and metastasis-related signaling.	[Oleinik, Natalia V.; Krupenko, Natalia I.; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Helke, Kristi L.] Med Univ S Carolina, Charleston, SC 29425 USA; [Kistner-Griffin, Emily; Krupenko, Natalia I.; Krupenko, Sergey A.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Krupenko, SA (corresponding author), Univ N Carolina, Dept Nutr, UNC Nutr Res Inst, 500 Laureate Way, Kannapolis, NC 28081 USA.	sergey_krupenko@unc.edu		Helke, Kris/0000-0001-9746-0764	National Institutes of Health Cancer Center Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA095030, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. Philips and Matsuda for providing corresponding plasmids. The Cell and Molecular Imaging Core Facility was supported in part by National Institutes of Health Cancer Center Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina.	Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Baggott JE, 2012, CANCER EPIDEMIOL, V36, P78, DOI 10.1016/j.canep.2011.05.003; BALAGHI M, 1995, AM J CLIN NUTR, V61, P90, DOI 10.1093/ajcn/61.1.90; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BUNNI MA, 1991, ARCH BIOCHEM BIOPHYS, V286, P633, DOI 10.1016/0003-9861(91)90092-W; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069389; Collazo J, 2014, CANCER RES, V74, P2362, DOI 10.1158/0008-5472.CAN-13-3058; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Garcia-Rodriguez S, 2003, FREE RADICAL BIO MED, V35, P428, DOI 10.1016/S0891-5849(03)00321-6; Goldman ID, 2010, CURR OPIN INVEST DR, V11, P1409; Gungabissoon RA, 2003, J HISTOCHEM CYTOCHEM, V51, P411, DOI 10.1177/002215540305100402; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Hou TC, 2013, BIOCHEM PHARMACOL, V85, P376, DOI 10.1016/j.bcp.2012.11.011; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kocher B, 2013, CANCER DISCOV, V3, P616, DOI 10.1158/2159-8290.CD-12-0503; Krupenko NI, 2010, J BIOL CHEM, V285, P23054, DOI 10.1074/jbc.M110.128843; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Lucock M, 2009, CURR OPIN CLIN NUTR, V12, P555, DOI 10.1097/MCO.0b013e32833192bc; Meadows GG, 2012, CANCER METAST REV, V31, P441, DOI 10.1007/s10555-012-9369-5; Molloy Anne M, 2012, Subcell Biochem, V56, P105, DOI 10.1007/978-94-007-2199-9_7; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Oleinik NV, 2006, BIOCHEM PHARMACOL, V72, P256, DOI 10.1016/j.bcp.2006.04.005; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Peris B, 2012, J NEUROCHEM, V121, P903, DOI 10.1111/j.1471-4159.2012.07733.x; Pogribny IP, 2002, CANCER LETT, V187, P69, DOI 10.1016/S0304-3835(02)00408-1; Reece RJ, 2006, BIOCHEM SOC SYMP, V73, P85; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ross S. A., 2010, Experimental Oncology, V32, P137; Salem S, 2012, BRIT J PHARMACOL, V166, P2036, DOI 10.1111/j.1476-5381.2012.01885.x; SCHMITZ JC, 1994, BIOCHEM PHARMACOL, V48, P319, DOI 10.1016/0006-2952(94)90103-1; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Siu MKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047201; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Steinestel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065189; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561; TERZIS AJA, 1993, INT J CANCER, V54, P112, DOI 10.1002/ijc.2910540118; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Wang TP, 2012, CARCINOGENESIS, V33, P1158, DOI 10.1093/carcin/bgs138; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2003, P NATL ACAD SCI USA, V100, P6529, DOI 10.1073/pnas.1135239100; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019	66	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26383	26394		10.1074/jbc.M114.569657	http://dx.doi.org/10.1074/jbc.M114.569657			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086046	Green Published, hybrid			2022-12-25	WOS:000342128800030
J	Shimizu, Y; Nishitsuji, H; Marusawa, H; Ujino, S; Takaku, H; Shimotohno, K				Shimizu, Yuko; Nishitsuji, Hironori; Marusawa, Hiroyuki; Ujino, Saneyuki; Takaku, Hiroshi; Shimotohno, Kunitada			The RNA-editing Enzyme APOBEC1 Requires Heterogeneous Nuclear Ribonucleoprotein Q Isoform 6 for Efficient Interaction with Interleukin-8 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; APO-B; COMPLEMENTATION FACTOR; MOLECULAR-CLONING; GRY-RBP; DEMETHYLATION; INVOLVEMENT; EXPRESSION; CARCINOMA; COMPONENT	Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 1 (APOBEC1) is an intestine-specific RNA-binding protein. However, inflammation or exposure to DNA-damaging agents can induce ectopic APOBEC1 expression, which can result in hepatocellular hyperplasia in animal models. To identify its RNA targets, FLAG-tagged APOBEC1 was immunoprecipitated from transfected HuH7.5 hepatocellular carcinoma cells and analyzed using DNA microarrays. The interleukin-8 (IL8) mRNA was the most abundant co-precipitated RNA. Exogenous APOBEC1 expression increased IL8 production by extending the half-life of the IL8 mRNA. A cluster of AU-rich elements in the 3'-UTR of IL8 was essential to the APOBEC1-mediated increase in IL8 production. Notably, IL8 mRNA did not co-immunoprecipitate with APOBEC1 from lysates of other cell types at appreciable levels; therefore, other factors may enhance the association between APOBEC1 and IL8 mRNA in a cell type-specific manner. A yeast two-hybrid analysis and siRNA screen were used to identify proteins that enhance the interaction between APOBEC1 and IL8 mRNA. Heterogeneous nuclear ribonucleoprotein Q(hnRNPQ) was essential to the APOBEC1/IL8 mRNA association in HuH7.5 cells. Of the seven hnRNPQ isoforms, only hnRNPQ6 enabled APOBEC1 to bind to IL8 mRNA when overexpressed in HEK293 cells, which expressed the lowest level of endogenous hnRNPQ6 among the cell types examined. The results of a reporter assay using a luciferase gene fused to the IL8 3'-UTR were consistent with the hypothesis that hnRNPQ6 is required for APOBEC1-enhanced IL8 production. Collectively, these data indicate that hnRNPQ6 promotes the interaction of APOBEC1 with IL8 mRNA and the subsequent increase in IL8 production.	[Shimizu, Yuko; Nishitsuji, Hironori; Ujino, Saneyuki; Shimotohno, Kunitada] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba 2728516, Japan; [Marusawa, Hiroyuki] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan	National Center for Global Health & Medicine - Japan; Kyoto University; Chiba Institute of Technology	Shimizu, Y (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai, Ichikawa, Chiba 2728516, Japan.	lbshimizuyk@hospk.ncgm.go.jp		Marusawa, Hiroyuki/0000-0002-4286-2712	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology; MEXT	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Health, Labor, and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology. This work was also supported in part by the MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2011-2015.	Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Anant S, 2004, GASTROENTEROLOGY, V127, P1139, DOI 10.1053/j.gastro.2004.06.022; Anant S, 2001, J BIOL CHEM, V276, P47338, DOI 10.1074/jbc.M104911200; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Ashur-Fabian O, 2010, CELL CYCLE, V9, P3761, DOI 10.4161/cc.9.18.12993; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Cappione AJ, 1997, AM J HUM GENET, V60, P305; Chen XJ, 2013, EUR REV MED PHARMACO, V17, P2949; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Greeve J, 1999, ONCOGENE, V18, P6357, DOI 10.1038/sj.onc.1203039; GREEVE J, 1993, J LIPID RES, V34, P1367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Lau PP, 2003, J BIOL CHEM, V278, P52988, DOI 10.1074/jbc.M310153200; Lau PP, 1997, J BIOL CHEM, V272, P1452, DOI 10.1074/jbc.272.3.1452; Lau PP, 2001, BIOCHEM BIOPH RES CO, V282, P977, DOI 10.1006/bbrc.2001.4679; Lau PP, 2001, J BIOL CHEM, V276, P46445, DOI 10.1074/jbc.M109215200; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Morrison JR, 1996, P NATL ACAD SCI USA, V93, P7154, DOI 10.1073/pnas.93.14.7154; Quaresma AJC, 2006, BIOCHEM BIOPH RES CO, V350, P288, DOI 10.1016/j.bbrc.2006.09.044; Ravet K, 2012, EMBO J, V31, P175, DOI 10.1038/emboj.2011.341; Richardson N, 1998, J BIOL CHEM, V273, P31707, DOI 10.1074/jbc.273.48.31707; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; SHAH RR, 1991, J BIOL CHEM, V266, P16301; Valdmanis PN, 2015, ONCOGENE, V34, P94, DOI 10.1038/onc.2013.523; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321	28	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26226	26238		10.1074/jbc.M114.563221	http://dx.doi.org/10.1074/jbc.M114.563221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100733	Green Published, hybrid			2022-12-25	WOS:000342128800018
J	Diez, MDA; Aleanzi, MC; Iglesias, AA; Ballicora, MA				Asencion Diez, Matias D.; Aleanzi, Mabel C.; Iglesias, Alberto A.; Ballicora, Miguel A.			A Novel Dual Allosteric Activation Mechanism of Escherichia coli ADP-Glucose Pyrophosphorylase: The Role of Pyruvate	PLOS ONE			English	Article							N-TERMINAL REGION; BACTERIAL GLYCOGEN; AGROBACTERIUM-TUMEFACIENS; BINDING-SITE; SCANNING MUTAGENESIS; REGULATORY ENZYME; BIOSYNTHESIS; INHIBITION; SYNTHASE; IDENTIFICATION	Fructose-1,6-bisphosphate activates ADP-glucose pyrophosphorylase and the synthesis of glycogen in Escherichia coli. Here, we show that although pyruvate is a weak activator by itself, it synergically enhances the fructose-1,6-bisphosphate activation. They increase the enzyme affinity for each other, and the combination increases V-max, substrate apparent affinity, and decreases AMP inhibition. Our results indicate that there are two distinct interacting allosteric sites for activation. Hence, pyruvate modulates E. coli glycogen metabolism by orchestrating a functional network of allosteric regulators. We postulate that this novel dual activator mechanism increases the evolvability of ADP-glucose pyrophosphorylase and its related metabolic control.	[Asencion Diez, Matias D.; Ballicora, Miguel A.] Loyola Univ, Dept Chem, Chicago, IL 60626 USA; [Asencion Diez, Matias D.; Aleanzi, Mabel C.; Iglesias, Alberto A.] UNL, CONICET, Inst Agrobiotecnol Litoral, Lab Enzimol Mol, Santa Fe, Argentina	Loyola University Chicago; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral	Ballicora, MA (corresponding author), Loyola Univ, Dept Chem, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	mballic@luc.edu		Ballicora, Miguel/0000-0002-5324-0724; Asencion Diez, Matias Damian/0000-0001-6495-387X; Iglesias, Alberto/0000-0001-9729-7338	CONICET [PIP 112-201101-00438]; UNL [CAI+D'11]; ANPCyT [PICT'12 2439]; National Science Foundation [MCB 1024945]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNL; ANPCyT(ANPCyT); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants to AAI from CONICET [PIP 112-201101-00438 and external collaboration], UNL [CAI+D'11 and Orientado], and ANPCyT [PICT'12 2439]; and to MAB from the National Science Foundation [MCB 1024945]. MDAD is Post-Doctoral Fellow from CONICET. AAI is Principal Investigator from the same Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diez MDA, 2013, MOL MICROBIOL, V90, P1011, DOI 10.1111/mmi.12413; Diez MDA, 2013, INT J MOL SCI, V14, P9703, DOI 10.3390/ijms14059703; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Ballicora MA, 2007, J BACTERIOL, V189, P5325, DOI 10.1128/JB.00481-07; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; EIDELS L, 1970, ARCH BIOCHEM BIOPHYS, V140, P60, DOI 10.1016/0003-9861(70)90010-X; Figueroa CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066824; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; FURLONG CE, 1969, J BIOL CHEM, V244, P2539; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gomez-Casati DF, 2001, BIOCHEMISTRY-US, V40, P10169, DOI 10.1021/bi002615e; Hill MA, 1998, BIOCHEM BIOPH RES CO, V244, P573, DOI 10.1006/bbrc.1998.8301; Iglesias A.A., 1992, BIOCHEM EDUC, V20, P196, DOI 10.1016/0307-4412(92)90191-N; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kuhn ML, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-51; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Machtey M, 2012, J BACTERIOL, V194, P6056, DOI 10.1128/JB.00810-12; PARSONS TF, 1978, J BIOL CHEM, V253, P7638; PARSONS TF, 1978, J BIOL CHEM, V253, P6197; PREISS J, 1966, BIOCHEMISTRY-US, V5, P1833, DOI 10.1021/bi00870a008; PREISS J, 1965, BIOCHEM BIOPH RES CO, V18, P180, DOI 10.1016/0006-291X(65)90737-0; Preiss J, 1996, Biotechnol Annu Rev, V2, P259, DOI 10.1016/S1387-2656(08)70013-9; PREISS J, 1989, ADV MICROB PHYSIOL, V30, P183; Sheng J, 1996, BIOCHEMISTRY-US, V35, P3115, DOI 10.1021/bi952359j; Uttaro AD, 1998, ARCH BIOCHEM BIOPHYS, V357, P13, DOI 10.1006/abbi.1998.0786; Wu MX, 2001, ARCH BIOCHEM BIOPHYS, V389, P159, DOI 10.1006/abbi.2001.2327; Wu MX, 1998, ARCH BIOCHEM BIOPHYS, V358, P182, DOI 10.1006/abbi.1998.0846; Yang YT, 2001, METAB ENG, V3, P115, DOI 10.1006/mben.2000.0166	36	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103888	10.1371/journal.pone.0103888	http://dx.doi.org/10.1371/journal.pone.0103888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102309	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900028
J	Darsalia, V; Hua, S; Larsson, M; Mallard, C; Nathanson, D; Nystrom, T; Sjoholm, A; Johansson, ME; Patrone, C				Darsalia, Vladimer; Hua, Sansan; Larsson, Martin; Mallard, Carina; Nathanson, David; Nystroem, Thomas; Sjoeholm, Ake; Johansson, Maria E.; Patrone, Cesare			Exendin-4 Reduces Ischemic Brain Injury in Normal and Aged Type 2 Diabetic Mice and Promotes Microglial M2 Polarization	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CEREBRAL-ISCHEMIA; RECEPTOR STIMULATION; STROKE; NEUROPROTECTION; INFARCTION; MECHANISM; FAILURE; MOUSE	Exendin-4 is a glucagon-like receptor 1 agonist clinically used against type 2 diabetes that has also shown neuroprotective effects in experimental stroke models. However, while the neuroprotective efficacy of Exendin-4 has been thoroughly investigated if the pharmacological treatment starts before stroke, the therapeutic potential of the Exendin-4 if the treatment starts acutely after stroke has not been clearly determined. Further, a comparison of the neuroprotective efficacy in normal and aged diabetic mice has not been performed. Finally, the cellular mechanisms behind the efficacy of Exendin-4 have been only partially studied. The main objective of this study was to determine the neuroprotective efficacy of Exendin4 in normal and aged type 2 diabetic mice if the treatment started after stroke in a clinically relevant setting. Furthermore we characterized the Exendin-4 effects on stroke-induced neuroinflammation. Two-month-old healthy and 14-month-old type 2 diabetic/obese mice were subjected to middle cerebral artery occlusion. 5 or 50 mg/kg Exendin-4 was administered intraperitoneally at 1.5, 3 or 4.5 hours thereafter. The treatment was continued (0.2 mg/kg/day) for 1 week. The neuroprotective efficacy was assessed by stroke volume measurement and stereological counting of NeuN-positive neurons. Neuroinflammation was determined by gene expression analysis of M1/M2 microglia subtypes and proinflammatory cytokines. We show neuroprotective efficacy of 50 mg/kg Exendin-4 at 1.5 and 3 hours after stroke in both young healthy and aged diabetic/obese mice. The 5 mu g/kg dose was neuroprotective at 1.5 hour only. Proinflammatory markers and M1 phenotype were not impacted by Exendin-4 treatment while M2 markers were significantly up regulated. Our results support the use of Exendin-4 to reduce stroke-damage in the prehospital/early hospitalization setting irrespectively of age/diabetes. The results indicate the polarization of microglia/macrophages towards the M2 reparative phenotype as a potential mechanism of neuroprotection.	[Darsalia, Vladimer; Larsson, Martin; Nathanson, David; Nystroem, Thomas; Patrone, Cesare] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hua, Sansan; Mallard, Carina; Johansson, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Sjoeholm, Ake] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Sjoeholm, Ake] Sodertalje Hosp, Diabet Res Unit, Dept Internal Med, Sodertalje, Sweden	Karolinska Institutet; University of Gothenburg; University of South Alabama	Darsalia, V (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	vladimer.darsalia@ki.se; cesare.patrone@ki.se	Larsson, Martin/C-2314-2017; Darsalia, Vladimer/AAF-3608-2019	Larsson, Martin/0000-0002-3226-7397; Mallard, Carina/0000-0001-8953-919X; Darsalia, Vladimer/0000-0002-6693-934X; Johansson, Maria/0000-0002-2569-2977	Novo Nordisk foundation [5421]; Diabetesfonden [DIA2013-010]; European foundation [94174]; AFA Insurance [110067]; Diabetes Research and Wellness Foundation [0245/2010W]; Swedish Heart and Lung Foundation [20130523]; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Research Council; Swedish Society of Medicine; foundation Bergvalls; Syskonen Svensson; Thuring; Lagerman; Osterman; Stohne; Alen; STROKE Riksforbundet; Tornspiran; Gamla Tjanarinnor	Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Diabetesfonden; European foundation(European Science Foundation (ESF)); AFA Insurance; Diabetes Research and Wellness Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; foundation Bergvalls; Syskonen Svensson; Thuring; Lagerman; Osterman; Stohne; Alen; STROKE Riksforbundet; Tornspiran; Gamla Tjanarinnor	This study was supported by 1) Novo Nordisk foundation [Grant number 5421]. http://www.novonordiskfonden.dk/en/grantrecipients? field_date_ value%5Bvalue%5D&field_date_value_1%5Bvalue%5D&field_related_center_tid=All&keys=&page=1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.2) Diabetesfonden [Grant number DIA2013-010]. http://www.diabetesfonden.se/Forskning/Beviljade-projekt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.3) European foundation for the study of diabetes [( EFSD/Lilly European Diabetes Research Programme) grant number: 94174]. www.EuropeanDiabetesFoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.4) AFA Insurance [grant number 110067]. http://www.afaforsakring.se/Forskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.5) Diabetes Research and Wellness Foundation [grant number 0245/2010W]. http://diabeteswellness.se/Research/2010%C3%A5rsforskningsanslag/tabid/841/language/en-US/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.6) the Swedish Heart and Lung Foundation [grant number: 20130523. http://www.hjart-lungfonden.se/Forskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.7) This work has also been supported by grants from: Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, The Swedish Research Council, the Swedish Society of Medicine and by the foundations Bergvalls, Syskonen Svensson, Thuring, Lagerman, Osterman, Stohne, Alen, STROKE Riksforbundet, Tornspiran, Gamla Tjanarinnor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Brott T, 1997, STROKE, V28, P1530, DOI 10.1161/01.STR.28.8.1530; Darsalia V, 2012, CLIN SCI, V122, P473, DOI 10.1042/CS20110374; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; HAMILTON A, 2009, NEUROREPORT; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Holscher C., 2013, J ENDOCRINOL; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Johnson SC, 2005, NEUROLOGY, V64, P654; Karapanayiotides T, 2004, NEUROLOGY, V62, P1558, DOI 10.1212/01.WNL.0000123252.55688.05; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lansberg MG, 2009, STROKE, V40, P2438, DOI 10.1161/STROKEAHA.109.552547; Lee CH, 2011, J NEUROSCI RES, V89, P1103, DOI 10.1002/jnr.22596; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Manning NW, 2014, STROKE, V45, P640, DOI 10.1161/STROKEAHA.113.003798; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Rother J, 2008, STROKE, V39, P523, DOI 10.1161/STROKEAHA.107.494799; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Sander D, 2009, J NEUROL, V256, P1603, DOI 10.1007/s00415-009-5143-1; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Shichita T, 2012, J NEUROCHEM, V123, P29, DOI 10.1111/j.1471-4159.2012.07941.x; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; Steiner I, 2008, J NEUROL SCI, V267, P187, DOI 10.1016/j.jns.2007.10.021; Stridh L, 2013, J NEUROSCI, V33, P12041, DOI 10.1523/JNEUROSCI.0673-13.2013; Teramoto S., 2011, J CEREB BLOOD FLOW M; Turner RC, 2013, J NEUROSURG, V118, P1072, DOI 10.3171/2012.11.JNS12408; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808	40	70	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103114	10.1371/journal.pone.0103114	http://dx.doi.org/10.1371/journal.pone.0103114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101679	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993900014
J	Heredia-Pi, I; Servan-Mori, EE; Wirtz, VJ; Avila-Burgos, L; Lozano, R				Heredia-Pi, Ileana; Servan-Mori, Edson E.; Wirtz, Veronika J.; Avila-Burgos, Leticia; Lozano, Rafael			Obstetric Care and Method of Delivery in Mexico: Results from the 2012 National Health and Nutrition Survey	PLOS ONE			English	Article							CESAREAN-SECTION RATE; RATES; PREGNANCY; PHYSICIANS; SERVICES; TRENDS; CHILE; WOMEN; LABOR	Objective: To identify the current clinical, socio-demographic and obstetric factors associated with the various types of delivery strategies in Mexico. Materials and Methods: This is a cross-sectional study based on the 2012 National Health and Nutrition Survey (ENSANUT) of 6,736 women aged 12 to 49 years. Delivery types discussed in this paper include vaginal delivery, emergency cesarean section and planned cesarean section. Using bivariate analyses, sub-population group differences were identified. Logistic regression models were applied, including both binary and multinomial outcome variables from the survey. The logistic regression results identify those covariates associated with the type of delivery. Results: 53.1% of institutional births in the period 2006 through 2012 were vaginal deliveries, 46.9% were either a planned or emergency cesarean sections. The highest rates of this procedure were among women who reported a complication during delivery (OR: 4.21; 95%CI: 3.66-4.84), between the ages of 35 and 49 at the time of their last child birth (OR: 2.54; 95%CI: 2.02-3.20) and women receiving care through private healthcare providers during delivery (OR: 2.36; 95%CI: 1.84-3.03). Conclusions: The existence of different socio-demographic and obstetric profiles among women who receive care for vaginal or cesarean delivery, are supported by the findings of the present study. The frequency of vaginal delivery is higher in indigenous women, when the care provider is public and, in women with two or more children at time of the most recent child birth. Planned cesarean deliveries are positively associated with years of schooling, a higher socioeconomic level, and higher age. The occurrence of emergency cesarean sections is elevated in women with a diagnosis of a health issue during pregnancy or delivery, and it is reduced in highly marginalized settings.	[Heredia-Pi, Ileana; Servan-Mori, Edson E.; Avila-Burgos, Leticia; Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Wirtz, Veronika J.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Lozano, Rafael] Inst Hlth Metr & Evaluat, Seattle, WA USA	Instituto Nacional de Salud Publica; Boston University; Institute for Health Metrics & Evaluation	Servan-Mori, EE (corresponding author), Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.	eservan@insp.mx	Wirtz, Veornika/AAG-9712-2019; Avila-Burgos, Leticia/AAR-1815-2021; Lozano, Rafael/T-5352-2018; Heredia-Pi, Ileana Beatriz/L-4247-2019	Lozano, Rafael/0000-0002-7356-8823; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Wirtz, Veronika J./0000-0002-0863-8768; Servan-Mori, Edson/0000-0001-9820-8325				Abenhaim HA, 2011, J OBSTET GYNAECOL CA, V33, P443, DOI 10.1016/S1701-2163(16)34876-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], IND 2011; Atout MM, 2012, CANADIAN J SCI IND R, V3, P179; Badakhsh MH, 2012, ARCH IRAN MED, V15, P4, DOI 012151/AIM.004; Brown CJ, 2005, HEALTH POLICY, V72, P81, DOI 10.1016/j.healthpol.2004.06.008; Cameron AC, 2010, MICROECONOMETRICS US, P448; Campero L, 2007, SALUD PUBLICA MEXICO, V49, P118, DOI 10.1590/S0036-36342007000200007; Chalmers B, 2001, BIRTH-ISS PERINAT C, V28, P202, DOI 10.1046/j.1523-536x.2001.00202.x; Chigbu CO, 2008, INT J GYNECOL OBSTET, V103, P158, DOI 10.1016/j.ijgo.2008.06.006; Comision Nacional para el Desarrollo de los Pueblos Indigenas (CDI), 2009, HOG POBL IND; Consejo Nacional de Poblacion (CONAPO), IND MARG LOC; Cragin L, 2007, REPROD HEALTH MATTER, V15, P50, DOI 10.1016/S0968-8080(07)30332-7; D'Orsi Eleonora, 2006, Cad. Saúde Pública, V22, P2067, DOI 10.1590/S0102-311X2006001000012; DeMaria LM, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-6; Dodd JM, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004224.pub2, DOI 10.1002/14651858.CD004224.PUB2]; Fondo de las Naciones Unidas para la Infancia (UNICEF), 2012, EST MUND INF 2012 NI; Freitas PF, 1999, THESIS LONDON SCH HY; Glei DA, 2003, SOC SCI MED, V57, P2447, DOI 10.1016/S0277-9536(03)00140-0; Gonzalez Perez G J, 2001, HLTH POLICY PLAN, V16, P62; Gonzalez Perez GJ, 1996, J EPIDEMIOL COMMUNIT, V52, P226; Gonzalez Perez GJ, 2011, CESAREAS MEXICO ASPE; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Gyimah SO, 2006, SOC SCI MED, V62, P2930, DOI 10.1016/j.socscimed.2005.11.034; Hamilton Brady E, 2010, Natl Vital Stat Rep, V59, P1; Heredia-Pi I, 2013, SALUD PUBLICA MEXICO, V55, pS249; Hong X, 2007, TOHOKU J EXP MED, V212, P283, DOI 10.1620/tjem.212.283; Hosmer D, 2000, WILEY SERIES PROBABI, P260; Instituto Nacional de Estadistica y Geografia, 2010, ENC NAC DIN DEM 2009; LOCALIO AR, 1993, JAMA-J AM MED ASSOC, V269, P366, DOI 10.1001/jama.269.3.366; Lopez-Cevallos DF, 2010, HEALTH POLICY PLANN, V25, P209, DOI 10.1093/heapol/czp052; Main EK, 2011, CESAREAN DELIVERIES; Patah LEM, 2011, REV SAUDE PUBL, V45, P185, DOI 10.1590/S0034-89102011000100021; Murray SF, 1997, BIRTH-ISS PERINAT C, V24, P258, DOI 10.1111/j.1523-536X.1997.tb00600.x; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; Puentes Rosas E, 2004, SALUD PUBLICA MEXICO, V46, P16; Sahn DE, 2003, OXFORD B ECON STAT, V65, P241, DOI 10.1111/1468-0084.t01-2-00046; Stanton C., 2008, B WHO, V86; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Stata Corp. LP, 2011, STAT SE 12 1 WIND XP; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Suarez L, 2013, ELEVADA RECURRENCIA; Valdivia M, 2002, HEALTH POLICY PLANN, V17, P12, DOI 10.1093/heapol/17.suppl_1.12; Velasco Murillo Vitelio, 1997, Revista Medica del Instituto Mexicano del Seguro Social, V35, P207; Villanueva-Egan LA, 2004, REV FAC MED UNAM, V47, P246; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Vimercati A, 2000, J PERINAT MED, V28, P111, DOI 10.1515/JPM.2000.014; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Wolfe S, 2011, GUIDE AVOIDING UNNEC	50	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104166	10.1371/journal.pone.0104166	http://dx.doi.org/10.1371/journal.pone.0104166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SB	25101781	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900047
J	Liu, ZL; Liu, YP; Gao, R; Li, HX; Dunn, T; Wu, P; Smith, RG; Sarkar, PS; Fang, X				Liu, Zilong; Liu, Yongping; Gao, Rui; Li, Haixia; Dunn, Tiffany; Wu, Ping; Smith, Robert G.; Sarkar, Partha S.; Fang, Xiang			Ethanol Suppresses PGC-1 alpha Expression by Interfering with the cAMP-CREB Pathway in Neuronal Cells	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ENERGY-METABOLISM; OXIDATIVE STRESS; SKELETAL-MUSCLE; GROWTH-FACTORS; RECEPTOR; PROTEIN; BRAIN; NEURODEGENERATION; MODULATION	Alcohol intoxication results in neuronal apoptosis, neurodegeneration and manifest with impaired balance, loss of muscle coordination and behavioral changes. One of the early events of alcohol intoxication is mitochondrial (Mt) dysfunction and disruption of intracellular redox homeostasis. The mechanisms by which alcohol causes Mt dysfunction, disrupts cellular redox homeostasis and triggers neurodegeneration remains to be further investigated. Proliferator-activated receptor gamma co-activator 1-alpha (PGC-1 alpha) plays critical roles in regulating Mt biogenesis and respiration, cellular antioxidant defense mechanism, and maintenance of neuronal integrity and function. In this study, we sought to investigate whether alcohol causes Mt dysfunction and triggers neurodegeneration by suppressing PGC-1 alpha expression. We report that ethanol suppresses PGC-1 alpha expression, and impairs mitochondrial function and enhances cellular toxicity in cultured neuronal cell line and also in human fetal brain neural stem cell-derived primary neurons. Moreover, we report that cells over-expressing exogenous PGC-1 alpha or treated with Rolipram, a selective phosphodiesterase-4 inhibitor, ameliorate alcohol-induced cellular toxicity. Further analysis show that ethanol decreases steady-state intracellular cAMP levels, and thus depletes phosphorylation of cAMP-response element binding protein (p-CREB), the key transcription factor that regulates transcription of PGC-1 alpha gene. Accordingly, we found PGC-1 alpha promoter activity and transcription was dramatically repressed in neuronal cells when exposed to ethanol, suggesting that ethanol blunts cAMP -> CREB signaling pathway to interfere with the transcription of PGC-1 alpha. Ethanol-mediated decrease in PGC-1 alpha activity results in the disruption of Mt respiration and function and higher cellular toxicity. This study might lead to potential therapeutic intervention to ameliorate alcohol-induced apoptosis and/or neurodegeneration by targeting PGC-1 alpha.	[Liu, Zilong; Liu, Yongping; Gao, Rui; Smith, Robert G.; Sarkar, Partha S.; Fang, Xiang] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Li, Haixia] Univ Texas Med Branch, Dept Internal Med Gastroenterol, Galveston, TX 77555 USA; [Dunn, Tiffany; Wu, Ping; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Liu, Zilong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Huazhong University of Science & Technology	Fang, X (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.	xiang.fang01@gmail.com			NINDS grant [1K02NS081000-01A1]; University of Texas Medical Branch (UTMB) start-up fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS081000] Funding Source: NIH RePORTER	NINDS grant; University of Texas Medical Branch (UTMB) start-up fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NINDS grant 1K02NS081000-01A1), and University of Texas Medical Branch (UTMB) start-up fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADICKES ED, 1988, ALCOHOL ALCOHOLISM, V23, P377, DOI 10.1093/oxfordjournals.alcalc.a044832; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Aksenova MV, 2005, CURR NEUROVASC RES, V2, P73, DOI 10.2174/1567202052773463; Antonio AM, 2008, BRAIN RES, V1204, P16, DOI 10.1016/j.brainres.2008.02.018; Bailey SM, 1998, HEPATOLOGY, V28, P1318, DOI 10.1002/hep.510280521; Castillo-Quan JI, 2011, DIS MODEL MECH, V4, P427, DOI 10.1242/dmm.008227; Chaung WW, 2008, INT J CLIN EXP MED, V1, P161; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Echevarria DJ, 2011, REV NEUROSCIENCE, V22, P85, DOI 10.1515/RNS.2011.010; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Garic-Stankovic A, 2005, ALCOHOL CLIN EXP RES, V29, P1237, DOI 10.1097/01.ALC.0000172460.05756.D9; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Heaton MB, 2004, DEV BRAIN RES, V150, P117, DOI 10.1016/j.devbrainres.2004.03.010; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hulley P, 1995, EUR J NEUROSCI, V7, P2431, DOI 10.1111/j.1460-9568.1995.tb01041.x; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; IVESTER P, 1995, ARCH BIOCHEM BIOPHYS, V322, P14, DOI 10.1006/abbi.1995.1430; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Kranz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092157; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luo J, 1997, ALCOHOL CLIN EXP RES, V21, P1186, DOI 10.1111/j.1530-0277.1997.tb04436.x; MORGAN AJ, 1993, BIOCHEM PHARMACOL, V45, P2373, DOI 10.1016/0006-2952(93)90216-J; Naseer MI, 2010, SYNAPSE, V64, P467, DOI 10.1002/syn.20752; Naseer MI, 2010, SYNAPSE, V65, P562; Patel M, 2010, EXP BRAIN RES, V202, P431, DOI 10.1007/s00221-009-2150-5; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Sakai R, 2005, J NEURAL TRANSM, V112, P1005, DOI 10.1007/s00702-004-0246-4; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Seiler AEM, 2001, J NEUROCHEM, V76, P573, DOI 10.1046/j.1471-4159.2001.00025.x; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; SMITH RA, 1991, VIRCHOWS ARCH B, V61, P209; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Thibault C, 2000, MOL PHARMACOL, V58, P1593, DOI 10.1124/mol.58.6.1593; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yan D, 2010, BIOCHEM PHARMACOL, V80, P144, DOI 10.1016/j.bcp.2010.03.004; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Zhang C, 2011, TOXICOLOGY, V287, P124, DOI 10.1016/j.tox.2011.06.006; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhu L, 2009, IEEE PHOTONICS J, V1, P1, DOI 10.1109/JPHOT.2009.2020963	52	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104247	10.1371/journal.pone.0104247	http://dx.doi.org/10.1371/journal.pone.0104247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099937	gold, Green Published			2022-12-25	WOS:000339995100055
J	Huang, SB; Lv, TY; Zhang, XZ; Yang, YE; Zheng, WM; Wen, C				Huang, Shaobin; Lv, Tianyang; Zhang, Xizhe; Yang, Yange; Zheng, Weimin; Wen, Chao			Identifying Node Role in Social Network Based on Multiple Indicators	PLOS ONE			English	Article							COMPLEX; DYNAMICS	It is a classic topic of social network analysis to evaluate the importance of nodes and identify the node that takes on the role of core or bridge in a network. Because a single indicator is not sufficient to analyze multiple characteristics of a node, it is a natural solution to apply multiple indicators that should be selected carefully. An intuitive idea is to select some indicators with weak correlations to efficiently assess different characteristics of a node. However, this paper shows that it is much better to select the indicators with strong correlations. Because indicator correlation is based on the statistical analysis of a large number of nodes, the particularity of an important node will be outlined if its indicator relationship doesn't comply with the statistical correlation. Therefore, the paper selects the multiple indicators including degree, ego-betweenness centrality and eigenvector centrality to evaluate the importance and the role of a node. The importance of a node is equal to the normalized sum of its three indicators. A candidate for core or bridge is selected from the great degree nodes or the nodes with great ego-betweenness centrality respectively. Then, the role of a candidate is determined according to the difference between its indicators' relationship with the statistical correlation of the overall network. Based on 18 real networks and 3 kinds of model networks, the experimental results show that the proposed methods perform quite well in evaluating the importance of nodes and in identifying the node role.	[Huang, Shaobin; Lv, Tianyang; Yang, Yange] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China; [Zhang, Xizhe; Wen, Chao] Northeastern Univ, Coll Informat Sci & Engn, Shenyang, Peoples R China; [Lv, Tianyang; Zheng, Weimin] Tsinghua Univ, Coll Comp Sci & Technol, Beijing 100084, Peoples R China; [Lv, Tianyang] Audit Res Inst, Natl Audit Off, Beijing, Peoples R China	Harbin Engineering University; Northeastern University - China; Tsinghua University	Lv, TY (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China.	raynor1979@163.com	Zhang, Xizhe/H-3429-2019; Zhang, Xizhe/B-9848-2019	Zhang, Xizhe/0000-0002-8684-4591	Ministry of Science and Technology of China [2012BAH08B02]; Natural Science Foundation of China [71272216, 60903080, 60093009]; Fundamental Research Funds for the Central Universities [HEUCF1212, HEUCF1208]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is sponsored by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China under grant number 2012BAH08B02, by the Natural Science Foundation of China under grant number 71272216, 60903080, 60093009, and by the Fundamental Research Funds for the Central Universities under grant number HEUCF1212, HEUCF1208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burt R.S., 1992, STRUCTURAL HOLES SOC, DOI DOI 10.1016/J.JET.2007.01.006; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Paparo GD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02773; De Nooy W, 1999, POETICS, V26, P385, DOI 10.1016/S0304-422X(99)00009-1; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; ERDOS P, 1960, B INT STATIST INST, V38, P343; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; FRANCIS J, 1961, COMPUT J, V4, P265, DOI 10.1093/comjnl/4.3.265; Freeman L., 2004, DEV SOCIAL NETWORK A; Freeman SC, 1979, SOCIAL SCI RES REPOR, V46; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Jacob LM, 1960, SOCIOMETRY READER; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Knuth DE., 1993, STANFORD GRAPH BASE; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Marsden PV, 2002, SOC NETWORKS, V24, P407, DOI 10.1016/S0378-8733(02)00016-3; Michael JH, 1997, FOREST PROD J, V47, P25; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Putnam R.D., 2000, COLLAPSE REVIVAL AM; Radicchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017249; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; SCOTT J., 1991, SOCIAL NETWORK ANAL; SCOWEN RS, 1965, COMMUN ACM, V8, P669, DOI 10.1145/365660.365678; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; Vaccaro R, 1984, IEEE INT C ICASSP, V9, P224; Wang X., 2006, COMPLEX NETWORK THEO; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White HC, 1970, CHAINS OPPORTUNITY; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	44	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103733	10.1371/journal.pone.0103733	http://dx.doi.org/10.1371/journal.pone.0103733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089823	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700047
J	Kubota, C; Okada, T; Aleksic, B; Nakamura, Y; Kunimoto, S; Morikawa, M; Shiino, T; Tamaji, A; Ohoka, H; Banno, N; Morita, T; Murase, S; Goto, S; Kanai, A; Masuda, T; Ando, M; Ozaki, N				Kubota, Chika; Okada, Takashi; Aleksic, Branko; Nakamura, Yukako; Kunimoto, Shohko; Morikawa, Mako; Shiino, Tomoko; Tamaji, Ai; Ohoka, Harue; Banno, Naomi; Morita, Tokiko; Murase, Satomi; Goto, Setsuko; Kanai, Atsuko; Masuda, Tomoko; Ando, Masahiko; Ozaki, Norio			Factor Structure of the Japanese Version of the Edinburgh Postnatal Depression Scale in the Postpartum Period	PLOS ONE			English	Article							ANXIETY; SYMPTOMS; REPLICABILITY; SCREEN; WOMEN; RISK	Background: The Edinburgh Postnatal Depression Scale (EPDS) is a widely used screening tool for postpartum depression (PPD). Although the reliability and validity of EPDS in Japanese has been confirmed and the prevalence of PPD is found to be about the same as Western countries, the factor structure of the Japanese version of EPDS has not been elucidated yet. Methods: 690 Japanese mothers completed all items of the EPDS at 1 month postpartum. We divided them randomly into two sample sets. The first sample set (n = 345) was used for exploratory factor analysis, and the second sample set was used (n = 345) for confirmatory factor analysis. Results: The result of exploratory factor analysis indicated a three-factor model consisting of anxiety, depression and anhedonia. The results of confirmatory factor analysis suggested that the anxiety and anhedonia factors existed for EPDS in a sample of Japanese women at 1 month postpartum. The depression factor varies by the models of acceptable fit. Conclusions: We examined EPDS scores. As a result, "anxiety" and "anhedonia" exist for EPDS among postpartum women in Japan as already reported in Western countries. Cross-cultural research is needed for future research.	[Kubota, Chika; Okada, Takashi; Aleksic, Branko; Nakamura, Yukako; Kunimoto, Shohko; Morikawa, Mako; Shiino, Tomoko; Tamaji, Ai; Banno, Naomi; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Ohoka, Harue] Nihon Fukushi Univ, Chuo Coll Social Serv, Nagoya, Aichi, Japan; [Morita, Tokiko] Meijo Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Murase, Satomi] Liaison Med Marunouchi, Nagoya, Aichi, Japan; [Goto, Setsuko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kanai, Atsuko] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Masuda, Tomoko] Nagoya Univ, Grad Sch Law, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan	Nagoya University; Meijo University; Nagoya University; Nagoya University; Nagoya University; Nagoya University	Okada, T (corresponding author), Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	okada@med.nagoya-u.ac.jp	Shiino, Tomoko/M-8903-2014; ANDO, Masahiko/F-7035-2015; Shiino, Tomoko/ABA-7481-2020; nakamura, yukako/M-8889-2014; Aleksic, Branko/G-1540-2011; Aleksic, Branko/L-7851-2019; Ozaki, Norio/M-8908-2014; OKADA, Takashi/M-8902-2014	Shiino, Tomoko/0000-0002-8750-0854; Shiino, Tomoko/0000-0002-8750-0854; nakamura, yukako/0000-0002-3306-7127; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; OKADA, Takashi/0000-0001-5580-9913	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; Core Research for Evolutional Science and Technology; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [21B-2]; Specific Research Fund for East Japan Great Earthquake Revival by The New Technology Development Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Specific Research Fund for East Japan Great Earthquake Revival by The New Technology Development Foundation	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; The Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; the Core Research for Evolutional Science and Technology; Intramural Research Grant (21B-2) for Neurological and Psychiatric Disorders of NCNP; and the Specific Research Fund 2012 for East Japan Great Earthquake Revival by The New Technology Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTBURY J, 1994, AUST J PUBLIC HEALTH, V18, P176; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bollen K. A., 1993, TESTING STRUCTURAL E; Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8; Browne M. W., 1993, SOCIOL METHOD RES, P136; Buist A, 1998, AUST NZ J PSYCHIAT, V32, P370, DOI 10.3109/00048679809065529; Carlson M, 2011, PSYCHOL ASSESSMENT, V23, P558, DOI 10.1037/a0022484; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Ishikawa N, 2011, J PSYCHOSOM RES, V71, P264, DOI 10.1016/j.jpsychores.2011.02.001; Jomeen J, 2007, J PSYCHIATR MENT HLT, V14, P319, DOI 10.1111/j.1365-2850.2007.01084.x; Joreskog K.G., 1993, LISREL 8 USERS GUIDE; Kabir K, 2008, PEDIATRICS, V122, pE696, DOI 10.1542/peds.2007-1759; Kelloway E. K., 1998, USING LISREL STRUCTU; King PAL, 2012, ARCH WOMEN MENT HLTH, V15, P77, DOI 10.1007/s00737-012-0260-8; Lau Y, 2010, INT J NURS STUD, V47, P1139, DOI 10.1016/j.ijnurstu.2010.02.005; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Lobato G, 2011, ARCH WOMEN MENT HLTH, V14, P187, DOI 10.1007/s00737-011-0206-6; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; Lydiard RB, 1998, J CLIN PSYCHIAT, V59, P10; Matthey S, 2012, J AFFECT DISORD; Matthey S, 2008, DEPRESS ANXIETY, V25, P926, DOI 10.1002/da.20415; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.1111/j.1467-8624.1996.tb01871.x; Oates MR, 2004, BRIT J PSYCHIAT, V184, pS10, DOI 10.1192/bjp.184.46.s10; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Okano T, 1996, ARCH PSYCHIATR DIAGN, V7, P525; Phillips J, 2009, J AFFECT DISORDERS, V118, P101, DOI 10.1016/j.jad.2009.02.004; POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4; Ross L E, 2003, Arch Womens Ment Health, V6, P51, DOI 10.1007/s00737-002-0155-1; Sato Y, 2008, J EPIDEMIOL, V18, P84, DOI 10.2188/jea.18.84; Small R, 2007, SOC PSYCH PSYCH EPID, V42, P70, DOI 10.1007/s00127-006-0134-3; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STAVRAKAKI C, 1986, BRIT J PSYCHIAT, V149, P7, DOI 10.1192/bjp.149.1.7; Swalm D, 2010, ARCH WOMEN MENT HLTH, V13, P515, DOI 10.1007/s00737-010-0170-6; Tamaki R, 1997, PSYCHIAT CLIN NEUROS, V51, P93, DOI 10.1111/j.1440-1819.1997.tb02368.x; Tuohy A, 2008, BRIT J CLIN PSYCHOL, V47, P153, DOI 10.1111/j.2044-8260.2008.tb00463.x; Weissman MM, 2002, J CLIN PSYCHIAT, V63, P641, DOI 10.4088/JCP.v63n0717; Yelland J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-771	39	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103941	10.1371/journal.pone.0103941	http://dx.doi.org/10.1371/journal.pone.0103941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089523	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700066
J	Nilvebrant, J; Astrand, M; Georgieva-Kotseva, M; Bjoernmalm, M; Lofblom, J; Hober, S				Nilvebrant, Johan; Astrand, Mikael; Georgieva-Kotseva, Maria; Bjoernmalm, Mattias; Loefblom, John; Hober, Sophia			Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin	PLOS ONE			English	Article							PICOMOLAR AFFINITY; STRUCTURAL BASIS; SURFACE DISPLAY; HER2; DOMAINS; SELECTION; COMPLEX; MODULE	The epidermal growth factor receptor 2, ERBB2, is a well-validated target for cancer diagnostics and therapy. Recent studies suggest that the over-expression of this receptor in various cancers might also be exploited for antibody-based payload delivery, e. g. antibody drug conjugates. In such strategies, the full-length antibody format is probably not required for therapeutic effect and smaller tumor-specific affinity proteins might be an alternative. However, small proteins and peptides generally suffer from fast excretion through the kidneys, and thereby require frequent administration in order to maintain a therapeutic concentration. In an attempt aimed at combining ERBB2-targeting with antibody-like pharmacokinetic properties in a small protein format, we have engineered bispecific ERBB2-binding proteins that are based on a small albumin-binding domain. Phage display selection against ERBB2 was used for identification of a lead candidate, followed by affinity maturation using second-generation libraries. Cell surface display and flow-cytometric sorting allowed stringent selection of top candidates from pools pre-enriched by phage display. Several affinity-matured molecules were shown to bind human ERBB2 with sub-nanomolar affinity while retaining the interaction with human serum albumin. Moreover, parallel selections against ERBB2 in the presence of human serum albumin identified several amino acid substitutions that dramatically modulate the albumin affinity, which could provide a convenient means to control the pharmacokinetics. The new affinity proteins competed for ERBB2-binding with the monoclonal antibody trastuzumab and recognized the native receptor on a human cancer cell line. Hence, high affinity tumor targeting and tunable albumin binding were combined in one small adaptable protein.	[Nilvebrant, Johan; Astrand, Mikael; Georgieva-Kotseva, Maria; Bjoernmalm, Mattias; Loefblom, John; Hober, Sophia] KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden	Royal Institute of Technology	Hober, S (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.	sophia@biotech.kth.se	Björnmalm, Mattias/H-7721-2014	Björnmalm, Mattias/0000-0002-9876-7079; Lofblom, John/0000-0001-9423-0541	Swedish Research Council; Royal Swedish Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences	This work was funded by the Swedish Research Council. JN acknowledges support from the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm T, 2010, BIOTECHNOL J, V5, P605, DOI 10.1002/biot.201000041; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Feldwisch Joachim, 2012, Methods Mol Biol, V899, P103, DOI 10.1007/978-1-61779-921-1_7; Feldwisch J, 2010, J MOL BIOL, V398, P232, DOI 10.1016/j.jmb.2010.03.002; Frejd F. Y., 2012, THERAPEUTIC PROTEINS; Gostring L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040023; Gulich S, 2000, J BIOTECHNOL, V80, P169, DOI 10.1016/S0168-1656(00)00259-5; He YN, 2007, PROTEIN SCI, V16, P1490, DOI 10.1110/ps.072799507; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Jost C, 2013, STRUCTURE, V21, P1979, DOI 10.1016/j.str.2013.08.020; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist N, 2011, PROTEIN ENG DES SEL, V24, P385, DOI 10.1093/protein/gzq118; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Miao Z, 2011, AMINO ACIDS, V41, P1037, DOI 10.1007/s00726-010-0503-9; Nahta R, 2012, BREAST CANCER-TARGET, V4, P53, DOI 10.2147/BCTT.S24976; Nilsson FY, 2007, CURR OPIN DRUG DISC, V10, P167; Nilvebrant J, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303009; Nilvebrant J, 2013, CELL MOL LIFE SCI, V70, P3973, DOI 10.1007/s00018-013-1370-9; Nilvebrant J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025791; NYGREN PA, 1991, VACCINES 91, P363; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Rosenstein R, 2009, APPL ENVIRON MICROB, V75, P811, DOI 10.1128/AEM.01982-08; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	36	39	44	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103094	10.1371/journal.pone.0103094	http://dx.doi.org/10.1371/journal.pone.0103094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089830	Green Published, gold			2022-12-25	WOS:000339812700014
J	Kadonosono, T; Yabe, E; Furuta, T; Yamano, A; Tsubaki, T; Sekine, T; Kuchimaru, T; Sakurai, M; Kizaka-Kondoh, S				Kadonosono, Tetsuya; Yabe, Etsuri; Furuta, Tadaomi; Yamano, Akihiro; Tsubaki, Takuya; Sekine, Takuya; Kuchimaru, Takahiro; Sakurai, Minoru; Kizaka-Kondoh, Shinae			A Fluorescent Protein Scaffold for Presenting Structurally Constrained Peptides Provides an Effective Screening System to Identify High Affinity Target-Binding Peptides	PLOS ONE			English	Article							PHAGE DISPLAY; IN-VIVO; BREAST CARCINOMAS; IMAGING AGENT; CELL-SURFACE; LIBRARY; GFP; INHIBITION; INSERTIONS; CASPASE-3	Peptides that have high affinity for target molecules on the surface of cancer cells are crucial for the development of targeted cancer therapies. However, unstructured peptides often fail to bind their target molecules with high affinity. To efficiently identify high-affinity target-binding peptides, we have constructed a fluorescent protein scaffold, designated gFPS, in which structurally constrained peptides are integrated at residues K131-L137 of superfolder green fluorescent protein. Molecular dynamics simulation supported the suitability of this site for presentation of exogenous peptides with a constrained structure. gFPS can present 4 to 12 exogenous amino acids without a loss of fluorescence. When gFPSs presenting human epidermal growth factor receptor type 2 (HER2)-targeting peptides were added to the culture medium of HER2-expressing cells, we could easily identify the peptides with high HER2-affinity and -specificity based on gFPS fluorescence. In addition, gFPS could be expressed on the yeast cell surface and applied for a high-throughput screening. These results demonstrate that gFPS has the potential to serve as a powerful tool to improve screening of structurally constrained peptides that have a high target affinity, and suggest that it could expedite the one-step identification of clinically applicable cancer cell-binding peptides.	[Kadonosono, Tetsuya; Yabe, Etsuri; Yamano, Akihiro; Tsubaki, Takuya; Sekine, Takuya; Kuchimaru, Takahiro; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Furuta, Tadaomi; Sakurai, Minoru] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Kizaka-Kondoh, S (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.	skondoh@bio.titech.ac.jp	Kondoh, Shinae/AAF-8745-2020; Furuta, Tadaomi/D-5225-2015; Kuchimaru, Takahiro/B-9269-2015; Kadonosono, Tetsuya/D-4651-2019; Kondoh, Shinae/C-6937-2015	Kondoh, Shinae/0000-0003-3085-5782; Furuta, Tadaomi/0000-0003-4568-9043; Kuchimaru, Takahiro/0000-0002-5355-3165; Kondoh, Shinae/0000-0003-3085-5782	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science [22700469]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to SKK) and partially supported by Grants-in-Aid from the Japan Society for Promotion of Science 22700469 (to T. Kadonosono). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Dai M, 2008, PROTEIN ENG DES SEL, V21, P413, DOI 10.1093/protein/gzn016; DENNIS MS, 1995, J BIOL CHEM, V270, P25411, DOI 10.1074/jbc.270.43.25411; Deutscher SL, 2010, CHEM REV, V110, P3196, DOI 10.1021/cr900317f; Deutscher SL, 2009, J LABELLED COMPD RAD, V52, P583, DOI 10.1002/jlcr.1691; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; Flores-Ramirez Gabriela, 2007, BMC Chemical Biology, V7, P1, DOI 10.1186/1472-6769-7-1; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Ganesan R, 2006, J MOL BIOL, V359, P1378, DOI 10.1016/j.jmb.2006.04.051; Herman RE, 2007, J BIOL CHEM, V282, P9813, DOI 10.1074/jbc.M610722200; Howell RC, 2007, BIOCONJUGATE CHEM, V18, P1739, DOI 10.1021/bc060330u; Hufton SE, 2000, FEBS LETT, V475, P225, DOI 10.1016/S0014-5793(00)01701-4; Karasseva NG, 2002, J PROTEIN CHEM, V21, P287, DOI 10.1023/A:1019749504418; Kelly KA, 2008, CANCER RES, V68, P2286, DOI 10.1158/0008-5472.CAN-07-1349; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Kiss C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl681; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Kumar SR, 2007, CLIN CANCER RES, V13, P6070, DOI 10.1158/1078-0432.CCR-07-0160; Kumar SR, 2010, CANCER BIOTHER RADIO, V25, P693, DOI 10.1089/cbr.2010.0820; Kuroda K, 2009, APPL MICROBIOL BIOT, V82, P713, DOI 10.1007/s00253-008-1808-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LADNER RC, 1995, TRENDS BIOTECHNOL, V13, P426, DOI 10.1016/S0167-7799(00)88997-0; Nakajima H, 2008, BREAST CANCER-TOKYO, V15, P65, DOI 10.1007/s12282-007-0018-8; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peelle B, 2001, CHEM BIOL, V8, P521, DOI 10.1016/S1074-5521(01)00031-X; Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002; Shi HD, 2001, ENZYME MICROB TECH, V28, P25, DOI 10.1016/S0141-0229(00)00281-7; Shibasaki S, 2001, APPL MICROBIOL BIOT, V55, P471, DOI 10.1007/s002530000539; Sulpizi M, 2003, BIOPHYS J, V84, P2207, DOI 10.1016/S0006-3495(03)75026-7; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Uchiyama F, 2005, J BIOSCI BIOENG, V99, P448, DOI 10.1263/jbb.99.448; Woodman R, 2005, J MOL BIOL, V352, P1118, DOI 10.1016/j.jmb.2005.08.001; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	40	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103397	10.1371/journal.pone.0103397	http://dx.doi.org/10.1371/journal.pone.0103397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084350	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800036
J	Rizwani, W; Fasim, A; Sharma, D; Reddy, DJ; Bin Omar, NAM; Singh, SS				Rizwani, Wasia; Fasim, Aneesa; Sharma, Deepshikha; Reddy, Divya J.; Bin Omar, Nabil A. M.; Singh, Surya S.			S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACTIN-BINDING PROTEIN; POLY L-PROLINE; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-PROLIFERATION; GROWTH-FACTOR; ANTIESTROGEN RESISTANCE; INTRACELLULAR MOTILITY; UP-REGULATION; IN-VITRO	Background: Profilins are actin-modulating proteins regulating many intracellular functions based on their multiple and diverse ligand interactions. They have been implicated to play a role in many pathological conditions such as allergies, cardiovascular diseases, muscular atrophy, diabetes, dementia and cancer. Post-translational modifications of profilin 1 can alter its properties and subsequently its function in a cell. In the present study, we identify the importance of phosphorylation of profilin 1 at serine 137 (S137) residue in breast cancer progression. Methods/Principal Findings: We found elevated profilin 1 (PFN) in human breast cancer tissues when compared to adjacent normal tissues. Overexpression of wild-type profilin 1 (PFN-WT) in breast cancer MCF7 cells made them more migratory, invasive and adherent independent in comparison to empty vector transfected cells. Mutation in serine phosphorylation site (S137) of profilin 1 (PFN-S137A) significantly abrogated these properties. Mutation affecting actin-binding ability (PFN-R74E) of profilin 1 enhanced its tumorigenic function whereas mutation affecting its poly-L-proline binding function (PFN-H133S) alleviated these mechanisms in breast cancer cells. PFN-WT was found to activate matrix metalloproteinases by zymography, MMP2 and MMP9 in presence of PDBu (phorbol 12, 13 dibutyrate, PI3K agonist) to enhance migration and invasion in MCF7 cells while PFN-S137A did not. Phosphorylation increased migration and invasion in other mutants of profilin 1. Nuclear profilin levels also increased in the presence of PDBu. Conclusions: Previous studies show that profilin could be executing a dual role in cancer by either suppressing or promoting tumorigenesis in a context dependent manner. In this study we demonstrate for the first time that phosphorylation of profilin 1 at serine 137 enhances oncogenic properties in breast cancer cells. Inhibitors targeting profilin 1 phosphorylation directly or indirectly through inhibition of kinases that phosphorylate profilin could be valuable therapeutic agents that can alter its activity and thereby control the progression of cancer.	[Rizwani, Wasia; Fasim, Aneesa; Sharma, Deepshikha; Reddy, Divya J.; Bin Omar, Nabil A. M.; Singh, Surya S.] Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India	Osmania University	Rizwani, W (corresponding author), Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India.	wasia.rizwani@gmail.com; suryasingh.oubioc@gmail.com		Fasim, Anees/0000-0003-0504-235X	UGC-MRP (India); UGC (University Grants Commission); CSIR (Council for Scientific and Industrial Research); UGC; ICCR (Indian Council for Cultural Relations Fellowship)	UGC-MRP (India); UGC (University Grants Commission)(University Grants Commission, India); CSIR (Council for Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); ICCR (Indian Council for Cultural Relations Fellowship)	This work was financially supported by UGC-MRP (India) funding to SSS. WR received a fellowship from UGC (University Grants Commission). DS is supported by a fellowship from CSIR (Council for Scientific and Industrial Research), DJR from UGC and NBO from ICCR (Indian Council for Cultural Relations Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, MOL CANCER THER, V5, P1183, DOI 10.1158/1535-7163.MCT-05-0400; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Bhargavi V, 1998, BIOCHEM MOL BIOL INT, V46, P241; BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CLARKE R, 1989, P NATL ACAD SCI USA, V86, P3649, DOI 10.1073/pnas.86.10.3649; Dai YP, 2006, VASC PHARMACOL, V44, P275, DOI 10.1016/j.vph.2005.11.008; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gershtein ES, 1999, CLIN CHIM ACTA, V287, P59, DOI 10.1016/S0009-8981(99)00118-7; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Grenklo S, 2003, EMBO REP, V4, P523, DOI 10.1038/sj.embor.embor823; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Huang CM, 2006, PROTEOMICS, V6, P6107, DOI 10.1002/pmic.200600287; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kasina S, 2005, J BIOCHEM, V138, P687, DOI 10.1093/jb/mvi163; Korenbaum E, 1998, BIOCHEMISTRY-US, V37, P9274, DOI 10.1021/bi9803675; Korupolu RV, 2009, INT J BIOL MACROMOL, V45, P265, DOI 10.1016/j.ijbiomac.2009.06.001; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; NAKAMURA H, 1994, BIOCHEM BIOPH RES CO, V198, P568, DOI 10.1006/bbrc.1994.1083; Oh JE, 2006, AMINO ACIDS, V31, P289, DOI 10.1007/s00726-005-0256-z; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Rizwani W, 2009, CELL CYCLE, V8, P1621, DOI 10.4161/cc.8.10.8578; Romeo GR, 2013, DIABETES, V62, P3718, DOI 10.2337/db13-0050; Rothkegel M, 1996, J CELL SCI, V109, P83; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Roy P, 2002, NAT CELL BIOL, V4, pE91, DOI 10.1038/ncb0402-e91; SANGER JM, 1995, CELL MOTIL CYTOSKEL, V30, P38, DOI 10.1002/cm.970300106; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032802; Shetty P, 2012, LANCET, V379, P992, DOI 10.1016/S0140-6736(12)60415-2; Singh SS, 1996, RECEPT SIGNAL TRANS, V6, P77; Singh SS, 1996, BIOCHEMISTRY-US, V35, P16544, DOI 10.1021/bi9609634; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Soderberg E, 2012, NUCLEUS-PHILA, V3, P290, DOI 10.4161/nucl.20327; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tamura M, 2000, J AM SOC NEPHROL, V11, P423, DOI 10.1681/ASN.V113423; Tamura M, 2000, J AM SOC NEPHROL, V11, P1620, DOI 10.1681/ASN.V1191620; TANAKA M, 1992, CANCER RES, V52, P3372; TATE EH, 1983, CYTOMETRY, V4, P211, DOI 10.1002/cyto.990040304; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Vemuri B, 2001, CELL SIGNAL, V13, P433, DOI 10.1016/S0898-6568(01)00164-4; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Zhang YH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2883; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	70	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103868	10.1371/journal.pone.0103868	http://dx.doi.org/10.1371/journal.pone.0103868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084196	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800094
J	Younes, A; Abdel-Aty, M				Younes, Ahmed; Abdel-Aty, Mahmoud			Collapsing a Perfect Superposition to a Chosen Quantum State without Measurement	PLOS ONE			English	Article							STORAGE	Given a perfect superposition of 2(n) states on a quantum system of n qubits. We propose a fast quantum algorithm for collapsing the perfect superposition to a chosen quantum state vertical bar x(s)> without applying any measurements. The basic idea is to use a phase destruction mechanism. Two operators are used, the first operator applies a phase shift and a temporary entanglement to mark vertical bar x(s)> in the superposition, and the second operator applies selective phase shifts on the states in the superposition according to their Hamming distance with vertical bar x(s)>. The generated state can be used as an excellent input state for testing quantum memories and linear optics quantum computers. We make no assumptions about the used operators and applied quantum gates, but our result implies that for this purpose the number of qubits in the quantum register offers no advantage, in principle, over the obvious measurement-based feedback protocol.	[Younes, Ahmed] Univ Alexandria, Fac Sci, Dept Math & Comp Sci, Alexandria, Egypt; [Abdel-Aty, Mahmoud] Univ Sci & Technol, Zewail City Sci & Technol, Cairo, Egypt; [Abdel-Aty, Mahmoud] Sohag Univ, Fac Sci, Dept Math, Sohag, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Sohag University	Younes, A (corresponding author), Univ Alexandria, Fac Sci, Dept Math & Comp Sci, Alexandria, Egypt.	ayounes2@yahoo.com	Abdel-Aty, Mahmoud/N-9553-2019; Abdel-Aty, Mahmoud/H-4358-2017; Younes, Ahmed/O-6505-2017	Abdel-Aty, Mahmoud/0000-0002-9058-7938; Younes, Ahmed/0000-0002-1594-1589				[Anonymous], 2002, QUANTUM COMPUTATION; Bao XH, 2012, NAT PHYS, V8, P517, DOI 10.1038/nphys2324; Bapst V, 2013, PHYS REP, V523, P127, DOI 10.1016/j.physrep.2012.10.002; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Darquie B, 2005, SCIENCE, V309, P454, DOI 10.1126/science.1113394; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Han Y, 2010, REV MOD PHYS, V83, P1; Kitaev A., 2002, CLASSICAL QUANTUM CO, VVolume 47; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Lapert M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033406; LIN H, 1995, OPT LETT, V20, P1658, DOI 10.1364/OL.20.001658; Macfarlane RM, 2002, J LUMIN, V100, P1, DOI 10.1016/S0022-2313(02)00450-7; Neergaard-Nielsen JS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083604; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Younes A, 2008, PHYSICA D, V237, P1074, DOI 10.1016/j.physd.2007.12.005; Younes A, 2013, QUANTUM INF PROCESS, V12, P2977, DOI 10.1007/s11128-013-0575-z	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103612	10.1371/journal.pone.0103612	http://dx.doi.org/10.1371/journal.pone.0103612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084459	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800057
J	Zhang, W; Zeng, LQ; Liu, YJ; Pan, Y; Zhang, W; Zhang, CQ; Zeng, BF; Chen, YF				Zhang, Wen; Zeng, Langqing; Liu, Yanjie; Pan, Yao; Zhang, Wei; Zhang, Changqing; Zeng, Bingfang; Chen, Yunfeng			The Mechanical Benefit of Medial Support Screws in Locking Plating of Proximal Humerus Fractures	PLOS ONE			English	Article							INTERNAL-FIXATION; OPEN REDUCTION; FAILURE; PLATES; HEAD; SITE	Background: The purpose of this study was to evaluate the biomechanical advantages of medial support screws (MSSs) in the locking proximal humeral plate for treating proximal humerus fractures. Methods: Thirty synthetic left humeri were randomly divided into 3 subgroups to establish two-part surgical neck fracture models of proximal humerus. All fractures were fixed with a locking proximal humerus plate. Group A was fixed with medial cortical support and no MSSs; Group B was fixed with 3 MSSs but without medial cortical support; Group C was fixed with neither medial cortical support nor MSSs. Axial compression, torsional stiffness, shear stiffness, and failure tests were performed. Results: Constructs with medial support from cortical bone showed statistically higher axial and shear stiffness than other subgroups examined (P<0.0001). When the proximal humerus was not supported by medial cortical bone, locking plating with medial support screws exhibited higher axial and torsional stiffness than locking plating without medial support screws (P <= 0.0207). Specimens with medial cortical bone failed primarily by fracture of the humeral shaft or humeral head. Specimens without medial cortical bone support failed primarily by significant plate bending at the fracture site followed by humeral head collapse or humeral head fracture. Conclusions: Anatomic reduction with medial cortical support was the stiffest construct after a simulated two-part fracture. Significant biomechanical benefits of MSSs in locking plating of proximal humerus fractures were identified. The reconstruction of the medial column support for proximal humerus fractures helps to enhance mechanical stability of the humeral head and prevent implant failure.	[Zhang, Wen; Liu, Yanjie; Pan, Yao; Zhang, Wei; Zhang, Changqing; Zeng, Bingfang; Chen, Yunfeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Zeng, Langqing] Jinan Univ, Affiliated Zhuhai Hosp, Zhuhai Peoples Hosp, Dept Orthopaed, Jinan, Guangdong, Peoples R China	Shanghai Jiao Tong University; Jinan University; University of Jinan	Chen, YF (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	chenyunfeng1969@163.com		zhang, changqing/0000-0002-7408-4126				Agudelo J, 2007, J ORTHOP TRAUMA, V21, P676, DOI 10.1097/BOT.0b013e31815bb09d; [Anonymous], 2009, J ORTHOP TRAUMA, V23, P113, DOI 10.1097/BOT.0b013e31819344bf; Badman B, 2011, J SHOULDER ELB SURG, V20, P616, DOI 10.1016/j.jse.2010.08.030; Bogner R, 2008, J BONE JOINT SURG BR, V90B, P1602, DOI 10.1302/0301-620X.90B12.20269; Brunner F, 2009, J ORTHOP TRAUMA, V23, P163, DOI 10.1097/BOT.0b013e3181920e5b; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Egol KA, 2012, J SHOULDER ELB SURG, V21, P741, DOI 10.1016/j.jse.2011.09.017; Friess DM, 2008, ORTHOPEDICS, V31, P1183, DOI 10.3928/01477447-20081201-07; Gardner MJ, 2007, J ORTHOP TRAUMA, V21, P185, DOI 10.1097/BOT.0b013e3180333094; Hardeman F, 2012, INJURY, V43, P153, DOI 10.1016/j.injury.2011.04.003; Helmy N, 2006, CLIN ORTHOP RELAT R, P100, DOI 10.1097/01.blo.0000194674.56764.c0; Hepp P, 2003, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000092968.12414.a8; Hettrich CM, 2012, J ORTHOP TRAUMA, V26, P212, DOI 10.1097/BOT.0b013e318243909c; Koval KJ, 1996, J TRAUMA, V40, P778, DOI 10.1097/00005373-199605000-00017; Krappinger D, 2011, INJURY, V42, P1283, DOI 10.1016/j.injury.2011.01.017; Lescheid J, 2010, J TRAUMA, V69, P1235, DOI 10.1097/TA.0b013e3181beed96; Liew ASL, 2000, J SHOULDER ELB SURG, V9, P423, DOI 10.1067/mse.2000.107089; Micic ID, 2009, J ORTHOP SCI, V14, P596, DOI 10.1007/s00776-009-1382-3; Osterhoff G, 2011, J SHOULDER ELB SURG, V20, P740, DOI 10.1016/j.jse.2010.10.040; Schulte LM, 2011, J SHOULDER ELB SURG, V20, P1234, DOI 10.1016/j.jse.2010.12.015; Sproul RC, 2011, INJURY, V42, P408, DOI 10.1016/j.injury.2010.11.058; Volgas DA, 2004, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000118697.84243.6c; Weeks CA, 2013, J SHOULDER ELB SURG, V22, P1552, DOI 10.1016/j.jse.2013.02.003; Zhang L, 2011, INT ORTHOP, V35, P1655, DOI 10.1007/s00264-011-1227-5	24	32	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103297	10.1371/journal.pone.0103297	http://dx.doi.org/10.1371/journal.pone.0103297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084520	Green Submitted, gold, Green Published			2022-12-25	WOS:000339819800028
J	Bardot, B; Bouarich-Bourimi, R; Leemput, J; Lejour, V; Hamon, A; Plancke, L; Jochemsen, AG; Simeonova, I; Fang, M; Toledo, F				Bardot, B.; Bouarich-Bourimi, R.; Leemput, J.; Lejour, V.; Hamon, A.; Plancke, L.; Jochemsen, A. G.; Simeonova, I.; Fang, M.; Toledo, F.			Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity	ONCOGENE			English	Article							ACTIVITY IN-VIVO; THERAPEUTIC TARGET; MESSENGER-RNA; HDMX GENE; CANCER; REVEALS; PATHWAY; DOMAIN; CELLS; AMPLIFICATION	Mdm4, a protein related to the ubiquitin-ligase Mdm2, is an essential inhibitor of tumor suppressor protein p53. In both human and mouse cells, the Mdm4 gene encodes two major transcripts: one encodes the full-length oncoprotein (designated below as Mdm4-FL), whereas the other, resulting from a variant splicing that skips exon 6, encodes the shorter isoform Mdm4-S. Importantly, increased Mdm4-S mRNA levels were observed in several human cancers, and correlated with poor survival. However, the role of Mdm4-S in cancer progression remains controversial, because the Mdm4-S protein appeared to be a potent p53 inhibitor when overexpressed, but the splice variant also leads to a decrease in Mdm4-FL expression. To unambiguously determine the physiological impact of the Mdm4-S splice variant, we generated a mouse model with a targeted deletion of the Mdm4 exon 6, thereby creating an obligatory exon skipping. The mutant allele (Mdm4(Delta E6)) prevented the expression of Mdm4-FL, but also led to increased Mdm4-S mRNA levels. Mice homozygous for this allele died during embryonic development, but were rescued by a concomitant p53 deficiency. Furthermore in a hypomorphic p53(Delta P/Delta P) context, the Mdm4(Delta E6) allele led to p53 activation and delayed the growth of oncogene-induced tumors. We next determined the effect of Mdm4(+/Delta E6) heterozygosity in a hypermorphic p53(+/Delta 31) genetic background, recently shown to be extremely sensitive to Mdm4 activity. Mdm4(+/Delta E6) p53(+/Delta 31) pups were born, but suffered from aplastic anemia and died before weaning, again indicating an increased p53 activity. Our results demonstrate that the main effect of a skipping of Mdm4 exon 6 is not the synthesis of the Mdm4-S protein, but rather a decrease in Mdm4-FL expression. These and other data suggest that increased Mdm4-S mRNA levels might correlate with more aggressive cancers without encoding significant amounts of a potential oncoprotein. Hypotheses that may account for this apparent paradox are discussed.	[Bardot, B.; Bouarich-Bourimi, R.; Leemput, J.; Lejour, V.; Hamon, A.; Plancke, L.; Simeonova, I.; Fang, M.; Toledo, F.] Inst Curie, Ctr Rech, Genet Tumor Suppress Equipe Labellisee Ligue 2014, F-75248 Paris 05, France; [Bardot, B.; Bouarich-Bourimi, R.; Leemput, J.; Lejour, V.; Hamon, A.; Plancke, L.; Simeonova, I.; Fang, M.; Toledo, F.] Univ Paris 06, Paris, France; [Bardot, B.; Bouarich-Bourimi, R.; Leemput, J.; Lejour, V.; Hamon, A.; Plancke, L.; Simeonova, I.; Fang, M.; Toledo, F.] CNRS, UMR 3244, Paris, France; [Jochemsen, A. G.] Leiden Univ, Med Ctr, Leiden, Netherlands	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Toledo, F (corresponding author), Inst Curie, Ctr Rech, UMR 3244, Genet Tumor Suppress, F-75248 Paris 05, France.	franck.toledo@curie.fr	Simeonova, Iva/Y-9412-2019; Hamon, Annaïg/AAG-4899-2021	Hamon, Annaïg/0000-0002-1662-1405; Toledo, Franck/0000-0003-3798-4106; Bardot, Boris/0000-0003-4976-9593; Leemput, Julia/0000-0001-8732-0741	Ligue Nationale contre le Cancer; Fondation de France (Comite Tumeurs); Ligue Nationale contre le Cancer (Comite Ile de France); Fondation ARC; Canceropole Ile de France	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation de France (Comite Tumeurs); Ligue Nationale contre le Cancer (Comite Ile de France); Fondation ARC; Canceropole Ile de France(Region Ile-de-France)	We thank members of the Curie technological platforms for their contribution to this study: I Grandjean, C Daviaud and M Verlhac from the Animal facility, C Alberti, E Belloir and N Mebirouk from the transgenesis platform, M Richardson, A Nicolas, R Leclere and M Huerre from the pathology service. Our lab received funding as an Equipe Labellisee by the Ligue Nationale contre le Cancer. The project was initiated by grants from the Fondation de France (Comite Tumeurs), the Ligue Nationale contre le Cancer (Comite Ile de France) and the Fondation ARC. JL was supported by a post-doctoral fellowship from the Canceropole Ile de France.	Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Bista M, 2013, P NATL ACAD SCI USA, V110, P17814, DOI 10.1073/pnas.1317398110; Fang M, 2014, ONCOGENE, V33, P1336, DOI 10.1038/onc.2013.62; Finch RA, 2002, CANCER RES, V62, P3221; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lenos K, 2012, CANCER RES, V72, P4074, DOI 10.1158/0008-5472.CAN-12-0215; Lenos K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/876173; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2011, CURR TOP DEV BIOL, V94, P45, DOI 10.1016/B978-0-12-380916-2.00003-6; Matijasevic Z, 2008, MOL CELL BIOL, V28, P1265, DOI 10.1128/MCB.01108-07; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Phillips A, 2010, J BIOL CHEM, V285, P29111, DOI 10.1074/jbc.M110.129726; Prodosmo A, 2008, J MOL MED-JMM, V86, P585, DOI 10.1007/s00109-008-0322-6; Prophet E, 1992, AFIP LAB METHODS HIS; Rallapalli R, 2003, J CELL BIOCHEM, V89, P563, DOI 10.1002/jcb.10535; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Ramos YFM, 2001, CANCER RES, V61, P1839; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Simeonova I, 2013, CELL REP, V3, P2046, DOI 10.1016/j.celrep.2013.05.028; Simeonova I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002731; Steinman HA, 2005, ONCOGENE, V24, P7935, DOI 10.1038/sj.onc.1208930; Steinman HA, 2004, ONCOGENE, V23, P303, DOI 10.1038/sj.onc.1206925; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Wang YYV, 2011, GENE DEV, V25, P1426, DOI 10.1101/gad.2024411; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008	38	23	23	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2943	2948		10.1038/onc.2014.230	http://dx.doi.org/10.1038/onc.2014.230			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25088193				2022-12-25	WOS:000355324300013
J	Ferguson, B; Ram, R; Handoko, HY; Mukhopadhyay, P; Muller, HK; Soyer, HP; Morahan, G; Walker, GJ				Ferguson, B.; Ram, R.; Handoko, H. Y.; Mukhopadhyay, P.; Muller, H. K.; Soyer, H. P.; Morahan, G.; Walker, G. J.			Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression	ONCOGENE			English	Article							CUTANEOUS MELANOMA; MELANOCYTIC LESIONS; MALIGNANT-MELANOMA; ATYPICAL NEVI; MUTATIONS; MICE; CLASSIFICATION; IDENTIFICATION; EXPRESSION; PATHWAYS	Susceptibility to most common cancers is likely to involve interaction between multiple low risk genetic variants. Although there has been great progress in identifying such variants, their effect on phenotype and the mechanisms by which they contribute to disease remain largely unknown. We have developed a mouse melanoma model harboring two mutant oncogenes implicated in human melanoma, CDK4(R24C) and NRAS(Q61K). In these mice, tumors arise from benign precursor lesions that are a recognized strong risk factor for this neoplasm in humans. To define molecular events involved in the pathway to melanoma, we have for the first time applied the Collaborative Cross (CC) to cancer research. The CC is a powerful resource designed to expedite discovery of genes for complex traits. We characterized melanoma genesis in more than 50 CC strains and observed tremendous variation in all traits, including nevus and melanoma age of onset and multiplicity, anatomical site predilection, time for conversion of nevi to melanoma and metastases. Intriguingly, neonatal ultraviolet radiation exposure exacerbated nevus and melanoma formation in most, but not all CC strain backgrounds, suggesting that genetic variation within the CC will help explain individual sensitivity to sun exposure, the major environmental skin carcinogen. As genetic variation brings about dramatic phenotypic diversity in a single mouse model, melanoma-related endophenotype comparisons provide us with information about mechanisms of carcinogenesis, such as whether melanoma incidence is dependent upon the density of pre-existing nevus cells. Mouse models have been used to examine the functional role of gene mutations in tumorigenesis. This work represents their next phase of development to study how biological variation greatly influences lesion onset and aggressiveness even in the setting of known somatic driver mutations.	[Ferguson, B.; Handoko, H. Y.; Mukhopadhyay, P.; Walker, G. J.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Ram, R.; Morahan, G.] Harry Perkins Inst Med Res, Ctr Diabet Res, Perth, WA, Australia; [Muller, H. K.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Soyer, H. P.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia	QIMR Berghofer Medical Research Institute; Harry Perkins Institute of Medical Research; University of Tasmania; University of Queensland	Walker, GJ (corresponding author), Queensland Inst Med Res, 300 Herston Rd, Herston, Qld 4006, Australia.	Graeme.Walker@qimr.edu.au	Soyer, H. Peter/E-6000-2010; Ferguson, Blake/J-4158-2016; Mukhopadhyay, Pamela/I-6373-2015; Soyer, H. Peter/W-3791-2017; Morahan, Grant/T-7501-2019	Soyer, H. Peter/0000-0002-4770-561X; Mukhopadhyay, Pamela/0000-0002-5905-1350; Soyer, H. Peter/0000-0002-4770-561X; Ferguson, Blake/0000-0002-5643-6976	Melanoma Research Alliance, Washington DC, USA; Scott Kirkbride Melanoma Research Centre, Perth, Western Australia; Diabetes Research Foundation of Western Australia; Australian Research Council Project [DP11010206]; National Health and Medical Research Council of Australia [1037321]; Ride To Cure Cancer, Western Australia	Melanoma Research Alliance, Washington DC, USA; Scott Kirkbride Melanoma Research Centre, Perth, Western Australia; Diabetes Research Foundation of Western Australia; Australian Research Council Project(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ride To Cure Cancer, Western Australia	This work was supported by a pilot study grant from the Melanoma Research Alliance, Washington DC, USA and a Discovery Research Priming Grant from the Scott Kirkbride Melanoma Research Centre, Perth, Western Australia. GM is supported by the Diabetes Research Foundation of Western Australia, by Australian Research Council Project DP11010206 and by Program Grant 1037321 from the National Health and Medical Research Council of Australia. RR is supported by RTCC funding from the Ride To Cure Cancer, Western Australia. We thank Geniad Pty Ltd for providing mice from the Collaborative Cross strains.	Abel EL, 2010, JNCI-J NATL CANCER I, V102, P1663, DOI 10.1093/jnci/djq392; Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Aoki H, 2011, PIGM CELL MELANOMA R, V24, P125, DOI 10.1111/j.1755-148X.2010.00801.x; Bradish JR, 2013, FUTURE ONCOL, V9, P245, DOI [10.2217/fon.12.179, 10.2217/FON.12.179]; Campagne C, 2013, PIGM CELL MELANOMA R, V26, P735, DOI 10.1111/pcmr.12115; Chai E, 2013, PIGM CELL MELANOMA R, V27, P317; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; de Snoo FA, 2008, EUR J HUM GENET, V16, P1135, DOI 10.1038/ejhg.2008.72; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Faraji F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002926; Ferguson B, 2010, PIGM CELL MELANOMA R, V23, P771, DOI 10.1111/j.1755-148X.2010.00752.x; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANC, V41, P28; Goldstein AM, 2002, MELANOMA RES, V12, P51, DOI 10.1097/00008390-200202000-00008; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; LeFur N, 1996, GENOMICS, V37, P245; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; LYNCH HT, 1980, BRIT J CANCER, V42, P58, DOI 10.1038/bjc.1980.203; Molven A, 2005, GENE CHROMOSOME CANC, V44, P10, DOI 10.1002/gcc.20202; Morahan G, 2008, MAMM GENOME, V19, P390, DOI 10.1007/s00335-008-9134-9; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Puig S, 1997, HUM GENET, V101, P359, DOI 10.1007/s004390050642; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rigel DS, 2008, J AM ACAD DERMATOL, V58, pS129, DOI 10.1016/j.jaad.2007.04.034; Threadgill DW, 2012, G3-GENES GENOM GENET, V2, P153, DOI 10.1534/g3.111.001891; Viros A, 2008, PLOS MED, V5, P941, DOI 10.1371/journal.pmed.0050120; Walker G, 2008, FUTURE ONCOL, V4, P841, DOI 10.2217/14796694.4.6.841; Walker GJ, 2011, PIGM CELL MELANOMA R, V24, P1158, DOI 10.1111/j.1755-148X.2011.00923.x; Welsh CE, 2012, MAMM GENOME, V23, P706, DOI 10.1007/s00335-012-9410-6; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; Wurm EMT, 2012, EXP DERMATOL, V21, P676, DOI 10.1111/j.1600-0625.2012.01543.x	38	22	22	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2879	2886		10.1038/onc.2014.227	http://dx.doi.org/10.1038/onc.2014.227			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25088201				2022-12-25	WOS:000355324300007
J	Menard, S; Guzylack-Piriou, L; Leveque, M; Braniste, V; Lencina, C; Naturel, M; Moussa, L; Sekkal, S; Harkat, C; Gaultier, E; Theodorou, V; Houdeau, E				Menard, Sandrine; Guzylack-Piriou, Laurence; Leveque, Mathilde; Braniste, Viorica; Lencina, Corinne; Naturel, Manon; Moussa, Lara; Sekkal, Soraya; Harkat, Cherryl; Gaultier, Eric; Theodorou, Vassilia; Houdeau, Eric			Food intolerance at adulthood after perinatal exposure to the endocrine disruptor bisphenol A	FASEB JOURNAL			English	Article						immune system; humoral and cellular response; oral challenge; systemic immunization	ORAL TOLERANCE; IMMUNE-RESPONSES; DENDRITIC CELLS; DEVELOPMENTAL IMMUNOTOXICOLOGY; WIDESPREAD EXPOSURE; MICE; INFLAMMATION; CHEMICALS; DISEASE; ALLERGY	The food contaminant bisphenol A (BPA) is pointed out as a risk factor in development of food allergy and food intolerance, two adverse food reactions increasing worldwide. We evaluated the consequences of perinatal exposure to low doses of BPA on immune-specific response to the food antigen ovalbumin (OVA) at adulthood. Perinatal exposure to BPA (0.5, 5, or 50 g/kg/d) from 15th day of gravidity to pups weaning resulted in an increase of anti-OVA IgG titers at all BPA dosages in OVA-tolerized rats, and at 5 g/kg/d in OVA-immunized rats compared to control rats treated with vehicle. In BPA-treated and OVA-tolerized rats, increased anti-OVA IgG titers were associated with higher IFN secretion by the spleen. This result is in accordance with the increase of activated CD4(+)CD44(high)CD62L(low) T lymphocytes observed in spleen of BPA-exposed rats compared to controls. Finally, when BPA-treated OVA-tolerized rats were orally challenged with OVA, colonic inflammation occurred, with neutrophil infiltration, increased IFN, and decreased TGF. We show that perinatal exposure to BPA altered oral tolerance and immunization to dietary antigens (OVA). In summary, the naive immune system of neonate is vulnerable to low doses of BPA that trigger food intolerance later in life.Menard, S., Guzylack-Piriou, L., Leveque, M., Braniste, V., Lencina, C., Naturel, M., Moussa, L., Sekkal, S., Harkat, C., Gaultier, E., Theodorou, V., Houdeau, E. Food intolerance at adulthood after perinatal exposure to the endocrine disruptor bisphenol A.	[Menard, Sandrine; Leveque, Mathilde; Lencina, Corinne; Naturel, Manon; Moussa, Lara; Harkat, Cherryl; Theodorou, Vassilia] INRA, UMR Toxalim 1331, Dept Neurogastroenterol & Nutr, F-31027 Toulouse 3, France; [Guzylack-Piriou, Laurence; Braniste, Viorica; Sekkal, Soraya; Gaultier, Eric; Houdeau, Eric] INRA, UMR Toxalim 1331, Dept Intestinal Dev Xenobiot & Immunotoxicol, F-31027 Toulouse 3, France	INRAE; INRAE	Menard, S (corresponding author), INRA, 180 Chemin Tournefeuille,BP93173, F-31027 Toulouse 3, France.	sandrine.menard@toulouse.inra.fr	Menard, Sandrine/ABF-8935-2021	Menard, Sandrine/0000-0001-8867-199X; Braniste, Viorica/0000-0003-1992-3609; Leveque, Mathilde/0000-0003-1253-3798	Agence Nationale de la Recherche (France) [ANR-10-CESA-005]; Institut National de la Recherche Agronomique [AP AlimH 2008]	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Institut National de la Recherche Agronomique	The authors are grateful to Dr. Raphael Garcia-Villar for discussion and help on the manuscript. This work was supported by grant ANR-10-CESA-005 from the Agence Nationale de la Recherche (France) and grant AP AlimH 2008 from the Institut National de la Recherche Agronomique. The authors declare no conflicts of interest.	Appleman LJ, 2003, IMMUNOL REV, V192, P161, DOI 10.1034/j.1600-065X.2003.00009.x; Braniste V., 2011, MULTISYSTEM ENDOCRIN, P127, DOI DOI 10.1007/978-3-642-22775-2_9; Braniste V, 2010, P NATL ACAD SCI USA, V107, P448, DOI 10.1073/pnas.0907697107; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Cochrane S, 2009, ALLERGY, V64, P1246, DOI 10.1111/j.1398-9995.2009.02128.x; Dietert Rodney R., 2012, Reviews on Environmental Health, V27, P117, DOI 10.1515/reveh-2012-0020; Dietert RR, 2009, CHEM RES TOXICOL, V22, P17, DOI 10.1021/tx800198m; Dietert RR, 2008, BIRTH DEFECTS RES B, V83, P547, DOI 10.1002/bdrb.20170; Dunbar B, 2012, MOL CELL ENDOCRINOL, V354, P85, DOI 10.1016/j.mce.2012.01.002; European Food Safety Authority, 2013, EFSA J; Fagin D, 2012, NATURE, V490, P462, DOI 10.1038/490462a; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; GALLIAERDE V, 1995, EUR J IMMUNOL, V25, P1385, DOI 10.1002/eji.1830250537; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2136, DOI 10.1271/bbb.70004; Houdeau E, 2005, AM J PHYSIOL-REG I, V288, pR630, DOI 10.1152/ajpregu.00482.2004; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kurebayashi H, 2005, ARCH TOXICOL, V79, P243, DOI 10.1007/s00204-004-0628-2; Mansueto P, 2006, WORLD J GASTROENTERO, V12, P7744, DOI 10.3748/wjg.v12.i48.7744; Marth T, 1998, ANN NY ACAD SCI, V859, P290, DOI 10.1111/j.1749-6632.1998.tb11148.x; Ohshima Y, 2007, PEDIATR RES, V62, P60, DOI 10.1203/PDR.0b013e3180674dae; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Skypala I, 2011, J AM DIET ASSOC, V111, P1877, DOI 10.1016/j.jada.2011.09.001; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Yoshino S, 2004, IMMUNOLOGY, V112, P489, DOI 10.1111/j.1365-2567.2004.01900.x; Yoshino S, 2003, BRIT J PHARMACOL, V138, P1271, DOI 10.1038/sj.bjp.0705166	31	52	53	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4893	4900		10.1096/fj.14-255380	http://dx.doi.org/10.1096/fj.14-255380			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25085925				2022-12-25	WOS:000344050900026
J	Haddad, N; Matos, RG; Pinto, T; Rannou, P; Cappelier, JM; Prevost, H; Arraiano, CM				Haddad, Nabila; Matos, Rute G.; Pinto, Teresa; Rannou, Pauline; Cappelier, Jean-Michel; Prevost, Herve; Arraiano, Cecilia M.			The RNase R from Campylobacter jejuni Has Unique Features and Is Involved in the First Steps of Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Campylobacter; Invasion; Ribonuclease; RNA Catalysis; RNA Metabolism; Foodborne Pathogen	RIBONUCLEASE-II; POLYNUCLEOTIDE PHOSPHORYLASE; EXORIBONUCLEASE; DEGRADATION; SURVIVAL; TEMPERATURE; MECHANISM; DOMAINS; GROWTH; CATALYSIS	Background: Members of the RNB family are involved in virulence; nothing is known about the Campylobacter jejuni homologue. Results:Cj-RNase R is active in several conditions. It is also important for adhesion and invasion. Conclusion: RNase R is important for C. jejuni biology and infection. Significance: RNase R could be targeted to reduce infection by this pathogen. Bacterial pathogens must adapt/respond rapidly to changing environmental conditions. Ribonucleases (RNases) can be crucial factors contributing to the fast adaptation of RNA levels to different environmental demands. It has been demonstrated that the exoribonuclease polynucleotide phosphorylase (PNPase) facilitates survival of Campylobacter jejuni in low temperatures and favors swimming, chick colonization, and cell adhesion/invasion. However, little is known about the mechanism of action of other ribonucleases in this microorganism. Members of the RNB family of enzymes have been shown to be involved in virulence of several pathogens. We have searched C. jejuni genome for homologues and found one candidate that displayed properties more similar to RNase R (Cj-RNR). We show here that Cj-RNR is important for the first steps of infection, the adhesion and invasion of C. jejuni to eukaryotic cells. Moreover, Cj-RNR proved to be active in a wide range of conditions. The results obtained lead us to conclude that Cj-RNR has an important role in the biology of this foodborne pathogen.	[Haddad, Nabila; Rannou, Pauline; Cappelier, Jean-Michel; Prevost, Herve] Univ Nantes, Oniris, LUNAM Univ, F-44200 Nantes, France; [Haddad, Nabila; Rannou, Pauline; Cappelier, Jean-Michel; Prevost, Herve] INRA, Securite Aliments & Microbiol UMR1014, F-44322 Nantes, France; [Matos, Rute G.; Pinto, Teresa; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; INRAE; Universidade Nova de Lisboa	Haddad, N (corresponding author), Oniris, UMR SECALIM INRA1014, Rue Geraudiere, F-44322 Nantes, France.	nabila.haddad@oniris-nantes.fr; cecilia@itqb.unl.pt	Matos, Rute/J-4983-2013	PREVOST, Herve/0000-0001-9384-8382; Matos Luis, Rute/0000-0002-9788-7562; Arraiano, Cecilia/0000-0003-1934-9301; Pinto, Teresa/0000-0002-7553-618X; Haddad, Nabila/0000-0001-7944-4824	Region Pays de la Loire through the program grant GENICAMP	Region Pays de la Loire through the program grant GENICAMP(Region Pays de la Loire)	We thank Andreia Aires for technical support at Instituto de Tecnologia Quimica e Biologica (ITQB) and Christopher M. Burns for discussion about construction of the plasmid overexpressing C. jejuni RNase R. RNA research in UMR1014 SECALIM was funded by the Region Pays de la Loire through the program grant GENICAMP.	Alluri RK, 2012, J BIOL CHEM, V287, P23427, DOI 10.1074/jbc.M111.324970; Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; DEMEDICIS E, 1986, APPL ENVIRON MICROB, V52, P567; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haddad N, 2013, BIOSCIENCE REP, V33, P889, DOI 10.1042/BSR20130090; Haddad N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00030; Haddad N, 2010, CURR MICROBIOL, V61, P500, DOI 10.1007/s00284-010-9644-z; Haddad N, 2009, APPL ENVIRON MICROB, V75, P7310, DOI 10.1128/AEM.01366-09; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Kelly AF, 2003, APPL ENVIRON MICROB, V69, P4975, DOI 10.1128/AEM.69.8.4975-4978.2003; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee A, 1998, J FOOD PROTECT, V61, P1609, DOI 10.4315/0362-028X-61.12.1609; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Matos RG, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00065; Matos RG, 2012, BBA-GEN SUBJECTS, V1820, P1543, DOI 10.1016/j.bbagen.2012.06.009; Matos RG, 2011, PROTEINS, V79, P1853, DOI 10.1002/prot.23010; Matos RG, 2009, BIOCHEM J, V423, P291, DOI 10.1042/BJ20090839; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Nyati KK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852195; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Park S.F., 2005, CAMPYLOBACTER MOL CE; Pogacar MS, 2009, INT J FOOD MICROBIOL, V129, P68, DOI 10.1016/j.ijfoodmicro.2008.11.010; Reis FP, 2013, WIRES RNA, V4, P607, DOI 10.1002/wrna.1180; Riddle Mark S, 2012, Curr Gastroenterol Rep, V14, P395, DOI 10.1007/s11894-012-0278-0; Ruiz-Palacios GM, 2007, CLIN INFECT DIS, V44, P701, DOI 10.1086/509936; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; TOBE T, 1992, J BACTERIOL, V174, P6359, DOI 10.1128/JB.174.20.6359-6367.1992; Tsao MY, 2009, J BACTERIOL, V191, P2691, DOI 10.1128/JB.01182-08; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Wyszynska A, 2007, ACTA BIOCHIM POL, V54, P143	51	16	16	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27814	27824		10.1074/jbc.M114.561795	http://dx.doi.org/10.1074/jbc.M114.561795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100732	Green Published, hybrid			2022-12-25	WOS:000342852800038
J	Li, ZY; Lin, F; Zhuo, CH; Deng, GP; Chen, ZJ; Yin, SY; Gao, ZM; Piccioni, M; Tsun, A; Cai, SJ; Zheng, SG; Zhang, Y; Li, B				Li, Zhiyuan; Lin, Fang; Zhuo, Changhua; Deng, Guoping; Chen, Zuojia; Yin, Shuying; Gao, Zhimei; Piccioni, Miranda; Tsun, Andy; Cai, Sanjun; Zheng, Song Guo; Zhang, Yu; Li, Bin			PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL FUNCTION; MEDIATED SUPPRESSION; CUTTING EDGE; IN-VIVO; IDENTIFICATION; DIFFERENTIATE; ACTIVATION; MECHANISMS; STABILITY; RESPONSES	Previous reports have suggested that human CD4(+) CD25(hi)FOXP3(+) T regulatory cells (Tregs) have functional plasticity and may differentiate into effector T cells under inflammation. The molecular mechanisms underlying these findings remain unclear. Here we identified the residue serine 422 of human FOXP3 as a phosphorylation site that regulates its function, which is not present in murine Foxp3. PIM1 kinase, which is highly expressed in human Tregs, was found to be able to interact with and to phosphorylate human FOXP3 at serine 422. T cell receptor (TCR) signaling inhibits PIM1 induction, whereas IL-6 promotes PIM1 expression in in vitro expanded human Tregs. PIM1 negatively regulates FOXP3 chromatin binding activity by specifically phosphorylating FOXP3 at Ser422. Our data also suggest that phosphorylation of FOXP3 at the Ser418 site could prevent FOXP3 phosphorylation at Ser422 mediated by PIM1. Knockdown of PIM1 in in vitro expanded human Tregs promoted FOXP3-induced target gene expression, including CD25, CTLA4, and glucocorticoid-induced tumor necrosis factor receptor (GITR), or weakened FOXP3-suppressed IL-2 gene expression and enhanced the immunosup-pressive activity of Tregs. Furthermore, PIM1-specific inhibitor boosted FOXP3 DNA binding activity in in vitro expanded primary Tregs and also enhanced their suppressive activity toward the proliferation of T effector cells. Taken together, our findings suggest that PIM1 could be a new potential therapeutic target in the prevention and treatment of human-specific autoimmune diseases because of its ability to modulate the immunosuppressive activity of human Tregs.	[Li, Zhiyuan; Lin, Fang; Chen, Zuojia; Yin, Shuying; Gao, Zhimei; Piccioni, Miranda; Tsun, Andy; Li, Bin] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Mol Immunol, Shanghai 200031, Peoples R China; [Zhuo, Changhua; Cai, Sanjun] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200032, Peoples R China; [Zhuo, Changhua; Cai, Sanjun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Zhuo, Changhua] Fujian Med Univ, Teaching Hosp, Fujian Prov Canc Hosp, Dept Surg Oncol, Fuzhou 350014, Peoples R China; [Deng, Guoping] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Zheng, Song Guo] Penn State Univ, Hershey Coll Med, Dept Med, Div Rheumatol, Carlisle, PA 17013 USA; [Zhang, Yu] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fudan University; Fudan University; Fujian Medical University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Shanghai Jiao Tong University	Zhang, Y (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Obstet & Gynecol, Shanghai 200127, Peoples R China.	sh_zhangyu@hotmail.com; binli@sibs.ac.cn	Piccioni, Miranda/X-4530-2018; ZHUO, CHANGHUA/H-7592-2012; Chen, Zuojia/AAM-9465-2020; lI, Bin/AAR-4966-2021	Piccioni, Miranda/0000-0002-4434-6770; ZHUO, CHANGHUA/0000-0002-5900-9048; lI, Bin/0000-0002-7640-8884	National Basic Research Program of China (973 Program) Grants [2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 81271835, 31200646, 81302532, 31350110505, SMCST 11ZR1404900]; Chinese Academy of Sciences Fellowship for Young International Scientists [2013Y1SB0005]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant [2012KIP204]	National Basic Research Program of China (973 Program) Grants(National Basic Research Program of China); Chinese Academy of Sciences Fellowship for Young International Scientists; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant	This work was supported by National Basic Research Program of China (973 Program) Grants 2014CB541803, 2014CB541903, NSFC 81330072, 31370863, 31170825, 81271835, 31200646, 81302532, 31350110505, and SMCST 11ZR1404900; by Chinese Academy of Sciences Fellowship for Young International Scientists 2013Y1SB0005; and by Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2012KIP204.	Alvarado Y, 2012, EXPERT REV HEMATOL, V5, P81, DOI [10.1586/EHM.11.69, 10.1586/ehm.11.69]; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudensky AY, 2006, J EXP MED, V203, P489, DOI 10.1084/jem.20060214; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Valmori D, 2010, P NATL ACAD SCI USA, V107, P19402, DOI 10.1073/pnas.1008247107; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang Z, 2001, J Vet Sci, V2, P167; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing JB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00178; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	37	74	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26872	26881		10.1074/jbc.M114.586651	http://dx.doi.org/10.1074/jbc.M114.586651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096571	hybrid, Green Published			2022-12-25	WOS:000342853900018
J	Samson, AL; Knaupp, AS; Kass, I; Kleifeld, O; Marijanovic, EM; Hughes, VA; Lupton, CJ; Buckle, AM; Bottomley, SP; Medcalf, RL				Samson, Andre L.; Knaupp, Anja S.; Kass, Itamar; Kleifeld, Oded; Marijanovic, Emilia M.; Hughes, Victoria A.; Lupton, Chris J.; Buckle, Ashley M.; Bottomley, Stephen P.; Medcalf, Robert L.			Oxidation of an Exposed Methionine Instigates the Aggregation of Glyceraldehyde-3-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; NUCLEAR TRANSLOCATION; PROTEIN AGGREGATION; ALPHA-CRYSTALLIN; CROSS-LINKS; GAPDH; MECHANISM; INTERACT; STRESS; IDENTIFICATION	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a ubiquitous and abundant protein that participates in cellular energy production. GAPDH normally exists in a soluble form; however, following necrosis, GAPDH and numerous other intracellular proteins convert into an insoluble disulfide-cross-linked state via the process of "nucleocytoplasmic coagulation." Here, free radical-induced aggregation of GAPDH was studied as an in vitro model of nucleocytoplasmic coagulation. Despite the fact that disulfide cross-linking is a prominent feature of GAPDH aggregation, our data show that it is not a primary rate-determining step. To identify the true instigating event of GAPDH misfolding, we mapped the post-translational modifications that arise during its aggregation. Solvent accessibility and energy calculations of the mapped modifications within the context of the high resolution native GAPDH structure suggested that oxidation of methionine 46 may instigate aggregation. We confirmed this by mutating methionine 46 to leucine, which rendered GAPDH highly resistant to free radical-induced aggregation. Molecular dynamics simulations suggest that oxidation of methionine 46 triggers a local increase in the conformational plasticity of GAPDH that likely promotes further oxidation and eventual aggregation. Hence, methionine 46 represents a "linchpin" whereby its oxidation is a primary event permissive for the subsequent misfolding, aggregation, and disulfide cross-linking of GAPDH. A critical role for linchpin residues in nucleocytoplasmic coagulation and other forms of free radical-induced protein misfolding should now be investigated. Furthermore, because disulfide-cross-linked aggregates of GAPDH arise in many disorders and because methionine 46 is irrelevant to native GAPDH function, mutation of methionine 46 in models of disease should allow the unequivocal assessment of whether GAPDH aggregation influences disease progression.	[Samson, Andre L.; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Samson, Andre L.; Knaupp, Anja S.; Kass, Itamar; Kleifeld, Oded; Marijanovic, Emilia M.; Hughes, Victoria A.; Lupton, Chris J.; Buckle, Ashley M.; Bottomley, Stephen P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Knaupp, Anja S.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Knaupp, Anja S.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Kass, Itamar] Monash Univ, Victorian Life Sci Computat Ctr, Clayton, Vic 3800, Australia	Monash University; Monash University; Australian Regenerative Medicine Institute; Monash University; Monash University; Monash University	Samson, AL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Level 4,89 Commercial Rd, Melbourne, Vic 3004, Australia.	andre.samson@monash.edu; robert.medcalf@monash.edu	Kass, Itamar/P-5724-2014; Buckle, Ashley/P-8366-2016; Medcalf, Robert L/E-9632-2011	Kass, Itamar/0000-0002-5368-937X; Buckle, Ashley/0000-0003-2943-9044; Samson, Andre/0000-0002-0637-2716; Lupton, Christopher Joseph/0000-0002-4617-4853; Knaupp, Anja/0000-0003-0493-7872	Faculty of Medicine, Nursing and Health Sciences early career development grant; Australian National Health and Medical Research Council (NHMRC) grant; Victorian Life Sciences Computation Initiative Grant [VR0303]; NHMRC senior research fellowship	Faculty of Medicine, Nursing and Health Sciences early career development grant; Australian National Health and Medical Research Council (NHMRC) grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative Grant; NHMRC senior research fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a Faculty of Medicine, Nursing and Health Sciences early career development grant (to A. L. S.), an Australian National Health and Medical Research Council (NHMRC) grant (to R. L. M., S. P. B., and A. L. S.), and Victorian Life Sciences Computation Initiative Grant VR0303 (to A. L. S. and I. K.) for use of its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia.; Supported by an NHMRC senior research fellowship.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cortez LM, 2010, FEBS LETT, V584, P625, DOI 10.1016/j.febslet.2009.12.012; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; DURCHSCHSLAG H, 1971, EUR J BIOCHEM, V19, P9, DOI 10.1111/j.1432-1033.1971.tb01282.x; DURRIEU C, 1987, MOL CELL BIOCHEM, V74, P55; Ferns JE, 2012, NEUROCHEM RES, V37, P244, DOI 10.1007/s11064-011-0601-4; Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Han X, 2011, J PROTEOME RES, V10, P2930, DOI 10.1021/pr200153k; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Herrero R, 2011, J CLIN INVEST, V121, P1174, DOI 10.1172/JCI43004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang JS, 2009, BRAIN RES, V1279, P1, DOI 10.1016/j.brainres.2009.05.011; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Koudelka T, 2012, J AGR FOOD CHEM, V60, P4144, DOI 10.1021/jf205168t; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Mitomi Y, 2012, J BIOL CHEM, V287, P34764, DOI 10.1074/jbc.M112.387035; Mulinacci F, 2013, EUR J PHARM BIOPHARM, V85, P42, DOI 10.1016/j.ejpb.2013.03.015; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Naletova IN, 2006, BBA-PROTEINS PROTEOM, V1764, P831, DOI 10.1016/j.bbapap.2006.02.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polyakova OV, 2005, PROTEIN SCI, V14, P921, DOI 10.1110/ps.041211205; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Samson AL, 2012, CELL REP, V2, P889, DOI 10.1016/j.celrep.2012.08.026; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seidler NW, 2013, ADV EXP MED BIOL, V985, P1, DOI 10.1007/978-94-007-4716-6_1; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Tanaka N, 2011, J BIOL CHEM, V286, P5884, DOI 10.1074/jbc.M110.176396; Tornvall U, 2010, ANAL METHODS-UK, V2, P1638, DOI 10.1039/c0ay00375a; Torosantucci R, 2013, MOL PHARMACEUT, V10, P2311, DOI 10.1021/mp300665u; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yan H, 2006, MOL VIS, V12, P1153; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	55	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26922	26936		10.1074/jbc.M114.570275	http://dx.doi.org/10.1074/jbc.M114.570275			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25086035	Green Published, hybrid			2022-12-25	WOS:000342853900023
J	Homma, Y; Kanno, S; Sasaki, K; Nishita, M; Yasui, A; Asano, T; Ohashi, K; Mizuno, K				Homma, Yuta; Kanno, Shin-ichiro; Sasaki, Kazutaka; Nishita, Michiru; Yasui, Akira; Asano, Tomoichiro; Ohashi, Kazumasa; Mizuno, Kensaku			Insulin Receptor Substrate-4 Binds to Slingshot-1 Phosphatase and Promotes Cofilin Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED ACTIN REORGANIZATION; LIM-KINASE; SIGNALING PATHWAY; BREAST-CANCER; PROTEIN; CELL; PHOSPHORYLATION; MICE; ACTIVATION; EXPRESSION	Cofilin plays an essential role in cell migration and morphogenesis by enhancing actin filament dynamics via its actin filament- severing activity. Slingshot-1 (SSH1) is a protein phosphatase that plays a crucial role in regulating actin dynamics by dephosphorylating and reactivating cofilin. In this study, we identified insulin receptor substrate (IRS)-4 as a novel SSH1-binding protein. Co-precipitation assays revealed the direct endogenous binding of IRS4 to SSH1. IRS4, but not IRS1 or IRS2, was bound to SSH1. IRS4 was bound to SSH1 mainly through the unique region (amino acids 335-400) adjacent to the C terminus of the phosphotyrosine-binding domain of IRS4. The N-terminal A, B, and phosphatase domains of SSH1 were bound to IRS4 independently. Whereas in vitro phosphatase assays revealed that IRS4 does not directly affect the cofilin phosphatase activity of SSH1, knockdown of IRS4 increased cofilin phosphorylation in cultured cells. Knockdown of IRS4 decreased phosphatidylinositol 3-kinase (PI3K) activity, and treatment with an inhibitor of PI3K increased cofilin phosphorylation. Akt preferentially phosphorylated SSH1 at Thr-826, but expression of a non-phosphorylatable T826A mutant of SSH1 did not affect insulin-induced cofilin dephosphorylation, and an inhibitor of Akt did not increase cofilin phosphorylation. These results suggest that IRS4 promotes cofilin dephosphorylation through sequential activation of PI3K and SSH1 but not through Akt. In addition, IRS4 co-localized with SSH1 in F-actin-rich membrane protrusions in insulin-stimulated cells, which suggests that the association of IRS4 with SSH1 contributes to localized activation of cofilin in membrane protrusions.	[Homma, Yuta; Sasaki, Kazutaka; Nishita, Michiru; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Kanno, Shin-ichiro; Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome Canc & Aging, Sendai, Miyagi 9808575, Japan; [Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Hiroshima 7348553, Japan	Tohoku University; Tohoku University; Hiroshima University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Kanno, Shin-ichiro/AAE-4549-2019; Ohashi, Kazumasa/U-7028-2019; Homma, Yuta/O-1029-2019; Homma, Yuta/T-3089-2018; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; Homma, Yuta/0000-0002-3676-6089; Homma, Yuta/0000-0002-3676-6089; 	Ministry of Education, Culture, Science, Sports and Technology of Japan [24121702, 24370051]	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants for Scientific Research 24121702 and 24370051 (to K. M.) from the Ministry of Education, Culture, Science, Sports and Technology of Japan.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031; Fantin VR, 1998, J BIOL CHEM, V273, P10726, DOI 10.1074/jbc.273.17.10726; Fantin VR, 2000, AM J PHYSIOL-ENDOC M, V278, pE127, DOI 10.1152/ajpendo.2000.278.1.E127; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Hoxhaj G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073327; Jung SK, 2007, PROTEINS, V68, P408, DOI 10.1002/prot.21399; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Numan S, 1999, MOL BRAIN RES, V72, P97, DOI 10.1016/S0169-328X(99)00160-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Shimwell NJ, 2009, ONCOGENE, V28, P686, DOI 10.1038/onc.2008.417; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Uchida T, 2000, MOL CELL BIOL, V20, P126, DOI 10.1128/MCB.20.1.126-138.2000; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	33	17	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26302	26313		10.1074/jbc.M114.565945	http://dx.doi.org/10.1074/jbc.M114.565945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100728	Green Published, hybrid			2022-12-25	WOS:000342128800024
J	Werner, KM; Perez, LJ; Ghosh, R; Semmelhack, MF; Bassler, BL				Werner, Kristen M.; Perez, Lark J.; Ghosh, Rajarshi; Semmelhack, Martin F.; Bassler, Bonnie L.			Caenorhabditis elegans Recognizes a Bacterial Quorum-sensing Signal Molecule through the AWC(ON) Neuron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE; ESCHERICHIA-COLI; DAUER LARVA; EL-TOR; AUTOINDUCER; CHEMOTAXIS; GENES; IDENTIFICATION; BIOSYNTHESIS; PHEROMONES	In a process known as quorum sensing, bacteria use chemicals called autoinducers for cell-cell communication. Population-wide detection of autoinducers enables bacteria to orchestrate collective behaviors. In the animal kingdom detection of chemicals is vital for success in locating food, finding hosts, and avoiding predators. This behavior, termed chemotaxis, is especially well studied in the nematode Caenorhabditis elegans. Here we demonstrate that the Vibrio cholerae autoinducer (S)-3-hydroxytridecan-4-one, termed CAI-1, influences chemotaxis in C. elegans. C. elegans prefers V. cholerae that produces CAI-1 over a V. cholerae mutant defective for CAI-1 production. The position of the CAI-1 ketone moiety is the key feature driving CAI-1-directed nematode behavior. CAI-1 is detected by the C. elegans amphid sensory neuron AWC(ON). Laser ablation of the AWC(ON) cell, but not other amphid sensory neurons, abolished chemoattraction to CAI-1. These analyses define the structural features of a bacterial-produced signal and the nematode chemosensory neuron that permit cross-kingdom interaction.	[Werner, Kristen M.; Bassler, Bonnie L.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Semmelhack, Martin F.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Perez, Lark J.] Rowan Univ, Dept Chem & Biochem, Glassboro, NJ 08028 USA; [Ghosh, Rajarshi] Baylor Coll Med, Dept Pediat Oncol, Houston, TX 77030 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Princeton University; Rowan University; Baylor College of Medicine; Howard Hughes Medical Institute	Bassler, BL (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	bbassler@princeton.edu		Perez, Lark/0000-0002-6920-7996; Bassler, Bonnie/0000-0002-0043-746X	National Institutes of Health [5R01GM065859]; Howard Hughes Medical Institute; National Science Foundation [MCB-0343821]; Div Of Molecular and Cellular Bioscience [0948112] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM065859 (to B. L. B.). This work was also supported by the Howard Hughes Medical Institute and National Science Foundation Grant MCB-0343821 (to B. L. B.)	Artyukhin AB, 2013, J BIOL CHEM, V288, P18778, DOI 10.1074/jbc.C113.477000; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann Cornelia I, 2006, WormBook, P1; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bolitho ME, 2011, BIOORGAN MED CHEM, V19, P6906, DOI 10.1016/j.bmc.2011.09.021; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRENNER S, 1974, GENETICS, V77, P71; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Choe A, 2012, P NATL ACAD SCI USA, V109, P20949, DOI 10.1073/pnas.1218302109; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; LEWIS JA, 1977, J COMP NEUROL, V172, P489, DOI 10.1002/cne.901720306; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Ng WL, 2011, MOL MICROBIOL, V79, P1407, DOI 10.1111/j.1365-2958.2011.07548.x; Ng WL, 2010, P NATL ACAD SCI USA, V107, P5575, DOI 10.1073/pnas.1001392107; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; THOMAS JH, 1990, GENETICS, V124, P855; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Wei YZ, 2011, ACS CHEM BIOL, V6, P356, DOI 10.1021/cb1003652; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Zagoriy V, 2010, CHEM BIODIVERS, V7, P2016, DOI 10.1002/cbdv.201000012; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	51	21	22	0	36	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26566	26573		10.1074/jbc.M114.573832	http://dx.doi.org/10.1074/jbc.M114.573832			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092291	Green Published, hybrid			2022-12-25	WOS:000342128800047
J	Agarwal, S; Jangir, DK; Mehrotra, R; Lohani, N; Rajeswari, MR				Agarwal, Shweta; Jangir, Deepak Kumar; Mehrotra, Ranjana; Lohani, Neelam; Rajeswari, M. R.			A Structural Insight into Major Groove Directed Binding of Nitrosourea Derivative Nimustine with DNA: A Spectroscopic Study	PLOS ONE			English	Article							CIRCULAR-DICHROISM; ECTEINASCIDIN 743; NUCLEIC-ACIDS; MINOR-GROOVE; C-FORM; QUADRUPLEXES; RADIOTHERAPY; ALKYLATION; TRANSITION; ENERGETICS	Nitrosourea therapeutics occupies a definite place in cancer therapy but its exact mechanism of action has yet to be established. Nimustine, a chloroethyl nitrosourea derivative, is used to treat various types of malignancy including gliomas. The present work focuses on the understanding of nimustine interaction with DNA to delineate its mechanism at molecular level. Attenuated total reflection-Fourier transform infrared (ATR-FTIR) has been used to determine the binding sites of nimustine on DNA. Circular dichroism (CD) spectroscopy has been used to confirm conformational variations in DNA molecule upon nimustine-DNA interaction. Thermodynamic parameters of nimustine-DNA reaction have been calculated by isothermal titration calorimetry. Results of the present study demonstrate that nimustine is not a simple alkylating agent rather it causes major grove-directed-alkylation. Spectroscopic data suggest binding of nimustine with nitrogenous bases guanine (C6 = O6) and thymine (C4 = O4) in DNA major groove. CD spectra of nimustine-DNA complexes point toward the perturbation of native B-conformation of DNA and its partial transition into C-form. Thermodynamically, nimustine-DNA interaction is an entropy driven endothermic reaction, which suggests hydrophobic interaction of nimustine in DNA-major groove pocket. Spectral results suggest base binding and local conformational changes in DNA upon nimustine interaction. Investigation of drug-DNA interaction is an essential part of rational drug designing that also provides information about the drug's action at molecular level. Results, demonstrated here, may contribute in the development of new nitrosourea therapeutics with better efficacy and fewer side effects.	[Agarwal, Shweta; Jangir, Deepak Kumar; Mehrotra, Ranjana] CSIR Natl Phys Lab, New Delhi, India; [Lohani, Neelam; Rajeswari, M. R.] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Physical Laboratory (NPL); All India Institute of Medical Sciences (AIIMS) New Delhi	Mehrotra, R (corresponding author), CSIR Natl Phys Lab, New Delhi, India.	ranjana@mail.nplindia.ernet.in		Jangir, Deepak Kumar/0000-0001-8838-3859	National Physical Laboratory, New Delhi	National Physical Laboratory, New Delhi	This work was supported by National Physical Laboratory, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, J PHOTOCHEMISTRY P B; Agarwal S, 2013, J PHOTOCHEMISTRY P B; ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Barcelo F, 2002, NUCLEIC ACIDS RES, V30, P4567, DOI 10.1093/nar/gkf558; BOKMA JT, 1987, BIOPOLYMERS, V26, P893, DOI 10.1002/bip.360260609; Braun CS, 2003, BIOPHYS J, V84, P1114, DOI 10.1016/S0006-3495(03)74927-3; Chaires JB, 1997, BIOPOLYMERS, V44, P201, DOI 10.1002/(SICI)1097-0282(1997)44:3<201::AID-BIP2>3.0.CO;2-Z; Chaires JB, 1998, CURR OPIN STRUC BIOL, V8, P314, DOI 10.1016/S0959-440X(98)80064-X; CHAN A, 1979, BIOCHEMISTRY-US, V18, P84, DOI 10.1021/bi00568a013; Curtis-Johnson W., 1994, CD NUCL ACIDS CIRCUL, P523; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; HANSEN M, 1995, J AM CHEM SOC, V117, P2421, DOI 10.1021/ja00114a006; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; Haq I, 2000, J MOL RECOGNIT, V13, P188, DOI 10.1002/1099-1352(200007/08)13:4<188::AID-JMR503>3.0.CO;2-1; Jangir DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069933; KENNARD O, 1993, PURE APPL CHEM, V65, P1213, DOI 10.1351/pac199365061213; Kondo N, 2010, CANCER SCI, V101, P1881, DOI 10.1111/j.1349-7006.2010.01591.x; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; MINEURA K, 1988, J NEUROL NEUROSUR PS, V51, P1391, DOI 10.1136/jnnp.51.11.1391; Miyagami M, 1990, Neurol Med Chir (Tokyo), V30, P582, DOI 10.2176/nmc.30.582; Miyahara T, 2013, J PHYS CHEM A, V117, P42, DOI 10.1021/jp3085556; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Pagano B, 2009, INT J MOL SCI, V10, P2935, DOI 10.3390/ijms10072935; Patil SD, 2000, NUCLEIC ACIDS RES, V28, P4125, DOI 10.1093/nar/28.21.4125; Pommier Y, 1996, BIOCHEMISTRY-US, V35, P13303, DOI 10.1021/bi960306b; PORTUGAL J, 1985, EMBO J, V4, P2403, DOI 10.1002/j.1460-2075.1985.tb03946.x; PULLMAN B, 1985, J BIOSCIENCE, V8, P681, DOI 10.1007/BF02702766; Puyo S, 2013, CRITICAL REV ONCOLOG; TAKAKURA K, 1986, J NEUROSURG, V64, P53, DOI 10.3171/jns.1986.64.1.0053; Tanaka M, 2001, JPN J CLIN ONCOL, V31, P246, DOI 10.1093/jjco/hye059; Tanaka S, 2003, INT J CANCER, V103, P67, DOI 10.1002/ijc.10757; Tyagi G, 2014, BBA-GEN SUBJECTS, V1840, P350, DOI 10.1016/j.bbagen.2013.09.007; Vijayalakshmi R, 2000, BIOCHEM BIOPH RES CO, V271, P731, DOI 10.1006/bbrc.2000.2707; Vorlickova M, 2012, CHIRALITY, V24, P691, DOI 10.1002/chir.22064; Xiong Y, 2001, PROTEIN NUCL ACID IN; Zerbe O, 2012, ANGEW CHEM INT EDIT, V51, P860, DOI 10.1002/anie.201107639; Zewail-Foote M, 1999, J MED CHEM, V42, P2493, DOI 10.1021/jm990241l; Zhang ZL, 2002, BIOPHYS CHEM, V97, P7, DOI 10.1016/S0301-4622(02)00006-6; Zhao CQ, 2012, NUCLEIC ACIDS RES, V40, P8186, DOI 10.1093/nar/gks524; Zuidam NJ, 1999, FEBS LETT, V457, P419, DOI 10.1016/S0014-5793(99)01053-4	42	22	22	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104115	10.1371/journal.pone.0104115	http://dx.doi.org/10.1371/journal.pone.0104115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101667	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000339993900038
J	Du, CZ; Li, Z; Wang, S; Zhou, ZM; Wang, JK; Dong, J; Chen, CS				Du, Chengzhi; Li, Zhen; Wang, Shuang; Zhou, Zhongmei; Wang, Jingkun; Dong, Jian; Chen, Ceshi			Tongshu Capsule Down-Regulates the Expression of Estrogen Receptor alpha and Suppresses Human Breast Cancer Cell Proliferation	PLOS ONE			English	Article							TAMOXIFEN; BETA; PHOSPHORYLATION; ESTRADIOL; DISEASE	The Tongshu Capsule (TSC) is a prevalent form of traditional Chinese medicine widely used for its purported effects in treating mammary gland hyperplasia and inflammation. Though successful in several clinical studies, there is no clear evidence as to why TSC has a positive treatment effect, and little known about underlying mechanism that may account for it. In this study, we examined the effects of TSC and found that it has a comparatively strong growth inhibition on ER alpha positive breast cancer cells. TSC seems to cause G1 cell cycle arrest instead of apoptosis. Interestingly, TSC also down-regulated the expression of ER alpha and Cyclin D1. Consistently, TSC suppressed E2 mediated ER alpha downstream gene expression and cell proliferation in ER alpha positive breast cancer cell lines MCF7 and T47D. Depletion of ER alpha partially abolished the effects of TSC on the decrease of Cyclin D1 and cell viability. Our findings suggest that TSC may have therapeutic effects on ER alpha positive breast cancers and moreover that TSC may suppress breast epithelial cell proliferation by inhibiting the estrogen pathway.	[Du, Chengzhi; Wang, Shuang; Zhou, Zhongmei; Chen, Ceshi] Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Li, Zhen; Dong, Jian] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Wang, Jingkun] Kunming Med Univ, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Kunming Medical University	Chen, CS (corresponding author), Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	chenc@mail.kiz.ac.cn			Yunnan Institute of Materia Medica; National Nature Science Foundation of China [81120108019, U1132605, 81325016]; Yunnan Province High-Profile Scientist Program [2010CI114]	Yunnan Institute of Materia Medica; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province High-Profile Scientist Program	This study was partially funded by Yunnan Institute of Materia Medica, which is the manufacturer of Tongshu Capsule. This funder provided support in the form of salaries for author JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, orpreparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This study was also supported in part by National Nature Science Foundation of China (81120108019, U1132605, and 81325016), and a grant from the Yunnan Province High-Profile Scientist Program (2010CI114). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRA JC, 1979, CANCER, V44, P228, DOI 10.1002/1097-0142(197907)44:1<228::AID-CNCR2820440137>3.0.CO;2-0; Altucci L, 1996, ONCOGENE, V12, P2315; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; Chen J, 2011, HEBEI MED J, V33, P623; Cheng L, 2012, J CLIN INVEST, V122, P2857, DOI 10.1172/JCI62676; Chu I, 2005, CANCER RES, V65, P18; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Kontostolis E, 1997, GYNECOL ENDOCRINOL, V11, P393, DOI 10.3109/09513599709152566; Lagiou P, 2013, ANN ONCOLOGY; Li X, 2006, GUIDE CHINA MED, V4; MADDOX PR, 1989, WORLD J SURG, V13, P699, DOI 10.1007/BF01658417; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Santen RJ, 2005, NEW ENGL J MED, V353, P275, DOI 10.1056/NEJMra035692; Sartippour MR, 2006, CARCINOGENESIS, V27, P2424, DOI 10.1093/carcin/bgl066; Sasaki Y, 2010, CANCER SCI, V101, P2286, DOI 10.1111/j.1349-7006.2010.01673.x; Shaw LE, 2006, J STEROID BIOCHEM, V99, P19, DOI 10.1016/j.jsbmb.2005.11.005	20	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104261	10.1371/journal.pone.0104261	http://dx.doi.org/10.1371/journal.pone.0104261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101695	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993900054
J	Guo, N; Zhu, MX; Han, XJ; Sui, D; Wang, Y; Yang, Q				Guo, Na; Zhu, Meixuan; Han, Xuejiao; Sui, Dan; Wang, Yang; Yang, Qian			The Metabolism of Salidroside to Its Aglycone p-Tyrosol in Rats following the Administration of Salidroside	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; N-TYROSOL; IN-VIVO; GASTROINTESTINAL-TRACT; TISSUE DISTRIBUTION; DIETARY FLAVONOIDS; SMALL-INTESTINE; GLYCOSIDES; PLASMA; DEGLYCOSYLATION	Salidroside is one of the major phenolic glycosides in Rhodiola, which has been reported to possess various biological activities. In the present study the in vivo deglycosylation metabolism of salidroside was investigated and its aglycone p-tyrosol but not the original salidroside was identified as the main form in rat tissues following the administration of salidroside. After the i.v. administration of salidroside at a dose of 50 mg/kg in rats, salidroside was quantified only in the liver, kidney and heart tissues. The highest level of p-tyrosol was detected in the heart, followed by the spleen, kidney, liver and lungs, in order. Salidroside was detected only in the liver, in contrast, p-tyrosol was detectable in most tissues except the brain, and the kidney tissues contained a significant amount of p-tyrosol compared to the other tissues after the i.g. administration of 100 mg/kg salidroside. The excretion behaviour revealed that the administrated salidroside mainly eliminated in the form of salidroside but not its aglycone metabolite p-tyrosol through urine. After i.v. and i.g. administration in rats, 64.00% and 23.80% of the total dose was excreted through urine in the form of salidroside, respectively. In addition, 0.19% and 2.25% of the dose was excreted in the form of p-tyrosol through urine after i.v. and i.g. administration, respectively. The faecal salidroside and p-tyrosol concentrations were 0.3% and 1.48% of the total dose after i.v. administration, respectively. After the i.g. administration of salidroside, trace salidroside and p-tyrosol were quantified in faeces within 72 h. In addition, the biliary excretion levels of salidroside after i.v. and i.g. administration were 2.86% and 0.02% of the dose, respectively. The obtained results show that salidroside was extensively metabolised to its aglycone p-tyrosol and distributed to various organs and the orginal salidroside was cleared rapidly through urine following the administration of salidroside.	[Guo, Na; Yang, Qian] Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150006, Peoples R China; [Guo, Na; Zhu, Meixuan; Han, Xuejiao; Wang, Yang] Northeast Forestry Univ, Alkali Soil Nat Environm Sci Ctr, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Harbin, Peoples R China; [Yang, Qian] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Sui, Dan] Northeast Forestry Univ, Management Off Lab & Equipment, Ctr Anal & Testing, Harbin, Peoples R China	Harbin Institute of Technology; Northeast Forestry University - China; Harbin Institute of Technology; Northeast Forestry University - China	Yang, Q (corresponding author), Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150006, Peoples R China.	ywang@nefu.edu.cn; yangq@hit.edu.cn						Chang YW, 2007, J CHROMATOGR B, V857, P164, DOI 10.1016/j.jchromb.2007.06.029; Chao PDL, 2006, BIOAVAILABILITY META; Chen J, 2003, J PHARMACOL EXP THER, V304, P1228, DOI 10.1124/jpet.102.046409; Chernyshova GA, 2007, B EXP BIOL MED+, V143, P689, DOI 10.1007/s10517-007-0215-7; Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4; Day AJ, 1998, FEBS LETT, V436, P71, DOI 10.1016/S0014-5793(98)01101-6; Day AJ, 2001, BRIT J NUTR, V86, pS105, DOI 10.1079/BJN2001342; Di Benedetto R, 2007, NUTR METAB CARDIOVAS, V17, P535, DOI 10.1016/j.numecd.2006.03.005; Giovannini C, 1999, J NUTR, V129, P1269, DOI 10.1093/jn/129.7.1269; Guo N, 2012, MOLECULES, V17, P4733, DOI 10.3390/molecules17044733; ICH, 1995, FED REGISTER, V60, P11274; Jin Z, 2009, CHINA SURFACTANT DET, V39, P402; Kanupriya D, 2005, MOL CELL BIOCHEM, V275, P1, DOI 10.1007/s11010-005-7637-1; Li M., 2008, J MED COLL PLA, V23, P88, DOI [DOI 10.1016/S1000-1948(08)60028-3, 10.1016/s1000-1948(08)60028-3]; Liu Z, 2002, CHINESE CEREALS OILS, V17, P24; Manjunath K, 2005, J CONTROL RELEASE, V107, P215, DOI 10.1016/j.jconrel.2005.06.006; Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3; Plotnikov MB, 2007, B EXP BIOL MED+, V143, P61, DOI 10.1007/s10517-007-0017-y; Samuel SM, 2008, J AGR FOOD CHEM, V56, P9692, DOI 10.1021/jf802050h; Spencer JPE, 2008, BRIT J NUTR, V99, P12, DOI 10.1017/S0007114507798938; Spencer JPE, 2003, J NUTR, V133, p3255S, DOI 10.1093/jn/133.10.3255S; Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558; Spencer JPE, 1999, FEBS LETT, V458, P224, DOI 10.1016/S0014-5793(99)01160-6; Tezuka Y, 1999, PHYTOMEDICINE, V6, P197, DOI 10.1016/S0944-7113(99)80009-9; Vivancos M, 2008, BRIT J NUTR, V99, P1199, DOI 10.1017/S0007114507876203; Wang DG, 2008, PHYTOMEDICINE, V15, P859, DOI 10.1016/j.phymed.2008.02.009; Wang HB, 2009, PHYTOMEDICINE, V16, P146, DOI 10.1016/j.phymed.2008.07.013; Williamson G, 2000, BIOCHEM SOC T, V28, P16, DOI 10.1042/bst0280016; Yang XJ, 2011, J CHROMATOGR B, V879, P2513, DOI 10.1016/j.jchromb.2011.07.002; YE YC, 1993, ACTA PHARM SINIC, V14, P424; Zhang JP, 2009, EUR J PHARMACOL, V607, P6, DOI 10.1016/j.ejphar.2009.01.046; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n	32	31	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103648	10.1371/journal.pone.0103648	http://dx.doi.org/10.1371/journal.pone.0103648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101641	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993900021
J	Hingsamer, P; Peeters, F; Hofmann, H				Hingsamer, Peter; Peeters, Frank; Hofmann, Hilmar			The Consequences of Internal Waves for Phytoplankton Focusing on the Distribution and Production of Planktothrix rubescens	PLOS ONE			English	Article							LAKE-AMMERSEE; VERTICAL-DISTRIBUTION; DEPTH; CYANOBACTERIA; DYNAMICS; PHOTOSYNTHESIS; ZOOPLANKTON; POPULATIONS; ABUNDANCE; TURNOVER	Consequences of internal wave motion for phytoplankton and in particular for the distribution and production of the harmful and buoyant cyanobacterium Planktothrix rubescens were investigated based on data from two field campaigns conducted in Lake Ammer during summer 2009 and 2011. In both years, P. rubescens dominated the phytoplankton community and formed a deep chlorophyll maximum (DCM) in the metalimnion. Internal wave motions caused vertical displacement of P. rubescens of up to 6 m and 10 m, respectively. Vertical displacements of isotherms and of isoconcentration lines of P. rubescens from the same depth range coincided, suggesting that P. rubescens did not or could not regulate its buoyancy to prevent wave-induced vertical displacements. Diatoms dominated the phytoplankton community in the epilimnion and were vertically separated from P. rubescens. The thickness of the diatom layer, but not the diatom concentrations within the layer, changed in phase with the changes in the thickness of the epilimnion caused by internal wave motions. Seiche induced vertical displacements of P. rubescens caused fluctuations in the light intensity available at the depth of the P. rubescens layer. The interplay between seiche induced vertical displacements of the P. rubescens layer and the daily cycle of incident light lead to differences in the daily mean available light intensity between lake ends by up to a factor of similar to 3. As a consequence, the daily mean specific oxygen production rate of P. rubescens differed by up to a factor of similar to 7 between lake ends. The horizontal differences in the specific oxygen production rate of P. rubescens were persistent over several days suggesting that the associated production of P. rubescens biomass may lead to phytoplankton patchiness. The effect of internal seiches on the spatial heterogeneity and the persistence of horizontal differences in production, however, depend on the timing and the synchronization between internal wave motion and the daily course of incident light intensity. Vertical displacements caused by internal waves could be distinguished from other factors influencing the distribution of P. rubescens (e. g. active buoyancy control, production, vertical mixing) by a temperature-based data transformation. This technique may be of general use for separating wave-induced transport from other processes (e. g. sedimentation, vertical mixing) that affect the distributions of dissolved substances and suspended particles.	[Hingsamer, Peter; Peeters, Frank; Hofmann, Hilmar] Univ Konstanz, Limnol Inst, Environm Phys Grp, Constance, Germany	University of Konstanz	Hingsamer, P (corresponding author), Univ Konstanz, Limnol Inst, Environm Phys Grp, Constance, Germany.	peter.hingsamer@uni-konstanz.de	Hofmann, Hilmar/G-8445-2011		German Research Foundation (DFG) [HO 4536/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by the German Research Foundation (DFG) - grant HO 4536/2-1 (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; Bright DI, 2000, NEW PHYTOL, V146, P301, DOI 10.1046/j.1469-8137.2000.00640.x; Burgi H, 2002, HYDROBIOLOGIA, V469, P33, DOI 10.1023/A:1015575527280; Carraro E, 2012, HYDROBIOLOGIA, V698, P77, DOI 10.1007/s10750-012-1096-y; Cuypers Y, 2011, ISME J, V5, P580, DOI 10.1038/ismej.2010.154; da Silva JCB, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013888; de Figueiredo DR, 2004, ECOTOX ENVIRON SAFE, V59, P151, DOI 10.1016/j.ecoenv.2004.04.006; Dokulil MT, 2012, HYDROBIOLOGIA, V698, P29, DOI 10.1007/s10750-012-1020-5; Ernst B, 2001, ENVIRON TOXICOL, V16, P483, DOI 10.1002/tox.10006.abs; Ernst B, 2009, HARMFUL ALGAE, V8, P329, DOI 10.1016/j.hal.2008.07.006; Evans MA, 2008, LIMNOL OCEANOGR, V53, P339, DOI 10.4319/lo.2008.53.1.0339; Franks PJS, 1997, ICES J MAR SCI, V54, P161, DOI 10.1006/jmsc.1996.0191; GAEDKE U, 1991, J PLANKTON RES, V13, P743, DOI 10.1093/plankt/13.4.743; Garneau ME, 2013, LIMNOL OCEANOGR, V58, P1892, DOI 10.4319/lo.2013.58.5.1892; Halstvedt CB, 2008, J PLANKTON RES, V30, P607, DOI 10.1093/plankt/fbn025; Halstvedt CB, 2007, J PLANKTON RES, V29, P471, DOI 10.1093/plankt/fbm036; Hofmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080913; Hossain MY, 2012, SAINS MALAYS, V41, P277; Huber AMR, 2011, LIMNOL OCEANOGR, V56, P695, DOI 10.4319/lo.2011.56.2.0695; Jacquet S, 2005, HARMFUL ALGAE, V4, P651, DOI 10.1016/j.hal.2003.12.006; Kaartvedt S, 2012, MAR ECOL PROG SER, V452, P1, DOI 10.3354/meps09688; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; Legnani Elena, 2005, Journal of Limnology, V64, P61; Lenard T, 2009, OCEANOL HYDROBIOL ST, V38, P45; MacIntyre S, 2001, HYDROBIOLOGIA, V466, P13, DOI 10.1023/A:1014563914112; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; MORTIMER CH, 1952, PHILOS T ROY SOC B, V236, P355, DOI 10.1098/rstb.1952.0005; Nixdorf B., 2004, DOKUMENTATION ZUSTAN; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Pannard A, 2011, LIMNOL OCEANOGR FLUI, V1, P91, DOI [DOI 10.1215/21573698-1303296, 10.1215/21573698-1303296]; Pannard A, 2008, CAN J FISH AQUAT SCI, V65, P47, DOI 10.1139/F07-149; PINELALLOUL B, 1995, HYDROBIOLOGIA, V300, P17; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/NCLIMATE1581, 10.1038/nclimate1581]; Preusse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041674; Rinke K, 2007, FRESHWATER BIOL, V52, P137, DOI 10.1111/j.1365-2427.2006.01687.x; Suda S, 2002, INT J SYST EVOL MICR, V52, P1577, DOI [10.1099/ijs.0.01834-0, 10.1099/00207713-52-5-1577]; Tsubo M, 2005, THEOR APPL CLIMATOL, V80, P17, DOI 10.1007/s00704-004-0080-5; Vetter M, 2012, FUND APPL LIMNOL, V180, P41, DOI 10.1127/1863-9135/2012/0123; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Walsby AE, 1998, J PLANKTON RES, V20, P1357, DOI 10.1093/plankt/20.7.1357; Walsby AE, 2004, NEW PHYTOL, V162, P133, DOI 10.1111/j.1469-8137.2004.01020.x; Walsby AE, 2001, AQUAT SCI, V63, P326, DOI 10.1007/PL00001358; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X	43	14	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104359	10.1371/journal.pone.0104359	http://dx.doi.org/10.1371/journal.pone.0104359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102279	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900060
J	Lee, SJ; Shin, SJ; Lee, MH; Lee, MG; Kang, TH; Park, WS; Soh, BY; Park, JH; Shin, YK; Kim, HW; Yun, CH; Jung, ID; Park, YM				Lee, Seung Jun; Shin, Sung Jae; Lee, Moon Hee; Lee, Min-Goo; Kang, Tae Heung; Park, Won Sun; Soh, Byoung Yul; Park, Jung Hee; Shin, Yong Kyoo; Kim, Han Wool; Yun, Cheol-Heui; Jung, In Duk; Park, Yeong-Min			A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CANCER-IMMUNOTHERAPY; CARCINOMA-CELLS; MELANOMA PATIENTS; IMMUNE-RESPONSES; INNATE IMMUNITY; T-CELLS; FUSIONS; ANTIGEN; MICE	A key factor in dendritic cell (DC)-based tumor immunotherapy is the identification of an immunoadjuvant capable of inducing DC maturation to enhance cellular immunity. The efficacy of a 50S ribosomal protein L7/L12 (rplL) from Mycobacterium tuberculosis Rv0652, as an immunoadjuvant for DC-based tumor immunotherapy, and its capacity for inducing DC maturation was investigated. In this study, we showed that Rv0652 is recognized by Toll-like receptor 4 (TLR4) to induce DC maturation, and pro-inflammatory cytokine production (TNF-alpha, IL-1beta, and IL-6) that is partially modulated by both MyD88 and TRIF signaling pathways. Rv0652-activated DCs could activate naive T cells, effectively polarize CD4(+) and CD8(+) T cells to secrete IFN-gamma, and induce T cell-mediated-cytotoxicity. Immunization of mice with Rv0652-stimulated ovalbumin (OVA)-pulsed DCs resulted in induction of a potent OVA-specific CD8(+) T cell response, slowed tumor growth, and promoted long-term survival in a murine OVA-expressing E. G7 thymoma model. These findings suggest that Rv0652 enhances the polarization of T effector cells toward a Th1 phenotype through DC maturation, and that Rv0652 may be an effective adjuvant for enhancing the therapeutic response to DC-based tumor immunotherapy.	[Lee, Seung Jun; Lee, Moon Hee; Kang, Tae Heung; Jung, In Duk; Park, Yeong-Min] Konkuk Univ, Sch Med, Dept Immunol, Lab Dendrit Cell Differentiat & Regulat, Chungju, South Korea; [Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol,Brain Korea PLUS Project Med Sci 2, Seoul, South Korea; [Lee, Min-Goo] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Soh, Byoung Yul] Seonam Univ, Coll Med, Dept Biochem, Namwon, Jeonbuk, South Korea; [Park, Jung Hee] Chonbuk Natl Univ, Coll Environm & Bioresources Sci, Adv Inst Environm & Biosci, Div Biotechnol, Iksan, South Korea; [Shin, Yong Kyoo] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul 156756, South Korea; [Kim, Han Wool; Yun, Cheol-Heui] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Han Wool; Yun, Cheol-Heui] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine); Kangwon National University; Seonam University; Jeonbuk National University; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Jung, ID (corresponding author), Konkuk Univ, Sch Med, Dept Immunol, Lab Dendrit Cell Differentiat & Regulat, Chungju, South Korea.	jungid@kku.ac.kr; immun3023@kku.ac.kr	LEE, Seung Jun/G-4846-2018; Lee, Moon Hee/K-8526-2014; YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887; Shin, Sung Jae/0000-0003-0854-4582	National Research Foundation of Korea (NRF) grant - Korean Government [NRF-2012R1A2A1A03008433, NRF-2012R1A1A4A01007325, NRF-2011-0028573]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1120390]	National Research Foundation of Korea (NRF) grant - Korean Government; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2012R1A2A1A03008433, NRF-2012R1A1A4A01007325, and NRF-2011-0028573), a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1120390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Andersen MH, 2001, INT J CANCER, V94, P820, DOI 10.1002/ijc.1536; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; CARTER WA, 1985, J BIOL RESP MODIF, V4, P495; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Gong JL, 2000, J IMMUNOL, V165, P1705, DOI 10.4049/jimmunol.165.3.1705; Gong JL, 1998, P NATL ACAD SCI USA, V95, P6279, DOI 10.1073/pnas.95.11.6279; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Grange JM, 2008, VACCINE, V26, P4984, DOI 10.1016/j.vaccine.2008.06.092; Gunzer M, 2001, CRIT REV IMMUNOL, V21, P133; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Homma S, 2006, CLIN EXP IMMUNOL, V144, P41, DOI 10.1111/j.1365-2249.2006.03029.x; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jung ID, 2011, CANCER RES, V71, P2858, DOI 10.1158/0008-5472.CAN-10-3487; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Kim K, 2012, IMMUNOLOGY, V136, P231, DOI 10.1111/j.1365-2567.2012.03575.x; Kitaura H, 1999, SCAND J IMMUNOL, V50, P580, DOI 10.1046/j.1365-3083.1999.00630.x; Koido S, 2005, INT J CANCER, V117, P587, DOI 10.1002/ijc.21184; Koido S, 2004, CLIN IMMUNOL, V113, P261, DOI 10.1016/j.clim.2004.08.004; Koido S, 2002, J IMMUNOL, V168, P2111, DOI 10.4049/jimmunol.168.5.2111; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Morefield GL, 2007, CLIN VACCINE IMMUNOL, V14, P1499, DOI 10.1128/CVI.00153-07; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; OHARA N, 1993, NUCLEIC ACIDS RES, V21, P3579, DOI 10.1093/nar/21.15.3579; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Przetak M, 2003, VACCINE, V21, P961, DOI 10.1016/S0264-410X(02)00737-5; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Sun SQ, 1998, J EXP MED, V187, P1145, DOI 10.1084/jem.187.7.1145; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	43	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104351	10.1371/journal.pone.0104351	http://dx.doi.org/10.1371/journal.pone.0104351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102137	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900059
J	Muller, JR; Waldmann, TA; Dubois, S				Mueller, Juergen R.; Waldmann, Thomas A.; Dubois, Sigrid			Loss of Cytotoxicity and Gain of Cytokine Production in Murine Tumor-Activated NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PERIPHERAL-BLOOD; DIFFERENTIAL EXPRESSION; INHIBITORY RECEPTORS; DENDRITIC CELLS; CD56(BRIGHT); IL-15; SUBSETS; MOUSE; CANCER	NK cells are able to form a functional memory suggesting that some NK cells are surviving the activation process. We hypothesized that NK cell activation causes the development of a distinct NK cell subset and studied the fate of murine post-activation NK cells. Activation was achieved by in vivo and in vitro exposures to the melanoma tumor cell line B16 that was followed by differentiation in IL-2. When compared with control NK cells, post-activation CD25(+) NK cells expressed little granzyme B or perforin and had low lysis activity. Post-activation NK cells expressed CD27, CD90, CD127, and were low for CD11b suggesting that tumor-induced activation is restricted to an early NK cell subset. Activation of NK cells led to decreases of CD16, CD11c and increases of CD62L and the IL-18 receptor. In vivo activated but not control NK cells expressed a variety of cytokines that included IFN gamma, TNF alpha, GM-CSF and IL-10. These data suggest that the exposure of a subset of peripheral NK cells to the B16 tumor environment caused an exhaustion of their cytolytic capacity but also a gain in their ability to produce cytokines.	[Mueller, Juergen R.; Waldmann, Thomas A.; Dubois, Sigrid] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dubois, S (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	duboiss@mail.nih.gov	Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Dubois, Sigrid/0000-0002-4543-5222	National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIASC004002] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research is supported by the intramural research program of the National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANEGON I, 1988, J EXP MED, V167, P452, DOI 10.1084/jem.167.2.452; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Aranami T, 2006, J IMMUNOL, V177, P5659, DOI 10.4049/jimmunol.177.8.5659; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Dalbeth N, 2004, J IMMUNOL, V173, P6418, DOI 10.4049/jimmunol.173.10.6418; Dalbeth N, 2002, ARTHRITIS RHEUM, V46, P1763, DOI 10.1002/art.10410; Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubois SP, 2005, P NATL ACAD SCI USA, V102, P8662, DOI 10.1073/pnas.0503360102; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Frey M, 1998, J IMMUNOL, V161, P400; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kunikata T, 1998, CELL IMMUNOL, V189, P135, DOI 10.1006/cimm.1998.1376; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LANIER LL, 1986, J IMMUNOL, V136, P4480; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lima M, 2002, BLOOD CELL MOL DIS, V28, P181, DOI 10.1006/bcmd.2002.0506; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Loza MJ, 2004, J IMMUNOL, V172, P88, DOI 10.4049/jimmunol.172.1.88; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; MAENPAA A, 1993, INT J CANCER, V53, P850, DOI 10.1002/ijc.2910530524; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; NAGLER A, 1990, J EXP MED, V171, P1527, DOI 10.1084/jem.171.5.1527; NAGLER A, 1989, J IMMUNOL, V143, P3183; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Sedlmayr P, 1996, INT ARCH ALLERGY IMM, V110, P308, DOI 10.1159/000237321; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102793	10.1371/journal.pone.0102793	http://dx.doi.org/10.1371/journal.pone.0102793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101668	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900006
J	Shah, KB; Tripathy, S; Suganthi, H; Rudraiah, M				Shah, Kunal B.; Tripathy, Sudeshna; Suganthi, Hepziba; Rudraiah, Medhamurthy			Profiling of Luteal Transcriptome during Prostaglandin F2-Alpha Treatment in Buffalo Cows: Analysis of Signaling Pathways Associated with Luteolysis	PLOS ONE			English	Article							BOVINE CORPUS-LUTEUM; MESSENGER-RIBONUCLEIC-ACID; LUTEINIZING-HORMONE RECEPTOR; HUMAN CHORIONIC-GONADOTROPIN; GENE-EXPRESSION ANALYSIS; ACUTE REGULATORY PROTEIN; ESTROUS-CYCLE; BCL-2 EXPRESSION; GRANULOSA-CELLS; BREAST-CANCER	In several species including the buffalo cow, prostaglandin (PG) F-2 alpha is the key molecule responsible for regression of corpus luteum (CL). Experiments were carried out to characterize gene expression changes in the CL tissue at various time points after administration of luteolytic dose of PGF(2 alpha) in buffalo cows. Circulating progesterone levels decreased within 1 h of PGF(2 alpha) treatment and evidence of apoptosis was demonstrable at 18 h post treatment. Microarray analysis indicated expression changes in several of immediate early genes and transcription factors within 3 h of treatment. Also, changes in expression of genes associated with cell to cell signaling, cytokine signaling, steroidogenesis, PG synthesis and apoptosis were observed. Analysis of various components of LH/CGR signaling in CL tissues indicated decreased LH/CGR protein expression, pCREB levels and PKA activity post PGF(2 alpha) treatment. The novel finding of this study is the down regulation of CYP19A1 gene expression accompanied by decrease in expression of E-2 receptors and circulating and intra luteal E-2 post PGF(2 alpha) treatment. Mining of microarray data revealed several differentially expressed E-2 responsive genes. Since CYP19A1 gene expression is low in the bovine CL, mining of microarray data of PGF(2 alpha)-treated macaques, the species with high luteal CYP19A1 expression, showed good correlation between differentially expressed E-2 responsive genes between both the species. Taken together, the results of this study suggest that PGF(2 alpha) interferes with luteotrophic signaling, impairs intraluteal E-2 levels and regulates various signaling pathways before the effects on structural luteolysis are manifest.	[Shah, Kunal B.; Tripathy, Sudeshna; Suganthi, Hepziba; Rudraiah, Medhamurthy] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rudraiah, M (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rmm@mrdg.iisc.ernet.in	Tripathy, Sudeshna/ABB-9975-2021	Tripathy, Sudeshna/0000-0002-6257-1461	DBT, Government of India [350]	DBT, Government of India(Department of Biotechnology (DBT) India)	The work was supported by DBT(350), Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta TJ, 2002, BIOL REPROD, V66, P651, DOI 10.1095/biolreprod66.3.651; AGUDO LS, 1984, J ANIM SCI, V58, P955, DOI 10.2527/jas1984.584955x; Arvisais E, 2010, MOL ENDOCRINOL, V24, P632, DOI 10.1210/me.2009-0312; Atli MO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094870; AULETTA FJ, 1988, ENDOCR REV, V9, P88, DOI 10.1210/edrv-9-1-88; AZHAR S, 1989, BIOL REPROD, V40, P961, DOI 10.1095/biolreprod40.5.961; BALAPURE AK, 1989, BIOL REPROD, V41, P385, DOI 10.1095/biolreprod41.3.385; Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001; BATTYE KM, 1988, J REPROD FERTIL, V84, P425, DOI 10.1530/jrf.0.0840425; BEHRMAN HR, 1978, ENDOCRINOLOGY, V103, P349, DOI 10.1210/endo-103-2-349; Benyo DF, 1997, ENDOCRINOLOGY, V138, P3452, DOI 10.1210/en.138.8.3452; Berisha B, 2005, DOMEST ANIM ENDOCRIN, V29, P305, DOI 10.1016/j.domaniend.2005.02.035; Berisha B, 2002, ENDOCRINE, V17, P207, DOI 10.1385/ENDO:17:3:207; Berisha B, 2010, BIOL REPROD, V82, P940, DOI 10.1095/biolreprod.109.076752; Bjurulf E, 1996, BIOL REPROD, V54, P1350, DOI 10.1095/biolreprod54.6.1350; Bratton MR, 2010, INT J ONCOL, V37, P541, DOI 10.3892/ijo_00000703; BRYNER RW, 1990, DOMEST ANIM ENDOCRIN, V7, P181, DOI 10.1016/0739-7240(90)90024-T; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Casey OM, 2005, THERIOGENOLOGY, V64, P1963, DOI 10.1016/j.theriogenology.2005.04.015; Coleman KM, 2001, FRONT BIOSCI, V6, pD1379, DOI 10.2741/Coleman; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Devoto L, 2000, J REPROD FERTIL, P13; Diaz FJ, 2004, BIOL REPROD, V70, P1333, DOI 10.1095/biolreprod.103.020461; Diaz FJ, 2011, BIOL REPROD, V84, P26, DOI 10.1095/biolreprod.110.084368; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; FITZ TA, 1982, BIOL REPROD, V27, P703, DOI 10.1095/biolreprod27.3.703; GARVERICK HA, 1985, J ANIM SCI, V61, P216, DOI 10.2527/jas1985.611216x; Ghosh S, 2005, ONCOGENE, V24, P2236, DOI 10.1038/sj.onc.1208415; GIBORI G, 1984, ENDOCRINOLOGY, V114, P609, DOI 10.1210/endo-114-2-609; Ginther OJ, 2011, DOMEST ANIM ENDOCRIN, V40, P119, DOI 10.1016/j.domaniend.2010.09.006; Ginther OJ, 2009, BIOL REPROD, V80, P641, DOI 10.1095/biolreprod.108.072769; Goodman SB, 1998, BIOL REPROD, V59, P820, DOI 10.1095/biolreprod59.4.820; Goravanahally MP, 2009, BIOL REPROD, V80, P980, DOI 10.1095/biolreprod.108.069518; GUY MK, 1995, ENDOCRINE, V3, P585, DOI 10.1007/BF02953023; HALL JE, 1991, J CLIN ENDOCR METAB, V72, P993, DOI 10.1210/jcem-72-5-993; HINSHELWOOD MM, 1995, BIOL REPROD, V53, P1151, DOI 10.1095/biolreprod53.5.1151; Hinshelwood MM, 1997, ENDOCRINOLOGY, V138, P3704, DOI 10.1210/en.138.9.3704; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKSON JA, 1985, BIOL REPROD, V33, P451, DOI 10.1095/biolreprod33.2.451; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; JUENGEL JL, 1993, ENDOCRINOLOGY, V132, P249, DOI 10.1210/en.132.1.249; JUENGEL JL, 1995, ENDOCRINOLOGY, V136, P5423, DOI 10.1210/en.136.12.5423; Jyotsna UR, 2009, ANIM REPROD SCI, V113, P71, DOI 10.1016/j.anireprosci.2008.08.001; Jyotsna UR, 2011, PLOS ONE, V6; KNICKERBOCKER JJ, 1988, DOMEST ANIM ENDOCRIN, V5, P91, DOI 10.1016/0739-7240(88)90011-2; Korzekwa AJ, 2008, REPROD DOMEST ANIM, V43, P464, DOI 10.1111/j.1439-0531.2007.00936.x; Kugu K, 1998, CELL DEATH DIFFER, V5, P67, DOI 10.1038/sj.cdd.4400316; Lahav M, 1989, J Reprod Fertil Suppl, V37, P233; Lee J, 2010, ENDOCRINOLOGY, V151, P3326, DOI 10.1210/en.2009-0948; Lenz S, 2004, MOL REPROD DEV, V67, P406, DOI 10.1002/mrd.20000; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Luo WX, 2011, BIOL REPROD, V84, P369, DOI 10.1095/biolreprod.110.085274; MAAS S, 1992, J CLIN ENDOCR METAB, V74, P306, DOI 10.1210/jc.74.2.306; Maranesi M, 2010, DOMEST ANIM ENDOCRIN, V39, P116, DOI 10.1016/j.domaniend.2010.03.001; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; MICHAEL AE, 1993, J REPROD FERTIL, V97, P425; MICHAEL AE, 1991, MOL CELL ENDOCRINOL, V82, P207, DOI 10.1016/0303-7207(91)90033-O; Minegishi K, 2002, AM J PHYSIOL-ENDOC M, V283, pE1308, DOI 10.1152/ajpendo.00240.2002; Miyamoto A, 2005, DOMEST ANIM ENDOCRIN, V29, P329, DOI 10.1016/j.domaniend.2005.03.011; Mondal M, 2011, PHYSIOL GENOMICS, V43, P447, DOI 10.1152/physiolgenomics.00155.2010; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Nimz M, 2009, DOMEST ANIM ENDOCRIN, V37, P45, DOI 10.1016/j.domaniend.2009.02.002; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Noda Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092999; Noseir Wael M B, 2003, Reprod Biol Endocrinol, V1, P50, DOI 10.1186/1477-7827-1-50; Okuda K, 2001, BIOL REPROD, V65, P1634, DOI 10.1095/biolreprod65.6.1634; Okuda K, 1999, REPROD FERT DEVELOP, V11, P147, DOI 10.1071/RD99027; Oshlack A, 2007, BIOINFORMATICS, V23, P1235, DOI 10.1093/bioinformatics/btm111; Pate JL, 1996, THERIOGENOLOGY, V45, P1381, DOI 10.1016/0093-691X(96)00102-1; Peluffo MC, 2006, REPRODUCTION, V132, P465, DOI 10.1530/rep.1.00910; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pescador N, 1996, BIOL REPROD, V55, P485, DOI 10.1095/biolreprod55.2.485; PETERS KE, 1994, BIOL REPROD, V51, P1248, DOI 10.1095/biolreprod51.6.1248; Pharriss B B, 1972, Recent Prog Horm Res, V28, P51; Priyanka S, 2007, MOL HUM REPROD, V13, P381, DOI 10.1093/molehr/gam015; Priyanka S, 2009, ENDOCRINOLOGY, V150, P1473, DOI 10.1210/en.2008-0840; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAVINDRANATH N, 1992, J CLIN ENDOCR METAB, V74, P779, DOI 10.1210/jc.74.4.779; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; RODGER FE, 1995, HUM REPROD, V10, P1566, DOI 10.1093/HUMREP/10.6.1566; Rueda BR, 1997, BIOL REPROD, V56, P186, DOI 10.1095/biolreprod56.1.186; RUEDA BR, 1995, BIOL REPROD, V52, P305, DOI 10.1095/biolreprod52.2.305; Sanders SL, 1997, BIOL REPROD, V56, P1077, DOI 10.1095/biolreprod56.5.1077; SCHALLENBERGER E, 1984, J REPROD FERTIL, V71, P493; Schams D, 2002, DOMEST ANIM ENDOCRIN, V23, P53, DOI 10.1016/S0739-7240(02)00145-5; Shibaya M, 2007, J REPROD DEVELOP, V53, P1059, DOI 10.1262/jrd.19065; Shirasuna K, 2008, REPRODUCTION, V135, P527, DOI 10.1530/REP-07-0496; Shirasuna K, 2010, J REPROD DEVELOP, V56, P428, DOI 10.1262/jrd.10-004O; Shirasuna K, 2010, J REPROD DEVELOP, V56, P124, DOI 10.1262/jrd.09-106O; SHUTT DA, 1975, STEROIDS, V26, P299, DOI 10.1016/0039-128X(75)90076-8; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Smith GW, 1996, BIOL REPROD, V54, P76, DOI 10.1095/biolreprod54.1.76; SNOOK RB, 1971, ENDOCRINOLOGY, V88, P678, DOI 10.1210/endo-88-3-678; SOTREL G, 1981, AM J OBSTET GYNECOL, V139, P134, DOI 10.1016/0002-9378(81)90434-8; Stevenson JS, 2010, THERIOGENOLOGY, V73, P1127, DOI 10.1016/j.theriogenology.2010.01.014; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Stouffer RL, 2013, REPROD BIOL, V13, P259, DOI 10.1016/j.repbio.2013.08.002; Sudeshna T, 2013, REPROD BIOL ENDOCRIN, V11, P1, DOI 10.1186/1477-7827-11-111; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Suresh PS, 2013, SYST BIOL REPROD MED, V59, P1, DOI 10.3109/19396368.2012.729647; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taniguchi H, 2009, MOL REPROD DEV, V76, P873, DOI 10.1002/mrd.21054; TILLY JL, 1993, J CELL PHYSIOL, V154, P519, DOI 10.1002/jcp.1041540310; Townson DH, 2006, INTEGR COMP BIOL, V46, P1055, DOI 10.1093/icb/icl021; TSUMAGARI S, 1993, J REPROD FERTIL, V98, P631, DOI 10.1530/jrf.0.0980631; Uma J, 2003, BIOL REPROD, V69, P1379, DOI 10.1095/biolreprod.103.017897; Utt MD, 2007, ANIM REPROD SCI, V97, P63, DOI 10.1016/j.anireprosci.2006.01.009; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; Vanselow J, 2005, MOL CELL ENDOCRINOL, V233, P57, DOI 10.1016/j.mce.2005.01.007; Vanselow J, 2004, DOMEST ANIM ENDOCRIN, V27, P99, DOI 10.1016/j.domaniend.2004.01.008; Vanselow J, 2010, BIOL REPROD, V82, P289, DOI 10.1095/biolreprod.109.079251; Waclawik A, 2011, REPRODUCTION, V142, P389, DOI 10.1530/REP-11-0033; WARSHAW ML, 1986, ENDOCRINOLOGY, V119, P2642, DOI 10.1210/endo-119-6-2642; Webb R, 2002, DOMEST ANIM ENDOCRIN, V23, P277, DOI 10.1016/S0739-7240(02)00163-7; WEBLEY GE, 1991, J ENDOCRINOL, V128, P121, DOI 10.1677/joe.0.1280121; Weinbauer GF, 2008, TOXICOL PATHOL, V36, p7S, DOI 10.1177/0192623308327412; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wiltbank MC, 2012, ANIM REPROD, V9, P242; WILTBANK MC, 1990, BIOL REPROD, V42, P239, DOI 10.1095/biolreprod42.2.239; Yadav VK, 2005, J BIOL CHEM, V280, P10357, DOI 10.1074/jbc.M409596200; Yadav VK, 2002, BIOL REPROD, V67, P752, DOI 10.1095/biolreprod.102.004077; Zalman Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095067	127	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104127	10.1371/journal.pone.0104127	http://dx.doi.org/10.1371/journal.pone.0104127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102061	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339993900043
J	Zarrineh, P; Sanchez-Rodriguez, A; Hosseinkhan, N; Narimani, Z; Marchal, K; Masoudi-Nejad, A				Zarrineh, Peyman; Sanchez-Rodriguez, Aminael; Hosseinkhan, Nazanin; Narimani, Zahra; Marchal, Kathleen; Masoudi-Nejad, Ali			Genome-Scale Co-Expression Network Comparison across Escherichia coli and Salmonella enterica Serovar Typhimurium Reveals Significant Conservation at the Regulon Level of Local Regulators Despite Their Dissimilar Lifestyles	PLOS ONE			English	Article							ADAPTIVE MUTATIONS; GENE-EXPRESSION; SIGMA-FACTORS; IDENTIFICATION; EVOLUTION; TRANSCRIPTION; INFORMATION; DISCOVERY; BACTERIA; DATABASE	Availability of genome-wide gene expression datasets provides the opportunity to study gene expression across different organisms under a plethora of experimental conditions. In our previous work, we developed an algorithm called COMODO (COnserved MODules across Organisms) that identifies conserved expression modules between two species. In the present study, we expanded COMODO to detect the co-expression conservation across three organisms by adapting the statistics behind it. We applied COMODO to study expression conservation/divergence between Escherichia coli, Salmonella enterica, and Bacillus subtilis. We observed that some parts of the regulatory interaction networks were conserved between E. coli and S. enterica especially in the regulon of local regulators. However, such conservation was not observed between the regulatory interaction networks of B. subtilis and the two other species. We found co-expression conservation on a number of genes involved in quorum sensing, but almost no conservation for genes involved in pathogenicity across E. coli and S. enterica which could partially explain their different lifestyles. We concluded that despite their different lifestyles, no significant rewiring have occurred at the level of local regulons involved for instance, and notable conservation can be detected in signaling pathways and stress sensing in the phylogenetically close species S. enterica and E. coli. Moreover, conservation of local regulons seems to depend on the evolutionary time of divergence across species disappearing at larger distances as shown by the comparison with B. subtilis. Global regulons follow a different trend and show major rewiring even at the limited evolutionary distance that separates E. coli and S. enterica.	[Zarrineh, Peyman] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Ctr Microbial & Plant Genet, Leuven, Belgium; [Sanchez-Rodriguez, Aminael] Univ Tecn Particula Loja, Dept Ciencias Nat, Loja, Ecuador; [Hosseinkhan, Nazanin; Narimani, Zahra; Masoudi-Nejad, Ali] Univ Tehran, Lab Syst Biol & Bioinformat LBB, Inst Biochem & Biophys, Tehran, Iran; [Marchal, Kathleen] Univ Ghent, Dept Informat Technol, IMinds, B-9000 Ghent, Belgium	KU Leuven; Universidad Tecnica Particular de Loja; University of Tehran; Ghent University; IMEC	Marchal, K (corresponding author), Univ Ghent, Dept Informat Technol, IMinds, B-9000 Ghent, Belgium.	kamar@psb.vib-ugent.be; amasoudin@ibb.ut.ac.ir	Hosseinkhan, Nazanin/AAA-6288-2019; Hosseinkhan, Nazanin/AAC-3321-2021; Marchal, Kathleen/O-7936-2017; Zarrineh, Peyman/AAE-2533-2022; Marchal, Kathleen/B-5001-2013; Masoudi-Nejad, Ali/ABH-2078-2021	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Sanchez-Rodriguez, Aminael/0000-0002-9269-0621; Narimani, Zahra/0000-0003-2534-9201	KULeuven Research Council [GOA/08/011, CoE EF/05/007, CoE NATAR IOK-C1895-PF/10/010, CREA/ 08/023, ZKB8933/CREA/08/023/BOF]; Flemish Interuniversity Council-University Development Cooperation [VLIR-UOS]; Agency for Innovation by Science and Technology [SBO-BioFrame]; Interuniversity Attraction Poles [P6/25-BioMaGNet]; Research Foundation-Flanders [IOK-B9725-G.0329.09]; Human Frontier Science Program [RGY0079/2007C]	KULeuven Research Council(KU Leuven); Flemish Interuniversity Council-University Development Cooperation [VLIR-UOS]; Agency for Innovation by Science and Technology [SBO-BioFrame]; Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Research Foundation-Flanders(FWO); Human Frontier Science Program(Human Frontier Science Program)	Funding from following source is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KULeuven Research Council [GOA AMBioRICS, GOA/08/011, CoE EF/05/007, SymBioSys, CoE NATAR IOK-C1895-PF/10/010, CREA/ 08/023, ZKB8933/CREA/08/023/BOF]; Flemish Interuniversity Council-University Development Cooperation [VLIR-UOS]; Agency for Innovation by Science and Technology [SBO-BioFrame]; Interuniversity Attraction Poles [P6/25-BioMaGNet]; Research Foundation-Flanders [IOK-B9725-G.0329.09]; Human Frontier Science Program [RGY0079/2007C]. Funding for the open access charge: Agency for Innovation by Science and Technology [SBO-BioFrame].	ANDREWS SC, 2006, BIOMETALS, V19, P143; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; BROOS S, 2013, NUCL ACIDS RES; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chadsey MS, 1998, GENE DEV, V12, P3123, DOI 10.1101/gad.12.19.3123; Chen Z, 2007, NUCLEIC ACIDS RES, V35, P6762, DOI 10.1093/nar/gkm631; Chikina MD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001074; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; Engelen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020938; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fadda A, 2009, MOL BIOSYST, V5, P1840, DOI 10.1039/b907310h; GALAGAN JE, 2013, NATURE; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Lim A, 1999, BIOINFORMATICS, V15, P1068, DOI 10.1093/bioinformatics/15.12.1068; Lozada-Chavez I, 2006, NUCLEIC ACIDS RES, V34, P3434, DOI 10.1093/nar/gkl423; Makarova KS, 2001, GENOME BIOL, V2; Menard A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-308; Meysman P, 2013, MOL BIOL EVOL, V30, P1302, DOI 10.1093/molbev/mst029; Okuda S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-48; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pons T, 2006, J MOL MODEL, V12, P973, DOI 10.1007/s00894-005-0096-5; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Wall Dennis P., 2007, V396, P95; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Yang ZW, 2006, MUTAT RES-FUND MOL M, V595, P107, DOI 10.1016/j.mrfmmm.2005.10.013; Yang ZW, 2001, MUTAT RES-FUND MOL M, V484, P95, DOI 10.1016/S0027-5107(01)00257-3; Zarrineh P, 2011, NUCLEIC ACIDS RES, V39, pE41, DOI 10.1093/nar/gkq1275	46	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102871	10.1371/journal.pone.0102871	http://dx.doi.org/10.1371/journal.pone.0102871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101984	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900010
J	Alvarez-Sandoval, BA; Manzanilla, LR; Montiel, R				Alvarez-Sandoval, Brenda A.; Manzanilla, Linda R.; Montiel, Rafael			Sex Determination in Highly Fragmented Human DNA by High-Resolution Melting (HRM) Analysis	PLOS ONE			English	Article							DISCRIMINANT FUNCTION-ANALYSIS; MEATUS ACUSTICUS INTERNUS; HUMAN Y-CHROMOSOME; AMELOGENIN GENE; HUMAN REMAINS; FORAMEN MAGNUM; HUMAN ENAMEL; RING FINGER; SHORT ARM; IDENTIFICATION	Sex identification in ancient human remains is a common problem especially if the skeletons are sub-adult, incomplete or damaged. In this paper propose a new method to identify sex, based on real-time PCR amplification of small fragments (61 and 64 bp) of the third exon within the amelogenin gene covering a 3-bp deletion on the AAAELX-allele, followed by a High Resolution Melting analysis (HRM). HRM is based on the melting curves of amplified fragments. The amelogenin gene is located on both chromosomes X and Y, showing dimorphism in length. This molecular tool is rapid, sensitive and reduces he risk of contamination from exogenous genetic material when used for ancient DNA studies. The accuracy of the new method described here has been corroborated by using control samples of known sex and by contrasting our results wit those obtained with other methods. Our method has proven to be useful even in heavily degraded samples, where other previously published methods failed. Stochastic problems such as the random allele drop-out phenomenon are expected cur in a less severe form, due to the smaller fragment size to be amplified. Thus, their negative effect could be easier overcome by a proper experimental design.	[Alvarez-Sandoval, Brenda A.; Montiel, Rafael] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Manzanilla, Linda R.] Univ Nacl Autonoma Mexico, Inst Invest Antropol, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Montiel, R (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.	montiel@langebio.cinvestav.mx	Montiel, Rafael/A-6774-2008	Montiel, Rafael/0000-0001-8052-0679	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2008-01-105481]; CONACYT fellowship [300750]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT; www.conacyt.gob.mx) grant No. CB-2008-01-105481 to Dr. Rafael Montiel. M.Sc. Alvarez-Sandoval is supported by a CONACYT fellowship (Reg. No. 300750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANE A, 1992, FORENSIC SCI INT, V52, P143, DOI 10.1016/0379-0738(92)90102-3; AKANE A, 1991, FORENSIC SCI INT, V49, P81, DOI 10.1016/0379-0738(91)90174-H; Albanese J, 2003, J FORENSIC SCI, V48, P263; Alonso A, 2003, CROAT MED J, V44, P273; Andreasson H, 2003, J FORENSIC SCI, V48, P1280; Atamturk D, 2010, ANTHROPOL ANZ, V68, P21, DOI 10.1127/0003-5548/2010/0026; Aye VO, 2010, FORENSIC SCI INT, V199, DOI 10.1016/j.forsciint.2010.03.001; BAILEY DMD, 1992, GENOMICS, V14, P203, DOI 10.1016/S0888-7543(05)80310-6; BERRIZBEITIA EL, 1989, J FORENSIC SCI, V34, P1206; Bongiovanni R, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2011.11.034; Burris BG, 1998, J FORENSIC SCI, V43, P959; Case DT, 2007, J FORENSIC SCI, V52, P264, DOI 10.1111/j.1556-4029.2006.00365.x; Chang YM, 2003, J FORENSIC SCI, V48, P1309; Dabbs GR, 2010, J FORENSIC SCI, V55, P149, DOI 10.1111/j.1556-4029.2009.01232.x; Daskalaki E, 2011, J ARCHAEOL SCI, V38, P1326, DOI 10.1016/j.jas.2011.01.009; Faerman M, 1995, GENE, V167, P327, DOI 10.1016/0378-1119(95)00697-4; Francesquini Junior L, 2007, J Forensic Odontostomatol, V25, P7; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Gapert R, 2009, INT J LEGAL MED, V123, P25, DOI 10.1007/s00414-008-0256-0; Gibbon V, 2009, FORENSIC SCI INT-GEN, V3, P74, DOI 10.1016/j.fsigen.2008.10.007; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Goncalves D, 2013, J FORENSIC LEG MED, V20, P906, DOI 10.1016/j.jflm.2013.07.003; Gonzalez RA, 2012, J FORENSIC SCI, V57, P24, DOI 10.1111/j.1556-4029.2011.01920.x; Gotherstrom A, 1997, INT J OSTEOARCHAEOL, V7, P71, DOI 10.1002/(SICI)1099-1212(199701)7:1<71::AID-OA321>3.0.CO;2-K; Graw M, 2005, FORENSIC SCI INT, V147, P113, DOI 10.1016/j.forsciint.2004.08.006; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; HaasRochholz H, 1997, INT J LEGAL MED, V110, P312, DOI 10.1007/s004140050094; Harris SM, 2012, J FORENSIC SCI, V57, P295, DOI 10.1111/j.1556-4029.2011.02004.x; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; HUMMEL S, 1991, NATURWISSENSCHAFTEN, V78, P266, DOI 10.1007/BF01134353; Introna F, 1998, FORENSIC SCI INT, V95, P39, DOI 10.1016/S0379-0738(98)00080-2; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Jowaheer V, 2011, J FORENSIC LEG MED, V18, P173, DOI 10.1016/j.jflm.2011.02.007; Kalmey JK, 1996, J FORENSIC SCI, V41, P865; Kanchan T, 2008, FORENSIC SCI INT, V181; Kanchan T, 2013, J FORENSIC LEG MED, V20, P855, DOI 10.1016/j.jflm.2013.06.016; Kanchan T, 2011, J FORENSIC LEG MED, V18, P14, DOI 10.1016/j.jflm.2010.11.013; Kanchan T, 2010, FORENSIC SCI MED PAT, V6, P255, DOI 10.1007/s12024-010-9156-y; Kanchan T, 2010, J FORENSIC LEG MED, V17, P243, DOI 10.1016/j.jflm.2010.02.009; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Kim KY, 2013, INT J LEGAL MED, V127, P55, DOI 10.1007/s00414-011-0663-5; Kindschuh SC, 2010, AM J PHYS ANTHROPOL, V143, P279, DOI 10.1002/ajpa.21315; Krishan K, 2013, J FORENSIC LEG MED, V20, P471, DOI 10.1016/j.jflm.2013.03.004; Krishan K, 2012, J FORENSIC SCI, V57, P172, DOI 10.1111/j.1556-4029.2011.01960.x; Lain R, 2011, FORENSIC SCI INT, V205, P36, DOI 10.1016/j.forsciint.2010.06.008; Lassen C, 2000, Anthropol Anz, V58, P1; Lassen Cadja, 1996, ANCIENT BIOMOLECULES, V1, P25; Lattanzi W, 2005, HUM GENET, V116, P395, DOI 10.1007/s00439-004-1238-z; LAU EC, 1990, CLEFT PALATE J, V27, P121, DOI 10.1597/1545-1569(1990)027<0121:AOHEGI>2.3.CO;2; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Macaluso PJ, 2011, FORENSIC SCI MED PAT, V7, P233, DOI 10.1007/s12024-010-9204-7; Mall G, 2001, FORENSIC SCI INT, V117, P23, DOI 10.1016/S0379-0738(00)00445-X; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; MANNUCCI A, 1994, INT J LEGAL MED, V106, P190, DOI 10.1007/BF01371335; Manzanilla LindaR., 2012, ESTUDIOS ARQUEOMETRI, P467; Masotti S, 2013, INT J LEGAL MED, V127, P1039, DOI 10.1007/s00414-013-0822-y; May H, 2011, INT J LEGAL MED, V125, P669, DOI 10.1007/s00414-010-0497-6; Meyer E, 2000, FORENSIC SCI INT, V113, P87, DOI 10.1016/S0379-0738(00)00220-6; Montiel R, 2001, HUM BIOL, V73, P689, DOI 10.1353/hub.2001.0069; Moudgil Rohan, 2008, J Forensic Leg Med, V15, P223, DOI 10.1016/j.jflm.2007.10.003; NAKAHORI Y, 1991, GENOMICS, V9, P264, DOI 10.1016/0888-7543(91)90251-9; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; Ozden H, 2005, FORENSIC SCI INT, V147, P181, DOI 10.1016/j.forsciint.2004.09.072; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Purkait R, 2005, FORENSIC SCI INT, V147, P135, DOI 10.1016/j.forsciint.2004.08.005; Ramadan SU, 2010, FORENSIC SCI INT, V197, DOI 10.1016/j.forsciint.2009.12.049; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rissech C, 2008, FORENSIC SCI INT, V180, P1, DOI 10.1016/j.forsciint.2008.06.006; Rodriguez JV, 1994, INTRO ANTROPOLOGIA F; Rogers NL, 2000, J FORENSIC SCI, V45, P61; ROGERS T, 1994, J FORENSIC SCI, V39, P1047; Rogers TL, 2009, AM J PHYS ANTHROPOL, V140, P143, DOI 10.1002/ajpa.21060; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; SASAKI S, 1995, INT J DEV BIOL, V39, P127; Schmidt D, 2003, AM J PHYS ANTHROPOL, V121, P337, DOI 10.1002/ajpa.10172; Scholtz Y, 2010, HOMO, V61, P253, DOI 10.1016/j.jchb.2010.01.048; Shinka T, 2001, J HUM GENET, V46, P263, DOI 10.1007/s100380170076; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Slavkin HC, 1997, J AM DENT ASSOC, V128, P1021, DOI 10.14219/jada.archive.1997.0311; Spradley MK, 2011, J FORENSIC SCI, V56, P289, DOI 10.1111/j.1556-4029.2010.01635.x; Steinlechner M, 2002, INT J LEGAL MED, V116, P117, DOI 10.1007/s00414-001-0264-9; Steyn M, 2012, FORENSIC SCI INT, V214, DOI 10.1016/j.forsciint.2011.07.049; Stone AC, 1996, AM J PHYS ANTHROPOL, V99, P231; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Teke HY, 2007, SURG RADIOL ANAT, V29, P9, DOI 10.1007/s00276-006-0157-1; Thangaraj K, 2002, INT J LEGAL MED, V116, P121, DOI 10.1007/s00414-001-0262-y; Tozzo P, 2013, J FORENSIC LEG MED, V20, P387, DOI 10.1016/j.jflm.2013.03.012; Tschentscher F, 2008, INT J LEGAL MED, V122, P333, DOI 10.1007/s00414-008-0228-4; Tvedebrink T, 2012, FORENSIC SCI INT-GEN, V6, P97, DOI 10.1016/j.fsigen.2011.03.001; Uthman AT, 2012, DENTOMAXILLOFAC RAD, V41, P197, DOI 10.1259/dmfr/21276789; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Velarde-Felix JS, 2008, REV MEX PATOL CLIN, V55, P17; Wescott DJ, 2001, J FORENSIC SCI, V46, P1159; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176, DOI 10.2144/97221pf02; Zemskova E Iu, 2003, Sud Med Ekspert, V46, P19; Zeybek G, 2008, FORENSIC SCI INT, V181, DOI DOI 10.1016/J.FORSCIINT.2008.08.003	100	17	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104629	10.1371/journal.pone.0104629	http://dx.doi.org/10.1371/journal.pone.0104629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098828	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100086
J	Calder, T; Kinch, LN; Fernandez, J; Salomon, D; Grishin, NV; Orth, K				Calder, Thomas; Kinch, Lisa N.; Fernandez, Jessie; Salomon, Dor; Grishin, Nick V.; Orth, Kim			Vibrio Type III Effector VPA1380 Is Related to the Cysteine Protease Domain of Large Bacterial Toxins	PLOS ONE			English	Article							ACTIN-BINDING; PARAHAEMOLYTICUS; ACTIVATION; PATHOGENS; KINASE; SEQUENCE	Vibrio parahaemolyticus is a Gram-negative halophilic bacterium and one of he leading causes of food-borne gastroenteritis. Its genome harbors two Type III Secretion Systems (T3SS1 and T3SS2), but only T3SS2 is required for enterotoxicity seen in animal models. Effector proteins secreted from T3SS2 have been previously shown to promote colonization of the intestinal epithelium, invasion of host cells, and destruction of the epithelial monolayer. In this study, we identify VPA1380, a T3SS2 effector protein that is toxic when expressed in yeast. Bioinformatic analyses revealed that VPA1380 is highly similar to the inositol hexakisphosphate (IP6)-inducible cysteine protease domains of several large bacterial toxins. Mutations in conserved catalytic residues and residues in the putative IP6-binding pocket abolished toxicity in yeast. Furthermore, VPA1380 was not toxic in IP6 deficient yeast cells Therefore, our findings that VPA1380 is a cysteine protease that requires IP6 as an activator.	[Calder, Thomas; Fernandez, Jessie; Salomon, Dor; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Fernandez, Jessie/AAR-3477-2021; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Kinch, Lisa/0000-0003-3041-2615; Fernandez, Jessie/0000-0002-0897-2707; Salomon, Dor/0000-0002-2009-9453	NIH [GM094575, R01-AI056404]; Welch Foundation from the Welch Research Foundation [I-1505, I-1561];  [T32 AI007520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520, R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation from the Welch Research Foundation(The Welch Foundation); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported in part by the NIH GM094575 and R01-AI056404, the Welch Foundation I-1505 and I-1561 from the Welch Research Foundation. DS is a Chilton Foundation Fellow. TC is supported by T32 AI007520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Broberg CA, 2011, MICROBES INFECT, V13, P992, DOI 10.1016/j.micinf.2011.06.013; Buss C, 2009, CELL MICROBIOL, V11, P661, DOI 10.1111/j.1462-5822.2009.01284.x; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Coaker G, 2006, MOL MICROBIOL, V61, P1485, DOI 10.1111/j.1365-2958.2006.05335.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Fukazawa A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000228; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; Hiyoshi H, 2011, CELL HOST MICROBE, V10, P401, DOI 10.1016/j.chom.2011.08.014; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Okada R, 2013, CELL MICROBIOL; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Pineyro P, 2010, INFECT IMMUN, V78, P4551, DOI 10.1128/IAI.00461-10; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pruitt RN, 2009, J BIOL CHEM, V284, P21934, DOI 10.1074/jbc.M109.018929; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Salomon D, 2010, J VIS EXP; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Salomon D, 2013, CELL HOST MICROBE, V14, P269, DOI 10.1016/j.chom.2013.07.008; Salomon D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061086; Salomon D, 2012, MICROBIOL-SGM, V158, P2859, DOI 10.1099/mic.0.062513-0; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Shimohata T, 2010, J MED INVESTIG, V57, P179, DOI 10.2152/jmi.57.179; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhang LL, 2012, CELL REP, V1, P453, DOI 10.1016/j.celrep.2012.04.004; Zhou XH, 2013, CELL REP, V3, P1690, DOI 10.1016/j.celrep.2013.03.039; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057558; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	44	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104387	10.1371/journal.pone.0104387	http://dx.doi.org/10.1371/journal.pone.0104387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099122	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100068
J	Cao, TW; Gao, Z; Gu, LY; Chen, ML; Yang, B; Cao, KJ; Huang, H; Li, MF				Cao, Tengwei; Gao, Zhen; Gu, Lingyun; Chen, Minglong; Yang, Bing; Cao, Kejiang; Huang, He; Li, Mingfang			AdipoR1/APPL1 Potentiates the Protective Effects of Globular Adiponectin on Angiotensin II-Induced Cardiac Hypertrophy and Fibrosis in Neonatal Rat Atrial Myocytes and Fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; VASCULAR ENDOTHELIAL-CELLS; KAPPA-B; FIBRILLATION; RECEPTORS; HEART; CARDIOMYOCYTES; MECHANISMS; DEATH; AKT	Atrial hypertrophy and fibrosis are essential pathological features of atrial fibrillation. Recently, adiponectin has become a protein of interest due to its beneficial effects on cardiovascular diseases. However, the molecular mechanism of atrial structural remodeling and signaling pathways evoked by adiponectin remain unclear. In the present study, we investigated the cardioprotective effect of globular adiponectin (gAcrp) on angiotensin II-induced atrial hypertrophy and fibrosis in neonatal Sprague-Dawley rat. To further investigate the molecular mechanisms underlying the preventive effect of gAcrp, transfection of cells with siRNA was used to suppress the mRNA expression of adiponectin receptor 1 (AdipoR1) and its downstream adaptor protein APPL1. Non-silencing-Cy-3 labelled siRNA was used to determine transfection efficiency using fluorescence microscopy. The expression of atrial natriuretic peptide and procollagen type1 alpha-1, hypertrophy marker and fibrosis one, respectively, was detected by real-time PCR. Furthermore, the expression of adenosine monophosphate-activated protein kinase (AMPK), phosphatidylinositol 3-kinase (PI3K) and Akt was detected by western blotting. In addition, nuclear p65 translocation activity was analyzed by EMSA supershift assay. Our results showed that AdipoR1 and the adaptor protein APPL1 mediated the protective effects of gAcrp. In addition, the function of adiponectin and phosphorylation of AMPK were prominently diminished by inhibition of PI3K. Furthermore, nuclear factor-kappa B (NF-kB) transcription was diminished by the specific inhibition of AMPK. Taken together, AMPK pivotally interacts with NF-kappa B and PI3K, mediating the cardioprotective effect of adiponectin, and may serve as a therapeutic target for preventing atrial hypertrophy and fibrosis. Our present study suggests that gAcrp could ameliorate AngII-induced cardiac hypertrophy and fibrosis in rat atrial cells, which is mediated by the activation of AMPK signaling pathways. APPL1 and AdipoR1 are the key factors involved in the downstream of gAcrp approach.	[Cao, Tengwei; Gao, Zhen; Huang, He] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Gu, Lingyun] Southeast Univ, Jiangyin Hosp, Div Cardiol, Jiangyin, Peoples R China; [Chen, Minglong; Yang, Bing; Cao, Kejiang; Li, Mingfang] Nanjing Med Univ, Affiliated Hosp 1, Dept Med, Div Cardiol, Nanjing, Jiangsu, Peoples R China; [Huang, He] State Key Lab Mat Oriented Chem Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Southeast University - China; Nanjing Medical University	Huang, H (corresponding author), Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China.	huangh@njtech.edu.cn; mingflee@hotmail.com			National Natural Science Foundation of China [81000083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (Young Project, No. 81000083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; BARKALOW K, 1995, CURR BIOL, V5, P1000, DOI 10.1016/S0960-9822(95)00200-4; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chlopcikova Sarka, 2001, Biomedical Papers (Olomouc), V145, P49; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Doughty RN, 2004, CIRCULATION, V109, P201, DOI 10.1161/01.CIR.0000108928.25690.94; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Sattar AA, 2012, BIOCHEM BIOPH RES CO, V424, P753, DOI 10.1016/j.bbrc.2012.07.027; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; Tian L, 2012, ATHEROSCLEROSIS, V221, P66, DOI 10.1016/j.atherosclerosis.2011.12.014; Tsai CT, 2008, CIRCULATION, V117, P344, DOI 10.1161/CIRCULATIONAHA.107.695346; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357; Zhu WD, 2008, CLIN SCI, V114, P361, DOI 10.1042/CS20070347	33	31	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103793	10.1371/journal.pone.0103793	http://dx.doi.org/10.1371/journal.pone.0103793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099270	gold, Green Submitted, Green Published			2022-12-25	WOS:000339995100031
J	Elston, TW; Pandian, A; Smith, GD; Holley, AJ; Gao, NJ; Lugo, JN				Elston, Thomas W.; Pandian, Ashvini; Smith, Gregory D.; Holley, Andrew J.; Gao, Nanjing; Lugo, Joaquin N.			Aniracetam Does Not Alter Cognitive and Affective Behavior in Adult C57BL/6J Mice	PLOS ONE			English	Article							MEMORY DEFICITS; RATS; TRANSMISSION; ENHANCEMENT; PERFORMANCE; SCOPOLAMINE; IMPAIRMENT; RECEPTORS; RESTORES; LESIONS	There a growing community of individuals who self-administer the nootropic aniracetam for its purported cognitive enhancing effects. Aniracetam is believed to be therapeutically useful for enhancing cognition, alleviating anxiety, and treating various neurodegenerative conditions. Physiologically, aniracetam enhances both glutamatergic neurotransmission and long-term potentiation. Previous studies of aniracetam have demonstrated the cognition-restoring effects of acute administration in different models of disease. No previous studies have explored the effects of aniracetam in healthy subjects. We investigated whether daily 50 mg/kg oral administration improves cognitive performance in naive C57BL/6J mice in a variety of aspects of cognitive behavior. We measured spatial learning in the Morris water maze test; associative learning in the fear conditioning test; motor learning in the accelerating rotarod test; and odor discrimination. We also measured locomotion in the open field test, anxiety through the elevated plus maze test and by measuring time in the center of the open field test. We measured repetitive behavior through the marble burying test. We detected no significant differences between the naive, placebo, and experimental groups across all measures. Despite several studies demonstrating efficacy in impaired subjects, our findings suggest that aniracetam does not alter behavior in normal healthy mice. This study is timely in light of the growing community of healthy humans self-administering nootropic drugs.	[Elston, Thomas W.; Pandian, Ashvini; Holley, Andrew J.; Gao, Nanjing; Lugo, Joaquin N.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Smith, Gregory D.; Lugo, Joaquin N.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA	Baylor University; Baylor University	Lugo, JN (corresponding author), Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA.	Joaquin_lugo@baylor.edu		Holley, Andrew/0000-0003-3658-9569	Baylor Undergraduate Research and Scholarly Achievement Small Grant Program; Vice Provost	Baylor Undergraduate Research and Scholarly Achievement Small Grant Program; Vice Provost	This study was supported in part by funds from the Baylor Undergraduate Research and Scholarly Achievement Small Grant Program and the Vice Provost for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini L, 1996, PHARMACOL BIOCHEM BE, V53, P277, DOI 10.1016/0091-3057(95)02021-7; Bogle Kristin E, 2009, Curr Drug Abuse Rev, V2, P157; CUMIN R, 1982, PSYCHOPHARMACOLOGY, V78, P104, DOI 10.1007/BF00432244; GOULIAEV AH, 1994, BRAIN RES REV, V19, P180, DOI 10.1016/0165-0173(94)90011-6; Ingvar M, 1997, EXP NEUROL, V146, P553, DOI 10.1006/exnr.1997.6581; Koliaki CC, 2012, CNS NEUROSCI THER, V18, P302, DOI 10.1111/j.1755-5949.2010.00244.x; Li Y, 2007, J NEURAL TRANSM, V114, P1407, DOI 10.1007/s00702-007-0760-2; Lu Y, 1997, BRAIN RES, V768, P197, DOI 10.1016/S0006-8993(97)00644-6; Lugo JN, 2012, LEARN MEMORY, V19, P182, DOI 10.1101/lm.023614.111; MARTIN JR, 1995, PHARMACOL RES, V31, P133, DOI 10.1016/1043-6618(95)80059-X; Masuoka T, 2008, PSYCHOPHARMACOLOGY, V197, P107, DOI 10.1007/s00213-007-1013-7; McCabe SE, 2005, ADDICT BEHAV, V30, P789, DOI 10.1016/j.addbeh.2004.08.024; McLaughlin L., 2011, ADDERALL WHOLE STORY; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakamura K, 2001, BRAIN RES, V897, P82, DOI 10.1016/S0006-8993(01)02096-0; Nakamura K, 2001, EUR J PHARMACOL, V420, P33, DOI 10.1016/S0014-2999(01)01005-6; Nakayama S, 1986, YAKURI TO CHIRYO, V14; Ogiso T, 1998, J PHARM SCI, V87, P594, DOI 10.1021/js970355p; Rao Y, 2001, NEUROSCI LETT, V298, P183, DOI 10.1016/S0304-3940(00)01744-4; Sara SJ, 1999, LEARN MEMORY, V6, P88; SPIGNOLI G, 1987, PHARMACOL BIOCHEM BE, V27, P491, DOI 10.1016/0091-3057(87)90353-4; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; Vaglenova J, 2008, NEUROPSYCHOPHARMACOL, V33, P1071, DOI 10.1038/sj.npp.1301496; Wijayawardhane N, 2008, NEUROBIOL DIS, V29, P81, DOI 10.1016/j.nbd.2007.08.001; Wijayawardhane N, 2007, NEUROBIOL DIS, V26, P696, DOI 10.1016/j.nbd.2007.03.009; Yu SM, 2003, NEUROSCI LETT, V339, P187, DOI 10.1016/S0304-3940(03)00028-4; Zhang J, 2007, J CHROMATOGR B, V858, P129, DOI 10.1016/j.jchromb.2007.08.010	28	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104443	10.1371/journal.pone.0104443	http://dx.doi.org/10.1371/journal.pone.0104443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099639	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100073
J	Nishida, K; Matsumura, S; Taniguchi, W; Uta, D; Furue, H; Ito, S				Nishida, Kazuhiko; Matsumura, Shinji; Taniguchi, Wataru; Uta, Daisuke; Furue, Hidemasa; Ito, Seiji			Three-Dimensional Distribution of Sensory Stimulation-Evoked Neuronal Activity of Spinal Dorsal Horn Neurons Analyzed by In Vivo Calcium Imaging	PLOS ONE			English	Article							SUBSTANTIA-GELATINOSA NEURONS; SUBNUCLEUS CAUDALIS NEURONS; PRIMARY AFFERENT NEURONS; AMINO-ACID ANTAGONISTS; RECEPTIVE-FIELD; RAT; CORD; EXPRESSION; ORGANIZATION; INTERNEURONS	The spinal dorsal horn comprises heterogeneous populations of interneurons and projection neurons, which form neuronal circuits crucial for processing of primary sensory information. Although electrophysiological analyses have uncovered sensory stimulation-evoked neuronal activity of various spinal dorsal horn neurons, monitoring these activities from large ensembles of neurons is needed to obtain a comprehensive view of the spinal dorsal horn circuitry. In the present study, we established in vivo calcium imaging of multiple spinal dorsal horn neurons by using a two-photon microscope and extracted three-dimensional neuronal activity maps of these neurons in response to cutaneous sensory stimulation. For calcium imaging, a fluorescence resonance energy transfer (FRET)-based calcium indicator protein, Yellow Cameleon, which is insensitive to motion artifacts of living animals was introduced into spinal dorsal horn neurons by in utero electroporation. In vivo calcium imaging following pinch, brush, and heat stimulation suggests that laminar distribution of sensory stimulation-evoked neuronal activity in the spinal dorsal horn largely corresponds to that of primary afferent inputs. In addition, cutaneous pinch stimulation elicited activities of neurons in the spinal cord at least until 2 spinal segments away from the central projection field of primary sensory neurons responsible for the stimulated skin point. These results provide a clue to understand neuronal processing of sensory information in the spinal dorsal horn.	[Nishida, Kazuhiko; Matsumura, Shinji; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Hirakata, Osaka, Japan; [Taniguchi, Wataru] Kansai Univ Hlth Sci, Pain Res Ctr, Kumatori, Osaka, Japan; [Uta, Daisuke; Furue, Hidemasa] Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 444, Japan	Kansai Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Ito, S (corresponding author), Kansai Med Univ, Dept Med Chem, Hirakata, Osaka, Japan.	ito@hirakata.kmu.ac.jp		ito, Seiji/0000-0002-0942-1624; Nishida, Kazuhiko/0000-0001-8825-8441; Taniguchi, Wataru/0000-0002-8333-7877	Japanese Ministry of Education, Culture, Sports, Science and Technology [24590736, 24590735, 23659322]; Grants-in-Aid for Scientific Research [25670289, 25860431, 26293132, 24590736] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (http://www.jsps.go.jp/english/e-grants/index.html) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, to KN (#24590736), SM (#24590735), and SI (#23659322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 1999, EUR J NEUROSCI, V11, P2758, DOI 10.1046/j.1460-9568.1999.00691.x; Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; BULLITT E, 1991, J COMP NEUROL, V312, P279, DOI 10.1002/cne.903120210; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; Graham BA, 2004, J PHYSIOL-LONDON, V561, P749, DOI 10.1113/jphysiol.2004.072645; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Grudt TJ, 2002, J PHYSIOL-LONDON, V540, P189, DOI 10.1113/jphysiol.2001.012890; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Johannssen HC, 2013, EXP NEUROL, V242, P18, DOI 10.1016/j.expneurol.2012.07.014; Johannssen HC, 2010, J PHYSIOL-LONDON, V588, P3397, DOI 10.1113/jphysiol.2010.191833; Kato G, 2011, J NEUROSCI, V31, P17300, DOI 10.1523/JNEUROSCI.4474-11.2011; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Laffray S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019928; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Light AR, 1999, J NEUROPHYSIOL, V82, P3316, DOI 10.1152/jn.1999.82.6.3316; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Lorenzo LE, 2008, J COMP NEUROL, V508, P592, DOI 10.1002/cne.21691; Luu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020940; Michael GJ, 1999, J NEUROSCI, V19, P1844; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Nishida K, 2011, MOL CELL NEUROSCI, V46, P662, DOI 10.1016/j.mcn.2011.01.007; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Saba R, 2003, J NEUROSCI, V23, P1987; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sardella TCP, 2011, NEUROSCIENCE, V192, P708, DOI 10.1016/j.neuroscience.2011.07.011; SHERMAN SE, 1994, PAIN, V56, P17, DOI 10.1016/0304-3959(94)90146-5; Sorkin LS, 1998, PAIN, V77, P181, DOI 10.1016/S0304-3959(98)00094-3; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Takahashi Y, 2002, J COMP NEUROL, V445, P133, DOI 10.1002/cne.10158; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; WOOLF CJ, 1983, J COMP NEUROL, V221, P313, DOI 10.1002/cne.902210307; Xu Y, 2013, J NEUROSCI, V33, P14738, DOI 10.1523/JNEUROSCI.5512-12.2013; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; YOKOTA T, 1979, BRAIN RES, V171, P369, DOI 10.1016/0006-8993(79)90345-7; YOKOTA T, 1979, BRAIN RES, V168, P430, DOI 10.1016/0006-8993(79)90188-4; Zhu Y, 2009, DEVELOPMENT, V136, P1919, DOI 10.1242/dev.032276	49	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103321	10.1371/journal.pone.0103321	http://dx.doi.org/10.1371/journal.pone.0103321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100083	Green Submitted, gold, Green Published			2022-12-25	WOS:000339995100017
J	Pelosi, B; Migliarini, S; Pacini, G; Pratelli, M; Pasqualetti, M				Pelosi, Barbara; Migliarini, Sara; Pacini, Giulia; Pratelli, Marta; Pasqualetti, Massimo			Generation of Pet1(210)-Cre Transgenic Mouse Line Reveals Non-Serotonergic Expression Domains of Pet1 Both in CNS and Periphery	PLOS ONE			English	Article							NAIL-PATELLA SYNDROME; DORSAL RAPHE NUCLEUS; CENTRAL SEROTONERGIC NEURONS; TRANSCRIPTION FACTOR; BRAIN-DEVELOPMENT; GENE-EXPRESSION; EWING SARCOMA; IN-VIVO; LMX1B; SYSTEM	Neurons producing serotonin (5-hydroxytryptamine, 5-HT) constitute one of the most widely distributed neuronal networks in the mammalian central nervous system (CNS) and exhibit a profuse innervation throughout the CNS already at early stages of development. Serotonergic neuron specification is controlled by a combination of secreted molecules and transcription factors such as Shh, Fgf4/8, Nkx2.2, Lmx1b and Pet1. In the mouse, Pet1 mRNA expression appears between 10 and 11 days post coitum (dpc) in serotonergic post-mitotic precursors and persists in serotonergic neurons up to adulthood, where it promotes the expression of genes defining the mature serotonergic phenotype such as tryptophan hydroxylase 2 (Tph2) and serotonin transporter (SERT). Hence, the generation of genetic tools based on Pet1 specific expression represents a valuable approach to study the development and function of the serotonergic system. Here, we report the generation of a Pet1(210)-Cre transgenic mouse line in which the Cre recombinase is expressed under the control of a 210 kb fragment from the Pet1 genetic locus to ensure a reliable and faithful control of somatic recombination in Pet1 cell lineage. Besides Cre-mediated recombination accurately occurred in the serotonergic system as expected and according to previous studies, Pet1(270)-Cre transgenic mouse line allowed us to identify novel, so far uncharacterized, Pet1 expression domains. Indeed, we showed that in the raphe Pet1 is expressed also in a non-serotonergic neuronal population intermingled with Tph2-expressing cells and mostly localized in the B8 and B9 nuclei. Moreover, we detected Cre-mediated recombination also in the developing pancreas and in the ureteric bud derivatives of the kidney, where it reflected a specific Pet1 expression. Thus, Pet1270-Cre transgenic mouse line faithfully drives Cre-mediated recombination in all Pet1 expression domains representing a valuable tool to genetically manipulate serotonergic and non-serotonergic Pet1 cell lineages.	[Pelosi, Barbara; Migliarini, Sara; Pacini, Giulia; Pratelli, Marta; Pasqualetti, Massimo] Univ Pisa, Unit Cell & Dev Biol, Dept Biol, Pisa, Italy; [Pasqualetti, Massimo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy	University of Pisa; Istituto Italiano di Tecnologia - IIT	Pasqualetti, M (corresponding author), Univ Pisa, Unit Cell & Dev Biol, Dept Biol, Pisa, Italy.	massimo.pasqualetti@unipi.it	Pratelli, Marta/GWQ-6324-2022	Pasqualetti, Massimo/0000-0002-0844-8139; Migliarini, Sara/0000-0003-2741-269X; Pelosi, Barbara/0000-0002-2829-2979	Italian Ministry of Education, University and Research (MIUR) [200894SYW2]; Toscana Life Sciences Foundation (Orphan_0108 program); University of Pisa; Regional Program; European Social Fund	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Toscana Life Sciences Foundation (Orphan_0108 program); University of Pisa; Regional Program; European Social Fund(European Social Fund (ESF))	This work was supported by the Italian Ministry of Education, University and Research (MIUR) (Prin 2008, 200894SYW2) and Toscana Life Sciences Foundation (Orphan_0108 program) to MP. BP and GP were supported by a PhD program from the University of Pisa. SM was supported by the Regional Program and European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade R, 2013, ACS CHEM NEUROSCI, V4, P22, DOI 10.1021/cn300224n; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Aznar S, 2004, NEUROSCIENCE, V124, P573, DOI 10.1016/j.neuroscience.2003.12.020; Bang SJ, 2012, J COMP NEUROL, V520, P4157, DOI 10.1002/cne.23146; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Berg T, 2009, CANCER GENET CYTOGEN, V194, P53, DOI 10.1016/j.cancergencyto.2009.06.002; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Cheng LP, 2003, J NEUROSCI, V23, P9961; Commons KG, 2003, NEUROPSYCHOPHARMACOL, V28, P206, DOI 10.1038/sj.npp.1300045; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Dahlstrom A, 1964, ACTA PHYSIOL SCAND S, V232, P1, DOI DOI 10.1007/BF00337069; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gras C, 2002, J NEUROSCI, V22, P5442; Halberstadt AL, 2006, NEUROSCIENCE, V140, P1067, DOI 10.1016/j.neuroscience.2006.02.053; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hendricks T, 1999, J NEUROSCI, V19, P10348; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Jackson LN, 2009, CLIN CANCER RES, V15, P2747, DOI 10.1158/1078-0432.CCR-08-2346; Jacob J, 2009, DEVELOPMENT, V136, P2477, DOI 10.1242/dev.034546; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jensen Patricia, 2014, Methods Mol Biol, V1092, P437, DOI 10.1007/978-1-60327-292-6_26; Kiyasova V, 2011, EUR J NEUROSCI, V34, P1553, DOI 10.1111/j.1460-9568.2011.07910.x; KOHLER C, 1982, NEUROSCIENCE, V7, P951, DOI 10.1016/0306-4522(82)90054-9; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; McIntosh I, 1998, AM J HUM GENET, V63, P1651, DOI 10.1086/302165; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Ng TL, 2007, J MOL DIAGN, V9, P459, DOI 10.2353/jmoldx.2007.070009; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Olivier B, 2005, NOVART FDN SYMP, V268, P242; OLIVIER B, 2005, NOVART FDN SYMP, V268, P183; Olivier Berend, 2005, Novartis Found Symp, V268, P171; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pfaar H, 2002, DEV GENES EVOL, V212, P43, DOI 10.1007/s00427-001-0208-x; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rohr C, 2002, J CLIN INVEST, V109, P1073, DOI 10.1172/JCI200213961; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; Soiza-Reilly M, 2011, J CHEM NEUROANAT, V41, P247, DOI 10.1016/j.jchemneu.2011.04.004; Song NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015998; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thomson RB, 1998, GENOMICS, V51, P445, DOI 10.1006/geno.1998.5402; Valentino RJ, 2005, NEUROPEPTIDES, V39, P1, DOI 10.1016/j.npep.2004.09.005; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	72	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104318	10.1371/journal.pone.0104318	http://dx.doi.org/10.1371/journal.pone.0104318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098329	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100062
J	Schreiter, S; Sandmann, M; Smalla, K; Grosch, R				Schreiter, Susanne; Sandmann, Martin; Smalla, Kornelia; Grosch, Rita			Soil Type Dependent Rhizosphere Competence and Biocontrol of Two Bacterial Inoculant Strains and Their Effects on the Rhizosphere Microbial Community of Field-Grown Lettuce	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; ANTAGONISTIC BACTERIA; ANTIBIOTIC PRODUCTION; GENOTYPIC DIVERSITY; FUSARIUM-OXYSPORUM; BIOLOGICAL-CONTROL; ROOT COLONIZATION; PSEUDOMONAS; IDENTIFICATION; AMPLIFICATION	Rhizosphere competence of bacterial inoculants is assumed to be important for successful biocontrol. Knowledge of factors influencing rhizosphere competence under field conditions is largely lacking. The present study is aimed to unravel the effects of soil types on the rhizosphere competence and biocontrol activity of the two inoculant strains Pseudomonas jessenii RU47 and Serratia plymuthica 3Re4-18 in field-grown lettuce in soils inoculated with Rhizoctonia solani AG1-IB or not. Two independent experiments were carried out in 2011 on an experimental plot system with three soil types sharing the same cropping history and weather conditions for more than 10 years. Rifampicin resistant mutants of the inoculants were used to evaluate their colonization in the rhizosphere of lettuce. The rhizosphere bacterial community structure was analyzed by denaturing gradient gel electrophoresis of 16S rRNA gene fragments amplified from total community DNA to get insights into the effects of the inoculants and R. solani on the indigenous rhizosphere bacterial communities. Both inoculants showed a good colonization ability of the rhizosphere of lettuce with more than 10 6 colony forming units per g root dry mass two weeks after planting. An effect of the soil type on rhizosphere competence was observed for 3Re4-18 but not for RU47. In both experiments a comparable rhizosphere competence was observed and in the presence of the inoculants disease symptoms were either significantly reduced, or at least a non-significant trend was shown. Disease severity was highest in diluvial sand followed by alluvial loam and loess loam suggesting that the soil types differed in their conduciveness for bottom rot disease. Compared to effect of the soil type of the rhizosphere bacterial communities, the effects of the pathogen and the inoculants were less pronounced. The soil types had a surprisingly low influence on rhizosphere competence and biocontrol activity while they significantly affected the bottom rot disease severity.	[Schreiter, Susanne; Smalla, Kornelia] Julius Kuhn Inst Fed Res Ctr Cultivated Plants JK, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Schreiter, Susanne; Sandmann, Martin; Grosch, Rita] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Hlth, Grossbeeren, Germany	Julius Kuhn-Institut; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Grosch, R (corresponding author), Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Hlth, Grossbeeren, Germany.	grosch@igzev.de	Grosch, Rita/HHM-5490-2022; Smalla, Kornelia/H-4002-2011	Grosch, Rita/0000-0002-7179-5715	'German Research Foundation' (DFG) [SM 59/11-1, GR 1729/8-1]	'German Research Foundation' (DFG)(German Research Foundation (DFG))	The study was funded by 'German Research Foundation' (DFG), SM 59/11-1; GR 1729/8-1: KS RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina MF, 2007, SOIL BIOL BIOCHEM, V39, P2818, DOI 10.1016/j.soilbio.2007.06.004; Adesina MF, 2009, FEMS MICROBIOL ECOL, V69, P62, DOI 10.1111/j.1574-6941.2009.00685.x; Alabouvette C, 2006, EUR J PLANT PATHOL, V114, P329, DOI 10.1007/s10658-005-0233-0; Barret M, 2011, BIOL FERT SOILS, V47, P729, DOI 10.1007/s00374-011-0605-x; Baudoin E, 2002, APPL SOIL ECOL, V19, P135, DOI 10.1016/S0929-1393(01)00185-8; Benizri E, 2007, SOIL BIOL BIOCHEM, V39, P1230, DOI 10.1016/j.soilbio.2006.12.026; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; BULL CT, 1991, PHYTOPATHOLOGY, V81, P954, DOI 10.1094/Phyto-81-954; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Davis R M, 1997, COMPENDIUM LETTUCE D, P15; De Bellis P, 2001, APPL ENVIRON MICROB, V67, P1945, DOI 10.1128/AEM.67.4.1945-1948.2001; Dekkers LC, 2000, MOL PLANT MICROBE IN, V13, P1177, DOI 10.1094/MPMI.2000.13.11.1177; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; Gomes NCM, 2005, FEMS MICROBIOL ECOL, V54, P21, DOI 10.1016/j.femsec.2005.02.005; Gotz M, 2006, FEMS MICROBIOL ECOL, V56, P207, DOI 10.1111/j.1574-6941.2006.00093.x; Grosch R, 2005, CAN J MICROBIOL, V51, P345, DOI 10.1139/W05-002; Grosch R, 2012, PLANT SOIL, V361, P343, DOI 10.1007/s11104-012-1239-y; Grosch R, 2011, J PHYTOPATHOL, V159, P35, DOI 10.1111/j.1439-0434.2010.01708.x; Gutezeit B, 1993, GEMUSE, V29, P106; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Heuer H., 2001, BACTERIAL COMMUNITY, P177; Kazempour M. N., 2004, Plant Pathology Journal, V3, P88; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Leistra M, 2004, J ENVIRON SCI HEAL B, V39, P1, DOI 10.1081/PFC-120027435; LEMANCEAU P, 1993, BIOCONTROL SCI TECHN, V3, P219, DOI 10.1080/09583159309355278; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lottmann J, 2000, FEMS MICROBIOL ECOL, V33, P41, DOI 10.1111/j.1574-6941.2000.tb00725.x; Lugtenberg BJJ, 2001, ANNU REV PHYTOPATHOL, V39, P461, DOI 10.1146/annurev.phyto.39.1.461; Mark GL, 2006, FEMS MICROBIOL ECOL, V56, P167, DOI 10.1111/j.1574-6941.2006.00056.x; Mavrodi DV, 2011, J BACTERIOL, V193, P177, DOI 10.1128/JB.00895-10; Neumann G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00002; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Paterson E, 2007, NEW PHYTOL, V173, P600, DOI 10.1111/j.1469-8137.2006.01931.x; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Persello-Cartieaux F, 2003, PLANT CELL ENVIRON, V26, P189, DOI 10.1046/j.1365-3040.2003.00956.x; Pierson LS, 1996, FEMS MICROBIOL LETT, V136, P101, DOI 10.1111/j.1574-6968.1996.tb08034.x; Quinlan RJ, 2010, N AM BIOPESTICIDES M; Raaijmakers JM, 2001, APPL ENVIRON MICROB, V67, P2545, DOI 10.1128/AEM.67.6.2545-2554.2001; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Ruhlmann J, 2005, ARCH AGRON SOIL SCI, V51, P163, DOI DOI 10.1080/03650340400026651; Scherwinski K, 2008, FEMS MICROBIOL ECOL, V64, P106, DOI 10.1111/j.1574-6941.2007.00421.x; Schneider JHM, 1997, EUR J PLANT PATHOL, V103, P265, DOI 10.1023/A:1008643311984; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Schreiter S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00144; Steidle A, 2002, APPL ENVIRON MICROB, V68, P6371, DOI 10.1128/AEM.68.12.6371-6382.2002; Steinberg C., 2007, MODERN SOIL MICROBIO, P455; Tikhonovich IA, 2011, ANN APPL BIOL, V159, P155, DOI 10.1111/j.1744-7348.2011.00489.x; Wang YS, 2004, ECOTOX ENVIRON SAFE, V59, P127, DOI 10.1016/j.ecoenv.2004.01.008; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010	57	45	48	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103726	10.1371/journal.pone.0103726	http://dx.doi.org/10.1371/journal.pone.0103726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099168	gold, Green Published, Green Submitted			2022-12-25	WOS:000339995100030
J	Vigneron, A; Cruaud, P; Roussel, EG; Pignet, P; Caprais, JC; Callac, N; Ciobanu, MC; Godfroy, A; Cragg, BA; Parkes, JR; Van Nostrand, JD; He, ZL; Zhou, JZ; Toffin, L				Vigneron, Adrien; Cruaud, Perrine; Roussel, Erwan G.; Pignet, Patricia; Caprais, Jean-Claude; Callac, Nolwenn; Ciobanu, Maria-Cristina; Godfroy, Anne; Cragg, Barry A.; Parkes, John R.; Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong; Toffin, Laurent			Phylogenetic and Functional Diversity of Microbial Communities Associated with Subsurface Sediments of the Sonora Margin, Guaymas Basin	PLOS ONE			English	Article							DEEP-SEA SEDIMENTS; SUBSEAFLOOR SEDIMENTS; MARINE-SEDIMENTS; ARCHAEAL COMMUNITIES; GROWTH-RATE; GULF; RNA; NITROGEN; BACTERIA; GEOCHIP	Subsurface sediments of the Sonora Margin (Guayma Basin), located in proximity of active cold seep sites were explored. The taxonomic and functional diversity of bacterial and archaeal communities were investigated from 1 to 10 meters below the seafloor. Microbial community structure and abundance and distribution of dominant populations were assessed using complementary molecular approaches (Ribosomal Intergenic Spacer Analysis, 16S rRNA libraries and quantitative PCR with an extensive primers set) and correlated to comprehensive geochemical data. Moreover the metabolic potentials and functional traits of the microbial community were also identified using the GeoChip functional gene microarray and metabolic rates. The active microbial community structure in the Sonora Margin sediments was related to deep subsurface ecosystems (Marine Benthic Groups B and D, Miscellaneous Crenarchaeotal Group, Chloroflexi and Candidate divisions) and remained relatively similar throughout the sediment section, despite defined biogeochemical gradients. However, relative abundances of bacterial and archaeal dominant lineages were significantly correlated with organic carbon quantity and origin. Consistently, metabolic pathways for the degradation and assimilation of this organic carbon as well as genetic potentials for the transformation of detrital organic matters, hydrocarbons and recalcitrant substrates were detected, suggesting that chemoorganotrophic microorganisms may dominate the microbial community of the Sonora Margin subsurface sediments.	[Vigneron, Adrien; Cruaud, Perrine; Pignet, Patricia; Callac, Nolwenn; Godfroy, Anne; Toffin, Laurent] IFREMER, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Vigneron, Adrien; Cruaud, Perrine; Pignet, Patricia; Callac, Nolwenn; Godfroy, Anne; Toffin, Laurent] Univ Bretagne Occidentale, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Vigneron, Adrien; Cruaud, Perrine; Pignet, Patricia; Callac, Nolwenn; Godfroy, Anne; Toffin, Laurent] CNRS, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France; [Caprais, Jean-Claude] IFREMER, Lab Etud Environm Profonds, UMR6197, Plouzane, France; [Callac, Nolwenn] Univ Brest, Domaines Ocean IUEM, UMR6538, Plouzane, France; [Ciobanu, Maria-Cristina] IFREMER, Geosci Marines, Lab Environm Sedimentaires, Plouzane, France; [Roussel, Erwan G.; Cragg, Barry A.; Parkes, John R.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AX, S Glam, Wales; [Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Ifremer; Cardiff University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Vigneron, A (corresponding author), IFREMER, Lab Microbiol Environm Extremes, UMR6197, Plouzane, France.	avignero@gmail.com	Cruaud, Perrine/U-9631-2019; Cragg, Barry/D-2690-2009; He, Zhili/C-2879-2012; Van Nostrand, Joy D/F-1740-2016; Roussel, Erwan G/B-9992-2009; 吴, 昊/AAB-1620-2020; Anne, Godfroy/J-9897-2017; Godfroy, Anne/X-1992-2018; Callac, Nolwenn/O-3579-2016	Cruaud, Perrine/0000-0001-8628-3600; He, Zhili/0000-0001-8225-7333; Van Nostrand, Joy D/0000-0001-9548-6450; Roussel, Erwan G/0000-0002-8735-5597; Anne, Godfroy/0000-0003-0483-4160; Godfroy, Anne/0000-0003-0483-4160; Callac, Nolwenn/0000-0002-7578-3455; Ciobanu, Maria-Cristina/0000-0002-7504-2358	IFREMER; IFREMER PhD grant	IFREMER; IFREMER PhD grant	The oceanographic cruise and this study was funded by IFREMER and a IFREMER PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENSDORF JJ, 1995, APPL ENVIRON MICROB, V61, P443, DOI 10.1128/AEM.61.2.443-447.1995; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Blazejak A, 2010, FEMS MICROBIOL ECOL, V72, P198, DOI 10.1111/j.1574-6941.2010.00838.x; Callac N, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00250; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Chan YK, 2013, P NATL ACAD SCI USA, V110, P8990, DOI 10.1073/pnas.1300643110; Cheshire H, 2005, J QUATERNARY SCI, V20, P457, DOI 10.1002/jqs.944; Ciobanu MC, 2012, BIOGEOSCIENCES DISCU, V9, P253; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Danovaro R, 1999, DEEP-SEA RES PT I, V46, P1077, DOI 10.1016/S0967-0637(98)00101-0; Dekas AE, 2009, SCIENCE, V326, P422, DOI 10.1126/science.1178223; Divins DL, 2003, TOTAL SEDIMENT TCHIC; Durbin AM, 2011, ENVIRON MICROBIOL, V13, P3219, DOI 10.1111/j.1462-2920.2011.02544.x; Fonselius S, 2007, METHODS SEAWATER ANA, P91, DOI DOI 10.1086/678125; Futagami T, 2009, APPL ENVIRON MICROB, V75, P6905, DOI 10.1128/AEM.01124-09; Govin A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003785; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Jorgensen BB, 2011, P NATL ACAD SCI USA, V108, P18193, DOI 10.1073/pnas.1115421108; Jorgensen SL, 2012, P NATL ACAD SCI USA, V109, pE2846, DOI 10.1073/pnas.1207574109; Kallmeyer J, 2012, P NATL ACAD SCI; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; KERKHOF L, 1993, APPL ENVIRON MICROB, V59, P1303, DOI 10.1128/AEM.59.5.1303-1309.1993; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kubo K, 2012, ISME J; Lazar CS, 2011, APPL ENVIRON MICROB, V77, P3120, DOI 10.1128/AEM.01296-10; Lazar CS, 2010, MICROB ECOL, V60, P516, DOI 10.1007/s00248-010-9654-1; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Lloyd KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008738; Lloyd KG, 2013, NATURE; Loffler FE, 2012, INT J SYSTEMATIC EVO; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Lu ZM, 2012, ENVIRON SCI TECHNOL, V46, P5824, DOI 10.1021/es300478j; Meng J, 2013, ISME J; Meyerdierks A, 2010, ENVIRON MICROBIOL, V12, P422, DOI 10.1111/j.1462-2920.2009.02083.x; Morono Y, 2011, P NATL ACAD SCI USA, V108, P18295, DOI 10.1073/pnas.1107763108; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; NATH BN, 1989, MAR GEOL, V87, P301, DOI 10.1016/0025-3227(89)90067-4; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Orsi WD, 2013, NATURE, V499, P205, DOI 10.1038/nature12230; Parkes RJ, 2007, ENVIRON MICROBIOL, V9, P1146, DOI 10.1111/j.1462-2920.2006.01237.x; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Roussel EG, 2008, SCIENCE, V320, P1046, DOI 10.1126/science.1154545; Roussel EG, 2009, ENVIRON MICROBIOL, V11, P2446, DOI 10.1111/j.1462-2920.2009.01976.x; Roy R, 2010, ESTUAR COAST SHELF S, V88, P311, DOI 10.1016/j.ecss.2010.04.011; Russ L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00219; Sarradin P-M, 1996, ANAL COMMUN, V33; SIMONEIT BRT, 1979, DEEP-SEA RES, V26, P879, DOI 10.1016/0198-0149(79)90102-X; SIMONEIT BRT, 1990, APPL GEOCHEM, V5, P41, DOI 10.1016/0883-2927(90)90034-3; SOWERS KR, 1983, APPL ENVIRON MICROB, V45, P684, DOI 10.1128/AEM.45.2.684-690.1983; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Vetriani C, 2003, APPL ENVIRON MICROB, V69, P6481, DOI 10.1128/AEM.69.11.6481-6488.2003; Vigneron A, 2013, ISME J; Vigneron A, 2014, ENV MICROBIOL; Webster G, 2004, APPL ENVIRON MICROB, V70, P5708, DOI 10.1128/AEM.70.9.5708-5713.2004; Zhou J, 2009, PHYTOPATHOLOGY, V99, pS164; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	65	21	22	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104427	10.1371/journal.pone.0104427	http://dx.doi.org/10.1371/journal.pone.0104427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099369	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000339995100071
J	Wang, IH; Chen, HY; Wang, YH; Chang, KW; Chen, YC; Chang, CR				Wang, I-Hua; Chen, Hsin-Yi; Wang, Yu-Han; Chang, Ko-Wei; Chen, Ying-Chieh; Chang, Chuang-Rung			Resveratrol Modulates Mitochondria Dynamics in Replicative Senescent Yeast Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CELLULAR SENESCENCE; FUSION; FISSION; PROTEIN; GTPASE; FZO1P; DNM1P; MORPHOLOGY	Mitochondria form a reticulum network dynamically fuse and divide in the cell. The balance between mitochondria fusion and fission is correlated to the shape, activity and integrity of these pivotal organelles. Resveratrol is a polyphenol antioxidant that can extend life span in yeast and worm. This study examined mitochondria dynamics in replicative senescent yeast cells as well as the effects of resveratrol on mitochondria fusion and fission. Collecting cells by biotin-streptavidin sorting method revealed that majority of the replicative senescent cells bear fragmented mitochondrial network, indicating mitochondria dynamics favors fission. Resveratrol treatment resulted in a reduction in the ratio of senescent yeast cells with fragmented mitochondria. The readjustment of mitochondria dynamics induced by resveratrol likely derives from altered expression profiles of fusion and fission genes. Our results demonstrate that resveratrol serves not only as an antioxidant, but also a compound that can mitigate mitochondria fragmentation in replicative senescent yeast cells.	[Wang, I-Hua; Chen, Hsin-Yi; Wang, Yu-Han; Chang, Ko-Wei; Chen, Ying-Chieh; Chang, Chuang-Rung] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Chang, Chuang-Rung] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Chang, CR (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	crchang@life.nthu.edu.tw	Chang, Chuang-Rung/C-1815-2012	Chang, Chuang-Rung/0000-0002-6124-5429	Ministry of Science and Technology of Taiwan [101-2311-B-007-012-MY3, 102-2320-B-007-008-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (http://web1.most.gov.tw/mp.aspx) under Grants 101-2311-B-007-012-MY3 and 102-2320-B-007-008-MY3 to CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackstone C, 2011, NAT CELL BIOL, V13, P521, DOI 10.1038/ncb0511-521; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Braun RJ, 2011, BIOCHEM SOC T, V39, P1520, DOI 10.1042/BST0391520; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Escobar-Henriques M, 2006, J CELL BIOL, V173, P645, DOI 10.1083/jcb.200512079; Ferretta A, 2014, BIOCH BIOPHYS ACTA; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoch HC, 2005, MYCOLOGIA, V97, P580, DOI 10.3852/mycologia.97.3.580; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838; Jayashankar V, 2014, CURR OPIN CELL BIOL, V26, P34, DOI 10.1016/j.ceb.2013.09.002; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kennedy BK, 2013, TRANSL RES; Lam YT, 2011, FREE RADICAL BIO MED, V50, P963, DOI 10.1016/j.freeradbiomed.2011.01.013; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rolland SG, 2013, P NATL ACAD SCI USA, V110, pE2967, DOI 10.1073/pnas.1303872110; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Scorrano L, 2013, EUR J CLIN INVEST, V43, P886, DOI 10.1111/eci.12135; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Viswanathan M, 2011, NATURE, V477, pE1, DOI 10.1038/nature10440; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	54	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104345	10.1371/journal.pone.0104345	http://dx.doi.org/10.1371/journal.pone.0104345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098588	Green Submitted, Green Published, gold			2022-12-25	WOS:000339995100064
J	Marko, PB; Nance, HA; van den Hurk, P				Marko, Peter B.; Nance, Holly A.; van den Hurk, Peter			Seafood Substitutions Obscure Patterns of Mercury Contamination in Patagonian Toothfish (Dissostichus eleginoides) or "Chilean Sea Bass''	PLOS ONE			English	Article							FISH; EXPOSURE; OCEAN	Seafood mislabeling distorts the true abundance of fish in the sea, defrauds consumers, and can also cause unwanted exposure to harmful pollutants. By combining genetic data with analyses of total mercury content, we have investigated how species substitutions and fishery-stock substitutions obscure mercury contamination in Patagonian toothfish (Dissostichus eleginoides), also known as "Chilean sea bass''. Patagonian toothfish show wide variation in mercury concentrations such that consumers may be exposed to either acceptable or unacceptable levels of mercury depending on the geographic origins of the fish and the allowable limits of different countries. Most notably, stocks of Patagonian toothfish in Chile accumulate significantly more mercury than stocks closer to the South Pole, including the South Georgia/Shag Rocks stock, a fishery certified by the Marine Stewardship Council (MSC) as sustainably fished. Consistent with the documented geography of mercury contamination, our analysis showed that, on average, retail fish labeled as MSC-certified Patagonian toothfish had only half the mercury of uncertified fish. However, consideration of genetic data that were informative about seafood substitutions revealed a complex pattern of contamination hidden from consumers: species substitutions artificially inflated the expected difference in mercury levels between MSC-certified and uncertified fish whereas fishery stock substitutions artificially reduced the expected difference in mercury content between MSC-certified and uncertified fish that were actually D. eleginoides. Among MSC-certified fish that were actually D. eleginoides, several with exogenous mtDNA haplotypes (i.e., not known from the certified fishery) had mercury concentrations on par with uncertified fish from Chile. Overall, our analysis of mercury was consistent with inferences from the genetic data about the geographic origins of the fish, demonstrated the potential negative impact of seafood mislabeling on unwanted mercury exposure for consumers, and showed that fishery-stock substitutions may expose consumers to significantly greater mercury concentrations in retail-acquired fish than species substitutions.	[Marko, Peter B.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Nance, Holly A.] Indian River State Coll, Ft Pierce, FL USA; [van den Hurk, Peter] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	University of Hawaii System; University of Hawaii Manoa; Clemson University	Marko, PB (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	pmarko@hawaii.edu		van den Hurk, Peter/0000-0002-8131-0996	National Science Foundation [OCE-0961996]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (OCE-0961996). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COSTA LG, 1988, TOXICOLOGY, V49, P359, DOI 10.1016/0300-483X(88)90019-4; Guynn KD, 2008, POLAR BIOL, V31, P269, DOI 10.1007/s00300-007-0354-3; Hanchet SM, 2012, ANTARCT SCI, V24, P34, DOI 10.1017/S0954102011000654; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Hightower JM, 2003, ENVIRON HEALTH PERSP, V111, P604, DOI 10.1289/ehp.5837; Hillary RM, 2006, CCAMLR SCI, V13, P65; Karimi R, 2012, ENVIRON HEALTH PERSP, V120, P1512, DOI 10.1289/ehp.1205122; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Marko PB, 2011, CURR BIOL, V21, pR621, DOI 10.1016/j.cub.2011.07.006; McArthur T, 2003, POLAR BIOL, V27, P1, DOI 10.1007/s00300-003-0560-6; Mendez E, 2001, J FOOD COMPOS ANAL, V14, P547, DOI 10.1006/jfca.2001.1006; Miller DD, 2014, SEAFOOD, V8, P517, DOI DOI 10.1890/090212; Piraino MN, 2009, MAR ENVIRON RES, V67, P117, DOI 10.1016/j.marenvres.2008.12.006; Sackett DK, 2013, INT J ENV RES PUB HE, V10, P638, DOI 10.3390/ijerph10020638; Shaw PW, 2004, MOL ECOL, V13, P3293, DOI 10.1111/j.1365-294X.2004.02327.x; Staff, 2011, CONSUMER REPORTS DEC; Streit Bruno, 1998, EXS, V86, P353; Sunderland EM, 2007, ENVIRON HEALTH PERSP, V115, P235, DOI 10.1289/ehp.9377; US EPA, 1994, 2008 US EPA; [US FDA US EPA], 2004, WHAT YOU NEED KNOW M; US-EPA, 1996, SW 846 TEST METHOD 3; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886	23	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104140	10.1371/journal.pone.0104140	http://dx.doi.org/10.1371/journal.pone.0104140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093736	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200071
J	Middleton, CH; Irving, W; Robertson, JFR; Murray, A; Parsy-Kowalska, CB; Macdonald, IK; McElveen, J; Allen, J; Healey, GF; Thomson, BJ; Ryder, SJ; Holdenrieder, S; Chapman, CJ				Middleton, Catrin H.; Irving, William; Robertson, John F. R.; Murray, Andrea; Parsy-Kowalska, Celine B.; Macdonald, Isabel K.; McElveen, Jane; Allen, Jared; Healey, Graham F.; Thomson, Brian J.; Ryder, Stephen J.; Holdenrieder, Stefan; Chapman, Caroline J.			Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED ANTIGENS; BREAST-CANCER; LUNG; BIOMARKERS; VALIDATION; ANTIBODIES; ALPHA; AID; P53	Background: Individuals with liver disease, and especially those with Hepatitis B or C, are at an increased risk of developing hepatocellular carcinoma (HCC) which is the third most common cause of cancer-related death worldwide. Inadequate screening tests largely account for presentation of advanced tumours and high mortality rates. Early detection of HCC amongst high-risk groups is paramount in improving prognosis. This research aimed to further characterise the previously described humoral immune response raised to tumour-associated antigens (TAAs) in the serum of patients with HCC. Methods: Serum from 96 patients with confirmed HCC, 96 healthy controls matched for age and sex, 78 patients with confirmed liver cirrhosis and 91 patients with confirmed chronic liver disease were analysed for the presence of IgG autoantibodies raised to 41 recombinant TAAs/antigen fragments by ELISA. Results: Varying autoantibody specificities (97-100%) and sensitivities (0-10%) were observed to individual TAAs. A 21-antigen panel achieved a specificity of 92% and sensitivity of 45% for the detection of HCC. This same panel identified 21% of 169 high-risk controls as having elevated autoantibody levels. A reproducible panel of 10 antigens achieved a specificity of 91% and sensitivity of 41% in HCC. 15% of 152 high-risk controls gave positive results with this panel. Conclusions: This minimally invasive blood test has the potential to offer advantages over currently available tools for the identification of HCC amongst pre-disposed patients. Results are comparable to current gold standards in HCC (Ultrasonography) and to similar tests in other cancers (EarlyCDT-Lung).	[Middleton, Catrin H.; Robertson, John F. R.; Chapman, Caroline J.] Univ Nottingham, Sch Med, Ctr Excellence Autoimmun Canc, Nottingham, England; [Murray, Andrea; Parsy-Kowalska, Celine B.; Macdonald, Isabel K.; McElveen, Jane; Allen, Jared; Healey, Graham F.] Oncimmune Ltd, Nottingham, England; [Irving, William; Thomson, Brian J.; Ryder, Stephen J.] Queens Med Ctr, Nottingham Digest Dis Biomed Res Unit, Nottingham NG7 2UH, England; [Holdenrieder, Stefan] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	University of Nottingham; University of Nottingham; University of Bonn	Chapman, CJ (corresponding author), Univ Nottingham, Sch Med, Ctr Excellence Autoimmun Canc, Nottingham, England.	caroline.chapman@nottingham.ac.uk		Thomson, Brian/0000-0001-8490-2332; Ryder, Stephen David/0000-0001-9649-4444; Allen, Jared/0000-0002-4061-3704; Irving, William/0000-0002-7268-3168	University of Nottingham; Oncimmune Ltd.	University of Nottingham; Oncimmune Ltd.	This work was supported by funding from the University of Nottingham and Oncimmune Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruno S, 2011, HEPATIC MED-EVID RES, V3, P21, DOI 10.2147/HMER.S16991; Cancer Research UK, 2010, CANCERSTATS; Chan CC, 2010, INT J CANCER, V126, P1683, DOI 10.1002/ijc.24912; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; Chapman CJ, 2011, CLIN CANCER RES, V17, P1474, DOI 10.1158/1078-0432.CCR-10-1363; Chapman CJ, 2010, CHEST, V138, p775A; Chen Y, 2010, CANCER LETT, V289, P32, DOI 10.1016/j.canlet.2009.07.016; Dutta J, 2008, J VIROL, V82, P10792, DOI 10.1128/JVI.00903-08; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hollander M, 1973, NONPARAMETRIC STAT M; Kilic A, 2008, J THORAC CARDIOV SUR, V136, P199, DOI 10.1016/j.jtcvs.2008.01.012; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Le Naour F, 2002, MOL CELL PROTEOMICS, V1, P197, DOI 10.1074/mcp.M100029-MCP200; Li J, 2012, SCAND J IMMUNOL, V75, P342, DOI 10.1111/j.1365-3083.2011.02657.x; Liu H, 2012, CANCER EPIDEMIOL, V36, P82, DOI 10.1016/j.canep.2011.04.001; Looi KS, 2008, J PROTEOME RES, V7, P4004, DOI 10.1021/pr800273h; Lu HL, 2012, CANCER PREV RES, V5, P1036, DOI 10.1158/1940-6207.CAPR-11-0558; Macdonald IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040759; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Piura B, 2009, J ONCOL, V2009, DOI 10.1155/2009/581939; Piura E, 2011, J ONCOL, V2011, DOI 10.1155/2011/982425; Robertson JFR, 2005, J CLIN ONCOL, V23, p16S; Robertson JFR, 2005, Tumour markers. European patent, Patent No. [EP-B 1078264, 1078264]; Shan Q, 2013, CANCER LETT, V328, P160, DOI 10.1016/j.canlet.2012.08.019; Storr SJ, 2006, EXPERT REV ANTICANC, V6, P1215, DOI 10.1586/14737140.6.8.1215; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Yi XY, 2013, CLIN CHIM ACTA, V425, P212, DOI 10.1016/j.cca.2013.08.005; Zayakin P, 2013, INT J CANCER, V132, P137, DOI 10.1002/ijc.27667; Zhang JY, 2007, J HEPATOL, V46, P107, DOI 10.1016/j.jhep.2006.08.010; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	39	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103867	10.1371/journal.pone.0103867	http://dx.doi.org/10.1371/journal.pone.0103867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093332	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200039
J	Chen, C; Shen, L; Cao, SP; Li, XX; Xuan, WL; Zhang, JW; Huang, XB; Bin, JP; Xu, DL; Li, GF; Kitakaze, M; Liao, YL				Chen, Ci; Shen, Liang; Cao, Shiping; Li, Xixian; Xuan, Wanling; Zhang, Jingwen; Huang, Xiaobo; Bin, Jianping; Xu, Dingli; Li, Guofeng; Kitakaze, Masafumi; Liao, Yulin			Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEIN; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; GENE-EXPRESSION; HEART-FAILURE; ANKRD1 MUTATIONS; CALPAIN; PATHWAY; DISEASE	The gene ankyrin repeat domain 1 (Ankrd1) is an enigmatic gene and may exert pleiotropic function dependent on its expression level, subcellular localization and even types of pathological stress, but it remains unclear how these factors influence the fate of cardiomyocytes. Here we attempted to investigate the role of CARP on cardiomyocyte hypertrophy. In neonatal rat ventricular cardiomyocytes (NRVCs), angiotensin II (Ang II) increased the expression of both calpain 1 and CARP, and also induced cytosolic translocation of CARP, which was abrogated by a calpain inhibitor. In the presence of Ang-II in NRVCs, infection with a recombinant adenovirus containing rat Ankrd1 cDNA (Ad-Ankrd1) enhanced myocyte hypertrophy, the upregulation of atrial natriuretic peptide and beta-myosin heavy chain genes and calcineurin proteins as well as nuclear translocation of nuclear factor of activated T cells. Cyclosporin A attenuated Ad-Ankrd1-enhanced cardiomyocyte hypertrophy. Intra-myocardial injection of Ad-Ankrd1 in mice with transverse aortic constriction (TAC) markedly increased the cytosolic CARP level, the heart weight/body weight ratio, while short hairpin RNA targeting Ankrd1 inhibited TAC-induced hypertrophy. The expression of calcineurin was also significantly increased in Ad-Ankrd1-infected TAC mice. Olmesartan (an Ang II receptor antagonist) prevented the upregulation of CARP in both Ang II-stimulated NRVCs and hearts with pressure overload. These findings indicate that overexpression of Ankrd1 exacerbates pathological cardiac remodeling through the enhancement of cytosolic translocation of CARP and upregulation of calcineurin.	[Chen, Ci; Shen, Liang; Cao, Shiping; Li, Xixian; Xuan, Wanling; Zhang, Jingwen; Huang, Xiaobo; Bin, Jianping; Xu, Dingli; Kitakaze, Masafumi; Liao, Yulin] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Li, Guofeng] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Med, Div Cardiovasc, Osaka, Japan	Southern Medical University - China; Southern Medical University - China; National Cerebral & Cardiovascular Center - Japan	Cao, SP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	csp2012@126.com; liao18@msn.com	Zhang, Jing/GWZ-7332-2022; Xu, Dingli/AAA-6176-2019; Liao, Yulin/AAP-6315-2021	Xu, Dingli/0000-0002-3193-4354; xuan, wanling/0000-0002-5443-8994	National Natural Science Foundation of China [81170146, 31271513]; Team Program of Natural Science Foundation of Guangdong Province, China [S2011030003134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Team Program of Natural Science Foundation of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (81170146, 31271513 to Y.L.), the Team Program of Natural Science Foundation of Guangdong Province, China (S2011030003134, to Y.L. and B.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Crocini C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0349-x; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Fu MG, 1999, HEART VESSELS, V14, P283, DOI 10.1007/BF03257240; Gaussin V, 2003, CIRCULATION, V108, P2926, DOI 10.1161/01.CIR.0000101922.18151.7B; Hsu SC, 2013, CARDIOVASC RES, V100, P222, DOI 10.1093/cvr/cvt190; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Laure L, 2010, FEBS J, V277, P4322, DOI 10.1111/j.1742-4658.2010.07820.x; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Mestroni L, 2009, J AM COLL CARDIOL, V54, P343, DOI 10.1016/j.jacc.2009.04.029; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nanni L, 2006, J MOL CELL CARDIOL, V41, P934, DOI 10.1016/j.yjmcc.2006.08.009; Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749; Scurr LL, 2008, CLIN CANCER RES, V14, P6924, DOI 10.1158/1078-0432.CCR-07-5189; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Stam FJ, 2007, EUR J NEUROSCI, V25, P3629, DOI 10.1111/j.1460-9568.2007.05597.x; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Yatabe J, 2009, AM J PHYSIOL-RENAL, V296, pF1052, DOI 10.1152/ajprenal.00580.2007; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	33	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104040	10.1371/journal.pone.0104040	http://dx.doi.org/10.1371/journal.pone.0104040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089522	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700088
J	Chen, JB; Lu, J				Chen, Jiabo; Lu, Jun			Effects of Land Use, Topography and Socio-Economic Factors on River Water Quality in a Mountainous Watershed with Intensive Agricultural Production in East China	PLOS ONE			English	Article							CAO-E RIVER; NUTRIENT CONCENTRATIONS; STREAM; COVER; BASIN; POLLUTION; NITROGEN; SYSTEM; MANAGEMENT; IMPACTS	Understanding the primary effects of anthropogenic activities and natural factors on river water quality is important in the study and efficient management of water resources. In this study, analysis of Variance (ANOVA), Principal component analysis (PCA), Pearson correlations, Multiple regression analysis (MRA) and Redundancy analysis (RDA) were applied as an integrated approach in a GIS environment to explore the temporal and spatial variations in river water quality and to estimate the influence of watershed land use, topography and socio-economic factors on river water quality based on 3 years of water quality monitoring data for the Cao-E River system. The statistical analysis revealed that TN, pH and temperature were generally higher in the rainy season, whereas BOD5, DO and turbidity were higher in the dry season. Spatial variations in river water quality were related to numerous anthropogenic and natural factors. Urban land use was found to be the most important explanatory variable for BOD5, CODMn, TN, DN, NH4+-N, NO3--N, DO, pH and TP. The animal husbandry output per capita was an important predictor of TP and turbidity, and the gross domestic product per capita largely determined spatial variations in EC. The remaining unexplained variance was related to other factors, such as topography. Our results suggested that pollution control of animal waste discharge in rural settlements, agricultural runoff in cropland, industrial production pollution and domestic pollution in urban and industrial areas were important within the Cao-E River basin. Moreover, the percentage of the total overall river water quality variance explained by an individual variable and/or all environmental variables (according to RDA) can assist in quantitatively identifying the primary factors that control pollution at the watershed scale.	[Chen, Jiabo; Lu, Jun] Zhejiang Univ, Coll Environm & Nat Resources, Dept Nat Resources, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Jun] Zhejiang Univ, Key Lab Environm Remediat & Ecol Hlth, China Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Lu, J (corresponding author), Zhejiang Univ, Coll Environm & Nat Resources, Dept Nat Resources, Hangzhou 310003, Zhejiang, Peoples R China.	jlu@zju.edu.cn	Jun, Lu/GMX-2504-2022		Chinese National Key Technology RD Program [2012BAC17B01]	Chinese National Key Technology RD Program(National Key Technology R&D Program)	Chinese National Key Technology R&D Program (Grant No. 2012BAC17B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Astaraie-Imani M, 2012, J ENVIRON MANAGE, V112, P1, DOI 10.1016/j.jenvman.2012.06.039; Aubert AH, 2013, J HYDROL, V478, P29, DOI 10.1016/j.jhydrol.2012.11.027; Belsey DA, 1980, REGRESSION DIAGNOSTI; Brett MT, 2005, ENVIRON MANAGE, V35, P330, DOI 10.1007/s00267-003-0311-z; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chang NB, 2005, STOCH ENV RES RISK A, V19, P97, DOI 10.1007/s00477-004-0217-1; Chen DJ, 2006, J ENVIRON SCI, V18, P680; Chen DJ, 2011, ENVIRON POLLUT, V159, P2989, DOI 10.1016/j.envpol.2011.04.023; Chen J, 2013, ENVIRON SCI POLLUT R, V4, P2496; Chen JS, 2000, J HAZARD MATER, V73, P107, DOI 10.1016/S0304-3894(99)00165-X; Costa-Cabral M, 2013, CLIMATIC CHANGE, V116, P1, DOI 10.1007/s10584-012-0630-2; Dodds WK, 2004, LIMNOL OCEANOGR-METH, V2, P333, DOI 10.4319/lom.2004.2.333; Heathcote AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053554; Hoorman J, 2008, WATER AIR SOIL POLL, V193, P309, DOI 10.1007/s11270-008-9692-1; Huang F, 2010, WATER RES, V44, P1562, DOI 10.1016/j.watres.2009.11.003; Jiang XY, 2011, ENERG POLICY, V39, P6073, DOI 10.1016/j.enpol.2011.07.007; Jin SQ, 2009, J ENVIRON SCI, V21, P429, DOI 10.1016/S1001-0742(08)62287-1; Kannel PR, 2008, J ENVIRON MANAGE, V86, P595, DOI 10.1016/j.jenvman.2006.12.021; Karaer F, 2006, ENVIRON MONIT ASSESS, V114, P391, DOI 10.1007/s10661-006-5029-y; Keatley Be, 2011, PLOS ONE, V6; Kolovos A, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000743; Miserendino ML, 2011, SCI TOTAL ENVIRON, V409, P612, DOI 10.1016/j.scitotenv.2010.10.034; Leps J, 2003, MULTIVARIATE ANAL EC; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604, 10.1371/journal.pone.0083037]; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Lindell L, 2010, APPL GEOCHEM, V25, P485, DOI 10.1016/j.apgeochem.2009.12.013; Liu WZ, 2012, ENVIRON SCI POLLUT R, V19, P858, DOI 10.1007/s11356-011-0616-z; Mehaffey MH, 2005, ENVIRON MONIT ASSESS, V107, P29, DOI 10.1007/s10661-005-2018-5; Myers R., 1990, CLASSICAL MODERN REG; Odokuma LO, 1997, ENVIRON MONIT ASSESS, V45, P43, DOI 10.1023/A:1005709709031; Olsen RL, 2012, WATER RES, V46, P3110, DOI 10.1016/j.watres.2012.03.028; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Sepbc, 2002, WAT WAST AN METH; Shah VG, 2007, WATER RES, V41, P3655, DOI 10.1016/j.watres.2007.02.052; Shaoxing City Statistical Bureau, 2005, SHZOX STAT YB; Shen YN, 2011, PEDOSPHERE, V21, P115, DOI 10.1016/S1002-0160(10)60086-0; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; ter Braak CJF, 2002, CANOCO REFERENCE MAN; Tian C, 2013, ENVIRON MONIT ASSESS, V185, P2627, DOI 10.1007/s10661-012-2736-4; Tong L, 2009, CHEMOSPHERE, V74, P1090, DOI 10.1016/j.chemosphere.2008.10.051; Wei RC, 2011, CHEMOSPHERE, V82, P1408, DOI 10.1016/j.chemosphere.2010.11.067; Xianghao Z, 2008, J MT SCI-ENGL, V1, P4; Xiao B, 2010, AGR ECOSYST ENVIRON, V139, P653, DOI 10.1016/j.agee.2010.10.011; Yang XE, 2008, J ZHEJIANG UNIV-SC B, V9, P197, DOI 10.1631/jzus.B0710626; Ye L, 2009, ENVIRON GEOL, V58, P937, DOI 10.1007/s00254-008-1573-9; Zhang Y, 2009, ENVIRON MONIT ASSESS, V152, P105, DOI 10.1007/s10661-008-0300-z; Zhao J, 2011, J ENVIRON SCI, V23, P1460, DOI 10.1016/S1001-0742(10)60599-2; Zhou NQ, 2011, J HYDROL, V396, P267, DOI 10.1016/j.jhydrol.2010.11.019	50	61	66	8	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102714	10.1371/journal.pone.0102714	http://dx.doi.org/10.1371/journal.pone.0102714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090375	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700008
J	Ohashi, S; Kikuchi, O; Tsurumaki, M; Nakai, Y; Kasai, H; Horimatsu, T; Miyamoto, S; Shimizu, A; Chiba, T; Muto, M				Ohashi, Shinya; Kikuchi, Osamu; Tsurumaki, Mihoko; Nakai, Yukie; Kasai, Hiroi; Horimatsu, Takahiro; Miyamoto, Shin'ichi; Shimizu, Akira; Chiba, Tsutomu; Muto, Manabu			Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ASPARTYL CHLORIN E(6); DIODE-LASER; PHASE-II; CANCER; DEATH; DIFFERENTIATION; PHOTORADIATION; TRANSFORMATION; METASTASIS; EXPRESSION	Photodynamic therapy (PDT) kills cancer cells via a photochemical reaction mediated by an oncotropic photosensitizer. Herein, we performed an experimental preclinical study to validate the anti-tumour effect of talaporfin sodium-mediated PDT (t-PDT) for esophageal squamous cell carcinoma (ESCC) cells. We used human ESCC cells derived from various differentiation grades or resistant to 5-fluorouracil (5-FU). The cytotoxic effect of t-PDT was determined by evaluating cell viability, apoptosis and generation of reactive oxygen species (ROS) and DNA double-strand breaks. Furthermore, the antitumour effect of t-PDT was assessed using an anchorage-independent cell-growth assay and xenograft transplantation models. t-PDT induced potent cytotoxicity in ESCC cells independent of their differentiation grade or 5-FU resistance. Moreover, t-PDT induced robust apoptosis, as indicated by cell shrinkage, perinuclear vacuolization, nuclear fragmentation and induction of annexin V-positive cells. This apoptotic response was accompanied by concurrent activation of ROS, and induction of DNA double-strand breakage. Importantly, t-PDT suppressed efficiently anchorage-independent cell growth as well as ESCC-xenografted tumor formation. In aggregate, t-PDT showed anti-tumor potential for ESCC cells with various histological grades or chemoresistance, providing a novel translational rationale of t-PDT for the treatment of ESCC.	[Ohashi, Shinya; Tsurumaki, Mihoko; Nakai, Yukie; Horimatsu, Takahiro; Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kyoto, Japan; [Kikuchi, Osamu; Miyamoto, Shin'ichi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto, Japan; [Kasai, Hiroi; Shimizu, Akira] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University	Muto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kawahara Cho, Kyoto, Japan.	mmuto@kuhp.kyoto-u.ac.jp	Ohashi, Shinya/AAD-8920-2022	Horimatsu, Takahiro/0000-0002-4188-9059; Kikuchi, Osamu/0000-0001-5012-5897	Health and Labor Sciences Research Grant, Research on Clinical Trial on Development of New Drugs and Medical Devices [H24-012]; Grants-in-Aid for Scientific Research [25293069] Funding Source: KAKEN	Health and Labor Sciences Research Grant, Research on Clinical Trial on Development of New Drugs and Medical Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labor Sciences Research Grant, Research on Clinical Trial on Development of New Drugs and Medical Devices (H24-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allison RR, 2013, CLIN ENDOSC, V46, P24, DOI 10.5946/ce.2013.46.1.24; BIEL MA, 1994, LARYNGOSCOPE, V104, P399; CALAF G, 1993, CARCINOGENESIS, V14, P483, DOI 10.1093/carcin/14.3.483; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; DOUGHERTY TJ, 1979, J NATL CANCER I, V62, P231; DOUGHERTY TJ, 1978, CANCER RES, V38, P2628; EDELL ES, 1989, CHEST, V96, P919, DOI 10.1378/chest.96.4.919; Evans HH, 1997, PHOTOCHEM PHOTOBIOL, V66, P690, DOI 10.1111/j.1751-1097.1997.tb03208.x; Grosjean P, 1996, J Clin Laser Med Surg, V14, P281; Kato H, 2003, LUNG CANCER, V42, P103, DOI 10.1016/S0169-5002(03)00242-3; KATO H, 1993, JPN J CANCER RES, V84, P1209, DOI 10.1111/j.1349-7006.1993.tb02823.x; Katsumi TA, 1996, PHOTOCHEM PHOTOBIOL, V64, P671, DOI 10.1111/j.1751-1097.1996.tb03122.x; Kishi K, 2010, INT J ONCOL, V36, P313, DOI 10.3892/ijo_00000502; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Luna MC, 2000, CANCER RES, V60, P1637; MCCORMICK JJ, 1990, PROG CLIN BIOL RES, V340, P195; MCMAHON KS, 1994, CANCER RES, V54, P5374; Miki Y, 2013, BIOL PHARM BULL, V36, P215, DOI 10.1248/bpb.b12-00567; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Nozoe T, 2006, ONCOLOGY-BASEL, V71, P402, DOI 10.1159/000108611; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Saito K, 2000, JPN J CANCER RES, V91, P560, DOI 10.1111/j.1349-7006.2000.tb00981.x; Savary JF, 1998, ENDOSCOPY, V30, P258, DOI 10.1055/s-2007-1001252; SCHWEITZER VG, 1990, OTOLARYNG HEAD NECK, V102, P225, DOI 10.1177/019459989010200304; Taber SW, 1998, CLIN CANCER RES, V4, P2741; Tajima Y, 2000, CANCER, V88, P1285; TAPAROWSKY EJ, 1987, CANCER RES, V47, P4125; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Yano T, 2012, INT J CANCER, V131, P1228, DOI 10.1002/ijc.27320	34	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103126	10.1371/journal.pone.0103126	http://dx.doi.org/10.1371/journal.pone.0103126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090101	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700017
J	Uchida, N; Hsieh, MM; Platner, C; Saunthararajah, Y; Tisdale, JF				Uchida, Naoya; Hsieh, Matthew M.; Platner, Charlotte; Saunthararajah, Yogen; Tisdale, John F.			Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; FETAL-HEMOGLOBIN LEVELS; GENE-THERAPY; MYELODYSPLASTIC SYNDROMES; REPOPULATING CELLS; SELF-RENEWAL; IN-VIVO; VECTOR; IMMUNODEFICIENCY; DISEASE	Efficient ex vivo transduction of hematopoietic stem cells (HSCs) is encumbered by differentiation which reduces engraftment. We hypothesized that inhibiting DNA methyltransferase with decitabine would block differentiation of transduced CD34(+) cells under cytokine stimulation and thus improve transduction efficiency for engrafting HSCs. Human CD34(+) cells in cytokine-containing media were treated with or without decitabine for 24 or 48 hours, and then these cells were transduced with a GFP-expressing lentiviral vector. Utilizing decitabine pre-treatment for 48 hours, we observed an equivalent percentage of successfully transduced cells (GFP-positivity) and a higher percentage of cells that retained CD34 positivity, compared to no decitabine exposure. Cell proliferation was inhibited after decitabine exposure. Similar results were observed among CD34(+) cells from six different donors. Repopulating activity was evaluated by transplantation into NOD/SCID/IL2R gamma(null) mice and demonstrated an equivalent percentage of GFP-positivity in human cells from decitabine-treated samples and a trend for higher human cell engraftment (measured 20-24 weeks after transplantation), compared to no decitabine exposure. In conclusion, ex vivo decitabine exposure inhibits both differentiation and proliferation in transduced human CD34(+) cells and modestly increases the engraftment ability in xenograft mice, while the transduction efficiency is equivalent in decitabine exposure, suggesting improvement of lentiviral transduction for HSCs.	[Uchida, Naoya; Hsieh, Matthew M.; Platner, Charlotte; Tisdale, John F.] NIH, NIDDK, NHLBI, Bethesda, MD 20892 USA; [Saunthararajah, Yogen] Cleveland Clin, Taussig Canc Inst, Translat Hematol & Oncol Res, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cleveland Clinic Foundation	Tisdale, JF (corresponding author), NIH, NIDDK, NHLBI, Bethesda, MD 20892 USA.	johntis@mail.nih.gov			intramural research program of the National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH)	intramural research program of the National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural research program of the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Atweh George F, 2003, Hematology Am Soc Hematol Educ Program, P14, DOI 10.1182/asheducation-2003.1.14; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; DeSimone J, 2002, BLOOD, V99, P3905, DOI 10.1182/blood.V99.11.3905; Evans ME, 2014, MOL THER, V22, P348, DOI 10.1038/mt.2013.256; Green R, 2011, BLOOD, V118; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hanawa H, 2005, J VIROL, V79, P8410, DOI 10.1128/JVI.79.13.8410-8421.2005; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Milhem M, 2004, BLOOD, V103, P4102, DOI 10.1182/blood-2003-07-2431; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Saunthararajah Y, 2003, BLOOD, V102, P3865, DOI 10.1182/blood-2003-05-1738; Saunthararajah Y, 2008, BRIT J HAEMATOL, V141, P126, DOI 10.1111/j.1365-2141.2008.07027.x; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Seet LF, 2009, EUR J HAEMATOL, V82, P124, DOI 10.1111/j.1600-0609.2008.01169.x; Stone RM, 2009, BLOOD, V113, P6296, DOI 10.1182/blood-2008-09-038935; Suzuki M, 2004, AM J HEMATOL, V77, P313, DOI 10.1002/ajh.20178; Uchida N, 2011, GENE THER, V18, P1078, DOI 10.1038/gt.2011.63; Uchida N, 2012, MOL THER, V20; Uchida N, 2013, HUM GENE THER METHOD, V24, P117, DOI 10.1089/hgtb.2012.152; Uchida N, 2012, MOL THER, V20, P1882, DOI 10.1038/mt.2012.159; Uchida N, 2011, MOL THER, V19, P133, DOI 10.1038/mt.2010.218; Uchida N, 2009, J VIROL, V83, P9854, DOI 10.1128/JVI.00357-09; Uchida Naoya, 2009, Journal of Nippon Medical School, V76, P134; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Young JC, 2004, CYTOTHERAPY, V6, P328, DOI 10.1080/14653240410004899	40	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104022	10.1371/journal.pone.0104022	http://dx.doi.org/10.1371/journal.pone.0104022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089909	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700081
J	Xiao, ZS; Huang, JS; Cao, L; Liang, YJ; Han, XB; Quarles, LD				Xiao, Zhousheng; Huang, Jinsong; Cao, Li; Liang, Yingjuan; Han, Xiaobin; Quarles, Leigh Darryl			Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; VITAMIN-D; FACTOR RECEPTOR-1; GENE-EXPRESSION; MOUSE MODEL; PHOSPHATE HOMEOSTASIS; MINERAL METABOLISM; SIGNALING PATHWAYS; FGF-23 EXPRESSION; TARGETED ABLATION	Increases in fibroblastic growth factor 23 (FGF23 or Fgf23) production by osteocytes result in hypophosphatemia and rickets in the Hyp mouse homologue of X-linked hypophosphatemia (XLH). Fibroblastic growth factor (FGF) signaling has been implicated in the pathogenesis of Hyp. Here, we conditionally deleted FGF receptor 1 (FGFR1 or Fgfr1) in osteocytes of Hyp mice to investigate the role of autocrine/paracrine FGFR signaling in regulating FGF23 production by osteocytes. Crossing dentin matrix protein 1 (Dmp1)-Cre;Fgfr1(null/+) mice with female Hyp; Fgfr1(flox/flox) mice created Hyp and Fgfr1 (Fgfr1(Dmp1-cKO))-null mice (Hyp; Fgfr1(Dmp1-cKO)) with a 70% decrease in bone Fgfr1 transcripts. Fgfr1(Dmp1-cKO)-null mice exhibited a 50% reduction in FGF23 expression in bone and 3-fold reduction in serum FGF23 concentrations, as well as reductions in sclerostin (Sost), phosphate regulating endopeptidase on X chromosome (PHEX or Phex), matrix extracellular phosphoglycoprotein (Mepe), and Dmp1 transcripts, but had no demonstrable alterations in phosphate or vitamin D homeostasis or skeletal morphology. Hyp mice had hypophosphatemia, reductions in 1,25(OH)(2)D levels, rickets/osteomalacia and elevated FGF2 expression in bone. Compared to Hyp mice, compound Hyp; Fgfr1(Dmp1-cKO)-null mice had significant improvement in rickets and osteomalacia in association with a decrease in serum FGF23 (3607 to 1099 pg/ml), an increase in serum phosphate (6.0 mg/dl to 9.3 mg/dl) and 1,25(OH)(2)D (121 +/- 23 to 192 +/- 34 pg/ml) levels, but only a 30% reduction in bone FGF23 mRNA expression. FGF23 promoter activity in osteoblasts was stimulated by FGFR1 activation and inhibited by overexpression of a dominant negative FGFR1(TK-), PLC gamma and MAPK inhibitors. FGF2 also stimulated the translation of an FGF23 cDNA transfected into osteoblasts via a FGFR1 and PI3K/Akt-dependent mechanism. Thus, activation of autocrine/paracrine FGF pathways is involved in the pathogenesis of Hyp through FGFR1-dependent regulation of FGF23 by both transcriptional and post-transcriptional mechanisms. This may serve to link local bone metabolism with systemic phosphate and vitamin D homeostasis.	[Xiao, Zhousheng; Huang, Jinsong; Cao, Li; Liang, Yingjuan; Han, Xiaobin; Quarles, Leigh Darryl] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [R01-AR045955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant R01-AR045955 to LDQ from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Freeman KW, 2003, CANCER RES, V63, P6237; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Ichikawa S, 2012, J BONE MINER RES, V27, P453, DOI 10.1002/jbmr.544; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Lim YH, 2014, HUM MOL GENET, V23, P397, DOI 10.1093/hmg/ddt429; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Martin A, 2011, FASEB J; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Martin A, 2008, J BONE MINER RES, V23, P2040, DOI 10.1359/JBMR.080708; Miyagawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093840; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Pendurthi UR, 1999, BLOOD, V94, P579, DOI 10.1182/blood.V94.2.579.414k23_579_586; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Quarles LD, 2011, NAT MED, V17, P428, DOI 10.1038/nm0411-428; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Senarath-Yapa K, 2013, INT J MOL SCI, V14, P5978, DOI 10.3390/ijms14035978; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang O, 2001, DEVELOPMENT, V128, P3867; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Wohrle S, 2013, J BONE MINER RES, V28, P899, DOI 10.1002/jbmr.1810; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wohrle S, 2011, J BONE MINER RES; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 1998, AM J PHYSIOL-ENDOC M, V275, pE700, DOI 10.1152/ajpendo.1998.275.4.E700; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xu N, 2007, J CLIN ENDOCR METAB, V92, P1155, DOI 10.1210/jc.2006-1183; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yang WC, 2013, J CELL SCI, V126, P4085, DOI 10.1242/jcs.118596; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	83	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104154	10.1371/journal.pone.0104154	http://dx.doi.org/10.1371/journal.pone.0104154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089825	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700102
J	Zeng, XQ; Chen, GQ; Liu, XH; Dong, B; Shi, HB; Lu, JP; Lin, FC				Zeng, Xiao-Qing; Chen, Guo-Qing; Liu, Xiao-Hong; Dong, Bo; Shi, Huan-Bin; Lu, Jian-Ping; Lin, Fucheng			Crosstalk between SNF1 Pathway and the Peroxisome-Mediated Lipid Metabolism in Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; APPRESSORIUM TURGOR GENERATION; PLANT-PATHOGENIC FUNGUS; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GLYOXYLATE CYCLE; GENE-EXPRESSION; BETA-OXIDATION; MAP KINASE; VIRULENCE	The SNF1/AMPK pathway has a central role in response to nutrient stress in yeast and mammals. Previous studies on SNF1 function in phytopathogenic fungi mostly focused on the catalytic subunit Snf1 and its contribution to the derepression of cell wall degrading enzymes (CWDEs). However, the MoSnf1 in Magnaporthe oryzae was reported not to be involved in CWDEs regulation. The mechanism how MoSnf1 functions as a virulence determinant remains unclear. In this report, we demonstrate that MoSnf1 retains the ability to respond to nutrient-free environment via its participation in peroxisomal maintenance and lipid metabolism. Observation of GFP-tagged peroxisomal targeting signal-1 (PTS1) revealed that the peroxisomes of Delta Mosnf1 were enlarged in mycelia and tended to be degraded before conidial germination, leading to the sharp decline of peroxisomal amount during appressorial development, which might impart the mutant great retard in lipid droplets mobilization and degradation. Consequently, Delta Mosnf1 exhibited inability to maintain normal appressorial cell wall porosity and turgor pressure, which are key players in epidermal infection process. Exogenous glucose could partially restore the appressorial function and virulence of Delta Mosnf1. Toward a further understanding of SNF1 pathway, the beta-subunit MoSip2, gamma-subunit MoSnf4, and two putative Snf1-activating kinases, MoSak1 and MoTos3, were additionally identified and characterized. Here we show the null mutants Delta Mosip2 and Delta Mosnf4 performed multiple disorders as Delta Mosnf1 did, suggesting the complex integrity is essential for M. oryzae SNF1 kinase function. And the upstream kinases, MoSak1 and MoTos3, play unequal roles in SNF1 activation with a clear preference to MoSak1 over MoTos3. Meanwhile, the mutant lacking both of them exhibited a severe phenotype comparable to Delta Mosnf1, uncovering a cooperative relationship between MoSak1 and MoTos3. Taken together, our data indicate that the SNF1 pathway is required for fungal development and facilitates pathogenicity by its contribution to peroxisomal maintenance and lipid metabolism in M. oryzae.	[Zeng, Xiao-Qing; Liu, Xiao-Hong; Shi, Huan-Bin; Lin, Fucheng] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Guo-Qing] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Peoples R China; [Dong, Bo] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Lu, Jian-Ping] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Fucheng] Zhengzhou Tobacco Inst CNTC, China Tobacco Gene Res Ctr, Zhengzhou, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang Academy of Agricultural Sciences; Zhejiang University; Zhengzhou Tobacco Research Institute of CNTC	Lin, FC (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	fuchenglin@zju.edu.cn	Lin, Fucheng/ABE-7591-2021; Chen, Guoqing/W-5308-2019	Lin, Fucheng/0000-0002-4127-8143; Chen, Guoqing/0000-0002-8448-6938; Liu, Xiaohong/0000-0002-7466-1261; Shi, Huanbin/0000-0002-4870-749X; Lu, Jian-Ping/0000-0001-9601-0040	National Natural Science Foundation of China [31371890, 31370171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 31371890 and 31370171) funded by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Bhadauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036266; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Chen GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067804; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; Deng YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079128; FERNANDEZ E, 1992, EUR J BIOCHEM, V204, P983, DOI 10.1111/j.1432-1033.1992.tb16720.x; Fernandez J, 2013, ANN REV PHYTOPATHOL; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085252; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JP, 2007, FUNGAL GENET BIOL, V44, P819, DOI 10.1016/j.fgb.2007.06.003; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Nadal M, 2010, PHYTOPATHOLOGY, V100, P1364, DOI 10.1094/PHYTO-01-10-0011; Ohneda M, 2002, FUNGAL GENET BIOL, V37, P29, DOI 10.1016/S1087-1845(02)00033-6; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Palecek SP, 2002, MOL MICROBIOL, V45, P453, DOI 10.1046/j.1365-2958.2002.03024.x; Perez-Sampietro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058283; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Rho HS, 2001, MOL CELLS, V12, P407; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yang J, 2012, CURR GENET, V58, P139, DOI 10.1007/s00294-012-0372-8; Yi M, 2008, FUNGAL GENET BIOL, V45, P1172, DOI 10.1016/j.fgb.2008.05.003; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang M, 2013, MOL CELL BIOL, V33, P4701, DOI 10.1128/MCB.00198-13	64	20	20	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103124	10.1371/journal.pone.0103124	http://dx.doi.org/10.1371/journal.pone.0103124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090011	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700016
J	Amodeo, GF; Scorciapino, MA; Messina, A; De Pinto, V; Ceccarelli, M				Amodeo, Giuseppe Federico; Scorciapino, Mariano Andrea; Messina, Angela; De Pinto, Vito; Ceccarelli, Matteo			Charged Residues Distribution Modulates Selectivity of the Open State of Human Isoforms of the Voltage Dependent Anion-Selective Channel	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; VDAC ISOFORMS; PERMEABILITY TRANSITION; BROWNIAN DYNAMICS; ION PERMEATION; N-TERMINUS; MITOCHONDRIAL; PROTEIN; MEMBRANE; CONFORMATION	Voltage Dependent Anion-selective Channels (VDACs) are pore-forming proteins located in the outer mitochondrial membrane. They are responsible for the access of ions and energetic metabolites into the inner membrane transport systems. Three VDAC isoforms exist in mammalian, but their specific role is unknown. In this work we have performed extensive (overall similar to 5 mu s) Molecular Dynamics (MD) simulations of the human VDAC isoforms to detect structural and conformational variations among them, possibly related to specific functional roles of these proteins. Secondary structure analysis of the N-terminal domain shows a high similarity among the three human isoforms of VDAC but with a different plasticity. In particular, the N-terminal domain of the hVDAC1 is characterized by a higher plasticity, with a similar to 20% occurrence for the 'unstructured' conformation throughout the folded segment, while hVDAC2, containing a peculiar extension of 11 amino acids at the N-terminal end, presents an additional 310-helical folded portion comprising residues 109 to 3, adhering to the barrel wall. The N-terminal sequences of hVDAC isoforms are predicted to have a low flexibility, with possible consequences in the dynamics of the human VDACs. Clear differences were found between hVDAC1 and hVDAC3 against hVDAC2: a significantly modified dynamics with possible important consequence on the voltage-gating mechanism. Charge distribution inside and at the mouth of the pore is responsible for a different preferential localization of ions with opposite charge and provide a valuable rationale for hVDAC1 and hVDAC3 having a Cl-/K+ selectivity ratio of 1.8, whereas hVDAC2 of 1.4. Our conclusion is that hVDAC isoforms, despite sharing a similar scaffold, have modified working features and a biological work is now requested to give evidence to the described dissimilarities.	[Amodeo, Giuseppe Federico] Univ Cagliari, Dept Chem & Geol Sci, Cagliari, Italy; [Scorciapino, Mariano Andrea; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, Cagliari, Italy; [Scorciapino, Mariano Andrea; Ceccarelli, Matteo] CNR, Ist Officina Mat, Cagliari, Italy; [Messina, Angela; De Pinto, Vito] Univ Catania, Dept Biol Geol & Environm Sci, Mol Biol Sect, Catania, Italy; [Messina, Angela; De Pinto, Vito] Natl Inst Biomembranes & Biosyst, Catania, Italy	University of Cagliari; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Catania	Ceccarelli, M (corresponding author), Univ Cagliari, Dept Phys, Cagliari, Italy.	matteo.ceccarelli@dsf.unica.it	Amodeo, Giuseppe/E-6810-2017; Amodeo, Giuseppe Federico/AAC-7068-2020; De Pinto, Vito/AAC-2634-2019; Ceccarelli, Matteo/C-8557-2018; Messina, Angela/ABC-9518-2020; Scorciapino, Mariano Andrea/AAD-1256-2020	Amodeo, Giuseppe/0000-0002-5316-2770; Amodeo, Giuseppe Federico/0000-0002-5316-2770; Ceccarelli, Matteo/0000-0003-4272-902X; SCORCIAPINO, MARIANO ANDREA/0000-0001-7502-7265; De Pinto, Vito/0000-0001-5513-2906; MESSINA, Angela Anna/0000-0002-5745-9846	MIUR [PRIN 2010CSJX4F]	MIUR(Ministry of Education, Universities and Research (MIUR))	The financial support of MIUR (PRIN 2010CSJX4F) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Beutner G, 1997, BIOCHEM SOC T, V25, P151, DOI 10.1042/bst0250151; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; De Pinto V, 2007, CHEMBIOCHEM, V8, P744, DOI 10.1002/cbic.200700009; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Huizing M, 1994, LANCET, V344, P1206; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; John E., 2007, CRC HDB CHEM PHYS; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krammer EM, 2013, BBA-BIOMEMBRANES, V1828, P1284, DOI 10.1016/j.bbamem.2012.12.018; Krammer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027994; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee KI, 2011, BIOPHYS J, V100, P611, DOI 10.1016/j.bpj.2010.12.3708; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Menzel VA, 2009, BIOSCIENCE REP, V29, P351, DOI 10.1042/BSR20080123; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Reina S, 2013, BBA-BIOENERGETICS, V1827, P793, DOI 10.1016/j.bbabio.2013.03.007; Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Schredelseker J, 2014, J BIOL CHEM, V289, P12566, DOI 10.1074/jbc.M113.497438; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sindhikara DJ, 2009, J CHEM THEORY COMPUT, V5, P1624, DOI 10.1021/ct800573m; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015	65	35	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103879	10.1371/journal.pone.0103879	http://dx.doi.org/10.1371/journal.pone.0103879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084457	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800097
J	Hufton, SE; Risley, P; Ball, CR; Major, D; Engelhardt, OG; Poole, S				Hufton, Simon E.; Risley, Paul; Ball, Christina R.; Major, Diane; Engelhardt, Othmar G.; Poole, Stephen			The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; MONOCLONAL-ANTIBODY; HIGH-AFFINITY; RECEPTOR-BINDING; IN-VITRO; VIRUS; H5N1; FRAGMENTS; TRANSMISSION; MECHANISMS	The response to the 2009 A(H1N1) influenza pandemic has highlighted the need for additional strategies for intervention which preclude the prior availability of the influenza strain. Here, 18 single domain VHH antibodies against the 2009 A(H1N1) hemagglutinin (HA) have been isolated from a immune alpaca phage displayed library. These antibodies have been grouped as having either (i) non-neutralising, (ii) H1N1 restricted neutralising or (iii) broad cross-subtype neutralising activity. The ability to neutralise different viral subtypes, including highly pathogenic avian influenza (H5N1), correlated with the absence of hemagglutination inhibition activity, loss of binding to HA at acid pH and the absence of binding to the head domain containing the receptor binding site. This data supports their binding to epitopes in the HA stem region and a mechanism of action other than blocking viral attachment to cell surface receptors. After conversion of cross-neutralising antibodies R1a-B6 and R1a-A5 into a bivalent format, no significant enhancement in neutralisation activity was seen against A(H1N1) and A(H5N1) viruses. However, bivalent R1a-B6 showed an 18 fold enhancement in potency against A(H9N2) virus and, surprisingly, gained the ability to neutralise an A(H2N2) virus. This demonstrates that cross-neutralising antibodies, which make lower affinity interactions with the membrane proximal stem region of more divergent HA sub-types, can be optimised by bivalency so increasing their breadth of anti-viral activity. The broad neutralising activity and favourable characteristics, such as high stability, simple engineering into bivalent molecules and low cost production make these single domain antibodies attractive candidates for diagnostics and immunotherapy of pandemic influenza.	[Hufton, Simon E.; Risley, Paul; Poole, Stephen] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Biotherapeut Grp, Potters Bar, Herts, England; [Hufton, Simon E.; Risley, Paul; Poole, Stephen] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Biotherapeut Grp, Potters Bar, Herts, England; [Major, Diane; Engelhardt, Othmar G.] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Virol, Potters Bar, Herts, England; [Ball, Christina R.] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Potters Bar, Herts, England	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control	Hufton, SE (corresponding author), Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Biotherapeut Grp, Potters Bar, Herts, England.	simon.hufton@nibsc.org	Hufton, Simon E/E-3949-2013; Risley, Paul/E-2489-2013; hufton, simon/AAA-8245-2019	hufton, simon/0000-0003-1756-0306				Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 1997, J IMMUNOL, V158, P1222; Feshchenko E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-77; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GIGANT B, 1995, PROTEINS, V23, P115, DOI 10.1002/prot.340230113; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HARMON MW, 1988, J CLIN MICROBIOL, V26, P333, DOI 10.1128/JCM.26.2.333-337.1988; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Heyndrickx L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036438; Hoag H, 2013, NAT MED, V19, P12, DOI 10.1038/nm0113-12; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lachmann P, 2009, VACCINE, V27, pG33, DOI 10.1016/j.vaccine.2009.09.137; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; de Jong MD, 2008, PEDIATR INFECT DIS J, V27, pS54, DOI 10.1097/INF.0b013e3181684d2d; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Robertson JS, 2010, VIRUSES-BASEL, V2, P532, DOI 10.3390/v2020532; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Schofield DJ, 1997, J GEN VIROL, V78, P2431, DOI 10.1099/0022-1317-78-10-2431; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Shen JQ, 2006, J BIOL CHEM, V281, P10706, DOI 10.1074/jbc.M513415200; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILSON IA, 1983, BIOCHEM SOC T, V11, P145, DOI 10.1042/bst0110145; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	77	23	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103294	10.1371/journal.pone.0103294	http://dx.doi.org/10.1371/journal.pone.0103294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084445	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800027
J	Satoyoshi, R; Aiba, N; Yanagihara, K; Yashiro, M; Tanaka, M				Satoyoshi, R.; Aiba, N.; Yanagihara, K.; Yashiro, M.; Tanaka, M.			Tks5 activation in mesothelial cells creates invasion front of peritoneal carcinomatosis	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; SCIRRHOUS CARCINOMA; PODOSOME FORMATION; SURGICAL-TREATMENT; INVADOPODIA; DIALYSIS; MIGRATION; MODELS; LINES	Scirrhous gastric cancer is frequently associated with peritoneal dissemination, and the interaction of cancer cells with peritoneal mesothelial cells (PMCs) is crucial for the establishment of the metastasis in the peritoneum. Although cells derived from PMCs are detected within tumors of peritoneal carcinomatosis, how PMCs are incorporated into tumor architecture is not understood. The present study shows that PMCs create the invasion front of peritoneal carcinomatosis, which depends on activation of Tks5 in PMCs. In peritoneal tumor implants, PMCs represent majority of cells located at the invasive edge of the cancer tissue. Exogenously implanted PMCs and host PMCs aggressively invade into abdominal wall upon the peritoneal inoculation of cancer cells, and PMCs locate ahead of cancer cells in the direction of invasion. Tks5, a substrate of Src kinase, is predominantly expressed in the PMCs of cancer tissue, and promotes the invasion of PMCs and cancer cells. Expression and activation of Tks5 was induced in PMCs following their exposure to gastric cancer cells, and increased Tks5 expression was detected in PMCs located at the invasion front. Reduced Tks5 expression in PMCs blocked PMC invasion, which in turn prevents cancer cell invasion both in vitro and in vivo. The peritoneal dissemination of gastric cancer was significantly increased by mixing cancer cells and PMCs, and was suppressed by knockdown of Tks5 in PMCs. These results suggest that cancer-activated PMCs create invasion front by guiding cancer cells. Signaling leading to Tks5 activation in PMCs may be a suitable therapeutic target for prevention of peritoneal carcinomatosis.	[Satoyoshi, R.; Aiba, N.; Tanaka, M.] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 0108543, Japan; [Yanagihara, K.] Natl Canc Ctr, Div Translat Res, Exploratory Oncol & Clin Trial Ctr, Chiba, Japan; [Yashiro, M.] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Akita University; National Cancer Center - Japan; Osaka Metropolitan University	Tanaka, M (corresponding author), Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, 1-1-1 Hondo, Akita 0108543, Japan.	mastanak@med.akita-u.ac.jp			JSPS KAKENHI [25290042, 26640068]; National Cancer Center Research and Development Fund [23-A-9]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Murata K (Department of Environmental Health Sciences, Akita University School of Medicine) for advice and discussion about statistics. This work was supported by JSPS KAKENHI (Grant Nos 25290042 and 26640068 to MT) Takeda Science Foundation (MT) and the National Cancer Center Research and Development Fund (Grant No. 23-A-9 to MT).	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Burger KL, 2014, PROSTATE, V74, P134, DOI 10.1002/pros.22735; Burger KL, 2011, CYTOSKELETON, V68, P694, DOI 10.1002/cm.20545; Courtneidge SA, 2012, BIOCHEM SOC T, V40, P129, DOI 10.1042/BST20110685; Fekete Anna, 2013, J Mol Signal, V8, P8, DOI 10.1186/1750-2187-8-8; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Jayne DG, 2000, BRIT J CANCER, V82, P1233; Kajiyama H, 2007, CELL TISSUE RES, V330, P221, DOI 10.1007/s00441-007-0455-x; Li CMC, 2013, GENE DEV, V27, P1557, DOI 10.1101/gad.222745.113; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lv ZD, 2013, MOL CELL BIOCHEM, V377, P177, DOI 10.1007/s11010-013-1583-0; MOTOYAMA T, 1986, ACTA PATHOL JAPON, V36, P65; Murphy DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022499; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5; Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Nishimura S, 1998, INT J ONCOL, V12, P847; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Otsuji E, 2004, AM J SURG, V188, P327, DOI 10.1016/j.amjsurg.2004.06.010; Sako A, 2003, J SURG RES, V115, P113, DOI 10.1016/S0022-4804(03)00307-X; Sandoval P, 2013, J PATHOL, V231, P517, DOI 10.1002/path.4281; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Schauer M, 2011, EUR J MED RES, V16, P29, DOI 10.1186/2047-783X-16-1-29; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Shimamura S, 2013, J BIOL CHEM, V288, P1171, DOI 10.1074/jbc.M112.386722; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Takemura S, 2004, CANCER SCI, V95, P893, DOI 10.1111/j.1349-7006.2004.tb02199.x; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Yonemura Y, 2010, EJSO-EUR J SURG ONC, V36, P1131, DOI 10.1016/j.ejso.2010.09.006; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21	41	20	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 11	2015	34	24					3176	3187		10.1038/onc.2014.246	http://dx.doi.org/10.1038/onc.2014.246			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3FD	25088196				2022-12-25	WOS:000356101100009
J	Suits, MDL; Pluvinage, B; Law, A; Liu, Y; Palma, AS; Chai, WG; Feizi, T; Boraston, AB				Suits, Michael D. L.; Pluvinage, Benjamin; Law, Adrienne; Liu, Yan; Palma, Angelina S.; Chai, Wengang; Feizi, Ten; Boraston, Alisdair B.			Conformational Analysis of the Streptococcus pneumoniae Hyaluronate Lyase and Characterization of Its Hyaluronan-specific Carbohydrate-binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; GENOME-BASED IDENTIFICATION; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; VIRULENCE FACTORS; STRUCTURAL BASIS; PROTEIN; SURFACE; CRYSTALLOGRAPHY; RECOGNITION	For a subset of pathogenic microorganisms, including Streptococcus pneumoniae, the recognition and degradation of host hyaluronan contributes to bacterial spreading through the extracellular matrix and enhancing access to host cell surfaces. The hyaluronate lyase (Hyl) presented on the surface of S. pneumoniae performs this role. Using glycan microarray screening, affinity electrophoresis, and isothermal titration calorimetry we show that the N-terminal module of Hyl is a hyaluronan-specific carbohydrate-binding module (CBM) and the founding member of CBM family 70. The 1.2 angstrom resolution-ray crystal structure of CBM70 revealed it to have a beta-sandwich fold, similar to other CBMs. The electrostatic properties of the binding site, which was identified by site-directed mutagenesis, are distinct from other CBMs and complementary to its acidic ligand, hyaluronan. Dynamic light scattering and solution small angle x-ray scattering revealed the full-length Hyl protein to exist as a monomer/dimer mixture in solution. Through a detailed analysis of the small angle x-ray scattering data, we report the pseudoatomic solution structures of the monomer and dimer forms of the full-length multimodular Hyl.	[Suits, Michael D. L.; Pluvinage, Benjamin; Law, Adrienne; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Liu, Yan; Palma, Angelina S.; Chai, Wengang; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Glycosci Lab, London W12 0NN, England; [Palma, Angelina S.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Chem, REQUIMTE, P-2829516 Caparica, Portugal	University of Victoria; Imperial College London; Universidade Nova de Lisboa	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Liu, Yan/D-9117-2013; Palma, Angelina S/D-2052-2013	Palma, Angelina S/0000-0001-5797-6555; Boraston, Alisdair/0000-0001-6417-0592; Feizi, Ten/0000-0001-6495-0329; Liu, Yan/0000-0002-2566-6867	Canadian Institutes of Health Research Operating Grant [FRN 86610]; UK Research Councils Basic Technology Initiative Glycoarrays Grant [GRS/79268]; UK Research Councils Translational Grant [EP/G037604/1]; Wellcome Trust [WT093378MA/Z/10/Z, WT099197/Z/12/ZMA]; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program [P41RR001209]; NIGMS, National Institutes of Health; EPSRC [EP/G037604/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G037604/1, GR/S79268/02] Funding Source: researchfish	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); UK Research Councils Basic Technology Initiative Glycoarrays Grant; UK Research Councils Translational Grant; Wellcome Trust(Wellcome TrustEuropean Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Canadian Institutes of Health Research Operating Grant FRN 86610. This work was also supported by UK Research Councils Basic Technology Initiative Glycoarrays Grant GRS/79268 and Translational Grant EP/G037604/1 and Wellcome Trust Grants WT093378MA/Z/10/Z and WT099197/Z/12/ZMA (to T. F.). The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The SSRL is a Directorate of Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health, NCRR, Biomedical Technology Program Grant P41RR001209, and NIGMS, National Institutes of Health.	Abbott DW, 2012, METHOD ENZYMOL, V510, P211, DOI 10.1016/B978-0-12-415931-0.00011-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; Bumbaca D, 2007, PROTEINS, V66, P547, DOI 10.1002/prot.21205; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chai WG, 2003, METHOD ENZYMOL, V362, P160; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Higgins MA, 2011, J MOL BIOL, V411, P1017, DOI 10.1016/j.jmb.2011.06.035; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOSTYUKOVA NN, 1995, FEMS IMMUNOL MED MIC, V10, P133, DOI 10.1111/j.1574-695X.1995.tb00022.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Lucas R, 2013, TOXINS, V5, P1244, DOI 10.3390/toxins5071244; Lundell A, 2004, STRUCTURE, V12, P1495, DOI 10.1016/j.str.2004.05.021; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; Palma AS, 2011, BIOCHEM BIOPH RES CO, V408, P548, DOI 10.1016/j.bbrc.2011.04.055; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Petoukhov MV, 2006, EUR BIOPHYS J BIOPHY, V35, P567, DOI 10.1007/s00249-006-0063-9; Petoukhov MV, 2013, BIOCHEMISTRY-US, V52, P6844, DOI 10.1021/bi400731u; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pluvinage B, 2013, J MOL BIOL, V425, P334, DOI 10.1016/j.jmb.2012.11.005; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RAPPORT MM, 1951, J BIOL CHEM, V192, P283; Rigden DJ, 2003, PROTEINS, V52, P203, DOI 10.1002/prot.10405; Rigden DJ, 2003, CRIT REV BIOCHEM MOL, V38, P143, DOI 10.1080/713609215; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stoll MS, 2009, P BEILST S GLYC BIOI, P123; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THOMPSON RT, 1948, J CLIN INVEST, V27, P558; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	54	10	10	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27264	27277		10.1074/jbc.M114.578435	http://dx.doi.org/10.1074/jbc.M114.578435			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100731	hybrid, Green Published			2022-12-25	WOS:000342853900048
J	Zhong, Y; Morris, DH; Jin, L; Patel, MS; Karunakaran, SK; Fu, YJ; Matuszak, EA; Weiss, HL; Chait, BT; Wang, QJ				Zhong, Yu; Morris, Deanna H.; Jin, Lin; Patel, Mittul S.; Karunakaran, Senthil K.; Fu, You-Jun; Matuszak, Emily A.; Weiss, Heidi L.; Chait, Brian T.; Wang, Qing Jun			Nrbf2 Protein Suppresses Autophagy by Modulating Atg14L Protein-containing Beclin 1-Vps34 Complex Architecture and Reducing Intracellular Phosphatidylinositol-3 Phosphate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; REGULATES AUTOPHAGY; 3-KINASE COMPLEXES; UP-REGULATION; KINASE; YEAST; GENE; TUMORIGENESIS; RECEPTOR; DOMAIN	Autophagy is a tightly regulated lysosomal degradation pathway for maintaining cellular homeostasis and responding to stresses. Beclin 1 and its interacting proteins, including the class III phosphatidylinositol-3 kinase Vps34, play crucial roles in autophagy regulation in mammals. We identified nuclear receptor binding factor 2 (Nrbf2) as a Beclin 1-interacting protein from Becn1(-/-); Becn1-EGFP/+ mouse liver and brain. We also found that Nrbf2-Beclin 1 interaction required the N terminus of Nrbf2. We next used the human retinal pigment epithelial cell line RPE-1 as a model system and showed that transiently knocking down Nrbf2 by siRNA increased autophagic flux under both nutrient-rich and starvation conditions. To investigate the mechanism by which Nrbf2 regulates autophagy, we demonstrated that Nrbf2 interacted and colocalized with Atg14L, suggesting that Nrbf2 is a component of the Atg14L-containing Beclin 1-Vps34 complex. Moreover, ectopically expressed Nrbf2 formed cytosolic puncta that were positive for isolation membrane markers. These results suggest that Nrbf2 is involved in autophagosome biogenesis. Furthermore, we showed that Nrbf2 deficiency led to increased intracellular phosphatidylinositol-3 phosphate levels and diminished Atg14L-Vps34/Vps15 interactions, suggesting that Nrbf2-mediated Atg14L-Vps34/Vps15 interactions likely inhibit Vps34 activity. Therefore, we propose that Nrbf2 may interact with the Atg14L-containing Beclin 1-Vps34 protein complex to modulate protein-protein interactions within the complex, leading to suppression of Vps34 activity, autophagosome biogenesis, and autophagic flux. This work reveals a novel aspect of the intricate mechanism for the Beclin 1-Vps34 protein-protein interaction network to achieve precise control of autophagy.	[Zhong, Yu; Morris, Deanna H.; Jin, Lin; Patel, Mittul S.; Karunakaran, Senthil K.; Fu, You-Jun; Wang, Qing Jun] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Matuszak, Emily A.; Wang, Qing Jun] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Weiss, Heidi L.; Wang, Qing Jun] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	University of Kentucky; University of Kentucky; University of Kentucky; Rockefeller University	Wang, QJ (corresponding author), Univ Kentucky Coll Med, Dept Mol & Cellular Biochem, B163 BBSRB,741 S Limestone, Lexington, KY 40536 USA.	qingjun.wang@uky.edu		Wang, Qingjun/0000-0002-1959-4107	National Institutes of Health [P20GM103486, RR00862, RR022220]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486, P41GM103314, P41GM109824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20GM103486 (to Q. J. W.) and RR00862 and RR022220 (to B. T. C.). This work was also supported by the Ellison Medical Foundation (to Q. J. W.).	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Araki Y, 2013, J CELL BIOL, V203, P299, DOI 10.1083/jcb.201304123; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cao YY, 2014, BIOCHEM J, V461, P315, DOI 10.1042/BJ20140515; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dou ZX, 2010, J CELL BIOL, V191, P827, DOI 10.1083/jcb.201006056; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Flores AM, 2004, J INVEST DERMATOL, V123, P1092, DOI 10.1111/j.0022-202X.2004.23424.x; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Koyama-Honda I, 2013, AUTOPHAGY, V9, P1491, DOI 10.4161/auto.25529; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Lu JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4920; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Menzies F.M., 2012, CURR PROTOC CELL BIO; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molejon MI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01055; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; STACK JH, 1994, J BIOL CHEM, V269, P31552; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Yasumo H, 2000, BBA-GENE STRUCT EXPR, V1490, P189, DOI 10.1016/S0167-4781(99)00244-4; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	63	58	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26021	26037		10.1074/jbc.M114.561134	http://dx.doi.org/10.1074/jbc.M114.561134			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086043	Green Published, hybrid			2022-12-25	WOS:000342128800003
J	Akella, SVS; Kirk, WDJ; Lu, YB; Murai, T; Walters, KFA; Hamilton, JGC				Akella, Sudhakar V. S.; Kirk, William D. J.; Lu, Yao-bin; Murai, Tamotsu; Walters, Keith F. A.; Hamilton, James G. C.			Identification of the Aggregation Pheromone of the Melon Thrips, Thrips palmi	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; FRANKLINIELLA-OCCIDENTALIS PERGANDE; THYSANOPTERA THRIPIDAE; SEX-PHEROMONE; ERADICATION; PEST	The objective of this study was to identify the aggregation pheromone of the melon thrips Thrips palmi, a major pest of vegetable and ornamental plants around the world. The species causes damage both through feeding activities and as a vector of tospoviruses, and is a threat to world trade and European horticulture. Improved methods of detecting and controlling this species are needed and the identification of an aggregation pheromone will contribute to this requirement. Bioassays with a Y-tube olfactometer showed that virgin female T. palmi were attracted to the odour of live males, but not to that of live females, and that mixed-age adults of both sexes were attracted to the odour of live males, indicating the presence of a male-produced aggregation pheromone. Examination of the headspace volatiles of adult male T. palmi revealed only one compound that was not found in adult females. It was identified by comparison of its mass spectrum and chromatographic details with those of similar compounds. This compound had a structure like that of the previously identified male-produced aggregation pheromone of the western flower thrips Frankliniella occidentalis. The compound was synthesised and tested in eggplant crops infested with T. palmi in Japan. Significantly greater numbers of both males and females were attracted to traps baited with the putative aggregation pheromone compared to unbaited traps. The aggregation pheromone of T. palmi is thus identified as (R)-lavandulyl 3-methyl-3-butenoate by spectroscopic, chromatographic and behavioural analysis.	[Akella, Sudhakar V. S.; Kirk, William D. J.; Hamilton, James G. C.] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England; [Lu, Yao-bin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Murai, Tamotsu] Utsunomiya Univ, Fac Agr, Appl Entomol Lab, Utsunomiya, Tochigi 321, Japan; [Walters, Keith F. A.] Food & Environm Res Agcy, York, N Yorkshire, England	Keele University; Zhejiang Academy of Agricultural Sciences; Utsunomiya University; Food & Environment Research Agency	Hamilton, JGC (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Huxley Bldg, Keele ST5 5BG, Staffs, England.	j.g.c.hamilton@keele.ac.uk	Hamilton, Gordon/AAA-6960-2022; Walters, Keith/AAK-3562-2020	Kirk, William/0000-0001-8586-4518; hamilton, james/0000-0001-9196-8516	European Union, Marie Curie, Incoming International Fellowship [252258]	European Union, Marie Curie, Incoming International Fellowship	This research was funded by a European Union, Marie Curie, Incoming International Fellowship scheme to Dr S. Akella (Project 252258) and as a subcontract of a project, The integrated control of Thrips palmi Karny, made to Central Science Laboratory by the United Kingdom government Department of Food Environment and Rural Affairs. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Austin AD, 2004, AUST J ENTOMOL, V43, P216, DOI 10.1111/j.1326-6756.2004.00448.x; Buckman RS, 2013, SYST ENTOMOL, V38, P123, DOI 10.1111/j.1365-3113.2012.00650.x; Cannon RJC, 2007, CROP PROT, V26, P1089, DOI 10.1016/j.cropro.2006.10.023; Cannon RJC, 2007, CROP PROT, V26, P1303, DOI 10.1016/j.cropro.2006.11.005; El-Ghariani I. M., 2008, Acta Phytopathologica et Entomologica Hungarica, V43, P257, DOI 10.1556/APhyt.43.2008.2.7; Gomez M., 2006, IOBC-WPRS Bulletin, V29, P153; Hamilton JGC, 2005, J CHEM ECOL, V31, P1369, DOI 10.1007/s10886-005-1351-z; Hamodi A.A., 2012, Arab Journal of Plant Protection, V30, P142; Hinkens DM, 2001, TETRAHEDRON LETT, V42, P1619, DOI 10.1016/S0040-4039(00)02347-9; Kawai A., 1986, B VEG ORNAM CROPS C, V9, P69; Kirk WDJ, 2004, J CHEM ECOL, V30, P167, DOI 10.1023/B:JOEC.0000013189.89576.8f; KIRK WDJ, 1985, ECOL ENTOMOL, V10, P433, DOI 10.1111/j.1365-2311.1985.tb00741.x; MacLeod A, 2004, CROP PROT, V23, P601, DOI 10.1016/j.cropro.2003.11.010; MATTESON NA, 1992, ENTOMOL EXP APPL, V63, P187, DOI 10.1007/BF00343578; Mound LA, 2009, ZOOTAXA, P29, DOI 10.11646/zootaxa.2129.1.2; Murai T., 1988, Bulletin of the Shimane Agricultural Experiment Station, P1; Murai T., 2002, P 7 INT S THYS 2 7 J, P19; OEPP/EPPO, 1989, B OEPP EPPO B, V19, P717; Olaniran OA, 2013, J CHEM ECOL, V39, P559, DOI 10.1007/s10886-013-0272-5; Palmer J.M., 1989, CIE GUIDES INSECTS I, P73; Sampson C., 2012, IOBC/WPRS Bulletin, V80, P313; Sampson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080787; Song Jeong-Heub, 1997, RDA Journal of Crop Protection, V39, P53; Sudo M, 2002, P ARTHROPODAN EMBRYO, V37, P35; TERRY LI, 1990, J INSECT BEHAV, V3, P133, DOI 10.1007/BF01049200; Theodorou V, 2007, TETRAHEDRON LETT, V48, P8230, DOI 10.1016/j.tetlet.2007.09.074; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Zada A, 2006, TETRAHEDRON-ASYMMETR, V17, P230, DOI 10.1016/j.tetasy.2005.12.021; Zhu Xiao-Yun, 2012, Acta Entomologica Sinica, V55, P376	29	29	36	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103315	10.1371/journal.pone.0103315	http://dx.doi.org/10.1371/journal.pone.0103315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101871	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339993900016
J	Peng, C; Zhu, J; Sun, HC; Huang, XP; Zhao, WA; Zheng, M; Liu, LJ; Tian, J				Peng, Chang; Zhu, Jing; Sun, Hui-Chao; Huang, Xu-Pei; Zhao, Wei-An; Zheng, Min; Liu, Ling-Juan; Tian, Jie			Inhibition of Histone H3K9 Acetylation by Anacardic Acid Can Correct the Over-Expression of Gata4 in the Hearts of Fetal Mice Exposed to Alcohol during Pregnancy	PLOS ONE			English	Article							EPIGENETIC REGULATION; CARDIAC MYOCYTES; DNA METHYLATION; TRANSCRIPTION; CHROMATIN; GCN5; DIFFERENTIATION; CARDIOMYOCYTES; CELLS	Background: Cardiovascular malformations can be caused by abnormalities in Gata4 expression during fetal development. In a previous study, we demonstrated that ethanol exposure could lead to histone hyperacetylation and Gata4 over-expression in fetal mouse hearts. However, the potential mechanisms of histone hyperacetylation and Gata4 over-expression induced by ethanol remain unclear. Methods and Results: Pregnant mice were gavaged with ethanol or saline. Fetal mouse hearts were collected for analysis. The results of ethanol fed groups showed that global HAT activity was unusually high in the hearts of fetal mice while global HDAC activity remained unchanged. Binding of P300, CBP, PCAF, SRC1, but not GCN5, were increased on the Gata4 promoter relative to the saline treated group. Increased acetylation of H3K9 and increased mRNA expression of Gata4, alpha-MHC, cTnT were observed in these hearts. Treatment with the pan-histone acetylase inhibitor, anacardic acid, reduced the binding of P300, PCAF to the Gata4 promoter and reversed H3K9 hyperacetylation in the presence of ethanol. Interestingly, anacardic acid attenuated over-expression of Gata4, alpha-MHC and cTnT in fetal mouse hearts exposed to ethanol. Conclusions: Our results suggest that P300 and PCAF may be critical regulatory factors that mediate Gata4 over-expression induced by ethanol exposure. Alternatively, P300, PCAF and Gata4 may coordinate over-expression of cardiac downstream genes in mouse hearts exposed to ethanol. Anacardic acid may thus protect against ethanol-induced Gata4, alpha-MHC, cTnT over-expression by inhibiting the binding of P300 and PCAF to the promoter region of these genes.	[Peng, Chang; Sun, Hui-Chao; Zhao, Wei-An; Zheng, Min; Liu, Ling-Juan; Tian, Jie] Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China; [Zhu, Jing; Liu, Ling-Juan] Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Peng, Chang] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Peng, Chang; Zhu, Jing] Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Huang, Xu-Pei] Florida Atlantic Univ, Dept Biomed Sci, Charlie E Schmidt Coll Med, Boca Raton, FL 33431 USA	Chongqing Medical University; State University System of Florida; Florida Atlantic University	Tian, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China.	jietian@cqmu.edu.cn			National Natural Science Foundation of China [81270234]; Chongqing key laboratory, CSTC, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing key laboratory, CSTC, China	This study was financially supported by research grants from National Natural Science Foundation of China (Grant Number: 81270234) and the special fund of Chongqing key laboratory, CSTC, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borah JC, 2011, CHEM BIOL, V18, P531, DOI 10.1016/j.chembiol.2010.12.021; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen L, 2013, J BIOL CHEM, V288, P14510, DOI 10.1074/jbc.M113.458737; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Connelly JJ, 2013, HUM MOL GENET, V22, P5107, DOI 10.1093/hmg/ddt365; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Misra C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002690; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; O'Leary CM, 2013, BIRTH DEFECTS RES A, V97, P497, DOI 10.1002/bdra.23142; Ohtani K, 2011, CARDIOVASC RES, V90, P404, DOI 10.1093/cvr/cvr019; Peng Yanyu, 2009, Journal of Pharmacological and Toxicological Methods, V59, P135, DOI 10.1016/j.vascn.2009.03.002; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Stashi E, 2013, MOL ENDOCRINOL, V27, P1776, DOI 10.1210/me.2013-1192; Sun YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073480; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tian Xiaohui, 2013, Virologica Sinica, V28, P216, DOI 10.1007/s12250-013-3344-3; van Berlo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084591; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang LY, 2012, BIOCHEM BIOPH RES CO, V424, P593, DOI 10.1016/j.bbrc.2012.06.158; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida Y, 2010, CIRC J, V74, P156, DOI 10.1253/circj.CJ-09-0050; Yu CE, 2013, HUM MOL GENET, V22, P5036, DOI 10.1093/hmg/ddt354; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhang YM, 2012, J MOL CELL BIOL, V4, P97, DOI 10.1093/jmcb/mjs002; Zhong LL, 2010, CARDIOVASC TOXICOL, V10, P268, DOI 10.1007/s12012-010-9081-z	32	25	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104135	10.1371/journal.pone.0104135	http://dx.doi.org/10.1371/journal.pone.0104135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101666	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993900046
J	Hsu, K; Chung, YM; Endoh, Y; Geczy, CL				Hsu, Kenneth; Chung, Yuen Ming; Endoh, Yasumi; Geczy, Carolyn L.			TLR9 Ligands Induce S100A8 in Macrophages via a STAT3-Dependent Pathway which Requires IL-10 and PGE(2)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; NF-KAPPA-B; CPG DNA; C/EBP-BETA; CYCLOOXYGENASE-2 EXPRESSION; CELL-DIFFERENTIATION; MESSENGER-RNA; BACTERIAL-DNA; TNF-ALPHA; INTERLEUKIN-10	S100A8 and S100A9 are highly-expressed calcium-binding proteins in neutrophils and monocytes, and in subsets of macrophages in inflammatory lesions. Unmethylated CpG motifs found in bacterial and viral DNA are potent activators of innate immunity via Toll-like receptor 9 (TLR9). S100A8, but not S100A9, mRNA and protein was directly induced by CpG-DNA in murine and human macrophages. Induction in murine macrophages peaked at 16 h. CpG-DNA-induced S100A8 required de novo protein synthesis; IL-10 and Prostaglandin E-2 (PGE(2)) synergistically enhanced expression and promoted earlier gene induction. Inhibitors of endogenous IL-10, PGE2, and the E prostanoid (EP) 4 receptor strongly suppressed S100A8 expression, particularly when combined. Thus, S100A8 induction by E. coli DNA required both IL-10 and PGE(2)/EP4 signaling. The MAPKs, PI3K and JAK pathways were essential, whereas ERK1/2 appeared to play a direct role. S100A8 induction by CpG-DNA was controlled at the transcriptional level. The promoter region responsible for activation, either directly, or indirectly via IL-10 and PGE(2), was located within a -178 to -34-bp region and required STAT3 binding. Because of the robust links connecting IL-10 and PGE(2) with an anti-inflammatory macrophage phenotype, the induction profile of S100A8 strongly indicates a role for this protein in resolution of	[Hsu, Kenneth; Chung, Yuen Ming; Endoh, Yasumi; Geczy, Carolyn L.] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Hsu, K (corresponding author), Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia.	k.hsu@unsw.edu.au	Hsu, Kenneth/ABA-4079-2020		National Health and Medical Research Council (NHMRC) Australia [455406, 455307]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants #455406 and #455307 from the National Health and Medical Research Council (NHMRC) Australia (http://www.nhmrc.gov.au/grants). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Aochi S, 2011, J AM ACAD DERMATOL, V64, P879, DOI 10.1016/j.jaad.2010.02.049; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; CASSATELLA MA, 1994, J EXP MED, V179, P1695, DOI 10.1084/jem.179.5.1695; Chen YJ, 2001, INT IMMUNOL, V13, P1013, DOI 10.1093/intimm/13.8.1013; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; DiSepio D, 1997, J BIOL CHEM, V272, P25555, DOI 10.1074/jbc.272.41.25555; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Fleming BD, 2011, EUR J IMMUNOL, V41, P2498, DOI 10.1002/eji.201141717; Gao JJ, 2001, J IMMUNOL, V166, P6855, DOI 10.4049/jimmunol.166.11.6855; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Gomes LH, 2013, FREE RADICAL BIO MED, V58, P170, DOI 10.1016/j.freeradbiomed.2012.12.012; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goyette J, 2009, J IMMUNOL, V183, P593, DOI 10.4049/jimmunol.0900373; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Harrison CA, 1999, J BIOL CHEM, V274, P8561, DOI 10.1074/jbc.274.13.8561; Hiroshima Y, 2014, J IMMUNOL, V192, P2800, DOI 10.4049/jimmunol.1302556; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Hu SP, 1996, BLOOD, V87, P3919, DOI 10.1182/blood.V87.9.3919.bloodjournal8793919; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; Jung M, 2012, MOL CELL BIOL, V32, P3938, DOI 10.1128/MCB.00413-12; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Newton RA, 1998, J IMMUNOL, V160, P1427; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Robb BW, 2002, SURGERY, V132, P226, DOI 10.1067/msy.2002.125354; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Sun Y, 2013, MOL IMMUNOL, V53, P443, DOI 10.1016/j.molimm.2012.10.002; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanaka N, 2005, AM J RESP CELL MOL, V33, P406, DOI 10.1165/rcmb.2005-0140OC; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; Yeo SJ, 2003, J BIOL CHEM, V278, P22563, DOI 10.1074/jbc.M302076200; Yeo SJ, 2003, J IMMUNOL, V170, P1052, DOI 10.4049/jimmunol.170.2.1052; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711; Zhao J, 2011, ANTIOXID REDOX SIGN, V14, P1589, DOI 10.1089/ars.2010.3583; ZWADLO G, 1988, CLIN EXP IMMUNOL, V72, P510	68	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103629	10.1371/journal.pone.0103629	http://dx.doi.org/10.1371/journal.pone.0103629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098409	gold, Green Submitted, Green Published			2022-12-25	WOS:000339995100023
J	Li, S; Pettersson, US; Hoorelbeke, B; Kolaczkowska, E; Schelfhout, K; Martens, E; Kubes, P; Van Damme, J; Phillipson, M; Opdenakker, G				Li, Sandra; Pettersson, Ulrika S.; Hoorelbeke, Bart; Kolaczkowska, Elzbieta; Schelfhout, Katrien; Martens, Erik; Kubes, Paul; Van Damme, Jo; Phillipson, Mia; Opdenakker, Ghislain			Interference with Glycosaminoglycan-Chemokine Interactions with a Probe to Alter Leukocyte Recruitment and Inflammation In Vivo	PLOS ONE			English	Article							GRANULOCYTE CHEMOTACTIC PROTEIN-2; HEPARAN-SULFATE; CXC CHEMOKINES; CC-CHEMOKINE; NEUTROPHIL; BINDING; INDUCTION; CELLS; IDENTIFICATION; FIBROBLASTS	In vivo leukocyte recruitment is not fully understood and may result from interactions of chemokines with glycosaminoglycans/GAGs. We previously showed that chlorite-oxidized oxyamylose/COAM binds the neutrophil chemokine GCP-2/CXCL6. Here, mouse chemokine binding by COAM was studied systematically and binding affinities of chemokines to COAM versus GAGs were compared. COAM and heparan sulphate bound the mouse CXC chemokines KC/CXCL1, MIP-2/CXCL2, IP-10/CXCL10 and I-TAC/CXCL11 and the CC chemokine RANTES/CCL5 with affinities in the nanomolar range, whereas no binding interactions were observed for mouse MCP-1/CCL2, MIP-1 alpha/CCL3 and MIP-1 beta/CCL4. The affinities of COAM-interacting chemokines were similar to or higher than those observed for heparan sulphate. Although COAM did not display chemotactic activity by itself, its co-administration with mouse GCP-2/CXCL6 and MIP-2/CXCL2 or its binding of endogenous chemokines resulted in fast and cooperative peritoneal neutrophil recruitment and in extravasation into the cremaster muscle in vivo. These local GAG mimetic features by COAM within tissues superseded systemic effects and were sufficient and applicable to reduce LPS-induced liver-specific neutrophil recruitment and activation. COAM mimics glycosaminoglycans and is a nontoxic probe for the study of leukocyte recruitment and inflammation in vivo.	[Li, Sandra; Kolaczkowska, Elzbieta; Schelfhout, Katrien; Martens, Erik; Opdenakker, Ghislain] Katholieke Univ Leuven, Immunobiol Lab, Rega Inst Med Res, Leuven, Belgium; [Pettersson, Ulrika S.; Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Hoorelbeke, Bart] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Rega Inst Med Res, Leuven, Belgium; [Kolaczkowska, Elzbieta] Jagiellonian Univ, Krakow, Poland; [Kolaczkowska, Elzbieta; Kubes, Paul] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Kolaczkowska, Elzbieta; Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Van Damme, Jo] Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst Med Res, Leuven, Belgium	KU Leuven; Uppsala University; KU Leuven; Jagiellonian University; University of Calgary; University of Calgary; KU Leuven	Opdenakker, G (corresponding author), Katholieke Univ Leuven, Immunobiol Lab, Rega Inst Med Res, Leuven, Belgium.	ghislain.opdenakker@rega.kuleuven.be	Opdenakker, Ghislain/V-8562-2019; Martens, Erik/F-9214-2015; Kolaczkowska, Elzbieta/AAC-1988-2021; Opdenakker, Ghislain/Q-3130-2017	Opdenakker, Ghislain/0000-0003-1714-2294; Martens, Erik/0000-0002-7947-6567; Kolaczkowska, Elzbieta/0000-0002-3573-3584; Opdenakker, Ghislain/0000-0003-1714-2294; Phillipson, Mia/0000-0002-2387-0266; Van Damme, Jo/0000-0002-6707-1167	Fund for Scientific Research of Flanders (FWO-Vlaanderen); Centre of Excellence [EF/05/015]; "Geconcerteerde OnderzoeksActies'' of the KU Leuven; Swedish Research Council [K2012-99x-20675-05-3]; Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation; University of Leuven (KU Leuven), Belgium [273340]; University of Calgary, Canada [273340]	Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Centre of Excellence; "Geconcerteerde OnderzoeksActies'' of the KU Leuven; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); University of Leuven (KU Leuven), Belgium; University of Calgary, Canada	This study was supported by grants from the Fund for Scientific Research of Flanders (FWO-Vlaanderen), the Centre of Excellence (EF/05/015) and the "Geconcerteerde OnderzoeksActies'' (GOA-15, 2007-2012) of the KU Leuven. The work performed in Uppsala was supported by the Swedish Research Council (K2012-99x-20675-05-3), the Ragnar Soderberg Foundation and the Knut and Alice Wallenberg Foundation. Elzbieta Kolaczkowska is a Marie Curie Fellow of the FP7 framework programme (FP7-PEOPLE-2010-IOF) under agreements between the University of Leuven (KU Leuven), Belgium, and the University of Calgary, Canada (grant No.273340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghmans N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-243; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; CLAES P, 1970, J VIROL, V5, P313, DOI 10.1128/JVI.5.3.313-320.1970; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Gouwy M, 2009, J LEUKOCYTE BIOL, V86, P671, DOI 10.1189/jlb.1008638; Hermanson GT, 1996, BIOCONJUGATE TECHNIQ, P390; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Li S, 2008, BIOCHEM PHARMACOL, V76, P831, DOI 10.1016/j.bcp.2008.07.022; Li S, 2010, J LEUKOCYTE BIOL, V88, P1017, DOI 10.1189/jlb.1109724; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Piccard H, 2012, INT J CANCER, V131, pE425, DOI 10.1002/ijc.26465; Piccinini AM, 2010, J BIOL CHEM, V285, P8782, DOI 10.1074/jbc.M109.043299; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ramdin L, 1998, CLIN EXP ALLERGY, V28, P616; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Strieter RM, 2005, CYTOKINE GROWTH F R, V16, P593, DOI 10.1016/j.cytogfr.2005.04.007; Struyf S, 2005, EUR J IMMUNOL, V35, P1583, DOI 10.1002/eji.200425753; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Visser CE, 1998, CLIN EXP IMMUNOL, V112, P270; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Witowski J, 2001, AM J PATHOL, V158, P1441, DOI 10.1016/S0002-9440(10)64095-3; Wuyts A, 1999, J IMMUNOL, V163, P6155; Wuyts A, 1996, J IMMUNOL, V157, P1736; Wuyts A, 1998, CYTOKINE HDB; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	37	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104107	10.1371/journal.pone.0104107	http://dx.doi.org/10.1371/journal.pone.0104107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093679	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200070
J	Robinson, C; Alfonso, H; Woo, S; Walsh, A; Olsen, N; Musk, AW; Robinson, BWS; Nowak, AK; Lake, RA				Robinson, Cleo; Alfonso, Helman; Woo, Samantha; Walsh, Amy; Olsen, Nola; Musk, Arthur W.; Robinson, Bruce W. S.; Nowak, Anna K.; Lake, Richard A.			Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans	PLOS ONE			English	Article							PROSTATE-CANCER; MALIGNANT MESOTHELIOMA; VITAMIN-A; CHEMOPREVENTION; APOPTOSIS; WITTENOOM; SELENIUM; ASPIRIN; RETINOL; MODEL	Mesothelioma is principally caused by asbestos and may be preventable because there is a long latent period between exposure and disease development. The most at-risk are a relatively well-defined population who were exposed as a consequence of their occupations. Although preventative agents investigated so far have not been promising, discovery of such an agent would have a significant benefit world-wide on healthcare costs and personal suffering. Statins are widely used for management of hypercholesterolemia and cardiovascular risk; they can induce apoptosis in mesothelioma cells and epidemiological data has linked their use to a lower incidence of cancer. We hypothesised that statins would inhibit the development of asbestos-induced mesothelioma in mice and humans. An autochthonous murine model of asbestos-induced mesothelioma was used to test this by providing atorvastatin daily in the feed at 100 mg/kg, 200 mg/kg and 400 mg/kg. Continuous administration of atorvastatin did not alter the rate of disease development nor increase the length of time that mice survived. Latency to first symptoms of disease and disease progression were also unaffected. In a parallel study, the relationship between the use of statins and development of mesothelioma was investigated in asbestos-exposed humans. In a cohort of 1,738 asbestos exposed people living or working at a crocidolite mine site in Wittenoom, Western Australia, individuals who reported use of statins did not have a lower incidence of mesothelioma (HR = 1.01; 95% CI = 0.44-2.29, p = 0.99). Some individuals reported use of both statins and non-steroidal anti-inflammatory drugs or COX-2 inhibitors, and these people also did not have an altered risk of mesothelioma development (HR = 1.01; 95% CI = 0.61-1.67, p = 0.97). We conclude that statins do not moderate the rate of development of mesothelioma in either a mouse model or a human cohort exposed to asbestos.	[Robinson, Cleo; Woo, Samantha; Walsh, Amy; Robinson, Bruce W. S.; Nowak, Anna K.; Lake, Richard A.] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Harry Perkins Inst Med Res, Perth, WA 6009, Australia; [Robinson, Cleo] PathWest, Anat Pathol, Perth, WA, Australia; [Alfonso, Helman] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Olsen, Nola; Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Curtin University; University of Western Australia; University of Western Australia	Robinson, C (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Harry Perkins Inst Med Res, Perth, WA 6009, Australia.	cleo.robinson@uwa.edu.au	Robinson, Bruce/N-1900-2014; Nowak, Anna K/B-2487-2013	Nowak, Anna K/0000-0002-9317-9526	NHMRC Centre for Research Excellence [1001020]; Insurance Commission of Western Australia	NHMRC Centre for Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); Insurance Commission of Western Australia	This work was funded by NHMRC Centre for Research Excellence grant ID 1001020 and a grant from Insurance Commission of Western Australia. Funding received by CR, BWSR, AKN, RAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso HS, 2010, EUR J CANCER PREV, V19, P355, DOI 10.1097/CEJ.0b013e32833c1bcb; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Beales ILP, 2012, EUR J GASTROEN HEPAT, V24, P917, DOI 10.1097/MEG.0b013e3283543f01; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Coogan PF, 2010, PHARMACOEPIDEM DR S, V19, P752, DOI 10.1002/pds.1970; de Klerk NH, 1998, INT J CANCER, V75, P362, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;362::AID-IJC6&gt;3.0.CO;2-0; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Gonzalez CA, 2006, BRIT J NUTR, V96, pS42, DOI 10.1079/BJN20061699; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Mamede AC, 2011, NUTR CANCER, V63, P479, DOI 10.1080/01635581.2011.539315; Mant A, 2007, BRIT J CLIN PHARMACO, V63, P125, DOI 10.1111/j.1365-2125.2006.02735.x; Musk AW, 2011, EUR RESPIR J, V38, P1420, DOI 10.1183/09031936.00000811; Musk AW, 1998, INT J CANCER, V75, P355, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;355::AID-IJC5&gt;3.0.CO;2-1; Nicholson W J, 1995, Med Lav, V86, P393; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Olsen NJ, 2011, MED J AUSTRALIA, V195, P271, DOI 10.5694/mja11.10125; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Riganti C, 2006, INT J CANCER, V119, P17, DOI 10.1002/ijc.21832; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson C, 2014, NUTR CANC; Robinson C, 2014, NSAIDS COX 2 I UNPUB; Robinson C, 2006, CANCER RES, V66, P10786, DOI 10.1158/0008-5472.CAN-05-4668; Robinson C, 2012, NUTR CANCER, V64, P315, DOI 10.1080/01635581.2012.649100; Robinson C, 2011, EUR J CANCER, V47, P151, DOI 10.1016/j.ejca.2010.08.015; Rubins JB, 1998, AM J RESP CRIT CARE, V157, P1616, DOI 10.1164/ajrccm.157.5.9709020; Shureiqi I, 2000, CRIT REV ONCOL HEMAT, V33, P157, DOI 10.1016/S1040-8428(99)00072-4; Strohmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054242; Xiao H, 2008, INT J CANCER, V123, P983, DOI 10.1002/ijc.23718; Zhou P, 2012, EUR J CANCER PREV, V21, P231, DOI 10.1097/CEJ.0b013e32834dbbfd	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103025	10.1371/journal.pone.0103025	http://dx.doi.org/10.1371/journal.pone.0103025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093718	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200017
J	Bernard, MA; Han, XB; Inderbitzin, S; Agbim, I; Zhao, H; Koziel, H; Tachado, SD				Bernard, Mark A.; Han, Xinbing; Inderbitzin, Sonya; Agbim, Ifunanya; Zhao, Hui; Koziel, Henry; Tachado, Souvenir D.			HIV-Derived ssRNA Binds to TLR8 to Induce Inflammation-Driven Macrophage Foam Cell Formation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TNF-ALPHA RELEASE; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; ATHEROSCLEROSIS; DISEASE; IMMUNODEFICIENCY; MICRORNAS; DNA; STIMULATION	Even though combined anti-retroviral therapy (cART) dramatically improves patient survival, they remain at a higher risk of being afflicted with non-infectious complications such as cardiovascular disease (CVD). This increased risk is linked to persistent inflammation and chronic immune activation. In this study, we assessed whether this complication is related to HIV-derived ssRNAs inducing in macrophages increases in TNF alpha release through TLR8 activation leading to foam cell formation. HIV ssRNAs induced foam cell formation in monocyte-derived macrophages (MDMs) in a dose-dependent manner. This response was reduced when either endocytosis or endosomal acidification was inhibited by dynasore or chloroquine, respectively. Using a flow cytometry FRET assay, we demonstrated that ssRNAs bind to TLR8 in HEK cells. In MDMs, ssRNAs triggered a TLR8-mediated inflammatory response that ultimately lead to foam cell formation. Targeted silencing of the TLR8 and MYD88 genes reduced foam cell formation. Furthermore, foam cell formation induced by these ssRNAs was blocked by an anti-TNF alpha neutralizing antibody. Taken together in MDMs, HIV ssRNAs are internalized; bind TLR8 in the endosome followed by endosomal acidification. TLR8 signaling then triggers TNF alpha release and ultimately leads to foam cell formation. As this response was inhibited by a blocking anti-TNF alpha antibody, drug targeting HIV ssRNA-driven TLR8 activation may serve as a potential therapeutic target to reduce chronic immune activation and inflammation leading to CVD in HIV+ patients.	[Bernard, Mark A.; Han, Xinbing; Inderbitzin, Sonya; Agbim, Ifunanya; Zhao, Hui; Koziel, Henry; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Bernard, Mark A.; Han, Xinbing; Inderbitzin, Sonya; Agbim, Ifunanya; Zhao, Hui; Koziel, Henry; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA USA; [Zhao, Hui] Shanxi Med Univ, Hosp 2, Dept Resp Med, Taiyuan, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Shanxi Medical University	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu		Tachado, Souvenir/0000-0002-8368-6102; Bernard, Mark/0000-0001-7141-2975	National Heart, Lung and Blood Institute of the National Institutes of Health [R01 HL92811, NIH NL 063655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute of the National Institutes of Health, Grant R01 HL92811 to SDT and NIH NL 063655 to Henry Koziel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barbaro G, 2002, J CARDIOVASC RISK, V9, P295, DOI 10.1097/00043798-200210000-00011; BARBOLINI G, 1969, VIRCHOWS ARCH B, V3, P24; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fabbri M, 2012, CANCER RES, V72, P6333, DOI 10.1158/0008-5472.CAN-12-3229; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Francisci D, 2009, AIDS, V23, P589, DOI 10.1097/QAD.0b013e328325a87c; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; GERRITY RG, 1980, ARTERY, V8, P208; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Han XB, 2009, J BIOL CHEM, V284, P32950, DOI 10.1074/jbc.M109.040899; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; He S, 2013, BLOOD, V121, P4663, DOI 10.1182/blood-2012-07-441360; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Iloeje UH, 2005, HIV MED, V6, P37, DOI 10.1111/j.1468-1293.2005.00265.x; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kim JS, 2009, BIOCHEM BIOPH RES CO, V390, P196, DOI 10.1016/j.bbrc.2009.09.009; LAFEUILLADE A, 1991, AIDS, V5, P1139, DOI 10.1097/00002030-199109000-00014; Lee JG, 2008, CELL SIGNAL, V20, P2266, DOI 10.1016/j.cellsig.2008.08.022; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lewis W, 2000, J MOL CELL CARDIOL, V32, P2115, DOI 10.1006/jmcc.2000.1271; Maria-Magdalena M, 2011, PROTEOMICS, V11, P2063, DOI 10.1002/pmic.201100028; Mehta NJ, 2003, ANGIOLOGY, V54, P269, DOI 10.1177/000331970305400302; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Ostrowski SR, 2005, J INFECT DIS, V191, P348, DOI 10.1086/427340; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Shrestha S, 2014, ARTERIOSCL THROM VAS, V34, P244, DOI 10.1161/ATVBAHA.113.302191; Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104; Tachado SD, 2005, AM J RESP CELL MOL, V33, P610, DOI 10.1165/rcmb.2004-0341OC; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vittecoq D, 2003, AIDS, V17, pS70, DOI 10.1097/00002030-200304001-00010; ZUCKERFRANKLIN D, 1978, LAB INVEST, V38, P620	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104039	10.1371/journal.pone.0104039	http://dx.doi.org/10.1371/journal.pone.0104039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090652	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700087
J	Petursdottir, DH; Chuquimia, OD; Freidl, R; Fernandez, C				Petursdottir, Dagbjort H.; Chuquimia, Olga D.; Freidl, Raphaela; Fernandez, Carmen			Macrophage Control of Phagocytosed Mycobacteria Is Increased by Factors Secreted by Alveolar Epithelial Cells through Nitric Oxide Independent Mechanisms	PLOS ONE			English	Article							INTERFERON-GAMMA; IFN-GAMMA; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; RESPIRATORY BURST; IMMUNE-RESPONSES; L-ARGININE; IN-VITRO; II CELLS; ACTIVATION	Tissue-resident macrophages are heterogeneous with tissue-specific and niche-specific functions. Thus, simplified models of macrophage activation do not explain the extent of heterogeneity seen in vivo. We focus here on the respiratory tract and ask whether factors secreted by alveolar epithelial cells (AEC) can influence the functionality of resident pulmonary macrophages (PuM). We have previously reported that factors secreted by AEC increase control of intracellular growth of BCG in macrophages. In the current study, we also aimed to investigate possible mechanisms by which AEC-derived factors increase intracellular control of BCG in both primary murine interstitial macrophages, and bone marrow-derived macrophages and characterize further the effect of these factors on macrophage differentiation. We show that; a) in contrast to other macrophage types, IFN-gamma did not increase intracellular growth control of Mycobacterium bovis, Bacillus Calmette-Guerin (BCG) by interstitial pulmonary macrophages although the same macrophages could be activated by factors secreted by AEC; b) the lack of response of pulmonary macrophages to IFN-gamma was apparently regulated by suppressor of cytokine signaling (SOCS) 1; c) AEC-derived factors did not induce pro-inflammatory pathways induced by IFN-gamma e.g. expression of inducible nitric oxide synthase (iNOS), secretion of nitric oxide (NO), or IL-12, d) in contrast to IFN-gamma, intracellular bacterial destruction induced by AEC-derived factors was not dependent on iNOS transcription and NO production. Collectively, our data show that PuM were restricted in inflammatory responses mediated by IFN-gamma through SOCS1 and that factors secreted by AEC-enhanced the microbicidal capacities of macrophages by iNOS independent mechanisms.	[Petursdottir, Dagbjort H.; Chuquimia, Olga D.; Freidl, Raphaela; Fernandez, Carmen] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Petursdottir, DH (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	dagbjort.petursdottir@su.se		Petursdottir, Dagbjort/0000-0003-0665-7719	European Commission [HEALTH-F3-2008-200732]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grant FP7 (HEALTH-F3-2008-200732) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Alvarez E, 2002, INT IMMUNOPHARMACOL, V2, P849, DOI 10.1016/S1567-5769(02)00032-2; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; BARRERA LF, 1994, IMMUNOLOGY, V82, P457; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Carow B, 2011, J BIOL CHEM, V286, P26873, DOI 10.1074/jbc.M111.238287; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Chuquimia OD, 2013, INFECT IMMUN, V81, P381, DOI 10.1128/IAI.00950-12; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fehrenbach H, 2012, EUR RESPIR J, V39, P240, DOI 10.1183/09031936.00162111; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081; HIBBS JB, 1987, J IMMUNOL, V138, P550; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Laskin DL, 2001, J LEUKOCYTE BIOL, V70, P163; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lefevre L, 2013, IMMUNITY, V38, P1038, DOI 10.1016/j.immuni.2013.04.010; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Orme J, 2012, DISCOV MED, V13, P151; Pechkovsky DV, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-75; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Rahman MJ, 2011, INFECT IMMUN, V79, P4649, DOI 10.1128/IAI.05724-11; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Sato K, 1998, CLIN EXP IMMUNOL, V112, P63; Schneberger D, 2011, CELL TISSUE RES, V343, P97, DOI 10.1007/s00441-010-1032-2; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinmuller C, 2000, AM J RESP CELL MOL, V22, P481, DOI 10.1165/ajrcmb.22.4.3336; TAUB DD, 1995, J IMMUNOL METHODS, V184, P187, DOI 10.1016/0022-1759(95)00087-Q; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Vereyken EJF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-58; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103411	10.1371/journal.pone.0103411	http://dx.doi.org/10.1371/journal.pone.0103411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089618	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700023
J	Zhao, WR; Ai, ZY; Dai, JS; Zhang, M				Zhao, Weirong; Ai, Zhuyu; Dai, Jiusong; Zhang, Meng			Enhanced Photocatalytic Activity for H-2 Evolution under Irradiation of UV-Vis Light by Au-Modified Nitrogen-Doped TiO2	PLOS ONE			English	Article							VISIBLE-LIGHT; HYDROGEN-PRODUCTION; SURFACE CHARACTERIZATION; TITANIUM-DIOXIDE; TEMPERATURE; NANOPARTICLES; REDUCTION; ORIGIN; OXIDE; NANOFIBERS	Background Purpose: Photocatalytic water splitting for hydrogen evolution is a potential way to solve many energy and environmental issues. Developing visible-light-active photocatalysts to efficiently utilize sunlight and finding proper ways to improve photocatalytic activity for H-2 evolution have always been hot topics for research. This study attempts to expand the use of sunlight and to enhance the photocatalytic activity of TiO2 by N doping and Au loading. Methods: Au/N-doped TiO2 photocatalysts were synthesized and successfully used for photocatalytic water splitting for H-2 evolution under irradiation of UV and UV-vis light, respectively. The samples were characterized using X-ray diffraction (XRD), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), UV-vis diffuse reflectance spectroscopy (DRS), photoluminescence spectroscopy (PL), and photoelectrochemical characterizations. Results: DRS displayed an extension of light absorption into the visible region by doping of N and depositing with Au, respectively. PL analysis indicated electron-hole recombination due to N doping and an efficient inhibition of electron-hole recombination due to the loaded Au particles. Under the irradiation of UV light, the photocatalytic hydrogen production rate of the as-synthesized samples followed the order Au/TiO2. Au/N-doped TiO2. TiO2. N-doped TiO2. While under irradiation of UV-vis light, the N-TiO2 and Au/N-TiO2 samples show higher H-2 evolution than their corresponding nitrogenfree samples (TiO2 and Au/TiO2). This inconsistent result could be attributed to the doping of N and the surface plasmonic resonance (SPR) effect of Au particles extending the visible light absorption. The photoelectrochemical characterizations further indicated the enhancement of the visible light response of Au/N-doped TiO2. Conclusion: Comparative studies have shown that a combination of nitrogen doping and Au loading enhanced the visible light response of TiO2 and increased the utilization of solar energy, greatly boosting the photocatalytic activity for hydrogen production under UV-vis light.	[Zhao, Weirong; Ai, Zhuyu; Dai, Jiusong; Zhang, Meng] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhao, WR (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	weirong@mail.hz.zj.cn		zhao, weirong/0000-0002-8597-2292	National Nature Science Foundation of China [51178412, 51278456]; National Key Technologies RD Program [2013BAC16B01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program)	This work has been partially supported by the National Nature Science Foundation of China (Grant nos. 51178412 and 51278456, http://www.nsfc.gov.cn) and the National Key Technologies R&D Program (Grant no. 2013BAC16B01, http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessekhouad Y, 2012, J PHOTOCH PHOTOBIO A, V248, P15, DOI 10.1016/j.jphotochem.2012.08.013; Chen JJ, 2011, J PHYS CHEM C, V115, P210, DOI 10.1021/jp1074048; Cong Y, 2007, J PHYS CHEM C, V111, P6976, DOI 10.1021/jp0685030; DeSario PA, 2013, NANOSCALE, V5, P8073, DOI 10.1039/c3nr01429k; Di Valentin C, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085116; Di Valentin C, 2007, CHEM PHYS, V339, P44, DOI 10.1016/j.chemphys.2007.07.020; Dong F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/36/365607; Epling WS, 1996, J PHYS CHEM-US, V100, P9929, DOI 10.1021/jp960593t; Erdem B, 2001, LANGMUIR, V17, P2664, DOI 10.1021/la0015213; Garcia MA, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/28/283001; Graciani J, 2008, J AM CHEM SOC, V130, P12056, DOI 10.1021/ja802861u; Hoang S, 2012, NANO LETT, V12, P26, DOI 10.1021/nl2028188; Iliev V, 2006, APPL CATAL A-GEN, V313, P115, DOI 10.1016/j.apcata.2006.06.039; Jia TT, 2014, CHEM COMMUN, V50, P1185, DOI 10.1039/c3cc47301e; Jiang Z, 2008, CHEM COMMUN, P6372, DOI 10.1039/b815430a; Kominami H, 2014, CHEM COMMUN, V50, P4558, DOI 10.1039/c3cc49340g; Li P, 2011, J AM CHEM SOC, V133, P5660, DOI 10.1021/ja111102u; Li XF, 2008, MICROPOR MESOPOR MAT, V116, P478, DOI 10.1016/j.micromeso.2008.05.007; Lin ZS, 2005, J PHYS CHEM B, V109, P20948, DOI 10.1021/jp053547e; Liu ZW, 2011, NANO LETT, V11, P1111, DOI 10.1021/nl104005n; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Mao YB, 2006, J AM CHEM SOC, V128, P8217, DOI 10.1021/ja0607483; Min YL, 2013, SEP PURIF TECHNOL, V106, P97, DOI 10.1016/j.seppur.2012.12.023; Ohno T, 2014, APPL CATAL B-ENVIRON, V152, P309, DOI 10.1016/j.apcatb.2014.01.048; Seh ZW, 2012, ADV MATER, V24, P2310, DOI 10.1002/adma.201104241; Sreethawong T, 2009, CATAL COMMUN, V10, P538, DOI 10.1016/j.catcom.2008.10.029; Taboada E, 2014, J CATAL, V309, P460, DOI 10.1016/j.jcat.2013.10.025; Tanaka A, 2012, LANGMUIR, V28, P13105, DOI 10.1021/la301944b; Tian BZ, 2009, CATAL COMMUN, V10, P925, DOI 10.1016/j.catcom.2008.12.029; Wang DA, 2013, ANGEW CHEM INT EDIT, V52, P11252, DOI 10.1002/anie.201303693; Wang HB, 2011, J MATER CHEM, V21, P5430, DOI 10.1039/c1jm00049g; Wang J, 2009, J AM CHEM SOC, V131, P12290, DOI 10.1021/ja903781h; Wang JW, 2007, J PHYS CHEM C, V111, P1010, DOI 10.1021/jp066156o; Wang P, 2012, PHYS CHEM CHEM PHYS, V14, P9813, DOI 10.1039/c2cp40823f; Wang P, 2011, CHEMCATCHEM, V3, P360, DOI 10.1002/cctc.201000380; Wu DY, 2010, J ALLOY COMPD, V502, P289, DOI 10.1016/j.jallcom.2010.04.189; Wu YM, 2009, J PHYS CHEM C, V113, P14689, DOI 10.1021/jp904465d; Xiang QJ, 2011, CHEM COMMUN, V47, P6906, DOI 10.1039/c1cc11740h; Xin BF, 2005, APPL SURF SCI, V252, P2050, DOI 10.1016/j.apsusc.2005.03.172; Yang GR, 2013, NANOSCALE, V5, P12432, DOI 10.1039/c3nr03462c; Yu JG, 2003, J PHYS CHEM B, V107, P13871, DOI 10.1021/jp036158y; Zhang JL, 2010, ENERG ENVIRON SCI, V3, P715, DOI 10.1039/b927575d; Zhang JY, 2013, ACS APPL MATER INTER, V5, P1031, DOI 10.1021/am302726y; Zhang P, 2012, J HAZARD MATER, V237, P331, DOI 10.1016/j.jhazmat.2012.08.054; Zhao W, 2013, APPL CATAL B-ENVIRON, V144, P468; Zheng ZF, 2013, CHEM-EUR J, V19, P5731, DOI 10.1002/chem.201203961; Zhou XM, 2012, J MATER CHEM, V22, P21337, DOI 10.1039/c2jm31902k	47	28	30	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103671	10.1371/journal.pone.0103671	http://dx.doi.org/10.1371/journal.pone.0103671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090093	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700039
J	Hobaiter, C; Schel, AM; Langergraber, K; Zuberbuhler, K				Hobaiter, Catherine; Schel, Anne Marijke; Langergraber, Kevin; Zuberbuehler, Klaus			'Adoption' by Maternal Siblings in Wild Chimpanzees	PLOS ONE			English	Article							ALTRUISM; HELP	The adoption of unrelated orphaned infants is something chimpanzees and humans have in common. Providing parental care has fitness implications for both the adopter and orphan, and cases of adoption have thus been cited as evidence for a shared origin of an altruistic behaviour. We provide new data on adoptions in the free-living Sonso chimpanzee community in Uganda, together with an analysis of published data from other long-term field sites. As a default pattern, we find that orphan chimpanzees do not become adopted by adult group members but wherever possible associate with each other, usually as maternal sibling pairs. This occurs even if both partners are still immature, with older individuals effectively becoming 'child household heads'. Adoption of orphans by unrelated individuals does occur but usually only if no maternal siblings or other relatives are present and only after significant delays. In conclusion, following the loss of their mother, orphaned chimpanzees preferentially associate along pre-existing social bonds, which are typically strongest amongst maternal siblings.	[Hobaiter, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Ctr Social Learning & Cognit Evolut, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Hobaiter, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [Schel, Anne Marijke] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Schel, Anne Marijke] Ecole Normale Super, Inst Jean Nicod, F-75231 Paris, France; [Langergraber, Kevin] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Langergraber, Kevin] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Zuberbuehler, Klaus] Univ Neuchatel, Inst Biol, Dept Comparat Cognit, CH-2000 Neuchatel, Switzerland; [Hobaiter, Catherine; Schel, Anne Marijke; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda	University of St Andrews; University of St Andrews; University of York - UK; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Boston University; Max Planck Society; University of Neuchatel	Hobaiter, C (corresponding author), Univ St Andrews, Ctr Social Learning & Cognit Evolut, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	clh42@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Hobaiter, Cat/0000-0002-3893-0524	Leverhulme Trust Research Leadership Award [F/00268/AP]; Wenner-Gren Foundation Dissertation Fieldwork grant; British Academy Grant [SG411998]; Royal Zoological Society of Scotland; European Union [283871]; Max Planck Society; Boston University; Leakey Foundation	Leverhulme Trust Research Leadership Award(Leverhulme Trust); Wenner-Gren Foundation Dissertation Fieldwork grant; British Academy Grant; Royal Zoological Society of Scotland; European Union(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Boston University; Leakey Foundation	This research was funded by the Leverhulme Trust Research Leadership Award F/00268/AP (http://www.leverhulme.ac.uk/), a Wenner-Gren Foundation Dissertation Fieldwork grant (http://www.wennergren.org/), the British Academy Grant SG411998 (http://www.brit.ac.uk) and the Royal Zoological Society of Scotland (http://www.rzss.org.uk). This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 283871. Genetic analyses were funded by the Max Planck Society, Boston University, and the Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Boesch C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008901; Bshary R, 2008, J EVOLUTION BIOL, V21, P405, DOI 10.1111/j.1420-9101.2007.01482.x; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Foster G., 1997, HLTH T REV S2, V7, P155; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Hirata S, 2011, BIOL LETTERS, V7, P686, DOI 10.1098/rsbl.2011.0214; Hirata S, 2009, PRIMATES, V50, P3, DOI 10.1007/s10329-008-0122-1; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2014, AM J PRIMATOL, V76, P640, DOI 10.1002/ajp.22258; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Lehmann J, 2004, BEHAV ECOL SOCIOBIOL, V56, P207, DOI 10.1007/s00265-004-0781-x; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lehmann L, 2006, J EVOLUTION BIOL, V19, P337; Liebal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084299; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Plumtre AJ, 2003, ALBERTINE RIFT TECHN, V2; Pruetz Jill D., 2009, Paleoanthropology, V2009, P252; Reynolds V., 2005, CHIMPANZEES BUDONGO; SAKURA O, 1994, INT J PRIMATOL, V15, P167, DOI 10.1007/BF02735272; Silk JB., 1987, CULTURAL ANTHR, V2, P39, DOI [10.1525/can.1987.2.1.02a00050, DOI 10.1525/CAN.1987.2.1.02A00050]; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; UEHARA S, 1983, Primates, V24, P456, DOI 10.1007/BF02381679; WEISNER TS, 1977, CURR ANTHROPOL, V18, P169, DOI 10.1086/201883; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Wroblewski E, 2010, THESIS U MINNESOTA; Wroblewski EE, 2008, AM J PRIMATOL, V70, P995, DOI 10.1002/ajp.20582; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; Zuberbuhler K, 2013, SONSO CHIMPANZEE DAT	36	21	21	6	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103777	10.1371/journal.pone.0103777	http://dx.doi.org/10.1371/journal.pone.0103777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084521	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800078
J	Liu, Y; Carson-Walter, E; Walter, KA				Liu, Yang; Carson-Walter, Eleanor; Walter, Kevin A.			Chemokine Receptor CXCR7 Is a Functional Receptor for CXCL12 in Brain Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR; TUMOR-GROWTH; IN-VIVO; HEPATOCELLULAR-CARCINOMA; PROGENITOR CELLS; GENE-EXPRESSION; ANGIOGENESIS; GLIOBLASTOMA; INVASION; PROLIFERATION	The chemokine CXCL12 regulates multiple cell functions through its receptor, CXCR4. However, recent studies have shown that CXCL12 also binds a second receptor, CXCR7, to potentiate signal transduction and cell activity. In contrast to CXCL12/CXCR4, few studies have focused on the role of CXCR7 in vascular biology and its role in human brain microvascular endothelial cells (HBMECs) remains unclear. In this report, we used complementary methods, including immunocytofluorescence, Western blot, and flow cytometry analyses, to demonstrate that CXCR7 was expressed on HBMECs. We then employed short hairpin RNA (shRNA) technology to knockdown CXCR7 in HBMECs. Knockdown of CXCR7 in HBMECs resulted in significantly reduced HBMEC proliferation, tube formation, and migration, as well as adhesion to matrigel and tumor cells. Blocking CXCR7 with a specific antibody or small molecule antagonist similarly disrupted HBMEC binding to matrigel or tumor cells. We found that tumor necrosis factor (TNF)-alpha induced CXCR7 in a time and dose-response manner and that this increase preceded an increase in vascular cell adhesion molecule-1 (VCAM-1). Knockdown of CXCR7 resulted in suppression of VCAM-1, suggesting that the reduced binding of CXCR7-knockdown HBMECs may result from suppression of VCAM-1. Collectively, CXCR7 acted as a functional receptor for CXCL12 in brain endothelial cells. Targeting CXCR7 in tumor vasculature may provide novel opportunities for improving brain tumor therapy.	[Liu, Yang; Carson-Walter, Eleanor; Walter, Kevin A.] Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY 14627 USA; [Walter, Kevin A.] Univ Rochester, Sch Med & Dent, Wilmot Canc Ctr, Rochester, NY USA	University of Rochester; University of Rochester	Liu, Y (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY 14627 USA.	yang_liu@urmc.rochester.edu; kevin_walter@urmc.rochester.edu			University of Rochester Clinical and Translational Science Institute Pilot Studies Award; National Institutes of Health [NINDS K08 NS046461]; American Brain Tumor Association; Ronald Bittner Brain Tumor Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS046461] Funding Source: NIH RePORTER	University of Rochester Clinical and Translational Science Institute Pilot Studies Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; Ronald Bittner Brain Tumor Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the University of Rochester Clinical and Translational Science Institute Pilot Studies Award to Y.L., the National Institutes of Health (NINDS K08 NS046461) to K.A.W., the American Brain Tumor Association to K.A.W., and the Ronald Bittner Brain Tumor Research Fund to K.A.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Brown JM, 2013, SEMIN RADIAT ONCOL, V23, P281, DOI 10.1016/j.semradonc.2013.05.002; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Costello CM, 2012, EUR RESPIR J, V39, P1415, DOI 10.1183/09031936.00044911; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Glushakova O, 2008, J AM SOC NEPHROL, V19, P1712, DOI 10.1681/ASN.2007121304; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Huang P, 2012, CANCER RES, V72, P1428, DOI 10.1158/0008-5472.CAN-11-2621; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kanda S, 2003, J BIOL CHEM, V278, P257, DOI 10.1074/jbc.M204771200; Kenig S, 2010, CANCER LETT, V289, P53, DOI 10.1016/j.canlet.2009.07.014; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Liu Y, 2010, J NEURO-ONCOL, V99, P13, DOI 10.1007/s11060-009-0105-0; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Madden SL, 2004, AM J PATHOL, V165, P601, DOI 10.1016/S0002-9440(10)63324-X; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Molino M, 2000, BBA-MOL BASIS DIS, V1500, P227, DOI 10.1016/S0925-4439(99)00110-6; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Rao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033005; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salmaggi A, 2009, CANCER BIOL THER, V8, P1615, DOI 10.4161/cbt.8.17.9202; Schutyser E, 2007, EUR CYTOKINE NETW, V18, P59, DOI 10.1684/ecn.2007.0087; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takano S, 2010, J ONCOL, V2010, DOI 10.1155/2010/351908; Totonchy JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069828; Walters MJ, 2014, BR J CANC; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Watanabe K, 2010, ARTHRITIS RHEUM-US, V62, P3211, DOI 10.1002/art.27650; Wurth R, 2011, J NEUROIMMUNOL, V234, P115, DOI 10.1016/j.jneuroim.2011.01.006; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31; Zheng YH, 2013, J BIOL CHEM, V288, P31488, DOI 10.1074/jbc.M113.499020; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	49	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103938	10.1371/journal.pone.0103938	http://dx.doi.org/10.1371/journal.pone.0103938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084358	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800106
J	Sonego, F; Castanheira, FVS; Czaikoski, PG; Kanashiro, A; Souto, FO; Franca, RO; Nascimento, DC; Freitas, A; Spiller, F; Cunha, LD; Zamboni, DS; Alves, JC; Cunha, FQ				Sonego, Fabiane; Castanheira, Fernanda V. S.; Czaikoski, Paula G.; Kanashiro, Alexandre; Souto, Fabricio O.; Franca, Rafael O.; Nascimento, Daniele C.; Freitas, Andressa; Spiller, Fernando; Cunha, Larissa D.; Zamboni, Dario S.; Alves-Filho, Jose C.; Cunha, Fernando Q.			MyD88-, but Not Nod1- and/or Nod2-Deficient Mice, Show Increased Susceptibility to Polymicrobial Sepsis due to Impaired Local Inflammatory Response	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; NEUTROPHIL MIGRATION; SEPTIC PERITONITIS; ORGAN INJURY; IN-VIVO; CHEMOKINE; CELLS; MURAMYLDIPEPTIDE; RECRUITMENT	Pathogen recognition and triggering of the inflammatory response following infection in mammals depend mainly on Toll like and Nod-like receptors. Here we evaluated the role of Nod1, Nod2 and MyD88-dependent signaling in the chemokine production and neutrophil recruitment to the infectious site during sepsis induced by cecal ligation and puncture (CLP) in C57BI/6 mice. We demonstrate that Nodi and Nod2 are not involved in the release of chemokines and recruitment of neutrophils to the infectious site during CLP-induced septic peritonitis because these events were similar in wild-type Nod Nod2-, Nod1/Nod2- and Rip2-deficient mice. Consequently, the local and systemic bacterial loads were not altered. Accordingly, her Nod1 nor Nod2 was involved in the production of he circulating cytokines and in the accumulation of leukocytes in By contrast, we showed that MyD88-dependent signaling is crucial for the establishment of the local inflammatory response during CLP-induced sepsis. MyD88-deficient mice were susceptible to sepsis because of an impaired local production chemokines and defective neutrophil recruitment to the infection site. Altogether, these data show that Nod1, Nod2 and Rip2 are not required for local chemokine production and neutrophil recruitment during CLP-Induced sepsis, and they importance of MyD88-dependent signaling for initiation of a protective host response.	[Sonego, Fabiane; Castanheira, Fernanda V. S.; Czaikoski, Paula G.; Kanashiro, Alexandre; Souto, Fabricio O.; Franca, Rafael O.; Nascimento, Daniele C.; Freitas, Andressa; Spiller, Fernando; Alves-Filho, Jose C.; Cunha, Fernando Q.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, BR-14049 Ribeirao Preto, SP, Brazil; [Cunha, Larissa D.; Zamboni, Dario S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogent, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cunha, FQ (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, BR-14049 Ribeirao Preto, SP, Brazil.	fdqcunha@fmrp.usp.br	Kanashiro, Alexandre/AAX-3823-2020; Souto, Fabricio/AAS-7671-2020; Cunha, Fernando Q/M-3090-2014; de Freitas, Andressa/B-7264-2012; Kanashiro, Alexandre/C-9435-2012; Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Larissa D/I-4204-2012; Souto, Fabricio/AAX-8668-2021; Freitas de Oliveira Franca, Rafael/ABB-2376-2021; Spiller, Fernando/P-2265-2017; Zamboni, Dario S/D-3024-2012	Kanashiro, Alexandre/0000-0003-0367-7503; de Freitas, Andressa/0000-0001-8453-7742; Kanashiro, Alexandre/0000-0003-0367-7503; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Souto, Fabricio/0000-0002-2392-8499; Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Spiller, Fernando/0000-0002-4875-5483; Zamboni, Dario S/0000-0002-7856-7512; Cunha, Fernando Queiroz/0000-0003-4755-1670; Castanheira, Fernanda/0000-0002-2024-7858; Dias da Cunha, Larissa/0000-0002-1290-0263	Sao Paulo Research Foundation (FAPESP) [2008/11593-4, 2011/19670-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); European Community [HEALTH-F4-2011-281608]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Community(European Commission)	This work was supported by Sao Paulo Research Foundation (FAPESP), grant #2008/11593-4 and #2011/19670-0, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement number HEALTH-F4-2011-281608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens P, 2004, PEDIATR RES, V55, P652, DOI 10.1203/01.PDR.0000112100.61253.85; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Benjamim CF, 2000, J INFECT DIS, V182, P214, DOI 10.1086/315682; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dharancy S, 2010, GASTROENTEROLOGY, V138, P1546, DOI 10.1053/j.gastro.2009.12.008; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; Farkas L, 2008, SCAND J IMMUNOL, V68, P315, DOI 10.1111/j.1365-3083.2008.02145.x; Feng Y, 2011, ANESTHESIOLOGY, V115, P555, DOI 10.1097/ALN.0b013e31822a22f7; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Gais P, 2012, J IMMUNOL, V188, P5833, DOI 10.4049/jimmunol.1200038; Godshall CJ, 2002, J SURG RES, V102, P45, DOI 10.1006/jsre.2001.6319; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Marriott I, 2005, INFECT IMMUN, V73, P2967, DOI 10.1128/IAI.73.5.2967-2973.2005; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Moyer MW, 2012, NAT MED, V18, P999, DOI 10.1038/nm0712-999; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003351; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Reim D, 2011, J LEUKOCYTE BIOL, V90, P613, DOI 10.1189/jlb.1110602; Seeley EJ, 2012, AM J PHYSIOL-LUNG C, V303, pL355, DOI 10.1152/ajplung.00069.2012; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Soehnlein O, 2008, CLIN EXP IMMUNOL, V151, P139, DOI 10.1111/j.1365-2249.2007.03532.x; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; Trevelin SC, 2012, CRIT CARE MED, V40, P2631, DOI 10.1097/CCM.0b013e318258fb70; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103734	10.1371/journal.pone.0103734	http://dx.doi.org/10.1371/journal.pone.0103734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084278	Green Published, gold			2022-12-25	WOS:000339819800075
J	Xu, H; Sun, YJ; Wang, XJ; Fu, Y; Dong, YF; Li, Y				Xu, Hao; Sun, Yujun; Wang, Xinjie; Fu, Yao; Dong, Yunfei; Li, Ying			Nonlinear Mixed-Effects (NLME) Diameter Growth Models for Individual China-Fir (Cunninghamia lanceolata) Trees in Southeast China	PLOS ONE			English	Article							DOMINANT HEIGHT GROWTH; INCREMENT MODEL; SLASH PINE; STONE PINE; STANDS	An individual-tree diameter growth model was developed for Cunninghamia lanceolata in Fujian province, southeast China. Data were obtained from 72 plantation-grown China-fir trees in 24 single-species plots. Ordinary non-linear least squares regression was used to choose the best base model from among 5 theoretical growth equations; selection criteria were the smallest absolute mean residual and root mean square error and the largest adjusted coefficient of determination. To account for autocorrelation in the repeated-measures data, we developed one-level and nested two-level nonlinear mixed-effects (NLME) models, constructed on the selected base model; the NLME models incorporated random effects of the tree and plot. The best random-effects combinations for the NLME models were identified by Akaike's information criterion, Bayesian information criterion and -2 logarithm likelihood. Heteroscedasticity was reduced with two residual variance functions, a power function and an exponential function. The autocorrelation was addressed with three residual autocorrelation structures: a first-order autoregressive structure [AR(1)], a combination of first-order autoregressive and moving average structures [ARMA(1,1)] and a compound symmetry structure (CS). The one-level (tree) NLME model performed best. Independent validation data were used to test the performance of the models and to demonstrate the advantage of calibrating the NLME models.	[Xu, Hao; Sun, Yujun; Wang, Xinjie; Fu, Yao; Dong, Yunfei] Beijing Forestry Univ, Coll Forestry, Key Lab Silviculture & Conservat, Minist Educ, Beijing, Peoples R China; [Li, Ying] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, YJ (corresponding author), Beijing Forestry Univ, Coll Forestry, Key Lab Silviculture & Conservat, Minist Educ, Beijing, Peoples R China.	sunyj@bjfu.edu.cn			Special Public Interest Research and Industry Fund of Forestry [200904003-1]; project of forestry science and technology research [2012-07]	Special Public Interest Research and Industry Fund of Forestry; project of forestry science and technology research	Total expense of field investigation was borne by the Special Public Interest Research and Industry Fund of Forestry (No. 200904003-1) and the project of forestry science and technology research (No. 2012-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame P, 2008, FOREST ECOL MANAG, V255, P1011, DOI 10.1016/j.foreco.2007.10.019; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barrio-Anta M, 2006, CAN J FOREST RES, V36, P1461, DOI 10.1139/X06-028; BIGING GS, 1985, FOREST SCI, V31, P248; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Castedo-Dorado F, 2007, ANN FOREST SCI, V64, P609, DOI 10.1051/forest:2007039; CHENG C, 2012, FORESTRY, V2, P271; Crecente-Campo F, 2010, FOREST ECOL MANAG, V260, P1965, DOI 10.1016/j.foreco.2010.08.044; Davidian M., 1995, NONLINEAR MODELS REP; Fang ZX, 2001, FOREST SCI, V47, P287; Fontes L, 2003, FORESTRY, V76, P509, DOI 10.1093/forestry/76.5.509; Fox JC, 2001, FOREST ECOL MANAG, V154, P261, DOI 10.1016/S0378-1127(00)00632-0; Fu LY, 2013, FOREST ECOL MANAG, V302, P210, DOI 10.1016/j.foreco.2013.03.036; GREGOIRE TG, 1995, CAN J FOREST RES, V25, P137, DOI 10.1139/x95-017; GREGOIRE TG, 1987, FOREST SCI, V33, P423; IHAKA R, 2004, R LANG ENV STAT COMP; Jordan L, 2005, FOREST SCI, V51, P357; Keselman HJ, 1999, BRIT J MATH STAT PSY, V52, P63, DOI 10.1348/000711099158964; Kitikidou K, 2012, RENEW SUST ENERG REV, V16, P1323, DOI 10.1016/j.rser.2011.10.010; LAPPI J, 1994, FOREST SCI, V40, P715; Lappi J, 1986, COMMUNICATIONS I FOR; Laubhann D, 2009, FOREST ECOL MANAG, V258, P1751, DOI 10.1016/j.foreco.2008.09.050; LEAK W, 1966, FOREST SCI, V12, P69; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; Lhotka JM, 2011, FOREST ECOL MANAG, V261, P770, DOI 10.1016/j.foreco.2010.12.008; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Meng SX, 2009, FOREST SCI, V55, P238; Nigh G, 2012, FOREST CHRON, V88, P340, DOI 10.5558/tfc2012-061; OMULE SAY, 1991, CAN J FOREST RES, V21, P1418, DOI 10.1139/x91-199; PALMER MJ, 1991, BIOMETRICS, V47, P623, DOI 10.2307/2532151; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 1995, MODEL BUILDING NONLI; Porte A, 2002, ECOL MODEL, V150, P141, DOI 10.1016/S0304-3800(01)00476-8; Rathbun LC, 2011, ECOL MODEL, V222, P2234, DOI 10.1016/j.ecolmodel.2011.04.004; Schabenberger Oliver, 1995, Silva Fennica, V29, P49; Timilsina N, 2013, FOREST SCI, V59, P27, DOI 10.5849/forsci.10-028; Uzoh FCC, 2008, FOREST ECOL MANAG, V256, P438, DOI 10.1016/j.foreco.2008.04.046; Vanclay J. K., 1994, Modelling forest growth and yield: applications to mixed tropical forests.; Vonesh E.F., 1997, LINEAR AND NONLINEAR; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; WEST PW, 1984, FOREST ECOL MANAG, V7, P207, DOI 10.1016/0378-1127(84)90068-9; WOLFINGER RD, 1999, FITTING NONLINEAR MI; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Yang YQ, 2009, EUR J FOREST RES, V128, P415, DOI 10.1007/s10342-009-0286-2; Zhang J.G., 2011, SELF THINNING GROWTH; Zhao L, 2012, J FOREST RES, V4, P305	47	27	31	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104012	10.1371/journal.pone.0104012	http://dx.doi.org/10.1371/journal.pone.0104012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084538	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800118
J	Ahmed, AU; Sarvestani, ST; Gantier, MP; Williams, BRG; Hannigan, GE				Ahmed, Afsar U.; Sarvestani, Soroush T.; Gantier, Michael P.; Williams, Bryan R. G.; Hannigan, Gregory E.			Integrin-linked Kinase Modulates Lipopolysaccharide- and Helicobacter pylori-induced Nuclear Factor kappa B-activated Tumor Necrosis Factor-alpha Production via Regulation of p65 Serine 536 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Helicobacter pylori; Inflammation; Innate Immunity; Lipopolysaccharide (LPS); NF-kappa B; Phosphatidylinositide 3-Kinase (PI 3-Kinase); Small Molecule; Tumor Necrosis Factor (TNF); Integrin-linked Kinase (ILK); p65	INFLAMMATORY RESPONSES; PROTEIN-KINASE; PROINFLAMMATORY CYTOKINES; GENE-EXPRESSION; INNATE IMMUNITY; CELL-SURVIVAL; UP-REGULATION; CANCER-CELLS; IKK-BETA; PATHWAY	Background: Aberrantly elevated integrin-linked kinase (ILK) activity is associated with inflammatory diseases and tumors. Results: In response to bacterial stimulus and infection, ILK modulates pro-inflammatory cytokine TNF- production and activates nuclear factor B signaling via p65 Ser-536 phosphorylation. Conclusion: ILK promotes pro-inflammatory signaling during immune responses to diverse stimuli. Significance: ILK is a potential therapeutic target for inflammatory diseases. Integrin-linked kinase (ILK) is a ubiquitously expressed and highly conserved serine-threonine protein kinase that regulates cellular responses to a wide variety of extracellular stimuli. ILK is involved in cell-matrix interactions, cytoskeletal organization, and cell signaling. ILK signaling has also been implicated in oncogenesis and progression of cancers. However, its role in the innate immune system remains unknown. Here, we show that ILK mediates pro-inflammatory signaling in response to lipopolysaccharide (LPS). Pharmacological or genetic inhibition of ILK in mouse embryonic fibroblasts and macrophages selectively blocks LPS-induced production of the pro-inflammatory cytokine tumor necrosis factor (TNF-). ILK is required for LPS-induced activation of nuclear factor B (NF-B) and transcriptional induction of TNF-. The modulation of LPS-induced TNF- synthesis by ILK does not involve the classical NF-B pathway, because IB- degradation and p65 nuclear translocation are both unaffected by ILK inhibition. Instead, ILK is involved in an alternative activation of NF-B signaling by modulating the phosphorylation of p65 at Ser-536. Furthermore, ILK-mediated alternative NF-B activation through p65 Ser-536 phosphorylation also occurs during Helicobacter pylori infection in macrophages and gastric cancer cells. Moreover, ILK is required for H. pylori-induced TNF- secretion in macrophages. Although ILK-mediated phosphorylation of p65 at Ser-536 is independent of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway during LPS stimulation, upon H. pylori infection this event is dependent on the PI3K/Akt pathway. Our findings implicate ILK as a critical regulatory molecule for the NF-B-mediated pro-inflammatory signaling pathway, which is essential for innate immune responses against pathogenic microorganisms.	[Hannigan, Gregory E.] MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic 3168, Australia; Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia	Prince Henry's Institute of Medical Research; Monash University	Williams, BRG (corresponding author), MIMR PHI Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia.	bryan.williams@mimr-phi.org; greg.hannigan@mimr-phi.org	Gantier, Michael/B-7512-2011; Williams, Bryan R. G./A-5021-2009; Gantier, Michael/H-7954-2019; Sarvestani, Soroush Tajadine/H-6495-2019; Ahmed, Afsar/I-7084-2013	Gantier, Michael/0000-0003-3740-698X; Williams, Bryan R. G./0000-0002-4969-1151; Gantier, Michael/0000-0003-3740-698X; Ahmed, Afsar Uddin/0000-0001-8788-6518; Ahmed, Afsar/0000-0001-9209-7089	Government of Victoria; Ron Evans Cancer Research Fellowship	Government of Victoria; Ron Evans Cancer Research Fellowship	This work was supported in part by the Operational Infrastructure Support Program of the Government of Victoria.; Supported by a Ron Evans Cancer Research Fellowship.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Agouni A, 2007, CARCINOGENESIS, V28, P1893, DOI 10.1093/carcin/bgm106; Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Chen DH, 2013, ACTA HISTOCHEM, V115, P128, DOI 10.1016/j.acthis.2012.05.004; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Dai Y, 2011, J BIOL CHEM, V286, P34036, DOI 10.1074/jbc.M111.284216; del Nogal M, 2012, APOPTOSIS, V17, P1261, DOI 10.1007/s10495-012-0769-3; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 2011, ONCOGENE, V30, P4375, DOI 10.1038/onc.2011.177; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Huang JA, 2006, BIOCHEM J, V396, P193, DOI 10.1042/BJ20051772; Huang X, 2013, WORLD J GASTROENTERO, V19, P5085, DOI 10.3748/wjg.v19.i31.5085; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kalra J, 2010, ONCOGENE, V29, P6343, DOI 10.1038/onc.2010.366; Kalra J, 2011, CANCER BIOL THER, V11, P826, DOI 10.4161/cbt.11.9.15183; Kalra J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2252; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li L, 2007, ADV EXP MED BIOL, V598, P49; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Makino K, 2004, ONCOGENE, V23, P3883, DOI 10.1038/sj.onc.1207485; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Marshall HE, 2002, J BIOL CHEM, V277, P34223, DOI 10.1074/jbc.M201638200; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Medvedev AE, 1998, J IMMUNOL, V160, P4535; Muranyi AL, 2010, LEUKEMIA RES, V34, P1358, DOI 10.1016/j.leukres.2010.01.006; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Piotrowski J, 1997, SCAND J GASTROENTERO, V32, P203, DOI 10.3109/00365529709000195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sandborn WJ, 1999, INFLAMM BOWEL DIS, V5, P119, DOI 10.1097/00054725-199905000-00008; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Slomiany BL, 1999, BIOCHEM BIOPH RES CO, V258, P17, DOI 10.1006/bbrc.1999.0578; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Suganuma M, 2006, J BIOCHEM MOL BIOL, V39, P1; Suganuma M, 2012, CANCER LETT, V322, P133, DOI 10.1016/j.canlet.2012.03.027; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tan C, 2002, J BIOL CHEM, V277, P3109, DOI 10.1074/jbc.M108673200; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wani AA, 2011, ONCOGENE, V30, P2778, DOI 10.1038/onc.2010.644; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yee NK, 2013, EUR J IMMUNOL, V43, P779, DOI 10.1002/eji.201242550	74	39	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27776	27793		10.1074/jbc.M114.574541	http://dx.doi.org/10.1074/jbc.M114.574541			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100717	Green Published, hybrid			2022-12-25	WOS:000342852800035
J	Yoshida, T; Yamashita, M; Horimai, C; Hayashi, M				Yoshida, Tadashi; Yamashita, Maho; Horimai, Chihiro; Hayashi, Matsuhiko			Kruppel-like Factor 4 Protein Regulates Isoproterenol-induced Cardiac Hypertrophy by Modulating Myocardin Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; IN-VIVO; GENE-EXPRESSION; DIFFERENTIATION MARKERS; OXIDIZED PHOSPHOLIPIDS; CONDITIONAL DELETION; KRUPPEL-LIKE-FACTOR-4; ACTIVATION; RECEPTOR; MICE	Kruppel-like factor 4 (KLF4) plays an important role in vascular diseases, including atherosclerosis and vascular injury. Although KLF4 is expressed in the heart in addition to vascular cells, the role of KLF4 in cardiac disease has not been fully determined. The goals of this study were to investigate the role of KLF4 in cardiac hypertrophy and to determine the underlying mechanisms. Cardiomyocyte-specific Klf4 knockout (CM Klf4 KO) mice were generated by the Cre/LoxP technique. Cardiac hypertrophy was induced by chronic infusion of the beta-adrenoreceptor agonist isoproterenol (ISO). Results showed that ISO-induced cardiac hypertrophy was enhanced in CM Klf4 KO mice compared with control mice. Accelerated cardiac hypertrophy in CM Klf4 KO mice was accompanied by the augmented cellular enlargement of cardiomyocytes as well as the exaggerated expression of fetal cardiac genes, including atrial natriuretic factor (Nppa). Additionally, induction of myocardin, a transcriptional cofactor regulating fetal cardiac genes, was enhanced in CM Klf4 KO mice. Interestingly, KLF4 regulated Nppa expression by modulating the expression and activity of myocardin, providing a mechanical basis for accelerated cardiac hypertrophy in CM Klf4 KO mice. Moreover, we showed that KLF4 mediated the antihypertrophic effect of trichostatin A, a histone deacetylase inhibitor, because ISO-induced cardiac hypertrophy in CM Klf4 KO mice was attenuated by olmesartan, an angiotensin II type 1 antagonist, but not by trichostatin A. These results provide novel evidence that KLF4 is a regulator of cardiac hypertrophy by modulating the expression and the activity of myocardin.	[Yoshida, Tadashi; Yamashita, Maho; Horimai, Chihiro; Hayashi, Matsuhiko] Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Tokyo 1608582, Japan	Keio University	Yoshida, T (corresponding author), Keio Univ, Sch Med, Apheresis & Dialysis Ctr, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tayoshida-npr@umin.ac.jp	Hayashi, Matsuhiko/J-4748-2013		Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. Y. and M. H.) and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. Y.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Ido A, 2003, J CARDIOVASC PHARM, V41, pS133; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kee HJ, 2008, CIRC RES, V103, P1259, DOI 10.1161/01.RES.0000338570.27156.84; Kee HJ, 2009, J MOL CELL CARDIOL, V47, P770, DOI 10.1016/j.yjmcc.2009.08.022; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lorell BH, 2000, CIRCULATION, V102, P470; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Noti JD, 2005, J BIOL CHEM, V280, P3449, DOI 10.1074/jbc.M412627200; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Yoshida T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000622; Yoshida T, 2014, J ATHEROSCLER THROMB, V21, P402; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360; Yoshida T, 2010, J BIOL CHEM, V285, P21175, DOI 10.1074/jbc.M110.112482; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhang GX, 2007, J MOL CELL CARDIOL, V42, P804, DOI 10.1016/j.yjmcc.2007.01.012; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	39	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26107	26118		10.1074/jbc.M114.582809	http://dx.doi.org/10.1074/jbc.M114.582809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100730	Green Published, hybrid			2022-12-25	WOS:000342128800008
J	Cao, HN; Walton, JD; Brumm, P; Phillips, GN				Cao, Hongnan; Walton, Jonathan D.; Brumm, Phil; Phillips, George N., Jr.			Structure and Substrate Specificity of a Eukaryotic Fucosidase from Fusarium graminearum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-FUCOSIDASE; HYDROLASE FAMILY 29; XYLOGLUCAN OLIGOSACCHARIDES; FUCOSYLATED XYLOGLUCAN; GLYCOSYLATION PATHWAYS; THERMOTOGA-MARITIMA; ESSENTIAL RESIDUES; CRYSTAL-STRUCTURE; L-FUCOSE; IDENTIFICATION	The secreted glycoside hydrolase family 29 (GH29) alpha-L-fucosidase from plant pathogenic fungus Fusarium graminearum (FgFCO1) actively releases fucose from the xyloglucan fragment. We solved crystal structures of two active-site conformations, i.e. open and closed, of apoFgFCO1 and an open complex with product fucose at atomic resolution. The closed conformation supports catalysis by orienting the conserved general acid/base Glu-288 nearest the predicted glycosidic position, whereas the open conformation possibly represents an unreactive state with Glu-288 positioned away from the catalytic center. A flexible loop near the substrate binding site containing a non-conserved GGSFT sequence is ordered in the closed but not the open form. We also identified a novel C-terminal beta gamma-crystallin domain in FgFCO1 devoid of calcium binding motif whose homologous sequences are present in various glycoside hydrolase families. N-Glycosylated FgFCO1 adopts a monomeric state as verified by solution small angle x-ray scattering in contrast to reported multimeric fucosidases. Steady-state kinetics shows that FgFCO1 prefers alpha 1,2 over alpha 1,3/4 linkages and displays minimal activity with p-nitrophenyl fucoside with an acidic pH optimum of 4.6. Despite a retaining GH29 family fold, the overall specificity of FgFCO1 most closely resembles inverting GH95 alpha-fucosidase, which displays the highest specificity with two natural substrates harboring the Fuc alpha 1-2Gal glycosidic linkage, a xyloglucan-derived nonasaccharide, and 2'-fucosyllactose. Furthermore, FgFCO1 hydrolyzes H-disaccharide (lacking a + 2 subsite sugar) at a rate 10(3)-fold slower than 2'-fucosyllactose. We demonstrated the structurally dynamic active site of FgFCO1 with flexible general acid/base Glu, a common feature shared by several bacterial GH29 fucosidases to various extents.	[Cao, Hongnan; Phillips, George N., Jr.] Rice Univ, Houston, TX 77005 USA; [Cao, Hongnan; Phillips, George N., Jr.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Walton, Jonathan D.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Brumm, Phil] C5 6 Technol Corp, Middleton, WI 53562 USA	Rice University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Michigan State University; United States Department of Energy (DOE)	Phillips, GN (corresponding author), Rice Univ, Dept Biochem & Cell Biol, MS140, Houston, TX 77005 USA.	georgep@rice.edu		Cao, Hongnan/0000-0003-2496-1298	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-+06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; National Institutes of Health [P41RR02301, RR02781, RR08438]; Biomedical Research Training Program/Center for Research Resources [P41GM66326(NIGMS)]; University of Wisconsin; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; National Institutes of Health Protein Structure Initiative Grant [U54 GM079401]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR008438, S10RR002781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326, U01GM098248] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Training Program/Center for Research Resources; University of Wisconsin; National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health Protein Structure Initiative Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the LS-CAT beamline for help and advice on data collection. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-+06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor under Grant 085P1000817. We also thank Dr. Sam Butcher and Dr. Jordan Burke of the Biochemistry Department, University of Wisconsin-Madison, for generously collecting SAXS data and advising on data analysis. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health Grants P41RR02301 (Biomedical Research Training Program/Center for Research Resources) and P41GM66326(NIGMS). Additional equipment was purchased with funds from the University of Wisconsin, the National Institutes of Health Grants Grant RR02781 and RR08438, National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394, and the United States Department of Agriculture. We thank Dr. Johnnie Walker and Dr. Brian Fox from the University of Wisconsin-Madison for advice on affinity gel electrophoresis assays. We thank Dr. Philip Gao from University of Kansas for graciously synthesizing crystallin domain of FgFCO1. Dr. Cao is especially thankful to Dr. Craig Bingman, Kate Helmich, and Bob Smith from the University of Wisconsin-Madison for valuable advice on crystallography and thermofluor assays and Dr. Ragothaman Yennamalli and Fengbin Wang from Rice University for helpful comments. We thank the Mass Spectrometry/Proteomics Facility of the Biotechnology Center at UW-Madison for the MALDI TOF analysis and the Iowa State University Protein Facility for the N-terminal sequencing. We acknowledge use of facilities acquired in part by the National Institutes of Health Protein Structure Initiative Grant U54 GM079401.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALHADEFF JA, 1977, MOL CELL BIOCHEM, V18, P33, DOI 10.1007/BF00215277; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Berteau O, 2002, GLYCOBIOLOGY, V12, P273, DOI 10.1093/glycob/12.4.273; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cobucci-Ponzano B, 2005, BIOCHEMISTRY-US, V44, P6331, DOI 10.1021/bi047495f; DAWSON G, 1977, ARCH BIOCHEM BIOPHYS, V184, P12, DOI 10.1016/0003-9861(77)90321-6; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; DICIOCCIO RA, 1982, J BIOL CHEM, V257, P714; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guillotin L, 2014, BIOCHEMISTRY-US, V53, P1447, DOI 10.1021/bi400951q; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Intra J, 2007, GENE, V392, P34, DOI 10.1016/j.gene.2006.11.002; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Joly C, 2002, J EXP BOT, V53, P1429, DOI 10.1093/jexbot/53.373.1429; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusaykin Mikhail, 2008, Biotechnology Journal, V3, P904, DOI 10.1002/biot.200700054; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard R, 2008, PHYTOCHEMISTRY, V69, P1983, DOI 10.1016/j.phytochem.2008.03.024; LEVY S, 1991, PLANT J, V1, P195; Liu SW, 2009, BIOCHEMISTRY-US, V48, P110, DOI 10.1021/bi801529t; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDOUGALL GJ, 1989, PLANT PHYSIOL, V89, P883, DOI 10.1104/pp.89.3.883; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nishitani K, 1997, INT REV CYTOL, V173, P157; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Paper JM, 2013, APPL MICROBIOL BIOT, V97, P5371, DOI 10.1007/s00253-012-4423-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Purkiss AG, 2002, J BIOL CHEM, V277, P4199, DOI 10.1074/jbc.M110083200; Roberts SM, 2012, METHOD ENZYMOL, V510, P141, DOI 10.1016/B978-0-12-415931-0.00008-2; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Shaikh FA, 2013, BIOCHEMISTRY-US, V52, P5857, DOI 10.1021/bi400183q; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TANAKA K, 1970, FEBS LETT, V9, P45, DOI 10.1016/0014-5793(70)80307-6; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; van Bueren AL, 2010, CHEMBIOCHEM, V11, P1971, DOI 10.1002/cbic.201000339; van Bueren AL, 2010, J AM CHEM SOC, V132, P1804, DOI 10.1021/ja908908q; Vanhooren PT, 1999, J CHEM TECHNOL BIOT, V74, P479, DOI 10.1002/(SICI)1097-4660(199906)74:6<479::AID-JCTB76>3.0.CO;2-E; Vanzin GF, 2002, P NATL ACAD SCI USA, V99, P3340, DOI 10.1073/pnas.052450699; Vincken JP, 1996, CARBOHYD RES, V288, P219, DOI 10.1016/0008-6215(96)00096-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; Willems PJ, 1999, EUR J HUM GENET, V7, P60, DOI 10.1038/sj.ejhg.5200272; YORK WS, 1984, PLANT PHYSIOL, V75, P295, DOI 10.1104/pp.75.2.295; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Zeleny R, 2006, PHYTOCHEMISTRY, V67, P641, DOI 10.1016/j.phytochem.2006.01.021	78	27	27	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25624	25638		10.1074/jbc.M114.583286	http://dx.doi.org/10.1074/jbc.M114.583286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086049	hybrid, Green Published			2022-12-25	WOS:000342130800023
J	Pereiro, P; Dios, S; Boltana, S; Coll, J; Estepa, A; Mackenzie, S; Novoa, B; Figueras, A				Pereiro, Patricia; Dios, Sonia; Boltana, Sebastian; Coll, Julio; Estepa, Amparo; Mackenzie, Simon; Novoa, Beatriz; Figueras, Antonio			Transcriptome Profiles Associated to VHSV Infection or DNA Vaccination in Turbot (Scophthalmus maximus)	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; TROUT ONCORHYNCHUS-MYKISS; MACROPHAGE MANNOSE RECEPTOR; TOLL-LIKE RECEPTORS; RAINBOW-TROUT; PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; IMMUNE-RESPONSES; DOWN-REGULATION; VIRUS	DNA vaccines encoding the viral G glycoprotein show the most successful protection capability against fish rhabdoviruses. Nowadays, the molecular mechanisms underlying the protective response remain still poorly understood. With the aim of shedding light on the protection conferred by the DNA vaccines based in the G glycoprotein of viral haemorrhagic septicaemia virus (VHSV) in turbot (Scophthalmus maximus) we have used a specific microarray highly enriched in antiviral sequences to carry out the transcriptomic study associated to VHSV DNA vaccination/infection. The differential gene expression pattern in response to empty plasmid (pMCV1.4) and DNA vaccine (pMCV1.4-G(860)) intramuscular administration with regard to non-stimulated turbot was analyzed in head kidney at 8, 24 and 72 hours post-vaccination. Moreover, the effect of VHSV infection one month after immunization was also analyzed in vaccinated and non-vaccinated fish at the same time points. Genes implicated in the Toll-like receptor signalling pathway, IFN inducible/regulatory proteins, numerous sequences implicated in apoptosis and cytotoxic pathways, MHC class I antigens, as well as complement and coagulation cascades among others were analyzed in the different experimental groups. Fish receiving the pMCV1.4-G(860) vaccine showed transcriptomic patterns very different to the ones observed in pMCV1.4-injected turbot after 72 h. On the other hand, VHSV challenge in vaccinated and non-vaccinated turbot induced a highly different response at the transcriptome level, indicating a very relevant role of the acquired immunity in vaccinated fish able to alter the typical innate immune response profile observed in non-vaccinated individuals. This exhaustive transcriptome study will serve as a complete overview for a better understanding of the crosstalk between the innate and adaptive immune response in fish after viral infection/vaccination. Moreover, it provides interesting dues about molecules with a potential use as vaccine adjuvants, antiviral treatments or markers for vaccine efficiency monitoring.	[Pereiro, Patricia; Dios, Sonia; Novoa, Beatriz; Figueras, Antonio] CSIC, Inst Invest Marinas, Vigo, Spain; [Boltana, Sebastian; Mackenzie, Simon] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Coll, Julio] Inst Nacl Invest Agr, Dpto Biotecnol, Madrid, Spain; [Estepa, Amparo] Miguel Hernandez Univ, Inst Biol & Mol Celular, Elche, Spain; [Boltana, Sebastian; Mackenzie, Simon] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Stirling; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Miguel Hernandez de Elche; Autonomous University of Barcelona	Novoa, B (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	virus@iim.csic.es	Figueras, Antonio/B-5133-2015; Boltana, Sebastian/AAC-8944-2019; Dios, Sonia/M-4201-2018; Pereiro, Patricia/AAS-9514-2020; Figueras, Antonio/AAB-8921-2019; MacKenzie, Simon/Q-2362-2019; Coll, julio/M-6071-2019; Novoa, Beatriz/K-3785-2014	Figueras, Antonio/0000-0002-0617-0030; Boltana, Sebastian/0000-0002-5195-0490; Dios, Sonia/0000-0002-2126-991X; Pereiro, Patricia/0000-0002-8734-3334; Figueras, Antonio/0000-0002-0617-0030; MacKenzie, Simon/0000-0003-1845-6826; Coll, julio/0000-0001-8496-3493; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovacion [AGL2011-28921-C03, CSD2007-00002]; Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC) [201230E057]; Ministerio de Educacion [AP2010-2408]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Educacion	This work has been funded by the project CSD2007-00002 "Aquagenomics" and AGL2011-28921-C03 from the Spanish Ministerio de Ciencia e Innovacion. The authors' laboratory is also funded by the project 201230E057 from the Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC). P. Pereiro gratefully acknowledges the Ministerio de Educacion for a FPU fellowship (AP2010-2408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmann M, 2008, VACCINE, V26, P837, DOI 10.1016/j.vaccine.2007.11.065; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; BERNARD J, 1983, INFECT IMMUN, V39, P7, DOI 10.1128/IAI.39.1.7-14.1983; Boraschi D, 2006, EUR CYTOKINE NETW, V17, P224; Brode S, 2004, IMMUNOLOGY, V112, P345, DOI 10.1111/j.1365-2567.2004.01920.x; Byon JY, 2006, VACCINE, V24, P921, DOI 10.1016/j.vaccine.2005.08.087; Byon JY, 2005, FISH SHELLFISH IMMUN, V18, P135, DOI 10.1016/j.fsi.2004.06.008; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; CASTRIC J, 1980, J FISH DIS, V3, P21, DOI 10.1111/j.1365-2761.1980.tb00180.x; Chang LL, 2007, ANTIVIR RES, V75, P43, DOI 10.1016/j.antiviral.2006.11.009; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dakhama A, 1998, CHEST, V114, P1681, DOI 10.1378/chest.114.6.1681; DEKINKELIN P, 1995, VET RES, V26, P379; DEKINKELIN P, 1980, J VIROL, V36, P652, DOI 10.1128/JVI.36.3.652-658.1980; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Glaros T, 2009, FRONT BIOSCI-LANDMRK, V14, P3988, DOI [10.2735/3506, 10.2741/3506]; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; HARRIS N, 1992, BLOOD, V80, P2363; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horlyck V., 1984, Bulletin of the European Association of Fish Pathologists, V4, P11; Iking-Konert C, 2002, CLIN EXP IMMUNOL, V130, P501, DOI 10.1046/j.1365-2249.2002.02008.x; Jorgensen JB, 2003, J VIROL, V77, P11471, DOI 10.1128/JVI.77.21.11471-11479.2003; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim CH, 2000, J VIROL, V74, P7048, DOI 10.1128/JVI.74.15.7048-7054.2000; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Krieg AM, 1998, TRENDS MICROBIOL, V6, P23, DOI 10.1016/S0966-842X(97)01145-1; LaPatra SE, 2001, VACCINE, V19, P4011, DOI 10.1016/S0264-410X(01)00113-X; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LECOCQXHONNEUX F, 1994, J GEN VIROL, V75, P1579, DOI 10.1099/0022-1317-75-7-1579; Leong J. C., 1993, Annual Review of Fish Diseases, V3, P225, DOI 10.1016/0959-8030(93)90036-B; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Lorenzen E, 2005, FISH SHELLFISH IMMUN, V19, P27, DOI 10.1016/j.fsi.2004.10.009; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; LORENZEN N, 1990, J GEN VIROL, V71, P561, DOI 10.1099/0022-1317-71-3-561; Luo RF, 2010, HUM PATHOL, V41, P271, DOI 10.1016/j.humpath.2009.07.022; Manders P, 2000, INFLAMM RES, V49, P199, DOI 10.1007/s000110050580; Martinez-Alonso S, 2011, VACCINE, V29, P1289, DOI 10.1016/j.vaccine.2010.11.073; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MORAHAN PS, 1985, BRIT MED BULL, V41, P15, DOI 10.1093/oxfordjournals.bmb.a072017; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Pereiro P, 2014, DEV COMP IMMUNOL, V45, P233, DOI 10.1016/j.dci.2014.03.006; Pereiro P, 2012, FISH SHELLFISH IMMUN, V32, P1088, DOI 10.1016/j.fsi.2012.03.004; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Roder G, 2008, J VIROL, V82, P8246, DOI 10.1128/JVI.00207-08; Ross K., 1994, Bulletin of the European Association of Fish Pathologists, V14, P213; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlotfeldt H.-J., 1991, Bulletin of the European Association of Fish Pathologists, V11, P105; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Sommerset I, 2003, VACCINE, V21, P4661, DOI 10.1016/S0264-410X(03)00526-7; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Tafalla C, 1998, VET IMMUNOL IMMUNOP, V62, P359, DOI 10.1016/S0165-2427(97)00167-0; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wolf K., 1988, FISH VIRUSES FISH VI, P217, DOI [10.7591/9781501746383, DOI 10.7591/9781501746383]; WU LX, 1990, MICROB PATHOGENESIS, V9, P293, DOI 10.1016/0882-4010(90)90064-W; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P103, DOI 10.1016/j.cimid.2010.03.001; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	72	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104509	10.1371/journal.pone.0104509	http://dx.doi.org/10.1371/journal.pone.0104509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098168	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100080
J	Sivera, M; Kvitek, L; Soukupova, J; Panacek, A; Prucek, R; Vecerova, R; Zboril, R				Sivera, Martin; Kvitek, Libor; Soukupova, Jana; Panacek, Ales; Prucek, Robert; Vecerova, Renata; Zboril, Radek			Silver Nanoparticles Modified by Gelatin with Extraordinary pH Stability and Long-Term Antibacterial Activity	PLOS ONE			English	Article							GREEN SYNTHESIS; REDUCING AGENT; CHITOSAN; BIONANOCOMPOSITES; POLYMERS; FACILE; SIZE	The potential for application of any nanoparticles, including silver nanoparticles (AgNPs), is strongly dependent on their stability against aggregation. Therefore, improvement of this parameter is a key task, especially in the case of AgNPs, because a correlation between size and biological activity has been demonstrated. In the present work, a natural stabilizer, gelatin, was investigated for the stabilization of AgNPs in an aqueous dispersion. The particles were prepared via a modified Tollens process, and the gelatin modifier was added prior to the reducing agent. The stability against aggregation of the AgNPs prepared by this method was more than one order of magnitude higher (on the basis of the critical coagulation concentration (CCC)) than that of AgNPs prepared via a similar method but without the assistance of gelatin. Their high stability against aggregation was confirmed over wide pH range (from 2 to 13) in which the particles did not exhibit rapid aggregation; such stability has not been previously reported for AgNPs. Additionally, gelatin not only fulfills the role of a unique stabilizer but also positively influences the modified Tollens process used to prepare the AgNPs. The diameter of the gelatin-modified AgNPs was substantially smaller in comparison to those prepared without gelatin. The polydispersity of the dispersion significantly narrowed. Moreover, the gelatin-stabilized AgNPs exhibited long-term stability against aggregation and maintained high antibacterial activity when stored for several months under ambient conditions.	[Sivera, Martin; Kvitek, Libor; Soukupova, Jana; Panacek, Ales; Prucek, Robert; Zboril, Radek] Palacky Univ, Fac Sci, Dept Phys Chem, CR-77147 Olomouc, Czech Republic; [Kvitek, Libor; Soukupova, Jana; Panacek, Ales; Prucek, Robert; Zboril, Radek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Vecerova, Renata] Palacky Univ, Fac Med, Dept Microbiol, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Kvitek, L (corresponding author), Palacky Univ, Fac Sci, Dept Phys Chem, CR-77147 Olomouc, Czech Republic.	libor.kvitek@upol.cz	Panacek, Ales/F-3867-2010; Zboril, Radek/F-5153-2015; Kvitek, Libor/L-1539-2018	Zboril, Radek/0000-0002-3147-2196; Kvitek, Libor/0000-0003-2005-560X; Vecerova, Renata/0000-0002-7546-530X	Operational Program Research and Development for Innovations - European Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/03.0058]; Operational Program Education for Competitiveness European Social Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ. 1.07/2.3.00/20.0056]; Technology Agency of the Czech Republic [TA03010799]; Internal Grant of Palacky University in Olomouc [PrF_2014_032]	Operational Program Research and Development for Innovations - European Regional Development Fund of the Ministry of Education, Youth and Sports of the Czech Republic; Operational Program Education for Competitiveness European Social Fund of the Ministry of Education, Youth and Sports of the Czech Republic; Technology Agency of the Czech Republic; Internal Grant of Palacky University in Olomouc	Operational Program Research and Development for Innovations - European Regional Development Fund, project CZ.1.05/2.1.00/03.0058 of the Ministry of Education, Youth and Sports of the Czech Republic; http://www.opvavpi.cz/ (LK AP RP RV RZ). Operational Program Education for Competitiveness European Social Fund, project CZ. 1.07/2.3.00/20.0056 of the Ministry of Education, Youth and Sports of the Czech Republic; http://www. op-vk.cz/ (LK JS AP RP). Technology Agency of the Czech Republic, project TA03010799; http://www.tacr.cz/ (MS LK RP RZ). Internal Grant of Palacky University in Olomouc, project PrF_2014_032; http://www.upol.cz/ (MS LK JS AP RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f; Bhaduri GA, 2013, J PHOTOCH PHOTOBIO A, V258, P1, DOI 10.1016/j.jphotochem.2013.02.015; Bin Ahmad M, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-101; Bin Ahmad M, 2011, MOLECULES, V16, P7237, DOI 10.3390/molecules16097237; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Csapo E, 2012, COLLOID SURFACE B, V98, P43, DOI 10.1016/j.colsurfb.2012.03.036; Darroudi M, 2012, MATER LETT, V66, P117, DOI 10.1016/j.matlet.2011.08.016; Farrugia CA, 1999, J PHARM PHARMACOL, V51, P643, DOI 10.1211/0022357991772925; Fortunati E, 2013, J FOOD ENG, V118, P117, DOI 10.1016/j.jfoodeng.2013.03.025; Gomes SIL, 2013, J HAZARD MATER, V254, P336, DOI 10.1016/j.jhazmat.2013.04.005; Inyang M, 2013, CHEM ENG J, V220, P221, DOI 10.1016/j.cej.2013.01.054; Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368; Jia ZQ, 2013, COLLOID SURFACE A, V419, P174, DOI 10.1016/j.colsurfa.2012.12.003; Kvitek L, 2005, J MATER CHEM, V15, P1099, DOI 10.1039/b417007e; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Lee C, 2013, J RAMAN SPECTROSC, V44, P823, DOI 10.1002/jrs.4304; Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361; Long Y, 2013, MATER LETT, V112, P101, DOI 10.1016/j.matlet.2013.09.035; Maity D, 2011, J APPL POLYM SCI, V122, P2189, DOI 10.1002/app.34266; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Moussa SH, 2013, J FOOD SCI, V78, pM1589, DOI 10.1111/1750-3841.12247; Oluwafemi OS, 2013, COLLOID SURFACE B, V102, P718, DOI 10.1016/j.colsurfb.2012.09.001; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pokhrel LR, 2013, ENVIRON SCI TECHNOL, V47, P12877, DOI 10.1021/es403462j; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Ravindra S, 2010, COLLOID SURFACE A, V367, P31, DOI 10.1016/j.colsurfa.2010.06.013; Roh J, 2013, KOREAN J CHEM ENG, V30, P671, DOI 10.1007/s11814-012-0172-3; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Teng HH, 2013, SEP SCI TECHNOL, V48, P1729, DOI 10.1080/01496395.2012.753905; Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002; Tokarek K, 2013, EUR J INORG CHEM, V2013, P4940, DOI 10.1002/ejic.201300594; Xiong YL, 2012, APPL SURF SCI, V258, P5822, DOI 10.1016/j.apsusc.2012.02.108; Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023; Zamiri R, 2012, B MATER SCI, V35, P727, DOI 10.1007/s12034-012-0360-0	35	48	49	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103675	10.1371/journal.pone.0103675	http://dx.doi.org/10.1371/journal.pone.0103675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098570	Green Submitted, gold, Green Published			2022-12-25	WOS:000339995100024
J	Pellier, AS; Wells, JA; Abram, NK; Gaveau, D; Meijaard, E				Pellier, Anne-Sophie; Wells, Jessie A.; Abram, Nicola K.; Gaveau, David; Meijaard, Erik			Through the Eyes of Children: Perceptions of Environmental Change in Tropical Forests	PLOS ONE			English	Article							BASE-LINE SYNDROME; CONSERVATION; BIODIVERSITY	This study seeks to understand children's perceptions of their present and future environments in the highly biodiverse and rapidly changing landscapes of Kalimantan, Indonesian Borneo. We analyzed drawings by children (target age 10-15 years) from 22 villages, which show how children perceive the present conditions of forests and wildlife surrounding their villages and how they expect conditions to change over the next 15 years. Analyses of picture elements and their relationships to current landscape variables indicate that children have a sophisticated understanding of their environment and how different environmental factors interact, either positively or negatively. Children appear to have landscape-dependent environmental perceptions, showing awareness of past environmental conditions and many aspects of recent trends, and translating these into predictions for future environmental conditions. The further removed their present landscape is from the originally forested one, the more environmental change they expect in the future, particularly declines in forest cover, rivers, animal diversity and increases in temperature and natural disasters. This suggests that loss of past perceptions and associated "shifting environmental baselines" do not feature strongly among children on Borneo, at least not for the perceptions we investigated here. Our findings that children have negative expectations of their future environmental conditions have important political implications. More than other generations, children have a stake in ensuring that future environmental conditions support their long-term well-being. Understanding what drives environmental views among children, and how they consider trade-offs between economic development and social and environmental change, should inform optimal policies on land use. Our study illuminates part of the complex interplay between perceptions of land cover and land use change. Capturing the views of children through artistic expressions provides a potentially powerful tool to influence public and political opinions, as well as a valuable approach for developing localized education and nature conservation programs.	[Pellier, Anne-Sophie; Gaveau, David; Meijaard, Erik] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Wells, Jessie A.; Meijaard, Erik] Univ Queensland, Ctr Biodivers & Conservat Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Abram, Nicola K.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Pellier, Anne-Sophie; Wells, Jessie A.; Abram, Nicola K.; Gaveau, David; Meijaard, Erik] People & Nat Consulting Int, Borneo Futures Initiat, Jakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); University of Queensland; University of Kent; People & Nature Consulting International	Pellier, AS (corresponding author), Ctr Int Forestry Res CIFOR, Bogor, Indonesia.	pellier.annesophie@gmail.com	Wells, Jessie A/F-7318-2010; Meijaard, Erik/A-2687-2016; Abram, Nicola/K-2060-2014	Wells, Jessie A/0000-0002-3555-5108; Meijaard, Erik/0000-0001-8685-3685; Abram, Nicola/0000-0003-1886-7297	United States Agency for International Development (USAID); Arcus Foundation; The CGIAR Research Program on Forests, Trees and Agroforestry	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Arcus Foundation; The CGIAR Research Program on Forests, Trees and Agroforestry	The study was financially supported by the United States Agency for International Development (USAID) (www.usaid.gov/) and the Arcus Foundation (http://www.arcusfoundation.org/). The CGIAR Research Program on Forests, Trees and Agroforestry, led by the Center for International Forestry Research (CIFOR), provided additional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerby E., 2000, ENVIRON EDUC RES, V6, P205, DOI [10.1080/13504620050076713, DOI 10.1080/13504620050076713]; ANDERSON S, 1993, INT J SCI EDUC, V15, P473, DOI 10.1080/0950069930150502; Barraza L, 1999, ENVIRON EDUC RES, V5, P49, DOI DOI 10.1080/1350462990050103; Bowker R., 2007, ENVIRON EDUC RES, V13, P75, DOI [10.1080/13504620601122731, DOI 10.1080/13504620601122731]; Bright EA, 2008, LANDSCAN 2007; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; COLFER CJP, 1999, CRITERIA INDICATORS, V6; Dove J, 2012, INT RES GEOGR ENVIRO, V21, P59, DOI 10.1080/10382046.2012.639150; FAO, 2010, 163 FAO; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; KAHN PH, 1995, CHILD DEV, V66, P1403; Kareiva P, 2008, P NATL ACAD SCI USA, V105, P2757, DOI 10.1073/pnas.0800474105; Lehner B, 2006, HYDROSHEDS TECHNICAL; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Malchiodi C. A., 1998, UNDERSTANDING CHILDR; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018008; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Snaddon JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002579; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Wells J.A., 2013, FORESTS FLOODS PEOPL; Whitten T, 2004, HOTSPOTS REVISITED A; Wich SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049142	30	26	27	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103005	10.1371/journal.pone.0103005	http://dx.doi.org/10.1371/journal.pone.0103005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093658	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200016
J	Yan, LM; Chen, SP; Xia, JY; Luo, YQ				Yan, Liming; Chen, Shiping; Xia, Jianyang; Luo, Yiqi			Precipitation Regime Shift Enhanced the Rain Pulse Effect on Soil Respiration in a Semi-Arid Steppe	PLOS ONE			English	Article							CO2 EFFLUX; DIFFERENTIAL RESPONSES; ECOSYSTEM RESPIRATION; TEMPORAL VARIATION; MICROBIAL BIOMASS; SONORAN DESERT; CLIMATE-CHANGE; ELEVATED CO2; CARBON; WATER	The effect of resource pulses, such as rainfall events, on soil respiration plays an important role in controlling grassland carbon balance, but how shifts in long-term precipitation regime regulate rain pulse effect on soil respiration is still unclear. We first quantified the influence of rainfall event on soil respiration based on a two-year (2006 and 2009) continuously measured soil respiration data set in a temperate steppe in northern China. In 2006 and 2009, soil carbon release induced by rainfall events contributed about 44.5% (83.3 g C m(-2)) and 39.6% (61.7 g C m(-2)) to the growing-season total soil respiration, respectively. The pulse effect of rainfall event on soil respiration can be accurately predicted by a water status index (WSI), which is the product of rainfall event size and the ratio between antecedent soil temperature to moisture at the depth of 10 cm (r(2)=0.92, P<0.001) through the growing season. It indicates the pulse effect can be enhanced by not only larger individual rainfall event, but also higher soil temperature/moisture ratio which is usually associated with longer dry spells. We then analyzed a long-term (1953-2009) precipitation record in the experimental area. We found both the extreme heavy rainfall events (>40 mm per event) and the long dry-spells (>5 days) during the growing seasons increased from 1953-2009. It suggests the shift in precipitation regime has increased the contribution of rain pulse effect to growing-season total soil respiration in this region. These findings highlight the importance of incorporating precipitation regime shift and its impacts on the rain pulse effect into the future predictions of grassland carbon cycle under climate change.	[Yan, Liming; Chen, Shiping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yan, Liming] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Xia, Jianyang; Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Fudan University; University of Oklahoma System; University of Oklahoma - Norman	Chen, SP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	spchen@ibcas.ac.cn	Chen, Shiping/AAH-9751-2019; Xia, Jianyang/S-9499-2019; Xia, Jianyang/A-7886-2008		"Strategic Priority Research Program" of the Chinese Academy of Sciences, Climate Change: Carbon Budget and Relevant Issues [XDA05050402]; National Natural Science Foundation of China [31170453]; National Basic Research Program of China (973 program) [2010CB833501]; Selected Young Scientist Program of the State Key Laboratory of Vegetation and Environment Change	"Strategic Priority Research Program" of the Chinese Academy of Sciences, Climate Change: Carbon Budget and Relevant Issues(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Selected Young Scientist Program of the State Key Laboratory of Vegetation and Environment Change	This study was supported partly by the "Strategic Priority Research Program" of the Chinese Academy of Sciences, Climate Change: Carbon Budget and Relevant Issues (XDA05050402), the National Natural Science Foundation of China (31170453), the National Basic Research Program of China (973 program, 2010CB833501), and a Selected Young Scientist Program of the State Key Laboratory of Vegetation and Environment Change to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boot CM, 2013, SOIL BIOL BIOCHEM, V57, P356, DOI 10.1016/j.soilbio.2012.09.005; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Bowling DR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2011JG001722, 10.1029/2011JG001643]; Cable JM, 2008, ECOSYSTEMS, V11, P961, DOI 10.1007/s10021-008-9172-x; Carbone MS, 2011, OECOLOGIA, V167, P265, DOI 10.1007/s00442-011-1975-3; Chen SP, 2009, GLOBAL CHANGE BIOL, V15, P2450, DOI 10.1111/j.1365-2486.2009.01879.x; Chen SP, 2008, J PLANT ECOL, V1, P237, DOI 10.1093/jpe/rtn020; Daly E, 2008, ADV WATER RESOUR, V31, P987, DOI 10.1016/j.advwatres.2008.04.001; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Fierer N, 2003, SOIL SCI SOC AM J, V67, P798, DOI 10.2136/sssaj2003.0798; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; GRIFFITHS E, 1961, NATURE, V189, P424, DOI 10.1038/189424a0; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Inglima I, 2009, GLOBAL CHANGE BIOL, V15, P1289, DOI 10.1111/j.1365-2486.2008.01793.x; JAGER G, 1975, SOIL BIOL BIOCHEM, V7, P153, DOI 10.1016/0038-0717(75)90013-9; KIEFT TL, 1987, SOIL BIOL BIOCHEM, V19, P119, DOI 10.1016/0038-0717(87)90070-8; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Kim DG, 2010, SOIL BIOL BIOCHEM, V42, P576, DOI 10.1016/j.soilbio.2009.12.005; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Lee MS, 2002, ECOL RES, V17, P401, DOI 10.1046/j.1440-1703.2002.00498.x; Lee R, 2002, INT J REMOTE SENS, V23, P2505, DOI 10.1080/01431160110106087; Lee X, 2004, GLOBAL CHANGE BIOL, V10, P1017, DOI 10.1111/j.1529-8817.2003.00787.x; Liu BH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004864; Liu R, 2013, PLANT SOIL, V373, P799, DOI 10.1007/s11104-013-1839-1; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; Ma SY, 2012, AGR FOREST METEOROL, V154, P203, DOI 10.1016/j.agrformet.2011.11.007; Meehl GA, 2005, GEOPHYS RES LETT, V32; Miller AE, 2005, SOIL BIOL BIOCHEM, V37, P2195, DOI 10.1016/j.soilbio.2005.03.021; New M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006289; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Paulo AA, 2006, WATER INT, V31, P37, DOI 10.1080/02508060608691913; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Schmidli J, 2005, INT J CLIMATOL, V25, P753, DOI 10.1002/joc.1179; Sharkhuu A, 2013, BIOGEOCHEMISTRY, V115, P333, DOI 10.1007/s10533-013-9839-z; Smart DR, 2005, APPL SOIL ECOL, V28, P247, DOI 10.1016/j.apsoil.2004.07.011; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sponseller RA, 2007, GLOBAL CHANGE BIOL, V13, P426, DOI 10.1111/j.1365-2486.2006.01307.x; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Vargas R, 2011, GLOBAL CHANGE BIOL, V16, P1589; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vargas R, 2012, GLOBAL CHANGE BIOL, V18, P1401, DOI 10.1111/j.1365-2486.2011.02628.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wu HJ, 2011, PLANT SOIL, V338, P329, DOI 10.1007/s11104-010-0548-2; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Yuste JC, 2005, BIOGEOCHEMISTRY, V73, P209, DOI 10.1007/s10533-004-7201-1	55	46	54	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104217	10.1371/journal.pone.0104217	http://dx.doi.org/10.1371/journal.pone.0104217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093573	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200087
J	Attili, S; Hughes, SM				Attili, Seetharamaiah; Hughes, Simon M.			Anaesthetic Tricaine Acts Preferentially on Neural Voltage-Gated Sodium Channels and Fails to Block Directly Evoked Muscle Contraction	PLOS ONE			English	Article							UNION-OF-PHARMACOLOGY; SKELETAL-MUSCLE; CALCIUM-CHANNEL; ELECTRICAL-STIMULATION; VENTRICULAR MYOCYTES; LOCAL-ANESTHETICS; ION CHANNELS; ZEBRAFISH; EXPRESSION; LIDOCAINE	Movements in animals arise through concerted action of neurons and skeletal muscle. General anaesthetics prevent movement and cause loss of consciousness by blocking neural function. Anaesthetics of the amino amide-class are thought to act by blockade of voltage-gated sodium channels. In fish, the commonly used anaesthetic tricaine methanesulphonate, also known as 3-aminobenzoic acid ethyl ester, metacaine or MS-222, causes loss of consciousness. However, its role in blocking action potentials in distinct excitable cells is unclear, raising the possibility that tricaine could act as a neuromuscular blocking agent directly causing paralysis. Here we use evoked electrical stimulation to show that tricaine efficiently blocks neural action potentials, but does not prevent directly evoked muscle contraction. Nifedipine-sensitive L-type Ca-v channels affecting movement are also primarily neural, suggesting that muscle Na-v channels are relatively insensitive to tricaine. These findings show that tricaine used at standard concentrations in zebrafish larvae does not paralyse muscle, thereby diminishing concern that a direct action on muscle could mask a lack of general anaesthesia.	[Attili, Seetharamaiah; Hughes, Simon M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London	Hughes, SM (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London WC2R 2LS, England.	simon.hughes@kcl.ac.uk	Hughes, Simon M/S-1073-2016	Hughes, Simon M/0000-0001-8227-9225	Biotechnology and Biological Sciences Research Council [BB/K0101151/1]; UK-India Partnering Award;  [G1001029]; MRC [G1001029] Funding Source: UKRI; Medical Research Council [G1001029] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK-India Partnering Award; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SMH is a Medical Research Council Scientist (www.mrc.ac.uk) with Programme Grant G1001029 support, which funded this study. Additional support to SMH that contributed to the work came from a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) project grant BB/K0101151/1 and UK-India Partnering Award grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; BARRY WH, 1985, BRIT J PHARMACOL, V85, P51, DOI 10.1111/j.1476-5381.1985.tb08830.x; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; CARMELIET E, 1986, J PHYSIOL-LONDON, V376, P143, DOI 10.1113/jphysiol.1986.sp016146; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2011, COLD SPRING HARBOR P, V3; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chen R, 2014, BIOCHEM BIOPH RES CO, V446, P370, DOI 10.1016/j.bbrc.2014.02.115; Chopra SS, 2010, CIRC RES, V106, P1342, DOI 10.1161/CIRCRESAHA.109.213132; Couchoux H, 2007, J PHYSIOL-LONDON, V580, P745, DOI 10.1113/jphysiol.2006.124198; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; Etard C, 2005, DEV DYNAM, V234, P1016, DOI 10.1002/dvdy.20592; Galvani L, 1791, VIRIBUS ELECTRICITAT; Hedrick MS, 2003, AM J PHYSIOL-REG I, V284, pR405, DOI 10.1152/ajpregu.00418.2002; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; JOSEPHSON IR, 1988, J MOL CELL CARDIOL, V20, P593, DOI 10.1016/S0022-2828(88)80117-2; Lacmova L, 2005, GEN PHYSIOL BIOPHYS, V24, P1; Maffiuletti NA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-137; Matthews G. G., 2003, CELLULAR PHYSL NERVE; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Nguemo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053407; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Nuss HB, 1995, J GEN PHYSIOL, V106, P1193, DOI 10.1085/jgp.106.6.1193; OYAMA Y, 1988, BRAIN RES, V442, P223, DOI 10.1016/0006-8993(88)91507-7; Pette D, 1999, MUSCLE NERVE, V22, P666, DOI 10.1002/(SICI)1097-4598(199906)22:6<666::AID-MUS3>3.0.CO;2-Z; Piriz J, 2003, J PHARMACOL EXP THER, V306, P658, DOI 10.1124/jpet.103.051524; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sanhueza D, 2009, ZYGOTE, V17, P131, DOI 10.1017/S0967199408005108; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Shang LJL, 2005, J BIOL CHEM, V280, P933, DOI 10.1074/jbc.M409977200; Skromne I, 2008, DEV DYNAM, V237, P861, DOI 10.1002/dvdy.21484; Spath M, 1997, N-S ARCH PHARMACOL, V297, P9; Strube C, 2000, BIOPHYS J, V78, P1282, DOI 10.1016/S0006-3495(00)76684-7; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; Toal CB, 2012, BLOOD PRESSURE, V21, P3, DOI 10.3109/08037051.2012.690615; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Wang GK, 2008, MOL PHARMACOL, V73, P940, DOI 10.1124/mol.107.041541; Westerfield M., 2000, ZEBRAFISH BOOK A GUI; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; WINLOW W, 1992, GEN PHARMACOL, V23, P985, DOI 10.1016/0306-3623(92)90276-P; Wong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088030; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1	50	38	38	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103751	10.1371/journal.pone.0103751	http://dx.doi.org/10.1371/journal.pone.0103751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090007	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700049
J	de Almeida Curi, NH; de Oliveira Paschoal, AM; Massara, RL; Marcelino, AP; Ribeiro, AA; Passamani, M; Demetrio, GR; Chiarello, AG				de Almeida Curi, Nelson Henrique; de Oliveira Paschoal, Ana Maria; Massara, Rodrigo Lima; Marcelino, Andreza Pain; Ribeiro, Adriana Aparecida; Passamani, Marcelo; Demetrio, Guilherme Ramos; Chiarello, Adriano Garcia			Factors Associated with the Seroprevalence of Leishmaniasis in Dogs Living around Atlantic Forest Fragments	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; INFANTUM INFECTION; RISK-FACTORS; WILDLIFE; AREA; TRANSMISSION; PSYCHODIDAE; PREVALENCE; DISEASES; DIPTERA	Canine visceral leishmaniasis is an important zoonosis in Brazil. However, infection patterns are unknown in some scenarios such as rural settlements around Atlantic Forest fragments. Additionally, controversy remains over risk factors, and most identified patterns of infection in dogs have been found in urban areas. We conducted a cross-sectional epidemiological survey to assess the prevalence of leishmaniasis in dogs through three different serological tests, and interviews with owners to assess features of dogs and households around five Atlantic Forest remnants in southeastern Brazil. We used Generalized Linear Mixed Models and Chi-square tests to detect associations between prevalence and variables that might influence Leishmania infection, and a nearest neighbor dispersion analysis to assess clustering in the spatial distribution of seropositive dogs. Our findings showed an average prevalence of 20% (ranging from 10 to 32%) in dogs. Nearly 40% (ranging from 22 to 55%) of households had at least one seropositive dog. Some individual traits of dogs (height, sterilization, long fur, age class) were found to positively influence the prevalence, while some had negative influence (weight, body score, presence of ectoparasites). Environmental and management features (number of cats in the households, dogs with free-ranging behavior) also entered models as negative associations with seropositivity. Strong and consistent negative (protective) influences of the presence of chickens and pigs in dog seropositivity were detected. Spatial clustering of cases was detected in only one of the five study sites. The results showed that different risk factors than those found in urban areas may drive the prevalence of canine leishmaniasis in farm/forest interfaces, and that humans and wildlife risk infection in these areas. Domestic dog population limitation by gonadectomy, legal restriction of dog numbers per household and owner education are of the greatest importance for the control of visceral leishmaniasis in rural zones near forest fragments.	[de Almeida Curi, Nelson Henrique; Passamani, Marcelo; Demetrio, Guilherme Ramos] Univ Fed Lavras, Postgrad Program Appl Ecol, Dept Biol, Lavras, Brazil; [de Oliveira Paschoal, Ana Maria; Massara, Rodrigo Lima] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biol, Postgrad Program Ecol Conservat & Management, Belo Horizonte, MG, Brazil; [Marcelino, Andreza Pain; Ribeiro, Adriana Aparecida] Ezequiel Dias Foundation FUNED, Lab Leishmaniasis, Belo Horizonte, MG, Brazil; [Chiarello, Adriano Garcia] Univ Sao Paulo, Dept Biol, Ribeirao Preto, Brazil	Universidade Federal de Lavras; Universidade Federal de Minas Gerais; Universidade de Sao Paulo	de Almeida Curi, NH (corresponding author), Univ Fed Lavras, Postgrad Program Appl Ecol, Dept Biol, Lavras, Brazil.	nelsoncuri@hotmail.com	Massara, Rodrigo Lima/Q-2223-2015; Chiarello, Adriano Garcia/G-2510-2012; Passamani, Marcelo/N-1168-2019; Demetrio, Guilherme/R-4979-2019; Passamani, Marcelo/H-3361-2015; Passamani, Marcelo/ABG-8886-2020; Ribeiro, Adriana/GZB-0082-2022	Massara, Rodrigo Lima/0000-0003-1221-2185; Chiarello, Adriano Garcia/0000-0003-1914-5480; Demetrio, Guilherme/0000-0002-6481-1633; Passamani, Marcelo/0000-0002-0940-4074; Ribeiro, Adriana/0000-0002-9765-7441	CAPES; Brazilian Science Council [CNPq 472802/2010-0]; Minas Gerais Science Foundation [FAPEMIG APQ 01145-10]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Science Council; Minas Gerais Science Foundation	Thanks to CAPES, who provided the scholarship for the first author. The Brazilian Science Council (CNPq 472802/2010-0) and Minas Gerais Science Foundation (FAPEMIG APQ 01145-10) also provided funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Alexander KA, 2010, FRONT ECOL ENVIRON, V8, P522, DOI 10.1890/090057; Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213; AYRES M., 2007, BIOESTAT 5 0 APLICAC; Belo VS, 2013, VET PARASITOL, V195, P1, DOI 10.1016/j.vetpar.2013.03.010; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Caldas AJM, 2002, T ROY SOC TROP MED H, V96, P21, DOI 10.1016/S0035-9203(02)90227-0; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cleaveland S, 2006, NATURE, V440, P605, DOI 10.1038/440605b; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Coura-Vital W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091009; Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, PARASITOLOGY, V125, P407, DOI 10.1017/S0031182002002238; Curi NHD, 2006, MEM I OSWALDO CRUZ, V101, P99, DOI 10.1590/S0074-02762006000100019; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Dantas-Torres F, 2011, TRENDS PARASITOL, V27, P155, DOI 10.1016/j.pt.2010.12.006; Dantas-Torres F, 2010, VET PARASITOL, V170, P313, DOI 10.1016/j.vetpar.2010.02.019; Xavier SCD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001647; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dias Flávio de Oliveira Passos, 2003, Cad. Saúde Pública, V19, P1373, DOI 10.1590/S0102-311X2003000500015; Donalisio Maria Rita, 2012, J Trop Med, V2012, P642910, DOI 10.1155/2012/642910; Faye B, 2011, T ROY SOC TROP MED H, V105, P333, DOI 10.1016/j.trstmh.2011.02.009; Gavgani ASM, 2002, AM J TROP MED HYG, V67, P511, DOI 10.4269/ajtmh.2002.67.511; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Halliday JEB, 2007, J R SOC INTERFACE, V4, P973, DOI 10.1098/rsif.2007.0237; Lacerda ACR, 2009, ANIM CONSERV, V12, P477, DOI 10.1111/j.1469-1795.2009.00277.x; Loss Scott R, 2013, Nat Commun, V4, P1396, DOI 10.1038/ncomms2380; Luppi MM, 2008, VET PARASITOL, V155, P146, DOI 10.1016/j.vetpar.2008.04.024; Maarschalkerweerd RJ, 1997, VET REC, V140, P617, DOI 10.1136/vr.140.24.617; Membrive NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047050; Moraes-Silva E, 2006, ACTA TROP, V98, P176, DOI 10.1016/j.actatropica.2006.04.002; Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393; Noguera Pedro, 2006, Biomed., V26, P57; Otranto D, 2010, ACTA TROP, V113, P80, DOI 10.1016/j.actatropica.2009.09.014; Otranto D, 2009, TRENDS PARASITOL, V25, P157, DOI 10.1016/j.pt.2009.01.003; de Almeida ADPF, 2012, REV BRAS PARASITOL V, V21, P359, DOI 10.1590/S1984-29612012005000005; Paschoal AMO, 2012, MAMMALIA, V76, P67, DOI 10.1515/mammalia-2012-0501; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; QUINNELL RJ, 1994, MED VET ENTOMOL, V8, P219, DOI 10.1111/j.1365-2915.1994.tb00502.x; R Core Team, 2021, R LANG ENV STAT COMP; Rabinowitz Peter M., 2005, EcoHealth, V2, P26, DOI 10.1007/s10393-004-0151-1; Reithinger R, 2003, T ROY SOC TROP MED H, V97, P141, DOI 10.1016/S0035-9203(03)90101-5; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodriguez-Cortes A, 2013, VET PARASITOL, V191, P363, DOI 10.1016/j.vetpar.2012.09.009; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Souza TD, 2014, VET PARASITOL, V200, P233, DOI 10.1016/j.vetpar.2013.12.025; Spain CV, 2004, JAVMA-J AM VET MED A, V224, P380, DOI 10.2460/javma.2004.224.380; Suzan G., 2012, NEW DIRECTIONS CONSE; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Woodroffe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030099; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	61	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104003	10.1371/journal.pone.0104003	http://dx.doi.org/10.1371/journal.pone.0104003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089629	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700078
J	Islam, MA; Sundaraj, K; Ahmad, RB; Sundaraj, S; Ahamed, NU; Ali, MA				Islam, Md. Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Sundaraj, Sebastian; Ahamed, Nizam Uddin; Ali, Md. Asraf			Longitudinal, Lateral and Transverse Axes of Forearm Muscles Influence the Crosstalk in the Mechanomyographic Signals during Isometric Wrist Postures	PLOS ONE			English	Article							SURFACE ELECTROMYOGRAPHY; EXTENSOR; CLASSIFICATION; ACCELEROMETER; PROPAGATION; FREQUENCY; FATIGUE	Problem Statement: In mechanomyography (MMG), crosstalk refers to the contamination of the signal from the muscle of interest by the signal from another muscle or muscle group that is in close proximity. Purpose: The aim of the present study was two-fold: i) to quantify the level of crosstalk in the mechanomyographic (MMG) signals from the longitudinal (L-o), lateral (L-a) and transverse (T-r) axes of the extensor digitorum (ED), extensor carpi ulnaris (ECU) and flexor carpi ulnaris (FCU) muscles during isometric wrist flexion (WF) and extension (WE), radial (RD) and ulnar (UD) deviations; and ii) to analyze whether the three-directional MMG signals influence the level of crosstalk between the muscle groups during these wrist postures. Methods: Twenty, healthy right-handed men (mean +/- SD: age = 26.7 +/- 3.83 y; height = 174.47 +/- 6.3 cm; mass = 72.79 +/- 14.36 kg) participated in this study. During each wrist posture, the MMG signals propagated through the axes of the muscles were detected using three separate tri-axial accelerometers. The x-axis, y-axis, and z-axis of the sensor were placed in the L-o, L-a, and T-r directions with respect to muscle fibers. The peak cross-correlations were used to quantify the proportion of crosstalk between the different muscle groups. Results: The average level of crosstalk in the MMG signals generated by the muscle groups ranged from: 34.28-69.69% for the L-o axis, 27.32-52.55% for the L-a axis and 11.38-25.55% for the T-r axis for all participants and their wrist postures. The T-r axes between the muscle groups showed significantly smaller crosstalk values for all wrist postures [F (2, 38) = 14-63, p<0.05, eta(2) = 0.416-0.769]. Significance: The results may be applied in the field of human movement research, especially for the examination of muscle mechanics during various types of the wrist postures.	[Islam, Md. Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Ahamed, Nizam Uddin; Ali, Md. Asraf] Univ Malaysia Perlis, Al Rehab Res Grp, Arau, Perlis, Malaysia; [Sundaraj, Sebastian] Malaysian Minist Hlth, Klang, Selangor, Malaysia	Universiti Malaysia Perlis; Kementerian Kesihatan Malaysia	Islam, MA (corresponding author), Univ Malaysia Perlis, Al Rehab Res Grp, Arau, Perlis, Malaysia.	anamulislam.phd@gmail.com	Sundaraj, Kenneth/AAD-1783-2019; Ahmad, RB/U-3211-2019; Ahmad, Badlishah/A-4703-2019; Rather, R A/J-3509-2019; Ahamed, Nizam Uddin/J-6248-2012	Sundaraj, Kenneth/0000-0001-7221-0072; Ahmad, RB/0000-0002-4862-2728; Ahmad, Badlishah/0000-0002-4862-2728; Ahamed, Nizam Uddin/0000-0003-0497-7356; Islam, Md. Anamul/0000-0001-6214-7081; Ali, Dr. Md Asraf/0000-0002-4732-5529				Al-Zahrani E, 2009, J ELECTROMYOGR KINES, V19, P695, DOI 10.1016/j.jelekin.2007.12.007; Alves N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-23; Archer AA, 2012, J ELECTROMYOGR KINES, V22, P51, DOI 10.1016/j.jelekin.2011.09.011; BARRY DT, 1987, BIOPHYS J, V51, P769, DOI 10.1016/S0006-3495(87)83403-3; Basmajian J.V., 1985, MUSCLES ALIVE THEIR; Beck TW, 2010, HUM MOVEMENT SCI, V29, P165, DOI 10.1016/j.humov.2009.11.005; Beck TW, 2010, APPL MECHANOMYOGRAPH, V37, P95; Cescon C, 2006, J ELECTROMYOGR KINES, V16, P17, DOI 10.1016/j.jelekin.2005.02.005; Cescon C, 2008, MED BIOL ENG COMPUT, V46, P871, DOI 10.1007/s11517-008-0357-4; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cramer J T, 2003, Electromyogr Clin Neurophysiol, V43, P293; Dillon MA, 2011, CLIN KINESIOLOGY J A, V65; DOBRUNZ LE, 1990, BIOPHYS J, V58, P557, DOI 10.1016/S0006-3495(90)82399-7; Ebersole KT, 2001, ISOKINET EXERC SCI, V9, P11, DOI 10.3233/IES-2001-0058; Farina D, 2002, MUSCLE NERVE, V26, P681, DOI 10.1002/mus.10256; Farina D, 1985, J APPL PHYSIOL, V92, P235; Farina D, 2008, J BIOMECH, V41, P2843, DOI 10.1016/j.jbiomech.2008.07.007; FRANGIONI JV, 1987, BIOPHYS J, V51, P775, DOI 10.1016/S0006-3495(87)83404-5; Hagg GM, 1997, CLIN BIOMECH, V12, P39, DOI 10.1016/S0268-0033(96)00049-6; Islam MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096628; Islam MA, 2013, IEEE SENS J, V13, P2499, DOI 10.1109/JSEN.2013.2255982; Islam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058902; Jaskolska A, 2004, J ELECTROMYOGR KINES, V14, P217, DOI 10.1016/j.jelekin.2003.08.001; Kim Tae-Kwang, 2008, Journal of Physiological Anthropology, V27, P121, DOI 10.2114/jpa2.27.121; Kong YK, 2010, J ELECTROMYOGR KINES, V20, P1223, DOI 10.1016/j.jelekin.2010.08.001; Li ZM, 2005, CLIN BIOMECH, V20, P177, DOI 10.1016/j.clinbiomech.2004.10.002; Lowery MM, 2003, J APPL PHYSIOL, V94, P1324, DOI 10.1152/japplphysiol.00698.2002; Matta TTd, 2005, REV BRAS MED ESPORTE, V11, P306; Mogk JPM, 2003, J ELECTROMYOGR KINES, V13, P63, DOI 10.1016/S1050-6411(02)00071-8; Orizio C, 2003, EUR J APPL PHYSIOL, V90, P326, DOI 10.1007/s00421-003-0924-1; Perotto A, 2005, ANATOMICAL GUIDE ELE; Riek S, 2000, J ELECTROMYOGR KINES, V10, P249, DOI 10.1016/S1050-6411(00)00017-1; Scheeren EM, 2010, J MED BIOL ENG, V30, P373, DOI 10.5405/jmbe.757; WINTER DA, 1994, J ELECTROMYOGR KINES, V4, P15, DOI 10.1016/1050-6411(94)90023-X; Xie HB, 2009, PHYSIOL MEAS, V30, P441, DOI 10.1088/0967-3334/30/5/002; Yoshimi Hidehiro, 2009, Head Face Med, V5, P7, DOI 10.1186/1746-160X-5-7; Yung M, 2013, J ELECTROMYOGR KINES, V23, P664, DOI 10.1016/j.jelekin.2013.01.001	37	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104280	10.1371/journal.pone.0104280	http://dx.doi.org/10.1371/journal.pone.0104280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090008	gold, Green Submitted, Green Published			2022-12-25	WOS:000339812700115
J	Mahende, C; Ngasala, B; Lusingu, J; Butichi, A; Lushino, P; Lemnge, M; Premji, Z				Mahende, Coline; Ngasala, Billy; Lusingu, John; Butichi, Allvan; Lushino, Paminus; Lemnge, Martha; Premji, Zul			Aetiology of Acute Febrile Episodes in Children Attending Korogwe District Hospital in North-Eastern Tanzania	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; SEVERE MALARIA; VIRAL ETIOLOGY; DIAGNOSIS; TRANSMISSION; BACTERIAL; ILLNESS; FEVER; PREVALENCE; MORTALITY	Introduction: Although the burden of malaria in many parts of Tanzania has declined, the proportion of children with fever has not changed. This situation underscores the need to explore the possible causes of febrile episodes in patients presenting with symptoms at the Korogwe District Hospital (KDH). Methods: A hospital based cross-sectional study was conducted at KDH, north-eastern Tanzania. Patients aged 2 to 59 months presenting at the outpatient department with an acute medical condition and fever (measured axillary temperature >= 37.5 degrees C) were enrolled. Blood samples were examined for malaria parasites, human immunodeficiency virus (HIV) and bacterial infections. A urine culture was performed in selected cases to test for bacterial infection and a chest radiograph was requested if pneumonia was suspected. Diagnosis was based on both clinical and laboratory investigations. Results: A total of 867 patients with a median age of 15.1 months (Interquartile range 8.6-29.9) were enrolled from January 2013 to October 2013. Respiratory tract infections were the leading clinical diagnosis with 406/867 (46.8%) of patients diagnosed with upper respiratory tract infection and 130/867 (15.0%) with pneumonia. Gastroenteritis was diagnosed in 184/867 (21.2%) of patients. Malaria infection was confirmed in 72/867 (8.3%) of patients. Bacterial infection in blood and urine accounted for 26/808 (3.2%) infections in the former, and 66/373 (17.7%) infections in the latter. HIV infection was confirmed in 10/824 (1.2%) of patients. Respiratory tract infections and gastroenteritis were frequent in patients under 36 months of age (87.3% and 91.3% respectively). Co-infections were seen in 221/867 (25.5%) of patients. The cause of fever was not identified in 65/867 (7.5%) of these patients. Conclusions: The different proportions of infections found among febrile children reflect the causes of fever in the study area. These findings indicate the need to optimise patient management by developing malaria and non-malaria febrile illnesses management protocols.	[Mahende, Coline; Lusingu, John; Butichi, Allvan; Lushino, Paminus; Lemnge, Martha] Natl Inst Med Res, Korogwe Res Lab, Tanga, Tanzania; [Mahende, Coline; Ngasala, Billy; Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Med Entomol & Parasitol, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Mahende, C (corresponding author), Natl Inst Med Res, Korogwe Res Lab, Tanga, Tanzania.	cbdmahende@yahoo.co.uk	Lusingu, John P. A./GSJ-3228-2022	Lusingu, John P. A./0000-0002-9407-0602	Swedish International Development Cooperation Agency (SIDA) through Muhimbili University of Health and Allied Sciences	Swedish International Development Cooperation Agency (SIDA) through Muhimbili University of Health and Allied Sciences	The study was sponsored by Swedish International Development Cooperation Agency (SIDA) through Muhimbili University of Health and Allied Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-18; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Baltzell K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-37; Biggs HM, 2014, CLIN INFECT DIS, V58, P638, DOI 10.1093/cid/cit798; Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; Choi Soo-Han, 2013, Korean J Pediatr, V56, P196, DOI 10.3345/kjp.2013.56.5.196; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hamilton JL, 2013, AM FAM PHYSICIAN, V87, P254; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Montini G, 2011, NEW ENGL J MED, V365, P239, DOI 10.1056/NEJMra1007755; Moon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089814; Moyo SJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-19; Msaki BP, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-4; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; National Aids Control Programme Ministry of Health and Social Welfare Tanzania, 2012, GUID HIV TEST; National Bureau of Statistics Ministry of Finance Tanzania, 2013, 2012 POP HOUS CENS; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Osei-Kwakye K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058107; PETIT PLC, 1995, J TROP MED HYG, V98, P217; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rutta ASM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-152; Schmiegelow C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053794; Sire JM, 2013, PAEDIATR INT CHILD H, V33, P139, DOI 10.1179/2046905512Y.0000000046; Strom GEA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-228; The United Republic of Tanzania MoHaSW, 2007, STAND TREATM GUID ST, P6; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; WHO, 2005, INT MAN CHILDH ILLN; WHO, 2010, GUID TREATM MAL, V2nd; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	44	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104197	10.1371/journal.pone.0104197	http://dx.doi.org/10.1371/journal.pone.0104197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090651	Green Published, gold			2022-12-25	WOS:000339812700109
J	Shirazi, SH; ul Haq, N; Hayat, K; Naz, S; ul Haque, I				Shirazi, Syed Hamad; ul Haq, Nuhman; Hayat, Khizar; Naz, Saeeda; ul Haque, Ihsan			Curvelet Based Offline Analysis of SEM Images	PLOS ONE			English	Article							WATERSHED SEGMENTATION; LEVEL	Manual offline analysis, of a scanning electron microscopy (SEM) image, is a time consuming process and requires continuous human intervention and efforts. This paper presents an image processing based method for automated offline analyses of SEM images. To this end, our strategy relies on a two-stage process, viz. texture analysis and quantification. The method involves a preprocessing step, aimed at the noise removal, in order to avoid false edges. For texture analysis, the proposed method employs a state of the art Curvelet transform followed by segmentation through a combination of entropy filtering, thresholding and mathematical morphology (MM). The quantification is carried out by the application of a box-counting algorithm, for fractal dimension (FD) calculations, with the ultimate goal of measuring the parameters, like surface area and perimeter. The perimeter is estimated indirectly by counting the boundary boxes of the filled shapes. The proposed method, when applied to a representative set of SEM images, not only showed better results in image segmentation but also exhibited a good accuracy in the calculation of surface area and perimeter. The proposed method outperforms the well-known Watershed segmentation algorithm.	[Shirazi, Syed Hamad; ul Haq, Nuhman; Hayat, Khizar; Naz, Saeeda] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [ul Haque, Ihsan] Univ Peshawar, Centralized Resource Lab, Peshawar, Pakistan; [Hayat, Khizar] Univ Nizwa, Nizwa, Oman	COMSATS University Islamabad (CUI); University of Peshawar; University of Nizwa	Hayat, K (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	khizarhayat@ciit.net.pk	Shirazi, Syed Hamad/GQI-1993-2022; Ul Haq, Nuhman/AGY-8616-2022; Hayat, Khizar/P-8954-2019	Shirazi, Syed Hamad/0000-0001-9534-4719; Hayat, Khizar/0000-0001-5216-6019				ap Gwynn I., 2001, European Cells & Materials, V1, P1; Baojun W, 2009, P INT C IM SIGN PROC, P1; Bennis H, 2010, S I V COMM MOB NETW, P1; Chen Q, 2010, SIGNAL PROCESS, V90, P44, DOI 10.1016/j.sigpro.2009.05.015; Cointault F., 2007, 2007 Third International IEEE Conference on Signal-Image Technologies and Internet-Based System (SITIS), P696, DOI 10.1109/SITIS.2007.80; Dettori L, 2007, COMPUT BIOL MED, V37, P486, DOI 10.1016/j.compbiomed.2006.08.002; Erikson M, 2006, PATTERN RECOGN LETT, V27, P160, DOI 10.1016/j.patrec.2005.07.010; Fattal R, 2007, ACM T GRAPHIC, P26; Flores FC, 2010, IMAGE VISION COMPUT, V28, P1491, DOI 10.1016/j.imavis.2009.06.015; Hafemeister L, 1994, P OCEANS 94 OC ENG T, V2, P69; Hamarneh G, 2009, IMAGE VISION COMPUT, V27, P59, DOI 10.1016/j.imavis.2006.10.009; Haq N, 2012, OPT COMMUN, V285; Herman GT, 2000, INT J IMAG SYST TECH, V11, P12, DOI 10.1002/(SICI)1098-1098(2000)11:1<12::AID-IMA3>3.0.CO;2-N; Hernandez BK, 2000, IEEE T IMAGE PROCESS; Holecz F, 1989, GEOSC REM SENS S 198, V5, P2789; Jiang XY, 2000, IMAGE VISION COMPUT, V18, P817, DOI 10.1016/S0262-8856(99)00049-9; Kayser K, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S10; Kim DH, 2010, NUCL INSTRUM METH A, V620, P112, DOI 10.1016/j.nima.2010.03.134; Li J., 2010, P IEEE INT C SERV OR, P1, DOI DOI 10.1109/S0CA.2010.5707146; LI JL, 2009, EMBC 2009 ANN INT C, P1449; Li PJ, 2004, GEOSCI J, V8, P325, DOI 10.1007/BF02910252; Li QW, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P2037, DOI 10.1109/ROBIO.2007.4522481; Lu CW, 2008, LECT NOTES COMPUT SC, V5370, P687; Lu Zhengyu, 2010, Proceedings 2010 International Conference on Intelligent System Design and Engineering Application (ISDEA 2010), P189, DOI 10.1109/ISDEA.2010.172; Ma W. Y., 1995, Proceedings. International Conference on Image Processing (Cat. No.95CB35819), P256, DOI 10.1109/ICIP.1995.537463; Malkucsh W, 2002, TECHNICAL REPORT; Mizoguchi Masanobu, 2009, 2009 International Symposium on Micro-NanoMechatronics and Human Science (MHS), P426, DOI 10.1109/MHS.2009.5351865; Mukhopadhyay S, 2000, SIGNAL PROCESS, V80, P685, DOI 10.1016/S0165-1684(99)00161-9; Myers B, HITACHI S 3500N VP S; Nemati KM, 1997, SCANNING, V19, P426; Nencini F, 2007, INFORM FUSION, V8, P143, DOI 10.1016/j.inffus.2006.02.001; Niwas S. Issac, 2010, 2010 5th International Conference on Industrial and Information Systems (ICIIS 2010), P348, DOI 10.1109/ICIINFS.2010.5578679; Padma MG, ENTROPY BASED TEXTUR; Prakongkep N, 2010, GEODERMA, V156, P20, DOI 10.1016/j.geoderma.2010.01.003; Salzer M, 2012, MATER CHARACT, V69, P115, DOI 10.1016/j.matchar.2012.04.003; SARKAR N, 1992, PATTERN RECOGN, V25, P1035, DOI 10.1016/0031-3203(92)90066-R; Sheppard AP, 2004, PHYSICA A, V339, P145, DOI 10.1016/j.physa.2004.03.057; Soroushian P, 2005, CEMENT CONCRETE COMP, V27, P823, DOI 10.1016/j.cemconcomp.2004.07.008; Sun W, 2009, IEEE T SEMICONDUCT M, V22, P180, DOI 10.1109/TSM.2008.2011174; Tremeau A, 2000, IEEE T IMAGE PROCESS, V9, P735, DOI 10.1109/83.841950; Tuceryan M, 1998, HDB PATTERN RECOGNIT, P1; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Weidong Chen, 2010, 2010 IEEE International Conference on Intelligent Computing and Intelligent Systems (ICIS 2010), P891, DOI 10.1109/ICICISYS.2010.5658369; Woodward JD, 2010, ULTRAMICROSCOPY, V110, P170, DOI 10.1016/j.ultramic.2009.11.001; Xu X., 2010, IGNEOUS PETROLOGY, P1; Yang Z, 2007, ADV POWDER TECHNOL, V18, P187, DOI 10.1163/156855207780208655; Yuan Li-hong, 2010, Journal of Computer Applications, V30, P44, DOI 10.3724/SP.J.1087.2010.00044; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007; Zhang YJ, 1996, PATTERN RECOGN, V29, P1335, DOI 10.1016/0031-3203(95)00169-7	49	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103942	10.1371/journal.pone.0103942	http://dx.doi.org/10.1371/journal.pone.0103942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089617	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700067
J	Zhu, GL; Wang, LJ; Tang, WQ; Liu, D; Yang, JQ				Zhu, Guoli; Wang, Liangjiang; Tang, Wenqiao; Liu, Dong; Yang, Jinquan			De Novo Transcriptomes of Olfactory Epithelium Reveal the Genes and Pathways for Spawning Migration in Japanese Grenadier Anchovy (Coilia nasus)	PLOS ONE			English	Article							JUVENILE SOCKEYE SALMON; RECEPTOR NEURONS; YANGTZE-RIVER; CHLORIDE ACCUMULATION; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; ATLANTIC SALMON; DESENSITIZATION; PHEROMONE; CELLS	Background: Coilia nasus (Japanese grenadier anchovy) undergoes spawning migration from the ocean to fresh water inland. Previous studies have suggested that anadromous fish use olfactory cues to perform successful migration to spawn. However, limited genomic information is available for C. nasus. To understand the molecular mechanisms of spawning migration, it is essential to identify the genes and pathways involved in the migratory behavior of C. nasus. Results: Using de novo transcriptome sequencing and assembly, we constructed two transcriptomes of the olfactory epithelium from wild anadromous and non-anadromous C. nasus. Over 178 million high-quality clean reads were generated using Illumina sequencing technology and assembled into 176,510 unigenes (mean length: 843 bp). About 51% (89,456) of the unigenes were functionally annotated using protein databases. Gene ontology analysis of the transcriptomes indicated gene enrichment not only in signal detection and transduction, but also in regulation and enzymatic activity. The potential genes and pathways involved in the migratory behavior were identified. In addition, simple sequence repeats and single nucleotide polymorphisms were analyzed to identify potential molecular markers. Conclusion: We, for the first time, obtained high-quality de novo transcriptomes of C. nasus using a high-throughput sequencing approach. Our study lays the foundation for further investigation of C. nasus spawning migration and genome evolution.	[Zhu, Guoli; Tang, Wenqiao; Liu, Dong; Yang, Jinquan] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Wang, Liangjiang] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Shanghai Ocean University; Clemson University	Tang, WQ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China.	wqtang@shou.edu.cn			Special Fund for Agro-Scientific Research in the Public Interest [201203065]; National Natural Science Foundation of China [31172407]; Ministry of Education's Doctoral Discipline Foundation [20123104110006]; Shanghai Universities First-class Disciplines Project of Fisheries	Special Fund for Agro-Scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education's Doctoral Discipline Foundation; Shanghai Universities First-class Disciplines Project of Fisheries	This study was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201203065), the National Natural Science Foundation of China (No. 31172407), the Ministry of Education's Doctoral Discipline Foundation (No. 20123104110006), and Shanghai Universities First-class Disciplines Project of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Bandoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016051; Barbin GP, 1998, ENVIRON BIOL FISH, V53, P283, DOI 10.1023/A:1007469232698; Barry PH, 2003, J GEN PHYSIOL, V122, P247, DOI 10.1085/jgp.200308910; Boekhoff I, 1997, J BIOL CHEM, V272, P4606, DOI 10.1074/jbc.272.7.4606; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Cheng Wan-Xiu, 2011, Chinese Journal of Zoology, V46, P33; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DOVING KB, 1985, CAN J FISH AQUAT SCI, V42, P1658, DOI 10.1139/f85-207; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [管卫兵 Guan Weibing], 2010, [海洋渔业, Marine Fisheries], V32, P73; Guo Hong-yi, 2006, Journal of Fisheries of China, V30, P347; Jahn LA, 1967, PROGR FISH CULTURIST, V38, P207; Johnstone KA, 2011, MOL ECOL, V20, P4059, DOI 10.1111/j.1365-294X.2011.05251.x; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kolmakov NN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-429; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; MCBRIDE JR, 1964, CAN J ZOOLOG, V42, P245, DOI 10.1139/z64-023; Moon C, 1998, J NEUROSCI, V18, P3195; Nakamura T, 2000, COMP BIOCHEM PHYS A, V126, P17, DOI 10.1016/S1095-6433(00)00191-4; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; NORDENG H, 1971, NATURE, V233, P411, DOI 10.1038/233411a0; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; TARRANT RM, 1966, T AM FISH SOC, V95, P112, DOI 10.1577/1548-8659(1966)95[112:TOPOEI]2.0.CO;2; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Whitehead P., 1988, FAO FISHERIES SYNOPS, V125, P460; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472; Xu G, 2013, J FISHERY SCI CHINA, V18, P537; [徐钢春 Xu Gangchun], 2012, [上海海洋大学学报, Journal of Shanghai Ocean University], V21, P481; [徐钢春 Xu Gangchun], 2012, [华中农业大学学报, Journal of Huazhong Agricultural University], V31, P247; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633; Yang Jin-Quand, 2008, Chinese Journal of Zoology, V43, P8; YANO K, 1992, ICHTHYOL RES, V39, P67; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan C.M., 1980, J NANJING U, V3, P67; Zheng Fei, 2012, Chinese Journal of Zoology, V47, P24; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	54	20	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103832	10.1371/journal.pone.0103832	http://dx.doi.org/10.1371/journal.pone.0103832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084282	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800085
J	Patsialou, A; Wang, Y; Pignatelli, J; Chen, X; Entenberg, D; Oktay, M; Condeelis, JS				Patsialou, A.; Wang, Y.; Pignatelli, J.; Chen, X.; Entenberg, D.; Oktay, M.; Condeelis, J. S.			Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGF beta in claudin-low breast tumor cells	ONCOGENE			English	Article							STIMULATING FACTOR-I; GENE-EXPRESSION; CIRCULATING LEVELS; MAMMARY-TUMORS; CANCER-CELLS; MOLECULAR PORTRAITS; METASTATIC BEHAVIOR; CSF-1 RECEPTOR; GROWTH; VIVO	Patient data suggest that colony-stimulating factor-1 (CSF1) and its receptor (CSF1R) have critical roles during breast cancer progression. We have previously shown that in human breast tumors expressing both CSF1 and CSF1R, invasion in vivo is dependent both on a paracrine interaction with tumor-associated macrophages and an autocrine regulation of CSF1R in the tumor cells themselves. Although the role of the paracrine interaction between tumor cells and macrophages has been extensively studied, very little is known about the mechanism by which the autocrine CSF1R signaling contributes to tumor progression. We show here that breast cancer patients of the claudin-low subtype have significantly increased expression of CSF1R. Using a panel of breast cancer cell lines, we confirm that CSF1R expression is elevated and regulated by TGF beta specifically in claudin-low cell lines. Abrogation of autocrine CSF1R signaling in MDA-MB-231 xenografts (a claudin-low cell line) leads to increased tumor size by enhanced proliferation, but significantly reduced invasion, dissemination and metastasis. Indeed, we show that proliferation and invasion are oppositely regulated by CSF1R downstream of TGF beta only in claudin-low cell lines. Intravital multiphoton imaging revealed that inhibition of CSF1R in the tumor cells leads to decreased in vivo motility and a more cohesive morphology. We show that, both in vitro and in vivo, CSF1R inhibition results in a reversal of claudin-low marker expression by significant upregulation of luminal keratins and tight-junction proteins such as claudins. Finally, we show that artificial overexpression of claudins in MDA-MB-231 cells is sufficient to tip the cells from an invasive state to a proliferative state. Our results suggest that autocrine CSF1R signaling is essential in maintaining low claudin expression and that it mediates a switch between the proliferative and the invasive state in claudin-low tumor cells downstream of TGF beta.	[Patsialou, A.; Wang, Y.; Pignatelli, J.; Chen, X.; Entenberg, D.; Condeelis, J. S.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Wang, Y.; Entenberg, D.; Condeelis, J. S.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA; [Oktay, M.] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Patsialou, A (corresponding author), UCL, UCL Canc Inst, Res Dept Canc Biol, 72 Huntley St, London WC1E 6DD, England.	a.patsialou@ucl.ac.uk; john.condeelis@einstein.yu.edu	Entenberg, David/AAT-2722-2020	Entenberg, David/0000-0003-0422-7264	NCI [P30 CA 013330, 5RO1CA164468, RO1CA170507]; NATIONAL CANCER INSTITUTE [P01CA100324, R01CA164468, R01CA170507, P30CA013330] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Paraic Kenny, Richard Stanley, Jeffrey Segall and members of the Condeelis lab for helpful discussions. The AFS98, total and phospho-Y559 CSF1R antibodies were a generous gift from Dr Richard Stanley. For technical help at Albert Einstein College of Medicine, we thank the Histotechnology and Comparative Pathology Facility, the shRNA Core Facility, the FACS Facility (supported by NCI P30 CA 013330) and the Genomics Facility. This work was supported by NCI grants 5RO1CA164468 (AP, YW, XC, DE and JSC) and RO1CA170507 (JP, MO and JSC).	Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; ARTEAGA CL, 1988, CANCER RES, V48, P3898; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cross M, 2005, PROTEOMICS, V5, P4754, DOI 10.1002/pmic.200500058; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Entenberg D, 2011, NAT PROTOC, V6, P1500, DOI 10.1038/nprot.2011.376; Farina AR, 1998, INT J CANCER, V75, P721; FILDERMAN AE, 1992, CANCER RES, V52, P3661; Gil-Henn H, 2013, ONCOGENE, V32, P2622, DOI 10.1038/onc.2012.284; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; KACINSKI BM, 1989, INT J RADIAT ONCOL, V17, P159, DOI 10.1016/0360-3016(89)90383-0; KACINSKI BM, 1988, INT J RADIAT ONCOL, V15, P823, DOI 10.1016/0360-3016(88)90113-7; KACINSKI BM, 1991, ONCOGENE, V6, P941; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; KACINSKI BM, 1990, AM J PATHOL, V137, P135; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Lanigan F, 2009, INT J CANCER, V124, P2088, DOI 10.1002/ijc.24159; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Morandi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027450; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Patsialou Antonia, 2013, Intravital, V2, pe25294; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Resnick MB, 2005, HUM PATHOL, V36, P886, DOI 10.1016/j.humpath.2005.05.019; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sapi E, 1996, CANCER RES, V56, P5704; Scholl SM, 1996, BREAST CANCER RES TR, V39, P275, DOI 10.1007/BF01806155; SCHOLL SM, 1994, BRIT J CANCER, V69, P342, DOI 10.1038/bjc.1994.62; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Sudo T, 1995, ONCOGENE, V11, P2469; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2000, CANCER RES, V60, P5401; Wyckoff JB, 2000, CANCER RES, V60, P2504; ZUGMAIER G, 1989, J CELL PHYSIOL, V141, P353, DOI 10.1002/jcp.1041410217	53	32	33	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2721	2731		10.1038/onc.2014.226	http://dx.doi.org/10.1038/onc.2014.226			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25088194	Green Accepted			2022-12-25	WOS:000354979500005
J	Fan, J; Kang, HB; Shan, CL; Elf, S; Lin, RT; Xie, JX; Gu, TL; Aguiar, M; Lonning, S; Chung, TW; Arellano, M; Khoury, HJ; Shin, DM; Khuri, FR; Boggon, TJ; Kang, SM; Chen, J				Fan, Jun; Kang, Hee-Bum; Shan, Changliang; Elf, Shannon; Lin, Ruiting; Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Boggon, Titus J.; Kang, Sumin; Chen, Jing			Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-LINE; TYROSINE PHOSPHORYLATION; CANCER-CELLS; TUMOR-GROWTH; LEUKEMIA; COMPLEX; METABOLISM; KINASE; ORGANIZATION; CHROMOSOME	The mitochondrial pyruvate dehydrogenase complex (PDC) plays a crucial role in regulation of glucose homoeostasis in mammalian cells. PDC flux depends on catalytic activity of the most important enzyme component pyruvate dehydrogenase (PDH). PDH kinase inactivates PDC by phosphorylating PDH at specific serine residues, including Ser-293, where as dephosphorylation of PDH by PDH phosphatase restores PDC activity. The current understanding suggests that Ser-293 phosphorylation of PDH impedes active site accessibility to its substrate pyruvate. Here, we report that phosphorylation of a tyrosine residue Tyr-301 also inhibits PDH alpha 1 (PDHA1) by blocking pyruvate binding through a novel mechanism in addition to Ser-293 phosphorylation. In addition, we found that multiple oncogenic tyrosine kinases directly phosphorylate PDHA1 at Tyr-301, and Tyr-301 phosphorylation of PDHA1 is common in EGF-stimulated cells as well as diverse human cancer cells and primary leukemia cells from human patients. Moreover, expression of a phosphorylation-deficient PDHA1 Y301F mutant in cancer cells resulted in increased oxidative phosphorylation, decreased cell proliferation under hypoxia, and reduced tumor growth in mice. Together, our findings suggest that phosphorylation at distinct serine and tyrosine residues inhibits PDHA1 through distinct mechanisms to impact active site accessibility, which act in concert to regulate PDC activity and promote the Warburg effect.	[Fan, Jun; Kang, Hee-Bum; Shan, Changliang; Elf, Shannon; Lin, Ruiting; Chung, Tae-Wook; Arellano, Martha; Khoury, Hanna J.; Shin, Dong M.; Khuri, Fadlo R.; Kang, Sumin; Chen, Jing] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Xie, Jianxin; Gu, Ting-Lei; Aguiar, Mike; Lonning, Scott] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Emory University; Yale University	Fan, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	jfan3@emory.edu; jchen@emory.edu	Shan, changliang/L-9029-2016; Shin, Dong Moon/G-9649-2013; LIN, RUITING/K-9743-2016; Khuri, Fadlo R./AAU-4942-2020	Shin, Dong Moon/0000-0002-8245-4174; LIN, RUITING/0000-0003-4274-4588; Khuri, Fadlo R./0000-0002-8638-7618; Chung, Tae-Wook/0000-0001-5243-5020; Kang, Hee-Bum/0000-0002-3781-6893; Aguiar, Mike/0000-0001-8175-010X	National Institutes of Health [CA140515, CA183594, CA174786, CA175316]; National Institutes of Health SPORE in Head and Neck Cancer [P50CA128613]; Pharmacological Sciences Training Grant [T32 GM008602]; Department of Defense [W81XWH-12-1-0217]; Charles Harris Run For Leukemia, Inc.; Hematology Tissue Bank of the Emory University School of Medicine; NATIONAL CANCER INSTITUTE [R01CA175316, R01CA174786, R01CA183594, R01CA140515, P50CA128613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health SPORE in Head and Neck Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; Department of Defense(United States Department of Defense); Charles Harris Run For Leukemia, Inc.; Hematology Tissue Bank of the Emory University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA140515, CA183594, CA174786 (to J. C.), CA175316 (to S. K.), the Career Development Fellow Award (to J. F.) from National Institutes of Health SPORE in Head and Neck Cancer P50CA128613 (to D. M. S.) and the Pharmacological Sciences Training Grant T32 GM008602 (to S. E.), Department of Defense Grant W81XWH-12-1-0217 (to J. C.), Charles Harris Run For Leukemia, Inc. (to H. J. K.) and the Hematology Tissue Bank of the Emory University School of Medicine (to H. J. K.). J. X., T.-L. G., M. A., and S. L. are employees of Cell Signaling Technology, Inc.	[Anonymous], 1996, J Cell Biochem Suppl, V24, P1; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Ciszak E. M., 2003, J BIOL; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Fan J, 2011, MOL CELL BIOL, V31, P4938, DOI 10.1128/MCB.06120-11; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Gu TL, 2006, BLOOD, V108, P4202, DOI 10.1182/blood-2006-06-026666; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2759; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; PAPAYANNOPOULOU T, 1983, BLOOD, V62, P832; Pezzato E, 2009, AMINO ACIDS, V36, P449, DOI 10.1007/s00726-008-0099-5; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shan CL, 2014, J BIOL CHEM, V289, P21413, DOI 10.1074/jbc.M114.581124; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	32	53	59	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26533	26541		10.1074/jbc.M114.593970	http://dx.doi.org/10.1074/jbc.M114.593970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104357	Green Published, hybrid			2022-12-25	WOS:000342128800044
J	Kehoe, MA; Coutts, BA; Buirchell, BJ; Jones, RAC				Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.			Plant Virology and Next Generation Sequencing: Experiences with a Potyvirus	PLOS ONE			English	Article							YELLOW-MOSAIC-VIRUS; NON-NECROTIC STRAINS; RESISTANCE; WILD; RNA	Next generation sequencing is quickly emerging as the go-to tool for plant virologists when sequencing whole virus genomes, and undertaking plant metagenomic studies for new virus discoveries. This study aims to compare the genomic and biological properties of Bean yellow mosaic virus (BYMV) (genus Potyvirus), isolates from Lupinus angustifolius plants with black pod syndrome (BPS), systemic necrosis or non-necrotic symptoms, and from two other plant species. When one Clover yellow vein virus (ClYVV) (genus Potyvirus) and 22 BYMV isolates were sequenced on the Illumina HiSeq2000, one new ClYVV and 23 new BYMV sequences were obtained. When the 23 new BYMV genomes were compared with 17 other BYMV genomes available on Genbank, phylogenetic analysis provided strong support for existence of nine phylogenetic groupings. Biological studies involving seven isolates of BYMV and one of ClYVV gave no symptoms or reactions that could be used to distinguish BYMV isolates from L. angustifolius plants with black pod syndrome from other isolates. Here, we propose that the current system of nomenclature based on biological properties be replaced by numbered groups (I-IX). This is because use of whole genomes revealed that the previous phylogenetic grouping system based on partial sequences of virus genomes and original isolation hosts was unsustainable. This study also demonstrated that, where next generation sequencing is used to obtain complete plant virus genomes, consideration needs to be given to issues regarding sample preparation, adequate levels of coverage across a genome and methods of assembly. It also provided important lessons that will be helpful to other plant virologists using next generation sequencing in the future.	[Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Dept Agr & Food Western Australia, Crop Protect Branch, Perth, WA, Australia; [Kehoe, Monica A.; Coutts, Brenda A.; Buirchell, Bevan J.; Jones, Roger A. C.] Dept Agr & Food Western Australia, Lupin Breeding Branch, Perth, WA, Australia	University of Western Australia; University of Western Australia	Kehoe, MA (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	monica.kehoe@agric.wa.gov.au	Jones, Roger A.C./B-1200-2011	Jones, Roger A.C./0000-0003-3593-3102; Buirchell, Bevan/0000-0001-8247-3570	Australian Postgraduate Award (APA); Australian Grains Research and Development Corporation (GRDC) Studentship [GRS10039]	Australian Postgraduate Award (APA)(Australian Government); Australian Grains Research and Development Corporation (GRDC) Studentship(Grains R&D Corp)	This research was funded by an Australian Postgraduate Award (APA), and an Australian Grains Research and Development Corporation (GRDC) Studentship, Project number GRS10039. It was undertaken using the facilities at the Department of Agriculture and Food, Western Australia. This study forms part of a PhD project by the first author at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Adams MJ, 2005, ARCH VIROL, V150, P459, DOI 10.1007/s00705-004-0440-6; Al Rwahnih M, 2011, ARCH VIROL, V156, P397, DOI 10.1007/s00705-010-0869-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berlandier FA, 1997, ANN APPL BIOL, V131, P297, DOI 10.1111/j.1744-7348.1997.tb05158.x; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Bos L, 1973, CMI AAB DESCRIPTIONS, P111; Buirchell B. J., 2008, Lupins for health and wealth. Proceedings of the 12th International Lupin Conference, Fremantle, Western Australia, 14-18 September 2008, P226; Cheng Y, 2000, ANN APPL BIOL, V136, P215, DOI 10.1111/j.1744-7348.2000.tb00028.x; Cheng Y, 1999, AUST J AGR RES, V50, P589, DOI 10.1071/A98116; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Edwardson JR, 1991, CRC HDB VIRUSES INFE, P137; Hollings M, 1974, CLOVER YELLOW VEIN V; Jones RAC, 2014, VIRUS RES, V186, P3, DOI 10.1016/j.virusres.2013.11.003; Jones R. A. C., 2001, Integrated Pest Management Reviews, V6, P15, DOI 10.1023/A:1020494604184; Jones RAC, 2005, ANN APPL BIOL, V146, P539, DOI 10.1111/j.1744-7348.2005.040148.x; Jones RAC, 2003, AUST J AGR RES, V54, P849, DOI 10.1071/AR03087; JONES RAC, 1989, ANN APPL BIOL, V114, P609, DOI 10.1111/j.1744-7348.1989.tb03376.x; Kehoe MA, 2014, PLANT DIS, V98, P739, DOI [10.1094/PDIS-11-13-1144-RE, 10.1094/PDIS-11-13-1144-]; Kehoe MA, 2014, VIRUS RES, V184, P87, DOI 10.1016/j.virusres.2014.02.012; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; MacDiarmid R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003337; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; PROVVIDENTI R, 1987, J HERED, V78, P126, DOI 10.1093/oxfordjournals.jhered.a110334; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; SCHROEDE.WT, 1971, PHYTOPATHOLOGY, V61, P846, DOI 10.1094/Phyto-61-846; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torrance L, 1986, DEV APPL BIOL, V1, P103; UYEDA I, 1991, INTERVIROLOGY, V32, P234, DOI 10.1159/000150205; Wetterstrand KA, 2014, DNA SEQUENCING COSTS; Wylie SJ, 2008, PLANT DIS, V92, P1596, DOI 10.1094/PDIS-92-12-1596; Wylie SJ, 2014, ARCH VIROL, V159, P1521, DOI 10.1007/s00705-013-1969-z; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x	33	58	61	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104580	10.1371/journal.pone.0104580	http://dx.doi.org/10.1371/journal.pone.0104580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102175	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900076
J	Siegel, KR; Ali, MK; Srinivasiah, A; Nugent, RA; Narayan, KMV				Siegel, Karen R.; Ali, Mohammed K.; Srinivasiah, Adithi; Nugent, Rachel A.; Narayan, K. M. Venkat			Do We Produce Enough Fruits and Vegetables to Meet Global Health Need?	PLOS ONE			English	Article							CONSUMPTION; DISEASE; RISK; OBESITY; POLICY	Background: Low fruit and vegetable (FV) intake is a leading risk factor for chronic disease globally, but much of the world's population does not consume the recommended servings of FV daily. It remains unknown whether global supply of FV is sufficient to meet current and growing population needs. We sought to determine whether supply of FV is sufficient to meet current and growing population needs, globally and in individual countries. Methods and Findings: We used global data on agricultural production and population size to compare supply of FV in 2009 with population need, globally and in individual countries. We found that the global supply of FV falls, on average, 22% short of population need according to nutrition recommendations (supply: need ratio: 0.78 [Range: 0.05-2.01]). This ratio varies widely by country income level, with a median supply: need ratio of 0.42 and 1.02 in low-income and high-income countries, respectively. A sensitivity analysis accounting for need-side food wastage showed similar insufficiency, to a slightly greater extent (global supply: need ratio: 0.66, varying from 0.37 [low-income countries] to 0.77 [high-income countries]). Using agricultural production and population projections, we also estimated supply and need for FV for 2025 and 2050. Assuming medium fertility and projected growth in agricultural production, the global supply: need ratio for FV increases slightly to 0.81 by 2025 and to 0.88 by 2050, with similar patterns seen across country income levels. In a sensitivity analysis assuming no change from current levels of FV production, the global supply: need ratio for FV decreases to 0.66 by 2025 and to 0.57 by 2050. Conclusion: The global nutrition and agricultural communities need to find innovative ways to increase FV production and consumption to meet population health needs, particularly in low-income countries.	[Siegel, Karen R.; Narayan, K. M. Venkat] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA; [Siegel, Karen R.; Ali, Mohammed K.; Narayan, K. M. Venkat] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Srinivasiah, Adithi] Emory Univ, Emory Coll, Atlanta, GA 30322 USA; [Nugent, Rachel A.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Emory University; Emory University; Emory University; University of Washington; University of Washington Seattle	Siegel, KR (corresponding author), Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA.	krsiege@emory.edu	Narayan, K.M. Venkat/J-9819-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Nugent, Rachel/0000-0001-6421-9077; Ali, Mohammed/0000-0001-7266-2503	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007734] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007734] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFT, 2010, 13 MIL MOR ACR; AFT, 2010, AM FARML TRUST SAYS; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; [Anonymous], 2004, GLOBAL TRADE PATTERN; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Bellavia A, 2013, AM J CLIN NUTR, V98, P454, DOI 10.3945/ajcn.112.056119; CDC, 2011, STRAT PREV OB OTH CH; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; FAO, 2009, FOOD AGR ORG FOOD BA; Franck C, 2013, AM J PREV MED, V45, P327, DOI 10.1016/j.amepre.2013.04.010; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Industry PMsCoTa, 2010, REP FOOD AGR IND MAN; Jackson RJ, 2009, J HUNGER ENVIRON NUT, V4, P393, DOI 10.1080/19320240903321367; Joffe M, 2001, PUBLIC HEALTH NUTR, V4, P893, DOI 10.1079/PHN2001126; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lock K, 2004, COMP QUANTIFICATION; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nugent R., 2011, BRINGING AGR TABLE A; Pollan M, 2003, NY TIMES MAGAZINE; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; Sekula W, 1991, WHO Reg Publ Eur Ser, V34, P91; Siegel KR, 2012, DIABETES RES CLIN PR, V96, P76, DOI 10.1016/j.diabres.2011.11.014; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; UNDESA, 2012, WORLD POP PROSP 2012; WHO/FAO, 2003, DIET NUTR; WHO/FAO, 2003, WHO TECHN REP SER; Wolfenden L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008552.pub2	27	99	100	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104059	10.1371/journal.pone.0104059	http://dx.doi.org/10.1371/journal.pone.0104059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099121	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100048
J	Cui, FM; Li, M; Chen, YJ; Liu, YM; He, Y; Jiang, DW; Tong, J; Li, JX; Shen, XR				Cui, Fengmei; Li, Ming; Chen, Yuejin; Liu, Yuming; He, Yin; Jiang, Dingwen; Tong, Jian; Li, Jianxiang; Shen, Xianrong			Protective Effects of Polysaccharides from Sipunculus nudus on Beagle Dogs Exposed to gamma-Radiation	PLOS ONE			English	Article							PROTEIN COMPLEXES; IMMUNITY; AGENTS; MOUSE	The aim of the study is to investigate the radioprotective effect of polysaccharide extract from Sipunculus nudus (SNP). Beagle dogs were randomly divided into the following six groups. Group-1: Un-treated and un-irradiated controls. Group-2: Exposed to a single acute dose of 2 Gy gamma-radiation alone. Groups-3, 4 and 5: Oral administration of SNP at 50, 100 or 200 mg/kg body weight once a day for 7 days followed by a single acute whole body exposure to 2 Gy gamma-radiation. The same doses of SNP were administered for further 27 days. Group-6: Positive controls treated with 1.6 mg/kg Nilestriol by gavage after radiation. Blood parameters including white/red cells and platelet counts, as well as hemoglobin level, were assessed every other day for 34 days (7 days before and 27 days of experiment). Serum separated from aliquots of the same blood sample was used to estimate enzyme activity of antioxidant superoxide-dismutase, and to determine levels of free radical, nitric oxide, hydroxyl and superoxide anion. At the end of the experiment, all dogs were euthanized to weigh the organs for organ co-efficient calculation. Pathological changes were assessed in the bone marrow. The results showed that the dogs exposed to gamma-radiation alone exhibited a typical hematopoietic syndrome. In contrast, at the end of 27 days experiment, dogs received oral administration of SNP+gamma-radiation showed: (i) a much improved blood picture as indicated by shorter duration of leucopenia, neutropenia, thrombocytopenia (platelet counts), as well as hemoglobin levels, (ii) significantly improved hematopoietic activity in the bone marrow, (iii) substantial decrease in nitric oxide levels, and notable increase in activity of antioxidant superoxide dismutase. The results suggested that oral administration of SNP in Beagle dogs was effective in facilitating the recovery of hematopoietic bone marrow damage induced by gamma-radiation.	[Cui, Fengmei; Li, Ming] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Dept Radiotoxicol, Suzhou, Peoples R China; [Chen, Yuejin; Tong, Jian; Li, Jianxiang] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Hlth Toxicol, Suzhou, Peoples R China; [Liu, Yuming; He, Yin; Jiang, Dingwen; Shen, Xianrong] Naval Med Res Inst, Dept Protect Med, Shanghai, Peoples R China	Soochow University - China; Soochow University - China	Li, JX (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Hlth Toxicol, Suzhou, Peoples R China.	aljxcr@suda.edu.cn; xianrong_sh@yahoo.com			National Natural Science Foundation of China [81172706, 81172707]; Province Natural Science Foundation [BK2012618]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Science Foundation; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81172706, 81172707), the Province Natural Science Foundation (BK2012618) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea L, 1993, CANCER IMMUNOL IMMUN, V3, P123; Boice JD, 2012, J RADIOL PROT, V32, pN33, DOI 10.1088/0952-4746/32/1/N33; Borchers AT, 1999, P SOC EXP BIOL MED, V221, P281, DOI 10.1046/j.1525-1373.1999.d01-86.x; Coleman C. Norman, 2003, Radiation Research, V159, P812, DOI 10.1667/RR3021; Guan S. H., 2009, CHINESE MAT MED OCEA; Han SB, 2001, INT IMMUNOPHARMACOL, V1, P1969, DOI 10.1016/S1567-5769(01)00124-2; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Joel S, 2009, IN VIVO, V23, P323; Kim HM, 1996, INT J IMMUNOPHARMACO, V18, P295, DOI 10.1016/0192-0561(96)00028-8; [李珂娴 Li Kexian], 2012, [中国海洋药物, Chinese Journal of Marine Drugs], V31, P46; Liu F, 1999, LIFE SCI, V64, P1005, DOI 10.1016/S0024-3205(99)00027-2; Liu F, 1996, LIFE SCI, V58, P1795, DOI 10.1016/0024-3205(96)00163-4; [刘玉明 Liu Yuming], 2012, [中国海洋药物, Chinese Journal of Marine Drugs], V31, P41; [刘玉明 LIU Yuming], 2011, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V22, P1454; Mao BZ, 2001, BASIS CLIN ACUTE RAD, P152; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Ovodova RG, 1990, CHEM NAT COMPD, V26, P626; Pataje GS, 2012, TRANSL CANC RES, V1, P35; Peng XN, 2007, J GUANGDONG OCEAN U, V27, P54; Pillai TG, 2013, MUTAT RES-GEN TOX EN, V751, P109, DOI 10.1016/j.mrgentox.2012.12.005; Robbins MEC, 2004, INT J RADIAT BIOL, V80, P251, DOI 10.1080/09553000410001692726; Shen XR, 2004, CHINESE J MARINE DRU, V97, P30; Sokolov M, 2013, INT J MOL SCI, V14, P15695, DOI 10.3390/ijms140815695; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Sowby D, 2003, J RADIOL PROT, V23, P157, DOI 10.1088/0952-4746/23/2/303; TSYBULSKY AV, 1990, VOP VIRUSOL+, V35, P194; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; Xia QF, 2009, SHANDONG MED J, V49, P35; ZAPOROZHETS TS, 1985, ANTIBIOT MED BIOTEK, V30, P43	30	16	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104299	10.1371/journal.pone.0104299	http://dx.doi.org/10.1371/journal.pone.0104299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093861	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200092
J	Liu, C; Wang, Y; Zhang, HL; Cheng, S; Charreyre, C; Audonnet, JC; Chen, P; He, QG				Liu, Chong; Wang, Yang; Zhang, Hengling; Cheng, Shuang; Charreyre, Catherine; Audonnet, Jean Christophe; Chen, Pin; He, Qigai			Porcine Coronin 1A Contributes to Nuclear Factor-Kappa B (NF-kappa B) Inactivation during Haemophilus parasuis Infection	PLOS ONE			English	Article							ACTIN-BINDING-PROTEIN; GENE-EXPRESSION; INNATE IMMUNITY; COAT PROTEIN; PK-15 CELLS; SEROVAR 5; MACROPHAGES; ACTIVATION; SURVIVAL; CYTOSKELETON	Haemophilus parasuis (H. parasuis) is the etiological agent of porcine polyserositis and arthritis (Glasser's disease) characterized by fibrinous polyserositis, meningitis and polyarthritis, causing severe economic losses to the swine industry. Currently, the molecular basis of this infection is largely unkonwn. Coronin 1A (Coro1A) plays important roles in host against bacterial infection, yet little is known about porcine Coro1A. In this study, we investigated the molecular characterization of porcine Coro1A, revealing that porcine Coro1A was widely expressed in different tissues. Coro1A could be induced by lipopolysaccharide (LPS), polyinosinic acid-polycytidylic acid [poly (I: C)] and H. parasuis in porcine kidney-15 (PK-15) cells. Functional analyses revealed that porcine Coro1A suppressed the NF-kappa B activation during H. parasuis infection by inhibiting the degradation of I kappa B alpha and nuclear translocation of p65. Overexpression of porcine Coro1A inhibited the transcription of NF-kappa B-mediated downstream genes [Interleukin-6 (IL-6), Interleukin-8 (IL-8) and COX-2] through down-regulation of NF-kappa B. The results indicated that porcine Coro1A is an important immunity related gene that helps to inhibit NF-kappa B activation during H. parasuis infection.	[Liu, Chong; Zhang, Hengling; Cheng, Shuang; Chen, Pin; He, Qigai] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China; [Wang, Yang] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Charreyre, Catherine; Audonnet, Jean Christophe] Merial SAS, Lyon, France	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Merial SASU	He, QG (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China.	he628@mail.hzau.edu.cn			China agriculture research system [CARS-36]; National Basic Research Program (973 Program) [2012CB518802]; Merial SAS, France	China agriculture research system; National Basic Research Program (973 Program)(National Basic Research Program of China); Merial SAS, France	This work was supported by the China agriculture research system (CARS-36), National Basic Research Program (973 Program, grant No. 2012CB518802) and Merial SAS, France (http://www.merial.com). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; AMANO H, 1994, J VET MED SCI, V56, P639, DOI 10.1292/jvms.56.639; Bouchet B, 2008, VET RES, V39, DOI 10.1051/vetres:2008019; Bouchet B, 2009, MICROB PATHOGENESIS, V46, P108, DOI 10.1016/j.micpath.2008.10.008; Chen HB, 2011, DEV COMP IMMUNOL, V35, P490, DOI 10.1016/j.dci.2010.11.017; Chen YS, 2012, VET MICROBIOL, V160, P259, DOI 10.1016/j.vetmic.2012.05.021; Constantoulakis P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-243; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Engler A, 2005, J NEUROIMMUNOL, V162, P103, DOI 10.1016/j.jneuroim.2005.01.017; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Frandoloso R, 2012, VET MICROBIOL, V154, P347, DOI 10.1016/j.vetmic.2011.07.022; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Grogan A, 1997, J CELL SCI, V110, P3071; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Liu XD, 2011, J IMMUNOL, V186, P3031, DOI 10.4049/jimmunol.0902687; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Purcell MK, 2011, FISH SHELLFISH IMMUN, V30, P84, DOI 10.1016/j.fsi.2010.09.007; Roadcap David W., 2008, V48, P124, DOI 10.1007/978-0-387-09595-0_12; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Schiotz BL, 2008, VIRUS RES, V136, P65, DOI 10.1016/j.virusres.2008.04.019; Schmitz F, 2004, EUR J IMMUNOL, V34, P2863, DOI 10.1002/eji.200425228; Segales J, 1997, J VET DIAGN INVEST, V9, P237, DOI 10.1177/104063879700900303; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-68; Wilkinson JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-455; Xavier Charks-Paer, 2008, V48, P98, DOI 10.1007/978-0-387-09595-0_9	42	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103904	10.1371/journal.pone.0103904	http://dx.doi.org/10.1371/journal.pone.0103904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093672	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200043
J	Spadacenta, S; Gallese, V; Fragola, M; Mirabella, G				Spadacenta, Silvia; Gallese, Vittorio; Fragola, Michele; Mirabella, Giovanni			Modulation of Arm Reaching Movements during Processing of Arm/Hand-Related Action Verbs with and without Emotional Connotation	PLOS ONE			English	Article							MOTOR SYSTEM; SEMANTIC RICHNESS; TIME-COURSE; LANGUAGE; EMBODIMENT; ATTENTION; RESPONSES; WORDS	The theory of embodied language states that language comprehension relies on an internal reenactment of the sensorimotor experience associated with the processed word or sentence. Most evidence in support of this hypothesis had been collected using linguistic material without any emotional connotation. For instance, it had been shown that processing of arm-related verbs, but not of those leg-related verbs, affects the planning and execution of reaching movements; however, at present it is unknown whether this effect is further modulated by verbs evoking an emotional experience. Showing such a modulation might shed light on a very debated issue, i. e. the way in which the emotional meaning of a word is processed. To this end, we assessed whether processing arm/hand-related verbs describing actions with negative connotations (e. g. to stab) affects reaching movements differently from arm/hand-related verbs describing actions with neutral connotation (e. g. to comb). We exploited a go/no-go paradigm in which healthy participants were required to perform arm-reaching movements toward a target when verbs expressing emotional hand actions, neutral hand actions or foot actions were shown, and to refrain from moving when no-effector-related verbs were presented. Reaction times and percentages of errors increased when the verb involved the same effector as used to give the response. However, we also found that the size of this interference decreased when the arm/hand-related verbs had a negative emotional connotation. Crucially, we show that such modulation only occurred when the verb semantics had to be retrieved. These results suggest that the comprehension of negatively valenced verbs might require the simultaneous reenactment of the neural circuitry associated with the processing of the emotion evoked by their meaning and of the neural circuitry associated with their motor features.	[Spadacenta, Silvia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, PhD Program Neurophysiol, I-00185 Rome, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Fragola, Michele; Mirabella, Giovanni] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy; [Spadacenta, Silvia; Mirabella, Giovanni] Ist Neurol Mediterraneo Neuromed, Pozzilli, IS, Italy	Sapienza University Rome; University of Parma; Sapienza University Rome; IRCCS Neuromed	Mirabella, G (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	giovanni.mirabella@uniroma1.it	ferraina, stefano/M-5230-2018; Gallese, Vittorio/ABD-5097-2021; Mirabella, Giovanni/AAB-2818-2019	ferraina, stefano/0000-0001-6100-2438; Gallese, Vittorio/0000-0003-4815-3607; Mirabella, Giovanni/0000-0002-4405-2609	Italian Ministry of Work, Health and Social Policies; Italian Ministry of University and Research [2008_RBFNLH_005]	Italian Ministry of Work, Health and Social Policies(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This research was supported by the Italian Ministry of Work, Health and Social Policies (Bando Giovani Ricercatori 2007 to G.M.) and by the Italian Ministry of University and Research (PRIN n.2008_RBFNLH_005 to G.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bertinetto P. M., 2005, CORPUS LESSICO FREQU; Boulenger V, 2008, NEUROPSYCHOLOGIA, V46, P743, DOI 10.1016/j.neuropsychologia.2007.10.007; Bradley M., 1999, TECHNICAL REPORT, DOI DOI 10.1109/MIC.2008.114; Buccino G, 2005, COGNITIVE BRAIN RES, V24, P355, DOI 10.1016/j.cogbrainres.2005.02.020; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Ferri F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054091; Fodor J. A, 1983, MODULARITY MIND; Foroni F, 2009, PSYCHOL SCI, V20, P974, DOI 10.1111/j.1467-9280.2009.02400.x; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, HUM BRAIN MAPP, V21, P191, DOI 10.1002/hbm.10157; Havas DA, 2007, PSYCHON B REV, V14, P436, DOI 10.3758/BF03194085; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kuperman V, 2014, J EXP PSYCHOL GEN, V143, P1065, DOI 10.1037/a0035669; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; McKenna FP, 2004, J EXP PSYCHOL LEARN, V30, P382, DOI 10.1037/0278-7393.30.2.382; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Mirabella G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062793; Mirabella G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035403; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nasrallah M, 2009, EMOTION, V9, P609, DOI 10.1037/a0016305; Neininger B, 2003, NEUROPSYCHOLOGIA, V41, P53, DOI 10.1016/S0028-3932(02)00126-4; Newcombe PI, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00275; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pexman PM, 2008, PSYCHON B REV, V15, P161, DOI 10.3758/PBR.15.1.161; Postle N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00011; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Pulvermuller F, 2013, BRAIN LANG, V127, P86, DOI 10.1016/j.bandl.2013.05.015; Pulvermuller F, 2005, EUR J NEUROSCI, V21, P793, DOI 10.1111/j.1460-9568.2005.03900.x; Raaijmakers JGW, 2003, CAN J EXP PSYCHOL, V57, P141, DOI 10.1037/h0087421; Sato M, 2008, BRAIN LANG, V105, P83, DOI 10.1016/j.bandl.2007.10.001; Scorolli C, 2007, BRAIN RES, V1130, P119, DOI 10.1016/j.brainres.2006.10.033; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; SOLARZ AK, 1960, J EXP PSYCHOL, V59, P239, DOI 10.1037/h0047274; Vigliocco G, 2014, CEREB CORTEX, V24, P1767, DOI 10.1093/cercor/bht025; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Yap MJ, 2011, PSYCHON B REV, V18, P742, DOI 10.3758/s13423-011-0092-y	49	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104349	10.1371/journal.pone.0104349	http://dx.doi.org/10.1371/journal.pone.0104349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093410	Green Published, gold			2022-12-25	WOS:000341357200103
J	Uraji, M; Arima, J; Inoue, Y; Harazono, K; Hatanaka, T				Uraji, Misugi; Arima, Jiro; Inoue, Yoshikazu; Harazono, Koichi; Hatanaka, Tadashi			Application of Two Newly Identified and Characterized Feruloyl Esterases from Streptomyces sp in the Enzymatic Production of Ferulic Acid from Agricultural Biomass	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; THERMOBIFIDA-FUSCA; OXIDATIVE STRESS; ETHYL-ESTER; PURIFICATION; EXPRESSION; RELEASE; GENE; BRAN	Ferulic acid (FA), a component of hemicellulose in plant cell walls, is a phenolic acid with several potential applications based on its antioxidant properties. Recent studies have shown that feruloyl esterase (FAE) is a key bacterial enzyme involved in FA production from agricultural biomass. In this study, we screened a library of 43 esterases from Streptomyces species and identified two enzymes, R18 and R43, that have FAE activity toward ethyl ferulate. In addition, we characterized their enzyme properties in detail. R18 and R43 showed esterase activity toward other hydroxycinnamic acid esters as well, such as methyl p-coumarate, methyl caffeate, and methyl sinapinate. The amino acid sequences of R18 and R43 were neither similar to each other, nor to other FAEs. We found that R18 and R43 individually showed the ability to produce FA from corn bran; however, combination with other Streptomyces enzymes, namely xylanase and a-L-arabinofuranosidase, increased FA production from biomass such as corn bran, defatted rice bran, and wheat bran. These results suggest that R18 and R43 are effective FAEs for the enzymatic production of FA from biomass.	[Uraji, Misugi; Hatanaka, Tadashi] Okayama Prefectural Technol Ctr Agr Forestry & Fi, RIBS, Okayama, Japan; [Arima, Jiro] Tottori Univ, Fac Agr, Dept Agr Biol & Environm Sci, Tottori 680, Japan; [Inoue, Yoshikazu] Satake Corp, Higashihiroshima, Hiroshima, Japan; [Harazono, Koichi] Nagase ChemteX Corp, Enzyme Div, Bio Chem Dept, Fukuchiyama, Kyoto, Japan	Tottori University	Hatanaka, T (corresponding author), Okayama Prefectural Technol Ctr Agr Forestry & Fi, RIBS, Okayama, Japan.	hatanaka@bio-ribs.com						Agger J, 2010, J AGR FOOD CHEM, V58, P6141, DOI 10.1021/jf100633f; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Crepin VF, 2004, APPL MICROBIOL BIOT, V63, P647, DOI 10.1007/s00253-003-1476-3; Di Domenico F, 2009, FREE RADICAL RES, V43, P365, DOI 10.1080/10715760902777329; Dobberstein D, 2010, J AGR FOOD CHEM, V58, P8927, DOI 10.1021/jf101514j; FAULDS CB, 1995, APPL MICROBIOL BIOT, V43, P1082, DOI 10.1007/BF00166929; FAULDS CB, 1991, J GEN MICROBIOL, V137, P2339, DOI 10.1099/00221287-137-10-2339; Hatanaka T, 2008, PROTEIN EXPRES PURIF, V62, P244, DOI 10.1016/j.pep.2008.09.001; Huang YC, 2011, BIORESOURCE TECHNOL, V102, P8117, DOI 10.1016/j.biortech.2011.05.062; Huang YC, 2010, BIOCHEM BIOPH RES CO, V400, P718, DOI 10.1016/j.bbrc.2010.08.136; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kheder F, 2009, CAN J MICROBIOL, V55, P729, DOI [10.1139/W09-027, 10.1139/w09-027]; Koseki T, 2005, BBA-GEN SUBJECTS, V1722, P200, DOI 10.1016/j.bbagen.2004.12.016; Koseki T, 1998, BIOSCI BIOTECH BIOCH, V62, P2032, DOI 10.1271/bbb.62.2032; Koseki T, 2009, APPL MICROBIOL BIOT, V84, P803, DOI 10.1007/s00253-009-2148-8; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; ROSAZZA JP, 1999, J IN DMICROBIOL, V15, P457; Rose DJ, 2010, J AGR FOOD CHEM, V58, P493, DOI 10.1021/jf9020416; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Topakas E, 2007, PROCESS BIOCHEM, V42, P497, DOI 10.1016/j.procbio.2007.01.007; Tsujibo H, 2002, BIOSCI BIOTECH BIOCH, V66, P434, DOI 10.1271/bbb.66.434; TSUJIBO H, 1992, APPL ENVIRON MICROB, V58, P371, DOI 10.1128/AEM.58.1.371-375.1992; Uraji M, 2013, APPL BIOCHEM BIOTECH, V171, P1085, DOI 10.1007/s12010-013-0190-6; Wong DWS, 2006, APPL BIOCHEM BIOTECH, V133, P87, DOI 10.1385/ABAB:133:2:87; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047	27	23	23	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104584	10.1371/journal.pone.0104584	http://dx.doi.org/10.1371/journal.pone.0104584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093500	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200113
J	Wang, LG; Feng, XY; Zhao, H; Wang, LD; An, LZ; Qiu, QS				Wang, Liguang; Feng, Xueying; Zhao, Hong; Wang, Lidong; An, Lizhe; Qiu, Quan-Sheng			Functional Analysis of the Na+, K+/H+ Antiporter PeNHX3 from the Tree Halophyte Populus euphratica in Yeast by Model-Guided Mutagenesis	PLOS ONE			English	Article							SALT TOLERANCE; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ION HOMEOSTASIS; EXCHANGER NHX1P; MORNING GLORY; PLANT-GROWTH; PROTEIN; ROLES; SOS1	Na+, K+/H+ antiporters are H+-coupled cotransporters that are crucial for cellular homeostasis. Populus euphratica, a well-known tree halophyte, contains six Na+/H+ antiporter genes (PeNHX1-6) that have been shown to function in salt tolerance. However, the catalytic mechanisms governing their ion transport remain largely unknown. Using the crystal structure of the Na+/H+ antiporter from the Escherichia coli (EcNhaA) as a template, we built the three-dimensional structure of PeNHX3 from P. euphratica. The PeNHX3 model displays the typical TM4-TM11 assembly that is critical for ion binding and translocation. The PeNHX3 structure follows the ` positive-inside' rule and exhibits a typical physicochemical property of the transporter proteins. Four conserved residues, including Tyr149, Asn187, Asp188, and Arg356, are indentified in the TM4-TM11 assembly region of PeNHX3. Mutagenesis analysis showed that these reserved residues were essential for the function of PeNHX3: Asn187 and Asp188 (forming a ND motif) controlled ion binding and translocation, and Tyr149 and Arg356 compensated helix dipoles in the TM4-TM11 assembly. PeNHX3 mediated Na+, K+ and Li+ transport in a yeast growth assay. Domainswitch analysis shows that TM11 is crucial to Li+ transport. The novel features of PeNHX3 in ion binding and translocation are discussed.	[Wang, Liguang; Feng, Xueying; Zhao, Hong; Wang, Lidong; An, Lizhe; Qiu, Quan-Sheng] Lanzhou Univ, MOE Key Lab Cell Activ & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University	Qiu, QS (corresponding author), Lanzhou Univ, MOE Key Lab Cell Activ & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31371438, 31070222]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20130211110001]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (973 project, 2013CB429904 to QSQ), the National Natural Science Foundation of China (NSFC) (31371438, 31070222 to QSQ), the Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20130211110001 to QSQ), and the Fundamental Research Funds for the Central Universities (lzujbky-2013-k10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Bressan R, 2009, MOL PLANT, V2, P1, DOI 10.1093/mp/ssn097; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Chanroj S, 2011, J BIOL CHEM, V286, P33931, DOI 10.1074/jbc.M111.252650; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo Y, 2004, PLANT CELL, V16, P435, DOI 10.1105/tpc.019174; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lawrence SP, 2010, MOL BIOL CELL, V21, P3540, DOI 10.1091/mbc.E09-12-1053; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Mitsui K, 2011, J BIOL CHEM, V286, P37625, DOI 10.1074/jbc.M111.260612; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Orsini F, 2010, J EXP BOT, V61, P3787, DOI 10.1093/jxb/erq188; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Pierri CL, 2010, BBA-PROTEINS PROTEOM, V1804, P1695, DOI 10.1016/j.bbapap.2010.04.008; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Qiu QS, 2012, J GENET GENOMICS, V39, P167, DOI 10.1016/j.jgg.2012.02.001; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Ye CY, 2009, PHYSIOL PLANTARUM, V137, P166, DOI 10.1111/j.1399-3054.2009.01269.x; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoshida K, 2005, PLANT CELL PHYSIOL, V46, P407, DOI 10.1093/pcp/pci057; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	10	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104147	10.1371/journal.pone.0104147	http://dx.doi.org/10.1371/journal.pone.0104147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093858	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200074
J	Wang, WQ; Bielefeldt-Ohmann, H; Traub, RJ; Cuttell, L; Owen, H				Wang, Wenqi; Bielefeldt-Ohmann, Helle; Traub, Rebecca J.; Cuttell, Leigh; Owen, Helen			Location and Pathogenic Potential of Blastocystis in the Porcine Intestine	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; HOMINIS INFECTION; ZOO ANIMALS; IDENTIFICATION; PREDOMINANCE; DIVERSITY; DIAGNOSIS; CHILDREN; SUBTYPES; MODEL	Blastocystis is an ubiquitous, enteric protozoan of humans and many other species. Human infection has been associated with gastrointestinal disease such as irritable bowel syndrome, however, this remains unproven. A relevant animal model is needed to investigate the pathogenesis/pathogenicity of Blastocystis. We concluded previously that pigs are likely natural hosts of Blastocystis with a potentially zoonotic, host-adapted subtype (ST), ST5, and may make suitable animal models. In this study, we aimed to characterise the host-agent interaction of Blastocystis and the pig, including localising Blastocystis in porcine intestine using microscopy, PCR and histopathological examination of tissues. Intestines from pigs in three different management systems, i.e., a commercial piggery, a small family farm and a research herd (where the animals were immunosuppressed) were examined. This design was used to determine if environment or immune status influences intestinal colonisation of Blastocystis as immunocompromised individuals may potentially be more susceptible to blastocystosis and development of associated clinical signs. Intestines from all 28 pigs were positive for Blastocystis with all pigs harbouring ST5. In addition, the farm pigs had mixed infections with STs 1 and/or 3. Blastocystis organisms/DNA were predominantly found in the large intestine but were also detected in the small intestine of the immunosuppressed and some of the farm pigs, suggesting that immunosuppression and/or husbandry factors may influence Blastocystis colonisation of the small intestine. No obvious pathology was observed in the histological sections. Blastocystis was present as vacuolar/granular forms and these were found within luminal material or in close proximity to epithelial cells, with no evidence of attachment or invasion. These results concur with most human studies, in which Blastocystis is predominantly found in the large intestine in the absence of significant organic pathology. Our findings also support the use of pigs as animal models and may have implications for blastocystosis diagnosis/treatment.	[Wang, Wenqi; Bielefeldt-Ohmann, Helle; Cuttell, Leigh; Owen, Helen] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Bielefeldt-Ohmann, Helle] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Traub, Rebecca J.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia	University of Queensland; University of Queensland; University of Melbourne	Wang, WQ (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	w.wang3@uq.edu.au	Traub, Rebecca/A-4273-2013	Traub, Rebecca/0000-0002-7484-7592	William Peter Richards Trust; University of Queensland [2010000368]	William Peter Richards Trust; University of Queensland(University of Queensland)	Financial support for this project has been provided for by: 1) William Peter Richards Trust Award Grant (WW) and 2) The University of Queensland New Staff Start-up Grant, Research Master number: 2010000368 (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafeez EH, 2012, KOREAN J PARASITOL, V50, P57, DOI 10.3347/kjp.2012.50.1.57; Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Aggarwal V, 1998, ARCH DIS CHILD, V78, P5, DOI 10.1136/adc.78.1.5; Agholi M, 2013, AIDS RES HUM RETROV, V29, P35, DOI [10.1089/aid.2012.0119, 10.1089/AID.2012.0119]; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; ALTAWIL YS, 1994, ARCH PEDIAT ADOL MED, V148, P882, DOI 10.1001/archpedi.1994.02170080112026; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Carrascosa M, 1996, ANN INTERN MED, V124, P278, DOI 10.7326/0003-4819-124-2-199601150-00031; Chandramathi S, 2012, T ROY SOC TROP MED H, V106, P267, DOI 10.1016/j.trstmh.2011.12.008; Clark CG, 1997, MOL BIOCHEM PARASIT, V87, P79, DOI 10.1016/S0166-6851(97)00046-7; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Fayer R, 2014, PARASITOL RES, V113, P1465, DOI 10.1007/s00436-014-3787-y; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Idris NS, 2010, J INFECT DEV COUNTR, V4, P309, DOI 10.3855/jidc.275; Iguchi A, 2007, PARASITOL INT, V56, P107, DOI 10.1016/j.parint.2006.12.004; Janarthanan S, 2011, ENDOSCOPY, V43, pE185, DOI 10.1055/s-0030-1256322; JEDDY TA, 1991, J ROY SOC MED, V84, P623; JONES WR, 1946, ANN TROP MED PARASIT, V40, P130, DOI 10.1080/00034983.1946.11685270; Kraaij MD, 2011, MOL IMMUNOL, V49, P549, DOI 10.1016/j.molimm.2011.10.002; Laodim P, 2012, FOODBORNE PATHOG DIS, V9, P1077, DOI 10.1089/fpd.2012.1177; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Li J, 2013, PARASITOL RES, V112, P3537, DOI 10.1007/s00436-013-3536-7; Marcos LA, 2013, CURR OPIN INFECT DIS, V26, P302, DOI [10.1097/QCO.0b013e3283630e85, 10.1097/QCO.0b013e3283630be3]; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Mounsey K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000756; PHILLIPS BP, 1976, EXP PARASITOL, V36, P358, DOI 10.1016/0014-4894(76)90039-4; Poirier P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002545; Preacher KJ, 2001, CALCULATION CHI SQUA; Roelen DL, 2008, TRANSPL IMMUNOL, V19, P220, DOI 10.1016/j.trim.2008.06.004; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold R, 2006, J PARASITOL, V92, P1081, DOI 10.1645/GE-840R.1; Tai WP, 2011, PARASITOL RES, V108, P1207, DOI 10.1007/s00436-010-2164-8; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wang WQ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-215; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yoshikawa H, 2004, PARASITOL RES, V94, P391, DOI 10.1007/s00436-004-1230-5	43	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103962	10.1371/journal.pone.0103962	http://dx.doi.org/10.1371/journal.pone.0103962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093578	Green Published, gold			2022-12-25	WOS:000341357200051
J	Jin, MF; Yang, ZJ; Ye, WP; Xu, HL; Hua, XL				Jin, Minfei; Yang, Zujing; Ye, Weiping; Xu, Hongling; Hua, Xiaolin			MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; POOR-PROGNOSIS; EXPRESSION; LYMPHOMA; MIR-150; GROWTH; BIOMARKERS; UPDATE	MicroRNA (miR)-150 has been reported to be dramatically downregulated in human epithelial ovarian cancer (EOC) tissues and patients' serum compared to normal controls. This study aimed to investigate clinical significance and molecular mechanisms of miR-150 in EOC. In the current study, quantitative real-time PCR analysis showed that miR-150 was significantly downregulated in human EOC tissues compared to normal tissue samples. Then, we demonstrated the significant associations of miR-150 downregulation with aggressive clinicopathological features of EOC patients, including high clinical stage and pathological grade, and shorter overall and progression-free survivals. More importantly, the multivariate analysis identified miR-150 expression as an independent prognostic biomarker in EOC. After that, luciferase reporter assays demonstrated that Zinc Finger E-Box Binding Homeobox 1 (ZEB1), a crucial regulator of epithelial-to-mesenchymal transition (EMT), was a direct target of miR-150 in EOC cells. Moreover, we found that the ectopic expression of miR-150 could efficiently inhibit cell proliferation, invasion and metastasis by suppressing the expression of ZEB1. Furthermore, we also observed a significantly negative correlation between miR-150 and ZEB1 mRNA expression in EOC tissues (rs = -0.45, P < 0.001). In conclusion, these findings offer the convincing evidence that aberrant expression of miR-150 may play a role in tumor progression and prognosis in patients with EOC. Moreover, our data reveal that miR-150 may function as a tumor suppressor and modulate EOC cell proliferation, and invasion by directly and negatively regulating ZEB1, implying the re-expression of miR-150 might be a potential therapeutic strategy for EOC.	[Jin, Minfei; Yang, Zujing; Ye, Weiping; Xu, Hongling; Hua, Xiaolin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Hua, XL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	huaxiaolin2014@163.com			Natural Science Foundation of Shanghai Municipal Health Bureau [20114y079]; Medicine and Engineering Foundation of Shanghai Jiaotong University [YG2011MS33]	Natural Science Foundation of Shanghai Municipal Health Bureau; Medicine and Engineering Foundation of Shanghai Jiaotong University	This study was supported by the Natural Science Foundation of Shanghai Municipal Health Bureau (No. 20114y079); Medicine and Engineering Foundation of Shanghai Jiaotong University (No. YG2011MS33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DY, 2013, INT J GYNECOL CANCER, V23, P1357, DOI 10.1097/IGC.0b013e3182a5e760; Chen ZL, 2013, HUM PATHOL, V44, P2097, DOI 10.1016/j.humpath.2013.04.001; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Foley OW, 2013, ONCOLOGY-NY, V27, P288; Gebauer N, 2014, CANCER GENOM PROTEOM, V11, P51; Gu XY, 2014, TUMOR BIOL IN PRESS; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Liu YQ, 2014, J BIOL CHEM, V289, P4116, DOI 10.1074/jbc.M113.533505; Lobert S, 2013, BIOCHEMISTRY-US, V52, P5482, DOI 10.1021/bi400340g; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Minig L, 2013, CLIN TRANSL ONCOL, V15, P259, DOI 10.1007/s12094-012-0963-3; Mraz M, 2014, BLOOD IN PRESS; Quan Y, 2014, CANC BIOL T IN PRESS; Roche Joelle, 2013, Cancers (Basel), V5, P334, DOI 10.3390/cancers5020334; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Wang M, 2014, EXP MOL PATHOL, V96, P261, DOI 10.1016/j.yexmp.2014.02.015; Wang YQ, 2013, J CELL BIOCHEM, V114, P1464, DOI 10.1002/jcb.24488; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wu HJ, 2013, BIOCHEM BIOPH RES CO, V441, P693, DOI 10.1016/j.bbrc.2013.10.053; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xu LJ, 2013, J CANCER RES CLIN, V139, P1257, DOI 10.1007/s00432-013-1435-z; Yang Y, 2014, J CLIN INVE IN PRESS; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Yokobori T, 2013, CANCER SCI, V104, P48, DOI 10.1111/cas.12030; Zaman MS, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-44; Zhang GJ, 2013, ONCOL LETT, V5, P564, DOI 10.3892/ol.2012.1026	32	62	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103965	10.1371/journal.pone.0103965	http://dx.doi.org/10.1371/journal.pone.0103965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090005	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700071
J	Li, LL; Sun, J; Xu, CQ; Zhang, HY; Wu, JF; Liu, BJ; Dong, JC				Li, Lulu; Sun, Jing; Xu, Changqing; Zhang, Hongying; Wu, Jinfeng; Liu, Baojun; Dong, Jingcheng			Icariin Ameliorates Cigarette Smoke Induced Inflammatory Responses via Suppression of NF-kappa B and Modulation of GR In Vivo and In Vitro	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; AIRWAY INFLAMMATION; EPITHELIAL-CELLS; LUNG-FUNCTION; ASTHMA; TRANSCRIPTION; RESISTANCE; PATHWAY; BURDEN	Purpose: To investigate the effects of icariin, a major constituent of flavonoids isolated from the herb Epimedium, on cigarette smoke (CS) induced inflammatory responses in vivo and in vitro. Methods: In vivo, BALB/c mice were exposed to smoke of 15 cigarettes for 1 h/day, 6 days/week for 3 months and dosed with icariin (25, 50 and 100 mg/kg) or dexamethasone (1 mg/kg). In vitro, A549 cells were incubated with icariin (10, 50 and 100 mu M) followed by treatments with CSE (2.5%). Results: We found that icariin significantly protected pulmonary function and attenuated CS-induced inflammatory response by decreasing inflammatory cells and production of TNF-alpha, IL-8 and MMP-9 in both the serum and BALF of CS-exposed mice and decreasing production of TNF-alpha and IL-8 in the supernatant of CSE-exposed A549 cells. Icariin also showed properties in inhibiting the phosphorylation of NF-kappa B p65 protein and blocking the degradation of IKB-alpha protein. Further studies revealed that icariin administration markedly restore CS-reduced GR protein and mRNA expression, which might subsequently contribute to the attenuation of CS-induced respiratory inflammatory response. Conclusion: Together these results suggest that icariin has anti-inflammatory effects in cigarette smoke induced inflammatory models in vivo and in vitro, possibly achieved by suppressing NF-kappa B activation and modulating GR protein expression.	[Li, Lulu; Sun, Jing; Zhang, Hongying; Wu, Jinfeng; Liu, Baojun; Dong, Jingcheng] Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Xu, Changqing] Hangzhou Normal Univ, Sch Med, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Fudan University; Hangzhou Normal University	Dong, JC (corresponding author), Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China.	jcdong2004@126.com		Dong, Jingcheng/0000-0002-5194-367X; Wu, Jinfeng/0000-0002-9579-9163	National Basic Science Program of China [2009CB523000]; National Natural Science Foundation of China [81102541, 81173390, 81302931]; Inheritance base of Yun's converged traditional and western medicine	National Basic Science Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inheritance base of Yun's converged traditional and western medicine	This project was funded by grants from National Basic Science Program of China (2009CB523000), National Natural Science Foundation of China (81102541, 81173390 and 81302931) and Inheritance base of Yun's converged traditional and western medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock Ian M, 2005, Proc Am Thorac Soc, V2, P313, DOI 10.1513/pats.200504-035SR; Baginski TK, 2006, AM J RESP CELL MOL, V35, P165, DOI 10.1165/rcmb.2005-0259OC; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes Peter J, 2004, Proc Am Thorac Soc, V1, P345, DOI 10.1513/pats.200409-045MS; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Barnes PJ, 2003, ANNU REV MED, V54, P113, DOI 10.1146/annurev.med.54.101601.152209; Barnes PJ, 2000, AM J RESP CRIT CARE, V161, P342; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P74, DOI 10.1164/rccm.200409-1257OC; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; HE W, 1995, ARZNEIMITTELFORSCH, V45-2, P910; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Korn SH, 1998, RESP MED, V92, P1102, DOI 10.1016/S0954-6111(98)90402-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Panayiotidis MI, 2004, CHEM-BIOL INTERACT, V147, P87, DOI 10.1016/j.cbi.2003.10.009; Plumb J, 2011, INT IMMUNOPHARMACOLO; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Sabroe I, 2007, AM J RESP CRIT CARE, V175, P306, DOI 10.1164/rccm.200606-777PP; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Turato G, 2002, AM J RESP CRIT CARE, V166, P105, DOI 10.1164/rccm.2111084; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wu JF, 2011, IMMUNOPHARM IMMUNOT, V33, P49, DOI 10.3109/08923971003725144; Wu JF, 2011, PHARMACOL BIOCHEM BE, V98, P273, DOI 10.1016/j.pbb.2011.01.008; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Zeng LX, 2010, PULM PHARMACOL THER, V23, P411, DOI 10.1016/j.pupt.2010.05.004	41	30	39	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102345	10.1371/journal.pone.0102345	http://dx.doi.org/10.1371/journal.pone.0102345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089961	gold, Green Submitted, Green Published			2022-12-25	WOS:000339812700005
J	Liu, CH; Hu, RH; Huang, MJ; Lai, IR; Chen, CH; Lai, HS; Wu, YM; Huang, MC				Liu, Chiung-Hui; Hu, Rey-Heng; Huang, Miao-Juei; Lai, I-Rue; Chen, Chia-Hua; Lai, Hong-Shiee; Wu, Yao-Ming; Huang, Min-Chuan			C1GALT1 Promotes Invasive Phenotypes of Hepatocellular Carcinoma Cells by Modulating Integrin beta 1 Glycosylation and Activity	PLOS ONE			English	Article							N-ACETYLGALACTOSAMINYLTRANSFERASE 6; FOCAL ADHESION KINASE; BREAST-CANCER; ALPHA-2-BETA-1 INTEGRIN; O-GLYCOSYLATION; METASTASIS; GROWTH; EXPRESSION; BETA-1-INTEGRIN; PROGRESSION	Cancer cell invasion and metastasis are the primary causes of treatment failure and death in hepatocellular carcinoma (HCC). We previously reported that core 1 beta 1,3-galactosyltransferase (C1GALT1) is frequently overexpressed in HCC tumors and its expression is associated with advanced tumor stage, metastasis, and poor survival. However, the underlying mechanisms of C1GALT1 in HCC malignancy remain unclear. In this study, we found that overexpression of C1GALT1 enhanced HCC cell adhesion to extracellular matrix (ECM) proteins, migration, and invasion, whereas RNAi-mediated knockdown of C1GALT1 suppressed these phenotypes. The promoting effect of C1GALT1 on the metastasis of HCC cells was demonstrated in a mouse xenograft model. Mechanistic investigations showed that the C1GALT1-enhanced phenotypic changes in HCC cells were significantly suppressed by anti-integrin beta 1 blocking antibody. Moreover, C1GALT1 was able to modify O-glycans on integrin beta 1 and regulate integrin beta 1 activity as well as its downstream signaling. These results suggest that C1GALT1 could enhance HCC invasiveness through integrin beta 1 and provide novel insights into the roles of O-glycosylation in HCC metastasis.	[Liu, Chiung-Hui; Huang, Miao-Juei; Lai, I-Rue; Chen, Chia-Hua; Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei, Taiwan; [Hu, Rey-Heng; Lai, I-Rue; Lai, Hong-Shiee; Wu, Yao-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Huang, Miao-Juei; Wu, Yao-Ming; Huang, Min-Chuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wu, YM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	wyaoming@gmail.com; mchuang@ntu.edu.tw	Liu, Chiung-Hui/K-2974-2016	Liu, Chiung-Hui/0000-0002-2656-2576; Chen, Chia-Hua/0000-0003-0536-8085	National Taiwan University [101R7808]; National Science Council NSC [NSC 99-3111-B-002-006, NSC 101-2314-B-002-053-MY2, NSC 101-2320-B-002-007-MY3]	National Taiwan University(National Taiwan University); National Science Council NSC(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from the National Taiwan University 101R7808 (Dr. Min-Chuan Huang), the National Science Council NSC NSC 99-3111-B-002-006 (Dr. Yao-Ming Wu), NSC 101-2314-B-002-053-MY2 (Dr. Rey-Heng Hu), and NSC 101-2320-B-002-007-MY3 (Dr. Min-Chuan Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Chang HH, 2013, CLIN CANCER RES, V19, P1705, DOI 10.1158/1078-0432.CCR-12-2367; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Kotani N, 1999, BIOCHEM BIOPH RES CO, V260, P94, DOI 10.1006/bbrc.1999.0872; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liao WC, 2012, PLACENTA, V33, P1005, DOI 10.1016/j.placenta.2012.08.007; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Marcucci F, 2013, INT J CANC; Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146; Mccall-Culbreath KD, 2008, BLOOD, V111, P3562, DOI 10.1182/blood-2007-08-107664; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Perrine C, 2009, GLYCOBIOLOGY, V19, P321, DOI 10.1093/glycob/cwn143; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Shen XH, 2010, WORLD J SURG, V34, P1028, DOI 10.1007/s00268-010-0400-0; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Wei YY, 2008, J HEPATOL, V49, P1029, DOI 10.1016/j.jhep.2008.09.003; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Yang CQ, 2003, CANCER RES, V63, P8312; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414	48	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e94995	10.1371/journal.pone.0094995	http://dx.doi.org/10.1371/journal.pone.0094995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089569	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700001
J	Qiu, YJ; Nakao, R; Ohnuma, A; Kawamori, F; Sugimoto, C				Qiu, Yongjin; Nakao, Ryo; Ohnuma, Aiko; Kawamori, Fumihiko; Sugimoto, Chihiro			Microbial Population Analysis of the Salivary Glands of Ticks; A Possible Strategy for the Surveillance of Bacterial Pathogens	PLOS ONE			English	Article							SPOTTED-FEVER; BOOPHILUS-MICROPLUS; FUKUI PREFECTURE; BORNE PATHOGENS; SPIROPLASMA-SP; RICKETTSIA; COXIELLA; SPP.; DNA; ENDOSYMBIONTS	Ticks are one of the most important blood-sucking vectors for infectious microorganisms in humans and animals. When feeding they inject saliva, containing microbes, into the host to facilitate the uptake of blood. An understanding of the microbial populations within their salivary glands would provide a valuable insight when evaluating the vectorial capacity of ticks. Three tick species (Ixodes ovatus, I. persulcatus and Haemaphysalis flava) were collected in Shizuoka Prefecture of Japan between 2008 and 2011. Each tick was dissected and the salivary glands removed. Bacterial communities in each salivary gland were characterized by 16S amplicon pyrosequencing using a 454 GS-Junior Next Generation Sequencer. The Ribosomal Database Project (RDP) Classifier was used to classify sequence reads at the genus level. The composition of the microbial populations of each tick species were assessed by principal component analysis (PCA) using the Metagenomics RAST (MG-RAST) metagenomic analysis tool. Rickettsia-specific PCR was used for the characterization of rickettsial species. Almost full length of 16S rDNA was amplified in order to characterize unclassified bacterial sequences obtained in I. persulcatus female samples. The numbers of bacterial genera identified for the tick species were 71 (I. ovatus), 127 (I. persulcatus) and 59 (H. flava). Eighteen bacterial genera were commonly detected in all tick species. The predominant bacterial genus observed in all tick species was Coxiella. Spiroplasma was detected in Ixodes, and not in H. flava. PCA revealed that microbial populations in tick salivary glands were different between tick species, indicating that host specificities may play an important role in determining the microbial complement. Four female I. persulcatus samples contained a high abundance of several sequences belonging to Alphaproteobacteria symbionts. This study revealed the microbial populations within the salivary glands of three species of ticks, and the results will contribute to the knowledge and prediction of emerging tick-borne diseases.	[Qiu, Yongjin; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan; [Nakao, Ryo] Hokkaido Univ, Res Ctr Zoonosis Control, Unit Risk Anal & Management, Sapporo, Hokkaido, Japan; [Ohnuma, Aiko] Hokkaido Univ, Res Ctr Zoonosis Control, Adm Off, Sapporo, Hokkaido, Japan; [Kawamori, Fumihiko] Shizuoka Prefectural Inst Publ Hlth & Environm Sc, Dept Microbiol, Shizuoka, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sugimoto, C (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan.	sugimoto@czc.hokudai.ac.jp	Sugimoto, Chihiro/F-6583-2012	Sugimoto, Chihiro/0000-0002-8708-0140; Qiu, Yongjin/0000-0001-8621-5472	Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID); Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" from the Ministry of Education, Culture, Sports, Science and Technology (NEXT)	Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID); Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" from the Ministry of Education, Culture, Sports, Science and Technology (NEXT)	This work was funded by the Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID) (http://www.crnid.riken.jp/jgrid/en/) and the Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" (http://www.jsps.go.jp/english/index.html) from the Ministry of Education, Culture, Sports, Science and Technology (NEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahantarig A, 2013, FOLIA MICROBIOL, V58, P419, DOI 10.1007/s12223-013-0222-1; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bastian FO, 2007, J MED MICROBIOL, V56, P1235, DOI 10.1099/jmm.0.47159-0; BENACH JL, 1987, J INFECT DIS, V155, P1300, DOI 10.1093/infdis/155.6.1300; Bernasconi MV, 2002, INFECT GENET EVOL, V2, P111, DOI 10.1016/S1567-1348(02)00092-8; Berrada ZL, 2009, TOP COMPANION ANIM M, V24, P175, DOI 10.1053/j.tcam.2009.06.005; Bonnet S, 2013, VECTOR-BORNE ZOONOT, V13, P226, DOI 10.1089/vbz.2011.0933; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Cooper A, 2013, VECTOR-BORNE ZOONOT, V13, P12, DOI 10.1089/vbz.2011.0853; Erickson DL, 2009, J MED ENTOMOL, V46, P1532, DOI 10.1603/033.046.0642; Fournier PE, 2002, J CLIN MICROBIOL, V40, P2176, DOI 10.1128/JCM.40.6.2176-2181.2002; Fujita H, 2007, ANN REPORT OHARA GEN, V47, P4; Fujita H, 2006, INT J SYST EVOL MICR, V56, P2365, DOI 10.1099/ijs.0.64177-0; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Gorenflot A, 1998, ANN TROP MED PARASIT, V92, P489, DOI 10.1080/00034989859465; Hashimoto S, 2007, J EPIDEMIOL, V17, pS48, DOI 10.2188/jea.17.S48; Henning K, 2006, INT J MED MICROBIOL, V296, P157, DOI 10.1016/j.ijmm.2006.01.012; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Ishiguro F, 2008, MICROBIOL IMMUNOL, V52, P305, DOI 10.1111/j.1348-0421.2008.00042.x; Kawahara M, 1999, J CLIN MICROBIOL, V37, P1123, DOI 10.1128/JCM.37.4.1123-1129.1999; Kim YS, 2011, J MICROBIOL, V49, P340, DOI 10.1007/s12275-011-0302-3; Klyachko O, 2007, APPL ENVIRON MICROB, V73, P6584, DOI 10.1128/AEM.00537-07; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtti TJ, 2002, J MED ENTOMOL, V39, P534, DOI 10.1603/0022-2585-39.3.534; Lee JH, 2004, MICROBIOL IMMUNOL, V48, P125, DOI 10.1111/j.1348-0421.2004.tb03498.x; Liu LM, 2013, APPL ENVIRON MICROB, V79, P2450, DOI 10.1128/AEM.03575-12; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Mahara F, 1997, EMERG INFECT DIS, V3, P105, DOI 10.3201/eid0302.970203; Matsuura Y, 2012, APPL ENVIRON MICROB, V78, P4149, DOI 10.1128/AEM.00673-12; Mediannikov O Iu, 2004, Zh Mikrobiol Epidemiol Immunobiol, P7; Menchaca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067129; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Nakao R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-137; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Noji Y, 2005, JPN J INFECT DIS, V58, P112; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; PETER TF, 1995, J CLIN MICROBIOL, V33, P166, DOI 10.1128/JCM.33.1.166-172.1995; Popov VL, 2007, VECTOR-BORNE ZOONOT, V7, P699, DOI 10.1089/vbz.2007.0148; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Santos AS, 2002, VECTOR-BORNE ZOONOT, V2, P165, DOI 10.1089/15303660260613738; Shibata S, 2000, J CLIN MICROBIOL, V38, P1331, DOI 10.1128/JCM.38.4.1331-1338.2000; Socolovschi C, 2009, VET RES, V40, DOI 10.1051/vetres/2009017; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taroura S, 2005, J VET MED SCI, V67, P1277, DOI 10.1292/jvms.67.1277; TULLY JG, 1981, SCIENCE, V212, P1043, DOI 10.1126/science.7233197; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wojcik-Fatla A, 2012, ANN AGR ENV MED, V19, P656; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	55	74	75	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103961	10.1371/journal.pone.0103961	http://dx.doi.org/10.1371/journal.pone.0103961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089898	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700070
J	Kojima, S; Nikaido, H				Kojima, Seiji; Nikaido, Hiroshi			High Salt Concentrations Increase Permeability through OmpC Channels of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PERMEABILITY; PORIN CHANNELS; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; BACTERIAL PORINS; MOLECULAR-BASIS; BETA-LACTAMS; ANTIBIOTICS; PERMEATION; TRANSPORT	OmpF and OmpC porin channels are responsible for the passage of small hydrophilic solutes across the outer membrane of Escherichia coli. Although these channels are two of the most extensively studied porin channels, what had yet remained elusive was the reason why OmpC shows markedly lower permeability than OmpF, despite having little difference in its channel size. The OmpC channel, however, is known to contain a larger number of ionizable residues than the OmpF channel. In this study, we examined the channel property of OmpF and OmpC using the intact cell of E. coli, and we found that the permeability of several beta-lactams and lactose through OmpC became increased to the level comparable with OmpF with up to 0.3 M salt that may increase the Debye-Huckel shielding or with 2% ethanol or 0.3 M urea that may perturb the short range ordering of water molecules. Replacing 10 pore-lining residues that show different ionization behavior between OmpC and OmpF led to substantial conversion of channel property with respect to their permeability and response to external salt concentration. We thus propose that the overall configuration of ionizable residues in the channel that may orient water molecules and the electrostatic profile of the channel play a decisive role in defining the channel property of the OmpC porin rather than its channel size.	[Kojima, Seiji; Nikaido, Hiroshi] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Nikaido, H (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 426 Barker Hall MC3202, Berkeley, CA 94720 USA.	nhiroshi@berkeley.edu	Kojima, Seiji/I-8643-2017	Kojima, Seiji/0000-0002-2184-1592	National Institutes of Health [RO1 AI-009644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI-009644 (to H. N.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dutzler R, 1999, STRUCT FOLD DES, V7, P425, DOI 10.1016/S0969-2126(99)80055-0; Hajjar E, 2010, BIOCHEMISTRY-US, V49, P6928, DOI 10.1021/bi100845x; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; JAFFE A, 1982, ANTIMICROB AGENTS CH, V22, P942, DOI 10.1128/AAC.22.6.942; JAURIN B, 1981, NATURE, V290, P221, DOI 10.1038/290221a0; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Kojima S, 2013, P NATL ACAD SCI USA, V110, pE2629, DOI 10.1073/pnas.1310333110; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOVICK RP, 1962, BIOCHEM J, V83, P236, DOI 10.1042/bj0830236; OZAWA Y, 1983, J BACTERIOL, V154, P669, DOI 10.1128/JB.154.2.669-675.1983; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; SCHNAITMAN CA, 1984, J BACTERIOL, V159, P555, DOI 10.1128/JB.159.2.555-563.1984; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; SCHULZ GE, 1992, JERUS SYM Q, V25, P403; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Takatsuka Y, 2006, J BACTERIOL, V188, P7284, DOI 10.1128/JB.00683-06; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; VONMEYEN.K, 1971, J BACTERIOL, V107, P878, DOI 10.1128/JB.107.3.878-888.1971; WRIGHT JK, 1984, EUR J BIOCHEM, V138, P497, DOI 10.1111/j.1432-1033.1984.tb07944.x; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; Ziervogel BK, 2013, STRUCTURE, V21, P76, DOI 10.1016/j.str.2012.10.014	39	42	44	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26464	26473		10.1074/jbc.M114.585869	http://dx.doi.org/10.1074/jbc.M114.585869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086034	Green Published, hybrid			2022-12-25	WOS:000342128800037
J	Krejciova, Z; Barria, MA; Jones, M; Ironside, JW; Jeffrey, M; Gonzalez, L; Head, MW				Krejciova, Zuzana; Barria, Marcelo A.; Jones, Michael; Ironside, James W.; Jeffrey, Martin; Gonzalez, Lorenzo; Head, Mark W.			Genotype-dependent Molecular Evolution of Sheep Bovine Spongiform Encephalopathy (BSE) Prions in Vitro Affects Their Zoonotic Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; PRP ACCUMULATION; INFECTED SHEEP; GREAT-BRITAIN; SCRAPIE; PROTEIN; TRANSMISSION; VARIANT; BRAIN	Prion diseases are rare fatal neurological conditions of humans and animals, one of which (variant Creutzfeldt-Jakob disease) is known to be a zoonotic form of the cattle disease bovine spongiform encephalopathy (BSE). What makes one animal prion disease zoonotic and others not is poorly understood, but it appears to involve compatibility between the prion strain and the host prion protein sequence. Concerns have been raised that the United Kingdom sheep flock may have been exposed to BSE early in the cattle BSE epidemic and that serial BSE transmission in sheep might have resulted in adaptation of the agent, which may have come to phenotypically resemble scrapie while maintaining its pathogenicity for humans. We have modeled this scenario in vitro. Extrapolation from our results suggests that if BSE were to infect sheep in the field it may, with time and in some sheep genotypes, become scrapie-like at the molecular level. However, the results also suggest that if BSE in sheep were to come to resemble scrapie it would lose its ability to affect humans.	[Krejciova, Zuzana; Barria, Marcelo A.; Ironside, James W.; Head, Mark W.] Univ Edinburgh, Natl CJD Res & Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Jones, Michael] Scottish Natl Blood Transfus Serv, Edinburgh EH17 7QT, Midlothian, Scotland; [Jeffrey, Martin; Gonzalez, Lorenzo] Anim Hlth & Vet Labs Agcy, Edinburgh EH26 0PZ, Midlothian, Scotland	University of Edinburgh	Head, MW (corresponding author), Univ Edinburgh, Natl CJD Res & Surveillance Unit, Western Gen Hosp, Bryan Matthews Bldg, Edinburgh EH4 2XU, Midlothian, Scotland.	m.w.head@ed.ac.uk	Jeffrey, Martin/D-2251-2009; González, Lorenzo/A-5325-2010; Jones, Michael G.K./M-5932-2013	González, Lorenzo/0000-0003-4199-4526; Jones, Michael G.K./0000-0001-5002-0227; Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108; Barria Matus, Marcelo/0000-0003-4789-7401	Alliance BioSecure Research Foundation (Paris, France); MRC [G0900580, G0600953] Funding Source: UKRI; Medical Research Council [G0600953, G0900580] Funding Source: researchfish	Alliance BioSecure Research Foundation (Paris, France); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was largely supported by Grant "SheepBSE" from the Alliance BioSecure Research Foundation (Paris, France).	Andreoletti O, 2006, J GEN VIROL, V87, P1043, DOI 10.1099/vir.0.81318-0; Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858; Bellworthy SJ, 2008, VET REC, V162, P130, DOI 10.1136/vr.162.4.130-c; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Cutlip RC, 2001, CAN J VET RES, V65, P131; Ferguson NM, 2002, NATURE, V415, P420, DOI 10.1038/nature709; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Foster JD, 2001, VET REC, V148, P165, DOI 10.1136/vr.148.6.165; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Gonzalez L, 2007, J GEN VIROL, V88, P714, DOI 10.1099/vir.0.82426-0; Gonzalez L, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-55; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill Andrew F., 2004, V11, P33; Hope J, 2013, CURR TOP MICROBIOL, V366, P37, DOI 10.1007/82_2012_264; Houston F, 2003, NATURE, V423, P498, DOI 10.1038/423498a; Hunter N, 2007, PRIONS IN HUMANS AND ANIMALS, P640; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; Jones M, 2009, EMERG INFECT DIS, V15, P2013, DOI 10.3201/eid1512.090194; Kao RR, 2002, SCIENCE, V295, P332, DOI 10.1126/science.1067475; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Moore RA, 2005, ARCH VIROL, P187; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Murayama Y, 2012, MICROBIOL IMMUNOL, V56, P541, DOI 10.1111/j.1348-0421.2012.00472.x; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; Priem J, 2014, J VIROL, V88, P2903, DOI 10.1128/JVI.02446-13; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Ronzon F, 2006, BIOCHEM BIOPH RES CO, V350, P872, DOI 10.1016/j.bbrc.2006.09.137; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Thorne L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-223; Thuring CMA, 2004, J CLIN MICROBIOL, V42, P972, DOI 10.1128/JCM.42.3.972-980.2004; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Yokoyama T, 2011, NEUROSCI LETT, V498, P119, DOI 10.1016/j.neulet.2011.04.072	52	6	6	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26075	26088		10.1074/jbc.M114.582965	http://dx.doi.org/10.1074/jbc.M114.582965			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100723	hybrid, Green Published			2022-12-25	WOS:000342128800006
J	Philipp, M; Berger, IM; Just, S; Caron, MG				Philipp, Melanie; Berger, Ina M.; Just, Steffen; Caron, Marc G.			Overlapping and Opposing Functions of G Protein-coupled Receptor Kinase 2 (GRK2) and GRK5 during Heart Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; NF-KAPPA-B; IN-VIVO; BETA(1)-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; ARRESTIN; PHOSPHORYLATION; DESENSITIZATION; EXPRESSION; TERMINUS	G protein-coupled receptor kinases 2 (GRK2) and 5 (GRK5) are fundamental regulators of cardiac performance in adults but are less well characterized for their function in the hearts of embryos. GRK2 and -5 belong to different subfamilies and function as competitors in the control of certain receptors and signaling pathways. In this study, we used zebrafish to investigate whether the fish homologs of GRK2 and -5, Grk2/3 and Grk5, also have unique, complementary, or competitive roles during heart development. We found that they differentially regulate the heart rate of early embryos and equally facilitate heart function in older embryos and that both are required to develop proper cardiac morphology. A loss of Grk2/3 results in dilated atria and hypoplastic ventricles, and the hearts of embryos depleted in Grk5 present with a generalized atrophy. This Grk5 morphant phenotype was associated with an overall decrease of early cardiac progenitors as well as a reduction in the area occupied by myocardial progenitor cells. In the case of Grk2/3, the progenitor decrease was confined to a subset of precursor cells with a committed ventricular fate. We attempted to rescue the GRK loss-of-function heart phenotypes by downstream activation of Hedgehog signaling. The Grk2/3 loss-of-function embryos were rescued by this approach, but Grk5 embryos failed to respond. In summary, we found that GRK2 and GRK5 control cardiac function as well as morphogenesis during development although with different morphological outcomes.	[Philipp, Melanie] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany; [Berger, Ina M.; Just, Steffen] Univ Ulm, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany; [Caron, Marc G.] Duke Univ Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ Med Ctr, Dept Med, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Ulm University; Ulm University; Duke University; Duke University; Duke University	Philipp, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	melanie.philipp@uni-ulm.de	Philipp, Melanie/B-5198-2016	Philipp, Melanie/0000-0003-2714-965X	National Institutes of Health [5R37MH073853]; Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft; Boehringer Ingelheim Ulm University BioCenter (BIU); European Commission; Marie Curie Reintegration Grant [268333]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Ulm University BioCenter (BIU); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Reintegration Grant(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R37MH073853 (to M. G. C.). Work in the laboratory of M. P. is further supported by grants from the Deutsche Herzstiftung, the Deutsche Forschungsgemeinschaft, and the Boehringer Ingelheim Ulm University BioCenter (BIU).; Recipient of a Marie Curie Outgoing International Fellowship of the European Commission and a Marie Curie Reintegration Grant (Contract 268333). To whom correspondence should be addressed. Tel.: 49-731-500-23287; Fax: 49-731-500-23277; E-mail: melanie.philipp@uni-ulm.de.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BODMER R, 1993, DEVELOPMENT, V118, P719; Burkhalter MD, 2013, CELL REP, V4, P625, DOI 10.1016/j.celrep.2013.07.036; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen EP, 2001, ANN THORAC SURG, V71, P1320, DOI 10.1016/S0003-4975(00)01754-9; Chen JN, 1996, DEVELOPMENT, V122, P3809; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Evron T, 2011, J BIOL CHEM, V286, P27676, DOI 10.1074/jbc.M111.234666; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Finn J, 2012, AQUAT TOXICOL, V122, P214, DOI 10.1016/j.aquatox.2012.06.013; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Fusco A, 2012, CELL SIGNAL, V24, P468, DOI 10.1016/j.cellsig.2011.09.026; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Islam KN, 2013, J BIOL CHEM, V288, P35683, DOI 10.1074/jbc.M113.529347; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Khan M, 2014, MOL THER, V22, P178, DOI 10.1038/mt.2013.200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Liggett SB, 2008, NAT MED, V14, P510, DOI 10.1038/nm1750; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Meder B, 2011, MOL CELL BIOL, V31, P3424, DOI 10.1128/MCB.05269-11; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Michal AM, 2012, J BIOL CHEM, V287, P6928, DOI 10.1074/jbc.M111.298034; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Philipp M, 2008, MOL BIOL CELL, V19, P5478, DOI 10.1091/mbc.E08-05-0448; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rivas V, 2013, J CLIN INVEST, V123, P4714, DOI 10.1172/JCI67333; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Sefton M, 2000, MECH DEVELOP, V98, P127, DOI 10.1016/S0925-4773(00)00441-X; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Steele SL, 2011, J EXP BIOL, V214, P1445, DOI 10.1242/jeb.052803; Sterne-Marr R, 2004, METHOD ENZYMOL, V390, P310; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Sun LW, 2014, ENVIRON TOXICOL, V29, P1367, DOI 10.1002/tox.21867; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Thomas NA, 2008, DEVELOPMENT, V135, P3789, DOI 10.1242/dev.024083; Vinge LE, 2001, AM J PHYSIOL-HEART C, V281, pH2490, DOI 10.1152/ajpheart.2001.281.6.H2490; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Watari Kenji, 2014, J Mol Signal, V9, P1, DOI 10.1186/1750-2187-9-1; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	66	19	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26119	26130		10.1074/jbc.M114.551952	http://dx.doi.org/10.1074/jbc.M114.551952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104355	Green Published, hybrid			2022-12-25	WOS:000342128800009
J	Jeganathan, S; Fiorino, C; Naik, U; Sun, HS; Harrison, RE				Jeganathan, Sujeeve; Fiorino, Cara; Naik, Urja; Sun, He Song; Harrison, Rene E.			Modulation of Osteoclastogenesis with Macrophage M1-and M2-Inducing Stimuli	PLOS ONE			English	Article							FOREIGN-BODY REACTION; GIANT-CELL FORMATION; ACTIVATED MACROPHAGES; STABLE MICROTUBULES; BIOACTIVE GLASSES; ACTIN-FILAMENTS; STROMAL CELLS; CATHEPSIN-K; MYOSIN-II; IN-VITRO	Macrophages are generated through the differentiation of monocytes in tissues and they have important functions in innate and adaptive immunity. In addition to their roles as phagocytes, macrophages can be further differentiated, in the presence of receptor activator of nuclear factor kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), into osteoclasts (multinucleated giant cells that are responsible for bone resorption). In this work, we set out to characterize whether various inflammatory stimuli, known to induce macrophage polarization, can alter the type of multinucleated giant cell obtained from RANKL differentiation. Following a four-day differentiation protocol, along with lipopolysaccharide (LPS)/interferon gamma (IFN gamma) as one stimulus, and interleukin-4 (IL-4) as the other, three types of multinucleated cells were generated. Using various microscopy techniques (bright field, epifluorescence and scanning electron), functional assays, and western blotting for osteoclast markers, we found that, as expected, RANKL treatment alone resulted in osteoclasts, whereas the addition of LPS/IFN gamma to RANKL pre-treated macrophages generated Langhans-type giant cells, while IL-4 led to giant cells resembling foreign body giant cells with osteoclast-like characteristics. Finally, to gain insight into the modulation of osteoclastogenesis, we characterized the formation and morphology of RANKL and LPS/IFN gamma-induced multinucleated giant cells.	[Jeganathan, Sujeeve] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Jeganathan, Sujeeve] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Fiorino, Cara; Naik, Urja; Sun, He Song; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.	harrison@utsc.utoronto.ca			Natural Science and Engineering Research Council (NSERC) [RGPIN 298538-09]; Canadian Institutes of Health Research	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Natural Science and Engineering Research Council (NSERC) grant (RGPIN 298538-09) to REH. REH is the recipient of an Ontario Early Researcher Award (ERA) and a Canadian Institutes of Health Research New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; BOGDAN C, 1992, J LEUKOCYTE BIOL, V52, P119, DOI 10.1002/jlb.52.1.119; Bohm KJ, 1999, CELL BIOL INT, V23, P431, DOI 10.1006/cbir.1999.0382; Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Buhling F, 2001, J PATHOL, V195, P375; CAMBRAYDEAKIN MA, 1987, CELL MOTIL CYTOSKEL, V8, P284, DOI 10.1002/cm.970080309; Carboni J M, 1993, J Natl Cancer Inst Monogr, P95; Carter JD, 2009, RHEUM DIS CLIN N AM, V35, P21, DOI 10.1016/j.rdc.2009.03.010; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Cheng J, 2011, J CELL BIOCHEM, V112, P3385, DOI 10.1002/jcb.23269; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Eng EW, 2007, MOL BIOL CELL, V18, P2389, DOI 10.1091/mbc.e06-12-1128; Fujii T, 2012, BONE, V51, P771, DOI 10.1016/j.bone.2012.06.024; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Grevers L, 2012, ANN RHEUMATIC DIS; Guerriero C, 2007, AM J PHYSIOL-CELL PH, V292, P6; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; HOGG N, 1980, CELL TISSUE RES, V212, P509; Islam S, 2007, BIOCHEM BIOPH RES CO, V360, P346, DOI 10.1016/j.bbrc.2007.06.023; Isowa N, 2000, AM J PHYSIOL-LUNG C, V279, P82; Ivashkiv L, 2012, TRENDS IMMUNOLOGY; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Jiang J, 2006, J ENDODONT, V32, P742, DOI 10.1016/j.joen.2006.02.003; Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220; Karpov M, 2008, J BIOMED MATER RES A, V84A, P718, DOI 10.1002/jbm.a.31386; Kotake S, 2005, EUR J IMMUNOL, V35, P3353, DOI 10.1002/eji.200526141; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008; McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stumpe KDM, 2009, SEMIN NUCL MED, V39, P27, DOI 10.1053/j.semnuclmed.2008.08.003; Vaahtio M, 2006, J MATER SCI-MATER M, V17, P1113, DOI 10.1007/s10856-006-0538-3; VANDERRHEE HJ, 1978, ARCH DERMATOL RES, V263, P13, DOI 10.1007/BF00446849; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Wijenayaka AKAR, 2009, J MATER SCI-MATER M, V20, P1467, DOI 10.1007/s10856-009-3718-0; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	58	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104498	10.1371/journal.pone.0104498	http://dx.doi.org/10.1371/journal.pone.0104498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101660	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900070
J	Masiulionis, VE; Rabeling, C; Licht, HHD; Schultz, T; Bacci, M; Bezerra, CMS; Pagnocca, FC				Masiulionis, Virginia E.; Rabeling, Christian; Licht, Henrik H. De Fine; Schultz, Ted; Bacci, Mauricio, Jr.; Santos Bezerra, Cintia M.; Pagnocca, Fernando C.			A Brazilian Population of the Asexual Fungus-Growing Ant Mycocepurus smithii (Formicidae, Myrmicinae, Attini) Cultivates Fungal Symbionts with Gongylidia-Like Structures	PLOS ONE			English	Article							ACROMYRMEX-OCTOSPINOSUS REICH; MULTIPLE SEQUENCE ALIGNMENT; NEST ARCHITECTURE; FARMING ANTS; HYMENOPTERA; ORIGIN; PHYLOGENY; EVOLUTION; DIVERSITY; NUTRIENTS	Attine ants cultivate fungi as their most important food source and in turn the fungus is nourished, protected against harmful microorganisms, and dispersed by the ants. This symbiosis evolved approximately 50-60 million years ago in the late Paleocene or early Eocene, and since its origin attine ants have acquired a variety of fungal mutualists in the Leucocoprineae and the distantly related Pterulaceae. The most specialized symbiotic interaction is referred to as "higher agriculture'' and includes leafcutter ant agriculture in which the ants cultivate the single species Leucoagaricus gongylophorus. Higher agriculture fungal cultivars are characterized by specialized hyphal tip swellings, so-called gongylidia, which are considered a unique, derived morphological adaptation of higher attine fungi thought to be absent in lower attine fungi. Rare reports of gongylidia-like structures in fungus gardens of lower attines exist, but it was never tested whether these represent rare switches of lower attines to L. gonglyphorus cultivars or whether lower attine cultivars occasionally produce gongylidia. Here we describe the occurrence of gongylidia-like structures in fungus gardens of the asexual lower attine ant Mycocepurus smithii. To test whether M. smithii cultivates leafcutter ant fungi or whether lower attine cultivars produce gongylidia, we identified the M. smithii fungus utilizing molecular and morphological methods. Results shows that the gongylidia-like structures of M. smithii gardens are morphologically similar to gongylidia of higher attine fungus gardens and can only be distinguished by their slightly smaller size. A molecular phylogenetic analysis of the fungal ITS sequence indicates that the gongylidia-bearing M. smithii cultivar belongs to the so-called "Clade 1'' of lower Attini cultivars. Given that M. smithii is capable of cultivating a morphologically and genetically diverse array of fungal symbionts, we discuss whether asexuality of the ant host maybe correlated with low partner fidelity and active symbiont choice between fungus and ant mutualists.	[Masiulionis, Virginia E.; Bacci, Mauricio, Jr.; Santos Bezerra, Cintia M.; Pagnocca, Fernando C.] Sao Paulo State Univ, Inst Biociencias, Rio Claro, SP, Brazil; [Rabeling, Christian] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Rabeling, Christian; Schultz, Ted] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Licht, Henrik H. De Fine] Univ Copenhagen, Sect Organismal Biol, Dept Plant & Environm Sci, Copenhagen, Denmark	Universidade Estadual Paulista; Harvard University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen	Masiulionis, VE (corresponding author), Sao Paulo State Univ, Inst Biociencias, Rio Claro, SP, Brazil.	vemasiulionis@gmail.com	Masiulionis, Virginia Elena/L-6800-2013; de Fine Licht, Henrik Hjarvard/G-3307-2014; Bacci, Mauricio/C-4960-2013	Masiulionis, Virginia Elena/0000-0002-3619-5781; de Fine Licht, Henrik Hjarvard/0000-0003-3326-5729; Bacci, Mauricio/0000-0002-5619-1411	CNPq; Fapesp; CAPES/PEC-PG scholarship; Harvard Society of Fellows; HMS Milton Fund; U.S. National Science Foundation [DEB 0949689]; Smithsonian Institution Scholarly Studies Program; Smithsonian NMNH Small Grants Program; Danish Research Council; Carlsberg Foundation	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES/PEC-PG scholarship; Harvard Society of Fellows; HMS Milton Fund; U.S. National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution Scholarly Studies Program; Smithsonian NMNH Small Grants Program; Danish Research Council(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation)	FCP and MB are grateful to CNPq and Fapesp for their financial support. VEM is a recipient of a CAPES/PEC-PG scholarship. CR was financially supported by a Junior Fellowship from the Harvard Society of Fellows and the HMS Milton Fund. TS was supported by the U.S. National Science Foundation grant DEB 0949689, the Smithsonian Institution Scholarly Studies Program, and the Smithsonian NMNH Small Grants Program. HHDFL was supported by grants from the Danish Research Council and the Carlsberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIPAPA J, 1985, ANN SCI NAT BOT BIOL, V7, P103; Ayres M., 2007, BIOESTAT 5 0; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; Bass M, 1996, FUNCT ECOL, V10, P55, DOI 10.2307/2390262; BENSON WW, 1975, EVOLUTION, V29, P659, DOI 10.1111/j.1558-5646.1975.tb00861.x; BLACKSTONE NW, 1995, EVOLUTION, V49, P785, DOI 10.1111/j.1558-5646.1995.tb02315.x; BRANDAO C R F, 1991, Revista Brasileira de Entomologia, V35, P319; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Fernandez-Marin H, 2005, J NAT HIST, V39, P1735, DOI 10.1080/00222930400027462; FURLETTI MEM, 1983, REV MICROBIOL, V14, P183; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Herre EA, 1996, J BIOGEOGR, V23, P521, DOI 10.1111/j.1365-2699.1996.tb00014.x; Himler AG, 2009, P ROY SOC B-BIOL SCI, V276, P2611, DOI 10.1098/rspb.2009.0313; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; Holldobler B., 1990, pi; Hu┬lldobler B., 2010, LEAFCUTTER ANTS CIVI; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kellner K, 2013, J EVOLUTION BIOL, V26, P1353, DOI 10.1111/jeb.12140; KEMPF W W, 1972, Studia Entomologica, V15, P3; Kempf W. W., 1963, Studia Entomologica Petropolis (NS), V6, P417; Licht HHDF, 2013, P NATL ACAD SCI USA, V110, P583, DOI 10.1073/pnas.1212709110; LITTLEDYKE M, 1976, B ENTOMOL RES, V66, P205, DOI 10.1017/S0007485300006647; Maddison DR, 2000, MACCLADE V4 0; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; MARTIN MM, 1969, ANN ENTOMOL SOC AM, V62, P11, DOI 10.1093/aesa/62.1.11; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; Mayhe-Nunes Antonio, 1998, Ecotropicos, V11, P45; Mehdiabadi NJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1844; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; Moller A., 1893, BOT MITT TROP, V6, P1; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Mueller UG, 2012, CURR OPIN MICROBIOL, V15, P269, DOI 10.1016/j.mib.2012.03.001; Murakami T, 1997, J ETHOL, V15, P17, DOI 10.1007/BF02767322; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Pagnocca F. C., 2012, Psyche: A Journal of Entomology, V2012, P905109, DOI 10.1155/2012/905109; Pellmyr O, 1996, AM NAT, V148, P827, DOI 10.1086/285958; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1979, ECOL ENTOMOL, V4, P151, DOI 10.1111/j.1365-2311.1979.tb00570.x; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; QUINLAN RJ, 1977, ECOL ENTOMOL, V2, P161, DOI 10.1111/j.1365-2311.1977.tb00877.x; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2004, THESIS U TUBINGEN GE; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rabeling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006781; Rambaut A., 2007, TRACER V1 5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; Schultz Ted R., 2005, P149; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2002, INSECT SOC, V49, P331, DOI 10.1007/PL00012657; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Schultz TR, 1993, NOTES UNDERGROUND, V8, P7; Silva A, 2003, J INSECT PHYSIOL, V49, P307, DOI 10.1016/S0022-1910(03)00004-0; Smith J M, 1998, MAJOR TRANSITIONS EV; Solomon SE, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0112; Sosa-Calvo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080498; Spegazzini C, 1922, VER MUS LA PLATA, V26, P166; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; Weber N.A., 1972, Memoirs Am phil Soc, V92, P1; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1957, ANAT REC, V128, P638; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; White T., 1990, PCR PROTOCOLS GUIDE, P315; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	78	14	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103800	10.1371/journal.pone.0103800	http://dx.doi.org/10.1371/journal.pone.0103800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101899	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900024
J	Xi, YY; Wu, XJ; Gao, LH; Shao, Y; Peng, H; Chen, HX; Chen, HP; Hu, XW; Yue, JJ				Xi, Yongyi; Wu, Xiaojie; Gao, Lihua; Shao, Yong; Peng, Hui; Chen, Hongxing; Chen, Huipeng; Hu, Xianwen; Yue, Junjie			Improving the Anti-Toxin Abilities of the CMG2-Fc Fusion Protein with the Aid of Computational Design	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; ANTHRAX TOXIN RECEPTOR; CRYSTAL-STRUCTURE; RECOMBINANT ANTHRAX; STRUCTURAL BIOLOGY; ANTIBODIES; LIGAND	CMG2-Fc is a fusion protein composed of the extracellular domain of capillary morphogenesis protein 2 (CMG2) and the Fc region of human immunoglobulin G; CMG2-Fc neutralizes anthrax toxin and offers protection against Bacillus anthracis challenge. To enhance the efficacy of CMG2-Fc against anthrax toxin, we attempted to engineer a CMG2-Fc with an improved affinity for PA. Using the automatic design algorithm FoldX and visual inspection, we devised two CMG2-Fc variants that introduce mutations in the CMG2 binding interface and improve the computationally assessed binding affinity for PA. An experimental affinity assay revealed that the two variants showed increased binding affinity, and in vitro and in vivo toxin neutralization testing indicated that one of these mutants (CMG2-Fc(E117Q)) has superior activity against anthrax toxin and was suitable for further development as a therapeutic agent for anthrax infections. This study shows that the computational design of the PA binding interface of CMG2 to obtain CMG2-Fc variants with improving anti-toxin abilities is viable. Our results demonstrate that computational design can be further applied to generate other CMG2-Fc mutants with greatly improved therapeutic efficacy.	[Xi, Yongyi; Wu, Xiaojie; Gao, Lihua; Shao, Yong; Peng, Hui; Chen, Hongxing; Chen, Huipeng; Hu, Xianwen; Yue, Junjie] Beijing Inst Biotechnol, Beijing, Peoples R China		Chen, HP (corresponding author), Beijing Inst Biotechnol, Beijing, Peoples R China.	hpcamms@126.com; hu.xianwen@tsinghua.org.cn; yue_junjie@126.com		Yue, Junjie/0000-0002-2549-9261	National Science Foundation of China [3090592, 81202445]; Chinese National Science and Technology Major Project [2012ZX09102301-001, 2011ZX09102-001-30]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Science and Technology Major Project	This work was supported in part by grants from the National Science Foundation of China (No. 3090592 & 81202445) and the Chinese National Science and Technology Major Project (Nos. 2012ZX09102301-001 & 2011ZX09102-001-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Andrianov V, 2010, PROTEIN EXPRES PURIF, V70, P158, DOI 10.1016/j.pep.2009.09.016; Bann JG, 2004, NATURE, V430, P843, DOI 10.1038/430843a; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Bouzianas DG, 2007, EXPERT REV ANTI-INFE, V5, P665, DOI 10.1586/14787210.5.4.665; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gao M, 2006, BIOPHYS J, V90, P3267, DOI 10.1529/biophysj.105.079376; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; Hocker B, 2012, NATURE, V491, P204, DOI 10.1038/491204a; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Li GL, 2009, BIOCHEM BIOPH RES CO, V385, P591, DOI 10.1016/j.bbrc.2009.05.114; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sharma S, 2009, ANTIMICROB AGENTS CH, V53, P1210, DOI 10.1128/AAC.01294-08; St Croix B, 2000, SCIENCE, V289, P1197; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Vuyisich M, 2008, PROTEIN J, V27, P292, DOI 10.1007/s10930-008-9137-0; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wycoff KL, 2011, ANTIMICROB AGENTS CH, V55, P132, DOI 10.1128/AAC.00592-10; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	33	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104674	10.1371/journal.pone.0104674	http://dx.doi.org/10.1371/journal.pone.0104674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101992	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900082
J	Xu, CL; Wang, YM; Sun, R; Qiao, XJ; Shang, XY; Niu, WN				Xu, Chunlan; Wang, Youming; Sun, Rui; Qiao, Xiangjin; Shang, Xiaoya; Niu, Weining			Modulatory Effects of Vasoactive Intestinal Peptide on Intestinal Mucosal Immunity and Microbial Community of Weaned Piglets Challenged by an Enterotoxigenic Escherichia coli (K88)	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; IN-VITRO; KAPPA-B; VIP; RECEPTORS; RESPONSES; SYSTEM; EXPRESSION; CYTOKINE; BARRIER	Toll-like receptors (TLRs) recognize microbial pathogens and trigger immune response, but their regulation by neuropeptide-vasoactive intestinal peptide (VIP) in weaned piglets infected by enterotoxigenic Escherichia coli (ETEC) K88 remains unexplored. Therefore, the study was conducted to investigate its role using a model of early weaned piglets infected by ETEC K88. Male DurocxLandracexYorkshire piglets (n = 24) were randomly divided into control, ETEC K88, VIP, and ETEC K88+VIP groups. On the first three days, ETEC K88 and ETEC K88+VIP groups were orally administrated with ETEC K88, other two groups were given sterile medium. Then each piglet from VIP and ETEC K88+VIP group received 10 nmol VIP intraperitoneally (i.p.) once daily, on day four and six. On the seventh day, the piglets were sacrificed. The results indicated that administration of VIP improved the growth performance, reduced diarrhea incidence of ETEC K88 challenged pigs, and mitigated the histopathological changes of intestine. Serum levels of IL-2, IL-6, IL-12p40, IFN-gamma and TNF-alpha in the ETEC K88+VIP group were significantly reduced compared with those in the ETEC group. VIP significantly increased IL-4, IL-10, TGF-beta and S-IgA production compared with the ETEC K88 group. Besides, VIP could inhibit the expression of TLR2, TLR4, MyD88, NF-kappa B p65 and the phosphorylation of I kappa B-alpha, p-ERK, p-JNK, and p-38 induced by ETEC K88. Moreover, VIP could upregulate the expression of occludin in the ileum mucosa compared with the ETEC K88 group. Colon and caecum content bacterial richness and diversity were lower for pigs in the ETEC group than the unchallenged groups. These results demonstrate that VIP is beneficial for the maturation of the intestinal mucosal immune system and elicited local immunomodulatory activities. The TLR2/4-MyD88 mediated NF-kappa B and MAPK signaling pathway may be critical to the mechanism underlying the modulatory effect of VIP on intestinal mucosal immune function and bacterial community.	[Xu, Chunlan; Sun, Rui; Qiao, Xiangjin; Shang, Xiaoya; Niu, Weining] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China; [Wang, Youming] Zhejiang Univ, Coll Anim Sci, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Northwestern Polytechnical University; Zhejiang University	Xu, CL (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China.	clxu@nwpu.edu.cn			National Natural Science Foundation of China [31001012, 31101304]; Programs for Agricultural Science and Technology Development of Shanxi Province, China [2013K02-16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for Agricultural Science and Technology Development of Shanxi Province, China	The research was supported by National Natural Science Foundation of China, No.31001012 and No.31101304; and Programs for Agricultural Science and Technology Development of Shanxi Province, China, No.2013K02-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; AISADI R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054; Arranz A, 2008, PEPTIDES, V29, P948, DOI 10.1016/j.peptides.2008.01.019; Augustyniak D, 2012, CURR PROTEIN PEPT SC, V13, P723, DOI 10.2174/138920312804871139; Bailey M, 2005, P NUTR SOC, V64, P451, DOI 10.1079/PNS2005452; Bik W, 2004, NEUROIMMUNOMODULAT, V11, P358, DOI 10.1159/000080145; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Campos-Salinas J, 2014, J BIOL CHEM, V289, P14583, DOI 10.1074/jbc.M114.560573; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chorny A, 2008, AM J PATHOL, V172, P1297, DOI 10.2353/ajpath.2008.070969; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; DelaFuente M, 1996, ADV NEUROIMMUNOL, V6, P75, DOI 10.1016/S0960-5428(96)00002-2; Delgado M, 2000, J NEUROIMMUNOL, V110, P97, DOI 10.1016/S0165-5728(00)00359-3; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Delgado M, 1999, J IMMUNOL, V162, P1707; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; Delgado M, 2001, J IMMUNOL, V166, P2907, DOI 10.4049/jimmunol.166.5.2907; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Delgado M, 2000, EUR J IMMUNOL, V30, P3236, DOI 10.1002/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L; Delgado M, 2003, BIOCHEM BIOPH RES CO, V302, P275, DOI 10.1016/S0006-291X(03)00149-9; DELGADO M, 1995, J NEUROIMMUNOL, V62, P137, DOI 10.1016/0165-5728(95)00105-6; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; El Karim IA, 2008, J NEUROIMMUNOL, V200, P11, DOI 10.1016/j.jneuroim.2008.05.014; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Francis DH, 1998, INFECT IMMUN, V66, P4050; GAASTRA W, 1982, MICROBIOL REV, V46, P129, DOI 10.1128/MMBR.46.2.129-161.1982; Gomariz RP, 2007, PEPTIDES, V28, P1825, DOI 10.1016/j.peptides.2007.07.005; Gomariz RP, 2010, CURR PHARM DESIGN, V16, P1063, DOI 10.2174/138161210790963841; Gonzalez-Rey E, 2007, NAT REV IMMUNOL, V7, P52, DOI 10.1038/nri1984; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Guzman JR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/425146; Hwang MH, 2011, VET RES COMMUN, V35, P21, DOI 10.1007/s11259-010-9447-5; Janjatovic AK, 2012, EUR J HISTOCHEM, V56, P185, DOI 10.4081/ejh.2012.e30; Juarranz Y, 2005, ARTHRITIS RES THER, V7, pR1034, DOI 10.1186/ar1779; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Kiarie E, 2011, J ANIM SCI, V89, P1062, DOI 10.2527/jas.2010-3424; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; KIMATA H, 1994, EUR J IMMUNOL, V24, P2262, DOI 10.1002/eji.1830240950; Kitazawa H., 2009, CURR OPIN IMMUNOL, V3, P87; Kitazawa H, 2008, ANIM SCI J, V79, P11, DOI [10.1111/j.1740-0929.2007.00492.x, 10.1111/j.1740-0929.2007.00491.x-i1]; Kojima M, 2005, PANCREAS, V30, P62; Konstantinov SR, 2004, ANIM RES, V53, P317, DOI 10.1051/animres:2004019; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; LABURTHE M, 1989, AM J PHYSIOL, V256, pG443, DOI 10.1152/ajpgi.1989.256.3.G443; Lalles JP, 2009, ANIMAL, V3, P1625, DOI 10.1017/S175173110900398X; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Long KZ, 2010, INFECT IMMUN, V78, P1221, DOI 10.1128/IAI.00767-09; MCCABE RD, 1988, ANN NY ACAD SCI, V527, P326; Mourad FH, 2000, GUT, V47, P382, DOI 10.1136/gut.47.3.382; Naiki Y, 2005, J BIOL CHEM, V280, P5491, DOI 10.1074/jbc.C400503200; Neunlist M, 2003, AM J PHYSIOL-GASTR L, V285, pG1028, DOI 10.1152/ajpgi.00066.2003; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Nyachoti CM, 2012, J ANIM SCI, V90, P252, DOI 10.2527/jas.2010-3596; Nyachoti CM, 2006, J ANIM SCI, V84, P125, DOI 10.2527/2006.841125x; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1790; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Pozo D, 2007, PEPTIDES, V28, P1833, DOI 10.1016/j.peptides.2007.04.008; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Roselli M, 2005, ANIM RES, V54, P203, DOI 10.1051/animres:2005012; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmidt PT, 1999, GUT, V45, P679, DOI 10.1136/gut.45.5.679; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Stokes CR, 2004, ANIM RES, V53, P325, DOI 10.1051/animres:2004020; Vaudry D, 2000, PHARMACOL REV, V52, P269; Westendorf AM, 2010, INT J MED MICROBIOL, V300, P11, DOI 10.1016/j.ijmm.2009.08.009; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	74	29	33	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104183	10.1371/journal.pone.0104183	http://dx.doi.org/10.1371/journal.pone.0104183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101851	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900048
J	Goodchild, SC; Sheynis, T; Thompson, R; Tipping, KW; Xue, WF; Ranson, NA; Beales, PA; Hewitt, EW; Radford, SE				Goodchild, Sophia C.; Sheynis, Tania; Thompson, Rebecca; Tipping, Kevin W.; Xue, Wei-Feng; Ranson, Neil A.; Beales, Paul A.; Hewitt, Eric W.; Radford, Sheena E.			beta(2)-Microglobulin Amyloid Fibril-Induced Membrane Disruption Is Enhanced by Endosomal Lipids and Acidic pH	PLOS ONE			English	Article							BIS-PHOSPHATIDIC ACID; CULTURED BHK-CELLS; A-BETA; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PORE FORMATION; NEUTRAL PH; IN-VITRO; GANGLIOSIDE GM1; BODY FORMATION	Although the molecular mechanisms underlying the pathology of amyloidoses are not well understood, the interaction between amyloid proteins and cell membranes is thought to play a role in several amlyloid diseases. Amyloid fibrils of beta(2)-microglobulin (beta(2)m), associated with dialysis-related amyloidosis (DRA), have been shown to cause disruption of anionic lipid bilayers in vitro. However, the effect of lipid composition and the chemical environment in which beta(2)-lipid interactions occur have not been investigated previously. Here we examine membrane damage resulting from the interaction of beta(2)m monomers and fibrils with lipid bilayers. Using dye release, tryptophan fluorescence quenching and fluorescence confocal microscopy assays we investigate the effect of anionic lipid composition and pH on the susceptibility of liposomes to fibril-induced membrane damage. We show that beta(2)m fibril-induced membrane disruption is modulated by anionic lipid composition and is enhanced by acidic pH. Most strikingly, the greatest degree of membrane disruption is observed for liposomes containing bis(monoacylglycero)phosphate (BMP) at acidic pH, conditions likely to reflect those encountered in the endocytic pathway. The results suggest that the interaction between beta(2)m fibrils and membranes of endosomal origin may play a role in the molecular mechanism of beta(2)m amyloid-associated osteoarticular tissue destruction in DRA.	[Goodchild, Sophia C.; Sheynis, Tania; Thompson, Rebecca; Tipping, Kevin W.; Xue, Wei-Feng; Ranson, Neil A.; Beales, Paul A.; Hewitt, Eric W.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Goodchild, Sophia C.; Sheynis, Tania; Thompson, Rebecca; Tipping, Kevin W.; Xue, Wei-Feng; Ranson, Neil A.; Hewitt, Eric W.; Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Beales, Paul A.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	S.E.Radford@leeds.ac.uk	Beales, Paul/E-2194-2013; Goodchild, Sophia/AAB-1465-2021	Beales, Paul/0000-0001-9076-9793; Xue, Wei-Feng/0000-0002-6504-0404; Goodchild, Sophia/0000-0002-5091-7576; Ranson, Neil/0000-0002-3640-5275; Hewitt, Eric/0000-0002-6238-6303; Radford, Sheena/0000-0002-3079-8039; Thompson, Rebecca/0000-0002-4254-8854	Wellcome Trust [092896, 096685/z/11/z, 080707/z/06/z]; Marie Curie Intra-European Fellowship [276621]; European Research Council under the European Union's [322408]; Engineering and Physical Sciences Research Council [EP/K03135X/1] Funding Source: researchfish; Wellcome Trust [092896/Z/10/Z] Funding Source: researchfish; EPSRC [EP/K03135X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Intra-European Fellowship(European Commission); European Research Council under the European Union's; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Wellcome Trust grants 092896 MA, 096685/z/11/z (RT) and 080707/z/06/z (KWT), http://www.wellcome.ac.uk/, and Marie Curie Intra-European Fellowship 276621 (TS), http://ec.europa.eu/research/. EWH and SER acknowledge funding from the European Research Council under the European Union's Seventh Framework Programme, FP7/2007-2013, and grant agreement no322408 (EWH), http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio EE, 2005, BIOPHYS J, V89, P1874, DOI 10.1529/biophysj.105.066589; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bergstrom CL, 2013, P NATL ACAD SCI USA, V110, P6269, DOI 10.1073/pnas.1303819110; Berthelot K, 2013, BIOCHIMIE, V95, P12, DOI 10.1016/j.biochi.2012.07.011; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Bostrom M, 2002, LANGMUIR, V18, P6010, DOI 10.1021/la0201220; BROTHERUS J, 1974, CHEM PHYS LIPIDS, V13, P11, DOI 10.1016/0009-3084(74)90038-3; BROTHERUS J, 1974, CHEM PHYS LIPIDS, V13, P178, DOI 10.1016/0009-3084(74)90034-6; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Cecchi C, 2009, BBA-BIOMEMBRANES, V1788, P2204, DOI 10.1016/j.bbamem.2009.07.019; Chebukati JN, 2010, BIOCHEM BIOPH RES CO, V394, P509, DOI 10.1016/j.bbrc.2010.02.180; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Duan MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047150; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Engel MFM, 2012, J AM CHEM SOC, V134, P14781, DOI 10.1021/ja3031664; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Fogarty MP, 2010, NEUROBIOL AGING, V31, P1774, DOI 10.1016/j.neurobiolaging.2008.09.018; Franzin CM, 2001, BIOPHYS J, V81, P3346, DOI 10.1016/S0006-3495(01)75968-1; Frederick TE, 2010, CHEM PHYS LIPIDS, V163, P703, DOI 10.1016/j.chemphyslip.2010.06.002; Frederick TE, 2009, BIOPHYS J, V96, P1847, DOI 10.1016/j.bpj.2008.12.3892; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Gallala HD, 2011, NEUROCHEM RES, V36, P1594, DOI 10.1007/s11064-010-0337-6; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hayakawa T, 2007, BIOPHYS J, V92, pL13, DOI 10.1529/biophysj.106.098657; Hirakura Y, 2001, AMYLOID, V8, P94, DOI 10.3109/13506120109007350; HUTERER S, 1979, J LIPID RES, V20, P966; Ivankin A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238103; Jahn TR, 2008, J BIOL CHEM, V283, P17279, DOI 10.1074/jbc.M710351200; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kobayashi T, 2001, BIOL CHEM, V382, P483, DOI 10.1515/BC.2001.059; Lee DE, 2013, CHEM PHYS LIPIDS, V166, P45, DOI 10.1016/j.chemphyslip.2012.11.004; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047580; Liguori N, 2013, BIOPHYS J, V105, P899, DOI 10.1016/j.bpj.2013.06.046; Luquain C, 2000, BIOCHEM J, V351, P795, DOI 10.1042/0264-6021:3510795; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Parsegia Va., 1973, ANNU REV BIOPHYS BIO, V2, P221; Petelska AD, 2000, BIOPHYS J, V78, P812, DOI 10.1016/S0006-3495(00)76638-0; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Pieri L, 2009, BIOPHYS J, V96, P3319, DOI 10.1016/j.bpj.2008.12.3958; Porter MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027353; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Sarell CJ, 2013, PRION, V7, P359, DOI 10.4161/pri.26415; Sciacca MFM, 2012, BIOCHEMISTRY-US, V51, P7676, DOI 10.1021/bi3009888; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sheynis T, 2013, BIOPHYS J, V105, P745, DOI 10.1016/j.bpj.2013.06.015; Smith A, 2006, AGENDA, V42, P9; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Villanueva J, 2004, PROTEIN SCI, V13, P797, DOI 10.1110/ps.03445704; WHERRETT JR, 1973, LIPIDS, V8, P531, DOI 10.1007/BF02531989; White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Williams TL, 2011, BIOCHEM J, V439, P67, DOI 10.1042/BJ20110750; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Xue WF, 2009, PROTEIN ENG DES SEL, V22, P489, DOI 10.1093/protein/gzp026; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	91	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104492	10.1371/journal.pone.0104492	http://dx.doi.org/10.1371/journal.pone.0104492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100247	Green Accepted, Green Published, gold			2022-12-25	WOS:000339995100078
J	Long, YM; Zheng, YB; Chen, MY; Zhang, B; Gao, C; Shan, FL; Yang, N; Fan, YX				Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Yang, Ning; Fan, Yongxiang			Serum Thyroid-Stimulating Hormone and Anti-Thyroglobulin Antibody Are Independently Associated with Lesions in Spinal Cord in Central Nervous System Demyelinating Diseases	PLOS ONE			English	Article							DEVICS-NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; TRANSVERSE MYELITIS; AUTOIMMUNE-DISEASE; AQUAPORIN-4; PREVALENCE; COHORT; DISORDERS; MS	Transverse myelitis (TM) is associated with neuromyelitis optica (NMO) and multiple sclerosis (MS). Early recognition of useful parameters may be helpful to distinguish their difference. This retrospective study analyzed thyroid parameters from 243 serum samples (relapse = 128; remission = 115) of 178 patients with demyelinating diseases (NMO, n = 25; TM, n = 48; MS, n = 105). The relationship between thyroid and clinical parameters was analyzed. Patients with NMO and TM had a higher frequency of abnormal thyroid-stimulating hormone (TSH), anti-thyroglobulin antibodies (TG-Ab), and antithyroid peroxidase antibody (TPO-Ab) than MS patients (p<0.05). The level of TSH and TG-Ab returned to normal levels after administration of high-dose intravenous methylprednisolone (p<0.05). In 96 patients (NMO, n = 19; TM, n = 25; MS, n = 52) without treatment, serum levels of TSH, TG-Ab and TPO-Ab were significantly different between patients with and without myelitis (p<0.01). Patients positive for aquaporin-4 (AQP4) antibodies showed higher abnormalities of TSH (p = 0.001), TGAb (p = 0.004) and TPO-Ab (p<0.0001) levels than AQP4 antibodies negative patients. Logistic regression analyses revealed independent relationships between TSH (odds ratio [OR] = 33.994; p<0.0001), TG-Ab (OR = 7.703; p = 0.017) and myelitis occurrence in 96 patients at the active stage. In 52 MS patients experiencing their first attack, MS patients with myelitis were associated with TSH abnormalities (OR = 42.778; p<0.0001). This study showed increased abnormalities of thyroid parameters in patients with NMO and TM than in MS patients. MS patients with myelitis also had greater TSH abnormality than in MS patients without myelitis. Abnormal TSH and TG-Ab were independently associated with myelitis occurrence in central nervous system demyelinating disorders.	[Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China; [Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Minist Educ China, Inst Neurosci, Guangzhou, Guangdong, Peoples R China; [Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Long, Youming; Zheng, Yangbo; Chen, Mengyu; Zhang, Bin; Gao, Cong; Shan, Fulan; Fan, Yongxiang] GuangZhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yang, Ning] GuangZhou Med Univ, Affiliated Hosp 5, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Gao, C (corresponding author), GuangZhou Med Univ, Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou, Guangdong, Peoples R China.	smilegaocong@126.com			China Postdoctoral Science Foundation [2012M521586]; Guangdong Natural Science Foundation [S2013010016262]; Science and Technology plan project of Guangdong Province [2012B031800240, 2012B061700042]; GuangZhou Medical University [2012C46]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology plan project of Guangdong Province; GuangZhou Medical University	This project was supported by the plan of China Postdoctoral Science Foundation Grant (2012M521586), Guangdong Natural Science Foundation (S2013010016262), the Science and Technology plan project of Guangdong Province (2012B031800240, 2012B061700042), and the plan of GuangZhou Medical University (2012C46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRABANT A, 1989, ACTA ENDOCRINOL-COP, V121, P95, DOI 10.1530/acta.0.1210095; Caraccio N, 2005, J CLIN ENDOCR METAB, V90, P4133, DOI 10.1210/jc.2004-2326; Cossburn M, 2011, NEUROLOGY, V77, P573, DOI 10.1212/WNL.0b013e318228bec5; DAWE K, 1993, SPRINGER SEMIN IMMUN, V14, P285; de Seze J, 2003, MULT SCLER J, V9, P521, DOI 10.1191/1352458503ms947oa; Durelli L, 1999, J NEUROL SCI, V162, P74, DOI 10.1016/S0022-510X(98)00299-8; Durelli L, 2001, J NEUROL SCI, V193, P17, DOI 10.1016/S0022-510X(01)00637-2; Hamnik Sheri E, 2008, Semin Ophthalmol, V23, P191, DOI 10.1080/08820530802049921; Jarius S, 2008, BRAIN, V131, P3072, DOI 10.1093/brain/awn240; Karni A, 1999, NEUROLOGY, V53, P883, DOI 10.1212/WNL.53.4.883; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li R, 2011, J NEUROL, V258, P2206, DOI 10.1007/s00415-011-6093-y; Long YM, 2012, NEUROIMMUNOMODULAT, V19, P96, DOI 10.1159/000330240; Marrie RA, 2012, NEUROEPIDEMIOLOGY, V39, P135, DOI 10.1159/000339757; McKeon A, 2008, NEUROLOGY, V71, P93, DOI 10.1212/01.wnl.0000314832.24682.c6; Munteis E, 2007, EUR J NEUROL, V14, P1048, DOI 10.1111/j.1468-1331.2007.01882.x; Nagaishi A, 2011, J NEUROL NEUROSUR PS, V82, P1360, DOI 10.1136/jnnp-2011-300403; Niederwieser G, 2003, J NEUROL, V250, P672, DOI 10.1007/s00415-003-1053-9; Niu DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040770; ORiordan JI, 1996, J NEUROL NEUROSUR PS, V60, P382, DOI 10.1136/jnnp.60.4.382; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qiu W, 2010, MULT SCLER J, V16, P351, DOI 10.1177/1352458509355463; Ramagopolan SV, 2007, LANCET NEUROL, V6, P604, DOI 10.1016/S1474-4422(07)70132-1; Sakuma R, 1999, J NEUROL, V246, P449, DOI 10.1007/s004150050381; Scott TF, 2006, ARCH NEUROL-CHICAGO, V63, P1398, DOI 10.1001/archneur.63.10.1398; Sellner J, 2011, CLIN ENDOCRINOL, V75, P271, DOI 10.1111/j.1365-2265.2011.04024.x; STEFANEANU L, 1986, ACTA HISTOCHEM, V78, P7; TORRES SMF, 1991, AM J VET RES, V52, P416; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; 2002, NEUROLOGY, V59, P499	33	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e100672	10.1371/journal.pone.0100672	http://dx.doi.org/10.1371/journal.pone.0100672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093326	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200003
J	Adam, MB; Dillmann, M; Chen, MK; Mbugua, S; Ndung'u, J; Mumbi, P; Waweru, E; Meissner, P				Adam, Mary B.; Dillmann, Maria; Chen, Mei-Kuang; Mbugua, Simon; Ndung'u, Joram; Mumbi, Priscilla; Waweru, Eunice; Meissner, Peter			Improving Maternal and Newborn Health: Effectiveness of a Community Health Worker Program in Rural Kenya	PLOS ONE			English	Article							WOMENS GROUPS; INTERVENTIONS; MORTALITY; SETTINGS; CARE	Background: Volunteer community health workers (CHWs) form an important element of many health systems, and in Kenya these volunteers are the foundation for promoting behavior change through health education, earlier case identification, and timely referral to trained health care providers. This study examines the effectiveness of a community health worker project conducted in rural Kenya that sought to promote improved knowledge of maternal newborn health and to increase deliveries under skilled attendance. Methods: The study utilized a quasi-experimental nonequivalent design that examined relevant demographic items and knowledge about maternal and newborn health combined with a comprehensive retrospective birth history of women's children using oral interviews of women who were exposed to health messages delivered by CHWs and those who were not exposed. The project trained CHWs in three geographically distinct areas. Results: Mean knowledge scores were higher in those women who reported being exposed to the health messages from CHWs, Eburru 32.3 versus 29.2, Kinale 21.8 vs 20.7, Nyakio 26.6 vs 23.8. The number of women delivering under skilled attendance was higher for those mothers who reported exposure to one or more health messages, compared to those who did not. The percentage of facility deliveries for women exposed to health messages by CHWs versus non-exposed was: Eburru 46% versus 19%; Kinale 94% versus 73%: and Nyakio 80% versus 78%. Conclusion: The delivery of health messages by CHWs increased knowledge of maternal and newborn care among women in the local community and encouraged deliveries under skilled attendance.	[Adam, Mary B.; Mbugua, Simon; Ndung'u, Joram; Mumbi, Priscilla; Waweru, Eunice] AIC Kijabe Med Ctr, Kijabe, Kenya; [Dillmann, Maria; Meissner, Peter] Univ Ulm, Dept Pediat & Adolescent Med, D-89069 Ulm, Germany; [Chen, Mei-Kuang] Univ Arizona, Tucson, AZ USA	Ulm University; University of Arizona	Adam, MB (corresponding author), AIC Kijabe Med Ctr, Kijabe, Kenya.	mary.b.adam@gmail.com		Chen, Mei-kuang/0000-0002-0407-6788	Intergreen Flower Farms Naivasha; foundation Stiching Roer; German Institute for Medical Mission; Agnes Phillipine Walters Foundation	Intergreen Flower Farms Naivasha; foundation Stiching Roer; German Institute for Medical Mission; Agnes Phillipine Walters Foundation	Funding for the research was received from Intergreen Flower Farms Naivasha and the foundation Stiching Roer. Funds to run the program were received from the German Institute for Medical Mission and the Agnes Phillipine Walters Foundation, however program funding did not include research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, KENYA DEMOGRAPHIC HL; [Anonymous], 2011, COMMUNITY BASED NEWB, P1; Bahl R, 2010, SEMIN PERINATOL, V34, P477, DOI 10.1053/j.semperi.2010.09.001; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Campbell C, 2011, GLOB PUBLIC HEALTH, V6, P125, DOI 10.1080/17441690903334232; Darmstadt GL, 2010, SEMIN PERINATOL, V34, P367, DOI 10.1053/j.semperi.2010.09.003; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Del Barco R. E., 2004, MONITORING BIRTH PRE; Hounton S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1947; Kawakatsu Yoshito, 2012, Prim Health Care Res Dev, V13, P294, DOI 10.1017/S1463423612000138; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Lehmann U., 2007, COMMUNITY HLTH WORKE, P1; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Mo Health, 2006, TAKING KENYA ESSENTI; Nair N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000246; Neeloy AA, 2008, J PERINATOL, V28, pS2, DOI 10.1038/jp.2008.166; Olang'o CO, 2010, HEALTH POLICY, V97, P232, DOI 10.1016/j.healthpol.2010.05.004; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rosato M, 2010, MALAWI MED J, V22, P112; Shaddish W.R., 2001, EXPT QUASIEXPERIMENT; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Takasugi T, 2012, PUBLIC HEALTH, V126, P839, DOI 10.1016/j.puhe.2012.06.005; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1	24	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104027	10.1371/journal.pone.0104027	http://dx.doi.org/10.1371/journal.pone.0104027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090111	gold, Green Submitted, Green Published			2022-12-25	WOS:000339812700083
J	Hemamalini, R; Khare, S				Hemamalini, R.; Khare, Sunil			A Proteomic Approach to Understand the Role of the Outer Membrane Porins in the Organic Solvent-Tolerance of Pseudomonas aeruginosa PseA	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PROTEIN; MECHANISMS; STRAIN; DIVERSITY; TOXICITY; BINDING; TOLUENE; GROWTH	Solvent-tolerant microbes have the unique ability to thrive in presence of organic solvents. The present study describes the effect of increasing hydrophobicity (log P-ow values) of organic solvents on the outer membrane proteome of the solvent-tolerant Pseudomonas aeruginosa PseA cells. The cells were grown in a medium containing 33% (v/v) alkanes of increasing log Pow values. The outer membrane proteins were extracted by alkaline extraction from the late log phase cells and changes in the protein expression were studied by 2-D gel electrophoresis. Seven protein spots showed significant differential expression in the solvent exposed cells. The tryptic digest of the differentially regulated proteins were identified by LC-ESI MS/MS. The identity of these proteins matched with porins OprD, OprE, OprF, OprH, Opr86, LPS assembly protein and A-type flagellin. The reported pI values of these proteins were in the range of 4.94-8.67 and the molecular weights were in the range of 19.5-104.5 kDa. The results suggest significant down-regulation of the A-type flagellin, OprF and OprD and up-regulation of OprE, OprH, Opr86 and LPS assembly protein in presence of organic solvents. OprF and OprD are implicated in antibiotic uptake and outer membrane stability, whereas A-type flagellin confers motility and chemotaxis. Upregulated OprE is an anaerobically-induced porin while Opr86 is responsible for transport of small molecules and assembly of the outer membrane proteins. Differential regulation of the above porins clearly indicates their role in adaptation to solvent exposure.	[Hemamalini, R.; Khare, Sunil] Indian Inst Technol, Dept Chem, Enzyme & Microbial Biochem Lab, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Khare, S (corresponding author), Indian Inst Technol, Dept Chem, Enzyme & Microbial Biochem Lab, New Delhi 110016, India.	skkhare@chemistry.iitd.ac.in		Khare, Sunil Kumar/0000-0002-7339-3058	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	RH gratefully acknowledges the Indian Council of Medical Research, New Delhi, India for providing research fellowship. ICMR Sanction Order No. No. 3/1/3/JRF-2010/MPD-47(36165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, MICROBIOL-SGM, V149, P1265, DOI 10.1099/mic.0.25927-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceylan S, 2011, CAN J MICROBIOL, V57, P295, DOI [10.1139/w11-009, 10.1139/W11-009]; Chantal W Nde, 2009, ENVIRON SCI TECHNOL, V43, P8406; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Gaur R, 2009, LETT APPL MICROBIOL, V49, P372, DOI 10.1111/j.1472-765X.2009.02671.x; Gupta A, 2006, BIORESOURCE TECHNOL, V97, P1788, DOI 10.1016/j.biortech.2005.09.006; Gupta A, 2009, CRIT REV BIOTECHNOL, V29, P44, DOI 10.1080/07388550802688797; HANCOCK REW, 1990, MOL MICROBIOL, V4, P1069, DOI 10.1111/j.1365-2958.1990.tb00680.x; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Joshi C, 2013, BIOCATAL AGR BIOTECH, V2, P32, DOI 10.1016/j.bcab.2012.08.006; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li H, 2012, INT J MED MICROBIOL, V302, P63, DOI 10.1016/j.ijmm.2011.10.001; Mastrobuoni G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-215; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Na KS, 2005, J BIOSCI BIOENG, V99, P378, DOI 10.1263/jbb.99.378; Nouwens AS, 2003, PROTEOMICS MICROORGA, P128; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Roma-Rodrigues C, 2010, J PROTEOMICS, V73, P1461, DOI 10.1016/j.jprot.2010.02.003; Sardessai YN, 2004, BIOTECHNOL PROGR, V20, P655, DOI 10.1021/bp0200595; Schliep M, 2012, MOL BIOSYST, V8, P3017, DOI 10.1039/c2mb25212k; Segura A, 2001, J BACTERIOL, V183, P4127, DOI 10.1128/JB.183.14.4127-4133.2001; Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Siqueira R, 2010, PROCESS BIOCHEM, V45, P1504; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; Sugawara E, 2006, J BIOL CHEM, V281, P16220, DOI 10.1074/jbc.M600680200; Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07; TRIAS J, 1990, J BIOL CHEM, V265, P15680; van Beilen JB, 2003, OIL GAS SCI TECHNOL, V58, P427, DOI 10.2516/ogst:2003026; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Watanabe R, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-58; WOODRUFF WA, 1989, J BACTERIOL, V171, P3304, DOI 10.1128/jb.171.6.3304-3309.1989; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422	37	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103788	10.1371/journal.pone.0103788	http://dx.doi.org/10.1371/journal.pone.0103788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089526	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700055
J	Viceconte, N; McKenna, T; Eriksson, M				Viceconte, Nikenza; McKenna, Tomas; Eriksson, Maria			Low Levels of the Reverse Transactivator Fail to Induce Target Transgene Expression in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; GENE-EXPRESSION; MICE; ATHEROSCLEROSIS; MUTATION; DISEASE; TTA	Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disease with multiple features that are suggestive of premature aging. Most patients with HGPS carry a mutation on one of their copies of the LMNA gene. The LMNA gene encodes the lamin A and lamin C proteins, which are the major proteins of the nuclear lamina. The organs of the cardiovascular system are amongst those that are most severely affected in HGPS, undergoing a progressive depletion of vascular smooth muscle cells, and most children with HGPS die in their early teens from cardio-vascular disease and other complications from atherosclerosis. In this study, we developed a transgenic mouse model based on the tet-ON system to increase the understanding of the molecular mechanisms leading to the most lethal aspect of HGPS. To induce the expression of the most common HGPS mutation, LMNA c.1824C>T; p.G608G, in the vascular smooth muscle cells of the aortic arch and thoracic aorta, we used the previously described reverse tetracycline-controlled transactivator, sm22 alpha-rtTA. However, the expression of the reverse sm22 alpha-transactivator was barely detectable in the arteries, and this low level of expression was not sufficient to induce the expression of the target human lamin A minigene. The results from this study are important because they suggest caution during the use of previously functional transgenic animal models and emphasize the importance of assessing transgene expression over time.	[Viceconte, Nikenza; McKenna, Tomas; Eriksson, Maria] Karolinska Inst, Novum, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet	Eriksson, M (corresponding author), Karolinska Inst, Novum, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden.	Maria.Eriksson.2@ki.se			Knut and Alice Wallenberg Foundation; Swedish Research Council and the Center for Biosciences; Swedish Research Council; OE & Edla Johansson foundation; Lars Hierta foundation; Svenska Lakare Sallskapet; Ake Wiberg foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council and the Center for Biosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); OE & Edla Johansson foundation; Lars Hierta foundation; Svenska Lakare Sallskapet; Ake Wiberg foundation	This study was in part performed at the Live Cell Imaging unit, Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden, supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Research Council and the Center for Biosciences. This research was supported by grants to ME from the Swedish Research Council, the OE & Edla Johansson foundation, the in memory of Lars Hierta foundation, the Svenska Lakare Sallskapet, and the Ake Wiberg foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek J-H MT, 2012, GENETIC DISORDERS IN, P65; Bao-Cutrona M, 2009, GENETICS, V181, P1687, DOI 10.1534/genetics.108.097600; Bernal-Mizrachi C, 2005, NATURE, V435, P502, DOI 10.1038/nature03527; Boger H, 1999, MECH DEVELOP, V83, P141, DOI 10.1016/S0925-4773(99)00042-8; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fedorov LM, 2001, GENESIS, V31, P78, DOI 10.1002/gene.10007; Goldman RD, 2004, ACCUMULATION MUTANT; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Lee S, 2006, J MOL CELL CARDIOL, V40, P148, DOI 10.1016/j.yjmcc.2005.09.015; Lee S, 2005, CIRC RES, V97, pE85; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; McKenna T, 2013, AGING CELL      1204, V4; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Schmidt E, 2012, J BIOL CHEM, V287, P33512, DOI 10.1074/jbc.M112.366450; Schmidt Eva, 2011, BMC Res Notes, V4, P282, DOI 10.1186/1756-0500-4-282; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021	26	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104098	10.1371/journal.pone.0104098	http://dx.doi.org/10.1371/journal.pone.0104098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090270	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700095
J	Al-Saffar, NMS; Marshall, LV; Jackson, LE; Balarajah, G; Eykyn, TR; Agliano, A; Clarke, PA; Jones, C; Workman, P; Pearson, ADJ; Leach, MO				Al-Saffar, Nada M. S.; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Eykyn, Thomas R.; Agliano, Alice; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.; Leach, Martin O.			Lactate and Choline Metabolites Detected In Vitro by Nuclear Magnetic Resonance Spectroscopy Are Potential Metabolic Biomarkers for PI3K Inhibition in Pediatric Glioblastoma	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; BREAST-CANCER CELLS; BRAIN-TUMORS; PHARMACODYNAMIC MARKERS; CLINICAL-TRIALS; HISTONE H3.3; TEMOZOLOMIDE; MUTATIONS; ADULT; RADIOTHERAPY	The phosphoinositide 3-kinase (PI3K) pathway is believed to be of key importance in pediatric glioblastoma. Novel inhibitors of the PI3K pathway are being developed and are entering clinical trials. Our aim is to identify potential non-invasive biomarkers of PI3K signaling pathway inhibition in pediatric glioblastoma using in vitro nuclear magnetic resonance (NMR) spectroscopy, to aid identification of target inhibition and therapeutic response in early phase clinical trials of PI3K inhibitors in childhood cancer. Treatment of SF188 and KNS42 human pediatric glioblastoma cell lines with the dual pan-Class I PI3K/ mTOR inhibitor PI-103, inhibited the PI3K signaling pathway and resulted in a decrease in phosphocholine (PC), total choline (tCho) and lactate levels (p<0.02) as detected by phosphorus (P-31)-and proton (H-1)-NMR. Similar changes were also detected using the pan-Class I PI3K inhibitor GDC-0941 which lacks significant mTOR activity and is entering Phase II clinical trials. In contrast, the DNA damaging agent temozolomide (TMZ), which is used as current frontline therapy in the treatment of glioblastoma postoperatively (in combination with radiotherapy), increased PC, glycerophosphocholine (GPC) and tCho levels (p<0.04). PI-103-induced NMR changes were associated with alterations in protein expression levels of regulatory enzymes involved in glucose and choline metabolism including GLUT1, HK2, LDHA and CHKA. Our results show that by using NMR we can detect distinct biomarkers following PI3K pathway inhibition compared to treatment with the DNA-damaging anti-cancer agent TMZ. This is the first study reporting that lactate and choline metabolites are potential non-invasive biomarkers for monitoring response to PI3K pathway inhibitors in pediatric glioblastoma.	[Al-Saffar, Nada M. S.; Jackson, L. Elizabeth; Balarajah, Geetha; Eykyn, Thomas R.; Agliano, Alice; Leach, Martin O.] Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK & EPSRC Canc Imaging Ctr, London SW3 6JB, England; [Al-Saffar, Nada M. S.; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Eykyn, Thomas R.; Agliano, Alice; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.; Leach, Martin O.] Royal Marsden NHS Fdn Trust, London, England; [Marshall, Lynley V.; Jones, Chris] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Marshall, Lynley V.; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Marshall, Lynley V.; Pearson, Andrew D. J.] Inst Canc Res, Div Clin Studies, London SW3 6JB, England; [Eykyn, Thomas R.] Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England; [Clarke, Paul A.; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Al-Saffar, NMS (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK & EPSRC Canc Imaging Ctr, London SW3 6JB, England.	Nada.Al-Saffar@icr.ac.uk	leach, martin o/C-2248-2008; Eykyn, Thomas/J-3284-2016; Jones, Chris/ABE-6059-2021	leach, martin o/0000-0002-0756-5368; Eykyn, Thomas/0000-0003-1768-3808; Jones, Chris/0000-0001-8118-2296; Clarke, Paul/0000-0001-9342-1290	Brain Tumour Charity [6/54]; Oak Foundation [OCay-04-169]; Cancer Research UK; EPSRC; MRC; Department of Health (England) [C1060/A10334, C1060/6916]; Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award [C347/A15403]; Cancer Research UK [C309/A2187, C309/A8274]; National Health Service; EPSRC [EP/H046526/1] Funding Source: UKRI; Cancer Research UK [11566, 16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S23612/01, EP/H046526/1] Funding Source: researchfish; The Brain Tumour Charity [6/54] Funding Source: researchfish	Brain Tumour Charity; Oak Foundation; Cancer Research UK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award; Cancer Research UK(Cancer Research UK); National Health Service; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Brain Tumour Charity	This work was supported by The Brain Tumour Charity [www.thebraintumourcharity.org] (6/54) to NMSA, GB and AA; The Oak Foundation (www.oakfnd.org] (OCay-04-169) to LVM; Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) (C1060/A10334, C1060/6916) to MOL, NMSA, LEJ and TE; Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award (C347/A15403) to AP; Cancer Research UK (C309/A2187, C309/A8274) to PW and PAC. PW is a Cancer Research UK Life Fellow; MOL is an NIHR senior investigator. The Institute of Cancer Research co-authors acknowledge National Health Service funding to the Biomedical Research Centre. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Al-Saffar NMS, 2006, CANCER RES, V66, P427, DOI 10.1158/0008-5472.CAN-05-1338; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2010, BRIT J CANCER, V102, P1, DOI 10.1038/sj.bjc.6605457; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Braccini L., 2012, Advances in Biological Regulation, V52, P389, DOI 10.1016/j.jbior.2012.04.002; Broniscer A, 2006, J NEURO-ONCOL, V76, P313, DOI 10.1007/s11060-005-7409-5; Bulik M, 2013, CLIN NEUROL NEUROSUR, V115, P146, DOI 10.1016/j.clineuro.2012.11.002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Clarke PA, 2012, J CLIN ONCOL, V30, P331, DOI 10.1200/JCO.2011.38.7167; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Gadian D. G, 1995, NMR ITS APPL LIVING, P29; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; HaasKogan DA, 1996, INT J RADIAT ONCOL, V36, P95, DOI 10.1016/S0360-3016(96)00244-1; Hargrave Darren R, 2007, Expert Rev Neurother, V7, P1029, DOI 10.1586/14737175.7.8.1029; HEISS WD, 1990, J NUCL MED, V31, P302; Hill DK, 2013, NMR BIOMED, V26, P1321, DOI 10.1002/nbm.2957; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Kelly CJ, 2012, NUCL MED BIOL, V39, P986, DOI 10.1016/j.nucmedbio.2012.04.006; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lee SC, 2013, NMR BIOMED, V26, P106, DOI 10.1002/nbm.2825; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lucignani G, 2011, EUR J NUCL MED MOL I, V38, P179, DOI 10.1007/s00259-010-1661-4; Murphy PS, 2004, BRIT J CANCER, V90, P781, DOI 10.1038/sj.bjc.6601593; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peet AC, 2012, NAT REV CLIN ONCOL, V9, P700, DOI 10.1038/nrclinonc.2012.187; Popov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056328; Nguyen QD, 2011, TRANSL ONCOL, V4, P241, DOI 10.1593/tlo.11118; Quon H, 2011, ANTICANCER RES, V31, P3559; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Su JS, 2012, NMR BIOMED, V25, P379, DOI 10.1002/nbm.1764; Takeshita I, 1987, Neurol Med Chir (Tokyo), V27, P581, DOI 10.2176/nmc.27.581; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6	51	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103835	10.1371/journal.pone.0103835	http://dx.doi.org/10.1371/journal.pone.0103835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084455	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800087
J	Oldenburger, A; Timens, W; Bos, S; Smit, M; Smrcka, AV; Laurent, AC; Cao, JJ; Hylkema, M; Meurs, H; Maarsingh, H; Lezoualc'h, F; Schmidt, M				Oldenburger, Anouk; Timens, Wim; Bos, Sophie; Smit, Marieke; Smrcka, Alan V.; Laurent, Anne-Coline; Cao, Junjun; Hylkema, Machteld; Meurs, Herman; Maarsingh, Harm; Lezoualc'h, Frank; Schmidt, Martina			Epac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke	FASEB JOURNAL			English	Article						exchange protein; cAMP; phospholipase C epsilon	OBSTRUCTIVE PULMONARY-DISEASE; PHOSPHOLIPASE-C-EPSILON; PROTEIN-KINASE-A; GROWTH-FACTOR; CYCLIC-AMP; CRUCIAL ROLE; CAMP; MACROPHAGES; ACTIVATION; COPD	Cigarette smoke (CS) induces inflammatory responses characterized by increase of immune cells and cytokine release. Remodeling processes, such as mucus hypersecretion and extracellular matrix protein production, are also directly or indirectly induced by CS. Recently, we showed that activation of the exchange protein directly activated by cAMP (Epac) attenuates CS extract-induced interleukin (IL)-8 release from cultured airway smooth muscle cells. Using an acute, short-term model of CS exposure, we now studied the role of Epac1, Epac2, and the Epac effector phospholipase-C epsilon (PLC epsilon) in airway inflammation and remodeling in vivo. Compared to wild-type mice exposed to CS, the number of total inflammatory cells, macrophages, and neutrophils and total IL-6 release was lower in Epac2(-/-) mice, which was also the case for neutrophils and IL-6 in PLC epsilon(-/-) mice. Taken together, Epac2, acting partly via PLC epsilon, but not Epac1, enhances CS-induced airway inflammation in vivo. In total lung homogenates of Epac1(-/-) mice, MUC5AC and matrix remodeling parameters (transforming growth factor-1, collagen I, and fibronectin) were increased at baseline. Our findings suggest that Epac1 primarily is capable of inhibiting remodeling processes, whereas Epac2 primarily increases inflammatory processes in vivo.Oldenburger, A., Timens, W., Bos, S., Smit, M., Smrcka, A. V., Laurent, A.-C., Cao, J., Hylkema, M., Meurs, H., Maarsingh, H., Lezoualc'h, F., and Schmidt, M. Epac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke.	[Oldenburger, Anouk; Bos, Sophie; Smit, Marieke; Meurs, Herman; Schmidt, Martina] Univ Groningen, Univ Med Ctr Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Oldenburger, Anouk; Timens, Wim; Cao, Junjun; Hylkema, Machteld; Meurs, Herman; Schmidt, Martina] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma, Groningen, Netherlands; [Oldenburger, Anouk; Timens, Wim; Cao, Junjun; Hylkema, Machteld; Meurs, Herman; Schmidt, Martina] Univ Groningen, Univ Med Ctr Groningen, COPD, Groningen, Netherlands; [Timens, Wim; Cao, Junjun; Hylkema, Machteld] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Smrcka, Alan V.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY USA; [Laurent, Anne-Coline; Lezoualc'h, Frank] Inst Malad Metab & Cardiovasc, INSERM, Unite Mixte Rech UMR 1048, Toulouse, France; [Laurent, Anne-Coline; Lezoualc'h, Frank] Univ Toulouse 3, F-31062 Toulouse, France; [Maarsingh, Harm] Palm Beach Atlantic Univ, Lloyd L Gregory Sch Pharm, Dept Pharmaceut Sci, W Palm Beach, FL USA	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Rochester; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Oldenburger, A (corresponding author), Univ Ctr Pharm, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	a.oldenburger@rug.nl	Schmidt, Martina/C-5339-2018; Maarsingh, Harm/AAD-5642-2019; Timens, Wim/K-5570-2013	Schmidt, Martina/0000-0003-3075-0630; Timens, Wim/0000-0002-4146-6363; Laurent, Anne-Coline/0000-0003-4382-3894	Dutch Lung Foundation [3.2.09.034]; U.S. National Institutes of Health [GM53536]; Abel Tasman Talent Program Fellowship from the University of Groningen; Region Midi-Pyrenees; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Association Francaise contre les Myopathies (AFM); GRRC; AFM; Fondation pour la Recherche Medicale (FRM) [Fondation pour la Recherche Medicale (FRM; DPC20111122995]; Merck Sharpe; Dohme; Rosalind Franklin Fellowship from the University of Groningen; Deutsche Forschungsgemeinschaft [IRTG1874/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	Dutch Lung Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abel Tasman Talent Program Fellowship from the University of Groningen; Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); GRRC; AFM(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Merck Sharpe; Dohme; Rosalind Franklin Fellowship from the University of Groningen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.O. was supported by a grant from the Dutch Lung Foundation (3.2.09.034); A. V. S was supported by a U.S. National Institutes of Health grant (GM53536); J.C. was the recipient of an Abel Tasman Talent Program Fellowship from the University of Groningen; A.-C. L. was the recipient of a grant from Region Midi-Pyrenees, Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC), and Association Francaise contre les Myopathies (AFM); F. L. was supported by grants from GRRC, AFM, and Fondation pour la Recherche Medicale (FRM; DPC20111122995); H. Ma. was supported by a grant from from Merck Sharpe and Dohme; M. S. was supported by a Rosalind Franklin Fellowship from the University of Groningen and a grant from the Deutsche Forschungsgemeinschaft (IRTG1874/1). The authors thank Malik Bisserier to support immunoblotting for Epac1 and Epac2.	Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Banner KH, 2009, BRIT J PHARMACOL, V157, P892, DOI 10.1111/j.1476-5381.2009.00170.x; Barnes PJ, 2008, CURR OPIN PHARMACOL, V8, P300, DOI 10.1016/j.coph.2008.03.001; Blacquiere MJ, 2009, EUR RESPIR J, V33, P1133, DOI 10.1183/09031936.00129608; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Bryn T, 2006, J IMMUNOL, V176, P7361, DOI 10.4049/jimmunol.176.12.7361; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Conrotto P, 2007, J PROTEOME RES, V6, P287, DOI 10.1021/pr060427q; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Dhami R, 2000, AM J RESP CELL MOL, V22, P244, DOI 10.1165/ajrcmb.22.2.3809; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Hardin M, 2012, AM J RESP CELL MOL, V47, P203, DOI 10.1165/rcmb.2012-0011OC; Holloway RA, 2013, CURR OPIN PULM MED, V19, P95, DOI 10.1097/MCP.0b013e32835cfff5; Homma S, 2006, INT J MOL MED, V18, P933; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Kasahara K, 2002, THORAX, V57, P242, DOI 10.1136/thorax.57.3.242; Kiml V, 2013, AM J RESP CRIT CARE, V187, P228, DOI 10.1164/rccm.201210-1843CI; Kistemaker LEM, 2013, EUR RESPIR J, V42, P1677, DOI 10.1183/09031936.00112412; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lee E, 2013, J ETHNOPHARMACOL, V149, P148, DOI 10.1016/j.jep.2013.06.014; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Murugan V, 2009, EXP LUNG RES, V35, P439, DOI 10.1080/01902140902759290; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Oka M, 2011, LAB INVEST, V91, P711, DOI 10.1038/labinvest.2011.10; Oldenburger A, 2014, AM J PHYSIOL-CELL PH, V306, pC585, DOI 10.1152/ajpcell.00183.2013; Oldenburger A, 2012, PHARMACEUTICALS, V5, P1291, DOI 10.3390/ph5121291; Oldenburger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031574; Page CP, 2012, CURR OPIN PHARMACOL, V12, P275, DOI 10.1016/j.coph.2012.02.016; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Perng DW, 2004, CHEST, V126, P375, DOI 10.1378/chest.126.2.375; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Raherison Chantal, 2011, Rev Prat, V61, P769; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Shibuya H, 2006, J DERMATOL SCI, V41, P187, DOI 10.1016/j.jdermsci.2005.10.005; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Takenaka N, 2011, EUR J IMMUNOL, V41, P202, DOI 10.1002/eji.201040675; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Taylor JD, 2010, PULM PHARMACOL THER, V23, P376, DOI 10.1016/j.pupt.2010.04.003; Vernooy JHJ, 2002, AM J RESP CELL MOL, V26, P152, DOI 10.1165/ajrcmb.26.1.4652; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	52	23	24	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4617	4628		10.1096/fj.13-248930	http://dx.doi.org/10.1096/fj.13-248930			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25103224	Green Published			2022-12-25	WOS:000344050900004
J	van den Beukel, JC; Grefhorst, A; Quarta, C; Steenbergen, J; Mastroberardino, PG; Lombes, M; Delhanty, PJ; Mazza, R; Pagotto, U; van der Lely, AJ; Themmen, APN				van den Beukel, Johanna C.; Grefhorst, Aldo; Quarta, Carmelo; Steenbergen, Jacobie; Mastroberardino, Pier G.; Lombes, Marc; Delhanty, Patric J.; Mazza, Roberta; Pagotto, Uberto; van der Lely, Aart Jan; Themmen, Axel P. N.			Direct activating effects of adrenocorticotropic hormone (ACTH) on brown adipose tissue are attenuated by corticosterone	FASEB JOURNAL			English	Article						HPA axis; hypothalamic-pituitary-adrenal axis; metabolism; cold exposure	ENERGY-BALANCE; ADRENERGIC-STIMULATION; METABOLIC PHENOTYPES; NATRIURETIC PEPTIDES; CUSHINGS-SYNDROME; PERIPHERAL-BLOOD; HUMAN ADIPOCYTES; MESSENGER-RNA; CELL-ACTIVITY; ADULT HUMANS	Brown adipose tissue (BAT) and brown-like cells in white adipose tissue (WAT) can dissipate energy through thermogenesis, a process mediated by uncoupling protein 1 (UCP1). We investigated whether stress hormones ACTH and corticosterone contribute to BAT activation and browning of WAT. ACTH and corticosterone were studied in male mice exposed to 4 or 23 degrees C for 24 h. Direct effects were studied in T37i mouse brown adipocytes and primary cultured murine BAT and inguinal WAT (iWAT) cells. In vivo effects were studied using F-18-deoxyglucose positron emission tomography. Cold exposure doubled serum ACTH concentrations (P=0.03) and fecal corticosterone excretion (P=0.008). In T37i cells, ACTH dose-dependently increased Ucp1 mRNA (EC50=1.8 nM) but also induced Ucp1 protein content 88% (P=0.02), glycerol release 32% (P=0.03) and uncoupled respiration 40% (P=0.003). In cultured BAT and iWAT, ACTH elevated Ucp1 mRNA by 3-fold (P=0.03) and 3.7-fold (P=0.01), respectively. In T37i cells, corticosterone prevented induction of Ucp1 mRNA and Ucp1 protein by both ACTH and norepinephrine in a glucocorticoid receptor (GR)-dependent fashion. ACTH and GR antagonist RU486 independently doubled BAT F-18-deoxyglucose uptake (P=0.0003 and P=0.004, respectively) in vivo. Our results show that ACTH activates BAT and browning of WAT while corticosterone counteracts this.Van den Beukel, J. C., Grefhorst, A., Quarta, C., Steenbergen, J., Mastroberardino, P. G., Lombes, M., Delhanty, P. J., Mazza, R., Pagotto, U., van der Lely, A. J., Themmen, A. P. N. Direct activating effects of adrenocorticotropic hormone (ACTH) on brown adipose tissue are attenuated by corticosterone.	[van den Beukel, Johanna C.; Grefhorst, Aldo; Steenbergen, Jacobie; Delhanty, Patric J.; van der Lely, Aart Jan; Themmen, Axel P. N.] Erasmus Univ, Med Ctr, Dept Internal Med, Endocrinol Sect, Rotterdam, Netherlands; [Mastroberardino, Pier G.] Erasmus Univ, Med Ctr, Dept Genet, Rotterdam, Netherlands; [Quarta, Carmelo; Mazza, Roberta; Pagotto, Uberto] Univ Bologna, S Orsola Malpighi Hosp, Endocrinol Unit, Bologna, Italy; [Quarta, Carmelo; Mazza, Roberta; Pagotto, Uberto] Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, Ctr Ric Biomed Appl, Bologna, Italy; [Lombes, Marc] Univ Paris 11, INSERM, Fac Med Paris Sud, Unite Mixte Rech UMR S693, Le Kremlin Bicetre, France	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	van den Beukel, JC (corresponding author), Erasmus MC, Dept Internal Med, Sect Endocrinol, Rm Ee542,POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.vandenbeukel@erasmusmc.nl	Lombes, Marc/L-5933-2018; Quarta, Carmelo/AAC-1629-2020	Lombes, Marc/0000-0003-3189-023X; Quarta, Carmelo/0000-0002-1352-4239; MASTROBERARDINO, PIER GIORGIO/0000-0003-2364-4258				Armengol J, 2012, BIOCHEM J, V443, P799, DOI 10.1042/BJ20111714; Bakopanos E, 2002, MOL CELL ENDOCRINOL, V190, P29, DOI 10.1016/S0303-7207(02)00027-8; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Betz MJ, 2013, J CLIN ENDOCR METAB, V98, P4097, DOI 10.1210/jc.2012-3535; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bowers SL, 2008, BRAIN BEHAV IMMUN, V22, P105, DOI 10.1016/j.bbi.2007.07.012; Burt MG, 2006, CLIN ENDOCRINOL, V64, P436, DOI 10.1111/j.1365-2265.2006.02488.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 1998, ANN NY ACAD SCI, V856, P171, DOI 10.1111/j.1749-6632.1998.tb08325.x; Carey AL, 2013, DIABETOLOGIA, V56, P147, DOI 10.1007/s00125-012-2748-1; CARNES M, 1994, EXP GERONTOL, V29, P625, DOI 10.1016/0531-5565(94)90075-2; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Celi FS, 2009, NEW ENGL J MED, V360, P1553, DOI 10.1056/NEJMe0900466; Cheung L, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.6; Cho KJ, 2005, J CELL BIOCHEM, V96, P869, DOI 10.1002/jcb.20561; Cinti S, 2002, J HISTOCHEM CYTOCHEM, V50, P21, DOI 10.1177/002215540205000103; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Deiuliis JA, 2010, LIPIDS, V45, P479, DOI 10.1007/s11745-010-3422-3; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P107, DOI 10.1139/y82-018; Frayn KN, 2012, AM J PHYSIOL-ENDOC M, V302, pE468, DOI 10.1152/ajpendo.00527.2011; GATTI G, 1993, BRAIN BEHAV IMMUN, V7, P16, DOI 10.1006/brbi.1993.1002; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gondo S, 2004, GENES CELLS, V9, P1239, DOI 10.1111/j.1365-2443.2004.00801.x; HARRI M, 1981, ACTA PHYSIOL SCAND, V113, P213, DOI 10.1111/j.1748-1716.1981.tb06885.x; Hoch M, 2007, OBESITY, V15, P40, DOI 10.1038/oby.2007.525; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Agulleiro MJ, 2013, MOL ENDOCRINOL, V27, P1934, DOI 10.1210/me.2013-1099; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kiwaki K, 2003, J COMP PHYSIOL B, V173, P675, DOI 10.1007/s00360-003-0377-1; Lacombe A, 2007, J ENDOCRINOL, V194, P153, DOI 10.1677/JOE-07-0102; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masera RG, 1999, EUR J ENDOCRINOL, V140, P299, DOI 10.1530/eje.0.1400299; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Nedergaard J, 2013, NAT MED, V19, P540, DOI 10.1038/nm.3187; Penfornis P, 2000, AM J PHYSIOL-ENDOC M, V279, pE386, DOI 10.1152/ajpendo.2000.279.2.E386; PEPPER GM, 1993, CELL IMMUNOL, V151, P110, DOI 10.1006/cimm.1993.1225; Qiao SJ, 2009, ENDOCRINOLOGY, V150, P4163, DOI 10.1210/en.2009-0195; Quarta C, 2012, J MOL ENDOCRINOL, V49, pR1, DOI 10.1530/JME-12-0043; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; ROCHON L, 1990, AM J PHYSIOL, V258, pC835, DOI 10.1152/ajpcell.1990.258.5.C835; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1986, METABOLISM, V35, P657, DOI 10.1016/0026-0495(86)90174-5; ROTHWELL NJ, 1985, COMP BIOCHEM PHYS A, V81, P99, DOI 10.1016/0300-9629(85)90273-7; SCARPACE PJ, 1988, AM J PHYSIOL, V255, pE153, DOI 10.1152/ajpendo.1988.255.2.E153; Scarpace PJ, 2000, J ENDOCRINOL, V164, P331, DOI 10.1677/joe.0.1640331; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Soumano K, 2000, MOL CELL ENDOCRINOL, V165, P7, DOI 10.1016/S0303-7207(00)00276-8; Spiga F, 2011, ENDOCRINOLOGY, V152, P1448, DOI 10.1210/en.2010-1209; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR1209, DOI 10.1152/ajpregu.1995.268.5.R1209; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Viengchareun S, 2001, AM J PHYSIOL-ENDOC M, V280, pE640, DOI 10.1152/ajpendo.2001.280.4.E640; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang TJ, 2012, NEW ENGL J MED, V367, P377, DOI 10.1056/NEJMcibr1204796; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 1998, FASEB J, V12, P1391, DOI 10.1096/fasebj.12.13.1391; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001; Zennaro MC, 1998, J CLIN INVEST, V101, P1254, DOI 10.1172/JCI1915	72	58	60	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					4857	4867		10.1096/fj.14-254839	http://dx.doi.org/10.1096/fj.14-254839			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25085924				2022-12-25	WOS:000344050900023
J	Kuiper, EG; Conn, GL				Kuiper, Emily G.; Conn, Graeme L.			Binding Induced RNA Conformational Changes Control Substrate Recognition and Catalysis by the Thiostrepton Resistance Methyltransferase (Tsr)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							23-S RIBOSOMAL-RNA; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; COMPLEX; SPOUT; STABILIZATION; MUTANTS; SITE	Ribosomal RNA (rRNA) post-transcriptional modifications are essential for ribosome maturation, translational fidelity, and are one mechanism used by both antibiotic-producing and pathogenic bacteria to resist the effects of antibiotics that target the ribosome. The thiostrepton producer Streptomyces azureus prevents self-intoxication by expressing the thiostrepton-resistance methyltransferase (Tsr), which methylates the 2'-hydroxyl of 23 S rRNA nucleotide adenosine 1067 within the thiostrepton binding site. Tsr is a homodimer with each protomer containing an L30e-like amino-terminal domain (NTD) and a SPOUT methyltransferase family catalytic carboxyl-terminal domain (CTD). We show that both enzyme domains are required for high affinity RNA substrate binding. The Tsr-CTD has intrinsic, weak RNA affinity that is necessary to direct the specific high-affinity Tsr-RNA interaction via NTDs, which have no detectable RNA affinity in isolation. RNA structure probing experiments identify the Tsr footprint on the RNA and structural changes in the substrate, induced specifically upon NTD binding, which are necessary for catalysis by the CTD. Additionally, we identify a key amino acid in each domain responsible for CTD-RNA binding and the observed NTD-dependent RNA structural changes. These studies allow us to develop a model for Tsr-RNA interaction in which the coordinated substrate recognition of each Tsr structural domain is an obligatory pre-catalytic recognition event. Our findings underscore the complexity of substrate recognition by RNA modification enzymes and the potential for direct involvement of the RNA substrate in controlling the process of its modification.	[Kuiper, Emily G.; Conn, Graeme L.] Emory Univ Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Conn, GL (corresponding author), 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu			National Institutes of Health [R01-AI088025, T32-GM008367]; United State Department of Agriculture National Institute of Food and Agriculture [2013-67011-21133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United State Department of Agriculture National Institute of Food and Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI088025 and T32-GM008367.; Supported by the Agriculture and Food Research Initiative Competitive Grant 2013-67011-21133 from the United State Department of Agriculture National Institute of Food and Agriculture.	Aminake MN, 2011, ANTIMICROB AGENTS CH, V55, P1338, DOI 10.1128/AAC.01096-10; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Burakovsky DE, 2012, NUCLEIC ACIDS RES, V40, P7885, DOI 10.1093/nar/gks508; Cameron DM, 2004, NUCLEIC ACIDS RES, V32, P3220, DOI 10.1093/nar/gkh644; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; Conn GL, 2002, J MOL BIOL, V318, P963, DOI 10.1016/S0022-2836(02)00147-X; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; CUNDLIFFE E, 1978, NATURE, V272, P792, DOI 10.1038/272792a0; CUNDLIFFE E, 1979, NATURE, V278, P859, DOI 10.1038/278859a0; Draper D E, 2001, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1103s02; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Dunstan MS, 2009, J BIOL CHEM, V284, P17013, DOI 10.1074/jbc.M901618200; Dunstan MS, 2005, CHEM BIOL, V12, P201, DOI 10.1016/j.chembiol.2004.11.019; Forouhar F, 2003, PROTEINS, V53, P329, DOI 10.1002/prot.10510; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; LAING LG, 1994, J MOL BIOL, V237, P577, DOI 10.1006/jmbi.1994.1256; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Linpinsel Jo L, 2012, Methods Mol Biol, V941, P43, DOI 10.1007/978-1-62703-113-4_4; Liu RJ, 2013, NUCLEIC ACIDS RES, V41, P7828, DOI 10.1093/nar/gkt568; LU M, 1994, J MOL BIOL, V244, P572, DOI 10.1006/jmbi.1994.1753; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; O'Dwyer K, 2004, J BACTERIOL, V186, P2346, DOI 10.1128/JB.186.8.2346-2354.2004; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; THOMPSON J, 1979, EUR J BIOCHEM, V98, P261, DOI 10.1111/j.1432-1033.1979.tb13184.x; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; WIENEN B, 1979, J BIOL CHEM, V254, P8031; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; XING YY, 1995, J MOL BIOL, V249, P319, DOI 10.1006/jmbi.1995.0299; Yang HR, 2010, BIOCHEMISTRY-US, V49, P6440, DOI 10.1021/bi1005915; Zearfoss N Ruth, 2012, Methods Mol Biol, V941, P181, DOI 10.1007/978-1-62703-113-4_14; Zhang H, 2012, J MOL BIOL, V423, P576, DOI 10.1016/j.jmb.2012.08.016	38	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26189	26200		10.1074/jbc.M114.574780	http://dx.doi.org/10.1074/jbc.M114.574780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086036	Green Published, hybrid			2022-12-25	WOS:000342128800015
J	Morinaga, T; Abe, K; Nakayama, Y; Yamaguchi, N; Yamaguchi, N				Morinaga, Takao; Abe, Kohei; Nakayama, Yuji; Yamaguchi, Noritaka; Yamaguchi, Naoto			Activation of Lyn Tyrosine Kinase through Decreased Membrane Cholesterol Levels during a Change in Its Membrane Distribution upon Cell Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LUNG ADENOCARCINOMA CELLS; SRC FAMILY KINASES; PLASMA-MEMBRANE; C-SRC; PROTEIN COMPLEXES; ANOIKIS; RECEPTOR; CANCER; TRAFFICKING	Cellular membranes, which can serve as scaffolds for signal transduction, dynamically change their characteristics upon cell detachment. Src family kinases undergo post-translational lipid modification and are involved in a wide range of signaling events at the plasma membrane, such as cell proliferation, cell adhesion, and survival. Previously, we showed the differential membrane distributions among the members of Src family kinases by sucrose density gradient fractionation. However, little is known about the regulation of the membrane distribution of Src family kinases upon cell detachment. Here, we show that cell detachment shifts the main peak of the membrane distribution of Lyn, a member of Src family kinase, from the low density to the high density membrane fractions and enhances the kinase activity of Lyn. The change in Lyn distribution upon cell detachment involves both dynamin activity and a decrease in membrane cholesterol. Cell detachment activates Lyn through decreased membrane cholesterol levels during a change in its membrane distribution. Furthermore, cholesterol incorporation decreases Lyn activity and reduces the viability of suspension cells. These results suggest that cell detachment-induced Lyn activation through the change in the membrane distribution of Lyn plays an important role in survival of suspension cells.	[Morinaga, Takao; Abe, Kohei; Nakayama, Yuji; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan	Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp		Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and the Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Belsches A P, 1997, Front Biosci, V2, pd501; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Connelly SF, 2010, MOL CARCINOGEN, V49, P1007, DOI 10.1002/mc.20684; COOPER RA, 1975, J CLIN INVEST, V55, P115, DOI 10.1172/JCI107901; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; FLEISCHER B, 1969, J CELL BIOL, V43, P59, DOI 10.1083/jcb.43.1.59; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Fukumoto Y, 2014, J BIOL CHEM, V289, P12313, DOI 10.1074/jbc.M113.533752; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Ikeda K, 2009, BBA-GEN SUBJECTS, V1790, P1345, DOI 10.1016/j.bbagen.2009.07.009; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Norambuena A, 2011, MOL BIOL CELL, V22, P3456, DOI 10.1091/mbc.E11-04-0361; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Pasquali C, 1999, J CHROMATOGR B, V722, P89, DOI 10.1016/S0378-4347(98)00314-4; PUCK TT, 1956, J EXP MED, V103, P273, DOI 10.1084/jem.103.2.273; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Ravnskov U, 2012, QJM-INT J MED, V105, P383, DOI 10.1093/qjmed/hcr243; Ringerike T, 2002, J CELL SCI, V115, P1331; Sakuma Y, 2010, J PATHOL, V220, P574, DOI 10.1002/path.2676; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	52	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26327	26343		10.1074/jbc.M114.580001	http://dx.doi.org/10.1074/jbc.M114.580001			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104351	Green Published, hybrid			2022-12-25	WOS:000342128800026
J	Schuler, P; Speck, T; Buhrig-Polaczek, A; Fleck, C				Schueler, Paul; Speck, Thomas; Buehrig-Polaczek, Andreas; Fleck, Claudia			Structure-Function Relationships in Macadamia integrifolia Seed Coats - Fundamentals of the Hierarchical Microstructure	PLOS ONE			English	Article							MECHANICAL-BEHAVIOR; NUT; SHELL; MICROSCOPY; NUTSHELL; ORCHARDS; FEATURES	The shells/coats of nuts and seeds are often very hard to crack. This is particularly the case with Macadamia seed coats, known to exhibit astoundingly high strength and toughness. We performed an extensive materials science characterization of the complex hierarchical structure of these coats, using light and scanning electron microscopy in 2D as well as microCT for 3D characterization. We differentiate nine hierarchical levels that characterize the structure ranging from the whole fruit on the macroscopic scale down to the molecular scale. From a biological viewpoint, understanding the hierarchical structure may elucidate why it is advantageous for these seed coats to be so difficult to break. From an engineering viewpoint, microstructure characterization is important for identifying features that contribute to the high strength and cracking resistance of these objects. This is essential for revealing the underlying structure-function-relationships. Such information will help us develop engineering materials and lightweight-structures with improved fracture and puncture resistance.	[Schueler, Paul; Fleck, Claudia] Tech Univ Berlin, Berlin, Germany; [Speck, Thomas] Univ Freiburg, Fac Biol, Plant Biomech Grp Freiburg, D-79106 Freiburg, Germany; [Buehrig-Polaczek, Andreas] Rhein Westfal TH Aachen, Foundry Inst, D-52062 Aachen, Germany	Technical University of Berlin; University of Freiburg; RWTH Aachen University	Fleck, C (corresponding author), Tech Univ Berlin, Berlin, Germany.	claudia.fleck@tu-berlin.de		Fleck, Claudia/0000-0002-8160-2710	German Research Foundation (DFG) [SPP 1420]; DFG	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work has been performed within the project "Impact resistant hierarchically structured materials based on fruit walls and nutshells'' funded by the German Research Foundation (DFG) within SPP 1420. The financial support of the DFG is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas T, 2007, J FOOD PROCESS ENG, V30, P773, DOI 10.1111/j.1745-4530.2007.00164.x; Braga GC, 1999, J AGR ENG RES, V72, P239, DOI 10.1006/jaer.1998.0369; Bresinsky A., 2008, STRASBURGER LEHRBUCH; Costello G, 2009, SO MACADAMIA SPECIES; Eldridge J., 2012, Australian Journal of Crop Science, V6, P1110; Elmouttie D, 2005, J ENVIRON MANAGE, V77, P79, DOI 10.1016/j.jenvman.2005.03.004; Esau K., 1977, ANATOMY SEED PLANTS; Fleck C, 2012, BIOINSPIR BIOMIM NAN, V1, P67, DOI 10.1680/bbn.11.00015; Guner M, 2003, BIOSYST ENG, V85, P485, DOI 10.1016/S1537-5110(03)00089-8; Hardner C. M., 2009, Horticultural Reviews, V35, P1; Hartung ME, 1939, J AGRIC RES, V59, P0397; Horskins K, 1999, CROP PROT, V18, P379, DOI 10.1016/S0261-2194(99)00038-1; Janick J., 2006, ENCY FRUIT NUTS; JENNINGS JS, 1986, J MATER SCI, V21, P1517, DOI 10.1007/BF01114704; Kaupp G, 2007, SCI RES ESSAYS, V2, P150; Kaupp G, 2011, J MATER CHEM, V21, P8389, DOI 10.1039/c0jm03713c; Ledbetter CA, 2008, BIORESOURCE TECHNOL, V99, P5567, DOI 10.1016/j.biortech.2007.10.059; Loprang RR, 2010, P WORLD C ENG, VII, P1586; Martone PT, 2010, INTEGR COMP BIOL, V50, P888, DOI 10.1093/icb/icq122; McConachie I, 1980, CALIFORNIA MACADAMIA, V26, P41; Menninger EA, 1977, EDIBLE NUTS WORLD; Naimi-Jamal MR, 2007, INT J MATER RES, V98, P438, DOI 10.3139/146.101490; Neves PC, 1993, ISHS ACT HORT 370 IN, P197; Peace C. P., 2005, South African Journal of Plant and Soil, V22, P71; Schopfer P, 2010, PFLANZENPHYSIOLOGIE; Schuler P, 2010, THESIS TU BERLIN; Sharifian Faroogh, 2008, Journal of Applied Sciences, V8, P886, DOI 10.3923/jas.2008.886.890; Speck O, 2011, SPRITZGIESSEN 2011, VVDI-Verlag, P25; Speck T, 2008, WIT TRANS ECOL ENVIR, V114, P3, DOI 10.2495/DN080011; Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425; Strohschen B, 1985, THESIS RHEINISCHE FR; Trueb LF, 1999, FRUCHTE NUSSE ALLER; VINCENT JFV, 1993, MATER RES SOC SYMP P, V292, P35; Walton DA, 2005, THESIS U SUNSHINE CO; WANG CH, 1994, INT J FRACTURE, V69, P67; Yan YY, 2011, ADV COLLOID INTERFAC, V169, P80, DOI 10.1016/j.cis.2011.08.005	36	32	32	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102913	10.1371/journal.pone.0102913	http://dx.doi.org/10.1371/journal.pone.0102913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102155	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900012
J	Kolodka, T; Charles, ML; Raghavan, A; Radichev, IA; Amatya, C; Ellefson, J; Savinov, AY; Nag, A; Williams, MS; Robbins, MS				Kolodka, Tadeusz; Charles, Matthew L.; Raghavan, Arvind; Radichev, Ilian A.; Amatya, Christina; Ellefson, Jacob; Savinov, Alexei Y.; Nag, Abhijeet; Williams, Mark S.; Robbins, Mark S.			Preclinical Characterization of Recombinant Human Tissue Kallikrein-1 as a Novel Treatment for Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; BRADYKININ B-2 RECEPTOR; KININ SYSTEM; INSULIN-RESISTANCE; GLUT4 TRANSLOCATION; SKELETAL-MUSCLE; GLUCOSE; PROKALLIKREIN; HYPERTENSION; LIRAGLUTIDE	Modulation of the kallikrein-kinin system (KKS) has been shown to have beneficial effects on glucose homeostasis and several other physiological responses relevant to the progression of type 2 diabetes mellitus (T2D). The importance of bradykinin and its receptors in mediating these responses is well documented, but the role of tissue kallikrein-1, the protease that generates bradykinin in situ, is much less understood. We developed and tested DM 199, recombinant human tissue kallikrein-1 protein (rhKLK-1), as a potential novel therapeutic for T2D. Hyperinsulinemic-euglycemic clamp studies suggest that DM199 increases whole body glucose disposal in non-diabetic rats. Single dose administration of DM199 in obese db/db mice and ZDF rats, showed an acute, dose-dependent improvement in whole-body glucose utilization. Sub-acute dosing for a week in ZDF rates improved glucose utilization, with a concomitant rise in fasting insulin levels and HOMA1 %B scores. After cessation of sub-acute dosing, fasting blood glucose levels were significantly lower in ZDF rats during a drug wash-out period. Our studies show for the first time that DM199 administration results in acute anti-hyperglycemic effects in several preclinical models, and demonstrate the potential for further development of DM199 as a novel therapeutic for T2D.	[Kolodka, Tadeusz; Charles, Matthew L.; Raghavan, Arvind; Williams, Mark S.; Robbins, Mark S.] DiaMed USA Inc, Minneapolis, MN 55441 USA; [Radichev, Ilian A.; Amatya, Christina; Ellefson, Jacob; Savinov, Alexei Y.] Sanford Res, Sanford Project, Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Nag, Abhijeet] Invitek Inc, Hayward, CA USA	Sanford Health	Raghavan, A (corresponding author), DiaMed USA Inc, Minneapolis, MN 55441 USA.	araghavan@diamedica.com		Raghavan, Arvind/0000-0002-2959-3626	Diamedica USA, Inc; Invitek, Inc.	Diamedica USA, Inc; Invitek, Inc.	All funding for the study and supply of the therapeutic test article, DM199, was provided by Diamedica USA, Inc. The funder and Invitek, Inc., provided support in the form of salaries for authors TK, MLC, AR, MSW, MSR, and AN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aref ABM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/429154; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Beard KM, 2006, DIABETES, V55, P2678, DOI 10.2337/db05-1538; Biyashev D, 2006, AM J PHYSIOL-HEART C, V290, pH1244, DOI 10.1152/ajpheart.00934.2005; Brand CL, 2009, DIABETES OBES METAB, V11, P795, DOI 10.1111/j.1463-1326.2009.01049.x; Brubaker PL, 2010, ENDOCRINOLOGY, V151, P1984, DOI 10.1210/en.2010-0115; Burgess GM, 2000, BRIT J PHARMACOL, V129, P77, DOI 10.1038/sj.bjp.0703012; Busse R, 1996, DIABETES, V45, pS8, DOI 10.2337/diab.45.1.S8; Campbell DJ, 2001, CLIN EXP PHARMACOL P, V28, P1060, DOI 10.1046/j.1440-1681.2001.03564.x; CAMPBELL DJ, 1994, HYPERTENSION, V23, P439, DOI 10.1161/01.HYP.23.4.439; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Damas J, 2004, DIABETES-METAB RES, V20, P288, DOI 10.1002/dmrr.489; Damas J, 1999, EXP PHYSIOL, V84, P549, DOI 10.1111/j.1469-445X.1999.01812.x; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Henriksen EJ, 1998, AM J PHYSIOL-REG I, V275, pR40, DOI 10.1152/ajpregu.1998.275.1.R40; Hillmeister P, 2012, ACTA PHYSIOL, V206, P215, DOI 10.1111/apha.12007; Houle S, 2003, HYPERTENSION, V41, P611, DOI 10.1161/01.HYP.0000054971.03046.9B; Isami S, 1996, DIABETOLOGIA, V39, P412, DOI 10.1007/s001250050460; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; KOHLMAN O, 1995, HYPERTENSION, V25, P1003, DOI 10.1161/01.HYP.25.5.1003; Lu HS, 1996, PROTEIN EXPRES PURIF, V8, P227, DOI 10.1006/prep.1996.0095; Lu HS, 1996, PROTEIN EXPRES PURIF, V8, P215, DOI 10.1006/prep.1996.0094; Madeddu P, 2007, NAT CLIN PRACT NEPHR, V3, P208, DOI 10.1038/ncpneph0444; Mayfield RK, 1996, DIABETES, V45, pS20, DOI 10.2337/diab.45.1.S20; Miyata T, 1998, EUR J ENDOCRINOL, V138, P344, DOI 10.1530/eje.0.1380344; Molitch ME, 2013, AM J MANAG CARE, V19; Montanari D, 2005, DIABETES, V54, P1573, DOI 10.2337/diabetes.54.5.1573; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; RHALEB NE, 1992, EUR J PHARMACOL, V210, P115, DOI 10.1016/0014-2999(92)90661-M; Rhaleb NE, 2011, COMPR PHYSIOL, V1, P971, DOI 10.1002/cphy.c100053; Shiuchi T, 2002, HYPERTENSION, V40, P329, DOI 10.1161/01.HYP.0000028979.98877.0C; Sturis J, 2003, BRIT J PHARMACOL, V140, P123, DOI 10.1038/sj.bjp.0705397; Tomita H, 2012, KIDNEY INT, V81, P733, DOI 10.1038/ki.2011.499; WANG J, 1994, HYPERTENSION, V23, P236, DOI 10.1161/01.HYP.23.2.236; XIONG W, 1995, HYPERTENSION, V25, P715, DOI 10.1161/01.HYP.25.4.715; YANG C, 1995, AM J PHYSIOL-ENDOC M, V268, pE1027, DOI 10.1152/ajpendo.1995.268.5.E1027; Yang C, 1997, REGUL PEPTIDES, V71, P23, DOI 10.1016/S0167-0115(97)01011-2; Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349; Yuan G, 2007, ENDOCRINOLOGY, V148, P2016, DOI 10.1210/en.2006-0602; Zhao CX, 2003, HYPERTENSION, V42, P1026, DOI 10.1161/01.HYP.0000097603.55404.35	41	11	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103981	10.1371/journal.pone.0103981	http://dx.doi.org/10.1371/journal.pone.0103981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100328	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100039
J	Adler, L; Alter, T; Sharbati, S; Golz, G				Adler, Linda; Alter, Thomas; Sharbati, Soroush; Goelz, Greta			Phenotypes of Campylobacter jejuni luxS Mutants Are Depending on Strain Background, Kind of Mutation and Experimental Conditions	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; AUTOINDUCER-2; BACTERIA; MOLECULE; METABOLISM; VIRULENCE; EXPRESSION; BIOFILM	Since the discovery that Campylobacter (C.) jejuni produces Autoinducer 2 (AI-2), various studies have been conducted to explore the function and role of AI-2 in C. jejuni. However, the interpretation of these analyses has been complicated by differences in strain backgrounds, kind of mutation and culture conditions used. Furthermore, all research on AI-2 dependent phenotypes has been conducted with AI-2 synthase (luxS) mutants. This mutation also leads to a disruption of the activated-methyl-cycle. Most studies lack sufficient complementation resulting in not knowing whether phenotypes of luxS mutants depend on disrupted metabolism or lack of AI-2. Additionally, no AI-2 receptor has been found yet. All this contributes to an intensive discussion about the exact role of AI-2 in C. jejuni. Therefore, we examined the impact of different experiment settings on three different C. jejuni luxS mutants on growth and motility (37 degrees C and 42 degrees C). Our study showed that differing phenotypes of C. jejuni luxS mutants depend on strain background, mutation strategy and culture conditions. Furthermore, we complemented experiments with synthetic AI-2 or homocysteine as well as the combination of both. Complementation with AI-2 and AI-2+ homocysteine significantly increased the cell number of C. jejuni NCTC 11168 Delta luxS in stationary phase compared to the non-complemented C. jejuni NCTC 11168 Delta luxS mutant. Genetic complementation of both C. jejuni 81-176 luxS mutants resulted in wild type comparable growth curves. Also swarming ability could be partially complemented. While genetic complementation restored swarming abilities of C. jejuni 81-176 Delta luxS, it did not fully restore the phenotype of C. jejuni 81-176:: luxS, which indicates that compensatory mutations in other parts of the chromosome and/or potential polar effects may appear in this mutant strain. Also with neither synthetic complementation, the phenotype of the wild type-strains was achieved, suggesting yet another reason for differing phenotypes other than communication and methionine metabolism for C. jejuni luxS mutants.	[Adler, Linda; Alter, Thomas; Goelz, Greta] Free Univ Berlin, Inst Food Hyg, Berlin, Germany; [Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany	Free University of Berlin; Free University of Berlin	Adler, L (corresponding author), Free Univ Berlin, Inst Food Hyg, Berlin, Germany.	lindaadler@fu-berlin.de	Alter, Thomas/J-4810-2014	Alter, Thomas/0000-0002-6048-5666; Sharbati, Soroush/0000-0003-3338-7654	German Federal Office for Agriculture and Food	German Federal Office for Agriculture and Food	GG was funded by the German Federal Office for Agriculture and Food within the project InnoStep (http://www.ble.de/DE/07_DieBLE/dieble_node.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Cloak OM, 2002, APPL ENVIRON MICROB, V68, P4666, DOI 10.1128/AEM.68.9.4666-4671.2002; Corcionivoschi N, 2009, INFECT IMMUN, V77, P1959, DOI 10.1128/IAI.01239-08; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dingle KE, 2001, J CLIN MICROBIOL, V39, P3346, DOI 10.1128/JCM.39.9.3346-3349.2001; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Golz G, 2012, EUR J MICROBIOL IMMU, V2, P50, DOI 10.1556/EuJMI.2.2012.1.8; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Haigh R, 2013, MOL MICROBIOL, V88, P951, DOI 10.1111/mmi.12237; He YP, 2008, FOODBORNE PATHOG DIS, V5, P399, DOI 10.1089/fpd.2008.0106; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Kavanaugh JS, 2011, ACTA CRYSTALLOGR F, V67, P1501, DOI 10.1107/S1744309111042953; Kint G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-276; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; NG LK, 1985, J CLIN MICROBIOL, V21, P226, DOI 10.1128/JCM.21.2.226-230.1985; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Plummer P, 2012, INFECT IMMUN, V80, P585, DOI 10.1128/IAI.05766-11; Plummer PJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00022; Quinones B, 2009, APPL ENVIRON MICROB, V75, P281, DOI 10.1128/AEM.01803-08; Rader BA, 2011, MICROBIOL-SGM, V157, P2445, DOI 10.1099/mic.0.049353-0; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Tsuchikama K, 2011, J ORG CHEM, V76, P6981, DOI 10.1021/jo200882k; Udekwu KI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013449; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; Winzer K, 2003, ADV APPL MICROBIOL, V53, P291, DOI 10.1016/S0065-2164(03)53009-X; Winzer K, 2002, MICROBIOL-SGM, V148, P909, DOI 10.1099/00221287-148-4-909	34	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104399	10.1371/journal.pone.0104399	http://dx.doi.org/10.1371/journal.pone.0104399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093839	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200109
J	Hung, HS; Chang, CH; Chang, CJ; Tang, CM; Kao, WC; Lin, SZ; Hsieh, HH; Chu, MY; Sun, WS; Hsu, SH				Hung, Huey-Shan; Chang, Chih-Hsuan; Chang, Chen-Jung; Tang, Cheng-Ming; Kao, Wei-Chien; Lin, Shinn-Zong; Hsieh, Hsien-Hsu; Chu, Mei-Yun; Sun, Wei-Shen; Hsu, Shan-hui			In Vitro Study of a Novel Nanogold-Collagen Composite to Enhance the Mesenchymal Stem Cell Behavior for Vascular Regeneration	PLOS ONE			English	Article							POLYURETHANE NANOCOMPOSITES; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; TISSUE; GOLD; SCAFFOLDS; BINDING; NANOPARTICLES; PROLIFERATION	Novel nanocomposites based on type I collagen (Col) containing a small amount (17.4, 43.5, and 174 ppm) of gold nanoparticles (AuNPs, approximately 5 nm) were prepared in this study. The pure Col and Col-AuNP composites (Col-Au) were characterized by the UV-Vis spectroscopy (UV-Vis), surface-enhanced raman spectroscopy (SERS) and atomic force microscopy (AFM). The interaction between Col and AuNPs was confirmed by infrared (IR) spectra. The effect of AuNPs on the biocompatibility of Col, evaluated by the proliferation and reactive oxygen species (ROS) production of mesenchymal stem cells (MSCs) as well as the activation of monocytes and platelets, was investigated. Results showed that Col-Au had better biocompatibility than Col. Upon stimulation by vascular endothelial growth factor (VEGF) and stromal derived factor-1 alpha (SDF-1 alpha), MSCs expressed the highest levels of alpha v beta 3 integrin/CXCR4, focal adhesion kinase (FAK), matrix metalloproteinase-2 (MMP-2), and Akt/endothelial nitric oxide synthase (eNOS) proteins when grown on the Col-Au (43.5 ppm) nanocomposite. Taken together, Col-Au nanocomposites may promote the proliferation and migration of MSCs and stimulate the endothelial cell differentiation. These results suggest that Col-Au may be used to construct tissue engineering scaffolds for vascular regeneration.	[Hung, Huey-Shan; Chang, Chih-Hsuan; Kao, Wei-Chien; Chu, Mei-Yun; Sun, Wei-Shen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Hung, Huey-Shan; Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Chang, Chen-Jung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Tang, Cheng-Ming] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigang Hosp, Yunlin, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Hsieh, Hsien-Hsu] Taichung Vet Gen Hosp, Blood Bank, Taichung, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan; [Hsu, Shan-hui] Natl Taiwan Univ, Rehabil Engn Res Ctr, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Central Taiwan University Science & Technology; Chung Shan Medical University; China Medical University Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University	Hsu, SH (corresponding author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.	shhsu@ntu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020	Hsu, Shan-hui/0000-0003-3399-055X	National Science Council, Taiwan; Blood Bank, Taichung Veterans General Hospital	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Blood Bank, Taichung Veterans General Hospital	The work was supported by both National Science Council, Taiwan, and Blood Bank, Taichung Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067; Buerck J, 2013, LANGMUIR, V29, P1562, DOI 10.1021/la3033258; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; CHAPUIS JF, 1992, J BIOMECH, V25, P115, DOI 10.1016/0021-9290(92)90250-5; Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073; Desimone MF, 2010, ACTA BIOMATER, V6, P3998, DOI 10.1016/j.actbio.2010.05.014; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Fortini C, 2011, J CELL MOL MED, V15, P1726, DOI 10.1111/j.1582-4934.2010.01195.x; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048; Ho TT, 2012, GOLD BULL, V45, P161, DOI 10.1007/s13404-012-0062-9; Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8; Horovitz O, 2007, GOLD BULL, V40, P295, DOI 10.1007/BF03215603; HSU S, 1994, BIORHEOLOGY, V31, P21; Hsu SH, 2008, BIOMACROMOLECULES, V9, P241, DOI 10.1021/bm700471k; Hsu SH, 2008, ACTA BIOMATER, V4, P1797, DOI 10.1016/j.actbio.2008.06.015; Huang CY, 2013, J MED BIOL ENG, V33, P139, DOI 10.5405/jmbe.1109; Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738; Hung HS, 2012, J BIOMED MATER RES A, V100A, P26, DOI 10.1002/jbm.a.33224; Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003; Kirschner C, 2004, J AGR FOOD CHEM, V52, P3920, DOI 10.1021/jf0306136; Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; LEE JM, 1986, BIOMATERIALS, V7, P423; Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453; Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096; MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386; Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mekhfi H, 2012, NUTRITION, V28, P937, DOI 10.1016/j.nut.2011.11.032; Mironov V, 2008, TRENDS BIOTECHNOL, V26, P338, DOI 10.1016/j.tibtech.2008.03.001; Nimi N, 2011, GOLD BULL, V44, P15, DOI 10.1007/s13404-010-0001-6; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04; Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460; Sedaghat A, 2013, CLIN RES CARDIOL, V102, P413, DOI 10.1007/s00392-013-0547-4; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sun WJ, 2007, GROWTH FACTORS, V25, P309, DOI 10.1080/08977190701803885; Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Wang DB, 2014, J COLLOID INTERF SCI, V417, P244, DOI 10.1016/j.jcis.2013.11.019; Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012; Xu HZ, 2012, INT J MOL SCI, V13, P3366, DOI 10.3390/ijms13033366; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zhang L, 2010, APPL SPECTROSC, V64, P23, DOI 10.1366/000370210790571918; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	56	38	39	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104019	10.1371/journal.pone.0104019	http://dx.doi.org/10.1371/journal.pone.0104019			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093502	Green Submitted, gold, Green Published			2022-12-25	WOS:000341357200059
J	Monument, MJ; Johnson, KM; McIlvaine, E; Abegglen, L; Watkins, WS; Jorde, LB; Womer, RB; Beeler, N; Monovich, L; Lawlor, ER; Bridge, JA; Schiffman, JD; Krailo, MD; Randall, RL; Lessnick, SL				Monument, Michael J.; Johnson, Kirsten M.; McIlvaine, Elizabeth; Abegglen, Lisa; Watkins, W. Scott; Jorde, Lynn B.; Womer, Richard B.; Beeler, Natalie; Monovich, Laura; Lawlor, Elizabeth R.; Bridge, Julia A.; Schiffman, Joshua D.; Krailo, Mark D.; Randall, R. Lor; Lessnick, Stephen L.			Clinical and Biochemical Function of Polymorphic NR0B1 GGAA-Microsatellites in Ewing Sarcoma: A Report from the Children's Oncology Group	PLOS ONE			English	Article							ROUND-CELL TUMORS; EWS/FLI; INSTABILITY; GENE; SPECIFICITY; ONCOPROTEIN; EXPRESSION; SEQUENCES; ELEMENTS; FAMILY	Background: The genetics involved in Ewing sarcoma susceptibility and prognosis are poorly understood. EWS/FLI and related EWS/ETS chimeras upregulate numerous gene targets via promoter-based GGAA-microsatellite response elements. These microsatellites are highly polymorphic in humans, and preliminary evidence suggests EWS/FLI-mediated gene expression is highly dependent on the number of GGAA motifs within the microsatellite. Objectives: Here we sought to examine the polymorphic spectrum of a GGAA-microsatellite within the NR0B1 promoter (a critical EWS/FLI target) in primary Ewing sarcoma tumors, and characterize how this polymorphism influences gene expression and clinical outcomes. Results: A complex, bimodal pattern of EWS/FLI-mediated gene expression was observed across a wide range of GGAA motifs, with maximal expression observed in constructs containing 20-26 GGAA motifs. Relative to white European and African controls, the NR0B1 GGAA-microsatellite in tumor cells demonstrated a strong bias for haplotypes containing 21-25 GGAA motifs suggesting a relationship between microsatellite function and disease susceptibility. This selection bias was not a product of microsatellite instability in tumor samples, nor was there a correlation between NR0B1 GGAA-microsatellite polymorphisms and survival outcomes. Conclusions: These data suggest that GGAA-microsatellite polymorphisms observed in human populations modulate EWS/FLI-mediated gene expression and may influence disease susceptibility in Ewing sarcoma.	[Monument, Michael J.; Randall, R. Lor; Lessnick, Stephen L.] Univ Utah, Dept Orthoped Surg, Sarcoma Serv, Salt Lake City, UT 84112 USA; [Monument, Michael J.; Johnson, Kirsten M.; Abegglen, Lisa; Schiffman, Joshua D.; Randall, R. Lor; Lessnick, Stephen L.] Univ Utah, Ctr Childrens Canc Res, Huntsman Canc Inst, Salt Lake City, UT USA; [McIlvaine, Elizabeth; Krailo, Mark D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Watkins, W. Scott; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Watkins, W. Scott; Jorde, Lynn B.] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Womer, Richard B.] Univ Penn, Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Beeler, Natalie; Monovich, Laura] Nationwide Childrens Hosp, Res Inst, Childrens Oncol Grp, Biopathol Ctr, Columbus, OH USA; [Lawlor, Elizabeth R.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Lawlor, Elizabeth R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bridge, Julia A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Nebraska Med Ctr, Omaha, NE USA; [Schiffman, Joshua D.; Lessnick, Stephen L.] Univ Utah, Div Pediat Hematol Oncol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Southern California; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Oncology Group (COG); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah	Lessnick, SL (corresponding author), Univ Utah, Dept Orthoped Surg, Sarcoma Serv, Salt Lake City, UT 84112 USA.	stephen.lessnick@hci.utah.edu		Johnson, Kirsten/0000-0003-2388-0621	Huntsman Cancer Institute [P30CA042014]; Terri Anne Perine Sarcoma fund; Orthopaedic Research and Education Fund (OREF); Nick Currey Fund; NIH/NCI [R01 CA140394, R01 CA161780]; Damon Runyon Cancer Research Foundation [56--<SUP>-</SUP>11]; NATIONAL CANCER INSTITUTE [U01CA114757, U54CA168512, R01CA161780, U10CA180899, U10CA180886, R01CA140394, U10CA098543, P30CA042014] Funding Source: NIH RePORTER	Huntsman Cancer Institute; Terri Anne Perine Sarcoma fund; Orthopaedic Research and Education Fund (OREF); Nick Currey Fund; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All listed authors acknowledge support from the Huntsman Cancer Institute via P30CA042014 and the Terri Anne Perine Sarcoma fund. MJM acknowledges support from the Orthopaedic Research and Education Fund (OREF); MDK and EM acknowledge support from the Nick Currey Fund; SLL acknowledges support from the NIH/NCI via R01 CA140394 and JDS acknowledges support from the Damon Runyon Cancer Research Foundation (CI#56--<SUP>-</SUP>11) and from the NIH/NCI via R01 CA161780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzimanoglou II, 1998, CANCER-AM CANCER SOC, V82, P1808, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO;2-J; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; Beck R, 2012, CANCER GENET-NY, V205, P304, DOI 10.1016/j.cancergen.2012.04.004; Borinstein SC, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00057; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Dubois SG, 2011, PEDIAT BLOOD CANC; Eckert KA, 2002, MOL CARCINOGEN, V34, P140, DOI 10.1002/mc.10058; Eckert KA, 2009, MOL CARCINOGEN, V48, P379, DOI 10.1002/mc.20499; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gangwal Kunal, 2010, Genes Cancer, V1, P177; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Iglesias AR, 2004, GENE, V341, P149, DOI 10.1016/j.gene.2004.06.035; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Martin SS, 1998, ANN SURG ONCOL, V5, P356, DOI 10.1007/BF02303500; Martinez-Ramirez A, 2003, CANCER GENET CYTOGEN, V141, P138, DOI 10.1016/S0165-4608(02)00670-2; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; Ohali A, 2004, CANCER GENET CYTOGEN, V150, P50, DOI 10.1016/j.cancergencyto.2003.08.014; Patel M, 2011, GENOME RES; Postel-Vinay S, 2012, NATURE GENETICS; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Torchia EC, 2007, MOL CELL BIOL, V27, P7918, DOI 10.1128/MCB.00099-07; Weiss R, 2009, J COMP PATHOL, V141, P182, DOI 10.1016/j.jcpa.2008.11.008; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Worch J, 2010, CANCER-AM CANCER SOC, V116, P983, DOI 10.1002/cncr.24865; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zucman-Rossi J, 1997, HUM GENET, V99, P357, DOI 10.1007/s004390050372	47	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104378	10.1371/journal.pone.0104378	http://dx.doi.org/10.1371/journal.pone.0104378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093581	Green Submitted, gold, Green Published			2022-12-25	WOS:000341357200105
J	Frew, L; Makieva, S; McKinlay, ATM; McHugh, BJ; Doust, A; Norman, JE; Davidson, DJ; Stock, SJ				Frew, Lorraine; Makieva, Sofia; McKinlay, Andrew T. M.; McHugh, Brian J.; Doust, Ann; Norman, Jane E.; Davidson, Donald J.; Stock, Sarah J.			Human Cathelicidin Production by the Cervix	PLOS ONE			English	Article							DEFENSE PEPTIDE LL-37; RECEPTOR-LIKE 1; VITAMIN-D DEFICIENCY; P2X(7) RECEPTOR; GROWTH-FACTOR; PLASMA-LEVEL; ACTIVATION; EXPRESSION; PREGNANCY; PATHWAYS	hCAP18/LL-37 is the sole human cathelicidin; a family of host defence peptides with key roles in innate host defence. hCAP18/LL-37 is expressed primarily by neutrophils and epithelial cells, but its production and function in the lower genital tract is largely uncharacterised. Despite the significant roles for cathelicidin in multiple organs and inflammatory processes, its impact on infections that could compromise fertility and pregnancy is unknown. The aim of this study was to investigate cathelicidin production, regulation and function in the cervix. hCAP18/LL-37 was found to be present in cervicovaginal secretions collected from women in the first trimester of pregnancy and to be expressed at significantly higher levels in samples from women with alterations in vaginal bacterial flora characteristic of bacterial vaginosis. In endocervical epithelial cell lines, expression of the gene encoding hCAP18/LL-37 (CAMP) was not affected by TLR agonists, but was found to be upregulated by both 1, 25 hydroxyvitamin D-3 and 25 hydroxyvitamin D-3 . However, no association was found between serum levels of vitamin D and hCAP18/LL-37 concentrations in cervicovaginal secretions (n = 116). Exposure to synthetic LL-37 had a pro-inflammatory effect on endocervical epithelial cell lines, increasing secretion of inflammatory cytokine IL-8. Together these data demonstrate inducible expression of hCAP18/LL-37 in the female lower reproductive tract in vivo and suggest the capacity for this peptide to modulate host defence to infection in this system. Further investigation will elucidate the effects of hCAP18/LL-37 on the physiology and pathophysiology of labour, and may lead to strategies for the prevention of infection-associated preterm birth.	[Frew, Lorraine; Makieva, Sofia; McKinlay, Andrew T. M.; Doust, Ann; Norman, Jane E.; Stock, Sarah J.] Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; [McHugh, Brian J.; Davidson, Donald J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Stock, SJ (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland.	sarah.stock@ed.ac.uk	McKinlay, Andrew T. M./B-3613-2010	McKinlay, Andrew T. M./0000-0002-5639-3267; Norman, Jane/0000-0001-6031-6953; McHugh, Brian/0000-0003-4747-0643; Makieva, Sofia/0000-0001-6143-3553	Academy of Medical Sciences [R41286]; Jennifer Brown Research Laboratory [D20309]; MRC Senior Non-clinical Fellowship [G1002046]; Medical Research Council [G1002046, G0901697, G1002033] Funding Source: researchfish; MRC [G1002033, G1002046, G0901697] Funding Source: UKRI	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Jennifer Brown Research Laboratory; MRC Senior Non-clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by grants from the Academy of Medical Sciences (R41286) and the Jennifer Brown Research Laboratory (D20309) to JEN and SJS, with infrastructure support from Tommy's Centre for Maternal and Fetal Health (R40738). DJD is supported by a MRC Senior Non-clinical Fellowship (G1002046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Beaumont PE, 2013, LL 37 IMMUNOMODULATO; Bhan I, 2011, J ALLERGY CLIN IMMUN, V127, P1302, DOI 10.1016/j.jaci.2010.12.1097; Byfield FJ, 2011, AM J PHYSIOL-CELL PH, V300, pC105, DOI 10.1152/ajpcell.00158.2010; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Dixon Brian M, 2012, BMC Res Notes, V5, P575, DOI 10.1186/1756-0500-5-575; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Gombart AF, 2009, CLIN INFECT DIS, V48, P418, DOI 10.1086/596314; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Haggarty P, 2013, BRIT J NUTR, V109, P898, DOI 10.1017/S0007114512002255; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Havelka AM, 2010, ACTA PAEDIATR, V99, P836, DOI 10.1111/j.1651-2227.2010.01726.x; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Johnson DD, 2011, AM J PERINAT, V28, P7, DOI 10.1055/s-0030-1262505; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Levinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031996; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu Q, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-15; McAree T, 2013, MATERN CHILD NUTR, V9, P23, DOI 10.1111/mcn.12014; Mitchell C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.019; Montreekachon P, 2011, J PERIODONTAL RES, V46, P327, DOI 10.1111/j.1600-0765.2011.01346.x; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; National Collaborating Centre for Ws and Children's H, 2008, ANT CAR ROUT CAR HLT; Nell MJ, 2004, FEMS IMMUNOL MED MIC, V42, P225, DOI 10.1016/j.femsim.2004.05.013; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Ruiz-Gonzalez V, 2009, INT J DERMATOL, V48, P846, DOI 10.1111/j.1365-4632.2008.03924.x; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Toher C, 2013, J HUM NUTR DIET; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	51	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103434	10.1371/journal.pone.0103434	http://dx.doi.org/10.1371/journal.pone.0103434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089904	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700026
J	Ruano, EG; Canivell, S; Vieira, E				Ruano, Elena G.; Canivell, Silvia; Vieira, Elaine			REV-ERB ALPHA Polymorphism Is Associated with Obesity in the Spanish Obese Male Population	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; CLOCK GENE; TRANSCRIPTION FACTOR; METABOLIC SYNDROME; EXPRESSION; SUSCEPTIBILITY; CORTISOL; LEPTIN; IMPACT; BMAL1	REV-ERB ALPHA has been shown to link metabolism with circadian rhythms. We aimed to identify new polymorphisms in the promoter of REV-ERB ALPHA and tested whether these polymorphisms could be associated with obesity in the Spanish population. Of the 1197 subjects included in our study, 779 were obese (BMI 34.38 +/- 3.1 kg/m(2)) and 418 lean (BMI 23.27 +/- 1.5 kg/m(2)). In the obese group, 469 of the 779 had type 2 diabetes. Genomic DNA from all the subjects was obtained from peripheral blood cells and the genotyping in the REV-ERB ALPHA promoter was analyzed by High Resolution Melting. We found six polymorphisms in the REV-ERB ALPHA promoter and identified rs939347 as a SNP with the highest frequency in the total population. We did not find any association between rs939347 and type 2 diabetes (p = 0.101), but rs939347 was associated with obesity (p = 0.036) with the genotype AA exhibiting higher frequency in the obese (5.2% in total obese vs 2.4% in lean). This association was found only in men (p = 0.031; 6.5% AA-carriers in obese men vs 1.9% AA-carriers in lean men), with no association found in the female population (p = 0.505; 4.4% AA-carriers in obese women vs 2.7% AA-carriers in lean women). Our results suggest that the REV-ERB ALPHA rs939347 polymorphism could modulate body fat mass in men. The present work supports the role of REV-ERB ALPHA in the development of obesity as well as a potential target for the treatment of obesity.	[Ruano, Elena G.; Vieira, Elaine] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain; [Ruano, Elena G.; Canivell, Silvia; Vieira, Elaine] IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Vieira, E (corresponding author), CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain.	evieira@ciberdem.org	Vieira, Elaine/F-7273-2019; Vieira, Elaine/AAG-1127-2020	Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Canivell, Silvia/0000-0002-0280-5035	EC [279171]; Spanish Ministry of Science and Innovation [SAF 2010-19527]; CIBER de Diabetes y Enfermedades Metabolicas	EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER de Diabetes y Enfermedades Metabolicas	This work was supported by the EC Seventh Framework Programme theme FP7-HEALTH-2011 (279171), Spanish Ministry of Science and Innovation (SAF 2010-19527), and CIBER de Diabetes y Enfermedades Metabolicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben Ali S, 2009, CLIN BIOCHEM, V42, P1642, DOI 10.1016/j.clinbiochem.2009.08.019; Buss J, 2012, WORKPLACE HEALTH SAF, V60, P453, DOI 10.3928/21650799-20120926-66; Butun I, 2013, BRATISL MED J, V114, P129, DOI 10.4149/BLL_2013_028; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Corbalan-Tutau D, 2014, PHYSIOL BEHAV, V123, P231, DOI 10.1016/j.physbeh.2012.06.005; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Galbete C, 2012, CHRONOBIOL INT, V29, P1397, DOI 10.3109/07420528.2012.728657; Garaulet M, 2014, MOL NUTR FOOD RES, V58, P821, DOI 10.1002/mnfr.201300361; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Goumidi L, 2013, INT J OBESITY, V37, P666, DOI 10.1038/ijo.2012.117; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Husse J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052983; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lardone P, 2013, CURR PHARM DES; Mantele S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037123; Migita H, 2004, FEBS LETT, V561, P69, DOI 10.1016/S0014-5793(04)00118-8; Praveen EP, 2011, DIABET METAB SYND OB, V4, P347, DOI 10.2147/DMSO.S23915; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stratmann M, 2012, CELL METAB, V15, P791, DOI 10.1016/j.cmet.2012.05.006; Travison TG, 2007, CLIN ENDOCRINOL, V67, P71, DOI 10.1111/j.1365-2265.2007.02837.x; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; WHO, WHO OB OV; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	40	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104065	10.1371/journal.pone.0104065	http://dx.doi.org/10.1371/journal.pone.0104065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089907	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700092
J	Sivanandhan, G; Selvaraj, N; Ganapathi, A; Manickavasagam, M				Sivanandhan, Ganeshan; Selvaraj, Natesan; Ganapathi, Andy; Manickavasagam, Markandan			Enhanced Biosynthesis of Withanolides by Elicitation and Precursor Feeding in Cell Suspension Culture of Withania somnifera (L.) Dunal in Shake-Flask Culture and Bioreactor	PLOS ONE			English	Article							PHENYLETHANOID GLYCOSIDES; SECONDARY METABOLITES; METHYL JASMONATE; ROOT CULTURES; WITHAFERIN; ACCUMULATION; STRATEGIES; PATHWAYS; GROWTH	The present study investigated the biosynthesis of major and minor withanolides of Withania somnifera in cell suspension culture using shake-flask culture and bioreactor by exploiting elicitation and precursor feeding strategies. Elicitors like cadmium chloride, aluminium chloride and chitosan, precursors such as cholesterol, mevalonic acid and squalene were examined. Maximum total withanolides detected [withanolide A (7606.75 mg), withanolide B (4826.05 mg), withaferin A (3732.81 mg), withanone (6538.65 mg), 12 deoxy withanstramonolide (3176.63 mg), withanoside IV (2623.21 mg) and withanoside V (2861.18 mg)] were achieved in the combined treatment of chitosan (100 mg/l) and squalene (6 mM) along with 1 mg/l picloram, 0.5 mg/l KN, 200 mg/l L-glutamine and 5% sucrose in culture at 4 h and 48 h exposure times respectively on 28th day of culture in bioreactor. We obtained higher concentrations of total withanolides in shake-flask culture (2.13-fold) as well as bioreactor (1.66-fold) when compared to control treatments. This optimized protocol can be utilized for commercial level production of withanolides from suspension culture using industrial bioreactors in a short culture period.	[Sivanandhan, Ganeshan; Ganapathi, Andy; Manickavasagam, Markandan] Bharathidasan Univ, Sch Life Sci, Dept Biotechnol & Genet Engn, Tiruchirappalli 620017, Tamil Nadu, India; [Selvaraj, Natesan] Govt Arts Coll, Kulithalai, Tamil Nadu, India	Bharathidasan University	Sivanandhan, G (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Biotechnol & Genet Engn, Tiruchirappalli 620017, Tamil Nadu, India.	gsivabdu@gmail.com; manickbiotech@gmail.com	Sivanandhan, Ganeshan/H-8864-2015	Sivanandhan, Ganeshan/0000-0001-7917-2371	Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]; University Grants Commission (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), Government of India(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]. Prof. A. Ganapathi is thankful to the University Grants Commission (UGC), Government of India, for the award of UGC-BSR (Basic Scientific Research Fellowship). The first author thankfully acknowledges the Council of Scientific and Industrial Research (CSIR), Government of India, for the award of CSIR SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, BIOTECHNOL BIOPROC E, DOI [DOI 10.1007/BF02933747, 10.1007/BF02933747]; Baldi A, 2008, APPL BIOCHEM BIOTECH, V151, P556, DOI 10.1007/s12010-008-8231-2; Baldi A, 2008, BIORESOURCE TECHNOL, V99, P4609, DOI 10.1016/j.biortech.2007.06.061; Bourgaud F, 2001, PLANT SCI, V161, P839, DOI 10.1016/S0168-9452(01)00490-3; Cardellina JH, 2002, J NAT PROD, V65, P1073, DOI 10.1021/np0200515; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Ciddi Veeresham, 2006, Indian Journal of Pharmaceutical Sciences, V68, P490; Dias LLC, 2009, PLANT CELL TISS ORG, V99, P199, DOI 10.1007/s11240-009-9594-y; DORNENBURG H, 1995, ENZYME MICROB TECH, V17, P674, DOI 10.1016/0141-0229(94)00108-4; Flores-Sanchez IJ, 2002, PLANT CELL PHYSIOL, V43, P1502, DOI 10.1093/pcp/pcf181; Khan S, 2009, VACCINE, V27, P6080, DOI 10.1016/j.vaccine.2009.07.011; Krzyzanowska J, 2012, PLANT CELL TISS ORG, V108, P73, DOI 10.1007/s11240-011-0014-8; Ku SK, 2014, VASC PHARMACOL, V60, P120, DOI 10.1016/j.vph.2014.01.009; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Liu JY, 2007, BIOCHEM ENG J, V33, P88, DOI 10.1016/j.bej.2006.09.002; Lucumi E, 2002, PLANT CELL TISS ORG, V68, P293, DOI 10.1023/A:1013993403959; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Mishra B, 2014, PROTOPLASMA, V251, P1031, DOI 10.1007/s00709-014-0613-4; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mustafa NR, 2011, NAT PROTOC, V6, P715, DOI 10.1038/nprot.2010.144; Nagella P, 2011, PLANT CELL TISS ORG, V104, P119, DOI 10.1007/s11240-010-9799-0; Nagella P, 2010, BIORESOURCE TECHNOL, V101, P6735, DOI 10.1016/j.biortech.2010.03.078; Ouyang J, 2005, PROCESS BIOCHEM, V40, P3480, DOI 10.1016/j.procbio.2005.02.025; Patil JG, 2013, APPL MICROBIOL BIOT, V97, P2379, DOI 10.1007/s00253-012-4489-y; Rao RS, 2002, BIOTECHNOL ADV, V20, P1; Rhee HS, 2010, PLANT CELL TISS ORG, V101, P295, DOI 10.1007/s11240-010-9688-6; Sabir F, 2012, J PLANT GROWTH REGUL, V31, P537, DOI 10.1007/s00344-012-9264-x; Sabir F, 2011, PLANT BIOTECHNOL REP, V5, P127, DOI 10.1007/s11816-011-0165-4; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sharada M., 2008, RECENT ADV PLANT BIO, P645; Singh M, 2012, BIOPROC BIOSYST ENG, V35, P943, DOI 10.1007/s00449-012-0679-3; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Sivanandhan G, 2013, PROTOPLASMA, V250, P885, DOI 10.1007/s00709-012-0471-x; Sivanandhan G, 2013, PLANT CELL TISS ORG, V114, P121, DOI 10.1007/s11240-013-0297-z; Sivanandhan G, 2012, APPL BIOCHEM BIOTECH, V168, P681, DOI 10.1007/s12010-012-9809-2; Sivanandhan G, 2011, ACTA PHYSIOL PLANT, V33, P2279, DOI 10.1007/s11738-011-0768-y; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Vasconsuelo A, 2007, PLANT SCI, V172, P861, DOI 10.1016/j.plantsci.2007.01.006; Verpoorte R, 1999, BIOTECHNOL LETT, V21, P467, DOI 10.1023/A:1005502632053; Zhang CH, 2007, PLANT SCI, V172, P158, DOI 10.1016/j.plantsci.2006.08.002; Zhang W, 2002, ENZYME MICROB TECH, V30, P688, DOI 10.1016/S0141-0229(02)00041-8; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao J, 2001, APPL MICROBIOL BIOT, V55, P693, DOI 10.1007/s002530000568; Zhao JL, 2010, APPL MICROBIOL BIOT, V87, P137, DOI 10.1007/s00253-010-2443-4	48	59	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104005	10.1371/journal.pone.0104005	http://dx.doi.org/10.1371/journal.pone.0104005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089711	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700079
J	Da Ros, S; Zorzan, E; Giantin, M; Shahidian, LZ; Palumbo, M; Dacasto, M; Sissi, C				Da Ros, Silvia; Zorzan, Eleonora; Giantin, Mery; Shahidian, Lara Zorro; Palumbo, Manlio; Dacasto, Mauro; Sissi, Claudia			Sequencing and G-Quadruplex Folding of the Canine Proto-Oncogene KIT Promoter Region: Might Dog Be Used as a Model for Human Disease?	PLOS ONE			English	Article							MAST-CELL TUMORS; OF-FUNCTION MUTATIONS; C-KIT; SMALL-MOLECULE; LYMPHOMA; DOMAIN	Downregulation of gene expression by induction of non-canonical DNA structures at promotorial level is a novel attractive anticancer strategy. In human, two guanine-rich sequences (h_kit1 and h_kit2) were identified in the promotorial region of oncogene KIT. Their stabilization into G-quadruplex structures can find applications in the treatment of leukemias, mastocytosis, gastrointestinal stromal tumor, and lung carcinomas which are often associated to c-kit mis-regulation. Also the most common skin cancer in domestic dog, mast cell tumor, is linked to a mutation and/or to an over-expression of c-kit, thus supporting dog as an excellent animal model. In order to assess if the G-quadruplex mediated mechanism of regulation of c-kit expression is conserved among the two species, herein we cloned and sequenced the canine KIT promoter region and we compared it with the human one in terms of sequence and conformational equilibria in physiologically relevant conditions. Our results evidenced a general conserved promotorial sequence between the two species. As experimentally confirmed, this grants that the conformational features of the canine kit1 sequence are substantially shared with the human one. Conversely, two isoforms of the kit2 sequences were identified in the analyzed dog population. In comparison with the human counterpart, both of them showed an altered distribution among several folded conformations.	[Da Ros, Silvia; Palumbo, Manlio; Sissi, Claudia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, PD, Italy; [Zorzan, Eleonora; Giantin, Mery; Shahidian, Lara Zorro; Dacasto, Mauro] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy	University of Padua; University of Padua	Dacasto, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	mauro.dacasto@unipd.it; claudia.sissi@unipd.it	Giantin, Mery/AAX-3235-2020	SISSI, CLAUDIA/0000-0002-9713-1415; Zorro Shahidian, Lara/0000-0002-3182-9642; Palumbo, Manlio/0000-0002-3163-1564	Italian Ministry of Education (PRIN) [20105YY2HL]; University of Padova [CPDA114388]	Italian Ministry of Education (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padova	This research was supported by the Italian Ministry of Education (PRIN 2010-11, code 20105YY2HL) and by University of Padova (grant #CPDA114388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato J, 2011, BIOCONJUGATE CHEM, V22, P654, DOI 10.1021/bc100444v; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bejugam M, 2007, J AM CHEM SOC, V129, P12926, DOI 10.1021/ja075881p; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Boerkamp KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071094; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Castor KJ, 2013, CHEM-EUR J, V19, P17836, DOI 10.1002/chem.201301590; Chauhan A, 2014, BIOORG MED CHEM; D'allard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060961; Dash J, 2008, CHEM COMMUN, P3055, DOI 10.1039/b806042h; Davis JT, 2007, CHEM SOC REV, V36, P296, DOI 10.1039/b600282j; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Frost D, 2003, VET PATHOL, V40, P42, DOI 10.1354/vp.40-1-42; Giantin M, 2012, J VET DIAGN INVEST, V24, P116, DOI 10.1177/1040638711425945; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Hsueh YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065762; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jantos K, 2006, J AM CHEM SOC, V128, P13662, DOI 10.1021/ja064713e; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Letard S, 2008, MOL CANCER RES, V6, P1137, DOI 10.1158/1541-7786.MCR-08-0067; London CA, 1999, EXP HEMATOL, V27, P689, DOI 10.1016/S0301-472X(98)00075-7; London CA, 2009, CLIN CANCER RES, V15, P3856, DOI 10.1158/1078-0432.CCR-08-1860; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; Marech I, 2013, CRIT REV ONCOL HEMAT; McLuckie KIE, 2011, J AM CHEM SOC, V133, P2658, DOI 10.1021/ja109474c; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nielsen MC, 2014, EUR J MED CHEM, V72, P119, DOI 10.1016/j.ejmech.2013.11.027; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pawlak A, 2013, POSTEP HIG MED DOSW, V67, P471, DOI 10.5604/17322693.1050411; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Rammohan A, 2013, WORLD J GASTRO ONCOL, V5, P102, DOI 10.4251/wjgo.v5.i6.102; Randazzo A, 2013, TOP CURR CHEM, V330, P67, DOI 10.1007/128_2012_331; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Shirude PS, 2007, J AM CHEM SOC, V129, P7484, DOI 10.1021/ja070497d; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Waller ZAE, 2009, J AM CHEM SOC, V131, P12628, DOI 10.1021/ja901892u; Warland J, 2013, VET J, V197, P496, DOI 10.1016/j.tvjl.2013.02.017; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Withrow SJ, 2009, CANCER TREAT RES, V152, P439, DOI 10.1007/978-1-4419-0284-9_24; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Zemke D, 2002, VET PATHOL, V39, P529, DOI 10.1354/vp.39-5-529; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	50	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103876	10.1371/journal.pone.0103876	http://dx.doi.org/10.1371/journal.pone.0103876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084283	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800095
J	Wolfrom, CM; Laurent, M; Deschatrette, J				Wolfrom, Claire M.; Laurent, Michel; Deschatrette, Jean			Can We Negotiate with a Tumor?	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; GROWTH-RATES; CELLS; PROGRESSION; HYPOXIA; MODEL; LIVER; TIME	Recent progress in deciphering the molecular portraits of tumors promises an era of more personalized drug choices. However, current protocols still follow standard fixed-time schedules, which is not entirely coherent with the common observation that most tumors do not grow continuously. This unpredictability of the increases in tumor mass is not necessarily an obstacle to therapeutic efficiency, particularly if tumor dynamics could be exploited. We propose a model of tumor mass evolution as the integrated result of the dynamics of two linked complex systems, tumor cell population and tumor microenvironment, and show the practical relevance of this nonlinear approach.	[Wolfrom, Claire M.; Laurent, Michel; Deschatrette, Jean] Univ Paris 11, Inserm Unite 757, Equipe Dynam Cellulaires & Modelisat, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Laurent, M (corresponding author), Univ Paris 11, Inserm Unite 757, Equipe Dynam Cellulaires & Modelisat, Orsay, France.	michel.laurent@u-psud.fr			INSERM; Association Biologie du Cancer et Dynamiques Complexes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Biologie du Cancer et Dynamiques Complexes	Funding from INSERM and additional funding from the Association Biologie du Cancer et Dynamiques Complexes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Balschun K, 2011, J MOL DIAGN, V13, P436, DOI 10.1016/j.jmoldx.2011.03.002; BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Bindea G, 2011, SEMIN IMMUNOPATHOL, V33, P335, DOI 10.1007/s00281-011-0264-x; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cara S, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1008389706725; Colombo M, 1998, HEPATO-GASTROENTEROL, V45, P1221; Coulon A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-2; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dancey JE, 2009, EUR J CANCER, V45, P281, DOI 10.1016/j.ejca.2008.10.042; de la Cruz-Merino L, 2008, ONCOLOGIST, V13, P1246, DOI 10.1634/theoncologist.2008-0166; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Deschatrette J., 2003, ComPlexUs, V1, P134, DOI 10.1159/000076101; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Ehemann V, 2003, CANCER LETT, V194, P125, DOI 10.1016/S0304-3835(03)00054-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Frei E, 1999, BONE MARROW TRANSPL, V24, P939, DOI 10.1038/sj.bmt.1702012; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2009, CANCER RES, V69, P7499, DOI 10.1158/0008-5472.CAN-09-1354; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gompertz B, 1825, PHILOS T ROY SOC LON, V31, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Gwyther SJ, 2008, EUR J CANCER, V44, P39, DOI 10.1016/j.ejca.2007.10.010; HEUSER L, 1979, CANCER, V43, P1888, DOI 10.1002/1097-0142(197905)43:5<1888::AID-CNCR2820430545>3.0.CO;2-M; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jennings SG, 2006, RADIOLOGY, V241, P554, DOI 10.1148/radiol.2412051185; Jensen AR, 2007, RADIOTHER ONCOL, V84, P5, DOI 10.1016/j.radonc.2007.04.001; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kasuya H, 2006, NEUROSURG REV, V29, P293, DOI 10.1007/s10143-006-0039-3; Kaufmann Y, 2005, J IMMUNOL, V175, P6940, DOI 10.4049/jimmunol.175.10.6940; Klotz L, 2007, NAT CLIN PRACT ONCOL, V4, P692, DOI 10.1038/ncponc0966; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kucerova L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-129; Kunkle DA, 2007, J UROLOGY, V177, P849, DOI 10.1016/j.juro.2006.10.073; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Laurent M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009346; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li XM, 2010, CANCER RES, V70, P3351, DOI 10.1158/0008-5472.CAN-09-4235; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meggiato T, 2000, PANCREAS, V20, P117, DOI 10.1097/00006676-200003000-00002; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Nguyen LK, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-51; Nieman KM, 2010, NAT MED, V17, P1498; NORTON L, 1988, CANCER RES, V48, P7067; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Pantel K, NAT REV CANC, V8, P329; Pikovsky AS, 1997, PHYSICA D, V104, P219, DOI 10.1016/S0167-2789(96)00301-6; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; PREHN RT, 1991, CANCER RES, V51, P2; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; RETSKY MW, 1987, CANCER RES, V47, P4982; RETSKY MW, 1990, MED HYPOTHESES, V33, P95, DOI 10.1016/0306-9877(90)90186-I; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sargent DJ, 2009, EUR J CANCER, V45, P290, DOI 10.1016/j.ejca.2008.10.030; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Slade MJ, 2009, BRIT J CANCER, V100, P160, DOI 10.1038/sj.bjc.6604773; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; SPEER JF, 1984, CANCER RES, V44, P4124; STAUNTON MJ, 1995, AM J CLIN PATHOL, V103, P300, DOI 10.1093/ajcp/103.3.300; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tanaka Y, 2003, J NEUROSURG, V98, P359, DOI 10.3171/jns.2003.98.2.0359; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; TUBIANA M, 1991, BREAST CANCER RES TR, V18, P125, DOI 10.1007/BF01990028; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Vassileva V, 2008, MOL CANCER THER, V7, P630, DOI 10.1158/1535-7163.MCT-07-2117; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wolfrom C, 2007, FEBS LETT, V581, P125, DOI 10.1016/j.febslet.2006.12.007; Wu JH, 2011, CANCER RES, V71, P2622, DOI 10.1158/0008-5472.CAN-10-3837; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9; Zhang JB, 2009, RADIOLOGY, V250, P137, DOI 10.1148/radiol.2501071712	85	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103834	10.1371/journal.pone.0103834	http://dx.doi.org/10.1371/journal.pone.0103834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084359	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800086
J	Ishii, M; Shibata, R; Kondo, K; Kambara, T; Shimizu, Y; Tanigawa, T; Bando, YK; Nishimura, M; Ouchi, N; Murohara, T				Ishii, Masakazu; Shibata, Rei; Kondo, Kazuhisa; Kambara, Takahiro; Shimizu, Yuuki; Tanigawa, Tohru; Bando, Yasuko K.; Nishimura, Masahiro; Ouchi, Noriyuki; Murohara, Toyoaki			Vildagliptin Stimulates Endothelial Cell Network Formation and Ischemia-induced Revascularization via an Endothelial Nitric-oxide Synthase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; ACTIVATED PROTEIN-KINASE; HEART-FAILURE; STEM-CELLS; ANGIOGENESIS; ADIPONECTIN; PATHOPHYSIOLOGY; SITAGLIPTIN; REPERFUSION; PRESSURE	Dipeptidyl peptidase-4 inhibitors are known to lower glucose levels and are also beneficial in the management of cardiovascular disease. Here, we investigated whether a dipeptidyl peptidase-4 inhibitor, vildagliptin, modulates endothelial cell network formation and revascularization processes in vitro and in vivo. Treatment with vildagliptin enhanced blood flow recovery and capillary density in the ischemic limbs of wild-type mice, with accompanying increases in phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). In contrast to wildtype mice, treatment with vildagliptin did not improve blood flow in ischemic muscles of eNOS-deficient mice. Treatment with vildagliptin increased the levels of glucagon-like peptide-1 (GLP-1) and adiponectin, which have protective effects on the vasculature. Both vildagliptin and GLP-1 increased the differentiation of cultured human umbilical vein endothelial cells (HUVECs) into vascular-like structures, although vildagliptin was less effective than GLP-1. GLP-1 and vildagliptin also stimulated the phosphorylation of Akt and eNOS in HUVECs. Pretreatment with a PI3 kinase or NOS inhibitor blocked the stimulatory effects of both vildagliptin and GLP-1 on HUVEC differentiation. Furthermore, treatment with vildagliptin only partially increased the limb flow of ischemic muscle in adiponectin-deficient mice in vivo. GLP-1, but not vildagliptin, significantly increased adiponectin expression in differentiated 3T3-L1 adipocytes in vitro. These data indicate that vildagliptin promotes endothelial cell function via eNOS signaling, an effect that may be mediated by both GLP-1-dependent and GLP-1-independent mechanisms. The beneficial activity of GLP-1 for revascularization may also be partially mediated by its ability to increase adiponectin production.	[Ishii, Masakazu; Shibata, Rei; Kondo, Kazuhisa; Kambara, Takahiro; Shimizu, Yuuki; Bando, Yasuko K.; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Tanigawa, Tohru] Aichi Med Univ, Dept Otolaryngol, Nagakute, Aichi 4801195, Japan; [Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Ishii, Masakazu; Nishimura, Masahiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Prosthodont, Kagoshima 8908544, Japan	Nagoya University; Aichi Medical University; Nagoya University; Kagoshima University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Bando, Yasuko K./M-4831-2014; Murohara, Toyoaki/M-4958-2014; Nishimura, Masahiro/ABD-7504-2020; OUCHI, Noriyuki/I-7306-2014	Bando, Yasuko K./0000-0003-4166-6784; Nishimura, Masahiro/0000-0001-5552-0693; 	Banyu Life Science Foundation International; Kanae Foundation; Kowa Life Science Foundation	Banyu Life Science Foundation International(Banyu Life Science Foundation International); Kanae Foundation; Kowa Life Science Foundation	This work was supported by a grant-in-aid for Young Scientists B, Banyu Life Science Foundation International, the Kanae Foundation, and the Kowa Life Science Foundation (to R. S.).	Aronis KN, 2013, METABOLISM, V62, P1279, DOI 10.1016/j.metabol.2013.04.010; Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Chrysant SG, 2012, AM J CARDIOL, V109, P1681, DOI 10.1016/j.amjcard.2012.01.398; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Dai Y, 2013, ACTA DIABETOL, V50, P827, DOI 10.1007/s00592-013-0496-4; Ding L, 2012, ACTA PHARMACOL SIN, V33, P75, DOI 10.1038/aps.2011.149; Fadini GP, 2013, ATHEROSCLEROSIS, V229, P23, DOI 10.1016/j.atherosclerosis.2013.04.007; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Ishii M, 2011, ARTERIOSCL THROM VAS, V31, P2210, DOI 10.1161/ATVBAHA.111.231100; Jungraithmayr W, 2012, EUR J CARDIO-THORAC, V41, P1166, DOI 10.1093/ejcts/ezr180; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Kubota Y, 2012, J KOREAN MED SCI, V27, P1364, DOI 10.3346/jkms.2012.27.11.1364; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035007; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Miyagawa K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-160; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Murohara T, 2012, J AM COLL CARDIOL, V59, P277, DOI 10.1016/j.jacc.2011.09.050; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shah Z, 2011, VASC PHARMACOL, V55, P2, DOI 10.1016/j.vph.2011.03.001; Sheikh A, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-47; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shimizu S, 2012, J MOL ENDOCRINOL, V49, P125, DOI 10.1530/JME-12-0039; Shimizu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000438; Takahashi A, 2013, AM J PHYSIOL-HEART C, V304, pH1361, DOI 10.1152/ajpheart.00454.2012; Takasawa W, 2010, BIOCHEM BIOPH RES CO, V401, P7, DOI 10.1016/j.bbrc.2010.08.112; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Wang CCL, 2012, AM J CARDIOL, V110, p58B, DOI 10.1016/j.amjcard.2012.08.036; Wang XM, 2013, CARDIOVASC DRUG THER, V27, P297, DOI 10.1007/s10557-013-6459-8; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026	37	45	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27235	27245		10.1074/jbc.M114.557835	http://dx.doi.org/10.1074/jbc.M114.557835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100725	hybrid, Green Published			2022-12-25	WOS:000342853900046
J	Jiang, YD; Thakran, S; Bheemreddy, R; Ye, EA; He, H; Walker, RJ; Steinle, JJ				Jiang, Youde; Thakran, Shalini; Bheemreddy, Rajini; Ye, Eun-Ah; He, Hui; Walker, Robert J.; Steinle, Jena J.			Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor alpha and Suppressor of Cytokine Signaling 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TNF-ALPHA; MULLER CELLS; VASCULAR DAMAGE; HIGH GLUCOSE; RESISTANCE; PHOSPHORYLATION; EXPRESSION; SOCS-3; INFLAMMATION	Dysfunctional insulin signaling is a key component of type 2 diabetes. Little is understood of the effects of systemic diabetes on retinal insulin signaling. Anumber of agents are used to treat patients with type 2 diabetes to normalize glucose levels and improve insulin signaling; however, little has been done to investigate the effects of these agents on retinal insulin signal transduction. We hypothesized that pioglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist, would normalize retinal insulin signal transduction through reduced tumor necrosis factor alpha (TNF alpha) and suppressor of cytokine signaling 3 (SOCS3) activities in whole retina and retinal endothelial cells (REC) and Muller test this hypothesis, we used the BBZDR/Wor type 2 diabetic rat model, as well as REC and Muller cells cultured in normoglycemia and hyperglycemic conditions, to investigate the effects of pioglitazone on TNF alpha, SOCS3, and downstream insulin signal transduction proteins. We also evaluated pioglitazone's effects on retinal function using electroretinogram and markers of apoptosis. Data demonstrate that 2 months of pioglitazone significantly increased electroretinogram amplitudes in type 2 diabetic obese rats, which was associated with improved insulin receptor activation. These changes occurred in both REC and Muller cells treated with pioglitazone, suggesting that these two cell types are key to insulin resistance in the retina. Taken together, these data provide evidence of impaired insulin signaling in type 2 diabetes rats, which was improved by increasing PPAR gamma activity. Further investigations of PPAR gamma actions in the retina may provide improved treatment options.	[Jiang, Youde; Thakran, Shalini; Bheemreddy, Rajini; Ye, Eun-Ah; Walker, Robert J.; Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [He, Hui; Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Walker, Robert J.] Philander Smith Coll, Dept Biol, Little Rock, AR 72202 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Philander Smith College	Steinle, JJ (corresponding author), Hamilton Eye Inst, Dept Ophthalmol, 930 Madison Ave,Suite 768A, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu		Steinle, Jena/0000-0002-7539-2892	National Institutes of Health, NEI [R01-EY022330]; National Institutes of Health, PHS [3P30 EY013080]; Juvenile Diabetes Research Foundation [2-2011-597]; Oxnard Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022330, P30EY013080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health, PHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oxnard Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants R01-EY022330 (to J. J. S.) and PHS 3P30 EY013080 (to Dianna Johnson). This work was also supported by Juvenile Diabetes Research Foundation Grant 2-2011-597 (to J. J. S.), the Oxnard Foundation (to J. J. S.), and Research to Prevent Blindness (to James C. Fleming).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Collino M, 2010, BRIT J PHARMACOL, V160, P1892, DOI 10.1111/j.1476-5381.2010.00671.x; Ding SY, 2005, ACTA PHARMACOL SIN, V26, P575, DOI 10.1111/j.1745-7254.2005.00090.x; Ellis EA, 1998, FREE RADICAL BIO MED, V24, P111, DOI 10.1016/S0891-5849(97)00202-5; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Ito I, 2006, INVEST OPHTH VIS SCI, V47, P683, DOI 10.1167/iovs.05-1012; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Jiang YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093788; Jiang Y, 2013, MOL VIS, V19, P804; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Joussen AM, 2009, MOL VIS, V15, P1418; Kanatani Y, 2007, DIABETES, V56, P795, DOI 10.2337/db06-1039; Malchiodi-Albedi F, 2008, PPAR RES, V2008, DOI 10.1155/2008/295784; Moezi L, 2014, INT J EXP PATHOL, V95, P78, DOI 10.1111/iep.12067; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Olson NC, 2012, J CLIN ENDOCR METAB, V97, P1032, DOI 10.1210/jc.2011-2155; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Schmidt RE, 2004, J NEUROPATH EXP NEUR, V63, P450, DOI 10.1093/jnen/63.5.450; Tawfik A, 2009, INVEST OPHTH VIS SCI, V50, P878, DOI 10.1167/iovs.08-2005; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Walker RJ, 2007, INVEST OPHTH VIS SCI, V48, P5276, DOI 10.1167/iovs.07-0129; Walker RJ, 2011, INVEST OPHTH VIS SCI, V52, P9527, DOI 10.1167/iovs.11-8631; Yau H, 2013, CURR DIABETES REP, V13, P329, DOI 10.1007/s11892-013-0378-8; Zerani M, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107383; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779; Zhang XY, 2013, INVEST OPHTH VIS SCI, V54, P3912, DOI 10.1167/iovs.13-11614; Zhu JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068935	34	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26395	26405		10.1074/jbc.M114.583880	http://dx.doi.org/10.1074/jbc.M114.583880			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086044	Green Published, hybrid			2022-12-25	WOS:000342128800031
J	Cornelie, S; Rossignol, M; Seveno, M; Demettre, E; Mouchet, F; Djegbe, I; Marin, P; Chandre, F; Corbel, V; Remoue, F; Mathieu-Daude, F				Cornelie, Sylvie; Rossignol, Marie; Seveno, Martial; Demettre, Edith; Mouchet, Francois; Djegbe, Innocent; Marin, Philippe; Chandre, Fabrice; Corbel, Vincent; Remoue, Franck; Mathieu-Daude, Francoise			Salivary Gland Proteome Analysis Reveals Modulation of Anopheline Unique Proteins in Insensitive Acetylcholinesterase Resistant Anopheles gambiae Mosquitoes	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MALARIA VECTOR; INSECTICIDE RESISTANCE; TRANSMISSION; DDT; IDENTIFICATION; EVOLUTION; GENES; COSTS; MASS	Insensitive acetylcholinesterase resistance due to a mutation in the acetylcholinesterase (ace) encoding ace-1 gene confers cross-resistance to organophosphate and carbamate insecticides in Anopheles gambiae populations from Central and West Africa. This mutation is associated with a strong genetic cost revealed through alterations of some life history traits but little is known about the physiological and behavioural changes in insects bearing the ace-1 R allele. Comparative analysis of the salivary gland contents between An. gambiae susceptible and ace-1 R resistant strains was carried out to charaterize factors that could be involved in modifications of blood meal process, trophic behaviour or pathogen interaction in the insecticide-resistant mosquitoes. Differential analysis of the salivary gland protein profiles revealed differences in abundance for several proteins, two of them showing major differences between the two strains. These two proteins identified as saglin and TRIO are salivary gland-1 related proteins, a family unique to anopheline mosquitoes, one of them playing a crucial role in salivary gland invasion by Plasmodium falciparum sporozoites. Differential expression of two other proteins previously identified in the Anopheles sialome was also observed. The differentially regulated proteins are involved in pathogen invasion, blood feeding process, and protection against oxidation, relevant steps in the outcome of malaria infection. Further functional studies and insect behaviour experiments would confirm the impact of the modification of the sialome composition on blood feeding and pathogen transmission abilities of the resistant mosquitoes. The data supports the hypothesis of alterations linked to insecticide resistance in the biology of the primary vector of human malaria in Africa.	[Cornelie, Sylvie; Rossignol, Marie; Mouchet, Francois; Chandre, Fabrice; Mathieu-Daude, Francoise] UM1, UM2, CNRS 5290, MIVEGEC,IRD,UMR IRD 224, Montpellier, France; [Seveno, Martial; Demettre, Edith; Marin, Philippe] UM1, UM2, INSERM 661, IGF,UMR CNRS 5203, Montpellier, France; [Djegbe, Innocent; Corbel, Vincent; Remoue, Franck] UM1, UM2, CREC, IRD,CNRS 5290,MIVEGEC,UMR IRD 224, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD)	Mathieu-Daude, F (corresponding author), UM1, UM2, CNRS 5290, MIVEGEC,IRD,UMR IRD 224, Montpellier, France.	francoise.mathieu-daude@ird.fr	Chandre, Fabrice/Q-3429-2019; Corbel, VIncent/G-9576-2016	Chandre, Fabrice/0000-0002-1994-9705; Mathieu-Daude, Francoise/0000-0003-2994-3697; SEVENO, Martial/0000-0002-5000-8735; cornelie, sylvie/0000-0003-3662-1450; corbel, vincent/0000-0003-0995-3257; REMOUE, Franck/0000-0003-3220-5660	French Institut de Recherche pour le Developpement (IRD)	French Institut de Recherche pour le Developpement (IRD)	This work was supported by the French Institut de Recherche pour le Developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2008, COMP BIOCHEM PHYS B, V150, P271, DOI 10.1016/j.cbpb.2008.03.008; Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Arca B, 2002, INSECT MOL BIOL, V11, P47, DOI 10.1046/j.0962-1075.2001.00309.x; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Chen LQ, 2003, ACTA CRYSTALLOGR D, V59, P2211, DOI 10.1107/S0907444903018493; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Crawford JE, 2013, INFECT GENET EVOL, V16, P87, DOI 10.1016/j.meegid.2013.01.006; Djegbe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017496; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Gazave L, 2001, HEREDITY, V87, P441, DOI 10.1046/j.1365-2540.2001.00926.x; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; Okulate MA, 2007, INSECT MOL BIOL, V16, P711, DOI 10.1111/j.1365-2583.2007.00765.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Prapanthadara La-Aied, 1993, Biochemical Society Transactions, V21, p304S; Ranson H, 1997, BIOCHEM J, V324, P97, DOI 10.1042/bj3240097; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; SHUTE G. T., 1956, ANN TROP MED AND PARASITOL, V50, P92; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Weill M, 2004, CURR BIOL, V14, pR552, DOI 10.1016/j.cub.2004.07.008; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wilkins MR, 1997, J THEOR BIOL, V186, P7, DOI 10.1006/jtbi.1996.0346; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	50	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103816	10.1371/journal.pone.0103816	http://dx.doi.org/10.1371/journal.pone.0103816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102176	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900027
J	Le Floc'h, N; Deblanc, C; Cariolet, R; Gautier-Bouchardon, AV; Merlot, E; Simon, G				Le Floc'h, Nathalie; Deblanc, Celine; Cariolet, Roland; Gautier-Bouchardon, Anne V.; Merlot, Elodie; Simon, Gaelle			Effect of Feed Restriction on Performance and Postprandial Nutrient Metabolism in Pigs Co-Infected with Mycoplasma hyopneumoniae and Swine Influenza Virus	PLOS ONE			English	Article							AMINO-ACID; IMMUNE-SYSTEM; GLUCOSE-METABOLISM; MUCIN SYNTHESIS; PRE-INFECTION; PROTEIN; PLASMA; INFLAMMATION; THREONINE; DISEASE	As nutritional status and inflammation are strongly connected, feeding and nutritional strategies could be effective to improve the ability of pigs to cope with disease. The aims of this study were to investigate the impact of a feed restriction on the ability of pigs to resist and be tolerant to a coinfection with Mycoplasma hyopneumoniae (Mhp) and the European H1N1 swine influenza virus, and the consequences for nutrient metabolism, with a focus on amino acids. Two groups of specific pathogen-free pigs were inoculated with Mhp and H1N1 21 days apart. One group was fed ad libitum, the other group was subjected to a two-week 40% feed restriction starting one week before H1N1 infection. The two respective mock control groups were included. Three days post-H1N1 infection, 200 g of feed was given to pigs previously fasted overnight and serial blood samples were taken over 4 hours to measure plasma nutrient concentrations. Throughout the study, clinical signs were observed and pathogens were detected in nasal swabs and lung tissues. Feed-restricted pigs presented shorter hyperthermia and a positive mean weight gain over the 3 days post-H1N1 infection whereas animals fed ad libitum lost weight. Both infection and feed restriction reduced postprandial glucose concentrations, indicating changes in glucose metabolism. Post-prandial plasma concentrations of the essential amino acids histidine, arginine and threonine were lower in co-infected pigs suggesting a greater use of those amino acids for metabolic purposes associated with the immune response. Altogether, these results indicate that modifying feeding practices could help to prepare animals to overcome an influenza infection. Connections with metabolism changes are discussed.	[Le Floc'h, Nathalie; Merlot, Elodie] INRA, PEGASE UMR1348, St Gilles, France; [Le Floc'h, Nathalie; Merlot, Elodie] Agrocampus Ouest, PEGASE UMR1348, Rennes, France; [Deblanc, Celine; Simon, Gaelle] Anses, Ploufragan Plouzane Lab, Swine Virol Immunol Unit, BP53, Ploufragan, France; [Deblanc, Celine; Cariolet, Roland; Gautier-Bouchardon, Anne V.; Simon, Gaelle] European Univ Brittany, Rennes, France; [Cariolet, Roland] Anses, Ploufragan Plouzane Lab, Prod Decontaminated Pigs & Testing, BP53, Ploufragan, France; [Gautier-Bouchardon, Anne V.] Anses, Ploufragan Plouzane Lab, Mycoplasmol Bacteriol Unit, BP53, Ploufragan, France	INRAE; Institut Agro; Agrocampus Ouest; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Deblanc, C (corresponding author), Anses, Ploufragan Plouzane Lab, Swine Virol Immunol Unit, BP53, Ploufragan, France.	celine.deblanc@anses.fr	Simon, Gaelle/ABI-1479-2020; Merlot, Elodie/AAQ-8761-2020; le floc'h, nathalie/L-6049-2018	Simon, Gaelle/0000-0003-1099-5075; Le Floch, Nathalie/0000-0001-9858-1584; Merlot, Elodie/0000-0003-2300-0970	FARM'APRO; Conseil General des Cotes d'Armor	FARM'APRO; Conseil General des Cotes d'Armor(Region BretagneRegion Pays de la Loire)	This work received financial support from FARM'APRO. FARM'APRO participated in the study design but had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. Remuneration of the Anses' personnel from the unit "Production of decontaminated pigs and testing'' was partially supported by the Conseil General des Cotes d'Armor. This funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHT H, 1971, J VIROL, V7, P204, DOI 10.1128/JVI.7.2.204-207.1971; Bruins MJ, 2003, CLIN SCI, V104, P127, DOI 10.1042/CS20020275; CALDER PC, 1995, P NUTR SOC, V54, P65, DOI 10.1079/PNS19950038; Calder PC, 2007, CURR OPIN CLIN NUTR, V10, P531, DOI 10.1097/MCO.0b013e3281e72ad4; CUARON JA, 1984, J ANIM SCI, V58, P631, DOI 10.2527/jas1984.583631x; Deblanc C, 2013, VET MICROBIOL, V162, P643, DOI 10.1016/j.vetmic.2012.11.028; Deblanc C, 2012, VET MICROBIOL, V157, P96, DOI 10.1016/j.vetmic.2011.12.027; Detilleux JC, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-9; Fablet C, 2012, VET MICROBIOL, V157, P152, DOI 10.1016/j.vetmic.2011.12.015; Grimble RF, 1998, NUTRITION, V14, P634, DOI 10.1016/S0899-9007(98)00010-0; Heyer A, 2007, J ANIM SCI, V85, P769, DOI 10.2527/jas.2006-164; IMAMURA M, 1975, SURGERY, V77, P868; Jahoor F, 1999, J NUTR, V129, P693, DOI 10.1093/jn/129.3.693; Jonasson R, 2007, RES VET SCI, V82, P323, DOI 10.1016/j.rvsc.2006.08.005; Kagemann G, 2005, BIOL CHEM, V386, P1055, DOI 10.1515/BC.2005.121; Kaore SN, 2013, FUND CLIN PHARMACOL, V27, P35, DOI 10.1111/j.1472-8206.2012.01059.x; Kim CH, 2012, VET J, V192, P120, DOI 10.1016/j.tvjl.2011.04.023; Klasing KC, 1999, EAAP PUBLIC, P253; Konsman JP, 2001, NUTRITION, V17, P664, DOI 10.1016/S0899-9007(01)00602-5; KOONG LJ, 1982, J NUTR, V112, P1638, DOI 10.1093/jn/112.8.1638; Kuntz-Simon G, 2009, ZOONOSES PUBLIC HLTH, V56, P310, DOI 10.1111/j.1863-2378.2009.01236.x; Kuntz -Simon G., 2010, INFECT PARASITIC DIS, V1, P273; Le Floc'h N, 2005, BRIT J NUTR, V93, P447, DOI 10.1079/BJN20051375; Le Floc'h N, 2004, LIVEST PROD SCI, V87, P37, DOI 10.1016/j.livprodsci.2003.09.005; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Li DF, 1999, ANIM FEED SCI TECH, V78, P179, DOI 10.1016/S0377-8401(99)00005-X; Lien KA, 1997, Z ERNAHRUNGSWISS, V36, P182, DOI 10.1007/BF01611398; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, P25; LLOYD C, 1984, IN VITRO CELL DEV B, V20, P416, DOI 10.1007/BF02619588; Madec F, 1982, J RECH PORCINE FRANC, V14, P405; Marois C, 2010, J APPL MICROBIOL, V108, P1523, DOI 10.1111/j.1365-2672.2009.04556.x; Mata M, 2011, BIOCHEM PHARMACOL, V82, P548, DOI 10.1016/j.bcp.2011.05.014; Matsuzaki J, 2001, J NUTR, V131, P2139, DOI 10.1093/jn/131.8.2139; Melchior D, 2004, J ANIM SCI, V82, P1091; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Nafikov RA, 2007, J NUTR, V137, P702, DOI 10.1093/jn/137.3.702; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Noah L, 2000, AM J PHYSIOL-ENDOC M, V278, pE181, DOI 10.1152/ajpendo.2000.278.2.E181; Obled C, 2002, CAN J ANIM SCI, V82, P55; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Perrone LA, 2013, J INFECT DIS, V207, P1576, DOI 10.1093/infdis/jit062; Pithon-Curi TC, 2004, CELL BIOCHEM FUNCT, V22, P321, DOI 10.1002/cbf.1109; Pol F, 2011, J VIROL METHODS, V171, P241, DOI 10.1016/j.jviromet.2010.11.007; Rantzer D, 1996, ACTA AGR SCAND A-AN, V46, P219, DOI 10.1080/09064709609415874; REEDS PJ, 1994, J NUTR, V124, P906, DOI 10.1093/jn/124.6.906; Reeds PJ, 2001, CLIN NUTR, V20, P15, DOI 10.1054/clnu.2001.0402; Reeth VK, 2012, DIS SWINE, V10th, P557; Remond D, 2009, J NUTR, V139, P720, DOI 10.3945/jn.108.101675; Rose N, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-72; WANNEMACHER RW, 1977, AM J CLIN NUTR, V30, P1269, DOI 10.1093/ajcn/30.8.1269; Yoo SS, 1997, J NUTR, V127, P2253, DOI 10.1093/jn/127.11.2253; Zervas S, 2002, J ANIM SCI, V80, P3238	52	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104605	10.1371/journal.pone.0104605	http://dx.doi.org/10.1371/journal.pone.0104605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101681	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900078
J	Szatmari, A; Zvara, A; Moricz, AM; Besenyei, E; Szabo, E; Ott, PG; Puskas, LG; Bozso, Z				Szatmari, Agnes; Zvara, Agnes; Moricz, Agnes M.; Besenyei, Eszter; Szabo, Erika; Ott, Peter G.; Puskas, Laszlo G.; Bozso, Zoltan			Pattern Triggered Immunity (PTI) in Tobacco: Isolation of Activated Genes Suggests Role of the Phenylpropanoid Pathway in Inhibition of Bacterial Pathogens	PLOS ONE			English	Article							ARABIDOPSIS INNATE IMMUNITY; PSEUDOMONAS-SYRINGAE; DEFENSE RESPONSES; BASAL RESISTANCE; CELL-WALL; HYPERSENSITIVE REACTION; DISEASE RESISTANCE; PLANTS; CALCIUM; LEAVES	Background: Pattern Triggered Immunity (PTI) or Basal Resistance (BR) is a potent, symptomless form of plant resistance. Upon inoculation of a plant with non-pathogens or pathogenicity-mutant bacteria, the induced PTI will prevent bacterial proliferation. Developed PTI is also able to protect the plant from disease or HR (Hypersensitive Response) after a challenging infection with pathogenic bacteria. Our aim was to reveal those PTI-related genes of tobacco (Nicotiana tabacum) that could possibly play a role in the protection of the plant from disease. Methodology/Principal Findings: Leaves were infiltrated with Pseudomonas syringae pv. syringae hrcC-mutant bacteria to induce PTI, and samples were taken 6 and 48 hours later. Subtraction Suppressive Hybridization (SSH) resulted in 156 PTI-activated genes. A cDNA microarray was generated from the SSH clone library. Analysis of hybridization data showed that in the early (6 hpi) phase of PTI, among others, genes of peroxidases, signalling elements, heat shock proteins and secondary metabolites were upregulated, while at the late phase (48 hpi) the group of proteolysis genes was newly activated. Microarray data were verified by real time RT-PCR analysis. Almost all members of the phenyl-propanoid pathway (PPP) possibly leading to lignin biosynthesis were activated. Specific inhibition of cinnamic-acid-4-hydroxylase (C4H), rate limiting enzyme of the PPP, decreased the strength of PTI - as shown by the HR-inhibition and electrolyte leakage tests. Quantification of cinnamate and p-coumarate by thin-layer chromatography (TLC)-densitometry supported specific changes in the levels of these metabolites upon elicitation of PTI. Conclusions/Significance: We believe to provide first report on PTI-related changes in the levels of these PPP metabolites. Results implicated an actual role of the upregulation of the phenylpropanoid pathway in the inhibition of bacterial pathogenic activity during PTI.	[Szatmari, Agnes; Moricz, Agnes M.; Besenyei, Eszter; Szabo, Erika; Ott, Peter G.; Bozso, Zoltan] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Dept Pathophysiol, Budapest, Hungary; [Zvara, Agnes; Puskas, Laszlo G.] Hungarian Acad Sci, Biol Res Ctr, Lab Funct Genom, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Szatmari, A (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Dept Pathophysiol, Budapest, Hungary.	szatmari.agnes@agrar.mta.hu	Móricz, Ágnes M/E-2416-2018; Ott, Pėter/AAH-1208-2020	Móricz, Ágnes M/0000-0002-4330-9396; Ott, Peter G./0000-0002-2252-7482; Szatmari, Agnes/0000-0001-8768-8212	OTKA [68386, 109050, K101271]; Bolyai Fellowships from the Hungarian Academy of Sciences	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Fellowships from the Hungarian Academy of Sciences	This research was supported by the OTKA 68386, 109050 and K101271 grants. A A. Szatmari and A. M. Moricz were supported by Bolyai Fellowships from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Bozso Z, 2005, J PHYTOPATHOL, V153, P596, DOI 10.1111/j.1439-0434.2005.01026.x; Bozso Z, 2009, PLANT MOL BIOL, V70, P627, DOI 10.1007/s11103-009-9496-8; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Collinge DB, 2009, J EXP BOT, V60, P351, DOI 10.1093/jxb/erp001; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; JAKOBEK JL, 1993, PLANT CELL, V5, P49, DOI 10.1105/tpc.5.1.49; JAKOBEK JL, 1993, PLANT CELL, V5, P57, DOI 10.1105/tpc.5.1.57; KING EO, 1954, J LAB CLIN MED, V44, P301; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; Klement Z, 1999, J PHYTOPATHOL, V147, P467, DOI 10.1111/j.1439-0434.1999.tb03852.x; Klement Z., 1990, METHODS PHYTOBACTERI, P96; Kostyn K, 2012, PLANT SCI, V190, P103, DOI 10.1016/j.plantsci.2012.03.011; Kuntze G, 2004, PLANT CELL, V6, P3496; LOVREKOVICH L, 1965, NATURE, V205, P823, DOI 10.1038/205823a0; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Meszaros T, 2007, PLANT SIGNAL BEHAV, V2, P30, DOI 10.4161/psb.2.1.3885; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Ott PG, 2006, MOL PLANT MICROBE IN, V19, P161, DOI 10.1094/MPMI-19-0161; Park CJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00177; Puskas LG, 2002, BIOTECHNIQUES, V33, P898, DOI 10.2144/02334mt03; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Savatin DV, 2014, PLANT PHYSIOL, V2014; Schalk M, 1998, PLANT PHYSIOL, V118, P209, DOI 10.1104/pp.118.1.209; Shinya T, 2007, PLANT CELL PHYSIOL, V48, P1404, DOI 10.1093/pcp/pcm115; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Szabo E, 2012, BIOL PLANTARUM, V56, P551, DOI 10.1007/s10535-011-0226-0; Szatmari A, 2006, PLANT CELL REP, V25, P728, DOI 10.1007/s00299-005-0110-5; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	53	11	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102869	10.1371/journal.pone.0102869	http://dx.doi.org/10.1371/journal.pone.0102869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101956	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900009
J	Tripathi, MK; Singh, R				Tripathi, Manish Kumar; Singh, Ramesh			Differential Suppressive Effects of Testosterone on Immune Function in Fresh Water Snake, Natrix piscator: An In Vitro Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; STEROID-HORMONES; SEX-HORMONES; PERITONEAL-MACROPHAGES; SURFACE-RECEPTORS; GONADAL-STEROIDS; WALL LIZARD; INFECTION; INTERLEUKIN-1; MODULATION	Reptiles represent the crucial phylogenetic group as they were the ancestors of both birds and mammals hence very important to study. The objectives of the present study were to investigate the potential roles of testosterone in the innate immune responses and splenic lymphocyte proliferation in fresh water snake, Natrix piscator. Animals were mildly anesthetized and spleens were taken out to study the splenic macrophage phagocytosis, super oxide production and nitrite release using in vitro testosterone. Splenic lymphocytes were isolated by density gradient centrifugation and were studied for mitogen induced proliferation in presence of in vitro testosterone. Testosterone suppressed the phagocytosis and nitrite release in a concentration dependent manner. Biphasic suppressive effect of testosterone was observed in superoxide production as judged by reduction of nitroblue tetrazolium salt where salt reduction was suppressed at lower and higher concentrations of testosterone. Mitogen induced splenic lymphocyte proliferation was also suppressed by testosterone. By suppressing immune responses, testosterone may, therefore, act as a physiological mechanism regulating the relative amount of energy invested into either reproductive effort or immunocompetence.	[Tripathi, Manish Kumar; Singh, Ramesh] Udai Pratap Autonomous Coll, Dept Zool, Varanasi, Uttar Pradesh, India	Udai Pratap College, Varanasi	Singh, R (corresponding author), Udai Pratap Autonomous Coll, Dept Zool, Varanasi, Uttar Pradesh, India.	upcrsingh@yahoo.com			Department of Science and Technology, New Delhi, Govt. of India [SR/SO/AS -15/2005]	Department of Science and Technology, New Delhi, Govt. of India(Department of Science & Technology (India))	This work was supported by a financial grant (SR/SO/AS -15/2005) from the Department of Science and Technology, New Delhi, Govt. of India to Ramesh Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DO, 1992, NATURAL IMMUNE SYSTE, P75; Al-Afaleq AI, 1998, IMMUNOPHARM IMMUNOT, V20, P315, DOI 10.3109/08923979809038547; ALEXANDER J, 1988, PARASITOL TODAY, V4, P189, DOI 10.1016/0169-4758(88)90077-4; BAGASRA O, 1988, IMMUNOLOGY, V65, P405; Benten WPM, 2002, STEROIDS, V67, P647, DOI 10.1016/S0039-128X(02)00013-2; Berger J., 2003, COMP CLIN PATHOL, V12, P84, DOI [10.1007/s00580-003-0478-y, DOI 10.1007/S00580-003-0478-Y]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bilbo SD, 2001, AM J PHYSIOL-REG I, V280, pR207, DOI 10.1152/ajpregu.2001.280.1.R207; Billingham RE, 1986, REPRODUCTIVE IMMUNOL, P109; BOORMAN GA, 1980, J RETICULOENDOTH SOC, V28, P547; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Cannon JG, 1997, J PSYCHIAT RES, V31, P99, DOI 10.1016/S0022-3956(96)00055-6; CHAO TC, 1995, CELL IMMUNOL, V160, P43, DOI 10.1016/0008-8749(95)80007-6; DASILVA JAP, 1995, ANN RHEUM DIS, V54, P6, DOI 10.1136/ard.54.1.6; De Leon-Nava MA, 2009, J STEROID BIOCHEM, V113, P57, DOI 10.1016/j.jsbmb.2008.11.003; Demas GE, 1998, J COMP PHYSIOL B, V168, P419, DOI 10.1007/s003600050161; DING AH, 1988, J IMMUNOL, V141, P2407; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; EIDINGER D, 1972, J EXP MED, V136, P1098, DOI 10.1084/jem.136.5.1098; FLYNN A, 1986, LIFE SCI, V38, P2455, DOI 10.1016/0024-3205(86)90616-8; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; GROSSMAN CJ, 1984, ENDOCR REV, V5, P435, DOI 10.1210/edrv-5-3-435; HALDAR C, 1989, GEN COMP ENDOCR, V76, P214, DOI 10.1016/0016-6480(89)90152-4; Hammar JA, 1929, Z MIKROSK ANAT FORSC, V16; HU SK, 1988, INT J IMMUNOPHARMACO, V10, P247; Hughes TK, 1995, INT J IMMUNOPHARMACO, V17, P857, DOI 10.1016/0192-0561(95)00078-X; KELLER R, 1993, RES IMMUNOL, V144, P271, DOI 10.1016/0923-2494(93)80105-8; Klein SL, 1997, HORM BEHAV, V32, P30, DOI 10.1006/hbeh.1997.1402; Klein SL, 1999, AM J PHYSIOL-REG I, V277, pR1362, DOI 10.1152/ajpregu.1999.277.5.R1362; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; LACHMAN LB, 1986, J IMMUNOL, V136, P3098; Mondal S, 2002, GEN COMP ENDOCR, V125, P264, DOI 10.1006/gcen.2001.7744; Mondal S, 2001, COMP BIOCHEM PHYS A, V129, P391, DOI 10.1016/S1095-6433(00)00356-1; Mondal S, 1999, GEN COMP ENDOCR, V116, P291, DOI 10.1006/gcen.1999.7370; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; PARK BH, 1968, LANCET, V2, P532; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; Poulin R, 1996, INT J PARASITOL, V26, P1311, DOI 10.1016/S0020-7519(96)00108-7; Rajput Z.I., 2005, Journal of Zhejiang University Science, V6B, P1057, DOI 10.1631/jzus.2005.B1057; Ramzan M, 2009, TROP ANIM HEALTH PRO, V41, P1225, DOI 10.1007/s11250-009-9304-0; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; SAAD AH, 1990, IMMUNOBIOLOGY, V180, P184, DOI 10.1016/S0171-2985(11)80327-X; Sano A, 1992, MYCOPATHOLOGIA, V14, P63; Savita, 1998, COMP BIOCHEM PHYS C, V119, P199, DOI 10.1016/S0742-8413(97)00207-7; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Straub RH, 2001, ARTHRITIS RHEUM-US, V44, P493, DOI 10.1002/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U; TIURIA R, 1995, PARASITE IMMUNOL, V17, P479, DOI 10.1111/j.1365-3024.1995.tb00918.x; VARAS A, 1992, DEV COMP IMMUNOL, V16, P165, DOI 10.1016/0145-305X(92)90016-6; VARAS A, 1991, THYMUS, V17, P129; VISELLI SM, 1995, IMMUNOLOGY, V84, P337; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104431	10.1371/journal.pone.0104431	http://dx.doi.org/10.1371/journal.pone.0104431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101765	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900063
J	Darimont, CT; Child, KR				Darimont, Chris T.; Child, K. Rosie			What Enables Size-Selective Trophy Hunting of Wildlife?	PLOS ONE			English	Article							HARVEST; AGE; EVOLUTION; SURVIVAL; BEHAVIOR; ORIGINS; SUCCESS; GENDER; HEALTH	Although rarely considered predators, wildlife hunters can function as important ecological and evolutionary agents. In part, their influence relates to targeting of large reproductive adults within prey populations. Despite known impacts of size-selective harvests, however, we know little about what enables hunters to kill these older, rarer, and presumably more wary individuals. In other mammalian predators, predatory performance varies with knowledge and physical condition, which accumulates and declines, respectively, with age. Moreover, some species evolved camouflage as a physical trait to aid in predatory performance. In this work, we tested whether knowledge-based faculty (use of a hunting guide with accumulated experience in specific areas), physical traits (relative body mass [RBM] and camouflage clothing), and age can predict predatory performance. We measured performance as do many hunters: size of killed cervid prey, using the number of antler tines as a proxy. Examining similar to 4300 online photographs of hunters posing with carcasses, we found that only the presence of guides increased the odds of killing larger prey. Accounting for this effect, modest evidence suggested that unguided hunters presumably handicapped with the highest RBM actually had greater odds of killing large prey. There was no association with hunter age, perhaps because of our coarse measure (presence of grey hair) and the performance trade-offs between knowledge accumulation and physical deterioration with age. Despite its prevalence among sampled hunters (80%), camouflage had no influence on size of killed prey. Should these patterns be representative of other areas and prey, and our interpretations correct, evolutionarily-enlightened harvest management might benefit from regulatory scrutiny on guided hunting. More broadly, we suggest that by being nutritionally and demographically de-coupled from prey and aided by efficient killing technology and road access, wildlife hunters in the developed world might have overcome many of the physical, but not knowledge-based, challenges of hunting.	[Darimont, Chris T.; Child, K. Rosie] Univ Victoria, Dept Geog, Victoria, BC, Canada; [Darimont, Chris T.; Child, K. Rosie] Raincoast Conservat Fdn, Sidney, BC, Canada	University of Victoria	Darimont, CT (corresponding author), Univ Victoria, Dept Geog, Victoria, BC, Canada.	darimont@uvic.ca			Natural Science and Engineering Research Council Discovery Grant [435683]	Natural Science and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	CTD was supported by a Natural Science and Engineering Research Council Discovery Grant 435683 (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, COMPENDIUM PHYS ACTI; Allen WL, 2011, P ROY SOC B-BIOL SCI, V278, P1373, DOI 10.1098/rspb.2010.1734; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Autry JK, 2012, SHOOTING IND MAGAZIN; Bertoli A, 2003, ACTA DIABETOL, V40, pS130, DOI 10.1007/s00592-003-0045-7; Blurton Jones N, 1976, KALAHARI HUNTER GATH, P325; Brodie J, 2013, J APPL ECOL, V50, P295, DOI 10.1111/1365-2664.12044; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Caro T., 1994, CHEETAHS SERENGETI P; Churchill SE., 1993, ARCHEOL PAP AM ANTHR, V4, P11, DOI [10.1525/ap3a.1993.4.1.11, DOI 10.1525/AP3A.1993.4.1.11]; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Coss RG, 2005, BEHAV PROCESS, V68, P145, DOI 10.1016/j.beproc.2004.12.004; Cott H.B., 1940, ADAPTIVE COLORATION; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Emery MR, 2005, ENVIRON PLANN A, V37, P981, DOI 10.1068/a36263; ESTES RD, 1967, J WILDLIFE MANAGE, V31, P52, DOI 10.2307/3798360; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Festa-Bianchet M, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P191; Garel M, 2007, ECOL APPL, V17, P1607, DOI 10.1890/06-0898.1; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; Hall JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0064; Hengeveld PE, 2011, J WILDLIFE MANAGE, V75, P189, DOI 10.1002/jwmg.14; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Liebenberg L., 1990, ART TRACKING ORIGIN; Lieberman Daniel E., 2009, P77, DOI 10.1007/978-1-4020-9980-9_8; Loehr J, 2005, CAN J ZOOL, V83, P1602, DOI 10.1139/Z05-162; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Poudyal N., 2008, Human Dimensions of Wildlife, V13, P158, DOI 10.1080/10871200801922965; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037; Schmidt JI, 2007, WILDLIFE BIOL, V13, P53, DOI 10.2981/0909-6396(2007)13[53:ASOAMA]2.0.CO;2; Shackleton DM., 1999, HOOFED MAMMALS BRIT; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Stedman R, 2004, J WILDLIFE MANAGE, V68, P762, DOI 10.2193/0022-541X(2004)068[0762:IWAHRM]2.0.CO;2; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Walker R, 2002, J HUM EVOL, V42, P639, DOI 10.1006/jhev.2001.0541; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Zimmer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016098	48	4	4	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103487	10.1371/journal.pone.0103487	http://dx.doi.org/10.1371/journal.pone.0103487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25098246	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100021
J	Longino, JT; Branstetter, MG; Colwell, RK				Longino, John T.; Branstetter, Michael G.; Colwell, Robert K.			How Ants Drop Out: Ant Abundance on Tropical Mountains	PLOS ONE			English	Article							DIVERSITY GRADIENTS; SPECIES RICHNESS; PRODUCTIVITY; TEMPERATURE; ENERGY	In tropical wet forests, ants are a large proportion of the animal biomass, but the factors determining abundance are not well understood. We characterized ant abundance in the litter layer of 41 mature wet forest sites spread throughout Central America (Chiapas, Guatemala, Honduras, Nicaragua, and Costa Rica) and examined the impact of elevation (as a proxy for temperature) and community species richness. Sites were intentionally chosen to minimize variation in precipitation and seasonality. From sea level to 1500 m ant abundance very gradually declined, community richness declined more rapidly than abundance, and the local frequency of the locally most common species increased. These results suggest that within this elevational zone, density compensation is acting, maintaining high ant abundance as richness declines. In contrast, in sites above 1500 m, ant abundance dropped abruptly to much lower levels. Among these high montane sites, community richness explained much more of the variation in abundance than elevation, and there was no evidence of density compensation. The relative stability of abundance below 1500 m may be caused by opposing effects of temperature on productivity and metabolism. Lower temperatures may decrease productivity and thus the amount of food available for consumers, but slower metabolisms of consumers may allow maintenance of higher biomass at lower resource supply rates. Ant communities at these lower elevations may be highly interactive, the result of continuous habitat presence over geological time. High montane sites may be ephemeral in geological time, resulting in non-interactive communities dominated by historical and stochastic processes. Abundance in these sites may be determined by the number of species that manage to colonize and/or avoid extinction on mountaintops.	[Longino, John T.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Branstetter, Michael G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Colwell, Robert K.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA	Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Connecticut; University of Colorado System; University of Colorado Boulder	Longino, JT (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jacklongino@gmail.com	Colwell, Robert K/C-7276-2015		National Science Foundation [DEB-0072702, DEB-0640015/DEB-1157383, DEB-1354739]; National Geographic Society [7331-02, 7751-04]; Conservation International; Smithsonian Institution	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Conservation International; Smithsonian Institution(Smithsonian Institution)	This work was supported by National Science Foundation grants DEB-0072702 (Project ALAS), DEB-0640015/DEB-1157383 (Project LLAMA), DEB-1354739 (Project ADMAC), National Geographic Society grants 7331-02 and 7751-04, and Conservation International. MB was supported by a Buck Postdoctoral Fellowship from the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Branstetter MG, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.295.4905; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; Donoso DA, 2013, SOIL BIOL BIOCHEM, V61, P45, DOI 10.1016/j.soilbio.2013.02.004; Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470; Fisher BL, 1999, ECOL APPL, V9, P714, DOI 10.1890/1051-0761(1999)009[0714:IIEACS]2.0.CO;2; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; Groc S, 2010, BIOL CONSERV, V143, P2832, DOI 10.1016/j.biocon.2010.07.034; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; JORDAN CF, 1985, NUTR CYCLING TROPICA; Kaspari M, 2003, AM NAT, V161, P459, DOI 10.1086/367906; Kaspari M, 1996, OIKOS, V76, P443, DOI 10.2307/3546338; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kaspari M, 2001, GLOBAL ECOL BIOGEOGR, V10, P229, DOI 10.1046/j.1466-822X.2001.00214.x; Kaspari M, 2012, ECOGRAPHY, V35, P65, DOI 10.1111/j.1600-0587.2011.06971.x; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; LEVINGS SC, 1984, BIOTROPICA, V16, P125, DOI 10.2307/2387844; LEVINGS SC, 1983, ECOL MONOGR, V53, P435, DOI 10.2307/1942647; Longino JT, 2012, ZOOTAXA, P1; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McGlynn TP, 2009, BIOTROPICA, V41, P234, DOI 10.1111/j.1744-7429.2008.00465.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x	32	32	32	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104030	10.1371/journal.pone.0104030	http://dx.doi.org/10.1371/journal.pone.0104030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098722	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100045
J	Marsicano, CA; Wilson, JA; Smith, RMH				Marsicano, Claudia A.; Wilson, Jeffrey A.; Smith, Roger M. H.			A Temnospondyl Trackway from the Early Mesozoic of Western Gondwana and Its Implications for Basal Tetrapod Locomotion	PLOS ONE			English	Article							TERRESTRIAL LOCOMOTION; ALLIGATOR-MISSISSIPPIENSIS; SOUTHERN AFRICA; TARICHA-TOROSA; EVOLUTION; LIMB; KINEMATICS; MECHANICS; WALKING; NEWT	Background: Temnospondyls are one of the earliest radiations of limbed vertebrates. Skeletal remains of more than 190 genera have been identified from late Paleozoic and early Mesozoic rocks. Paleozoic temnospondyls comprise mainly small to medium sized forms of diverse habits ranging from fully aquatic to fully terrestrial. Accordingly, their ichnological record includes tracks described from many Laurasian localities. Mesozoic temnospondyls, in contrast, include mostly medium to large aquatic or semi-aquatic forms. Exceedingly few fossil tracks or trackways have been attributed to Mesozoic temnospondyls, and as a consequence very little is known of their locomotor capabilities on land. Methodology/Principal Findings: We report a ca. 200 Ma trackway, Episcopopus ventrosus, from Lesotho, southern Africa that was made by a 3.5 m-long animal. This relatively long trackway records the trackmaker dragging its body along a wet substrate using only the tips of its digits, which in the manus left characteristic drag marks. Based on detailed mapping, casting, and laser scanning of the best-preserved part of the trackway, we identified synapomorphies (e.g., tetradactyl manus, pentadactyl pes) and symplesiomorphies (e.g., absence of claws) in the Episcopopus trackway that indicate a temnospondyl trackmaker. Conclusions/Significance: Our analysis shows that the Episcopopus trackmaker progressed with a sprawling posture, using a lateral-sequence walk. Its forelimbs were the major propulsive elements and there was little lateral bending of the trunk. We suggest this locomotor style, which differs dramatically from the hindlimb-driven locomotion of salamanders and other extant terrestrial tetrapods can be explained by the forwardly shifted center of mass resulting from the relatively large heads and heavily pectoral girdles of temnospondyls.	[Marsicano, Claudia A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Buenos Aires, DF, Argentina; [Wilson, Jeffrey A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Wilson, Jeffrey A.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Smith, Roger M. H.] Iziko South Africa Museum, Dept Karoo Paleontol, Cape Town, South Africa; [Smith, Roger M. H.] Univ Cape Town, Dept Geol Sci, ZA-7925 Cape Town, South Africa	University of Buenos Aires; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Cape Town	Marsicano, CA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ciencias Geol, Buenos Aires, DF, Argentina.	claumar@gl.fcen.uba.ar	Wilson, Jeffrey/C-2737-2008; Smith, Roger/AAF-7947-2019		Universidad de Buenos Aires Ciencia y Tecnica; Woodrow Wilson National Fellowship Foundation; Palaeontological Scientific Trust	Universidad de Buenos Aires Ciencia y Tecnica; Woodrow Wilson National Fellowship Foundation; Palaeontological Scientific Trust	This research was partially supported by grants Universidad de Buenos Aires Ciencia y Tecnica (to CAM), a Woodrow Wilson National Fellowship Foundation Career Enhancement Fellowship for Junior Faculty (to JAW), and Palaeontological Scientific Trust (to RMHS) which also supported our field work during 2005-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; [Anonymous], [No title captured]; [Anonymous], 1974, [No title captured]; Ashley-Ross MA, 2004, J EXP BIOL, V207, P461, DOI 10.1242/jeb.00769; Ashley-Ross MA, 2009, J EXP ZOOL PART A, V311A, P240, DOI 10.1002/jez.522; ASHLEYROSS MA, 1994, J EXP BIOL, V193, P255; BAIRD DONALD, 1952, JOUR PALEONTOL, V26, P832; Blob RW, 2001, J EXP BIOL, V204, P1099; Braddy SJ, 2003, PALAEONTOLOGY, V46, P671, DOI 10.1111/1475-4983.00315; Brand LR, 1996, J PALEONTOL, V70, P1004, DOI 10.1017/S0022336000038701; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Carroll RL., 2009, RISE AMPHIBIANS 365; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638, DOI 10.1152/jn.1997.78.2.638; EDWARDS JL, 1989, AM ZOOL, V29, P235; Falcon-Lang HJ, 2010, PALAEOGEOGR PALAEOCL, V296, P1, DOI 10.1016/j.palaeo.2010.06.020; FROLICH LM, 1992, J EXP BIOL, V162, P107; FUGLEWICZ R, 1990, Acta Palaeontologica Polonica, V35, P109; Gray J, 1944, J EXP BIOL, V20, P88; HAUBOLD H, 1971, HDB PALAOHERPETOLOGI, V18, P1; Haubold H., 1971, PALAONTOLOGISCHE A A, V4, P395; Haubold H., 2005, PENNSYLVANIAN FOOTPR, P75; Horner AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096516; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Kawano SM, 2013, INTEGR COMP BIOL, V53, P283, DOI 10.1093/icb/ict051; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; KITCHING J W, 1984, Palaeontologia Africana, V25, P111; Knoll F, 2005, B SOC GEOL FR, V176, P81, DOI 10.2113/176.1.81; Lehman J. P., 1971, Annls Paleont Vert, V57, P71; Lucas SG, 2010, ICHNOS, V17, P177, DOI 10.1080/10420940.2010.502492; Lucas Spencer G., 2009, Volumina Jurassica, V6, P99; Maddin HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050743; Maddin HC, 2009, J ANAT, V214, P607, DOI 10.1111/j.1469-7580.2009.01052.x; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Minter NJ, 2007, LETHAIA, V40, P365, DOI 10.1111/j.1502-3931.2007.00035.x; Noffke N, 2009, EARTH-SCI REV, V96, P173, DOI 10.1016/j.earscirev.2008.08.002; Olsen P.E., 1986, P321; OLSEN P E, 1984, Palaeontologia Africana, V25, P87; Pawley K, 2006, J PALEONTOL, V80, P561, DOI 10.1666/0022-3360(2006)80[561:TASOEM]2.0.CO;2; Peabody FE., 1948, B DEP GEOLOGICAL SCI, V27, P295; PEABODY FRANK, 1959, UNIV CALIFORNIA PUBL ZOOL, V63, P1; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; POHLING H, 1893, VERHANDLUNGEN NATURH, V50, P82; Porada H, 2008, PALAIOS, V23, P65, DOI 10.2110/palo.2006.p06-095r; Porchetti Simone D'Orazi, 2007, Ichnos, V14, P219, DOI 10.1080/10420940601049990; Prave AR, 2002, GEOLOGY, V30, P811, DOI 10.1130/0091-7613(2002)030<0811:LOLITP>2.0.CO;2; Ptaszynski T, 2004, ACTA PALAEONTOL POL, V49, P289; Reilly SM, 2006, P ROYAL SOC LONDON B; Requirand C, 2001, CATALOGUE PISTES STO; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Sarjeant W, 1974, PALAEOGEOGR PALAEOCL, V23, P279; SCARBORO DD, 1995, PALAEOGEOGR PALAEOCL, V113, P335, DOI 10.1016/0031-0182(95)00068-W; Schaeffer B, 1941, B AM MUS NAT HIST, V48, P395; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V278, P1; SCHOCH RR, 2000, STEREOSPONDYLI; Smith RMH, 2009, PALAIOS, V24, P672, DOI 10.2110/palo.2008.p08-115r; Spitz W., 1923, Palaeontologische Zeitschrift, V5, P380; TUREK V, 1989, PALAEONTOLOGY, V32, P623; Voigt S, 2011, GEOBIOS-LYON, V44, P399, DOI 10.1016/j.geobios.2010.11.008; WARREN AA, 1983, PHILOS T ROY SOC B, V303, P1, DOI 10.1098/rstb.1983.0080; Warren Anne, 2000, Amphibian Biology, V4, P1121; Warren Anne, 1999, Palaeontologia Africana, V35, P45; Watson D. M. S., 1958, Bulletin of the British Museum (Natural History) Geology, V3, P233; Welles S. P., 1965, University of California Publications in Geological Sciences, V54, P1; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; Wilson JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007331	67	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103255	10.1371/journal.pone.0103255	http://dx.doi.org/10.1371/journal.pone.0103255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099971	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100016
J	Feretzaki, M; Hardison, SE; Wormley, FL; Heitman, J				Feretzaki, Marianna; Hardison, Sarah E.; Wormley, Floyd L., Jr.; Heitman, Joseph			Cryptococcus neoformans Hyperfilamentous Strain Is Hypervirulent in a Murine Model of Cryptococcal Meningoencephalitis	PLOS ONE			English	Article							MATING-TYPE; CANDIDA-ALBICANS; VAR. GRUBII; SEROTYPE-A; VIRULENCE; CAPSULE; ALPHA; GATTII; INFECTION; MICE	Cryptococcus neoformans is a human fungal pathogen that causes lethal infections of the lung and central nervous system in immunocompromised individuals. C. neoformans has a defined bipolar sexual life cycle with a and a mating types. During the sexual cycle, which can occur between cells of opposite mating types (bisexual reproduction) or cells of one mating type (unisexual reproduction), a dimorphic transition from yeast to hyphal growth occurs. Hyphal development and meiosis generate abundant spores that, following inhalation, penetrate deep into the lung to enter the alveoli, germinate, and establish a pulmonary infection growing as budding yeast cells. Unisexual reproduction has been directly observed only in the Cryptococcus var. neoformans (serotype D) lineage under laboratory conditions. However, hyphal development has been previously associated with reduced virulence and the serotype D lineage exhibits limited pathogenicity in the murine model. In this study we show that the serotype D hyperfilamentous strain XL280a is hypervirulent in an animal model. It can grow inside the lung of the host, establish a pulmonary infection, and then disseminate to the brain to cause cryptococcal meningoencephalitis. Surprisingly, this hyperfilamentous strain triggers an immune response polarized towards Th2-type immunity, which is usually observed in the highly virulent sibling species C. gattii, responsible for the Pacific Northwest outbreak. These studies provide a technological advance that will facilitate analysis of virulence genes and attributes in C. neoformans var. neoformans, and reveal the virulence potential of serotype D as broader and more dynamic than previously appreciated.	[Feretzaki, Marianna; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; [Hardison, Sarah E.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	Duke University; University of Texas System; University of Texas at San Antonio (UTSA)	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	heitm001@duke.edu	Hardison, Sarah E./AAC-7510-2019; Heitman, Joseph/ABC-6006-2021; Hardison, Sarah/ABB-1606-2021		Duke University Center for AIDS Research (CFAR) [National Institutes of Health (NIH)] [2P30 AI64518-07]; NIH/NIAID [AI50438-10, AI39115-16]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050438, P30AI064518, R37AI039115] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR) [National Institutes of Health (NIH)]; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Duke University Center for AIDS Research (CFAR) [National Institutes of Health (NIH)-funded program (2P30 AI64518-07 to M.F.)] and NIH/NIAID R01 grant AI50438-10 and R37 MERIT award AI39115-16 to J.H. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Barchiesi F, 2005, J INFECTION, V51, P10, DOI 10.1016/j.jinf.2004.07.013; Bartlett Karen H, 2008, Curr Infect Dis Rep, V10, P58, DOI 10.1007/s11908-008-0011-1; Bartlett KH, 2012, MYCOPATHOLOGIA, V173, P311, DOI 10.1007/s11046-011-9475-x; Beenhouwer DO, 2001, INFECT IMMUN, V69, P6445, DOI 10.1128/IAI.69.10.6445-6455.2001; Botts MR, 2009, EUKARYOT CELL, V8, P595, DOI 10.1128/EC.00352-08; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chang YC, 2001, P NATL ACAD SCI USA, V98, P3258, DOI 10.1073/pnas.061031998; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chen GH, 2008, INFECT IMMUN, V76, P2379, DOI 10.1128/IAI.01143-07; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Chowdhary A, 2011, ENVIRON MICROBIOL, V13, P1875, DOI 10.1111/j.1462-2920.2011.02510.x; Clarke DL, 2001, MOL MICROBIOL, V40, P200, DOI 10.1046/j.1365-2958.2001.02375.x; Crabtree JN, 2012, INFECT IMMUN, V80, P3776, DOI 10.1128/IAI.00507-12; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; Gazzoni AF, 2010, REV INST MED TROP SP, V52, P145, DOI 10.1590/S0036-46652010000300006; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FREED ER, 1971, AM J CLIN PATHOL, V55, P30; FROMTLING RA, 1979, MYCOPATHOLOGIA, V68, P179, DOI 10.1007/BF00578527; FROMTLING RA, 1979, INFECT IMMUN, V24, P449, DOI 10.1128/IAI.24.2.449-453.1979; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Garcia-Hermoso D, 2004, INFECT IMMUN, V72, P3359, DOI 10.1128/IAI.72.6.3359-3365.2004; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Guillot L, 2008, INFECT IMMUN, V76, P4745, DOI 10.1128/IAI.00341-08; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Heitman J, 1999, FUNGAL GENET BIOL, V28, P1, DOI 10.1006/fgbi.1999.1155; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Huffnagle GB, 1998, RES IMMUNOL, V149, P387, DOI 10.1016/S0923-2494(98)80762-1; Huffnagle GB, 1998, RES IMMUNOL, V149, P512; Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245; Imwidthaya P, 2000, POSTGRAD MED J, V76, P85, DOI 10.1136/pmj.76.892.85; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; KOZEL TR, 1995, TRENDS MICROBIOL, V3, P295, DOI 10.1016/S0966-842X(00)88957-X; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lee SC, 2012, EUKARYOT CELL, V11, P1391, DOI 10.1128/EC.00242-12; Lin XR, 2008, INFECT IMMUN, V76, P2923, DOI 10.1128/IAI.00168-08; Lin X, 2007, PLOS GENET, V3, P1975, DOI 10.1371/journal.pgen.0030186; Lin XR, 2006, PLOS GENET, V2, P1801, DOI 10.1371/journal.pgen.0020187; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Magditch DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002936; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Moyrand F, 2004, EUKARYOT CELL, V3, P1513, DOI 10.1128/EC.3.6.1513-1524.2004; NEILSON JB, 1978, INFECT IMMUN, V20, P262, DOI 10.1128/IAI.20.1.262-266.1978; Ngamskulrungroj Popchai, 2012, mBio, V3, DOI 10.1128/mBio.00103-12; Ni M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001653; Nielsen K, 2005, GENETICS, V171, P975, DOI 10.1534/genetics.105.045039; Nielsen K, 2005, INFECT IMMUN, V73, P4922, DOI 10.1128/IAI.73.8.4922-4933.2005; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Noverr MC, 2003, INFECT IMMUN, V71, P1538, DOI 10.1128/IAI.71.3.1538-1547.2003; O'Meara TR, 2010, EUKARYOT CELL, V9, P1193, DOI 10.1128/EC.00098-10; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Ren P, 2006, EUKARYOT CELL, V5, P1065, DOI 10.1128/EC.00009-06; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Shen G, 2008, EUKARYOT CELL, V7, P1540, DOI 10.1128/EC.00154-08; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; TODD RAMONA L., 1936, JOUR BACT, V32, P89; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Vecchiarelli A, 2003, J LEUKOCYTE BIOL, V74, P370, DOI 10.1189/jlb.1002476; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wang LQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002765; Wang P, 2004, EUKARYOT CELL, V3, P1028, DOI 10.1128/EC.3.4.1028-1035.2004; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Wickes BL, 1996, P NATL ACAD SCI USA, V93, P7327, DOI 10.1073/pnas.93.14.7327; Williams KL, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P451; Williamson JD, 1996, ACTA CYTOL, V40, P363, DOI 10.1159/000333769; Wright L, 2002, MICROBES INFECT, V4, P1427, DOI 10.1016/S1286-4579(02)00024-2; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945; Zhai B, 2013, INFECT IMMUN, V81, P2626, DOI 10.1128/IAI.00259-13; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x	89	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104432	10.1371/journal.pone.0104432	http://dx.doi.org/10.1371/journal.pone.0104432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093333	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200111
J	Tsugama, D; Liu, SK; Takano, T				Tsugama, Daisuke; Liu, Shenkui; Takano, Tetsuo			Analysis of Functions of VIP1 and Its Close Homologs in Osmosensory Responses of Arabidopsis thaliana	PLOS ONE			English	Article							BZIP TRANSCRIPTIONAL ACTIVATOR; REPRESSION OFSHOOT GROWTH; ABSCISIC-ACID; MOLECULAR CHARACTERIZATION; PROTEIN PHOSPHATASE; EXPRESSION PROFILES; HISTIDINE KINASE; GENE-EXPRESSION; DROUGHT; TRANSFORMATION	VIP1 is a bZIP protein in Arabidopsis thaliana. VIP1 accumulates in the nucleus under hypo-osmotic conditions and interacts with the promoters of hypo-osmolarity-responsive genes, CYP707A1 and CYP707A3 (CYP707A1/3), but neither overexpression of VIP1 nor truncation of its DNA-binding region affects the expression of CYP707A3 in vivo, raising the possibility that VIP and other proteins are functionally redundant. Here we show further analyses on VIP1 and its close homologs, namely, Arabidopsis group I bZIP proteins. The patterns of the signals of the GFP-fused group I bZIP proteins were similar in onion and Arabidopsis cells, suggesting that they have similar subcellular localization. In a yeast one-hybrid assay, the group I bZIP proteins caused reporter gene activation in the yeast reporter strain. VIP1 and other group I bZIP proteins showed positive results in a yeast two-hybrid assay and a bimolecular fluorescence complementation assay, suggesting that they physically interact. These results support the idea that they have somewhat similar functions. By gel shift assays, VIP1-binding sequences in the CYP707A1/3 promoters were confirmed to be AGCTGT/G. Their presence in the promoters of the genes that respond to hypo-osmotic conditions was evaluated using previously published microarray data. Interestingly, a significantly higher proportion of the promoters of the genes that were up-regulated by rehydration treatment and/or submergence treatment (treatment by a hypotonic solution) and a significantly lower proportion of the promoters of the genes that were down-regulated by such treatment shared AGCTGT/G. To further assess the physiological role of VIP1, constitutively nuclear-localized variants of VIP1 were generated. When overexpressed in Arabidopsis, some of them as well as VIP1 caused growth retardation under a mannitol-stressed condition, where VIP1 is localized mainly in the cytoplasm. This raises the possibility that the expression of VIP1 itself rather than its nuclear localization is responsible for regulating the mannitol responses.	[Tsugama, Daisuke; Takano, Tetsuo] Univ Tokyo, ANESC, Nishi Tokyo, Tokyo, Japan; [Tsugama, Daisuke] Univ Tokyo, Plant Mol Genet Lab, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Liu, Shenkui] Northeast Forestry Univ, ASNESC, Harbin, Peoples R China	University of Tokyo; University of Tokyo; Northeast Forestry University - China	Takano, T (corresponding author), Univ Tokyo, ANESC, Nishi Tokyo, Tokyo, Japan.	takano@anesc.u-tokyo.ac.jp	Tsugama, Daisuke/N-6054-2014; Liu, Shenkui/AAC-5405-2019	Tsugama, Daisuke/0000-0002-4946-678X; Liu, Shenkui/0000-0001-5294-4765	JSPS [22-2144, 25-7247]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-aid for Scientific Research (22-2144 and 25-7247) to DT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chang-Qing Z, 2008, BMB REP, V41, P448, DOI 10.5483/BMBRep.2008.41.6.448; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai SH, 2004, P NATL ACAD SCI USA, V101, P687, DOI 10.1073/pnas.0307687100; Dai SH, 2003, J BIOL CHEM, V278, P36396, DOI 10.1074/jbc.M304862200; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fukazawa J, 2010, PLANT J, V62, P1035, DOI 10.1111/j.1365-313X.2010.04215.x; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kumar MN, 2013, PLANT PHYSIOL, V161, P942, DOI 10.1104/pp.112.209791; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee SC, 2011, NEW PHYTOL, V190, P457, DOI 10.1111/j.1469-8137.2010.03590.x; Li JX, 2005, P NATL ACAD SCI USA, V102, P5733, DOI 10.1073/pnas.0404118102; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Narusaka M, 2006, PLANT BIOTECHNOL-NAR, V23, P321, DOI DOI 10.5511/plantbiotechnology.23.321; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Ringli C, 1998, PLANT MOL BIOL, V37, P977, DOI 10.1023/A:1006030007333; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; TorresSchumann S, 1996, PLANT J, V9, P283, DOI 10.1046/j.1365-313X.1996.09030283.x; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tsugama D, 2012, BIOCHEM BIOPH RES CO, V426, P626, DOI 10.1016/j.bbrc.2012.08.141; Tsugama D, 2012, PLANT PHYSIOL, V159, P144, DOI 10.1104/pp.112.197020; Tsugama D, 2012, FEBS LETT, V586, P693, DOI 10.1016/j.febslet.2012.02.019; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2002, P NATL ACAD SCI USA, V99, P10435, DOI 10.1073/pnas.162304099; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Wu Y, 2010, J EXP BOT, V61, P3407, DOI 10.1093/jxb/erq161; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247	45	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103930	10.1371/journal.pone.0103930	http://dx.doi.org/10.1371/journal.pone.0103930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093810	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200045
J	Smith, MA; Canfell, K				Smith, Megan A.; Canfell, Karen			Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ADOLESCENT MALES; COST-EFFECTIVENESS; PREDICTED IMPACT; CERVICAL-CANCER; SEXUAL-BEHAVIOR; NATIONAL-SURVEY; HERD-IMMUNITY; UNITED-STATES; ACCEPTABILITY	Background: Vaccines against HPV16/18 are approved for use in females and males but most countries currently have female-only programs. Cultural and geographic factors associated with HPV vaccine uptake might also influence sexual partner choice; this might impact post-vaccination outcomes. Our aims were to examine the population-level impact of adding males to HPV vaccination programs if factors influencing vaccine uptake also influence partner choice, and additionally to quantify how this changes the post-vaccination distribution of disease between subgroups, using incident infections as the outcome measure. Methods: A dynamic model simulated vaccination of pre-adolescents in two scenarios: 1) vaccine uptake was correlated with factors which also affect sexual partner choice ("correlated"); 2) vaccine uptake was unrelated to these factors ("unrelated"). Coverage and degree of heterogeneity in uptake were informed by observed data from Australia and the USA. Population impact was examined via the effect on incident HPV16 infections. The rate ratio for post-vaccination incident HPV16 in the lowest compared to the highest coverage subgroup (RRL) was calculated to quantify between-group differences in outcomes. Results: The population-level incremental impact of adding males was lower if vaccine uptake was "correlated", however the difference in population-level impact was extremely small (<1%) in the Australia and USA scenarios, even under the conservative and extreme assumption that subgroups according to coverage did not mix at all sexually. At the subgroup level, "correlated" female-only vaccination resulted in RRL = 1.9 (Australia) and 1.5 (USA) in females, and RRL = 1.5 and 1.3 in males. "Correlated" both-sex vaccination increased RRL to 4.2 and 2.1 in females and 3.9 and 2.0 in males in the Australia and USA scenarios respectively. Conclusions: The population-level incremental impact of male vaccination is unlikely to be substantially impacted by feasible levels of heterogeneity in uptake. However, these findings emphasize the continuing importance of prioritizing high coverage across all groups in HPV vaccination programs in terms of achieving equality of outcomes.	[Smith, Megan A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Smith, Megan A.; Canfell, Karen] UNSW Australia, Prince Wales Clin Sch, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney	Smith, MA (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	megan.smith@unsw.edu.au		Smith, Megan/0000-0002-0401-2653; Canfell, Karen/0000-0002-6443-6618	National Health and Medical Research Council [440200, 1007518]; Cancer Council NSW; National Health and Medical Research Council Australia [CDF1007994]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	Development of the model used in this analysis was partially funded by National Health and Medical Research Council Project Grants #440200, #1007518 and by Cancer Council NSW. Karen Canfell receives salary support from the National Health and Medical Research Council Australia (CDF1007994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No specific funding was received for the current analysis.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Australian Bureau of Statistics, 2008, POP AG SEX AUSTR STA, V3201; Barbaro B, 2012, MED J AUSTRALIA, V196, P445, DOI 10.5694/mja11.11360; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Bundesministerium fur Gesundheit (Austrian Federal Ministry for Health), 2013, AUSB KIND IMPFPR AUF; Canfell K, 2012, VACCINE, V30, pF157, DOI 10.1016/j.vaccine.2012.06.091; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dempsey AF, 2012, J ADOLESCENT HEALTH, V50, P421, DOI 10.1016/j.jadohealth.2011.08.017; Department of Health and Ageing, 2011, HUM PAP HPV IMM AUST; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; European Centre for Disease Prevention and Control, 2012, INTR HPV VACC EU COU; Fisher H, 2013, INT J EPIDEMIOL, V42, P896, DOI 10.1093/ije/dyt049; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gilkey MB, 2012, VACCINE, V30, P5928, DOI 10.1016/j.vaccine.2012.07.045; Hamlish T, 2012, VACCINE, V30, P6472, DOI 10.1016/j.vaccine.2012.07.085; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Keenan K, 2012, HEALTH PSYCHOL, V31, P31, DOI 10.1037/a0026812; Kessels SJ, 2012, VACCINE; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kumar VM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-172; LECLERC A, 1990, INT J EPIDEMIOL, V19, P1001, DOI 10.1093/ije/19.4.1001; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Liddon N, 2010, J ADOLESCENT HEALTH, V46, P113, DOI 10.1016/j.jadohealth.2009.11.199; Liddon NC, 2012, AM J PREV MED, V42, P44, DOI 10.1016/j.amepre.2011.09.024; Malagon T, 2013, VACCINE, V31, P1740, DOI 10.1016/j.vaccine.2013.01.026; Marlow LAV, 2011, BRIT J CANCER, V105, P486, DOI 10.1038/bjc.2011.272; Musto R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-640; National Advisory Committee on Immunization, 2012, CAN COMMUNDIS REP; Ogilvie GS, 2008, SEX TRANSM INFECT, V84, P318, DOI 10.1136/sti.2007.029389; Palefsky JM, 2010, J ADOLESCENT HEALTH, V46, pS12, DOI 10.1016/j.jadohealth.2010.01.010; Pharmaceutical Benefits Advisory Committee, 2011, NOV 2011 PBAC OUTC P; Preston SH, 1981, IUSSP 19 INT POP C L, P233; Reiter PL, 2013, VACCINE, V31, P2816, DOI 10.1016/j.vaccine.2013.04.010; Reiter PL, 2011, VACCINE, V29, P5595, DOI 10.1016/j.vaccine.2011.06.020; Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114; Sadigh G, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18456; Shafer LA, 2013, VACCINE, V31, P4848, DOI 10.1016/j.vaccine.2013.07.073; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Smith L, 2012, HPV IMMUNISATION PRO; Smith M, 2013, NATL CERVICAL SCREEN; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633; Smith MA, 2011, VACCINE, V29, P9112, DOI 10.1016/j.vaccine.2011.02.091; U. S. Census Bureau, 2011, NSTEST201101 US CENS; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Walker R, 2012, STAT MED, V31, P3419, DOI 10.1002/sim.5545; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Zhang SK, 2013, VACCINE, V31, P3244, DOI 10.1016/j.vaccine.2013.05.046	54	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e101048	10.1371/journal.pone.0101048	http://dx.doi.org/10.1371/journal.pone.0101048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089637	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700002
J	Saresella, M; Piancone, F; Marventano, I; La Rosa, F; Tortorella, P; Caputo, D; Rovaris, M; Clerici, M				Saresella, Marina; Piancone, Federica; Marventano, Ivana; La Rosa, Francesca; Tortorella, Paola; Caputo, Domenico; Rovaris, Marco; Clerici, Mario			A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis	FASEB JOURNAL			English	Article						apoptosis; myelin basic protein; T cell	PROGRAMMED CELL-DEATH; T-CELLS; TIM-3 LIGAND; DEMYELINATING DISEASE; RHEUMATOID-ARTHRITIS; PERIPHERAL TOLERANCE; AUTOIMMUNE-DISEASE; RESPONSES; GALECTIN-9; EXPRESSION	T-cell immunoglobulin and mucin domain 3 (Tim-3) ligates galectin-9 (Gal-9); this process, resulting in the inhibition of T(h)1 responses and in the apoptosis of antigen-specific cells, is hampered by binding of the molecular adaptor human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) to the intracellular tail of Tim-3. Apoptosis of myelin basic protein (MBP)-specific T lymphocytes correlates with reduced rates of disease progression in multiple sclerosis (MS). We extensively analyzed the Tim-3/Gal-9/Bat3 pathway in 87 patients with a diagnosis of stable relapsing-remitting MS (RRMS), primary progressive MS (PPMS), or benign MS (BEMS), as well as in 40 healthy control (HC) subjects. Results showed that MBP-specific CD4(+)Tim-3(+), CD4(+)/Gal-9(+), and CD4(+)/Tim-3(+)/AV(+) (apoptotic) T lymphocytes were augmented in the BEMS group, whereas CD4(+)/Bat3(+) and CD8(+)/Bat3(+) T lymphocytes were increased and CD4(+)/Tim-3(+)/AV(+) T cells were reduced in the PPMS group (>2 fold and P<0.05 in all cases). Blocking the Tim-3/Gal-9 interaction with specific mAb reduced T-lymphocyte apoptosis and augmented production of IFN and IL-17 in the BEMS, RRMS, and HC groups, but not in the PPMS group. The Tim-3/Gal-9 interaction favors apoptosis of MBP-specific T lymphocytes in BEMS; this process is reduced in PPMS by the up-regulation of Bat3. Therapeutic interventions aimed at silencing Bat3 could be beneficial in MS.Saresella, M., Piancone, F., Marventano, I., La Rosa, F., Tortorella, P., Caputo, D., Rovaris, M., Clerici, M. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.	[Saresella, Marina; Piancone, Federica; Marventano, Ivana; La Rosa, Francesca; Tortorella, Paola; Caputo, Domenico; Rovaris, Marco; Clerici, Mario] Fdn Don C Gnocchi, IRCCS, I-20100 Milan, Italy; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplants, Milan, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan	Saresella, M (corresponding author), Fdn Don C Gnocchi, IRCCS, Pzza Morandi 3, I-20100 Milan, Italy.	msaresella@dongnocchi.it	La Rosa, Francesca FLR/J-4757-2018; Piancone, Federica/K-5893-2016; Rovaris, Marco/AAA-6040-2020; Saresella, Marina/G-7810-2012	Piancone, Federica/0000-0001-7951-1169; Rovaris, Marco/0000-0001-9691-1957; Saresella, Marina/0000-0002-2295-3043; Marventano, Ivana/0000-0001-8111-3522; La Rosa, Francesca/0000-0003-3181-9505; Clerici, Mario/0000-0001-5920-6191	Ricerca Corrente (Italian Ministry of Health)	Ricerca Corrente (Italian Ministry of Health)(Ministry of Health, Italy)	This study was supported by 2012-2013 Ricerca Corrente (Italian Ministry of Health).	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gooden MJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065616; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Joller N, 2012, IMMUNOL REV, V248, P122, DOI 10.1111/j.1600-065X.2012.01136.x; Kaneyama T, 2014, INT IMMUNOL, V26, P369, DOI 10.1093/intimm/dxt056; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lee J, 2011, SCAND J RHEUMATOL, V40, P334, DOI 10.3109/03009742.2010.547871; Lee SY, 2013, J IMMUNOL, V190, P4991, DOI 10.4049/jimmunol.1300083; Li X, 2012, EXPERT OPIN THER TAR, V16, P1145, DOI 10.1517/14728222.2012.726616; Liu Y, 2010, CLIN IMMUNOL, V137, P288, DOI 10.1016/j.clim.2010.07.012; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Niwa H, 2009, CLIN IMMUNOL, V132, P184, DOI 10.1016/j.clim.2009.04.012; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Pan HF, 2010, MOL BIOL REP, V37, P395, DOI 10.1007/s11033-009-9833-7; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Riou C, 2014, J VIROL, V88, P1819, DOI 10.1128/JVI.02968-13; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakhdari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040146; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Saresella M, 2005, J NEUROIMMUNOL, V166, P173, DOI 10.1016/j.jneuroim.2005.05.010; Saresella M, 2008, CLIN IMMUNOL, V129, P509, DOI 10.1016/j.clim.2008.08.010; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Trabattoni D, 2009, J IMMUNOL, V183, P4984, DOI 10.4049/jimmunol.0901038; Troncoso Maria F, 2012, Front Biosci (Schol Ed), V4, P864; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	44	22	24	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2014	28	11					5000	5009		10.1096/fj.14-258194	http://dx.doi.org/10.1096/fj.14-258194			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AS1OU	25091272				2022-12-25	WOS:000344050900035
J	Mathew, E; Collins, MA; Fernandez-Barrena, MG; Holtz, AM; Yan, W; Hogan, JO; Tata, Z; Allen, BL; Fernandez-Zapico, ME; di Magliano, MP				Mathew, Esha; Collins, Meredith A.; Fernandez-Barrena, Maite G.; Holtz, Alexander M.; Yan, Wei; Hogan, James O.; Tata, Zachary; Allen, Benjamin L.; Fernandez-Zapico, Martin E.; di Magliano, Marina Pasca			The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Fibroblast; Hedgehog Signaling Pathway; Inflammation; Macrophage; Pancreas; Pancreatic Cancer	DUCTAL ADENOCARCINOMA; INTRAEPITHELIAL NEOPLASIA; IN-VIVO; CANCER; MOUSE; HEDGEHOG; CELLS; REGENERATION; INDUCTION; GENES	Background:Gli1 is induced during pancreatic injury; its function remains unknown. Results: Loss of Gli1 in the stromal compartment impairs cytokine production, myeloid cell recruitment, and tissue repair. Conclusion:Gli1 regulates remodeling during pancreatic tissue recovery. Significance: This study defines a novel role for GLI1 in pancreas remodeling and expands the repertoire of target genes mediating GLI1 cellular functions. Pancreatic cancer, one of the deadliest human malignancies, is almost uniformly associated with a mutant, constitutively active form of the oncogene Kras. Studies in genetically engineered mouse models have defined a requirement for oncogenic KRAS in both the formation of pancreatic intraepithelial neoplasias, the most common precursor lesions to pancreatic cancer, and in the maintenance and progression of these lesions. Previous work using an inducible model allowing tissue-specific and reversible expression of oncogenic Kras in the pancreas indicates that inactivation of this GTPase at the pancreatic intraepithelial neoplasia stage promotes pancreatic tissue repair. Here, we extend these findings to identify GLI1, a transcriptional effector of the Hedgehog pathway, as a central player in pancreatic tissue repair upon Kras inactivation. Deletion of a single allele of Gli1 results in improper stromal remodeling and perdurance of the inflammatory infiltrate characteristic of pancreatic tumorigenesis. Strikingly, this partial loss of Gli1 affects activated fibroblasts in the pancreas and the recruitment of immune cells that are vital for tissue recovery. Analysis of the mechanism using expression and chromatin immunoprecipitation assays identified a subset of cytokines, including IL-6, mIL-8, Mcp-1, and M-csf (Csf1), as direct GLI1 target genes potentially mediating this phenomenon. Finally, we demonstrate that canonical Hedgehog signaling, a known regulator of Gli1 activity, is required for pancreas recovery. Collectively, these data delineate a new pathway controlling tissue repair and highlight the importance of GLI1 in regulation of the pancreatic microenvironment during this cellular process.	[Mathew, Esha; Collins, Meredith A.; Holtz, Alexander M.; Allen, Benjamin L.; di Magliano, Marina Pasca] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Fernandez-Barrena, Maite G.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Holtz, Alexander M.; di Magliano, Marina Pasca] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Yan, Wei] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Yan, Wei] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Hogan, James O.; Tata, Zachary] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Holtz, Alexander M.; Allen, Benjamin L.; di Magliano, Marina Pasca] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Mayo Clinic; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	di Magliano, MP (corresponding author), Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	marinapa@umich.edu	Fernandez-Barrena, Maite G/J-8040-2014	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Pasca di Magliano, Marina/0000-0001-9632-9035	National Institutes of Health [1R01CA151588-01, 1R21CA167122-01]; University of Michigan Biological Scholar Program; University of Michigan Comprehensive Cancer Center; National Institutes of Health Training Grant [T32 GM007315, T32 DK094775, 5-T32-HD007515]; National Institutes of Health Predoctoral Fellowship [1F31NS081806-01A1]; American Heart Association Scientist Development Grant [11SDG6380000]; National Institutes of Health from NCI [R01 CA136526]; Mayo Clinic Pancreatic SPORE Grant [P50 CA102701]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA136526, R01CA151588, R21CA167122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK094775, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biological Scholar Program; University of Michigan Comprehensive Cancer Center; National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Pancreatic SPORE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA151588-01 (to M. P. d. M.) and 1R21CA167122-01 (to B. L. A. and M. P. d. M.). This work was also supported by the University of Michigan Biological Scholar Program, the University of Michigan Comprehensive Cancer Center.; Supported by National Institutes of Health Training Grant T32 GM007315.; Supported by National Institutes of Health Training Grant T32 DK094775.; Supported by National Institutes of Health Training Grant 5-T32-HD007515.; Supported by National Institutes of Health Predoctoral Fellowship 1F31NS081806-01A1.; Supported by American Heart Association Scientist Development Grant 11SDG6380000.; Supported by National Institutes of Health R01 CA136526 from NCI and Mayo Clinic Pancreatic SPORE Grant P50 CA102701.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Andoh A, 2000, GASTROENTEROLOGY, V119, P211, DOI 10.1053/gast.2000.8538; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Bai CB, 2002, DEVELOPMENT, V129, P4753; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bowers SLK, 2010, ANN NY ACAD SCI, V1188, P143, DOI 10.1111/j.1749-6632.2009.05094.x; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Collins MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049707; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; El-Zaatari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058935; Eto I, 2000, CELL PROLIFERAT, V33, P167, DOI 10.1046/j.1365-2184.2000.00176.x; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingerslev HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009304; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Lees CW, 2008, PLOS MED, V5, P1761, DOI 10.1371/journal.pmed.0050239; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; O'Brien J, 2010, AM J PATHOL, V176, P1241, DOI 10.2353/ajpath.2010.090735; Park HL, 2000, DEVELOPMENT, V127, P1593; Rooman I, 2012, GUT, V61, P449, DOI 10.1136/gut.2010.235804; SALUJA A, 1985, AM J PHYSIOL, V249, pG702, DOI 10.1152/ajpgi.1985.249.6.G702; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09	52	29	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27727	27743		10.1074/jbc.M114.556563	http://dx.doi.org/10.1074/jbc.M114.556563			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25104358	Green Published, hybrid			2022-12-25	WOS:000342852800031
J	Tomasella, A; Blangy, A; Brancolini, C				Tomasella, Andrea; Blangy, Anne; Brancolini, Claudio			A Receptor-interacting Protein 1 (RIP1)-independent Necrotic Death under the Control of Protein Phosphatase PP2A That Involves the Reorganization of Actin Cytoskeleton and the Action of Cofilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PROGRAMMED NECROSIS; POLY(ADP-RIBOSE) POLYMERASE-1; MEMBRANE PERMEABILIZATION; CASPASE ACTIVATION; SIGNALING COMPLEX; APOPTOSIS; UBIQUITIN; KINASE; 2A	Cell death by necrosis is emerging not merely as a passive phenomenon but as a cell-regulated process. Here, by using different necrotic triggers, we prove the existence of two distinct necrotic pathways. The mitochondrial reactive oxygen species generator 2,3-dimethoxy-1,4-naphthoquinone elicits necrosis characterized by the involvement of RIP1 and Drp1. However, G5, a non-selective isopeptidase inhibitor, triggers a distinct necrotic pathway that depends on the protein phosphatase PP2A and the actin cytoskeleton. PP2A catalytic subunit is stabilized by G5 treatment, and its activity is increased. Furthermore, PP2Ac accumulates into the cytoplasm during necrosis similarly to HMGB1. We have also defined in the actin-binding protein cofilin-1 a link between PP2A, actin cytoskeleton, and necrotic death. Cofilin-1-severing/depolymerization activity is negatively regulated by phosphorylation of serine 3. PP2A contributes to the dephosphorylation of serine 3 elicited by G5. Finally, a cofilin mutant that mimics phosphorylated Ser-3 can partially rescue necrosis in response to G5.	[Tomasella, Andrea; Brancolini, Claudio] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy; [Blangy, Anne] Univ Montpellier, CNRS, CRBM, UMR 5237, F-34293 Montpellier 5, France	University of Udine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Brancolini, C (corresponding author), Univ Udine, Dipartimento Sci Med & Biol, Ple Kolbe 4, I-33100 Udine, Italy.	claudio.brancolini@uniud.it		BRANCOLINI, Claudio/0000-0002-6597-5373; BLANGY, Anne/0000-0001-7043-0784	Associazione Italiana per la Ricerca sul Cancro [IG-10437]; FIRB [RBAP11S8C3_002]; Associazione Italiana per la Ricerca sul Cancro	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (IG-10437) and FIRB (Progetto RBAP11S8C3_002) (to C. B.); Recipient of a fellowship from Associazione Italiana per la Ricerca sul Cancro.	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Arnandis T, 2012, CELL DEATH DIFFER, V19, P1536, DOI 10.1038/cdd.2012.46; Blangy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045909; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen L, 2009, INT J BIOCHEM CELL B, V41, P1284, DOI 10.1016/j.biocel.2008.10.029; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fontanini A, 2009, J BIOL CHEM, V284, P8369, DOI 10.1074/jbc.M806113200; Foti C, 2009, MOL CANCER THER, V8, P3140, DOI 10.1158/1535-7163.MCT-09-0431; Guo X, 2014, BIOCHEM J, V461, P137, DOI 10.1042/BJ20131438; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim JE, 2014, CELL DEATH DIFFER, V21, P1036, DOI 10.1038/cdd.2014.17; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lecis D, 2012, BIOORGAN MED CHEM, V20, P6709, DOI 10.1016/j.bmc.2012.09.041; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Mochizuki T, 2002, J BIOL CHEM, V277, P2790, DOI 10.1074/jbc.M106361200; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18; Mullally JE, 2002, MOL PHARMACOL, V62, P351, DOI 10.1124/mol.62.2.351; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Su Y. C., 2014, APOPTOSIS IN PRESS; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P135, DOI DOI 10.1038/NRM3737; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Wegner Adam M., 2007, V365, P61; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200	52	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25699	25710		10.1074/jbc.M114.575134	http://dx.doi.org/10.1074/jbc.M114.575134			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25096578	Green Published, hybrid			2022-12-25	WOS:000342130800029
J	Witek, ME; Snook, AE; Lin, JE; Blomain, ES; Xiang, B; Magee, M; Waldman, SA				Witek, Matthew E.; Snook, Adam E.; Lin, Jieru E.; Blomain, Erik S.; Xiang, Bo; Magee, Michael; Waldman, Scott A.			A Novel CDX2 Isoform Regulates Alternative Splicing	PLOS ONE			English	Article							RNA-RECOGNITION MOTIF; MESSENGER-RNA; TRANSCRIPTION FACTORS; SUBNUCLEAR LOCALIZATION; TUMOR-SUPPRESSOR; SR PROTEINS; GENE; EXPRESSION; BINDING; PROMOTER	Gene expression is a dynamic and coordinated process coupling transcription with pre-mRNA processing. This regulation enables tissue-specific transcription factors to induce expression of specific transcripts that are subsequently amplified by alternative splicing allowing for increased proteome complexity and functional diversity. The intestine-specific transcription factor CDX2 regulates development and maintenance of the intestinal epithelium by inducing expression of genes characteristic of the mature enterocyte phenotype. Here, sequence analysis of CDX2 mRNA from colonic mucosa-derived tissues revealed an alternatively spliced transcript (CDX2/AS) that encodes a protein with a truncated homeodomain and a novel carboxy-terminal domain enriched in serine and arginine residues (RS domain). CDX2 and CDX2/AS exhibited distinct nuclear expression patterns with minimal areas of co-localization. CDX2/AS did not activate the CDX2-dependent promoter of guanylyl cyclase C nor inhibit transcriptional activity of CDX2. Unlike CDX2, CDX2/AS co-localized with the putative splicing factors ASF/SF2 and SC35. CDX2/AS altered splicing patterns of CD44v5 and Tra2-beta 1 minigenes in Lovo colon cancer cells independent of CDX2 expression. These data demonstrate unique dual functions of the CDX2 gene enabling it to regulate gene expression through both transcription (CDX2) and pre-mRNA processing (CDX2/AS).	[Witek, Matthew E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Witek, Matthew E.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Snook, Adam E.; Lin, Jieru E.; Blomain, Erik S.; Xiang, Bo; Magee, Michael; Waldman, Scott A.] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Waldman, SA (corresponding author), Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA.	scott.waldman@jefferson.edu	Snook, Adam E./P-2585-2015; Magee, Michael/L-8354-2013	Snook, Adam E./0000-0001-9216-4560; Waldman, Scott/0000-0001-6619-175X; Magee, Michael/0000-0002-0480-4618	National Institutes of Health [R01 CA75123, R01 CA95026, RC1 CA146033, P30 CA56036, R01 CA170533, T32 GM08562, F30 CA180500]; Pennsylvania Department of Health [SAP] [4100059197, 4100051723]; Targeted Diagnostic and Therapeutics, Inc.; Measey Foundation Fellowship; NATIONAL CANCER INSTITUTE [R01CA095026, F30CA180500, RC1CA146033, R01CA170533, R01CA075123, P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health [SAP]; Targeted Diagnostic and Therapeutics, Inc.; Measey Foundation Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01 CA75123, R01 CA95026, RC1 CA146033, P30 CA56036, R01 CA170533, T32 GM08562 to JEL, F30 CA180500 to ESB]; the Pennsylvania Department of Health [SAP #4100059197, SAP #4100051723]; and Targeted Diagnostic and Therapeutics, Inc. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions. AES is the recipient of the Measey Foundation Fellowship. SAW is the Samuel MV Hamilton Professor of Thomas Jefferson University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Charlieu JP, 1995, J CELL SCI, P95; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Chun SY, 2007, ONCOGENE, V26, P4725, DOI 10.1038/sj.onc.1210258; Dang LH, 2006, ONCOGENE, V25, P2264, DOI 10.1038/sj.onc.1209247; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Drummond F, 1997, ANN HUM GENET, V61, P393, DOI 10.1017/S0003480097006465; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; Escobar Andres J. Gutierrez, 2006, In Silico Biology, V6, P347; Fang RX, 2000, GASTROENTEROLOGY, V118, P115, DOI 10.1016/S0016-5085(00)70420-3; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; IANNELLO RC, 1993, J BIOL CHEM, V268, P22581; Jin DK, 1999, RENAL FAILURE, V21, P685, DOI 10.3109/08860229909094162; Kaitaniemi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054151; Kim YD, 2011, NUCLEIC ACIDS RES, V39, P4300, DOI 10.1093/nar/gkq1267; Lambert M, 1996, EUR J BIOCHEM, V236, P778, DOI 10.1111/j.1432-1033.1996.00778.x; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Li QP, 2012, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-3-642-23731-7; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Magnani E, 2008, PLANT CELL, V20, P875, DOI 10.1105/tpc.108.058495; Mangs AH, 2006, NUCLEIC ACIDS RES, V34, P4976, DOI 10.1093/nar/gkl660; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Noh SJ, 2006, DNA RES, V13, P229, DOI 10.1093/dnares/dsl011; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Park J, 2000, GASTROENTEROLOGY, V119, P89, DOI 10.1053/gast.2000.8520; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Siehl JM, 2004, ANN HEMATOL, V83, P745, DOI 10.1007/s00277-004-0941-0; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suh E, 1996, MOL CELL BIOL, V16, P619; SUH E, 1994, MOL CELL BIOL, V14, P7340, DOI 10.1128/MCB.14.11.7340; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Tamai Y, 1999, CANCER RES, V59, P2965; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Uesaka T, 2002, AM J PHYSIOL-GASTR L, V283, pG840, DOI 10.1152/ajpgi.00075.2002; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104293	10.1371/journal.pone.0104293	http://dx.doi.org/10.1371/journal.pone.0104293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101906	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900056
J	Pan, LL; North, HA; Sahni, V; Jeong, SJ; Mcguire, TL; Berns, EJ; Stupp, SI; Kessler, JA				Pan, Liuliu; North, Hilary A.; Sahni, Vibhu; Jeong, Su Ji; Mcguire, Tammy L.; Berns, Eric J.; Stupp, Samuel I.; Kessler, John A.			beta 1-Integrin and Integrin Linked Kinase Regulate Astrocytic Differentiation of Neural Stem Cells	PLOS ONE			English	Article							ALTERNATIVELY SPLICED REGION; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; SYNTHETIC PEPTIDE; SCAR FORMATION; GLIAL SCAR; A-CHAIN; ACTIVATION; TENASCIN; ADHESION	Astrogiiosis with glial scar formation after damage to the nervous system is a major impediment to axonal regeneration and functional recovery. The present study examined the role of beta 1-integrin signaling in regulating astrocytic differentiation of neural stem cell. In the adult spinal cord beta 1-integrin is expressed predominantly in the ependymal region where ependymal stem cell (ESCs) reside. beta 1-integrin signaling suppressed astrocytic differentiation of both cultured ESCs and subventricular zone (SVZ) progenitor cells. Conditional knockout of beta 1-integrin enhanced astrogliogenesis both by cultured ECS and by SVZ progenitor cells. Previous studies have shown that injection into the injured spinal cord of a self-assembling peptide amphiphile that display an IKVA epitope (IKVAV-PA) limits glial scar formation and enhances functional recovery. Here we find that injection of IKVAV-PA induced high levels of beta 1-integrin in ESCs in vivo, and that conditional knockout of beta 1-integrin abolished the astroglial suppressive effects of IKVAV-PA in vitro, Injection into an injured spinal cord of PAs expressing two other epitopes known to interact with beta 1-integrin, a Tenascin C epitope and the fibronectin epitope RGD, improved functional recovery comparable to the effects of IKVAV-PA. Finally we found that the effects of beta 1-integrin signaling on astrogliosis are mediated by integrin linked kinase (ILK). These observations demonstrate an important role for beta 1-integrin/ILK signaling in regulating astrogliosis from ESCs and suggest ILK as a potential target for limiting glial scar formation after nervous system injury.	[Pan, Liuliu; North, Hilary A.; Sahni, Vibhu; Jeong, Su Ji; Mcguire, Tammy L.; Kessler, John A.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Berns, Eric J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Pan, LL (corresponding author), Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.	liuliupan2012@u.northwestern.edu	Stupp, Samuel/AGV-1942-2022; Stupp, Samuel/B-6737-2009	Berns, Eric/0000-0002-2203-0847	National Institutes of Health [R01 NS 20013, R01 NS 20778]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Institutes of Health Grants R01 NS 20013 and R01 NS 20778. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Casar B, 2012, ONCOGENE; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Lee KK, 2006, GLIA, V53, P836, DOI 10.1002/glia.20343; Lee SL, 2011, J MED CHEM, V54, P6364, DOI 10.1021/jm2007744; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Liu SC, 2000, J CELL SCI, V113, P3563; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Meiners S, 2001, J NEUROSCI, V21, P7215, DOI 10.1523/JNEUROSCI.21-18-07215.2001; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mercado MLT, 2004, J NEUROSCI, V24, P238, DOI 10.1523/JNEUROSCI.4519-03.2004; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006; NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; SanchezMateos P, 1996, SEMIN CANCER BIOL, V7, P99, DOI 10.1006/scbi.1996.0015; SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	56	51	51	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104335	10.1371/journal.pone.0104335	http://dx.doi.org/10.1371/journal.pone.0104335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098415	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100063
J	Suzuki, S; Kakuta, M; Ishida, T; Akiyama, Y				Suzuki, Shuji; Kakuta, Masanori; Ishida, Takashi; Akiyama, Yutaka			GHOSTX: An Improved Sequence Homology Search Algorithm Using a Query Suffix Array and a Database Suffix Array	PLOS ONE			English	Article							LOCAL ALIGNMENT SEARCH; PROTEIN; BLAST; GENERATION; KEGG; TOOL	DNA sequences are translated into protein coding sequences and then further assigned to protein families in metagenomic analyses, because of the need for sensitivity. However, huge amounts of sequence data create the problem that even general homology search analyses using BLASTX become difficult in terms of computational cost. We designed a new homology search algorithm that finds seed sequences based on the suffix arrays of a query and a database, and have implemented it as GHOSTX. GHOSTX achieved approximately 131-165 times acceleration over a BLASTX search at similar levels of sensitivity. GHOSTX is distributed under the BSD 2-clause license and is available for download at http://www.bi.cs.titech.ac.jp/ghostx/. Currently, sequencing technology continues to improve, and sequencers are increasingly producing larger and larger quantities of data. This explosion of sequence data makes computational analysis with contemporary tools more difficult. We offer this tool as a potential solution to this problem.	[Suzuki, Shuji; Kakuta, Masanori; Ishida, Takashi; Akiyama, Yutaka] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan	Tokyo Institute of Technology	Akiyama, Y (corresponding author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan.	akiyama@cs.titech.ac.jp	Kakuta, Masanori/D-2096-2015; Kakuta, Masanori/AAA-5810-2020; Ishida, Takashi/D-2017-2015; Akiyama, Yutaka/D-2048-2015	Ishida, Takashi/0000-0002-9478-3223; Akiyama, Yutaka/0000-0003-2863-8703	JSPS [248766]; MEXT of Japan; National Cancer Center, Japan	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center, Japan(National Cancer Center - Japan)	This research was supported by a Grant-in-Aid for JSPS Fellows (248766) and HPCI Strategic Program Computational Life Science, Application in Drug Discovery and Medical Development by MEXT of Japan, Cancer Research Development funding by National Cancer Center, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ghodsi M, 2009, IEEE INT C BIOINFORM, P83, DOI 10.1109/BIBM.2009.25; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Manber U, 1990, P 1 ANN ACM SIAM S D, P319; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	15	49	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103833	10.1371/journal.pone.0103833	http://dx.doi.org/10.1371/journal.pone.0103833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099887	gold, Green Submitted, Green Published			2022-12-25	WOS:000339995100035
J	De Batista, PR; Palacios, R; Martin, A; Hernanz, R; Medici, CT; Silva, MASC; Rossi, EM; Aguado, A; Vassallo, DV; Salaices, M; Alonso, MJ				De Batista, Priscila R.; Palacios, Roberto; Martin, Angela; Hernanz, Raquel; Medici, Cindy T.; Silva, Marito A. S. C.; Rossi, Emilly M.; Aguado, Andrea; Vassallo, Dalton V.; Salaices, Mercedes; Alonso, Maria J.			Toll-Like Receptor 4 Upregulation by Angiotensin II Contributes to Hypertension and Vascular Dysfunction through Reactive Oxygen Species Production	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; RESISTANCE ARTERIES; OXIDATIVE STRESS; IMMUNE-SYSTEM; EXPRESSION; INFLAMMATION; LIPOPOLYSACCHARIDE; ACTIVATION	Hypertension is considered as a low-grade inflammatory disease, with adaptive immunity being an important mediator of this pathology. TLR4 may have a role in the development of several cardiovascular diseases; however, little is known about its participation in hypertension. We aimed to investigate whether TLR4 activation due to increased activity of the renin-angiotensin system (RAS) contributes to hypertension and its associated endothelial dysfunction. For this, we used aortic segments from Wistar rats treated with a non-specific IgG (1 mu g/day) and SHRs treated with losartan (15 mg/kg? day), the non-specific IgG or the neutralizing antibody anti-TLR4 (1 mg/day), as well as cultured vascular smooth muscle cells (VSMC) from Wistar and SHRs. TLR4 mRNA levels were greater in the VSMC and aortas from SHRs compared with Wistar rats; losartan treatment reduced those levels in the SHRs. Treatment of the SHRs with the anti-TLR4 antibody: 1) reduced the increased blood pressure, heart rate and phenylephrine-induced contraction while it improved the impaired acetylcholine-induced relaxation; 2) increased the potentiation of phenylephrine contraction after endothelium removal; and 3) abolished the inhibitory effects of tiron, apocynin and catalase on the phenylephrine-induced response as well as its enhancing effect of acetylcholine-induced relaxation. In SHR VSMCs, angiotensin II increased TLR4 mRNA levels, and losartan reduced that increase. CLI-095, a TLR4 inhibitor, mitigated the increases in NAD(P) H oxidase activity, superoxide anion production, migration and proliferation that were induced by angiotensin II. In conclusion, TLR4 pathway activation due to increased RAS activity is involved in hypertension, and by inducing oxidative stress, this pathway contributes to the endothelial dysfunction associated with this pathology. These results suggest that TLR4 and innate immunity may play a role in hypertension and its associated end-organ damage.	[De Batista, Priscila R.; Palacios, Roberto; Martin, Angela; Hernanz, Raquel; Alonso, Maria J.] Univ Rey Juan Carlos, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain; [De Batista, Priscila R.; Medici, Cindy T.; Silva, Marito A. S. C.; Rossi, Emilly M.; Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil; [Aguado, Andrea; Salaices, Mercedes] Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain	Universidad Rey Juan Carlos; Universidade Federal do Espirito Santo; Autonomous University of Madrid	Salaices, M (corresponding author), Univ Autonoma Madrid, Dept Pharmacol, Madrid, Spain.	mercedes.salaices@uam.es; mariajesus.alonso@urjc.es	Martin, Angela/AAB-4185-2019; Palacios, Roberto/H-9905-2015; HERNANZ, RAQUEL/H-8943-2015; Palacios, Roberto/GYU-6427-2022; Alonso, María/AAB-4309-2019; Palacios, Roberto/K-7889-2019; Vassallo, Dalton/K-8289-2016	Martin, Angela/0000-0002-4368-6300; Palacios, Roberto/0000-0002-0867-1277; HERNANZ, RAQUEL/0000-0002-2624-9387; Palacios, Roberto/0000-0002-0867-1277; Alonso, María/0000-0003-4912-1121; Vassallo, Dalton/0000-0002-4463-4174; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Silva, Marito/0000-0003-0515-2540	MINECO [SAF2012-36400]; ISCIII [RD12/0042/0024]; MEC [PHB2011-0001-PC]; URJC [PRIN13_CS12]; CAPES; PRONEX-FAPES/CNPq	MINECO(Spanish Government); ISCIII(Instituto de Salud Carlos III); MEC(European Commission); URJC; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX-FAPES/CNPq	This work was supported by MINECO (SAF2012-36400), ISCIII (RD12/0042/0024), MEC (PHB2011-0001-PC), URJC (PRIN13_CS12), CAPES and PRONEX-FAPES/CNPq. PRB was a fellow of CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, J PHARMACOL EXP THER, V321, P381, DOI 10.1124/jpet.106.115287; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Garcia-Redondo AB, 2009, J PHARMACOL EXP THER, V328, P19, DOI 10.1124/jpet.108.144295; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Bomfim GF, 2012, CLIN SCI, V122, P535, DOI 10.1042/CS20110523; Brandes RP, 1999, HYPERTENSION, V33, P1243, DOI 10.1161/01.HYP.33.5.1243; Briones AM, 2000, BRIT J PHARMACOL, V131, P185, DOI 10.1038/sj.bjp.0703552; Briones AM, 1999, BRIT J PHARMACOL, V126, P111, DOI 10.1038/sj.bjp.0702281; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Dange RB, 2014, CARDIOVASC RES, V103, P17, DOI 10.1093/cvr/cvu067; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Dasu MR, 2009, ATHEROSCLEROSIS, V202, P76, DOI 10.1016/j.atherosclerosis.2008.04.010; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Eissler R, 2011, HYPERTENS RES, V34, P551, DOI 10.1038/hr.2010.270; Freitas MG, 2003, J HYPERTENS, V21, P1505, DOI 10.1097/00004872-200308000-00014; Hernanz R, 2004, AM J PHYSIOL-HEART C, V287, pH225, DOI 10.1152/ajpheart.00548.2003; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Liang CF, 2013, ARTERIOSCL THROM VAS, V33, P777, DOI 10.1161/ATVBAHA.112.301087; Lv JL, 2009, BIOCHEM BIOPH RES CO, V380, P81, DOI 10.1016/j.bbrc.2009.01.035; Marketou ME, 2012, J CLIN HYPERTENS, V14, P330, DOI 10.1111/j.1751-7176.2012.00620.x; Martin A, 2012, J HYPERTENS, V30, P315, DOI 10.1097/HJH.0b013e32834f043b; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Ogawa K, 2011, J CARDIOVASC PHARM, V58, P543, DOI 10.1097/FJC.0b013e31822e6b40; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; Pacquelet S, 2007, BIOCHEM J, V403, P451, DOI 10.1042/BJ20061184; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Perticone F, 2001, CIRCULATION, V104, P191, DOI 10.1161/01.CIR.104.2.191; Pi Y, 2013, LAB INVEST, V93, P880, DOI 10.1038/labinvest.2013.79; Pineda A, 2011, ARCH MED RES, V42, P382, DOI 10.1016/j.arcmed.2011.08.003; Pleiner J, 2002, CIRCULATION, V106, P1460, DOI 10.1161/01.CIR.0000030184.70207.FF; Ryan KA, 2004, INFECT IMMUN, V72, P2123, DOI 10.1128/IAI.72.4.2123-2130.2004; Sanchez-Lemus E, 2008, ENDOCRINOLOGY, V149, P5177, DOI 10.1210/en.2008-0242; Sanchez-Lemus E, 2009, AM J PHYSIOL-REG I, V296, pR1376, DOI 10.1152/ajpregu.90962.2008; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Schiffrin EL, 2013, CAN J CARDIOL, V29, P543, DOI 10.1016/j.cjca.2012.06.009; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Sollinger D, 2014, CARDIOVASC RES, V101, P464, DOI 10.1093/cvr/cvt265; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Virdis A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/916310; Wolf G, 2006, J AM SOC NEPHROL, V17, P1585, DOI 10.1681/ASN.2005070699; Wu J, 2009, INFLAMM RES, V58, P473, DOI 10.1007/s00011-009-0012-z; Xavier FE, 2003, VASC PHARMACOL, V40, P67, DOI 10.1016/S1537-1891(02)00315-4; Xie BG, 2014, EXP THER MED, V7, P236, DOI 10.3892/etm.2013.1360; Yang J, 2009, MOL CELL BIOCHEM, V330, P39, DOI 10.1007/s11010-009-0098-1; Yuen CY, 2012, CIRC RES, V111, pE55, DOI 10.1161/CIRCRESAHA.112.271361; Zhang Z, 2011, INFLAMM RES, V60, P37, DOI 10.1007/s00011-010-0232-2	54	70	73	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104020	10.1371/journal.pone.0104020	http://dx.doi.org/10.1371/journal.pone.0104020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093580	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200060
J	Kalbouneh, H; Schlicksupp, A; Kirsch, J; Kuhse, J				Kalbouneh, Heba; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen			Cyclin-Dependent Kinase 5 Is Involved in the Phosphorylation of Gephyrin and Clustering of GABA(A) Receptors at Inhibitory Synapses of Hippocampal Neurons	PLOS ONE			English	Article							GLYCINE-RECEPTOR; TYROSINE PHOSPHORYLATION; CDK5; EXPRESSION; COLLYBISTIN; SUBUNIT; DOMAIN; P35	CDK5 has been implicated in neural functions including growth, neuronal migration, synaptic transmission and plasticity of excitatory chemical synapses. Here we report robust effects of CDK5 on phosphorylation of the postsynaptic scaffold protein gephyrin and clustering of inhibitory GABA(A) receptors in hippocampal neurons. shRNA-mediated knockdown of CDK5 and pharmacological inhibition of cyclin-dependent kinases reduced phosphorylated gephyrin clusters and postsynaptic gamma 2-containing GABA(A) receptors. Phosphorylation of S270 is antagonized by PP1/PP2a phosphatase and site-directed mutagenesis and in vitro phosphorylation experiments indicate that S270 is a putative CDK5 phosphorylation site of gephyrin. Our data suggest that CDK5 plays an essential role for the stability of gephyrin-dependent GABA(A) receptor clusters in hippocampal neurons.	[Kalbouneh, Heba; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen] Heidelberg Univ, Dept Anat & Cell Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kuhse, J (corresponding author), Heidelberg Univ, Dept Anat & Cell Biol, Heidelberg, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kalbouneh, Heba/P-4801-2015; Kuhse, Jochen/T-3864-2019	Kalbouneh, Heba/0000-0002-0956-9223; 				Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Herweg J, 2012, J BIOL CHEM, V287, P12645, DOI 10.1074/jbc.M112.341826; Hirasawa M, 2004, P NATL ACAD SCI USA, V101, P6249, DOI 10.1073/pnas.0307322101; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Kuhse J, 2012, J BIOL CHEM, V287, P30952, DOI 10.1074/jbc.M112.349597; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nani F, 2013, J NEUROSCI, V33, P12718, DOI 10.1523/JNEUROSCI.0388-13.2013; Nawrotzki R, 2012, HISTOCHEM CELL BIOL, V137, P471, DOI 10.1007/s00418-012-0914-7; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Saliba RS, 2012, EMBO J, V31, P2937, DOI 10.1038/emboj.2012.109; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Vithlani M, 2009, BIOCHEM SOC T, V37, P1355, DOI 10.1042/BST0371355; Wuchter J, 2012, J NEUROSCI, V32, P14821, DOI 10.1523/JNEUROSCI.1261-12.2012; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	41	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104256	10.1371/journal.pone.0104256	http://dx.doi.org/10.1371/journal.pone.0104256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093719	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200089
J	Leasi, F; Norenburg, JL				Leasi, Francesca; Norenburg, Jon L.			The Necessity of DNA Taxonomy to Reveal Cryptic Diversity and Spatial Distribution of Meiofauna, with a Focus on Nemertea	PLOS ONE			English	Article							MONOCELIS-LINEATA PROSERIATA; SPECIES COMPLEX; PHYLOGENETIC-RELATIONSHIPS; GENETIC-STRUCTURE; PHYLUM NEMERTEA; PHYLOGEOGRAPHY; OTOTYPHLONEMERTES; HOPLONEMERTEA; COSMOPOLITAN; MORPHOLOGY	Meiofauna represent one of the most abundant and diverse communities in marine benthic ecosystems. However, an accurate assessment of diversity at the level of species has been and remains challenging for these microscopic organisms. Therefore, for many taxa, especially the soft body forms such as nemerteans, which often lack clear diagnostic morphological traits, DNA taxonomy is an effective means to assess species diversity. Morphological taxonomy of Nemertea is well documented as complicated by scarcity of unambiguous character states and compromised by diagnoses of a majority of species (and higher clades) being inadequate or based on ambiguous characters and character states. Therefore, recent studies have advocated for the primacy of molecular tools to solve the taxonomy of this group. DNA taxonomy uncovers possible hidden cryptic species, provides a coherent means to systematize taxa in definite clades, and also reveals possible biogeographic patterns. Here, we analyze diversity of nemertean species by considering the barcode region of the mitochondrial gene Cytochrome Oxidase subunit I (COI) and different species delineation approaches in order to infer evolutionarily significant units. In the aim to uncover actual diversity of meiofaunal nemerteans across different sites in Central America, COI sequences were obtained for specimens assigned here to the genera Cephalothrix, Ototyphlonemertes, and Tetrastemma-like worms, each commonly encountered in our sampling. Additional genetic, taxonomic, and geographic data of other specimens belonging to these genera were added from GenBank. Results are consistent across different DNA taxonomy approaches, and revealed (i) the presence of several hidden cryptic species and (ii) numerous potential misidentifications due to traditional taxonomy. (iii) We additionally test a possible biogeographic pattern of taxonomic units revealed by this study, and, except for a few cases, the putative species seem not to be widely distributed, in contrast to what traditional taxonomy would suggest for the recognized morphotypes.	[Leasi, Francesca; Norenburg, Jon L.] Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Leasi, F (corresponding author), Smithsonian Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	leasif@si.edu	Leasi, Francesca/E-4361-2017; Norenburg, Jon L/K-3481-2015	Leasi, Francesca/0000-0001-6995-0934; Norenburg, Jon L/0000-0001-7776-1527	Smithsonian Marine Networks grant; Encyclopedia of Life Synthesis award; LAB (Laboratory of Analytical Biology) (LAB, Smithsonian National Museum of Natural History)	Smithsonian Marine Networks grant; Encyclopedia of Life Synthesis award; LAB (Laboratory of Analytical Biology) (LAB, Smithsonian National Museum of Natural History)	The workshops were partially funded by a Smithsonian Marine Networks grant, an Encyclopedia of Life Synthesis award and laboratory work was partially subsidized by LAB (Laboratory of Analytical Biology) (LAB, Smithsonian National Museum of Natural History). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SCS, 2011, MAR BIOL, V158, P2109, DOI 10.1007/s00227-011-1718-3; Fernandez-Alvarez FA, 2013, HELGOLAND MAR RES, V67, P599, DOI 10.1007/s10152-013-0346-3; Artois T, 2011, BIOGEOGRAPHY MICROSC; Baker JM, 2007, MAR BIOL, V151, P2183, DOI 10.1007/s00227-007-0654-8; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Casu M, 2004, MAR BIOL, V145, P669, DOI 10.1007/s00227-004-1367-x; Casu M, 2014, J ZOOL SYST EVOL RES, V52, P190, DOI 10.1111/jzs.12058; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Curini-Galletti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033801; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2008, ZOOL J LINN SOC-LOND, V152, P1, DOI 10.1111/j.1096-3642.2007.00365.x; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Di Domenico M, 2014, MOL PHYLOGENET EVOL, V75, P202, DOI 10.1016/j.ympev.2014.02.003; Envall M, 1998, ZOOL J LINN SOC-LOND, V123, P105, DOI 10.1006/zjls.1996.0130; Envall M, 2001, HYDROBIOLOGIA, V456, P145, DOI 10.1023/A:1013029310452; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Fontaneto D, 2011, BIOGEOGRAPHY MICROSC; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2014, INT REV HYDROBIOL, V99, P178, DOI 10.1002/iroh.201301719; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Giere O, 2009, MEIOBENTHOLOGY MICRO; Gomez A, 2002, EVOLUTION, V56, P1431; Guil N, 2011, BIOGEOGRAPHY MICROSC, P244; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higgins R.P., 1988, P1; Kajihara H, 2013, ZOO SCI, V30, P895; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kieneke A, 2012, MOL ECOL, V21, P1239, DOI 10.1111/j.1365-294X.2011.05421.x; Leasi F, 2013, ZOOL J LINN SOC-LOND, V168, P17, DOI 10.1111/zoj.12020; Leasi F, 2009, MAR BIOL, V156, P1335, DOI 10.1007/s00227-009-1175-4; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Meyer CP, 2004, MALACOLOGIA, V46, P127; Norenburg J.L., 1988, P287; NORENBURG JL, 1988, HYDROBIOLOGIA, V156, P87, DOI 10.1007/BF00027981; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANG ENV STAT COMP; Reygel P, 2014, MAR BIODIVERS, V44, P279, DOI 10.1007/s12526-014-0205-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanna D, 2009, GENET MOL BIOL, V32, P864, DOI 10.1590/S1415-47572009005000076; Ceccarelli FS, 2012, MOL PHYLOGENET EVOL, V62, P485, DOI 10.1016/j.ympev.2011.10.018; Schmidt H, 2000, ZOOL SCR, V29, P17, DOI 10.1046/j.1463-6409.2000.00026.x; Strand M, 2005, MOL PHYLOGENET EVOL, V37, P144, DOI 10.1016/j.ympev.2005.02.006; Strand M, 2005, BIOL J LINN SOC, V86, P201, DOI 10.1111/j.1095-8312.2005.00535.x; Strand M, 2011, MAR BIOL RES, V7, P63, DOI 10.1080/17451001003713563; Sundberg P, 2010, J ZOOL SYST EVOL RES, V48, P283, DOI 10.1111/j.1439-0469.2010.00568.x; Sundberg P, 2009, ZOOL J LINN SOC-LOND, V157, P264, DOI 10.1111/j.1096-3642.2008.00514.x; Tang CQ, 2012, P NATL ACAD SCI USA, V109, P16208, DOI 10.1073/pnas.1209160109; Thollesson M, 2003, P ROY SOC B-BIOL SCI, V270, P407, DOI 10.1098/rspb.2002.2254; Tulchinsky AY, 2012, MAR BIOL, V159, P661, DOI 10.1007/s00227-011-1844-y; Walczynska A, 2014, EVOL ECOL, V28, P131, DOI 10.1007/s10682-013-9664-9; Westheide W, 2003, HELGOLAND MAR RES, V57, P1, DOI 10.1007/s10152-002-0114-2; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	61	50	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104385	10.1371/journal.pone.0104385	http://dx.doi.org/10.1371/journal.pone.0104385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093815	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200108
J	Mei, M; Xie, D; Zhang, Y; Jin, J; You, F; Li, Y; Dai, JG; Chen, XG				Mei, Mei; Xie, Dan; Zhang, Yi; Jin, Jing; You, Feng; Li, Yan; Dai, Jungui; Chen, Xiaoguang			A New 2 alpha,5 alpha,10 beta,14 beta-tetraacetoxy-4(20), 11-taxadiene (SIA) Derivative Overcomes Paclitaxel Resistance by Inhibiting MAPK Signaling and Increasing Paclitaxel Accumulation in Breast Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; DRUG-RESISTANCE; IN-VIVO; REVERSAL AGENTS; TUMOR-CELLS; NUDE-MICE; PATHWAY; APOPTOSIS	Tumor resistance due to multiple mechanisms seriously hinders the efficacy of chemotherapy drugs such as paclitaxel. The most widely studied P-glycoprotein inhibitors still have limited ability to reverse resistance in the clinic. In this study, NPB304, a novel Sinenxan A (SIA) derivative, was found to significantly sensitize resistant breast cancer cells to paclitaxel in vitro and in vivo. Treatment with NPB304 increased paclitaxel-induced apoptosis in a p53-dependent manner through PARP cleavage. Importantly, NPB304 enhanced the antitumor effect of paclitaxel in resistant breast tumor xenografts in nude mice without significantly affecting weight loss. NPB304 regulated cell resistance through inhibition of MAPK pathway components, including p-ERK and p-p38. Moreover, NPB304 increased paclitaxel accumulation by affecting P-gp function. In addition to increasing Rhodamine 123 accumulation, NPB304 promoted bidirectional permeability but decreased the efflux ratio of paclitaxel in a Caco-2 monolayer model, thereby increasing the intracellular concentration of paclitaxel. Similarly, NPB304 increased the concentration of paclitaxel in the resistant tumor tissue. Hence, NPB304 is a novel compound that promotes the sensitization of resistant cells to paclitaxel through multiple mechanisms and has the potential for use in combination therapies to treat resistant breast cancer.	[Mei, Mei; Xie, Dan; Zhang, Yi; Jin, Jing; You, Feng; Li, Yan; Dai, Jungui; Chen, Xiaoguang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Mei, Mei; Xie, Dan; Zhang, Yi; Jin, Jing; You, Feng; Li, Yan; Dai, Jungui; Chen, Xiaoguang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chen, XG (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	chxg@imm.ac.cn		ZHANG, YI/0000-0001-8373-017X	National Natural Science Foundation of China [81102469]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Number 81102469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bello E, 2013, MOL CANCER THER, V12, P131, DOI 10.1158/1535-7163.MCT-12-0275-T; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Brooks T, 2003, MOL CANCER THER, V2, P1195; Chou TC, 2005, CANCER CHEMOTH PHARM, V56, P379, DOI 10.1007/s00280-005-1019-y; Cossa G, 2013, CURR PHARM DESIGN, V19, P883, DOI 10.2174/138161213804547187; Dai JG, 2009, CURR TOP MED CHEM, V9, P1625, DOI 10.2174/156802609789941924; Dent P, 1998, LEUKEMIA, V12, P1843, DOI 10.1038/sj.leu.2401222; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Geney R, 2002, CLIN CHEM LAB MED, V40, P918, DOI 10.1515/CCLM.2002.161; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; He D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054181; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Horwitz S. B., 1994, ANN ONCOL, V5, pS3, DOI DOI 10.1093/ANN0NC/5.SUPPL_4.S3; Huang M, 2010, BIOORG MED CHEM LETT, V20, P5418, DOI 10.1016/j.bmcl.2010.07.099; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Li Y, 2011, MOL MED REP, V4, P739, DOI 10.3892/mmr.2011.494; Liu KJ, 2013, INT J CANCER, V132, P224, DOI 10.1002/ijc.27649; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Makin G, 2001, BREAST CANCER RES, V3, P150, DOI 10.1186/bcr289; Marengo B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.118; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; McDaid HM, 2005, CANCER RES, V65, P2854, DOI 10.1158/0008-5472.CAN-04-4391; McDaid HM, 2001, MOL PHARMACOL, V60, P290, DOI 10.1124/mol.60.2.290; Mekhail Tarek M, 2002, Expert Opin Pharmacother, V3, P755; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Ojima I, 2005, J MED CHEM, V48, P2218, DOI 10.1021/jm049483y; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Sauvant C, 2008, INT J CANCER, V123, P2532, DOI 10.1002/ijc.23818; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sparreboom A, 2003, DRUG RESIST UPDATE, V6, P71, DOI 10.1016/S1368-7646(03)00005-0; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Thews O, 2013, ADV EXP MED BIOL, V765, P279, DOI 10.1007/978-1-4614-4989-8_39; Thews O, 2010, EUR J NUCL MED MOL I, V37, P1935, DOI 10.1007/s00259-010-1504-3; Thomas Hilary, 2003, Cancer Control, V10, P159; Torres K, 1998, CANCER RES, V58, P3620; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Trock BJ, 1997, J NATL CANCER I, V89, P917, DOI 10.1093/jnci/89.13.917; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xie D, 2011, CHEM PHARM BULL, V59, P1038, DOI 10.1248/cpb.59.1038; You F, 2013, CANCER CHEMOTH PHARM, V71, P1453, DOI 10.1007/s00280-013-2144-7; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zhang Y, 2010, CANCER CHEMOTH PHARM, V66, P851, DOI 10.1007/s00280-009-1229-9; Zhou Q, 2012, BIOL PHARM BULL, V35, P2170, DOI 10.1248/bpb.b12-00513; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x	58	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104317	10.1371/journal.pone.0104317	http://dx.doi.org/10.1371/journal.pone.0104317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093335	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200093
J	Cruz, E; Lopez, AV; Porter, JT				Cruz, Emmanuel; Lopez, Ana V.; Porter, James T.			Spontaneous Recovery of Fear Reverses Extinction- Induced Excitability of Infralimbic Neurons	PLOS ONE			English	Article							INTRINSIC EXCITABILITY; CONDITIONED FEAR; AMYGDALA; EXPRESSION; MEMORY; CONSOLIDATION; PLASTICITY	In rodents, the infralimbic (IL) region of the medial prefrontal cortex plays a key role in the recall of fear extinction. Previously we showed that fear conditioning decreases the intrinsic excitability of IL neurons, and that fear extinction reverses the depressed excitability. In the current study, we examined the time course of the extinction-induced changes in adolescent rats. Immediately after extinction, IL neurons continued to show depressed excitability. However 4 hours after extinction, IL neurons showed an increase in evoked spikes that correlated with a reduced fast afterhyperpolarizing potential. This suggests that acquisition of fear extinction induces an increase in spike firing 4 hours later, during the consolidation of extinction. We also examined IL excitability in a group of rats that showed spontaneous recovery of fear 17 days after extinction (SR group). Similar to neurons after fear conditioning, IL neurons from the SR group showed depressed intrinsic excitability compared to neurons 4 hours after extinction, suggesting that extinction-induced enhancement in intrinsic excitability decreases with time reverting back to a depressed state. These results suggest that plasticity in IL contributes to the spontaneous recovery of fear and preventing this depression of IL excitability could prolong fear extinction.	[Cruz, Emmanuel; Lopez, Ana V.; Porter, James T.] Ponce Sch Med, Dept Physiol & Pharmacol, Ponce, PR 00716 USA		Porter, JT (corresponding author), Ponce Sch Med, Dept Physiol & Pharmacol, Ponce, PR 00716 USA.	jporter@psm.edu		Porter, James/0000-0002-8122-6487	National Institutes of Health [MBRS-RISE R25 GM082406]; RCMI [G12 MD007579, R15 MH101700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM082406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH101700] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the following grants from the National Institutes of Health grants: MBRS-RISE R25 GM082406 to EC and by RCMI G12 MD007579 and R15 MH101700 to JTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Cho JH, 2013, NEURON, V80, P1491, DOI 10.1016/j.neuron.2013.09.025; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Fontanez-Nuin DE, 2011, CEREB CORTEX, V21, P727, DOI 10.1093/cercor/bhq147; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Hugues S, 2007, LEARN MEMORY, V14, P520, DOI 10.1101/lm.625407; Kim JH, 2011, CEREB CORTEX, V21, P530, DOI 10.1093/cercor/bhq116; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; McCallum J, 2010, NEUROPSYCHOPHARMACOL, V35, P2134, DOI 10.1038/npp.2010.92; Mickley GA, 2007, BRAIN RES, V1152, P139, DOI 10.1016/j.brainres.2007.03.050; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2012, CURR OPIN NEUROBIOL, V22, P717, DOI 10.1016/j.conb.2012.02.014; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Santini E, 2010, J NEUROSCI, V30, P12379, DOI 10.1523/JNEUROSCI.1295-10.2010; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Sepulveda-Orengo MT, 2013, J NEUROSCI, V33, P7184, DOI 10.1523/JNEUROSCI.5198-12.2013; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Vouimba RM, 2011, NEUROPSYCHOPHARMACOL, V36, P2276, DOI 10.1038/npp.2011.115	34	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103596	10.1371/journal.pone.0103596	http://dx.doi.org/10.1371/journal.pone.0103596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089624	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700034
J	Soh, SX; Lim, JYS; Huang, JWJ; Jiang, N; Yeoh, AEJ; Ong, ST				Soh, Sheila Xinxuan; Lim, Joshua Yew Suang; Huang, John W. J.; Jiang, Nan; Yeoh, Allen Eng Juh; Ong, S. Tiong			Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GERMLINE GENETIC-VARIATION; CELLULAR-DRUG RESISTANCE; INDUCED APOPTOSIS; KINASE INHIBITORS; CHILDREN; CELLS; EXPRESSION; PREDICTION; CANCER	A broad range of anti-cancer agents, including glucocorticoids (GCs) and tyrosine kinase inhibitors (TKIs), kill cells by upregulating the pro-apoptotic BCL2 family member, BIM. A common germline deletion in the BIM gene was recently shown to favor the production of non-apoptotic BIM isoforms, and to predict inferior responses in TKI-treated chronic myeloid leukemia (CML) and EGFR-driven lung cancer patients. Given that both in vitro and in vivo GC resistance are predictive of adverse outcomes in acute lymphoblastic leukemia (ALL), we hypothesized that this polymorphism would mediate GC resistance, and serve as a biomarker of poor response in ALL. Accordingly, we used zinc finger nucleases to generate ALL cell lines with the BIM deletion, and confirmed the ability of the deletion to mediate GC resistance in vitro. In contrast to CML and lung cancer, the BIM deletion did not predict for poorer clinical outcome in a retrospective analysis of 411 pediatric ALL patients who were uniformly treated with GCs and chemotherapy. Underlying the lack of prognostic significance, we found that the chemotherapy agents used in our cohort (vincristine, L-asparaginase, and methotrexate) were each able to induce ALL cell death in a BIM-independent fashion, and resensitize BIM deletion-containing cells to GCs. Together, our work demonstrates how effective therapy can overcome intrinsic resistance in ALL patients, and suggests the potential of using combinations of drugs that work via divergent mechanisms of cell killing to surmount BIM deletion-mediated drug resistance in other cancers.	[Soh, Sheila Xinxuan; Huang, John W. J.; Ong, S. Tiong] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Lim, Joshua Yew Suang; Jiang, Nan; Yeoh, Allen Eng Juh] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Yeoh, Allen Eng Juh] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Yeoh, Allen Eng Juh] Viva Univ, Natl Univ Hlth Syst, Univ Childrens Med Inst, Childrens Canc Ctr, Singapore, Singapore; [Yeoh, Allen Eng Juh] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Ong, S. Tiong] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Ong, S. Tiong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Ong, S. Tiong] Duke Univ, Med Ctr, Div Med Oncol, Durham, NC USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Duke University	Ong, ST (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore.	sintiong.ong@duke-nus.edu.sg	Yeoh, Allen EJ/D-9663-2015	Yeoh, Allen EJ/0000-0002-6454-976X; Jiang, Nan/0000-0002-7661-5728; Ong, S. Tiong/0000-0001-9460-3483	Leukemia & Lymphoma Society Translational Research Program [R913-302-026-597]; Singapore National Medical Research Council [NMRC/0582/2001, NMRC/CSA/003/2008]; A*STAR [SCS-POU98, NMRC/CSI/004/2005]; Children's Cancer Foundation, Singapore; VIVA Foundation for Children with Cancer, Singapore	Leukemia & Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Singapore National Medical Research Council(National Medical Research Council, Singapore); A*STAR(Agency for Science Technology & Research (A*STAR)); Children's Cancer Foundation, Singapore; VIVA Foundation for Children with Cancer, Singapore	STO was supported by the Leukemia & Lymphoma Society Translational Research Program Grant (R913-302-026-597) www.lls.org. AEY was supported by the Singapore National Medical Research Council (NMRC/0582/2001, NMRC/CSA/003/2008). www.nmrc.gov.sg, and by A*STAR (SCS-POU98, NMRC/CSI/004/2005). www.a-star.edu.sg, and by Children's Cancer Foundation, Singapore. www.ccf.org.sg, and by VIVA Foundation for Children with Cancer, Singapore. www.viva.sg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Augis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078582; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Coate L, 2010, J CLIN ONCOL, V28, P4029, DOI 10.1200/JCO.2009.27.2336; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; DeVita Jr VT, 2008, DEVITA HELLMAN ROSEN, p[427, 451, 490]; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Gagne V, 2013, CLIN CANCER RES, V19, P5240, DOI 10.1158/1078-0432.CCR-13-1215; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Jabbour E, 2009, MAYO CLIN PROC, V84, P161, DOI 10.1016/S0025-6196(11)60824-0; Jiang N, 2011, EXP HEMATOL, V39, P321, DOI 10.1016/j.exphem.2010.11.009; Juan WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095210; Kaspers GJL, 1998, BLOOD, V92, P259, DOI 10.1182/blood.V92.1.259.413k21_259_266; KASPERS GJL, 1995, LEUKEMIA LYMPHOMA, V19, P407, DOI 10.3109/10428199509112198; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lauten M, 2012, HAEMATOL-HEMATOL J, V97, P1048, DOI 10.3324/haematol.2011.047613; Locatelli F, 2012, BLOOD, V120, P2807, DOI 10.1182/blood-2012-02-265884; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; MIYAGI T, 1993, INT J CANCER, V53, P457, DOI 10.1002/ijc.2910530318; Morel F, 2003, LEUKEMIA LYMPHOMA, V44, P1333, DOI 10.1080/1042819031000097384; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; PIETERS R, 1993, LEUKEMIA, V7, P392; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Radtke S, 2013, BLOOD, V121, P5145, DOI 10.1182/blood-2013-01-480335; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Sanchez R, 2014, HAEMATOLOGICA, V99, P314, DOI 10.3324/haematol.2013.085340; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schrappe M, 1998, BLOOD, V92, P2730; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Xu H, 2012, J CLIN ONCOL, V30, P751, DOI 10.1200/JCO.2011.38.0345; Yang JJ, 2012, BLOOD, V120, P4197, DOI 10.1182/blood-2012-07-440107; Yang JJ, 2009, JAMA-J AM MED ASSOC, V301, P393, DOI 10.1001/jama.2009.7; Yeoh AEJ, 2012, J CLIN ONCOL, V30, P2384, DOI 10.1200/JCO.2011.40.5936; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	50	8	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103435	10.1371/journal.pone.0103435	http://dx.doi.org/10.1371/journal.pone.0103435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090024	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700027
J	Bunimovich, YL; Nair-Gill, E; Riedinger, M; McCracken, MN; Cheng, DH; McLaughlin, J; Radu, CG; Witte, ON				Bunimovich, Yuri L.; Nair-Gill, Evan; Riedinger, Mireille; McCracken, Melissa N.; Cheng, Donghui; McLaughlin, Jami; Radu, Caius G.; Witte, Owen N.			Deoxycytidine Kinase Augments ATM-Mediated DNA Repair and Contributes to Radiation Resistance	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RIBONUCLEOTIDE REDUCTASE; ATAXIA-TELANGIECTASIA; CELL LINE; NUCLEOTIDE-METABOLISM; PHOSPHORYLATION SITES; NUCLEOSIDE ANALOGS; CARCINOMA CELLS; GAMMA-DELTA; IN-VITRO	Efficient and adequate generation of deoxyribonucleotides is critical to successful DNA repair. We show that ataxia telangiectasia mutated (ATM) integrates the DNA damage response with DNA metabolism by regulating the salvage of deoxyribonucleosides. Specifically, ATM phosphorylates and activates deoxycytidine kinase (dCK) at serine 74 in response to ionizing radiation (IR). Activation of dCK shifts its substrate specificity toward deoxycytidine, increases intracellular dCTP pools post IR, and enhances the rate of DNA repair. Mutation of a single serine 74 residue has profound effects on murine T and B lymphocyte development, suggesting that post-translational regulation of dCK may be important in maintaining genomic stability during hematopoiesis. Using [F-18]-FAC, a dCK-specific positron emission tomography (PET) probe, we visualized and quantified dCK activation in tumor xenografts after IR, indicating that dCK activation could serve as a biomarker for ATM function and DNA damage response in vivo. In addition, dCK-deficient leukemia cell lines and murine embryonic fibroblasts exhibited increased sensitivity to IR, indicating that pharmacologic inhibition of dCK may be an effective radiosensitization strategy.	[Bunimovich, Yuri L.; Nair-Gill, Evan; Riedinger, Mireille; McCracken, Melissa N.; Radu, Caius G.; Witte, Owen N.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Bunimovich, Yuri L.; Radu, Caius G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Radu, Caius G.] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Imaging Div, Los Angeles, CA 90095 USA; [Cheng, Donghui; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [McLaughlin, Jami; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bunimovich, YL (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	bunimovichyl@upmc.edu; OwenWitte@mednet.ucla.edu	; Radu, Caius/D-3936-2013	Bunimovich, Yuri/0000-0002-7920-8781; Radu, Caius/0000-0002-9338-5397; Nair-Gill, Evan/0000-0002-9876-7853	NIH grant [R25T CA098010]; NIAID UCLA CMCR seed grant [U19AI067769, NIH 5T32 AI06567, CIRM TG2-01169]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; NATIONAL CANCER INSTITUTE [R25CA098010, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID UCLA CMCR seed grant; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R25T CA098010 [to YLB] and NIAID UCLA CMCR seed grant U19AI067769 [to YLB and ONW], NIH 5T32 AI06567 [to EN-G], CIRM TG2-01169 [to MNM]. ONW is an Investigator of the Howard Hughes Medical Institute and partially supported by the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aude-Garcia C, 2011, CELL MOL LIFE SCI, V68, P687, DOI 10.1007/s00018-010-0477-5; Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Burkhalter MD, 2009, DNA REPAIR, V8, P1258, DOI 10.1016/j.dnarep.2009.07.009; Cardoen S, 2001, CLIN CANCER RES, V7, P3559; Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; CHOTTINER EG, 1991, P NATL ACAD SCI USA, V88, P1531, DOI 10.1073/pnas.88.4.1531; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Ciofani M, 2010, NAT REV IMMUNOL, V10, P657, DOI 10.1038/nri2820; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Csapo Z, 2003, BIOCHEM PHARMACOL, V65, P2031, DOI 10.1016/S0006-2952(03)00182-5; Csapo Z, 1998, ADV EXP MED BIOL, V431, P525; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Falk I, 1996, J EXP MED, V184, P2327, DOI 10.1084/jem.184.6.2327; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HAMACHER K, 1986, J NUCL MED, V27, P235; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Haveman J, 2006, ONCOL REP, V16, P901; HAWLEY RG, 1994, GENE THER, V1, P136; Hazra S, 2011, BIOCHEMISTRY-US, V50, P2870, DOI 10.1021/bi2001032; Hesse JE, 2009, EXP GERONTOL, V44, P676, DOI 10.1016/j.exger.2009.06.009; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Keszler G, 2006, NUCLEOS NUCLEOT NUCL, V25, P1147, DOI 10.1080/15257770600894345; Keszler G, 2004, BIOCHEM PHARMACOL, V67, P947, DOI 10.1016/j.bcp.2003.10.019; Kim SH, 1998, INT J RADIAT ONCOL, V42, P789, DOI 10.1016/S0360-3016(98)00338-1; Kunos CA, 2011, RADIAT RES, V176, P425, DOI 10.1667/RR2556.1; Kunos CA, 2010, RADIAT RES, V174, P574, DOI 10.1667/RR2273.1; Laing RE, 2009, P NATL ACAD SCI USA, V106, P2847, DOI 10.1073/pnas.0812890106; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee MW, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-223; Ljungman M, 2009, CHEM REV, V109, P2929, DOI 10.1021/cr900047g; Loening AM, 2001, J NUCL MED, V42, p192P; Luo LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030541; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McSorley T, 2008, FEBS LETT, V582, P720, DOI 10.1016/j.febslet.2008.01.048; Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Piao C, 2009, ONCOGENE, V28, P2173, DOI 10.1038/onc.2009.84; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Secretan MB, 2004, MUTAT RES-FUND MOL M, V554, P351, DOI 10.1016/j.mrfmmm.2004.05.016; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shu CJ, 2010, J NUCL MED, V51, P1092, DOI 10.2967/jnumed.109.073361; Smal C, 2006, NUCLEOS NUCLEOT NUCL, V25, P1141, DOI 10.1080/15257770600890194; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; Smal C, 2004, NUCLEOS NUCLEOT NUCL, V23, P1363, DOI 10.1081/NCN-200027620; Smal C, 2004, BIOCHEM PHARMACOL, V68, P95, DOI 10.1016/j.bcp.2004.02.031; Smal C, 2007, CANCER LETT, V253, P68, DOI 10.1016/j.canlet.2007.01.013; Smal C, 2007, BIOCHEM PHARMACOL, V73, P351, DOI 10.1016/j.bcp.2006.10.012; Spasokoukotskaja T, 1999, EUR J CANCER, V35, P1862, DOI 10.1016/S0959-8049(99)00223-3; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Staub M, 1998, ANN ONCOL, V9, P113; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Stout DB, 2005, MOL IMAGING BIOL, V7, P393, DOI 10.1007/s11307-005-0015-2; Stuschke M, 1997, INT J RADIAT ONCOL, V37, P259, DOI 10.1016/S0360-3016(96)00511-1; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Van den Neste E, 2003, BIOCHEM PHARMACOL, V65, P573, DOI 10.1016/S0006-2952(02)01559-9; Warren LA, 2009, MECH AGEING DEV, V130, P46, DOI 10.1016/j.mad.2008.03.010; Wei S, 1999, INT J RADIAT BIOL, V75, P1005, DOI 10.1080/095530099139764; Wong S, 2004, P NATL ACAD SCI USA, V101, P17456, DOI 10.1073/pnas.0407061101; Yang CY, 2012, NUCLEIC ACIDS RES, V40, P9621, DOI 10.1093/nar/gks707; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4; Yu XC, 2010, J BIOMOL SCREEN, V15, P72, DOI 10.1177/1087057109353604	81	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104125	10.1371/journal.pone.0104125	http://dx.doi.org/10.1371/journal.pone.0104125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101980	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900042
J	Jia, MY; Yang, BY; Li, ZY; Shen, HL; Song, XX; Gu, W				Jia, Minyue; Yang, Boyun; Li, Zhongyi; Shen, Huiling; Song, Xiaoxiao; Gu, Wei			Computational Analysis of Functional Single Nucleotide Polymorphisms Associated with the CYP11B2 Gene	PLOS ONE			English	Article							ALDOSTERONE SYNTHASE GENE; PROTEIN FUNCTION; SNPS; IDENTIFICATION; MUTATIONS; SEQUENCES; VARIANTS; DATABASE; DISEASE; REGIONS	Single nucleotide polymorphisms (SNPs) are the most common type of genetic variations in humans and play a major role in the genetics of human phenotype variation and the genetic basis of human complex diseases. Recently, there is considerable interest in understanding the possible role of the CYP11B2 gene with corticosterone methyl oxidase deficiency, primary aldosteronism, and cardio-cerebro-vascular diseases. Hence, the elucidation of the function and molecular dynamic behavior of CYP11B2 mutations is crucial in current genomics. In this study, we investigated the pathogenic effect of 51 nsSNPs and 26 UTR SNPs in the CYP11B2 gene through computational platforms. Using a combination of SIFT, PolyPhen, I-Mutant Suite, and ConSurf server, four nsSNPs (F487V, V129M, T498A, and V403E) were identified to potentially affect the structure, function, and activity of the CYP11B2 protein. Furthermore, molecular dynamics simulation and structure analyses also confirmed the impact of these nsSNPs on the stability and secondary properties of the CYP11B2 protein. Additionally, utilizing the UTRscan, MirSNP, PolymiRTS and miRNASNP, three SNPs in the 3'UTR region were predicted to exhibit a pattern change in the upstream open reading frames (uORF), and eight microRNA binding sites were found to be highly affected due to 3'UTR SNPs. This cataloguing of deleterious SNPs is essential for narrowing down the number of CYP11B2 mutations to be screened in genetic association studies and for a better understanding of the functional and structural aspects of the CYP11B2 protein.	[Jia, Minyue; Yang, Boyun; Shen, Huiling; Song, Xiaoxiao; Gu, Wei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhongyi] Zhejiang Univ, Hangzhou Binjiang Hosp, Affiliated Hosp 2, Dept Urol,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gu, W (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China.	xsong103@gmail.com; guwei_1957@126.com		Yang, boyun/0000-0001-6221-2461	Science Technology Department of Zhejiang Province of China [2011C23018]; Research Fund for the Doctoral Program of Higher Education of China [20130101120038]	Science Technology Department of Zhejiang Province of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from Science Technology Department of Zhejiang Province of China [grant number 2011C23018], and grants from Research Fund for the Doctoral Program of Higher Education of China [grant number 20130101120038]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Androulakis E, 2013, INT J CARDIOL, V168, P1605, DOI 10.1016/j.ijcard.2013.01.035; Bhattacharya A, 2014, NUCLEIC ACIDS RES, V42, pD86, DOI 10.1093/nar/gkt1028; Brand E, 1998, HYPERTENSION, V32, P198, DOI 10.1161/01.HYP.32.2.198; Cao Fei-fei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1069; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cazzola M, 2000, BLOOD, V95, P3280, DOI 10.1182/blood.V95.11.3280.011k41_3280_3288; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Feng HJ, 2014, BRAZ J MED BIOL RES; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Huang H, 2011, EUR HEART J, V32, P355; Hui E, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-29; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji P, 2013, GENET TEST MOL BIOMA, V17, P548, DOI 10.1089/gtmb.2013.0026; Jia M, 2013, ENDOCR J, V60, P861, DOI 10.1507/endocrj.EJ12-0455; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Kayes-Wandover KM, 2001, J CLIN ENDOCR METAB, V86, P1008, DOI 10.1210/jc.86.3.1008; Ke X, 2008, EUR J HUM GENET, V16, P506, DOI 10.1038/sj.ejhg.5201987; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Mayosi BM, 2003, EUR J HUM GENET, V11, P395, DOI 10.1038/sj.ejhg.5200967; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nicod J, 2002, TRANSPLANTATION, V73, P960, DOI 10.1097/00007890-200203270-00023; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Quinkler M, 2010, HORM METAB RES, V42, P429, DOI 10.1055/s-0029-1243257; Rajith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024607; Reynolds PR, 2002, ARCH DIS CHILD, V86, P322, DOI 10.1136/adc.86.5.322; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Tousoulis D, 2013, AM J HYPERTENS, V26, P683, DOI 10.1093/ajh/hps089; Wu JX, 2013, SCI WORLD J, DOI 10.1155/2013/675851; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	50	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104311	10.1371/journal.pone.0104311	http://dx.doi.org/10.1371/journal.pone.0104311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102047	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900058
J	Mondal, SP; Yamage, M				Mondal, Shankar P.; Yamage, Mat			A Retrospective Study on the Epidemiology of Anthrax, Foot and Mouth Disease, Haemorrhagic Septicaemia, Peste des Petits Ruminants and Rabies in Bangladesh, 2010-2012	PLOS ONE			English	Article							SOUTH-EAST-ASIA; CUTANEOUS ANTHRAX; WEST-BENGAL; VIRUS; OUTBREAKS; INDIA; PREVALENCE; MORBIDITY; MORTALITY; CATTLE	Anthrax, foot and mouth disease (FMD), haemorrhagic septicaemia (HS), peste des petits ruminants (PPR) and rabies are considered to be endemic in Bangladesh. This retrospective study was conducted to understand the geographic and seasonal distribution of these major infectious diseases in livestock based on data collected through passive surveillance from 1 January 2010 to 31 December 2012. Data analysis for this period revealed 5,937 cases of anthrax, 300,333 of FMD, 13,436 of HS, 247,783 of PPR and 14,085 cases of dog bite/rabies. While diseases were reported in almost every district of the country, the highest frequency of occurrence corresponded to the susceptible livestock population in the respective districts. There was no significant difference in the disease occurrences between districts bordering India/Myanmar and non-border districts (p>0.05). Significantly higher (p<0.01) numbers of anthrax (84.5%), FMD (88.3%), HS (84.9%) and dog bite/rabies (64.3%) cases were reported in cattle than any other species. PPR cases were reported mostly (94.8%) in goats with only isolated cases (5.2%) in sheep. The diseases occur throughout the year with peak numbers reported during June through September and lowest during December through April, with significant differences (p<0.01) between the months. The annual usages of vaccines for anthrax, FMD, HS and PPR were only 7.31%, 0.61%, 0.84% and 11.59% of the susceptible livestock population, respectively. Prophylactic vaccination against rabies was 21.16% of cases. There were significant differences (p<0.01) in the administration of anthrax, FMD and HS vaccines between border and non-border districts, but not PPR or rabies vaccines. We recommend that surveillance and reporting of these diseases need to be improved throughout the country. Furthermore, all suspected clinical cases should be confirmed by laboratory examination. The findings of this study can be used in the formulation of more effective disease management and control strategies, including appropriate vaccination policies in Bangladesh.	[Mondal, Shankar P.; Yamage, Mat] Food & Agr Org United Nations, Dhaka, Bangladesh	Food & Agriculture Organization of the United Nations (FAO)	Mondal, SP (corresponding author), Univ Kentucky, Maxwell H Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY 40506 USA.	shankarpm@yahoo.com			United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID))	The study was supported by the United States Agency for International Development. The views expressed in this manuscript do not necessarily represent the position of the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2009, TROP ANIM HEALTH PRO, V41, P1197, DOI 10.1007/s11250-008-9300-9; Ahmed S, 1996, ASIAN LIVESTOCK J, V21, P112; [Anonymous], 2009, BANGL EC REV; Balamurugan V, 2012, J VET SCI, V13, P279, DOI 10.4142/jvs.2012.13.3.279; Bangladesh Bureau of Statistics, 2010, AGR CENS 2005; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; BARC Bangladesh, 2010, AGR RES PRIOR VIS 20; Benkirane A, 2002, VET MED-CZECH, V47, P234, DOI 10.17221/5830-VETMED; Bhattacharya S, 2005, REV SCI TECH OIE, V24, P945, DOI 10.20506/rst.24.3.1622; Biswas PK, 2012, EPIDEMIOL INFECT, V140, P1888, DOI 10.1017/S0950268811002408; Chakraborty A, 2012, AM J TROP MED HYG, V86, P703, DOI 10.4269/ajtmh.2012.11-0234; Chhetri BK, 2010, TROP ANIM HEALTH PRO, V42, P1441, DOI 10.1007/s11250-010-9573-7; Chowdhury S. M. Z. H., 1993, Asian-Australasian Journal of Animal Sciences, V6, P423; Coleman PG, 1996, VACCINE, V14, P185, DOI 10.1016/0264-410X(95)00197-9; Davies G, 2002, RES VET SCI, V73, P195, DOI 10.1016/S0034-5288(02)00105-4; DEALWIS MCL, 1990, TROP ANIM HEALTH PRO, V22, P185, DOI 10.1007/BF02241015; DEBNATH NC, 1990, PREV VET MED, V9, P1, DOI 10.1016/0167-5877(90)90037-I; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dukpa K, 2011, TROP ANIM HEALTH PRO, V43, P495, DOI 10.1007/s11250-010-9722-z; FAO, 2011, P INT WORKSH FAO ROM; FAO/OIE, 2012, FAO OIE GLOB C FOOT; Food and Agriculture Organization (FAO) of the United Nations, 2001, ANTHR AN; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Gleeson LJ, 2002, REV SCI TECH OIE, V21, P465, DOI 10.20506/rst.21.3.1346; Gongal Gyanendra, 2011, Adv Prev Med, V2011, P383870, DOI 10.4061/2011/383870; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hossain M, 2013, PREV VET MED, V111, P134, DOI 10.1016/j.prevetmed.2013.03.008; Hossain M, 2011, VACCINE, V29, P1036, DOI 10.1016/j.vaccine.2010.11.052; HOWLADER MMR, 2004, J BIOL SCI, V4, P581; Islam M. R., 2001, Bangladesh Veterinarian, V18, P14; Jamil KM, 2012, EMERG INFECT DIS, V18, P2021, DOI 10.3201/eid1812.120061; Khounsy S, 2008, REV SCI TECH OIE, V27, P839, DOI 10.20506/rst.27.3.1840; Khounsy S, 2009, VET MICROBIOL, V137, P178, DOI 10.1016/j.vetmic.2008.12.008; Kitching RP, 2002, REV SCI TECH OIE, V21, P499, DOI 10.20506/rst.21.3.1343; Lefevre PC, 1990, OFFICE INT EPIZOOTIE, V9, P951, DOI DOI 10.20506/rst.9.4.532; Livestock Research Institute, 2010, ANN REP PROD DISTR B; Loth L, 2011, TRANSBOUND EMERG DIS, V58, P240, DOI 10.1111/j.1865-1682.2011.01206.x; Madin B, 2011, PREV VET MED, V102, P230, DOI 10.1016/j.prevetmed.2011.07.010; MALAGA H, 1979, INT J EPIDEMIOL, V8, P243, DOI 10.1093/ije/8.3.243; Mannan MA, 2009, J BANGLADESH AGR U, V7, P317; Mumford JA, 2007, REV SCI TECH OIE, V26, P69, DOI 10.20506/rst.26.1.1730; Nandi SP, 2015, TRANSBOUND EMERG DIS, V62, P328, DOI 10.1111/tbed.12113; Ozkul A, 2002, EMERG INFECT DIS, V8, P708; Perry BD, 2002, REV SCI TECH OIE, V21, P663, DOI 10.20506/rst.21.3.1354; PHARO HJ, 1987, TROP ANIM HEALTH PRO, V19, P136, DOI 10.1007/BF02239707; Plotkin SA, 2000, CLIN INFECT DIS, V30, P4, DOI 10.1086/313632; Chakma S., 2012, Bangladesh Veterinarian, V29, P1, DOI 10.3329/bvet.v29i1.11883; Rahman MS, 2010, INT J BIORES, V2, P17; Ray TK, 2009, EMERG INFECT DIS, V15, P497, DOI 10.3201/eid1503.080972; Rosenberger G., 1979, CLIN EXAMINATION CAT; Samad MA, 2000, LEP PUB, V07; Sarker S, 2011, WAYAMBA J ANI S 0310; Sarker S, 2011, VET WORLD, V4, P546, DOI 10.5455/vetworld.2011.546-549; Siddiqui Muhammad Afsar, 2012, BMC Res Notes, V5, P464, DOI 10.1186/1756-0500-5-464; Sil BK, 1995, ANN C BANGL SOC VET; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; Sumption K, 2008, TRANSBOUND EMERG DIS, V55, P5, DOI 10.1111/j.1865-1682.2007.01017.x; Thiptara A, 2011, AM J TROP MED HYG, V85, P138, DOI 10.4269/ajtmh.2011.10-0535; UN, 2011, WORLD POPULATION PRO; Verma A. K., 2008, Asian Journal of Epidemiology, V1, P40, DOI 10.3923/aje.2008.40.46; *WORLD ORG AN HLTH, 2010, WORLD AN HLTH INF DA; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	63	29	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104435	10.1371/journal.pone.0104435	http://dx.doi.org/10.1371/journal.pone.0104435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101836	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900064
J	Son, JY; Lee, HY; Lee, KS; Kim, JH; Han, J; Jeong, JY; Kwon, OJ; Shim, YM				Son, Ji Ye; Lee, Ho Yun; Lee, Kyung Soo; Kim, Jae-Hun; Han, Joungho; Jeong, Ji Yun; Kwon, O. Jung; Shim, Young Mog			Quantitative CT Analysis of Pulmonary Ground-Glass Opacity Nodules for the Distinction of Invasive Adenocarcinoma from Pre-Invasive or Minimally Invasive Adenocarcinoma	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; LUNG ADENOCARCINOMA; HISTOGRAM ANALYSIS; TEXTURE ANALYSIS; PATHOLOGY; CANCER; CELL; HISTOPATHOLOGY; DIAGNOSIS; SUBTYPE	Objectives: We aimed to analyze the CT findings of ground-glass opacity nodules diagnosed pathologically as adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive adenocarcinoma in order to investigate whether quantitative CT parameters enable distinction of invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma. Methods: We reviewed CT images and pathologic specimens from 191 resected ground-glass opacity nodules with little or no solid component at CT. Nodule size, volume, density, mass, skewness/kurtosis, and CT attenuation values at the 2.5th-97.5th percentiles on histogram, and texture parameters (uniformity and entropy) were assessed from CT datasets. Results: Of 191 tumors, 38 were AISs (20%), 61 were MIAs (32%), and 92 (48%) were invasive adenocarcinomas. Multivariate logistic regression analysis helped identify the 75th percentile CT attenuation value (P = 0.04) and entropy (P<0.01) as independent predictors for invasive adenocarcinoma, with an area under the receiver operating characteristic curve of 0.780. Conclusion: Quantitative analysis of preoperative CT imaging metrics can help distinguish invasive adenocarcinoma from pre-invasive or minimally invasive adenocarcinoma.	[Son, Ji Ye; Lee, Ho Yun; Lee, Kyung Soo; Kim, Jae-Hun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Son, Ji Ye; Lee, Ho Yun; Lee, Kyung Soo; Kim, Jae-Hun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea; [Han, Joungho; Jeong, Ji Yun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Kwon, O. Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Resp & Crit Med, Seoul, South Korea; [Shim, Young Mog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, HY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	hoyunlee96@gmail.com	Lee, Ho Yun/D-6086-2012	Kim, Jae-Hun/0000-0003-3064-6948				Borezuk AC, 2009, AM J SURG PATHOL, V33, P462, DOI 10.1097/PAS.0b013e318190157c; Chandarana H, 2012, RADIOLOGY, V265, P790, DOI 10.1148/radiol.12111281; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; Hashizume T, 2008, CHEST, V133, P441, DOI 10.1378/chest.07-1533; Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Ikeda N, 2004, ANN THORAC SURG, V78, P1011, DOI 10.1016/j.athoracsur.2004.03.048; Kato F, 2012, LUNG CANCER, V77, P495, DOI 10.1016/j.lungcan.2012.05.109; Kayser G, 2013, ACTA HISTOCHEM; Kim HK, 2009, J THORAC ONCOL, V4, P1242, DOI 10.1097/JTO.0b013e3181b3fee3; Lee HY, 2014, AM J ROENTGENOL, V202, pW224, DOI 10.2214/AJR.13.11819; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Lim HJ, 2013, CHEST, V144, P1291, DOI 10.1378/chest.12-2987; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Min JH, 2010, LUNG CANCER, V69, P123, DOI 10.1016/j.lungcan.2010.04.022; Neltner JH, 2012, J NEUROPATH EXP NEUR, V71, P1075, DOI 10.1097/NEN.0b013e3182768de4; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Onozato Maristela L, 2012, Stud Health Technol Inform, V179, P250; Ozluk Y, 2012, CLIN TRANSPLANT, V26, P336, DOI 10.1111/j.1399-0012.2011.01506.x; Sakurai H, 2004, AM J SURG PATHOL, V28, P198, DOI 10.1097/00000478-200402000-00007; Shimizu K, 2005, CHEST, V127, P871, DOI 10.1378/chest.127.3.871; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Thunnissen E, 2012, MODERN PATHOL, V25, P1574, DOI 10.1038/modpathol.2012.106; Travis WD, 2005, J CLIN ONCOL, V23, P3279, DOI 10.1200/JCO.2005.15.776; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wang SM, 2012, RADIOLOGY, V262, P584, DOI 10.1148/radiol.11110576; Xu X, 2010, J THORAC ONCOL, V5, P39, DOI 10.1097/JTO.0b013e3181c09f9c	28	108	126	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104066	10.1371/journal.pone.0104066	http://dx.doi.org/10.1371/journal.pone.0104066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102064	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900035
J	Zhou, RP; Li, ZK; He, CY; Li, RL; Xia, HB; Li, CY; Xiao, J; Chen, ZY				Zhou, Ruiping; Li, Zhuokun; He, Chengyi; Li, Ronglin; Xia, Hongbin; Li, Chunyang; Xiao, Jia; Chen, Zhi-Ying			Human Umbilical Cord Mesenchymal Stem Cells and Derived Hepatocyte-Like Cells Exhibit Similar Therapeutic Effects on an Acute Liver Failure Mouse Model	PLOS ONE			English	Article							METASTASIS; PROMOTE	Mesenchymal stem cells (MSCs) have exhibited therapeutic effects in multiple animal models so that are promising liver substitute for transplantation treatment of end-stage liver diseases. However, it has been shown that over-manipulation of these cells increased their tumorigenic potential, and that reducing the in vitro culture time could minimize the risk. In this study, we used a D-galactosamine plus lipopolysaccharide (Gal/LPS)-induced acute liver failure mouse model, which caused death of about 50% of the mice with necrosis of more than 50% hepatocytes, to compare the therapeutic effects of human umbilical cord MSCs (hUCMSCs) before and after induction of differentiation into hepatocyte (i-Heps). Induction of hUCMSCs to become i-Heps was achieved by treatment of the cells with a group of growth factors within 4 weeks. The resulted i-Heps exhibited a panel of human hepatocyte biomarkers including cytokeratin (hCK-18), alpha-fetoprotein (hAFP), albumin (hALB), and hepatocyte-specific functions glycogen storage and urea metabolism. We demonstrated that transplantation of both cell types through tail vein injection rescued almost all of the Gal/LPS-intoxicated mice. Although both cell types exhibited similar ability in homing at the mouse livers, the populations of the hUCMSCs-derived cells, as judged by expressing hAFP, hCK-18 and human hepatocyte growth factor (hHGF), were small. These observations let us to conclude that the hUCMSCs was as effective as the i-Heps in treatment of the mouse acute liver failure, and that the therapeutic effects of hUCMSCs were mediated largely via stimulation of host hepatocyte regeneration, and that delivery of the cells through intravenous injection was effective.	[Zhou, Ruiping; Li, Zhuokun; He, Chengyi; Xia, Hongbin; Chen, Zhi-Ying] Chinese Acad Sci, Shenzhen Inst Adv Technol, Lab Gene & Cell Therapy, Shenzhen, Peoples R China; [Xiao, Jia] Jinan Univ, Inst Tissue Transplantat & Immunol, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China; [Zhou, Ruiping; Li, Ronglin; Chen, Zhi-Ying] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Chunyang] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Stomatol, Zhuhai, Peoples R China; [Xiao, Jia] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Zhou, Ruiping] Shenzhen Seventh Yantian Dist Peoples Hosp, Dept Stomatol, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Jinan University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong	Xiao, J (corresponding author), Jinan Univ, Inst Tissue Transplantat & Immunol, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China.	tjxiao@jnu.edu.cn; zy.chen1@siat.ac.cn		LI, Zhuokun/0000-0001-7297-6916	National Natural Science Foundation of China [31300813]; Science and Technology Foundation of Shenzhen, China [FGW2012.566, KCW2012.237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Shenzhen, China	This study was funded by the National Natural Science Foundation of China (Grant No. 31300813, http://www.nsfc.gov.cn/) and Science and Technology Foundation of Shenzhen, China (Grant No. FGW2012.566 and KCW2012.237, www.szsti.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Burra P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-88; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; Gomez-Aristizabal A, 2009, MOL THER, V17, P1504, DOI 10.1038/mt.2009.158; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee JH, 2012, ARCH PLAST SURG-APS, V39, P593, DOI 10.5999/aps.2012.39.6.593; Li J, 2010, SCI CHINA LIFE SCI, V53, P1073, DOI 10.1007/s11427-010-4055-8; Li TR, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-34; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mohseny AB, 2009, J PATHOL, V219, P294, DOI 10.1002/path.2603; Moslem M, 2013, CELL TRANSPLANT; O'Grady JG, 2008, LIVER TRANSPLANT, V14, pS97, DOI 10.1002/lt.21640; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Song PY, 2012, STEM CELL REV REP, V8, P1155, DOI 10.1007/s12015-012-9406-3; van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yagi H, 2009, TISSUE ENG PT A, V15, P3377, DOI [10.1089/ten.tea.2008.0681, 10.1089/ten.TEA.2008.0681]; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	27	28	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104392	10.1371/journal.pone.0104392	http://dx.doi.org/10.1371/journal.pone.0104392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101638	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993900061
J	Kotzerke, J; Punzet, R; Runge, R; Ferl, S; Oehme, L; Wunderlich, G; Freudenberg, R				Kotzerke, Joerg; Punzet, Robert; Runge, Roswitha; Ferl, Sandra; Oehme, Liane; Wunderlich, Gerd; Freudenberg, Robert			(99)mTc-Labeled HYNIC-DAPI Causes Plasmid DNA Damage with High Efficiency	PLOS ONE			English	Article							STRAND BREAKS; INTRACELLULAR UPTAKE; CLONOGENIC SURVIVAL; POSITIONAL CHANGES; IN-VITRO; TC-99M; CELLS; I-125; REDUCTION; SITES	Tc-99m is the standard radionuclide used for nuclear medicine imaging. In addition to gamma irradiation, Tc-99m emits low-energy Auger and conversion electrons that deposit their energy within nanometers of the decay site. To study the potential for DNA damage, direct DNA binding is required. Plasmid DNA enables the investigation of the unprotected interactions between molecules and DNA that result in single-strand breaks (SSBs) or double-strand breaks (DSBs); the resulting DNA fragments can be separated by gel electrophoresis and quantified by fluorescent staining. This study aimed to compare the plasmid DNA damage potential of a Tc-99m-labeled HYNIC-DAPI compound with that of Tc-99m pertechnetate ((TcO4-)-Tc-99m). pUC19 plasmid DNA was irradiated for 2 or 24 hours. Direct and radical-induced DNA damage were evaluated in the presence or absence of the radical scavenger DMSO. For both compounds, an increase in applied activity enhanced plasmid DNA damage, which was evidenced by an increase in the open circular and linear DNA fractions and a reduction in the supercoiled DNA fraction. The number of SSBs elicited by Tc-99m-HYNIC-DAPI (1.03) was twice that caused by (TcO4-)-Tc-99m (0.51), and the number of DSBs increased fivefold in the Tc-99m-HYNIC-DAPI-treated sample compared with the (TcO4-)-Tc-99m treated sample (0.02 to 0.10). In the presence of DMSO, the numbers of SSBs and DSBs decreased to 0.03 and 0.00, respectively, in the (TcO4-)-Tc-99m treated samples, whereas the numbers of SSBs and DSBs were slightly reduced to 0.95 and 0.06, respectively, in the Tc-99m-HYNIC-DAPI-treated samples. These results indicated that Tc-99m-HYNIC-DAPI induced SSBs and DSBs via a direct interaction of the Tc-99m-labeled compound with DNA. In contrast to these results, (TcO4-)-Tc-99m induced SSBs via radical formation, and DSBs were formed by two nearby SSBs. The biological effectiveness of Tc-99m-HYNIC-DAPI increased by approximately 4-fold in terms of inducing SSBs and by approximately 10-fold in terms of inducing DSBs.	[Kotzerke, Joerg; Punzet, Robert; Runge, Roswitha; Ferl, Sandra; Oehme, Liane; Wunderlich, Gerd; Freudenberg, Robert] Tech Univ Dresden, Univ Hosp, Dept Nucl Med, Fac Med Carl Gustav Carus, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Freudenberg, R (corresponding author), Tech Univ Dresden, Univ Hosp, Dept Nucl Med, Fac Med Carl Gustav Carus, D-01062 Dresden, Germany.	robert.freudenberg@uniklinikum-dresden.de			Deutsche Forschungsgemeinschaft (DFG) [KO 1695/4-1]; Europaischer Sozialfonds (ESF) [080951832]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Europaischer Sozialfonds (ESF)(European Commission)	The research (JK, GW) was partly supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/, Grant No. KO 1695/4-1). Sandra Ferl (SF) was supported by the Europaischer Sozialfonds (ESF, http://www.esf.de/portal/generator/8/startseite.html, grant code 080951832). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein SJ, 1996, ACTA ONCOL, V35, P797, DOI 10.3109/02841869609104029; BABICH JW, 1993, J NUCL MED, V34, P1964; Balagurumoorthy P, 2008, RADIAT RES, V170, P70, DOI 10.1667/RR1072.1; Balagurumoorthy P, 2012, INT J RADIAT BIOL, V88, P998, DOI 10.3109/09553002.2012.706360; Balagurumoorthy P, 2008, INT J RADIAT BIOL, V84, P976, DOI 10.1080/09553000802512568; Cambien B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092729; COWAN R, 1987, J THEOR BIOL, V127, P229, DOI 10.1016/S0022-5193(87)80133-9; Freudenberg R, 2012, INT J RADIAT BIOL, V88, P991, DOI 10.3109/09553002.2012.728303; Hafliger P, 2005, CHEMBIOCHEM, V6, P414, DOI 10.1002/cbic.200400210; HOWELL RW, 1992, MED PHYS, V19, P1371, DOI 10.1118/1.596927; HUMM JL, 1989, INT J RADIAT ONCOL, V17, P351, DOI 10.1016/0360-3016(89)90450-1; KASSIS AI, 1989, RADIAT RES, V118, P283, DOI 10.2307/3577443; Kassis AI, 1999, RADIAT RES, V152, P530, DOI 10.2307/3580150; Kotzerke J, 2012, NUKLEARMED-NUCL MED, V51, P170, DOI 10.3413/Nukmed-0506-12-05; Kriehuber R, 2004, INT J RADIAT BIOL, V80, P875, DOI 10.1080/09553000400017705; Pomplun E, 2004, INT J RADIAT BIOL, V80, P855, DOI 10.1080/09553000400017614; Pomplun E, 2002, RADIAT PROT DOSIM, V99, P81, DOI 10.1093/oxfordjournals.rpd.a006844; Santos-Cuevas CL, 2011, NUCL MED COMMUN, V32, P303, DOI 10.1097/MNM.0b013e328341b27f; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schipper ML, 2007, EUR J NUCL MED MOL I, V34, P638, DOI 10.1007/s00259-006-0254-8; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; Walicka MA, 2000, RADIAT RES, V154, P326, DOI 10.1667/0033-7587(2000)154[0326:TODIIQ]2.0.CO;2; Wendisch M, 2010, NUKLEARMED-NUCL MED, V49, P154, DOI 10.3413/nukmed-0300; Wunderlich G, 2012, NUKLEARMED-NUCL MED, V51, P179, DOI 10.3413/Nukmed-0450-11-12; Yasui LS, 2007, RADIAT RES, V167, P167, DOI 10.1667/RR0584.1	25	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104653	10.1371/journal.pone.0104653	http://dx.doi.org/10.1371/journal.pone.0104653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098953	gold, Green Published, Green Submitted			2022-12-25	WOS:000339995100087
J	Niang, EA; Konate, L; Diallo, M; Faye, O; Dia, I				Niang, El Hadji Amadou; Konate, Lassana; Diallo, Mawlouth; Faye, Ousmane; Dia, Ibrahima			Reproductive Isolation among Sympatric Molecular Forms of An. gambiae from Inland Areas of South-Eastern Senegal	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; INCIPIENT SPECIATION; MALARIA VECTORS; PLASMODIUM-FALCIPARUM; POPULATION-STRUCTURE; CHROMOSOMAL FORMS; WEST-AFRICA; ARABIENSIS; COMPLEX; CULICIDAE	The Anopheles gambiae species complex includes at least seven morphologically indistinguishable species, one of which, Anopheles gambiae sensu stricto, is the primary mosquito vector responsible for the transmission of malaria across sub-Saharan Africa. Sympatric ecological diversification of An. gambiae s.s. is in progress within this complex, leading to the emergence of at least two incipient species (the M and S molecular forms now recognized as good species and named An. coluzzii and An. gambiae respectively) that show heterogeneous levels of divergence in most parts of Africa. However, this process seems to have broken down in coastal areas of West Africa at the extreme edge of the distribution. We undertook a longitudinal study to describe An. gambiae s.s. populations collected from two inland transects with different ecological characteristics in south-eastern Senegal. Analysis of samples collected from 20 sites across these two transects showed the M and S molecular forms coexisted at almost all sampled sites. Overall, similar hybridization rates (2.16% and 1.86%) were recorded in the two transects; sites with relatively high frequencies of M/S hybrids (up to 7%) were clustered toward the north-western part of both transects, often near urban settings. Estimated inbreeding indices for this putative speciation event varied spatially (range: 0.52-1), with hybridization rates being generally lower than expected under panmictic conditions. Such observations suggest substantial reproductive isolation between the M and S molecular forms, and further support the ongoing process of speciation in these inland areas. According to a recent reclassification of the An. gambiae complex, the M and S molecular forms from this zone correspond to An. coluzzii and An. gambiae, respectively. There is considerable evidence that these molecular forms differ in their behavioural and ecological characteristics. Detailed study of these characteristics will allow the development and implementation of better insect control strategies for combating malaria.	[Niang, El Hadji Amadou; Diallo, Mawlouth; Dia, Ibrahima] Inst Pasteur, Unite Entomol Med, Dakar, Senegal; [Niang, El Hadji Amadou; Konate, Lassana; Faye, Ousmane] Univ Cheikh Anta Diop Dakar, Lab Ecol Vectorielle & Parasitaire, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar	Dia, I (corresponding author), Inst Pasteur, Unite Entomol Med, Dakar, Senegal.	dia@pasteur.sn	Niang, E.A./X-3152-2018	Niang, E.A./0000-0001-5611-1998	EU project INFRAVEC (Research capacity for the implementation of genetic control of Mosquitoes); European Commission's [228421]	EU project INFRAVEC (Research capacity for the implementation of genetic control of Mosquitoes); European Commission's(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the EU project INFRAVEC (Research capacity for the implementation of genetic control of Mosquitoes); funded by the European Commission's Seventh Framework Research Programme under the grant agreement 228421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, ANOPHELINAE AFR S SA; Bogh C, 2003, B ENTOMOL RES, V93, P279, DOI 10.1079/BER2003239; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Collins F.H., 1988, Parassitologia (Rome), V30, P231; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Diabate A, 2005, J MED ENTOMOL, V42, P548, DOI 10.1603/0022-2585(2005)042[0548:LDOTMF]2.0.CO;2; Djogbenou L, 2010, ACTA TROP, V114, P116, DOI 10.1016/j.actatropica.2010.02.001; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; FONTENILLE D, 1993, ANN PARASIT HUM COMP, V68, P239; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; Lee Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-75; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	37	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104622	10.1371/journal.pone.0104622	http://dx.doi.org/10.1371/journal.pone.0104622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098711	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100085
J	Triest, L; Sierens, T				Triest, Ludwig; Sierens, Tim			Seagrass Radiation after Messinian Salinity Crisis Reflected by Strong Genetic Structuring and Out-of-Africa Scenario (Ruppiaceae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; POPULATION-GENETICS; POSIDONIA-OCEANICA; MEDITERRANEAN SEA; RAPID RADIATION; DISPERSAL; DIVERSITY; ZOSTERA; RBCL; EVOLUTIONARY	Many aquatic plant and seagrass species are widespread and the origin of their continent-wide ranges might result from high gene flow levels. The response of species when extending northwards since the Last Glacial Maximum can be opposed to the structuring of their populations that survived glaciation cycles in southern regions. The peri-Mediterranean is a complex series of sea basins, coastlines, islands and river deltas with a unique history since the Messinian Crisis that potentially influenced allopatric processes of aquatic life. We tested whether vast ranges across Europe and the peri-Mediterranean of a global seagrass group (Ruppia species complexes) can be explained by either overall high levels of gene flow or vicariance through linking population genetics, phylogeography and shallow phylogenetics. A multigene approach identified haplogroup lineages of two species complexes, of ancient and recent hybrids with most of the diversity residing in the South. High levels of connectivity over long distances were only observed at recently colonized northern ranges and in recently-filled seas following the last glaciation. A strong substructure in the southern Mediterranean explained an isolation-by-distance model across Europe. The oldest lineages of the southern Mediterranean Ruppia dated back to the period between the end of the Messinian and Late Pliocene. An imprint of ancient allopatric origin was left at basin level, including basal African lineages. Thus both vicariance in the South and high levels of connectivity in the North explained vast species ranges. Our findings highlight the need for interpreting global distributions of these seagrass and euryhaline species in the context of their origin and evolutionary significant units for setting up appropriate conservation strategies.	[Triest, Ludwig; Sierens, Tim] Vrije Univ Brussel, Brussels, Belgium	Vrije Universiteit Brussel	Triest, L (corresponding author), Vrije Univ Brussel, Brussels, Belgium.	ltriest@vub.ac.be		Triest, Ludwig/0000-0002-4946-9614	Fund for Scientific Research Flanders [G.0076.05]; Vrije Universiteit Brussel [OZR 1189BOF, BAS42]	Fund for Scientific Research Flanders(FWO); Vrije Universiteit Brussel	This project was financed by the Fund for Scientific Research Flanders (G.0076.05, Sabbatical leave contract for Ludwig Triest) and by the Vrije Universiteit Brussel (OZR 1189BOF, Sabbatical leave research funding for Ludwig Triest; BAS42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2008, J BIOGEOGR, V35, P1279, DOI 10.1111/j.1365-2699.2007.01876.x; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Arranz SE, 2013, MOL ECOL RESOUR, V13, P546, DOI 10.1111/1755-0998.12095; BRASIER M D, 1975, Palaeontology (Oxford), V18, P681; Bremer K, 2000, P NATL ACAD SCI USA, V97, P4707, DOI 10.1073/pnas.080421597; Carreras-Carbonell J, 2005, MOL PHYLOGENET EVOL, V37, P751, DOI 10.1016/j.ympev.2005.04.021; Chen JM, 2008, MOL PHYLOGENET EVOL, V48, P168, DOI 10.1016/j.ympev.2008.03.008; Clauzon G, 1996, GEOLOGY, V24, P363, DOI 10.1130/0091-7613(1996)024<0363:AIOTMS>2.3.CO;2; Coyer JA, 2008, ANN BOT-LONDON, V101, P73, DOI 10.1093/aob/mcm288; Coyer JA, 2013, SYST BIODIVERS, V11, P271, DOI 10.1080/14772000.2013.821187; Coyer JA, 2004, MAR ECOL PROG SER, V281, P51, DOI 10.3354/meps281051; DenHartog C, 1970, SEA GRASSES WORLD; Doadrio I, 2004, GENETICS, V15, P398; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Godwin H., 1956, HIST BRIT FLORA FACT; Green P., 2003, WORLD ATLAS SEAGRASS; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Ignatius H., 1981, BALTIC SEA, P54; Ito Y, 2013, J PLANT RES, V126, P753, DOI 10.1007/s10265-013-0570-6; Ito Y, 2010, AM J BOT, V97, P1156, DOI 10.3732/ajb.0900168; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Kato Y, 2003, GENES GENET SYST, V78, P329, DOI 10.1266/ggs.78.329; van Dijk JK, 2010, AQUAT BOT, V92, P63, DOI 10.1016/j.aquabot.2009.10.005; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Larkum AWD, 1989, BIOL SEAGRASSES TREA, P112; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987; Mannino AM, 2014, AQUAT BOT UNPUB; Masucci AP, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds11; MCCULLOCH MT, 1989, NATURE, V342, P62, DOI 10.1038/342062a0; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079889; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Papenbrock J, 2012, ISRN BOT, V2012, DOI [DOI 10.5402/2012/103892, 10.5402/2012/103892]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pons O, 1996, GENETICS, V144, P1237; Procaccini G, 1999, AQUAT BOT, V62, P269, DOI 10.1016/S0304-3770(98)00099-0; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Ruggiero MV, 2004, J MOL EVOL, V58, P115, DOI 10.1007/s00239-003-2536-0; Ruggiero MV, 2002, CONSERV GENET, V3, P71; RUSSELL G, 1985, BRIT PHYCOL J, V20, P87, DOI 10.1080/00071618500650111; Sanna D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067372; Santamaria L, 2002, ACTA OECOL, V23, P137, DOI 10.1016/S1146-609X(02)01146-3; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; SLATKIN M, 1995, GENETICS, V139, P457; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka N, 2003, J PLANT RES, V116, P273, DOI 10.1007/s10265-003-0090-x; Tay PL, 2002, MAR GEOL, V186, P167, DOI 10.1016/S0025-3227(02)00178-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Triest L, 1991, OPERA BOT BELG, V4; Triest L, 2013, AQUAT BOT, V104, P176, DOI 10.1016/j.aquabot.2011.09.009; Triest L, 2010, AQUAT BOT, V93, P68, DOI 10.1016/j.aquabot.2010.03.007; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; Veith M, 2003, MOL PHYLOGENET EVOL, V26, P310, DOI 10.1016/S1055-7903(02)00324-X; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wissler L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-8; Yu S, 2014, J SYST EVOL, V52, P231, DOI 10.1111/jse.12069; Zhao LC, 2008, J SYST EVOL, V46, P467, DOI 10.3724/SP.J.1002.2008.07070	71	25	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104264	10.1371/journal.pone.0104264	http://dx.doi.org/10.1371/journal.pone.0104264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100173	gold, Green Published, Green Submitted			2022-12-25	WOS:000339995100057
J	Wang, F; Song, YF; Yin, J; Liu, ZH; Mo, XD; Wang, DG; Gao, LP; Jing, YH				Wang, Fang; Song, Yan-Feng; Yin, Jie; Liu, Zi-Hua; Mo, Xiao-Dan; Wang, De-Gui; Gao, Li-Ping; Jing, Yu-Hong			Spatial Memory Impairment Is Associated with Hippocampal Insulin Signals in Ovariectomized Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; WORKING-MEMORY; BETA; ESTRADIOL; BRAIN; TRANSMISSION; PERFORMANCE; EXPRESSION	Estrogen influences memory formation and insulin sensitivity. Meanwhile, glucose utilization directly affects learning and memory, which are modulated by insulin signals. Therefore, this study investigated whether or not the effect of estrogen on memory is associated with the regulatory effect of this hormone on glucose metabolism. The relative expression of estrogen receptor beta (ER beta) and glucose transporter type 4 (GLUT4) in the hippocampus of rats were evaluated by western blot. Insulin level was assessed by ELISA and quantitative RT-PCR, and spatial memory as tested by the Morris water maze. Glucose utilization in the hippocampus was measured by 2-NBDG uptake analysis. Results showed that ovariectomy impaired the spatial memory of rats. These impairments are similar as the female rats treated with the ER beta antagonist tamoxifen (TAM). Estrogen blockade by ovariectomy or TAM treatment obviously decreased glucose utilization. This phenomenon was accompanied by decreased insulin level and GLUT4 expression in the hippocampus. The female rats were neutralized with hippocampal insulin with insulin antibody, which also impaired memory and local glucose consumption These results indicated that estrogen blockade impaired the spatial memory of the female rats. The mechanisms by which estrogen blockade impaired memory partially contributed to the decline in hippocampal insulin signals, which diminished glucose consumption.	[Wang, Fang; Song, Yan-Feng; Yin, Jie; Liu, Zi-Hua; Mo, Xiao-Dan; Wang, De-Gui; Jing, Yu-Hong] Lanzhou Univ, Sch Basic Med Sci, Inst Anat & Embryol, Lanzhou 730000, Peoples R China; [Gao, Li-Ping] Lanzhou Univ, Sch Basic Med Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China; [Gao, Li-Ping; Jing, Yu-Hong] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Wang, Fang] Maternal & Child Hlth Hosp Gansu Prov, Lanzhou, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Jing, YH (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Inst Anat & Embryol, Lanzhou 730000, Peoples R China.	jingyh@lzu.edu.cn			National Natural Science Foundation of China [30872731, 81370448]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30872731 and No. 81370448) to Yu-Hong Jing. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Azizi-Malekabadi H, 2012, ARQ NEURO-PSIQUIAT, V70, P447, DOI 10.1590/S0004-282X2012000600012; CRAMER JH, 1981, AM J OBSTET GYNECOL, V139, P285, DOI 10.1016/0002-9378(81)90011-9; Davey DA, 2013, WOMENS HEALTH, V9, P279, DOI [10.2217/whe.13.22, 10.2217/WHE.13.22]; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Emmanuel Y, 2013, BRAIN BEHAV, V3, P134, DOI 10.1002/brb3.124; Fester L, 2013, J STEROID BIOCHEM, V138, P455, DOI 10.1016/j.jsbmb.2013.09.004; Foster TC, 2012, HIPPOCAMPUS, V22, P656, DOI 10.1002/hipo.20935; Fox EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3449; Fugger HN, 2000, BRAIN RES, V883, P258, DOI 10.1016/S0006-8993(00)02993-0; Galea LAM, 2001, BEHAV BRAIN RES, V126, P115, DOI 10.1016/S0166-4328(01)00255-8; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Holmes MM, 2002, BEHAV NEUROSCI, V116, P928, DOI 10.1037//0735-7044.116.5.928; Jin G Y, 1989, Sheng Li Ke Xue Jin Zhan, V20, P148; Lu YH, 2012, PHYSIOL BEHAV, V106, P631, DOI 10.1016/j.physbeh.2012.04.019; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McClellan KM, 2006, FRONT NEUROENDOCRIN, V27, P193, DOI 10.1016/j.yfrne.2006.02.002; Mendoza-Garces L, 2011, ANAT REC, V294, P1913, DOI 10.1002/ar.21247; Messier C, 1996, BEHAV BRAIN RES, V75, P1, DOI 10.1016/0166-4328(95)00153-0; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; Newhouse P, 2013, NEUROPSYCHOPHARMACOL, V38, P2632, DOI 10.1038/npp.2013.172; Palmer Jaime L, 2008, J Cancer Surviv, V2, P275, DOI 10.1007/s11764-008-0070-1; Qu N, 2013, INT J NEUROPSYCHOPH, V16, P1071, DOI 10.1017/S1461145712000958; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Touraine P, 2003, ANN MED INTERNE, V154, P103; Vearncombe KJ, 2009, MENOPAUSE, V16, P188, DOI 10.1097/gme.0b013e3181775eb4; Walker CL, 2002, RECENT PROG HORM RES, V57, P277, DOI 10.1210/rp.57.1.277; Wu WW, 2013, J NEUROSCI, V33, P16158, DOI 10.1523/JNEUROSCI.2001-13.2013; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zhao LQ, 2013, J ALZHEIMERS DIS, V37, P403, DOI 10.3233/JAD-122341	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104450	10.1371/journal.pone.0104450	http://dx.doi.org/10.1371/journal.pone.0104450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099767	gold, Green Submitted, Green Published			2022-12-25	WOS:000339995100074
J	Charbonneau, ME; Gonzalez-Hernandez, MJ; Showalter, HD; Donato, NJ; Wobus, CE; O'Riordan, MXD				Charbonneau, Marie-Eve; Gonzalez-Hernandez, Marta J.; Showalter, Hollis D.; Donato, Nicholas J.; Wobus, Christiane E.; O'Riordan, Mary X. D.			Small Molecule Deubiquitinase Inhibitors Promote Macrophage Anti-Infective Capacity	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; NORWALK VIRUS-RNA; LISTERIA-MONOCYTOGENES; UBIQUITIN SYSTEM; UNITED-STATES; ENZYMES; CELLS; REPLICATION; NOROVIRUSES; PROTEASOME	The global spread of anti-microbial resistance requires urgent attention, and diverse alternative strategies have been suggested to address this public health concern. Host-directed immunomodulatory therapies represent one approach that could reduce selection for resistant bacterial strains. Recently, the small molecule deubiquitinase inhibitor WP1130 was reported as a potential anti-infective drug against important human food-borne pathogens, notably Listeria monocytogenes and noroviruses. Utilization of WP1130 itself is limited due to poor solubility, but given the potential of this new compound, we initiated an iterative rational design approach to synthesize new derivatives with increased solubility that retained antii-nfective activity. Here, we test a small library of novel synthetic molecules based on the structure of the parent compound, WP1130, for anti-infective activity in vitro. Our studies identify a promising candidate, compound 9, which reduced intracellular growth of L. monocytogenes at concentrations that caused minimal cellular toxicity. Compound 9 itself had no bactericidal activity and only modestly slowed Listeria growth rate in liquid broth culture, suggesting that this drug acts as an anti-infective compound by modulating host-cell function. Moreover, this new compound also showed anti-infective activity against murine norovirus (MNV-1(and human norovirus, using the Norwalk virus replicon system. This small molecule inhibitor may provide a chemical platform for further development of therapeutic deubiquitinase inhibitors with broad-spectrum anti-infective activity.	[Charbonneau, Marie-Eve; Gonzalez-Hernandez, Marta J.; Wobus, Christiane E.; O'Riordan, Mary X. D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Donato, Nicholas J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Showalter, Hollis D.] Univ Michigan, Coll Pharm, Dept Med Chem, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	O'Riordan, MXD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	oriordan@umich.edu		Wobus, Christiane/0000-0001-5286-0924; O'Riordan, Mary/0000-0001-6014-4637	National Institutes of Health [1 R21 AI 102106]; Leukemia Lymphoma Society; University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund; University of Michigan Institute for Clinical and Health Research MICHR [U024225]; Fond de recherche sante Quebec [27881]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund; University of Michigan Institute for Clinical and Health Research MICHR; Fond de recherche sante Quebec; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by National Institutes of Health grant 1 R21 AI 102106 to M. O. R. and C. E. W. These studies were partially supported by a grant from the Leukemia Lymphoma Society to N. J. D. and H. D. S., the University Of Michigan College Of Pharmacy Ella and Hans Vahlteich Research Fund to H. D. S., and the University of Michigan Institute for Clinical and Health Research MICHR U024225 to N. J. D. and H. D. S. M-E. C. was supported in part by a fellowship from the Fond de recherche sante Quebec (Fellowship #27881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose PG, 2011, NAT MED, V17, P772, DOI 10.1038/nm0711-772; Boucher HW, 2013, CLIN INFECT DIS, V56, P1685, DOI 10.1093/cid/cit152; Burkholder KM, 2011, INFECT IMMUN, V79, P4850, DOI 10.1128/IAI.05456-11; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Gonzalez-Hernandez MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094491; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hancock REW, 2013, CURR OPIN MICROBIOL, V16, P519, DOI 10.1016/j.mib.2013.08.004; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Mostowy S, 2012, ADV IMMUNOL, V113, P19, DOI 10.1016/B978-0-12-394590-7.00007-5; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nijnik A, 2013, CURR OPIN MICROBIOL, V16, P590, DOI 10.1016/j.mib.2013.06.011; Perry JW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002783; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Pham LV, 2010, MOL CANCER THER, V9, P2026, DOI 10.1158/1535-7163.MCT-10-0238; Randow F, 2012, TRENDS IMMUNOL, V33, P475, DOI 10.1016/j.it.2012.06.003; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rytkonen A, 2007, CELL HOST MICROBE, V1, P13, DOI 10.1016/j.chom.2007.02.003; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	39	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104096	10.1371/journal.pone.0104096	http://dx.doi.org/10.1371/journal.pone.0104096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093325	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200066
J	Goldsby, HJ; Knoester, DB; Kerr, B; Ofria, C				Goldsby, Heather J.; Knoester, David B.; Kerr, Benjamin; Ofria, Charles			The Effect of Conflicting Pressures on the Evolution of Division of Labor	PLOS ONE			English	Article							GROUP SELECTION CONTROVERSY; ARTIFICIAL SELECTION; SOCIAL-BEHAVIOR; COOPERATION	Within nature, many groups exhibit division of labor. Individuals in these groups are under seemingly antagonistic pressures to perform the task most directly beneficial to themselves and to potentially perform a less desirable task to ensure the success of the group. Performing experiments to study how these pressures interact in an evolutionary context is challenging with organic systems because of long generation times and difficulties related to group propagation and fine-grained control of within-group and between-group pressures. Here, we use groups of digital organisms (i.e., self-replicating computer programs) to explore how populations respond to antagonistic multilevel selection pressures. Specifically, we impose a within-group pressure to perform a highly-rewarded role and a between-group pressure to perform a diverse suite of roles. Thus, individuals specializing on highly-rewarded roles will have a within-group advantage, but groups of such specialists have a between-group disadvantage. We find that digital groups could evolve to be either single-lineage or multi-lineage, depending on experimental parameters. These group compositions are reminiscent of different kinds of major evolutionary transitions that occur within nature, where either relatives divide labor (fraternal transitions) or multiple different organisms coordinate activities to form a higher-level individual (egalitarian transitions). Regardless of group composition, organisms embraced phenotypic plasticity as a means for genetically similar individuals to perform different roles. Additionally, in multi-lineage groups, organisms from lineages performing highly-rewarded roles also employed reproductive restraint to ensure successful coexistence with organisms from other lineages.	[Goldsby, Heather J.; Kerr, Benjamin] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Knoester, David B.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Ofria, Charles] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA; [Goldsby, Heather J.; Knoester, David B.; Kerr, Benjamin; Ofria, Charles] Michigan State Univ, BEACON Ctr Evolut Act, E Lansing, MI 48824 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University; Michigan State University	Goldsby, HJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	goldsby@uw.edu		Ofria, Charles/0000-0003-2924-1732	BEACON Center for the Study of Evolution in Action (NSF) [DBI-0939454]; NSF [DEB0952825, OCI-1122620, OCI-1122617, CCF-0643952, CCF-0820220]; Office of Advanced Cyberinfrastructure (OAC) [1122620] Funding Source: National Science Foundation	BEACON Center for the Study of Evolution in Action (NSF); NSF(National Science Foundation (NSF)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454), an NSF CAREER award to B. K. (DEB0952825), NSF FELLOWSHIP award to H. G (OCI-1122620) and D. K (OCI-1122617), and NSF Grants (CCF-0643952, CCF-0820220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, SOVIET PHYS DOKLADY; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Buss L., 1987, EVOLUTION INDIVIDUAL; Clune J, 2011, P ROY SOC B-BIOL SCI, V278, P666, DOI 10.1098/rspb.2010.1557; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Darwin C., 1859, ORIGIN SPECIES MEANS; Duffy JE, 2003, GENES BEHAV EVOLUTIO; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Gintis H., 2005, MORAL SENTIMENTS MAT; Goings S, 2004, ARTIFICIAL LIFE IX, P303; Goldsby HJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001858; Goldsby HJ, 2012, P NATL ACAD SCI USA, V109, P13686, DOI 10.1073/pnas.1202233109; Goldsby HJ, 2012, ARTIF LIFE, V13, P178, DOI DOI 10.7551/978-0-262-31050-5-ch025; Goodnight CJ, 1997, AM NAT, V150, pS59, DOI 10.1086/286050; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hamilton WD, 1963, AM NATURALIST, V97; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Johnson AE, 2014, P GEN EV COMP C GECC; Johnson AE, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P120, DOI 10.7551/978-0-262-32621-6-ch020; Kerr B, 2011, MAJOR TRANSITIONS RE; Knoester DB, 2011, ARTIF LIFE, V17, P1, DOI 10.1162/artl_a_00014; Knoester DB, 2009, INT CONF SELF SELF, P223, DOI 10.1109/SASO.2009.29; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; McKinley PK, 2008, IEEE COMPUTER, V41; Ofria C, 2004, ARTIF LIFE, V10, P191, DOI 10.1162/106454604773563612; Ofria C, 2002, IEEE T EVOLUT COMPUT, V6, P420, DOI 10.1109/TEVC.2002.802442; Ofria C, 1999, P DIMACS WORKSH EV C; Okasha S, 2001, BRIT J PHILOS SCI, V52, P25, DOI 10.1093/bjps/52.1.25; Penn A, 2004, Artificial Life IX, P352; Penn A, 2003, LECT NOTES ARTIF INT, V2801, P659; Queller DC, 2003, CURR BIOL, V13, pR861, DOI 10.1016/j.cub.2003.10.043; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Queller DC., 1997, Q REV BIOL, V72, P184, DOI [10.1086/419766, DOI 10.1086/419766]; Smith Adam, 1976, WEALTH NATIONS; Smith J. M., 1997, MAJOR TRANSITIONS EV; Sober E., 1998, OTHERS EVOLUTION PSY; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; Swenson W, 2000, ENVIRON MICROBIOL, V2, P564, DOI 10.1046/j.1462-2920.2000.00140.x; Swenson W, 2000, P NATL ACAD SCI USA, V97, P9110, DOI 10.1073/pnas.150237597; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; WADE MJ, 1980, ECOLOGY, V61, P1056, DOI 10.2307/1936824; WADE MJ, 1977, EVOLUTION, V31, P134, DOI 10.1111/j.1558-5646.1977.tb00991.x; Williams HTP, 2007, P NATL ACAD SCI USA, V104, P8918, DOI 10.1073/pnas.0610038104; WILSON DS, 1983, ANNU REV ECOL SYST, V14, P159, DOI 10.1146/annurev.es.14.110183.001111; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520	48	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102713	10.1371/journal.pone.0102713	http://dx.doi.org/10.1371/journal.pone.0102713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093399	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200013
J	Sang, A; Zheng, YY; Yin, YM; Dozmorov, I; Li, H; Hsu, HC; Mountz, JD; Morel, L				Sang, Allison; Zheng, Ying-Yi; Yin, Yiming; Dozmorov, Igor; Li, Hao; Hsu, Hui-Chen; Mountz, John D.; Morel, Laurence			Dysregulated Cytokine Production by Dendritic Cells Modulates B Cell Responses in the NZM2410 Mouse Model of Lupus	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; I INTERFERON; AUTOIMMUNE-DISEASE; TISSUE-DAMAGE; ERYTHEMATOSUS; ACTIVATION; MICE; DIFFERENTIATION; IL-6; INTERLEUKIN-6	The breakdown in tolerance of autoreactive B cells in the lupus-prone NZM2410-derived B6.Sle1.Sle2.Sle3 (TC) mice results in the secretion of autoantibodies. TC dendritic cells (DCs) enhance B cell proliferation and antibody secretion in a cytokine-dependent manner. However, the specific cytokine milieu by which TC DCs activate B cells was not known. In this study, we compared TC and C57BL/6 (B6) control for the distribution of DC subsets and for their production of cytokines affecting B cell responses. We show that TC DCs enhanced B cell proliferation through the production of IL-6 and IFN-gamma, while antibody secretion was only dependent on IL-6. Pre-disease TC mice showed an expanded PDCA1(+) cells prior to disease onset that was localized to the marginal zone and further expanded with age. The presence of PDCA1(+) cells in the marginal zone correlated with a Type I Interferon (IFN) signature in marginal zone B cells, and this response was higher in TC than B6 mice. In vivo administration of anti-chromatin immune complexes upregulated IL-6 and IFN-gamma production by splenic DCs from TC but not B6 mice. The production of BAFF and APRIL was decreased upon TC DC stimulation both in vitro and in vivo, indicating that these B cell survival factors do not play a role in B cell modulation by TC DCs. Finally, TC B cells were defective at downregulating IL-6 expression in response to anti-inflammatory apoptotic cell exposure. Overall, these results show that the TC autoimmune genetic background induces the production of B cell-modulating inflammatory cytokines by DCs, which are regulated by the microenvironment as well as the interplay between DC.	[Sang, Allison; Zheng, Ying-Yi; Yin, Yiming; Morel, Laurence] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Dozmorov, Igor] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Hao; Hsu, Hui-Chen; Mountz, John D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham	Morel, L (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	morel@ufl.edu	Li, Hao/N-7406-2015	Li, Hao/0000-0002-2171-8826	VA Merit Review Grant [1I01BX000600-01]; National Institutes of Health/National Institute of Allergy and Infectious Diseases [1AI 071110]; Rheumatology Education Foundation; NIH/NIAID [1RO1AI083705]; Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074491, R01AI083705, R01AI071110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	VA Merit Review Grant(US Department of Veterans Affairs); National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rheumatology Education Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lupus Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	JDM is supported by VA Merit Review Grant (1I01BX000600-01), National Institutes of Health/National Institute of Allergy and Infectious Diseases (1AI 071110), and Rheumatology Education Foundation. HCH is supported by NIH/NIAID (1RO1AI083705) and Lupus Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Cuda CM, 2012, J IMMUNOL, V188, P604, DOI 10.4049/jimmunol.1002362; Dubois B, 1998, J IMMUNOL, V161, P2223; Elkon KB, 2012, CURR OPIN RHEUMATOL, V24, P499, DOI 10.1097/BOR.0b013e3283562c3e; Esposito P, 2009, LUPUS, V18, P1329, DOI 10.1177/0961203309106183; FINCK BK, 1994, J CLIN INVEST, V94, P585, DOI 10.1172/JCI117373; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gerl V, 2010, ANN RHEUM DIS, V69, P1370, DOI 10.1136/ard.2009.111021; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hirano T, 1989, Prog Growth Factor Res, V1, P133, DOI 10.1016/0955-2235(89)90007-0; Hofmann SR, 2012, CLIN IMMUNOL, V143, P116, DOI 10.1016/j.clim.2012.02.005; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jego Gaetan, 2005, V8, P124; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kaneko T, 2012, J IMMUNOL, V188, P5397, DOI 10.4049/jimmunol.1103210; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kutzner H, 2009, AM J SURG PATHOL, V33, P1307, DOI 10.1097/PAS.0b013e3181a6ae1e; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lantow M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4208; Ling GS, 2011, RHEUMATOLOGY, V50, P1773, DOI 10.1093/rheumatology/ker198; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069547; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mihara M, 1998, CLIN EXP IMMUNOL, V112, P397; Miles K, 2012, P NATL ACAD SCI USA, V109, P887, DOI 10.1073/pnas.1109173109; Mohan C, 1998, J CLIN INVEST, V101, P1362; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Ramanujam M, 2010, ARTHRITIS RHEUM-US, V62, P1457, DOI 10.1002/art.27368; Sakurai D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003870; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Sriram U, 2012, J IMMUNOL, V189, P80, DOI 10.4049/jimmunol.1101686; Teichmann LL, 2013, IMMUNITY, V38, P528, DOI 10.1016/j.immuni.2012.11.017; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Wan SG, 2008, ARTHRITIS RHEUM, V58, P1741, DOI 10.1002/art.23515; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Wang B, 2013, GENE, V519, P209, DOI 10.1016/j.gene.2013.01.026; Wang JH, 2011, ARTHRITIS RHEUM-US, V63, P1054, DOI 10.1002/art.30231; Wang JH, 2010, J IMMUNOL, V184, P442, DOI 10.4049/jimmunol.0900870; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Xu ZW, 2011, J IMMUNOL, V186, P4130, DOI 10.4049/jimmunol.1003512	61	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102151	10.1371/journal.pone.0102151	http://dx.doi.org/10.1371/journal.pone.0102151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093822	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200009
J	Guillaud-Bataille, M; Ragazzon, B; de Reynies, A; Chevalier, C; Francillard, I; Barreau, O; Steunou, V; Guillemot, J; Tissier, F; Rizk-Rabin, M; Rene-Corail, F; Al Ghuzlan, A; Assie, G; Bertagna, X; Baudin, E; Le Bouc, Y; Bertherat, J; Clauser, E				Guillaud-Bataille, Marine; Ragazzon, Bruno; de Reynies, Aurelien; Chevalier, Claire; Francillard, Isabelle; Barreau, Olivia; Steunou, Virginie; Guillemot, Johann; Tissier, Frederique; Rizk-Rabin, Marthe; Rene-Corail, Fernande; Al Ghuzlan, Abir; Assie, Guillaume; Bertagna, Xavier; Baudin, Eric; Le Bouc, Yves; Bertherat, Jerome; Clauser, Eric			IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma	PLOS ONE			English	Article							FACTOR-II GENE; MESSENGER-RNA; FACTOR SYSTEM; LARGE COHORT; INSULIN; TUMORS; EXPRESSION; TUMORIGENESIS; MALIGNANCY; RECEPTOR	Insulin-like growth factor 2 (IGF2) overexpression is an important molecular marker of adrenocortical carcinoma (ACC), which is a rare but devastating endocrine cancer. It is not clear whether IGF2 overexpression modifies the biology and growth of this cancer, thus more studies are required before IGF2 can be considered as a major therapeutic target. We compared the phenotypical, clinical, biological, and molecular characteristics of ACC with or without the overexpression of IGF2, to address these issues. We also carried out a similar analysis in an ACC cell line (H295R) in which IGF2 expression was knocked down with si-or shRNA. We found no significant differences in the clinical, biological and molecular (transcriptomic) traits between IGF2-high and IGF2-low ACC. The absence of IGF2 overexpression had little influence on the activation of tyrosine kinase pathways both in tumors and in H295 cells that express low levels of IGF2. In IGF2-low tumors, other growth factors (FGF9, PDGFA) are more expressed than in IGF2-high tumors, suggesting that they play a compensatory role in tumor progression. In addition, IGF2 knock-down in H295R cells substantially impaired growth (>50% inhibition), blocked cells in G1 phase, and promoted apoptosis (>2-fold). Finally, analysis of the 11p15 locus showed a paternal uniparental disomy in both IGF2-high and IGF2-low tumors, but low IGF2 expression could be explained in most IGF2-low ACC by an additional epigenetic modification at the 11p15 locus. Altogether, these observations confirm the active role of IGF2 in adrenocortical tumor growth, but also suggest that other growth promoting pathways may be involved in a subset of ACC with low IGF2 expression, which creates opportunities for the use of other targeted therapies.	[Guillaud-Bataille, Marine; Chevalier, Claire; Francillard, Isabelle; Guillemot, Johann; Clauser, Eric] Univ Paris 05, Paris Cardiovasc Ctr, Inst Natl Sante & Rech Med U970, Paris, France; [Guillaud-Bataille, Marine; Francillard, Isabelle; Clauser, Eric] Hop Cochin, AP HP, Dept Biol Hormonale, F-75674 Paris, France; [Ragazzon, Bruno; Barreau, Olivia; Tissier, Frederique; Rizk-Rabin, Marthe; Rene-Corail, Fernande; Assie, Guillaume; Bertagna, Xavier; Bertherat, Jerome] Univ Paris 05, Inst Cochin, Inst Natl Sante & Rech Med U1016, Ctr Natl Rech Scientif UMR8104, Paris, France; [de Reynies, Aurelien] Ligue Natl Ctr, Programme Cartes Identite Tumeurs, Paris, France; [Barreau, Olivia; Assie, Guillaume; Bertagna, Xavier; Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, F-75674 Paris, France; [Steunou, Virginie; Le Bouc, Yves] Univ Paris 06, Inst Natl Sante & Rech Med U938, Paris, France; [Steunou, Virginie; Le Bouc, Yves] Hop Armand Trousseau, AP HP, Lab Explorat Fonct Endocrinienn, Paris, France; [Tissier, Frederique] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Anat Pathol, Paris, France; [Al Ghuzlan, Abir] Inst Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France; [Baudin, Eric] Inst Gustave Roussy, Dept Imagerie Med, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Clauser, E (corresponding author), Univ Paris 05, Paris Cardiovasc Ctr, Inst Natl Sante & Rech Med U970, Paris, France.	eric.clauser@inserm.fr	Ragazzon, Bruno/E-6541-2017; de Reyniès, Aurélien/Q-8640-2017; Guillemot, Johann/O-1066-2013; Rizk-Rabin, Marthe/A-1698-2018	Ragazzon, Bruno/0000-0001-9476-4973; de Reyniès, Aurélien/0000-0002-1328-5290; Guillemot, Johann/0000-0002-5902-9188; Al Ghuzlan, Abir/0000-0001-5198-6111; chevalier, claire/0000-0003-0902-0756; BERTHERAT, Jerome/0000-0003-2551-3008; Rizk-Rabin, Marthe/0000-0003-1558-737X; Assie, Guillaume/0000-0001-9590-0906	INSERM; Assistance Publique Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Assistance Publique Hopitaux de Paris	INSERM; Assistance Publique Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065; Azzi S, 2011, HUM MUTAT, V32, P249, DOI 10.1002/humu.21403; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Barlaskar FM, 2009, J CLIN ENDOCR METAB, V94, P204, DOI 10.1210/jc.2008-1456; Boulle N, 1998, J CLIN ENDOCR METAB, V83, P1713, DOI 10.1210/jc.83.5.1713; Callan AC, 2009, CANCER CAUSE CONTROL, V20, P1783, DOI 10.1007/s10552-009-9378-z; CARIANI E, 1988, CANCER RES, V48, P6844; Cerquetti L, 2008, ENDOCR-RELAT CANCER, V15, P623, DOI 10.1677/erc.1.1315; de Fraipont F, 2005, J CLIN ENDOCR METAB, V90, P1819, DOI 10.1210/jc.2004-1075; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Drelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044171; Edgren M, 1997, ANTICANCER RES, V17, P1303; ELBADRY OM, 1989, J CLIN INVEST, V84, P829, DOI 10.1172/JCI114243; Else T, 2013, ENDOCRINE REV; Fassnacht M, 2005, J CLIN ENDOCR METAB, V90, P4366, DOI 10.1210/jc.2004-2198; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Gicquel C, 1997, HORM RES, V47, P269, DOI 10.1159/000185475; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; Gicquel C, 1997, J CLIN ENDOCR METAB, V82, P2559, DOI 10.1210/jc.82.8.2559; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2003, ENDOCR PATHOL, V14, P107, DOI 10.1385/EP:14:2:107; GOURMELEN M, 1994, NUCL MED BIOL, V21, P297, DOI 10.1016/0969-8051(94)90053-1; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Haluska P, 2010, CANCER CHEMOTH PHARM, V65, P765, DOI 10.1007/s00280-009-1083-9; Harris LK, 2012, GROWTH FACTORS, V30, P1, DOI 10.3109/08977194.2011.640325; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; KAMIO T, 1991, AM J PATHOL, V138, P83; Kaneda A, 2007, P NATL ACAD SCI USA, V104, P20926, DOI 10.1073/pnas.0710359105; Leboulleux S, 2001, EUR J ENDOCRINOL, V144, P163, DOI 10.1530/eje.0.1440163; Libe R, 2007, CLIN CANCER RES, V13, P844, DOI 10.1158/1078-0432.CCR-06-2085; Logie A, 1999, J MOL ENDOCRINOL, V23, P23, DOI 10.1677/jme.0.0230023; LUTON JP, 1990, NEW ENGL J MED, V322, P1195, DOI 10.1056/NEJM199004263221705; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ribeiro TC, 2012, MOL CELL ENDOCRINOL, V351, P96, DOI 10.1016/j.mce.2011.09.042; Shen Wen, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P88; TRICOLI JV, 1986, CANCER RES, V46, P6169; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Weber MM, 1997, EUR J ENDOCRINOL, V136, P296, DOI 10.1530/eje.0.1360296; Weber MM, 2000, EUR J CLIN INVEST, V30, P69, DOI 10.1046/j.1365-2362.2000.0300s3069.x; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; West AN, 2007, CANCER RES, V67, P600, DOI 10.1158/0008-5472.CAN-06-3767; ZHAN SL, 1994, J CLIN INVEST, V94, P445, DOI 10.1172/JCI117344	46	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103744	10.1371/journal.pone.0103744	http://dx.doi.org/10.1371/journal.pone.0103744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089899	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700048
J	Kienapfel, K; Link, Y; van Borstel, UK				Kienapfel, Kathrin; Link, Yvonne; van Borstel, Uta Konig			Prevalence of Different Head-Neck Positions in Horses Shown at Dressage Competitions and Their Relation to Conflict Behaviour and Performance Marks	PLOS ONE			English	Article							TEMPERATURE; VARIABILITY	Much controversy exists among riders, and in particular among those practicing dressage, regarding what can be considered an "appropriate" Head-Neck-Position (HNP). The objective was to assess the prevalence of different HNPs in the field, the behavioural reactions of horses during warm-up and competition rides in relation to HNP and the relation between HNP and marks achieved in the competition. Horses (n = 171) were selected during dressage competitions according to their HNP (3 categories based on the degree of flexion), and their behaviour was recorded during 3 minutes each of riding in the warm-up area and in the competition. Scans were carried out on an additional 355 horses every 15 minutes to determine the proportion of each HNP in the warm-up area. Sixty-nine percent of the 355 horses were ridden with their nasal planes behind the vertical in the warm-up area, 19% were ridden at or behind the vertical and only 12% were ridden with their nasal plane in front of the vertical. Horses carrying their nasal plane behind the vertical exhibited significantly (P<0.0001) more conflict behaviours than horses with their nose held in front of the vertical. Horses were commonly presented with a less flexed HNP during competition compared to warm-up (P<0.05). A HNP behind the vertical was penalised with lower marks in the lower (P = 0.0434) but not in the higher (P = 0.9629) competition levels. Horses in higher classes showed more (P = 0.0015) conflict behaviour than those in lower classes. In conclusion, dressage horses are commonly ridden during warm-up for competitions with their nasal plane behind the vertical, and this posture seems to cause significantly more conflict behaviour than HNPs in front of the vertical.	[Kienapfel, Kathrin] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Link, Yvonne] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [van Borstel, Uta Konig] Univ Gottingen, Dept Anim Breeding & Genet, D-37073 Gottingen, Germany	Ruhr University Bochum; University of Kiel; University of Gottingen	Kienapfel, K (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, Bochum, Germany.	Kathrin.Kienapfel@rub.de	von Borstel, Uta U. König/H-6747-2012	Konig von Borstel, Uta/0000-0002-7313-1197	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker-Birck M, 2013, J ANIM PHYSIOL AN N, V97, P322, DOI 10.1111/j.1439-0396.2012.01274.x; Caanitz H, 1996, THESIS TIERARZDICHE; Cavendish William, 1667, NEW METHOD EXTRAORDI; Doherty O, 2013, 9 INT EQ SCI C P NEW, P38; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Hawson LA, 2010, J VET BEHAV, V5, P170, DOI 10.1016/j.jveb.2009.12.010; HDV, 1937, HEER; Hutchings K, 2013, 9 INT EQ SCI C P NEW, P79; Kienapfel K, 2014, J ANIMAL PH IN PRESS, P10; Kienapfel K, 2011, PFERDEHEILKUNDE, V27, P372, DOI 10.21836/PEM20110402; Kienapfel K, 2010, PFERDEHEILKUNDE, V26, P178, DOI 10.21836/PEM20100210; Konig von Borstel U, 2011, P 7 INT EQ SCI C 26, P75; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Ludewig AK, 2011, P 7 INT EQ SCI C HOO; MCDONNELL SM, 1990, APPL ANIM BEHAV SCI, V27, P1, DOI 10.1016/0168-1591(90)90002-U; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; McGreevy P, 2012, J VET BEHAV, V7, P142, DOI 10.1016/j.jveb.2011.08.001; McGreevy PD, 2010, J VET BEHAV, V5, P180, DOI 10.1016/j.jveb.2010.03.004; McGrogan C, 2008, APPL ANIM BEHAV SCI, V113, P206, DOI 10.1016/j.applanim.2007.10.006; McLean AN, 2010, J VET BEHAV, V5, P187, DOI 10.1016/j.jveb.2010.04.002; Murray R. C., 2006, Equine and Comparative Exercise Physiology, V3, P185, DOI 10.1017/S1478061506339242; Pfeil-Rotermund S, 1994, KTBL SCHRIFT 281 ARB, P231; Plewa D., 2006, Pferdeheilkunde, V22, P700; van Dierendonck M, 2012, 8 INT EQ SCI C ED, P62; von Borstel UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087285; von Borstel UK, 2012, APPL ANIM BEHAV SCI, V139, P251, DOI 10.1016/j.applanim.2012.04.007; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Waldern NM, 2009, EQUINE VET J, V41, P268, DOI 10.2746/042516409X397389; Weishaupt M A, 2006, Equine Vet J Suppl, P387; Wijnberg ID, 2010, EQUINE VET J, V42, P261, DOI 10.1111/j.2042-3306.2010.00224.x; Zeitler-Feicht M., 2008, HDB PFERDEVERHALTEN	31	24	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103140	10.1371/journal.pone.0103140	http://dx.doi.org/10.1371/journal.pone.0103140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090242	gold, Green Published			2022-12-25	WOS:000339812700018
J	Kissick, HT; Dunn, LK; Ghosh, S; Nechama, M; Kobzik, L; Arredouani, MS				Kissick, Haydn T.; Dunn, Laura K.; Ghosh, Sanjukta; Nechama, Morris; Kobzik, Lester; Arredouani, Mohamed S.			The Scavenger Receptor MARCO Modulates TLR-Induced Responses in Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SR-AI/II; T-CELLS; IMMUNOSUPPRESSION; INTERLEUKIN-12; MACROPHAGES; ACTIVATION; EXPRESSION; PARTICLES; PROGRAM	The scavenger receptor MARCO mediates macrophage recognition and clearance of pathogens and their polyanionic ligands. However, recent studies demonstrate MARCO expression and function in dendritic cells, suggesting MARCO might serve to bridge innate and adaptive immunity. To gain additional insight into the role of MARCO in dendritic cell activation and function, we profiled transcriptomes of mouse splenic dendritic cells obtained from MARCO deficient mice and their wild type counterparts under resting and activating conditions. In silico analysis uncovered major alterations in gene expression in MARCO deficient dendritic cells resulting in dramatic alterations in key dendritic cell-specific pathways and functions. Specifically, changes in CD209, FCGR4 and Complement factors can have major consequences on DC-mediated innate responses. Notably, these perturbations were magnified following activation with the TLR-4 agonist lipopolysaccharide. To validate our in silico data, we challenged DC's with various agonists that recognize all mouse TLRs and assessed expression of a set of immune and inflammatory marker genes. This approach identified a differential contribution of MARCO to TLR activation and validated a major role for MARCO in mounting an inflammatory response. Together, our data demonstrate that MARCO differentially affects TLR-induced DC activation and suggest targeting of MARCO could lead to different outcomes that depend on the inflammatory context encountered by DC.	[Kissick, Haydn T.; Dunn, Laura K.; Arredouani, Mohamed S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Sch Med, Boston, MA 02215 USA; [Ghosh, Sanjukta; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Nechama, Morris] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Kobzik, Lester] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Arredouani, MS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Sch Med, Boston, MA 02215 USA.	marredou@bidmc.harvard.edu	Kissick, Haydn/AAS-6292-2021	Kissick, Haydn/0000-0001-7624-5598	Prostate Cancer Foundation; Department of Defense Prostate Cancer Research Program [W81XWH-09-1-0448]	Prostate Cancer Foundation; Department of Defense Prostate Cancer Research Program(United States Department of Defense)	This work was supported by the Prostate Cancer Foundation Young Investigator Award (M.S. Arredouani) and the Department of Defense Prostate Cancer Research Program New Investigator Award W81XWH-09-1-0448 (M. S. Arredouani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amiel E, 2009, J LEUKOCYTE BIOL, V85, P595, DOI 10.1189/jlb.1008631; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912; Arredouani MS, 2004, CELL MOL BIOL, V50, P657; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Czerkies M, 2013, IMMUNOBIOLOGY, V218, P1217, DOI 10.1016/j.imbio.2013.04.005; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Grolleau A, 2003, J IMMUNOL, V171, P2879, DOI 10.4049/jimmunol.171.6.2879; Haram KM, 2008, PROSTATE, V68, P1517, DOI 10.1002/pros.20803; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kobie JJ, 2003, CANCER RES, V63, P1860; Komine H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067795; Matsushita N, 2010, CANCER IMMUNOL IMMUN, V59, P875, DOI 10.1007/s00262-009-0813-5; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Saas P, 2012, CRIT REV IMMUNOL, V32, P529, DOI 10.1615/CritRevImmunol.2013005868; Shen ZH, 1997, J IMMUNOL, V158, P2723; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wojtowicz-Praga S, 2003, INVEST NEW DRUG, V21, P21, DOI 10.1023/A:1022951824806	37	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104148	10.1371/journal.pone.0104148	http://dx.doi.org/10.1371/journal.pone.0104148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089703	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700101
J	Modi, KK; Jana, A; Ghosh, S; Watson, R; Pahan, K				Modi, Khushbu K.; Jana, Arundhati; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; RESPONSE ELEMENT-BINDING; KAPPA-B ACTIVATION; NEURODEGENERATIVE DISORDERS; MOUSE MODEL; IN-VITRO; INHIBITION; KINASE; GLYCOGEN-SYNTHASE-KINASE-3; HYPERPHOSPHORYLATION	Alzheimer's disease (AD), the leading cause of dementia in the aging population, is characterized by the presence of neuritic plaques, neurofibrillary tangles and extensive neuronal apoptosis. Neuritic plaques are mainly composed of aggregates of amyloid-beta (A beta) protein while neurofibrillary tangles are composed of the hyperphosphorylated tau protein. Despite intense investigations, no effective therapy is currently available to halt the progression of this disease. Here, we have undertaken a novel approach to attenuate apoptosis and tau phosphorylation in cultured neuronal cells and in a transgenic animal model of AD. RNS60 is a 0.9% saline solution containing oxygenated nanobubbles that is generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. In our experiments, fibrillar A beta 1-42, but not the reverse peptide A beta 42-1, induced apoptosis and cell death in human SHSY5Y neuronal cells. RNS60, but not NS (normal saline), RNS10.3 (TCP-modified saline without excess oxygen) or PNS60 (saline containing excess oxygen without TCP modification), attenuated A beta(1-42)-induced cell death. RNS60 inhibited neuronal cell death via activation of the type 1A phosphatidylinositol-3 (PI-3) kinase - Akt - BAD pathway. Furthermore, RNS60 also decreased A beta(1-42)-induced tau phosphorylation via (PI-3 kinase - Akt)-mediated inhibition of GSK-3 beta. Similarly, RNS60 treatment suppressed neuronal apoptosis, attenuated Tau phosphorylation, inhibited glial activation, and reduced the burden of Ab in the hippocampus and protected memory and learning in 5XFAD transgenic mouse model of AD. Therefore, RNS60 may be a promising pharmaceutical candidate in halting or delaying the progression of AD.	[Modi, Khushbu K.; Jana, Arundhati; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			Revalesio Corporation	Revalesio Corporation	This work was supported by the Revalesio Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Citron M, 2000, MOL MED TODAY, V6, P392, DOI 10.1016/S1357-4310(00)01759-7; Corbett GT, 2013, J BIOL CHEM, V288, P8299, DOI 10.1074/jbc.M112.426536; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Franke TF, 1997, NATURE, V390, P116, DOI 10.1038/36442; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Goedert M, 1998, PROG BRAIN RES, V117, P287; Hernandez F, 2013, J ALZHEIMERS DIS; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Johansson S, 2006, NEUROREPORT, V17, P907, DOI 10.1097/01.wnr.0000221844.35502.29; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Khasnavis S, 2013, J NEUROIMMUNE PHARM; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lee CWC, 2003, NEUROREPORT, V14, P257, DOI 10.1097/00001756-200302100-00020; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li X, 2006, J NEURAL TRANSM, V113, P93, DOI 10.1007/s00702-005-0303-7; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Mondal S., 2012, PLOS ONE, V7; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Noh MY, 2009, J NEUROCHEM, V108, P1116, DOI 10.1111/j.1471-4159.2008.05837.x; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Prut L, 2007, BEHAV BRAIN RES, V179, P107, DOI 10.1016/j.bbr.2007.01.017; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	45	45	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103606	10.1371/journal.pone.0103606	http://dx.doi.org/10.1371/journal.pone.0103606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089827	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700036
J	Willis, CM; Kluppel, M				Willis, Catherine M.; Klueppel, Michael			Chondroitin Sulfate-E Is a Negative Regulator of a Pro-Tumorigenic Wnt/Beta-Catenin-Collagen 1 Axis in Breast Cancer Cells	PLOS ONE			English	Article							STAGE PROSTATE-CANCER; COSTELLO SYNDROME; CARCINOMA CELLS; GLYCOSAMINOGLYCANS; DISEASE; GROWTH; CHONDROITIN-4-SULFOTRANSFERASE-1; MORPHOGENESIS; PROGRESSION; INDUCTION	Expression of the glycosaminoglycan chondroitin sulfate-E (CS-E) is misregulated in many human cancers, including breast cancer. Cell-surface associated CS-E has been shown to have pro-tumorigenic functions, and pharmacological treatment with exogenous CS-E has been proposed to interfere with tumor progression mediated by endogenous CS-E. However, the effects of exogenous CS-E on breast cancer cell behavior, and the molecular mechanisms deployed by CS-E are not well understood. We show here that treatment with CS-E, but not other chondroitin forms, could interfere with the invasive protrusion formation and migration of breast cancer cells in three-dimensional organotypic cultures. Microarray analysis identified transcriptional programs controlled by CS-E in these cells. Importantly, negative regulation of the pro-metastatic extracellular matrix gene Col1a1 was required for the anti-migratory effects of exogenous CS-E. Knock-down of Col1a1 gene expression mimics the effects of CS-E treatment, while exposing cells to a preformed collagen I matrix interfered with the anti-migratory effects of CS-E. In addition, CS-E specifically interfered with Wnt/beta-catenin signaling, a known pro-tumorigenic pathway. Lastly, we demonstrate that Col1a1 is a positively regulated target gene of the Wnt/beta-catenin pathway in breast cancer cells. Together, our data identify treatment with exogenous CS-E as negative regulatory mechanism of breast cancer cell motility through interference with a pro-tumorigenic Wnt/beta-catenin - Collagen I axis.	[Willis, Catherine M.; Klueppel, Michael] Stanley Manne Childrens Res Inst, Chicago, IL 60614 USA; [Willis, Catherine M.; Klueppel, Michael] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Pediat, Chicago, IL 60611 USA; [Klueppel, Michael] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kluppel, M (corresponding author), Stanley Manne Childrens Res Inst, Chicago, IL 60614 USA.	m-kluppel@northwestern.edu			US Department of Defense Breast Cancer Program [BC097232]; Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	US Department of Defense Breast Cancer Program(United States Department of Defense); Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	This study was supported by 1) US Department of Defense Breast Cancer Program (Grant #BC097232) http://cdmrp.army.mil/bcrp/ 2) Internal grants from Ann and Robert H. Lurie Children's Hospital of Chicago Research Center http://www.luriechildrensresearch.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALINI M, 1991, CANCER RES, V51, P1443; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Brown AMC, 2001, BREAST CANCER RES, V3, P351, DOI 10.1186/bcr321; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Kalathas D, 2009, ONCOL REP, V22, P369, DOI 10.3892/or_00000447; Karangelis DE, 2010, CURR MED CHEM, V17, P4018; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kluppel M, 2012, EUR J HUM GENET, V20, P870, DOI 10.1038/ejhg.2012.12; Kluppel M, 2011, MOL CELL BIOCHEM, V351, P1, DOI 10.1007/s11010-010-0705-1; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OLSEN EB, 1988, ACTA OBSTET GYN SCAN, V67, P539, DOI 10.3109/00016348809029866; Pothacharoen P, 2006, J BIOCHEM, V140, P517, DOI 10.1093/jb/mvj181; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Prinz RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092381; Ramaswamy S, 2003, LANCET, V361, P1576, DOI 10.1016/S0140-6736(03)13322-3; Ricciardelli C, 1997, CLIN CANCER RES, V3, P983; Ricciardelli C, 1999, CANCER RES, V59, P2324; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673; Willis CM, 2012, J BIOL CHEM, V287, P37042, DOI 10.1074/jbc.M112.391490; Zeltz C, 2013, BIOCH BIOPHYS ACTA	44	38	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103966	10.1371/journal.pone.0103966	http://dx.doi.org/10.1371/journal.pone.0103966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090092	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700072
J	Xu, G; Chen, J; Pan, QS; Huang, KT; Pan, JY; Zhang, WH; Chen, J; Yu, FY; Zhou, TL; Wang, YM				Xu, Gang; Chen, Jie; Pan, Qinshi; Huang, Keta; Pan, Jingye; Zhang, Wenhui; Chen, Jian; Yu, Fangyou; Zhou, Tieli; Wang, Yumin			Long Noncoding RNA Expression Profiles of Lung Adenocarcinoma Ascertained by Microarray Analysis	PLOS ONE			English	Article							PROSTATE-CANCER; GENE; METASTASIS; EVOLUTION; SURVIVAL; DATABASE; NSCLC; STATE; CELLS	Background: Long noncoding RNAs (lncRNAs) have been shown to be involved in the development and progression of lung cancer. However, the roles of lncRNAs in lung cancer are not well understood. Methodology/Principal Findings: We used a high-throughput microarray to compare the lncRNA and messenger RNA (mRNA) expression profiles in lung adenocarcinoma and normal tissue (NT) samples. Several candidate adenocarcinoma-associated lncRNAs were verified by real-time quantitative reverse transcription polymerase chain reaction (PCR) analysis. Using abundant and varied probes, we were able to assess 30,586 lncRNAs and 26,109 mRNAs in our microarray. We found that 2,420 lncRNAs and 1,109 mRNAs were differentially expressed (>= 2-fold change) in lung adenocarcinoma samples and NT, indicating that many lncRNAs were significantly upregulated or downregulated in lung adenocarcinoma. We also found, via quantitative PCR, that 19 lncRNAs were aberrantly expressed in lung adenocarcinoma compared with matched histologically normal lung tissues. Among these, LOC100132354 and RPLP0P2 were the most aberrantly expressed lncRNAs, as estimated by quantitative PCR in 100 pairs of lung adenocarcinoma and NT samples. Conclusions/Significance: Our study ascertained the expression patterns of lncRNAs in lung adenocarcinoma by microarray. The results revealed that many lncRNAs were differentially expressed in lung adenocarcinoma tissues and NT, suggesting that they may play a key role in tumor development.	[Xu, Gang; Pan, Qinshi; Zhang, Wenhui; Chen, Jian; Yu, Fangyou; Zhou, Tieli; Wang, Yumin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China; [Huang, Keta] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China; [Chen, Jie; Pan, Jingye] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, YM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China.	wym0577@163.com			National Natural Science Foundation of China [81171614, 81271906]; Wenzhou Municipal Science and Technology Bureau of China [Y20110041, Y20130170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau of China	This work was supported by the National Natural Science Foundation of China (81171614, 81271906), Wenzhou Municipal Science and Technology Bureau of China (Y20110041, Y20130170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gridelli C, 2003, ONCOGENE, V22, P6629, DOI 10.1038/sj.onc.1206957; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Han L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0694-5; Hauptman N, 2013, INT J MOL SCI, V14, P4655, DOI 10.3390/ijms14034655; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rachet B, 2008, BRIT J CANCER, V99, pS2, DOI 10.1038/sj.bjc.6604571; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065309; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37	25	54	57	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104044	10.1371/journal.pone.0104044	http://dx.doi.org/10.1371/journal.pone.0104044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089627	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700089
J	Yan, L; Zhou, J; Gao, Y; Ghazal, S; Lu, L; Bellone, S; Yang, Y; Liu, N; Zhao, X; Santin, AD; Taylor, H; Huang, Y				Yan, L.; Zhou, J.; Gao, Y.; Ghazal, S.; Lu, L.; Bellone, S.; Yang, Y.; Liu, N.; Zhao, X.; Santin, A. D.; Taylor, H.; Huang, Y.			Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation	ONCOGENE			English	Article							EPITHELIAL-OVARIAN-CANCER; C-MYC ONCOGENE; NONCODING RNA; SIGNALING PATHWAY; H19; EXPRESSION; GROWTH; LET-7; METASTASIS; BINDING	The imprinted, developmentally regulated H19 long noncoding RNA has been implicated in the pathogenesis of diverse human cancers, but the underlying mechanisms have remained poorly understood. Here, we report that H19 promotes tumor cell migration and invasion by inhibiting let-7, a potent tumor suppressor microRNA that functions to posttranscriptionally suppress the expression of oncogenes that regulate cell growth and motility. We show that H19 depletion impairs, whereas its overexpression enhances the motility and invasiveness of tumor cells. These phenomena occur, at least in part through affecting let-7-mediated regulation of metastasis-promoting genes, including Hmga2, c-Myc and Igf2bp3. This H19/let-7-dependent regulation is recapitulated in vivo where co-expressions of oncogenes and H19 exist in both primary human ovarian and endometrial cancers. Furthermore, we provide evidence that the anti-diabetic drug metformin inhibits tumor cell migration and invasion, partly by downregulating H19 via DNA methylation. Our results reveal a novel mechanism underpinning H19-mediated regulation in metastasis and may explain why in some cases increased let-7 expression unexpectedly correlates with poor prognosis, given the widely accepted role for let-7 as a tumor suppressor. Targeting this newly identified pathway might offer therapeutic opportunities.	[Yan, L.; Zhao, X.] Shandong Univ, Shandong Prov Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Yan, L.; Zhou, J.; Gao, Y.; Ghazal, S.; Bellone, S.; Yang, Y.; Liu, N.; Santin, A. D.; Taylor, H.; Huang, Y.] Yale Univ, Sch Med, Yale Stem Cell Ctr, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; [Zhou, J.] Zhejiang Univ, Sch Med, Affiliated Sir Run Run Shaw Hosp, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Y.] Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing 100853, Peoples R China; [Lu, L.] Yale Univ, Sch Med, Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Liu, N.] Cent S Univ, Xiangya Hosp, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Yale University; Zhejiang University; Chinese People's Liberation Army General Hospital; Yale University; Central South University	Huang, Y (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, Dept Obstet Gynecol & Reprod Sci, 310 Cedar St LSOG 205C, New Haven, CT 06510 USA.	yingqun.huang@yale.edu	Zhou, Jichun/Q-8646-2019	Zhou, Jichun/0000-0002-0727-4034; Bellone, Stefania/0000-0001-5909-5292	State of Connecticut Stem Cell grant [09SCAYALE14]; Albert McKern Scholar Award [1063338]; National Natural Science Foundation of China [81202057, 81272858]	State of Connecticut Stem Cell grant; Albert McKern Scholar Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Gil Mor for A2780 and Tara R127 cells. This work was supported by the following grants: the State of Connecticut Stem Cell grant 09SCAYALE14, Albert McKern Scholar Award 1063338, and funds from National Natural Science Foundation of China 81202057 and 81272858.	Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Bednar F, 2012, CANCER PREV RES, V5, P351, DOI 10.1158/1940-6207.CAPR-12-0026; BEHRENS BC, 1987, CANCER RES, V47, P414; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Cerezo M, 2013, MOL CANCER THER, V12, P1605, DOI 10.1158/1535-7163.MCT-12-1226-T; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Fu X, 2014, ONCOGENE, V33, P4296, DOI 10.1038/onc.2013.385; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gao ZH, 2002, J CLIN ENDOCR METAB, V87, P1170, DOI 10.1210/jc.87.3.1170; Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969; Grayson DR, 2013, NEUROPSYCHOPHARMACOL, V38, P138, DOI 10.1038/npp.2012.125; Green JM, 2009, MOL CANCER THER, V8, P1385; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Huang YQ, 2012, WIRES RNA, V3, P483, DOI 10.1002/wrna.1112; Jeng YM, 2008, HEPATOLOGY, V48, P1118, DOI 10.1002/hep.22459; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liu Q, 2012, MOL BIOL REP, V39, P1239, DOI 10.1007/s11033-011-0854-7; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Lu LG, 2011, BREAST CANCER RES TR, V126, P687, DOI 10.1007/s10549-010-1168-5; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Matouk I, 2013, INT J MOL SCI, V14, P4298, DOI 10.3390/ijms14024298; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Riaz M, 2011, BREAST CANC RES TREA, V133, P12; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Samanta S, 2012, ONCOGENE, V31, P4689, DOI 10.1038/onc.2011.620; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Srivastava M, 2000, GENE DEV, V14, P1186; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Suvasini R, 2011, J BIOL CHEM, V286, P25882, DOI 10.1074/jbc.M110.178012; Tang ZQ, 2014, INT J CANCER, V134, P306, DOI 10.1002/ijc.28371; Tanos V, 2004, INT J GYNECOL CANCER, V14, P521, DOI 10.1111/j.1048-891x.2004.014314.x; Tanos V, 1999, EUR J OBSTET GYN R B, V85, P7, DOI 10.1016/S0301-2115(98)00275-9; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Toledano H, 2012, NATURE, V485, P605, DOI 10.1038/nature11061; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; Wu BC, 2012, ONCOL REP, V28, P903, DOI 10.3892/or.2012.1890; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Yin G, 2013, ONCOGENE, V32, P39, DOI 10.1038/onc.2012.33; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang L, 2013, CARCINOGENESIS, V34, P577, DOI 10.1093/carcin/bgs381; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	70	153	170	4	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3076	3084		10.1038/onc.2014.236	http://dx.doi.org/10.1038/onc.2014.236			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25088204				2022-12-25	WOS:000356100500012
J	Martinez, E; Yoshihara, K; Kim, H; Mills, GM; Trevino, V; Verhaak, RGW				Martinez, E.; Yoshihara, K.; Kim, H.; Mills, G. M.; Trevino, V.; Verhaak, R. G. W.			Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects	ONCOGENE			English	Article							PREDICTOR; KNOWLEDGE; RESPONSES; ANTI-PD-1; SUBTYPES; REVEALS; SAFETY; EGFR	Transcriptional profile-based subtypes of cancer are often viewed as identifying different diseases from the same tissue origin. Understanding the mechanisms driving the subtypes may be key in development of novel therapeutics but is challenged by lineage-specific expression signals. Using a t-test statistics approach, we compared gene expression subtypes across 12 tumor types, which identified eight transcriptional superclusters characterized by commonly activated disease pathways and similarities in gene expression. One of the largest superclusters was determined by the upregulation of a proliferation signature, significant enrichment in TP53 mutations, genomic loss of CDKN2A (p16(ARF)), evidence of increased numbers of DNA double strand breaks and high expression of cyclin B1 protein. These correlations suggested that abrogation of the P53-mediated apoptosis response to DNA damage results in activation of cell cycle pathways and represents a common theme in cancer. A second consistent pattern, observed in 9 of 11 solid tumor types, was a subtype related to an activated tumor-associated stroma. The similarity in transcriptional footprints across cancers suggested that tumor subtypes are commonly unified by a limited number of molecular themes.	[Martinez, E.; Yoshihara, K.; Kim, H.; Verhaak, R. G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Martinez, E.; Trevino, V.] Tecnol Monterrey, Catedra Bioinformat, Monterrey, Nuevo Leon, Mexico; [Yoshihara, K.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Niigata, Japan; [Mills, G. M.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Verhaak, R. G. W.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Niigata University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Verhaak, RGW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1400 Pressler St, Houston, TX 77030 USA.	rverhaak@mdanderson.org	Kim, Hoon/AAL-9283-2020; Verhaak, Roel/ABE-7058-2020; Yoshihara, Kosuke/AAU-9874-2020; Trevino, Victor/C-9219-2009	Kim, Hoon/0000-0003-4244-6126; Yoshihara, Kosuke/0000-0002-2254-3378; Martinez Ledesma, Juan Emmanuel/0000-0003-1191-7917; Trevino, Victor/0000-0002-7472-9844	U.S. National Cancer Institute (NCI; MD Anderson TCGA Genome Data Analysis Center) [CA143883, CA083639]; Odyssey Program; Theodore N, Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center; MD Anderson Cancer Center [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, U24CA143883, P50CA083639] Funding Source: NIH RePORTER	U.S. National Cancer Institute (NCI; MD Anderson TCGA Genome Data Analysis Center); Odyssey Program; Theodore N, Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center; MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at 'http://cancergenome.nih.gov'. This work was supported in part by U.S. National Cancer Institute (NCI; MD Anderson TCGA Genome Data Analysis Center) grant numbers CA143883 and CA083639, and MD Anderson Cancer Center Support Grant P30 CA016672. HK is supported in part by the Odyssey Program and the Theodore N, Law Endowment for Scientific Achievement at The University of Texas MD Anderson Cancer Center.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Everitt B. S., 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li JN, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.61; Martinsson-Ahlzen HS, 2008, MOL CELL BIOL, V28, P5698, DOI 10.1128/MCB.01833-07; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RC, 2013, RA LANG ENV STAT COM, V13, P497; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	43	33	35	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 21	2015	34	21					2732	2740		10.1038/onc.2014.216	http://dx.doi.org/10.1038/onc.2014.216			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CI7XN	25088195	Green Accepted			2022-12-25	WOS:000354979500006
J	Nokwe, CN; Zacharias, M; Yagi, H; Hora, M; Reif, B; Goto, Y; Buchner, J				Nokwe, Cardine N.; Zacharias, Martin; Yagi, Hisashi; Hora, Manuel; Reif, Bernd; Goto, Yuji; Buchner, Johannes			A Residue-specific Shift in Stability and Amyloidogenicity of Antibody Variable Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; LIGHT-CHAIN AMYLOIDOSIS; IMMUNOGLOBULIN DEPOSITION DISEASE; PRIMARY SYSTEMIC AMYLOIDOSIS; CRYSTAL-STRUCTURE; AL AMYLOIDOSIS; HEAVY-CHAIN; HYDROPHOBIC CORE; FOLDING PATHWAY; FAB FRAGMENT	Variable (V) domains of antibodies are essential for antigen recognition by our adaptive immune system. However, some variants of the light chain V domains (V-L) form pathogenic amyloid fibrils in patients. It is so far unclear which residues play a key role in governing these processes. Here, we show that the conserved residue 2 of V-L domains is crucial for controlling its thermodynamic stability and fibril formation. Hydrophobic side chains at position 2 stabilize the domain, whereas charged residues destabilize and lead to amyloid fibril formation. NMR experiments identified several segments within the core of the V-L domain to be affected by changes in residue 2. Furthermore, molecular dynamic simulations showed that hydrophobic side chains at position 2 remain buried in a hydrophobic pocket, and charged side chains show a high flexibility. This results in a predicted difference in the dissociation free energy of similar to 10 kJ mol(-1), which is in excellent agreement with our experimental values. Interestingly, this switch point is found only in V-L domains of the kappa family and not in V-L lambda or in V-H domains, despite a highly similar domain architecture. Our results reveal novel insight into the architecture of variable domains and the prerequisites for formation of amyloid fibrils. This might also contribute to the rational design of stable variable antibody domains.	[Nokwe, Cardine N.; Hora, Manuel; Reif, Bernd; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Zacharias, Martin] Tech Univ Munich, Dept Phys, Ctr Integrated Prot Sci, D-85748 Garching, Germany; [Yagi, Hisashi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 6808550, Japan; [Yagi, Hisashi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 6808550, Japan; [Yagi, Hisashi; Goto, Yuji] Osaka Univ, Inst Prot Res, Div Prot Struct Biol, Suita, Osaka 5650871, Japan	Technical University of Munich; Technical University of Munich; Tottori University; Tottori University; Osaka University	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@tum.de	Hora, Manuel/G-7077-2018; Buchner, Johannes/A-2651-2010	Hora, Manuel/0000-0002-5156-0687; Reif, Bernd/0000-0001-7368-7198; Buchner, Johannes/0000-0003-1282-7737	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung (BMBF) within the framework of the research network GERAMY	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) within the framework of the research network GERAMY(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to J. B.) and by a grant from the Bundesministerium fur Bildung und Forschung (BMBF) within the framework of the research network GERAMY (to B. R.).	Abraham RS, 2003, BLOOD, V101, P3801, DOI 10.1182/blood-2002-09-2707; Augustine JG, 2001, J BIOL CHEM, V276, P3287, DOI 10.1074/jbc.M005221200; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Benitez-Cardoza CG, 2004, BIOCHEMISTRY-US, V43, P5195, DOI 10.1021/bi0361620; Billings KS, 2008, J MOL BIOL, V375, P560, DOI 10.1016/j.jmb.2007.10.056; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Buxbaum J, 1999, HEMATOL ONCOL CLIN N, V13, P1235, DOI 10.1016/S0889-8588(05)70123-4; BUXBAUM JN, 1990, ANN INTERN MED, V112, P455, DOI 10.7326/0003-4819-76-3-112-6-455; Case D. A., 2012, AMBER 12; Chacko S, 1996, J BIOL CHEM, V271, P12191, DOI 10.1074/jbc.271.21.12191; Chatani E, 2009, P NATL ACAD SCI USA, V106, P11119, DOI 10.1073/pnas.0901422106; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DOTY P, 1950, J CHEM PHYS, V18, P1211, DOI 10.1063/1.1747913; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Faber C, 1998, IMMUNOTECHNOLOGY, V3, P253, DOI 10.1016/S1380-2933(97)10003-3; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Feige MJ, 2007, J MOL BIOL, V365, P1232, DOI 10.1016/j.jmb.2006.10.049; Feige MJ, 2010, J MOL BIOL, V399, P719, DOI 10.1016/j.jmb.2010.04.032; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Johnson G, 2000, NUCLEIC ACIDS RES, V28, P214, DOI 10.1093/nar/28.1.214; Jones S, 2003, J MOL BIOL, V330, P935, DOI 10.1016/S0022-2836(03)00688-0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kitayama H, 2013, BBA-PROTEINS PROTEOM, V1834, P2640, DOI 10.1016/j.bbapap.2013.09.016; KODANDAPANI R, 1995, J BIOL CHEM, V270, P2268, DOI 10.1074/jbc.270.5.2268; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; Lefranc MP, 2003, NUCLEIC ACIDS RES, V31, P307, DOI 10.1093/nar/gkg085; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LILIE H, 1995, FEBS LETT, V362, P43, DOI 10.1016/0014-5793(95)00203-L; Merlini G, 2008, ANN ONCOL, V19, P63, DOI 10.1093/annonc/mdn200; Miyazaki D, 2008, AMYLOID, V15, P125, DOI 10.1080/13506120802006229; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mukherjee S, 2011, BIOCHEMISTRY-US, V50, P5845, DOI 10.1021/bi200410c; Nowak M, 2004, PROTEINS, V55, P11, DOI 10.1002/prot.10606; Ohhashi Y, 2005, J BIOL CHEM, V280, P32843, DOI 10.1074/jbc.M506501200; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; Pozzi C, 2003, AM J KIDNEY DIS, V42, P1154, DOI 10.1053/j.ajkd.2003.08.040; Raffen R, 1999, PROTEIN SCI, V8, P509; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schiffer M, 1996, AM J PATHOL, V148, P1339; Simpson ER, 2009, J MOL BIOL, V392, P1326, DOI 10.1016/j.jmb.2009.07.075; So M, 2011, J MOL BIOL, V412, P568, DOI 10.1016/j.jmb.2011.07.069; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yagi H, 2013, BBA-PROTEINS PROTEOM, V1834, P2480, DOI 10.1016/j.bbapap.2013.08.013; Yoshimura Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.07HA01	69	13	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26829	26846		10.1074/jbc.M114.582247	http://dx.doi.org/10.1074/jbc.M114.582247			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096580	Green Published, hybrid			2022-12-25	WOS:000342853900015
J	Borgal, L; Rinschen, MM; Dafinger, C; Hoff, S; Reinert, MJ; Lamkemeyer, T; Lienkamp, SS; Benzing, T; Schermer, B				Borgal, Lori; Rinschen, Markus M.; Dafinger, Claudia; Hoff, Sylvia; Reinert, Matthaeus J.; Lamkemeyer, Tobias; Lienkamp, Soeren S.; Benzing, Thomas; Schermer, Bernhard			Casein Kinase 1 alpha Phosphorylates the Wnt Regulator Jade-1 and Modulates Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN DEGRADATION; NEGATIVE REGULATOR; SIGNALING PATHWAY; EPITHELIAL-CELLS; PROTEIN-KINASE; STEM-CELLS; DISEASE; REPAIR; CK1; QUANTIFICATION	Tight regulation of Wnt/beta-catenin signaling is critical for vertebrate development and tissue maintenance, and deregulation can lead to a host of disease phenotypes, including developmental disorders and cancer. Proteins associated with primary cilia and centrosomes have been demonstrated to negatively regulate canonical Wnt signaling in interphase cells. The plant homeodomain zinc finger protein Jade-1 can act as an E3 ubiquitin ligase-targeting beta-catenin for proteasomal degradation and concentrates at the centrosome and ciliary basal body in addition to the nucleus in interphase cells. We demonstrate that the destruction complex component casein kinase 1 beta(CK1 alpha) phosphorylates Jade-1 at a conserved SLS motif and reduces the ability of Jade-1 to inhibit beta-catenin signaling. Consistently, Jade-1 lacking the SLS motif is more effective than wild-type Jade-1 in reducing beta-catenin-induced secondary axis formation in Xenopus laevis embryos in vivo. Interestingly, CK1 alpha also phosphorylates beta-catenin and the destruction complex component adenomatous polyposis coli at a similar SLS motif to the effect that beta-catenin is targeted for degradation. The opposing effect of Jade-1 phosphorylation by CK1 alpha suggests a novel example of the dual functions of CK1 alpha activity to either oppose or promote canonical Wnt signaling in a context-dependent manner.	[Borgal, Lori; Rinschen, Markus M.; Dafinger, Claudia; Reinert, Matthaeus J.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Borgal, Lori; Rinschen, Markus M.; Dafinger, Claudia; Reinert, Matthaeus J.; Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Rinschen, Markus M.; Lamkemeyer, Tobias; Schermer, Bernhard] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Benzing, Thomas; Schermer, Bernhard] Univ Cologne, Syst Biol Ageing Cologne, D-50931 Cologne, Germany; [Hoff, Sylvia; Lienkamp, Soeren S.] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany; [Lienkamp, Soeren S.] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79108 Freiburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Freiburg; University of Freiburg	Schermer, B (corresponding author), Univ Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany.	bernhard.schermer@uk-koeln.de	Borgal, Lori/ABB-9343-2021; Lienkamp, Soeren/AAH-6296-2020; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; Rinschen, Markus/N-7283-2019	Lienkamp, Soeren/0000-0003-2963-6865; Schermer, Bernhard/0000-0002-5194-9000; Rinschen, Markus/0000-0002-9252-1342	Deutsche Forschungsgemeinschaft [SCHE1562-2, SFB832]; Koln Fortune Program / Faculty of Medicine (University of Cologne); Koln Fortune Program/Faculty of Medicine (University of Cologne); UoC Postdoc grant (University of Cologne); Fritz-Scheler-Stipendium (KfH Stiftung fur Praventivmedizin); Deutsche Forschungsgemeinschaft (DFG) within clinical research unit (KFO) [201]; Emmy Noether Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune Program / Faculty of Medicine (University of Cologne); Koln Fortune Program/Faculty of Medicine (University of Cologne); UoC Postdoc grant (University of Cologne); Fritz-Scheler-Stipendium (KfH Stiftung fur Praventivmedizin); Deutsche Forschungsgemeinschaft (DFG) within clinical research unit (KFO)(German Research Foundation (DFG)); Emmy Noether Program(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHE1562-2 (to B. S.) and SFB832 (to B. S. and T. B.).; Supported by the Koln Fortune Program / Faculty of Medicine (University of Cologne).; Supported by the Koln Fortune Program/Faculty of Medicine (University of Cologne), by a UoC Postdoc grant (University of Cologne), and by the Fritz-Scheler-Stipendium (KfH Stiftung fur Praventivmedizin).; Supported by the Deutsche Forschungsgemeinschaft (DFG) within the clinical research unit (KFO) 201 and the Emmy Noether Program.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Borgal L, 2012, J BIOL CHEM, V287, P25370, DOI 10.1074/jbc.M112.385658; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Chen LH, 2005, MOL CELL BIOL, V25, P6509, DOI 10.1128/MCB.25.15.6509-6520.2005; Chilov D, 2011, DEV BIOL, V357, P259, DOI 10.1016/j.ydbio.2011.06.029; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Choo Yeun Su, 2009, J Vis Exp, DOI 10.3791/1293; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dale T, 2006, NAT STRUCT MOL BIOL, V13, P9, DOI 10.1038/nsmb0106-9; del Valle-Perez B, 2011, MOL CELL BIOL, V31, P2877, DOI 10.1128/MCB.01466-10; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferrarese A, 2007, BIOCHEMISTRY-US, V46, P11902, DOI 10.1021/bi701674z; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Ishibe S, 2008, CURR OPIN NEPHROL HY, V17, P379, DOI 10.1097/MNH.0b013e3283046507; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kawakami T, 2013, J PATHOL, V229, P221, DOI 10.1002/path.4121; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MARIN O, 1994, EUR J BIOCHEM, V223, P647, DOI 10.1111/j.1432-1033.1994.tb19037.x; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; MEGGIO F, 1991, FEBS LETT, V283, P303, DOI 10.1016/0014-5793(91)80614-9; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pulgar V, 1999, EUR J BIOCHEM, V260, P520, DOI 10.1046/j.1432-1327.1999.00195.x; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rinschen MM, 2014, J AM SOC NEPHROL, V25, P1509, DOI 10.1681/ASN.2013070760; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Wang GH, 2006, ANAL CHEM, V78, P5752, DOI 10.1021/ac060611v; Yamamoto S, 2013, AM J PHYSIOL-GASTR L, V305, pG241, DOI 10.1152/ajpgi.00480.2012; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	63	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26344	26356		10.1074/jbc.M114.562165	http://dx.doi.org/10.1074/jbc.M114.562165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100726	hybrid, Green Published			2022-12-25	WOS:000342128800027
J	Evans, SK; Burgess, KEV; Gray, JV				Evans, Stephanie K.; Burgess, Karl E. V.; Gray, Joseph V.			Recovery from Rapamycin DRUG-INSENSITIVE ACTIVITY OF YEAST TARGET OF RAPAMYCIN COMPLEX 1 (TORC1) SUPPORTS RESIDUAL PROLIFERATION THAT DILUTES RAPAMYCIN AMONG PROGENY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; FISSION YEAST; LIFE-SPAN; AUTOPHAGY; COMPLEX; TARGET; GROWTH; PERMEASE	The target of rapamycin complex 1 (TORC1) is a key conserved regulator of eukaryotic cell growth. The xenobiotic rapamycin is a potent inhibitor of the yeast complex. Surprisingly, the EGO complex, a nonessential in vivo activator of TORC1, is somehow required for yeast cells to recover efficiently from a period of treatment with rapamycin. Why? Here, we found that rapamycin is only a partial inhibitor of TORC1. We confirmed that saturating amounts of rapamycin do not fully inhibit proliferation of wild-type cells, and we found that the residual proliferation in the presence of the drug is dependent on the EGO complex and on the activity of TORC1. We found that this residual TORC1-dependent proliferation is key to recovery from rapamycin treatment. First, the residual proliferation rate correlates with the ability of cells to recover from treatment. Second, the residual proliferation rate persists long after washout of the drug and until cells recover. Third, the total observable pool of cell-associated rapamycin is extremely stable and decreases only with increasing cell number after washout of the drug. Finally, consideration of the residual proliferation rate alone accurately and quantitatively accounts for the kinetics of recovery of wild-type cells and for the nature and severity of the ego - mutant defect. Overall, our results revealed that rapamycin is a partial inhibitor of yeast TORC1, that persistence of the drug limits recovery, and that rapamycin is not detoxified by yeast but is passively diluted among progeny cells because of residual proliferation.	[Evans, Stephanie K.; Gray, Joseph V.] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Burgess, Karl E. V.] Univ Glasgow, Glasgow Poly, Translat Canc Res Ctr, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Glasgow	Gray, JV (corresponding author), Univ Glasgow, Bower Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.	Joseph.Gray@glasgow.ac.uk		Burgess, Karl/0000-0002-0881-715X	Biotechnology and Biological Sciences Research Council; School of Life Sciences	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Life Sciences	This work was supported by a departmental training award Ph.D. studentship from the Biotechnology and Biological Sciences Research Council (to S. K. E.) and a research award from the School of Life Sciences (to J. V. G.).	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Butcher RA, 2006, NAT CHEM BIOL, V2, P103, DOI 10.1038/nchembio762; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Geda P, 2008, YEAST, V25, P577, DOI 10.1002/yea.1610; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Ronald TKN, 2008, P NATL ACAD SCI USA, V105, P15166, DOI 10.1073/pnas.0807712105; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Shin CS, 2011, AUTOPHAGY, V7, P854, DOI 10.4161/auto.7.8.15696; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Umekawa M, 2012, J BIOL CHEM, V287, P16300, DOI 10.1074/jbc.M112.344952; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	36	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26554	26565		10.1074/jbc.M114.589754	http://dx.doi.org/10.1074/jbc.M114.589754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104356	hybrid, Green Published			2022-12-25	WOS:000342128800046
J	Park, ES; Lee, JH; Hong, JH; Park, YK; Lee, JW; Lee, WJ; Lee, JW; Kim, KP; Kim, KH				Park, Eun-Sook; Lee, Jeong Hwa; Hong, Ji Hye; Park, Yong Kwang; Lee, Joon Won; Lee, Won-Jae; Lee, Jae Won; Kim, Kwang Pyo; Kim, Kyun-Hwan			Phosphatidylcholine Alteration Identified Using MALDI Imaging MS in HBV-Infected Mouse Livers and Virus-Mediated Regeneration Defects	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; PARTIAL-HEPATECTOMY; PLASMA-MEMBRANE; RAT-LIVER; CELL-CYCLE; VIRAL-DNA; PROTEIN; METABOLISM; PROLIFERATION; REQUIREMENT	In this study, we investigated whether hepatitis B virus (HBV) causes the alteration of lipid metabolism and composition during acute infection and liver regeneration in a mouse model. The liver controls lipid biogenesis and bile acid homeostasis. Infection of HBV causes various liver diseases and impairs liver regeneration. As there are very few reports available in the literature on lipid alterations by HBV infection or HBV-mediated liver injury, we have analyzed phospholipids that have important roles in liver regeneration by using matrix-assisted laser desorption/ionization (MALDI)-imaging mass spectrometry (IMS) in the livers of HBV model mice. As a result, we identified different phosphatidylcholines (PCs) showing significant changes in their composition as well as cationized ion adduct formation in HBV-infected mouse livers which are associated with virus-mediated regeneration defects. To find the factor of altered PCs, the expression kinetics of enzymes was also examined that regulate PC biosynthesis during liver regeneration. It is noteworthy that the expression of choline-phosphate cytidylyltransferase A (PCYT1A) was significantly delayed in wild type HBV-expressing livers. Moreover, the amount of hepatic total PC was also significantly decreased in wt HBV-expressing mice. These results suggest that infection of HBV alters the composition of PCs which may involve in HBV-mediated regeneration defects and liver disease.	[Park, Eun-Sook; Park, Yong Kwang; Lee, Won-Jae; Kim, Kyun-Hwan] Konkuk Univ, Dept Pharmacol, Seoul, South Korea; [Park, Eun-Sook; Park, Yong Kwang; Lee, Won-Jae; Kim, Kyun-Hwan] Konkuk Univ, Ctr Canc Res & Diagnost Med, IBST, Sch Med, Seoul, South Korea; [Park, Eun-Sook; Kim, Kyun-Hwan] Konkuk Univ, KU Open Innovat Ctr, Seoul, South Korea; [Kim, Kyun-Hwan] Konkuk Univ, Res Inst Med Sci, Seoul, South Korea; [Lee, Jeong Hwa; Hong, Ji Hye; Lee, Joon Won; Lee, Jae Won; Kim, Kwang Pyo] Kyung Hee Univ, Dept Appl Chem, Yongin, Gyeonggi, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Kyung Hee University	Kim, KP (corresponding author), Kyung Hee Univ, Dept Appl Chem, Yongin, Gyeonggi, South Korea.	kimkp@khu.ac.kr; khkim10@kku.ac.kr	Kim, Kwang Pyo/AAG-1815-2020	Park, Eun-Sook/0000-0002-6652-9404; Kim, Kyun-Hwan/0000-0001-5266-072X; Kim, Kwang Pyo/0000-0003-0095-3787	Proteogenomic Research Program; Bio- and Medical Technology Development Program [2012M3A9B6055305]; Basic Science Research Program through the National Research Foundation of the Ministry of Science, ICT & Future Planning [NRF-2013R1A1A3008681]	Proteogenomic Research Program; Bio- and Medical Technology Development Program; Basic Science Research Program through the National Research Foundation of the Ministry of Science, ICT & Future Planning	This work was supported by Proteogenomic Research Program, the Bio- and Medical Technology Development Program (Project No. 2012M3A9B6055305), and Basic Science Research Program (NRF-2013R1A1A3008681) through the National Research Foundation of the Ministry of Science, ICT & Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; BRUSCALUPI G, 1980, BIOCHIM BIOPHYS ACTA, V597, P263, DOI 10.1016/0005-2736(80)90104-2; CORNELL R, 1977, EXP CELL RES, V109, P299, DOI 10.1016/0014-4827(77)90009-X; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DELAHUNTY TJ, 1970, J LIPID RES, V11, P536; DELICONSTANTINOS G, 1983, BIOCHEM J, V212, P445, DOI 10.1042/bj2120445; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Feitelson MA, 1999, J CELL PHYSIOL, V181, P188; FEX G, 1970, BIOCHEM J, V119, P743, DOI 10.1042/bj1190743; GLENDE EA, 1968, EXP MOL PATHOL, V8, P190, DOI 10.1016/0014-4800(68)90015-4; Hodgson AJ, 2008, CANCER RES, V68, P10341, DOI 10.1158/0008-5472.CAN-08-2695; HOUWELING M, 1991, BIOCHEM J, V278, P347, DOI 10.1042/bj2780347; Kang HS, 2011, BMC CANCER, V11, P747; Kang S, 2011, INT J GYNECOL CANCER, V21, P1566, DOI 10.1097/IGC.0b013e318226c5f5; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Miyamura N, 2011, BIOCHEM BIOPH RES CO, V408, P120, DOI 10.1016/j.bbrc.2011.03.133; Moustafa T, 2012, GASTROENTEROLOGY, V142, P140, DOI 10.1053/j.gastro.2011.09.051; MURRAY AB, 1981, J CELL SCI, V50, P433; Park ES, 2013, HEPATOLOGY, V58, P762, DOI 10.1002/hep.26379; Park YS, 2011, CLIN CHIM ACTA, V412, P1978, DOI 10.1016/j.cca.2011.07.008; Quetier I, 2013, J HEPATOL, V59, P285, DOI 10.1016/j.jhep.2013.03.021; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shanta SR, 2012, J LIPID RES, V53, P1823, DOI 10.1194/jlr.M022558; Shanta SR, 2011, ANAL CHEM, V83, P1252, DOI 10.1021/ac1029659; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; SUMMERS RM, 1991, INVEST RADIOL, V26, P233, DOI 10.1097/00004424-199103000-00007; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TERCE F, 1994, J LIPID RES, V35, P2130; Tralhao JG, 2002, P NATL ACAD SCI USA, V99, P6991, DOI 10.1073/pnas.092657699; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; VANHOEVEN RP, 1979, BIOCHIM BIOPHYS ACTA, V551, P44, DOI 10.1016/0005-2736(79)90351-1; WRIGHT GH, 1977, BIOCHIM BIOPHYS ACTA, V470, P368, DOI 10.1016/0005-2736(77)90128-6; Wu BK, 2006, BIOCHEM BIOPH RES CO, V340, P916, DOI 10.1016/j.bbrc.2005.12.089; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599	41	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103955	10.1371/journal.pone.0103955	http://dx.doi.org/10.1371/journal.pone.0103955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101682	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993900030
J	Fackler, PL; Pacifici, K; Martin, J; McIntyre, C				Fackler, Paul L.; Pacifici, Krishna; Martin, Julien; McIntyre, Carol			Efficient Use of Information in Adaptive Management with an Application to Managing Recreation near Golden Eagle Nesting Sites	PLOS ONE			English	Article							CONSERVATION; MODELS	It is generally the case that a significant degree of uncertainty exists concerning the behavior of ecological systems. Adaptive management has been developed to address such structural uncertainty, while recognizing that decisions must be made without full knowledge of how a system behaves. This paradigm attempts to use new information that develops during the course of management to learn how the system works. To date, however, adaptive management has used a very limited information set to characterize the learning that is possible. This paper uses an extension of the Partial Observable Markov Decision Process (POMDP) framework to expand the information set used to update belief in competing models. This feature can potentially increase the speed of learning through adaptive management, and lead to better management in the future. We apply this framework to a case study wherein interest lies in managing recreational restrictions around golden eagle (Aquila chrysaetos) nesting sites. The ultimate management objective is to maintain an abundant eagle population in Denali National Park while minimizing the regulatory burden on park visitors. In order to capture this objective, we developed a utility function that trades off expected breeding success with hiker access. Our work is relevant to the management of human activities in protected areas, but more generally demonstrates some of the benefits of POMDP in the context of adaptive management.	[Fackler, Paul L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Pacifici, Krishna] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Martin, Julien] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Martin, Julien] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA; [McIntyre, Carol] Natl Pk Serv, Fairbanks, AK USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Department of the Interior; United States Geological Survey; Florida Fish & Wildlife Conservation Commission; United States Department of the Interior	Fackler, PL (corresponding author), N Carolina State Univ, Raleigh, NC 27695 USA.	paul_fackler@ncsu.edu	Pacifici, Krishna/AAF-5171-2020; Nieuwkerk, Pythia/S-4084-2017	Nieuwkerk, Pythia/0000-0002-2616-1414; Martin, Julien/0000-0002-7375-129X; Pichler, Mario/0000-0002-5027-809X; Pacifici, Krishna/0000-0002-7518-7186	U.S. Geological Survey Status and Trends of Biological Resource Program; National Park Service Vital Signs Monitoring Program; Denali National Park and Preserve; United States Department of Agriculture Hatch Project [NC0228]; NCSU Department of Applied Ecology	U.S. Geological Survey Status and Trends of Biological Resource Program(United States Geological Survey); National Park Service Vital Signs Monitoring Program; Denali National Park and Preserve; United States Department of Agriculture Hatch Project; NCSU Department of Applied Ecology	This work was supported by the U.S. Geological Survey Status and Trends of Biological Resource Program, the National Park Service Vital Signs Monitoring Program, and Denali National Park and Preserve. P.L. Fackler's contribution to this paper was supported in part from United States Department of Agriculture Hatch Project NC0228. The authors would like to acknowledge the NCSU Department of Applied Ecology for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya-Lopez M., 2010, 22 INT C TOOLS ART I; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Chades I., 2012, P 26 AAAI C ARTIFICI, P267; Fackler P, 2014, J ENVIRON MANAGE, V133, P27, DOI 10.1016/j.jenvman.2013.11.004; Fackler PL, 2012, METHODS ECOL EVOL, V3, P555, DOI 10.1111/j.2041-210X.2012.00191.x; Fackler PL, 2014, RESOURCE EN IN PRESS; Gill JA, 2007, IBIS, V149, P9, DOI 10.1111/j.1474-919X.2007.00642.x; Gonzalez LM, 2006, ANIM CONSERV, V9, P85, DOI 10.1111/j.1469-1795.2005.00016.x; Holling CrawfordS., 1978, ADAPTIVE ENV ASSESSM; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kaisanlahti-Jokimaki ML, 2008, ORNIS FENNICA, V85, P2; Margalida A, 2011, ANIM CONSERV, V14, P167, DOI 10.1111/j.1469-1795.2010.00412.x; Martin J, 2011, CONSERV BIOL, V25, P316, DOI 10.1111/j.1523-1739.2010.01644.x; Martin J, 2009, BIOL CONSERV, V142, P2726, DOI 10.1016/j.biocon.2009.06.027; MONAHAN GE, 1982, MANAGE SCI, V28, P1, DOI 10.1287/mnsc.28.1.1; Ong S. C. W, 2009, P ROBOTICS SCI SYSTE; Puterman ML, 2005, MARKOV DECISION PROC; Walters C., 1986, ADAPTIVE MANAGEMENT; Williams BK, 2011, ECOL MODEL, V222, P1092, DOI 10.1016/j.ecolmodel.2010.12.015; Young J, 2005, BIODIVERS CONSERV, V14, P1641, DOI 10.1007/s10531-004-0536-z	20	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102434	10.1371/journal.pone.0102434	http://dx.doi.org/10.1371/journal.pone.0102434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098955	gold, Green Published, Green Submitted			2022-12-25	WOS:000339995100007
J	Arreola, SL; Intanon, M; Suljic, J; Kittl, R; Pham, NH; Kosma, P; Haltrich, D; Nguyen, TH				Arreola, Sheryl Lozel; Intanon, Montira; Suljic, Jasmina; Kittl, Roman; Ngoc Hung Pham; Kosma, Paul; Haltrich, Dietmar; Thu-Ha Nguyen			Two beta-Galactosidases from the Human Isolate Bifidobacterium breve DSM 20213: Molecular Cloning and Expression, Biochemical Characterization and Synthesis of Galacto-Oligosaccharides	PLOS ONE			English	Article							HUMAN COLONIC MICROBIOTA; LACTOBACILLUS-REUTERI; PREBIOTIC GALACTOOLIGOSACCHARIDES; ENZYMATIC-HYDROLYSIS; DIETARY MODULATION; BIFIDUM NCIMB41171; INFANTIS HL96; LACTOSE; PURIFICATION; SYNBIOTICS	Two beta-galactosidases, beta-gal I and beta-gal II, from Bifidobacterium breve DSM 20213, which was isolated from the intestine of an infant, were overexpressed in Escherichia coli with co-expression of the chaperones GroEL/GroES, purified to electrophoretic homogeneity and biochemically characterized. Both beta-gal I and beta-gal II belong to glycoside hydrolase family 2 and are homodimers with native molecular masses of 220 and 211 kDa, respectively. The optimum pH and temperature for hydrolysis of the two substrates o-nitrophenyl-beta-D-galactopyranoside (oNPG) and lactose were determined at pH 7.0 and 50 degrees C for beta-gal I, and at pH 6.5 and 55 degrees C for beta-gal II, respectively. The k(cat)/K-m values for oNPG and lactose hydrolysis are 722 and 7.4 mM(-1)s(-1) for beta-gal I, and 543 and 25 mM(-1)s(-1) for beta-gal II. Both beta-gal I and beta-gal II are only moderately inhibited by their reaction products D-galactose and D-glucose. Both enzymes were found to be very well suited for the production of galacto-oligosaccharides with total GOS yields of 33% and 44% of total sugars obtained with beta-gal I and beta-gal II, respectively. The predominant transgalactosylation products are beta-D-Galp-(1 -> 6)-D-Glc (allolactose) and beta-D-Galp-(1 -> 3)-D-Lac, accounting together for more than 75% and 65% of the GOS formed by transgalactosylation by beta-gal I and beta-gal II, respectively, indicating that both enzymes have a propensity to synthesize beta-(1 -> 6) and beta-(1 -> 3)-linked GOS. The resulting GOS mixtures contained relatively high fractions of allolactose, which results from the fact that glucose is a far better acceptor for galactosyl transfer than galactose and lactose, and intramolecular transgalactosylation contributes significantly to the formation of this disaccharide.	[Arreola, Sheryl Lozel; Intanon, Montira; Suljic, Jasmina; Kittl, Roman; Ngoc Hung Pham; Haltrich, Dietmar; Thu-Ha Nguyen] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria; [Arreola, Sheryl Lozel] Univ Philippines Los Banos, Inst Chem, College Los Banos, Laguna, Philippines; [Ngoc Hung Pham] Hanoi Univ Sci & Technol, Sch Food Biotechnol & Food Technol, Hanoi, Vietnam; [Kosma, Paul] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Organ Chem, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of the Philippines System; University of the Philippines Los Banos; Hanoi University of Science & Technology; University of Natural Resources & Life Sciences, Vienna	Nguyen, TH (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria.	thu-ha.nguyen@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Kosma, Paul/Y-7443-2019	Haltrich, Dietmar/0000-0002-8722-8176; Kosma, Paul/0000-0001-5342-7161; Kittl, Roman/0000-0002-8923-481X; Arreola, Sheryl Lozel/0000-0003-0385-1911; Nguyen, Thu-Ha/0000-0002-5253-6865	Austrian Science Fund (FWF) [P24868-B22, P25313-B20]; Austrian Federal Ministry of Science and Research; European Commission; Austrian Science Fund (FWF) [P 24868, P 25313] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF: www.fwf.ac.at): Individual grants P24868-B22 for THN, and P25313-B20 for RK. SLA and MI had the scholarships 'Technologiestipendium Sudostasien in the frame of the ASEA-Uninet granted by the OeAD - Austrian Agency for International Cooperation in Education & Research' financed by the Austrian Federal Ministry of Science and Research, and HNP received the Erasmus Mundus scholarship granted by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, ENCY BIOPROCESS TECH; BIAVATI B, 1986, MICROBIOLOGICA, V9, P39; Biavati B, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P322, DOI 10.1007/0-387-30743-5_17; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crittenden RG, 1996, TRENDS FOOD SCI TECH, V7, P353, DOI 10.1016/S0924-2244(96)10038-8; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; DEROOS A, 2004, ENZYMES IND, P144; Ganzle MG, 2008, INT DAIRY J, V18, P685, DOI 10.1016/j.idairyj.2008.03.003; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gopal PK, 2001, INT DAIRY J, V11, P19, DOI 10.1016/S0958-6946(01)00026-7; Goulas T, 2009, APPL MICROBIOL BIOT, V84, P899, DOI 10.1007/s00253-009-2009-5; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P1079, DOI 10.1007/s00253-008-1795-5; Goulas TK, 2007, APPL MICROBIOL BIOT, V76, P1365, DOI 10.1007/s00253-007-1099-1; Hinz SWA, 2004, APPL MICROBIOL BIOT, V66, P276, DOI 10.1007/s00253-004-1745-9; Holzapfel WH, 2002, FOOD RES INT, V35, P109, DOI 10.1016/S0963-9969(01)00171-5; Hung MN, 2002, APPL MICROBIOL BIOT, V58, P439, DOI 10.1007/s00253-001-0911-6; Hung MN, 2001, APPL ENVIRON MICROB, V67, P4256, DOI 10.1128/AEM.67.9.4256-4263.2001; Iqbal S, 2011, J AGR FOOD CHEM, V59, P3803, DOI 10.1021/jf103832q; Iqbal S, 2010, CARBOHYD RES, V345, P1408, DOI 10.1016/j.carres.2010.03.028; Juajun O, 2011, APPL MICROBIOL BIOT, V89, P645, DOI 10.1007/s00253-010-2862-2; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Jurado E, 2002, ENZYME MICROB TECH, V31, P300, DOI 10.1016/S0141-0229(02)00107-2; Kim CS, 2003, BIOTECHNOL LETT, V25, P1769, DOI 10.1023/A:1026092029785; Kim JW, 2000, FOLIA MICROBIOL, V45, P29, DOI 10.1007/BF02817446; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; Mahoney RR, 1998, FOOD CHEM, V63, P147, DOI 10.1016/S0308-8146(98)00020-X; Maischberger T, 2010, BIOTECHNOL J, V5, P838, DOI 10.1002/biot.201000126; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Moller PL, 2001, APPL ENVIRON MICROB, V67, P2276, DOI 10.1128/AEM.67.5.2276-2283.2001; Nguyen TH, 2007, FEMS MICROBIOL LETT, V269, P136, DOI 10.1111/j.1574-6968.2006.00614.x; Nguyen TH, 2006, J AGR FOOD CHEM, V54, P4989, DOI 10.1021/jf053126u; Osman A, 2013, J AGR FOOD CHEM, V61, P2213, DOI 10.1021/jf304792g; Osman A, 2012, J AGR FOOD CHEM, V60, P740, DOI 10.1021/jf204719w; Petzelbauer I, 2000, BIOTECHNOL BIOENG, V69, P140, DOI 10.1002/(SICI)1097-0290(20000720)69:2&lt;140::AID-BIT3&gt;3.0.CO;2-R; Pivarnik Lori F., 1995, V38, P1; PRENOSIL JE, 1987, BIOTECHNOL BIOENG, V30, P1019, DOI 10.1002/bit.260300904; Rabiu BA, 2001, APPL ENVIRON MICROB, V67, P2526, DOI 10.1128/AEM.67.6.2526-2530.2001; Rastall RA, 2002, CURR OPIN BIOTECH, V13, P490, DOI 10.1016/S0958-1669(02)00365-8; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Sangwan V, 2011, J FOOD SCI, V76, pR103, DOI 10.1111/j.1750-3841.2011.02131.x; Splechtna Barbara, 2007, Biotechnology Journal, V2, P480, DOI 10.1002/biot.200600230; Splechtna B, 2007, J AGR FOOD CHEM, V55, P6772, DOI 10.1021/jf070643z; Splechtna B, 2006, J AGR FOOD CHEM, V54, P4999, DOI 10.1021/jf053127m; Tanaka R, 1995, OLD HER U M, V8, P141; Nguyen TT, 2012, J AGR FOOD CHEM, V60, P1713, DOI 10.1021/jf203909e; Van Laere KMJ, 2000, APPL ENVIRON MICROB, V66, P1379, DOI 10.1128/AEM.66.4.1379-1384.2000; Yi SH, 2011, NEW BIOTECHNOL, V28, P806, DOI 10.1016/j.nbt.2011.07.006	50	26	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104056	10.1371/journal.pone.0104056	http://dx.doi.org/10.1371/journal.pone.0104056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089712	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700090
J	Baumgartner, FA; Pavia, H; Toth, GB				Baumgartner, Finn A.; Pavia, Henrik; Toth, Gunilla B.			Individual Specialization to Non-Optimal Hosts in a Polyphagous Marine Invertebrate Herbivore	PLOS ONE			English	Article							SACOGLOSSA MOLLUSCA; CHEMICAL DEFENSES; FOOD; OPISTHOBRANCHIA; ASCOGLOSSA; PHOTOSYNTHESIS; EVOLUTION; KLEPTOPLASTS; MAINTENANCE; SPECIFICITY	Factors determining the degree of dietary generalism versus specialism are central in ecology. Species that are generalists at the population level may in fact be composed of specialized individuals. The optimal diet theory assumes that individuals choose diets that maximize fitness, and individual specialization may occur if individuals' ability to locate, recognize, and handle different food types differ. We investigate if individuals of the marine herbivorous slug Elysia viridis, which co-occur at different densities on several green macroalgal species in the field, are specialized to different algal hosts. Individual slugs were collected from three original algal host species (Cladophora sericea, Cladophora rupestris and Codium fragile) in the field, and short-term habitat choice and consumption, as well as long-term growth (proxy for fitness), on four algal diet species (the original algal host species and Chaetomorpha melagonium) were studied in laboratory experiments. Nutritional (protein, nitrogen, and carbon content) and morphological (dry weight, and cell/utricle volume) algal traits were also measured to investigate if they correlated with the growth value of the different algal diets. E. viridis individuals tended to choose and consume algal species that were similar to their original algal host. Long-term growth of E. viridis, however, was mostly independent of original algal host, as all individuals reached a larger size on the non-host C. melagonium. E. viridis growth was positively correlated to algal cell/utricle volume but not to any of the other measured algal traits. Because E. viridis feeds by piercing individual algal cells, the results indicate that slugs may receive more cytoplasm, and thus more energy per unit time, on algal species with large cells/utricles. We conclude that E. viridis individuals are specialized on different hosts, but host choice in natural E. viridis populations is not determined by the energetic value of seaweed diets as predicted by the ODT.	[Baumgartner, Finn A.; Pavia, Henrik; Toth, Gunilla B.] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Gothenburg	Toth, GB (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden.	gunilla.toth@bioenv.gu.se	Toth, Gunilla B/E-8737-2013	Toth, Gunilla/0000-0002-1225-7773	Colliander foundation; Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (CeMaCE); Swedish National Science Foundation [621-2007-5874, 621-2011-5630]	Colliander foundation; Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (CeMaCE); Swedish National Science Foundation	This work was financially supported via grants from the Colliander foundation to FAB, the Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (CeMaCE) to HP and GBT, and the Swedish National Science Foundation grants 621-2007-5874 to GBT and 621-2011-5630 to HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Baumgartner FA, 2014, PLOS ONE IN PRESS; Becerro MA, 2001, J CHEM ECOL, V27, P2287, DOI 10.1023/A:1012287105923; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casalduero FG, 2008, J EXP MAR BIOL ECOL, V357, P181, DOI 10.1016/j.jembe.2008.01.020; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK KB, 1990, VELIGER, V33, P339; CLARK KB, 1978, J MOLLUS STUD, V44, P272; Clark Kerry B., 1992, P515; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Cruz S, 2014, J MOLLUS STUD, V80, P475, DOI 10.1093/mollus/eyu021; DAVIS EM, 1988, AM BIOTECHNOL LAB, V6, P28; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; Evertsen J, 2007, MAR BIOL, V151, P2159, DOI 10.1007/s00227-007-0648-6; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; GAVAGNIN M, 1994, J EXP MAR BIOL ECOL, V175, P197, DOI 10.1016/0022-0981(94)90026-4; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Handeler K, 2010, MOL ECOL RESOUR, V10, P968, DOI 10.1111/j.1755-0998.2010.02853.x; Hay Mark E., 1992, P371; HAY ME, 1990, LIMNOL OCEANOGR, V35, P1734, DOI 10.4319/lo.1990.35.8.1734; HINDE R, 1975, BIOL J LINN SOC, V7, P161, DOI 10.1111/j.1095-8312.1975.tb00738.x; JENSEN KR, 1994, ETHOL ECOL EVOL, V6, P87, DOI 10.1080/08927014.1994.9523011; JENSEN KR, 1989, J MOLLUS STUD, V55, P79, DOI 10.1093/mollus/55.1.79; JENSEN KR, 1993, BIOL J LINN SOC, V48, P135, DOI 10.1111/j.1095-8312.1993.tb00883.x; Jensen KR, 1997, EVOL ECOL, V11, P301, DOI 10.1023/A:1018468420368; Jormalainen V, 2001, OIKOS, V93, P77, DOI 10.1034/j.1600-0706.2001.930108.x; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Marin A, 2004, SCI MAR, V68, P227, DOI 10.3989/scimar.2004.68s1227; MORAN JAG, 1994, J EXP MAR BIOL ECOL, V182, P111, DOI 10.1016/0022-0981(94)90214-3; PAUL VJ, 1988, J EXP MAR BIOL ECOL, V119, P15, DOI 10.1016/0022-0981(88)90149-9; Poore AGB, 2006, MAR BIOL, V149, P1403, DOI 10.1007/s00227-006-0307-3; Raven JA, 2009, J EXP BOT, V60, P3975, DOI 10.1093/jxb/erp282; ROUGHGARDEN J, 1974, AM NAT, V108, P429, DOI 10.1086/282924; Stachowicz JJ, 1999, ECOLOGY, V80, P495, DOI 10.1890/0012-9658(1999)080[0495:RPTCMC]2.0.CO;2; Stephens D.W., 1986, pi; Svanback R, 2005, EVOL ECOL RES, V7, P993; Teugels B, 2008, AQUAT BIOL, V4, P15, DOI 10.3354/ab00092; TROWBRIDGE CD, 1991, ECOLOGY, V72, P1880, DOI 10.2307/1940985; Trowbridge CD, 2000, J MAR BIOL ASSOC UK, V80, P1087, DOI 10.1017/S0025315400003155; Trowbridge CD, 2008, J MAR BIOL ASSOC UK, V88, P771, DOI 10.1017/S0025315408001690; Vesakoski O, 2008, J EXP MAR BIOL ECOL, V367, P118, DOI 10.1016/j.jembe.2008.09.006; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Williamson JE, 2004, ECOLOGY, V85, P1355, DOI 10.1890/02-4083	46	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102752	10.1371/journal.pone.0102752	http://dx.doi.org/10.1371/journal.pone.0102752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090601	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700009
J	Cho, SH; Oh, SY; Lane, AP; Lee, J; Oh, MH; Lee, S; Zheng, T; Zhu, Z				Cho, Seok Hyun; Oh, Sun Young; Lane, Andrew P.; Lee, Joan; Oh, Min-Hee; Lee, Seakwoo; Zheng, Tao; Zhu, Zhou			Regulation of Nasal Airway Homeostasis and Inflammation in Mice by SHP-1 and Th2/Th1 Signaling Pathways	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ALLERGIC RHINITIS PATIENTS; INTERFERON-GAMMA; MOTH-EATEN; IMMUNODEFICIENT MUTANT; CYTOKINE PRODUCTION; GENE-EXPRESSION; NECROSIS-FACTOR; MESSENGER-RNA; MOUSE MODEL	Allergic rhinitis is a chronic inflammatory disease orchestrated by Th2 lymphocytes. Src homology 2 domain-containing protein tyrosine phosphatase (SHP)-1 is known to be a negative regulator in the IL-4 alpha/STAT-6 signaling pathway of the lung. However, the role of SHP-1 enzyme and its functional relationship with Th2 and Th1 cytokines are not known in the nasal airway. In this study, we aimed to study the nasal inflammation as a result of SHP-1 deficiency in viable motheaten (mev) mice and to investigate the molecular mechanisms involved. Cytology, histology, and expression of cytokines and chemokines were analyzed to define the nature of the nasal inflammation. Targeted gene depletion of Th1 (IFN-gamma) and Th2 (IL-4 and IL-13) cytokines was used to identify the critical pathways involved. Matrix metalloproteinases (MMPs) were studied to demonstrate the clearance mechanism of recruited inflammatory cells into the nasal airway. We showed here that mev mice had a spontaneous allergic rhinitis-like inflammation with eosinophilia, mucus metaplasia, up-regulation of Th2 cytokines (IL-4 and IL-13), chemokines (eotaxin), and MMPs. All of these inflammatory mediators were clearly counter-regulated by Th2 and Th1 cytokines. Deletion of IFN-gamma gene induced a strong Th2-skewed inflammation with transepithelial migration of the inflammatory cells. These findings suggest that SHP-1 enzyme and Th2/Th1 paradigm may play a critical role in the maintenance of nasal immune homeostasis and in the regulation of allergic rhinitis.	[Cho, Seok Hyun; Lane, Andrew P.; Lee, Joan] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Oh, Sun Young; Oh, Min-Hee; Zheng, Tao; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Lee, Seakwoo] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Cho, Seok Hyun] Hanyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 133791, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Hanyang University	Zhu, Z (corresponding author), Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	zhou.zhu@yale.edu	Cho, Seok Hyun/F-6753-2017	Cho, Seok Hyun/0000-0001-8218-5894; Oh, Min-Hee/0000-0003-1581-4288	NIH [HL079349, HL107151, AI075025, AI072502]; AAAAI Women's Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151, R01HL079349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025, R01AI072502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAAAI Women's Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants HL079349 and HL107151 to ZZ; NIH AI075025 grant and the AAAAI Women's Award Grant to TZ; and NIH Grant AI072502 to APL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano R, 2003, ALLERGY ASTHMA PROC, V24, P179; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Blanchard C, 2009, ADV IMMUNOL, V101, P81, DOI 10.1016/S0065-2776(08)01003-1; Broide DH, 2010, ALLERGY ASTHMA PROC, V31, P370, DOI 10.2500/aap.2010.31.3388; Cataldo D, 2000, INT ARCH ALLERGY IMM, V123, P259, DOI 10.1159/000024452; Cho SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035114; Cho YS, 2008, AM J RESP CELL MOL, V39, P412, DOI 10.1165/rcmb.2007-0229OC; Christodoulopoulos P, 2000, J ALLERGY CLIN IMMUN, V105, P211, DOI 10.1016/S0091-6749(00)90068-X; CLARK EA, 1981, IMMUNOGENETICS, V12, P601, DOI 10.1007/BF01561700; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Fulkerson PC, 2004, J IMMUNOL, V173, P7565, DOI 10.4049/jimmunol.173.12.7565; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Jyonouchi H, 2003, ARCH OTOLARYNGOL, V129, P563, DOI 10.1001/archotol.129.5.563; Jyonouchi H, 2001, ARCH OTOLARYNGOL, V127, P1488, DOI 10.1001/archotol.127.12.1488; Kaiko GE, 2011, CURR OPIN ALLERGY CL, V11, P39, DOI 10.1097/ACI.0b013e328342322f; Kim SW, 2007, ANN OTO RHINOL LARYN, V116, P76, DOI 10.1177/000348940711600113; Kim TH, 2010, CLIN EXP ALLERGY, V40, P1742, DOI 10.1111/j.1365-2222.2010.03612.x; Krakowiak A, 2008, INT J OCCUP MED ENV, V21, P165, DOI 10.2478/v10001-008-0015-y; Lee KS, 2004, CLIN EXP ALLERGY, V34, P276, DOI 10.1111/j.1365-2222.2004.01849.x; Lee SN, 2013, EUR RESPIR J, V42, P1379, DOI 10.1183/09031936.00100412; Leonard C, 1997, AM J RESP CELL MOL, V17, P368, DOI 10.1165/ajrcmb.17.3.2797; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; MING WJ, 1987, J IMMUNOL, V138, P1469; Mo JH, 2011, ALLERGY, V66, P279, DOI 10.1111/j.1398-9995.2010.02476.x; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nieminen K, 2009, INT ARCH ALLERGY IMM, V150, P370, DOI 10.1159/000226238; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Okano M, 2013, INT ARCH ALLERGY IMM, V160, P275, DOI 10.1159/000341668; Ouyang Yuhui, 2010, Allergol Int, V59, P313, DOI 10.2332/allergolint.10-SC-0172; OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Piirila P, 2009, ALLERGY; Romagnani S, 1998, ALLERGY, V53, P12, DOI 10.1111/j.1398-9995.1998.tb04951.x; ROSSI GA, 1985, AM REV RESPIR DIS, V131, P150; Sannohe S, 2003, EUR RESPIR J, V21, P925, DOI 10.1183/09031936.03.00028103a; Savolainen J, 2004, CLIN EXP ALLERGY, V34, P413, DOI 10.1111/j.1365-2222.2004.01823.x; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takahashi Y, 2009, INT IMMUNOPHARMACOL, V9, P734, DOI 10.1016/j.intimp.2009.02.011; Teixeira LK, 2005, MEM I OSWALDO CRUZ, V100, P137, DOI 10.1590/S0074-02762005000900024; Temann UA, 1997, AM J RESP CELL MOL, V16, P471, DOI 10.1165/ajrcmb.16.4.9115759; Verhaeghe B, 2002, ALLERGY, V57, P825, DOI 10.1034/j.1398-9995.2002.23539.x; Wang HY, 2007, EUR J PHARMACOL, V577, P162, DOI 10.1016/j.ejphar.2007.08.023; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203; Wenzel SE, 2003, J ALLERGY CLIN IMMUN, V111, P1345, DOI 10.1067/mai.2003.1464	54	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103685	10.1371/journal.pone.0103685	http://dx.doi.org/10.1371/journal.pone.0103685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090641	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700043
J	Dorri, F; Mahini, H; Sharifi-Zarchi, A; Totonchi, M; Tusserkani, R; Pezeshk, H; Sadeghi, M				Dorri, Faezeh; Mahini, Hamid; Sharifi-Zarchi, Ali; Totonchi, Mehdi; Tusserkani, Ruzbeh; Pezeshk, Hamid; Sadeghi, Mehdi			Natural Biased Coin Encoded in the Genome Determines Cell Strategy	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; GENE-REGULATION; DECISION-MAKING; RIGHT OPERATOR; EVOLUTION; LYSOGENIZATION; NETWORKS; BISTABILITY; EQUILIBRIA; EXPRESSION	Decision making at a cellular level determines different fates for isogenic cells. However, it is not yet clear how rational decisions are encoded in the genome, how they are transmitted to their offspring, and whether they evolve and become optimized throughout generations. In this paper, we use a game theoretic approach to explain how rational decisions are made in the presence of cooperators and competitors. Our results suggest the existence of an internal switch that operates as a biased coin. The biased coin is, in fact, a biochemical bistable network of interacting genes that can flip to one of its stable states in response to different environmental stimuli. We present a framework to describe how the positions of attractors in such a gene regulatory network correspond to the behavior of a rational player in a competing environment. We evaluate our model by considering lysis/lysogeny decision making of bacteriophage lambda in E. coli.	[Dorri, Faezeh; Sharifi-Zarchi, Ali] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Mahini, Hamid] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Sharifi-Zarchi, Ali; Totonchi, Mehdi] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Totonchi, Mehdi] Royan Inst Reprod Biomedicine, ACECR, Reprod Biomed Res Ctr, Dept Genet, Tehran, Iran; [Tusserkani, Ruzbeh] Inst Res Fundamental Sci, Sch Comp Sci, Tehran, Iran; [Pezeshk, Hamid] Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Pezeshk, Hamid] Inst Res Fundamental Sci, Sch Biol Sci, Tehran, Iran; [Sadeghi, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran	University of Tehran; University System of Maryland; University of Maryland College Park; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); University of Tehran	Sadeghi, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Tehran, Iran.	sadeghi@nigeb.ac.ir	Sharifi-Zarchi, Ali/ABB-7910-2020	Sharifi-Zarchi, Ali/0000-0002-0087-7596; Totonchi, Mehdi/0000-0002-7285-3155				Abramowitz M., 1964, HDB MATH FUNCTIONS F; Alon U, 2007, INTRO SYSTEMS BIOL D; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Avlund M, 2009, J VIROL, V83, P11416, DOI 10.1128/JVI.01057-09; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Cao JG, 2012, METHODS MOL BIOL, V802, P185, DOI 10.1007/978-1-61779-400-1_12; Cao YF, 2010, P NATL ACAD SCI USA, V107, P18445, DOI 10.1073/pnas.1001455107; Chettaoui C, 2006, LECT NOTES COMPUT SC, V4210, P257; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Cover T. M, 2006, ELEMENTS INFORM THEO, V2nd, DOI 10.1002/0471200611; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; Davidson EH, 2010, REGULATORY GENOME GE; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; ELLISON G, 1993, ECONOMETRICA, V61, P1047, DOI 10.2307/2951493; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gupta R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-52; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Harmer GP, 2001, CHAOS, V11, P705, DOI 10.1063/1.1395623; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; KOURILSKY P, 1974, BIOCHIMIE, V56, P1511; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; Levins R., 1968, EVOLUTION CHANGING E; MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2; McFadden D, 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; MEYER BJ, 1980, J MOL BIOL, V139, P195, DOI 10.1016/0022-2836(80)90304-6; Montanari A, 2010, P NATL ACAD SCI USA, V107, P20196, DOI 10.1073/pnas.1004098107; MOOKHERJEE D, 1994, GAME ECON BEHAV, V7, P62, DOI 10.1006/game.1994.1037; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Papoulis A, 1984, PROBABILITY RANDOM V; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Pfeiffer T, 2005, TRENDS BIOCHEM SCI, V30, P20, DOI 10.1016/j.tibs.2004.11.006; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Refardt D, 2010, EVOLUTION, V64, P1086, DOI 10.1111/j.1558-5646.2009.00882.x; Sandholm WH., 2010, POPULATION GAMES EVO; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Waddington C. H., 1957, STRATEGY GENES, P11; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	54	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103569	10.1371/journal.pone.0103569	http://dx.doi.org/10.1371/journal.pone.0103569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090629	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700031
J	Sant'Anna, R; Braga, C; Varejao, N; Pimenta, KM; Grana-Montes, R; Alves, A; Cortines, J; Cordeiro, Y; Ventura, S; Foguel, D				Sant'Anna, Ricardo; Braga, Carolina; Varejao, Nathalia; Pimenta, Karinne M.; Grana-Montes, Ricardo; Alves, Aline; Cortines, Juliana; Cordeiro, Yraima; Ventura, Salvador; Foguel, Debora			The Importance of a Gatekeeper Residue on the Aggregation of Transthyretin IMPLICATIONS FOR TRANSTHYRETIN-RELATED AMYLOIDOSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SHEET PROTEINS; FIBRIL FORMATION; ALZHEIMERS-DISEASE; HEPARAN-SULFATE; PRESSURE; SEQUENCE; PEPTIDE; POLYNEUROPATHY; CONFORMATION; DIVERSITY	Protein aggregation into beta-sheet-enriched amyloid fibrils is associated with an increasing number of human disorders. The adoption of such amyloid conformations seems to constitute a generic property of polypeptide chains. Therefore, during evolution, proteins have adopted negative design strategies to diminish their intrinsic propensity to aggregate, including enrichment of gatekeeper charged residues at the flanks of hydrophobic aggregation-prone segments. Wild type transthyretin (TTR) is responsible for senile systemic amyloidosis, and more than 100 mutations in the TTR gene are involved in familial amyloid polyneuropathy. The TTR 26-57 segment bears many of these aggressive amyloidogenic mutations as well as the binding site for heparin. We demonstrate here that Lys-35 acts as a gatekeeper residue in TTR, strongly decreasing its amyloidogenic potential. This protective effect is sequence-specific because Lys-48 does not affect TTR aggregation. Lys-35 is part of the TTR basic heparin-binding motif. This glycosaminoglycan blocks the protective effect of Lys-35, probably by neutralization of its side chain positive charge. A K35L mutation emulates this effect and results in the rapid self-assembly of the TTR 26-57 region into amyloid fibrils. This mutation does not affect the tetrameric protein stability, but it strongly increases its aggregation propensity. Overall, we illustrate how TTR is yet another amyloidogenic protein exploiting negative design to prevent its massive aggregation, and we show how blockage of conserved protective features by endogenous factors or mutations might result in increased disease susceptibility.	[Foguel, Debora] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med Leopoldo de Meis, BR-21941590 Rio De Janeiro, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil; [Cortines, Juliana] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, BR-21941590 Rio De Janeiro, Brazil; [Grana-Montes, Ricardo; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Autonomous University of Barcelona	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Spain.	salvador.ventura@uab.es; foguel@bioqmed.ufrj.br	Ventura, Salvador/C-7021-2008; Cortines, Juliana/V-3997-2019; Ventura, Salvador/AAY-3170-2021; Alves, Aline Araujo/AAR-9678-2020; Cordeiro, Yraima/J-7619-2012	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Alves, Aline Araujo/0000-0003-4360-7681; Cordeiro, Yraima/0000-0003-4278-212X; Foguel, Debora/0000-0001-7312-7115; Varejao, Nathalia/0000-0002-6952-8896; Grana-Montes, Ricardo/0000-0003-1932-1077	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-BEB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); Ministerio de Ciencia e Innovacion (Spain) [BFU2010-14901]; AGAUR (Generalitat de Catalunya) [2009-SGR-760]; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia award	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-BEB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia award(ICREA)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagem (INCT-BEB), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ) (to D. F.) and by Ministerio de Ciencia e Innovacion (Spain) Grant BFU2010-14901 and AGAUR (Generalitat de Catalunya) Grant 2009-SGR-760 (to S. V.).; Recipient of an Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia award. To whom correspondence may be addressed. E-mail: salvador.ventura@uab.es.	Beerten J, 2012, PROTEIN ENG DES SEL, V25, P357, DOI 10.1093/protein/gzs031; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cordeiro Y, 2006, BIOPHYS J, V91, P957, DOI 10.1529/biophysj.106.085928; de Groot NS, 2012, BIOCHEM SOC T, V40, P1032, DOI 10.1042/BST20120160; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Foguel D, 2005, PROTEIN PEPTIDE LETT, V12, P245, DOI 10.2174/0929866053587200; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Grana-Montes R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00438; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; JARVIS JA, 1994, INT J PEPT PROT RES, V44, P388; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; KELLY JW, 1994, AMYLOID, V1, P186, DOI 10.3109/13506129409148451; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Long D, 2012, OPHTHALMIC GENET, V33, P28, DOI 10.3109/13816810.2011.599356; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MURAKAMI T, 1992, BIOCHEM BIOPH RES CO, V187, P397, DOI 10.1016/S0006-291X(05)81506-2; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Parrini C, 2005, STRUCTURE, V13, P1143, DOI 10.1016/j.str.2005.04.022; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; REILLY MM, 1995, BRAIN, V118, P849, DOI 10.1093/brain/118.4.849; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Saraiva MJ, 2012, CURR MED CHEM, V19, P2304; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; SILVA JL, 1989, J BIOL CHEM, V264, P15863; Soto C, 1996, BIOCHEM J, V314, P701, DOI 10.1042/bj3140701; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195	70	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2014	289	41					28324	28337		10.1074/jbc.M114.563981	http://dx.doi.org/10.1074/jbc.M114.563981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AR7NC	25086037	Green Published, hybrid			2022-12-25	WOS:000343765400027
J	Ohmomo, H; Hachiya, T; Shiwa, Y; Furukawa, R; Ono, K; Ito, S; Ishida, Y; Satoh, M; Hitomi, J; Sobue, K; Shimizu, A				Ohmomo, Hideki; Hachiya, Tsuyoshi; Shiwa, Yu; Furukawa, Ryohei; Ono, Kanako; Ito, Shigeki; Ishida, Yoji; Satoh, Mamoru; Hitomi, Jiro; Sobue, Kenji; Shimizu, Atsushi			Reduction of Systematic Bias in Transcriptome Data from Human Peripheral Blood Mononuclear Cells for Transportation and Biobanking	PLOS ONE			English	Article							GREAT EAST JAPAN; EXPRESSION; COLLECTION; EARTHQUAKE; PROFILES; TSUNAMI	Transportation of samples is essential for large-scale biobank projects. However, RNA degradation during pre-analytical operations prior to transportation can cause systematic bias in transcriptome data, which may prevent subsequent biomarker identification. Therefore, to collect high-quality biobank samples for expression analysis, specimens must be transported under stable conditions. In this study, we examined the effectiveness of RNA-stabilizing reagents to prevent RNA degradation during pre-analytical operations with an emphasis on RNA from peripheral blood mononuclear cells (PBMCs) to establish a protocol for reducing systematic bias. To this end, we obtained PBMCs from 11 healthy volunteers and analyzed the purity, yield, and integrity of extracted RNA after performing pre-analytical operations for freezing PBMCs at -80 degrees C. We randomly chose 7 samples from 11 samples individually, and systematic bias in expression levels was examined by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), RNA sequencing (RNA-Seq) experiments and data analysis. Our data demonstrated that omission of stabilizing reagents significantly lowered RNA integrity, suggesting substantial degradation of RNA molecules due to pre-analytical freezing. qRT-PCR experiments for 19 selected transcripts revealed systematic bias in the expression levels of five transcripts. RNA-Seq for 25,223 transcripts also suggested that about 40% of transcripts were systematically biased. These results indicated that appropriate reduction in systematic bias is essential in protocols for collection of RNA from PBMCs for large-scale biobank projects. Among the seven commercially available stabilizing reagents examined in this study, qRT-PCR and RNA-Seq experiments consistently suggested that RNALock, RNA/DNA Stabilization Reagent for Blood and Bone Marrow, and 1-Thioglycerol/Homogenization solution could reduce systematic bias. On the basis of the results of this study, we established a protocol to reduce systematic bias in the expression levels of RNA transcripts isolated from PBMCs. We believe that these data provide a novel methodology for collection of high-quality RNA from PBMCs for biobank researchers.	[Ohmomo, Hideki; Hachiya, Tsuyoshi; Shiwa, Yu; Furukawa, Ryohei; Ono, Kanako; Satoh, Mamoru] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biobank & Data Management, Morioka, Iwate 020, Japan; [Hachiya, Tsuyoshi; Satoh, Mamoru; Shimizu, Atsushi] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Morioka, Iwate 020, Japan; [Ito, Shigeki; Ishida, Yoji] Iwate Med Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Morioka, Iwate 020, Japan; [Satoh, Mamoru] Iwate Med Univ, Sch Med, Dept Internal Med, Div Cardioangiol, Morioka, Iwate 020, Japan; [Satoh, Mamoru] Iwate Med Univ, Sch Med, Mem Heart Ctr, Morioka, Iwate 020, Japan; [Hitomi, Jiro] Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan; [Hitomi, Jiro; Sobue, Kenji] Iwate Med Univ, Iwate Tohoku Med Megabank Org, Morioka, Iwate 020, Japan; [Sobue, Kenji] Iwate Med Univ, Inst Biomed Sci, Dept Neurosci, Morioka, Iwate 020, Japan	Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate Medical University	Shimizu, A (corresponding author), Iwate Med Univ, Iwate Tohoku Med Megabank Org, Div Biomed Informat Anal, Morioka, Iwate 020, Japan.	ashimizu@iwate-med.ac.jp	Hachiya, Tsuyoshi/AAM-8691-2021	Hachiya, Tsuyoshi/0000-0002-5274-3266; Ohmomo, Hideki/0000-0002-3524-6524	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japan	This work was supported by a grant of the Tohoku Medical Megabank Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463; Aoki T, 2012, EUR HEART J, V33, P2796, DOI 10.1093/eurheartj/ehs288; Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Baine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017014; Bayatti N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087508; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey S, 2006, GENOMICS, V87, P653, DOI 10.1016/j.ygeno.2005.11.010; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nakamura M, 2012, AM J CARDIOL, V110, P1856, DOI 10.1016/j.amjcard.2012.08.020; Nederhand RJ, 2003, J THROMB HAEMOST, V1, P987, DOI 10.1046/j.1538-7836.2003.00216.x; Omama S, 2013, STROKE, V44, P1518, DOI 10.1161/STROKEAHA.111.000442; PAWLOWSKI NA, 1983, J EXP MED, V158, P393, DOI 10.1084/jem.158.2.393; Rainen L, 2002, CLIN CHEM, V48, P1883; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Steinberg K, 2002, EPIDEMIOLOGY, V13, P246, DOI 10.1097/00001648-200205000-00003; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Wahlberg K, 2012, BIOPRESERV BIOBANK, V10, P266, DOI 10.1089/bio.2012.0004; Wright C, 2008, CLIN CHEM, V54, P396, DOI 10.1373/clinchem.2007.093419	25	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104283	10.1371/journal.pone.0104283	http://dx.doi.org/10.1371/journal.pone.0104283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101803	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900055
J	Pavlova, V; Nabe-Nielsen, J; Dietz, R; Svenning, JC; Vorkamp, K; Riget, FF; Sonne, C; Letcher, RJ; Grimm, V				Pavlova, Viola; Nabe-Nielsen, Jacob; Dietz, Rune; Svenning, Jens-Christian; Vorkamp, Katrin; Riget, Frank Farso; Sonne, Christian; Letcher, Robert J.; Grimm, Volker			Field Metabolic Rate and PCB Adipose Tissue Deposition Efficiency in East Greenland Polar Bears Derived from Contaminant Monitoring Data	PLOS ONE			English	Article							DIGESTIVE-TRACT ABSORPTION; DOUBLY LABELED WATER; URSUS-MARITIMUS; RINGED SEALS; POLYCHLORINATED-BIPHENYLS; TEMPORAL TRENDS; PHOCA-HISPIDA; ICE; MASS; REQUIREMENTS	Climate change will increasingly affect the natural habitat and diet of polar bears (Ursus maritimus). Understanding the energetic needs of polar bears is therefore important. We developed a theoretical method for estimating polar bear food consumption based on using the highly recalcitrant polychlorinated biphenyl (PCB) congener, 2,2',4,4',55-hexaCB (CB153) in bear adipose tissue as an indicator of food intake. By comparing the CB153 tissue concentrations in wild polar bears with estimates from a purposely designed individual-based model, we identified the possible combinations of field metabolic rates (FMR) and CB153 deposition efficiencies in East Greenland polar bears. Our simulations indicate that if 30% of the CB153 consumed by polar bear individuals were deposited into their adipose tissue, the corresponding FMR would be only two times the basal metabolic rate. In contrast, if the modelled CB153 deposition efficiency were 10%, adult polar bears would require six times more energy than that needed to cover basal metabolism. This is considerably higher than what has been assumed for polar bears in previous studies though it is similar to FMRs found in other marine mammals. An implication of this result is that even relatively small reductions in future feeding opportunities could impact the survival of East Greenland polar bears.	[Pavlova, Viola; Nabe-Nielsen, Jacob; Dietz, Rune; Riget, Frank Farso; Sonne, Christian] Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark; [Nabe-Nielsen, Jacob; Dietz, Rune; Vorkamp, Katrin; Sonne, Christian] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark; [Vorkamp, Katrin] Aarhus Univ, Dept Environm Sci, Sect Environm Chem & Toxicol, Roskilde, Denmark; [Grimm, Volker] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Grimm, Volker] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Letcher, Robert J.] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ecotoxicol & Wildlife Div,Sci & Technol Branch, Ottawa, ON K1S 5B6, Canada	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Potsdam; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	Pavlova, V (corresponding author), Aarhus Univ, Dept Biosci, Sect Marine Mammal Res, Roskilde, Denmark.	vpa@dmu.dk	Dietz, Rune/F-9154-2015; Svenning, Jens-Christian/C-8977-2012; Pavlova, Viola/P-2714-2017; Nabe-Nielsen, Jacob/A-5891-2010; Sonne, Christian/I-7532-2013	Dietz, Rune/0000-0001-9652-317X; Svenning, Jens-Christian/0000-0002-3415-0862; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Sonne, Christian/0000-0001-5723-5263; Vorkamp, Katrin/0000-0002-1131-5687	European Union [PITN-GA-2009-238148]; Danish Environmental Protection Agency within the Danish Cooperation for Environment in the Arctic (DANCEA); Greenland Institute of Natural Resources (Nuuk); Aage V. Jensens Foundation; DANCEA (Danish Cooperation for Environment in the Arctic) programme; KVUG (The Commission for Scientific Research in Greenland); The Center for Informatics Research on Complexity in Ecology (CIRCE); Aarhus University; Aarhus University Research Foundation	European Union(European Commission); Danish Environmental Protection Agency within the Danish Cooperation for Environment in the Arctic (DANCEA); Greenland Institute of Natural Resources (Nuuk); Aage V. Jensens Foundation; DANCEA (Danish Cooperation for Environment in the Arctic) programme; KVUG (The Commission for Scientific Research in Greenland); The Center for Informatics Research on Complexity in Ecology (CIRCE); Aarhus University; Aarhus University Research Foundation	This study was financially supported by the European Union under the 7th Framework Programme (project acronym CREAM, contract number PITN-GA-2009-238148) http://ec.europa.eu/research/fp7/index_en.cfm, VP JNN VG. The research on contamination of ringed seals was funded by the Danish Environmental Protection Agency within the Danish Cooperation for Environment in the Arctic (DANCEA). The early sampling of polar bears in Greenland was funded by the Greenland Institute of Natural Resources (Nuuk), Aage V. Jensens Foundation. Samplings since 1999 and all chemical analyses were funded by a number of projects under the DANCEA (Danish Cooperation for Environment in the Arctic) programme including the CORE programme and the large scale IPY programme "BearHealth'', which was also supported by KVUG (The Commission for Scientific Research in Greenland) and The Prince Albert II Foundation for the POP time trend analysis; KV CS RD RJL FF. The Center for Informatics Research on Complexity in Ecology (CIRCE, Aarhus University and Aarhus University Research Foundation for funding CIRCE under the AU IDEAS program, JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquarone Mario, 2006, Aquatic Mammals, V32, P363, DOI 10.1578/AM.32.3.2006.363; ARNOULD JPY, 1994, CAN J ZOOL, V72, P1365, DOI 10.1139/z94-180; Bentzen TW, 2008, SCI TOTAL ENVIRON, V406, P352, DOI 10.1016/j.scitotenv.2008.07.030; BEST RC, 1985, CAN J ZOOL, V63, P1033, DOI 10.1139/z85-155; Best RC, 1976, THESIS U GUELPH GUEL; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Christensen JR, 2009, ENVIRON TOXICOL CHEM, V28, P2206, DOI 10.1897/08-582.1; Costa DP, 2000, BIOL MARINE MAMMALS, P176; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Derocher AE, 2002, J ZOOL, V256, P343, DOI 10.1017/S0952836902000377; Derocher AE, 1996, CAN J ZOOL, V74, P1246, DOI 10.1139/z96-138; DEROCHER AE, 1994, J ZOOL, V234, P527, DOI 10.1111/j.1469-7998.1994.tb04863.x; Derocher AE, 2013, CONSERV LETT, V6, P368, DOI 10.1111/conl.12009; Dietz R, 2004, SCI TOTAL ENVIRON, V331, P107, DOI 10.1016/j.scitotenv.2004.03.025; Dietz R, 2013, ENVIRON INT, V59, P485, DOI 10.1016/j.envint.2012.09.004; Durner GM, 2011, POLAR BIOL, V34, P975, DOI 10.1007/s00300-010-0953-2; European Pet Food Industry Federation (FEDIAF), 2011, NUTR GUID COMPL COMP; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; Ginsberg G, 2002, TOXICOL SCI, V66, P185, DOI 10.1093/toxsci/66.2.185; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Henriksen EO, 2001, J ENVIRON MONITOR, V3, P493, DOI 10.1039/b102683f; Hickie BE, 1999, ENVIRON TOXICOL CHEM, V18, P2622, DOI [10.1897/1551-5028(1999)018&lt;2622:LPMFHC&gt;2.3.CO;2, 10.1002/etc.5620181132]; HURST RJ, 1982, ACTA PHYSIOL SCAND, V115, P391, DOI 10.1111/j.1748-1716.1982.tb07096.x; Iversen M, 2013, POLAR BIOL, V36, P561, DOI 10.1007/s00300-012-1284-2; Jakoby O, 2014, ECOL MODEL, V275, P78, DOI 10.1016/j.ecolmodel.2013.12.009; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Knott KK, 2012, CHEMOSPHERE, V88, P395, DOI 10.1016/j.chemosphere.2012.02.053; Krafft BA, 2006, ICES J MAR SCI, V63, P1136, DOI 10.1016/j.icesjms.2006.04.001; Letcher RJ, 2009, ENVIRON INT, V35, P1118, DOI 10.1016/j.envint.2009.07.006; Lintzenich BA, 2006, POLAR BEAR NUTR GUID; Mathewson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072863; Mauritzen M, 2003, ANIM BEHAV, V66, P107, DOI 10.1006/anbe.2003.2171; McKinney MA, 2014, ECOL EVOL, V4, P516, DOI 10.1002/ece3.956; McKinney MA, 2013, GLOBAL CHANGE BIOL, V19, P2360, DOI 10.1111/gcb.12241; McKinney MA, 2011, ENVIRON INT, V37, P365, DOI 10.1016/j.envint.2010.10.008; Mckinney MA, 2009, ENVIRON SCI TECHNOL, V43, P4334, DOI 10.1021/es900471g; MCLACHLAN MS, 1993, TOXICOL APPL PHARM, V123, P68, DOI 10.1006/taap.1993.1222; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Noren DP, 2011, MAR MAMMAL SCI, V27, P60, DOI 10.1111/j.1748-7692.2010.00386.x; Pilfold NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041429; Polischuk SC, 1999, THESIS U SASKATCHEWA; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Riget F, 2008, J ENVIRON MONITOR, V10, P935, DOI 10.1039/b807017b; Riget F, 2006, J ENVIRON MONITOR, V8, P1000, DOI 10.1039/b609522d; Schliebe S, 2008, IUCN 2012 IUCN RED L; Schlummer M, 1998, TOXICOL APPL PHARM, V152, P128, DOI 10.1006/taap.1998.8487; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SMITH TG, 1980, CAN J ZOOL, V58, P2201, DOI 10.1139/z80-302; Sonne C, 2009, CHEMOSPHERE, V77, P1558, DOI 10.1016/j.chemosphere.2009.09.044; STIRLING I, 1977, J FISH RES BOARD CAN, V34, P1126, DOI 10.1139/f77-169; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; STIRLING I, 1975, CAN J ZOOL, V53, P1021, DOI 10.1139/z75-117; STIRLING I, 1974, CAN J ZOOL, V52, P1191, DOI 10.1139/z74-157; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Trites Andrew W., 1997, Journal of Northwest Atlantic Fishery Science, V22, P173; Vorkamp K, 2011, ENVIRON SCI TECHNOL, V45, P1243, DOI 10.1021/es102755x; WATTS PD, 1991, COMP BIOCHEM PHYS A, V98, P191, DOI 10.1016/0300-9629(91)90518-H; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wilensky U., 1999, NETLOGO CTR CONNECTE; Winship AJ, 2002, MAR ECOL PROG SER, V229, P291, DOI 10.3354/meps229291	66	8	8	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104037	10.1371/journal.pone.0104037	http://dx.doi.org/10.1371/journal.pone.0104037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101837	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900032
J	Christensen, HB				Christensen, Hilary B.			Similar Associations of Tooth Microwear and Morphology Indicate Similar Diet across Marsupial and Placental Mammals	PLOS ONE			English	Article							DENTAL MICROWEAR; MOLAR MICROWEAR; LATE MIOCENE; HERBIVOROUS MAMMALS; TEXTURE ANALYSIS; FEEDING ECOLOGY; INGESTA PASSAGE; JAW MOVEMENTS; ERROR RATES; FOOD-INTAKE	Low-magnification microwear techniques have been used effectively to infer diets within many unrelated mammalian orders, but the extent to which patterns are comparable among such different groups, including long extinct mammal lineages, is unknown. Microwear patterns between ecologically equivalent placental and marsupial mammals are found to be statistically indistinguishable, indicating that microwear can be used to infer diet across the mammals. Microwear data were compared to body size and molar shearing crest length in order to develop a system to distinguish the diet of mammals. Insectivores and carnivores were difficult to distinguish from herbivores using microwear alone, but combining microwear data with body size estimates and tooth morphology provides robust dietary inferences. This approach is a powerful tool for dietary assessment of fossils from extinct lineages and from museum specimens of living species where field study would be difficult owing to the animal's behavior, habitat, or conservation status.	[Christensen, Hilary B.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Christensen, Hilary B.] Bates Coll, Dept Geol, Lewiston, ME 04240 USA	University of Chicago	Christensen, HB (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	hchriste@bates.edu			Evolving Earth Foundation; Sigma Xi; University of Chicago's Hinds Fund	Evolving Earth Foundation; Sigma Xi; University of Chicago's Hinds Fund	The Evolving Earth Foundation, Sigma Xi, and the University of Chicago's Hinds Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY MRL, 1993, AM J SCI, V293A, P356, DOI 10.2475/ajs.293.A.356; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Calandra I, 2012, J HUM EVOL, V63, P85, DOI 10.1016/j.jhevol.2012.05.001; Charles C, 2007, NATURWISSENSCHAFTEN, V94, P71, DOI 10.1007/s00114-006-0161-7; Christensen H, 2012, THESIS; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Clauss Marcus, 2008, V195, P47, DOI 10.1007/978-3-540-72422-3_3; Clauss M, 2008, COMP BIOCHEM PHYS A, V150, P274, DOI 10.1016/j.cbpa.2008.03.012; Clauss M, 2007, OIKOS, V116, P209, DOI [10.1111/j.2006.0030-1299.15461.x, 10.1111/j.0030-1299.2007.15461.x]; Clissold FJ, 2007, ADV INSECT PHYSIOL, V34, P317, DOI 10.1016/S0065-2806(07)34006-X; Cope E. D., 1887, American Naturalist, Vxxi, P985; Crompton AW, 2008, COMP BIOCHEM PHYS A, V150, P109, DOI 10.1016/j.cbpa.2007.10.015; Crompton AW, 2011, INTEGR COMP BIOL, V51, P271, DOI 10.1093/icb/icr028; Crompton Alfred W., 2008, P83, DOI 10.1007/978-0-387-76585-3_5; Crompton AW, 2010, J EXP ZOOL PART A, V313A, P564, DOI 10.1002/jez.628; Cuozzo FP, 2012, AM J PHYS ANTHROPOL, V148, P159, DOI 10.1002/ajpa.22082; Damuth J., 1990, P1; Danielson DR, 1998, AM J PHYS ANTHROPOL, V107, P297, DOI 10.1002/(SICI)1096-8644(199811)107:3<297::AID-AJPA6>3.0.CO;2-M; Demment MW, 2009, AM NAT, P641; DeSantis L, 2013, PLOS ONE, DOI [10.1371/journal.pone.0071428.s006, DOI 10.1371/JOURNAL.PONE.0071428.S006]; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; Dewar E, 2004, J VERTEBR PALEONTOL, V24, p52A; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 2003, BIOL J LINN SOC, V78, P173, DOI 10.1046/j.1095-8312.2003.00146.x; FORTELLIUS M, 1990, NETH J ZOOL, V40, P312; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; Galbany J, 2005, SCANNING, V27, P23; Galbany J, 2009, PRIMATES, V50, P221, DOI 10.1007/s10329-009-0139-0; Godfrey LR, 2005, INT J PRIMATOL, V26, P825, DOI 10.1007/s10764-005-5325-3; Godfrey LR, 2004, J HUM EVOL, V47, P145, DOI 10.1016/j.jhevol.2004.06.003; Goillot C, 2009, PALAEOGEOGR PALAEOCL, V271, P13, DOI 10.1016/j.palaeo.2008.09.004; GORDON KD, 1988, SCANNING MICROSCOPY, V2, P1139; Green JL, 2009, ZOOL J LINN SOC-LOND, V156, P201, DOI 10.1111/j.1096-3642.2008.00486.x; Green JL, 2005, PALAEOGEOGR PALAEOCL, V223, P34, DOI 10.1016/j.palaeo.2005.03.026; GRINE FE, 1981, S AFR J SCI, V77, P203; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; HERRING SW, 1993, AM ZOOL, V33, P289; HIIEMAE K, 1972, NATURE, V240, P486, DOI 10.1038/240486a0; Hogue AS, 2010, AUST J ZOOL, V58, P56, DOI 10.1071/ZO09084; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; KAY RF, 1978, AM J PHYS ANTHROPOL, V49, P119, DOI 10.1002/ajpa.1330490118; Krueger KL, 2008, AM J PHYS ANTHROPOL, V137, P485, DOI 10.1002/ajpa.20928; Legendre S., 1986, Palaeovertebrata (Montpellier), V16, P191; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Lucas PW, 2002, FOOD QUAL PREFER, V13, P203, DOI 10.1016/S0950-3293(00)00036-7; Lucas PW, 2012, J R SOC INTERFACE, V10, DOI [10.1007/s10856-010-3988-6, DOI 10.1007/S10856-010-3988-6]; Lucas PW., 2004, DENT FUNCTIONAL MORP, DOI [10.1017/CBO9780511735011, DOI 10.1017/CB09780511735011]; Mainland I, 2006, J ARCHAEOL SCI, V33, P238, DOI 10.1016/j.jas.2005.07.013; Mainland IL, 2003, J ARCHAEOL SCI, V30, P1513, DOI 10.1016/S0305-4403(03)00055-4; Mainland IL, 2000, INT J OSTEOARCHAEOL, V10, P93, DOI 10.1002/(SICI)1099-1212(200003/04)10:2<93::AID-OA513>3.3.CO;2-L; McNab B.K., 2002, PHYSL ECOLOGY VERTEB, P576; Merceron G, 2005, PALAIOS, V20, P551, DOI 10.2110/palo.2004.p04-17; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2004, SMALL RUMINANT RES, V53, P125, DOI [10.1016/j.smallrumres.2003.10.002, 10.1016/j.smallrumers.2003.10.002]; Merceron G, 2007, GEODIVERSITAS, V29, P421; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Mihlbachler Matthew C., 2012, Palaeontologia Electronica, V15, P1; Nelson Sherry, 2005, Palaeontologia Electronica, V8, P1; Nowak R.M., 1999, WALKERS MAMMALS WORL, P1936; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; Purnell MA, 2013, J ZOOL, V291, P249, DOI 10.1111/jzo.12068; Purnell MA, 2012, J R SOC INTERFACE, V9, P2225, DOI 10.1098/rsif.2012.0140; Rafferty KL, 2002, J HUM EVOL, V43, P645, DOI 10.1006/jhev.2002.0592; Ramdarshan A, 2010, J HUM EVOL, V59, P96, DOI 10.1016/j.jhevol.2010.04.007; RENSBERGER JM, 1984, PALEOBIOLOGY, V10, P439, DOI 10.1017/S0094837300008447; Rivals F, 2008, PALAEOGEOGR PALAEOCL, V265, P134, DOI 10.1016/j.palaeo.2008.05.001; Rivals Florent, 2007, Journal of Mammalian Evolution, V14, P182, DOI 10.1007/s10914-007-9044-8; Rivals F, 2012, QUATERN INT, V255, P188, DOI 10.1016/j.quaint.2011.05.036; Rivals F, 2011, QUATERN INT, V245, P279, DOI 10.1016/j.quaint.2010.08.001; Rodrigues HG, 2009, NATURWISSENSCHAFTEN, V96, P537, DOI 10.1007/s00114-008-0501-x; Ross CF, 2007, J EXP BIOL, V210, P1046, DOI 10.1242/jeb.02733; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; SANSON GD, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P151; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Schulz E, 2013, WEAR, V300, P169, DOI 10.1016/j.wear.2013.01.115; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semprebon GM, 2011, J MAMM EVOL, V18, P33, DOI 10.1007/s10914-010-9149-3; Semprebon GM, 2004, J HUM EVOL, V47, P115, DOI 10.1016/j.jhevol.2004.06.004; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Strait DS, 2012, J HUM EVOL, V62, P165, DOI 10.1016/j.jhevol.2011.10.006; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; STRAIT SG, 1993, AM J PHYS ANTHROPOL, V92, P63, DOI 10.1002/ajpa.1330920106; Strait SG, 2001, J VERTEBR PALEONTOL, V21, P322, DOI 10.1671/0272-4634(2001)021[0322:DROSBO]2.0.CO;2; STRAIT SG, 1993, J HUM EVOL, V25, P471, DOI 10.1006/jhev.1993.1062; Strait Suzanne G., 1997, Evolutionary Anthropology, V5, P199, DOI 10.1002/(SICI)1520-6505(1997)5:6<199::AID-EVAN2>3.0.CO;2-8; Teaford MF, 1996, AM J PHYS ANTHROPOL, V101, P527; TEAFORD MF, 1991, AM J PHYS ANTHROPOL, V85, P313, DOI 10.1002/ajpa.1330850310; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1149; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Townsend KEB, 2008, J MAMMAL, V89, P730, DOI 10.1644/06-MAMM-A-336R1.1; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2010, MAMMALIA, V74, P219, DOI 10.1515/MAMM.2010.015; UNGAR PS, 1995, P NATL ACAD SCI USA, V92, P5479, DOI 10.1073/pnas.92.12.5479; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; UNGAR PS, 1995, SCANNING, V17, P57; Ungar PS, 2010, MAMMAL TEETH ORIGIN, P304; Van Valkenburgh B., 1989, CARNIVORE BEHAV ECOL, P410, DOI DOI 10.1007/978-1-4757-4716-4; VANVALKENBURGH B, 1990, J ZOOL, V222, P319; VINCENT JFV, 1990, ADV BOT RES, V17, P235, DOI 10.1016/S0065-2296(08)60135-4; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Wright W, 1996, BIOL REV, V71, P401, DOI 10.1111/j.1469-185X.1996.tb01280.x	117	12	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e102789	10.1371/journal.pone.0102789	http://dx.doi.org/10.1371/journal.pone.0102789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6SM	25099537	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100013
J	Davis, CM; Roma, PG; Armour, E; Gooden, VL; Brady, JV; Weed, MR; Hienz, RD				Davis, Catherine M.; Roma, Peter G.; Armour, Elwood; Gooden, Virginia L.; Brady, Joseph V.; Weed, Michael R.; Hienz, Robert D.			Effects of X-Ray Radiation on Complex Visual Discrimination Learning and Social Recognition Memory in Rats	PLOS ONE			English	Article							SCHEDULE-CONTROLLED PERFORMANCE; IONIZING-RADIATION; INDUCED DISRUPTION; LITHIUM-CHLORIDE; FE-56 PARTICLES; EXPOSURE; NEUROGENESIS; ACQUISITION; DEFICITS; LESIONS	The present report describes an animal model for examining the effects of radiation on a range of neurocognitive functions in rodents that are similar to a number of basic human cognitive functions. Fourteen male Long-Evans rats were trained to perform an automated intra-dimensional set shifting task that consisted of their learning a basic discrimination between two stimulus shapes followed by more complex discrimination stages (e.g., a discrimination reversal, a compound discrimination, a compound reversal, a new shape discrimination, and an intra-dimensional stimulus discrimination reversal) One group of rats was exposed to head-only X-ray radiation (2.3 Gy at a dose rate of 1.9 Gy/min), while a second group received a sham-radiation exposure using the same anesthesia protocol. The irradiated group responded less, had elevated numbers of omitted trials, increased errors, and greater response latencies compared to the sham-irradiated control group. Additionally, social odor recognition memory was tested after radiation exposure by assessing the degree to which rats explored wooden beads impregnated with either their own odors or with the odors of novel, unfamiliar rats however, no significant effects of radiation on social odor recognition memory were observed. These data suggest that rodent tasks assessing higher-level human cognitive domains are useful in examining the effects of radiation on the CNS, and may be applicable in approximating CNS risks from radiation exposure in clinical populations receiving whole brain irradiation.	[Davis, Catherine M.; Roma, Peter G.; Gooden, Virginia L.; Brady, Joseph V.; Weed, Michael R.; Hienz, Robert D.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA; [Armour, Elwood] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21205 USA; [Roma, Peter G.; Brady, Joseph V.; Hienz, Robert D.] Inst Behav Resources, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Davis, CM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Behav Biol, Baltimore, MD 21205 USA.	cdavis91@jhmi.edu		Davis-Takacs, Catherine/0000-0002-2591-6352	National Space Biomedical Research Institute (NSBRI) through NASA [NCC 9-58, NBPF01604, NBPF02802, PF02602]	National Space Biomedical Research Institute (NSBRI) through NASA	This study was supported by the National Space Biomedical Research Institute (NSBRI) through NASA cooperative agreement NCC 9-58, grants NBPF01604 (R.D.H.), NBPF02802 (R.D.H.), and PF02602 (C.M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ator AA, 1991, EXPT ANAL BEHAV 1, P1; BOGO V, 1989, RADIAT RES, V118, P341, DOI 10.2307/3577448; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Davis CM, 2014, RADIAT RES, V181, P258, DOI 10.1667/RR13359.1; Davis CM, 2013, NASA HUM RES PERF IN; Davis CM, 2012, NASA HUM RES PERF IN; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Feinberg LM, 2012, NEUROBIOL LEARN MEM, V97, P7, DOI 10.1016/j.nlm.2011.08.008; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Greene-Schloesser D, 2012, NEURO-ONCOLOGY, V14, P37, DOI 10.1093/neuonc/nos196; Hienz RD, 2008, RADIAT RES, V170, P292, DOI 10.1667/RR1222.1; Lonart G, 2012, RADIAT RES, V178, P289, DOI 10.1667/RR2862.1; MELE PC, 1995, NEUROTOXICOLOGY, V16, P497; MELE PC, 1988, PHARMACOL BIOCHEM BE, V30, P1007, DOI 10.1016/0091-3057(88)90133-5; MELE PC, 1990, NEUROTOXICOL TERATOL, V12, P367, DOI 10.1016/0892-0362(90)90056-I; Mizumatsu S, 2003, CANCER RES, V63, P4021; Ng T, 2014, EXPERT OPIN DRUG SAF, V13, P83, DOI 10.1517/14740338.2013.828034; RABIN BM, 1989, RADIAT RES, V119, P113, DOI 10.2307/3577371; RABIN BM, 1994, ADV SPACE RES, V14, P457, DOI 10.1016/0273-1177(94)90500-2; Rabin BM, 2005, RADIAT RES, V164, P552, DOI 10.1667/RR3349.1; Rabin BM, 2005, BRAIN RES, V1036, P122, DOI 10.1016/j.brainres.2004.12.041; Rabin BM, 2004, ADV SPACE RES, V33, P1330, DOI 10.1016/j.asr.2003.09.051; Rabin BM, 2002, J RADIAT RES, V43, pS225; Rabin BM, 2001, PHYS MEDICA, V17, P196; RABIN BM, 1992, BEHAV NEURAL BIOL, V58, P83, DOI 10.1016/0163-1047(92)90291-B; RABIN BM, 1988, PHARMACOL BIOCHEM BE, V31, P909, DOI 10.1016/0091-3057(88)90404-2; RABIN BM, 1992, AVIAT SPACE ENVIR MD, V63, P702; RABIN BM, 1986, NEUROSCI BIOBEHAV R, V10, P55, DOI 10.1016/0149-7634(86)90033-3; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; Roberts AC, 1996, COGNITIVE BRAIN RES, V3, P319, DOI 10.1016/0926-6410(96)00017-1; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Shukitt-Hale B, 2003, ADV SPACE RES-SERIES, V31, P119, DOI 10.1016/S0273-1177(02)00878-5; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; STEBBINS WC, 1964, J EXP ANAL BEHAV, V7, P309, DOI 10.1901/jeab.1964.7-309; WINSAUER PJ, 1995, NEUROTOXICOLOGY, V16, P257; WINSAUER PJ, 1993, PHARMACOL BIOCHEM BE, V44, P809, DOI 10.1016/0091-3057(93)90010-Q; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025	39	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104393	10.1371/journal.pone.0104393	http://dx.doi.org/10.1371/journal.pone.0104393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099152	gold, Green Submitted, Green Published			2022-12-25	WOS:000339995100069
J	Dileo, MV; Bostock, RM; Rizzo, DM				Dileo, Matthew V.; Bostock, Richard M.; Rizzo, David M.			Microclimate Impacts Survival and Prevalence of Phytophthora ramorum in Umbellularia californica, a Key Reservoir Host of Sudden Oak Death in Northern California Forests	PLOS ONE			English	Article							TEMPERATURE; TRANSMISSION; SPORULATION; PATHOGEN; EXPOSURE	Phytophthora ramorum, an invasive pathogen and the causal agent of Sudden Oak Death, has become established in mixed-evergreen and redwood forests in coastal northern California. While oak and tanoak mortality is the most visible indication of P. ramorum's presence, epidemics are largely driven by the presence of bay laurel (Umbellularia californica), a reservoir host that supports both prolific sporulation in the winter wet season and survival during the summer dry season. In order to better understand how over-summer survival of the pathogen contributes to variability in the severity of annual epidemics, we monitored the viability of P. ramorum leaf infections over three years along with coincident microclimate. The proportion of symptomatic bay laurel leaves that contained viable infections decreased during the first summer dry season and remained low for the following two years, likely due to the absence of conducive wet season weather during the study period. Over-summer survival of P. ramorum was positively correlated with high percent canopy cover, less negative bay leaf water potential and few days exceeding 30 degrees C but was not significantly different between mixed-evergreen and redwood forest ecosystems. Decreased summer survival of P. ramorum in exposed locations and during unusually hot summers likely contributes to the observed spatiotemporal heterogeneity of P. ramorum epidemics.	[Dileo, Matthew V.; Bostock, Richard M.; Rizzo, David M.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Rizzo, DM (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	dmrizzo@ucdavis.edu			USDA Forest Service Pacific Southwest Research Station; Gordon and Betty Moore Foundation; Department of Homeland Security	USDA Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Homeland Security(United States Department of Homeland Security (DHS))	This research was supported by the USDA Forest Service Pacific Southwest Research Station, the Gordon and Betty Moore Foundation, and the Department of Homeland Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AQ, 1959, LEAF TEMPERATURES, P713; Beh MM, 2012, NEW PHYTOL, V196, P1145, DOI 10.1111/j.1469-8137.2012.04352.x; Browning M, 2008, MYCOLOGIA, V100, P236, DOI 10.3852/mycologia.100.2.236; Buffo J, 1972, PNWRP142; Chimento A, 2012, FOREST PATHOL, V42, P14, DOI 10.1111/j.1439-0329.2011.00717.x; Condeso TE, 2007, J ECOL, V95, P364, DOI 10.1111/j.1365-2745.2006.01206.x; Davidson JM, 2008, PHYTOPATHOLOGY, V98, P860, DOI 10.1094/PHYTO-98-8-0860; Davidson JM, 2011, PHYTOPATHOLOGY, V101, P492, DOI 10.1094/PHYTO-03-10-0064; Davidson JM, 2005, PHYTOPATHOLOGY, V95, P587, DOI 10.1094/PHYTO-95-0587; DiLeo MV, 2009, PHYTOPATHOLOGY, V99, P1307, DOI 10.1094/PHYTO-99-11-1307; DiLeo MV, 2006, PHYTOPATHOLOGY; Duniway JM, 1983, PHYTOPHTHORA ITS BIO, P175; Englander L, 2006, MYCOLOGIA, V98, P365, DOI 10.3852/mycologia.98.3.365; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fichtner EJ, 2007, PHYTOPATHOLOGY, V97, P1366, DOI 10.1094/PHYTO-97-10-1366; Fichtner EJ, 2009, PHYTOPATHOLOGY, V99, P608, DOI 10.1094/PHYTO-99-5-0608; FUCHS M, 1990, THEOR APPL CLIMATOL, V42, P253, DOI 10.1007/BF00865986; Huberli D, 2012, PLANT PATHOL, V61, P579, DOI 10.1111/j.1365-3059.2011.02535.x; Konzanitas M, 2012, 5 SUDD OAK DEATH SCI; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; MCCUTCHAN H, 1992, J AM SOC HORTIC SCI, V117, P607, DOI 10.21273/JASHS.117.4.607; McPherson BA, 2005, FOREST ECOL MANAG, V213, P71, DOI 10.1016/j.foreco.2005.03.048; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Tooley PW, 2008, PLANT DIS, V92, P431, DOI 10.1094/PDIS-92-3-0431	25	12	12	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e98195	10.1371/journal.pone.0098195	http://dx.doi.org/10.1371/journal.pone.0098195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098281	Green Published, gold			2022-12-25	WOS:000339995100001
J	Richards, MA; Cassen, V; Heavner, BD; Ajami, NE; Herrmann, A; Simeonidis, E; Price, ND				Richards, Matthew A.; Cassen, Victor; Heavner, Benjamin D.; Ajami, Nassim E.; Herrmann, Andrea; Simeonidis, Evangelos; Price, Nathan D.			MediaDB: A Database of Microbial Growth Conditions in Defined Media	PLOS ONE			English	Article							MARINE-BACTERIA; DILUTION CULTURE; SOIL BACTERIA; PURE CULTURE; CULTIVATION; MICROORGANISMS; CULTURABILITY; INCUBATION; STRATEGIES; PROJECT	Isolating pure microbial cultures and cultivating them in the laboratory on defined media is used to more fully characterize the metabolism and physiology of organisms. However, identifying an appropriate growth medium for a novel isolate remains a challenging task. Even organisms with sequenced and annotated genomes can be difficult to grow, despite our ability to build genome-scale metabolic networks that connect genomic data with metabolic function. The scientific literature is scattered with information about defined growth media used successfully for cultivating a wide variety of organisms, but to date there exists no centralized repository to inform efforts to cultivate less characterized organisms by bridging the gap between genomic data and compound composition for growth media. Here we present MediaDB, a manually curated database of defined media that have been used for cultivating organisms with sequenced genomes, with an emphasis on organisms with metabolic network models. The database is accessible online, can be queried by keyword searches or downloaded in its entirety, and can generate exportable individual media formulation files. The data assembled in MediaDB facilitate comparative studies of organism growth media, serve as a starting point for formulating novel growth media, and contribute to formulating media for in silico investigation of metabolic networks. MediaDB is freely available for public use at https://mediadb.systemsbiology.net.	[Richards, Matthew A.; Ajami, Nassim E.; Herrmann, Andrea] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL USA; [Richards, Matthew A.; Cassen, Victor; Heavner, Benjamin D.; Simeonidis, Evangelos; Price, Nathan D.] Inst Syst Biol, Seattle, WA 98109 USA; [Simeonidis, Evangelos] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg	University of Illinois System; University of Illinois Urbana-Champaign; Institute for Systems Biology (ISB); University of Luxembourg	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	nprice@systemsbiology.org		Heavner, Benjamin/0000-0003-2898-9044; Simeonidis, Vangelis/0000-0001-6153-4493; Price, Nathan/0000-0002-4157-0267	Camille Dreyfus Teacher-Scholar Award; Department of Energy Genomic Sciences Program [DE-FG02-10ER64999]; National Institutes of Health Center for Systems Biology [2P50 GM076547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	Camille Dreyfus Teacher-Scholar Award; Department of Energy Genomic Sciences Program(United States Department of Energy (DOE)); National Institutes of Health Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a Camille Dreyfus Teacher-Scholar Award (http://www.dreyfus.org/), a Department of Energy Genomic Sciences Program (DE-FG02-10ER64999, http://genomicscience.energy.gov/), and National Institutes of Health Center for Systems Biology (2P50 GM076547, http://www.nih.gov/). Nathan D. Price received the funding from these sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain K, 2009, EXTREMOPHILES, V13, P583, DOI 10.1007/s00792-009-0261-3; Amann R, 2000, SYST APPL MICROBIOL, V23, P1; Benedict MN, 2012, J BACTERIOL, V194, P855, DOI 10.1128/JB.06040-11; Bollmann A, 2007, APPL ENVIRON MICROB, V73, P6386, DOI 10.1128/AEM.01309-07; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Bruns A, 2003, APPL ENVIRON MICROB, V69, P1980, DOI 10.1128/AEM.69.4.1980-1989.2003; Bruns A, 2002, APPL ENVIRON MICROB, V68, P3978, DOI 10.1128/AEM.68.8.3978-3987.2002; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Carini P, 2013, ISME J, V7, P592, DOI 10.1038/ismej.2012.122; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Covert MW, 2003, BIOTECHNOL BIOENG, V84, P763, DOI 10.1002/bit.10849; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Imanishi T, 2009, NUCLEIC ACIDS RES, V37, pW17, DOI 10.1093/nar/gkp355; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; Joint I, 2010, MICROB BIOTECHNOL, V3, P564, DOI 10.1111/j.1751-7915.2010.00188.x; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Nichols D, 2008, APPL ENVIRON MICROB, V74, P4889, DOI 10.1128/AEM.00393-08; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pham VH, 2012, TRENDS BIOTECHNOLOGY; Prakash O, 2013, APPL MICROBIOL BIOT, V97, P51, DOI 10.1007/s00253-012-4533-y; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Song H, 2008, APPL MICROBIOL BIOT, V79, P263, DOI 10.1007/s00253-008-1425-2; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P4748, DOI 10.1128/AEM.70.8.4748-4755.2004; Stott MB, 2008, ENVIRON MICROBIOL, V10, P2030, DOI 10.1111/j.1462-2920.2008.01621.x; Subramaniam S, 1998, PROTEINS, V32, P1; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Watve M, 2000, CURR SCI INDIA, V78, P1535; Yasumoto-Hirose M, 2006, MAR BIOTECHNOL, V8, P227, DOI 10.1007/s10126-005-5015-3; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zengler K, 2005, METHOD ENZYMOL, V397, P124, DOI 10.1016/S0076-6879(05)97007-9	49	29	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103548	10.1371/journal.pone.0103548	http://dx.doi.org/10.1371/journal.pone.0103548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098325	Green Submitted, Green Published, gold			2022-12-25	WOS:000339995100022
J	Gea, J; Munoz, MA; Costa, I; Ciria, LF; Miranda, JGV; Montoya, P				Gea, Juan; Munoz, Miguel A.; Costa, Isis; Ciria, Luis F.; Miranda, Jose G. V.; Montoya, Pedro			Viewing Pain and Happy Faces Elicited Similar Changes in Postural Body Sway	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTION; FEAR; MOTIVATION; PICTURES; THREAT	Affective facial expressions are potent social cues that can induce relevant physiological changes, as well as behavioral dispositions in the observer. Previous studies have revealed that angry faces induced significant reductions in body sway as compared with neutral and happy faces, reflecting an avoidance behavioral tendency as freezing. The expression of pain is usually considered an unpleasant stimulus, but also a relevant cue for delivering effective care and social support. Nevertheless, there are few data about behavioral dispositions elicited by the observation of pain expressions in others. The aim of the present research was to evaluate approach-avoidance tendencies by using video recordings of postural body sway when participants were standing and observing facial expressions of pain, happy and neutral. We hypothesized that although pain faces would be rated as more unpleasant than the other faces, they would provoke significant changes in postural body sway as compared to neutral facial expressions. Forty healthy female volunteers (mean age 25) participated in the study. Amplitude of forward movements and backward movements in the anterior-posterior and medial-lateral axes were obtained. Statistical analyses revealed that pain faces were the most unpleasant stimuli, and that both happy and pain faces were more arousing than neutral ones. Happy and pain faces also elicited greater amplitude of body sway in the anterior-posterior axes as compared with neutral faces. In addition, significant positive correlations were found between body sway elicited by pain faces and pleasantness and empathic ratings, suggesting that changes in postural body sway elicited by pain faces might be associated with approach and cooperative behavioral responses.	[Gea, Juan; Costa, Isis; Montoya, Pedro] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Spain; [Munoz, Miguel A.; Ciria, Luis F.] Univ Granada, Dept Personal, Granada, Spain; [Miranda, Jose G. V.] Univ Fed Bahia, Dept Phys Earth & Environm, Salvador, BA, Brazil	Universitat de les Illes Balears; University of Granada; Universidade Federal da Bahia	Montoya, P (corresponding author), Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Spain.	pedro.montoya@uib.es	Miranda, Jose/HCI-6099-2022; Ciria, Luis/AAA-7528-2020; Montoya, Pedro/A-4666-2009; Muñoz, Miguel Angel/A-8067-2017	Montoya, Pedro/0000-0001-8652-948X; Muñoz, Miguel Angel/0000-0002-8361-7297; Ciria, Luis/0000-0001-7067-5060	Spanish Ministry of Science and Innovation [PSI2010-19372]; European Regional Development Funds	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Funds(European Commission)	Research was funded by grant #PSI2010-19372 from Spanish Ministry of Science and Innovation and European Regional Development Funds (http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.dbc68b34d11ccbd5d52ffeb801432ea0/?vgnextoid = 17aba53632295210VgnVCM1000001d04140aRCRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo TM, 2005, PSYCHOPHYSIOLOGY, V42, P255, DOI 10.1111/j.1469-8986.2005.00287.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Davis JR, 2009, GAIT POSTURE, V29, P275, DOI 10.1016/j.gaitpost.2008.09.006; Eerland A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031291; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037/0022-3514.80.1.75; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gonzalez-Roldan AM, 2013, ALTERED PSYCHOPHYSIO; Gonzalez-Roldan AM, 2011, PAIN, V152, P853, DOI 10.1016/j.pain.2010.12.037; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; Horslen BC, 2011, EXP BRAIN RES, V215, P27, DOI 10.1007/s00221-011-2867-9; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 1997, ATTENTION ORIENTING; Latash ML, 2003, EXP BRAIN RES, V150, P314, DOI 10.1007/s00221-003-1419-3; Lopes FL, 2009, DEPRESS ANXIETY, V26, P917, DOI 10.1002/da.20593; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Peña Norberto, 2013, Rev. Bras. Ensino Fís., V35, P1, DOI 10.1590/S1806-11172013000300024; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Stins JF, 2011, EXP BRAIN RES, V212, P603, DOI 10.1007/s00221-011-2767-z; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Vuillerme N, 2007, PSYCHOL RES-PSYCH FO, V71, P192, DOI 10.1007/s00426-005-0018-2; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Williams LM, 2004, COGNITIVE BRAIN RES, V21, P114, DOI 10.1016/j.cogbrainres.2004.06.005	34	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104381	10.1371/journal.pone.0104381	http://dx.doi.org/10.1371/journal.pone.0104381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093727	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200107
J	Ishida, M; Ishida, T; Tashiro, S; Uchida, H; Sakai, C; Hironobe, N; Miura, K; Hashimoto, Y; Arihiro, K; Chayama, K; Kihara, Y; Yoshizumi, M				Ishida, Mari; Ishida, Takafumi; Tashiro, Satoshi; Uchida, Hitomi; Sakai, Chiemi; Hironobe, Naoya; Miura, Katsuya; Hashimoto, Yu; Arihiro, Koji; Chayama, Kazuaki; Kihara, Yasuki; Yoshizumi, Masao			Smoking Cessation Reverses DNA Double-Strand Breaks in Human Mononuclear Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LUNG-CANCER PATIENTS; CIGARETTE-SMOKING; CARBON-MONOXIDE; ANGIOTENSIN-II; TOBACCO-SMOKE; DAMAGE; REPAIR; ATHEROSCLEROSIS; SENESCENCE	Objective: Cigarette smoking is a major risk factor for atherosclerotic cardiovascular disease, which is responsible for a significant proportion of smoking-related deaths. However, the precise mechanism whereby smoking induces this pathology has not been fully delineated. Based on observation of DNA double-strand breaks (DSBs), the most harmful type of DNA damage, in atherosclerotic lesions, we hypothesized that there is a direct association between smoking and DSBs. The goal of this study was to investigate whether smoking induces DSBs and smoking cessation reverses DSBs in vivo through examination of peripheral mononuclear cells (MNCs). Approach and Results: Immunoreactivity of oxidative modification of DNA and DSBs were increased in human atherosclerotic lesions but not in the adjacent normal area. DSBs in human MNCs isolated from the blood of volunteers can be detected as cytologically visible "foci'' using an antibody against the phosphorylated form of the histone H2AX (gamma-H2AX). Young healthy active smokers (n = 15) showed increased gamma-H2AX foci number when compared with non-smokers (n = 12) (foci number/cell: median, 0.37/cell; interquartile range [IQR], 0.31-0.58 vs. 4.36/cell; IQR, 3.09-7.39, p<0.0001). Smoking cessation for 1 month reduced the gamma-H2AX foci number (median, 4.44/cell; IQR, 4.36-5.24 to 0.28/cell; IQR, 0.12-0.53, p<0.05). A positive correlation was noted between gamma-H2AX foci number and exhaled carbon monoxide levels (r = 0.75, p<0.01). Conclusions: Smoking induces DSBs in human MNCs in vivo, and importantly, smoking cessation for 1 month resulted in a decrease in DSBs to a level comparable to that seen in non-smokers. These data reinforce the notion that the cigarette smoking induces DSBs and highlight the importance of smoking cessation.	[Ishida, Mari; Uchida, Hitomi; Sakai, Chiemi; Miura, Katsuya; Yoshizumi, Masao] Hiroshima Univ, Dept Cardiovasc Physiol & Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Ishida, Takafumi; Hironobe, Naoya; Hashimoto, Yu; Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Tashiro, Satoshi] Hiroshima Univ, Dept Cellular Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan; [Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Ishida, T (corresponding author), Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	ishidat@hiroshima-u.ac.jp	Ishida, Mari/L-8208-2016; Chayama, Kazuaki/B-2493-2016	Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590528]; Takeda Science Foundation; Kurozumi Medical Foundation; SENSHIN Medical Research Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kurozumi Medical Foundation(Kurozumi Medical Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, #22590528 (http://www.jsps.go.jp/english/e-grants/index.html) to MI and TI, research grants from the Takeda Science Foundation (http://www.takeda-sci.or.jp/index.html), the Kurozumi Medical Foundation (http://www.kmf.or.jp/), and the SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan/) to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AP, 2009, MUTAT RES-GEN TOX EN, V678, P43, DOI 10.1016/j.mrgentox.2009.06.009; Albino AP, 2004, CELL CYCLE, V3, P1062; Asami S, 1996, CANCER RES, V56, P2546; Babizhayev MA, 2011, FUND CLIN PHARMACOL, V25, P425, DOI 10.1111/j.1472-8206.2010.00866.x; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; BURR ML, 1992, EUR HEART J, V13, P166, DOI 10.1093/oxfordjournals.eurheartj.a060141; Chen YY, 2007, CELL METAB, V6, P164, DOI 10.1016/j.cmet.2007.07.001; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957; Hou SM, 1999, CARCINOGENESIS, V20, P437, DOI 10.1093/carcin/20.3.437; Ishida M, 1998, CIRC RES, V82, P7; Jorgensen ED, 2010, CELL CYCLE, V9, P2170, DOI 10.4161/cc.9.11.11842; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Lodovici M, 2009, INT J ENV RES PUB HE, V6, P874, DOI 10.3390/ijerph6030874; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899; Meyers DG, 2008, AM J CARDIOL, V102, P1421, DOI 10.1016/j.amjcard.2008.06.065; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Moreno H, 1998, AM J PHYSIOL-HEART C, V275, pH1040, DOI 10.1152/ajpheart.1998.275.3.H1040; Nowosielska A, 2008, DNA REPAIR, V7, P48, DOI 10.1016/j.dnarep.2007.07.015; Peluso M, 2000, CARCINOGENESIS, V21, P183, DOI 10.1093/carcin/21.2.183; Rahman AA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/189129; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Skosareva LV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P524, DOI 10.1134/S0006297912050136; Slatter TL, 2014, HUM PATHOL, V45, P17, DOI 10.1016/j.humpath.2013.07.024; Thorne D, 2009, MUTAT RES-GEN TOX EN, V673, P3, DOI 10.1016/j.mrgentox.2008.11.008; Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495; Vamvakas S, 1997, CRIT REV TOXICOL, V27, P155, DOI 10.3109/10408449709021617; van Zeeland AA, 1999, MUTAT RES-GEN TOX EN, V439, P249, DOI 10.1016/S1383-5718(98)00192-2; Varkonyi A, 2006, CANCER LETT, V236, P24, DOI 10.1016/j.canlet.2005.04.034; WALD NJ, 1981, THORAX, V36, P366, DOI 10.1136/thx.36.5.366; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388	36	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103993	10.1371/journal.pone.0103993	http://dx.doi.org/10.1371/journal.pone.0103993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093845	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200055
J	Topf, A; Griffin, HR; Glen, E; Soemedi, R; Brown, DL; Hall, D; Rahman, TJ; Eloranta, JJ; Jungst, C; Stuart, AG; O'Sullivan, J; Keavney, BD; Goodship, JA				Toepf, Ana; Griffin, Helen R.; Glen, Elise; Soemedi, Rachel; Brown, Danielle L.; Hall, Darroch; Rahman, Thahira J.; Eloranta, Jyrki J.; Juengst, Christoph; Stuart, A. Graham; O'Sullivan, John; Keavney, Bernard D.; Goodship, Judith A.			Functionally Significant, Rare Transcription Factor Variants in Tetralogy of Fallot	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; MISSENSE MUTATIONS; MENTAL-RETARDATION; NKX2.5 MUTATIONS; GENETIC SYNDROME; SEPTAL-DEFECT; FOXC1; GATA4; TBX1; EXPRESSION	Objective: Rare variants in certain transcription factors involved in cardiac development cause Mendelian forms of congenital heart disease. The purpose of this study was to systematically assess the frequency of rare transcription factor variants in sporadic patients with the cardiac outflow tract malformation tetralogy of Fallot (TOF). Methods and Results: We sequenced the coding, 5'UTR, and 3'UTR regions of twelve transcription factor genes implicated in cardiac outflow tract development (NKX2.5, GATA4, ISL1, TBX20, MEF2C, BOP/SMYD1, HAND2, FOXC1, FOXC2, FOXH, FOXA2 and TBX1) in 93 non-syndromic, non-Mendelian TOF cases. We also analysed Illumina Human 660W-Quad SNP Array data for copy number variants in these genes; none were detected. Four of the rare variants detected have previously been shown to affect transactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP. Two further rare variants, HAND2 p.A25_A26insAA and FOXC1 p.G378_G380delGGG, A488_491delAAAA, affected transactivation in in vitro reporter assays. Each of these six functionally significant variants was present in a single patient in the heterozygous state; each of the four for which parental samples were available were maternally inherited. Thus in the 93 TOF cases we identified six functionally significant mutations in the secondary heart field transcriptional network. Significance: This study indicates that rare genetic variants in the secondary heart field transcriptional network with functional effects on protein function occur in 3-13% of patients with TOF. This is the first report of a functionally significant HAND2 mutation in a patient with congenital heart disease.	[Toepf, Ana; Griffin, Helen R.; Glen, Elise; Soemedi, Rachel; Brown, Danielle L.; Hall, Darroch; Rahman, Thahira J.; Keavney, Bernard D.; Goodship, Judith A.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Eloranta, Jyrki J.; Juengst, Christoph] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Juengst, Christoph] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Stuart, A. Graham] Bristol Royal Hosp Children, Bristol, Avon, England; [O'Sullivan, John] Freeman Hosp Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Keavney, Bernard D.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	Newcastle University - UK; University of Zurich; University Zurich Hospital; Saarland University; Bristol Royal Hospital For Children; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Manchester	Keavney, BD (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	bernard.keavney@manchester.ac.uk; judith.goodship@ncl.ac.uk		Keavney, Bernard/0000-0001-9573-0812; Griffin, Helen R/0000-0002-5288-3322; Jungst, Christoph/0000-0001-5048-390X; Stuart, Alan Graham/0000-0003-2789-2216	British Heart Foundation; British Heart Foundation [RG/08/012/25941] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by a British Heart Foundation Programme Grant. BDK holds a BHF Personal Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bourgeois CF, 1999, MOL CELL BIOL, V19, P7347; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brice G, 2002, J MED GENET, V39, P478, DOI 10.1136/jmg.39.7.478; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cunningham ET, 1998, ARCH OPHTHALMOL-CHIC, V116, P78, DOI 10.1001/archopht.116.1.78; Fetterman CD, 2009, CLIN GENET, V76, P296, DOI 10.1111/j.1399-0004.2009.01210.x; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Granados-Riveron JT, 2012, CONGENIT HEART DIS, V7, P151, DOI 10.1111/j.1747-0803.2011.00573.x; Griffin HR, 2010, HEART, V96, P1651, DOI 10.1136/hrt.2010.200121; Grosso S, 2002, AM J MED GENET, V111, P182, DOI 10.1002/ajmg.10493; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Posch MG, 2010, J MED GENET, V47, P230, DOI 10.1136/jmg.2009.069997; Roessler E, 2008, AM J HUM GENET, V83, P18, DOI 10.1016/j.ajhg.2008.05.012; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Shen L, 2010, CHINESE MED J-PEKING, V123, P1623, DOI 10.3760/cma.j.issn.0366-6999.2010.13.002; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Strehle EM, 2012, AM J MED GENET A, V158A, P2139, DOI 10.1002/ajmg.a.35502; Tamura M, 2013, HUM MOL GENET, V22, P2471, DOI 10.1093/hmg/ddt099; Thattaliyath BD, 2002, J MOL CELL CARDIOL, V34, P1335, DOI 10.1006/jmcc.2002.2085; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; van Steensel MAM, 2009, HUM MUTAT, V30, pE1002, DOI 10.1002/humu.21127; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; Wendl T, 2007, DEVELOPMENT, V134, P2871, DOI 10.1242/dev.02872; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Zidere V, 2006, ULTRASOUND OBST GYN, V28, P876, DOI 10.1002/uog.3841; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	32	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e95453	10.1371/journal.pone.0095453	http://dx.doi.org/10.1371/journal.pone.0095453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093829	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000341357200001
J	Zhou, WW; Zhang, BL; Chen, HM; Jin, JQ; Yang, JX; Wang, YY; Jiang, K; Murphy, RW; Zhang, YP; Che, J				Zhou, Wei-wei; Zhang, Bao-lin; Chen, Hong-man; Jin, Jie-qiong; Yang, Jun-xiao; Wang, Yun-yu; Jiang, Ke; Murphy, Robert W.; Zhang, Ya-ping; Che, Jing			DNA Barcodes and Species Distribution Models Evaluate Threats of Global Climate Changes to Genetic Diversity: A Case Study from Nanorana parkeri (Anura: Dicroglossidae)	PLOS ONE			English	Article							POPULATION-GROWTH; SYSTEM; CONSERVATISM; ECOLOGY; HISTORY	Anthropogenic global climate changes are one of the greatest threats to biodiversity. Distribution modeling can predict the effects of climate changes and potentially their effects on genetic diversity. DNA barcoding quickly identifies patterns of genetic diversity. As a case study, we use DNA barcodes and distribution models to predict threats under climate changes in the frog Nanorana parkeri, which is endemic to the Qinghai-Tibetan Plateau. Barcoding identifies major lineages W and E. Lineage W has a single origin in a refugium and Lineage E derives from three refugia. All refugia locate in river valleys and each greatly contributes to the current level of intraspecific genetic diversity. Species distribution models suggest that global climate changes will greatly influence N. parkeri, especially in the level of genetic diversity, because two former refugia will fail to provide suitable habitat. Our pipeline provides a novel application of DNA barcoding and has important implications for the conservation of biodiversity in southern areas of the Qinghai-Tibetan Plateau.	[Zhou, Wei-wei; Zhang, Bao-lin; Chen, Hong-man; Jin, Jie-qiong; Yang, Jun-xiao; Wang, Yun-yu; Jiang, Ke; Murphy, Robert W.; Che, Jing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhou, Wei-wei; Zhang, Bao-lin; Chen, Hong-man; Jin, Jie-qiong; Yang, Jun-xiao; Wang, Yun-yu; Jiang, Ke; Murphy, Robert W.; Che, Jing] Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming, Peoples R China; [Zhang, Bao-lin; Zhang, Ya-ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Royal Ontario Museum	Zhang, YP (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn; chej@mail.kiz.ac.cn			Strategic Priority Research Program (B) [XDB03030113]; Ministry of Science and Technology of China (MOST) [2014FY210200]; Chinese Academy of Sciences (CAS); CAS [KJZD-EW-L07]; National Natural Science Foundation of China [31090250]; MOST [2011FY120200]; Bureau of Science and Technology of Yunnan, China [2010CI045]; Major Innovation Program of CAS [KSCX2-EW-Z-2]; Natural Sciences and Engineering Research Council of Canada [3148]	Strategic Priority Research Program (B)(Chinese Academy of Sciences); Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST; Bureau of Science and Technology of Yunnan, China; Major Innovation Program of CAS; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants of the Strategic Priority Research Program (B) (XDB03030113), the Ministry of Science and Technology of China (MOST) (2014FY210200), and the "Western Light" Talents Training Program of the Chinese Academy of Sciences (CAS) to ZWW; the Key Research Program (KJZD-EW-L07) of CAS, the National Natural Science Foundation of China (31090250), MOST (2011FY120200), and the Bureau of Science and Technology of Yunnan, China (2010CI045) to JC; and the Major Innovation Program of CAS (KSCX2-EW-Z-2) to ZYP. Research also was supported by Discovery Grant 3148 from the Natural Sciences and Engineering Research Council of Canada to RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dellicour S, 2013, MOL ECOL RE IN PRESS; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fei L, 2005, ILLUSTRATED KEY CHIN; Fu YX, 1997, GENETICS, V147, P915; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hasumi H, 2004, K 1 COUPLED GCM MIRC; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2003, EVOL ECOL RES, V5, P159; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; [李生辰 Li Shengzhen], 2007, [中国沙漠, Journal of Desert Research], V27, P307; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Rambaut A., 2007, TRACER V1 4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Sambrook J., 2001, MOL CLONING LAB MANU; Smith AB, 2013, DIVERS DISTRIB, V19, P867, DOI 10.1111/ddi.12031; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yao T, 2000, CHINESE SCI BULL, V45, P98; [赵井东 ZHAO Jingdong], 2011, [地理学报, Acta Geographica Sinica], V66, P867; Zheng D, 1996, SCI CHINA SER D, V39, P410; Zhou WW, 2013, MOL ECOL, V22, P130, DOI 10.1111/mec.12087	57	10	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103899	10.1371/journal.pone.0103899	http://dx.doi.org/10.1371/journal.pone.0103899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093586	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200042
J	Aragon, P; Fitze, PS				Aragon, Pedro; Fitze, Patrick S.			Geographical and Temporal Body Size Variation in a Reptile: Roles of Sex, Ecology, Phylogeny and Ecology Structured in Phylogeny	PLOS ONE			English	Article							BERGMANNS RULE; LACERTID LIZARDS; SPECIES RICHNESS; PSAMMODROMUS SQUAMATA; ECTOTHERMS; PATTERNS; SCALE; BIOGEOGRAPHY; COVARIATION; TEMPERATURE	Geographical body size variation has long interested evolutionary biologists, and a range of mechanisms have been proposed to explain the observed patterns. It is considered to be more puzzling in ectotherms than in endotherms, and integrative approaches are necessary for testing non-exclusive alternative mechanisms. Using lacertid lizards as a model, we adopted an integrative approach, testing different hypotheses for both sexes while incorporating temporal, spatial, and phylogenetic autocorrelation at the individual level. We used data on the Spanish Sand Racer species group from a field survey to disentangle different sources of body size variation through environmental and individual genetic data, while accounting for temporal and spatial autocorrelation. A variation partitioning method was applied to separate independent and shared components of ecology and phylogeny, and estimated their significance. Then, we fed-back our models by controlling for relevant independent components. The pattern was consistent with the geographical Bergmann's cline and the experimental temperature-size rule: adults were larger at lower temperatures (and/or higher elevations). This result was confirmed with additional multi-year independent data-set derived from the literature. Variation partitioning showed no sex differences in phylogenetic inertia but showed sex differences in the independent component of ecology; primarily due to growth differences. Interestingly, only after controlling for independent components did primary productivity also emerge as an important predictor explaining size variation in both sexes. This study highlights the importance of integrating individual-based genetic information, relevant ecological parameters, and temporal and spatial autocorrelation in sex-specific models to detect potentially important hidden effects. Our individual-based approach devoted to extract and control for independent components was useful to reveal hidden effects linked with alternative non-exclusive hypothesis, such as those of primary productivity. Also, including measurement date allowed disentangling and controlling for short-term temporal autocorrelation reflecting sex-specific growth plasticity.	[Aragon, Pedro] Museo Nacl Ciencias Natur, Dept Biogeografi & Cambio Global, Madrid, Spain; [Fitze, Patrick S.] Museo Nacl Ciencias Natur, Dept Biodiversidad Biologi Evolutiva, Madrid, Spain; [Fitze, Patrick S.] Univ Lausanne, Biophore, Dept Ecol & Evolut, Lausanne, Switzerland; [Fitze, Patrick S.] IPE CSIC, Madrid, Spain; [Fitze, Patrick S.] Fundacion Araid, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Aragon, P (corresponding author), Museo Nacl Ciencias Natur, Dept Biogeografi & Cambio Global, Madrid, Spain.	paragon@mncn.csic.es	Aragón, Pedro/B-2598-2009; Fitze, Patrick S./C-1377-2011; Fitze, Patrick S/A-4719-2011	Aragón, Pedro/0000-0002-6849-7274; Fitze, Patrick S./0000-0002-6298-2471; Fitze, Patrick S/0000-0002-6298-2471	Swiss National Science Foundation (SNF); Ramon y Cajal [RYC-2011-07670]; SNF [PPOOP3_128375]; Comunidad de Madrid, Spain [200530M090]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ramon y Cajal(Spanish Government); SNF; Comunidad de Madrid, Spain(Comunidad de Madrid)	PA was supported by the Swiss National Science Foundation (SNF) and by a Ramon y Cajal contract (RYC-2011-07670). Financial support was provided by the SNF (PPOOP3_128375 to PSF) and by the Comunidad de Madrid, Spain (200530M090 to PSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarello M, 2010, J ARID ENVIRON, V74, P1443, DOI 10.1016/j.jaridenv.2010.05.019; Angilletta MJ, 2003, AM NAT, V162, P332; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Angilletta MJ, 2004, AM NAT, V164, pE168, DOI 10.1086/425222; Aragon P, 2001, CAN J ZOOL, V79, P1965, DOI 10.1139/cjz-79-11-1965; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; Aubad J, 2008, FOREST ECOL MANAG, V255, P1892, DOI 10.1016/j.foreco.2007.12.011; Aubret F, 2012, AM NAT, V179, P756, DOI 10.1086/665653; Bauwens D, 1997, AM NAT, V149, P91, DOI 10.1086/285980; Belliure J, 1996, ECOLOGY, V77, P1163, DOI 10.2307/2265585; Bergmann K., 1847, GOTTINGER STUDIEN, V3, P595; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; CARRETERO M A, 1991, Amphibia-Reptilia, V12, P395, DOI 10.1163/156853891X00040; Carretero MA, 1994, BUTLL NAT DELT LLOB, V1, P13; Chamaille-Jammes S, 2006, GLOBAL CHANGE BIOL, V12, P392, DOI 10.1111/j.1365-2486.2005.01088.x; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Desdevises Y, 2003, EVOLUTION, V57, P2647; Diaz JA, 1996, PHYSIOL ZOOL, V69, P1359, DOI 10.1086/physzool.69.6.30164264; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2007, ECOGRAPHY, V30, P598, DOI 10.1111/j.2007.0906-7590.04988.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Ficetola GF, 2010, GLOBAL ECOL BIOGEOGR, V19, P485, DOI 10.1111/j.1466-8238.2010.00535.x; Fitze PS, 2012, ZOOTAXA, P41; Fitze PS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-347; Fitze PS, 2012, ENCICLOPEDIA VIRTUAL, P18; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Guillaumet A, 2008, J BIOGEOGR, V35, P579, DOI 10.1111/j.1365-2699.2007.01826.x; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horvathova T, 2013, ECOL EVOL, V3, P2424, DOI 10.1002/ece3.613; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Massot M, 2013, CURR BIOL, V23, P1320, DOI 10.1016/j.cub.2013.05.047; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2011, GLOBAL ECOL BIOGEOGR, V20, P203, DOI 10.1111/j.1466-8238.2010.00577.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olalla-Tarraga MA, 2011, OIKOS, V120, P1441, DOI 10.1111/j.1600-0706.2011.19319.x; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Oufiero CE, 2011, EVOLUTION, V65, P3590, DOI 10.1111/j.1558-5646.2011.01405.x; Pascual Gonzalez J.A., 1989, Donana Acta Vertebrata, V16, P45; Pincheira-Donoso D, 2010, THEOR BIOSCI, V129, P247, DOI 10.1007/s12064-010-0101-0; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Quinn GP, 2002, EXPERIMENTAL DESIGN; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; San-Jose LM, 2012, CONTRIB ZOOL, V81, P181, DOI 10.1163/18759866-08104001; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x	55	18	18	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104026	10.1371/journal.pone.0104026	http://dx.doi.org/10.1371/journal.pone.0104026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090025	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700082
J	Chen, M; Huang, Q; Xu, W; She, C; Xie, ZG; Mao, YT; Dong, QR; Ling, M				Chen, Ming; Huang, Qun; Xu, Wei; She, Chang; Xie, Zong-Gang; Mao, Yong-Tao; Dong, Qi-Rong; Ling, Ming			Low-Dose X-Ray Irradiation Promotes Osteoblast Proliferation, Differentiation and Fracture Healing	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; IONIZING-RADIATION; MC3T3-E1 CELLS; STRAND BREAKS; BONE; EXPRESSION; MICE; QUANTIFICATION; MINERALIZATION; EXPOSURE	Great controversy exists regarding the biologic responses of osteoblasts to X-ray irradiation, and the mechanisms are poorly understood. In this study, the biological effects of low-dose radiation on stimulating osteoblast proliferation, differentiation and fracture healing were identified using in vitro cell culture and in vivo animal studies. First, low-dose (0.5 Gy) X-ray irradiation induced the cell viability and proliferation of MC3T3-E1 cells. However, high-dose (5 Gy) X-ray irradiation inhibited the viability and proliferation of osteoblasts. In addition, dynamic variations in osteoblast differentiation markers, including type I collagen, alkaline phosphatase, Runx2, Osterix and osteocalcin, were observed after both low-dose and high-dose irradiation by Western blot analysis. Second, fracture healing was evaluated via histology and gene expression after single-dose X-ray irradiation, and low-dose X-ray irradiation accelerates fracture healing of closed femoral fractures in rats. In low-dose X-ray irradiated fractures, an increase in proliferating cell nuclear antigen (PCNA)-positive cells, cartilage formation and fracture calluses was observed. In addition, we observed more rapid completion of endochondral and intramembranous ossification, which was accompanied by altered expression of genes involved in bone remodeling and fracture callus mineralization. Although the expression level of several osteoblast differentiation genes was increased in the fracture calluses of high-dose irradiated rats, the callus formation and fracture union were delayed compared with the control and low-dose irradiated fractures. These results reveal beneficial effects of low-dose irradiation, including the stimulation of osteoblast proliferation, differentiation and fracture healing, and highlight its potential translational application in novel therapies against bone-related diseases.	[Chen, Ming; Ling, Ming] Shaanxi Prov Peoples Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China; [Huang, Qun; Xu, Wei; She, Chang; Xie, Zong-Gang; Mao, Yong-Tao; Dong, Qi-Rong] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China	Xi'an Medical University; Soochow University - China	Dong, QR (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.	dongqirong@hotmail.com; lingming029@163.com		Mao, Yongtao/0000-0002-3572-3044	National Natural Science Foundation of China [81171730]; Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province [CXZZ12_0841]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (81171730) and the Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province (CXZZ12_0841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwood Joshua S, 2012, J Aging Res, V2012, P481983, DOI 10.1155/2012/481983; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Chae HU, 1999, J RADIAT RES, V40, P323, DOI 10.1269/jrr.40.323; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Green DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064952; He J, 2011, J CRANIOFAC SURG, V22, P1635, DOI 10.1097/SCS.0b013e31822e5f66; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Jia D, 2011, RADIAT RES, V176, P624, DOI 10.1667/RR2505.1; Lau P, 2010, RADIAT ENVIRON BIOPH, V49, P271, DOI 10.1007/s00411-010-0272-6; Lee IJ, 2009, INT J RADIAT ONCOL, V75, P1084, DOI 10.1016/j.ijrobp.2008.12.052; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; Liang XY, 2011, J RADIAT RES, V52, P380, DOI 10.1269/jrr.10121; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Matsumura S, 1998, RADIAT RES, V149, P463, DOI 10.2307/3579786; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Park SS, 2012, BMB REP, V45, P571, DOI 10.5483/BMBRep.2012.45.10.101; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Peyre HM, 2000, INT J RADIAT BIOL, V76, P87, DOI 10.1080/095530000139041; Phulpin B, 2010, EXP THER MED, V1, P553, DOI 10.3892/etm_00000087; Pramojanee SN, 2012, ARCH ORAL BIOL, V57, P252, DOI 10.1016/j.archoralbio.2011.09.004; Sakurai T, 2007, J RADIAT RES, V48, P515, DOI 10.1269/jrr.07012; Sangsliwan T, 2008, RADIAT RES, V170, P776, DOI 10.1667/RR1399.1; Schnoke M, 2009, BONE, V45, P590, DOI 10.1016/j.bone.2009.05.006; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smialek MA, 2009, RADIAT RES, V172, P529, DOI 10.1667/RR1684.1; SRIVASTAVA UK, 1989, INDIAN J EXP BIOL, V27, P602; Sugrue T, 2013, STEM CELLS, V31, P137, DOI 10.1002/stem.1222; Szymczyk KH, 2004, BONE, V34, P148, DOI 10.1016/j.bone.2003.09.003; TAKAHASHI S, 1994, J BONE JOINT SURG AM, V76A, P722, DOI 10.2106/00004623-199405000-00014; Theocharopoulos N, 2003, J BONE JOINT SURG AM, V85A, P1698, DOI 10.2106/00004623-200309000-00007; Tsai CJ, 2013, INT J RADIAT ONCOL, V85, P415, DOI 10.1016/j.ijrobp.2012.05.032; Williams HJ, 2006, EUR RADIOL, V16, P619, DOI 10.1007/s00330-005-0010-7; Xu W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-94; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Zhang MJ, 2011, J BONE MINER RES, V26, P792, DOI 10.1002/jbmr.272; Zhou XZ, 2009, ARCH ORTHOP TRAUM SU, V129, P125, DOI 10.1007/s00402-008-0634-6	39	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104016	10.1371/journal.pone.0104016	http://dx.doi.org/10.1371/journal.pone.0104016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089831	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700080
J	Domagalska-Szopa, M; Szopa, A				Domagalska-Szopa, Malgorzata; Szopa, Andrzej			Gait Pattern Differences between Children with Mild Scoliosis and Children with Unilateral Cerebral Palsy	PLOS ONE			English	Article							SPASTIC HEMIPLEGIA; DEFORMITY; KINEMATICS; PATHOLOGY; SPINE	This study was conducted to investigate the effects of asymmetrical body posture alone, i.e., the effects seen in children with mild scoliosis, vs. the effects of body posture control impairment, i.e., those seen in children with unilateral cerebral palsy on gait patterns. Three-dimensional instrumented gait analysis (3DGA) was conducted in 45 children with hemiplegia and 51 children with mild scoliosis. All the children were able to walk without assistance devices. A set of 35 selected spatiotemporal gait and kinematics parameters were evaluated when subjects walked on a treadmill. A cluster analysis revealed 3 different gait patterns: a scoliotic gait pattern and 2 different hemiplegic gait patterns. The results showed that the discrepancy in gait patterns was not simply a lower limb kinematic deviation in the sagittal plane, as expected. Additional altered kinematics, such as pelvic misorientation in the coronal plane in both the stance and swing phases and inadequate stance phase hip ad/abduction, which resulted from postural pattern features, were distinguished between the 3 gait patterns. Our study provides evidence for a strong correlation between postural and gait patterns in children with unilateral cerebral palsy. Information on differences in gait patterns may be used to improve the guidelines for early therapy for children with hemiplegia before abnormal gait patterns are fully established. The gait pathology characteristic of scoliotic children is a potential new direction for treating scoliosis that complements the standard posture and walking control therapy exercises with the use of biofeedback.	[Domagalska-Szopa, Malgorzata] Med Univ Silesia, Sch Hlth Sci, Dept Physiotherapy, Inst Med Rehabil, Katowice, Poland; [Szopa, Andrzej] Med Univ Silesia, Sch Hlth Sci, Dept Physiotherapy, Inst Physiotherapy, Katowice, Poland	Medical University Silesia; Medical University Silesia	Domagalska-Szopa, M (corresponding author), Med Univ Silesia, Sch Hlth Sci, Dept Physiotherapy, Inst Med Rehabil, Katowice, Poland.	mdomagalska@sum.edu.pl		Domagalska-Szopa, Malgorzata/0000-0001-9086-9970; Szopa, Andrzej/0000-0002-1765-1622				Becher JG., 2002, J PROSTHET ORTHOT, V14, P143, DOI DOI 10.1097/00008526-200212000-00004; Carlberg Eva Brogren, 2005, Neural Plast, V12, P221, DOI 10.1155/NP.2005.221; Chen PQ, 1998, CLIN BIOMECH, V13, pS52, DOI 10.1016/S0268-0033(97)00075-2; Davidson I, 2002, 022 SUNY; Domagalska M, 2013, GAIT POSTURE, V38, P1038, DOI 10.1016/j.gaitpost.2013.05.031; Domagalska Malgorzata, 2006, Ortop Traumatol Rehabil, V8, P291; Domagalska-Szopa M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/462094; GAGE JR, 1995, J BONE JOINT SURG AM, V77, P1607, DOI 10.2106/00004623-199510000-00017; GAGE JR, 1993, CLIN ORTHOP RELAT R, P126; Gage JR, 2004, TREATMENT GAIT PROBL; Graham HK, 2004, CLIN DEV MED, P105; Hullin MG, 1996, J PEDIATR ORTHOP B, V5, P247, DOI 10.1097/01202412-199605040-00006; Mahaudens P, 2009, EUR SPINE J, V18, P512, DOI 10.1007/s00586-009-0899-7; Mahaudens Philippe, 2005, Spine J, V5, P427; Molenaers G, 2006, J BONE JOINT SURG AM, V88A, P161, DOI 10.2106/JBJS.C.01497; Ounpuu S, 1996, J PEDIATR ORTHOPED, V16, P378, DOI 10.1097/01241398-199605000-00017; Paroczai R., 2006, PHYS ED SPORT, V4, P49; Perry J., 1992, GAIT ANAL NORMAL PAT; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Stebbins J., 2004, GAIT POSTURE, V20, pS82; Syczewska M, 2012, GAIT POSTURE, V35, P209, DOI 10.1016/j.gaitpost.2011.09.008; Syczewska M, 2010, ACTA BIOENG BIOMECH, V12, P25; Unsworth C. A, 2007, PHYS REHABILITATION, P1149; van der Heide Jolanda C., 2005, Neural Plasticity, V12, P197; Winter David A., 2009, BIOMECHANICS MOTOR C, V4th, P75; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211	27	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103095	10.1371/journal.pone.0103095	http://dx.doi.org/10.1371/journal.pone.0103095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089908	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700015
J	Lee, J; Jain, A; Kim, P; Lee, T; Kuller, A; Princen, F; In-Gudo; Kim, SH; Park, JO; Park, YS; Singh, S; Kim, HC				Lee, Jeeyun; Jain, Anjali; Kim, Phillip; Lee, Tani; Kuller, Anne; Princen, Fred; In-Gudo; Kim, Suk Hyeong; Park, Joon Oh; Park, Young Suk; Singh, Sharat; Kim, Hee Cheol			Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status	PLOS ONE			English	Article							1ST-LINE TREATMENT; CETUXIMAB; RAS; FLUOROURACIL; CHEMOTHERAPY; PANITUMUMAB; OXALIPLATIN; COMBINATION; LEUCOVORIN; INHIBITORS	Background: Oncogenic mutational analysis provides predictive guidance for therapeutics such as anti-EGFR antibodies, but it is successful only for a subset of colorectal cancer (CRC) patients. Method: A comprehensive molecular profiling of 120 CRC patients, including 116 primary, 15 liver metastasis, and 1 peritoneal seeding tissue samples was performed to identify the relationship between v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) WT and mutant CRC tumors and clinical outcomes. This included determination of the protein activation patterns of human epidermal receptor 1 (HER1), HER2, HER3, c-MET, insulin-like growth factor 1 receptor (IGF1R), phosphatidylinositide 3-kinase (PI3K), Src homology 2 domain containing (Shc), protein kinase B (AKT), and extracellular signal-regulated kinase (ERK) kinases using multiplexed collaborative enzyme enhanced reactive (CEER) immunoassay. Results: KRAS WT and mutated CRCs were not different with respect to the expression of the various signaling molecules. Poor prognosis in terms of early relapse (<2 years) and shorter disease-free survival (DFS) correlated with enhanced activation of PI3K signaling relative to the HER kinase pathway signaling, but not with the KRAS mutational status. KRAS WT CRCs were identified as a mixed prognosis population depending on their level of PI3K signaling. KRAS WT CRCs with high HER1/c-MET index ratio demonstrated a better DFS post-surgery. c-MET and IGF1R activities relative to HER axis activity were considerably higher in early relapse CRCs, suggesting a role for these alternative receptor tyrosine kinases (RTKs) in driving high PI3K signaling. Conclusions: The presented data subclassified CRCs based on their activated signaling pathways and identify a role for c-MET and IGF1R-driven PI3K signaling in CRCs, which is superior to KRAS mutational tests alone. The results from this study can be utilized to identify aggressive CRCs, explain failure of currently approved therapeutics in specific CRC subsets, and, most importantly, generate hypotheses for pathway-guided therapeutic strategies that can be tested clinically.	[Lee, Jeeyun; Park, Joon Oh; Park, Young Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea; [Kim, Hee Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Jain, Anjali; Kim, Phillip; Lee, Tani; Kuller, Anne; Princen, Fred; Singh, Sharat] Prometheus Labs, San Diego, CA USA; [In-Gudo; Kim, Suk Hyeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, HC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea.	hckim@skku.edu	Lee, Jeeyun/I-7171-2015; Lee, Jee Yun/C-9646-2011		Samsung Biomedical Research Institute [SS1-B3-011-1]; Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C1951]	Samsung Biomedical Research Institute(Samsung); Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was partially supported by Samsung Biomedical Research Institute grant #SS1-B3-011-1. This research was suppoorted by a grant of the Korea Health technology R&D Project through the Korea Health Industry Development Institute(KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. (Grant Number: HI13C1951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Coffee EM, 2013, CLIN CANCER RES, V19, P2688, DOI 10.1158/1078-0432.CCR-12-2556; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Juric D, 2012, J CLIN ONCOL, V30, P765, DOI 10.1200/JCO.2011.39.6390; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-75; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Martin-Fernandez C, 2009, MOL CANCER RES, V7, P955, DOI 10.1158/1541-7786.MCR-08-0445; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Poehlmann A, 2007, PATHOL RES PRACT, V203, P489, DOI 10.1016/j.prp.2007.06.001; Raponi M, 2008, CURR OPIN PHARMACOL, V8, P413, DOI 10.1016/j.coph.2008.06.006; Roper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025132; Starling Naureen, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS28, DOI 10.3816/CCC.2005.s.004; Tabernero J, 2007, J CLIN ONCOL, V25, P5225, DOI 10.1200/JCO.2007.13.2183; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Ward TM, 2013, ONCOGENE, V32, P2463, DOI 10.1038/onc.2012.256	26	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103551	10.1371/journal.pone.0103551	http://dx.doi.org/10.1371/journal.pone.0103551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090459	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700030
J	Milet, C; Rincheval-Arnold, A; Morieras, A; Clavier, A; Garrigue, A; Mignotte, B; Guenal, I				Milet, Cecile; Rincheval-Arnold, Aurore; Morieras, Angeline; Clavier, Amandine; Garrigue, Alexandrine; Mignotte, Bernard; Guenal, Isabelle			Mutating RBF Can Enhance Its Pro-Apoptotic Activity and Uncovers a New Role in Tissue Homeostasis	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; PROTEIN INDUCES APOPTOSIS; DROSOPHILA IMAGINAL DISCS; SVM-BASED PREDICTION; CELL-CYCLE CONTROL; COMPENSATORY PROLIFERATION; CASPASE DRONC; CLEAVAGE SITES; MUTANT-CELLS; DEATH	The tumor suppressor retinoblastoma protein (pRb) is inactivated in a wide variety of cancers. While its role during cell cycle is well characterized, little is known about its properties on apoptosis regulation and apoptosis-induced cell responses. pRb shorter forms that can modulate pRB apoptotic properties, resulting from cleavages at caspase specific sites are observed in several cellular contexts. A bioinformatics analysis showed that a putative caspase cleavage site (TELD) is found in the Drosophila homologue of pRb (RBF) at a position similar to the site generating the p76Rb form in mammals. Thus, we generated a punctual mutant form of RBF in which the aspartate of the TELD site is replaced by an alanine. This mutant form, RBFD253A, conserved the JNK-dependent pro-apoptotic properties of RBF but gained the ability of inducing overgrowth phenotypes in adult wings. We show that this overgrowth is a consequence of an abnormal proliferation in wing imaginal discs, which depends on the JNK pathway activation but not on wingless (wg) ectopic expression. These results show for the first time that the TELD site of RBF could be important to control the function of RBF in tissue homeostasis in vivo.	[Milet, Cecile; Rincheval-Arnold, Aurore; Morieras, Angeline; Clavier, Amandine; Garrigue, Alexandrine; Mignotte, Bernard; Guenal, Isabelle] Univ Versailles St Quentin En Yvelines, Ecole Prat Hautes Etud, Lab Genet & Biol Cellulaire EA4589, Montigny Le Bretonneux, France	UDICE-French Research Universities; Universite Paris Saclay	Guenal, I (corresponding author), Univ Versailles St Quentin En Yvelines, Ecole Prat Hautes Etud, Lab Genet & Biol Cellulaire EA4589, Montigny Le Bretonneux, France.	isabelle.guenal@uvsq.fr	Mignotte, Bernard/A-3499-2009; Guenal, Isabelle/F-3415-2019	Mignotte, Bernard/0000-0002-8512-8518; Guenal, Isabelle/0000-0003-1186-1458; Garrigue, Alexandrine/0000-0002-2660-3681	Universite de Versailles Saint-Quentin-en-Yvelines; Association pour la Recherche contre le Cancer; Ligue Nationale Contre le Cancer; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ecole Pratique des Hautes Etudes	Universite de Versailles Saint-Quentin-en-Yvelines; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ecole Pratique des Hautes Etudes	This work was supported by the Universite de Versailles Saint-Quentin-en-Yvelines and by grants from the Association pour la Recherche contre le Cancer and the Ligue Nationale Contre le Cancer. Cecile Milet held successive fellowships from the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche and the Ecole Pratique des Hautes Etudes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2012, G3-GENES GENOM GENET, V2, P1459, DOI 10.1534/g3.112.004424; Berge EO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-173; Bertin-Ciftci J, 2013, CELL DEATH DIFFER, V20, P755, DOI 10.1038/cdd.2013.6; Borges HL, 2005, P NATL ACAD SCI USA, V102, P15587, DOI 10.1073/pnas.0503925102; Bosco G, 2010, NATURE, V466, P1051, DOI 10.1038/4661051a; Boutillier AL, 2000, ONCOGENE, V19, P2171, DOI 10.1038/sj.onc.1203532; Bowen C, 1998, CANCER RES, V58, P3275; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen W D, 1999, Mol Cell Biol Res Commun, V1, P216, DOI 10.1006/mcbr.1999.0132; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Fattman CL, 1998, CANCER LETT, V130, P103, DOI 10.1016/S0304-3835(98)00121-9; Fattman CL, 1997, J CELL BIOCHEM, V67, P399; Ferecatu I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-50; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Herrera SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003446; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Knudsen KE, 1999, ONCOGENE, V18, P5239, DOI 10.1038/sj.onc.1202910; Le Floch N, 2010, BIOCHEM BIOPH RES CO, V399, P173, DOI 10.1016/j.bbrc.2010.07.041; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lemaire C, 2005, ONCOGENE, V24, P3297, DOI 10.1038/sj.onc.1208493; Milet C, 2010, CELL CYCLE, V9, P97, DOI 10.4161/cc.9.1.10251; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Moon NS, 2006, MOL CELL BIOL, V26, P7601, DOI 10.1128/MCB.00836-06; Moon NS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000153; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2005, P NATL ACAD SCI USA, V102, P17664, DOI 10.1073/pnas.0508966102; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Snipas SJ, 2008, CELL DEATH DIFFER, V15, P938, DOI 10.1038/cdd.2008.23; Tan XQ, 1997, J BIOL CHEM, V272, P9613; Tanaka-Matakatsu M, 2009, DEV BIOL, V326, P347, DOI 10.1016/j.ydbio.2008.11.035; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Young AP, 2004, ONCOGENE, V23, P2587, DOI 10.1038/sj.onc.1207330	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102902	10.1371/journal.pone.0102902	http://dx.doi.org/10.1371/journal.pone.0102902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089524	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700011
J	Wang, LG; Zhang, LC; Yan, H; Liu, X; Li, N; Liang, J; Pu, L; Zhang, YB; Shi, HB; Zhao, KB; Wang, LX				Wang, Ligang; Zhang, Longchao; Yan, Hua; Liu, Xin; Li, Na; Liang, Jing; Pu, Lei; Zhang, Yuebo; Shi, Huibi; Zhao, Kebin; Wang, Lixian			Genome-Wide Association Studies Identify the Loci for 5 Exterior Traits in a Large White x Minzhu Pig Population	PLOS ONE			English	Article							SUS-SCROFA CHROMOSOME-7; MEAT QUALITY; BACKFAT THICKNESS; BOAR TAINT; BODY-SIZE; GENE; GROWTH; IDENTIFICATION; HERITABILITY; EXPRESSION	As one of the main breeding selection criteria, external appearance has special economic importance in the hog industry. In this study, an Illumina Porcine SNP60 BeadChip was used to conduct a genome-wide association study (GWAS) in 605 pigs of the F-2 generation derived from a Large White x Minzhu intercross. Traits under study were abdominal circumference (AC), body height (BH), body length (BL), cannon bone circumference (CBC), chest depth (CD), chest width (CW), rump circumference (RC), rump width (RW), scapula width (SW), and waist width (WW). A total of 138 SNPs (the most significant being MARC0033464) on chromosome 7 were found to be associated with BH, BL, CBC, and RC (P-value = 4.15E-6). One SNP on chromosome 1 was found to be associated with CD at genome-wide significance levels. The percentage phenotypic variance of these significant SNPs ranged from 0.1-25.48%. Moreover, a conditional analysis revealed that the significant SNPs were derived from a single quantitative trait locus (QTL) and indicated additional chromosome-wide significant association for 25 SNPs on SSC4 (BL, CBC) and 9 SNPs on SSC7 (RC). Linkage analysis revealed two complete linkage disequilibrium haplotype blocks that contained seven and four SNPs, respectively. In block 1, the most significant SNP, MARC0033464, was present. Annotations from pig reference genome suggested six genes (GRM4, HMGA1, NUDT3, RPS10, SPDEF and PACSIN1) in block 1 (495 kb), and one gene (SCUBE3) in block 3 (124 kb). Functional analysis indicated that HMGA1 and SCUBE3 genes are the potential genes controlling BH, BL, and RC in pigs, with an application in breeding programs. We screened several candidate intervals and genes based on SNP location and gene function, and predicted their function using bioinformatics analyses.	[Wang, Ligang; Zhang, Longchao; Yan, Hua; Liu, Xin; Li, Na; Liang, Jing; Pu, Lei; Zhang, Yuebo; Shi, Huibi; Zhao, Kebin; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Li, Na] Jilin Acad Agr Sci, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Academy of Agricultural Sciences	Wang, LX (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	iaswlx@263.net			Agricultural Science and Technology Innovation Program (ASTIP-IAS); National Key Technology R&D Program of China [2011BAD28B01]; National Natural Science Foundation of China [31201781]; earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China [2011ZX08006-003]; Chinese Academy of Agricultural Sciences Foundation [2014ZL006, 2011cj-5, 2012ZL069, 2014ywf-yb-8]	Agricultural Science and Technology Innovation Program (ASTIP-IAS); National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences)	This research was supported by The Agricultural Science and Technology Innovation Program (ASTIP-IAS02), National Key Technology R&D Program of China (No. 2011BAD28B01), National Natural Science Foundation of China (31201781), earmarked fund for Modern Agro-industry Technology Research System, National Technology Program of China (No. 2011ZX08006-003) and Chinese Academy of Agricultural Sciences Foundation (No. 2014ZL006, 2011cj-5, No. 2012ZL069 and 2014ywf-yb-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chiappetta G, 1996, ONCOGENE, V13, P2439; Cleynen I, 2008, INT J ONCOL, V32, P289; Demeure O, 2005, J ANIM SCI, V83, P1979; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grindflek E, 2011, J ANIM SCI, V89, P680, DOI 10.2527/jas.2010-3290; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Hristov AC, 2010, MODERN PATHOL, V23, P98, DOI 10.1038/modpathol.2009.139; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson ZB, 2003, J ANIM SCI, V81, P1943; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Ma J, 2009, ANIM GENET, V40, P637, DOI 10.1111/j.1365-2052.2009.01892.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; Niu P, 2013, GENES GENOM, V35, P523, DOI 10.1007/s13258-013-0098-0; Okumura N, 2013, ANIM GENET, V44, P454, DOI 10.1111/age.12018; Ramos AM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-35; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schreiweis MA, 2005, GENET SEL EVOL, V37, P677, DOI 10.1051/gse:2005023; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Sironen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-699; Soller M, 2006, POULTRY SCI, V85, P2061, DOI 10.1093/ps/85.12.2061; Soma Y, 2011, J ANIM SCI, V89, P601, DOI 10.2527/jas.2010-3119; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Uemoto Y, 2008, J ANIM SCI, V86, P2833, DOI 10.2527/jas.2007-0293; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang M, 2013, MED HYPOTHESES, V81, P948, DOI 10.1016/j.mehy.2013.09.001	41	21	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103766	10.1371/journal.pone.0103766	http://dx.doi.org/10.1371/journal.pone.0103766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090094	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700050
J	Conese, M; Castellani, S; Lepore, S; Palumbo, O; Manca, A; Santostasis, T; Polizzi, AM; Copetti, M; Di Gioia, S; Casavola, V; Guerra, L; Diana, A; Montemurro, P; Mariggio, A; Gallo, C; Maffione, AB; Carella, M				Conese, Massimo; Castellani, Stefano; Lepore, Silvia; Palumbo, Orazio; Manca, Antonio; Santostasis, Teresa; Polizzi, Angela Maria; Copetti, Massimiliano; Di Gioia, Sante; Casavola, Valeria; Guerra, Lorenzo; Diana, Anna; Montemurro, Pasqualina; Mariggio, Addolorata; Gallo, Crescenzio; Maffione, Angela Bruna; Carella, Massimo			Evaluation of Genome-Wide Expression Profiles of Blood and Sputum Neutrophils in Cystic Fibrosis Patients Before and After Antibiotic Therapy	PLOS ONE			English	Article							BH3-ONLY PROTEIN NOXA; PULMONARY EXACERBATIONS; GENE-EXPRESSION; LUNG-DISEASE; INFLAMMATORY MARKERS; G-CSF; BIOMARKERS; INFECTION; APOPTOSIS; CYTOKINES	In seeking more specific biomarkers of the cystic fibrosis (CF) lung inflammatory disease that would be sensitive to antibiotic therapy, we sought to evaluate the gene expression profiles of neutrophils in CF patients before treatment in comparison with non-CF healthy individuals and after antibiotic treatment. Genes involved in neutrophil-mediated inflammation, i.e. chemotaxis, respiratory burst, apoptosis, and granule exocytosis, were the targets of this study. Microarray analysis was carried out in blood and airway neutrophils from CF patients and in control subjects. A fold change (log) threshold of 1.4 and a cut-off of p<0.05 were utilized to identify significant genes. Community networks and principal component analysis were used to distinguish the groups of controls, pre- and post-therapy patients. Control subjects and CF patients before therapy were readily separated, whereas a clear distinction between patients before and after antibiotic therapy was not possible. Blood neutrophils before therapy presented 269 genes down-regulated and 56 up-regulated as compared with control subjects. Comparison between the same patients before and after therapy showed instead 44 genes down-regulated and 72 up-regulated. Three genes appeared to be sensitive to therapy and returned to "healthy'' condition: phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), hydrogen voltage-gated channel 1 (HVCN1), and beta-arrestin 1 (ARRB1). The up-regulation of these genes after therapy were confirmed by real time PCR. In airway neutrophils, 1029 genes were differentially expressed post-vs pre-therapy. Of these, 30 genes were up-regulated and 75 down-regulated following antibiotic treatment. However, biological plausibility determined that only down-regulated genes belonged to the gene classes studied for blood neutrophils. Finally, it was observed that commonly expressed genes showed a greater variability in airway neutrophils than that found in blood neutrophils, both before and after therapy. These results indicate more specific targets for future interventions in CF patients involving respiratory burst, apoptosis, and granule exocytosis.	[Conese, Massimo; Castellani, Stefano; Di Gioia, Sante] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Lepore, Silvia] IRCCS CROB, Lab Preclin & Translat Res, Rionero In Vulture, Italy; [Palumbo, Orazio; Carella, Massimo] CSS Hosp, IRCCS, Med Genet Unit, San Giovanni Rotondo, Italy; [Manca, Antonio; Diana, Anna] Az Univ Osp Policlin, Ctr Riferimento Reg Pugliese Fibrosi Cist, Bari, Italy; [Santostasis, Teresa; Polizzi, Angela Maria] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Pediat, Bari, Italy; [Copetti, Massimiliano] CSS Hosp, IRCCS, Biostat Unit, San Giovanni Rotondo, Italy; [Casavola, Valeria; Guerra, Lorenzo] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Montemurro, Pasqualina; Mariggio, Addolorata] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Hyg, Bari, Italy; [Gallo, Crescenzio; Maffione, Angela Bruna] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy	University of Foggia; IRCCS CROB; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Foggia	Conese, M (corresponding author), Univ Foggia, Dept Med & Surg Sci, Foggia, Italy.	massimo.conese@unifg.it	PALUMBO, ORAZIO/C-1133-2014; Copetti, Massimiliano/K-3186-2016; Maffione, angela bruna/AAC-2193-2022; COPETTI, MASSIMILIANO/AAG-1473-2021; Lepore, Silvia/AAB-8005-2020; Gallo, Crescenzio/AAC-1482-2019; Castellani, Stefano/AAR-4143-2021; Conese, Massimo/AAB-7926-2019; Carella, Massimo/A-2804-2014	PALUMBO, ORAZIO/0000-0001-6583-3482; Copetti, Massimiliano/0000-0002-7960-5947; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Gallo, Crescenzio/0000-0002-3929-462X; castellani, stefano/0000-0003-0201-7298; Conese, Massimo/0000-0003-3465-6641; CASAVOLA, Valeria/0000-0003-4471-4948; Montemurro, Pasqualina/0000-0003-4768-8618; Mariggio, Maria Addolorata/0000-0002-3508-8706; Lepore, Silvia/0000-0002-1918-8547; Carella, Massimo/0000-0002-6830-6829; GUERRA, Lorenzo/0000-0003-3950-9405	Italian law 548/93 project "Study of factors which influence prognosis in cystic fibrosis"	Italian law 548/93 project "Study of factors which influence prognosis in cystic fibrosis"	This work was supported by the Italian law 548/93 for the years 1999-2003, project "Study of factors which influence prognosis in cystic fibrosis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2008, MOL MED, V14, P36, DOI 10.2119/2007-00081.Adib-Conquy; Bankey PE, 2010, IMMUNOL LETT, V129, P100, DOI 10.1016/j.imlet.2010.01.006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Colombo C, 2005, PEDIATR PULM, V40, P15, DOI 10.1002/ppul.20237; Corvol H, 2003, AM J PHYSIOL-LUNG C, V284, pL997, DOI 10.1152/ajplung.00156.2002; Dorlochter Ludger, 2004, J Cyst Fibros, V3, P179, DOI 10.1016/j.jcf.2004.04.005; Downey DG, 2007, PEDIATR PULM, V42, P729, DOI 10.1002/ppul.20646; Downey DG, 2007, PEDIATR PULM, V42, P216, DOI 10.1002/ppul.20553; Fruhwirth M, 1998, INT ARCH ALLERGY IMM, V117, P270, DOI 10.1159/000024022; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Hauber Hans-Peter, 2004, J Cyst Fibros, V3, P129, DOI 10.1016/j.jcf.2004.03.006; Hauber Hans-Peter, 2003, J Cyst Fibros, V2, P189, DOI 10.1016/S1569-1993(03)00091-2; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; Jensen PO, 2006, J CYST FIBROS, V5, P145, DOI 10.1016/j.jcf.2005.12.004; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; McKeon DJ, 2008, THORAX, V63, P660, DOI 10.1136/thx.2008.096834; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Muhlebach MS, 2004, PEDIATR PULM, V37, P393, DOI 10.1002/ppul.20010; Nick JA, 2013, THORAX, V68, P929, DOI 10.1136/thoraxjnl-2012-202278; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Petit-Bertron AF, 2008, CYTOKINE, V41, P54, DOI 10.1016/j.cyto.2007.10.012; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Saavedra MT, 2008, AM J RESP CRIT CARE, V178, P929, DOI 10.1164/rccm.200803-387OC; Sagel SD, 2003, CURR OPIN PULM MED, V9, P516, DOI 10.1097/00063198-200311000-00012; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Tirelli AS, 2013, CYTOKINE, V62, P413, DOI 10.1016/j.cyto.2013.03.029; Tirouvanziam R, 2008, P NATL ACAD SCI USA, V105, P4335, DOI 10.1073/pnas.0712386105; WitkoSarsat V, 1996, J IMMUNOL, V157, P2728; Wolter JM, 1999, CLIN DIAGN LAB IMMUN, V6, P260, DOI 10.1128/CDLI.6.2.260-265.1999; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004	46	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104080	10.1371/journal.pone.0104080	http://dx.doi.org/10.1371/journal.pone.0104080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084273	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800125
J	Lian, JM; Huang, XF; Pai, N; Deng, C				Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao			Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; 2ND-GENERATION ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; FOOD-INTAKE; RECEPTORS; AMPK; H1; THERMOGENESIS; PHARMACOLOGY; ADOLESCENTS	Olanzapine is the one of first line antipsychotic drug for schizophrenia and other serious mental illness. However, it is associated with troublesome metabolic side-effects, particularly body weight gain and obesity. The antagonistic affinity to histamine H-1 receptors (H1R) of antipsychotic drugs has been identified as one of the main contributors to weight gain/obesity side-effects. Our previous study showed that a short term (2 weeks) combination treatment of betahistine (an H1R agonist and H3R antagonist) and olanzapine (O+B) reduced (-45%) body weight gain induced by olanzapine in drug-naive rats. A key issue is that clinical patients suffering with schizophrenia, bipolar disease and other mental disorders often face chronic, even life-time, antipsychotic treatment, in which they have often had previous antipsychotic exposure. Therefore, we investigated the effects of chronic O+B co-treatment in controlling body weight in female rats with chronic and repeated exposure of olanzapine. The results showed that co-administration of olanzapine (3 mg/kg, t.i.d.) and betahistine (9.6 mg/kg, t.i.d.) significantly reduced (-51.4%) weight gain induced by olanzapine. Co-treatment of O+B also led to a decrease in feeding efficiency, liver and fat mass. Consistently, the olanzapine-only treatment increased hypothalamic H1R protein levels, as well as hypothalamic pAMPK alpha, AMPK alpha and NPY protein levels, while reducing the hypothalamic POMC, and UCP1 and PGC-1 alpha protein levels in brown adipose tissue (BAT). The olanzapine induced changes in hypothalamic H1R, pAMPK alpha, BAT UCP1 and PGC-1 alpha could be reversed by co-treatment of O+B. These results supported further clinical trials to test the effectiveness of co-treatment of O+B for controlling weight gain/obesity side-effects in schizophrenia with chronic antipsychotic treatment.	[Lian, Jiamei; Deng, Chao] Univ Wollongong, Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia; [Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao] Univ Wollongong, Sch Med, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Huang, Xu-Feng; Deng, Chao] Schizophrenia Res Inst, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	Deng, C (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia.	chao@uow.edu.au	Deng, Chao/F-4417-2016; Huang, Xu-Feng/D-6053-2013; Huang, Xu-Feng/H-7408-2015	Deng, Chao/0000-0003-1147-5741; Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Lian, Jiamei/0000-0002-8850-2536	Australian National Health and Medical Research Council (NHMRC) [APP1027493, APP1008473]; Schizophrenia Research Institute (SRI); New South Wales Health	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute (SRI); New South Wales Health	This study was supported by the Australian National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) Project Grants (APP1027493 to XH and CD; APP1008473 to CD), and by the Schizophrenia Research Institute (SRI, www.schizophreniaresearch.org.au), utilising infrastructure funding from New South Wales Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; Botta L, 2001, Acta Otorhinolaryngol Ital, V21, P24; Bustillo JR, 2003, NEUROPSYCHOPHARMACOL, V28, P527, DOI 10.1038/sj.npp.1300089; Cinti S, 2006, NUTR METAB CARDIOVAS, V16, P569, DOI 10.1016/j.numecd.2006.07.009; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Correll CU, 2010, EUR PSYCHIAT, V25, pS12, DOI 10.1016/S0924-9338(10)71701-6; Correll CU, 2008, INT REV PSYCHIATR, V20, P195, DOI 10.1080/09540260801889179; Correll CU, 2011, TRENDS MOL MED, V17, P97, DOI 10.1016/j.molmed.2010.10.010; Dalvi PS, 2011, AM J PHYSIOL-REG I, V300, pR1030, DOI 10.1152/ajpregu.00649.2010; Das Chandan, 2012, Ann Clin Psychiatry, V24, P225; Davoodi N, 2008, BEHAV PHARMACOL, V19, P121, DOI 10.1097/FBP.0b013e3282f62c66; Deng C, 2007, PROG NEURO-PSYCHOPH, V31, P915, DOI 10.1016/j.pnpbp.2007.02.009; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; Deng C, 2012, J PSYCHOPHARMACOL, V26, P1271, DOI 10.1177/0269881112449396; Deng C, 2010, PROG NEURO-PSYCHOPH, V34, P1, DOI 10.1016/j.pnpbp.2009.11.009; Depping AM, 2010, COCHRANE DB SYST REV, V12; FDA, 2005, EST SAF START DOS CL; Fell MJ, 2004, J PSYCHOPHARMACOL, V18, P149, DOI 10.1177/0269881104042613; Ferno J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020571; Gebhardt S, 2009, J PSYCHIATR RES, V43, P620, DOI 10.1016/j.jpsychires.2008.11.001; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Han M, 2008, PSYCHONEUROENDOCRINO, V33, P569, DOI 10.1016/j.psyneuen.2008.01.018; He M, 2014, PSYCHONEUROENDOCRINO, V42, P153, DOI 10.1016/j.psyneuen.2014.01.018; He M, 2013, CNS DRUGS, V27, P423, DOI 10.1007/s40263-013-0062-1; Hillebrand JJG, 2002, PEPTIDES, V23, P2283, DOI 10.1016/S0196-9781(02)00269-3; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Jeck-Thole S, 2006, DRUG SAFETY, V29, P1049, DOI 10.2165/00002018-200629110-00004; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kim DH, 2009, NEUROTHERAPEUTICS, V6, P78, DOI 10.1016/j.nurt.2008.10.020; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; KOMOSSA K, 2010, COCHRANE DB SYST REV, V17; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Kwok AKH, 2001, AM J OPHTHALMOL, V132, P178, DOI 10.1016/S0002-9394(01)00976-X; Lian JM, 2010, PROG NEURO-PSYCHOPH, V34, P1157, DOI 10.1016/j.pnpbp.2010.03.035; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Maffulli N, 2000, AM J SPORT MED, V28, P857, DOI 10.1177/03635465000280061401; Martins PJF, 2010, DIABETES, V59, P2418, DOI 10.2337/db10-0449; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Olds R.J., 1979, COLOUR ATLAS RAT DIS; Osuntokun O, 2011, J PSYCHOPHARMACOL, V25, P630, DOI 10.1177/0269881110368872; Pai N, 2012, ASIAN J PSYCHIATR, V5, P315, DOI 10.1016/j.ajp.2012.05.005; Patel JK, 2009, SCHIZOPHR RES, V111, P9, DOI 10.1016/j.schres.2009.03.025; Paxinos G, 2007, RAT BRAIN STEROTAXIC, V6; Perez-Iglesias R, 2008, J CLIN PSYCHOPHARM, V28, P289, DOI 10.1097/JCP.0b013e318172b8e6; Poyurovsky M, 2005, INT CLIN PSYCHOPHARM, V20, P101, DOI 10.1097/00004850-200503000-00007; Poyurovsky M, 2007, PSYCHOPHARMACOLOGY, V192, P441, DOI 10.1007/s00213-007-0731-1; Poyurovsky M, 2013, PSYCHOPHARMACOLOGY, V226, P615, DOI 10.1007/s00213-012-2935-2; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Remington G, 2011, PHARMACOL BIOCHEM BE, V100, P86, DOI 10.1016/j.pbb.2011.07.019; Richelson E, 1996, J CLIN PSYCHIAT, V57, P4; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Sethi J, 2012, NEUROSCIENCE, V217, P84, DOI 10.1016/j.neuroscience.2012.04.068; Skrede S, 2014, INT J NEUROPSYCHOPH, V17, P91, DOI 10.1017/S1461145713000862; Souza RP, 2012, J PSYCHIATR RES, V46, P462, DOI 10.1016/j.jpsychires.2012.01.010; Stahl SM, 2009, ACTA PSYCHIAT SCAND, V119, P171, DOI 10.1111/j.1600-0447.2008.01334.x; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Tauscher J, 2002, MOL PSYCHIATR, V7, P317, DOI 10.1038/sj.mp.4001009; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vehof J, 2011, PSYCHOPHARMACOLOGY, V216, P257, DOI 10.1007/s00213-011-2211-x; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Weston-Green K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033548; Weston-Green K, 2012, EUR NEUROPSYCHOPHARM, V22, P364, DOI 10.1016/j.euroneuro.2011.09.003; Weston-Green K, 2011, BEHAV BRAIN RES, V217, P337, DOI 10.1016/j.bbr.2010.10.039; Zhang Q, 2014, INT J NEUROPSYCHOPHA, V17; Zhang QS, 2014, PROG NEURO-PSYCHOPH, V51, P172, DOI 10.1016/j.pnpbp.2014.02.003; Zipursky RB, 2005, BRIT J PSYCHIAT, V187, P537, DOI 10.1192/bjp.187.6.537; Zuddas A, 2011, EUR NEUROPSYCHOPHARM, V21, P600, DOI 10.1016/j.euroneuro.2011.04.001	77	51	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104160	10.1371/journal.pone.0104160	http://dx.doi.org/10.1371/journal.pone.0104160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084453	Green Published, gold			2022-12-25	WOS:000339819800127
J	Reiner, D; Lee, RY; Dekan, G; Epstein, MM				Reiner, Daniela; Lee, Rui-Yun; Dekan, Gerhard; Epstein, Michelle M.			No Adjuvant Effect of Bacillus thuringiensis-Maize on Allergic Responses in Mice	PLOS ONE			English	Article							SALMO-SALAR L.; ATLANTIC SALMON; CRY1AC PROTOXIN; IMMUNE-RESPONSE; BT CORN; PERFORMANCE; ACTIVATION; PROTECTION; MUCOSAL; PROTEIN	Genetically modified (GM) foods are evaluated carefully for their ability to induce allergic disease. However, few studies have tested the capacity of a GM food to act as an adjuvant, i.e. influencing allergic responses to other unrelated allergens at acute onset and in individuals with pre-existing allergy. We sought to evaluate the effect of short-term feeding of GM Bacillus thuringiensis (Bt)-maize (MON810) on the initiation and relapse of allergic asthma in mice. BALB/c mice were provided a diet containing 33% GM or non-GM maize for up to 34 days either before ovalbumin (OVA)-induced experimental allergic asthma or disease relapse in mice with pre-existing allergy. We observed that GM-maize feeding did not affect OVA-induced eosinophilic airway and lung inflammation, mucus hypersecretion or OVA-specific antibody production at initiation or relapse of allergic asthma. There was no adjuvant effect upon GM-maize consumption on the onset or severity of allergic responses in a mouse model of allergic asthma.	[Reiner, Daniela; Lee, Rui-Yun; Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Dekan, Gerhard] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Epstein, MM (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria.	Michelle.Epstein@meduniwien.ac.at		Epstein, Michelle/0000-0002-4755-0224	GMSAFOOD project [211820]	GMSAFOOD project	Funding for this research was provided by the GMSAFOOD project (grant number 211820), through the 7th Framework grant, administered by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2005, ALLERGY, V60, P658, DOI 10.1111/j.1398-9995.2005.00767.x; Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2193; Batista R, 2005, J ALLERGY CLIN IMMUN, V116, P403, DOI 10.1016/j.jaci.2005.04.014; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; Carrasco-Yepez M, 2010, PARASITE IMMUNOL, V32, P664, DOI 10.1111/j.1365-3024.2010.01222.x; Codex Alimentarius Commission, 2003, COD AL COMM 25 SESS, P47; Crickmore N, 2005, TRENDS MICROBIOL, V13, P347, DOI 10.1016/j.tim.2005.06.002; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Custodio MG, 2006, CAN J ANIM SCI, V86, P461, DOI 10.4141/A05-082; EFSA, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.99; EFSA, 2009, EFSA J, P1149; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flachowsky G, 2007, ANIM FEED SCI TECH, V133, P2, DOI 10.1016/j.anifeedsci.2006.08.002; Guimaraes VD, 2008, FOOD AGR IMMUNOL, V19, P325, DOI 10.1080/09540100802495651; Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Lee RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052972; Legorreta-Herrera M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/198921; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Moreno-Fierros L, 2003, SCAND J IMMUNOL, V57, P45, DOI 10.1046/j.1365-3083.2003.01190.x; Moreno-Fierros L, 2013, INT IMMUNOPHARMACOL, V17, P1051, DOI 10.1016/j.intimp.2013.10.005; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Reuter T, 2002, ARCH ANIM NUTR, V56, P319, DOI 10.1080/00039420215628; Rodriguez-Monroy MA, 2010, SCAND J IMMUNOL, V71, P159, DOI 10.1111/j.1365-3083.2009.02358.x; Rojas-Hernandez S, 2004, INFECT IMMUN, V72, P4368, DOI 10.1128/IAI.72.8.4368-4375.2004; Sanden M, 2006, AQUACULT NUTR, V12, P1, DOI 10.1111/j.1365-2095.2006.00367.x; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; Shimada N, 2006, J VET MED SCI, V68, P1113, DOI 10.1292/jvms.68.1113; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Vazquez-Padron RI, 2000, BRAZ J MED BIOL RES, V33, P147, DOI 10.1590/S0100-879X2000000200002; Verdin-Teran SL, 2009, SCAND J IMMUNOL, V70, P596, DOI 10.1111/j.1365-3083.2009.02332.x; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011	33	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103979	10.1371/journal.pone.0103979	http://dx.doi.org/10.1371/journal.pone.0103979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084284	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800115
J	Kurklu, B; Whitehead, RH; Ong, EK; Minamoto, T; Fox, JG; Mann, JR; Judd, LM; Giraud, AS; Menheniott, TR				Kurklu, B.; Whitehead, R. H.; Ong, E. K.; Minamoto, T.; Fox, J. G.; Mann, J. R.; Judd, L. M.; Giraud, A. S.; Menheniott, T. R.			Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer	ONCOGENE			English	Article							DNA METHYLATION; TUMOR-SUPPRESSOR; T-CELLS; EXPRESSION; GENES; HYPERMETHYLATION; PROTEINS; ENHANCER; COLITIS; ABSENCE	Runt domain transcription factor 3 (RUNX3) is widely regarded as a tumour-suppressor gene inactivated by DNA hypermethylation of its canonical CpG (cytidine-phosphate-guanidine) island (CGI) promoter in gastric cancer (GC). Absence of RUNX3 expression from normal gastric epithelial cells (GECs), the progenitors to GC, coupled with frequent RUNX3 overexpression in GC progression, challenge this longstanding paradigm. However, epigenetic models to better describe RUNX3 deregulation in GC have not emerged. Here, we identify lineage-specific DNA methylation at an alternate, non-CGI promoter (P1) as a new mechanism of RUNX3 epigenetic control. In normal GECs, P1 was hypermethylated and repressed, whereas in immune lineages P1 was hypomethylated and widely expressed. In human GC development, we detected aberrant P1 hypomethylation signatures associated with the early inflammatory, preneoplastic and tumour stages. Aberrant P1 hypomethylation was fully recapitulated in mouse models of gastric inflammation and tumorigenesis. Cell sorting showed that P1 hypomethylation reflects altered cell-type composition of the gastric epithelium/tumour microenvironment caused by immune cell recruitment, not methylation loss. Finally, via long-term culture of gastric tumour epithelium, we revealed that de novo methylation of the RUNX3 canonical CGI promoter is a bystander effect of oncogenic immortalization and not likely causal in GC pathogenesis as previously argued. We propose a new model of RUNX3 epigenetic control in cancer, based on immune-specific, non-CGI promoter hypomethylation. This novel epigenetic signature may have utility in early detection of GC and possibly other epithelial cancers with premalignant immune involvement.	[Kurklu, B.; Ong, E. K.; Mann, J. R.; Judd, L. M.; Giraud, A. S.; Menheniott, T. R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Infect & Immun, Parkville, Vic 3052, Australia; [Kurklu, B.; Whitehead, R. H.; Judd, L. M.; Giraud, A. S.; Menheniott, T. R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Minamoto, T.] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa 920, Japan; [Fox, J. G.] MIT, Div Comparat Med, Dept Biol Engn, Cambridge, MA 02139 USA; [Mann, J. R.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Kanazawa University; Massachusetts Institute of Technology (MIT); University of Melbourne	Menheniott, TR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Infect & Immun, Flemington Rd, Parkville, Vic 3052, Australia.	treve.menheniott@mcri.edu.au	Menheniott, Treve/D-7964-2015	Menheniott, Treve/0000-0003-2349-8238; Judd, Louise/0000-0003-3613-4839	National Health and Medical Research Council (NH&MRC) of Australia [1006542]; Victorian Government's Medical Research Operational Infrastructure Program; Grants-in-Aid for Scientific Research [25670572] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Health and Medical Research Council (NH&MRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Medical Research Operational Infrastructure Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Professor Y Groner and Dr D Levanon (The Weizmann Institute of Science, Rehovot, Israel) for their gift of anti-Runx3 antiserum and critical reviews of the manuscript. We thank Professor I van Driel (University of Melbourne, Australia) for providing H+/K+ ATPase-gmcsf transgenic mice and Professor M Ernst (Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) for providing gp130<SUP>F/F</SUP> mice. We thank Dr J Dabritz (Murdoch Children's Research Institute) for critically reviewing the manuscript. This work was supported by a project grant (1006542) awarded to TRM by the National Health and Medical Research Council (NH&MRC) of Australia and by the Victorian Government's Medical Research Operational Infrastructure Program.	Biondo M, 2001, J IMMUNOL, V166, P2090, DOI 10.4049/jimmunol.166.3.2090; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; CORREA P, 1975, LANCET, V2, P58; Dedeurwaerder S, 2012, ONCOIMMUNOLOGY, V1, P962, DOI 10.4161/onci.19996; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2001, CANCER RES, V61, P3225; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fan XY, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-92; Ferlay J, 2013, IARC CANCERBASE; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hoffmann Werner, 2013, Front Biosci (Schol Ed), V5, P720; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hu SL, 2011, MED ONCOL, V28, P447, DOI 10.1007/s12032-010-9467-6; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kudo Y, 2011, J CELL BIOCHEM, V112, P387, DOI 10.1002/jcb.22967; Lai CB, 2012, J BIOL CHEM, V287, P7324, DOI 10.1074/jbc.M111.306936; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030786; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2014, MOL CELL BIOL, V34, P1158, DOI 10.1128/MCB.01202-13; Levanon D, 2011, EMBO MOL MED, V3, P593, DOI 10.1002/emmm.201100168; Li J, 2004, J CLIN PATHOL, V57, P294, DOI 10.1136/jcp.2003.013011; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Menheniott TR, 2010, GASTROENTEROLOGY, V138, P1823, DOI 10.1053/j.gastro.2010.01.050; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Salto-Tellez M, 2006, ONCOGENE, V25, P7646, DOI 10.1038/sj.onc.1209739; Schier S, 2005, ONCOLOGY-BASEL, V69, P9, DOI 10.1159/000086625; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schmid CA, 2013, GASTROENTEROLOGY, V144, P22, DOI 10.1053/j.gastro.2012.11.014; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; So K, 2006, PATHOL INT, V56, P571, DOI 10.1111/j.1440-1827.2006.02010.x; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Sugai M, 2011, J IMMUNOL, V186, P6515, DOI 10.4049/jimmunol.1001671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Westendorf JJ, 1999, J CELL BIOCHEM, P51; Whitehead RH, 2003, CULTURE HUMAN TUMOR, P68; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yeoh KG, 2007, J GASTROEN HEPATOL, V22, P970, DOI 10.1111/j.1440-1746.2007.04956.x	53	17	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2856	2866		10.1038/onc.2014.233	http://dx.doi.org/10.1038/onc.2014.233			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25088199	Green Published, Green Accepted			2022-12-25	WOS:000355324300005
J	Streit, AK; Matschke, LA; Dolga, AM; Rinne, S; Decher, N				Streit, Anne K.; Matschke, Lina A.; Dolga, Amalia M.; Rinne, Susanne; Decher, Niels			RNA Editing in the Central Cavity as a Mechanism to Regulate Surface Expression of the Voltage-gated Potassium Channel Kv1.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; AMINO-ACIDS; PORE REGION; RAT-BRAIN; TRAFFICKING; CLATHRIN; SUBUNITS; BINDING	Voltage-gated potassium (Kv) 1.1 channels undergo a specific enzymatic RNA deamination, generating a channel with a single amino acid exchange located in the inner pore cavity (Kv1.1(I400V)). We studied (I400V)-edited Kv1.1 channels in more detail and found that Kv1.1(I400V) gave rise to much smaller whole-cell currents than Kv1.1. To elucidate the mechanism behind this current reduction, we conducted electrophysiological recordings on single-channel level and did not find any differences. Next we examined channel surface expression in Xenopus oocytes and HeLa cells using a chemiluminescence assay and found the edited channels to be less readily expressed at the surface membrane. This reduction in surface expression was verified by fluorescence imaging experiments. Western blot analysis for comparison of protein abundances and glycosylation patterns did not show any difference between Kv1.1 and Kv1.1(I400V), further indicating that changed trafficking of Kv1.1(I400V) is causing the current reduction. Block of endocytosis by dynasore or AP180C did not abolish the differences in current amplitudes between Kv1.1 and Kv1.1(I400V), suggesting that backward trafficking is not affected. Therefore, our data suggest that I400V RNA editing of Kv1.1 leads to a reduced current size by a decreased forward trafficking of the channel to the surface membrane. This effect is specific for Kv1.1 because coexpression of Kv1.4 channel subunits with Kv1.1(I400V) abolishes these trafficking effects. Taken together, we identified RNA editing as a novel mechanism to regulate homomeric Kv1.1 channel trafficking. Fine-tuning of Kv1.1 surface expression by RNA editing might contribute to the complexity of neuronal Kv channel regulation.	[Streit, Anne K.; Matschke, Lina A.; Rinne, Susanne; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Fachbereich Med, D-35037 Marburg, Germany; [Dolga, Amalia M.] Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Decher, N (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	decher@staff.uni-marburg.de	Decher, Niels/AAF-5002-2020; Dolga, Amalia/C-9664-2018	Dolga, Amalia/0000-0001-5400-5614	Deutsche Forschungsgemeinschaft Grant [DE1432-3/2]; P. E. Kempkes Foundation	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); P. E. Kempkes Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant DE1432-3/2 (to N. D.) and by the P. E. Kempkes Foundation (to A. K. S.).	Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Decher N, 2010, EMBO J, V29, P2101, DOI 10.1038/emboj.2010.88; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Peters CJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03025; Pineda RH, 2008, J NEUROPHYSIOL, V100, P2125, DOI 10.1152/jn.90667.2008; Rajakulendran S, 2007, NEUROTHERAPEUTICS, V4, P258, DOI 10.1016/j.nurt.2007.01.010; Renigunta V, 2014, MOL BIOL CELL, V25, P1877, DOI [10.1091/mbc.E13-0592, 10.1091/mbc.E13-10-0592]; Rinne S, 2014, PFLUG ARCH EUR J PHY, V466, P1559, DOI 10.1007/s00424-013-1384-z; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Streit AK, 2011, EPILEPSIA, V52, P645, DOI 10.1111/j.1528-1167.2011.02986.x; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; Utsunomiya I, 2010, J NEUROCHEM, V112, P913, DOI 10.1111/j.1471-4159.2009.06523.x; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; Zhu J, 2005, BIOCHEM J, V388, P355, DOI 10.1042/BJ20041447; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	26	9	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26762	26771		10.1074/jbc.M113.545731	http://dx.doi.org/10.1074/jbc.M113.545731			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100718	hybrid, Green Published			2022-12-25	WOS:000342853900009
J	Choi, SS; Kim, ES; Koh, M; Lee, SJ; Lim, D; Yang, YR; Jang, HJ; Seo, KA; Min, SH; Lee, IH; Park, SB; Suh, PG; Choi, JH				Choi, Sun-Sil; Kim, Eun Sun; Koh, Minseob; Lee, Soo-Jin; Lim, Donghyun; Yang, Yong Ryoul; Jang, Hyun-Jun; Seo, Kyung-ah; Min, Sang-Hyun; Lee, In Hee; Park, Seung Bum; Suh, Pann-Ghill; Choi, Jang Hyun			A Novel Non-agonist Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Ligand UHC1 Blocks PPAR gamma Phosphorylation by Cyclin-dependent Kinase 5 (CDK5) and Improves Insulin Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; MACROPHAGES; LIPASE; FAT; THIAZOLIDINEDIONE; INFLAMMATION; RESISTANCE; REGULATOR; COMPLEX; GENES	Thiazolidinedione class of anti-diabetic drugs which are known as peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands have been used to treat metabolic disorders, but thiazolidinediones can also cause several severe side effects, including congestive heart failure, fluid retention, and weight gain. In this study, we describe a novel synthetic PPAR gamma ligand LTNIST HYUNDAI Compound 1 (UH('1) that binds tightly to PPAR gamma without the classical agonism and which blocks cyclin-dependent kinase 5 (CDK5)-mediated PPAR gamma phosphorylation. We modified the non-agonist PPAR gamma ligand SR1664 chemically to improve its solubility and then developed a novel PPAR gamma ligand, UHC1. According to our docking simulation, UHC1 occupied the ligand-binding site of P PARy with a higher docking score than SR1664. In addition, UHC1 more potently blocked CDK5-mediated PPAR gamma phosphorylation at Ser273. Surprisingly, UHC1 treatment effectively ameliorated the inflammatory response both in vitro and in high-fat diet-fed mice. Furthermore, UHC1 treatment dramatically improved insulin sensitivity in high-flit diet-fed mice without causing fluid retention and weight gain. Taken together, compared with SR 1 664, UHC1 exhibited greater beneficial effects on glucose and lipid metabolism by blocking CD K5-mediated PPAR gamma phosphorylation, and these data indicate that UHC1 could be a novel therapeutic agent for use in type 2 diabetes and related metabolic disorders.	[Choi, Sun-Sil; Kim, Eun Sun; Lee, Soo-Jin; Yang, Yong Ryoul; Jang, Hyun-Jun; Suh, Pann-Ghill; Choi, Jang Hyun] Ulsan Natl Inst Sci & Technol, Dept Biol Sci, Ulsan 689798, South Korea; [Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lim, Donghyun; Park, Seung Bum] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Taegu 701310, South Korea; [Seo, Kyung-ah; Min, Sang-Hyun] Seoul Natl Univ, Dept Biophys & Chem Biol, BioMAX Inst, Seoul 151747, South Korea; [Lee, In Hee] Hyundai Pharm Co Ltd, Dept Med Chem, Suwon 443270, Gyonggi, South Korea	Ulsan National Institute of Science & Technology (UNIST); Seoul National University (SNU); Seoul National University (SNU)	Choi, JH (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Biol Sci, Ulsan 689798, South Korea.	janghchoi@unist.ac.kr	Suh, Pann-Ghill/F-3610-2010; Choi, Jang Hyun/B-3055-2012; Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433; Koh, Minseob/0000-0003-1935-4776; Lim, Donghyun/0000-0002-6070-198X	Laboratory Animal Center in Daegu-Gyeongbuk Medical Innovation Foundation	Laboratory Animal Center in Daegu-Gyeongbuk Medical Innovation Foundation	We thank Dr. Bruce M. Spiegelman for supporting phospho-specific antibody against Ser-273 residue. We thank Dr. Fun g Kyun Kim at UNIST OLYMPUS Biomed Imaging Center (UOBC) for supporting microscopic images. The pharmacokinetic study was supported by the Laboratory Animal Center in Daegu-Gyeongbuk Medical Innovation Foundation.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Henchoz Y, 2009, ANAL BIOANAL CHEM, V394, P707, DOI 10.1007/s00216-009-2634-y; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Young PW, 1998, J PHARMACOL EXP THER, V284, P751; Zhang F, 2007, PPAR RES, V2007, DOI 10.1155/2007/32696	40	55	55	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26618	26629		10.1074/jbc.M114.566794	http://dx.doi.org/10.1074/jbc.M114.566794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100724	hybrid, Green Published			2022-12-25	WOS:000342128800052
J	Pha, K; Wright, ME; Barr, TM; Eigenheer, RA; Navarro, L				Pha, Khavong; Wright, Matthew E.; Barr, Tasha M.; Eigenheer, Richard A.; Navarro, Lorena			Regulation of Yersinia Protein Kinase A (YpkA) Kinase Activity by Multisite Autophosphorylation and Identification of an N-terminal Substrate-binding Domain in YpkA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION; TYROSINE-PHOSPHATASE; POSTTRANSLATIONAL MODIFICATION; OUTER PROTEINS; SER/THR KINASE; VIRULENCE; ACTIVATION; PHOSPHORYLATION; ACETYLATION; MODULATION	The serine/threonine protein kinase YpkA is an essential virulence factor produced by pathogenic Yersinia species. YpkA is delivered into host mammalian cells via a type III secretion system and localizes to the inner side of the plasma membrane. We have previously shown that YpkA binds to and phosphorylates the alpha subunit of the heterotrimeric G protein complex, G alpha q, resulting in inhibition of G alpha q signaling. To identify residues in YpkA involved in substrate binding activity we generated GFP-YpkA N-terminal deletion mutants and performed coimmunoprecipitation experiments. We located a substrate-binding domain on amino acids 40-49 of YpkA, which lies within the previously identified membrane localization domain on YpkA. Deletion of amino acids 40-49 on YpkA interfered with substrate binding, substrate phosphorylation and substrate inhibition. Autophosphorylation regulates the kinase activity of YpkA. To dissect the mechanism by which YpkA transmits signals, we performed nano liquid chromatography coupled to tandem mass spectrometry to map in vivo phosphorylation sites. Multiple serine phosphorylation sites were identified in the secretion/translocation region, kinase domain, and C-terminal region of YpkA. Using site-directed mutagenesis we generated multiple YpkA constructs harboring specific serine to alanine point mutations. Our results demonstrate that multiple autophosphorylation sites within the N terminus regulate YpkA kinase activation, whereas mutation of serine to alanine within the C terminus of YpkA had no effect on kinase activity. YpkA autophosphorylation on multiple sites may be a strategy used by pathogenic Yersinia to prevent inactivation of this important virulence protein by host proteins.	[Pha, Khavong; Wright, Matthew E.; Barr, Tasha M.; Navarro, Lorena] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Eigenheer, Richard A.] Univ Calif Davis, Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Navarro, L (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	lonavarro@ucdavis.edu			Hellman Fellows Program; ASM Robert D. Watkins Graduate Research Fellowship Program	Hellman Fellows Program; ASM Robert D. Watkins Graduate Research Fellowship Program	This work was supported in part by grants from the Hellman Fellows Program (to L. N.) and the ASM Robert D. Watkins Graduate Research Fellowship Program (to K. P.).	Aepfelbacher M, 2005, REV PHYSIOL BIOCH P, V152, P65, DOI 10.1007/s10254-004-0035-3; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Groves E, 2010, J BIOL CHEM, V285, P4087, DOI 10.1074/jbc.M109.071035; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; Hentschke M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013165; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Salomon D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3973; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; Sorg I, 2003, INFECT IMMUN, V71, P4623, DOI 10.1128/IAI.71.8.4623-4632.2003; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Trosky JE, 2008, CELL MICROBIOL, V10, P557, DOI 10.1111/j.1462-5822.2007.01109.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001	43	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26167	26177		10.1074/jbc.M114.601153	http://dx.doi.org/10.1074/jbc.M114.601153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086045	Green Published, hybrid			2022-12-25	WOS:000342128800013
J	Roston, RL; Wang, K; Kuhn, LA; Benning, C				Roston, Rebecca L.; Wang, Kun; Kuhn, Leslie A.; Benning, Christoph			Structural Determinants Allowing Transferase Activity in SENSITIVE TO FREEZING 2, Classified as a Family I Glycosyl Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER ENVELOPE MEMBRANE; PROTEIN MODEL QUALITY; CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; BETA-GLUCOSIDASE; EVOLUTIONARY CONSERVATION; DISORDER PREDICTION; PREPROTEIN RECEPTOR; ESCHERICHIA-COLI; SCORING FUNCTION	SENSITIVE TO FREEZING 2 (SFR2) is classified as a family I glycosyl hydrolase but has recently been shown to have galactosyltransferase activity in Arabidopsis thaliana. Natural occurrences of apparent glycosyl hydrolases acting as transferases are interesting from a biocatalysis standpoint, and knowledge about the interconversion can assist in engineering SFR2 in crop plants to resist freezing. To understand how SFR2 evolved into a transferase, the relationship between its structure and function are investigated by activity assay, molecular modeling, and site-directed mutagenesis. SFR2 has no detectable hydrolase activity, although its catalytic site is highly conserved with that of family 1 glycosyl hydrolases. Three regions disparate from glycosyl hydrolases are identified as required for transferase activity as follows: a loop insertion, the C-terminal peptide, and a hydrophobic patch adjacent to the catalytic site. Rationales for the effects of these regions on the SFR2 mechanism are discussed.	[Roston, Rebecca L.; Wang, Kun; Kuhn, Leslie A.; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Kuhn, Leslie A.] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Roston, RL (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr N200, 1901 Vine St, Lincoln, NE 68588 USA.	rroston@unl.edu	Roston, Rebecca/AAQ-5309-2020; Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667; Roston, Rebecca/0000-0002-3063-5002; Wang, Kun/0000-0003-1715-990X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-98ER20305]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-98ER20305 (to C. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Assuncao AGL, 2013, METALLOMICS, V5, P1110, DOI 10.1039/c3mt00070b; Babor M, 2008, PROTEINS, V70, P208, DOI 10.1002/prot.21587; Balsera M, 2009, J BIOL CHEM, V284, P2603, DOI 10.1074/jbc.M807134200; BARRETT T, 1995, STRUCTURE, V3, P951, DOI 10.1016/S0969-2126(01)00229-5; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; Bodennec J, 2003, J LIPID RES, V44, P218, DOI 10.1194/jlr.D200026-JLR200; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Britton KL, 2001, ACTA CRYSTALLOGR D, V57, P1209, DOI 10.1107/S0907444901008642; Bruce B.D., 1994, PLANT MOL BIOL MANUA, VJ1, P1; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Cairns J. R. K., 2012, Journal of Applied Glycoscience, V59, P51, DOI 10.5458/jag.jag.JAG-2011_022; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell ZT, 2009, J BIOL CHEM, V284, P32827, DOI 10.1074/jbc.M109.031716; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi YI, 1999, FEBS LETT, V445, P375, DOI 10.1016/S0014-5793(99)00090-3; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Czjzek M, 2001, BIOCHEM J, V354, P37, DOI 10.1042/0264-6021:3540037; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Deckert K, 2012, J AM CHEM SOC, V134, P10055, DOI 10.1021/ja301409g; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Ebert JC, 2008, PROTEIN SCI, V17, P54, DOI 10.1110/ps.073138508; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fourrier N, 2008, PLANT J, V55, P734, DOI 10.1111/j.1365-313X.2008.03549.x; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Gloster TM, 2004, BIOCHEMISTRY-US, V43, P6101, DOI 10.1021/bi049666m; GREER J, 1981, J MOL BIOL, V153, P1027, DOI 10.1016/0022-2836(81)90465-4; Halperin SJ, 2003, J EXP BOT, V54, P2035, DOI 10.1093/jxb/erg219; HEEMSKERK JW, 1983, BIOCHIM BIOPHYS ACTA, V754, P181, DOI 10.1016/0005-2760(83)90160-1; Heger A, 2007, BIOINFORMATICS, V23, P2361, DOI 10.1093/bioinformatics/btm358; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636; Kikuchi S, 2006, PLANT CELL PHYSIOL, V47, P363, DOI 10.1093/pcp/pcj002; Korndorfer IP, 2000, J MOL BIOL, V300, P917, DOI 10.1006/jmbi.2000.3896; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Kuntal Bhusan K, 2010, BMC Res Notes, V3, P226, DOI 10.1186/1756-0500-3-226; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Luang S, 2013, J BIOL CHEM, V288, P10111, DOI 10.1074/jbc.M112.423533; Lung SC, 2012, PLANT CELL, V24, P1560, DOI 10.1105/tpc.112.096248; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moellering ER, 2011, TRENDS PLANT SCI, V16, P98, DOI 10.1016/j.tplants.2010.11.004; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; MONSAN P, 1995, FEMS MICROBIOL REV, V16, P187; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Muckel E, 1996, J BIOL CHEM, V271, P23846, DOI 10.1074/jbc.271.39.23846; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Offredi F, 2003, J MOL BIOL, V325, P163, DOI 10.1016/S0022-2836(02)01206-8; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Roston RL, 2012, J BIOL CHEM, V287, P21406, DOI 10.1074/jbc.M112.370213; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Schrodinger L., 2020, PYMOL; Shafii B., 2012, THESIS; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Snyder R.L., 2005, FROST PROTECTION FUN, V1; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Sue M, 2006, PLANT PHYSIOL, V141, P1237, DOI 10.1104/pp.106.077693; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Teze D, 2013, BIOCHEMISTRY-US, V52, P5900, DOI 10.1021/bi400260b; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Tribolo S, 2007, J MOL BIOL, V370, P964, DOI 10.1016/j.jmb.2007.05.034; van der Veen BA, 2001, J BIOL CHEM, V276, P44557, DOI 10.1074/jbc.M107533200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Warren G, 1996, PLANT PHYSIOL, V111, P1011, DOI 10.1104/pp.111.4.1011; Withers SG, 2001, CARBOHYD POLYM, V44, P325, DOI 10.1016/S0144-8617(00)00249-6; Xia LQ, 2012, ACS CHEM BIOL, V7, P226, DOI 10.1021/cb200267w; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1	99	17	18	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26089	26106		10.1074/jbc.M114.576694	http://dx.doi.org/10.1074/jbc.M114.576694			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100720	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000342128800007
J	Zhao, X; Rotenberg, SA				Zhao, Xin; Rotenberg, Susan A.			Phosphorylation of Cdc42 Effector Protein-4 (CEP4) by Protein Kinase C Promotes Motility of Human Breast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO FAMILY GTPASES; CANCER CELLS; PKC-ALPHA; SPECIFICITY; ACTIVATION; EXPRESSION; POLARITY; DESIGN; TARGET; RAC	Cdc42 effector protein-4 (CEP4) was recently identified by our laboratory to be a substrate of multiple PKC isoforms in non-transformed MCF-10A human breast cells. The significance of phosphorylated CEP4 to PKC-stimulated motility of MCF-10A cells was evaluated. Single site mutants at Ser residues embedded in potential PKC consensus sites (Ser(18), Ser(77), Ser(80), and Ser(86)) were individually replaced with Asp residues to simulate phosphorylation. Following expression in weakly motile MCF-10A cells, the S18D and S80D mutants each promoted increased motility, and the double mutant (S18D/S80D) produced a stronger effect. MS/MS analysis verified that Ser(18) and Ser(80) were directly phosphorylated by PKC alpha in vitro. Phosphorylation of CEP4 severely diminished its affinity for Cdc42 while promoting Rac activation and formation of filopodia (microspikes). In contrast, the phosphorylation-resistant double mutant S18A/S80A-CEP4 blocked CEP4 phosphorylation and inhibited motility of MCF-10A cells that had been stimulated with PKC activator diacylglycerol lactone. In view of the dissociation of phospho-CEP4 from Cdc42, intracellular binding partners were explored by expressing each CEP4 double mutant from a tandem affinity purification vector followed by affinity chromatography, SDS-PAGE, and identification of protein bands evident only with S18D/S80D-CEP4. One binding partner was identified as tumor endothelial marker-4 (TEM4; ARHGEF17), a guanine nucleotide exchange factor that is involved in migration. In motile cells expressing S18D/S80D-CEP4, knockdown of TEM4 inhibited both Rac activation and motility. These findings support a model in which PKC-mediated phosphorylation of CEP4 at Ser18 and Ser80 causes its dissociation from Cdc42, thereby increasing its affinity for TEM4 and producing Rac activation, filopodium formation, and cell motility.	[Zhao, Xin; Rotenberg, Susan A.] Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA; [Zhao, Xin] CUNY, Grad Ctr, New York, NY 10016 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System	Rotenberg, SA (corresponding author), CUNY Queens Coll, Dept Chem & Biochem, 65-30 Kissena Blvd, Flushing, NY 11367 USA.	Susan.Rotenberg@qc.cuny.edu		Rotenberg, Susan/0000-0002-6618-686X	National Institutes of Health [CA125632]; NATIONAL CANCER INSTITUTE [R15CA125632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA125632 (to S. A. R.).	Abeyweera TP, 2007, BIOCHEMISTRY-US, V46, P2364, DOI 10.1021/bi0622017; Abeyweera TP, 2009, J BIOL CHEM, V284, P17648, DOI 10.1074/jbc.M902005200; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Burbelo PD, 1999, P NATL ACAD SCI USA, V96, P9083, DOI 10.1073/pnas.96.16.9083; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Chen XY, 2012, BIOCHEMISTRY-US, V51, P7087, DOI 10.1021/bi300999c; Cunliffe HE, 2012, AM J CANCER RES, V2, P478; De S, 2014, CYTOSKELETON, V71, P257, DOI 10.1002/cm.21167; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; McCracken MA, 2003, MOL CANCER THER, V2, P273; Mitin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066260; Mitin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041876; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Ngok SP, 2013, J CELL SCI, V126, P3271, DOI 10.1242/jcs.123869; Osada N, 2000, J HUM GENET, V45, P374, DOI 10.1007/s100380070012; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Rumenapp U, 2002, BIOCHEM J, V366, P721, DOI 10.1042/BJ20020654; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Xu XL, 2010, PROTEIN EXPRES PURIF, V72, P149, DOI 10.1016/j.pep.2010.04.009; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853	35	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 12	2014	289	37					25844	25854		10.1074/jbc.M114.577783	http://dx.doi.org/10.1074/jbc.M114.577783			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5PJ	25086031	Green Published, hybrid			2022-12-25	WOS:000342130800041
J	Arellano-Garcia, ME; Misuno, K; Tran, SD; Hu, S				Arellano-Garcia, Martha E.; Misuno, Kaori; Tran, Simon D.; Hu, Shen			Interferon-gamma Induces Immunoproteasomes and the Presentation of MHC I-Associated Peptides on Human Salivary Gland Cells	PLOS ONE			English	Article							SJOGRENS-SYNDROME; EPITHELIAL-CELLS; PROTEASOME; EXPRESSION; 20S; DEGRADATION; PROPEPTIDES; LACTACYSTIN; BIOMARKERS; APOPTOSIS	A prominent histopathological feature of Sjogren's syndrome, an autoimmune disease, is the presence of lymphocytic infiltrates in the salivary and lachrymal glands. Such infiltrates are comprised of activated lymphocytes and macrophages, and known to produce multiple cytokines including interferon-gamma (IFN-gamma). In this study, we have demonstrated that IFN-gamma strongly induces the expression of immunoproteasome beta subunits (beta 1i, beta 2i and beta 5i) and immunoproteasome activity but conversely inhibits the expression of proteasome beta subunits (beta 1, beta 2 and beta 5) in human salivary gland (HSG) cells. Mass spectrometric analysis has revealed potential MHC I-associated peptides on the HSG cells, including a tryptic peptide derived from salivary amylase, due to IFN-gamma stimulation. These results suggest that IFN-gamma induces immunoproteasomes in HSG cells, leading to enhanced presentation of MHC I-associated peptides on cell surface. These peptide-presenting salivary gland cells may be recognized and targeted by auto-reactive T lymphocytes. We have also found that lactacystin, a proteasome inhibitor, inhibits the expression of beta 1 subunit in HSG cells and blocks the IFN-gamma-induced expression of beta 1i and immunoproteasome activity. However, the expression of beta 2i and beta 5i in HSG cells is not affected by lactacystin. These results may add new insight into the mechanism regarding how lactacystin blocks the action of proteasomes or immunoproteasomes.	[Arellano-Garcia, Martha E.; Misuno, Kaori; Hu, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Arellano-Garcia, Martha E.; Misuno, Kaori; Hu, Shen] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Tran, Simon D.] McGill Univ, Fac Dent, Montreal, PQ, Canada	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; McGill University	Hu, S (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	shenhu@ucla.edu	Hu, Steve/B-3799-2011		Sjogren's Syndrome Foundation	Sjogren's Syndrome Foundation	This study was supported by the Sjogren's Syndrome Foundation (SH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baturone R, 2009, SCAND J RHEUMATOL, V38, P386, DOI 10.1080/03009740902973821; Cha S, 2004, SCAND J IMMUNOL, V60, P552, DOI 10.1111/j.0300-9475.2004.01508.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Das A, 2007, AM J PHYSIOL-LUNG C, V292, pL74, DOI 10.1152/ajplung.00103.2006; De M, 2003, J BIOL CHEM, V278, P6153, DOI 10.1074/jbc.M209292200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fox PC, 2007, ANN NY ACAD SCI, V1098, P15, DOI 10.1196/annals.1384.003; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FOX RI, 1994, J IMMUNOL, V152, P5532; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hu S, 2007, ARTHRITIS RHEUM-US, V56, P3588, DOI 10.1002/art.22954; Hu S, 2010, ARTHRIT CARE RES, V62, P1633, DOI 10.1002/acr.20289; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kesmir C, 2003, IMMUNOGENETICS, V55, P437, DOI 10.1007/s00251-003-0585-6; Krause S, 2006, ANN RHEUM DIS, V65, P1021, DOI 10.1136/ard.2005.045930; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsumura R, 2000, CLIN EXP RHEUMATOL, V18, P311; Morawietz L, 2009, J RHEUMATOL, V36, P2694, DOI 10.3899/jrheum.081098; Ping L, 2005, ARTHRITIS RHEUM-US, V52, P573, DOI 10.1002/art.20789; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; Tanaka K, 1998, IMMUNOL REV, V163, P161; Thomas E, 2006, ARTHRITIS RHEUM, V54, P1501; Tran SD, 2007, ANN RHEUM DIS, V66, P812, DOI 10.1136/ard.2006.064030; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; Vigneron N, 2012, CURR OPIN IMMUNOL, V24, P84, DOI 10.1016/j.coi.2011.12.002; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wu AJ, 1996, J CELL PHYSIOL, V167, P297, DOI 10.1002/(SICI)1097-4652(199605)167:2<297::AID-JCP14>3.0.CO;2-5; Yin HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018003; Yuan C, 2013, JSM OPHTHALMOL, V1, P1001; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	34	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102878	10.1371/journal.pone.0102878	http://dx.doi.org/10.1371/journal.pone.0102878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102056	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900011
J	Liu, YB; Lu, LG; Jin, HS; Chen, XM; Zhang, ZL; Liu, ZY; Liang, CH				Liu, Yubao; Lu, Ligong; Jin, Haosheng; Chen, Xiaoming; Zhang, Zhonglin; Liu, Zaiyi; Liang, Changhong			Radiofrequency Ablation of Liver VX2 Tumor: Experimental Results with MR Diffusion-Weighted Imaging at 3.0T	PLOS ONE			English	Article							STAGE HEPATOCELLULAR-CARCINOMA; FOLLOW-UP; RF ABLATION; PROGRESSION; SONOGRAPHY; ELECTRODES; MODEL	Purpose: To evaluate the value of DWI in detecting the lesions of pre- and post-radiofrequency ablation (RFA) of the rabbit liver VX2 tumors. Materials and Methods: Twenty-two New Zealand White rabbits were tested. The protocol was approved by the Committee on the Ethics of Animal Experiments. Twenty separate tumor fragments were implanted into the livers of 20 rabbits, the liver was exposed by performing midline laparotomy. 3.0T MR DWI (b = 0, 200, 400, 600, 800,1000 s/mm(2)) were performed 14-21 days after tumor implantation (mean, 17 days) in the 18 tumor-bearing animals. Then RFA was performed in the 18 tumor-bearing animals and in the two healthy animals. 3.0T MR DWI was performed 7-10 days after RFA (mean, 8 days). Pathology exam was performed immediately after the completion of post-RFA MR imaging. Analyzing the features of MRI and ADC values in the pre- and post-RFA lesions of the VX2 tumors, and histopathologic results were compared with imaging findings. Results: The difference of ADC value between viable tumor and normal liver parenchyma was significant (P<.001). After RFA, when b = 200, 400, 600, 800, 1000 s/mm(2), the differences of ADC values of viable tumor, granulation tissue, necrosis, normal liver parenchyma were significant (P,. 001). At the time the animals were sacrificed after RFA and MR imaging, histopathologic results of local viable tumors were found in 9 (50%) of the 18 treated tumors. Macroscopic viable tumors were found at the RFA sites in 3 (17%), all 3 macroscopic viable tumors were visualized at the periphery of the RFA areas. Conclusions: 3.0T MR DWI can be used to follow up the progress of the RFA lesion, it is useful in detecting different tissues after RFA, and it is valuable in the further clinical research.	[Liu, Yubao; Zhang, Zhonglin; Liu, Zaiyi; Liang, Changhong] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Lu, Ligong; Chen, Xiaoming] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Intervent Therapy, Guangzhou, Guangdong, Peoples R China; [Jin, Haosheng] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liang, CH (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	cjr.lchh@vip.163.com	Liang, Chang Hong/L-1885-2016		National Natural Science Foundation of China [30970798, 81271654]; Key Research Program of Joint Fund for National Natural Science Foundation of China (NSFC)-Guangdong [U1301258]; Science and Technology Planning Project of Guangzhou [2010J-E481]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of Joint Fund for National Natural Science Foundation of China (NSFC)-Guangdong(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangzhou	This work was supported by grants from the National Natural Science Foundation of China (30970798, 81271654), Key Research Program of Joint Fund for National Natural Science Foundation of China (NSFC)-Guangdong (U1301258), Science and Technology Planning Project of Guangzhou (2010J-E481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2012, HEPATOLOGY, V55, P476, DOI 10.1002/hep.24710; Cho YK, 2010, HEPATOLOGY, V51, P1284, DOI 10.1002/hep.23466; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Deng J, 2006, INVEST RADIOL, V41, P410, DOI 10.1097/01.rli.0000201232.14903.da; Dromain C, 2002, RADIOLOGY, V223, P255, DOI 10.1148/radiol.2231010780; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; Kei SK, 2008, AM J ROENTGENOL, V190, P1544, DOI 10.2214/AJR.07.2798; Koda M, 2004, AM J ROENTGENOL, V183, P583, DOI 10.2214/ajr.183.3.1830583; Kuehl H, 2008, EUR J RADIOL, V67, P362, DOI 10.1016/j.ejrad.2007.11.017; Kuszyk BS, 2000, RADIOLOGY, V217, P477, DOI 10.1148/radiology.217.2.r00nv41477; Kwee TC, 2008, J MAGN RESON IMAGING, V28, P1141, DOI 10.1002/jmri.21569; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lim HK, 2001, RADIOLOGY, V221, P447, DOI 10.1148/radiol.2212010446; Lin SM, 2004, GASTROENTEROLOGY, V127, P1714, DOI 10.1053/j.gastro.2004.09.003; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; McGahan JP, 2001, AM J ROENTGENOL, V176, P3, DOI 10.2214/ajr.176.1.1760003; Meloni MF, 2001, AM J ROENTGENOL, V177, P375, DOI 10.2214/ajr.177.2.1770375; Morimoto M, 2002, HEPATOLOGY, V35, P1467, DOI 10.1053/jhep.2002.33635; PRAT F, 1995, HEPATOLOGY, V21, P832, DOI 10.1002/hep.1840210333; Rhim H, 2008, AM J ROENTGENOL, V190, P1324, DOI 10.2214/AJR.07.2970; Rodriguez-Sanjuan JC, 2010, HEPATOLOGY, V51, P723, DOI 10.1002/hep.23454; Seror O, 2008, RADIOLOGY, V248, P288, DOI 10.1148/radiol.2481071101; Sofocleous CT, 2008, RADIOLOGY, V249, P364, DOI 10.1148/radiol.2491071752; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Teratani T, 2006, HEPATOLOGY, V43, P1101, DOI 10.1002/hep.21164; Youn BJ, 2008, ACAD RADIOL, V15, P593, DOI 10.1016/j.acra.2007.10.022; Yuan YH, 2005, WORLD J GASTROENTERO, V11, P3070, DOI 10.3748/wjg.v11.i20.3070	29	6	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104239	10.1371/journal.pone.0104239	http://dx.doi.org/10.1371/journal.pone.0104239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102074	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900051
J	Borie, A; Mok, HK; Chao, NL; Fine, ML				Borie, Alfredo; Mok, Hin-Kiu; Chao, Ning L.; Fine, Michael L.			Spatiotemporal Variability and Sound Characterization in Silver Croaker Plagioscion squamosissimus (Sciaenidae) in the Central Amazon	PLOS ONE			English	Article							PASSIVE ACOUSTICS; POGONIAS-CROMIS; SONIC MUSCLE; WEAKFISH; LOCALIZATION; MORPHOLOGY; HECKEL; WATERS; RIVER	Background: The fish family Sciaenidae has numerous species that produce sounds with superfast muscles that vibrate the swimbladder. These muscles form post embryonically and undergo seasonal hypertrophy-atrophy cycles. The family has been the focus of numerous passive acoustic studies to localize spatial and temporal occurrence of spawning aggregations. Fishes produce disturbance calls when hand-held, and males form aggregations in late afternoon and produce advertisement calls to attract females for mating. Previous studies on five continents have been confined to temperate species. Here we examine the calls of the silver croaker Plagioscion squamosissimus, a freshwater equatorial species, which experiences constant photoperiod, minimal temperature variation but seasonal changes in water depth and color, pH and conductivity. Methods and Principal Findings: Dissections indicate that sonic muscles are present exclusively in males and that muscles are thicker and redder during the mating season. Disturbance calls were recorded in hand-held fish during the low-water mating season and high-water period outside of the mating season. Advertisement calls were recorded from wild fish that formed aggregations in both periods but only during the mating season from fish in large cages. Disturbance calls consist of a series of short individual pulses in mature males. Advertisement calls start with single and paired pulses followed by greater amplitude multi-pulse bursts with higher peak frequencies than in disturbance calls. Advertisement-like calls also occur in aggregations during the off season, but bursts are shorter with fewer pulses. Conclusions and Significance: Silver croaker produce complex advertisement calls that vary in amplitude, number of cycles per burst and burst duration of their calls. Unlike temperate sciaenids, which only call during the spawning season, silver croaker produce advertisement calls in both seasons. Sonic muscles are thinner, and bursts are shorter than at the spawning peak, but males still produce complex calls outside of the mating season.	[Borie, Alfredo] Amazon Fed Univ, Dept Fishery, Manaus, Amazonas, Brazil; [Mok, Hin-Kiu] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan; [Mok, Hin-Kiu] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung, Taiwan; [Chao, Ning L.] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Fine, Michael L.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	National Sun Yat Sen University; National Sun Yat Sen University; National Museum of Marine Biology & Aquarium; Virginia Commonwealth University	Fine, ML (corresponding author), Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.	mfine@vcu.edu	Fine, Michael/I-2656-2019	Fine, Michael/0000-0001-9665-1462	Bio-Amazon Conservation; Brazilian Research and Technology National Council (CNPq)	Bio-Amazon Conservation; Brazilian Research and Technology National Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge the Bio-Amazon Conservation for the financial support and the Brazilian Research and Technology National Council (CNPq) for the MSc. scholarship during the study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucour AM, 2003, CHEM GEOL, V197, P271, DOI 10.1016/S0009-2541(02)00398-4; Barbosa ND, 2012, J APPL ICHTHYOL, V28, P800, DOI 10.1111/j.1439-0426.2012.02040.x; Borie A, 2014, B I PESCA IN PRESS; Casatti L, 2005, ZOOTAXA, P39; Casatti Lilian, 2002, Zootaxa, V26, P1; Chao NL, 1978, NMFS TECHNICAL REPOR, V415, P1; CONNAUGHTON MA, 1995, ENVIRON BIOL FISH, V42, P233, DOI 10.1007/BF00004916; Connaughton MA, 1996, COPEIA, P195; Connaughton MA, 1997, J EXP BIOL, V200, P2449; CONNAUGHTON MA, 1995, GEN COMP ENDOCR, V100, P238, DOI 10.1006/gcen.1995.1153; Fine ML, 2001, J COMP PHYSIOL A, V187, P371, DOI 10.1007/s003590100209; Fine ML, 2004, J ACOUST SOC AM, V116, P1271, DOI 10.1121/1.1736271; Fine ML, 2004, COPEIA, P235, DOI 10.1643/CP-03-073R1; FINE ML, 1978, OECOLOGIA, V36, P45, DOI 10.1007/BF00344570; HILL GL, 1987, COPEIA, P708; KONHAUSER KO, 1994, CHEM GEOL, V111, P155, DOI 10.1016/0009-2541(94)90088-4; Ladich Friedrich, 2006, P3; Lagardere JP, 2006, J FISH BIOL, V69, P1697, DOI 10.1111/j.1095-8649.2006.01237.x; Lin YC, 2007, J ACOUST SOC AM, V121, P586, DOI 10.1121/1.2384844; Locascio JV, 2011, J ACOUST SOC AM, V130, P1868, DOI 10.1121/1.3621514; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Mitchell S, 2008, ANIM BEHAV, V76, P1011, DOI 10.1016/j.anbehav.2008.03.024; Mok HK, 2009, ZOOL STUD, V48, P325; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; ONO RD, 1982, CAN J ZOOL, V60, P1955, DOI 10.1139/z82-253; Parsons MJG, 2012, J ACOUST SOC AM, V132, P3559, DOI 10.1121/1.4756927; Picculin M, 2012, BIOACOUSTICS, P1; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Rountree RA, 2006, FISHERIES, V31, P433, DOI 10.1577/1548-8446(2006)31[433:LTF]2.0.CO;2; SANTOS S.B., 2003, REV CIENCIA AGRONOMI, V34, P5; Siqueira-Souza FK, 2006, PEIXES MEDIO RIO NEG; Tellechea J, 2010, J EXP ZOOL PART A, V313A, P1, DOI DOI 10.1002/JEZ.551; Tellechea JS, 2011, BIOACOUSTICS, V20, P159, DOI 10.1080/09524622.2011.9753641; Devincenti CV, 2012, INT J MORPHOL, V30, P1442, DOI 10.4067/S0717-95022012000400027; WORTHMANN HO, 1992, AMAZONIANA, V12, P17	35	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e99326	10.1371/journal.pone.0099326	http://dx.doi.org/10.1371/journal.pone.0099326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098347	Green Submitted, Green Published, gold			2022-12-25	WOS:000339995100002
J	Roughan, JV; Coulter, CA; Flecknell, PA; Thomas, HD; Sufka, KJ				Roughan, John V.; Coulter, Claire A.; Flecknell, Paul A.; Thomas, Huw D.; Sufka, Kenneth J.			The Conditioned Place Preference Test for Assessing Welfare Consequences and Potential Refinements in a Mouse Bladder Cancer Model	PLOS ONE			English	Article							POSTOPERATIVE PAIN; THERMAL NOCICEPTION; SEX-DIFFERENCES; TUMOR-GROWTH; 2 STRAINS; MORPHINE; BEHAVIOR; BUPRENORPHINE; LAPAROTOMY; SURGERY	Most pre-clinical analgesic efficacy assays still involve nociceptive testing in rodents. This is despite concerns as to the relevance of these tests for evaluating the pain-preventative properties of drugs. More appropriate methods would target pain rather than nociception, but these are currently not available, so it remains unknown whether animal pain equates to the negatively affective and subjective/emotional state it causes in humans. Mouse cancer models are common despite the likelihood of substantial pain. We used Conditioned Place Preference (CPP) testing, assessments of thermal hyperalgesia and behaviour to determine the likelihood that MBT-2 bladder cancer impacts negatively on mouse welfare, such as by causing pain. There was no CPP to saline, but morphine preference in tumour bearing mice exceeded that seen in tumour-free controls. This occurred up to 10 days before the study end-point alongside reduced body weight, development of hyperalgesia and behaviour changes. These effects indicated mice experienced a negative welfare state caused by malaise (if not pain) before euthanasia. Due to the complexity of the assessments needed to demonstrate this, it is unlikely that this approach could be used for routine welfare assessment on a study-by-study basis. However, our results show mice in sufficiently similar studies are likely to benefit from more intensive severity assessment and re-evaluation of end-points with a view to implementing appropriate refinements. In this particular case, a refinement would have been to have euthanased mice at least 7 days earlier or possibly by provision of end-stage pain relief. CPP testing was found to be a helpful method to investigate the responses of mice to analgesics, possibly on a subjective level. These findings and those of other recent studies show it could be a valuable method of screening candidate analgesics for efficacy against cancer pain and possibly other pain or disease models.	[Roughan, John V.; Coulter, Claire A.; Flecknell, Paul A.] Univ Newcastle, Sch Med, Comparat Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Thomas, Huw D.] Univ Newcastle, Sch Med, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Sufka, Kenneth J.] Univ Mississippi, Pharmaceut Sci Res Inst, Oxford, MS USA; [Sufka, Kenneth J.] Univ Mississippi, Dept Psychol, Oxford, MS USA; [Sufka, Kenneth J.] Univ Mississippi, Dept Pharmacol, Oxford, MS USA	Newcastle University - UK; Newcastle University - UK; University of Mississippi; University of Mississippi; University of Mississippi	Roughan, JV (corresponding author), Univ Newcastle, Sch Med, Comparat Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	j.v.roughan@ncl.ac.uk	Roughan, John Vincent/AAF-3586-2021	Roughan, John Vincent/0000-0002-0031-3918; Flecknell, Paul/0000-0002-1075-1129	UK National Centre for the 3Rs (NC3Rs) [G0900763]; National Centre for the Replacement [G0900763/1] Funding Source: researchfish	UK National Centre for the 3Rs (NC3Rs); National Centre for the Replacement	The study was funded by the UK National Centre for the 3Rs (NC3Rs): http://www.nc3rs.org.uk/, Grant Number G0900763, PI: JV Roughan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai H, 2005, PAIN, V117, P19, DOI 10.1016/j.pain.2005.05.010; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; BATESON P, 1991, ANIM BEHAV, V42, P827, DOI 10.1016/S0003-3472(05)80127-7; BATESON PPG, 1973, SCIENCE, V181, P576, DOI 10.1126/science.181.4099.576; Betourne A, 2008, NEUROSCIENCE, V157, P12, DOI 10.1016/j.neuroscience.2008.08.045; Calixto-Campos C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/624815; Cesarovic N, 2014, APPL ANIM BEHAV SCI; CHIN J, 1991, J UROLOGY, V145, P1297, DOI 10.1016/S0022-5347(17)38618-4; COWAN A, 1977, BRIT J PHARMACOL, V60, P547, DOI 10.1111/j.1476-5381.1977.tb07533.x; Craft RM, 1995, J PHARMACOL EXP THER, V275, P1535; Dashti-Rahmatabadi MH, 2007, J ETHNOPHARMACOL, V109, P226, DOI 10.1016/j.jep.2006.07.035; Davoody L, 2011, J PAIN, V12, P868, DOI 10.1016/j.jpain.2011.01.010; DENNIS SG, 1979, ADV PAIN RES THER, V3, P747; Dickinson AL, 2009, LAB ANIM-UK, V43, P357, DOI 10.1258/la.2009.009005; Dimitrijevic M, 2001, BRAIN BEHAV IMMUN, V15, P255, DOI 10.1006/brbi.2000.0599; Duncan IJH, 1996, ACTA AGR SCAND A-AN, P29; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Flecknell P, 2011, PAIN, V152, P963, DOI 10.1016/j.pain.2011.01.030; Fox A, 2004, PAIN, V107, P33, DOI 10.1016/j.pain.2003.09.003; Franchi S, 2007, BRAIN BEHAV IMMUN, V21, P767, DOI 10.1016/j.bbi.2007.01.001; Hang LH, 2013, BASIC CLIN PHARMACOL, V113, P325, DOI 10.1111/bcpt.12099; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hasegawa H, 2002, JPN J CANCER RES, V93, P729, DOI 10.1111/j.1349-7006.2002.tb01313.x; Hayes JH, 1999, LAB ANIM-UK, V33, P16, DOI 10.1258/002367799780578534; Hayes KE, 2000, CONTEMP TOP LAB ANIM, V39, P18; HMSO, 2012, STAT SCI PROC LIV AN; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; Lee BH, 2005, YONSEI MED J, V46, P252, DOI 10.3349/ymj.2005.46.2.252; LILES JH, 1993, LAB ANIM, V27, P374, DOI 10.1258/002367793780745552; LILES JH, 1993, BRIT VET J, V149, P515, DOI 10.1016/S0007-1935(05)80036-3; Liu M, 2013, PAIN, V154, P1551, DOI 10.1016/j.pain.2013.04.022; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Martucci C, 2004, PAIN, V110, P385, DOI 10.1016/j.pain.2004.04.020; Matsumiya LC, 2012, J AM ASSOC LAB ANIM, V51, P42; McNabb CT, 2012, NEUROSCI LETT, V507, P57, DOI 10.1016/j.neulet.2011.11.051; Medhurst S, 2001, BRIT J PHARMACOL, V134; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miller AL, 2012, LAB ANIM-UK, V46, P304, DOI 10.1258/la.2012.012078; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Mogil JS, 2006, HAND CLINIC, V81, P325, DOI 10.1016/S0072-9752(06)80027-8; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; Nagahata S, 2007, EUR J PAIN, V11, P69; Okun A, 2012, PAIN, V153, P924, DOI 10.1016/j.pain.2012.01.022; Park HJ, 2013, ANESTH ANALG, V116, P224, DOI 10.1213/ANE.0b013e31826e1007; Qu CL, 2011, PAIN, V152, P1641, DOI 10.1016/j.pain.2011.03.002; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2004, LAB ANIM-UK, V38, P286, DOI 10.1258/002367704323133673; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2000, RES VET SCI, V69, P283, DOI 10.1053/rvsc.2000.0430; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Roughan JV, 2003, 8 WORLD C VET AN KNO, P143; Roughan JV, 2003, VET ANAESTH ANALG, V30, P54; Rutten K, 2011, EUR J PAIN, V15, P299, DOI 10.1016/j.ejpain.2010.07.011; Sasamura T, 2002, EUR J PHARMACOL, V441, P185, DOI 10.1016/S0014-2999(02)01450-4; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Stevenson GW, 2006, J PAIN, V7, P408, DOI 10.1016/j.jpain.2006.01.447; Sufka KJ, 2011, PAIN, V152, P1942, DOI 10.1016/j.pain.2011.04.028; Sufka KJ, 1996, PAIN, V66, P99, DOI 10.1016/0304-3959(96)02990-9; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Suzuki T, 1996, J PHARMACOL EXP THER, V279, P177; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; Valeberg BT, 2008, EUR J PAIN, V12, P582, DOI 10.1016/j.ejpain.2007.09.004; Vermeirsch H, 2004, PHARMACOL BIOCHEM BE, V79, P243, DOI 10.1016/j.pbb.2004.07.011; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Workman P, 1998, BRIT J CANCER, V77, P1; Wright-Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075948; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003; Zhang HW, 2003, J PHARMACOL SCI, V91, P167; Zhao J, 2013, NEUROSCIENCE, V253, P172, DOI 10.1016/j.neuroscience.2013.08.026	79	29	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103362	10.1371/journal.pone.0103362	http://dx.doi.org/10.1371/journal.pone.0103362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100208	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100018
J	Wehner, K; Scheu, S; Maraun, M				Wehner, Katja; Scheu, Stefan; Maraun, Mark			Resource Availability as Driving Factor of the Reproductive Mode in Soil Microarthropods (Acari, Oribatida)	PLOS ONE			English	Article							SEXUAL REPRODUCTION; MITES ACARI; PARTHENOGENESIS; DIVERSITY; DENSITY; BEECH; COLONIZATION; COMMUNITY; SELECTION; PATTERNS	The availability of high quality resources is an important factor driving community structure and reproductive mode of animals. Parthenogenetic reproduction prevails when resources are available in excess, whereas sexuality correlates with resource shortage. We investigated the effect of resource availability on the community structure of oribatid mites in a laboratory experiment. Availability of food resources was increased by addition of glucose to leaf litter and reduced by leaching of nutrients from leaf litter. Experimental systems were incubated at three different temperatures to establish different regimes of resource exploitation. Community structure of oribatids and numbers of eggs per female were measured over a period of ten months. We expected the density of oribatid mites to decline in the reduced litter quality treatment but to increase in the glucose treatment. Both effects were assumed to be more pronounced at higher temperatures. We hypothesized sexual species to be less affected than parthenogenetic species by reduced resource quality due to higher genetic diversity allowing more efficient exploitation of limited resources, but to be outnumbered by parthenogenetic species in case of resource addition due to faster reproduction. In contrast to our hypotheses, both sexual and parthenogenetic oribatid mite species responded similarly with their densities declining uniformly during incubation. The parthenogenetic Brachychthoniidae and Tectocepheus dominated early in the experiment but were replaced later by parthenogenetic Desmonomata and Rhysotritia. In parthenogenetic species the number of eggs per female increased during the experiment while the number of eggs in sexual females remained constant or decreased slightly; in general, egg numbers were higher in sexual than in parthenogenetic species. The results indicate that for sustaining oribatid mite populations other resources than litter and associated saprotrophic microorganisms are needed. They also indicate that there are two groups of parthenogenetically reproducing species: exploiters of easily available resources and consumers of leaf litter associated resources.	[Wehner, Katja] Univ Technol, Inst Zool, Darmstadt, Germany; [Scheu, Stefan; Maraun, Mark] Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany	Technical University of Darmstadt; University of Gottingen	Maraun, M (corresponding author), Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany.	mmaraun@gwdg.de	Scheu, Stefan/H-7049-2015		German Research Foundation [SCHE 376/19-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation SCHE 376/19-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bell G., 1982, MASTERPIECE NATURE E; Chahartaghi M, 2009, PEDOBIOLOGIA, V52, P181, DOI 10.1016/j.pedobi.2008.08.003; Cianciolo JM, 2006, EXP APPL ACAROL, V40, P1, DOI 10.1007/s10493-006-9016-3; DeBarro PJ, 1995, P ROY SOC B-BIOL SCI, V262, P321, DOI 10.1098/rspb.1995.0212; Domes K, 2007, PEDOBIOLOGIA, V51, P1, DOI 10.1016/j.pedobi.2006.11.001; Eissfeller V, 2013, SOIL BIOL BIOCHEM, V62, P76, DOI 10.1016/j.soilbio.2013.03.002; Erdmann G, 2006, PEDOBIOLOGIA, V50, P433, DOI 10.1016/j.pedobi.2006.08.004; Fioretto A, 2003, BIOL FERT SOILS, V39, P37, DOI 10.1007/s00374-003-0675-5; Fujikawa T., 1988, Edaphologia, P1; FUJIKAWA T, 1988, ACAROLOGIA, V29, P307; Ghiselin M.T., 1974, EC NATURE EVOLUTION; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; Grandjean F, 1941, CR HEBD ACAD SCI, V212, P463; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Hammer M., 1979, Kongelige Danske Videnskabernes Selskab Biologiske Skrifter, V22, P1; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Kempson D., 1963, Pedobiologia, V3, P1; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LUXTON M, 1981, PEDOBIOLOGIA, V21, P312; Lynch Michael, 1994, P109; MACFADYEN A, 1970, Soil Biology and Biochemistry, V2, P9, DOI 10.1016/0038-0717(70)90020-9; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; Maraun M, 2013, PEDOBIOLOGIA, V56, P185, DOI 10.1016/j.pedobi.2013.07.001; Maraun M, 2012, EVOL ECOL RES, V14, P311; Martens K, 2003, P ROY SOC B-BIOL SCI, V270, P723, DOI 10.1098/rspb.2002.2270; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; NICOLAI V, 1986, OECOLOGIA, V69, P148, DOI 10.1007/BF00399052; Norton R.A., 1991, P107; NORTON RA, 1988, J PALEONTOL, V62, P259, DOI 10.1017/S0022336000029905; Norton Roy A., 1993, P8; PALMER SC, 1992, BIOCHEM SYST ECOL, V20, P219, DOI 10.1016/0305-1978(92)90056-J; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Redfield RJ, 1999, J EVOLUTION BIOL, V12, P1043; RHOMBERG LR, 1985, CAN J GENET CYTOL, V27, P224, DOI 10.1139/g85-033; Schaefer M., 1991, P51; Scheiner SM, 2001, DESIGN ANAL ECOLOGIC; Scheu S, 2007, P ROY SOC B-BIOL SCI, V274, P1225, DOI 10.1098/rspb.2007.0040; Scheu S, 1996, BIODIVERS CONSERV, V5, P235, DOI 10.1007/BF00055833; Schneider K, 2004, SOIL BIOL BIOCHEM, V36, P1769, DOI 10.1016/j.soilbio.2004.04.033; Schneider K, 2007, BASIC APPL ECOL, V8, P26, DOI 10.1016/j.baae.2006.03.004; SHEAR WA, 1984, SCIENCE, V224, P492, DOI 10.1126/science.224.4648.492; SMITH JM, 1978, EVOLUTION SEX; Song Y, 2012, J EVOLUTION BIOL, V25, P556, DOI 10.1111/j.1420-9101.2012.02454.x; Song Y, 2011, OIKOS, V120, P1601, DOI 10.1111/j.1600-0706.2011.19698.x; Sovik G, 2003, CAN J ZOOL, V81, P1579, DOI [10.1139/z03-113, 10.1139/Z03-113]; TABERLY G, 1988, ACAROLOGIA, V29, P95; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Trave J., 1996, ACARIENS ORIBATES; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; YOUNG JPW, 1979, GENETICS, V92, P953	57	11	14	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104243	10.1371/journal.pone.0104243	http://dx.doi.org/10.1371/journal.pone.0104243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099762	Green Submitted, gold, Green Published			2022-12-25	WOS:000339995100054
J	Oh, JJ; Park, S; Lee, SE; Hong, SK; Lee, S; Choe, G; Yoon, S; Byun, SS				Oh, Jong Jin; Park, Seunghyun; Lee, Sang Eun; Hong, Sung Kyu; Lee, Sangchul; Choe, Gheeyoung; Yoon, Sungroh; Byun, Seok-soo			The Use of Exome Genotyping to Predict Pathological Gleason Score Upgrade after Radical Prostatectomy in Low-Risk Prostate Cancer Patients	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; EPSTEIN CRITERIA; AFRICAN-AMERICAN; URINE ASSAY; MEN; OUTCOMES; CANDIDATES; PCA3	Background: Active surveillance (AS) is a promising option for patients with low-risk prostate cancer (PCa), however current criteria could not select the patients correctly, many patients who fulfilled recent AS criteria experienced pathological Gleason score upgrade (PGU) after radical prostatectomy (RP). In this study, we aimed to develop an accurate model for predicting PGU among low-risk PCa patients by using exome genotyping. Methods: We genotyped 242,221 single nucleotide polymorphisms (SNP)s on a custom HumanExome BeadChip v1.0 (Illuminam Inc.) in blood DNA from 257 low risk PCa patients (PSA <10 ng/ml, biopsy Gleason score (GS) <= 6 and clinical stage <= T2a) who underwent radical prostatectomy. Genetic data were analyzed using an unconditional logistic regression to calculate an odds ratio as an estimate of relative risk of PGU, which defined pathologic GS above 7. Among them, we selected persistent SNPs after multiple testing using FDR method, and we compared accuracies from the multivariate logistic model incorporating clinical factors between included and excluded selected SNP information. Results: After analysis of exome genotyping, 15 SNPs were significant to predict PGU in low risk PCa patients. Among them, one SNP - rs33999879 remained significant after multiple testing. When a multivariate model incorporating factors in Epstein definition - PSA density, biopsy GS, positive core number, tumor per core ratio and age was devised for the prediction of PGU, the predictive accuracy of the multivariate model was 78.4% (95% CI: 0.726-0.834). By addition the factor of rs33999879 in aforementioned multivariate model, the predictive accuracy was 82.9%, which was significantly increased (p = 0.0196). Conclusion: The rs33999879 SNP is a predictor for PGU. The addition of genetic information from the exome sequencing effectively enhanced the predictive accuracy of the multivariate model to establish suitable active surveillance criteria.	[Oh, Jong Jin; Lee, Sang Eun; Hong, Sung Kyu; Lee, Sangchul; Byun, Seok-soo] Seoul Natl Univ, Dept Urol, Bundang Hosp, Songnam, South Korea; [Park, Seunghyun; Yoon, Sungroh] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Park, Seunghyun] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Choe, Gheeyoung] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University; Seoul National University (SNU)	Yoon, S (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	sryoon@gmail.com; ssbyun@snubh.org		Park, Seunghyun/0000-0002-8509-9163	SNUBH (Seoul National University Bundang Hospital) Research Fund [12-2013-015]; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning) [2011-0009963]	SNUBH (Seoul National University Bundang Hospital) Research Fund; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning)	This work was supported by grant no. 12-2013-015 from the SNUBH (Seoul National University Bundang Hospital) Research Fund and supported in part by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT and Future Planning) (No. 2011-0009963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barocas DA, 2008, J UROLOGY, V180, P1330, DOI 10.1016/j.juro.2008.06.019; Bastian PJ, 2009, EUR UROL, V55, P1321, DOI 10.1016/j.eururo.2009.02.028; Bastian PJ, 2004, CANCER-AM CANCER SOC, V101, P2001, DOI 10.1002/cncr.20586; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chun FKH, 2008, CANCER-AM CANCER SOC, V113, P701, DOI 10.1002/cncr.23610; Conti SL, 2009, J UROLOGY, V181, P1628, DOI 10.1016/j.juro.2008.11.107; Conti SL, 2009, J UROLOGY, V181, P1633; Dall'Era MA, 2012, EUR UROL, V62, P976, DOI 10.1016/j.eururo.2012.05.072; Deras IL, 2008, J UROLOGY, V179, P1587, DOI 10.1016/j.juro.2007.11.038; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Haese A, 2008, EUR UROL, V54, P1081, DOI 10.1016/j.eururo.2008.06.071; HEDRICK PW, 1987, GENETICS, V117, P331; Jeldres C, 2008, EUR UROL, V54, P1306, DOI 10.1016/j.eururo.2007.11.057; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Klotz L, 2005, J CLIN ONCOL, V23, P8165, DOI 10.1200/JCO.2005.03.3134; Lee SE, 2010, BJU INT, V105, P1526, DOI 10.1111/j.1464-410X.2009.09070.x; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P897, DOI 10.1097/00000478-198812000-00001; Mitsuzuka K, 2013, BJU INT, V111, P914, DOI 10.1111/j.1464-410X.2012.11658.x; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Roemeling S, 2007, EUR UROL, V51, P1244, DOI 10.1016/j.eururo.2006.11.053; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Song C, 2006, UROLOGY, V68, P820, DOI 10.1016/j.urology.2006.04.029; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sundi D, 2013, J CLIN ONCOL, V31, P2991, DOI 10.1200/JCO.2012.47.0302; Thaxton CS, 2010, UROLOGY, V75, P414, DOI 10.1016/j.urology.2009.07.1353; van Houten ME, 2000, ASIAN J ANDROL, V2, P13; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; Wu AH, 2001, CANCER EPIDEM BIOMAR, V10, P533; Zhou B, 2012, ONCOL REP, V28, P1263, DOI 10.3892/or.2012.1929	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104146	10.1371/journal.pone.0104146	http://dx.doi.org/10.1371/journal.pone.0104146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093842	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200073
J	Schoffelen, T; Limonard, GJM; Bleeker-Rovers, CP; Bouwman, JJM; van der Meer, JWM; Nabuurs-Franssen, M; Sprong, T; van Deuren, M				Schoffelen, Teske; Limonard, Gijs J. M.; Bleeker-Rovers, Chantal P.; Bouwman, John J. M.; van der Meer, Jos W. M.; Nabuurs-Franssen, Marrigje; Sprong, Tom; van Deuren, Marcel			Diagnosis of Coxiella burnetii Infection: Comparison of a Whole Blood Interferon-Gamma Production Assay and a Coxiella ELISPOT	PLOS ONE			English	Article							CHRONIC Q-FEVER; T-CELLS; TUBERCULOSIS; IMMUNODIAGNOSIS; CLEARANCE; HISTORY	Diagnosis of ongoing or past infection with Coxiella burnetii, the causative agent of Q fever, relies heavily on serology: the measurement of C. burnetii-specific antibodies, reflecting the host's humoral immune response. However, cell-mediated immune responses play an important, probably even more relevant, role in infections caused by the intracellular C. burnetii bacterium. Recent studies have investigated interferon-gamma (IFN-gamma) based assays, including a whole-blood IFN-gamma production assay and a Coxiella enzyme-linked immunospot (Coxiella ELISPOT), as potential diagnostic tools for Q fever diagnosis. Both are in-house developed assays using stimulating antigens of different origin. The main objective of this study was to compare the test performance of the IFN-gamma production assay and the Coxiella ELISPOT for detecting a cellular immune response to C. burnetii in Q fever patients, and to assess the correlation between both assays. To that end, both tests were performed in a well-defined patient group of chronic Q fever patients (n = 16) and a group of healthy seronegative individuals (n = 17). Among patients, both the Coxiella ELISPOT and the IFN-gamma production assay detected positive response in 14/16. Among controls, none were positive in the Coxiella ELISPOT, whereas the IFN-gamma production assay detected positive results in 1/17 and 3/17, when using Henzerling and Nine Mile as stimulating antigens, respectively. These results suggest the Coxiella ELISPOT has a somewhat higher specificity than the IFN-gamma production assay when Nine Mile is used as antigen stimulus. The assays showed moderate correlation: the Spearman correlation coefficient r ranged between 0.37-0.60, depending on the antigens used. Further investigation of the diagnostic potential for C. burnetii infection of both assays is warranted.	[Schoffelen, Teske; Bleeker-Rovers, Chantal P.; van der Meer, Jos W. M.; van Deuren, Marcel] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Limonard, Gijs J. M.] Diakonessenhuis Utrecht, Dept Pulm Dis, Utrecht, Netherlands; [Bouwman, John J. M.] Univ Appl Sci, Inst Life Sci, Utrecht, Netherlands; [Nabuurs-Franssen, Marrigje; Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Sprong, Tom] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands	Radboud University Nijmegen; Diakonessenhuis; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital	Schoffelen, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	Teske.Schoffelen@radboudumc.nl	Bleeker-Rovers, Chantal P/D-4833-2009; van der Meer, Jos W.M./C-8521-2013	Bleeker-Rovers, Chantal P/0000-0003-4900-6262; van der Meer, Jos W.M./0000-0001-5120-3690	Netherlands Organisation for Health Research and Development [205520002]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Health Research and Development www.zonmw.nl [grant number 205520002 to TSc]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2013, MMWR RECOMM REP, V62, P1; Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Ghigo E, 2009, ANN NY ACAD SCI, V1166, P55, DOI 10.1111/j.1749-6632.2009.04515.x; Goletti D, 2005, CLIN DIAGN LAB IMMUN, V12, P1311, DOI 10.1128/CDLI.12.11.1311-1316.2005; Kampschreur LM, 2012, CLIN VACCINE IMMUNOL, V19, P1165, DOI 10.1128/CVI.00185-12; Limonard GJM, 2012, FEMS IMMUNOL MED MIC, V64, P57, DOI 10.1111/j.1574-695X.2011.00890.x; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Schoffelen T, 2013, CLIN MICROBIOL INFEC; Schoffelen T, 2013, J INFECTION, V67, P565, DOI 10.1016/j.jinf.2013.08.008; Schoffelen T, 2013, CLIN INFECT DIS, V56, P1742, DOI 10.1093/cid/cit129; Scholvinck E, 2004, J CLIN MICROBIOL, V42, P829, DOI 10.1128/JCM.42.2.829-831.2004; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P16; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014	16	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103749	10.1371/journal.pone.0103749	http://dx.doi.org/10.1371/journal.pone.0103749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084353	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800076
J	Schwarz, F; Lange, P; Zinsser, D; Greif, M; Boekstegers, P; Schmitz, C; Reiser, MF; Kupatt, C; Becker, HC				Schwarz, Florian; Lange, Philipp; Zinsser, Dominik; Greif, Martin; Boekstegers, Peter; Schmitz, Christoph; Reiser, Maximilian F.; Kupatt, Christian; Becker, Hans C.			CT-Angiography Based Evaluation of the Aortic Annulus for Prosthesis Sizing in Transcatheter Aortic Valve Implantation (TAVI)-Predictive Value and Optimal Thresholds for Major Anatomic Parameters	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; ELDERLY-PATIENTS; ROOT DIMENSIONS; HEART-VALVE; REPLACEMENT; STENOSIS; VALVULOPLASTY; REGURGITATION; DECISION; SURGERY	Background/Objectives: To evaluate the predictive value of CT-derived measurements of the aortic annulus for prosthesis sizing in transcatheter aortic valve implantation (TAVI) and to calculate optimal cutoff values for the selection of various prosthesis sizes. Methods: The local IRB waived approval for this single-center retrospective analysis. Of 441 consecutive TAVI-patients, 90 were excluded (death within 30 days: 13; more than mild aortic regurgitation: 10; other reasons: 67). In the remaining 351 patients, the CoreValve (Medtronic) and the Edwards Sapien XT valve (Edwards Lifesciences) were implanted in 235 and 116 patients. Optimal prosthesis size was determined during TAVI by inflation of a balloon catheter at the aortic annulus. All patients had undergone CT-angiography of the heart or body trunk prior to TAVI. Using these datasets, the diameter of the long and short axis as well as the circumference and the area of the aortic annulus were measured. Multi-Class Receiver-Operator-Curve analyses were used to determine the predictive value of all variables and to define optimal cutoff-values. Results: Differences between patients who underwent implantation of the small, medium or large prosthesis were significant for all except the large vs. medium CoreValve (all p's<0.05). Furthermore, mean diameter, annulus area and circumference had equally high predictive value for prosthesis size for both manufacturers (multi-class AUC's: 0.80, 0.88, 0.91, 0.88, 0.88, 0.89). Using the calculated optimal cutoff-values, prosthesis size is predicted correctly in 85% of cases. Conclusion: CT-based aortic root measurements permit excellent prediction of the prosthesis size considered optimal during TAVI.	[Schwarz, Florian; Zinsser, Dominik; Reiser, Maximilian F.; Becker, Hans C.] Hosp Univ Munich, Inst Clin Radiol, Munich, Germany; [Lange, Philipp; Greif, Martin; Kupatt, Christian] Hosp Univ Munich, Med Clin Cardiol 1, Munich, Germany; [Boekstegers, Peter] HELIOS Kliniken GmbH, HELIOS Klinikum Siegburg, Siegburg, Germany; [Schmitz, Christoph] Hosp Univ Munich, Dept Cardiac Surg, Munich, Germany; [Reiser, Maximilian F.; Kupatt, Christian; Becker, Hans C.] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	University of Munich; University of Munich; Helios Kliniken; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Schwarz, F (corresponding author), Hosp Univ Munich, Inst Clin Radiol, Munich, Germany.	Florian.Schwarz@med.uni-muenchen.de	Schwarz, Florian/AAE-5840-2022	Schwarz, Florian/0000-0001-9889-5153; Kupatt, Christian/0000-0002-3611-1218; Becker, Hans-Christoph/0000-0001-6059-4937	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2012, J CARDIOVASC COMPUT; Altiok E, 2011, HEART, V97, P1578, DOI 10.1136/hrt.2011.223974; [Anonymous], 2010, R LANG ENV STAT COMP; Babaliaros VC, 2010, JACC-CARDIOVASC INTE, V3, P114, DOI 10.1016/j.jcin.2009.09.017; Babaliaros VC, 2008, JACC-CARDIOVASC INTE, V1, P580, DOI 10.1016/j.jcin.2008.06.010; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bertaso AG, 2012, INT J CARDIOVAS IMAG, V28, P2091, DOI 10.1007/s10554-012-0018-4; Binder RK, 2013, J AM COLL CARDIOL; Blanke P, 2012, JACC-CARDIOVASC INTE, V5, P984, DOI 10.1016/j.jcin.2012.05.014; Blanke P, 2012, CIRC-CARDIOVASC INTE, V5, P540, DOI 10.1161/CIRCINTERVENTIONS.111.967349; Blanke P, 2010, EUR J CARDIO-THORAC, V38, P750, DOI 10.1016/j.ejcts.2010.03.039; Bolen MA, 2012, J CARDIOVASC COMPUT, V6, P393, DOI 10.1016/j.jcct.2012.10.006; Bouma BJ, 1999, HEART, V82, P143, DOI 10.1136/hrt.82.2.143; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Cerillo AG, 2012, ANN CARDIOTHORAC SUR, V1, P245, DOI 10.3978/j.issn.2225-319X.2012.06.13; Cheung A, 2011, CURR OPIN CARDIOL, V26, P106, DOI 10.1097/HCO.0b013e32834398ba; del Valle-Fernandez R, 2010, EUR HEART J, V31, P2170, DOI 10.1093/eurheartj/ehq093; Delgado V, 2011, ANN THORAC SURG, V91, P716, DOI 10.1016/j.athoracsur.2010.09.060; Delgado Victoria, 2010, Expert Rev Cardiovasc Ther, V8, P113, DOI 10.1586/erc.09.135; Delgado V, 2010, EUR HEART J, V31, P1114, DOI 10.1093/eurheartj/ehq018; Gurvitch R, 2011, JACC-CARDIOVASC INTE, V4, P1235, DOI 10.1016/j.jcin.2011.07.014; Halpern EJ, 2012, ACAD RADIOL; Hayashida K, 2012, J AM COLL CARDIOL, V59, pE2142, DOI 10.1016/S0735-1097(12)62143-3; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Krishnaswamy A, 2011, CATHETER CARDIO INTE, V77, P860, DOI 10.1002/ccd.22740; Lehmkuhl L, 2013, INT J CARDIOVAS IMAG, V29, P693, DOI 10.1007/s10554-012-0123-4; Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Ng ACT, 2010, CIRC-CARDIOVASC IMAG, V3, P94, DOI 10.1161/CIRCIMAGING.109.885152; Schultz C, 2010, EUROINTERVENTION, V6, P505, DOI 10.4244/EIJ30V6I4A84; Schultz CJ, 2010, EUR HEART J, V31, P849, DOI 10.1093/eurheartj/ehp534; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Wood DA, 2009, AM J CARDIOL, V103, P1295, DOI 10.1016/j.amjcard.2009.01.034; Wuest W, 2012, EUR RADIOL, V22, P51, DOI 10.1007/s00330-011-2233-0	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103481	10.1371/journal.pone.0103481	http://dx.doi.org/10.1371/journal.pone.0103481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084451	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800047
J	Zanucco, E; El-Nikhely, N; Gotz, R; Weidmann, K; Pfeiffer, V; Savai, R; Seeger, W; Ullrich, A; Rapp, UR				Zanucco, Emanuele; El-Nikhely, Nefertiti; Goetz, Rudolf; Weidmann, Katharina; Pfeiffer, Verena; Savai, Rajkumar; Seeger, Werner; Ullrich, Axel; Rapp, Ulf R.			Elimination of B-RAF in Oncogenic C-RAF-expressing Alveolar Epithelial Type II Cells Reduces MAPK Signal Intensity and Lung Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE; CANCER; BRAF; HETERODIMERIZATION; PROGRESSION; PATHWAY; KINASE; ACTIVATE; MELANOMA; TARGETS	Tumors are often greatly dependent on signaling cascades promoting cell growth or survival and may become hypersensitive to inactivation of key components within these signaling pathways. Ras and RAF mutations found in human cancer confer constitutive activity to these signaling molecules thereby converting them into an oncogenic state. RAF dimerization is required for normal Ras-dependent RAF activation and is required for the oncogenic potential of mutant RAFs. Here we describe a new mouse model for lung tumor development to investigate the role of B-RAF in oncogenic C-RAF-mediated adenoma initiation and growth. Conditional elimination of B-RAF in C-RAF BxB-expressing embryonic alveolar epithelial type II cells did not block adenoma formation. However, loss of B-RAF led to significantly reduced tumor growth. The diminished tumor growth upon B-RAF inactivation was due to reduced cell proliferation in absence of senescence and increased apoptosis. Furthermore, B-RAF elimination inhibited C-RAF BxB-mediated activation of the mitogenic cascade. In line with these data, mutation of Ser-621 in C-RAF BxB abrogated in vitro the dimerization with B-RAF and blocked the ability to activate the MAPK cascade. Taken together these data indicate that B-RAF is an important factor in oncogenic C-RAF-mediated tumorigenesis.	[Zanucco, Emanuele; Ullrich, Axel; Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-85152 Martinsried, Germany; [El-Nikhely, Nefertiti; Savai, Rajkumar; Seeger, Werner] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, D-61231 Bad Nauheim, Germany; [Goetz, Rudolf; Weidmann, Katharina; Pfeiffer, Verena] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97078 Wurzburg, Germany	Max Planck Society; Max Planck Society; University of Wurzburg	Zanucco, E (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-85152 Martinsried, Germany.	zanucco@biochem.mpg.de; Ulf.Rapp@mpi-bn.mpg.de		Seeger, Werner/0000-0003-1946-0894; El-Nikhely, Nefertiti/0000-0002-6675-234X	institutional grant from the Max Planck Society; UGMLC; Loewe Program; DZL (The German Center for Lung Research); German Excellence Initiative	institutional grant from the Max Planck Society; UGMLC; Loewe Program; DZL (The German Center for Lung Research); German Excellence Initiative	This work was supported by an institutional grant from the Max Planck Society (to U. R. R.) and by the UGMLC and Loewe Program as well as DZL (The German Center for Lung Research).; Supported by a grant from the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Ahlbrecht K, 2008, AM J RESP CELL MOL, V39, P163, DOI 10.1165/rcmb.2007-0231OC; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Ceteci F, 2007, CANCER CELL, V12, P145, DOI 10.1016/j.ccr.2007.06.014; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis MJ, 2012, J CELL BIOL, V199, P15, DOI 10.1083/jcb.201205167; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; Kramer BW, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-24; McMahon M, 2010, NAT MED, V16, P749, DOI 10.1038/nm0710-749; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pfeiffer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058259; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Unkel B, 2012, J CLIN INVEST, V122, P3652, DOI 10.1172/JCI62139; Weber CK, 2001, CANCER RES, V61, P3595; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	24	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26804	26816		10.1074/jbc.M114.558999	http://dx.doi.org/10.1074/jbc.M114.558999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096573	Green Published, hybrid			2022-12-25	WOS:000342853900013
J	Bozue, J; Cote, CK; Chance, T; Kugelman, J; Kern, SJ; Kijek, TK; Jenkins, A; Mou, S; Moody, K; Fritz, D; Robinson, CG; Bell, T; Worsham, P				Bozue, Joel; Cote, Christopher K.; Chance, Taylor; Kugelman, Jeffrey; Kern, Steven J.; Kijek, Todd K.; Jenkins, Amy; Mou, Sherry; Moody, Krishna; Fritz, David; Robinson, Camenzind G.; Bell, Todd; Worsham, Patricia			A Yersinia pestis tat Mutant Is Attenuated in Bubonic and Small-Aerosol Pneumonic Challenge Models of Infection but Not As Attenuated by Intranasal Challenge	PLOS ONE			English	Article							ARGININE TRANSLOCATION SYSTEM; PROTEIN-TRANSPORT SYSTEM; ESCHERICHIA-COLI; SIGNAL PEPTIDE; V-ANTIGEN; PLASMINOGEN-ACTIVATOR; PSEUDOMONAS-SYRINGAE; REGULATORY PROTEIN; BIOFILM FORMATION; PLAGUE VACCINE	Bacterial proteins destined for the Tat pathway are folded before crossing the inner membrane and are typically identified by an N-terminal signal peptide containing a twin arginine motif. Translocation by the Tat pathway is dependent on the products of genes which encode proteins possessing the binding site of the signal peptide and mediating the actual translocation event. In the fully virulent CO92 strain of Yersinia pestis, the tatA gene was deleted. The mutant was assayed for loss of virulence through various in vitro and in vivo assays. Deletion of the tatA gene resulted in several consequences for the mutant as compared to wild-type. Cell morphology of the mutant bacteria was altered and demonstrated a more elongated form. In addition, while cultures of the mutant strain were able to produce a biofilm, we observed a loss of adhesion of the mutant biofilm structure compared to the biofilm produced by the wild-type strain. Immuno-electron microscopy revealed a partial disruption of the F1 antigen on the surface of the mutant. The virulence of the Delta tatA mutant was assessed in various murine models of plague. The mutant was severely attenuated in the bubonic model with full virulence restored by complementation with the native gene. After small-particle aerosol challenge in a pneumonic model of infection, the mutant was also shown to be attenuated. In contrast, when mice were challenged intranasally with the mutant, very little difference in the LD50 was observed between wild-type and mutant strains. However, an increased time-to- death and delay in bacterial dissemination was observed in mice infected with the Delta tatA mutant as compared to the parent strain. Collectively, these findings demonstrate an essential role for the Tat pathway in the virulence of Y. pestis in bubonic and small-aerosol pneumonic infection but less important role for intranasal challenge.	[Bozue, Joel; Cote, Christopher K.; Kijek, Todd K.; Jenkins, Amy; Mou, Sherry; Moody, Krishna; Fritz, David; Worsham, Patricia] US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA; [Chance, Taylor; Robinson, Camenzind G.; Bell, Todd] US Army, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA; [Kugelman, Jeffrey] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA; [Kern, Steven J.] US Army, Med Res Inst Infect Dis, Off Res Support, Ft Detrick, MD 21702 USA		Bozue, J (corresponding author), US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA.	joel.a.bozue@us.army.mil	Bozue, Joel/AAE-4357-2022; Robinson, Camenzind G/O-5097-2018; Bozue, Joel/AAE-4363-2022	Bozue, Joel/0000-0001-6959-8176; Robinson, Camenzind G/0000-0002-7277-692X; Bozue, Joel/0000-0001-6959-8176	Defense Threat Reduction Agency JSTO-CBD [923698]	Defense Threat Reduction Agency JSTO-CBD(United States Department of DefenseDefense Threat Reduction Agency)	The research described herein was sponsored by the Defense Threat Reduction Agency JSTO-CBD (project number 923698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2009, AM J PATHOL, V174, P910, DOI 10.2353/ajpath.2009.071168; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; Anisimov AP, 2009, J MED MICROBIOL, V58, P26, DOI 10.1099/jmm.0.005678-0; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Benoit SL, 2014, MBIO, V5, DOI 10.1128/mBio.01016-13; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bozue J, 2012, FEMS MICROBIOL LETT, V332, P113, DOI 10.1111/j.1574-6968.2012.02583.x; Bozue J, 2011, MICROB PATHOGENESIS, V50, P314, DOI 10.1016/j.micpath.2011.02.005; Bronstein PA, 2005, J BACTERIOL, V187, P8450, DOI 10.1128/JB.187.24.8450-8461.2005; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Buchrieser C, 1998, MOL MICROBIOL, V30, P965, DOI 10.1046/j.1365-2958.1998.01124.x; Caldelari I, 2006, MOL PLANT MICROBE IN, V19, P200, DOI 10.1094/MPMI-19-0200; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chen L, 2009, ARCH MICROBIOL, V191, P163, DOI 10.1007/s00203-008-0440-0; CHEN TH, 1977, INFECT IMMUN, V15, P972, DOI 10.1128/IAI.15.3.972-977.1977; CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L; CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x; Cornelius CA, 2009, INFECT IMMUN, V77, P1807, DOI 10.1128/IAI.01162-08; DALY JA, 1985, J CLIN MICROBIOL, V21, P919, DOI 10.1128/JCM.21.6.919-921.1985; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P865; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; DiMezzo TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006281; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Felek S, 2011, MICROBIOL-SGM, V157, P805, DOI 10.1099/mic.0.044826-0; Ferrandez Y, 2008, MOL MICROBIOL, V69, P1349, DOI 10.1111/j.1365-2958.2008.06366.x; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FETHERSTON JD, 1994, MOL MICROBIOL, V13, P697, DOI 10.1111/j.1365-2958.1994.tb00463.x; Fisher ML, 2007, INFECT IMMUN, V75, P429, DOI 10.1128/IAI.01287-06; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; GALYOV EE, 1991, FEBS LETT, V286, P79, DOI 10.1016/0014-5793(91)80945-Y; Glornski IJ, 2008, MICROBES INFECT, V10, P1398, DOI 10.1016/j.micinf.2008.07.042; Glynn A, 2005, INFECT IMMUN, V73, P5256, DOI 10.1128/IAI.73.8.5256-5261.2005; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Guarner J, 2002, AM J CLIN PATHOL, V117, P205; HALLETT AF, 1973, INFECT IMMUN, V8, P876, DOI 10.1128/IAI.8.6.876-881.1973; He HH, 2011, CURR MICROBIOL, V62, P1193, DOI 10.1007/s00284-010-9844-6; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hinchliffe SJ, 2003, GENOME RES, V13, P2018, DOI 10.1101/gr.1507303; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; KARLYSHEV AV, 1992, FEBS LETT, V297, P77, DOI 10.1016/0014-5793(92)80331-A; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; Kolkman MAB, 2008, APPL ENVIRON MICROB, V74, P7507, DOI 10.1128/AEM.01401-08; Koskiniemi S, 1998, FEMS IMMUNOL MED MIC, V21, P159, DOI 10.1111/j.1574-695X.1998.tb01162.x; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; MEHIGH RJ, 1993, INFECT IMMUN, V61, P13, DOI 10.1128/IAI.61.1.13-22.1993; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; PRICE SB, 1991, J BACTERIOL, V173, P2649, DOI 10.1128/jb.173.8.2649-2657.1991; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Rodriguez-Sanz M, 2010, FEMS MICROBIOL LETT, V302, P151, DOI 10.1111/j.1574-6968.2009.01844.x; Rossier O, 2005, INFECT IMMUN, V73, P2020, DOI 10.1128/IAI.73.4.2020-2032.2005; Runco LM, 2008, J BACTERIOL, V190, P3381, DOI 10.1128/JB.01840-07; Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998; Sarker MR, 1998, INFECT IMMUN, V66, P2976, DOI 10.1128/IAI.66.6.2976-2979.1998; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; SIMPSON WJ, 1990, AM J TROP MED HYG, V43, P389, DOI 10.4269/ajtmh.1990.43.389; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; STRALEY SC, 1991, MICROB PATHOGENESIS, V10, P87, DOI 10.1016/0882-4010(91)90069-M; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Wagley S, 2014, J BACTERIOL, V196, P407, DOI 10.1128/JB.01046-13; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; Weening EH, 2011, INFECT IMMUN, V79, P644, DOI 10.1128/IAI.00981-10; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Welkos SL, 1995, CONTRIB TO MICROBIOL, V13, P299; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Worsham PL, 2003, ADV EXP MED BIOL, V529, P129; Worsham PL, 1995, CONTRIB TO MICROBIOL, V13, P325; WORSHAM PL, 2007, MED ASPECTS BIOL WAR, P91; Zhang LJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-114	94	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104524	10.1371/journal.pone.0104524	http://dx.doi.org/10.1371/journal.pone.0104524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101850	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900072
J	Tsuji, S; Kawamura, F; Kubiura, M; Hayashi, A; Ohbayashi, T; Kazuki, Y; Chesne, C; Oshimura, M; Tada, M				Tsuji, Saori; Kawamura, Fumihiko; Kubiura, Musashi; Hayashi, Ayaka; Ohbayashi, Tetsuya; Kazuki, Yasuhiro; Chesne, Christophe; Oshimura, Mitsuo; Tada, Masako			Dual-Color Fluorescence Imaging to Monitor CYP3A4 and CYP3A7 Expression in Human Hepatic Carcinoma HepG2 and HepaRG Cells	PLOS ONE			English	Article							PREGNANE X RECEPTOR; NUCLEAR RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; LIVER MATURATION; INDUCTION; FETAL; HEPATOCYTES; PXR; RIFAMPICIN	Human adult hepatocytes expressing CYP3A4, a major cytochrome P450 enzyme, are required for cell-based assays to evaluate the potential risk of drug-drug interactions caused by transcriptional induction of P450 enzymes in early-phase drug discovery and development. However, CYP3A7 is preferentially expressed in premature hepatoblasts and major hepatic carcinoma cell lines. The human hepatocellular carcinoma cell line HepaRG possesses a high self-renewal capacity and can differentiate into hepatic cells similar to human adult hepatocytes in vitro. Transgenic HepaRG cells, in which the expression of fluorescent reporters is regulated by 35 kb regulatory elements of CYP3A4, have a distinct advantage over human hepatocytes isolated by collagenase perfusion, which are unstable in culture. Thus, we created transgenic HepaRG and HepG2 cells by replacing the protein-coding regions of human CYP3A4 and CYP3A7 with enhanced green fluorescent protein (EGFP) and DsRed reporters, respectively, in a bacterial artificial chromosome vector that included whole regulatory elements. The intensity of DsRed fluorescence was initially high during the proliferation of transgenic HepaRG cells. However, most EGFP-positive cells were derived from those in which DsRed fluorescence was extinguished. Comparative analyses in these transgenic clones showed that changes in the total fluorescence intensity of EGFP reflected fold changes in the mRNA level of endogenous CYP3A4. Moreover, CYP3A4 induction was monitored by the increase in EGFP fluorescence. Thus, this assay provides a real-time evaluation system for quality assurance of hepatic differentiation into CYP3A4-expressing cells, unfavourable CYP3A4 induction, and fluorescence-activated cell sorting-mediated enrichment of CYP3A4-expressing hepatocytes based on the total fluorescence intensities of fluorescent reporters, without the need for many time-consuming steps.	[Tsuji, Saori] Org Tottori Ind Promot, Bio Frontier Project Promot Sect, Yonago, Tottori, Japan; [Kawamura, Fumihiko; Kubiura, Musashi; Hayashi, Ayaka; Kazuki, Yasuhiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci,Div Mol Genet & Biofunct, Yonago, Tottori, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo; Tada, Masako] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Chesne, Christophe] Biopred Int, Rennes, France	Tottori University; Tottori University; Tottori University	Tada, M (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan.	matada@med.tottori-u.ac.jp	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973	Regional Innovation Cluster Program, MEXT, Japan; A-STEP FS, JST, Japan; Cosmetology Research Foundation, Japan	Regional Innovation Cluster Program, MEXT, Japan; A-STEP FS, JST, Japan; Cosmetology Research Foundation, Japan	This study was supported by grants from the Regional Innovation Cluster Program 2010, MEXT, Japan; A-STEP FS 2013, JST, Japan; and The Cosmetology Research Foundation 2013, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Barwick JL, 1996, MOL PHARMACOL, V50, P10; Bertilsson G, 2001, BIOCHEM BIOPH RES CO, V280, P139, DOI 10.1006/bbrc.2000.4066; BISGAARD HC, 1994, J CELL PHYSIOL, V159, P475, DOI 10.1002/jcp.1041590312; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Greuet J, 1996, BIOCHEM BIOPH RES CO, V225, P689, DOI 10.1006/bbrc.1996.1231; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hart SN, 2009, DRUG METAB DISPOS, V37, P116, DOI 10.1124/dmd.108.023812; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kubiura M, 2012, CHROMOSOME RES, V20, P837, DOI 10.1007/s10577-012-9317-9; Lacroix D, 1997, EUR J BIOCHEM, V247, P625, DOI 10.1111/j.1432-1033.1997.00625.x; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Li Y, 2009, MOL PHARMACOL, V75, P1171, DOI 10.1124/mol.108.052993; Maruyama M, 2007, BIOL PHARM BULL, V30, P2091, DOI 10.1248/bpb.30.2091; Matsunaga T, 2004, BIOCHEM BIOPH RES CO, V318, P428, DOI 10.1016/j.bbrc.2004.04.041; Robertson GR, 2003, MOL PHARMACOL, V64, P42, DOI 10.1124/mol.64.1.42; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Takiguchi M., 2012, ACS SYNTH BIOL; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Usui T, 2003, BIOL PHARM BULL, V26, P510; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Zhang WS, 2003, DRUG METAB DISPOS, V31, P1054, DOI 10.1124/dmd.31.8.1054	29	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104123	10.1371/journal.pone.0104123	http://dx.doi.org/10.1371/journal.pone.0104123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101946	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900041
J	Wang, FY; Fu, WC; Wang, IL; Yan, HY; Wang, TY				Wang, Feng-Yu; Fu, Wen-Chun; Wang, I-Li; Yan, Hong Young; Wang, Tzi-Yuan			The Giant Mottled Eel, Anguilla marmorata, Uses Blue-Shifted Rod Photoreceptors during Upstream Migration	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; TUNING SPECTRAL SENSITIVITY; OPSIN GENE-EXPRESSION; COLOR-VISION; FRESH-WATER; HABITAT USE; MOLECULAR EVOLUTION; TROPICAL EEL; EUROPEAN EEL; TOKAY-GECKO	Catadromous fishes migrate between ocean and freshwater during particular phases of their life cycle. The dramatic environmental changes shape their physiological features, e. g. visual sensitivity, olfactory ability, and salinity tolerance. Anguilla marmorata, a catadromous eel, migrates upstream on dark nights, following the lunar cycle. Such behavior may be correlated with ontogenetic changes in sensory systems. Therefore, this study was designed to identify changes in spectral sensitivity and opsin gene expression of A. marmorata during upstream migration. Microspectrophotometry analysis revealed that the tropical eel possesses a duplex retina with rod and cone photoreceptors. The lambda(max) of rod cells are 493, 489, and 489 nm in glass, yellow, and wild eels, while those of cone cells are 508, and 517 nm in yellow, and wild eels, respectively. Unlike European and American eels, Asian eels exhibited a blue-shifted pattern of rod photoreceptors during upstream migration. Quantitative gene expression analyses of four cloned opsin genes (Rh1f, Rh1d, Rh2, and SWS2) revealed that Rh1f expression is dominant at all three stages, while Rh1d is expressed only in older yellow eel. Furthermore, sequence comparison and protein modeling studies implied that a blue shift in Rh1d opsin may be induced by two known (N83, S292) and four putative (S124, V189, V286, I290) tuning sites adjacent to the retinal binding sites. Finally, expression of blue-shifted Rh1d opsin resulted in a spectral shift in rod photoreceptors. Our observations indicate that the giant mottled eel is color-blind, and its blue-shifted scotopic vision may influence its upstream migration behavior and habitat choice.	[Wang, Feng-Yu] Taiwan Ocean Res Inst, Natl Appl Res Labs, Kaohsiung, Taiwan; [Fu, Wen-Chun; Yan, Hong Young] Acad Sinica, Sensory Physiol Lab, Marine Res Stn, Jiaoshi, I Lan County, Taiwan; [Wang, I-Li] Acad Sinica, Inst Biol Chem, Taiwan Int Grad Program, Chem Biol & Mol Biophys, Taipei, Taiwan; [Wang, I-Li] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Yan, Hong Young] Hanse Wissenschaftskolleg Inst Adv Study, Delmenhorst, Germany; [Wang, Tzi-Yuan] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	National Applied Research Laboratories - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Yan, HY (corresponding author), Acad Sinica, Sensory Physiol Lab, Marine Res Stn, Jiaoshi, I Lan County, Taiwan.	hyyan@gate.sinica.edu.tw; tziyuan@gmail.com	Wang, Tzi-Yuan/C-2874-2014	Wang, Tzi-Yuan/0000-0002-1562-0144	Academia Sinca, Taiwan; National Science Council [NSC 100-2311-B-001-001-MY2, NSC 102-2311-B-001-019, NSC 102-2311-B-001-010]	Academia Sinca, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by intramural grants from Academia Sinca, Taiwan, and by the National Science Council grants (NSC 100-2311-B-001-001-MY2, NSC 102-2311-B-001-019 and NSC 102-2311-B-001-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2012, J FISH BIOL, V81, P442, DOI 10.1111/j.1095-8649.2012.03353.x; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; BEATTY DD, 1975, VISION RES, V15, P771, DOI 10.1016/0042-6989(75)90254-0; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bowmaker JK, 2008, VISUAL NEUROSCI, V25, P249, DOI 10.1017/S0952523808080152; Bowmaker JK, 1995, PROG RETIN EYE RES, V15, P1; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; Briones AA, 2007, RAFFLES B ZOOL, P141; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Cheng CL, 2004, NATURE, V428, P279, DOI 10.1038/428279a; Chinen A, 2005, MOL BIOL EVOL, V22, P1001, DOI 10.1093/molbev/msi086; Chinen A, 2005, J BIOL CHEM, V280, P9460, DOI 10.1074/jbc.M413001200; Chinen A, 2003, GENETICS, V163, P663; Chino N, 2010, ECOL FRESHW FISH, V19, P19, DOI 10.1111/j.1600-0633.2009.00385.x; Chino N, 2010, ENVIRON BIOL FISH, V89, P571, DOI 10.1007/s10641-010-9677-y; Cottrill PB, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-71; Damjanovic I, 2005, ANN NY ACAD SCI, V1048, P69, DOI 10.1196/annals.1342.007; Endler JA, 2001, AM NAT, V158, P36, DOI 10.1086/320862; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Jessop BM, 2002, MAR ECOL PROG SER, V233, P217, DOI 10.3354/meps233217; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; Jokela M, 2003, J EXPT BIOL, V206; Kusmic C, 2000, MICRON, V31, P183, DOI 10.1016/S0968-4328(99)00081-5; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; LEVINE JS, 1979, SENS PROCESS, V3, P95; LIPETZ LE, 1988, VISION RES, V28, P1083, DOI 10.1016/0042-6989(88)90135-6; LOEW ER, 1994, VISION RES, V34, P1427, DOI 10.1016/0042-6989(94)90143-0; Marshall N. J., 2006, COMMUNICATION FISHES, V2, P393; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Minamoto T, 2005, COMP BIOCHEM PHYS B, V140, P197, DOI 10.1016/j.cbpc.2004.09.028; NAWROCKI L, 1985, VISION RES, V25, P1569, DOI 10.1016/0042-6989(85)90127-0; Neafsey DE, 2005, GENE, V350, P161, DOI 10.1016/j.gene.2005.02.011; Palacios AG, 1998, VISION RES, V38, P2135, DOI 10.1016/S0042-6989(97)00411-2; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Roesler CS, 1998, LIMNOL OCEANOGR, V43, P1649, DOI 10.4319/lo.1998.43.7.1649; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandstrom Alfred, 1999, Fiskeriverket Rapport, V2, P45; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shand J, 2002, J EXP BIOL, V205, P3661; SHAPLEY R, 1980, PROC R SOC SER B-BIO, V209, P317, DOI 10.1098/rspb.1980.0097; Shiao JC, 2003, MAR ECOL PROG SER, V261, P233, DOI 10.3354/meps261233; Sillman AJ, 1999, J EXP BIOL, V202, P1931; SILLMAN AJ, 2001, J EXPT ZOOLOGY, V290, P259; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Takenaka N, 2007, GENE, V399, P26, DOI 10.1016/j.gene.2007.04.036; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsukamoto K, 2002, CAN J FISH AQUAT SCI, V59, P1989, DOI 10.1139/F02-165; Tsukamoto K, 2001, MAR ECOL PROG SER, V220, P265, DOI 10.3354/meps220265; Tzeng WN, 1997, MAR ECOL PROG SER, V149, P73, DOI 10.3354/meps149073; Wang FY, 2008, VISION RES, V48, P1695, DOI 10.1016/j.visres.2008.04.026; Wang FY, 2011, VISION RES, V51, P1099, DOI 10.1016/j.visres.2011.02.025; Wang FY, 2009, VISION RES, V49, P1860, DOI 10.1016/j.visres.2009.04.023; WOOD P, 1992, J FISH BIOL, V41, P601, DOI 10.1111/j.1095-8649.1992.tb02686.x; WOOD P, 1993, P ROY SOC B-BIOL SCI, V254, P227, DOI 10.1098/rspb.1993.0150; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 2002, GENE, V300, P69, DOI 10.1016/S0378-1119(02)00845-4; Yokoyama S, 2003, GENE, V306, P91, DOI 10.1016/S0378-1119(03)00424-4; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang H, 2000, FEBS LETT, V469, P39, DOI 10.1016/S0014-5793(00)01233-3	71	14	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103953	10.1371/journal.pone.0103953	http://dx.doi.org/10.1371/journal.pone.0103953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101636	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900029
J	Marra, DM; Chambers, JQ; Higuchi, N; Trumbore, SE; Ribeiro, GHPM; dos Santos, J; Negron-Juarez, RI; Reu, B; Wirth, C				Marra, Daniel Magnabosco; Chambers, Jeffrey Q.; Higuchi, Niro; Trumbore, Susan E.; Ribeiro, Gabriel H. P. M.; dos Santos, Joaquim; Negron-Juarez, Robinson I.; Reu, Bjoern; Wirth, Christian			Large-Scale Wind Disturbances Promote Tree Diversity in a Central Amazon Forest	PLOS ONE			English	Article							BARRO-COLORADO-ISLAND; TROPICAL RAIN-FOREST; WOOD DENSITY; SPECIES-RICHNESS; GAP DISTURBANCES; LARGE BLOWDOWNS; HURRICANE HUGO; PATTERNS; BIOMASS; DAMAGE	Canopy gaps created by wind-throw events, or blowdowns, create a complex mosaic of forest patches varying in disturbance intensity and recovery in the Central Amazon. Using field and remote sensing data, we investigated the shortterm (four-year) effects of large (>2000 m(2)) blowdown gaps created during a single storm event in January 2005 near Manaus, Brazil, to study (i) how forest structure and composition vary with disturbance gradients and (ii) whether tree diversity is promoted by niche differentiation related to wind-throw events at the landscape scale. In the forest area affected by the blowdown, tree mortality ranged from 0 to 70%, and was highest on plateaus and slopes. Less impacted areas in the region affected by the blowdown had overlapping characteristics with a nearby unaffected forest in tree density (583 +/- 46 trees ha(-1)) (mean +/- 699% Confidence Interval) and basal area (26.7 +/- 2.4 m(2) ha(-1)). Highly impacted areas had tree density and basal area as low as 120 trees ha(-1) and 14.9 m 2 ha(-1), respectively. In general, these structural measures correlated negatively with an index of tree mortality intensity derived from satellite imagery. Four years after the blowdown event, differences in size-distribution, fraction of resprouters, floristic composition and species diversity still correlated with disturbance measures such as tree mortality and gap size. Our results suggest that the gradients of wind disturbance intensity encompassed in large blowdown gaps (>2000 m(2)) promote tree diversity. Specialists for particular disturbance intensities existed along the entire gradient. The existence of species or genera taking an intermediate position between undisturbed and gap specialists led to a peak of rarefied richness and diversity at intermediate disturbance levels. A diverse set of species differing widely in requirements and recruitment strategies forms the initial post-disturbance cohort, thus lending a high resilience towards wind disturbances at the community level.	[Marra, Daniel Magnabosco; Reu, Bjoern; Wirth, Christian] Univ Leipzig, D-04109 Leipzig, Germany; [Marra, Daniel Magnabosco; Trumbore, Susan E.; Wirth, Christian] Max Planck Inst Biogeochem, BGC Prozesse, D-07745 Jena, Germany; [Marra, Daniel Magnabosco; Chambers, Jeffrey Q.; Higuchi, Niro; Trumbore, Susan E.; Ribeiro, Gabriel H. P. M.; dos Santos, Joaquim] Inst Nacl de Pesquisas da Amazonia, Lab Manejo Florestal, Manaus, Amazonas, Brazil; [Chambers, Jeffrey Q.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Chambers, Jeffrey Q.; Negron-Juarez, Robinson I.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Climate Sci Dept, Berkeley, CA 94720 USA; [Chambers, Jeffrey Q.; Negron-Juarez, Robinson I.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Wirth, Christian] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Leipzig University; Max Planck Society; Institute Nacional de Pesquisas da Amazonia; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tulane University	Marra, DM (corresponding author), Univ Leipzig, D-04109 Leipzig, Germany.	daniel.marra@uni-leipzig.de	Trumbore, Susan/B-1948-2013; Marra, Daniel Magnabosco/ABE-4452-2020; Higuchi, Niro/ABC-9134-2020; Chambers, Jeffrey Q/J-9021-2014; Wirth, Christian/A-4446-2016; Santos, Joaquim dos/ABG-1455-2020; Ribeiro, Gabriel Henrique Pires de Mello/H-8948-2019; Reu, Björn/HDM-4363-2022; Higuchi, Niro/ABC-8890-2020; Chambers, Jeffrey Q/AAU-7097-2021; Higuchi, Niro/J-1287-2016; Negron-Juarez, Robinson/I-6289-2016	Marra, Daniel Magnabosco/0000-0003-1216-2982; Higuchi, Niro/0000-0002-1203-4502; Chambers, Jeffrey Q/0000-0003-3983-7847; Santos, Joaquim dos/0000-0002-4789-6110; Ribeiro, Gabriel Henrique Pires de Mello/0000-0002-3343-3043; Higuchi, Niro/0000-0002-1203-4502; Negron-Juarez, Robinson/0000-0002-4691-2692; Reu, Bjorn/0000-0001-5271-6420	Brazilian Council for Scientific and Technological Development (CNPq); National Aeronautics and Space Administration's Biodiversity Program [08-BIODIV-10]; Max-Planck-Institute for Biogeochemistry (BGC-Processes, Jena); Coordination for the Improvement of Higher Level Personal (CAPES)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Aeronautics and Space Administration's Biodiversity Program; Max-Planck-Institute for Biogeochemistry (BGC-Processes, Jena); Coordination for the Improvement of Higher Level Personal (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed by the Brazilian Council for Scientific and Technological Development (CNPq) [Projeto SAWI (Chamada Universal MCTI/No 14/2012, Proc. 473357/2012-7) and INCT - Madeiras da Amazonia], by the National Aeronautics and Space Administration's Biodiversity Program (Project 08-BIODIV-10), and by the Max-Planck-Institute for Biogeochemistry (BGC-Processes, Jena). The presented results are part of the first author's PhD thesis, which incorporate data from his Master thesis, undertaken at the INPA/CFT, with fellowship funded by the Coordination for the Improvement of Higher Level Personal (CAPES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1995, REMOTE SENS ENVIRON, V52, P137, DOI 10.1016/0034-4257(94)00098-8; ADAMS JB, 2006, REMOTE SENSING LANDS; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], [No title captured]; BELLINGHAM PJ, 1995, ECOLOGY, V76, P2562, DOI 10.2307/2265828; Boose ER, 2004, ECOL MONOGR, V74, P335, DOI 10.1890/02-4057; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Braga PIS, 1979, ACTA AMAZONICA S, V9, P53, DOI [10.1590/1809-43921979094s053, DOI 10.1590/1809-43921979094S053]; BROKAW NVL, 1991, BIOTROPICA, V23, P442, DOI 10.2307/2388264; BROKAW NVL, 1991, BIOTROPICA, V23, P386, DOI 10.2307/2388256; BROKAW NVL, 1985, ECOLOGY, V66, P682, DOI 10.2307/1940529; Burslem DFRP, 2000, J ECOL, V88, P1063, DOI 10.1046/j.1365-2745.2000.00517.x; Canham CD, 2010, BIOTROPICA, V42, P87, DOI 10.1111/j.1744-7429.2009.00545.x; Carlotto MJ, 1999, INT J REMOTE SENS, V20, P3333, DOI 10.1080/014311699211363; Carneiro V, 2005, VIS PORT 5 C FLOR NA; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Chambers JQ, 2009, OECOLOGIA, V160, P107, DOI 10.1007/s00442-008-1274-9; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Clark DA, 2001, ECOLOGY, V82, P1460, DOI 10.1890/0012-9658(2001)082[1460:GTTCTH]2.0.CO;2; CLARK DB, 1991, J ECOL, V79, P447, DOI 10.2307/2260725; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; Coley PD, 2014, SCIENCE, V343, P35, DOI 10.1126/science.1248110; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; CURTIS JT, 1950, ECOLOGY, V31, P434, DOI 10.2307/1931497; da Silva RP, 2002, FOREST ECOL MANAG, V166, P295, DOI 10.1016/S0378-1127(01)00678-8; Dalling JW, 2004, FUNCT ECOL, V18, P725, DOI 10.1111/j.0269-8463.2004.00868.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Oliveira AA, 2001, FOREST ECOL MANAG, V146, P169, DOI 10.1016/S0378-1127(00)00458-8; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; de Toledo JJ, 2013, J VEG SCI, V24, P651, DOI 10.1111/j.1654-1103.2012.01491.x; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DENSLOW JS, 1980, OECOLOGIA, V46, P18, DOI 10.1007/BF00346960; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Di Vittorio AV, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034010; Espirito-Santo FDB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043146; Espirito-Santo FDB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4434; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Garstang M, 1998, METEOROL ATMOS PHYS, V67, P199, DOI 10.1007/BF01277510; Gloor M, 2009, GLOBAL CHANGE BIOL, V15, P2418, DOI 10.1111/j.1365-2486.2009.01891.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUILLAUMET JL, 1987, EXPERIENTIA, V43, P241, DOI 10.1007/BF01945547; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Higuchi N., 2004, Floresta, V34, P295; Higuchi N., 2011, Floresta, V41, P427; Higuchi N., 1998, PESQUISAS FLORESTAIS, P51; Hijmans R., 2012, RASTER GEOGRAPHIC DA; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; KAHN F, 1986, BIOTROPICA, V18, P214, DOI 10.2307/2388487; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Lewin-Koh N, 2013, MAPTOOLS TOOLS READI; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; Lugo AE, 2008, AUSTRAL ECOL, V33, P368, DOI 10.1111/j.1442-9993.2008.01894.x; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Massoca P. E. dos S., 2012, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V7, P235; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Negron-Juarez R, 2014, REMOTE SENS ENVIRON, V140, P679, DOI 10.1016/j.rse.2013.09.028; Negron-Juarez RI, 2011, REMOTE SENS ENVIRON, V115, P3322, DOI 10.1016/j.rse.2011.07.015; Negron-Juarez RI, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043733; NELSON BW, 1994, ECOLOGY, V75, P853, DOI 10.2307/1941742; Nogueira EM, 2005, FOREST ECOL MANAG, V208, P261, DOI 10.1016/j.foreco.2004.12.007; Nogueira EM, 2007, FOREST ECOL MANAG, V248, P119, DOI 10.1016/j.foreco.2007.04.047; Lima Adriano José Nogueira, 2007, Acta Amaz., V37, P49, DOI 10.1590/S0044-59672007000100005; Oksanen J., 2017, R PACKAGE VERSION 26; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Ribeiro GHPD, 2014, JARQ-JPN AGR RES Q, V48, P213; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; PRANCE G T, 1976, Acta Amazonica, V6, P9; PUTZ FE, 1989, ECOLOGY, V70, P508, DOI 10.2307/1937555; PUTZ FE, 1983, ECOLOGY, V64, P1069, DOI 10.2307/1937815; R Core Team, 2021, R LANG ENV STAT COMP; RANZANI G, 1980, Acta Amazonica, V10, P7; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Scariot A, 2000, BIOTROPICA, V32, P662, DOI 10.1646/0006-3606(2000)032[0662:SMBLIA]2.0.CO;2; Schnitzer SA, 2000, J ECOL, V88, P655, DOI 10.1046/j.1365-2745.2000.00489.x; SCHUPP EW, 1989, ECOLOGY, V70, P562, DOI 10.2307/1940206; Sombroek W, 2001, AMBIO, V30, P388, DOI 10.1639/0044-7447(2001)030[0388:SATPOA]2.0.CO;2; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stevens P. F., 2012, ANGIOSPERM PHYLOGENY; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Thompson J, 2002, ECOL APPL, V12, P1344, DOI 10.1890/1051-0761(2002)012[1344:LUHEAT]2.0.CO;2; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; UHL C, 1988, ECOLOGY, V69, P751, DOI 10.2307/1941024; Uriarte M, 2005, J ECOL, V93, P291, DOI 10.1111/j.0022-0477.2005.00984.x; Vandecar KL, 2011, BIOTROPICA, V43, P676, DOI 10.1111/j.1744-7429.2011.00756.x; Vandermeer J, 2000, SCIENCE, V290, P788, DOI 10.1126/science.290.5492.788; Vieira S, 2004, OECOLOGIA, V140, P468, DOI 10.1007/s00442-004-1598-z; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; VITOUSEK PM, 1986, J ECOL, V74, P1167, DOI 10.2307/2260241; WALKER LR, 1991, BIOTROPICA, V23, P379, DOI 10.2307/2388255; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Xi WM, 2008, FORESTRY, V81, P317, DOI 10.1093/forestry/cpn020; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	105	50	50	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103711	10.1371/journal.pone.0103711	http://dx.doi.org/10.1371/journal.pone.0103711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099118	Green Published, gold			2022-12-25	WOS:000339995100028
J	Csato, V; Peto, A; Koller, A; Edes, I; Toth, A; Papp, Z				Csato, Viktoria; Peto, Attila; Koller, Akos; Edes, Istvan; Toth, Attila; Papp, Zoltan			Hydrogen Peroxide Elicits Constriction of Skeletal Muscle Arterioles by Activating the Arachidonic Acid Pathway	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT CONTRACTIONS; PORCINE CORONARY-ARTERIES; SMOOTH-MUSCLE; HYPERPOLARIZING FACTOR; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; HYPERTENSIVE-RATS; THROMBOXANE A(2); FREE-RADICALS; NITRIC-OXIDE	Aims: The molecular mechanisms of the vasoconstrictor responses evoked by hydrogen peroxide (H2O2) have not been clearly elucidated in skeletal muscle arterioles. Methods and Results: Changes in diameter of isolated, cannulated and pressurized gracilis muscle arterioles (GAs) of Wistar-Kyoto rats were determined under various test conditions. H2O2 (10-100 mu M) evoked concentration-dependent constrictions in the GAs, which were inhibited by endothelium removal, or by antagonists of phospholipase A (PLA; 100 mu M 7,7-dimethyl-(5Z, 8Z)-eicosadienoic acid), protein kinase C (PKC; 10 mu M chelerythrine), phospholipase C (PLC; 10 mu M U-73122), or Src family tyrosine kinase (Src kinase; 1 mu M Src Inhibitor-1). Antagonists of thromboxane A2 (TXA2; 1 mu M SQ-29548) or the non-specific cyclooxygenase (COX) inhibitor indomethacin (10 mu M) converted constrictions to dilations. The COX-1 inhibitor (SC-560, 1 mu M) demonstrated a greater reduction in constriction and conversion to dilation than that of COX-2 (celecoxib, 3 mu M). H2O2 did not elicit significant changes in arteriolar Ca2+ levels measured with Fura-2. Conclusions: These data suggest that H2O2 activates the endothelial Src kinase/PLC/PKC/PLA pathway, ultimately leading to the synthesis and release of TXA2 by COX-1, thereby increasing the Ca2+ sensitivity of the vascular smooth muscle cells and eliciting constriction in rat skeletal muscle arterioles.	[Csato, Viktoria; Peto, Attila; Edes, Istvan; Toth, Attila; Papp, Zoltan] Univ Debrecen, Div Clin Physiol, Inst Cardiol, H-4012 Debrecen, Hungary; [Csato, Viktoria; Peto, Attila; Edes, Istvan; Toth, Attila; Papp, Zoltan] Univ Debrecen, Res Ctr Mol Med, H-4012 Debrecen, Hungary; [Koller, Akos] Univ Pecs, Dept Pathophysiol & Gerontol, Pecs, Hungary; [Koller, Akos] Semmelweis Univ, Dept Pathophysiol, H-1085 Budapest, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	University of Debrecen; University of Debrecen; University of Pecs; Semmelweis University; New York Medical College	Papp, Z (corresponding author), Univ Debrecen, Div Clin Physiol, Inst Cardiol, H-4012 Debrecen, Hungary.	pappz@med.unideb.hu	Papp, Zoltán/HDO-3347-2022; Tóth, Attila/F-4859-2010; Ákos, Koller/Q-4672-2019	Tóth, Attila/0000-0001-6503-3653; 	Hungarian Scientific Research Fund (OTKA) [K 108444, K 84300, K 109083]; Social Renewal Operational Programme [TAMOP-4.2.A-11/1KONV-2012-0045];  [SROP-4.2.2.A-11/1/KONV-2012-0024];  [SROP-4.2.2.A-11/1/KONV-2012-0017]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Social Renewal Operational Programme; ; 	Funding by grants from Hungarian Scientific Research Fund (OTKA): K 108444 (to AK), K 84300 (to AT), K 109083 (to ZP); by the Social Renewal Operational Programme TAMOP-4.2.A-11/1KONV-2012-0045; by grants SROP-4.2.2.A-11/1/KONV-2012-0024 and SROP-4.2.2.A-11/1/KONV-2012-0017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Ardanaz N, 2007, VASC PHARMACOL, V47, P288, DOI 10.1016/j.vph.2007.08.007; Barlow RS, 1998, AM J PHYSIOL-HEART C, V275, pH1283, DOI 10.1152/ajpheart.1998.275.4.H1283; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cai H, 2005, CIRC RES, V96, P818, DOI 10.1161/01.RES.0000163631.07205.fb; Cseko C, 2004, J APPL PHYSIOL, V97, P1130, DOI 10.1152/japplphysiol.00106.2004; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; Erdei N, 2007, AM J PHYSIOL-HEART C, V292, pH649, DOI 10.1152/ajpheart.00596.2006; Feher A, 2010, CARDIOVASC RES, V87, P732, DOI 10.1093/cvr/cvq088; Gao YJ, 2005, BRIT J PHARMACOL, V146, P1061, DOI 10.1038/sj.bjp.0706423; Gao YJ, 2003, BRIT J PHARMACOL, V138, P1085, DOI 10.1038/sj.bjp.0705147; Gao YJ, 2001, BRIT J PHARMACOL, V134, P1639, DOI 10.1038/sj.bjp.0704420; GAO YS, 1993, J APPL PHYSIOL, V74, P2105, DOI 10.1152/jappl.1993.74.5.2105; Gil-Longo J, 2005, VASC PHARMACOL, V43, P128, DOI 10.1016/j.vph.2005.06.001; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hayabuchi Y, 1998, HEART VESSELS, V13, P9, DOI 10.1007/BF02750638; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Iida Y, 2000, STROKE, V31, P2224, DOI 10.1161/01.STR.31.9.2224; Kandasamy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063465; KATUSIC ZS, 1993, AM J PHYSIOL, V264, pH859, DOI 10.1152/ajpheart.1993.264.3.H859; Koller A, 2004, AM J PHYSIOL-HEART C, V287, pH2461, DOI 10.1152/ajpheart.00295.2004; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Liu YP, 2011, CIRC RES, V108, P566, DOI 10.1161/CIRCRESAHA.110.237636; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Matoba T, 2003, ARTERIOSCL THROM VAS, V23, P1224, DOI 10.1161/01.ATV.0000078601.79536.6C; Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Meier M, 2000, VASC MED, V5, P173, DOI 10.1177/1358836X0000500307; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Nedeljkovic ZS, 2003, POSTGRAD MED J, V79, P195, DOI 10.1136/pmj.79.930.195; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Pelaez NJ, 2000, AM J PHYSIOL-HEART C, V279, pH1185, DOI 10.1152/ajpheart.2000.279.3.H1185; Rodriguez-Martinez MA, 1998, BRIT J PHARMACOL, V125, P1329, DOI 10.1038/sj.bjp.0702200; Rogers PA, 2007, AM J PHYSIOL-HEART C, V292, pH1404, DOI 10.1152/ajpheart.00696.2006; Rogers PA, 2006, AM J PHYSIOL-HEART C, V291, pH2473, DOI 10.1152/ajpheart.00172.2006; ROOT RK, 1977, J CLIN INVEST, V60, P1266, DOI 10.1172/JCI108886; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; SHEEHAN DW, 1993, AM J PHYSIOL, V264, pH1542, DOI 10.1152/ajpheart.1993.264.5.H1542; Shi Y, 2007, BRIT J PHARMACOL, V152, P1033, DOI 10.1038/sj.bjp.0707439; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Thengchaisri N, 2003, AM J PHYSIOL-HEART C, V285, pH2255, DOI 10.1152/ajpheart.00487.2003; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Wagenfeld L, 2013, GRAEF ARCH CLIN EXP, V251, P2339, DOI 10.1007/s00417-013-2387-3; Walsh MP, 2013, J CEREBR BLOOD F MET, V33, P1, DOI 10.1038/jcbfm.2012.144; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Wong MSK, 2010, ACTA PHARMACOL SIN, V31, P1095, DOI 10.1038/aps.2010.127; Yada T, 2003, CIRCULATION, V107, P1040, DOI 10.1161/01.CIR.0000050145.25589.65; Yang Z, 1998, BRAIN RES BULL, V47, P257, DOI 10.1016/S0361-9230(98)00120-8; Yang ZW, 1999, N-S ARCH PHARMACOL, V360, P646, DOI 10.1007/s002109900128; Yang ZW, 1998, EUR J PHARMACOL, V344, P169, DOI 10.1016/S0014-2999(97)01576-8; ZEMBOWICZ A, 1993, BRIT J PHARMACOL, V110, P151, DOI 10.1111/j.1476-5381.1993.tb13785.x; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhang DX, 2012, CIRC RES, V110, P471, DOI 10.1161/CIRCRESAHA.111.258871	63	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103858	10.1371/journal.pone.0103858	http://dx.doi.org/10.1371/journal.pone.0103858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093847	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200037
J	Zhang, J; Kong, YY; Ruan, Z; Huang, J; Song, TJ; Song, JJ; Jiang, Y; Yu, YS; Xie, XY				Zhang, Jun; Kong, Yingying; Ruan, Zhi; Huang, Jun; Song, Tiejun; Song, Jingjuan; Jiang, Yan; Yu, Yunsong; Xie, Xinyou			Correlation between Ureaplasma Subgroup 2 and Genitourinary Tract Disease Outcomes Revealed by an Expanded Multilocus Sequence Typing (eMLST) Scheme	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; UREALYTICUM; PARVUM; IDENTIFICATION; VIRULENCE; SEROVARS	The multilocus sequence typing (MLST) scheme of Ureaplasma based on four housekeeping genes (ftsH, rpL22, valS, and thrS) was described in our previous study; here we introduced an expanded MLST (eMLST) scheme with improved discriminatory power, which was developed by adding two putative virulence genes (ureG and mba-np1) to the original MLST scheme. To evaluate the discriminatory power of eMLST, a total of 14 reference strains of Ureaplasma serovars and 269 clinical strains (134 isolated from symptomatic patients and 135 obtained from asymptomatic persons) were investigated. Our study confirmed that all 14 serotype strains could successfully be differentiated into 14 eMLST STs (eSTs), while some of them could not even be differentiated by the MLST, and a total of 136 eSTs were identified among the clinical isolates we investigated. In addition, phylogenetic analysis indicated that two genetically significantly distant clusters (cluster I and II) were revealed and most clinical isolates were located in cluster I. These findings were in accordance with and further support for the concept of two well-known genetic lineages (Ureaplasma parvum and Ureaplasma urealyticum) in our previous study. Interestingly, although both clusters were associated with clinical manifestation, the sub-group 2 of cluster II had pronounced and adverse effect on patients and might be a potential risk factor for clinical outcomes. In conclusion, the eMLST scheme offers investigators a highly discriminative typing tool that is capable for precise epidemiological investigations and clinical relevance of Ureaplasma.	[Zhang, Jun; Kong, Yingying; Huang, Jun; Song, Tiejun; Song, Jingjuan; Xie, Xinyou] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jun; Kong, Yingying; Ruan, Zhi; Song, Jingjuan; Jiang, Yan; Yu, Yunsong; Xie, Xinyou] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xie, XY (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	scottxie@mail.hz.zj.cn	Ruan, Zhi/P-3987-2015; Kong, Yingying/GQP-9865-2022	Ruan, Zhi/0000-0001-8648-4592; 	National Natural Science Foundation of China [81171629]; Zhejiang Provincial Natural Science Foundation [Y2080234]; Zhejiang Provincial Health Bureau Foundation [2012KYA115, 2013KYA216, 2014PYA011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Health Bureau Foundation	This study was supported by grants from the National Natural Science Foundation of China (grant no. 81171629), Zhejiang Provincial Natural Science Foundation (grant no. Y2080234), and Zhejiang Provincial Health Bureau Foundation (grant no. 2012KYA115, 2013KYA216 and 2014PYA011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbeleHorn M, 1997, J CLIN MICROBIOL, V35, P1199, DOI 10.1128/JCM.35.5.1199-1202.1997; Cooper JE, 2004, TRENDS MICROBIOL, V12, P373, DOI 10.1016/j.tim.2004.06.003; Feavers IM, 1999, J CLIN MICROBIOL, V37, P3883, DOI 10.1128/JCM.37.12.3883-3887.1999; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Heggie AD, 2001, PEDIATR INFECT DIS J, V20, P854, DOI 10.1097/00006454-200109000-00006; Hunjak B, 2014, ARCH GYNECOL OBSTET, V289, P407, DOI 10.1007/s00404-013-2980-z; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Katz B, 2005, J CLIN MICROBIOL, V43, P4852, DOI 10.1128/JCM.43.9.4852-4854.2005; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Kong FR, 2000, J CLIN MICROBIOL, V38, P1175, DOI 10.1128/JCM.38.3.1175-1179.2000; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; Mohamad KY, 2008, INFECT GENET EVOL, V8, P764, DOI 10.1016/j.meegid.2008.06.009; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Robertson JA, 2002, INT J SYST EVOL MICR, V52, P587, DOI 10.1099/00207713-52-2-587; Robinson JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062746; Ruan Z, 2013, INT J ANTIMICROB AG, V42, P322, DOI 10.1016/j.ijantimicag.2013.06.019; Salmeri M, 2012, J CHEMOTHERAPY, V24, P81, DOI 10.1179/1120009X12Z.00000000021; SANCHEZ PJ, 1987, PEDIATR INFECT DIS J, V6, P825, DOI 10.1097/00006454-198709000-00006; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Shariat N, 2013, FOOD MICROBIOL, V34, P164, DOI 10.1016/j.fm.2012.11.012; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teh CSJ, 2011, INFECT GENET EVOL, V11, P1121, DOI 10.1016/j.meegid.2011.04.005; Viscardi RM, 2009, PEDIATR RES, V65, p84R, DOI 10.1203/PDR.0b013e31819dc2f9; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Xiao L, 2011, J CLIN MICROBIOL, V49, P3325, DOI 10.1128/JCM.01235-11; Xiao L, 2010, J CLIN MICROBIOL, V48, P2715, DOI 10.1128/JCM.01877-09; Zhang J, 2014, EUR J CLIN MICROBIOL, V33, P537, DOI 10.1007/s10096-013-1981-y; Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004	35	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104347	10.1371/journal.pone.0104347	http://dx.doi.org/10.1371/journal.pone.0104347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093900	gold, Green Submitted, Green Published			2022-12-25	WOS:000341357200101
J	Allen, KD; Gourov, AV; Harte, C; Gao, P; Lee, C; Sylvain, D; Splett, JM; Oxberry, WC; van de Nes, PS; Troy-Regier, MJ; Wolk, J; Alarcon, JM; Hernandez, AI				Allen, Kim D.; Gourov, Andrei V.; Harte, Christopher; Gao, Peng; Lee, Clarice; Sylvain, Darlene; Splett, Joshua M.; Oxberry, William C.; van de Nes, Paula S.; Troy-Regier, Matthew J.; Wolk, Jason; Alarcon, Juan M.; Hernandez, A. Ivan			Nucleolar Integrity Is Required for the Maintenance of Long-Term Synaptic Plasticity	PLOS ONE			English	Article							RNA-POLYMERASE-I; APLYSIA SENSORY NEURONS; LOCAL PROTEIN-SYNTHESIS; ACTINOMYCIN-D; POLY(ADP-RIBOSE) POLYMERASE; POLYADP-RIBOSYLATION; RIBOSOME BIOGENESIS; MEMORY FORMATION; TRANSCRIPTION; FACILITATION	Long-term memory (LTM) formation requires new protein synthesis and new gene expression. Based on our work in Aplysia, we hypothesized that the rRNA genes, stimulation-dependent targets of the enzyme Poly(ADP-ribose) polymerase-1 (PARP-1), are primary effectors of the activity-dependent changes in synaptic function that maintain synaptic plasticity and memory. Using electrophysiology, immunohistochemistry, pharmacology and molecular biology techniques, we show here, for the first time, that the maintenance of forskolin-induced late-phase long-term potentiation (L-LTP) in mouse hippocampal slices requires nucleolar integrity and the expression of new rRNAs. The activity-dependent upregulation of rRNA, as well as L-LTP expression, are poly(ADP-ribosyl) ation (PAR) dependent and accompanied by an increase in nuclear PARP-1 and Poly(ADP) ribose molecules (pADPr) after forskolin stimulation. The upregulation of PARP-1 and pADPr is regulated by Protein kinase A (PKA) and extracellular signal-regulated kinase (ERK)-two kinases strongly associated with long-term plasticity and learning and memory. Selective inhibition of RNA Polymerase I (Pol I), responsible for the synthesis of precursor rRNA, results in the segmentation of nucleoli, the exclusion of PARP-1 from functional nucleolar compartments and disrupted L-LTP maintenance. Taken as a whole, these results suggest that new rRNAs (28S, 18S, and 5.8S ribosomal components)-hence, new ribosomes and nucleoli integrity-are required for the maintenance of long-term synaptic plasticity. This provides a mechanistic link between stimulation-dependent gene expression and the new protein synthesis known to be required for memory consolidation.	[Allen, Kim D.; Gourov, Andrei V.; Harte, Christopher; Gao, Peng; Lee, Clarice; Sylvain, Darlene; Splett, Joshua M.; Oxberry, William C.; Wolk, Jason; Alarcon, Juan M.; Hernandez, A. Ivan] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Allen, Kim D.] CUNY, Medgar Evers Coll, Sch Sci Hlth & Technol, Dept Biol, Brooklyn, NY 11210 USA; [Oxberry, William C.; Alarcon, Juan M.; Hernandez, A. Ivan] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [van de Nes, Paula S.; Troy-Regier, Matthew J.] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; [van de Nes, Paula S.; Troy-Regier, Matthew J.] Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; Medgar Evers College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Alarcon, JM (corresponding author), Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA.	JuanMarcos.Alarcon@downstate.edu; ivan.hernandez@downstate.edu		Allen, Kim D/0000-0001-9774-5014; Regier, Matthew/0000-0002-4641-3316	Department of Pathology at SUNY-Downstate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS081625] Funding Source: NIH RePORTER	Department of Pathology at SUNY-Downstate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Start Up fund to AIH from the Department of Pathology at SUNY-Downstate to carry out this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Boamah EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002442; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1986, J PHYSIOL-PARIS, V81, P349; Chen M, 2004, ACTA PHARMACOL SIN, V25, P902; Christensen MO, 2004, J BIOL CHEM, V279, P21873, DOI 10.1074/jbc.M400498200; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Day JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P357, DOI 10.1038/npp.2010.125; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Fontan-Lozano A, 2010, J NEUROSCI, V30, P13305, DOI 10.1523/JNEUROSCI.3010-10.2010; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; GOLDBERG IH, 1964, FED PROC, V23, P958; Goldberg S, 2009, J NEUROCHEM, V111, P72, DOI 10.1111/j.1471-4159.2009.06296.x; Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guetg C, 2012, CELL CYCLE, V11, P2217, DOI 10.4161/cc.20622; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Haddach M, 2012, BIOORG MED CHEM LETT, V22, P45, DOI 10.1016/j.bmcl.2011.11.087; Hernandez AI, 2009, J NEUROSCI, V29, P9553, DOI 10.1523/JNEUROSCI.1512-09.2009; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; HERNANDEZVERDUN D, 1991, J CELL SCI, V99, P465; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kill IR, 1996, J CELL SCI, V109, P1253; Kiryk A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00207; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Parlato R, 2013, J MOL MED, V91, P541, DOI 10.1007/s00109-012-0981-1; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sgambato V, 1998, J NEUROSCI, V18, P8814; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; TOKU S, 1983, J BIOCHEM-TOKYO, V93, P349, DOI 10.1093/oxfordjournals.jbchem.a134187; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Vargas JP, 2000, BRAIN RES, V865, P77, DOI 10.1016/S0006-8993(00)02220-4; Wilson DM, 1999, J HISTOCHEM CYTOCHEM, V47, P1095, DOI 10.1177/002215549904700814	60	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104364	10.1371/journal.pone.0104364	http://dx.doi.org/10.1371/journal.pone.0104364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089620	gold, Green Published			2022-12-25	WOS:000339812700121
J	Hung, CY; Wang, KY; Wu, TJ; Hsieh, YC; Huang, JL; Loh, EW; Lin, CH				Hung, Chen-Ying; Wang, Kuo-Yang; Wu, Tsu-Juey; Hsieh, Yu-Cheng; Huang, Jin-Long; Loh, El-Wui; Lin, Ching-Heng			Resistant Hypertension, Patient Characteristics, and Risk of Stroke	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; GENDER-DIFFERENCES; PREVALENCE; POPULATION; MANAGEMENT; COMMITTEE; DISEASE; STATIN; ADULTS; HEALTH	Background: Little is known about the prognosis of resistant hypertension (RH) in Asian population. This study aimed to evaluate the impacts of RH in Taiwanese patients with hypertension, and to ascertain whether patient characteristics influence the association of RH with adverse outcomes. Methods and Results: Patients aged >= 45 years with hypertension were identified from the National Health Insurance Research Database. Medical records of 111,986 patients were reviewed in this study, and 16,402 (14.6%) patients were recognized as having RH (continuously concomitant use of >= 3 anti-hypertensive medications, including a diuretic, for >= 2 years). Risk of major adverse cardiovascular events (MACE, a composite of all-cause mortality, acute coronary syndrome, and stroke [included both fatal and nonfatal events]) in patients with RH and non-RH was analyzed. A total of 11,856 patients experienced MACE in the follow-up period (average 7.1 +/- 3.0 years). There was a higher proportion of females in the RH group, they were older than the non-RH (63.1 vs. 60.5 years) patients, and had a higher prevalence of cardiovascular comorbidities. Overall, patients with RH had higher risks of MACE (adjusted HR 1.17; 95% CI 1.09-1.26; p<0.001). Significantly elevated risks of stroke (10,211 events; adjusted HR 1.17; 95% CI 1.08-1.27; p<0.001), especially ischemic stroke (6,235 events; adjusted HR 1.34; 95% CI 1.20-1.48; p<0.001), but not all-cause mortality (4,594 events; adjusted HR 1.06; 95% CI 0.95-1.19; p = 0.312) or acute coronary syndrome (2,145 events; adjusted HR 1.17; 95% CI 0.99-1.39; p = 0.070) were noted in patients with RH compared to those with non-RH. Subgroup analysis showed that RH increased the risks of stroke in female and elderly patients. However, no significant influence was noted in young or male patients. Conclusions: Patients with RH were associated with higher risks of MACE and stroke, especially ischemic stroke. The risks were greater in female and elderly patients than in male or young patients.	[Hung, Chen-Ying; Wang, Kuo-Yang; Wu, Tsu-Juey; Hsieh, Yu-Cheng; Huang, Jin-Long] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Hung, Chen-Ying] Taipei Vet Gen Hosp, Hsinchu Branch, Dept Internal Med, Hsinchu County, Taiwan; [Wang, Kuo-Yang; Wu, Tsu-Juey; Huang, Jin-Long] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Tsu-Juey; Hsieh, Yu-Cheng; Huang, Jin-Long] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Dept Internal Med,Fac Med,Inst Clin Med, Taipei 112, Taiwan; [Loh, El-Wui] Kaohsiung Municipal Kai Syuan Psychiat Hosp, Kaohsiung, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan	Taichung Veterans General Hospital; Taipei Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Wang, KY (corresponding author), Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan.	wky@vghtc.gov.tw; epid@vghtc.gov.tw	Loh, El-Wui/ABD-6129-2020	Loh, El-Wui/0000-0001-9346-6886	Taichung Veterans General Hospital, Taiwan [TCVGH-1027308C, NHIRD-101-560]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1027308C) (Registered number NHIRD-101-560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambilla G, 2013, J HYPERTENS, V31, P2018, DOI 10.1097/HJH.0b013e328363823f; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Daugherty SL, 2013, J HYPERTENS, V31, P271, DOI 10.1097/HJH.0b013e32835bdc44; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Daugherty SL, 2011, J HYPERTENS, V29, P1005, DOI 10.1097/HJH.0b013e3283449512; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; De Nicola L, 2013, J AM COLL CARDIOL, V61, P2461, DOI 10.1016/j.jacc.2012.12.061; Gu QP, 2008, AM J HYPERTENS, V21, P789, DOI 10.1038/ajh.2008.185; Hung CY, 2013, INT J CARDIOL, V168, P1131, DOI 10.1016/j.ijcard.2012.11.087; Hung CY, 2013, AM J MED, V126, P133, DOI 10.1016/j.amjmed.2012.06.027; Kim YS, 2011, GENDER MED, V8, P14, DOI 10.1016/j.genm.2011.01.001; Kumbhani DJ, 2013, EUR HEART J, V34, P1204, DOI 10.1093/eurheartj/ehs368; Lao XQ, 2013, AM J HYPERTENS; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Nishikawa T, 2013, HYPERTENS RES, V36, P924, DOI 10.1038/hr.2013.107; Pierdomenico SD, 2005, AM J HYPERTENS, V18, P1422, DOI 10.1016/j.amjhyper.2005.05.014; Quan HD, 2013, HEART, V99, P715, DOI 10.1136/heartjnl-2012-303152; Roberie DR, 2012, CURR OPIN CARDIOL, V27, P386, DOI 10.1097/HCO.0b013e328353ad6e; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sim JJ, 2013, MAYO CLIN PROC, V88, P1099, DOI 10.1016/j.mayocp.2013.06.017; Smith SM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000660; Tang Xun, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P379; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	27	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104362	10.1371/journal.pone.0104362	http://dx.doi.org/10.1371/journal.pone.0104362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089520	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700120
J	Miyawaki, T; Norimoto, H; Ishikawa, T; Watanabe, Y; Matsuki, N; Ikegaya, Y				Miyawaki, Takeyuki; Norimoto, Hiroaki; Ishikawa, Tomoe; Watanabe, Yusuke; Matsuki, Norio; Ikegaya, Yuji			Dopamine Receptor Activation Reorganizes Neuronal Ensembles during Hippocampal Sharp Waves In Vitro	PLOS ONE			English	Article							RIPPLE COMPLEXES; MEMORY CONSOLIDATION; NETWORK ACTIVITY; RAT HIPPOCAMPUS; SLICES; MECHANISMS; PATTERNS; MODEL; SCHIZOPHRENIA; INTERNEURONS	Hippocampal sharp wave (SW)/ripple complexes are thought to contribute to memory consolidation. Previous studies suggest that behavioral rewards facilitate SW occurrence in vivo. However, little is known about the precise mechanism underlying this enhancement. Here, we examined the effect of dopaminergic neuromodulation on spontaneously occurring SWs in acute hippocampal slices. Local field potentials were recorded from the CA1 region. A brief (1 min) treatment with dopamine led to a persistent increase in the event frequency and the magnitude of SWs. This effect lasted at least for our recording period of 45 min and did not occur in the presence of a dopamine D-1/D-5 receptor antagonist. Functional multineuron calcium imaging revealed that dopamine-induced SW augmentation was associated with an enriched repertoire of the firing patterns in SW events, whereas the overall tendency of individual neurons to participate in SWs and the mean number of cells participating in a single SW were maintained. Therefore, dopaminergic activation is likely to reorganize cell assemblies during SWs.	[Miyawaki, Takeyuki; Norimoto, Hiroaki; Ishikawa, Tomoe; Watanabe, Yusuke; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan; [Ikegaya, Yuji] Ctr Informat & Neural Networks, Suita, Osaka, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Norimoto, Hiroaki/E-1238-2019	Norimoto, Hiroaki/0000-0002-7351-5457; Miyawaki, Takeyuki/0000-0002-5335-7551; Ikegaya, Yuji/0000-0003-2260-8191	Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy [LS023];  [22115003];  [25119004]; Grants-in-Aid for Scientific Research [25119004] Funding Source: KAKEN	Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Science Research on Innovative Areas (22115003; 25119004) (http://www.jsps.go.jp/english/e-grants/grants01.html) and the Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (LS023) (http://www.jsps.go.jp/english/e-jisedai/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivar P, 2014, J NEUROSCI, V34, P2989, DOI 10.1523/JNEUROSCI.2826-13.2014; AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Di Sebastiano AR, 2012, PROG BRAIN RES, V198, P65, DOI 10.1016/B978-0-444-59489-1.00006-9; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hajos N, 2013, J NEUROSCI, V33, P11677, DOI 10.1523/JNEUROSCI.5729-12.2013; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee TH, 1996, J NEUROSCI METH, V67, P221; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2011, NEURON, V72, P137, DOI 10.1016/j.neuron.2011.08.016; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Mizunuma M, 2014, NAT NEUROSCI, V17, P503, DOI 10.1038/nn.3674; Norimoto H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02696; Norimoto H, 2012, BRAIN RES, V1461, P1, DOI 10.1016/j.brainres.2012.04.037; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Papatheodoropoulos C, 2008, NEUROSCIENCE, V157, P495, DOI 10.1016/j.neuroscience.2008.09.040; Reichinnek S, 2012, NEUROIMAGE, V60, P139, DOI 10.1016/j.neuroimage.2011.12.018; Reichinnek S, 2010, J NEUROSCI, V30, P15441, DOI 10.1523/JNEUROSCI.2535-10.2010; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Sasaki T, 2014, EUR J NEUROSCI, V39, P2027, DOI 10.1111/ejn.12554; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Singer AC, 2013, NEURON, V77, P1163, DOI 10.1016/j.neuron.2013.01.027; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Suh J, 2013, NEURON, V80, P484, DOI 10.1016/j.neuron.2013.09.014; Sun Y, 2012, J PHARMACOL SCI, V118, P288, DOI 10.1254/jphs.11199FP; Takahashi Naoya, 2011, Curr Protoc Neurosci, VChapter 2, DOI 10.1002/0471142301.ns0214s57; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Weiss T, 2003, EUR J NEUROSCI, V18, P2573, DOI 10.1046/j.1460-9568.2003.02970.x; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Wu CP, 2005, J NEUROPHYSIOL, V94, P741, DOI 10.1152/jn.00086.2005; YLINEN A, 1995, J NEUROSCI, V15, P30; Zylla MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080718	59	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104438	10.1371/journal.pone.0104438	http://dx.doi.org/10.1371/journal.pone.0104438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089705	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700122
J	Tang, SY; Zhang, W; Soffe, R; Nahavandi, S; Shukla, R; Khoshmanesh, K				Tang, Shi-Yang; Zhang, Wei; Soffe, Rebecca; Nahavandi, Sofia; Shukla, Ravi; Khoshmanesh, Khashayar			High Resolution Scanning Electron Microscopy of Cells Using Dielectrophoresis	PLOS ONE			English	Article							PLATFORMS; MORPHOLOGY; PARTICLES; PHEROMONE; TUMORS	Ultrastructural analysis of cells can reveal valuable information about their morphological, physiological, and biochemical characteristics. Scanning electron microscopy (SEM) has been widely used to provide high-resolution images from the surface of biological samples. However, samples need to be dehydrated and coated with conductive materials for SEM imaging. Besides, immobilizing non-adherent cells during processing and analysis is challenging and requires complex fixation protocols. In this work, we developed a novel dielectrophoresis based microfluidic platform for interfacing non-adherent cells with high-resolution SEM at low vacuum mode. The system enables rapid immobilization and dehydration of samples without deposition of chemical residues over the cell surface. Moreover, it enables the on-chip chemical stimulation and fixation of immobilized cells with minimum dislodgement. These advantages were demonstrated for comparing the morphological changes of non-budding and budding yeast cells following Lyticase treatment.	[Tang, Shi-Yang; Zhang, Wei; Soffe, Rebecca; Khoshmanesh, Khashayar] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia; [Nahavandi, Sofia] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Shukla, Ravi] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Tang, SY (corresponding author), RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia.	shiyang.tang@rmit.edu.au; khashayar.khoshmanesh@rmit.edu.au	Tang, Shi-Yang/ABA-1995-2020; Tang, Shiyang/I-3580-2018	Tang, Shiyang/0000-0002-3079-8880; Shukla, Ravi/0000-0002-1537-9637; Khoshmanesh, Khashayar/0000-0001-6036-7371; Soffe, Rebecca/0000-0003-3340-3642	Australian Research Council [DE120101402]	Australian Research Council(Australian Research Council)	K. Khoshmanesh acknowledges the Australian Research Council for funding under Discovery Early Career Researcher Award (DECRA) scheme, (project DE120101402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Baratchi S, 2014, BIOTECHNOL ADV, V32, P333, DOI 10.1016/j.biotechadv.2013.11.008; BOULTON C, 2006, BREWING YEAST FERMEN; Centurione L, 2010, REPROD BIOMED ONLINE, V20, P625, DOI 10.1016/j.rbmo.2010.02.009; Chau LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051577; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Chrimes AF, 2013, BIOSENS BIOELECTRON, V49, P536, DOI 10.1016/j.bios.2013.05.053; Chrimes AF, 2013, CHEM SOC REV, V42, P5880, DOI 10.1039/c3cs35515b; CRUZ YP, 1992, MICROSC RES TECHNIQ, V22, P103; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Dementhon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032621; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s; Docoslis A, 2002, ELECTROPHORESIS, V23, P2174, DOI 10.1002/1522-2683(200207)23:14<2174::AID-ELPS2174>3.0.CO;2-3; GOULD VE, 1980, PATHOL RES PRACT, V167, P45; Gupta S, 2010, LANGMUIR, V26, P3441, DOI 10.1021/la902989r; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Horstmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064764; JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1; Jesus-Perez NM, 2011, ELECTROPHORESIS, V32, P2331, DOI 10.1002/elps.201100107; Kalantar-zadeh K, 2007, NANOTECHNOLOGY ENABL; Kempaiah R, 2011, ACS NANO, V5, P6025, DOI 10.1021/nn201791k; Khoshmanesh K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879457; Khoshmanesh K, 2011, ANAL CHEM, V83, P3217, DOI 10.1021/ac2002142; Khoshmanesh K, 2011, BIOSENS BIOELECTRON, V26, P1800, DOI 10.1016/j.bios.2010.09.022; Khoshmanesh K, 2010, MICROFLUID NANOFLUID, V9, P411, DOI 10.1007/s10404-009-0558-7; Kirk S, 2009, J MICROSC-OXFORD, V233, P205, DOI 10.1111/j.1365-2818.2009.03111.x; Krylova G, 2010, PHYS CHEM CHEM PHYS, V12, P15101, DOI 10.1039/c004517a; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Min KW, 2013, ULTRASTRUCT PATHOL, V37, P23, DOI 10.3109/01913123.2012.707962; Moran P., 2012, MICROSC TODAY, V20, P28, DOI [10.1017/S1551929511001374, DOI 10.1017/S1551929511001374]; Morgan H., 2003, AC ELECTROKINETICS C, Vfirst; Muscariello L, 2005, J CELL PHYSIOL, V205, P328, DOI 10.1002/jcp.20444; Nahavandi S, 2014, LAB CHIP, V14, P1496, DOI 10.1039/c3lc51124c; Namiki Y, 2011, J ELECTRON MICROSC, V60, P157, DOI 10.1093/jmicro/dfq082; Pethig R, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3456626; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Rowan NJ, 1998, APPL ENVIRON MICROB, V64, P2065; Sakr SA, 2012, TOXICOL IND HEALTH, V28, P276, DOI 10.1177/0748233711412427; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Soe AK, 2012, BIOSENS BIOELECTRON, V35, P1, DOI 10.1016/j.bios.2012.02.012; Stewart P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-60; Stockman DL, 2012, AM J SURG PATHOL, V36, P857, DOI 10.1097/PAS.0b013e31824644ac; Tang SY, 2013, ANAL CHEM, V85, P6364, DOI 10.1021/ac400741v; Tang SY, 2013, ELECTROPHORESIS, V34, P1407, DOI 10.1002/elps.201200659; Yarmush ML, 2009, ANNU REV BIOMED ENG, V11, P235, DOI 10.1146/annurev.bioeng.10.061807.160502	51	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104109	10.1371/journal.pone.0104109	http://dx.doi.org/10.1371/journal.pone.0104109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089528	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700099
J	Zgheib, S; Mequinion, M; Lucas, S; Leterme, D; Ghali, O; Tolle, V; Zizzari, P; Bellefontaine, N; Legroux-Gerot, I; Hardouin, P; Broux, O; Viltart, O; Chauveau, C				Zgheib, Sara; Mequinion, Mathieu; Lucas, Stephanie; Leterme, Damien; Ghali, Olfa; Tolle, Virginie; Zizzari, Philippe; Bellefontaine, Nicole; Legroux-Gerot, Isabelle; Hardouin, Pierre; Broux, Odile; Viltart, Odile; Chauveau, Christophe			Long-Term Physiological Alterations and Recovery in a Mouse Model of Separation Associated with Time-Restricted Feeding: A Tool to Study Anorexia Nervosa Related Consequences	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; CALORIC RESTRICTION; GROWTH-HORMONE; BROWN ADIPOCYTES; EATING-DISORDERS; LEPTIN LEVELS; WEIGHT-LOSS; FOOD RESTRICTION; BONE METABOLISM; SERUM LEPTIN	Background: Anorexia nervosa is a primary psychiatric disorder, with non-negligible rates of mortality and morbidity. Some of the related alterations could participate in a vicious cycle limiting the recovery. Animal models mimicking various physiological alterations related to anorexia nervosa are necessary to provide better strategies of treatment. Aim: To explore physiological alterations and recovery in a long-term mouse model mimicking numerous consequences of severe anorexia nervosa. Methods: C57Bl/6 female mice were submitted to a separation-based anorexia protocol combining separation and time-restricted feeding for 10 weeks. Thereafter, mice were housed in standard conditions for 10 weeks. Body weight, food intake, body composition, plasma levels of leptin, adiponectin, IGF-1, blood levels of GH, reproductive function and glucose tolerance were followed. Gene expression of several markers of lipid and energy metabolism was assayed in adipose tissues. Results: Mimicking what is observed in anorexia nervosa patients, and despite a food intake close to that of control mice, separation-based anorexia mice displayed marked alterations in body weight, fat mass, lean mass, bone mass acquisition, reproductive function, GH/IGF-1 axis, and leptinemia. mRNA levels of markers of lipogenesis, lipolysis, and the brown-like adipocyte lineage in subcutaneous adipose tissue were also changed. All these alterations were corrected during the recovery phase, except for the hypoleptinemia that persisted despite the full recovery of fat mass. Conclusion: This study strongly supports the separation-based anorexia protocol as a valuable model of long-term negative energy balance state that closely mimics various symptoms observed in anorexia nervosa, including metabolic adaptations. Interestingly, during a recovery phase, mice showed a high capacity to normalize these parameters with the exception of plasma leptin levels. It will be interesting therefore to explore further the central and peripheral effects of the uncorrected hypoleptinemia during recovery from separation-based anorexia.	[Zgheib, Sara; Mequinion, Mathieu; Lucas, Stephanie; Leterme, Damien; Ghali, Olfa; Bellefontaine, Nicole; Legroux-Gerot, Isabelle; Hardouin, Pierre; Broux, Odile; Viltart, Odile; Chauveau, Christophe] Univ Lille Nord France, Boulogne Sur Mer, France; [Mequinion, Mathieu; Bellefontaine, Nicole; Viltart, Odile] UMR INSERM 837, Lille, France; [Tolle, Virginie; Zizzari, Philippe] Univ Paris 05, Ctr Psychiat & Neurosci, UMR S INSERM 894, Sorbonne Paris Cite, Paris, France; [Legroux-Gerot, Isabelle] CHU Lille, Hop Roger Salengro, Serv Rhumatol, Lille, France; [Viltart, Odile] Univ Lille 1, F-59655 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Chauveau, C (corresponding author), Univ Lille Nord France, Boulogne Sur Mer, France.	chauveau@univ-littoral.fr	Tolle, Virginie S/H-5264-2015	Tolle, Virginie S/0000-0003-4456-0002; Zizzari, Philippe/0000-0001-8838-0762; LUCAS, Stephanie/0000-0001-7530-7486; Chauveau, Christophe/0000-0003-4668-9272; Hardouin, Pierre/0000-0002-1928-6382				Austad S N, 2001, Sci Aging Knowledge Environ, V2001, ppe3, DOI 10.1126/sageke.2001.6.pe3; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Boakes RA, 2001, BEHAV NEUROSCI, V115, P718, DOI 10.1037/0735-7044.115.3.718; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; COUSIN B, 1992, J CELL SCI, V103, P931; Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Faje AT, 2014, INT J EAT DISORDER, V47, P458, DOI 10.1002/eat.22248; Ferguson M, 2007, MECH AGEING DEV, V128, P539, DOI 10.1016/j.mad.2007.07.005; Gahete MD, 2013, ENDOCRINOLOGY, V154, P263, DOI 10.1210/en.2012-1849; Gairdner SE, 2012, APPL PHYSIOL NUTR ME, V37, P1063, DOI [10.1139/h2012-092, 10.1139/H2012-092]; Gendall KA, 1999, BIOL PSYCHIAT, V46, P292, DOI 10.1016/S0006-3223(98)00292-3; Hao SZ, 2001, PHARMACOL BIOCHEM BE, V68, P273, DOI 10.1016/S0091-3057(00)00448-2; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hebebrand J, 2003, PHYSIOL BEHAV, V79, P25, DOI 10.1016/S0031-9384(03)00102-1; Hebebrand J, 1997, MOL PSYCHIATR, V2, P330, DOI 10.1038/sj.mp.4000282; HERESI G, 1980, J NUTR, V110, P1888, DOI 10.1093/jn/110.9.1888; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Holtkamp K, 2004, PSYCHONEUROENDOCRINO, V29, P791, DOI 10.1016/S0306-4530(03)00143-4; Holtkamp K, 2003, J PSYCHIATR RES, V37, P165, DOI 10.1016/S0022-3956(02)00100-0; Jappe LM, 2014, INT J EAT DISORDER, V47, P181, DOI 10.1002/eat.22211; Lawson EA, 2008, NAT CLIN PRACT ENDOC, V4, P407, DOI 10.1038/ncpendmet0872; Legroux-Gerot I, 2012, OSTEOPOROSIS INT, V23, P2855, DOI 10.1007/s00198-012-1919-8; Legroux-Gerot I, 2010, OSTEOPOROSIS INT, V21, P1715, DOI 10.1007/s00198-009-1120-x; Legroux-Gerot I, 2007, CALCIFIED TISSUE INT, V81, P174, DOI 10.1007/s00223-007-9038-9; Mequinion Mathieu, 2013, Front Endocrinol (Lausanne), V4, P15, DOI 10.3389/fendo.2013.00015; Misra M, 2003, J CLIN ENDOCR METAB, V88, P5615, DOI 10.1210/jc.2003-030532; Okita N, 2012, MECH AGEING DEV, V133, P255, DOI 10.1016/j.mad.2012.02.003; Park S, 2006, EXP GERONTOL, V41, P837, DOI 10.1016/j.exger.2006.06.055; PIRKE KM, 1993, NEUROSCI BIOBEHAV R, V17, P287, DOI 10.1016/S0149-7634(05)80012-0; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Rojo L, 2006, PSYCHOSOM MED, V68, P628, DOI 10.1097/01.psy.0000227749.58726.41; ROUTTENBERG A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Tatsumi S, 2008, ENDOCRINOLOGY, V149, P634, DOI 10.1210/en.2007-1089; Tropp J, 2001, PHYSIOL BEHAV, V73, P553, DOI 10.1016/S0031-9384(01)00487-5; vanLeeuwen SD, 1997, PHYSIOL BEHAV, V62, P77, DOI 10.1016/S0031-9384(97)00144-3; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; ZAMIRI MJ, 1978, AUST J BIOL SCI, V31, P629; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zipfel S, 2001, J CLIN ENDOCR METAB, V86, P5227, DOI 10.1210/jc.86.11.5227	48	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103775	10.1371/journal.pone.0103775	http://dx.doi.org/10.1371/journal.pone.0103775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090643	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700054
J	Roberts, AJ; Druckenmiller, PS; Saetre, GP; Hurum, JH				Roberts, Aubrey Jane; Druckenmiller, Patrick Scott; Saetre, Glenn-Peter; Hurum, Jorn Harald			A New Upper Jurassic Ophthalmosaurid Ichthyosaur from the Slottsmoya Member, Agardhfjellet Formation of Central Spitsbergen	PLOS ONE			English	Article							PLESIOSAURIANS REPTILIA SAUROPTERYGIA; HYDROCARBON SEEP CARBONATES; NEUQUEN BASIN; PLATYPTERYGIUS-AUSTRALIS; CRETACEOUS ICHTHYOSAUR; GENUS; JANUSFJELLET; REDESCRIPTION; SASSENFJORDEN; LAGERSTATTE	Abundant new ichthyosaur material has recently been documented in the Slottsmoya Member of the Agardhfjellet Formation from the Svalbard archipelago of Norway. Here we describe a partial skeleton of a new taxon, Janusaurus lundi, that includes much of the skull and representative portions of the postcranium. The new taxon is diagnosed by a suite of cranial character states including a very gracile stapedial shaft, the presence of a dorsal process on the prearticular and autapomorphic postcranial features such as the presence of an interclavicular trough and a conspicuous anterodorsal process of the ilium. The peculiar morphology of the ilia indicates a previously unrecognized degree of morphological variation in the pelvic girdle of ophthalmosaurids. We also present a large species level phylogenetic analysis of ophthalmosaurids including new and undescribed ichthyosaur material from the Upper Jurassic of Svalbard. Our results recover all Svalbard taxa in a single unresolved polytomy nested within Ophthalmosaurinae, which considerably increases the taxonomic composition of this clade. The paleobiogeographical implications of this result suggest the presence of a single clade of Boreal ophthalmosaurid ichthyosaurs that existed during the latest Jurassic, a pattern also reflected in the high degree of endemicity among some Boreal invertebrates, particularly ammonoids. Recent and ongoing descriptions of marine reptiles from the Slottsmoya Member Lagerstatte provide important new data to test hypotheses of marine amniote faunal turnover at the Jurassic-Cretaceous boundary.	[Roberts, Aubrey Jane; Hurum, Jorn Harald] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Druckenmiller, Patrick Scott] Univ Alaska, Univ Alaska Museum, Fairbanks, AK 99701 USA; [Druckenmiller, Patrick Scott] Univ Alaska, Dept Geol & Geophys, Fairbanks, AK 99775 USA; [Saetre, Glenn-Peter] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Oslo	Roberts, AJ (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England.	ajr1g13@soton.ac.uk			Spitsbergen Tavel; Fugro; OMV; Exonmobil; CEES at the Department of Biosciences, University of Oslo	Spitsbergen Tavel; Fugro; OMV; Exonmobil; CEES at the Department of Biosciences, University of Oslo	Funding for fieldwork in 2010: Spitsbergen Tavel, Fugro, OMV and Exonmobil. In-kind donations from Powershop, Lividi, Telenor, Simula, Forskning.no, Directconnect, National Geographic, and Livestream.com. AJR's collections visit was funded by CEES at the Department of Biosciences, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst D, 2010, B SOC GEOL FR, V181, P453, DOI 10.2113/gssgfbull.181.5.453; Arkhangelsky M.S, 1998, PALEONTOL J, V32, P611; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; Cecca F, 2005, J BIOGEOGR, V32, P535, DOI 10.1111/j.1365-2699.2005.01176.x; Collignon M, 2012, NORW J GEOL, V92, P89; Druckenmiller PS, 2012, NORW J GEOL, V92, P311; Druckenmiller PS, 2012, NORW J GEOL, V92, P277; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; DYPVIK H, 1991, POLAR RES, V9, P21, DOI 10.1111/j.1751-8369.1991.tb00400.x; Dypvik H, 2012, NORW J GEOL, V92, P65; Efimov, 1999, PALEONTOL J, V33, P174; Fernandez MS, 2012, GEOBIOS-LYON, V45, P535, DOI 10.1016/j.geobios.2012.02.001; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fernandez MS, 2013, GEOLOGICAL MAGAZINE, V151, P49; Fernandez MS, 2007, J PALEONTOL, V81, P677; Fischer V, 2014, GEOL MAG, V151, P60, DOI 10.1017/S0016756812000994; Fischer V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084709; Fischer V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0021; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; GILMORE C. W., 1905, MEM CARNEGIE MUS, V2, P77; Godefroit Pascal, 1994, Revue de Paleobiologie Volume Special, V7, P67; Goloboff P, 2010, TNT 1 1 TREE ANAL US; Hammer O, 2011, PALAEOGEOGRAPHY PALA, V306; Hammer O, 2013, ACTA PALAEONTOL POL, V58, P827, DOI 10.4202/app.2012.0020; Herrera Y, 2015, HIST BIOL, V27, P33, DOI 10.1080/08912963.2013.861831; Hjalmarsdottir HR, 2012, NORW J GEOL, V92, P157; Holmer LE, 2012, NORW J GEOL, V92, P167; Hryniewicz K, 2012, NORW J GEOL, V92, P113; Hurum JH, 2012, NORW J GEOL, V92, P55; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Kear BP, 2014, GEOL MAG, V151, P71, DOI 10.1017/S0016756813000113; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kirton A.M., 1983, THESIS U NEWCASTLE U; Knutsen EM, 2012, NORW J GEOL, V92, P235; Knutsen EM, 2012, NORW J GEOL, V92, P213; Knutsen EM, 2012, NORW J GEOL, V92, P175; Knutsen EM, 2012, NORW J GEOL, V92, P187; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2012, J VERTEBR PALEONTOL, V32, P1207, DOI 10.1080/02724634.2012.682834; Maxwell EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041692; Maxwell EE, 2011, PALAEONTOL Z, V85, P457, DOI 10.1007/s12542-011-0106-0; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Mutterlose J, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000625; Nagy J, 2009, POLAR RES, V28, P214, DOI 10.1111/j.1751-8369.2009.00112.x; Nakrem HA, 2012, NORW J GEOL, V92, P149; Novis L.K., 2012, THESIS U OSLO; PARKER JR, 1967, GEOL MAG, V104, P487, DOI 10.1017/S0016756800049220; ROMER ALFRED SHERWOOD, 1968, CONTRIB GEOL, V7, P27; Rousseau J, 2012, NORW J GEOL, V92, P133; Seeley HG, 1874, Q J GEOLOGICAL SOC, V30, P635; Smelror M., 2009, ATLAS GEOLOGICAL HIS; Spalletti LA, 1999, REV GEOL CHILE, V26, P109; Torsvik T., 2002, BATLASMID NORWAY PLA, P18; WADE M, 1984, LETHAIA, V17, P99, DOI 10.1111/j.1502-3931.1984.tb01713.x; Wierzbowski A, 2011, NEUES JAHRB GEOL P-A, V262, P267, DOI 10.1127/0077-7749/2011/0198; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930	65	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103152	10.1371/journal.pone.0103152	http://dx.doi.org/10.1371/journal.pone.0103152			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084533	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800018
J	Albertson, LK; Cardinale, BJ; Sklar, LS				Albertson, Lindsey K.; Cardinale, Bradley J.; Sklar, Leonard S.			Non-Additive Increases in Sediment Stability Are Generated by Macroinvertebrate Species Interactions in Laboratory Streams	PLOS ONE			English	Article							NET-SPINNING CADDISFLIES; BED MATERIAL TRANSPORT; LARVAE TRICHOPTERA; SIERRA-NEVADA; SHEAR-STRESS; ECOSYSTEM; DIVERSITY; BIODIVERSITY; HYDROPSYCHE; RIVER	Previous studies have shown that biological structures such as plant roots can have large impacts on landscape morphodynamics, and that physical models that do not incorporate biology can generate qualitatively incorrect predictions of sediment transport. However, work to date has focused almost entirely on the impacts of single, usually dominant, species. Here we ask whether multiple, coexisting species of hydropsychid caddisfly larvae have different impacts on sediment mobility compared to single-species systems due to competitive interactions and niche differences. We manipulated the presence of two common species of net-spinning caddisfly (Ceratopsyche oslari, Arctopsyche californica) in laboratory mesocosms and measured how their silk filtration nets influence the critical shear stress required to initiate sediment grain motion when they were in monoculture versus polyculture. We found that critical shear stress increases non-additively in polycultures where species were allowed to interact. Critical shear stress was 26% higher in multi-species assemblages compared to the average single-species monoculture, and 21% greater than levels of stability achieved by the species having the largest impact on sediment motion in monoculture. Supplementary behavioral experiments suggest the non-additive increase in critical shear stress may have occurred as competition among species led to shifts in the spatial distribution of the two populations and complementary habitat use. To explore the implications of these results for field conditions, we used results from the laboratory study to parameterize a common model of sediment transport. We then used this model to estimate potential bed movement in a natural stream for which we had measurements of channel geometry, grain size, and daily discharge. Although this extrapolation is speculative, it illustrates that multi-species impacts could be sufficiently large to reduce bedload sediment flux over annual time scales in streams where multiple species of caddisfly are present.	[Albertson, Lindsey K.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Sklar, Leonard S.] San Francisco State Univ, Dept Earth & Climate Sci, San Francisco, CA 94132 USA	University of California System; University of California Santa Barbara; University of Michigan System; University of Michigan; California State University System; San Francisco State University	Albertson, LK (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	lalbertson@stroudcenter.org	Cardinale, Bradley J/I-7076-2013	Sklar, Leonard/0000-0001-9626-733X	National Science Foundation [1110571]; Valentine Eastern Sierra Reserve; Dawdy Fund for Hydrologic Science at SFSU; UCSB's Ecology, Evolution, and Marine Biology Department	National Science Foundation(National Science Foundation (NSF)); Valentine Eastern Sierra Reserve; Dawdy Fund for Hydrologic Science at SFSU; UCSB's Ecology, Evolution, and Marine Biology Department	This work was supported by grants from the National Science Foundation (1110571), the Valentine Eastern Sierra Reserve, the Dawdy Fund for Hydrologic Science at SFSU, and UCSB's Ecology, Evolution, and Marine Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson LK, 2011, RESTOR ECOL, V19, P627, DOI 10.1111/j.1526-100X.2010.00672.x; Allen DC, 2011, ECOLOGY, V92, P1013, DOI 10.1890/i0012-9658-92-5-1013; Andrews ED, 2000, WATER RESOUR RES, V36, P585, DOI 10.1029/1999WR900257; Braudrick CA, 2009, P NATL ACAD SCI USA, V106, P16936, DOI 10.1073/pnas.0909417106; Brown SA, 2004, J N AM BENTHOL SOC, V23, P771, DOI 10.1899/0887-3593(2004)023<0771:PPOHST>2.0.CO;2; Buffington JM, 1997, WATER RESOUR RES, V33, P1993, DOI 10.1029/96WR03190; Cardinale BJ, 2004, FUNCT ECOL, V18, P381, DOI 10.1111/j.0269-8463.2004.00865.x; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Church M, 2006, ANNU REV EARTH PL SC, V34, P325, DOI 10.1146/annurev.earth.33.092203.122721; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DIETRICH WE, 1989, NATURE, V340, P215, DOI 10.1038/340215a0; Dingman S. L, 2009, FLUVIAL HYDRAULICS; ENGLUND G, 1990, ANIM BEHAV, V39, P55, DOI 10.1016/S0003-3472(05)80725-0; Fuller BM, 2012, GEOMORPHOLOGY, V126, P732; GEORGIAN T, 1992, ECOLOGY, V73, P229, DOI 10.2307/1938734; Gordon ND, 2004, STREAM HYDROLOGY INT; Harding JS, 1997, HYDROBIOLOGIA, V350, P25, DOI 10.1023/A:1003012512998; Herbst D., 2004, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P133; Herbst DB, 2010, J N AM BENTHOL SOC, V29, P1354, DOI 10.1899/09-185.1; HILDREW AG, 1979, J ANIM ECOL, V48, P557, DOI 10.2307/4180; HOBBIE SE, 1992, TRENDS ECOL EVOL, V7, P336, DOI 10.1016/0169-5347(92)90126-V; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MF, 2009, EARTH SURF PROC LAND, V34, P413, DOI 10.1002/esp.1750; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kouwen N, 2000, J HYDRAUL ENG-ASCE, V126, P732, DOI 10.1061/(ASCE)0733-9429(2000)126:10(732); Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; LELAND HV, 1986, GREAT BASIN NAT, V46, P595; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LOUDON C, 1992, CAN J ZOOL, V70, P1166, DOI 10.1139/z92-163; MACKAY RJ, 1979, ANNU REV ENTOMOL, V24, P185, DOI 10.1146/annurev.en.24.010179.001153; Meyer-Peter E., 1948, P IAHSR 2 M STOCKH, P39; MILLER JC, 1984, OIKOS, V43, P117, DOI 10.2307/3544253; Nunokawa M, 2008, LANDSC ECOL ENG, V4, P125, DOI 10.1007/s11355-008-0044-5; OSBORNE L L, 1987, Journal of the North American Benthological Society, V6, P115, DOI 10.2307/1467221; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; PETERSEN LBM, 1983, FRESHWATER BIOL, V13, P185, DOI 10.1111/j.1365-2427.1983.tb00670.x; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reinhardt L, 2010, EARTH SURF PROC LAND, V35, P78, DOI 10.1002/esp.1912; Renschler CS, 2007, GEOMORPHOLOGY, V89, P1, DOI 10.1016/j.geomorph.2006.07.011; Rixen C, 2005, OECOLOGIA, V146, P287, DOI 10.1007/s00442-005-0196-z; Statzner B, 1999, WATER RESOUR RES, V35, P3495, DOI 10.1029/1999WR900196; Statzner B, 2008, GEOMORPHOLOGY, V93, P267, DOI 10.1016/j.geomorph.2007.02.019; TACHET H, 1992, J N AM BENTHOL SOC, V11, P350, DOI 10.2307/1467557; Takao A, 2006, J N AM BENTHOL SOC, V25, P545, DOI 10.1899/0887-3593(2006)25[545:PIOANC]2.0.CO;2; Tal M, 2007, GEOLOGY, V35, P347, DOI 10.1130/G23260A.1; Tilman D., 1982, Monographs in Population Biology, pi; WIBERG PL, 1987, WATER RESOUR RES, V23, P1471, DOI 10.1029/90WR02770; Wiggins GB, 1977, LARVAE N AM CADDISFL; Wilcock PR, 1996, WATER RESOUR RES, V32, P3361, DOI 10.1029/96WR02277; Wong MG, 2006, J HYDRAUL ENG, V132, P1159, DOI 10.1061/(ASCE)0733-9429(2006)132:11(1159)	54	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103417	10.1371/journal.pone.0103417	http://dx.doi.org/10.1371/journal.pone.0103417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101964	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900017
J	Bosch, MK; Nerbonne, JM; Ornitz, DM				Bosch, Marie K.; Nerbonne, Jeanne M.; Ornitz, David M.			Dual Transgene Expression in Murine Cerebellar Purkinje Neurons by Viral Transduction In Vivo	PLOS ONE			English	Article							RAT SUBSTANTIA-NIGRA; LENTIVIRAL VECTORS; GENE-EXPRESSION; FIBROBLAST-GROWTH-FACTOR-14 GENE; SPINOCEREBELLAR ATAXIA; MULTIPLE PROTEINS; INITIAL SEGMENT; NERVOUS-SYSTEM; CULTURED-CELLS; MUTATION	Viral-vector mediated gene transfer to cerebellar Purkinje neurons in vivo is a promising avenue for gene therapy of cerebellar ataxias and for genetic manipulation in functional studies of animal models of cerebellar disease. Here, we report the results of experiments designed to identify efficient methods for viral transduction of adult murine Purkinje neurons in vivo. For these analyses, several lentiviral and an adeno-associated virus (AAV), serotype 1, vector with various promoter combinations were generated and compared for in situ transduction efficiency, assayed by fluorescent reporter protein expression in Purkinje neurons. Additional experiments were also conducted to identify the optimal experimental strategy for co-expression of two proteins in individual Purkinje neurons. Of the viruses tested, AAV1 with a CAG promoter exhibited the highest specificity for Purkinje neurons. To deliver two proteins to the same Purkinje neuron, several methods were tested, including: an internal ribosome entry site (IRES), a 2A sequence, a dual promoter vector, and co-injection of two viruses. Efficient expression of both proteins in the same Purkinje neuron was only achieved by co-injecting two AAV1-CAG viruses. We found that use of an AAV1-CAG virus outperformed similar lentivirus vectors and that co-injection of two AAV1-CAG viruses could be used to efficiently deliver two proteins to the same Purkinje neuron in adult mice. AAV1 with a CAG promoter is highly efficient and selective at transducing adult cerebellar Purkinje neurons and two AAV-CAG viruses can be used to efficiently express two proteins in the same neuron in vivo.	[Bosch, Marie K.; Nerbonne, Jeanne M.; Ornitz, David M.] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Ornitz, DM (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	dornitz@wustl.edu		Ornitz, David/0000-0003-1592-7629	NIH [R01NS065761, T32 GM007200, T32 HL007275, P30 NS057105]; Genome Institute at Washington University; Children's Discovery Institute [CDI-LI-2010-94]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065761, P30NS057105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Institute at Washington University; Children's Discovery Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grant# R01NS065761 (DMO, JMN). MKB was supported by NIH Grant# T32 GM007200 and NIH Grant# T32 HL007275. The Hope Center Viral Vectors Core is supported by a Neuroscience Blueprint Core Grant# P30 NS057105 from NIH to Washington University. The Washington University RNAi Core is supported by the Genome Institute at Washington University and the Children's Discovery Institute (CDI-LI-2010-94). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2000, NEUROREPORT, V11, P2669, DOI 10.1097/00001756-200008210-00013; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHALLITA PM, 1995, J VIROL, V69, P748, DOI 10.1128/JVI.69.2.748-755.1995; Croci C, 2006, DEV NEUROSCI-BASEL, V28, P216, DOI 10.1159/000091919; Dalski A, 2005, EUR J HUM GENET, V13, P118, DOI 10.1038/sj.ejhg.5201286; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Delzor A, 2012, HUM GENE THER METHOD; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dodge JC, 2005, P NATL ACAD SCI USA, V102, P17822, DOI 10.1073/pnas.0509062102; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; Furler S, 2001, GENE THER, V8, P864, DOI 10.1038/sj.gt.3301469; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Goenawan H, 2012, J NEUROVIROL, V18, P521, DOI 10.1007/s13365-012-0134-x; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kaemmerer WF, 2000, MOL THER, V2, P446, DOI 10.1006/mthe.2000.0134; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Kobayashi H, 2005, MOL THER, V11, P776, DOI 10.1016/j.ymthe.2004.10.006; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; Li MJ, 2007, CSH PROTOC 2007 PDB, V2007; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Manoonkitiwongsa PS, 2002, HISTOCHEM J, V34, P365; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Misceo D, 2009, NEUROGENETICS; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohashi Y, 2011, MOL CELL NEUROSCI, V46, P136, DOI 10.1016/j.mcn.2010.08.013; Okubo Y, 2001, NEURON, V32, P113, DOI 10.1016/S0896-6273(01)00464-0; Ramesh N, 1996, NUCLEIC ACIDS RES, V24, P2697, DOI 10.1093/nar/24.14.2697; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Rendahl KG, 1998, NAT BIOTECHNOL, V16, P757, DOI 10.1038/nbt0898-757; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Wang Q, 2000, MECH DEVELOP, V90, P283, DOI 10.1016/S0925-4773(99)00241-5; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xiao ML, 2013, MOL CELL NEUROSCI, V56, P393, DOI 10.1016/j.mcn.2013.07.008; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	62	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104062	10.1371/journal.pone.0104062	http://dx.doi.org/10.1371/journal.pone.0104062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093726	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200062
J	Chakraborty, A; Pasek, DA; Huang, TQ; Gomez, AC; Yamaguchi, N; Anderson, ME; Meissner, G				Chakraborty, Asima; Pasek, Daniel A.; Huang, Tai-Qin; Gomez, Angela C.; Yamaguchi, Naohiro; Anderson, Mark E.; Meissner, Gerhard			Inhibition of CaMKII Does Not Attenuate Cardiac Hypertrophy in Mice with Dysfunctional Ryanodine Receptor	PLOS ONE			English	Article							PROTEIN-KINASE-II; HEART-FAILURE; CALMODULIN; PHOSPHORYLATION; DELTA; ISOFORM; SITE	In cardiac muscle, the release of calcium ions from the sarcoplasmic reticulum through ryanodine receptor ion channels (RyR2s) leads to muscle contraction. RyR2 is negatively regulated by calmodulin (CaM) and by phosphorylation of Ca2+/CaM-dependent protein kinase II (CaMKII). Substitution of three amino acid residues in the CaM binding domain of RyR2 (RyR2-W3587A/L3591D/F3603A, RyR2(ADA)) impairs inhibition of RyR2 by CaM and results in cardiac hypertrophy and early death of mice carrying the RyR2(ADA) mutation. To test the cellular function of CaMKII in cardiac hypertrophy, mutant mice were crossed with mice expressing the CaMKII inhibitory AC3-I peptide or the control AC3-C peptide in the myocardium. Inhibition of CaMKII by AC3-I modestly reduced CaMKII-dependent phosphorylation of RyR2 at Ser-2815 and markedly reduced CaMKII-dependent phosphorylation of SERCA2a regulatory subunit phospholamban at Thr-17. However the average life span and heart-to-body weight ratio of Ryr2(ADA/ADA) mice expressing the inhibitory peptide were not altered compared to control mice. In Ryr2(ADA/ADA) homozygous mice, AC3-I did not alter cardiac morphology, enhance cardiac function, improve sarcoplasmic reticulum Ca2+ handling, or suppress the expression of genes implicated in cardiac remodeling. The results suggest that CaMKII was not required for the rapid development of cardiac hypertrophy in Ryr2(ADA/ADA) mice.	[Chakraborty, Asima; Pasek, Daniel A.; Huang, Tai-Qin; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Gomez, Angela C.; Yamaguchi, Naohiro] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Anderson, Mark E.] Univ Iowa, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Div Cardiovasc Med, Iowa City, IA USA	University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; University of Iowa; University of Iowa	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA.	meissner@med.unc.edu	Huang, Taiqin/J-7827-2019	Gomez, Angela/0000-0001-7019-9607	National Institutes of Health [HL070250, HL079031, HL096652, HL113001, AR061030]; American Heart Association [10SDG3500001]; National Science Foundation [EPS0903795, HL073051]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096652, R01HL079031, R01HL113001, R01HL070250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support of National Institutes of Health grants HL070250, HL079031, HL096652, HL113001 (to MEA), AR061030, American Heart Association grant 10SDG3500001 and National Science Foundation grant EPS0903795 (to NY), and HL073051 (to GM) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Anderson ME, 2004, TRENDS CARDIOVAS MED, V14, P152, DOI 10.1016/j.tcm.2004.02.005; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Caron KMI, 2004, P NATL ACAD SCI USA, V101, P3106, DOI 10.1073/pnas.0307333101; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Halling DB, 2005, SCI STKE, V20, pre15; Khoo MSC, 2005, HEART RHYTHM, V2, P634, DOI 10.1016/j.hrthm.2005.03.019; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Li BL, 2006, BBA-MOL CELL RES, V1763, P1275, DOI 10.1016/j.bbamcr.2006.09.029; Li N, 2012, CIRC RES, V110, P465, DOI 10.1161/CIRCRESAHA.111.253229; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Mattiazzi A, 2011, HEART RHYTHM, V8, P784, DOI 10.1016/j.hrthm.2010.11.035; McCauley MD, 2011, TRENDS CARDIOVAS MED, V21, P48, DOI 10.1016/j.tcm.2012.02.004; Respress JL, 2012, CIRC RES, V110, P1474, DOI 10.1161/CIRCRESAHA.112.268094; Rokita AG, 2012, CIRCULATION, V126, P2125, DOI 10.1161/CIRCULATIONAHA.112.124990; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Said M, 2011, J MOL CELL CARDIOL, V51, P936, DOI 10.1016/j.yjmcc.2011.08.010; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Sutko JL, 1997, PHARMACOL REV, V49, P53; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yamaguchi N, 2013, AM J PHYSIOL-HEART C, V305, pH86, DOI 10.1152/ajpheart.00144.2013; Yamaguchi N, 2011, AM J PHYSIOL-HEART C, V300, pH2187, DOI 10.1152/ajpheart.00719.2010; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	39	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104338	10.1371/journal.pone.0104338	http://dx.doi.org/10.1371/journal.pone.0104338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093823	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200099
J	Lopez, S; Garcia, O; Yurrebaso, I; Flores, C; Acosta-Herrera, M; Chen, H; Gardeazabal, J; Careaga, JM; Boyano, MD; Sanchez, A; Raton-Nieto, JA; Sevilla, A; Smith-Zubiaga, I; de Galdeano, AG; Martinez-Cadenas, C; Izagirre, N; de la Rua, C; Alonso, S				Lopez, Saioa; Garcia, Oscar; Yurrebaso, Inaki; Flores, Carlos; Acosta-Herrera, Marialbert; Chen, Hua; Gardeazabal, Jesus; Maria Careaga, Jesus; Dolores Boyano, Maria; Sanchez, Ana; Antonio Raton-Nieto, Juan; Sevilla, Arrate; Smith-Zubiaga, Isabel; Garcia de Galdeano, Alicia; Martinez-Cadenas, Conrado; Izagirre, Neskuts; de la Rua, Concepcion; Alonso, Santos			The Interplay between Natural Selection and Susceptibility to Melanoma on Allele 374F of SLC45A2 Gene in a South European Population	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; SKIN PIGMENTATION; MATP GENE; VITAMIN-D; GENOME; EVOLUTION; VARIANTS; POLYMORPHISM; ASSOCIATION; COLOR	We aimed to study the selective pressures interacting on SLC45A2 to investigate the interplay between selection and susceptibility to disease. Thus, we enrolled 500 volunteers from a geographically limited population (Basques from the North of Spain) and by resequencing the whole coding region and intron 5 of the 34 most and the 34 least pigmented individuals according to the reflectance distribution, we observed that the polymorphism Leu374Phe (L374F, rs16891982) was statistically associated with skin color variability within this sample. In particular, allele 374F was significantly more frequent among the individuals with lighter skin. Further genotyping an independent set of 558 individuals of a geographically wider population with known ancestry in the Spanish population also revealed that the frequency of L374F was significantly correlated with the incident UV radiation intensity. Selection tests suggest that allele 374F is being positively selected in South Europeans, thus indicating that depigmentation is an adaptive process. Interestingly, by genotyping 119 melanoma samples, we show that this variant is also associated with an increased susceptibility to melanoma in our populations. The ultimate driving force for this adaptation is unknown, but it is compatible with the vitamin D hypothesis. This shows that molecular evolution analysis can be used as a useful technology to predict phenotypic and biomedical consequences in humans.	[Lopez, Saioa; Sevilla, Arrate; Izagirre, Neskuts; de la Rua, Concepcion; Alonso, Santos] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Bizkaia, Spain; [Garcia, Oscar; Yurrebaso, Inaki] Ertzaintza Forens Unit, Erandio, Bizkaia, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Flores, Carlos; Acosta-Herrera, Marialbert] Hosp Univ NS Candelaria, Res Unit, Tenerife, Spain; [Flores, Carlos] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Genet Lab, G2A, Tenerife, Spain; [Acosta-Herrera, Marialbert] Univ Hosp Dr Negrin, Res Unit, Las Palmas Gan Canaria, Spain; [Chen, Hua] Temple Univ, Ctr Computat Genet & Genom, Philadelphia, PA 19122 USA; [Gardeazabal, Jesus; Antonio Raton-Nieto, Juan] Cruces Univ Hosp, BioCruces Hlth Res Inst, Dermatol Serv, Cruces Barakaldo, Bizkaia, Spain; [Maria Careaga, Jesus; Sanchez, Ana] Basurto Univ Hosp, BioCruces Hlth Res Inst, Dermatol Serv, Bilbao, Bizkaia, Spain; [Dolores Boyano, Maria; Garcia de Galdeano, Alicia] Univ Basque Country UPV EHU, Dept Cell Biol & Histol, Leioa, Bizkaia, Spain; [Smith-Zubiaga, Isabel] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, Bizkaia, Spain; [Martinez-Cadenas, Conrado] Jaume I Univ Castellon, Dept Med, Castellon de La Plana, Spain	University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hospital Universitario Cruces; Basurto Hospital; University of Basque Country; University of Basque Country; Universitat Jaume I	Lopez, S (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Bizkaia, Spain.	saioa.lopez@ehu.es	BOYANO LOPEZ, MARIA DOLORES/ABF-6668-2021; Flores, Carlos/R-1159-2019; Alonso, Santos/L-8316-2014; Martinez-Cadenas, Conrado/AAB-3266-2021; Smith-Zubiaga, Isabel/L-5176-2014	BOYANO LOPEZ, MARIA DOLORES/0000-0001-6051-1054; Alonso, Santos/0000-0003-0221-4048; Martinez-Cadenas, Conrado/0000-0002-5252-563X; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; Smith Zubiaga, Isabel/0000-0002-4509-9492; Lopez, Saioa/0000-0003-2936-4070; Flores, Carlos/0000-0001-5352-069X; Sevilla Mambrilla, Arrate/0000-0002-4860-3359; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; Chen, Hua/0000-0002-9829-6561	Spanish Ministerio de Ciencia e Innovacion [CGL2008-04066/BOS]; Dpt. Educacion, Universidades e Investigacion of the Basque Government [IT542-10]; University of the Basque Country [UFI11/09]; Dept. Educacion, Universidades e Investigacion of the Basque Government [BFI09.248]; Programa de Investigacion Cientifica de la Universidad de La Laguna [boc-a-2010-255-7177]; Health Institute "Carlos III" [FIS PI11/00623]; European Regional Development Funds, "A way of making Europe" from the European Union; Instituto de Salud Carlos III [FI11/00074]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Dpt. Educacion, Universidades e Investigacion of the Basque Government; University of the Basque Country; Dept. Educacion, Universidades e Investigacion of the Basque Government; Programa de Investigacion Cientifica de la Universidad de La Laguna; Health Institute "Carlos III"(Instituto de Salud Carlos III); European Regional Development Funds, "A way of making Europe" from the European Union; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the former Spanish Ministerio de Ciencia e Innovacion, project CGL2008-04066/BOS to S.A.; by the Dpt. Educacion, Universidades e Investigacion of the Basque Government, project IT542-10 to C.R.; the University of the Basque Country program UFI11/09; a predoctoral fellowship from the Dept. Educacion, Universidades e Investigacion of the Basque Government to S.L. (BFI09.248); "Programa de Investigacion Cientifica de la Universidad de La Laguna" (boc-a-2010-255-7177) the Health Institute "Carlos III" (FIS PI11/00623) to C.F. and co-financed by the European Regional Development Funds, "A way of making Europe" from the European Union. M.A.H. was supported by a fellowship from the Instituto de Salud Carlos III (FI11/00074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; American Cancer Society, 2012, CANC FACTS FIG; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Beleza S, 2013, MOL BIOL EVOL, V30, P24, DOI 10.1093/molbev/mss207; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Chaplin G, 2009, AM J PHYS ANTHROPOL, V139, P451, DOI 10.1002/ajpa.21079; Chen H, 2013, G3-GENES GENOM GENET, V3, P1429, DOI 10.1534/g3.113.006197; de Gruijter Johanna Maria, 2011, Investig Genet, V2, P24, DOI 10.1186/2041-2223-2-24; de Vries E, 2005, BRIT MED J, V331, P698, DOI 10.1136/bmj.331.7518.698; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Donnelly MP, 2012, HUM GENET, V131, P683, DOI 10.1007/s00439-011-1110-x; Dooley CM, 2012, PIGM CELL MELANOMA R, V26, P205, DOI DOI 10.1111/PCMR; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Falush D, 2003, GENETICS, V164, P1567; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Ibarrola-Villava M, 2012, EUR J CANCER, V48, P2183, DOI 10.1016/j.ejca.2012.03.006; Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lewis PO, 2002, GENETIC DATA ANAL CO; Li W. H, 1997, MOL EVOLUTION; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; Lucotte G, 2013, BIOCHEM GENET, V51, P655, DOI 10.1007/s10528-013-9595-8; Lucotte G, 2010, BIOCHEM GENET, V48, P26, DOI 10.1007/s10528-009-9289-4; Martinez-Cadenas C, 2013, MOL BIOL EVOL, V30, P2654, DOI 10.1093/molbev/mst158; Nakayama K, 2002, J HUM GENET, V47, P92, DOI 10.1007/s100380200007; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; Pino-Yanes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018389; Prado-Martinez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-363; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Robbins AH, 1991, BIOL PERSPECTIVES HU; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; TAJIMA F, 1989, GENETICS, V123, P597; THOMSON ML, 1951, J PHYSIOL-LONDON, V112, P31, DOI 10.1113/jphysiol.1951.sp004506; Tsetskhladze ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047398; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Yuasa I, 2007, BIOCHEM GENET, V45, P535, DOI 10.1007/s10528-007-9095-9; Yuasa I, 2006, ANN HUM GENET, V70, P802, DOI 10.1111/j.1469-1809.2006.00261.x; Yuasa I, 2004, INT J LEGAL MED, V118, P364, DOI 10.1007/s00414-004-0490-z; Zeng K, 2007, MOL BIOL EVOL, V24, P1898, DOI 10.1093/molbev/msm119	72	12	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104367	10.1371/journal.pone.0104367	http://dx.doi.org/10.1371/journal.pone.0104367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093503	gold, Green Published			2022-12-25	WOS:000341357200104
J	Franklin, TR; Wetherill, RR; Jagannathan, K; Johnson, B; Mumma, J; Hager, N; Rao, H; Childress, AR				Franklin, Teresa R.; Wetherill, Reagan R.; Jagannathan, Kanchana; Johnson, Barbara; Mumma, Joel; Hager, Nathan; Rao, Hengyi; Childress, Anna Rose			The Effects of Chronic Cigarette Smoking on Gray Matter Volume: Influence of Sex	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; OBSESSIVE-COMPULSIVE DISORDER; CEREBRAL-BLOOD-FLOW; ADULT HUMAN BRAINS; ORBITOFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; NICOTINE DEPENDENCE; NEURAL SYSTEMS; SMOKERS; METAANALYSIS	Cigarette smoke contains nicotine and toxic chemicals and may cause significant neurochemical and anatomical brain changes. Voxel-based morphometry studies have examined the effects of smoking on the brain by comparing gray matter volume (GMV) in nicotine dependent individuals (NDs) to nonsmoking individuals with inconsistent results. Although sex differences in neural and behavioral features of nicotine dependence are reported, sex differences in regional GMV remain unknown. The current study examined sex differences in GMV in a large sample of 80 NDs (41 males) and 80 healthy controls (41 males) using voxel-based morphometry. Within NDs, we explored whether GMV was correlated with measures of cigarette use and nicotine dependence. High-resolution T1 structural scans were obtained from all participants. Segmentation and registration were performed in SPM8 using the optimized DARTEL approach. Covariates included age and an estimate of total global GMV. Differences were considered significant at p <= 0.001, with a whole brain FWE-corrected cluster probability of p<0.025. Among NDs compared to Controls less GMV was observed in the thalamus and bilateral cerebellum and greater GMV was observed in the bilateral putamen and right parahippocampus. Lower thalamic GMV was observed in both female and male NDs compared to Controls. Female NDs also had lower GMV in the left cerebellum and in the ventral medial and orbitofrontal cortices with no areas of greater GMV. Male NDs had lower GMV in bilateral cerebellum and greater GMV in bilateral parahippocampus and left putamen. Within male NDs, GMV in the left putamen was correlated with number of pack years. This study, conducted in a large cohort, contributes to our knowledge of brain morphology in nicotine addiction and provides additional evidence of sex-specific effects on GMV in NDs. Identifying brain vulnerabilities with respect to sex provides a methodological framework for personalized therapies to improve relapse rates for both sexes.	[Franklin, Teresa R.; Wetherill, Reagan R.; Jagannathan, Kanchana; Johnson, Barbara; Mumma, Joel; Hager, Nathan; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Franklin, TR (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	teresafr@mail.med.upenn.edu	Rao, Hengyi/AAQ-4919-2020; Wetherill, Reagan/AAA-4215-2022; Rao, Hengyi/K-5152-2019; Rao, Hengyi/A-7064-2009	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; Wetherill, Reagan/0000-0002-1991-6292	National Institutes of Health [R21 DA032022, R21 DA25882, R03 DA027098, R01 HL102119, R01 DA029845, R01 DA030394-01A1]; Pfizer Pharma; Institute for Translational Medicine and Therapeutics (ITMAT) of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032022, R01DA029845, R21DA025882, R01DA030394, R03DA027098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Pharma(Pfizer); Institute for Translational Medicine and Therapeutics (ITMAT) of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants received from National Institutes of Health (R21 DA032022 (HR), R21 DA25882 (TF), R03 DA027098 (HR), R01 HL102119 (HR), R01 DA029845 (TF), R01 DA030394-01A1 (TF)) and Pfizer Pharma (Investigator-initiated Award) (TF) and a pilot grant from the Institute for Translational Medicine and Therapeutics (ITMAT) of the University of Pennsylvania (HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BAILLIE AJ, 1995, AUST J PUBLIC HEALTH, V19, P129; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; Bergen AW, 2009, NEUROPSYCHOPHARMACOL, V34, P2252, DOI 10.1038/npp.2009.52; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; BUIST AS, 1993, CHEST, V103, P1863, DOI 10.1378/chest.103.6.1863; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Centers for Disease Control and Prevention, 2008, SMOK ATTR MORT YEARS; Chase HW, 2011, BIOL PSYCHIAT, V70, P785, DOI 10.1016/j.biopsych.2011.05.025; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Court JA, 1998, NEUROSCIENCE, V87, P63, DOI 10.1016/S0306-4522(98)00088-8; CZERNIN J, 1995, CIRCULATION, V91, P2891, DOI 10.1161/01.CIR.91.12.2891; Department of Health and Human Services National Toxicology Program, 2011, REP CARC; Domino EF, 2004, PROG NEURO-PSYCHOPH, V28, P319, DOI 10.1016/j.pnpbp.2003.10.011; Drum ML, 2009, J GERONTOL B-PSYCHOL, V64, pI119, DOI 10.1093/geronb/gbn017; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Franklin TR, 2011, ADDICT BIOL, V16, P308, DOI 10.1111/j.1369-1600.2010.00277.x; Franklin TR, 2012, BRAIN STRUCTURE FUNC; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Goldstein RZ, 2007, NEUROSCIENCE, V144, P1153, DOI 10.1016/j.neuroscience.2006.11.024; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Hughes JR, 2003, TOB CONTROL, V12, P21, DOI 10.1136/tc.12.1.21; Kandel D B, 2000, Nicotine Tob Res, V2, P263; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhn S, 2012, BRAIN STRUCT FUNCT, V217, P517, DOI 10.1007/s00429-011-0346-5; Liao YH, 2012, ADDICT BIOL, V17, P977, DOI 10.1111/j.1369-1600.2010.00250.x; Longstreth WT, 2001, NEUROLOGY, V56, P368, DOI 10.1212/WNL.56.3.368; Lynch WJ, 2010, EXP CLIN PSYCHOPHARM, V18, P451, DOI 10.1037/a0021265; Mackiewicz KL, 2006, P NATL ACAD SCI USA, V103, P14200, DOI 10.1073/pnas.0601648103; Mak HKF, 2011, J ALZHEIMERS DIS, V23, P655, DOI 10.3233/JAD-2010-101659; Morales AM, 2012, DRUG ALCOHOL DEPEN, V125, P230, DOI 10.1016/j.drugalcdep.2012.02.017; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Pfefferbaum A, 2001, AM J PSYCHIAT, V158, P188, DOI 10.1176/appi.ajp.158.2.188; Picard F, 2013, NEUROIMAGE, V79, P42, DOI 10.1016/j.neuroimage.2013.04.074; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Rando K, 2013, ADDICT BIOL, V18, P147, DOI 10.1111/adb.12008; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rose JE, 2003, AM J PSYCHIAT, V160, P323, DOI 10.1176/appi.ajp.160.2.323; Salgado-Pineda P, 2006, BRIT J CLIN PHARMACO, V62, P546, DOI 10.1111/j.1365-2125.2006.02695.x; SCARONE S, 1992, PSYCHIAT RES-NEUROIM, V45, P115, DOI 10.1016/0925-4927(92)90005-O; Seidlitz L, 1998, J PERS SOC PSYCHOL, V74, P262, DOI 10.1037/0022-3514.74.1.262; Slotkin TA, 2002, NEUROTOXICOL TERATOL, V24, P369, DOI 10.1016/S0892-0362(02)00199-X; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Trauth JA, 1999, BRAIN RES, V851, P9, DOI 10.1016/S0006-8993(99)01994-0; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Wetherill R.R., 2012, ADDICTION BIOL; Wetherill RR, 2014, ADDICT BEHAV, V39, P789, DOI 10.1016/j.addbeh.2014.01.006; Wetherill RR, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-9; Yamasue H, 2007, ANN NEUROL, V61, P37, DOI 10.1002/ana.21024; Yu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021255; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063; Zubieta JK, 2005, AM J PSYCHIAT, V162, P567, DOI 10.1176/appi.ajp.162.3.567	61	66	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104102	10.1371/journal.pone.0104102	http://dx.doi.org/10.1371/journal.pone.0104102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25090480	gold, Green Submitted, Green Published			2022-12-25	WOS:000339812700096
J	Naranjo-Diaz, N; Altamiranda, M; Luckhart, S; Conn, JE; Correa, MM				Naranjo-Diaz, Nelson; Altamiranda, Mariano; Luckhart, Shirley; Conn, Jan E.; Correa, Margarita M.			Malaria Vectors in Ecologically Heterogeneous Localities of the Colombian Pacific Region	PLOS ONE			English	Article							ANOPHELES-DARLINGI ROOT; DIPTERA-CULICIDAE; PLASMODIUM-FALCIPARUM; NATURAL INFECTIVITY; BITING BEHAVIOR; TRANSMISSION; NEIVAI; PUNCTIMACULA; ANTIOQUIA; ABUNDANCE	The Colombian Pacific region is second nationally in number of malaria cases reported. This zone presents great ecological heterogeneity and Anopheles species diversity. However, little is known about the current spatial and temporal distribution of vector species. This study, conducted in three ecologically different localities of the Pacific region, aimed to evaluate the composition and distribution of Anopheles species and characterize transmission intensity. A total of 4,016 Anopheles mosquitoes were collected representing seven species. The composition and dominant species differed in each locality. Three species were infected with malaria parasites: Anopheles darlingi and An. calderoni were infected with Plasmodium falciparum and An. nuneztovari with Plasmodium vivax VK210 and VK247. Annual EIRs varied from 3.5-7.2 infective bites per year. These results confirm the importance of the primary vector An. nuneztovari in areas disturbed by human interventions, of An. darlingi in deforested margins of humid tropical rainforest and An. albimanus and the suspected vector An. calderoni in areas impacted by urbanization and large-scale palm oil agriculture close to the coast. This constitutes the first report in the Colombia Pacific region of naturally infected An. darlingi, and in Colombia of naturally infected An. calderoni. Further studies should evaluate the epidemiological importance of An. calderoni in the Pacific region.	[Naranjo-Diaz, Nelson; Altamiranda, Mariano; Correa, Margarita M.] Univ Antioquia UdeA, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia; [Luckhart, Shirley] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, New York, NY USA; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	Universidad de Antioquia; University of California System; University of California Davis; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Correa, MM (corresponding author), Univ Antioquia UdeA, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia.	margaritcorrea@gmail.com		Naranjo, Nelson/0000-0001-8307-2859; Conn, Jan/0000-0002-5301-7020	National Institutes of Health-United States of America [R03-AI076710]; Estrategia para la Sostenibilidad de Grupos; Universidad de Antioquia [E01719]; Comite para el Desarrollo de la Investigacion, UdeA [8700-074]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia [Convocatoria 511-2010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI076710] Funding Source: NIH RePORTER	National Institutes of Health-United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estrategia para la Sostenibilidad de Grupos; Universidad de Antioquia; Comite para el Desarrollo de la Investigacion, UdeA; Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received funding from the National Institutes of Health-United States of America, Grant No. R03-AI076710 to MMC. Additional support was received from Estrategia para la Sostenibilidad de Grupos 2013-2014, Universidad de Antioquia-Grant No. E01719 and Comite para el Desarrollo de la Investigacion, UdeA, Grant No. 8700-074. NND received financial support for his doctoral studies from Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Convocatoria 511-2010, Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FARAN M E, 1980, Contributions of the American Entomological Institute, V15, P1; Brochero Helena, 2006, Biomed., V26, P269; Calderon G, 1995, REV PERU EPIDEM, V8, P5; CARVAJAL H, 1989, T ROY SOC TROP MED H, V83, P609, DOI 10.1016/0035-9203(89)90372-6; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Cienfuegos AV, 2008, REV BIOMED, V19, P35; Cruz G Carmen, 2004, Rev. perú. med. exp. salud publica, V21, P223; Escovar JE, 2013, MEM I OSWALDO CRUZ, V108, P1057, DOI 10.1590/0074-0276130256; ELLIOTT R, 1972, AM J TROP MED HYG, V21, P755, DOI 10.4269/ajtmh.1972.21.755; Fajardo P, 1987, COLOMB MEDICA, V18, P14; FARAN M E, 1981, Mosquito Systematics, V13, P1; Ferro Vargas C. A., 1979, Revista de la Escuela Nacional de Salud Publica, V5, P11; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frederickson E, 1993, BIONOMIA CONTROL ANO; Girod R, 2008, MEM I OSWALDO CRUZ, V103, P702, DOI 10.1590/S0074-02762008000700013; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Gonzalez R, 2007, INTRO ESTUDIO TAXONO; Gonzalez R, 2009, INTRO ESTUDIO TAXONO; Gonzalez R, 2010, MEM I OSWALDO CRUZ, V105, P1001, DOI 10.1590/S0074-02762010000800009; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Gutierrez LA, 2009, MEM I OSWALDO CRUZ, V104, P1117, DOI 10.1590/S0074-02762009000800008; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herrera S, 1987, COLOMB MEDICA, V18, P2; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; HUDSON JE, 1984, B ENTOMOL RES, V74, P129, DOI 10.1017/S0007485300010002; HUFFAKER CB, 1945, AM J HYG, V42, P107, DOI 10.1093/oxfordjournals.aje.a119027; Instituto Geografico Agustin Codazzi, 2002, ATL COL; Instituto Nacional de Salud, 2011, B EP SEM EST SIST VI; Instituto Nacional de Salud, 2012, B EP SEM EST SIST VI; Instituto Nacional de Salud, 2010, B EP SEM EST SIST VI; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kroeger A, 1993, MALARIA ECUADOR PERU, P316; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lucumi-Aragon D, 2011, REV COLOMB ENTOMOL, V37, P256; Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Naranjo-Diaz N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-61; Ochoa Johanna, 2006, Biomed., V26, P278; Olano V, 1997, Rev Panam Salud Publica, V1, P287, DOI 10.1590/S1020-49891997000400005; Olano VA, 2001, BIOMEDICA, V21, P402; Organizacion Panamericana de la Salud, 2011, INF SIT PAL AM; Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707; Povoa MM, 2001, MEM I OSWALDO CRUZ, V96, P179, DOI 10.1590/S0074-02762001000200008; Rosero DA, 2013, ISRN PARASITOL, V2013, P10; Rosero DA, 2010, REV COLOMB ENTOMOL, V36, P260; ROZENDAAL J A, 1987, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V25, P33; ROZENDAAL JA, 1992, MED VET ENTOMOL, V6, P16, DOI 10.1111/j.1365-2915.1992.tb00029.x; Rubio-Palis Yasmin, 2005, ENTOMOTROPICA, V20, P29; Servicio de Erradicacion de la Malaria, 1957, PLAN ERR MAL COL; Solarte Y, 1996, MEM I OSWALDO CRUZ, V91, P141, DOI 10.1590/S0074-02761996000200002; Souza-Santos Reinaldo, 2002, Cad. Saúde Pública, V18, P1813, DOI 10.1590/S0102-311X2002000600039; SUAREZ MF, 1990, J AM MOSQUITO CONTR, V6, P72; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; Ulloa A, 2006, J AM MOSQUITO CONTR, V22, P648, DOI 10.2987/8756-971X(2006)22[648:HSAGCL]2.0.CO;2; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WILKERSON R C, 1991, Mosquito Systematics, V23, P25; WILKERSON RC, 1990, J MED ENTOMOL, V27, P225, DOI 10.1093/jmedent/27.2.225; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; WIRTZ RA, 1992, J MED ENTOMOL, V29, P854, DOI 10.1093/jmedent/29.5.854; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67	63	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103769	10.1371/journal.pone.0103769	http://dx.doi.org/10.1371/journal.pone.0103769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090233	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700051
J	Wang, YK; Wang, CY; Jia, YJ; Cheng, XH; Lin, Q; Zhu, MJ; Lu, YS; Ding, LL; Weng, ZY; Wu, KJ				Wang, Yongkun; Wang, Chuanying; Jia, Yijun; Cheng, Xianhua; Lin, Qing; Zhu, Mingjie; Lu, Yunshu; Ding, Longlong; Weng, Ziyi; Wu, Kejin			Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INDUCED APOPTOSIS; DELIVERY; DRUG; RESISTANCE; REOXYGENATION; ENHANCEMENT; EXPRESSION; MECHANISM; SURVIVAL	Objective: To study the in vivo and in vitro effects of adding oxygen carbon nanotubes (CNTs) to chemotherapy for breast cancer. Methods: MCF-7 and SK-BR-3 breast cancer cells were co-cultured with paclitaxel and then exposed to oxygen-CNTs under hypoxic conditions. Cell proliferation, viability, and apoptosis rate were analyzed. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression was measured using reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Nude mice were used as a human breast cancer model to explore the impact of oxygen-CNTs on the in vivo chemotherapeutic effect of paclitaxel. Results: Oxygen-CNTs had no significant effects on the growth of breast cancer cells under normoxia and hypoxia. However, in the hypoxic environment, oxygen-CNTs significantly enhanced the inhibitory effect of paclitaxel on cell proliferation, as well as the apoptosis rate. Under hypoxia, downregulation of HIF-1 alpha and upregulation of caspase-3, caspase-8, caspase-9, LC3 and Beclin-1 were observed when paclitaxel was combined with oxygen-CNT. Furthermore, addition of oxygen-CNTs to chemotherapy was found to significantly reduce tumor weight in the tumor-bearing mice model. Conclusions: Oxygen-CNTs can significantly increase the chemotherapeutic effect of paclitaxel on breast cancer cells. Oxygen-CNTs may be a potential chemosensitizer in breast cancer therapy.	[Wang, Yongkun; Jia, Yijun; Lu, Yunshu; Ding, Longlong; Wu, Kejin] Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, XinHua Hosp, Shanghai 200030, Peoples R China; [Wang, Chuanying; Cheng, Xianhua] Shanghai Jiao Tong Univ, Sch Mech & Power Engn, Shanghai 200030, Peoples R China; [Lin, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, XinHua Hosp, Shanghai 200030, Peoples R China; [Zhu, Mingjie] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Pathol, Shanghai 200030, Peoples R China; [Weng, Ziyi] Shanghai Jiao Tong Univ, Sch Med, Dept Anorectal Surg, XinHua Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Weng, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Anorectal Surg, XinHua Hosp, Shanghai 200030, Peoples R China.	wzysn88@163.com; kejinwu@163.com			National Natural Science Foundation of China [81102016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (Project No. 81102016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avouris P, 2002, CHEM PHYS, V281, P429, DOI 10.1016/S0301-0104(02)00376-2; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bhattacharya S, 2012, NANOTECHNOL REV, V1, P235, DOI 10.1515/ntrev-2011-0010; Bonard JM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.197602; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; He H, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/578290, 10.1155/2013/798912]; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Korkeila EA, 2011, ANTICANCER RES, V31, P4529; Lay CL, 2011, EXPERT REV MED DEVIC, V8, P561, DOI [10.1586/ERD.11.34, 10.1586/erd.11.34]; Liu F, 2009, CHINESE GERMAN J CLI, V8, P199; Madani SY, 2011, INT J NANOMED, V6, P2963, DOI 10.2147/IJN.S16923; McEuen PL, 2002, IEEE T NANOTECHNOL, V1, P78, DOI 10.1109/TNANO.2002.1005429; Merighi S, 2007, MOL PHARMACOL, V72, P162, DOI 10.1124/mol.106.031849; MILAS L, 1995, ACTA ONCOL, V34, P409, DOI 10.3109/02841869509093999; MILAS L, 1995, CANCER RES, V55, P3564; Naruse T, 2011, ANTICANCER RES, V31, P4429; Neves LFF, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375104; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Prylutska S, 2013, J BIOSCI BIOENG, V115, P674, DOI 10.1016/j.jbiosc.2012.12.016; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; Shao W, 2013, BIOMATERIALS, V34, P10109, DOI 10.1016/j.biomaterials.2013.09.007; Shao ZM, 2011, CHIN J PRACTICAL SUR, V10, P915; Shi YH, 2010, ONCOL LETT, V1, P657, DOI 10.3892/ol_00000115; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525643; Witters L, 2002, ONCOL REP, V9, P1163; Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618; Zhang RG, 2011, CANCER BIOTHER RADIO, V26, P335, DOI 10.1089/cbr.2010.0814; Zhang WX, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-555; Zhang Y, 2010, DRUG DISCOV TODAY, V15, P428, DOI 10.1016/j.drudis.2010.04.005; Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831; Zhong H, 1999, CANCER RES, V59, P5830; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	41	7	7	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104209	10.1371/journal.pone.0104209	http://dx.doi.org/10.1371/journal.pone.0104209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089613	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700111
J	Zhang, YY; Hu, Y; Guan, SC; Hong, XL; Wang, ZX; Li, XC				Zhang, Yangyang; Hu, Yang; Guan, Shuchen; Hong, Xiaolong; Wang, Zhaoxin; Li, Xianchun			Neural Substrate of Initiation of Cross-Modal Working Memory Retrieval	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; MULTISENSORY INTEGRATION; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; MANIPULATION; PRIMATE; MAINTENANCE; ASSOCIATION; REPRESENTATION; DISSOCIATIONS	Cross-modal working memory requires integrating stimuli from different modalities and it is associated with co-activation of distributed networks in the brain. However, how brain initiates cross-modal working memory retrieval remains not clear yet. In the present study, we developed a cued matching task, in which the necessity for cross-modal/unimodal memory retrieval and its initiation time were controlled by a task cue appeared in the delay period. Using functional magnetic resonance imaging (fMRI), significantly larger brain activations were observed in the left lateral prefrontal cortex (l-LPFC), left superior parietal lobe (l-SPL), and thalamus in the cued cross-modal matching trials (CCMT) compared to those in the cued unimodal matching trials (CUMT). However, no significant differences in the brain activations prior to task cue were observed for sensory stimulation in the l-LPFC and l-SPL areas. Although thalamus displayed differential responses to the sensory stimulation between two conditions, the differential responses were not the same with responses to the task cues. These results revealed that the frontoparietal-thalamus network participated in the initiation of cross-modal working memory retrieval. Secondly, the l-SPL and thalamus showed differential activations between maintenance and working memory retrieval, which might be associated with the enhanced demand for cognitive resources.	[Zhang, Yangyang; Guan, Shuchen; Hong, Xiaolong; Li, Xianchun] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Hu, Yang; Wang, Zhaoxin] E China Normal Univ, Inst Cognit Neurosci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Li, XC (corresponding author), E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China.	xcli@psy.ecnu.edu.cn	zhang, yangyang/GZG-7467-2022	Guan, Shuchen/0000-0001-6281-8623	National Natural Science Foundation of China [31000501]; Shanghai Pujiang Program [11PJC044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by (1) National Natural Science Foundation of China (No. 31000501, http://www.nsfc.gov.cn/) and (2) Shanghai Pujiang Program (No. 11PJC044, http://www.stcsm.gov.cn/gk/ywgz/bssx/kyjh/76.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barone P., 2012, NEURAL BASES MULTISE; Blau V, 2009, CURR BIOL, V19, P503, DOI 10.1016/j.cub.2009.01.065; Cappe C, 2009, CEREB CORTEX, V19, P2025, DOI 10.1093/cercor/bhn228; Chiu YC, 2011, J COGNITIVE NEUROSCI, V23, P1198, DOI 10.1162/jocn.2010.21503; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GATTASS R, 1979, BRAIN RES, V160, P413, DOI 10.1016/0006-8993(79)91070-9; Glahn DC, 2002, NEUROIMAGE, V17, P201, DOI 10.1006/nimg.2002.1161; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hill SK, 2010, PSYCHOL MED, V40, P1979, DOI 10.1017/S003329171000019X; Komura Y, 2005, NAT NEUROSCI, V8, P1203, DOI 10.1038/nn1528; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Meck WH, 2013, BEHAV NEUROSCI, V127, P655, DOI 10.1037/a0034188; Mohr HM, 2006, J NEUROSCI, V26, P4465, DOI 10.1523/JNEUROSCI.5232-05.2006; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; Moran RJ, 2008, EUR J NEUROSCI, V27, P2303, DOI 10.1111/j.1460-9568.2008.06187.x; Nakashita S, 2008, BRAIN RES BULL, V75, P513, DOI 10.1016/j.brainresbull.2007.09.004; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Ramirez S, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00226; Sherman SM, 2011, J NEUROPHYSIOL, V106, P1068, DOI 10.1152/jn.00429.2011; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Tanabe HC, 2005, J NEUROSCI, V25, P6409, DOI 10.1523/JNEUROSCI.0636-05.2005; Travis SG, 2014, NEUROPSYCHOLOGIA, V53, P233, DOI 10.1016/j.neuropsychologia.2013.11.016; Viaene AN, 2011, J NEUROPHYSIOL, V105, P279, DOI 10.1152/jn.00747.2010; Wang LP, 2012, J COGNITIVE NEUROSCI, V24, P664, DOI 10.1162/jocn_a_00169; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Woolgar A, 2011, NEUROIMAGE, V56, P744, DOI 10.1016/j.neuroimage.2010.04.035; YIRMIYA R, 1987, BRAIN RES, V402, P93, DOI 10.1016/0006-8993(87)91051-1; Zangenehpour S, 2010, NEUROPSYCHOLOGIA, V48, P591, DOI 10.1016/j.neuropsychologia.2009.10.022	42	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103991	10.1371/journal.pone.0103991	http://dx.doi.org/10.1371/journal.pone.0103991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090230	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700073
J	Vassilopoulos, A; Tominaga, Y; Kim, HS; Lahusen, T; Li, B; Yu, H; Gius, D; Deng, CX				Vassilopoulos, A.; Tominaga, Y.; Kim, H-Seok; Lahusen, T.; Li, B.; Yu, H.; Gius, D.; Deng, C-X			WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis	ONCOGENE			English	Article							CELL-CYCLE CHECKPOINTS; DNA-DAMAGING AGENTS; FISSION YEAST; TYROSINE KINASE; CDC25 PROTEIN; MITOTIC INHIBITOR; G(2) CHECKPOINT; GENE DELETION; CANCER; P53	The tyrosine kinase WEE1 controls the timing of entry into mitosis in eukaryotes and its genetic deletion leads to pre-implantation lethality in mice. Here, we show that besides the premature mitotic entry phenotype, Wee1 mutant murine cells fail to complete mitosis properly and exhibit several additional defects that contribute to the deregulation of mitosis, allowing mutant cells to progress through mitosis at the expense of genomic integrity. WEE1 interacts with the anaphase promoting complex, functioning as a negative regulator, and the deletion of Wee1 results in hyper-activation of this complex. Mammary specific knockout mice overcome the DNA damage response pathway triggered by the mis-coordination of the cell cycle in mammary epithelial cells and heterozygote mice spontaneously develop mammary tumors. Thus, WEE1 functions as a haploinsufficient tumor suppressor that coordinates distinct cell division events to allow correct segregation of genetic information into daughter cells and maintain genome integrity.	[Vassilopoulos, A.; Tominaga, Y.; Kim, H-Seok; Lahusen, T.; Deng, C-X] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Vassilopoulos, A.; Gius, D.] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA; [Kim, H-Seok] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Li, B.; Yu, H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Northwestern University; Feinberg School of Medicine; Ewha Womans University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10 Room 9N105, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016		NIDDK; NCI [1R01CA152601-01]; DOD [BC093803]; SPORE [P50CA98131]; Hirshberg Foundation for Pancreatic Cancer Research Seed Grant Award; CCR, NIH; NATIONAL CANCER INSTITUTE [R01CA152799, P50CA098131, R01CA168292, R01CA152601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056009] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); SPORE; Hirshberg Foundation for Pancreatic Cancer Research Seed Grant Award; CCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the critical reading and helpful discussion of members of the Deng laboratory. This work was supported in part by the Intramural Research Program of the NIDDK, NCI and CCR, NIH. DG is supported by 1R01CA152601-01 from the NCI, BC093803 from the DOD, SPORE P50CA98131 and a Hirshberg Foundation for Pancreatic Cancer Research Seed Grant Award. Melissa Stauffer, PhD, of Scientific Editing Solutions, provided editorial assistance.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dine J, 2013, CANCER METAST REV, V32, P25, DOI 10.1007/s10555-012-9403-7; Dixon H, 2002, CELL CYCLE, V1, P362, DOI 10.4161/cc.1.6.257; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Hirai H, 2010, CANCER BIOL THER, V9, P514, DOI 10.4161/cbt.9.7.11115; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Li M, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-2; Lianga N, 2013, J CELL BIOL, V201, P843, DOI 10.1083/jcb.201212038; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1995, P NATL ACAD SCI USA, V92, P9638, DOI 10.1073/pnas.92.21.9638; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pines J, 2009, MOL CELL, V34, P135, DOI 10.1016/j.molcel.2009.04.006; PosthumaDeBoer J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-156; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Robinson GW, 2011, ANAL BIOCHEM, V412, P92, DOI 10.1016/j.ab.2011.01.020; Saeki T, 2009, INT J BIOL SCI, V5, P722; Schmit TL, 2009, CELL CYCLE, V8, P2697, DOI 10.4161/cc.8.17.9413; Simanski S, 2010, IDENTIFICATION SMALL; Simpson-Lavy KJ, 2010, CELL CYCLE, V9, P3046, DOI [10.4161/cc..9.115.12457, 10.4161/cc.9.115.12457]; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Stumpff J, 2005, CURR BIOL, V15, P1525, DOI 10.1016/j.cub.2005.07.031; THURIAUX P, 1978, MOL GEN GENET, V161, P215, DOI 10.1007/BF00274190; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Tominaga Y, 2006, INT J BIOL SCI, V2, P161; Towler WI, 2013, HUM MUTAT, V34, P439, DOI 10.1002/humu.22251; Trovesi C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002263; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Wang YL, 2001, CANCER RES, V61, P8211	59	19	21	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3023	3035		10.1038/onc.2014.239	http://dx.doi.org/10.1038/onc.2014.239			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25088202	Green Accepted			2022-12-25	WOS:000356100500008
J	Wei, F; Ojo, D; Lin, X; Wong, N; He, L; Yan, J; Xu, S; Major, P; Tang, D				Wei, F.; Ojo, D.; Lin, X.; Wong, N.; He, L.; Yan, J.; Xu, S.; Major, P.; Tang, D.			BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; CELL SELF-RENEWAL; POLYCOMB GROUP PROTEINS; MYC TRANSGENIC MICE; GROUP GENE BMI1; GENOMIC INSTABILITY; MOLECULAR MARKER; PROSTATE-CANCER; HISTONE H2AX	The BMI1 protein contributes to stem cell pluripotency and oncogenesis via multiple functions, including its newly identified role in DNA damage response (DDR). Although evidence clearly demonstrates that BMI1 facilitates the repair of double-stranded breaks via homologous recombination (HR), it remains unclear how BMI1 regulates checkpoint activation during DDR. We report here that BMI1 has a role in G2/M checkpoint activation in response to etoposide (ETOP) treatment. Ectopic expression of BMI1 in MCF7 breast cancer and DU145 prostate cancer cells significantly reduced ETOP-induced G2/M arrest. Conversely, knockdown of BMI1 in both lines enhanced the arrest. Consistent with ETOP-induced activation of the G2/M checkpoints via the ATM pathway, overexpression and knockdown of BMI1, respectively, reduced and enhanced ETOP-induced phosphorylation of ATM at serine 1981 (ATM pS1981). Furthermore, the phosphorylation of ATM targets, including gamma H2AX, threonine 68 (T68) on CHK2 (CHK2 pT68) and serine 15 (S15) on p53 were decreased in overexpression and increased in knockdown BMI1 cells in response to ETOP. In line with the requirement of NBS1 in ATM activation, we were able to show that BMI1 associates with NBS1 and that this interaction altered the binding of NBS1 with ATM. BMI1 consists of a ring finger (RF), helix-turn-helix-turn-helix-turn (HT), proline/serine (PS) domain and two nuclear localization signals (NLS). Although deletion of either RF or HT did not affect the association of BMI1 with NBS1, the individual deletions of PS and one NLS (KRMK) robustly reduced the interaction. Stable expression of these BMI1 mutants decreased ETOP-induced ATM pS1981 and CHK2 pT68, but not ETOP-elicited gamma H2AX in MCF7 cells. Furthermore, ectopic expression of BMI1 in non-transformed breast epithelial MCF10A cells also compromised ETOP-initiated ATM pS1981 and gamma H2AX. Taken together, we provide compelling evidence that BMI1 decreases ETOP-induced G2/M checkpoint activation via reducing NBS1-mediated ATM activation.	[Wei, F.; Ojo, D.; Lin, X.; Wong, N.; He, L.; Yan, J.; Xu, S.; Tang, D.] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [Wei, F.; Ojo, D.; Lin, X.; Wong, N.; He, L.; Yan, J.; Xu, S.; Tang, D.] Father Sean OSullivan Res Inst, Hamilton, ON, Canada; [Wei, F.; Ojo, D.; Lin, X.; Wong, N.; He, L.; Yan, J.; Xu, S.; Tang, D.] St Josephs Hosp, Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada; [Wei, F.] Inst Women & Childrens Hlth, Genet Lab, Shenzhen, Guangdong, Peoples R China; [He, L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Major, P.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University; Harvard University; Harvard Medical School; Massachusetts General Hospital; McMaster University	Tang, D (corresponding author), St Josephs Hosp, Father Sean OSullivan Res Inst, T3310,50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada.	damut@mcmaster.ca	Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521	CIHR grant [MOP-84381]	CIHR grant(Canadian Institutes of Health Research (CIHR))	This work was supported by a CIHR grant (MOP-84381) to D Tang.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bea S, 2001, CANCER RES, V61, P2409; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Cohen KJ, 1996, MOL CELL BIOL, V16, P5527; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dong QH, 2011, J INVEST DERMATOL, V131, P1216, DOI 10.1038/jid.2011.11; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Gieni RS, 2011, CELL CYCLE, V10, P883, DOI 10.4161/cc.10.6.14907; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HAUPT Y, 1993, ONCOGENE, V8, P3161; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu ZG, 2012, ONCOL REP, V27, P1116, DOI 10.3892/or.2011.1615; Mihara K, 2006, BLOOD, V107, P305, DOI 10.1182/blood-2005-06-2393; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; QUELLE DE, 1995, CELL, V83, P993; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Tang D, 2001, J BIOL CHEM, V276, P30461, DOI 10.1074/jbc.M102045200; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; van Galen JC, 2007, J CLIN PATHOL, V60, P167, DOI 10.1136/jcp.2006.038752; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei FX, 2010, CELL SIGNAL, V22, P1783, DOI 10.1016/j.cellsig.2010.07.007; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	64	21	23	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					3063	3075		10.1038/onc.2014.235	http://dx.doi.org/10.1038/onc.2014.235			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25088203				2022-12-25	WOS:000356100500011
J	Jayakar, SS; Zhou, XJ; Chiara, DC; Dostalova, Z; Savechenkov, PY; Bruzik, KS; Dailey, WP; Miller, KW; Eckenhoff, RG; Cohen, JB				Jayakar, Selwyn S.; Zhou, Xiaojuan; Chiara, David C.; Dostalova, Zuzana; Savechenkov, Pavel Y.; Bruzik, Karol S.; Dailey, William P.; Miller, Keith W.; Eckenhoff, Roderic G.; Cohen, Jonathan B.			Multiple Propofol-binding Sites in a gamma-Aminobutyric Acid Type A Receptor (GABA(A)R) Identified Using a Photoreactive Propofol Analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anesthesia; GABA Receptor; Nicotinic Acetylcholine Receptors (nAChR); Photoaffinity Labeling; Protein Drug Interaction; General Anesthetics; Propofol	NICOTINIC ACETYLCHOLINE-RECEPTOR; GENERAL ANESTHETIC ETOMIDATE; GATED ION CHANNELS; AMINO-ACID; SUBUNIT INTERFACES; LOOP; CHOLESTEROL; BARBITURATE; SENSITIVITY; MODULATION	Background: Propofol binding to GABA(A)R sites of uncertain location potentiates receptor function and produces anesthesia in vivo. Results: A photoreactive propofol analog identifies propofol-binding sites in 13 GABA(A)Rs. Conclusion: Propofol binds to each class of intersubunit sites in the GABA(A)R transmembrane domain. Significance: This study demonstrates that propofol binds to the same sites in a GABA(A)R as etomidate and barbiturates. Propofol acts as a positive allosteric modulator of -aminobutyric acid type A receptors (GABA(A)Rs), an interaction necessary for its anesthetic potency in vivo as a general anesthetic. Identifying the location of propofol-binding sites is necessary to understand its mechanism of GABA(A)R modulation. [H-3]2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(phenylethyl)-1H-imidazole-5-carboxylate (azietomidate) and R-[H-3]5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl)barbituric acid (mTFD-MPAB), photoreactive analogs of 2-ethyl 1-(phenylethyl)-1H-imidazole-5-carboxylate (etomidate) and mephobarbital, respectively, have identified two homologous but pharmacologically distinct classes of intersubunit-binding sites for general anesthetics in the GABA(A)R transmembrane domain. Here, we use a photoreactive analog of propofol (2-isopropyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenol ([H-3]AziPm)) to identify propofol-binding sites in heterologously expressed human 13 GABA(A)Rs. Propofol, AziPm, etomidate, and R-mTFD-MPAB each inhibited [H-3]AziPm photoincorporation into GABA(A)R subunits maximally by approximate to 50%. When the amino acids photolabeled by [H-3]AziPm were identified by protein microsequencing, we found propofol-inhibitable photolabeling of amino acids in the 3-1 subunit interface (3Met-286 in 3M3 and 1Met-236 in 1M1), previously photolabeled by [H-3]azietomidate, and 1Ile-239, located one helical turn below 1Met-236. There was also propofol-inhibitable [H-3]AziPm photolabeling of 3Met-227 in M1, the amino acid in the 1-3 subunit interface photolabeled by R-[H-3]mTFD-MPAB. The propofol-inhibitable [H-3]AziPm photolabeling in the GABA(A)R 3 subunit in conjunction with the concentration dependence of inhibition of that photolabeling by etomidate or R-mTFD-MPAB also establish that each anesthetic binds to the homologous site at the 3-3 subunit interface. These results establish that AziPm as well as propofol bind to the homologous intersubunit sites in the GABA(A)R transmembrane domain that binds etomidate or R-mTFD-MPAB with high affinity.	[Jayakar, Selwyn S.; Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Dostalova, Zuzana; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA; [Dailey, William P.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408; Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health, USPHS [GM-58448, GM-55876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-58448 (to J. B. C., K. S. B., and K. W. M.) and GM-55876 (to R. G. E.) from USPHS.	Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2012, J BIOL CHEM, V287, P27762, DOI 10.1074/jbc.M112.363341; Bayley H, 1983, PHOTOREGENERATED REA, P40; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bertaccini EJ, 2013, ANESTHESIOLOGY, V119, P1087, DOI 10.1097/ALN.0b013e31829e47e3; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BRISTOW DR, 1987, J NEUROCHEM, V49, P1386, DOI 10.1111/j.1471-4159.1987.tb01004.x; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; Chiara DC, 2014, BIOCHEMISTRY-US, V53, P135, DOI 10.1021/bi401492k; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; da Silva G, 2007, J PHYS CHEM A, V111, P7987, DOI 10.1021/jp073335c; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; DUNN SMJ, 1989, BIOCHEMISTRY-US, V28, P2545, DOI 10.1021/bi00432a030; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Modica E, 2001, J ORG CHEM, V66, P41, DOI 10.1021/jo0006627; Moraga-Cid G, 2011, ANESTHESIOLOGY, V115, P464, DOI 10.1097/ALN.0b013e31822550f7; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Richardson JE, 2007, ANESTHESIOLOGY, V107, P412, DOI 10.1097/01.anes.0000278875.36639.2c; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sooksawate T, 2001, BRIT J PHARMACOL, V134, P1303, DOI 10.1038/sj.bjp.0704360; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Yip GMS, 2013, NAT CHEM BIOL, V9, P715, DOI [10.1038/NCHEMBIO.1340, 10.1038/nchembio.1340]; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	46	90	91	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27456	27468		10.1074/jbc.M114.581728	http://dx.doi.org/10.1074/jbc.M114.581728			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25086038	hybrid, Green Published			2022-12-25	WOS:000342852800009
J	Rothlein, C; Miettinen, MS; Borwankar, T; Burger, J; Mielke, T; Kumke, MU; Ignatova, Z				Roethlein, Christoph; Miettinen, Markus S.; Borwankar, Tejas; Buerger, Joerg; Mielke, Thorsten; Kumke, Michael U.; Ignatova, Zoya			Architecture of Polyglutamine-containing Fibrils from Time-resolved Fluorescence Decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; AMYLOID FORMATION; MAMMALIAN-CELLS; STERIC ZIPPERS; AGGREGATION; DISEASE; ORGANIZATION; PROTEIN; MODEL; FRET	The disease risk and age of onset of Huntington disease (HD) and nine other repeat disorders strongly depend on the expansion of CAG repeats encoding consecutive polyglutamines (polyQ) in the corresponding disease protein. PolyQ length-dependent misfolding and aggregation are the hallmarks of CAG pathologies. Despite intense effort, the overall structure of these aggregates remains poorly understood. Here, we used sensitive time-dependent fluorescent decay measurements to assess the architecture of mature fibrils of huntingtin (Htt) exon 1 implicated in HD pathology. Varying the position of the fluorescent labels in the Htt monomer with expanded 51Q (Htt51Q) and using structural models of putative fibril structures, we generated distance distributions between donors and acceptors covering all possible distances between the monomers or monomer dimensions within the polyQ amyloid fibril. Using Monte Carlo simulations, we systematically scanned all possible monomer conformations that fit the experimentally measured decay times. Monomers with four-stranded 51Q stretches organized into five-layered beta-sheets with alternating N termini of the monomers perpendicular to the fibril axis gave the best fit to our data. Alternatively, the core structure of the polyQ fibrils might also be a zipper layer with antiparallel four-stranded stretches as this structure showed the next best fit. All other remaining arrangements are clearly excluded by the data. Furthermore, the assessed dimensions of the polyQ stretch of each monomer provide structural evidence for the observed polyQ length threshold in HD pathology. Our approach can be used to validate the effect of pharmacological substances that inhibit or alter amyloid growth and structure.	[Roethlein, Christoph; Borwankar, Tejas; Ignatova, Zoya] Univ Potsdam, Inst Biochem & Biol, D-14467 Potsdam, Germany; [Kumke, Michael U.] Univ Potsdam, Inst Chem, D-14467 Potsdam, Germany; [Miettinen, Markus S.] Free Univ Berlin, Inst Theoret Phys, Dept Theory Biol Soft Matter Syst, D-14195 Berlin, Germany; [Buerger, Joerg] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Potsdam; University of Potsdam; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Rothlein, C (corresponding author), Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14467 Potsdam, Germany.	roethch@uni-potsdam.de; ignatova@uni-potsdam.de	Miettinen, Markus S./A-2214-2013	Miettinen, Markus S./0000-0002-3999-4722; Ignatova, Zoya/0000-0002-9478-8825; Burger, Jorg/0000-0002-4326-5047; Kumke, Michael/0000-0002-3395-9379				Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Borwankar T, 2011, BIOCHEMISTRY-US, V50, P2048, DOI 10.1021/bi1018368; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Corry B, 2005, BIOPHYS J, V89, P3822, DOI 10.1529/biophysj.105.069351; De Los Rios P, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/244105; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Frederix PLTM, 2002, J PHYS CHEM B, V106, P6793, DOI 10.1021/jp014549b; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kar K, 2013, J MOL BIOL, V425, P1183, DOI 10.1016/j.jmb.2013.01.016; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943; Miettinen MS, 2014, BIOPHYS J, V106, P1721, DOI 10.1016/j.bpj.2014.02.027; Miettinen MS, 2012, J PHYS CHEM B, V116, P10259, DOI 10.1021/jp305065c; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tanaka M, 2005, J MOL MED, V83, P343, DOI 10.1007/s00109-004-0632-2; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zanuy D, 2006, J MOL BIOL, V358, P330, DOI 10.1016/j.jmb.2006.01.070; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013	37	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26817	26828		10.1074/jbc.M114.581991	http://dx.doi.org/10.1074/jbc.M114.581991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25092288	Green Published, hybrid			2022-12-25	WOS:000342853900014
J	Rahman, M; Lovat, F; Romano, G; Calore, F; Acunzo, M; Bell, EH; Nana-Sinkam, P				Rahman, Mohammad; Lovat, Francesca; Romano, Giulia; Calore, Federica; Acunzo, Mario; Bell, Erica Hlavin; Nana-Sinkam, Patrick			miR-15b/16-2 Regulates Factors That Promote p53 Phosphorylation and Augments the DNA Damage Response following Radiation in the Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; IONIZING-RADIATION; CANCER; MICRORNA; TUMOR; PROLIFERATION; MIR-16; WIP1	MicroRNAs (miRNAs) are regulatory RNAs frequently dysregulated in disease and following cellular stress. Investigators have described changes in miR-15b expression following exposure to several stress-inducing anticancer agents, including ionizing radiation (IR), etoposide, and hydrogen peroxide. However, the role for miR-15b as a mediator of cellular injury in organs such as the lung has yet to be explored. In this study, we examined miR-15b expression patterns as well as its potential role in DNA damage and repair in the setting of IR exposure. We showed that miR-15b is up-regulated in a dose-and time-dependent manner in human bronchial epithelial cells following IR. miR-15b expression was highest after 2 h of IR and decreased gradually. Survival rates following IR were also higher in miR-15b/16-2-overexpressing cells. Cell cycle arrest in G(2)/M phase and an increased DNA repair response were observed in IR-exposed miR-15b/16-2 stable cells. We observed an up-regulation of components of the ataxia telangiectasia mutated (ATM)/Chek1/p53 pathway in miR-15b/16-2-overexpressing cells after IR. Moreover, a pathway-based PCR expression array of genes demonstrated that miR-15b/16-2 overexpression significantly induced the expression of genes involved in ATM/ataxia telangiectasia and Rad-3-related (ATR) signaling, apoptosis, the cell cycle, and DNA repair pathways. Here we demonstrated a novel biological link between miR-15b and DNA damage and cellular protection in lung cells. We identified Wip1 (PPM1D) as a functional target for miR-15b and determined that miR-15b induction of the DNA damage response is partially dependent upon suppression of Wip1. Our study suggests that miR-15b/Wip1 could be a potential therapeutic target in radiation-induced lung disease.	[Rahman, Mohammad; Nana-Sinkam, Patrick] Ohio State Univ, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Lovat, Francesca; Romano, Giulia; Calore, Federica; Acunzo, Mario] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Bell, Erica Hlavin] Ohio State Univ, Dept Radiat Oncol, Columbus, OH 43210 USA; [Bell, Erica Hlavin; Nana-Sinkam, Patrick] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Nana-Sinkam, P (corresponding author), Ohio State Univ, Coll Med, Div Pulm Allergy Crit Care & Sleep Med, 460 W 12th Ave, Columbus, OH 43210 USA.	patrick.nana-sinkam@osumc.edu	Bell, Erica/J-2950-2015; Acunzo, Mario/ABE-1739-2020	Acunzo, Mario/0000-0002-3942-9061				Chang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054117; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Choi DW, 2013, MOL CELL, V51, P374, DOI 10.1016/j.molcel.2013.06.010; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Crescenzi E, 2013, J BIOL CHEM, V288, P16212, DOI 10.1074/jbc.M112.435149; DAVIS SD, 1992, AM J ROENTGENOL, V159, P1157, DOI 10.2214/ajr.159.6.1442375; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Lautenschlaeger T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-246; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; Ma JL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/794249; Maas C, 2011, ONCOGENE, V30, P3636, DOI 10.1038/onc.2011.75; Martin NT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003505; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Ohta N., 2014, CASE REP OTOLARYNGOL, V2014, P1; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Ouyang WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-491; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Sperk E, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-154; Sugawara K, 2014, RARE TUMORS, V6, P36, DOI 10.4081/rt.2014.5177; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xia LQ, 2004, CANCER RES, V64, P221, DOI 10.1158/0008-5472.CAN-03-0969; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu YY, 2013, FEBS J, V280, P3768, DOI 10.1111/febs.12365; Yamamura S, 2012, CARCINOGENESIS, V33, P294, DOI 10.1093/carcin/bgr286; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3	33	49	53	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26406	26416		10.1074/jbc.M114.573592	http://dx.doi.org/10.1074/jbc.M114.573592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092292	hybrid, Green Published			2022-12-25	WOS:000342128800032
J	Andresen, H; Strasser, M; van der Meer, J				Andresen, Henrike; Strasser, Matthias; van der Meer, Jaap			Estimation of Density-Dependent Mortality of Juvenile Bivalves in the Wadden Sea	PLOS ONE			English	Article							MACOMA-BALTHICA; SEVERE WINTER; LONG-TERM; OBSERVATION ERROR; PROCESS NOISE; TIDAL FLATS; RECRUITMENT; POPULATION; LIMITATION; SCALE	We investigated density-dependent mortality within the early months of life of the bivalves Macoma balthica (Baltic tellin) and Cerastoderma edule (common cockle) in the Wadden Sea. Mortality is thought to be density-dependent in juvenile bivalves, because there is no proportional relationship between the size of the reproductive adult stocks and the numbers of recruits for both species. It is not known however, when exactly density dependence in the pre-recruitment phase occurs and how prevalent it is. The magnitude of recruitment determines year class strength in bivalves. Thus, understanding pre-recruit mortality will improve the understanding of population dynamics. We analyzed count data from three years of temporal sampling during the first months after bivalve settlement at ten transects in the Sylt-Romo-Bay in the northern German Wadden Sea. Analyses of density dependence are sensitive to bias through measurement error. Measurement error was estimated by bootstrapping, and residual deviances were adjusted by adding process error. With simulations the effect of these two types of error on the estimate of the density-dependent mortality coefficient was investigated. In three out of eight time intervals density dependence was detected for M. balthica, and in zero out of six time intervals for C. edule. Biological or environmental stochastic processes dominated over density dependence at the investigated scale.	[Andresen, Henrike; van der Meer, Jaap] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Netherlands; [Strasser, Matthias] Alfred Wegener Inst, Div Coastal Ecol, Wadden Sea Stn Sylt, List Auf Sylt, Germany; [van der Meer, Jaap] Vrije Univ Amsterdam, Dept Theoret Biol, Amsterdam, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Vrije Universiteit Amsterdam	Andresen, H (corresponding author), Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Netherlands.	henrikea@gmx.de	Andresen, Henrike/C-3977-2017		Netherlands Organization for Scientific Research (NWO); Netherlands-Bremen Oceanography II (NEBROC)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands-Bremen Oceanography II (NEBROC)	This research was funded by the Netherlands Organization for Scientific Research (NWO) and Netherlands-Bremen Oceanography II (NEBROC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen H, 2013, THESIS VU U AMSTERDA; BEUKEMA JJ, 1982, NETH J SEA RES, V16, P37, DOI 10.1016/0077-7579(82)90015-1; Beukema JJ, 1996, ICES J MAR SCI, V53, P964, DOI 10.1006/jmsc.1996.0119; BEVERTON RJH, 1992, NETH J SEA RES, V29, P61, DOI 10.1016/0077-7579(92)90008-3; Bos OG, 2005, THESIS U GRONINGEN; Bos OG, 2007, MAR ECOL PROG SER, V330, P155, DOI 10.3354/meps330155; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Dekker R, 2007, MAR ECOL PROG SER, V337, P117, DOI 10.3354/meps337117; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Forrester GE, 2008, ECOLOGY, V89, P2980, DOI 10.1890/07-1546.1; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Fuiman L.A., 2002, FISHERY SCI UNIQUE C; Gascoigne J, 2004, MAR ECOL PROG SER, V269, P49, DOI 10.3354/meps269049; Hewitt JE, 1997, J EXP MAR BIOL ECOL, V216, P77, DOI 10.1016/S0022-0981(97)00091-9; Hiddink JG, 2002, MAR BIOL, V140, P1149, DOI 10.1007/s00227-002-0794-9; Hiddink JG, 2002, THESIS U GRONINGEN; KAMERMANS P, 1992, J EXP MAR BIOL ECOL, V162, P113, DOI 10.1016/0022-0981(92)90127-V; Kammermans P, 1994, MAR ECOL PROG SER, V104, P63; Kraan C, 2009, MAR ECOL PROG SER, V383, P211, DOI 10.3354/meps07994; LEVINTON J, 1972, AM NAT, V106, P472, DOI 10.1086/282788; Luttikhuizen PC, 2011, J EXP MAR BIOL ECOL, V396, P156, DOI 10.1016/j.jembe.2010.10.017; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; OLAFSSON EB, 1986, J ANIM ECOL, V55, P517, DOI 10.2307/4735; Planes S, 1998, OIKOS, V83, P293, DOI 10.2307/3546840; Powers SP, 2000, LIMNOL OCEANOGR, V45, P727, DOI 10.4319/lo.2000.45.3.0727; Ruesink JL, 2000, ECOLOGY, V81, P3377; Sale PF, 2000, OECOLOGIA, V124, P166, DOI 10.1007/s004420050003; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; STEWARTOATEN A, 1990, J ANIM ECOL, V59, P1027, DOI 10.2307/5029; Strasser M, 2003, J SEA RES, V49, P47, DOI 10.1016/S1385-1101(02)00198-3; Strasser M, 2002, MAR ECOL PROG SER, V241, P113, DOI 10.3354/meps241113; Strasser M, 2001, J SEA RES, V46, P57, DOI 10.1016/S1385-1101(01)00063-6; Strasser M, 2001, HELGOLAND MAR RES, V55, P182, DOI 10.1007/s101520100080; Strasser M, 2000, THESIS U HAMBURG, P377; TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012; van Beusekom JEE, 2009, J SEA RES, V61, P26, DOI 10.1016/j.seares.2008.06.005; van der Meer J, 2001, ECOL STU AN, V151, P317; Van der Meer J, 2001, J ANIM ECOL, V70, P159, DOI 10.1046/j.1365-2656.2001.00469.x; van der Veer HW, 2000, MAR ECOL PROG SER, V199, P255, DOI 10.3354/meps199255; van Gils JA, 2009, BIOL LETTERS, V5, P5, DOI 10.1098/rsbl.2008.0452	43	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e102491	10.1371/journal.pone.0102491	http://dx.doi.org/10.1371/journal.pone.0102491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105293	Green Published, gold			2022-12-25	WOS:000343231900005
J	Zhou, X; Wu, XC; An, YY; Fu, F				Zhou, Xiao; Wu, Xinchun; An, Yuanyuan; Fu, Fang			Longitudinal Relationships between Posttraumatic Stress Symptoms and Sleep Problems in Adolescent Survivors following the Wenchuan Earthquake in China	PLOS ONE			English	Article							ATTEMPTED THOUGHT SUPPRESSION; EXPOSURE THERAPY; PTSD SYMPTOMS; REM-SLEEP; DISORDER; CHILDREN; INSOMNIA; QUALITY; PSYCHOPATHOLOGY; VALIDATION	Purpose: To examine the longitudinal relationships between Posttraumatic Stress Disorder (PTSD) and sleep problems among adolescent survivors in the Wenchuan earthquake, China. Methods: 350 adolescent survivors were randomly selected from several primary and secondary schools in the counties of Wenchuan and Maoxian, the two areas most severely affected by the Wenchuan earthquake. Participants completed Revised Child PTSD Symptom Scale and Sleep Problems Subscale of Self-generated Child Behavior Problems Questionnaire at one year (T1), one-and-a-half years (T2), two years (T3) after the earthquake, respectively. Results: There was a bidirectional relationship between intrusive symptom clusters of PTSD and sleep problems from T1 to T2, and this relationship became non-significant from T2 to T3. There was a one-way predictive relationship of avoidance symptom clusters of PTSD onto sleep problems from T1 to T3. The hyperarousal symptom clusters of PTSD had effects on sleep problems from T1 to T2 but not from T2 to T3, while sleep problems have no significant effect on hyperarousal symptom clusters of PTSD from T1 to T3. In addition, the relationships between three symptom clusters of PTSD and sleep problems weakened with time change. Conclusions: From 1 year to 1.5 years after the earthquake, all the three symptom clusters of PTSD could be important predictive factors for the development and maintenance of sleep problems, while sleep problems could only be risk factors for the intrusive symptom clusters of PTSD. From 1.5 years to 2 years, only the avoidance symptom clusters of PTSD were risk factors for sleep problems, and sleep problems had no significant effects on any symptom clusters of PTSD. Overall, the relationship between PTSD and sleep problems weakened with time change.	[Zhou, Xiao; Wu, Xinchun] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [An, Yuanyuan] Nanjing Normal Univ, Sch Psychol, Nanjing, Jiangsu, Peoples R China; [Fu, Fang] Fudan Univ, Sch Social Dev & Publ Policy, Shanghai 200433, Peoples R China	Beijing Normal University; Nanjing Normal University; Fudan University	Wu, XC (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	xcwu@bnu.edu.cn			Ministry of Education, China [11JJD190006]	Ministry of Education, China(Ministry of Education, China)	Supported was provided by the "Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China (Grant No. 11JJD190006). http://www.sinoss.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amir M, 1997, PERS INDIV DIFFER, V23, P399, DOI 10.1016/S0191-8869(97)80005-0; Arbuckle J. L., 2006, AMOS 7 0; Babson K, 2011, J ANXIETY DISORD, V25, P706, DOI 10.1016/j.janxdis.2011.03.007; Babson KA, 2012, J TRAUMA STRESS, V25, P503, DOI 10.1002/jts.21739; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Bader K, 2007, SOMNOLOGIE, V11, P101, DOI [10.1007/s11818-007-0299-3, DOI 10.1007/S11818-007-0299-3]; Badour CL, 2012, BEHAV RES THER, V50, P610, DOI 10.1016/j.brat.2012.06.006; BRENER ND, 1995, AM J EPIDEMIOL, V141, P575, DOI 10.1093/oxfordjournals.aje.a117473; Brown TH, 2011, J TRAUMA STRESS, V24, P575, DOI 10.1002/jts.20680; CARSKADON M A, 1990, Pediatrician, V17, P5; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Charuvastra A, 2009, CHILD ADOL PSYCH CL, V18, P877, DOI 10.1016/j.chc.2009.04.002; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; DAGAN Y, 1991, BIOL PSYCHIAT, V30, P618, DOI 10.1016/0006-3223(91)90031-G; Dahl RE, 1996, DEV PSYCHOPATHOL, V8, P3, DOI 10.1017/S0954579400006945; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Foa EB, 1998, PSYCHOL ASSESSMENT, V10, P206, DOI 10.1037/1040-3590.10.3.206; Foa EB., 1998, TREATING TRAUMA RAPE; Germain A, 2004, J TRAUMA STRESS, V17, P477, DOI 10.1007/s10960-004-5796-6; Halper JMD, 2008, EXCEPTIONAL PARENT; Harvey AG, 1998, BEHAV RES THER, V36, P583, DOI 10.1016/S0005-7967(98)00052-7; Harvey AG, 2003, CLIN PSYCHOL REV, V23, P377, DOI 10.1016/S0272-7358(03)00032-1; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Harvey AG, 1999, COGNITIVE THER RES, V23, P39, DOI 10.1023/A:1018758623889; Huntley ED, 2014, J TRAUMA STRESS, V27, P103, DOI 10.1002/jts.21882; Iwadare Y, 2014, SLEEP BIOL RHYTHMS, V12, P53, DOI 10.1111/sbr.12047; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Kovachy B, 2013, J CLIN SLEEP MED, V9, P503, DOI 10.5664/jcsm.2678; Krakow B, 2001, J TRAUMA STRESS, V14, P647, DOI 10.1023/A:1013029819358; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Mellman TA, 1997, ANN NY ACAD SCI, V821, P142, DOI 10.1111/j.1749-6632.1997.tb48275.x; Mellman TA, 2008, SLEEP MED REV, V12, P165, DOI 10.1016/j.smrv.2008.02.001; Mellman TA, 2007, J TRAUMA STRESS, V20, P893, DOI 10.1002/jts.20246; Pillar G, 2000, SLEEP MED REV, V4, P183, DOI 10.1053/smrv.1999.0095; Rothbaum BO, 2001, J TRAUMA STRESS, V14, P481, DOI 10.1023/A:1011104521887; Schneier FR, 2012, AM J PSYCHIAT, V169, P80, DOI 10.1176/appi.ajp.2011.11020321; SOUTHWICK SM, 1994, PSYCHIAT CLIN N AM, V17, P251; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Taylor S., 2009, CLIN GUIDE PTSD COGN; Tull MT, 2007, ANXIETY STRESS COPIN, V20, P337, DOI 10.1080/10615800701379249; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; [温忠麟 Wen Zhonglin], 2004, [心理学报, Acta Psychologica Sinica], V36, P186; Wittmann L, 2010, J TRAUMA STRESS, V23, P232, DOI 10.1002/jts.20514; WOODWARD SH, 2000, SLEEP, V23, P356; Zeng EJ, 2011, SCHOOL PSYCHOL INT, V32, P498, DOI 10.1177/0143034311402921	47	24	24	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104470	10.1371/journal.pone.0104470	http://dx.doi.org/10.1371/journal.pone.0104470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR0CG	25105288	Green Published, gold, Green Submitted			2022-12-25	WOS:000343231900061
J	Huang, QY; Swatantran, A; Dubayah, R; Goetz, SJ				Huang, Qiongyu; Swatantran, Anu; Dubayah, Ralph; Goetz, Scott J.			The Influence of Vegetation Height Heterogeneity on Forest and Woodland Bird Species Richness across the United States	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; HABITAT HETEROGENEITY; AVIAN BIODIVERSITY; SCALE PATTERNS; IMAGE TEXTURE; ENERGY; POPULATION; FRAGMENTATION; DISTRIBUTIONS; PRODUCTIVITY	Avian diversity is under increasing pressures. It is thus critical to understand the ecological variables that contribute to large scale spatial distribution of avian species diversity. Traditionally, studies have relied primarily on two-dimensional habitat structure to model broad scale species richness. Vegetation vertical structure is increasingly used at local scales. However, the spatial arrangement of vegetation height has never been taken into consideration. Our goal was to examine the efficacies of three-dimensional forest structure, particularly the spatial heterogeneity of vegetation height in improving avian richness models across forested ecoregions in the U.S. We developed novel habitat metrics to characterize the spatial arrangement of vegetation height using the National Biomass and Carbon Dataset for the year 2000 (NBCD). The height-structured metrics were compared with other habitat metrics for statistical association with richness of three forest breeding bird guilds across Breeding Bird Survey (BBS) routes: a broadly grouped woodland guild, and two forest breeding guilds with preferences for forest edge and for interior forest. Parametric and non-parametric models were built to examine the improvement of predictability. Height-structured metrics had the strongest associations with species richness, yielding improved predictive ability for the woodland guild richness models (r(2) = similar to 0.53 for the parametric models, 0.63 the non-parametric models) and the forest edge guild models (r(2) = similar to 0.34 for the parametric models, 0.47 the non-parametric models). All but one of the linear models incorporating height-structured metrics showed significantly higher adjusted-r(2) values than their counterparts without additional metrics. The interior forest guild richness showed a consistent low association with height-structured metrics. Our results suggest that height heterogeneity, beyond canopy height alone, supplements habitat characterization and richness models of forest bird species. The metrics and models derived in this study demonstrate practical examples of utilizing three-dimensional vegetation data for improved characterization of spatial patterns in species richness.	[Huang, Qiongyu; Swatantran, Anu; Dubayah, Ralph] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Goetz, Scott J.] Woods Hole Res Ctr, Falmouth, MA USA	University System of Maryland; University of Maryland College Park; Woods Hole Research Center	Huang, QY (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	qhuang@umd.edu	Goetz, Scott J/A-3393-2015; Swatantran, Anu/B-8786-2016	Goetz, Scott J/0000-0002-6326-4308; Huang, Qiongyu/0000-0002-1450-3587	NASA [NNX09AK20G]	NASA(National Aeronautics & Space Administration (NASA))	The research received support from the NASA Applied Sciences programs on Ecological Forecasting and Biological Diversity (http://www.nasa.gov/applied-sciences/eco-forecasting.html) (grant # NNX09AK20G to SJG and RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baatz M., 2003, ECOGNITION USER GUID; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Bailey RG, 1995, DESCRIPITON ECOREGIO; Bergen KM, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000883; Bergen KM, 2007, ECOL INFORM, V2, P9, DOI 10.1016/j.ecoinf.2007.01.001; Biau G, 2012, J MACH LEARN RES, V13, P1063; Boulinier T, 1998, P NATL ACAD SCI USA, V95, P7497, DOI 10.1073/pnas.95.13.7497; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broughton RK, 2006, IBIS, V148, P744, DOI 10.1111/j.1474-919X.2006.00583.x; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Duro D, 2007, PROG PHYS GEOG, V31, P235, DOI 10.1177/0309133307079054; Coburn CA, 2004, INT J REMOTE SENS, V25, P4287, DOI 10.1080/0143116042000192367; Cody M.L, 1974, COMPETITION STRUCTUR; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Culbert PD, 2013, AUK, V130, P656, DOI 10.1525/auk.2013.13007; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Franklin SE, 2000, INT J REMOTE SENS, V21, P61, DOI 10.1080/014311600210993; Gaston K. J., 2004, BIODIVERSITY INTRO; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Goetz SJ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034013; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Griffith EH, 2010, AUK, V127, P387, DOI 10.1525/auk.2009.09056; Griffiths GH, 2000, INT J REMOTE SENS, V21, P2685, DOI 10.1080/01431160050110232; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Helzer CJ, 1999, ECOL APPL, V9, P1448; Hill RA, 2004, INT J REMOTE SENS, V25, P4851, DOI 10.1080/0143116031000139962; Hines JE, 1999, BIRD STUDY, V46, P209; Hinsley SA, 2009, COMMUNITY ECOL, V10, P99, DOI 10.1556/ComEc.10.2009.1.12; Hurlbert AH, 2003, AM NAT, V161, P83, DOI 10.1086/345459; Imhoff ML, 1997, REMOTE SENS ENVIRON, V60, P217, DOI 10.1016/S0034-4257(96)00116-2; Keller CME, 1999, CONDOR, V101, P50, DOI 10.2307/1370445; Kellndorfer J, 2011, NATL BIOMASS CARBON; Kellndorfer JM, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000997; KELLY JP, 1993, CONDOR, V95, P83, DOI 10.2307/1369389; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kerr JT, 2001, P NATL ACAD SCI USA, V98, P11365, DOI 10.1073/pnas.201398398; Kery M, 2004, BASIC APPL ECOL, V5, P65, DOI 10.1078/1439-1791-00194; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MORGAN K, 1985, Canadian Field-Naturalist, V100, P506; North MP, 1999, FOREST SCI, V45, P520; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Phillips LB, 2008, REMOTE SENS ENVIRON, V112, P3538, DOI [10.1016/j.rse.2008.04.012, 10.1016/j.rse.2008.08.002]; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; R Core Team, 2021, R LANG ENV STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; Rittenhouse CD, 2012, CONSERV BIOL, V26, P821, DOI 10.1111/j.1523-1739.2012.01867.x; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; Robbins CS, 1986, BREEDING BIRD SURVEY; ROBINSON SK, 1984, AUK, V101, P672, DOI 10.2307/4086894; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; SAUER JR, 2011, N AM BREEDING BIRD S; Schiewe J., 2002, ISPRS S GEOSP THEOR, V34; Seto KC, 2004, INT J REMOTE SENS, V25, P4309, DOI 10.1080/0143116042000192358; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; STRELKE WK, 1980, J WILDLIFE MANAGE, V44, P559, DOI 10.2307/3808003; Swatantran A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028922; TURNER JRG, 1988, NATURE, V335, P539, DOI 10.1038/335539a0; U.S. Geological Survey, 2012, LIST SPEC GROUP; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Walker WS, 2007, REMOTE SENS ENVIRON, V109, P482, DOI 10.1016/j.rse.2007.02.001; Whitehurst AS, 2013, REMOTE SENS-BASEL, V5, P2014, DOI 10.3390/rs5042014; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zellweger F, 2013, FOREST ECOL MANAG, V307, P303, DOI [10.1016/j.foreco.2013.07.023, 10.1016/j.]	87	32	32	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103236	10.1371/journal.pone.0103236	http://dx.doi.org/10.1371/journal.pone.0103236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101782	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993900015
J	Kim, DS; Wang, Y; Oh, HJ; Lee, K; Hahn, Y				Kim, Dong Seon; Wang, Yao; Oh, Hye Ji; Lee, Kangseok; Hahn, Yoonsoo			Frequent Loss and Alteration of the MOXD2 Gene in Catarrhines and Whales: A Possible Connection with the Evolution of Olfaction	PLOS ONE			English	Article							DOPAMINE-BETA-HYDROXYLASE; GENOME SEQUENCE; MULTIGENE FAMILY; INSIGHTS; VERTEBRATES; COMPONENT; RESOURCE; ACCURACY; PROVIDE; TRPC2	The MOXD2 gene encodes a membrane-bound monooxygenase similar to dopamine-beta-hydroxylase, and has been proposed to be associated with olfaction. In this study, we analyzed MOXD2 genes from 64 mammalian species, and identified loss-of-function mutations in apes (humans, Sumatran and Bornean orangutans, and five gibbon species from the four major gibbon genera), toothed whales (killer whales, bottlenose dolphins, finless porpoises, baijis, and sperm whales), and baleen whales (minke whales and fin whales). We also identified a shared 13-nt deletion in the last exon of Old World cercopithecine monkeys that results in conversion of a membrane-bound protein to a soluble form. We hypothesize that the frequent inactivation and alteration of MOXD2 genes in catarrhines and whales may be associated with the evolution of olfaction in these clades.	[Kim, Dong Seon; Wang, Yao; Oh, Hye Ji; Lee, Kangseok; Hahn, Yoonsoo] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea	Chung Ang University	Hahn, Y (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea.	yoonsoo.hahn@gmail.com		HAHN, YOONSOO/0000-0003-4273-9842	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [NRF-2012R1A1B3001513, 2011-0028553]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF) grants (NRF-2012R1A1B3001513 and 2011-0028553) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1212; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Godfrey SJ, 2013, ANAT REC, V296, P257, DOI 10.1002/ar.22637; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hahn Y, 2007, MOL BIOL EVOL, V24, P2203, DOI 10.1093/molbev/msm146; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Perez SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068029; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Jirimutu, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2192; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; Meredith RW, 2011, P ROY SOC B-BIOL SCI, V278, P993, DOI 10.1098/rspb.2010.1280; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Partridge MA, 2007, DNA SEQUENCE, V18, P341, DOI 10.1080/10425170601101287; Perry GH, 2013, P NATL ACAD SCI USA, V110, P5823, DOI 10.1073/pnas.1211990110; Perry GH, 2012, GENOME BIOL EVOL, V4, P126, DOI 10.1093/gbe/evr132; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Pipes L, 2013, NUCLEIC ACIDS RES, V41, pD906, DOI 10.1093/nar/gks1268; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Ruedi M, 2013, MOL PHYLOGENET EVOL, V69, P437, DOI 10.1016/j.ympev.2013.08.011; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Smith Timothy D., 2004, Anatomical Record Part B:The New Anatomist, V279, P24, DOI 10.1002/ar.b.20026; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xin XN, 2004, J BIOL CHEM, V279, P48159, DOI 10.1074/jbc.M407486200; Yan Guangmei, 2011, Nat Biotechnol, V29, P1019, DOI 10.1038/nbt.1992; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Yu L, 2010, MOL BIOL EVOL, V27, P1467, DOI 10.1093/molbev/msq027; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3708	68	5	5	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104085	10.1371/journal.pone.0104085	http://dx.doi.org/10.1371/journal.pone.0104085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102179	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900036
J	Zhou, P; Cowled, C; Mansell, A; Monaghan, P; Green, D; Wu, LJ; Shi, ZL; Wang, LF; Baker, ML				Zhou, Peng; Cowled, Chris; Mansell, Ashley; Monaghan, Paul; Green, Diane; Wu, Lijun; Shi, Zhengli; Wang, Lin-Fa; Baker, Michelle L.			IRF7 in the Australian Black Flying Fox, Pteropus alecto: Evidence for a Unique Expression Pattern and Functional Conservation	PLOS ONE			English	Article							REGULATORY FACTOR FAMILY; TOLL-LIKE RECEPTORS; MOLECULAR CHARACTERIZATION; POSITIVE FEEDBACK; FRUIT BATS; INTERFERON; VIRUS; INDUCTION; GENE; TRANSCRIPTION	As the only flying mammal, bats harbor a number of emerging and re-emerging viruses, may of which cause severe diseases in humans and other mammals yet results in no clinical symptoms in bats. As the master regulator of the interferon (IFN)-dependent immune response, IFN regulatory factor 7 (IRF7) plays a central role in innate antiviral immunity. To explore the role of bat IRF7 in the regulation of IFN response, we performed sequence and functional analysis of IRF7 from the pteropid bat, Pteropus alecto. Our results demonstrate that bat IRF7 retains the ability to bind to MyD88 and activate the IFN response despite unique changes in the MyD88 binding domain. We also demonstrate that bat IRF7 has a unique expression pattern across noth immune and non-immune related tissues and is inducible by double-strand RNA. The broad tissue compared to other mammals. The importance of IRF7 in antiviral activity against the bat reovirus, pulau virus ws confirmed by siRNA knockdown of IRF7 in bat cells resulting in enhanced viral replication. Our results highlight the importance of IRF7 in innate antiviral immunity in bats.	[Zhou, Peng; Cowled, Chris; Monaghan, Paul; Green, Diane; Wang, Lin-Fa; Baker, Michelle L.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Mansell, Ashley] Monash Univ, Prince Henry Inst Med Res, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Wu, Lijun; Shi, Zhengli] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Wuhan, Peoples R China; [Wang, Lin-Fa] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Prince Henry's Institute of Medical Research; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; National University of Singapore	Baker, ML (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Michelle.Baker@csiro.au	Baker, Michelle/AAX-9171-2020; Zhou, Peng/I-8578-2015; Cowled, Christopher JE/H-5308-2013; wang, lin/HHM-2225-2022; Monaghan, Paul/H-1973-2013; wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022; Baker, Michelle L/C-9694-2013; Mansell, Ashley/B-9553-2008; Shi, Zheng-Li/A-1013-2013	Baker, Michelle/0000-0002-7993-9971; Zhou, Peng/0000-0003-1938-8255; Cowled, Christopher JE/0000-0002-1969-9371; Baker, Michelle L/0000-0002-7993-9971; Mansell, Ashley/0000-0002-6540-1281; Shi, Zheng-Li/0000-0001-8089-163X; Wang, Lin-Fa/0000-0003-2752-0535	Australian Research Council Future Fellowship [FT110100234]; CSIRO OCE Science Leaders award; Victorian Government's Operational Infrastructure Support Program	Australian Research Council Future Fellowship(Australian Research Council); CSIRO OCE Science Leaders award; Victorian Government's Operational Infrastructure Support Program	This work was supported by funding from the Australian Research Council Future Fellowship (FT110100234) to M. L. B. and a CSIRO OCE Science Leaders award to L. -F. W. and support from the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Civas A, 2002, BIOCHIMIE, V84, P643, DOI 10.1016/S0300-9084(02)01431-1; Cowled C, 2012, DEV COMP IMMUNOL, V36, P657, DOI 10.1016/j.dci.2011.11.008; Cowled C, 2011, DEV COMP IMMUNOL, V35, P7, DOI 10.1016/j.dci.2010.07.006; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Genin P, 2009, CYTOKINE GROWTH F R, V20, P283, DOI 10.1016/j.cytogfr.2009.07.005; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Hu GB, 2010, FISH SHELLFISH IMMUN, V29, P963, DOI 10.1016/j.fsi.2010.08.002; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Jia WZ, 2008, MOL IMMUNOL, V45, P2419, DOI 10.1016/j.molimm.2007.11.011; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Sun BJ, 2007, VET IMMUNOL IMMUNOP, V116, P26, DOI 10.1016/j.vetimm.2007.01.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Poel WHM, 2006, VECTOR-BORNE ZOONOT, V6, P315, DOI 10.1089/vbz.2006.6.315; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang YB, 2003, FISH SHELLFISH IMMUN, V15, P453, DOI 10.1016/S1050-4648(03)00025-1; Zhou P, 2013, DEV COMP IMMUNOL, V40, P240, DOI 10.1016/j.dci.2013.03.006; Zhou P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025385; Zhou P, 2011, J IMMUNOL, V186, P3138, DOI 10.4049/jimmunol.1003115	48	33	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103875	10.1371/journal.pone.0103875	http://dx.doi.org/10.1371/journal.pone.0103875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25100081	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100037
J	Britze, A; Birkler, RID; Gregersen, N; Ovesen, T; Palmfeldt, J				Britze, Anders; Birkler, Rune Isak Dupont; Gregersen, Niels; Ovesen, Therese; Palmfeldt, Johan			Large-Scale Proteomics Differentiates Cholesteatoma from Surrounding Tissues and Identifies Novel Proteins Related to the Pathogenesis	PLOS ONE			English	Article							MIDDLE-EAR CHOLESTEATOMA; ACQUIRED CHOLESTEATOMA; CYTOKERATIN EXPRESSION; GENE-EXPRESSION; STEROID SULFATASE; BASEMENT-MEMBRANE; PSORIASIN S100A7; NIDOGEN-2 GENE; BREAST-CANCER; SKIN	Cholesteatoma is the growth of keratinizing squamous epithelium in the middle ear. It is associated with severe complications and has a poorly understood etiopathogenesis. Here, we present the results from extensive bioinformatics analyses of the first large-scale proteomic investigation of cholesteatoma. The purpose of this study was to take an unbiased approach to identifying alterations in protein expression and in biological processes, in order to explain the characteristic phenotype of this skin-derived tumor. Five different human tissue types (cholesteatoma, neck of cholesteatoma, tympanic membrane, external auditory canal skin, and middle ear mucosa) were analyzed. More than 2,400 unique proteins were identified using nanoLC-MS/MS based proteomics (data deposited to the ProteomeXchange), and 295 proteins were found to be differentially regulated in cholesteatoma. Validation analyses were performed by SRM mass spectrometry. Proteins found to be up- or down-regulated in cholesteatoma were analyzed using Ingenuity Pathway Analysis and clustered into functional groups, for which activation state and associations to disease processes were predicted. Cholesteatoma contained high levels of pro-inflammatory S100 proteins, such as S100A7A and S100A7. Several proteases, such as ELANE, were up-regulated, whereas extracellular matrix proteins, such as COL18A1 and NID2, were under-represented. This may lead to alterations in integrity and differentiation of the tissue (as suggested by the up-regulation of KRT4 in the cholesteatoma). The presented data on the differential protein composition in cholesteatoma corroborate previous studies, highlight novel protein functionalities involved in the pathogenesis, and identify new areas for targeted research that hold therapeutic potential for the disease.	[Britze, Anders; Ovesen, Therese] Aarhus Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, DK-8000 Aarhus, Denmark; [Birkler, Rune Isak Dupont; Gregersen, Niels; Palmfeldt, Johan] Aarhus Univ Hosp, Res Unit Mol Med, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Britze, A (corresponding author), Aarhus Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, DK-8000 Aarhus, Denmark.	andersbritze@gmail.com		Ovesen, Therese/0000-0003-0864-7987; Britze, Anders/0000-0002-2481-0425; Palmfeldt, Johan/0000-0001-5585-639X	Hans Skoubys og Hustru Emma Skoubys Foundation; John and Birthe Meyer Foundation; Aarhus University Hospital - Institute of Clinical Medicin	Hans Skoubys og Hustru Emma Skoubys Foundation; John and Birthe Meyer Foundation; Aarhus University Hospital - Institute of Clinical Medicin	The work was supported by external sources: *Hans Skoubys og Hustru Emma Skoubys Foundation - http://www.audioweb.dk/Skouby/index.htm *John and Birthe Meyer Foundation *Danaflex - www.danaflex.com; Internal source: Aarhus University Hospital - Institute of Clinical Medicin - http://clin.au.dk/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG B, 1993, ARCH OTOLARYNGOL, V119, P272; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Baiges I, 2010, MOL CELL PROTEOMICS, V9, P1499, DOI 10.1074/mcp.M000055-MCP201; Baysal E, 2013, EUR ARCH OTO-RHINO-L, V270, P1203, DOI 10.1007/s00405-012-2070-z; Bloksgaard M, 2012, OTOL NEUROTOL, V33, P177, DOI 10.1097/MAO.0b013e318241be63; Britze A, 2014, ACTA OTO-LARYNGOL, V134, P41, DOI 10.3109/00016489.2013.844360; BROEKAERT D, 1992, ANN OTO RHINOL LARYN, V101, P931, DOI 10.1177/000348949210101109; Bujia J, 1996, EUR ARCH OTO-RHINO-L, V253, P21; Bujia J, 1996, ORL J OTO-RHINO-LARY, V58, P23, DOI 10.1159/000276789; BUJIA J, 1993, ACTA OTO-LARYNGOL, V113, P364, DOI 10.3109/00016489309135826; Cameron S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-74; Canfield AE, 2007, BIOCHEM SOC T, V35, P669, DOI 10.1042/BST0350669; Chole RA, 2002, ARCH OTOLARYNGOL, V128, P1129, DOI 10.1001/archotol.128.10.1129; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DALLARI S, 1994, ACTA OTO-LARYNGOL, V114, P188, DOI 10.3109/00016489409126040; Das D, 2012, J AM COLL CARDIOL, V60, P775, DOI 10.1016/j.jacc.2012.04.027; Djurhuus BD, 2010, DAN MED BULL, V57; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Fleming JM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-266; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Garca MF, 2013, J MEMBRANE BIOL, V246, P519, DOI 10.1007/s00232-013-9561-8; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hansen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026634; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; Haruyama T, 2010, ORL-J OTO-RHIN-LARYN, V72, P325, DOI 10.1159/000319897; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hegyi Z, 2012, J INVEST DERMATOL, V132, P1416, DOI 10.1038/jid.2011.486; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Ho KY, 2013, INT J MOL SCI, V14, P14439, DOI 10.3390/ijms140714439; Ho KY, 2012, LARYNGOSCOPE, V122, P2818, DOI 10.1002/lary.23547; HOLLY A, 1995, LARYNGO RHINO OTOL, V74, P33, DOI 10.1055/s-2007-997682; Huisman MA, 2003, ACTA OTO-LARYNGOL, V123, P377, DOI 10.1080/00016480310001376; Hussein MRA, 2010, EXP MOL PATHOL, V88, P316, DOI 10.1016/j.yexmp.2009.12.006; JACKSON DG, 1978, ACTA OTO-LARYNGOL, V86, P71, DOI 10.3109/00016487809124722; Jeong JH, 2006, LARYNGOSCOPE, V116, P1180, DOI 10.1097/01.mlg.0000224345.59291.da; KAKOI H, 1995, ACTA OTO-LARYNGOL, V115, P804, DOI 10.3109/00016489509139405; Kemppainen HO, 1999, ACTA OTO-LARYNGOL, V119, P568; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim JL, 2004, ACTA OTO-LARYNGOL, V124, P783, DOI 10.1080/00016480410017882; Kim KH, 2009, ACTA OTO-LARYNGOL, V129, P1067, DOI 10.1080/00016480802455291; Klenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052718; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kwon KH, 2006, ACTA OTO-LARYNGOL, V126, P691, DOI 10.1080/00016480500475633; Louw L, 2010, J LARYNGOL OTOL, V124, P587, DOI 10.1017/S0022215109992763; Ma CY, 2011, ONCOL REP, V26, P813, DOI 10.3892/or.2011.1365; Macias JD, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.24176; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Olszewska E, 2007, HISTOL HISTOPATHOL, V22, P37, DOI 10.14670/HH-22.37; Olszewska E, 2005, EUR ARCH OTO-RHINO-L, V262, P731, DOI 10.1007/s00405-004-0875-0; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Olszewska E, 2006, MED SCI MONITOR, V12, pCR337; Olszewska E, 2006, EUR ARCH OTO-RHINO-L, V263, P409, DOI 10.1007/s00405-005-1026-y; Pelc P, 2003, HISTOPATHOLOGY, V42, P387, DOI 10.1046/j.1365-2559.2003.01588.x; Raffa S, 2012, HISTOCHEM CELL BIOL, V138, P251, DOI 10.1007/s00418-012-0947-y; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Revadi G, 2011, OTOL NEUROTOL, V32, P504, DOI 10.1097/MAO.0b013e31820d97e2; Ricciardiello F, 2009, ACTA OTORHINOLARYNGO, V29, P197; Sanjuan M, 2007, OTOL NEUROTOL, V28, P504, DOI 10.1097/mao.0b013e3180321352; Sarra M, 2011, J IMMUNOL, V186, P5435, DOI 10.4049/jimmunol.1003326; Schymeinsky J, 2002, MOL CELL BIOL, V22, P6820, DOI 10.1128/MCB.22.19.6820-6830.2002; SHINODA H, 1995, LARYNGOSCOPE, V105, P1232, DOI 10.1288/00005537-199511000-00018; Shunyu NB, 2011, OTOLARYNG HEAD NECK, V145, P628, DOI 10.1177/0194599811409303; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Sudhoff H, 1996, ANN OTO RHINOL LARYN, V105, P804; Sudhoff H, 2000, AM J OTOL, V21, P786; Sudhoff H, 2000, AM J OTOL, V21, P793; Sudhoff H, 2007, EUR ARCH OTO-RHINO-L, V264, P1137, DOI 10.1007/s00405-007-0340-y; Szczepanski M, 2006, EUR ARCH OTO-RHINO-L, V263, P603, DOI 10.1007/s00405-006-0030-1; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tokuriki M, 2003, LARYNGOSCOPE, V113, P808, DOI 10.1097/00005537-200305000-00008; Ulazzi L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-17; Vennix PPCA, 1996, ARCH OTOLARYNGOL, V122, P825; VENNIX PPCA, 1994, ARCH OTOLARYNGOL, V120, P1102; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Waters Katrina M., 2006, Briefings in Functional Genomics & Proteomics, V5, P261, DOI 10.1093/bfgp/ell019; WEINBERGER J, 1990, J OTOLARYNGOL, V19, P83; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Xiong GP, 2012, NEOPLASMA, V59, P409, DOI 10.4149/neo_2012_053	82	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104103	10.1371/journal.pone.0104103	http://dx.doi.org/10.1371/journal.pone.0104103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093596	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200069
J	Gu, SP; Wu, WJ; Liu, C; Yang, L; Sun, C; Ye, WD; Li, XH; Chen, JQ; Long, FX; Chen, YP				Gu, Shuping; Wu, Weijie; Liu, Chao; Yang, Ling; Sun, Cheng; Ye, Wenduo; Li, Xihai; Chen, Jianquan; Long, Fanxin; Chen, YiPing			BMPRIA Mediated Signaling Is Essential for Temporomandibular Joint Development in Mice	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CONDYLAR CARTILAGE; EXPRESSION PATTERNS; DOUBLE MUTATIONS; GENE-EXPRESSION; SYNOVIAL JOINT; CELL LINEAGE; MOUSE; DIFFERENTIATION; CHONDROGENESIS	The central importance of BMP signaling in the development and homeostasis of synovial joint of appendicular skeleton has been well documented, but its role in the development of temporomandibular joint (TMJ), also classified as a synovial joint, remains completely unknown. In this study, we investigated the function of BMPRIA mediated signaling in TMJ development in mice by transgenic loss-of-and gain-of-function approaches. We found that BMPRIA is expressed in the cranial neural crest (CNC)-derived developing condyle and glenoid fossa, major components of TMJ, as well as the interzone mesenchymal cells. Wnt1-Cre mediated tissue specific inactivation of BmprIa in CNC lineage led to defective TMJ development, including failure of articular disc separation from a hypoplastic condyle, persistence of interzone cells, and failed formation of a functional fibrocartilage layer on the articular surface of the glenoid fossa and condyle, which could be at least partially attributed to the down-regulation of Ihh in the developing condyle and inhibition of apoptosis in the interzone. On the other hand, augmented BMPRIA signaling by Wnt1-Cre driven expression of a constitutively active form of BmprIa (caBmprIa) inhibited osteogenesis of the glenoid fossa and converted the condylar primordium from secondary cartilage to primary cartilage associated with ectopic activation of Smad-dependent pathway but inhibition of JNK pathway, leading to TMJ agenesis. Our results present unambiguous evidence for an essential role of finely tuned BMPRIA mediated signaling in TMJ development.	[Gu, Shuping; Wu, Weijie; Liu, Chao; Yang, Ling; Sun, Cheng; Ye, Wenduo; Li, Xihai; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Wu, Weijie] Fudan Univ, ZhongShan Hosp, Dept Dent, Shanghai 200433, Peoples R China; [Yang, Ling] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xihai] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Fujian, Peoples R China; [Chen, Jianquan; Long, Fanxin] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Tulane University; Fudan University; Sun Yat Sen University; Fujian University of Traditional Chinese Medicine; Washington University (WUSTL)	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	ychen@tulane.edu			ZhongShan Hospital, FuDan University; China Scholarship Council [201208440191]; National Institutes of Health [R01 DE14044, DE17792]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017792, R01DE014044] Funding Source: NIH RePORTER	ZhongShan Hospital, FuDan University; China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	WW was supported by a fellowship from ZhongShan Hospital, FuDan University. LY was supported by a scholarship from the China Scholarship Council (No. 201208440191). This work was supported by the National Institutes of Health grants (R01 DE14044, DE17792) to YC. The funders had no role in this design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuHijleh G, 1997, CLIN ANAT, V10, P183, DOI 10.1002/(SICI)1098-2353(1997)10:3<183::AID-CA4>3.0.CO;2-V; Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Dixon AD, 1997, FUNDAMENTALS CRANIOF, P99; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; FROMMER J, 1964, ANAT RECORD, V150, P449, DOI 10.1002/ar.1091500414; Fukada K, 1999, J ANAT, V195, P321, DOI 10.1046/j.1469-7580.1999.19530321.x; Fukuoka H, 2007, J ANAT, V211, P8, DOI 10.1111/j.1469-7580.2007.00739.x; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; Gu SP, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P71; Hall B.K., 2015, BONES CARTILAGE DEV; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; KERMACK KA, 1972, P ROY SOC MED, V65, P389, DOI 10.1177/003591577206500439; Kimura S, 1996, J MORPHOL, V229, P337, DOI 10.1002/(SICI)1097-4687(199609)229:3<337::AID-JMOR8>3.0.CO;2-V; Komatsu Y, 2013, J BONE MINER RES, V28, P1422, DOI 10.1002/jbmr.1857; Kuboki T, 2003, ARCH ORAL BIOL, V48, P519, DOI 10.1016/S0003-9969(03)00088-8; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066107; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuda S, 1997, ANAT EMBRYOL, V196, P383, DOI 10.1007/s004290050106; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MITROVIC D, 1978, AM J ANAT, V151, P475, DOI 10.1002/aja.1001510403; MITROVIC DR, 1977, AM J ANAT, V150, P333, DOI 10.1002/aja.1001500207; Miyake T, 1997, J ANAT, V190, P239, DOI 10.1046/j.1469-7580.1997.19020239.x; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Morikawa Y, 2008, CIRC RES, V103, P1422, DOI 10.1161/CIRCRESAHA.108.180083; NALIN AM, 1995, DEV DYNAM, V203, P352, DOI 10.1002/aja.1002030307; Ochiai T, 2010, J DENT RES, V89, P349, DOI 10.1177/0022034510363078; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; PRESNELL JK, 1997, HUMASONS ANIMAL TISS; Purcell P, 2012, J DENT RES, V91, P387, DOI 10.1177/0022034512438401; Purcell P, 2009, P NATL ACAD SCI USA, V106, P18297, DOI 10.1073/pnas.0908836106; Rountree R, 2004, PLOS BIOL, V11, pe255; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shibata S, 2006, J ANAT, V208, P169, DOI 10.1111/j.1469-7580.2006.00525.x; Shibata S, 2004, ANAT EMBRYOL, V208, P273, DOI 10.1007/s00429-004-0393-2; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; Sperber G.H., 2001, CRANIOFACIAL DEV; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Stottmann RW, 2004, DEVELOPMENT, V131, P2205, DOI 10.1242/dev.01086; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Wang Y, 2011, DEV DYNAM, V240, P2466, DOI 10.1002/dvdy.22748; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	62	25	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101000	10.1371/journal.pone.0101000	http://dx.doi.org/10.1371/journal.pone.0101000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093411	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200004
J	Ud-Dean, SMM; Gunawan, R				Ud-Dean, S. M. Minhaz; Gunawan, Rudiyanto			Ensemble Inference and Inferability of Gene Regulatory Networks	PLOS ONE			English	Article							BIOLOGICAL NETWORKS	The inference of gene regulatory network (GRN) from gene expression data is an unsolved problem of great importance. This inference has been stated, though not proven, to be underdetermined implying that there could be many equivalent (indistinguishable) solutions. Motivated by this fundamental limitation, we have developed new framework and algorithm, called TRaCE, for the ensemble inference of GRNs. The ensemble corresponds to the inherent uncertainty associated with discriminating direct and indirect gene regulations from steady-state data of gene knock-out (KO) experiments. We applied TRaCE to analyze the inferability of random GRNs and the GRNs of E. coli and yeast from single-and double-gene KO experiments. The results showed that, with the exception of networks with very few edges, GRNs are typically not inferable even when the data are ideal (unbiased and noise-free). Finally, we compared the performance of TRaCE with top performing methods of DREAM4 in silico network inference challenge.	[Ud-Dean, S. M. Minhaz; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Gunawan, Rudiyanto/D-4650-2009; UD-DEAN, S M MINHAZ/A-8135-2010	Gunawan, Rudiyanto/0000-0002-6480-7976; UD-DEAN, S M MINHAZ/0000-0002-7428-3432	Swiss National Science Foundation [137614]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by funding from the Swiss National Science Foundation (grant 137614, http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho A. V., 1972, SIAM Journal on Computing, V1, P131, DOI 10.1137/0201008; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Apic G, 2005, FEBS LETT, V579, P1872, DOI 10.1016/j.febslet.2005.02.023; Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Gadkar KG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-155; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Jackson SL, 2011, RES METHODS STAT CRI; Jia G, 2012, METABOLITES, V2, P891, DOI 10.3390/metabo2040891; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2007, ANN NY ACAD SCI, V1115, P51, DOI 10.1196/annals.1407.019; Miskovic L, 2011, BIOTECHNOL BIOENG, V108, P413, DOI 10.1002/bit.22932; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Siegenthaler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090481; Srinath S, 2010, J BIOTECHNOL, V149, P132, DOI 10.1016/j.jbiotec.2010.02.019; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szederkenyi G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-177; Tan YK, 2012, BIOTECHNOL J, V7, P343, DOI 10.1002/biot.201100186; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323; [No title captured]	30	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103812	10.1371/journal.pone.0103812	http://dx.doi.org/10.1371/journal.pone.0103812			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093509	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200032
J	Allen, EK; Manichaikul, A; Chen, WM; Rich, SS; Daly, KA; Sale, MM				Allen, E. Kaitlynn; Manichaikul, Ani; Chen, Wei-Min; Rich, Stephen S.; Daly, Kathleen A.; Sale, Michele M.			Evaluation of Replication of Variants Associated with Genetic Risk of Otitis Media	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; HERITABILITY; DISEASE; DISEQUILIBRIUM; SCAN; TWIN	The first Genome Wide Association Study (GWAS) of otitis media (OM) found evidence of association in the Western Australian Pregnancy Cohort (Raine) study, but lacked replication in an independent OM population. The aim of this study was to investigate association at these loci in our family-based sample of chronic otitis media with effusion and recurrent otitis media (COME/ROM). Autosomal SNPs were selected from the Raine OM GWAS results. SNPs from the Raine cohort GWAS genotyped in our GWAS of COME/ROM had P-values ranging from P = 0.06-0.80. After removal of SNPs previously genotyped in our GWAS of COME/ROM (N = 21) and those that failed Fluidigm assay design (N = 1), 26 SNPs were successfully genotyped in 716 individuals from our COME/ROM family population. None of the SNP associations replicated in our family-based population (unadjusted P = 0.03-0.93). Replication in an independent sample would confirm that these represent novel OM loci, and that further investigation is warranted.	[Allen, E. Kaitlynn; Manichaikul, Ani; Chen, Wei-Min; Rich, Stephen S.; Sale, Michele M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Allen, E. Kaitlynn; Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Daly, Kathleen A.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA; [Sale, Michele M.] Univ Virginia, Dept Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia	Sale, MM (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	msale@virginia.edu		Rich, Stephen/0000-0003-3872-7793; Manichaikul, Ani/0000-0002-5998-795X	National Institutes of Health [DC003166]; Hearing Health Foundation Emerging Research Grant; National Institute of General Medical Sciences of the National Institutes of Health [T32GM008715]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation Emerging Research Grant; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant DC003166 (KAD) and the Hearing Health Foundation Emerging Research Grant. Ms. Allen received support from the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM008715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EK, 2013, JARO-J ASSOC RES OTO, V14, P791, DOI 10.1007/s10162-013-0411-2; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chen WM, 2001, GENET EPIDEMIOL, V21, P53, DOI 10.1002/gepi.1018; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 1996, GENET EPIDEMIOL, V13, P451, DOI 10.1002/(SICI)1098-2272(1996)13:5<451::AID-GEPI2>3.0.CO;2-5; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; Kvestad E, 2004, TWIN RES, V7, P239, DOI 10.1375/twin.7.3.239; Kvestad E, 2006, INT J PEDIATR OTORHI, V70, P1561, DOI 10.1016/j.ijporl.2006.04.004; Li Y, 2010, GENET EPIDEMIOL; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048215; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	15	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104212	10.1371/journal.pone.0104212	http://dx.doi.org/10.1371/journal.pone.0104212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089819	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700113
J	Budka, M; Osiejuk, TS				Budka, Michal; Osiejuk, Tomasz S.			Individually Specific Call Feature Is Not Used to Neighbour-Stranger Discrimination: The Corncrake Case	PLOS ONE			English	Article							KING PENGUIN; RECOGNITION; MALES; SONG; VOCALIZATIONS; SYSTEM; PARENT; SIGNAL; FROGS	In various contexts, animals rely on acoustic signals to differentiate between conspecifics. Currently, studies examining vocal signatures use two main approaches. In the first approach, researchers search for acoustic characteristics that have the potential to be individual specific. This approach yields information on variation in signal parameters both within and between individuals and generates practical tools that can be used in population monitoring. In the second approach, playback experiments with natural calls are conducted to discern whether animals are capable of discriminating among the vocal signatures of different individuals. However, both approaches do not reveal the exact signal characteristics that are being used in the discrimination process. In this study, we tested whether an individual-specific call characteristic - namely the length of the intervals between successive maximal amplitude peaks within syllables (PPD) - is crucial in neighbour-stranger discrimination by males of the nocturnal and highly secretive bird species, the corncrake (Crex crex). We conducted paired playback experiments in which corncrakes (n = 47) were exposed to artificial calls with PPD characteristics of neighbour and stranger birds. These artificial calls differed only in PPD structure. The calls were broadcast from a speaker, and we recorded the birds' behavioural responses. Although corncrakes have previously been experimentally shown to discriminate between neighbours and strangers, we found no difference in the responses to the artificial calls representing neighbours versus strangers. This finding demonstrates that even if vocal signatures are individual specific within a species, it does not automatically mean that said signatures are being crucial in discrimination among individuals. At the same time, the birds' aggressive responses to the artificial calls indicated that the information transmitted by PPDs is important in species-specific call recognition and may be used by males and/or females to evaluate sender quality, similarly like sound frequency in some insect species.	[Budka, Michal; Osiejuk, Tomasz S.] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Behav Ecol, Poznan, Poland	Adam Mickiewicz University	Budka, M (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Behav Ecol, Poznan, Poland.	m.budka@amu.edu.pl	Budka, Michał/R-5812-2019; Osiejuk, Tomasz S/A-1230-2008	Budka, Michał/0000-0002-1244-013X; Osiejuk, Tomasz/0000-0001-5980-7421	Department of Behavioural Ecology, Adam Mickiewicz University in Poznan	Department of Behavioural Ecology, Adam Mickiewicz University in Poznan	The study was funded by Department of Behavioural Ecology, Adam Mickiewicz University in Poznan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2013, BEHAV ECOL, V24, P898, DOI 10.1093/beheco/art018; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Beckers OM, 2011, ANIM BEHAV, V81, P519, DOI 10.1016/j.anbehav.2010.11.022; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Brenowitz E.A., 1991, Seminars in the Neurosciences, V3, P399, DOI 10.1016/1044-5765(91)90030-R; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Briefer EF, 2012, P ROY SOC B-BIOL SCI, V279, P3749, DOI 10.1098/rspb.2012.0986; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Budka M, 2013, J ORNITHOL, V154, P685, DOI 10.1007/s10336-013-0933-8; Budka M, 2013, AGR ECOSYST ENVIRON, V171, P33, DOI 10.1016/j.agee.2013.03.007; Clark JA, 2006, ANIM BEHAV, V72, P1141, DOI 10.1016/j.anbehav.2006.04.002; Dentressangle F, 2012, ANIM BEHAV, V84, P413, DOI 10.1016/j.anbehav.2012.05.012; Dooling R., 2004, NATURES MUSIC SCI BI, P209; Dragonetti M, 2007, BIOACOUSTICS, V16, P147, DOI 10.1080/09524622.2007.9753573; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Fisher J., 1954, P71; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; Green Rhys E., 1997, Vogelwelt, V118, P117; Hodl W, 2004, J COMP PHYSIOL A, V190, P823, DOI 10.1007/s00359-004-0536-1; Hoodless AN, 2008, IBIS, V150, P80; Hopp SL, 2001, ANIM BEHAV, V62, P297, DOI 10.1006/anbe.2001.1745; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; Judge KA, 2011, ANIM BEHAV, V81, P185, DOI 10.1016/j.anbehav.2010.09.032; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Knudsen DP, 2010, BRAIN LANG, V115, P59, DOI 10.1016/j.bandl.2009.09.008; Lengagne T, 2001, J EXP BIOL, V204, P663; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Mikkelsen G, 2013, J ORNITHOL, V154, P751, DOI 10.1007/s10336-013-0939-2; Osiejuk TS, 2004, ANIM BIOL, V54, P207, DOI 10.1163/1570756041445218; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Pettitt BA, 2013, ETHOLOGY, V119, P244, DOI 10.1111/eth.12058; Price JJ, 2004, J AVIAN BIOL, V35, P135; Rek P, 2013, ANIM BEHAV, V86, P451, DOI 10.1016/j.anbehav.2013.05.042; Rek P, 2013, BEHAV ECOL, V24, P547, DOI 10.1093/beheco/ars196; Rek P, 2011, BEHAV ECOL, V22, P657, DOI 10.1093/beheco/arr027; Rek P, 2011, BEHAV PROCESS, V86, P323, DOI 10.1016/j.beproc.2011.01.011; Rek P, 2010, BEHAV ECOL, V21, P1203, DOI 10.1093/beheco/arq143; Schaeffer Norbert, 1999, Oekologie der Voegel, V21, P1; Skierczynski M, 2007, J AVIAN BIOL, V38, P415, DOI 10.1111/j.2007.0908-8857.04123.x; Smith AS, 2009, AM J PRIMATOL, V71, P324, DOI 10.1002/ajp.20656; Specht R, 2007, AVISOFT SASLAB PROVE; Stoddard Philip Kraft, 1996, P356; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Terry AMR, 2002, ANIM CONSERV, V5, P103, DOI 10.1017/S1367943002002147; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Wilk T., 2010, IMPORTANT BIRD AREAS; Xia C, 2013, PLOS ONE, V7	51	5	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104031	10.1371/journal.pone.0104031	http://dx.doi.org/10.1371/journal.pone.0104031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090457	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700085
J	Laurent, AJ; Bindslev, N; Johansson, B; Berg, L				Laurent, Agneta J.; Bindslev, Niels; Johansson, Bjorn; Berg, Louise			Synergistic Effects of Ethanol and Isopentenyl Pyrophosphate on Expansion of gamma delta T Cells in Synovial Fluid from Patients with Arthritis	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; RHEUMATOID-ARTHRITIS; ALCOHOL-CONSUMPTION; RISK-FACTORS; RECOGNITION; SUBSETS; STIMULATION; RESPONSES; MEMORY; PROLIFERATION	Low to moderate ethanol consumption has been associated with protective effects in autoimmune diseases such as rheumatoid arthritis, RA. An expansion of gamma delta T cells induced by isopentenyl pyrophosphate, IPP, likewise seems to have a protective role in arthritis. The aim of this project was to test the hypothesis that low doses of ethanol can enhance IPP-induced expansion of synovial fluid gamma delta T cells from patients with arthritis and may thereby potentially account for the beneficial effects of ethanol on symptoms of the arthritic process. Thus, mononuclear cells from synovial fluid (SF) from 15 patients with arthritis and from peripheral blood (PB) from 15 healthy donors were stimulated with low concentrations of ethanol and IPP for 7 days in vitro. IPP in combination with ethanol 0.015%, 2.5 mM, equivalent to the decrease per hour in blood ethanol concentration due to metabolism, gave a significantly higher fractional expansion of SF gamma delta T cells compared with IPP alone after 7 days (ratio 10.1+/24.0, p<0.0008, n = 12) in patients with arthritis. Similar results were obtained for PB gamma delta T cells from healthy controls (ratio 2.0+/20.4, p< 0.011, n = 15). The augmented expansion of gamma delta T cells in SF is explained by a higher proliferation (p = 0.0034, n = 11) and an increased survival (p<0.005, n = 11) in SF cultures stimulated with IPP plus ethanol compared to IPP alone. The synergistic effects of IPP and ethanol indicate a possible allosteric effect of ethanol. Similar effects could be seen when stimulating PB with ethanol in presence of risedronate, which has the ability to increase endogenous levels of IPP. We conclude that expansion of gamma delta T cells by combinatorial drug effects, possibly in fixed-dose combination, FDC, of ethanol in the presence of IPP might give a protective role in diseases such as arthritis.	[Laurent, Agneta J.; Berg, Louise] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Bindslev, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Laurent, Agneta J.; Johansson, Bjorn] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden	Karolinska Institutet; University of Copenhagen; Karolinska Institutet	Laurent, AJ (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.	agneta.laurent@comhem.se		Berg, Louise/0000-0001-6538-2837	Borje Dahlin's Foundation; Polysackaridforskning i Uppsala AB	Borje Dahlin's Foundation; Polysackaridforskning i Uppsala AB	This study was financed by Borje Dahlin's Foundation and Polysackaridforskning i Uppsala AB. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1993, ANN RHEUM DIS, V52, P897, DOI 10.1136/ard.52.12.897-b; Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; ATKINSON JP, 1977, J CLIN INVEST, V60, P284, DOI 10.1172/JCI108776; Bank I, 2002, ANN RHEUM DIS, V61, P438, DOI 10.1136/ard.61.5.438; Bendersky A, 2012, J IMMUNOL, V188, P4349, DOI 10.4049/jimmunol.1102403; Bendersky A, 2010, IMMUNOBIOLOGY, V215, P380, DOI 10.1016/j.imbio.2009.05.012; Berkun Y, 2011, J RHEUMATOL, V38, P1123, DOI 10.3899/jrheum.100938; Bindslev Niels, 2004, BMC Pharmacology, V4, P11, DOI 10.1186/1471-2210-4-11; Bindslev N, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-4; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133; Cerhan JR, 2002, J RHEUMATOL, V29, P246; Das H, 2001, BLOOD, V98, P1616, DOI 10.1182/blood.V98.5.1616; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Di Giuseppe D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4230; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; EMERY P, 1984, CLIN EXP IMMUNOL, V57, P123; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HAZES JMW, 1990, ANN RHEUM DIS, V49, P980, DOI 10.1136/ard.49.12.980; HERMANN E, 1992, CLIN EXP IMMUNOL, V89, P427; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; Hu CY, 2012, CELL MOL IMMUNOL, V9, P245, DOI 10.1038/cmi.2011.50; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kabelitz Dieter, 1997, Frontiers in Bioscience (online), V2, pD61; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lee W, 1843, BRANWIN SALT LAKEMED; Lentner C., 1981, GEIGY SCI TABLES, P165; LUNARDI C, 1992, BRIT J RHEUMATOL, V31, P527; Martinet L, 2010, BIOCHEM PHARMACOL, V80, P838, DOI 10.1016/j.bcp.2010.05.002; Martinet L, 2009, EUR J IMMUNOL, V39, P752, DOI 10.1002/eji.200838812; Maxwell JR, 2010, RHEUMATOLOGY, V49, P2140, DOI 10.1093/rheumatology/keq202; Monkkonen H, 2006, BRIT J PHARMACOL, V147, P437, DOI 10.1038/sj.bjp.0706628; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Myllykangas-Luosujarvi R, 2000, ANN RHEUM DIS, V59, P75, DOI 10.1136/ard.59.1.75; Nedellec S, 2010, SEMIN IMMUNOL, V22, P199, DOI 10.1016/j.smim.2010.04.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Scott IC, 2013, RHEUMATOLOGY, V52, P856, DOI 10.1093/rheumatology/kes376; Siegel J., 2000, ENCY FORENSIC SCI; Siegers GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016700; SZABO G, 1993, J LEUKOCYTE BIOL, V54, P534, DOI 10.1002/jlb.54.6.534; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; VANDEPUTTE LBA, 1976, ANN RHEUM DIS, V35, P451, DOI 10.1136/ard.35.5.451; VOIGT LF, 1994, EPIDEMIOLOGY, V5, P525; Wang H, 2011, J IMMUNOL, V187, P5099, DOI 10.4049/jimmunol.1002697; Yoshimura M, 1999, ALCOHOL CLIN EXP RES, V23, P1457, DOI 10.1097/00000374-199909000-00006; Young JL, 1997, IMMUNOLOGY, V91, P503, DOI 10.1046/j.1365-2567.1997.00289.x	55	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103683	10.1371/journal.pone.0103683	http://dx.doi.org/10.1371/journal.pone.0103683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090614	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700042
J	Lee, WY; Kim, M; Jablonski, PG; Choe, JC; Lee, SI				Lee, Won Young; Kim, Mincheol; Jablonski, Piotr G.; Choe, Jae Chun; Lee, Sang-im			Effect of Incubation on Bacterial Communities of Eggshells in a Temperate Bird, the Eurasian Magpie (Pica pica)	PLOS ONE			English	Article							REAL-TIME PCR; NEST MATERIAL; PSEUDOMONAS-FLUORESCENS; MICROBIAL-GROWTH; EGG VIABILITY; AVIAN EGG; SP NOV.; QUANTIFICATION; LOADS; SOIL	Inhibitory effect of incubation on microbial growth has extensively been studied in wild bird populations using culture-based methods and conflicting results exist on whether incubation selectively affects the growth of microbes on the egg surface. In this study, we employed culture-independent methods, quantitative PCR and 16S rRNA gene pyrosequencing, to elucidate the effect of incubation on the bacterial abundance and bacterial community composition on the eggshells of the Eurasian Magpie (Pica pica). We found that total bacterial abundance increased and diversity decreased on incubated eggs while there were no changes on non-incubated eggs. Interestingly, Gram-positive Bacillus, which include mostly harmless species, became dominant and genus Pseudomonas, which include opportunistic avian egg pathogens, were significantly reduced after incubation. These results suggest that avian incubation in temperate regions may promote the growth of harmless (or benevolent) bacteria and suppress the growth of pathogenic bacterial taxa and consequently reduce the diversity of microbes on the egg surface. We hypothesize that this may occur due to difference in sensitivity to dehydration on the egg surface among microbes, combined with the introduction of Bacillus from bird feathers and due to the presence of antibiotics that certain bacteria produce.	[Lee, Won Young; Jablonski, Piotr G.; Lee, Sang-im] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea; [Kim, Mincheol] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Lab Prokaryot Biol & Bioinformat, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Choe, Jae Chun] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Lee, Sang-im] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Ewha Womans University; Seoul National University (SNU)	Lee, SI (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea.	MagpieKorea@gmail.com	Jablonski, Piotr G/A-2753-2015	/0000-0002-8333-0106	Hi Seoul Science/Humanities Fellowship from Seoul Scholarship Foundation; Next Generation Researcher Scholarship of Seoul National University; National Research Foundation [NRF 2013-055323, 2013-005769]; Longterm Ecological Monitoring Project - Ministry of Environment	Hi Seoul Science/Humanities Fellowship from Seoul Scholarship Foundation; Next Generation Researcher Scholarship of Seoul National University; National Research Foundation; Longterm Ecological Monitoring Project - Ministry of Environment	This work was supported by Hi Seoul Science/Humanities Fellowship from Seoul Scholarship Foundation (2010-2011 for WYL), by the Next Generation Researcher Scholarship of Seoul National University (2012-2013 for WYL), research grants from National Research Foundation (NRF 2013-055323 and 2013-005769) and the Longterm Ecological Monitoring Project funded by the Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Aitchison J, 1986, STAT ANAL COMPOSITIO; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Awais M, 2007, PAK J BOT, V39, P1303; BAUMANN P, 1968, J BACTERIOL, V96, P39, DOI 10.1002/path.1700960105; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128; Birkhead TR, 1991, MAGPIES; Bruce J., 1994, P63; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cummins S, 2002, BIRD STUDY, V49, P139, DOI 10.1080/00063650209461258; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Deeming DC, 2002, OX ORN SER, V13, P1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fontana A., 2007, WATER ACTIVITY FOODS, P405; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Goodfellow M., 1987, FRONT APPL MICROBIOL, V2, P97; Green SJ, 2007, ISME J, V1, P291, DOI 10.1038/ismej.2007.33; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; Gunderson AR, 2008, AUK, V125, P972, DOI 10.1525/auk.2008.91008; Gwinner H, 2005, J ORNITHOL, V146, P365, DOI 10.1007/s10336-005-0012-x; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; HAGEDORN C, 1975, CAN J MICROBIOL, V21, P353, DOI 10.1139/m75-050; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kampfer P, 2010, INT J SYST EVOL MICR, V60, P824, DOI 10.1099/ijs.0.013540-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Kuta F. A., 2009, Applied Medical Informatics, V24, P42; Ledford H, 2008, NATURE, V455, P847, DOI 10.1038/455847a; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee WY, 2013, J FIELD ORNITHOL, V84, P304, DOI 10.1111/jofo.12031; Levitski-Heikkila TV, 2005, AM J KIDNEY DIS, V46, DOI 10.1053/j.ajkd.2005.08.021; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Mannanov RN, 2001, CHEM NAT COMPD, V37, P117, DOI 10.1023/A:1012314516354; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Moller AP, 2009, FUNCT ECOL, V23, P1097, DOI 10.1111/j.1365-2435.2009.01594.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Narushin VG, 1997, J AGR ENG RES, V68, P201, DOI 10.1006/jaer.1997.0188; Nijburg JW, 1998, FEMS MICROBIOL ECOL, V26, P345, DOI 10.1111/j.1574-6941.1998.tb00519.x; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83, DOI 10.1099/00207713-50-1-83; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Roberts D.W., 2013, ORDINATION MULTIVARI, V775; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Ruiz-de-Castaneda R, 2011, CONDOR, V113, P200, DOI 10.1525/cond.2011.100035; Ruiz-de-Castaneda R, 2012, CONDOR, V114, P203, DOI 10.1525/cond.2011.100230; Ruiz-Rodriguez M, 2013, FEMS MICROBIOL ECOL, V85, P495, DOI 10.1111/1574-6941.12138; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Simoes M, 2008, BIOFOULING, V24, P339, DOI 10.1080/08927010802239154; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Steinberg DC, 2009, MICROORGANISMS COSME, P223; STIERITZ DD, 1975, J INFECT DIS, V131, P688, DOI 10.1093/infdis/131.6.688; Tamehiro N, 2002, ANTIMICROB AGENTS CH, V46, P315, DOI 10.1128/AAC.46.2.315-320.2002; TATNER P, 1983, IBIS, V125, P90, DOI 10.1111/j.1474-919X.1983.tb03086.x; Turnbull P., 1990, Topley & Wilson's Principles of bacteriology, virology and immunity. Volume 2. Systematic bacteriology., P187; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Walls JG, 2011, AUK, V128, P663, DOI 10.1525/auk.2011.11124; Wang JM, 2011, ECOLOGY, V92, P1137, DOI 10.1890/i0012-9658-92-5-1137; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P445, DOI 10.1099/00207713-41-3-445; Yu EN, 2002, AM J OPHTHALMOL, V134, P613, DOI 10.1016/S0002-9394(02)01586-6; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	89	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103959	10.1371/journal.pone.0103959	http://dx.doi.org/10.1371/journal.pone.0103959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089821	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700069
J	Ku, KM; Jeffery, EH; Juvik, JA				Ku, Kang-Mo; Jeffery, Elizabeth H.; Juvik, John A.			Exogenous Methyl Jasmonate Treatment Increases Glucosinolate Biosynthesis and Quinone Reductase Activity in Kale Leaf Tissue	PLOS ONE			English	Article							BROCCOLI FLORETS; ANTICANCER PROPERTIES; ANTIOXIDANT ACTIVITY; MARKER ENZYME; INDUCTION; CANCER; CELLS; PLANT; ACID; ISOTHIOCYANATES	Methyl jasmonate (MeJA) spray treatments were applied to the kale varieties 'Dwarf Blue Curled Vates' and 'Red Winter' in replicated field plantings in 2010 and 2011 to investigate alteration of glucosinolate (GS) composition in harvested leaf tissue. Aqueous solutions of 250 mu M MeJA were sprayed to saturation on aerial plant tissues four days prior to harvest at commercial maturity. The MeJA treatment significantly increased gluconasturtiin (56%), glucobrassicin (98%), and neoglucobrassicin (150%) concentrations in the apical leaf tissue of these genotypes over two seasons. Induction of quinone reductase (QR) activity, a biomarker for anti-carcinogenesis, was significantly increased by the extracts from the leaf tissue of these two cultivars. Extracts of apical leaf tissues had greater MeJA mediated increases in phenolics, glucosinolate concentrations, GS hydrolysis products, and QR activity than extracts from basal leaf tissue samples. The concentration of the hydrolysis product of glucoraphanin, sulforphane was significantly increased in apical leaf tissue of the cultivar 'Red Winter' in both 2010 and 2011. There was interaction between exogenous MeJA treatment and environmental conditions to induce endogenous JA. Correlation analysis revealed that indole-3-carbanol (I3C) generated from the hydrolysis of glucobrassicin significantly correlated with QR activity (r = 0.800, P<0.001). Concentrations required to double the specific QR activity (CD values) of I3C was calculated at 230 mu M, which is considerably weaker at induction than other isothiocyanates like sulforphane. To confirm relationships between GS hydrolysis products and QR activity, a range of concentrations of MeJA sprays were applied to kale leaf tissues of both cultivars in 2011. Correlation analysis of these results indicated that sulforaphane, NI3C, neoascorbigen, I3C, and diindolylmethane were all significantly correlated with QR activity. Thus, increased QR activity may be due to combined increases in phenolics (quercetin and kaempferol) and GS hydrolysis product concentrations rather than by individual products alone.	[Ku, Kang-Mo; Juvik, John A.] Univ Illinois, Urbana, IL 61801 USA; [Jeffery, Elizabeth H.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Juvik, JA (corresponding author), Univ Illinois, Urbana, IL 61801 USA.	juvik@illinois.edu		Ku, Kang Mo/0000-0002-8588-1163; Jeffery, Elizabeth/0000-0002-8827-9469	Boerner Fellowship in Crop Sciences	Boerner Fellowship in Crop Sciences	The Boerner Fellowship in Crop Sciences partially supported the first author. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bradlow HL, 2008, IN VIVO, V22, P441; Brown AF, 2002, J AM SOC HORTIC SCI, V127, P807, DOI 10.21273/JASHS.127.5.807; CARLSON DG, 1987, J AM SOC HORTIC SCI, V112, P173; Clapper ML, 1998, CHEM-BIOL INTERACT, V112, P377, DOI 10.1016/S0009-2797(97)00174-9; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Cuendet M, 2006, J NAT PROD, V69, P460, DOI 10.1021/np050362q; Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313; Galati G, 2004, FREE RADICAL BIO MED, V37, P287, DOI 10.1016/j.freeradbiomed.2004.04.034; Harvey JA, 2011, OECOLOGIA, V166, P421, DOI 10.1007/s00442-010-1861-4; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Kang YH, 2004, METHOD ENZYMOL, V382, P380; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Kim HS, 2011, J AM SOC HORTIC SCI, V136, P239, DOI 10.21273/JASHS.136.4.239; Ku KM, 2014, J SCI FOOD AGR, V94, P2090, DOI 10.1002/jsfa.6529; Ku KM, 2013, J AGR FOOD CHEM, V61, P9623, DOI 10.1021/jf4027734; Ku KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077127; Ku KM, 2013, HORTSCIENCE, V48, P996, DOI 10.21273/HORTSCI.48.8.996; Ku KM, 2013, PLANT FOOD HUM NUTR, V68, P113, DOI 10.1007/s11130-013-0356-y; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; Morton LW, 2000, CLIN EXP PHARMACOL P, V27, P152, DOI 10.1046/j.1440-1681.2000.03214.x; Neave AS, 2005, TOXICOL SCI, V83, P126, DOI 10.1093/toxsci/kfi008; Nestle M, 1998, NUTR REV, V56, P127; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Rose P, 2000, CARCINOGENESIS, V21, P1983, DOI 10.1093/carcin/21.11.1983; Sato C, 2009, BIOSCI BIOTECH BIOCH, V73, P1962, DOI 10.1271/bbb.90119; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Tian QG, 2005, ANAL BIOCHEM, V343, P93, DOI 10.1016/j.ab.2005.04.045; Tong Y, 2014, FOOD CHEM, V152, P190, DOI 10.1016/j.foodchem.2013.11.099; U. S. Department of Agriculture Agricultural Research Service, 2011, USDA DAT FLAV CONT S; Uda Y, 1997, CANCER LETT, V120, P213, DOI 10.1016/S0304-3835(97)00311-X; Velasco P, 2008, J AM SOC HORTIC SCI, V133, P551, DOI 10.21273/JASHS.133.4.551; Velasco P, 2007, J AGR FOOD CHEM, V55, P955, DOI 10.1021/jf0624897; Velasco P, 2011, PHYTOCHEM ANALYSIS, V22, P144, DOI 10.1002/pca.1259; Wathelet Jean-Paul, 1995, Natural Toxins, V3, P299, DOI 10.1002/nt.2620030425; Williamson G, 1996, CARCINOGENESIS, V17, P2385, DOI 10.1093/carcin/17.11.2385; Wilson EA, 2011, CHROMATOGRAPHIA, V73, pS137, DOI 10.1007/s10337-010-1878-1; Yoshihara T, 1996, PLANT CELL PHYSIOL, V37, P586, DOI 10.1093/oxfordjournals.pcp.a028985; Yudina LN, 2000, CHEM HETEROCYCL COMP, V36, P144; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhu CY, 2003, FOOD CHEM TOXICOL, V41, P455, DOI 10.1016/S0278-6915(02)00278-8	44	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103407	10.1371/journal.pone.0103407	http://dx.doi.org/10.1371/journal.pone.0103407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084454	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800037
J	Gurgis, FMS; Yeung, YT; Tang, MXM; Heng, B; Buckland, M; Ammit, AJ; Haapasalo, J; Haapasalo, H; Guillemin, GJ; Grewal, T; Munoz, L				Gurgis, F. M. S.; Yeung, Y. T.; Tang, M. X. M.; Heng, B.; Buckland, M.; Ammit, A. J.; Haapasalo, J.; Haapasalo, H.; Guillemin, G. J.; Grewal, T.; Munoz, L.			The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1 beta-driven IL-6 secretion in glioblastoma cells	ONCOGENE			English	Article							PROTEIN-KINASE 2; TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; RICH ELEMENTS; HUR; CYTOKINE; EXPRESSION; GLIOMA; INHIBITORS; GROWTH	The microenvironment of glioblastoma (GBM) contains high levels of inflammatory cytokine interleukin 6 (IL-6), which contributes to promote tumour progression and invasion. The common epidermal growth factor receptor variant III (EGFRvIII) mutation in GBM is associated with significantly higher levels of IL-6. Furthermore, elevated IL-1 beta levels in GBM tumours are also believed to activate GBM cells and enhance IL-6 production. However, the crosstalk between these intrinsic and extrinsic factors within the oncogene-microenvironment of GBM causing overproduction of IL-6 is poorly understood. Here, we show that EGFRvIII potentiates IL-1 beta-induced IL-6 secretion from GBM cells. Importantly, exacerbation of IL-6 production is most effectively attenuated in EGFRvIII-expressing GBM cells with inhibitors of p38 mitogen-activated protein kinase (p38 MAPK) and MAPK-activated protein kinase 2 (MK2). Enhanced IL-6 production and increased sensitivity toward pharmacological p38 MAPK and MK2 inhibitors in EGFRvIII-expressing GBM cells is associated with increased MK2-dependent nuclear-cytoplasmic shuttling and accumulation of human antigen R (HuR), an IL-6 mRNA-stabilising protein, in the cytosol. IL-1 beta-stimulated activation of the p38 MAPK-MK2-HuR pathway significantly enhances IL-6 mRNA stability in GBM cells carrying EGFRvIII. Further supporting a role for the p38 MAPK-MK2-HuR pathway in the development of inflammatory environment in GBM, activated MK2 is found in more than 50% of investigated GBM tissues and correlates with lower grade and secondary GBMs. Taken together, p38 MAPK-MK2-HuR signalling may enhance the potential of intrinsic (EGFRvIII) and extrinsic (IL-1 beta) factors to develop an inflammatory GBM environment. Hence, further improvement of brain-permeable and anti-inflammatory inhibitors targeting p38 MAPK, MK2 and HuR may combat progression of lower grade gliomas into aggressive GBMs.	[Gurgis, F. M. S.; Yeung, Y. T.; Tang, M. X. M.; Munoz, L.] Univ Sydney, Sch Med Sci Pharmacol, Sydney, NSW 2006, Australia; [Yeung, Y. T.; Ammit, A. J.; Grewal, T.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Heng, B.; Guillemin, G. J.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW 2109, Australia; [Buckland, M.] Univ Sydney, Sch Med Sci Pathol, Sydney, NSW 2006, Australia; [Haapasalo, J.; Haapasalo, H.] Tampere Univ Hosp, Dept Pathol, Tampere, Finland; [Haapasalo, J.; Haapasalo, H.] Tampere Univ Hosp, Fimlab Labs, Tampere, Finland; [Haapasalo, J.] Tampere Univ Hosp, Neurosurg Unit, Tampere, Finland	University of Sydney; University of Sydney; Macquarie University; University of Sydney; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital	Munoz, L (corresponding author), Univ Sydney, Sch Med Sci Pharmacol, Sydney, NSW 2006, Australia.	lenka.munoz@sydney.edu.au	Guillemin, Gilles J/C-3878-2015; Yeung, Yiu/AAH-6863-2021	Guillemin, Gilles J/0000-0001-8105-4470; Grewal, Thomas/0000-0002-7937-8887; Heng, Ruiwen Benjamin/0000-0002-0247-2920; Ammit, Alaina/0000-0003-0555-2544	National Foundation for Medical Research and Innovation; National Health and Medical Research Council of Australia [510294, 1025637]; University of Sydney [2010-02681]; Australian Research Council [FT120100397]; Tour de Cure; University of Sydney Brown Fellowship	National Foundation for Medical Research and Innovation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Australian Research Council(Australian Research Council); Tour de Cure; University of Sydney Brown Fellowship	This study was supported by grants from National Foundation for Medical Research and Innovation and the University of Sydney Brown Fellowship to LM. TG acknowledges support from the National Health and Medical Research Council of Australia (510294) and the University of Sydney (2010-02681). GJG is supported by the Australian Research Council (FT120100397) and Tour de Cure. AJA is supported by the National Health and Medical Research Council of Australia (1025637). We would like to thank Maggie Lee for technical assistance with immunohistochemistry and Myriam Gorospe for pHuR(S202) antibody.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bolognani F, 2012, J NEURO-ONCOL, V106, P531, DOI 10.1007/s11060-011-0707-1; Bonavia R, 2012, ONCOGENE, V31, P4054, DOI 10.1038/onc.2011.563; Brzezinska AA, 2009, IMMUNOLOGY, V127, P386, DOI 10.1111/j.1365-2567.2008.02980.x; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jin X, 2011, CANCER RES, V71, P7125, DOI 10.1158/0008-5472.CAN-11-1330; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; Liao WL, 2011, J BIOL CHEM, V286, P35499, DOI 10.1074/jbc.M111.263582; Lin WN, 2011, BRIT J PHARMACOL, V163, P1691, DOI 10.1111/j.1476-5381.2011.01312.x; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Miyata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059095; Mourey RJ, 2010, J PHARMACOL EXP THER, V333, P797, DOI 10.1124/jpet.110.166173; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Munoz L, 2010, EUR J PHARMACOL, V635, P212, DOI 10.1016/j.ejphar.2010.02.037; Munoz L, 2010, ANAL BIOCHEM, V401, P125, DOI 10.1016/j.ab.2010.02.016; Nabors LB, 2001, CANCER RES, V61, P2154; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ramgolam VS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014450; Schulz I, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-86; Spooren A, 2011, BIOCHEM PHARMACOL, V81, P1004, DOI 10.1016/j.bcp.2011.01.019; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Wang SB, 2008, J LEUKOCYTE BIOL, V83, P982, DOI 10.1189/jlb.0907641; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yeung YT, 2013, BRIT J PHARMACOL, V168, P591, DOI 10.1111/bph.12008; Yeung YT, 2012, J NEURO-ONCOL, V109, P35, DOI 10.1007/s11060-012-0875-7; Zhang J, 2012, CARCINOGENESIS, V33, P312, DOI 10.1093/carcin/bgr289	38	50	53	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 28	2015	34	22					2934	2942		10.1038/onc.2014.225	http://dx.doi.org/10.1038/onc.2014.225			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CJ2OM	25088200	Bronze			2022-12-25	WOS:000355324300012
J	Ruiz, A; Pauls, E; Badia, R; Riveira-Munoz, E; Clotet, B; Ballana, E; Este, JA				Ruiz, Alba; Pauls, Eduardo; Badia, Roger; Riveira-Munoz, Eva; Clotet, Bonaventura; Ballana, Ester; Este, Jose A.			Characterization of the Influence of Mediator Complex in HIV-1 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Human Immunodeficiency Virus (HIV); RNA Polymerase II; RNA Silencing; Transcription; Viral Transcription; Host Factor; RNAP II; Tat	RNA-POLYMERASE-II; IN-VITRO; P-TEFB; TAT-TRANSACTIVATION; ELONGATION-FACTORS; INFECTION; REPLICATION; LATENCY; IDENTIFICATION; MACROPHAGES	Background: The transcription Mediator complex was suggested to influence HIV infection, but a more accurate study is needed to define this contribution. Results: Nine Mediator subunits are implicated in early and late HIV transcription, although MED14 plays a major role. Conclusion: HIV transcription needs specific Mediator subunits interacting with HIV Tat. Significance: This work enables further studies on cofactors influencing HIV transcription. HIV-1 exploits multiple host proteins during infection. siRNA-based screenings have identified new proteins implicated in different pathways of the viral cycle that participate in a broad range of cellular functions. The human Mediator complex (MED) is composed of 28 elements and represents a fundamental component of the transcription machinery, interacting with the RNA polymerase II enzyme and regulating its ability to express genes. Here, we provide an evaluation of the MED activity on HIV replication. Knockdown of 9 out of 28 human MED proteins significantly impaired viral replication without affecting cell viability, including MED6, MED7, MED11, MED14, MED21, MED26, MED27, MED28, and MED30. Impairment of viral replication by MED subunits was at a post-integration step. Inhibition of early HIV transcripts was observed by siRNA-mediated knockdown of MED6, MED7, MED11, MED14, and MED28, specifically affecting the transcription of the nascent viral mRNA transactivation-responsive element. In addition, MED14 and MED30 were shown to have special relevance during the formation of unspliced viral transcripts (p < 0.0005). Knockdown of the selected MED factors compromised HIV transcription induced by Tat, with the strongest inhibitory effect shown by siMED6 and siMED14 cells. Co-immunoprecipitation experiments suggested physical interaction between MED14 and HIV-1 Tat protein. A better understanding of the mechanisms and factors controlling HIV-1 transcription is key to addressing the development of new strategies required to inhibit HIV replication or reactivate HIV-1 from the latent reservoirs.	Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, IrsiCaixa, AIDS Res Inst, Badalona 08916, Spain; Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Unit, Badalona 08916, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Este, JA (corresponding author), Hosp Badalona Germans Trias & Pujol, IrsiCaixa, C Canyet S-N, Badalona 08916, Spain.	jaeste@irsicaixa.es	Badia, Roger/T-6929-2017; Guix, Ester Ballana/R-4117-2018; Este, Jose/B-5509-2008	Badia, Roger/0000-0003-3982-7577; Este, Jose/0000-0002-1436-5823; Pauls, Eduardo/0000-0002-2511-0711; Riveira Munoz, Eva/0000-0002-6396-1162; Ballana, Ester/0000-0002-5215-7363	Spanish Ministerio de Economia y Competitividad [BFU2012-31569-06958, PI1301083]; Gala Contra la SIDA	Spanish Ministerio de Economia y Competitividad(Spanish Government); Gala Contra la SIDA	This work was supported in part by Spanish Ministerio de Economia y Competitividad Projects BFU2012-31569-06958 and PI1301083 and Gala Contra la SIDA.	ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Ansari SA, 2013, CELL MOL LIFE SCI, V70, P2743, DOI 10.1007/s00018-013-1265-9; Ballana E, 2013, ANTIVIR RES, V100, P473, DOI 10.1016/j.antiviral.2013.09.017; Ballana E, 2011, J IMMUNOL, V186, P464, DOI 10.4049/jimmunol.1002693; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Ballana E, 2009, BLOOD, V113, P1278, DOI 10.1182/blood-2008-06-161869; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chou S, 2013, P NATL ACAD SCI USA, V110, pE123, DOI 10.1073/pnas.1216971110; Ciuffi A, 2004, J VIROL, V78, P10747, DOI 10.1128/JVI.78.19.10747-10754.2004; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; ESTE JA, 1995, AIDS RES HUM RETROV, V11, P1355, DOI 10.1089/aid.1995.11.1355; Fahey ME, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-298; Galdieri L, 2012, J MOL BIOL, V415, P464, DOI 10.1016/j.jmb.2011.11.020; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marcello A, 2001, IUBMB LIFE, V51, P175, DOI 10.1080/152165401753544241; Napoli C, 2012, BIOCHIMIE, V94, P579, DOI 10.1016/j.biochi.2011.09.016; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pauls E, 2013, J IMMUNOL, V190, P4736, DOI 10.4049/jimmunol.1203226; Pauls E, 2013, ANTIVIR RES, V97, P180, DOI 10.1016/j.antiviral.2012.12.009; Permanyer M, 2012, J BIOL CHEM, V287, P32017, DOI 10.1074/jbc.M112.343293; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Tsutsui T, 2013, J BIOL CHEM, V288, P20955, DOI 10.1074/jbc.M113.486746; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vijayalingam S, 2013, J VIROL, V87, P3425, DOI 10.1128/JVI.03046-12; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Witvrouw M, 1997, AIDS RES HUM RETROV, V13, P187, DOI 10.1089/aid.1997.13.187; Zhang Y, 2013, J BIOL CHEM, V288, P14544, DOI 10.1074/jbc.M112.427054; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	42	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27665	27676		10.1074/jbc.M114.570341	http://dx.doi.org/10.1074/jbc.M114.570341			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100719	Green Published, hybrid			2022-12-25	WOS:000342852800026
J	Hansen, DB; Ye, ZC; Calloe, K; Braunstein, TH; Hofgaard, JP; Ransom, BR; Nielsen, MS; MacAulay, N				Hansen, Daniel Bloch; Ye, Zu-Cheng; Calloe, Kirstine; Braunstein, Thomas Hartig; Hofgaard, Johannes Pauli; Ransom, Bruce R.; Nielsen, Morten Schak; MacAulay, Nanna			Activation, Permeability, and Inhibition of Astrocytic and Neuronal Large Pore (Hemi)channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; CONNEXIN-43 HEMICHANNELS; ATP RELEASE; PANNEXIN 1; 3-DIMENSIONAL STRUCTURE; FUNCTIONAL-PROPERTIES; CX43 HEMICHANNELS; MIMETIC PEPTIDES; CHANNELS; RECEPTOR	Astrocytes and neurons express several large pore (hemi)channels that may open in response to various stimuli, allowing fluorescent dyes, ions, and cytoplasmic molecules such as ATP and glutamate to permeate. Several of these large pore (hemi)channels have similar characteristics with regard to activation, permeability, and inhibitor sensitivity. Consequently, their behaviors and roles in astrocytic and n(e)uronal (patho)physiology remain undefined. We took advantage of the Xenopus laevis expression system to determine the individual characteristics of several large pore channels in isolation. Expression of connexins Cx26, Cx30, Cx36, or Cx43, the pannexins Px1 or Px2, or the purinergic receptor P2X(7) yielded functional (hemi)channels with isoform-specific characteristics. Connexin hemichannels had distinct sensitivity to alterations of extracellular Ca2+ and their permeability to dyes and small atomic ions (conductance) were not proportional. Px1 and Px2 exhibited conductance at positive membrane potentials, but only Px1 displayed detectable fluorescent dye uptake. P2X(7), in the absence of Px1, was permeable to fluorescent dyes in an agonist-dependent manner. The large pore channels displayed overlapping sensitivity to the inhibitors Brilliant Blue, gadolinium, and carbenoxolone. These results demonstrated isoform-specific characteristics among the large pore membrane channels; an open (hemi)channel is not a nonselective channel. With these isoform-specific properties in mind, we characterized the divalent cation-sensitive permeation pathway in primary cultured astrocytes. We observed no activation of membrane conductance or Cx43-mediated dye uptake in astrocytes nor in Cx43-expressing C6 cells. Our data underscore that although Cx43-mediated transport is observed in overexpressing cell systems, such transport may not be detectable in native cells under comparable experimental conditions.	[Hansen, Daniel Bloch; MacAulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Ye, Zu-Cheng; Ransom, Bruce R.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Calloe, Kirstine] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, DK-1870 Frederiksberg, Denmark; [Braunstein, Thomas Hartig; Hofgaard, Johannes Pauli; Nielsen, Morten Schak] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-2200 Copenhagen, Denmark; [Braunstein, Thomas Hartig; Hofgaard, Johannes Pauli; Nielsen, Morten Schak] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Washington; University of Washington Seattle; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen	MacAulay, N (corresponding author), Panum Inst, Blegdamsvej 3,Bldg 12-6, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	Ransom, Bruce/ABE-4606-2021; MacAulay, Nanna/AER-7709-2022; Calloe, Kirstine/H-8643-2016; Nielsen, Morten Schak/C-1494-2009; Ye, Zucheng/AFP-8574-2022	MacAulay, Nanna/0000-0002-7800-6600; Calloe, Kirstine/0000-0002-1777-7938; Nielsen, Morten Schak/0000-0002-9718-5421; Hansen, Daniel Bloch/0000-0002-1250-4754; Ransom, Bruce R./0000-0002-9658-0294	Danish Medical Research Foundation; Danish National Research Foundation	Danish Medical Research Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish Medical Research Foundation (to N. M.), and the Danish National Research Foundation (to M. S. N.).	Al-Ubaidi MR, 2000, J NEUROSCI RES, V59, P813, DOI 10.1002/(SICI)1097-4547(20000315)59:6<813::AID-JNR14>3.3.CO;2-R; Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Bhaskaracharya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093058; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chanson M, 2007, PROG BIOPHYS MOL BIO, V94, P233, DOI 10.1016/j.pbiomolbio.2007.03.002; Charpantier E, 2007, DIABETOLOGIA, V50, P2332, DOI 10.1007/s00125-007-0807-9; Cheung KK, 2005, NEUROSCIENCE, V133, P937, DOI 10.1016/j.neuroscience.2005.03.032; Clair C, 2008, EXP CELL RES, V314, P1250, DOI 10.1016/j.yexcr.2007.12.021; Condorelli DF, 2013, GAP JUNCTIONS IN THE BRAIN: PHYSIOLOGICAL AND PATHOLOGICAL ROLES, P69, DOI 10.1016/B978-0-12-415901-3.00005-0; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 2000, J NEUROSCI, V20, P2835; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Dahl G, 2007, CELL COMMUN ADHES, V14, P259, DOI 10.1080/15419060801891018; De Bock M, 2012, J BIOL CHEM, V287, P12250, DOI 10.1074/jbc.M111.299610; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Figueroa XF, 2013, NEUROPHARMACOLOGY, V75, P471, DOI 10.1016/j.neuropharm.2013.02.022; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Hansen DB, 2014, FEBS LETT, V588, P1446, DOI 10.1016/j.febslet.2014.01.036; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Harris Andrew L., 2009, P165, DOI 10.1007/978-1-59745-489-6_7; Hofgaard JP, 2009, AM J PHYSIOL-REG I, V297, pR243, DOI 10.1152/ajpregu.00089.2009; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kubick C, 2011, BBA-BIOMEMBRANES, V1808, P2913, DOI 10.1016/j.bbamem.2011.08.017; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Lippiat Jonathan D., 2008, V491, P141, DOI 10.1007/978-1-59745-526-8_11; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Marandykina A, 2013, J PHYSIOL-LONDON, V591, P2087, DOI 10.1113/jphysiol.2013.250910; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Morita M, 2007, GLIA, V55, P508, DOI 10.1002/glia.20471; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orellana JA, 2011, BIOCHEM BIOPH RES CO, V409, P603, DOI 10.1016/j.bbrc.2011.05.031; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Poornima V, 2012, J MOL NEUROSCI, V46, P585, DOI 10.1007/s12031-011-9646-8; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Salas E, 2013, J PHARMACOL EXP THER, V347, P802, DOI 10.1124/jpet.113.209452; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Scemes E, 2008, CELL COMMUN ADHES, V15, P143, DOI 10.1080/15419060802014255; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Schalper KA, 2008, MOL BIOL CELL, V19, P3501, DOI 10.1091/mbc.E07-12-1240; Schilling WP, 1999, AM J PHYSIOL-CELL PH, V277, pC755, DOI 10.1152/ajpcell.1999.277.4.C755; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Singh D, 2003, CELL COMMUN ADHES, V10, P215, DOI 10.1080/714040430; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Stroud RM, 2003, FEBS LETT, V555, P79, DOI 10.1016/S0014-5793(03)01195-5; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Suadicani SO, 2012, GLIA, V60, P1106, DOI 10.1002/glia.22338; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Valiunas V, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00075; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wang N, 2013, NEUROPHARMACOLOGY, V75, P506, DOI 10.1016/j.neuropharm.2013.08.021; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wang N, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0304-2; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Ye ZC, 2009, GLIA, V57, P258, DOI 10.1002/glia.20754; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007	89	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26058	26073		10.1074/jbc.M114.582155	http://dx.doi.org/10.1074/jbc.M114.582155			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086040	Green Published, hybrid			2022-12-25	WOS:000342128800005
J	Mika, J; Popiolek-Barczyk, K; Rojewska, E; Makuch, W; Starowicz, K; Przewlocka, B				Mika, Joanna; Popiolek-Barczyk, Katarzyna; Rojewska, Ewelina; Makuch, Wioletta; Starowicz, Katarzyna; Przewlocka, Barbara			Delta-Opioid Receptor Analgesia Is Independent of Microglial Activation in a Rat Model of Neuropathic Pain	PLOS ONE			English	Article							ATTENUATES MECHANICAL ALLODYNIA; PERIPHERAL-NERVE INJURY; ROOT GANGLION NEURONS; SPINAL-CORD; PROINFLAMMATORY CYTOKINES; KNOCKOUT MICE; HETEROLOGOUS DESENSITIZATION; CHRONIC INFLAMMATION; CHEMOKINE RECEPTORS; MORPHINE-TOLERANCE	The analgesic effect of delta-opioid receptor (DOR) ligands in neuropathic pain is not diminished in contrast to other opioid receptor ligands, which lose their effectiveness as analgesics. In this study, we examine whether this effect is related to nerve injury-induced microglial activation. We therefore investigated the influence of minocycline-induced inhibition of microglial activation on the analgesic effects of opioid receptor agonists: morphine, DAMGO, U50,488H, DPDPE, Deltorphin II and SNC80 after chronic constriction injury (CCI) to the sciatic nerve in rats. Pre-emptive and repeated administration of minocycline (30 mg/kg, i.p.) over 7 days significantly reduced allodynia and hyperalgesia as measured on day 7 after CCI. The antiallodynic and antihyperalgesic effects of intrathecally (i.t.) administered morphine (10-20 mu g), DAMGO (1-2 mu g) and U50,488H (25-50 mu g) were significantly potentiated in rats after minocycline, but no such changes were observed after DPDPE (10-20 mu g), deltorphin II (1.5-15 mu g) and SNC80 (10-20 mu g) administration. Additionally, nerve injury-induced down-regulation of all types of opioid receptors in the spinal cord and dorsal root ganglia was not influenced by minocycline, which indicates that the effects of opioid ligands are dependent on other changes, presumably neuroimmune interactions. Our study of rat primary microglial cell culture using qRT-PCR, Western blotting and immunocytochemistry confirmed the presence of mu-opioid receptors (MOR) and kappa-opioid receptors (KOR), further we provide the first evidence for the lack of DOR on microglial cells. In summary, DOR analgesia is different from analgesia induced by MOR and KOR receptors because it does not dependent on injury-induced microglial activation. DOR agonists appear to be the best candidates for new drugs to treat neuropathic pain.	[Mika, Joanna; Popiolek-Barczyk, Katarzyna; Rojewska, Ewelina; Makuch, Wioletta; Starowicz, Katarzyna; Przewlocka, Barbara] Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland	Polish Academy of Sciences	Mika, J (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland.	joamika@if-pan.krakow.pl; przebar@if-pan.krakow.pl	Starowicz, Katarzyna/AAB-8595-2022	Popiolek-Barczyk, Katarzyna/0000-0003-4366-6577; Mika, Joanna/0000-0003-1986-7205; Rojewska, Ewelina/0000-0001-8383-7356; PRZEWLOCKA, BARBARA/0000-0002-6672-1906; Starowicz, Katarzyna/0000-0003-0091-0066; Makuch, Wioletta/0000-0002-1579-3643	MNiSzW/NCN [NN405375937]; grant OPUS NCN [2011/03/B/NZ4/00042]; grant PRELUDIUM NCN [2012/07/N/NZ3/00379]; grant MAESTRO NCN [2012/06/A/NZ4/00028]; KNOW - Ministry of Science and Higher Education, Republic of Poland	MNiSzW/NCN; grant OPUS NCN; grant PRELUDIUM NCN; grant MAESTRO NCN; KNOW - Ministry of Science and Higher Education, Republic of Poland	This work was supported by MNiSzW/NCN grant NN405375937, grant OPUS NCN 2011/03/B/NZ4/00042, grant PRELUDIUM NCN 2012/07/N/NZ3/00379, grant MAESTRO NCN 2012/06/A/NZ4/00028 and statutory funds. Katarzyna Popiolek-Barczyk is a Ph.D. student and has a scholarship from the KNOW sponsored by the Ministry of Science and Higher Education, Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bie BH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-37; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cahill CM, 2003, PAIN, V101, P199, DOI 10.1016/S0304-3959(02)00333-0; Chang AC, 1996, J MED CHEM, V39, P1729, DOI 10.1021/jm950813b; Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010; Chao CC, 1997, J PHARMACOL EXP THER, V281, P998; Chao CC, 1996, P NATL ACAD SCI USA, V93, P8051, DOI 10.1073/pnas.93.15.8051; CHEN Y, 1993, BIOCHEM J, V295, P625, DOI 10.1042/bj2950625; Cheng PY, 1997, BRAIN RES, V778, P367, DOI 10.1016/S0006-8993(97)00891-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Commons KG, 1996, BRAIN RES, V738, P181, DOI 10.1016/S0006-8993(96)00774-3; Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Eisenberg E, 2005, JAMA-J AM MED ASSOC, V293, P3043, DOI 10.1001/jama.293.24.3043; El-Hage N, 2013, AIDS, V27, P2181, DOI 10.1097/QAD.0b013e3283639804; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Fillpovic R, 2008, EXP NEUROL, V211, P41, DOI 10.1016/j.expneurol.2007.12.024; Fraser GL, 2000, BRIT J PHARMACOL, V129, P1668, DOI 10.1038/sj.bjp.0703248; Gallantine EL, 2005, BASIC CLIN PHARMACOL, V97, P39, DOI 10.1111/j.1742-7843.2005.pto_97107.x; Gaveriaux-Ruff C, 2008, EUR J NEUROSCI, V27, P2558, DOI 10.1111/j.1460-9568.2008.06223.x; Gaveriaux-Ruff C, 2011, BEHAV PHARMACOL, V22, P405, DOI 10.1097/FBP.0b013e32834a1f2c; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gomes I, 2004, P NATL ACAD SCI USA, V101, P5135, DOI 10.1073/pnas.0307601101; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Gonzalez JC, 2007, EUR J NEUROSCI, V26, P2481, DOI 10.1111/j.1460-9568.2007.05873.x; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Happel C, 2008, J LEUKOCYTE BIOL, V83, P956, DOI 10.1189/jlb.1007685; Herradon G, 2008, NEUROSCI LETT, V438, P186, DOI 10.1016/j.neulet.2008.03.095; Hirsch SJ, 2014, NEUROSCI LETT, V562, P97, DOI 10.1016/j.neulet.2013.10.007; Holdridge SV, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-7; Holdridge SV, 2007, EUR J PAIN, V11, P685, DOI 10.1016/j.ejpain.2006.10.008; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Hurley RW, 2000, J NEUROSCI, V20, P1249, DOI 10.1523/JNEUROSCI.20-03-01249.2000; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; Jin SX, 2003, J NEUROSCI, V23, P4017; Kabli N, 2007, PAIN, V127, P84, DOI 10.1016/j.pain.2006.08.003; Kerros C, 2010, J NEUROIMMUNOL, V220, P69, DOI 10.1016/j.jneuroim.2010.01.010; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Kim TH, 2011, BRAIN RES, V1370, P34, DOI 10.1016/j.brainres.2010.11.038; Ko JL, 1999, MOL BRAIN RES, V69, P171, DOI 10.1016/S0169-328X(99)00094-7; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; LEE YW, 1995, NEUROSCI LETT, V199, P111, DOI 10.1016/0304-3940(95)12034-2; Liu XQ, 2013, NEUROSCI LETT, V542, P30, DOI 10.1016/j.neulet.2013.03.011; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Makuch W, 2013, NEUROPHARMACOLOGY, V75, P445, DOI 10.1016/j.neuropharm.2013.08.031; MANSSON E, 1994, BIOCHEM BIOPH RES CO, V202, P1431, DOI 10.1006/bbrc.1994.2091; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; McQuay HJ, 2002, EUR J PAIN-LONDON, V6, P11, DOI 10.1053/eujp.2001.0316; Merighi S, 2013, BIOCHEM PHARMACOL, V86, P487, DOI 10.1016/j.bcp.2013.05.027; Mika J, 2010, NEUROSCIENCE, V165, P1420, DOI 10.1016/j.neuroscience.2009.11.064; Mika J, 2001, EUR J PHARMACOL, V415, P31, DOI 10.1016/S0014-2999(01)00814-7; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016/j.ejphar.2007.01.013; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; Mika J, 2009, BRAIN BEHAV IMMUN, V23, P75, DOI 10.1016/j.bbi.2008.07.005; MINAMI M, 1993, NEUROSCI LETT, V162, P161, DOI 10.1016/0304-3940(93)90585-9; Nadal X, 2006, EUR J NEUROSCI, V23, P830, DOI 10.1111/j.1460-9568.2006.04569.x; Niimi N, 2013, NEUROPATHOLOGY, V33, P612, DOI 10.1111/neup.12039; Nozaki C, 2012, J PHARMACOL EXP THER, V342, P799, DOI 10.1124/jpet.111.188987; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Osikowicz M, 2008, PAIN, V139, P117, DOI 10.1016/j.pain.2008.03.017; Osikowicz M, 2013, EXP PHYSIOL, V98, P372, DOI 10.1113/expphysiol.2012.069922; OSSIPOV MH, 1995, NEUROSCI LETT, V199, P87, DOI 10.1016/0304-3940(95)12022-V; Pinkernelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073422; Pol O, 2006, NEUROPHARMACOLOGY, V50, P123, DOI 10.1016/j.neuropharm.2005.11.002; Porreca F, 1998, BRAIN RES, V795, P197, DOI 10.1016/S0006-8993(98)00292-3; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Przewlocka B, 1999, EUR J PHARMACOL, V367, P189, DOI 10.1016/S0014-2999(98)00956-X; Przewlocki R, 2005, CURR PHARM DESIGN, V11, P3013, DOI 10.2174/1381612054865055; Przewlocki R, 2001, EUR J PHARMACOL, V429, P79, DOI 10.1016/S0014-2999(01)01308-5; Quock RM, 1999, PHARMACOL REV, V51, P503; Radad K, 2010, CAN J NEUROL SCI, V37, P81, DOI 10.1017/S0317167100009690; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rowbotham MC, 2003, NEW ENGL J MED, V348, P1223, DOI 10.1056/NEJMoa021420; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Sluka KA, 2002, J PHARMACOL EXP THER, V302, P1146, DOI 10.1124/jpet.102.033167; Somvanshi RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085193; Steele AD, 2002, CYTOKINE GROWTH F R, V13, P209, DOI 10.1016/S1359-6101(02)00007-2; Stone LS, 2004, NEUROSCI LETT, V361, P208, DOI 10.1016/j.neulet.2003.12.067; Szabo I, 2002, P NATL ACAD SCI USA, V99, P10276, DOI 10.1073/pnas.102327699; Thorlin T, 1999, GLIA, V25, P370, DOI 10.1002/(SICI)1098-1136(19990215)25:4<370::AID-GLIA6>3.0.CO;2-J; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Wieseler-Frank J, 2005, NEUROSIGNALS, V14, P166, DOI 10.1159/000087655; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zhang X, 2006, TRENDS PHARMACOL SCI, V27, P324, DOI 10.1016/j.tips.2006.04.005; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zychowska M, 2013, J NEUROIMMUNOL, V262, P35, DOI 10.1016/j.jneuroim.2013.06.005	105	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104420	10.1371/journal.pone.0104420	http://dx.doi.org/10.1371/journal.pone.0104420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105291	Green Published, Green Submitted, gold			2022-12-25	WOS:000343231900054
J	Kobayashi, DR; Farman, R; Polovina, JJ; Parker, DM; Rice, M; Balazs, GH				Kobayashi, Donald R.; Farman, Richard; Polovina, Jeffrey J.; Parker, Denise M.; Rice, Marc; Balazs, George H.			"Going with the Flow'' or Not: Evidence of Positive Rheotaxis in Oceanic Juvenile Loggerhead Turtles (Caretta caretta) in the South Pacific Ocean Using Satellite Tags and Ocean Circulation Data	PLOS ONE			English	Article							CENTRAL NORTH PACIFIC; OLIVACEA SEA-TURTLES; ORIENTATION; MOVEMENT; BEHAVIOR; HABITAT	The movement of juvenile loggerhead turtles (n = 42) out-fitted with satellite tags and released in oceanic waters off New Caledonia was examined and compared with ocean circulation data. Merging of the daily turtle movement data with drifter buoy movements, OSCAR (Ocean Surface Current Analyses - Real time) circulation data, and three different vertical strata (05 m, 0-40 m, 0-100 m) of HYCOM (HYbrid Coordinate Ocean Model) circulation data indicated the turtles were swimming against the prevailing current in a statistically significant pattern. This was not an artifact of prevailing directions of current and swimming, nor was it an artifact of frictional slippage. Generalized additive modeling was used to decompose the pattern of swimming into spatial and temporal components. The findings are indicative of a positive rheotaxis whereby an organism is able to detect the current flow and orient itself to swim into the current flow direction or otherwise slow down its movement. Potential mechanisms for the means and adaptive significance of rheotaxis in oceanic juvenile loggerhead turtles are discussed.	[Kobayashi, Donald R.; Polovina, Jeffrey J.; Balazs, George H.] NOAA, Pacific Islands Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96813 USA; [Farman, Richard] Aquarium Lagons, Noumea, New Caledonia; [Parker, Denise M.] Univ Hawaii, Joint Inst Marine & Atmospher Res, Newport, OR USA; [Rice, Marc] Hawaii Preparatory Acad, Kamuela, HI USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Kobayashi, DR (corresponding author), NOAA, Pacific Islands Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96813 USA.	Donald.Kobayashi@noaa.gov		Kobayashi, Donald/0000-0002-1582-1544	United States government to National Oceanic and Atmospheric Administration	United States government to National Oceanic and Atmospheric Administration	The funders were base funding and add-on funding from the United States government to National Oceanic and Atmospheric Administration and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073274; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Balazs G.H., 1996, P 15 ANN S SEA TURTL, P21; Batschelet E, 1981, CIRCULAR STAT BIOL; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Conant TA., 2009, LOGGERHEAD SEA TURTL; Cressie N, 1991, STAT SPATIAL DATA; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; DODD KC., 1988, SYNOPSIS BIOL DATA L; DURAND D, 1958, J GEOL, V66, P229, DOI 10.1086/626501; Edwards KP, 2006, J ATMOS OCEAN TECH, V23, P1614, DOI 10.1175/JTECH1933.1; Fossette S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013908; Galli S, 2012, ANIM BEHAV, V84, P1491, DOI 10.1016/j.anbehav.2012.09.022; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Hedges LV, 2007, J EDUC BEHAV STAT, V32, P151, DOI 10.3102/1076998606298040; Howell EA, 2010, MAR BIOL, V157, P1011, DOI 10.1007/s00227-009-1381-0; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jones TT, 2013, METHODS ECOLOGY EVOL; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kobayashi DR, 2008, J EXP MAR BIOL ECOL, V356, P96, DOI 10.1016/j.jembe.2007.12.019; Kobayashi DR, 2011, ICES J MAR SCI, V68, P707, DOI 10.1093/icesjms/fsq185; Krauss W, 1996, J GEOPHYS RES-OCEANS, V101, P1309, DOI 10.1029/95JC02686; LOHMANN KJ, 1994, J EXP BIOL, V190, P1; LOHMANN KJ, 1995, J EXP BIOL, V198, P1079; Margaritoulis D., 2003, LOGGERHEAD SEA TURTL, P175; MONAHAN EC, 1973, LIMNOL OCEANOGR, V18, P981, DOI 10.4319/lo.1973.18.6.0981; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Polovina JJ, 2003, FISH B-NOAA, V101, P189; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Roberts A, 2009, J EXP BIOL, V212, P914, DOI 10.1242/jeb.027250; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Salumae T, 2012, IEEE INT CONF ROBOT, P4210, DOI 10.1109/ICRA.2012.6225023; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Wolf JB, 2011, GENETICS, V189, P1069, DOI 10.1534/genetics.111.130591; Wyneken J., 2001, ANATOMY SEA TURTLES; Zar J. H., 2009, BIOSTATISTICAL ANAL	45	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103701	10.1371/journal.pone.0103701	http://dx.doi.org/10.1371/journal.pone.0103701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098694	Green Published, gold			2022-12-25	WOS:000339995100025
J	Wolf, S; McMahon, DP; Lim, KS; Pull, CD; Clark, SJ; Paxton, RJ; Osborne, JL				Wolf, Stephan; McMahon, Dino P.; Lim, Ka S.; Pull, Christopher D.; Clark, Suzanne J.; Paxton, Robert J.; Osborne, Juliet L.			So Near and Yet So Far: Harmonic Radar Reveals Reduced Homing Ability of Nosema Infected Honeybees	PLOS ONE			English	Article							DECREASES FORAGING SUCCESS; APIS-MELLIFERA; MICROSPORIDIAN PARASITE; FLIGHT PATHS; CERANAE; BEE; POLLINATORS; SCALE; HYMENOPTERA; TEMPERATURE	Pathogens may gain a fitness advantages through manipulation of the behaviour of their hosts. Likewise, host behavioural changes can be a defence mechanism, counteracting the impact of pathogens on host fitness. We apply harmonic radar technology to characterize the impact of an emerging pathogen - Nosema ceranae (Microsporidia) - on honeybee (Apis mellifera) flight and orientation in the field. Honeybees are the most important commercial pollinators. Emerging diseases have been proposed to play a prominent role in colony decline, partly through sub-lethal behavioural manipulation of their hosts. We found that homing success was significantly reduced in diseased (65.8%) versus healthy foragers (92.5%). Although lost bees had significantly reduced continuous flight times and prolonged resting times, other flight characteristics and navigational abilities showed no significant difference between infected and non-infected bees. Our results suggest that infected bees express normal flight characteristics but are constrained in their homing ability, potentially compromising the colony by reducing its response inputs, but also counteracting the intra-colony spread of infection. We provide the first high-resolution analysis of sub-lethal effects of an emerging disease on insect flight behaviour. The potential causes and the implications for both host and parasite are discussed.	[Wolf, Stephan; Lim, Ka S.; Pull, Christopher D.; Osborne, Juliet L.] Rothamsted Res, Dept Agroecol, Harpenden, Herts, England; [Wolf, Stephan] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [McMahon, Dino P.; Paxton, Robert J.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [McMahon, Dino P.; Paxton, Robert J.] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Germany; [Pull, Christopher D.] IST Austria, Klosterneuburg, Austria; [Clark, Suzanne J.] Rothamsted Res, Dept Computat & Syst Biol, Harpenden, Herts, England; [Osborne, Juliet L.] Univ Exeter, Environm & Sustainabil Inst, Falmouth, Cornwall, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of London; Queen Mary University London; Queens University Belfast; Martin Luther University Halle Wittenberg; Institute of Science & Technology - Austria; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter	Wolf, S (corresponding author), Rothamsted Res, Dept Agroecol, Harpenden, Herts, England.	s.wolf@qmul.ac.uk	Lim, Ka Sing/B-4480-2012; Osborne, Juliet L/I-6776-2012; Paxton, Robert John/D-7082-2015; McMahon, Dino/S-2620-2019; McMahon, Dino P/F-7006-2012; Wolf, Stephan/C-1106-2009	Lim, Ka Sing/0000-0002-9166-2928; Paxton, Robert John/0000-0003-2517-1351; McMahon, Dino/0000-0003-1119-5299; McMahon, Dino P/0000-0003-1119-5299; Wolf, Stephan/0000-0002-7349-7113	BBSRC; Defra; NERC; Scottish Government; Wellcome Trust [BB/I00097/1, BB/I000100/1)]; UK Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/I000097/1, BB/I000100/1, BB/I000097/2] Funding Source: researchfish; BBSRC [BB/I000097/2, BB/I000100/1, BB/I000097/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded jointly by a grant from BBSRC, Defra, NERC, the Scottish Government and the Wellcome Trust, under the Insect Pollinators Initiative (grant numbers BB/I00097/1 and BB/I000100/1). Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Bollan KA, 2013, PARASITOL RES, V112, P751, DOI 10.1007/s00436-012-3195-0; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Cant ET, 2005, P ROY SOC B-BIOL SCI, V272, P785, DOI 10.1098/rspb.2004.3002; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Cresswell JE, 2012, SCIENCE, V337, DOI 10.1126/science.1224618; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Dyer FC, 1996, J EXP BIOL, V199, P147; Dyer Fred C., 1994, P66; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Fries I., 2013, J APICULT RES, V52, P1, DOI [10.3896/ IBRA. 1.52.1.14, DOI 10.3896/IBRA.1.52.1.14]; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Goulson D, 2009, CONTEMP TOP ENTOMOL, P97; Hansen H, 1999, BEE WORLD, V80, P5, DOI 10.1080/0005772X.1999.11099415; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Lane PW, 2011, GENSTAT RELEASE 14 R; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2012, APIDOLOGIE, V43, P229, DOI 10.1007/s13592-012-0127-z; Menzel R, 2011, CURR BIOL, V21, P645, DOI 10.1016/j.cub.2011.02.039; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078681; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Pahl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019669; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reynolds AM, 2007, J EXP BIOL, V210, P3763, DOI 10.1242/jeb.009563; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds AM, 2009, BEHAV ECOL SOCIOBIOL, V64, P19, DOI 10.1007/s00265-009-0813-7; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Riley JR, 2002, COMPUT ELECTRON AGR, V35, P151, DOI 10.1016/S0168-1699(02)00016-9; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Schmid-Hempel P., 1998, Parasites in social insects.; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Sherman PW, 1998, AM NAT, V151, P392, DOI 10.1086/286127; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042	65	87	87	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103989	10.1371/journal.pone.0103989	http://dx.doi.org/10.1371/journal.pone.0103989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098331	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100042
J	Adelfinger, M; Gentschev, I; de Guibert, JG; Weibel, S; Langbein-Laugwitz, J; Hartl, B; Escobar, HM; Nolte, I; Chen, NHG; Aguilar, RJ; Yu, YA; Zhang, Q; Frentzen, A; Szalay, AA				Adelfinger, Marion; Gentschev, Ivaylo; de Guibert, Julio Grimm; Weibel, Stephanie; Langbein-Laugwitz, Johanna; Haertl, Barbara; Escobar, Hugo Murua; Nolte, Ingo; Chen, Nanhai G.; Aguilar, Richard J.; Yu, Yong A.; Zhang, Qian; Frentzen, Alexa; Szalay, Aladar A.			Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; MICROVASCULAR DENSITY; VEGF; CANINE; ANGIOGENESIS; COMBINATION; VIROTHERAPY; NEOPLASMS; TUMORS; DOGS	Virotherapy on the basis of oncolytic vaccinia virus (VACV) infection is a promising approach for cancer therapy. In this study we describe the establishment of a new preclinical model of feline mammary carcinoma (FMC) using a recently established cancer cell line, DT09/06. In addition, we evaluated a recombinant vaccinia virus strain, GLV-5b451, expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb) GLAF-2 as an oncolytic agent against FMC. Cell culture data demonstrate that GLV-5b451 virus efficiently infected, replicated in and destroyed DT09/06 cancer cells. In the selected xenografts of FMC, a single systemic administration of GLV-5b451 led to significant inhibition of tumor growth in comparison to untreated tumor-bearing mice. Furthermore, tumor-specific virus infection led to overproduction of functional scAb GLAF-2, which caused drastic reduction of intratumoral VEGF levels and inhibition of angiogenesis. In summary, here we have shown, for the first time, that the vaccinia virus strains and especially GLV-5b451 have great potential for effective treatment of FMC in animal model.	[Adelfinger, Marion; Gentschev, Ivaylo; de Guibert, Julio Grimm; Weibel, Stephanie; Langbein-Laugwitz, Johanna; Haertl, Barbara; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Gentschev, Ivaylo; Chen, Nanhai G.; Aguilar, Richard J.; Yu, Yong A.; Zhang, Qian; Frentzen, Alexa; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Haertl, Barbara] Genelux GmbH, Bernried, Germany; [Escobar, Hugo Murua; Nolte, Ingo] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Escobar, Hugo Murua; Szalay, Aladar A.] Univ Rostock, Div Med Clin 3, D-18055 Rostock, Germany; [Chen, Nanhai G.; Yu, Yong A.; Zhang, Qian; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Med & Appl Sci, Rebecca & John Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Veterinary Medicine Hannover, Foundation; University of Rostock; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/AAJ-5819-2021		Research and Development Division of Genelux Corporation, San Diego, USA; Service Grant - Genelux Corp.; Genelux Corporation; Genelux GmbH	Research and Development Division of Genelux Corporation, San Diego, USA; Service Grant - Genelux Corp.; Genelux Corporation; Genelux GmbH	This work was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wuerzburg, Germany funded by Genelux Corp. MA and SW received postdoctoral fellowship. The funder, Genelux Corporation, and Genelux GmbH provided support in the form of salaries for authors IG NGC RJA YAY QA AF, AAS, and BH retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angarita FA, 2013, TRENDS MOL MED, V19, P378, DOI 10.1016/j.molmed.2013.02.008; BOSTOCK DE, 1986, BRIT VET J, V142, P506, DOI 10.1016/0007-1935(86)90107-7; Braghiroli MI, 2012, EXPERT REV ANTICANC, V12, P567, DOI [10.1586/ERA.12.13, 10.1586/era.12.13]; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Buckel L, 2013, INT J CANCER, V133, P2989, DOI 10.1002/ijc.28296; Chen NG, 2012, ADV VIROL, V2012, DOI 10.1155/2012/320206; de Queiroz GF, 2010, J VET DIAGN INVEST, V22, P105, DOI 10.1177/104063871002200121; DORN CR, 1968, JNCI-J NATL CANCER I, V40, P307; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frentzen A, 2009, P NATL ACAD SCI USA, V106, P12915, DOI 10.1073/pnas.0900660106; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Gentschev I, 2014, VIRUSES-BASEL, V6, P2122, DOI 10.3390/v6052122; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gentschev I, 2013, BIOENGINEERED, V4, P84, DOI 10.4161/bioe.22462; Gentschev I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037239; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; HAYDEN DW, 1971, J SMALL ANIM PRACT, V12, P687, DOI 10.1111/j.1748-5827.1971.tb06197.x; HAYES HM, 1981, VET REC, V108, P476, DOI 10.1136/vr.108.22.476; Islam MS, 2012, VET J, V192, P338, DOI 10.1016/j.tvjl.2011.08.032; John LB, 2012, CANCER RES, V72, P1651, DOI 10.1158/0008-5472.CAN-11-2788; Jourdier TM, 2003, GENE THER, V10, P2126, DOI 10.1038/sj.gt.3302124; Kamstock D, 2007, CANCER IMMUNOL IMMUN, V56, P1299, DOI 10.1007/s00262-007-0282-7; MacNeill AL, 2012, RES VET SCI, V93, P1036, DOI 10.1016/j.rvsc.2011.10.016; Martin I, 2007, J ANIM SCI, V85, P2734, DOI 10.2527/jas.2007-0048; Millanta F, 2002, VET PATHOL, V39, P690, DOI 10.1354/vp.39-6-690; NELSONRE.WA, 1972, P SOC EXP BIOL MED, V139, P6; Patil SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047472; PATNAIK AK, 1975, JNCI-J NATL CANCER I, V54, P855; Patruno R, 2009, J CELL MOL MED, V13, P555, DOI 10.1111/j.1582-4934.2008.00355.x; Sterenczak KA, 2009, GENE, V434, P35, DOI 10.1016/j.gene.2008.10.027; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-106; WEIJER K, 1983, J NATL CANCER I, V70, P709; Zizzo N, 2010, LEUKEMIA LYMPHOMA, V51, P291, DOI 10.3109/10428190903452818	37	12	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104337	10.1371/journal.pone.0104337	http://dx.doi.org/10.1371/journal.pone.0104337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093734	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200098
J	Lillie, M; Shine, R; Belov, K				Lillie, Mette; Shine, Richard; Belov, Katherine			Characterisation of Major Histocompatibility Complex Class I in the Australian Cane Toad, Rhinella marina	PLOS ONE			English	Article							MHC CLASS-I; BUFO-MARINUS; EVOLUTION; PARASITES; GENES; LOCUS; ORGANIZATION; POPULATIONS; VERTEBRATES; DIVERSITY	The Major Histocompatibility Complex (MHC) class I is a highly variable gene family that encodes cell-surface receptors vital for recognition of intracellular pathogens and initiation of immune responses. The MHC class I has yet to be characterised in bufonid toads (Order: Anura; Suborder: Neobatrachia; Family: Bufonidae), a large and diverse family of anurans. Here we describe the characterisation of a classical MHC class I gene in the Australian cane toad, Rhinella marina. From 25 individuals sampled from the Australian population, we found only 3 alleles at this classical class I locus. We also found large number of class I alpha 1 alleles, implying an expansion of class I loci in this species. The low classical class I genetic diversity is likely the result of repeated bottleneck events, which arose as a result of the cane toad's complex history of introductions as a biocontrol agent and its subsequent invasion across Australia.	[Lillie, Mette; Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Belov, K (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au		Lillie, Mette/0000-0001-8714-0812; Belov, Katherine/0000-0002-9762-5554	University of Sydney; Australian Research Council; ARC	University of Sydney(University of Sydney); Australian Research Council(Australian Research Council); ARC(Australian Research Council)	This work was supported by the University of Sydney and the Australian Research Council. KB is supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahram S, 2000, Adv Immunol, V76, P1; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bonneaud C, 2004, IMMUNOGENETICS, V55, P855, DOI 10.1007/s00251-004-0648-3; Borg AA, 2011, ECOL EVOL, V1, P145, DOI 10.1002/ece3.13; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; EASTEAL S, 1981, BIOL J LINN SOC, V16, P93, DOI 10.1111/j.1095-8312.1981.tb01645.x; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Flajnik MF, 1999, J IMMUNOL, V163, P3826; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; FLAJNIK MF, 1991, P NATL ACAD SCI USA, V88, P537, DOI 10.1073/pnas.88.2.537; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Goyos A, 2011, J IMMUNOL, V186, P372, DOI 10.4049/jimmunol.1001467; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelehear C, 2009, PARASITOLOGY, V136, P919, DOI 10.1017/S0031182009006325; Kiemnec-Tyburczy KM, 2012, HEREDITY, V109, P146, DOI 10.1038/hdy.2012.22; KLEIN J, 1986, NATURAL HIST MAJOR H; Llewellyn D, 2012, BIOL INVASIONS, V14, P999, DOI 10.1007/s10530-011-0135-3; McClelland EK, 2011, FISH SHELLFISH IMMUN, V31, P507, DOI 10.1016/j.fsi.2011.06.012; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Okamura K, 1997, IMMUNITY, V7, P777, DOI 10.1016/S1074-7613(00)80396-9; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Salter-Cid L, 1998, J IMMUNOL, V160, P2853; Schut E, 2011, IMMUNOGENETICS, V63, P531, DOI 10.1007/s00251-011-0532-x; SHUM BP, 1993, J IMMUNOL, V151, P5376; Slade RW, 1998, P ROY SOC B-BIOL SCI, V265, P769, DOI 10.1098/rspb.1998.0359; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teacher AGF, 2009, PLOS ONE, V4; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114	37	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102824	10.1371/journal.pone.0102824	http://dx.doi.org/10.1371/journal.pone.0102824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093458	gold, Green Submitted, Green Published			2022-12-25	WOS:000341357200014
J	Jabourian, A; Lancrenon, S; Delva, C; Perreve-Genet, A; Lablanchy, JP; Jabourian, M				Jabourian, Artin; Lancrenon, Sylvie; Delva, Catherine; Perreve-Genet, Alain; Lablanchy, Jean-Pierre; Jabourian, Maritza			Gait Velocity Is an Indicator of Cognitive Performance in Healthy Middle-Aged Adults	PLOS ONE			English	Article							OSTERRIETH COMPLEX FIGURE; FALL-RELATED FRACTURES; MINI-MENTAL STATE; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; SPATIAL COGNITION; PHYSICAL FUNCTION; OLDER PERSONS; DUAL-TASK; DECLINE	Psychomotor retardation, especially motor and cognitive slowing down, has been described many times in the elderly but to our knowledge, has never been examined in healthy middle-aged adults. The present study explores whether walking time may provide an early signal of cognitive performance, using 266 healthy adults ([18-65] years old, mean age: 45.7 +/- 12.9 years) who were also subdivided in 2 groups: under or over 50. Walking time (50 meters) and cognitive performances (mini-mental state examination, Benton Visual Retention Test and Rey Complex Figure) were assessed; total psychometric score was the sum of individual test scores. Analyses were controlled for age, gender, education level, height and weight. The mean psychometric scores were within the normal range. A substantial proportion of subjects exhibited low performance in some aspects of visuospatial memory, particularly in the older subset. In the total population, walking time was negatively correlated with all cognitive tests, particularly to total psychometric score (R = -0.817, p < 0.0001); the unique contribution of walking time on all cognitive scores was very high (delta R-squared = 0.496). In the older subset, performances on walk and cognition were lower than in the younger subset. Total psychometric score showed the strongest correlation with walking time in the older subset (R = -0.867; p<0.001). In all subsets, walking time was the main explanatory variable of the total psychometric score (delta R-squared: <= 49 = 0.361; >= 50 = 0.613). These findings indicate that i) a significant proportion of adults without cognitive complaints exhibit low cognitive performance including visuospatial memory and longer walking time, ii) cognitive functioning is strongly correlated to walking time in healthy middle-aged adults, iii) gait velocity (GV) could be an indicator of cognitive performance in some important cognitive domains. These results warrant further investigation because such data may represent a marker for the detection of middle-aged adults who are at risk for further cognitive decline.	[Jabourian, Artin; Jabourian, Maritza] Clin Neurophysiol Lab, Paris, France; [Lancrenon, Sylvie; Delva, Catherine] SYLIA STAT, Bourg La Reine, France; [Perreve-Genet, Alain] Ctr Cardiol, Paris, France; [Lablanchy, Jean-Pierre] Ctr Psychiat, Paris, France		Jabourian, M (corresponding author), Clin Neurophysiol Lab, Paris, France.	maritza.jabourian@gmail.com						Abrams L, 2009, NEUROBIOL AGING, V30, P525, DOI 10.1016/j.neurobiolaging.2008.11.012; [Anonymous], GERIATRIC NEUROPSYCH; BENSON DF, 1988, ARCH NEUROL-CHICAGO, V45, P789, DOI 10.1001/archneur.1988.00520310107024; Benton A, 1965, MANUEL APPL TEST RET; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; DEJAEGER C, 1994, J AM GERIATR SOC, V42, P1305, DOI 10.1111/j.1532-5415.1994.tb06519.x; Deshpande N, 2009, AGE AGEING, V38, P509, DOI 10.1093/ageing/afp093; FARBER JF, 1988, J AM GERIATR SOC, V36, P509, DOI 10.1111/j.1532-5415.1988.tb04020.x; Fastenau PS, 1999, CLIN NEUROPSYCHOL, V13, P30, DOI 10.1076/clin.13.1.30.1976; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; GOLDSTEIN G, 1981, Journal of Clinical Neuropsychology, V3, P65, DOI 10.1080/01688638108403114; Gorelick PB, 1999, NEUROLOGY, V52, P1114, DOI 10.1212/WNL.52.6.1114; HACHINSKI VC, 1993, NEUROLOGY, V43, P2159, DOI 10.1212/WNL.43.10.2159-a; Hausdorff JM, 1999, J AM GERIATR SOC, V47, P1346, DOI 10.1111/j.1532-5415.1999.tb07437.x; HENNERICI MG, 1994, DEMENTIA, V5, P197, DOI 10.1159/000106723; Holtzer R, 2012, MOTOR CONTROL, V16, P64, DOI 10.1123/mcj.16.1.64; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; JABOURIAN AP, 1995, ANN MED-PSYCHOL, V153, P89; JABOURIAN AP, 1994, BRIT J PSYCHIAT, V165, P122, DOI 10.1192/bjp.165.1.122b; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Maquet D, 2010, CLIN PHYSIOL FUNCT I, V30, P51, DOI 10.1111/j.1475-097X.2009.00903.x; Marquis S, 2002, ARCH NEUROL-CHICAGO, V59, P601, DOI 10.1001/archneur.59.4.601; Muir SW, 2012, GAIT POSTURE, V35, P96, DOI 10.1016/j.gaitpost.2011.08.014; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Parkin A. J, 1996, NEUROPSYCHOLOGY, V9, P304, DOI DOI 10.1037/0894-4105.9.3.304; Rey A., 1959, MANUEL TEST COPIE RE; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Ruggiero G, 2008, MEMORY, V16, P821, DOI 10.1080/09658210802307695; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Scherder E, 2007, NEUROSCI BIOBEHAV R, V31, P485, DOI 10.1016/j.neubiorev.2006.11.007; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Verlinden VJA, 2013, GAIT POSTURE, V37, P500, DOI 10.1016/j.gaitpost.2012.09.005; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007; Wiener SI, 2002, COGNITIVE BRAIN RES, V14, P75, DOI 10.1016/S0926-6410(02)00062-9	47	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103211	10.1371/journal.pone.0103211	http://dx.doi.org/10.1371/journal.pone.0103211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089518	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700022
J	Leet, JK; Lindberg, CD; Bassett, LA; Isales, GM; Yozzo, KL; Raftery, TD; Volz, DC				Leet, Jessica K.; Lindberg, Casey D.; Bassett, Luke A.; Isales, Gregory M.; Yozzo, Krystle L.; Raftery, Tara D.; Volz, David C.			High-Content Screening in Zebrafish Embryos Identifies Butafenacil as a Potent Inducer of Anemia	PLOS ONE			English	Article							RISK-ASSESSMENT; ASSAY; HAZARD; MODEL	Using transgenic zebrafish (fli1:egfp) that stably express enhanced green fluorescent protein (eGFP) within vascular endothelial cells, we recently developed and optimized a 384-well high-content screening (HCS) assay that enables us to screen and identify chemicals affecting cardiovascular development and function at non-teratogenic concentrations. Within this assay, automated image acquisition procedures and custom image analysis protocols are used to quantify body length, heart rate, circulation, pericardial area, and intersegmental vessel area within individual live embryos exposed from 5 to 72 hours post-fertilization. After ranking developmental toxicity data generated from the U.S. Environmental Protection Agency's (EPA's) zebrafish teratogenesis assay, we screened 26 of the most acutely toxic chemicals within EPA's ToxCast Phase-I library in concentration-response format (0.05-50 mu M) using this HCS assay. Based on this screen, we identified butafenacil as a potent inducer of anemia, as exposure from 0.39 to 3.125 mu M butafenacil completely abolished arterial circulation in the absence of effects on all other endpoints evaluated. Butafenacil is an herbicide that inhibits protoporphyrinogen oxidase (PPO)-an enzyme necessary for heme production in vertebrates. Using o-dianisidine staining, we then revealed that severe butafenacil-induced anemia in zebrafish was due to a complete loss of hemoglobin following exposure during early development. Therefore, six additional PPO inhibitors within the ToxCast Phase-I library were screened to determine whether anemia represents a common adverse outcome for these herbicides. Embryonic exposure to only one of these PPO inhibitors - flumioxazin - resulted in a similar phenotype as butafenacil, albeit not as severe as butafenacil. Overall, this study highlights the potential utility of this assay for (1) screening chemicals for cardiovascular toxicity and (2) prioritizing chemicals for future hypothesis-driven and mechanism-focused investigations within zebrafish and mammalian models.	[Leet, Jessica K.; Lindberg, Casey D.; Bassett, Luke A.; Isales, Gregory M.; Yozzo, Krystle L.; Raftery, Tara D.; Volz, David C.] Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Volz, DC (corresponding author), Univ S Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.	volz@mailbox.sc.edu	Catron, Tara/J-2009-2019	Catron, Tara/0000-0003-1193-9366	U.S. Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant [R835169]	U.S. Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant	Funding was provided by a U.S. Environmental Protection Agency (EPA) Science to Achieve Results (STAR) Grant No. R835169 to DCV. The contents of this manuscript are solely the responsibility of DCV and do not necessarily represent the official views of the U.S. EPA. Further, the U.S. EPA does not endorse the purchase of any commercial products or services mentioned in the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Dooley KA, 2008, EXP HEMATOL, V36, P1132, DOI 10.1016/j.exphem.2008.04.008; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Halder Marlies, 2010, Integrated Environmental Assessment and Management, V6, P484, DOI 10.1002/ieam.48; Hanaoka R, 2007, DNA SEQUENCE, V18, P54, DOI 10.1080/10425170601060848; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kawamura S, 1996, TOXICOL APPL PHARM, V141, P520, DOI 10.1006/taap.1996.0317; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Letamendia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036690; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; National Research Council, 2007, TOXICITY TESTING 21; NIH, 2007, GUID US ZEBR NIH INT; NRA, 2002, EV NEW ACT BUT PROD; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Programs OoP, 2003, BUT PEST TOL, P54818; Ransom DG, 1996, DEVELOPMENT, V123, P311; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Van den Bulck K, 2011, REPROD TOXICOL, V32, P213, DOI 10.1016/j.reprotox.2011.06.119; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Yozzo KL, 2013, ENVIRON SCI TECHNOL, V47, P11302, DOI 10.1021/es403360y	27	35	36	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104190	10.1371/journal.pone.0104190	http://dx.doi.org/10.1371/journal.pone.0104190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090246	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700106
J	Noseda, R; Kainz, V; Borsook, D; Burstein, R				Noseda, Rodrigo; Kainz, Vanessa; Borsook, David; Burstein, Rami			Neurochemical Pathways That Converge on Thalamic Trigeminovascular Neurons: Potential Substrate for Modulation of Migraine by Sleep, Food Intake, Stress and Anxiety	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; LATERAL GENICULATE-NUCLEUS; LOCUS-COERULEUS STIMULATION; OREXIN NEURONS; VENTROPOSTEROMEDIAL NUCLEUS; NORADRENERGIC MODULATION; SYNAPTIC ORGANIZATION; DOPAMINE INNERVATION; VENTROBASAL THALAMUS; CEREBRAL-CORTEX	Dynamic thalamic regulation of sensory signals allows the cortex to adjust better to rapidly changing behavioral, physiological and environmental demands. To fulfill this role, thalamic neurons must themselves be subjected to constantly changing modulatory inputs that originate in multiple neurochemical pathways involved in autonomic, affective and cognitive functions. Our overall goal is to define an anatomical framework for conceptualizing how a 'decision' is made on whether a trigeminovascular thalamic neuron fires, for how long, and at what frequency. To begin answering this question, we determine which neuropeptides/neurotransmitters are in a position to modulate thalamic trigeminovascular neurons. Using a combination of in-vivo single-unit recording, juxtacellular labeling with tetramethylrhodamine dextran (TMR) and in-vitro immunohistochemistry, we found that thalamic trigeminovascular neurons were surrounded by high density of axons containing biomarkers of glutamate, GABA, dopamine and serotonin; moderate density of axons containing noradrenaline and histamine; low density of axons containing orexin and melanin concentrating hormone (MCH); but not axons containing CGRP, serotonin 1D receptor, oxytocin or vasopressin. In the context of migraine, the findings suggest that the transmission of headache-related nociceptive signals from the thalamus to the cortex may be modulated by opposing forces (i.e., facilitatory, inhibitory) that are governed by continuous adjustments needed to keep physiological, behavioral, cognitive and emotional homeostasis.	[Noseda, Rodrigo; Kainz, Vanessa; Burstein, Rami] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA; [Borsook, David] Harvard Univ, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Noseda, R (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	rnoseda@bidmc.harvard.edu	Noseda, Rodrigo/AAN-1761-2020	Noseda, Rodrigo/0000-0002-9641-4691	National Institutes of Health [NS-069847, NS-079687]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069847, R37NS079678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health Grants NS-069847 and NS-079687 (R.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2009, PEPTIDES, V30, P2066, DOI 10.1016/j.peptides.2009.06.024; AEBELHOLTKRABBE A, 1980, PAIN, V8, P253, DOI 10.1016/0304-3959(88)90012-7; Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Barroso-Chinea P, 2008, J CHEM NEUROANAT, V35, P101, DOI 10.1016/j.jchemneu.2007.08.001; Bergerot A, 2007, ANN NEUROL, V61, P251, DOI 10.1002/ana.21077; Berridge CW, 2012, SLEEP MED REV, V16, P187, DOI 10.1016/j.smrv.2011.12.003; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bittencourt JC, 1998, BRAIN RES, V804, P140, DOI 10.1016/S0006-8993(98)00662-3; Broberger C, 1998, J COMP NEUROL, V402, P460; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; CONSOLAZIONE A, 1984, BRAIN RES, V322, P233, DOI 10.1016/0006-8993(84)90113-6; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; DELIMA AD, 1987, J COMP NEUROL, V259, P92, DOI 10.1002/cne.902590107; DESCHENES M, 1990, BRAIN RES, V513, P339, DOI 10.1016/0006-8993(90)90478-T; Devilbiss DM, 2004, J NEUROSCI, V24, P10773, DOI 10.1523/JNEUROSCI.1573-04.2004; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; EATON SA, 1989, NEUROSCIENCE, V33, P285, DOI 10.1016/0306-4522(89)90208-X; Ego-Stengel V, 2002, NEUROSCIENCE, V111, P275, DOI 10.1016/S0306-4522(02)00011-8; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Garcia-Cabezas MA, 2009, CEREB CORTEX, V19, P424, DOI 10.1093/cercor/bhn093; Ge SN, 2010, J COMP NEUROL, V518, P3149, DOI 10.1002/cne.22389; Girault EM, 2012, PROG BRAIN RES, V198, P47, DOI 10.1016/B978-0-444-59489-1.00005-7; Gonzalez MI, 1996, PEPTIDES, V17, P171, DOI 10.1016/0196-9781(95)02092-6; Govindaiah G, 2006, NEUROPHARMACOLOGY, V51, P414, DOI 10.1016/j.neuropharm.2006.03.030; Govindaiah G, 2010, NEUROSCIENCE, V170, P981, DOI 10.1016/j.neuroscience.2010.08.043; Graziano A, 2008, J COMP NEUROL, V507, P1258, DOI 10.1002/cne.21592; Green AR, 2006, BRIT J PHARMACOL, V147, pS145; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Homberg JR, 2012, NEUROSCI BIOBEHAV R, V36, P218, DOI 10.1016/j.neubiorev.2011.06.001; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kagan R, 2013, NEUROSCIENCE, V248, P359, DOI 10.1016/j.neuroscience.2013.06.014; KANEKO T, 1988, J COMP NEUROL, V267, P590, DOI 10.1002/cne.902670411; KAYAMA Y, 1982, NEUROSCIENCE, V7, P655, DOI 10.1016/0306-4522(82)90071-9; KAYAMA Y, 1985, VISION RES, V25, P339, DOI 10.1016/0042-6989(85)90058-6; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Leinninger GM, 2011, PHYSIOL BEHAV, V104, P572, DOI 10.1016/j.physbeh.2011.04.060; Levy D, 2004, P NATL ACAD SCI USA, V101, P4274, DOI 10.1073/pnas.0306147101; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LINDVALL O, 1974, J COMP NEUROL, V154, P317, DOI 10.1002/cne.901540307; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1991, J NEUROSCI, V11, P3188; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; MELTZER H, 1989, BRIT J PSYCHIAT, V155, P25, DOI 10.1192/S0007125000291733; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONTI JM, 1993, LIFE SCI, V53, P1331, DOI 10.1016/0024-3205(93)90592-Q; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MORRISON JH, 1986, J COMP NEUROL, V243, P117, DOI 10.1002/cne.902430110; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nathan DE, 2012, IEEE ENG MED BIO, P5445, DOI 10.1109/EMBC.2012.6347226; Nielsen K, 2006, SYNAPSE, V59, P270, DOI 10.1002/syn.20240; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; NOTHIAS F, 1988, NEUROSCI LETT, V95, P59, DOI 10.1016/0304-3940(88)90632-5; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PAPADOPOULOS GC, 1990, J COMP NEUROL, V294, P345, DOI 10.1002/cne.902940304; PAPADOPOULOS GC, 1990, J COMP NEUROL, V294, P356, DOI 10.1002/cne.902940305; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Paxinos G, 2008, RAT BRAIN STEREOTAXI; Peyron C, 1998, J NEUROSCI, V18, P9996; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; ROGAWSKI MA, 1980, NATURE, V287, P731, DOI 10.1038/287731a0; ROGAWSKI MA, 1980, EXP NEUROL, V69, P678, DOI 10.1016/0014-4886(80)90060-6; Rondou P, 2010, CELL MOL LIFE SCI, V67, P1971, DOI 10.1007/s00018-010-0293-y; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; SALT TE, 1989, EXP BRAIN RES, V77, P646; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Shields KG, 2006, NEUROBIOL DIS, V23, P491, DOI 10.1016/j.nbd.2006.04.003; Shields KG, 2005, BRAIN, V128, P86, DOI 10.1093/brain/awh298; SICUTERI F, 1972, HEADACHE, V12, P69, DOI 10.1111/j.1526-4610.1972.hed1202069.x; SICUTERI F, 1977, HEADACHE, V17, P129, DOI 10.1111/j.1526-4610.1977.hed1703129.x; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Summ O, 2010, BRAIN, V133, P2540, DOI 10.1093/brain/awq224; TAKADA M, 1988, BRAIN RES, V455, P346, DOI 10.1016/0006-8993(88)90093-5; Takahashi H, 2006, BIOL PSYCHIAT, V59, P919, DOI 10.1016/j.biopsych.2006.01.022; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; WELCH KMA, 1993, NEW ENGL J MED, V329, P1476; WESTLUND KN, 1990, J COMP NEUROL, V295, P197, DOI 10.1002/cne.902950204; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	109	51	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103929	10.1371/journal.pone.0103929	http://dx.doi.org/10.1371/journal.pone.0103929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090640	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700065
J	Zhang, ZQ; He, LP; Xie, XY; Ling, WH; Deng, J; Su, YX; Chen, YM				Zhang, Zhe-qing; He, Li-ping; Xie, Xiao-yan; Ling, Wen-hua; Deng, Juan; Su, Yi-xiang; Chen, Yu-ming			Association of Simple Anthropometric Indices and Body Fat with Early Atherosclerosis and Lipid Profiles in Chinese Adults	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; CAROTID-ARTERY; CARDIOMETABOLIC RISK; METABOLIC SYNDROME; ABDOMINAL OBESITY; MYOCARDIAL-INFARCTION	Objective: The discriminatory capability of different adiposity indices for atherosclerosis and lipid abnormalities remains uncertain. This study aimed to identify the best adiposity index for predicting early atherosclerosis and abnormal lipid profiles among anthropometric parameters and body fat measures in middle-aged and elderly Chinese. Method: A total of 2,063 women and 814 men (57.6 +/- 5.2 y) were recruited for this community-based cross-sectional study. Body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) were assessed. Body fat mass and its percentage values for the whole body and trunk were measured by bioelectrical impedance analysis (BIA). The intima-media thicknesses (IMTs) of the common carotid arteries (CCA), internal carotid arteries (ICA) and bifurcation (BIF) were determined via B-mode ultrasound. The fasting lipid profiles were assessed. Results: With per SD increase of adiposity indices, the magnitude of the changes of IMT values and lipid profiles was more substantial for WC, WHR and WHtR in both genders. A multivariate logistic regression analysis indicated that WC, WHR and WHtR were more sensitive in predicting the presence of intima-media thickening at the three segments as well as the lipids disturbances in women and men. In general, BIA-derived measures have no added predictive value for IMT-thickening as opposed to those three traditional abdominal measures. Conclusion: Our findings suggest that abdominal anthropometric measures including WC, WHR and WHtR are sensitive for discriminating carotid atherosclerosis and lipids abnormalities. WC is the best index because of its simplicity in routine use.	[Zhang, Zhe-qing; He, Li-ping; Ling, Wen-hua; Deng, Juan; Su, Yi-xiang; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Xiao-yan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Ultrasound, Guangzhou 510275, Guangdong, Peoples R China; [He, Li-ping] Guangzhou Panyu Cent Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Su, YX (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food, Guangzhou 510275, Guangdong, Peoples R China.	suyx@mail.sysu.edu.cn; chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019		5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China [2007032]; State Key Program of National Natural Science of China [81130052]	5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was jointly supported by the 5010 Program for Clinical Researches by Sun Yat-sen University, Guangzhou, China (No. 2007032), and the State Key Program of National Natural Science of China (No. 81130052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Beni MH, 2012, ASIA PAC J CLIN NUTR, V21, P220; Browning LM, 2010, OBESITY, V18, P2385, DOI 10.1038/oby.2010.71; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Chen MM, 2001, OBES RES, V9, P651, DOI 10.1038/oby.2001.87; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Czernichow S, 2005, INT J OBESITY, V29, P826, DOI 10.1038/sj.ijo.0802986; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; De Michele M, 2002, STROKE, V33, P2923, DOI 10.1161/01.STR.0000038989.90931.BE; Despres JP, 2008, ANN MED, V40, P514, DOI 10.1080/07853890802004959; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Gonzalez AS, 2007, NUTRITION, V23, P36, DOI 10.1016/j.nut.2006.08.019; Ho JS, 2009, AM J CARDIOL, V104, P943, DOI 10.1016/j.amjcard.2009.05.047; Ho SY, 2003, ANN EPIDEMIOL, V13, P683, DOI 10.1016/S1047-2797(03)00067-X; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Kawamoto R, 2008, INTERNAL MED, V47, P143, DOI 10.2169/internalmedicine.47.0478; Kay SJ, 2006, OBES REV, V7, P183, DOI 10.1111/j.1467-789X.2006.00250.x; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Lee K, 2008, OBESITY, V16, P834, DOI 10.1038/oby.2007.109; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Maher V, 2009, INT J OBESITY, V33, P136, DOI 10.1038/ijo.2008.254; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Salonen JT, 1997, CIRCULATION, V95, P840; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Takami R, 2001, DIABETES CARE, V24, P1248, DOI 10.2337/diacare.24.7.1248; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Wang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032736; Wannamethee SG, 2005, AM J CLIN NUTR, V81, P1313; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Xu L, 2011, J CLIN DENSITOM, V14, P458, DOI 10.1016/j.jocd.2011.04.001; Yan RT, 2009, ATHEROSCLEROSIS, V207, P232, DOI 10.1016/j.atherosclerosis.2009.03.053; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yu RHY, 2008, MENOPAUSE, V15, P185, DOI 10.1097/gme.0b013e31806458c9; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhang Z.G., 2013, PLOS ONE, P8; 2001, JAMA, V285, P2486	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104361	10.1371/journal.pone.0104361	http://dx.doi.org/10.1371/journal.pone.0104361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090639	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700119
J	Kondo, Y; Iwao, T; Yoshihashi, S; Mimori, K; Ogihara, R; Nagata, K; Kurose, K; Saito, M; Niwa, T; Suzuki, T; Miyata, N; Ohmori, S; Nakamura, K; Matsunaga, T				Kondo, Yuki; Iwao, Takahiro; Yoshihashi, Sachimi; Mimori, Kayo; Ogihara, Ruri; Nagata, Kiyoshi; Kurose, Kouichi; Saito, Masayoshi; Niwa, Takuro; Suzuki, Takayoshi; Miyata, Naoki; Ohmori, Shigeru; Nakamura, Katsunori; Matsunaga, Tamihide			Histone Deacetylase Inhibitor Valproic Acid Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells	PLOS ONE			English	Article							SMALL MOLECULES; FUNCTIONAL HEPATOCYTES; EFFICIENT GENERATION; LIVER DEVELOPMENT; DEFINED FACTORS; IDENTIFICATION; TRANSDUCTION; INDUCTION; ENDODERM; DRUGS	In this study, we aimed to elucidate the effects and mechanism of action of valproic acid on hepatic differentiation from human induced pluripotent stem cell-derived hepatic progenitor cells. Human induced pluripotent stem cells were differentiated into endodermal cells in the presence of activin A and then into hepatic progenitor cells using dimethyl sulfoxide. Hepatic progenitor cells were matured in the presence of hepatocyte growth factor, oncostatin M, and dexamethasone with valproic acid that was added during the maturation process. After 25 days of differentiation, cells expressed hepatic marker genes and drug-metabolizing enzymes and exhibited drug-metabolizing enzyme activities. These expression levels and activities were increased by treatment with valproic acid, the timing and duration of which were important parameters to promote differentiation from human induced pluripotent stem cell-derived hepatic progenitor cells into hepatocytes. Valproic acid inhibited histone deacetylase activity during differentiation of human induced pluripotent stem cells, and other histone deacetylase inhibitors also enhanced differentiation into hepatocytes. In conclusion, histone deacetylase inhibitors such as valproic acid can be used to promote hepatic differentiation from human induced pluripotent stem cell-derived hepatic progenitor cells.	[Kondo, Yuki; Iwao, Takahiro; Nakamura, Katsunori; Matsunaga, Tamihide] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Nagoya, Aichi, Japan; [Iwao, Takahiro; Yoshihashi, Sachimi; Mimori, Kayo; Ogihara, Ruri; Nakamura, Katsunori; Matsunaga, Tamihide] Nagoya City Univ, Fac Pharmaceut Sci, Educ Res Ctr Clin Pharm, Nagoya, Aichi 467, Japan; [Nagata, Kiyoshi] Tohoku Pharmaceut Univ, Environm & Hlth Res Dept, Sendai, Miyagi, Japan; [Kurose, Kouichi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan; [Saito, Masayoshi; Niwa, Takuro] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Toda, Saitama, Japan; [Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Miyata, Naoki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Organ & Med Chem, Nagoya, Aichi, Japan; [Ohmori, Shigeru] Shinshu Univ, Dept Biochem Pharmacol & Toxicol, Matsumoto, Nagano 390, Japan	Nagoya City University; Nagoya City University; Tohoku Medical & Pharmaceutical University; Tokyo University of Marine Science & Technology; Mitsubishi Tanabe Pharma Corporation; Kyoto Prefectural University of Medicine; Nagoya City University; Shinshu University	Matsunaga, T (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Nagoya, Aichi, Japan.	tmatsu@phar.nagoya-cu.ac.jp	Nakamura, Katsunori/ABA-7439-2021; Kurose, Kouichi/O-1966-2014	Kurose, Kouichi/0000-0002-7042-0153	Japan Society for the Promotion of Science [23390036, 22390028, 25460193]; Japan Health Sciences Foundation [KHB1011, KHB1208]; Japanese Ministry of Health, Labor, and Welfare [H22-003]; Mitsubishi Tanabe Pharma Corporation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Sciences Foundation; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This work was supported, in part, by Grants-in-Aid from the Japan Society for the Promotion of Science (23390036, 22390028 and 25460193), by Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation (KHB1011 and KHB1208), and by a National Grant-in-Aid from Japanese Ministry of Health, Labor, and Welfare (H22-003). Mitsubishi Tanabe Pharma Corporation provided support in the form of salaries for authors MS & TN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Dong XJ, 2009, WORLD J GASTROENTERO, V15, P5165, DOI 10.3748/wjg.15.5165; Dong XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063405; EADIE MJ, 1991, CLIN PHARMACOKINET, V21, P27, DOI 10.2165/00003088-199121010-00003; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hannoun Z, 2010, CURR STEM CELL RES T, V5, P233, DOI 10.2174/157488810791824403; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iwao T, 2014, DRUG METAB PHARMACOK, V29, P44, DOI 10.2133/dmpk.DMPK-13-RG-005; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P237, DOI 10.2133/dmpk.DMPK-13-RG-104; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Suzuki T, 2005, CURR MED CHEM, V12, P2867, DOI 10.2174/092986705774454706; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068669; Suzuki T, 2012, J MED CHEM, V55, P9562, DOI 10.1021/jm300837y; Tahamtani Y, 2013, STEM CELLS DEV, V22, P1419, DOI 10.1089/scd.2012.0453; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wen X, 2001, BRIT J CLIN PHARMACO, V52, P547, DOI 10.1046/j.0306-5251.2001.01474.x; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699	30	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104010	10.1371/journal.pone.0104010	http://dx.doi.org/10.1371/journal.pone.0104010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084468	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800117
J	Renault, TT; Elkholi, R; Bharti, A; Chipuk, JE				Renault, Thibaud T.; Elkholi, Rana; Bharti, Archana; Chipuk, Jerry E.			B Cell Lymphoma-2 (BCL-2) Homology Domain 3 (BH3) Mimetics Demonstrate Differential Activities Dependent upon the Functional Repertoire of Pro-and Anti-apoptotic BCL-2 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL-MEMBRANE; OLIGOMERIZES BAK; DEATH; INHIBITORS; POTENT; DISCOVERY; ADDICTION; CANCERS	The B cell lymphoma-2 (BCL-2) family is the key mediator of cellular sensitivity to apoptosis during pharmacological interventions for numerous human pathologies, including cancer. There is tremendous interest to understand how the proapoptotic BCL-2 effector members (e. g. BCL-2-associated X protein, BAX) cooperate with the BCL-2 homology domain only (BH3-only) subclass (e. g. BCL-2 interacting mediator of death, BIM; BCL-2 interacting-domain death agonist, BID) to induce mitochondrial outer membrane permeabilization (MOMP) and apoptosis and whether these mechanisms may be pharmacologically exploited to enhance the killing of cancer cells. Indeed, small molecule inhibitors of the anti-apoptotic BCL-2 family members have been designed rationally. However, the success of these "BH3 mimetics" in the clinic has been limited, likely due to an incomplete understanding of how these drugs function in the presence of multiple BCL-2 family members. To increase our mechanistic understanding of how BH3 mimetics cooperate with multiple BCL-2 family members in vitro, we directly compared the activity of several BH3-mimetic compounds (i.e. ABT-263, ABT-737, GX15-070, HA14.1, TW-37) in biochemically defined large unilamellar vesicle model systems that faithfully recapitulate BAX-dependent mitochondrial outer membrane permeabilization. Our investigations revealed that the presence of BAX, BID, and BIM differentially regulated the ability of BH3 mimetics to derepress proapoptotic molecules from anti-apoptotic proteins. Using mitochondria loaded with fluorescent BH3 peptides and cells treated with inducers of cell death, these differences were supported. Together, these data suggest that although the presence of anti-apoptotic BCL-2 proteins primarily dictates cellular sensitivity to BH3 mimetics, additional specificity is conferred by proapoptotic BCL-2 proteins.	[Renault, Thibaud T.; Elkholi, Rana; Bharti, Archana; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Renault, Thibaud T.; Elkholi, Rana; Bharti, Archana; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Elkholi, Rana; Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Chipuk, Jerry E.] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chipuk, JE (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	jerry.chipuk@mssm.edu		Chipuk, Jerry Edward/0000-0002-1337-842X; Renault, Thibaud/0000-0002-1530-2613	National Institutes of Health [CA157740, P20AA017067]; JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; March of Dimes Foundation [5-FY11-74, 1-FY13-416]; Developmental Research Pilot Project Program within Department of Oncological Sciences at Mount Sinai; NATIONAL CANCER INSTITUTE [R01CA157740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JJR Foundation; William A. Spivak Fund; Fridolin Charitable Trust; March of Dimes Foundation(March of Dimes); Developmental Research Pilot Project Program within Department of Oncological Sciences at Mount Sinai; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants CA157740 (to J. E. C.) and a pilot project from National Institutes of Health P20AA017067 (to J. E. C.); the JJR Foundation (to J. E. C.), the William A. Spivak Fund (to J. E. C.), and the Fridolin Charitable Trust (to J. E. C.). This work was also supported in part by Research Grants 5-FY11-74 and 1-FY13-416 from the March of Dimes Foundation (to J. E. C.) and the Developmental Research Pilot Project Program within the Department of Oncological Sciences at Mount Sinai (to J. E. C.).	Asciolla JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4291; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Elkholi Rana, 2011, Genes Cancer, V2, P523, DOI 10.1177/1947601911417177; Ertel F, 2013, EMBO REP, V14, P328, DOI 10.1038/embor.2013.20; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Kitada S, 2008, BLOOD, V111, P3211, DOI 10.1182/blood-2007-09-113647; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lickliter JD, 2003, LEUKEMIA, V17, P2074, DOI 10.1038/sj.leu.2403102; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Renault TT, 2013, METHODS, V61, P146, DOI 10.1016/j.ymeth.2013.03.030; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Serasinghe MN, 2015, ONCOGENE, V34, P857, DOI 10.1038/onc.2014.21; Sun J, 2008, ANTI-CANCER DRUG, V19, P967, DOI 10.1097/CAD.0b013e32831087e8; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2000, GENE DEV, V14, P2060; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	42	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26481	26491		10.1074/jbc.M114.569632	http://dx.doi.org/10.1074/jbc.M114.569632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25096574	Green Published, hybrid			2022-12-25	WOS:000342128800039
J	Vatsyayan, R; Kothari, H; Mackman, N; Pendurthi, UR; Rao, LVM				Vatsyayan, Rit; Kothari, Hema; Mackman, Nigel; Pendurthi, Usha R.; Rao, L. Vijaya Mohan			Inactivation of Factor VIIa by Antithrombin In Vitro, Ex Vivo and In Vivo: Role of Tissue Factor and Endothelial Cell Protein C Receptor	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; III-HEPARIN; PLASMA; COMPLEXES; HEMOSTASIS; BINDING; COAGULATION; EXPRESSION; THROMBOSIS; ARTERIAL	Recent studies have suggested that antithrombin (AT) could act as a significant physiologic regulator of FVIIa. However, in vitro studies showed that AT could inhibit FVIIa effectively only when it was bound to tissue factor (TF). Circulating blood is known to contain only traces of TF, at best. FVIIa also binds endothelial cell protein C receptor (EPCR), but the role of EPCR on FVIIa inactivation by AT is unknown. The present study was designed to investigate the role of TF and EPCR in inactivation of FVIIa by AT in vivo. Low human TF mice (low TF, similar to 1% expression of the mouse TF level) and high human TF mice (HTF, similar to 100% of the mouse TF level) were injected with human rFVIIa (120 mu g kg(-1) body weight) via the tail vein. At varying time intervals following rFVIIa administration, blood was collected to measure FVIIa-AT complex and rFVIIa antigen levels in the plasma. Despite the large difference in TF expression in the mice, HTF mice generated only 40-50% more of FVIIa-AT complex as compared to low TF mice. Increasing the concentration of TF in vivo in HTF mice by LPS injection increased the levels of FVIIa-AT complexes by about 25%. No significant differences were found in FVIIa-AT levels among wild-type, EPCR-deficient, and EPCR-overexpressing mice. The levels of FVIIa-AT complex formed in vitro and ex vivo were much lower than that was found in vivo. In summary, our results suggest that traces of TF that may be present in circulating blood or extravascular TF that is transiently exposed during normal vessel damage contributes to inactivation of FVIIa by AT in circulation. However, TF's role in AT inactivation of FVIIa appears to be minor and other factor(s) present in plasma, on blood cells or vascular endothelium may play a predominant role in this process.	[Vatsyayan, Rit; Kothari, Hema; Pendurthi, Usha R.; Rao, L. Vijaya Mohan] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA; [Mackman, Nigel] Univ N Carolina, Dept Med, McAllister Heart Inst, Div Hematol & Oncol, Chapel Hill, NC USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of North Carolina; University of North Carolina Chapel Hill	Rao, LVM (corresponding author), Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75799 USA.	Vijay.rao@uthct.edu			National Institutes of Health [HL107483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health grant HL107483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso H, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2010.04152.x; Agerso H, 2011, EUR J PHARM SCI, V42, P578, DOI 10.1016/j.ejps.2011.02.013; BROZE GJ, 1993, BLOOD, V82, P1679; BROZE GJ, 1995, BLOOD COAGUL FIBRIN, V6, pS7, DOI 10.1097/00001721-199506001-00002; Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567; Clark CA, 2012, J THROMB HAEMOST, V10, P2383, DOI 10.1111/j.1538-7836.2012.04917.x; Geddings JE, 2013, BLOOD, V122, P1873, DOI 10.1182/blood-2013-04-460139; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gopalakrishnan R, 2012, J THROMB HAEMOST, V10, P971, DOI 10.1111/j.1538-7836.2012.04670.x; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P2318, DOI 10.1111/j.1538-7836.2010.04010.x; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Hamamoto T, 1996, INT J HEMATOL, V63, P51; HAMAMOTO T, 1993, J BIOL CHEM, V268, P8704; Kothari H, 2010, BLOOD, V115, P4273, DOI 10.1182/blood-2009-09-241356; LAWSON JH, 1993, J BIOL CHEM, V268, P767; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Mackman N, 2008, J THROMB HAEMOST, V6, P303, DOI 10.1111/j.1538-7836.2007.02873.x; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Petersen LC, 2011, BRIT J HAEMATOL, V152, P99, DOI 10.1111/j.1365-2141.2010.08432.x; Petersen LC, 2009, THROMB HAEMOSTASIS, V101, P818, DOI 10.1160/TH08-10-0699; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; RAO LVM, 1993, BLOOD, V81, P2600; RAO LVM, 1995, BLOOD, V85, P121, DOI 10.1182/blood.V85.1.121.bloodjournal851121; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; RAPAPORT SI, 1992, ARTERIOSCLER THROMB, V12, P1111, DOI 10.1161/01.ATV.12.10.1111; Sen P, 2012, THROMB HAEMOSTASIS, V107, P951, DOI 10.1160/TH11-09-0672; Sen P, 2011, BLOOD, V117, P3199, DOI 10.1182/blood-2010-09-310706; SHIGEMATSU Y, 1992, J BIOL CHEM, V267, P21329; Silveira A, 2012, THROMB RES, V130, P221, DOI 10.1016/j.thromres.2011.08.029; Simioni P, 2011, THROMB RES, V128, P507, DOI 10.1016/j.thromres.2011.09.020; Smith SA, 2007, J THROMB HAEMOST, V5; Spiezia L, 2011, THROMB RES, V128, P303, DOI 10.1016/j.thromres.2011.05.020; Spiezia L, 2010, THROMB HAEMOSTASIS, V103, P1188, DOI 10.1160/TH09-08-0606; Sundaram J, 2014, J THROMB HAEMOST, V12, P690, DOI 10.1111/jth.12532; TAKAHASHI H, 1994, AM J HEMATOL, V46, P333, DOI 10.1002/ajh.2830460414; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; WARR TA, 1990, BLOOD, V75, P1481	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103505	10.1371/journal.pone.0103505	http://dx.doi.org/10.1371/journal.pone.0103505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102166	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900020
J	Pearson, DE; Icasatti, NS; Hierro, JL; Bird, BJ				Pearson, Dean E.; Icasatti, Nadia S.; Hierro, Jose L.; Bird, Benjamin J.			Are Local Filters Blind to Provenance? Ant Seed Predation Suppresses Exotic Plants More than Natives	PLOS ONE			English	Article							FEEDING-PREFERENCE EXPERIMENTS; HARVESTER ANTS; BIOTIC RESISTANCE; INVASIONS; COMMUNITY; DESERT; DESIGN; SIZE; INVASIVENESS; MYRMECOCHORY	The question of whether species' origins influence invasion outcomes has been a point of substantial debate in invasion ecology. Theoretically, colonization outcomes can be predicted based on how species' traits interact with community filters, a process presumably blind to species' origins. Yet, exotic plant introductions commonly result in monospecific plant densities not commonly seen in native assemblages, suggesting that exotic species may respond to community filters differently than natives. Here, we tested whether exotic and native species differed in their responses to a local community filter by examining how ant seed predation affected recruitment of eighteen native and exotic plant species in central Argentina. Ant seed predation proved to be an important local filter that strongly suppressed plant recruitment, but ants suppressed exotic recruitment far more than natives (89% of exotic species vs. 22% of natives). Seed size predicted ant impacts on recruitment independent of origins, with ant preference for smaller seeds resulting in smaller seeded plant species being heavily suppressed. The disproportionate effects of provenance arose because exotics had generally smaller seeds than natives. Exotics also exhibited greater emergence and earlier peak emergence than natives in the absence of ants. However, when ants had access to seeds, these potential advantages of exotics were negated due to the filtering bias against exotics. The differences in traits we observed between exotics and natives suggest that higher-order introduction filters or regional processes preselected for certain exotic traits that then interacted with the local seed predation filter. Our results suggest that the interactions between local filters and species traits can predict invasion outcomes, but understanding the role of provenance will require quantifying filtering processes at multiple hierarchical scales and evaluating interactions between filters.	[Pearson, Dean E.] Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59808 USA; [Pearson, Dean E.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Hierro, Jose L.] Univ Nacl La Pampa, Consejo Nacl Invest Cient & Tecn, Inst Ciencias Tierra & Ambientales La Pampa, Santa Rosa, La Pampa, Argentina; [Hierro, Jose L.] Univ Nacl La Pampa, Fac Ciencias Exactas & Nat, Santa Rosa, La Pampa, Argentina; [Icasatti, Nadia S.; Bird, Benjamin J.] Forest Serv, Rocky Mt Res Stn, USDA, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); United States Department of Agriculture (USDA); United States Forest Service	Pearson, DE (corresponding author), Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59808 USA.	dpearson@fs.fed.us			PECASE (President's Early Career Award in Science and Engineering); Rocky Mountain Research Station, USDA Forest Service	PECASE (President's Early Career Award in Science and Engineering); Rocky Mountain Research Station, USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This project was supported by funding from PECASE (President's Early Career Award in Science and Engineering) and the Rocky Mountain Research Station, USDA Forest Service to DEP. ANPCyT (Agencia Nacional para la Promocion de la Cienciay la Tecnologi a), FCEyN (Facultad de Ciencias Exactas y Naturales), and CIN (Interuniversity National Council of Argentina) Consejo Interuniversitario Nacional to JLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Lynn C, 2010, PLANT ECOL, V210, P291, DOI 10.1007/s11258-010-9757-2; Allington GRH, 2013, ECOL LETT, V16, P158, DOI 10.1111/ele.12023; ANDERSEN AN, 1987, OIKOS, V48, P171, DOI 10.2307/3565852; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; Beattie Andrew J., 2002, P211; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; Cadotte MW, 2001, ECOSCIENCE, V8, P230, DOI 10.1080/11956860.2001.11682649; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Connolly B, 2014, ECOLOGY IN PRESS; COTTRELL HJ, 1947, NATURE, V159, P748, DOI 10.1038/159748a0; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Ferreira AV, 2011, OIKOS, V120, P1013, DOI 10.1111/j.1600-0706.2010.19052.x; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Heredia A, 2005, BEHAV PROCESS, V70, P289, DOI 10.1016/j.beproc.2005.08.001; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; HUGHES L, 1994, FUNCT ECOL, V8, P358, DOI 10.2307/2389829; HUGHES L, 1992, ECOLOGY, V73, P1300, DOI 10.2307/1940677; Jensen JM, 2006, ENVIRON ENTOMOL, V35, P326, DOI 10.1603/0046-225X-35.2.326; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kaspari M, 1996, OECOLOGIA, V105, P397, DOI 10.1007/BF00328743; Leffler AJ, 2014, ECOLOGY, V95, P298, DOI 10.1890/13-0102.1; Lengyel S, 2010, PERSPECT PLANT ECOL, V12, P43, DOI 10.1016/j.ppees.2009.08.001; MacMahon JA, 2000, ANNU REV ECOL SYST, V31, P265, DOI 10.1146/annurev.ecolsys.31.1.265; MANLY BFJ, 1993, OECOLOGIA, V93, P149, DOI 10.1007/BF00321205; Maron JL, 2014, ECOL LETT, V17, P499, DOI 10.1111/ele.12250; Maron JL, 2012, J ECOL, V100, P1492, DOI 10.1111/j.1365-2745.2012.02027.x; Moore RJ, 1974, RES BRANCH CANADA DE, V10, P54; Moravcova L, 2010, PRESLIA, V82, P365; Nunez MA, 2008, BIOL INVASIONS, V10, P1389, DOI 10.1007/s10530-007-9214-x; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pearson DE, 2014, BIOL INVASIONS, V16, P1185, DOI 10.1007/s10530-013-0573-1; Pearson DE, 2012, J ECOL, V100, P1383, DOI 10.1111/j.1365-2745.2012.02025.x; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Pearson DE, 2011, ECOLOGY, V92, P1748, DOI 10.1890/11-0164.1; PEMBERTON RW, 1990, WEED SCI, V38, P615, DOI 10.1017/S0043174500051584; Peters HA, 2005, OIKOS, V109, P351, DOI 10.1111/j.0030-1299.2005.13282.x; Pirk GI, 2009, INSECT SOC, V56, P277, DOI 10.1007/s00040-009-0021-5; Prince JS, 2004, OECOLOGIA, V138, P1, DOI 10.1007/s00442-003-1413-2; Pysek Petr, 2007, V193, P97; R Development Core Team, 2006, R LANG ENV STAT COMP; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; SAMSON DA, 1992, OIKOS, V65, P61, DOI 10.2307/3544888; Simberloff D, 2014, OIKOS, V123, P408, DOI 10.1111/j.1600-0706.2013.01228.x; Simberloff D, 2011, NATURE, V475, P36, DOI 10.1038/475036a; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Tizón F. Rodrigo, 2009, Rev. Soc. Entomol. Argent., V68, P365; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Weiher E., 1999, ECOLOGICAL ASSEMBLY	54	25	25	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103824	10.1371/journal.pone.0103824	http://dx.doi.org/10.1371/journal.pone.0103824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099535	Green Published, gold			2022-12-25	WOS:000339995100033
J	Tzamali, E; Grekas, G; Marias, K; Sakkalis, V				Tzamali, Eleftheria; Grekas, Georgios; Marias, Konstantinos; Sakkalis, Vangelis			Exploring the Competition between Proliferative and Invasive Cancer Phenotypes in a Continuous Spatial Model	PLOS ONE			English	Article							NONLINEAR TUMOR-GROWTH; HYPOXIA; MIGRATION; CELLS; GLIOMAS; HETEROGENEITY; MECHANISMS; MORPHOLOGY; EVOLUTION; DRIVEN	Tumor is characterized by extensive heterogeneity with respect to its microenvironment and its genetic composition. We extend a previously developed monoclonal continuous spatial model of tumor growth to account for polyclonal cell populations and investigate the interplay between a more proliferative and a more invasive phenotype under different conditions. The model simulations demonstrate a transition from the dominance of the proliferative to the dominance of the invasive phenotype resembling malignant tumor progression and show a time period where both subpopulations are abundant. As the dominant phenotype switches from proliferative to invasive, the geometry of tumor changes from a compact and almost spherical shape to a more diffusive and fingered morphology with the proliferative phenotype to be restricted in the tumor bulk and the invasive to dominate at tumor edges. Different micro-environmental conditions and different phenotypic properties can promote or inhibit invasion demonstrating their mutual importance. The model provides a computational framework to investigate tumor heterogeneity and the constant interplay between the environment and the specific characteristics of phenotypes that should be taken into account for the prediction of tumor evolution, morphology and effective treatment.	[Tzamali, Eleftheria; Grekas, Georgios; Marias, Konstantinos; Sakkalis, Vangelis] Fdn Res & Technol Hellas, Inst Comp Sci, Computat Med Lab, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH)	Tzamali, E (corresponding author), Fdn Res & Technol Hellas, Inst Comp Sci, Computat Med Lab, Iraklion, Greece.	etzamali@gmail.com	Marias, Kostas/AAM-2330-2021; Sakkalis, Vangelis/M-3815-2019; Sakkalis, Vangelis/P-6883-2015	Marias, Kostas/0000-0003-3783-5223; Sakkalis, Vangelis/0000-0003-4701-850X; Grekas, Georgios/0000-0002-0267-0150	European Commission under the Transatlantic Tumor Model Repositories - TUMOR [FP7-ICT-2009.5.4-247754]; Computational Horizons In Cancer - CHIC [FP7-ICT-2011.5.2-600841]	European Commission under the Transatlantic Tumor Model Repositories - TUMOR; Computational Horizons In Cancer - CHIC	This work was supported in part by the European Commission under the Transatlantic Tumor Model Repositories - TUMOR (FP7-ICT-2009.5.4-247754) and the Computational Horizons In Cancer - CHIC (FP7-ICT-2011.5.2-600841) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Cronin PA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-225; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Douglas J., 1962, NUMER MATH, V4, P41, DOI DOI 10.1007/BF01386295; Eckerich C, 2007, INT J CANCER, V121, P276, DOI 10.1002/ijc.22679; Fedotov S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.118101; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Hadeler K.P., 2009, SPATIAL ECOLOGY; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Mansury Y, 2006, J THEOR BIOL, V238, P146, DOI 10.1016/j.jtbi.2005.05.027; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pham K, 2012, J BIOL DYNAM, V6, P54, DOI 10.1080/17513758.2011.590610; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roniotis A, 2012, IEEE T INF TECHNOL B, V16, P299, DOI 10.1109/TITB.2012.2185704; Sakkalis V, 2010, IEEE ENG MED BIO, P6809, DOI 10.1109/IEMBS.2010.5625961; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tektonidis M, 2011, J THEOR BIOL, V287, P131, DOI 10.1016/j.jtbi.2011.07.012; WACHSPRESS EL, 1960, J SOC IND APPL MATH, V8, P403, DOI 10.1137/0108027; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103191	10.1371/journal.pone.0103191	http://dx.doi.org/10.1371/journal.pone.0103191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099885	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100015
J	Zhao, M; He, MX; Huang, XD; Wang, Q				Zhao, Mi; He, Maoxian; Huang, Xiande; Wang, Qi			A Homeodomain Transcription Factor Gene, PfMSX, Activates Expression of Pif Gene in the Pearl Oyster Pinctada fucata	PLOS ONE			English	Article							ACIDIC MATRIX PROTEIN; MSX HOMEOBOX GENES; DNA-BINDING; KEY MACROMOLECULE; EVOLUTION; IDENTIFICATION; CONSERVATION; REGENERATION; PLANARIAN; MUTATION	We reported pearl oyster Pinctada fucata cDNA and genomic characterization of a new homeobox-containing protein, PfMSX. The PfMSX gene encodes a transcription factor that was localized to the nucleus. Analyses of PfMSX mRNA in tissues and developmental stages showed high expressions in mantle or D-shaped larvae. In electrophoretic mobility shift assays (EMSAs) PfMSX binded to MSX consensus binding sites in the 59 flanking region of the Pif promoter. In co-transfection experiment PfMSX transactivated reporter constructs containing Pif promoter sequences, and mutation of the MSX-binding sites attenuated transactivation. A knockdown experiment using PfMSX dsRNA showed decreased Pif mRNA and unregular crystallization of the nacreous layer using scanning electron microscopy. Our results suggested that PfMSX was a conserved homeodomain transcription factor gene, which can activate Pif gene expression through MSX binding site, and was then involved in the mineralization process in pearl oyster Pinctada fucata. Our data provided important clues about mechanisms regulating biomineralization in pearl oyster.	[Zhao, Mi; He, Maoxian; Huang, Xiande; Wang, Qi] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Zhao, Mi; Wang, Qi] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, MX (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China.	hmx@scsio.ac.cn			National Natural Science Foundation of China [41376159]; National Science and technology program of China [2012AA10A410]; Funds of Knowledge Innovation Program of Chinese Academy of Sciences [ZCX2-EW-Q21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and technology program of China; Funds of Knowledge Innovation Program of Chinese Academy of Sciences	National Natural Science Foundation of China (41376159) http://www.nsfc.gov.cn/; the National Science and technology program of China (2012AA10A410) and the Funds of Knowledge Innovation Program of Chinese Academy of Sciences (ZCX2-EW-Q21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Aniello F, 1999, MECH DEVELOP, V88, P123, DOI 10.1016/S0925-4773(99)00178-1; Bensoussan-Trigano V, 2011, DEV DYNAM, V240, P1190, DOI 10.1002/dvdy.22619; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Dobias SL, 1997, MECH DEVELOP, V61, P37, DOI 10.1016/S0925-4773(96)00617-X; Ekker M, 1997, MOL BIOL EVOL, V14, P1008, DOI 10.1093/oxfordjournals.molbev.a025707; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Galle S, 2005, INT J DEV BIOL, V49, P961, DOI 10.1387/ijdb.052009sg; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Haerry TE, 1997, DEV BIOL, V186, P1, DOI 10.1006/dbio.1997.8582; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holland PWH, 2005, BRAIN RES BULL, V66, P484, DOI 10.1016/j.brainresbull.2005.06.003; Hovde S, 2001, BIOCHEMISTRY-US, V40, P12013, DOI 10.1021/bi0108148; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Huang XD, 2013, MAR BIOTECHNOL, V15, P253, DOI 10.1007/s10126-012-9484-x; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Lallemand Y, 2009, DEV BIOL, V331, P189, DOI 10.1016/j.ydbio.2009.04.038; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liang J, 2012, EUR J ORAL SCI, V120, P278, DOI 10.1111/j.1600-0722.2012.00965.x; Liu Y, 1999, OPT EXPRESS, V4, P177, DOI 10.1364/OE.4.000177; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Mannini L, 2008, INT J DEV BIOL, V52, P943, DOI 10.1387/ijdb.072476lm; Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216; Pan C, 2014, J BIOL CHEM, V289, P2776, DOI 10.1074/jbc.M113.504027; Saadi I, 2013, DEVELOPMENT, V140, P2697, DOI 10.1242/dev.088393; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schierwater B, 2002, MOL PHYLOGENET EVOL, V24, P374, DOI 10.1016/S1055-7903(02)00238-5; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takahashi H, 2008, MOL BIOL EVOL, V25, P69, DOI 10.1093/molbev/msm228; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P1484, DOI 10.1210/me.8.11.1484; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wilson KA, 2005, EVOL DEV, V7, P416, DOI 10.1111/j.1525-142X.2005.05046.x; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	45	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103830	10.1371/journal.pone.0103830	http://dx.doi.org/10.1371/journal.pone.0103830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099698	gold, Green Submitted, Green Published			2022-12-25	WOS:000339995100034
J	Gahring, LC; Myers, E; Palumbos, S; Rogers, SW				Gahring, Lorise C.; Myers, Elizabeth; Palumbos, Sierra; Rogers, Scott W.			Nicotinic Receptor Alpha7 Expression during Mouse Adrenal Gland Development	PLOS ONE			English	Article							BOVINE CHROMAFFIN CELLS; MEDIATED INTERCELLULAR COMMUNICATION; TRANSCRIPTION FACTOR EGR-1; ACETYLCHOLINE-RECEPTOR; NERVOUS-SYSTEM; CATECHOLAMINE RELEASE; IMMUNE-SYSTEM; RAT; MEDULLA; INFLAMMATION	The nicotinic acetylcholine receptor alpha 7 (alpha 7) is a ligand-activated ion channel that contributes to a diversity of cellular processes involved in development, neurotransmission and inflammation. In this report the expression of a7 was examined in the mouse developing and adult adrenal gland that expresses a green fluorescent protein (GFP) reporter as a bi-cistronic extension of the endogenous alpha 7 transcript (alpha 7(G)). At embryonic day 12.5 (E12.5) alpha 7(G) expression was associated with the suprarenal ganglion and precursor cells of the adrenal gland. The a7 G cells are catecholaminergic chromaffin cells as reflected by their progressive increase in the co-expression of tyrosine hydroxylase (TH) and dopamine-beta-hydroxylase (DBH) that is complete by E18.5. In the adult, alpha 7(G) expression is limited to a subset of chromaffin cells in the adrenal medulla that cluster near the border with the adrenal cortex. These chromaffin cells co-express alpha 7(G), TH and DBH, but they lack phenylethanolamine N-methyltransferase (PNMT) consistent with only norepinephrine (NE) synthesis. These cell groups appear to be preferentially innervated by pre-ganglionic afferents identified by the neurotrophin receptor p75. No afferents identified by beta-III tubulin, neurofilament proteins or p75 co-expressed alpha 7(G). Occasional alpha 7(G) cells in the pre-E14.5 embryos express neuronal markers consistent with intrinsic ganglion cells and in the adult some alpha 7(G) cells co-express glutamic acid decarboxylase. The transient expression of alpha 7 during adrenal gland development and its prominent co-expression by a subset of NE chromaffin cells in the adult suggests that the alpha 7 receptor contributes to multiple aspects of adrenal gland development and function that persist into adulthood.	[Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City VA Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84112 USA; [Gahring, Lorise C.; Myers, Elizabeth] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Palumbos, Sierra; Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Salt Lake City VA Geriatr Res Educ & Clin Ctr, Salt Lake City, UT 84112 USA.	Scott.Rogers@hsc.utah.edu		Palumbos, Sierra/0000-0002-3595-984X	National Institutes of Health (NIH) [DA025057, AG029838]; NATIONAL INSTITUTE ON AGING [R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants DA025057 and AG029838. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Bitner RS, 2002, BRAIN RES, V938, P45, DOI 10.1016/S0006-8993(02)02485-X; Buttigieg J, 2009, J NEUROSCI, V29, P7137, DOI 10.1523/JNEUROSCI.0544-09.2009; CamposCaro A, 1997, J NEUROCHEM, V68, P488; Carrasco-Serrano C, 2004, FEBS LETT, V566, P247, DOI 10.1016/j.febslet; Castro E, 2003, J NEUROSCI RES, V71, P375, DOI 10.1002/jnr.10488; Colomer C, 2008, J NEUROSCI, V28, P6616, DOI 10.1523/JNEUROSCI.5597-07.2008; Colomer C, 2012, BBA-BIOMEMBRANES, V1818, P1937, DOI 10.1016/j.bbamem.2011.07.034; Colomer C, 2010, J NEUROSCI, V30, P6732, DOI 10.1523/JNEUROSCI.4997-09.2010; Colomer C, 2009, MOL NEUROBIOL, V40, P87, DOI 10.1007/s12035-009-8073-0; Colomer C, 2008, ANN NY ACAD SCI, V1148, P106, DOI 10.1196/annals.1410.040; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016/j.neubiorev.2007.10.007; Criado M, 1997, J NEUROSCI, V17, P6554; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; del Barrio L, 2011, BRIT J PHARMACOL, V162, P94, DOI 10.1111/j.1476-5381.2010.01034.x; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Fu YT, 1999, J PHARMACOL EXP THER, V289, P133; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GARCIAGUZMAN M, 1995, EUR J NEUROSCI, V7, P647, DOI 10.1111/j.1460-9568.1995.tb00668.x; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; Habecker BA, 2008, AUTON NEUROSCI-BASIC, V140, P40, DOI 10.1016/j.autneu.2008.03.002; HIGGINS LS, 1988, J NEUROSCI, V8, P1436; Huber K, 2006, GENE EXPRESSION, V13, P133, DOI 10.3727/000000006783991854; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Hunter RG, 2010, BRAIN RES, V1325, P141, DOI 10.1016/j.brainres.2010.02.014; Iwasa K, 1999, J VET MED SCI, V61, P631, DOI 10.1292/jvms.61.631; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; KATAOKA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3218, DOI 10.1073/pnas.81.10.3218; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Leslie FM, 2013, MOL PHARMACOL, V83, P753, DOI 10.1124/mol.112.083659; Lopez MG, 1998, P NATL ACAD SCI USA, V95, P14184, DOI 10.1073/pnas.95.24.14184; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Martin AO, 2005, J CELL BIOL, V169, P503, DOI 10.1083/jcb.200411054; Martin AO, 2003, J NEUROSCI, V23, P3669; Martin AO, 2001, J NEUROSCI, V21, P5397, DOI 10.1523/JNEUROSCI.21-15-05397.2001; Metz CN, 2005, NAT IMMUNOL, V6, P756, DOI 10.1038/ni0805-756; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; Mousavi M, 2001, LIFE SCI, V70, P577, DOI 10.1016/S0024-3205(01)01427-8; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; OOMORI Y, 1991, ANAT REC, V229, P407, DOI 10.1002/ar.1092290313; OSETGASQUE MJ, 1990, J NEUROSCI RES, V26, P181, DOI 10.1002/jnr.490260207; PARKER TL, 1993, J ANAT, V183, P265; Perez-Alvarez A, 2007, J NEUROCHEM, V103, P2281, DOI 10.1111/j.1471-4159.2007.04932.x; Perez-Alvarez A, 2012, BRIT J PHARMACOL, V165, P908, DOI 10.1111/j.1476-5381.2011.01596.x; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Rogers SW, 2012, BRAIN BEHAV, V2, P628, DOI 10.1002/brb3.84; Rogers SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036467; Rogers SW, 2012, AM J MED GENET A, V158A, P1135, DOI 10.1002/ajmg.a.35372; ROSENTHAL RN, 1977, BRIT J PHARMACOL, V60, P59, DOI 10.1111/j.1476-5381.1977.tb16747.x; Rosol TJ, 2001, TOXICOL PATHOL, V29, P41, DOI 10.1080/019262301301418847; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Sanders VM, 2002, INT REV NEUROBIOL, V52, P17; SCHATTEMAN GC, 1993, SOMATOSENS MOT RES, V10, P415, DOI 10.3109/08990229309028847; Schober A, 1998, J NEUROSCI, V18, P7272; Tsoyi K, 2011, ANTIOXID REDOX SIGN, V14, P2057, DOI 10.1089/ars.2010.3555; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; UNSICKER K, 1993, J ANAT, V183, P207; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WILSON SP, 1977, J NEUROCHEM, V28, P687, DOI 10.1111/j.1471-4159.1977.tb10615.x; Young JB, 2002, TRENDS ENDOCRIN MET, V13, P381, DOI 10.1016/S1043-2760(02)00661-6; Zaika OL, 2004, ARCH BIOCHEM BIOPHYS, V424, P23, DOI 10.1016/j.abb.2004.01.012	69	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103861	10.1371/journal.pone.0103861	http://dx.doi.org/10.1371/journal.pone.0103861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093893	gold, Green Submitted, Green Published			2022-12-25	WOS:000341357200038
J	Holfeld, J; Tepekoylu, C; Blunder, S; Lobenwein, D; Kirchmair, E; Dietl, M; Kozaryn, R; Lener, D; Theurl, M; Paulus, P; Kirchmair, R; Grimm, M				Holfeld, Johannes; Tepekoeylue, Can; Blunder, Stefan; Lobenwein, Daniela; Kirchmair, Elke; Dietl, Marion; Kozaryn, Radoslaw; Lener, Daniela; Theurl, Markus; Paulus, Patrick; Kirchmair, Rudolf; Grimm, Michael			Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation	PLOS ONE			English	Article							MYOCARDIAL VIABILITY ASSESSMENT; HEART-FAILURE; ENDOTHELIAL-CELLS; GENE-THERAPY; INFARCTION; MODEL; DYSFUNCTION; EXPRESSION; CHALLENGES	Objectives: Low energy shock waves have been shown to induce angiogenesis, improve left ventricular ejection fraction and decrease angina symptoms in patients suffering from chronic ischemic heart disease. Whether there is as well an effect in acute ischemia was not yet investigated. Methods: Hind-limb ischemia was induced in 10-12 weeks old male C57/Bl6 wild-type mice by excision of the left femoral artery. Animals were randomly divided in a treatment group (SWT, 300 shock waves at 0.1 mJ/mm(2), 5 Hz) and untreated controls (CTR), n = 10 per group. The treatment group received shock wave therapy immediately after surgery. Results: Higher gene expression and protein levels of angiogenic factors VEGF-A and PlGF, as well as their receptors Flt-1 and KDR have been found. This resulted in significantly more vessels per high-power field in SWT compared to controls. Improvement of blood perfusion in treatment animals was confirmed by laser Doppler perfusion imaging. Receptor tyrosine kinase profiler revealed significant phosphorylation of VEGF receptor 2 as an underlying mechanism of action. The effect of VEGF signaling was abolished upon incubation with a VEGFR2 inhibitor indicating that the effect is indeed VEGFR 2 dependent. Conclusions: Low energy shock wave treatment induces angiogenesis in acute ischemia via VEGF receptor 2 stimulation and shows the same promising effects as known from chronic myocardial ischemia. It may therefore develop as an adjunct to the treatment armentarium of acute muscle ischemia in limbs and myocardium.	[Holfeld, Johannes; Tepekoeylue, Can; Lobenwein, Daniela; Kirchmair, Elke; Dietl, Marion; Kozaryn, Radoslaw; Grimm, Michael] Med Univ Innsbruck, Univ Hosp Cardiac Surg, A-6020 Innsbruck, Austria; [Tepekoeylue, Can] Med Univ Innsbruck, Div Clin & Funct Anat, Dept Anat Histol & Embryol, A-6020 Innsbruck, Austria; [Blunder, Stefan] Med Univ Innsbruck, Univ Hosp Dermatol & Venerol, A-6020 Innsbruck, Austria; [Lener, Daniela; Theurl, Markus; Kirchmair, Rudolf] Med Univ Innsbruck, Univ Hosp Internal Med 3, Dept Cardiol & Angiol, A-6020 Innsbruck, Austria; [Paulus, Patrick] Goethe Univ Hosp, Clin Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Holfeld, J (corresponding author), Med Univ Innsbruck, Univ Hosp Cardiac Surg, A-6020 Innsbruck, Austria.	johannes.holfeld@i-med.ac.at		Dietl, Marion/0000-0001-6171-577X; Gollmann-Tepekoylu, Can/0000-0001-6584-3488; Holfeld, Johannes/0000-0001-6623-0595; Theurl, Markus/0000-0002-3609-9730	Medizinischer Forschungsfonds Tirol (MFF) [220]; CRT - Cardiac Regeneration Technologies LLC., Woodstock, Georgia, USA	Medizinischer Forschungsfonds Tirol (MFF); CRT - Cardiac Regeneration Technologies LLC., Woodstock, Georgia, USA	This work was in part supported by a research grant of Medizinischer Forschungsfonds Tirol (MFF), project no. 220 and by a research grant provided by CRT - Cardiac Regeneration Technologies LLC., Woodstock, Georgia, USA, both to J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Blunder S, 2012, ATHEROSCLEROSIS, V220, P355, DOI 10.1016/j.atherosclerosis.2011.11.035; Carluccio E, 2012, ECHOCARDIOGR-J CARD, V29, P298, DOI 10.1111/j.1540-8175.2011.01575.x; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Di Carli MF, 1998, J THORAC CARDIOV SUR, V116, P997, DOI 10.1016/S0022-5223(98)70052-2; DREYFUS GD, 1994, ANN THORAC SURG, V57, P1402, DOI 10.1016/0003-4975(94)90091-4; Elster EA, 2010, J ORTHOP TRAUMA, V24, P133, DOI 10.1097/BOT.0b013e3181b26470; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Holfeld J, 2016, J TISSUE ENG REGEN M, V10, P1057, DOI 10.1002/term.1890; Holfeld J, 2014, JOVE-J VIS EXP, DOI 10.3791/51076; Isner JM, 2002, NATURE, V415, P234, DOI 10.1038/415234a; Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001; Leibowitz D, 2013, INT J CARDIOL, V167, P3033, DOI 10.1016/j.ijcard.2012.11.099; Marwick TH, 1999, J AM COLL CARDIOL, V33, P750, DOI 10.1016/S0735-1097(98)00642-1; Meirer R, 2007, J RECONSTR MICROSURG, V23, P231, DOI 10.1055/s-2007-981506; Mittermayr R, 2012, WOUND REPAIR REGEN, V20, P456, DOI 10.1111/j.1524-475X.2012.00796.x; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Ottomann C, 2012, ANN SURG, V255, P23, DOI 10.1097/SLA.0b013e318227b3c0; Pearle MS, 2012, NEW ENGL J MED, V367, P50, DOI 10.1056/NEJMct1103074; Pleger ST, 2013, CIRC RES, V113, P792, DOI 10.1161/CIRCRESAHA.113.300269; Post MJ, 2001, CARDIOVASC RES, V49, P522, DOI 10.1016/S0008-6363(00)00216-9; Pourrajab F, 2014, INT J CARDIOL, V173, P12, DOI 10.1016/j.ijcard.2014.02.006; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sems A, 2006, J AM ACAD ORTHOP SUR, V14, P195, DOI 10.5435/00124635-200604000-00001; Shah BN, 2013, EUR HEART J, V34, P1323, DOI 10.1093/eurheartj/eht018; Siow RCM, 2012, METHODS MOL BIOL, V806, P265, DOI 10.1007/978-1-61779-367-7_18; Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338; Tepekoylu C, 2013, J THORAC CARDIOV SUR, V146, P971, DOI 10.1016/j.jtcvs.2013.01.017; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Uwatoku T, 2007, CORONARY ARTERY DIS, V18, P397, DOI 10.1097/MCA.0b013e328089f19b; Wang Y, 2010, CLIN CARDIOL, V33, P693, DOI 10.1002/clc.20811; Zhao HQ, 2013, CORONARY ARTERY DIS, V24, P493, DOI 10.1097/MCA.0b013e328363244b; Zimpfer D, 2009, J THORAC CARDIOV SUR, V137, P963, DOI 10.1016/j.jtcvs.2008.11.006	37	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103982	10.1371/journal.pone.0103982	http://dx.doi.org/10.1371/journal.pone.0103982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093816	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200054
J	Kong, XM; Zhang, XL; Zhao, Q; He, J; Chen, L; Zhao, ZG; Li, Q; Ge, JP; Chen, G; Guo, XH; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Shan, ZY; Liu, J; Tian, HM; Ji, QH; Zhu, DL; Zhou, ZG; Shan, GL; Yang, WY				Kong, Xiaomu; Zhang, Xuelian; Zhao, Qi; He, Jiang; Chen, Li; Zhao, Zhigang; Li, Qiang; Ge, Jiapu; Chen, Gang; Guo, Xiaohui; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Ji, Qiuhe; Zhu, Dalong; Zhou, Zhiguang; Shan, Guangliang; Yang, Wenying			Obesity-Related Genomic Loci Are Associated with Type 2 Diabetes in a Han Chinese Population	PLOS ONE			English	Article							BODY-MASS INDEX; WIDE ASSOCIATION; GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; WAIST CIRCUMFERENCE; ASIAN POPULATIONS; COMMON VARIANTS; MC4R GENE; RISK; WOMEN	Background and Aims: Obesity is a well-known risk factor for type 2 diabetes. Genome-wide association studies have identified a number of genetic loci associated with obesity. The aim of this study is to examine the contribution of obesity-related genomic loci to type 2 diabetes in a Chinese population. Methods: We successfully genotyped 18 obesity-related single nucleotide polymorphisms among 5338 type 2 diabetic patients and 4663 controls. Both individual and joint effects of these single nucleotide polymorphisms on type 2 diabetes and quantitative glycemic traits (assessing beta-cell function and insulin resistance) were analyzed using logistic and linear regression models, respectively. Results: Two single nucleotide polymorphisms near MC4R and GNPDA2 genes were significantly associated with type 2 diabetes before adjusting for body mass index and waist circumference (OR (95% CI) = 1.14 (1.06, 1.22) for the A allele of rs12970134, P = 4.75x10(-4); OR (95% CI) = 1.10 (1.03, 1.17) for the G allele of rs10938397, P = 4.54x10(-3)). When body mass index and waist circumference were further adjusted, the association of MC4R with type 2 diabetes remained significant (P = 1.81x10(-2)) and that of GNPDA2 was attenuated (P = 1.26x10(-1)), suggesting the effect of the locus including GNPDA2 on type 2 diabetes may be mediated through obesity. Single nucleotide polymorphism rs2260000 within BAT2 was significantly associated with type 2 diabetes after adjusting for body mass index and waist circumference (P = 1.04x10(-2)). In addition, four single nucleotide polymorphisms (near or within SEC16B, BDNF, MAF and PRL genes) showed significant associations with quantitative glycemic traits in controls even after adjusting for body mass index and waist circumference (all P values<0.05). Conclusions: This study indicates that obesity-related genomic loci were associated with type 2 diabetes and glycemic traits in the Han Chinese population.	[Kong, Xiaomu; Xiao, Jianzhong; Yang, Wenying] China Japan Friendship Hosp, Key Lab Diabet Prevent & Control, Dept Endocrinol, Beijing, Peoples R China; [Zhao, Qi; He, Jiang] Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Chen, Li] Shandong Univ, Qilu Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Zhao, Zhigang] Henan Prov Peoples Hosp, Dept Endocrinol, Zhengzhou, Henan, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Dept Endocrinol, Urumqi, Xinjiang, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Fujian, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang, Liaoning, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Dept Endocrinol, Taiyuan, Shanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, Dept Endocrinol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Shaanxi, Peoples R China; [Zhu, Dalong] Nanjing Univ, Sch Med, Dept Endocrinol, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Shan, Guangliang] Peking Union Med Coll, Dept Epidemiol, Beijing 100021, Peoples R China	China-Japan Friendship Hospital; Tulane University; Shandong University; Zhengzhou University; Harbin Medical University; Fujian Provincial Hospital; Peking University; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Air Force Military Medical University; Nanjing University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kong, XM (corresponding author), China Japan Friendship Hosp, Key Lab Diabet Prevent & Control, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Jia, Weiping/B-7483-2012; Linong, Ji/AAB-6543-2020; Zhao, Qi/Y-9866-2019; He, Jiang/AAF-5303-2020	He, Jiang/0000-0002-8286-9652; Weng, Jianping/0000-0002-7889-1697; Kong, Xiaomu/0000-0002-5920-4759; Zhou, Zhiguang/0000-0002-0374-1838	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program [2011CB504001]; China Postdoctoral Science Foundation [2012M520200]; Fogarty International Center of the National Institutes of Health [D43TW009107]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Chinese National Diabetes and Metabolic Disorders Study was supported by grants from the Chinese Medical Association Foundation (http://en.cma.org.cn), Sanofi (China) Investment Company Limited (http://www.sanofi.cn/l/cn/zh/index.jsp) and the National 973 Program (2011CB504001) (http://www.973.gov.cn). XK was supported by Award Number 2012M520200 from China Postdoctoral Science Foundation Grant (http://res.chinapostdoctor.org.cn) and the Award Number D43TW009107 from Fogarty International Center of the National Institutes of Health (http://www.fic.nih.gov). QZ was supported by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (http://www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Cauchi S, 2012, DIABETES METAB, V38, P316, DOI 10.1016/j.diabet.2012.02.003; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Dwivedi OP, 2013, J HUM GENET, V58, P27, DOI 10.1038/jhg.2012.129; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Han X, 2013, PLOS ONE, V8; Hashimoto M, 1999, HUM GENET, V105, P197, DOI 10.1007/s004390051089; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Janipalli CS, 2012, DIABETIC MED, V29, P121, DOI 10.1111/j.1464-5491.2011.03438.x; Li S, 2011, DIABETOLOGIA, V54, P776, DOI 10.1007/s00125-011-2044-5; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Lu YC, 2013, GENOME MED, V5, DOI 10.1186/gm459; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mutombo PB, 2013, ENDOCR RES IN PRESS; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rees SD, 2011, DIABETIC MED, V28, P673, DOI 10.1111/j.1464-5491.2011.03257.x; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Robiou-du-Pont S, 2013, INT J OBESITY, V37, P980, DOI 10.1038/ijo.2012.175; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Tao LM, 2012, MOL BIOL REP, V39, P6487, DOI 10.1007/s11033-012-1476-4; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xi B, 2012, DIABETOLOGIA, V55, P2660, DOI 10.1007/s00125-012-2655-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	40	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104486	10.1371/journal.pone.0104486	http://dx.doi.org/10.1371/journal.pone.0104486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093408	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200112
J	Nascimento, F; Pousinha, PA; Correia, AM; Gomes, R; Sebastiao, AM; Ribeiro, JA				Nascimento, Filipe; Pousinha, Paula A.; Correia, Alexandra M.; Gomes, Rui; Sebastiao, Ana M.; Ribeiro, Joaquim A.			Adenosine A(2A) Receptors Activation Facilitates Neuromuscular Transmission in the Pre-Symptomatic Phase of the SOD1(G93A) ALS Mice, but Not in the Symptomatic Phase	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSMITTER RELEASE; A(2A)-ADENOSINE RECEPTOR; ENDOGENOUS ADENOSINE; NERVE ENDINGS; MOUSE MODEL; RAT; NEUROTROPHINS; MODULATION; PARADIGM	Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease leading to motor neuron dysfunction resulting in impairment of neuromuscular transmission. A(2A) adenosine receptors have already been considered as a potential therapeutical target for ALS but their neuromodulatory role at the neuromuscular junction in ALS remains to be clarified. In the present work, we evaluated the effects of A(2A) receptors on neuromuscular transmission of an animal model of ALS: SOD1(G93A) mice either in the pre-symptomatic (4-6 weeks old) or in the symptomatic (12-14 weeks old) stage. Electrophysiological experiments were performed obtaining intracellular recordings in Mg2+ paralyzed phrenic nerve-hemidiaphragm preparations. Endplate potentials (EPPs), quantal content (q. c.) of EPPs, miniature endplate potentials (MEPPs) and giant miniature endplate potential (GMEPPs) were recorded. In the pre-symptomatic phase of the disease (4-6 weeks old mice), the selective A(2A) receptor agonist, CGS 21680, significantly enhanced (p<0.05 Unpaired t-test) the mean amplitude and q. c. of EPPs, and the frequency of MEPPs and GMEPPs at SOD1(G93A) neuromuscular junctions, the effect being of higher magnitude (p<0.05, Unpaired t-test) than age-matched control littermates. On the contrary, in symptomatic mice (12-14 weeks old), CGS 21680 was devoid of effect on both the amplitude and q. c. of EPPs and the frequency of MEPPs and GMEPPs (p<0.05 Paired t-test). The results herein reported clearly document that at the neuromuscular junction of SOD1(G93A) mice there is an exacerbation of A(2A) receptor-mediated excitatory effects at the pre-symptomatic phase, whereas in the symptomatic phase A(2A) receptor activation is absent. The results thus suggest that A(2A) receptors function changes with ALS progression.	[Nascimento, Filipe; Pousinha, Paula A.; Sebastiao, Ana M.; Ribeiro, Joaquim A.] Univ Lisbon, Inst Pharmacol & Neurosci, Fac Med, P-1699 Lisbon, Portugal; [Nascimento, Filipe; Pousinha, Paula A.; Correia, Alexandra M.; Gomes, Rui; Sebastiao, Ana M.; Ribeiro, Joaquim A.] Univ Lisbon, Unit Neurosci, Inst Med Mol, P-1699 Lisbon, Portugal; [Correia, Alexandra M.] Univ Lisbon, Natl Museum Nat Hist & Sci, P-1699 Lisbon, Portugal; [Gomes, Rui] Univ Lisbon, Fac Sci, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Ribeiro, JA (corresponding author), Univ Lisbon, Inst Pharmacol & Neurosci, Fac Med, P-1699 Lisbon, Portugal.	jaribeiro@medicina.ulisboa.pt	Correia, Alexandra Marcal/W-8107-2018; Gomes, Rui APL/M-1803-2015; Gomes, Rui/AAE-9130-2022	Correia, Alexandra Marcal/0000-0002-4999-0477; Gomes, Rui APL/0000-0002-7242-6540; Gomes, Rui/0000-0002-7242-6540; Sebastiao, Ana M/0000-0001-9030-6115; Pousinha, Paula/0000-0002-5992-9418	Fundacao do Ministerio da Ciencia e Tecnologia de Portugal [PTDC/SAU-FAR/118787/2010]	Fundacao do Ministerio da Ciencia e Tecnologia de Portugal	This work was supported by Fundacao do Ministerio da Ciencia e Tecnologia de Portugal [Grant PTDC/SAU-FAR/118787/2010] (http://www.fct.pt/index.phtml.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghi E, 2011, AM J EPIDEMIOL, V174, P1002, DOI 10.1093/aje/kwr229; Belluardo N, 2001, MOL CELL NEUROSCI, V18, P56, DOI 10.1006/mcne.2001.1001; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Correia-de-Sa P, 2000, J NEUROCHEM, V74, P2462, DOI 10.1046/j.1471-4159.2000.0742462.x; CORREIADESA P, 1994, N-S ARCH PHARMACOL, V350, P514; CORREIADESA P, 1991, BRIT J PHARMACOL, V103, P1614, DOI 10.1111/j.1476-5381.1991.tb09836.x; CORREIADESA P, 1994, EUR J PHARMACOL, V271, P349, DOI 10.1016/0014-2999(94)90793-5; CORREIADESA P, 1994, BRIT J PHARMACOL, V111, P582, DOI 10.1111/j.1476-5381.1994.tb14777.x; CorreiadeSa P, 1996, J NEUROPHYSIOL, V76, P3910, DOI 10.1152/jn.1996.76.6.3910; Fratantoni SA, 2000, MUSCLE NERVE, V23, P543, DOI 10.1002/(SICI)1097-4598(200004)23:4<543::AID-MUS13>3.0.CO;2-S; Fredholm BB, 1998, J NEUROCHEM, V70, P1210; Fuchs A, 2013, J PHYSIOL-LONDON, V591, P2723, DOI 10.1113/jphysiol.2012.247981; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888; Kim YI, 1997, P IEEE EMBS, V18, P1773, DOI 10.1109/IEMBS.1996.647655; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Li N, 2012, EUR J IMMUNOL, V42, P1140, DOI 10.1002/eji.201142088; Lopes LV, 1999, J NEUROCHEM, V73, P1733, DOI 10.1046/j.1471-4159.1999.731733.x; Mantilla CB, 2004, MUSCLE NERVE, V29, P381, DOI 10.1002/mus.10558; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Noronha-Matos JB, 2011, J NEUROCHEM, V117, P797, DOI 10.1111/j.1471-4159.2011.07216.x; NORRIS FH, 1955, ELECTROEN CLIN NEURO, V7, P115, DOI 10.1016/0013-4694(55)90064-X; Oliveira L, 2004, J PHYSIOL-LONDON, V560, P157, DOI 10.1113/jphysiol.2004.067595; Palma AG, 2011, NEUROSCIENCE, V172, P164, DOI 10.1016/j.neuroscience.2010.10.015; Phani S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00150; Potenza RL, 2013, J NEUROSCI RES, V91, P585, DOI 10.1002/jnr.23185; Pousinha PA, 2006, NEUROSCI LETT, V404, P143, DOI 10.1016/j.neulet.2006.05.036; Pousinha PA, 2012, NEUROBIOL AGING, V33, P2869, DOI 10.1016/j.neurobiolaging.2012.01.008; Pousinha PA, 2010, J PHARMACOL EXP THER, V332, P153, DOI 10.1124/jpet.109.157255; RIBEIRO JA, 1975, BRIT J PHARMACOL, V54, P213, DOI 10.1111/j.1476-5381.1975.tb06931.x; RIBEIRO JA, 1987, J PHYSIOL-LONDON, V384, P571, DOI 10.1113/jphysiol.1987.sp016470; Ribeiro JA, 1996, PROG BRAIN RES, V109, P231; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Sebastiao Ana M, 2009, Handb Exp Pharmacol, P471, DOI 10.1007/978-3-540-89615-9_16; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; Todd KJ, 2006, PFLUG ARCH EUR J PHY, V452, P608, DOI 10.1007/s00424-006-0068-3; Tsentsevitsky A, 2013, NEUROSCIENCE, V248, P699, DOI 10.1016/j.neuroscience.2013.05.065; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; UCHITEL OD, 1988, P NATL ACAD SCI USA, V85, P7371, DOI 10.1073/pnas.85.19.7371; Vincenzi F, 2013, AMYOTROPH LAT SCL FR, V14, P406, DOI 10.3109/21678421.2013.793358; WEINSTEIN SP, 1980, J PHYSIOL-LONDON, V307, P453, DOI 10.1113/jphysiol.1980.sp013446; Yanpallewar SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039946; Ydens E, 2013, NEUROBIOL DIS, V55, P95, DOI 10.1016/j.nbd.2013.03.005	51	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104081	10.1371/journal.pone.0104081	http://dx.doi.org/10.1371/journal.pone.0104081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093813	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200063
J	Schoelinck, C; Hinsinger, DD; Dettai, A; Cruaud, C; Justine, JL				Schoelinck, Charlotte; Hinsinger, Damien D.; Dettai, Agnes; Cruaud, Corinne; Justine, Jean-Lou			A Phylogenetic Re-Analysis of Groupers with Applications for Ciguatera Fish Poisoning	PLOS ONE			English	Article							MARKET SUBSTITUTION; MOLECULAR PHYLOGENY; DNA BARCODE; TELEOSTEI; IDENTIFICATION; MITOCHONDRIAL; ACANTHOMORPHA; EPIDEMIOLOGY; VARIABILITY; PERFORMANCE	Background: Ciguatera fish poisoning (CFP) is a significant public health problem due to dinoflagellates. It is responsible for one of the highest reported incidence of seafood-borne illness and Groupers are commonly reported as a source of CFP due to their position in the food chain. With the role of recent climate change on harmful algal blooms, CFP cases might become more frequent and more geographically widespread. Since there is no appropriate treatment for CFP, the most efficient solution is to regulate fish consumption. Such a strategy can only work if the fish sold are correctly identified, and it has been repeatedly shown that misidentifications and species substitutions occur in fish markets. Methods: We provide here both a DNA-barcoding reference for groupers, and a new phylogenetic reconstruction based on five genes and a comprehensive taxonomical sampling. We analyse the correlation between geographic range of species and their susceptibility to ciguatera accumulation, and the co-occurrence of ciguatoxins in closely related species, using both character mapping and statistical methods. Results: Misidentifications were encountered in public databases, precluding accurate species identifications. Epinephelinae now includes only twelve genera (vs. 15 previously). Comparisons with the ciguatera incidences show that in some genera most species are ciguateric, but statistical tests display only a moderate correlation with the phylogeny. Atlantic species were rarely contaminated, with ciguatera occurrences being restricted to the South Pacific. Conclusions: The recent changes in classification based on the reanalyses of the relationships within Epinephelidae have an impact on the interpretation of the ciguatera distribution in the genera. In this context and to improve the monitoring of fish trade and safety, we need to obtain extensive data on contamination at the species level. Accurate species identifications through DNA barcoding are thus an essential tool in controlling CFP since meal remnants in CFP cases can be easily identified with molecular tools.	[Schoelinck, Charlotte; Hinsinger, Damien D.; Dettai, Agnes; Justine, Jean-Lou] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat Adaptat Evolut 7138, F-75231 Paris, France; [Schoelinck, Charlotte] Fisheries & Oceans Canada, Mol Biol, Aquat Anim Hlth, Moncton, NB, Canada; [Cruaud, Corinne] Ctr Natl Sequencage, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Fisheries & Oceans Canada; UDICE-French Research Universities; Universite Paris Saclay	Schoelinck, C (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR Systemat Adaptat Evolut 7138, F-75231 Paris, France.	schoelinck@mnhn.fr	Hinsinger, Damien/V-5892-2019; Dettai, Agnes/Q-6743-2019; Justine, Jean-Lou/B-1298-2010	Hinsinger, Damien/0000-0001-7459-7610; Justine, Jean-Lou/0000-0002-7155-4540; Cruaud, Corinne/0000-0002-4752-7278	MNHN ATM Barcode; MNHN ATM Biodiversite Actuelle et Fossile; MNHN BQR; Consortium National de Recherche en Genomique; "Service de Systematique Moleculaire" of Museum National d'Histoire Naturelle [CNRS UMS 2700]	MNHN ATM Barcode; MNHN ATM Biodiversite Actuelle et Fossile; MNHN BQR; Consortium National de Recherche en Genomique; "Service de Systematique Moleculaire" of Museum National d'Histoire Naturelle	This study was funded by MNHN ATM Barcode (2010, 2011), MNHN ATM Biodiversite Actuelle et Fossile (2010) and MNHN BQR (2011), awarded to CS and JLJ. This work was supported by the "Consortium National de Recherche en Genomique", and the "Service de Systematique Moleculaire" of the Museum National d'Histoire Naturelle (CNRS UMS 2700). It is part of the agreement no2005/67 between the Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of life" directed by Guillaume Lecointre. This work is part of the project @ SPEED-ID "Accurate SPEciEs Delimitation and IDentification of eukaryotic biodiversity using DNA markers'' proposed by F-BoL, the French Barcode of life initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann F, 2010, TOXICON, V56, P662, DOI 10.1016/j.toxicon.2009.10.015; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Carvalho DC, 2011, MITOCHONDR DNA, V22, P97, DOI 10.3109/19401736.2011.588219; Centers for disease control and prevention, 2013, JAMA-J AM MED ASSOC, V309, P1102; Chateau-Degat ML, 2007, AM J TROP MED HYG, V77, P842, DOI 10.4269/ajtmh.2007.77.842; Chateau-Degat ML, 2005, HARMFUL ALGAE, V4, P1053, DOI 10.1016/j.hal.2005.03.003; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cline E, 2012, FOOD RES INT, V45, P388, DOI 10.1016/j.foodres.2011.10.043; Clua E, 2011, TOXICON, V58, P591, DOI 10.1016/j.toxicon.2011.08.020; Collins R. A., 2012, PLOS ONE, Ve7; Craig M. T., 2012, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; De Fouw JC, 2001, CIGUATERA FISH POISO; Dettai A, 2012, MAR GENOM, V8, P49, DOI 10.1016/j.margen.2012.02.003; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; *FAO, 2010, CAPT PROD 1950 2008; Fricke Ronald, 2011, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V4, P341; Friedman MA, 2008, MAR DRUGS, V6, P456, DOI [10.3390/md20080022, 10.3390/md6030456]; FROESE R., 2012, FISHBASE; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Harikrishnan R, 2010, AQUACULTURE, V309, P1, DOI 10.1016/j.aquaculture.2010.09.011; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Heemstra P. C., 1993, FAO FISH SYNOPSIS, V125, P382; Kipping R, 2006, J PUBLIC HEALTH, V28, P343, DOI 10.1093/pubmed/fdl064; Laboute P, 2000, POISSONS NOUVELLE CA; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Laurent D., 2005, CIGUATERA FIELD REFE; Lautredou AC, 2010, POLAR SCI, V4, P333, DOI 10.1016/j.polar.2010.04.006; Lautredou AC, 2013, MOL PHYLOGENET EVOL, V67, P140, DOI 10.1016/j.ympev.2012.12.020; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; LEWIS ND, 1986, MAR FISH REV, V48, P6; Lewis RJ, 2006, TOXICON, V48, P799, DOI 10.1016/j.toxicon.2006.07.019; Lewis RJ, 1997, TOXICON, V35, P159, DOI 10.1016/S0041-0101(96)00132-8; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Maddison WP, 2009, MESQUITE MODULAR SYS; Mariani S, 2014, CONSERVATION LETT; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; Moore SK, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S4; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Nelson JS, 1984, FISHES WORLD; OLSEN DA, 1984, MAR FISH REV, V46, P13; Oshiro N, 2010, TOXICON, V56, P656, DOI 10.1016/j.toxicon.2009.05.036; Ottolenghi F., 2004, FATTENING EELS GROUP; Palumbi Stephen R., 1996, P205; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perez-Arellano JL, 2005, EMERG INFECT DIS, V11, P1981, DOI 10.3201/eid1112.050393; Pierre S, 2008, AQUAT CONSERV, V18, P297, DOI 10.1002/aqc.840; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Quod JP, 1996, TOXICON, V34, P779, DOI 10.1016/0041-0101(95)00164-6; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 4; Randall John E., 1991, Indo-Pacific Fishes, V20, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richlen ML, 2008, HARMFUL ALGAE, V7, P614, DOI 10.1016/j.hal.2007.12.020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlaich C, 2012, J TRAVEL MED, V19, P238, DOI 10.1111/j.1708-8305.2012.00619.x; Skinner MP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001416; Smith WL, 2007, COPEIA, P35, DOI 10.1643/0045-8511(2007)7[35:CTPNWT]2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Stewart I, 2010, TOXICON, V56, P804, DOI 10.1016/j.toxicon.2009.07.028; Streelman JT, 1997, P ROY SOC B-BIOL SCI, V264, P1011, DOI 10.1098/rspb.1997.0140; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tester Patricia A., 2009, Smithsonian Contributions to the Marine Sciences, P301; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Villareal TA, 2007, HARMFUL ALGAE, V6, P253, DOI 10.1016/j.hal.2006.08.008; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wong CK, 2008, BIOMED ENVIRON SCI, V21, P521, DOI 10.1016/S0895-3988(09)60012-X; Wong CK, 2005, TOXICON, V46, P563, DOI 10.1016/j.toxicon.2005.06.023; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	78	21	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e98198	10.1371/journal.pone.0098198	http://dx.doi.org/10.1371/journal.pone.0098198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093850	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200002
J	Xiao, DF; Wang, YF; Liu, G; He, JH; Qiu, W; Hu, XG; Feng, ZM; Ran, ML; Nyachoti, CM; Kim, SW; Tang, ZR; Yin, YL				Xiao, Dingfu; Wang, Yongfei; Liu, Gang; He, Jianhua; Qiu, Wei; Hu, Xionggui; Feng, Zemeng; Ran, Maoliang; Nyachoti, Charles M.; Kim, Sung Woo; Tang, Zhiru; Yin, Yulong			Effects of Chitosan on Intestinal Inflammation in Weaned Pigs Challenged by Enterotoxigenic Escherichia coli	PLOS ONE			English	Article							FECAL CALPROTECTIN; BOWEL-DISEASE; ANTIINFLAMMATORY ACTIVITY; GROWTH-PERFORMANCE; SIGNALING PATHWAY; OXIDATIVE STRESS; DIETARY CHITOSAN; OLIGOSACCHARIDE; SUPPLEMENTATION; PIGLETS	The aim of this study was to investigate whether supplementation with chitosan (COS) could reduce diarrhea and to explore how COS alleviates intestinal inflammation in weaned pigs. Thirty pigs (Duroc6Landrace6Yorkshire, initial BW of 5.65 +/- 0.27) weaned at age 21 d were challenged with enterotoxigenic Escherichia coli during a preliminary trial period, and then divided into three treatment groups. Pigs in individual pens were fed a corn-soybean meal diet, that contained either 0 (control), 50 mg/kg chlortetracycline, or 300 mg/kg COS for 21 days. The post-weaning diarrhea frequency, calprotectin levels and TLR4 protein expression were decreased (P < 0.05) in both the COS and chlortetracycline groups compared with control. Simultaneously, supplemental COS and chlortetracycline had no effect on the mRNA expression of TNF-alpha in the jejunal mucosa, or on the concentrations of IL-1 beta, IL-6 and TNF-alpha in serum. However, COS supplementation improved (P < 0.05) the mRNA expression of IL-1 beta and IL-6 in the jejunal mucosa. The results indicate that supplementation with COS at 300 mg/kg was effective for alleviating intestinal inflammation and enhancing the cell-mediated immune response. As feed additives, chitosan and chlortetracycline may influence different mechanisms for alleviating inflammation in piglets.	[Xiao, Dingfu; He, Jianhua; Ran, Maoliang] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Wang, Yongfei; Feng, Zemeng] Twins Grp Co Ltd, Ctr Res & Dev, Nanchang, Jiangxi, Peoples R China; [Liu, Gang; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Hunan Engn & Res Ctr Anim & Poultry Sci, Changsha, Hunan, Peoples R China; [Liu, Gang; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agro ecol Processes Subtrop Reg, Changsha, Hunan, Peoples R China; [Qiu, Wei] Hunan New Wellful Co LTD, Changsha, Hunan, Peoples R China; [Hu, Xionggui] Hunan Inst Anim & Vet Sci, Changsha, Peoples R China; [Nyachoti, Charles M.] Univ Manitoba, Fac Agr & Food Sci, Dept Anim Sci, Winnipeg, MB, Canada; [Kim, Sung Woo] N Carolina State Univ, Dept Anim Sci, Raleigh, NC USA; [Tang, Zhiru] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China	Hunan Agricultural University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; University of Manitoba; University of North Carolina; North Carolina State University; Southwest University - China	Tang, ZR (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.	tangzhiru2326@sina.com; yinyulong@isa.ac.cn	JIANHUA, HE/G-3340-2014; Liu, Gang/G-5283-2017; Kim, Sung Woo/AFQ-7580-2022	JIANHUA, HE/0000-0002-9289-4405; Liu, Gang/0000-0002-9475-5134; Kim, Sung Woo/0000-0003-4591-1943	National Natural Science Foundation of China [31330075, 31301985]; Scientific Research Fund of Hunan Provincial Education Department Project of China [12B058]; National Program on Key Basic Research Project of China [2013CB127303]; Natural Science Foundation Project of CQ CSTC [cstc2012jjA80001]; Chinese Academy of Sciences [ISACX-LYQY-QN-1205, 2013T2S0014, 2013T2S0015, 2013T2S0012, 2013T1S0010, 2011T2S15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Hunan Provincial Education Department Project of China; National Program on Key Basic Research Project of China(National Basic Research Program of China); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by National Natural Science Foundation of China (31330075, 31301985), Scientific Research Fund of Hunan Provincial Education Department Project of China (12B058), the National Program on Key Basic Research Project of China (2013CB127303), Natural Science Foundation Project of CQ CSTC (cstc2012jjA80001) and Chinese Academy of Sciences (ISACX-LYQY-QN-1205) and Chinese Academy of Sciences visiting professorship for senior international scientists (Grant no. 2013T2S0014, 2013T2S0015, 2013T2S0012, 2013T1S0010 and 2011T2S15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan R, 2012, INT J BIOL MACROMOL, V51, P783, DOI 10.1016/j.ijbiomac.2012.07.016; Beser OF, 2014, ALLERGY ASTHMA IMMUN, V6, P33, DOI 10.4168/aair.2014.6.1.33; Byun EB, 2013, INT IMMUNOPHARMACOL, V15, P450, DOI 10.1016/j.intimp.2012.11.021; Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023; Choi HK, 2013, YONSEI MED J, V54, P1336, DOI 10.3349/ymj.2013.54.6.1336; Costa F, 2003, DIGEST LIVER DIS, V35, P642, DOI 10.1016/S1590-8658(03)00381-5; Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fernandes JC, 2010, MAR DRUGS, V8, P1763, DOI 10.3390/md8061763; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Hormannsperger G, 2010, INT J MED MICROBIOL, V300, P63, DOI 10.1016/j.ijmm.2009.08.006; Kobayashi S, 2002, BRIT POULTRY SCI, V43, P270, DOI 10.1080/00071660120121490; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6655, DOI 10.1016/j.bmcl.2009.10.007; Liu P, 2008, J ANIM SCI, V86, P2609, DOI 10.2527/jas.2007-0668; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Liu YL, 2013, J NUTR, V143, P1799, DOI 10.3945/jn.113.179960; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Sahlander K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031646; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Splichal I, 2005, IMMUNOBIOLOGY, V209, P681, DOI 10.1016/j.imbio.2004.09.009; Tang ZR, 2005, DOMEST ANIM ENDOCRIN, V28, P430, DOI 10.1016/j.domaniend.2005.02.003; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Kralingen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084269; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; Xiao DF, 2013, INT IMMUNOPHARMACOL, V17, P670, DOI 10.1016/j.intimp.2013.07.023; Yin YL, 2008, ASIAN AUSTRAL J ANIM, V21, P723, DOI 10.5713/ajas.2008.70408; Yoon HJ, 2007, BIOCHEM BIOPH RES CO, V358, P954, DOI 10.1016/j.bbrc.2007.05.042	32	54	59	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104192	10.1371/journal.pone.0104192	http://dx.doi.org/10.1371/journal.pone.0104192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090447	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700107
J	Morita, C; Sumioka, R; Nakata, M; Okahashi, N; Wada, S; Yamashiro, T; Hayashi, M; Hamada, S; Sumitomo, T; Kawabata, S				Morita, Chisato; Sumioka, Ryuichi; Nakata, Masanobu; Okahashi, Nobuo; Wada, Satoshi; Yamashiro, Takashi; Hayashi, Mikako; Hamada, Shigeyuki; Sumitomo, Tomoko; Kawabata, Shigetada			Cell Wall-Anchored Nuclease of Streptococcus sanguinis Contributes to Escape from Neutrophil Extracellular Trap-Mediated Bacteriocidal Activity	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; INFECTIVE ENDOCARDITIS; NUCLEOTIDE-SEQUENCE; EXPRESSION; DNASE; DEOXYRIBONUCLEASE; GENE; MAGNESIUM; PROTEINS; GORDONII	Streptococcus sanguinis, a member of the commensal mitis group of streptococci, is a primary colonizer of the tooth surface, and has been implicated in infectious complications including bacteremia and infective endocarditis. During disease progression, S. sanguinis may utilize various cell surface molecules to evade the host immune system to survive in blood. In the present study, we discovered a novel cell surface nuclease with a cell-wall anchor domain, termed SWAN (streptococcal wall-anchored nuclease), and investigated its contribution to bacterial resistance against the bacteriocidal activity of neutrophil extracellular traps (NETs). Recombinant SWAN protein (rSWAN) digested multiple forms of DNA including NET DNA and human RNA, which required both Mg2+ and Ca2+ for optimum activity. Furthermore, DNase activity of S. sanguinis was detected around growing colonies on agar plates containing DNA. In-frame deletion of the swan gene mostly reduced that activity. These findings indicated that SWAN is a major nuclease displayed on the surface, which was further confirmed by immuno-detection of SWAN in the cell wall fraction. The sensitivity of S. sanguinis to NET killing was reduced by swan gene deletion. Moreover, heterologous expression of the swan gene rendered a Lactococcus lactis strain more resistant to NET killing. Our results suggest that the SWAN nuclease on the bacterial surface contributes to survival in the potential situation of S. sanguinis encountering NETs during the course of disease progression.	[Morita, Chisato; Sumioka, Ryuichi; Nakata, Masanobu; Wada, Satoshi; Sumitomo, Tomoko; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Osaka, Japan; [Morita, Chisato; Yamashiro, Takashi] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Osaka, Japan; [Sumioka, Ryuichi; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Osaka, Japan; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Osaka, Japan; [Hamada, Shigeyuki] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Nakata, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Osaka, Japan.	nakata@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Yamashiro, Takashi/Y-6411-2019; Yamashiro, Takashi/S-6010-2019	okahashi, nobuo/0000-0002-8045-7021; Yamashiro, Takashi/0000-0002-4419-9643; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [24390410, 23390103, 23592700]; Grants-in-Aid for Scientific Research [26463112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (#24390410, SK), (B) (#23390103, SH), and (C) (#23592700, MN) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salih G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045695; BALES CW, 1990, AM J CLIN NUTR, V51, P462, DOI 10.1093/ajcn/51.3.462; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Castonguay MC, 2013, CARDIOVASC PATHOL, V22, P19, DOI 10.1016/j.carpath.2012.05.007; Chang A, 2011, MOL MICROBIOL, V79, P1629, DOI 10.1111/j.1365-2958.2011.07550.x; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; de Buhr N, 2014, MICROBIOL-SGM, V160, P385, DOI 10.1099/mic.0.072199-0; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Fujihara J, 2012, COMP BIOCHEM PHYS B, V163, P263, DOI 10.1016/j.cbpb.2012.07.002; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HAMADA S, 1989, J GEN MICROBIOL, V135, P335; Hasegawa T, 2010, MICROBIOL-SGM, V156, P184, DOI 10.1099/mic.0.031955-0; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Health Protection Agency, 2012, HLTH PROT REP; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; JABLON JM, 1966, J BACTERIOL, V92, P1590, DOI 10.1128/JB.92.6.1590-1596.1966; Jarvill-Taylor KJ, 1999, J BACTERIOL, V181, P1853, DOI 10.1128/JB.181.6.1853-1860.1999; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LACKS S, 1975, J BACTERIOL, V124, P1321, DOI 10.1128/JB.124.3.1321-1329.1975; Lacy P, 2008, FRONT BIOSCI-LANDMRK, V13, P5559; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MATSUO S, 1991, ARCH ORAL BIOL, V36, P525, DOI 10.1016/0003-9969(91)90146-L; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nakata M, 2011, J BIOL CHEM, V286, P37566, DOI 10.1074/jbc.M111.239780; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Suck Dietrich, 1994, Journal of Molecular Recognition, V7, P65, DOI 10.1002/jmr.300070203; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; WHITE JC, 1946, J BACTERIOL, V51, P717, DOI 10.1128/JB.51.6.717-722.1946; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06	56	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103125	10.1371/journal.pone.0103125	http://dx.doi.org/10.1371/journal.pone.0103125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084357	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800016
J	Peng, P; Wang, L; Yang, X; Huang, XY; Ba, YN; Chen, XL; Guo, J; Lian, JF; Zhou, JQ				Peng, Ping; Wang, Lu; Yang, Xi; Huang, Xiaoyan; Ba, Yanna; Chen, Xiaoliang; Guo, Jian; Lian, Jiangfang; Zhou, Jianqing			A Preliminary Study of the Relationship between Promoter Methylation of the ABCG1, GALNT2 and HMGCR Genes and Coronary Heart Disease	PLOS ONE			English	Article							CATALYTIC ACTIVITY CONCENTRATIONS; DNA METHYLATION; ARTERY-DISEASE; ENZYMES; IFCC; ATHEROSCLEROSIS; 37-DEGREES-C; EXPRESSION; CANCER; HDL	Aims: To investigate the association of ABCG1, GALNT2 and HMGCR genes promoter DNA methylation with coronary heart disease (CHD) and explore the interaction between their methylation status and the CHD patients' clinical characteristics in Han Chinese population. Methods and results: Methylation-specific polymerase chain reaction (MSP) technology was used to examine the role of the aberrant gene promoter methylation in CHD in Han Chinese population. A total of 85 CHD patients and 54 participants without CHD confirmed by angiography were recruited. 82.8% of the participants with ABCG1 gene promoter hypermethylation have CHD, while only 17.4% of the participants without hypermethylation have it. The average age of the participants with GALNT2 gene promoter hypermethylation is 62.10 +/- 8.21, while that of the participants without hypermethylation is 57.28 +/- 9.87; in the former group, 75.4% of the participants have CHD, compared to only 50% in the latter group. As for the HMGCR gene, the average age of the participants with promoter hypermethylation is 63.24 +/- 8.10 and that of the participants without hypermethylation is 57.79 +/- 9.55; its promoter hypermethylation is likely to be related to smoking. Our results indicated a significant statistical association of promoter methylation of the ABCG1 gene with increased risk of CHD (OR = 19.966; 95% CI, 7.319-54.468; P*<0.001; P*: adjusted for age, gender, smoking, lipid level, hypertension, and diabetes). Similar results were obtained for that of the GALNT2 gene (OR = 2.978; 95% CI, 1.335-6.646; P* = 0.008), but not of HMGCR gene (OR = 1.388; 95% CI, 0.572-3.371; P* = 0.469). Conclusions: The present work provides evidence to support the association of promoter DNA methylation status with the risk profile of CHD. Our data indicates that promoter DNA hypermethylation of the ABCG1 and GALNT2 genes, but not the HMGCR gene, is associated with an increased risk of CHD. CHD, smoking and aging are likely to be the important factors influencing DNA hypermethylation.	[Peng, Ping; Yang, Xi; Huang, Xiaoyan; Ba, Yanna; Chen, Xiaoliang; Guo, Jian; Lian, Jiangfang; Zhou, Jianqing] Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China; [Peng, Ping; Ba, Yanna; Chen, Xiaoliang; Guo, Jian] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Lu] Univ Cambridge, Sch Clin Med, Cambridge, England	Ningbo University; Ningbo University; University of Cambridge	Lian, JF (corresponding author), Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China.	pengpingnb@163.com; hjmpin@163.com	Wang, Lu/AAZ-5097-2021	Wang, Lu/0000-0002-4418-8602	Advanced Key Scientific and Technological Programs of NingBo [2011C51001]; Fund of NingBo Science and Technology Innovation team [2011B82015]; Natural Science Foundation of the Zhejiang Province [LY13H020008]; Ningbo Personnel Training Project; Project of Ningbo Medicine and Science [2009A02]	Advanced Key Scientific and Technological Programs of NingBo; Fund of NingBo Science and Technology Innovation team; Natural Science Foundation of the Zhejiang Province(Natural Science Foundation of Zhejiang Province); Ningbo Personnel Training Project; Project of Ningbo Medicine and Science	The research was supported by the grants from Advanced Key Scientific and Technological Programs of NingBo (2011C51001), Fund of NingBo Science and Technology Innovation team (2011B82015), Natural Science Foundation of the Zhejiang Province (LY13H020008), Ningbo Personnel Training Project (first level), and the Project of Ningbo Medicine and Science (2009A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Indian J Med Sci, V58, P405; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Chen CX, 2001, CHINESE MED J-PEKING, V114, P1095; Doumas BT, 1997, CLIN CHIM ACTA, V258, P3, DOI 10.1016/S0009-8981(96)06446-7; Eastwood JA, 2011, HEART LUNG, V40, P147, DOI [10.1016/j.hrtlng.2010.04.002, 10.1016/j.hrtlng.2010.05.056]; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Friso S, 2012, J MED GENET, V49, P192, DOI 10.1136/jmedgenet-2011-100195; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeemon P, 2011, WORLD J CARDIOL, V3, P230, DOI 10.4330/wjc.v3.i7.230; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Peng P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050126; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sadeghi M, 2012, J RES MED SCI, V17, P787; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; Schumann G, 2010, CLIN CHEM LAB MED, V48, P615, DOI 10.1515/CCLM.2010.137; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tietjen I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037437; Viles-Gonzalez JF, 2004, MT SINAI J MED, V71, P197; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Yin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066924; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025; Zhuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047193	34	49	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102265	10.1371/journal.pone.0102265	http://dx.doi.org/10.1371/journal.pone.0102265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084356	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800007
J	Ito, S; Akamatsu, Y; Noma, A; Kimura, S; Miyauchi, K; Ikeuchi, Y; Suzuki, T; Suzuki, T				Ito, Satoshi; Akamatsu, Yu; Noma, Akiko; Kimura, Satoshi; Miyauchi, Kenjyo; Ikeuchi, Yoshiho; Suzuki, Takeo; Suzuki, Tsutomu			A Single Acetylation of 18 S rRNA Is Essential for Biogenesis of the Small Ribosomal Subunit in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; PROTEIN; ACETYLTRANSFERASE; IDENTIFICATION; PROLIFERATION; BIOSYNTHESIS; NUCLEOTIDE; DATABASE; CLEAVAGE; ARCHAEA	Biogenesis of eukaryotic ribosome is a complex event involving a number of non-ribosomal factors. During assembly of the ribosome, rRNAs are post-transcriptionally modified by 2'-O-methylation, pseudouridylation, and several base-specific modifications, which are collectively involved in fine-tuning translational fidelity and/or modulating ribosome assembly. By mass-spectrometric analysis, we demonstrated that N-4-acetylcytidine (ac(4)C) is present at position 1773 in the 18 S rRNA of Saccharomyces cerevisiae. In addition, we found an essential gene, KRE33 (human homolog, NAT10), that we renamed RRA1 (ribosomal RNA cytidine acetyltransferase 1) encoding an RNA acetyltransferase responsible for ac(4)C1773 formation. Using recombinant Rra1p, we could successfully reconstitute ac(4)C1773 in a model rRNA fragment in the presence of both acetyl-CoA and ATP as substrates. Upon depletion of Rra1p, the 23 S precursor of 18 S rRNA was accumulated significantly, which resulted in complete loss of 18 S rRNA and small ribosomal subunit (40 S), suggesting that ac(4)C1773 formation catalyzed by Rra1p plays a critical role in processing of the 23 S precursor to yield 18 S rRNA. When nuclear acetyl-CoA was depleted by inactivation of acetyl-CoA synthetase 2 (ACS2), we observed temporal accumulation of the 23 S precursor, indicating that Rra1p modulates biogenesis of 40 S subunit by sensing nuclear acetyl-CoA concentration.	[Ito, Satoshi; Akamatsu, Yu; Noma, Akiko; Kimura, Satoshi; Miyauchi, Kenjyo; Ikeuchi, Yoshiho; Suzuki, Takeo; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	ikeuchi, yoshiho/C-1713-2014; Suzuki, Tsutomu/J-1776-2015; Ikeuchi, Yoshiho/N-1057-2019	ikeuchi, yoshiho/0000-0002-2829-3840; Suzuki, Tsutomu/0000-0002-9731-1731; Kimura, Satoshi/0000-0003-3555-5877	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan (to T. S.).	Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; BRAND RC, 1978, BIOCHEM J, V169, P71, DOI 10.1042/bj1690071; BRUENGER E, 1993, FASEB J, V7, P196, DOI 10.1096/fasebj.7.1.8422966; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chimnaronk S, 2009, EMBO J, V28, P1362, DOI 10.1038/emboj.2009.69; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Eschrich D, 2002, CURR GENET, V40, P326, DOI 10.1007/s00294-001-0269-4; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; KRATZER S, 1995, GENE, V161, P75, DOI 10.1016/0378-1119(95)00289-I; LAFONTAINE D, 1995, GENE DEV, V9, P2470, DOI 10.1101/gad.9.20.2470; Larrieu D, 2014, SCIENCE, V344, P527, DOI 10.1126/science.1252651; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MCCARROLL R, 1983, BIOCHEMISTRY-US, V22, P5858, DOI 10.1021/bi00294a027; McCarthy JEG, 1998, MICROBIOL MOL BIOL R, V62, P1492, DOI 10.1128/MMBR.62.4.1492-1553.1998; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Miyauchi K, 2013, NAT CHEM BIOL, V9, P105, DOI [10.1038/NCHEMBIO.1137, 10.1038/nchembio.1137]; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; Page N, 2003, GENETICS, V163, P875; Pendrak ML, 2011, RNA, V17, P2235, DOI 10.1261/rna.028050.111; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Peter A, 2002, EMBO REP, V3, P34, DOI 10.1093/embo-reports/kvf012; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Sanchez-Diaz Alberto, 2004, Sci STKE, V2004, pPL8, DOI 10.1126/stke.2232004pl8; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; TAN TZ, 2013, EMBO MOL MED, V0005; THOMAS G, 1978, J BIOL CHEM, V253, P1101; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waters K, 2010, DEV BIOL, V344, P1011, DOI 10.1016/j.ydbio.2010.06.022; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Wurm JP, 2010, NUCLEIC ACIDS RES, V38, P2387, DOI 10.1093/nar/gkp1189	54	42	44	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26201	26212		10.1074/jbc.M114.593996	http://dx.doi.org/10.1074/jbc.M114.593996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086048	hybrid, Green Published			2022-12-25	WOS:000342128800016
J	Zhao, YL; Xiao, M; Sun, BG; Zhang, ZM; Shen, T; Duan, XY; Yu, PB; Feng, XH; Lin, X				Zhao, Yulan; Xiao, Mu; Sun, Baoguo; Zhang, Zhengmao; Shen, Tao; Duan, Xueyan; Yu, Paul Borchyung; Feng, Xin-Hua; Lin, Xia			C-terminal Domain (CTD) Small Phosphatase-like 2 Modulates the Canonical Bone Morphogenetic Protein (BMP) Signaling and Mesenchymal Differentiation via Smad Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; IDENTIFICATION; PATHWAYS	The bone morphogenetic protein (BMP) signaling pathway regulates a wide range of cellular responses in metazoans. A key step in the canonical BMP signaling is the phosphorylation and activation of transcription factors Smad1, Smad5, and Smad8 (collectively Smad1/5/8) by the type I BMP receptors. We previously identified PPM1A as a phosphatase toward dephosphorylation of all receptor-regulated Smads (R-Smads), including Smad1/5/8. Here we report another nuclear phosphatase named SCP4/CTDSPL2, belonging to the FCP/SCP family, as a novel Smad phosphatase in the nucleus. SCP4 physically interacts with and specifically dephosphorylates Smad1/5/8, and as a result attenuates BMP-induced transcriptional responses. Knockdown of SCP4 in multipotent mesenchymal C2C12 cells leads to increased expression of BMP target genes and consequently promotes BMP-induced osteogenic differentiation. Collectively, our results demonstrate that SCP4, as a Smad phosphatase, plays a critical role in BMP-induced signaling and cellular functions.	[Zhao, Yulan; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Yulan; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Sun, Baoguo; Zhang, Zhengmao; Shen, Tao; Feng, Xin-Hua; Lin, Xia] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Sun, Baoguo; Feng, Xin-Hua] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Duan, Xueyan; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Shen, Tao] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Yu, Paul Borchyung] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Massachusetts General Hospital	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xhfeng@zju.edu.cn; xialin@bcm.edu	Zhang, Zhengmao/C-4566-2014; Huang, Xiaoyan/N-2561-2014; Yu, Paul B./J-7540-2019	Zhang, Zhengmao/0000-0002-7968-9968; Yu, Paul B./0000-0003-2145-4944; Xiao, Mu/0000-0003-3058-2905; ZHANG, ZHENGMAO/0000-0003-4035-0331	Ministry of Science and Technology [2012CB966600]; National Natural Science Foundation of China [31090360]; National Institutes of Health [R01GM63773, R01AR053591, R01CA108454, R01DK073932]; Project 111 [B13026]; Project 985; Fundamental Research Funds for the Central Universities; NATIONAL CANCER INSTITUTE [R01CA108454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591, R01AR057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project 111(Ministry of Education, China - 111 Project); Project 985; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partly supported by grants from the Ministry of Science and Technology (2012CB966600); the National Natural Science Foundation of China (31090360); the National Institutes of Health (R01GM63773, R01AR053591, and R01CA108454 to X.-H. F., and R01DK073932 to X. L.); Project 111 (B13026); Project 985; and the Fundamental Research Funds for the Central Universities.	Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R., 2008, TGF BETA FAMILY; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Reguly T, 2003, TRENDS CELL BIOL, V13, P216, DOI 10.1016/S0962-8924(03)00075-8; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Shen T, 2014, CELL RES, V24, P727, DOI 10.1038/cr.2014.48; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singbrant S, 2010, BLOOD, V115, P4689, DOI 10.1182/blood-2009-05-220988; WLODARSKI KH, 1990, CLIN ORTHOP RELAT R, P276; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JJ, 2013, J BIOL CHEM, V288, P79, DOI 10.1074/jbc.M112.413856; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027	32	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26441	26450		10.1074/jbc.M114.568964	http://dx.doi.org/10.1074/jbc.M114.568964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25100727	hybrid, Green Published			2022-12-25	WOS:000342128800035
J	Fu, K; Cheng, Q; Liu, ZW; Chen, Z; Wang, Y; Ruan, HG; Zhou, L; Xiong, J; Xiao, RJ; Liu, SW; Zhang, QP; Yang, DC				Fu, Kai; Cheng, Qin; Liu, Zhenwei; Chen, Zhen; Wang, Yan; Ruan, Honggang; Zhou, Lu; Xiong, Jie; Xiao, Ruijing; Liu, Shengwu; Zhang, Qiuping; Yang, Daichang			Immunotoxicity Assessment of Rice-Derived Recombinant Human Serum Albumin Using Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY TGN1412; PROTEIN O-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; CYTOKINE STORM; EXPRESSION; SECRETION; SAFETY; YEAST; PURIFICATION	Human serum albumin (HSA) is extensively used in clinics to treat a variety of diseases, such as hypoproteinemia, hemorrhagic shock, serious burn injuries, cirrhotic ascites and fetal erythroblastosis. To address supply shortages and high safety risks from limited human donors, we recently developed recombinant technology to produce HSA from rice endosperm. To assess he risk potential of HSA derived from Oryza sativa (OsrHSA) before a First-in-human (FIH) trial, we compared OsrHSA and plasma-derived HSA (pHSA), evaluating the potential for an immune reaction and toxicity using human peripheral blood mononuclear cells (PBMCs). The results indicated that neither OsrHSA nor pHSA stimulated T cell proliferation at 1x and 5x dosages. We also found no significant differences in the profiles of the CD4(+) and CD8(+) T cell subsets between OsrHSA- and pHSA-treated cells. Furthermore, the results showed that there were no significant differences between OsrHSA and pHSA in the production of cytokines such as interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-10 and IL-4. Our results demonstrated that OsrHSA has equivalent immunotoxicity to pHSA when using the PBMC model. Moreover, this ex vivo system could provide an alternative approach to predict potential risks in novel biopharmaceutical development.	[Fu, Kai; Cheng, Qin; Liu, Zhenwei; Chen, Zhen; Yang, Daichang] Wuhan Univ, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Fu, Kai; Cheng, Qin; Liu, Zhenwei; Chen, Zhen; Yang, Daichang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ruan, Honggang; Zhou, Lu; Xiong, Jie; Xiao, Ruijing; Liu, Shengwu; Zhang, Qiuping] Wuhan Univ, Dept Immunol, Coll Basic Med Sci, Wuhan 430072, Peoples R China; [Wang, Yan] Chinese Acad Sci, Inst Hydrobiol, Anal & Testing Ctr, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Yang, DC (corresponding author), Wuhan Univ, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	dyang@whu.edu.cn	zhang, qiu/GXG-5600-2022		National Essential New Drug Research and Development of China [2013ZX09102038]; National High-Tech R&D Program 863 of China [2011AA100604]	National Essential New Drug Research and Development of China; National High-Tech R&D Program 863 of China(National High Technology Research and Development Program of China)	Major Projects of National Essential New Drug Research and Development of China (2013ZX09102038) and National High-Tech R&D Program 863 of China (2011AA100604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MR, 1979, JAMA-J AM MED ASSOC, V241, P2527, DOI 10.1001/jama.241.23.2527; An N, 2013, INT J MOL SCI, V14, P3556, DOI 10.3390/ijms14023556; [Anonymous], 2011, ROITTS ESSENTIAL IMM; BARASH I, 1993, TRANSGENIC RES, V2, P266, DOI 10.1007/BF01968839; Baroncelli S, 1997, VET IMMUNOL IMMUNOP, V59, P141, DOI 10.1016/S0165-2427(97)00040-8; Cavagnaro JA, 2008, PRECLINICAL SAFETY E; Czyz CN, 2012, DERMATOL SURG, V38, P445, DOI 10.1111/j.1524-4725.2011.02215.x; Farran I, 2002, TRANSGENIC RES, V11, P337, DOI 10.1023/A:1016356510770; Fernandez-San Millan A, 2003, PLANT BIOTECHNOL J, V1, P71, DOI 10.1046/j.1467-7652.2003.00008.x; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; FLEER R, 1991, BIO-TECHNOL, V9, P968, DOI 10.1038/nbt1091-968; Foster JR, 2001, INT J EXP PATHOL, V82, P171, DOI 10.1046/j.1365-2613.2001.00192.x; Frantz S, 2007, NAT REV DRUG DISCOV, V6, P5, DOI 10.1038/nrd2230; Hastings G E, 1992, Arch Fam Med, V1, P281, DOI 10.1001/archfami.1.2.281; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Herzyk DJ, 2008, IMMUNOTOXICOLOGY STR; House RV, 1999, METHODS, V19, P17, DOI 10.1006/meth.1999.0823; Huang LF, 2005, TRANSGENIC RES, V14, P569, DOI 10.1007/s11248-004-6481-5; Joubert MK, 2012, J BIOL CHEM, V287, P25266, DOI 10.1074/jbc.M111.330902; Kasahara A, 2008, J GASTROENTEROL, V43, P464, DOI 10.1007/s00535-008-2178-5; Kishimoto T, 1999, ARCH BIOCHEM BIOPHYS, V370, P271, DOI 10.1006/abbi.1999.1406; Kobayashi K, 2000, J BIOSCI BIOENG, V89, P55, DOI 10.1016/S1389-1723(00)88050-0; Kooijman R, 2010, TOXICOL IN VITRO, V24, P1782, DOI 10.1016/j.tiv.2010.07.007; LATTA M, 1987, BIO-TECHNOL, V5, P1309, DOI 10.1038/nbt1287-1309; LUSSIER M, 1995, J BIOL CHEM, V270, P2770, DOI 10.1074/jbc.270.6.2770; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; MOOLENAAR WH, 1990, CIBA F SYMP, V150, P99; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Okamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054817; Olsen SC, 2012, CLIN VACCINE IMMUNOL, V19, P642, DOI 10.1128/CVI.00033-12; Oszvald M, 2008, MOL BIOTECHNOL, V40, P261, DOI 10.1007/s12033-008-9083-2; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Schindel F, 2003, J CLIN PHARMACOL, V43, P1032; SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217; SLEEP D, 1990, BIO-TECHNOL, V8, P42, DOI 10.1038/nbt0190-42; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Stebbings R, 2009, CURR OPIN BIOTECH, V20, P673, DOI 10.1016/j.copbio.2009.10.002; Stolevik SB, 2011, TOXICOL IN VITRO, V25, P555, DOI 10.1016/j.tiv.2010.11.021; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; TIGYI G, 1994, P NATL ACAD SCI USA, V91, P1908, DOI 10.1073/pnas.91.5.1908; Tomita Michiyo, 2004, Lipids Health Dis, V3, P1, DOI 10.1186/1476-511X-3-1; Vidal Jean-Marc, 2010, Cytokine, V51, P213, DOI 10.1016/j.cyto.2010.04.008; Walker MR, 2011, INT IMMUNOPHARMACOL, V11, P1697, DOI 10.1016/j.intimp.2011.06.001; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; Wongtangtintharn S, 2005, LIPIDS HLTH DIS, V4, P1476; WU AM, 1994, MOL CELL BIOCHEM, V137, P39, DOI 10.1007/BF00926038; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; Zhang DS, 2010, PROTEIN EXPRES PURIF, V74, P69, DOI 10.1016/j.pep.2010.04.019; Zhang LP, 2013, J BIOTECHNOL, V164, P300, DOI 10.1016/j.jbiotec.2013.01.008	53	7	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104426	10.1371/journal.pone.0104426	http://dx.doi.org/10.1371/journal.pone.0104426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099245	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100070
J	Martinez-Maza, C; Alberdi, MT; Nieto-Diaz, M; Prado, JL				Martinez-Maza, Cayetana; Teresa Alberdi, Maria; Nieto-Diaz, Manuel; Luis Prado, Jose			Life-History Traits of the Miocene Hipparion concudense (Spain) Inferred from Bone Histological Structure	PLOS ONE			English	Article							GROWTH-PATTERNS; SEXUAL-MATURITY; ARRESTED GROWTH; DINOSAURS; MAMMALS; SKELETOCHRONOLOGY; PHYSIOLOGY; DYNAMICS; LIGHT; LINES	Histological analyses of fossil bones have provided clues on the growth patterns and life history traits of several extinct vertebrates that would be unavailable for classical morphological studies. We analyzed the bone histology of Hipparion to infer features of its life history traits and growth pattern. Microscope analysis of thin sections of a large sample of humeri, femora, tibiae and metapodials of Hipparion concudense from the upper Miocene site of Los Valles de Fuentiduena (Segovia, Spain) has shown that the number of growth marks is similar among the different limb bones, suggesting that equivalent skeletochronological inferences for this Hipparion population might be achieved by means of any of the elements studied. Considering their abundance, we conducted a skeletechronological study based on the large sample of third metapodials from Los Valles de Fuentiduena together with another large sample from the Upper Miocene locality of Concud (Teruel, Spain). The data obtained enabled us to distinguish four age groups in both samples and to determine that Hipparion concudense tended to reach skeletal maturity during its third year of life. Integration of bone microstructure and skeletochronological data allowed us to identify ontogenetic changes in bone structure and growth rate and to distinguish three histologic ontogenetic stages corresponding to immature, subadult and adult individuals. Data on secondary osteon density revealed an increase in bone remodeling throughout the ontogenetic stages and a lesser degree thereof in the Concud population, which indicates different biomechanical stresses in the two populations, likely due to environmental differences. Several individuals showed atypical growth patterns in the Concud sample, which may also reflect environmental differences between the two localities. Finally, classification of the specimens' age within groups enabled us to characterize the age structure of both samples, which is typical of attritional assemblages.	[Martinez-Maza, Cayetana; Teresa Alberdi, Maria] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Nieto-Diaz, Manuel] Hosp Nacl Paraplej Toledo, Mol Neuroprotect Grp, Toledo, Castilla La Man, Spain; [Luis Prado, Jose] CONICET UNICEN Univ Olavarria, UE INCUAPA, Olavarria, Argentina	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Hospital Nacional de Paraplejicos	Martinez-Maza, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	cayetana@mncn.csic.es	Alberdi, Maria Teresa/ABG-8623-2020; Nieto-Diaz, Manuel/R-5163-2017; Prado, Jose Luis/N-2001-2019; Díaz, Manuel Nieto/ABD-7144-2020	Alberdi, Maria Teresa/0000-0002-7071-360X; Nieto-Diaz, Manuel/0000-0002-7244-794X; Prado, Jose Luis/0000-0003-0579-8747; 	Ministerio de Economia y Competitividad, Spain [CGL2010-19116/BOS]; JAE-DOC postdoctoral contract (CSIC); European Social Fund	Ministerio de Economia y Competitividad, Spain; JAE-DOC postdoctoral contract (CSIC); European Social Fund(European Social Fund (ESF))	This study was funded by the research project CGL2010-19116/BOS (Ministerio de Economia y Competitividad, Spain). CMM was supported by a JAE-DOC postdoctoral contract (CSIC) co-funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi M.T., 1981, Estudios Geologicos (Madrid), V37, P503; Alcala L., 1999, Publicaciones del Seminario de Paleontologia de Zaragoza, V4, P117; Alcala L, 1994, MACROMAMIFEROS NEOGE, P554; Alcala L., 1998, 4 REUN NAC COM PATR, P29; Amprino R., 1947, ARCH BIOL SCI, V58, P315; [Anonymous], 1999, WALKERS MAMMALS WORL; Bennett D, 2008, TIMING RATE SKLETAL; Brown-Douglas C., 2011, Equine reproduction, Volume 1, P280; Brown-Douglas CG, 2004, EQUINE VET J, V36, P499, DOI 10.2746/0425164044877422; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J., 1993, BONE, P245; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Chinsamy A, 2008, S AFR J SCI, V104, P311; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cubit TA, 2004, THESIS VIRGINIA POLY; de Boef M, 2007, CAN J ZOOL, V85, P63, DOI 10.1139/Z06-195; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A., 1991, BONE, V3, P255; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fernandez P, 2006, J ARCHAEOL SCI, V33, P176, DOI 10.1016/j.jas.2005.07.005; Francillon-Vieillot H., 1990, P471; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; KLEIN R G, 1982, Annals of the South African Museum, V90, P49; Klevezal G., 1996, RECORDING STRUCTURES; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Marin-Moratalla N, 2013, MAMM BIOL, V78, P422, DOI 10.1016/j.mambio.2013.07.079; Marin-Moratalla N, 2011, CR PALEVOL, V10, P469, DOI 10.1016/j.crpv.2011.03.007; Martin RB, 1996, J BIOMECH, V29, P1515, DOI 10.1016/0021-9290(96)00082-6; Martin-Rosset W, 2005, EAAP PUBLIC, P15; MCFADDEN BJ, 1992, FOSSIL HORSES SYSTEM; MILLAR JS, 1983, ECOLOGY, V64, P631, DOI 10.2307/1937181; Nunez C. M. V., 2011, Equine reproduction, Volume 2, P2851; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P35; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Pesquero MD, 2012, ESTUD GEOL-MADRID, V68, P47; Redelstorff R, 2012, ACTA PALAEONTOLOGICA, DOI org/10.4202/app.2012.0073; Ricklefs R. E., 2007, EC NATURE; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skedros JG, 2009, BONE, V44, P392, DOI 10.1016/j.bone.2008.10.053; Stearns S.C., 1992, pi; Stein M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068590; STOVER SM, 1992, J ANAT, V181, P455; Warren LK, 1997, PROCEEDINGS OF THE FIFTEENTH EQUINE NUTRITION & PHYSIOLOGY SYMPOSIUM, P65; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; WESTERN D, 1979, AFR J ECOL, V17, P185, DOI 10.1111/j.1365-2028.1979.tb00256.x; Wilson James W., 1994, P205; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195	60	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e103708	10.1371/journal.pone.0103708	http://dx.doi.org/10.1371/journal.pone.0103708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098950	Green Submitted, gold, Green Published			2022-12-25	WOS:000339995100027
J	Burrow, CJ; Rudkin, D				Burrow, Carole J.; Rudkin, David			Oldest Near-Complete Acanthodian: The First Vertebrate from the Silurian Bertie Formation Konservat-Lagerstatte, Ontario	PLOS ONE			English	Article							NORTH-AMERICA; FISHES; CHELICERATA; EURYPTERIDA; PLACODERM; CANADA; BONES	Background: The relationships between early jawed vertebrates have been much debated, with cladistic analyses yielding little consensus on the position (or positions) of acanthodians with respect to other groups. Whereas one recent analysis showed various acanthodians (classically known as 'spiny sharks') as stem osteichthyans (bony fishes) and others as stem chondrichthyans, another shows the acanthodians as a paraphyletic group of stem chondrichthyans, and the latest analysis shows acanthodians as the monophyletic sister group of the Chondrichthyes. Methodology/Principal Findings: A small specimen of the ischnacanthiform acanthodian Nerepisacanthus denisoni is the first vertebrate fossil collected from the Late Silurian Bertie Formation Konservat-Lagerstatte of southern Ontario, Canada, a deposit well-known for its spectacular eurypterid fossils. The fish is the only near complete acanthodian from pre-Devonian strata worldwide, and confirms that Nerepisacanthus has dentigerous jaw bones, body scales with superposed crown growth zones formed of ondontocytic mesodentine, and a patch of chondrichthyan-like scales posterior to the jaw joint. Conclusions/Significance: The combination of features found in Nerepisacanthus supports the hypothesis that acanthodians could be a group, or even a clade, on the chondrichthyan stem. Cladistic analyses of early jawed vertebrates incorporating Nerepisacanthus, and updated data on other acanthodians based on publications in press, should help clarify their relationships.	[Burrow, Carole J.] Queensland Museum, Brisbane, Qld 4101, Australia; [Rudkin, David] Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada	Queensland Museum; Royal Ontario Museum	Burrow, CJ (corresponding author), Queensland Museum, POB 300, Brisbane, Qld 4101, Australia.	carole.burrow@gmail.com	Burrow, Carole J./AAG-4327-2021					Braddy SJ, 2001, PALAEOGEOGR PALAEOCL, V172, P115, DOI 10.1016/S0031-0182(01)00274-7; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Brett CE, 1998, GEOLOGICAL SOCIETY O, V16, P32; Burrow CJ, 2013, ALCHERINGA, V37, P392, DOI 10.1080/03115518.2013.765656; Burrow CJ, 2011, CAN J EARTH SCI, V48, P1329, DOI 10.1139/E11-023; Burrow CJ, 2011, PALAEONTOLOGY, V54, P207, DOI 10.1111/j.1475-4983.2010.01003.x; Caron JB, 2004, J PALEONTOL, V78, P1138, DOI 10.1666/0022-3360(2004)078<1138:ANLSPN>2.0.CO;2; Cramer BD, 2011, LETHAIA, V44, P185, DOI 10.1111/j.1502-3931.2010.00234.x; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R. H., 1979, HDB PALEOICHTHYOLO 5; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Edwards D, 2004, BOT J LINN SOC, V146, P399, DOI 10.1111/j.1095-8339.2004.00332.x; Fritsch A., 1907, MISCELLANEA PALAEONT; Hermus Chelsea R., 2001, Journal of Vertebrate Paleontology, V21, p61A; Miles R. S., 1973, ZOOLOGICAL J LINNEAN, P63; MILES RS, 1966, ARK ZOOL, V18, P147; MILES RS, 1970, LETHAIA, V3, P343, DOI 10.1111/j.1502-3931.1970.tb00828.x; NUDDS JR, 2008, FOSSIL ECOSYSTEMS N; Tetlie O. Erik, 2007, Bulletin of the Peabody Museum of Natural History, V48, P139, DOI 10.3374/0079-032X(2007)48[139:ERAELC]2.0.CO;2; Tetlie OE, 2008, PALAEOGEOGR PALAEOCL, V265, P182, DOI 10.1016/j.palaeo.2008.05.008; Upeniece Ieva, 1996, Modern Geology, V20, P383; Valiukevicius J., 1992, FOSSIL FISHES LIVING, P193; Valiukevicius Juozas, 2003, Geodiversitas, V25, P131; Valiukevicus J, 2005, ACTA PALAEONTOL POL, V50, P635; Wells J. W., 1944, PALAEONTOGRAPH AMER, V3, P99; Williams ME, 1998, J VERTEBR PALEONTOL, V18, P251, DOI 10.1080/02724634.1998.10011054; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; ZIDEK J, 1985, Palaeontologische Zeitschrift, V59, P147	28	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104171	10.1371/journal.pone.0104171	http://dx.doi.org/10.1371/journal.pone.0104171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093877	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200083
J	Ghiglione, Y; Falivene, J; Ruiz, MJ; Laufer, N; Socias, ME; Cahn, P; Giavedoni, L; Sued, O; Gherardi, MM; Salomon, H; Turk, G				Ghiglione, Yanina; Falivene, Juliana; Julia Ruiz, Maria; Laufer, Natalia; Eugenia Socias, Maria; Cahn, Pedro; Giavedoni, Luis; Sued, Omar; Magdalena Gherardi, Maria; Salomon, Horacio; Turk, Gabriela			Early Skewed Distribution of Total and HIV-Specific CD8(+) T-Cell Memory Phenotypes during Primary HIV Infection Is Related to Reduced Antiviral Activity and Faster Disease Progression	PLOS ONE			English	Article							PROGRAMMED DEATH-1; FUNCTIONAL PROFILE; VIRAL LOAD; PD-1 EXPRESSION; EX-VIVO; RESPONSES; DIFFERENTIATION; ASSOCIATION; EXHAUSTION; CAPACITY	The important role of the CD8(+) T-cells on HIV control is well established. However, correlates of immune protection remain elusive. Although the importance of CD8(+) T-cell specificity and functionality in virus control has been underscored, further unraveling the link between CD8(+) T-cell differentiation and viral control is needed. Here, an immunophenotypic analysis (in terms of memory markers and Programmed cell death 1 (PD-1) expression) of the CD8(+) T-cell subset found in primary HIV infection (PHI) was performed. The aim was to seek for associations with functional properties of the CD8(+) T-cell subsets, viral control and subsequent disease progression. Also, results were compared with samples from Chronics and Elite Controllers. It was found that normal maturation of total and HIV-specific CD8(+) T-cells into memory subsets is skewed in PHI, but not at the dramatic level observed in Chronics. Within the HIV-specific compartment, this alteration was evidenced by an accumulation of effector memory CD8(+) T (T-EM) cells over fully differentiated terminal effector CD8(+) T (T-TE) cells. Furthermore, higher proportions of total and HIV-specific CD8(+) T-EM cells and higher HIV-specific T-EM/(T-EM+T-TE) ratio correlated with markers of faster progression. Analysis of PD-1 expression on total and HIV-specific CD8(+) T-cells from PHI subjects revealed not only an association with disease progression but also with skewed memory CD8(+) T-cell differentiation. Most notably, significant direct correlations were obtained between the functional capacity of CD8(+) T-cells to inhibit viral replication in vitro with higher proportions of fully-differentiated HIV-specific CD8(+) T-TE cells, both at baseline and at 12 months post-infection. Thus, a relationship between preservation of CD8(+) T-cell differentiation pathway and cell functionality was established. This report presents evidence concerning the link among CD8(+) T-cell function, phenotype and virus control, hence supporting the instauration of early interventions to prevent irreversible immune damage.	[Ghiglione, Yanina; Falivene, Juliana; Julia Ruiz, Maria; Laufer, Natalia; Magdalena Gherardi, Maria; Salomon, Horacio; Turk, Gabriela] Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina; [Eugenia Socias, Maria; Cahn, Pedro; Sued, Omar] Fdn Huesped, Buenos Aires, DF, Argentina; [Laufer, Natalia; Eugenia Socias, Maria; Cahn, Pedro; Sued, Omar] Hosp JA Fernandez, Buenos Aires, DF, Argentina; [Giavedoni, Luis] Texas Biomed, Res Inst, Southwest Natl Primate Res Ctr, Dept Virol & Immunol, San Antonio, TX USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Texas Biomedical Research Institute	Turk, G (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Biomed Retrovirus & SIDA INBIRS, Buenos Aires, DF, Argentina.	gturk@fmed.uba.ar	Sued, Omar/H-3325-2019; Laufer, Natalia/AAB-7472-2022	Sued, Omar/0000-0001-5818-770X; Laufer, Natalia/0000-0002-5690-9454; Falivene, Juliana/0000-0003-3437-4863	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCYT [2008/0549, 2011/1658, 2011/0271]; Universidad de Buenos Aires [UBACyT 2013-201620020120200263BA]	Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCYT(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This research was funded by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, ANPCYT, Grants #2008/0549 and #2011/1658 to MMG, Grant #2011/0271 to HS and a grant from Universidad de Buenos Aires (UBACyT 2013-201620020120200263BA) to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Buckheit RW, 2012, J VIROL, V86, P13679, DOI 10.1128/JVI.02439-12; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Silva TI, 2013, BLOOD, V121, P4330, DOI 10.1182/blood-2012-12-472787; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; Emu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085613; Socias ME, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-40; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Janetzki Sylvia, 2005, Methods Mol Biol, V302, P51; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Killian MS, 2011, J VIROL, V85, P1696, DOI 10.1128/JVI.01120-10; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Mahnke YD, 2013, AIDS, V27, P697, DOI 10.1097/QAD.0b013e32835ce2e9; Malhotra U, 2007, J VIROL, V81, P5225, DOI 10.1128/JVI.02564-06; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meyer-Olson D, 2010, BLOOD, V116, P396, DOI 10.1182/blood-2009-11-254136; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Patrick C, 2001, NATURE, P410; Peretz Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002840; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Pires A, 2004, JAIDS-J ACQ IMM DEF, V36, P783, DOI 10.1097/00126334-200407010-00004; Riou C, 2014, J VIROL, V88, P1819, DOI 10.1128/JVI.02968-13; Riou C, 2012, J IMMUNOL, V189, P3838, DOI 10.4049/jimmunol.1201488; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; Yamamoto T, 2012, J VIROL, V86, P5877, DOI 10.1128/JVI.00315-12; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	62	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104235	10.1371/journal.pone.0104235	http://dx.doi.org/10.1371/journal.pone.0104235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093660	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200088
J	Paterson, C; Law, AJ				Paterson, Clare; Law, Amanda J.			Transient Overexposure of Neuregulin 3 during Early Postnatal Development Impacts Selective Behaviors in Adulthood	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DEVELOPING NEOCORTEX; RECOGNITION MEMORY; PREFRONTAL CORTEX; ANIMAL-MODEL; SCHIZOPHRENIA; MICE; RECEPTOR; SUSCEPTIBILITY; INTERNEURONS	Neuregulin 3 (NRG3), a specific ligand for ErbB4 and a neuronal-enriched neurotrophin is implicated in the genetic predisposition to a broad spectrum of neurodevelopmental, neurocognitive and neuropsychiatric disorders, including Alzheimer's disease, autism and schizophrenia. Genetic studies in schizophrenia demonstrate that risk variants in NRG3 are associated with cognitive and psychotic symptom severity, accompanied by increased expression of prefrontal cortical NRG3. Despite our expanding knowledge of genetic involvement of NRG3 in neurological disorders, little is known about the neurodevelopmental mechanisms of risk. Here we exploited the fact that a paralog of NRG3, NRG1, readily penetrates the murine blood brain barrier (BBB). In this study we synthesized the bioactive epidermal growth factor (EGF) domain of NRG3, and using previously validated in-vivo peripheral injection methodologies in neonatal mice, demonstrate that NRG3 successfully crosses the BBB, where it activates its receptor ErbB4 and downstream Akt signaling at levels of bioactivity comparable to NRG1. To determine the impact of NRG3 overexpression during one critical developmental window, C57BL/6 male mice were subcutaneously injected daily with NRG1-EGF, NRG3-EGF or vehicle from postnatal days 2-10. Mice were tested in adulthood using a comprehensive battery of behavioral tasks relevant to neurocognitive and psychiatric disorders. In agreement with previous studies, developmental overexposure to NRG1 induced multiple non-CNS mediated peripheral effects as well as severely disrupting performance of prepulse inhibition of the startle response. In contrast, NRG3 had no effect on any peripheral measures investigated or sensorimotor gating. Specifically, developmental NRG3 overexposure produced an anxiogenic-like phenotype and deficits in social behavior in adulthood. These results provide primary data to support a role for NRG3 in brain development and function, which appears to be distinct from its paralog NRG1. Furthermore we demonstrate how perturbations in NRG3 expression at distinct developmental stages may contribute to the neurological deficits observed in brain disorders such as schizophrenia and autism.	[Paterson, Clare; Law, Amanda J.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA; [Law, Amanda J.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Law, AJ (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA.	amanda.law@ucdenver.edu	Law, Amanda J/G-6372-2012	Law, Amanda J/0000-0002-2574-1564; Paterson, Clare/0000-0001-7454-560X	National Institute of Mental Health; Brain Behavior Research Foundations, Sidney R. Baer Jr. Award for Schizophrenia Research	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain Behavior Research Foundations, Sidney R. Baer Jr. Award for Schizophrenia Research	This work was supported by funds from the Intramural Research Program, National Institute of Mental Health, and from the Brain Behavior Research Foundations, Sidney R. Baer Jr. Award for Schizophrenia Research, awarded to Amanda J. Law at the University of Colorado, Denver, School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Abe Y, 2011, J NEUROSCI, V31, P5699, DOI 10.1523/JNEUROSCI.3477-10.2011; Assimacopoulos S, 2003, J NEUROSCI, V23, P6399; Balciuniene J, 2007, AM J HUM GENET, V80, P938, DOI 10.1086/513607; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bortolato M, 2013, NEUROPHARMACOLOGY, V75, P223, DOI 10.1016/j.neuropharm.2013.07.003; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Chen PL, 2009, AM J HUM GENET, V84, P21, DOI 10.1016/j.ajhg.2008.12.005; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Deakin IH, 2012, CEREB CORTEX, V22, P1520, DOI 10.1093/cercor/bhr223; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Dean B, 2008, SCHIZOPHR RES, V99, P341, DOI 10.1016/j.schres.2007.10.013; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Futamura T, 2003, MOL PSYCHIATR, V8, P19, DOI 10.1038/sj.mp.4001138; Grant E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00053; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hatzimanolis A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.33; Henck JW, 2001, TOXICOL SCI, V62, P80, DOI 10.1093/toxsci/62.1.80; Hobbs SS, 2002, ONCOGENE, V21, P8442, DOI 10.1038/sj.onc.1205960; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kastin AJ, 2004, J NEUROCHEM, V88, P965, DOI 10.1046/j.1471-4159.2003.02224.x; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Law AJ, 2012, P NATL ACAD SCI USA, V109, P12165, DOI 10.1073/pnas.1206118109; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; Longart M, 2004, J COMP NEUROL, V472, P156, DOI 10.1002/cne.20016; Loos M, 2014, BIOL PSYCHIAT; Mahar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026610; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; Meier S, 2013, INT J NEUROPSYCHOPH, V16, P549, DOI 10.1017/S1461145712000697; Mizuno M, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.29; Morar B, 2011, MOL PSYCHIATR, V16, P860, DOI 10.1038/mp.2010.70; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; Shamir A, 2012, J NEUROSCI, V32, P2988, DOI 10.1523/JNEUROSCI.1899-11.2012; Tost H, 2014, J NEUROSCI, V34, P1051, DOI 10.1523/JNEUROSCI.3496-13.2014; Turner J.R., 2013, MOL PSYCHIAT; Vullhorst D, 2009, J NEUROSCI, V29, P12255, DOI 10.1523/JNEUROSCI.2454-09.2009; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang YC, 2008, BIOL PSYCHIAT, V64, P1093, DOI 10.1016/j.biopsych.2008.07.012; Yin DM, 2013, NEURON, V78, P644, DOI 10.1016/j.neuron.2013.03.028; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562	54	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104172	10.1371/journal.pone.0104172	http://dx.doi.org/10.1371/journal.pone.0104172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093331	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200084
J	Pradier, C; Sakarovitch, C; Le Duff, F; Layese, R; Metelkina, A; Anthony, S; Tifratene, K; Robert, P				Pradier, Christian; Sakarovitch, Charlotte; Le Duff, Franck; Layese, Richard; Metelkina, Asya; Anthony, Sabine; Tifratene, Karim; Robert, Philippe			The Mini Mental State Examination at the Time of Alzheimer's Disease and Related Disorders Diagnosis, According to Age, Education, Gender and Place of Residence: A Cross-Sectional Study among the French National Alzheimer Database	PLOS ONE			English	Article							LATENT PROCESS; RESERVE; BRAIN; NORMS; MODEL	The aim of this study: was firstly to describe the MMSE (Mini- Mental State Examination) score upon initial diagnosis of Alzheimer's disease and related disorders among the French population, according to age. Secondly, education, gender and place of residence were studied as factors potentially associated with delayed Alzheimer's disease diagnosis. Design: we conducted a cross sectional analysis of the French National Alzheimer database (BNA). Data from 2008 to 2012 were extracted. Patients were selected at the moment of their first diagnosis of AD (n = 39,451). Results: The MMSE score at initial diagnosis dropped significantly with increasing age. The test score increased with the degree of educational background regardless of age. Gender and place of residence were significantly related to the MMSE score, women and persons living in medical institutions having lower MMSE scores under the age of 90 years and at all educational levels. Conclusions: Health care professionals should be aware of these risk factors in order to maximize chances of earliest possible diagnosis of Alzheimer's disease and related disorders.	[Pradier, Christian; Le Duff, Franck; Metelkina, Asya; Anthony, Sabine; Tifratene, Karim] Nice Univ Hosp, Dept Publ Hlth, Nice, France; [Pradier, Christian; Le Duff, Franck; Metelkina, Asya; Anthony, Sabine; Tifratene, Karim] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Sakarovitch, Charlotte; Layese, Richard] Nice Univ Hosp Nice, Dept Clin Res, Nice, France; [Tifratene, Karim; Robert, Philippe] Univ Nice Sophia Antipolis, CoBTeK Res Unit, F-06189 Nice, France; [Robert, Philippe] Nice Univ Hosp, Memory Ctr CMRR, Nice, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Pradier, C (corresponding author), Nice Univ Hosp, Dept Publ Hlth, Nice, France.	pradier.c@chu-nice.fr	Pradier, Christian/AAE-9669-2022; Pradier, Christian/AFE-8255-2022; LAYESE, Richard/R-4395-2018	LAYESE, Richard/0000-0002-2855-4908; LE DUFF, Franck/0000-0002-7899-491X	French Ministry of Health	French Ministry of Health	The BNA is funded by the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2007, J CLIN EXP NEUROPSYC, V29, P530, DOI 10.1080/13803390600814740; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chene G, 2013, ALZHEIMER DEMENT; COMMENGES D, 1992, J NERV MENT DIS, V180, P28, DOI 10.1097/00005053-199201000-00007; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GANGULI M, 1991, NEUROEPIDEMIOLOGY, V10, P42, DOI 10.1159/000110246; Jacqmin-Gadda H, 2010, STAT MED, V29, P2723, DOI 10.1002/sim.4035; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Le Duff F, 2012, J ALZHEIMERS DIS, V29, P891, DOI 10.3233/JAD-2012-111943; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; Perneczky R, 2007, INT J GERIATR PSYCH, V22, P1135, DOI 10.1002/gps.1803; Perneczky R, 2007, J NEUROL, V254, P1395, DOI 10.1007/s00415-007-0558-z; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Proust C, 2006, BIOMETRICS, V62, P1014, DOI 10.1111/j.1541-0420.2006.00573.x; Roberts RO, 2012, NEUROLOGY, V78, P342, DOI 10.1212/WNL.0b013e3182452862; Roselli F, 2009, CLIN NEUROL NEUROSUR, V111, P327, DOI 10.1016/j.clineuro.2008.10.006; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sinforiani E, 2010, DEMENT GERIATR COGN, V30, P147, DOI 10.1159/000318842; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006	22	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103630	10.1371/journal.pone.0103630	http://dx.doi.org/10.1371/journal.pone.0103630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093735	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200026
J	Sabater-Lleal, M; Malarstig, A; Folkersen, L; Artigas, MS; Baldassarre, D; Kavousi, M; Almgren, P; Veglia, F; Brusselle, G; Hofman, A; Engstrom, G; Franco, OH; Melander, O; Paulsson-Berne, G; Watkins, H; Eriksson, P; Humphries, SE; Tremoli, E; de Faire, U; Tobin, MD; Hamsten, A				Sabater-Lleal, Maria; Maelarstig, Anders; Folkersen, Lasse; Artigas, Maria Soler; Baldassarre, Damiano; Kavousi, Maryam; Almgren, Peter; Veglia, Fabrizio; Brusselle, Guy; Hofman, Albert; Engstrom, Gunnar; Franco, Oscar H.; Melander, Olle; Paulsson-Berne, Gabrielle; Watkins, Hugh; Eriksson, Per; Humphries, Steve E.; Tremoli, Elena; de Faire, Ulf; Tobin, Martin D.; Hamsten, Anders			Common Genetic Determinants of Lung Function, Subclinical Atherosclerosis and Risk of Coronary Artery Disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INTIMA-MEDIA THICKNESS; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR RISK; GLOBAL BURDEN; INFLAMMATION; VARIANTS; IDENTIFICATION; COPD; TOOL	Chronic obstructive pulmonary disease (COPD) independently associates with an increased risk of coronary artery disease (CAD), but it has not been fully investigated whether this co-morbidity involves shared pathophysiological mechanisms. To identify potential common pathways across the two diseases, we tested all recently published single nucleotide polymorphisms (SNPs) associated with human lung function (spirometry) for association with carotid intima-media thickness (cIMT) in 3,378 subjects with multiple CAD risk factors, and for association with CAD in a case-control study of 5,775 CAD cases and 7,265 controls. SNPs rs2865531, located in the CFDP1 gene, and rs9978142, located in the KCNE2 gene, were significantly associated with CAD. In addition, SNP rs9978142 and SNP rs3995090 located in the HTR4 gene, were associated with average and maximal cIMT measures. Genetic risk scores combining the most robustly spirometry-associated SNPs from the literature were modestly associated with CAD, (odds ratio (OR) (95% confidence interval (CI95) = 1.06 (1.03, 1.09); P-value = 1.5x10(-4), per allele). In conclusion, our study suggests that some genetic loci implicated in determining human lung function also influence cIMT and susceptibility to CAD. The present results should help elucidate the molecular underpinnings of the co-morbidity observed across COPD and CAD.	[Sabater-Lleal, Maria; Folkersen, Lasse; Eriksson, Per; Hamsten, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Maelarstig, Anders] Pfizer Worldwide Res & Dev, Cambridge, England; [Artigas, Maria Soler; Tobin, Martin D.] Univ Leicester, Genet Epidemiol Grp, Dept Hlth Sci, Leicester, Leics, England; [Artigas, Maria Soler; Tobin, Martin D.] Glenfield Hosp, Natl Inst Hlth Res, Leicester Resp Biomed Res Unit, Leicester, Leics, England; [Baldassarre, Damiano; Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Baldassarre, Damiano; Veglia, Fabrizio; Tremoli, Elena] Ist Ricovero & Cura Cattere Sci, Ctr Cardiol Monzino, Milan, Italy; [Kavousi, Maryam; Brusselle, Guy; Hofman, Albert; Franco, Oscar H.] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus Med Ctr, Rotterdam, Netherlands; [Almgren, Peter; Engstrom, Gunnar; Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Brusselle, Guy] Univ Med Ctr Rotterdam, Dept Internal Med, Erasmus Med Ctr, Rotterdam, Netherlands; [Brusselle, Guy] Inspectorate Hlth Care, The Hague, Netherlands; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Paulsson-Berne, Gabrielle] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Cardiovasc Res Unit, Stockholm, Sweden; [Watkins, Hugh] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Pfizer; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Milan; IRCCS Centro Cardiologico Monzino; Erasmus University Rotterdam; Erasmus MC; Lund University; Erasmus University Rotterdam; Erasmus MC; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; Karolinska Institutet	Sabater-Lleal, M (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden.	maria.sabater.lleal@ki.se	Artigas, María Soler/L-6529-2013; Franco, Óscar H/ABE-2305-2020; Baldassarre, Damiano/J-3295-2016; Lleal, Maria Sabater/I-5832-2013; Veglia, Fabrizio/K-1958-2016; Kavousi, Maryam/F-1174-2018; TREMOLI, ELENA/I-8126-2018	Artigas, María Soler/0000-0002-3213-1107; Franco, Óscar H/0000-0002-4606-4929; Baldassarre, Damiano/0000-0002-2766-8882; Lleal, Maria Sabater/0000-0002-0128-379X; Veglia, Fabrizio/0000-0002-9378-8874; Kavousi, Maryam/0000-0001-5976-6519; Folkersen, Lasse/0000-0003-0708-9530; Watkins, Hugh/0000-0002-5287-9016; Malarstig, Anders/0000-0003-2608-1358; Melander, Olle/0000-0002-2581-484X; Eriksson, Per/0000-0002-5635-2692; Engstrom, Gunnar/0000-0002-8618-9152; Brusselle, Guy/0000-0001-7021-8505; TREMOLI, ELENA/0000-0002-0929-6106; Humphries, Stephen E/0000-0002-8221-6547; Tobin, Martin/0000-0002-3596-7874	Pfizer; MRC [G0902313] Funding Source: UKRI; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0902313] Funding Source: researchfish	Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	On behalf of all the authors, Dr. Sabater-Lleal would like to state that the authors received no specific funding for this work, however Pfizer provided support in the form of salary for author Dr. Malarstig, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Baldassarre D, ARTERIOSCLER THROMB, V33, P2273; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Bhatt SP, 2013, TRANSL RES; Castaldi PJ, 2011, AM J RESP CELL MOL, V45, P1147, DOI 10.1165/rcmb.2011-0055OC; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gertow K, 2012, CIRC-CARDIOVASC GENE, V5, P656, DOI 10.1161/CIRCGENETICS.112.963660; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Maclay JD, 2007, RESPIROLOGY, V12, P634, DOI 10.1111/j.1440-1843.2007.01136.x; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schroeder EB, 2005, ATHEROSCLEROSIS, V180, P367, DOI 10.1016/j.atherosclerosis.2004.12.012; Silverman Edwin K, 2006, Proc Am Thorac Soc, V3, P405, DOI 10.1513/pats.200603-092AW; Silverman EK, 1996, MED CLIN N AM, V80, P501, DOI 10.1016/S0025-7125(05)70451-X; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WRIGHT JL, 1988, LUNG, V166, P277, DOI 10.1007/BF02714058	35	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104082	10.1371/journal.pone.0104082	http://dx.doi.org/10.1371/journal.pone.0104082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093840	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200064
J	Yan, LX; Liu, YH; Luo, DL; Zhang, F; Cheng, Y; Luo, XL; Xu, J; Cheng, J; Zhuang, HG				Yan, Li-Xu; Liu, Yan-Hui; Luo, Dong-Lan; Zhang, Fen; Cheng, Yu; Luo, Xin-Lan; Xu, Jie; Cheng, Jie; Zhuang, Heng-Guo			MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	PLOS ONE			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; CHOP CONSORTIUM PROGRAM; GERMINAL CENTER; TISSUE MICROARRAY; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; PROTEIN; VINCRISTINE; DOXORUBICIN; PREDNISONE	Recent studies provide convincing evidence that a combined immunohistochemical or fluorescence in situ hybridization (FISH) score of MYC, BCL2, BCL6 proteins and MYC translocations predicted outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, by far, all these researches are based on Western populations. Therefore, we investigate the prognostic relevance of MYC, BCL2- and BCL6-rearrangements and protein expression by immunohistochemistry and FISH from 336 de novo DLBCL, NOS treated with CHOP or R-CHOP. Breaks in MYC and BCL6, and fusion in IGH/BCL2 were detected in 9.7%, 20.0%, and 11.1% of the cases, respectively, and were not significantly associated with clinical outcomes. Protein overexpression of MYC (>= 40%), BCL2 (>= 70%) and BCL6 (>= 50%) was encountered in 51%, 51% and 36% of the tumors, respectively. On the basis of MYC, BCL2 and BCL6 expression, double-hit scores (DHSs) and triple-hit score (THS) were assigned to all patients with DLBCL. Patients with high MYC/BCL2 DHS, high MYC/BCL6 DHS and high THS had multiple adverse prognostic factors including high LDH level, poor performance status, advanced clinical stage, high International Prognostic Index (IPI) score, and non-germinal center B-cell. In univariate analysis, high MYC/BCL2 DHS, high MYC/BCL6 DHS and high THS were associated with inferior OS and PFS in both CHOP and R-CHOP cohorts (P<0.05). The highly significant correlations with OS and PFS were maintained in multivariate models that controlled for IPI (P<0.05). DLBCLs with high DHSs and high THS share the clinical features and poor prognosis of double-hit lymphoma (P>0.05). These data together suggest that the immunohistochemical DHSs and THS defined a large subset of DLBCLs with double-hit biology and was strongly associated with poor outcome in patients treated with R-CHOP or CHOP.	[Yan, Li-Xu; Liu, Yan-Hui; Luo, Dong-Lan; Zhang, Fen; Cheng, Yu; Luo, Xin-Lan; Xu, Jie; Cheng, Jie; Zhuang, Heng-Guo] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liu, YH (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	yanh_liu@163.com			National Natural Science Foundation of China (NSFC) [81172244]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a National Natural Science Foundation of China (NSFC, http://www.nsfc.gov.cn/) (Grant No. 81172244). YL, FZ, JX, and HZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Biagi JJ, 2002, BLOOD, V99, P4265, DOI 10.1182/blood.V99.12.4265; Chen PM, 2002, CANCER, V94, P2635, DOI 10.1002/cncr.10545; Chen Y, 2010, AM J CLIN PATHOL, V133, P305, DOI 10.1309/AJCP4H6ADGYDZMOA; Chen YW, 2006, BLOOD, V108, P2373, DOI 10.1182/blood-2006-05-022517; Chen Z, 2011, MED ONCOL, V28, P241, DOI 10.1007/s12032-010-9433-3; de Jong D, 2007, J CLIN ONCOL, V25, P805, DOI 10.1200/JCO.2006.09.4490; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Green TM, 2012, AM J SURG PATHOL, V36, P612, DOI 10.1097/PAS.0b013e318244e2ba; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Gutierrez-Garcia G, 2011, BLOOD, V117, P4836, DOI 10.1182/blood-2010-12-322362; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Huang Y, 2012, SCI WORLD J, DOI 10.1100/2012/897178; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Hussain AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060540; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kluk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033813; Krol ADG, 2003, ANN ONCOL, V14, P131, DOI 10.1093/annonc/mdg004; Leucci E, 2008, J PATHOL, V216, P440, DOI 10.1002/path.2410; Li X, 2011, ANN ONCOL, V22, P141; Lu Hong-Yu, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P315; Mitchell KA, 2008, LEUKEMIA LYMPHOMA, V49, P1717, DOI 10.1080/10428190802238552; Perry AM, 2014, BR J HAEMATOL; Pfreundschuh M, 2012, J CLIN ONCOL, V30, P3433, DOI 10.1200/JCO.2012.44.4729; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Shiozawa E, 2007, LEUKEMIA RES, V31, P1579, DOI 10.1016/j.leukres.2007.03.017; Swerdlow E., 2008, WHO CLASSIFICATION T; Thompson RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062822; Toda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057677; Valentino C, 2013, AM J CLIN PATHOL, V139, P242, DOI 10.1309/AJCP2Z0TAGMUYJEB; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; Veelken H, 2007, ANN ONCOL, V18, P931, DOI 10.1093/annonc/mdm012; Visco C, 2013, HAEMATOLOGICA, V98, P255, DOI 10.3324/haematol.2012.066209; Xia ZG, 2010, ANN HEMATOL, V89, P171, DOI 10.1007/s00277-009-0799-2; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	44	36	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104068	10.1371/journal.pone.0104068	http://dx.doi.org/10.1371/journal.pone.0104068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090026	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700093
J	Xu, LF; Wu, ZP; Chen, Y; Zhu, QS; Hamidi, S; Navab, R				Xu, Long-feng; Wu, Zhi-ping; Chen, Yan; Zhu, Qi-Shun; Hamidi, Shoeleh; Navab, Roya			MicroRNA-21 (miR-21) Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by Targeting PTEN, RECK and Bcl-2 in Lung Squamous Carcinoma, Gejiu City, China	PLOS ONE			English	Article							CANCER; INHIBITION; CELLS; SENSITIVITY; EXPRESSION; PATHWAY; PROTEIN; GROWTH; GENES; CYCLE	Background: In South China (Gejiu City, Yunnan Province), lung cancer incidence and associated mortality rate is the most prevalent and observed forms of cancer. Lung cancer in this area is called Gejiu squamous cell lung carcinoma (GSQCLC). Research has demonstrated that overexpression of miR-21 occurs in many cancers. However, the unique relationship between miR-21 and its target genes in GSQCLC has never been investigated. The molecular mechanism involved in GSQCLC must be compared to other non-small cell lung cancers in order to establish a relation and identify potential therapeutic targets. Methodology/Principal Findings: In the current study, we initially found overexpression of miR-21 occurring in non-small cell lung cancer (NSCLC) cell lines when compared to the immortalized lung epithelial cell line BEAS-2B. We also demonstrated that high expression of miR-21 could increase tumor cell proliferation, invasion, viability, and migration in GSQCLC cell line (YTMLC-90) and NSCLC cell line (NCI-H157). Additionally, our results revealed that miR-21 could suppress YTMLC-90 and NCI-H157 cell apoptosis through arresting cell-cycle at G(2)/M phase. Furthermore, we demonstrated that PTEN, RECK and Bcl-2 are common target genes of miR-21 in NSCLC. Finally, our studies showed that down-regulation of miR-21 could lead to a significant increase in PTEN and RECK and decrease in Bcl-2 at the mRNA and protein level in YTMLC-90 and NCI-H157 cell lines. However, we have not observed any remarkable difference in the levels of miR-21 and its targets in YTMLC-90 cells when compared with NCI-H157 cells. Conclusions/Significance: miR-21 simultaneously regulates multiple programs that enhance cell proliferation, apoptosis and tumor invasiveness by targeting PTEN, RECK and Bcl-2 in GSQCLC. Our results demonstrated that miR-21 may play a vital role in tumorigenesis and progression of lung squamous cell carcinoma and suppression of miR-21 may be a novel approach for the treatment of lung squamous cell carcinoma.	[Xu, Long-feng; Zhu, Qi-Shun] Yunnan Univ, Key Lab Anim Genet Div & Evolut High Educ Yunnan, Kunming, Yunan, Peoples R China; [Wu, Zhi-ping; Chen, Yan] Kunming Med Univ, Affiliated Hosp 3, Tumor Inst, Kunming, Yunan, Peoples R China; [Hamidi, Shoeleh] Northeast Missouri Hlth Co, Kirksville, MO USA; [Navab, Roya] Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Navab, Roya] Campbell Family Inst Canc Res, Toronto, ON, Canada	Yunnan University; Kunming Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zhu, QS (corresponding author), Yunnan Univ, Key Lab Anim Genet Div & Evolut High Educ Yunnan, Kunming, Yunan, Peoples R China.	zhuqsfa@aliyun.com	Navab, Roya/AGD-7380-2022		Science and Technology Project of the Yunnan Health Department [2011WS0065]; Research and Talent Training Open Foundation of Life science college, Yunnan University [2013S213]	Science and Technology Project of the Yunnan Health Department; Research and Talent Training Open Foundation of Life science college, Yunnan University	This work was supported by the Science and Technology Project of the Yunnan Health Department (Grant No. 2011WS0065) and the Research and Talent Training Open Foundation of Life science college, Yunnan University (Grant No. 2013S213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Jian-Ye, 2003, Ai Zheng, V22, P938; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Du GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072044; Duan J, 2009, CHINESE J SOCIAL MED, V26, P377; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Gompelmann D, 2011, RESPIRATION, V82, P111, DOI 10.1159/000329703; Han L, 2012, CNS NEUROSCI THER, V18, P573, DOI 10.1111/j.1755-5949.2012.00344.x; Hiroshi H, 2012, PLOS ONE, V7; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Jones N, 2013, INT J CANCER, V133, P323, DOI 10.1002/ijc.28021; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Katlic MR, 2011, CA-CANCER J CLIN, V61, P382, DOI 10.3322/caac.20119; Lan Hai, 2011, Zhonghua Zhong Liu Za Zhi, V33, P742; LAURER GR, 1993, HEALTH PHYS, V64, P253, DOI 10.1097/00004032-199303000-00003; Lei L, 2014, MOL CELL BIOCHEM, V387, P171, DOI 10.1007/s11010-013-1882-5; Li X, 2013, INT J MOL MED, V32, P439, DOI 10.3892/ijmm.2013.1411; Li Y, 2013, ASIAN PAC J CANCER P, V14, P4599, DOI 10.7314/APJCP.2013.14.8.4599; Liu H., 2012, OPTIM METHOD SOFTW, V1, P1, DOI DOI 10.1128/GEN0MEA.00936-13; Liu J, 2004, ONCOGENE, V23, P6316, DOI 10.1038/sj.onc.1207795; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Liu Xiaomei, 2013, Zhongguo Fei Ai Za Zhi, V16, P184, DOI 10.3779/j.issn.1009-3419.2013.04.03; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Lubin JH, 1994, RADON LUNG CANC RISK; Mao BL, 1994, YUNXI KEJI, V21, P50; Mao BL, 1982, TUMOR, V2, P337; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-14; Ruan YH, 2004, ACAD J KUNMING MED C, V4, P6; Ruan YH, 2005, DETECTION RELATED GE, P1; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Sun SQ, 1998, CHIN J RADIOL MED PR, V18, P295; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Wei B, 2013, ONCOL LETT, V6, P1713, DOI 10.3892/ol.2013.1609; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xiong Y, 2013, ONCOL LETT, V6, P1789, DOI 10.3892/ol.2013.1613; Xu LF, 2013, CHINESE GERMEN J CLI, V12, P443; Yang F, 2006, MED ONCOL, V23, P191, DOI 10.1385/MO:23:2:191; Yang TS, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-68; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zeng N, 2013, AGING CELL, V12, P1000, DOI 10.1111/acel.12132; Zhang FM, 1985, IND HLTH OCCUPATIONA, V11, P343; Zhang JG, 2012, CLIN CHIM ACTA, V411, P846; Zhang W., 2013, CLIN TRANSL ONCOL, P1, DOI DOI 10.1007/S00417-013-2267-X; Zhao GF, 1987, RAD PROTECTION, V7, P203; Zhu Y, 2010, J ZHENGZHOU U MED SC, V45, P493; 方国强, 2010, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V22, P65	59	147	163	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103698	10.1371/journal.pone.0103698	http://dx.doi.org/10.1371/journal.pone.0103698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084400	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800067
J	Macdonald-Obermann, JL; Pike, LJ				Macdonald-Obermann, Jennifer L.; Pike, Linda J.			Different Epidermal Growth Factor (EGF) Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB RECEPTORS; AUTOPHOSPHORYLATION SITES; KINASE ACTIVATION; CRYSTAL-STRUCTURE; BREAST-CANCER; MECHANISM; DOMAIN; BINDING; PROTEIN; IDENTIFICATION	The EGF receptor has seven different cognate ligands. Previous work has shown that these different ligands are capable of inducing different biological effects, even in the same cell. To begin to understand the molecular basis for this variation, we used luciferase fragment complementation to measure ligand-induced dimer formation and radioligand binding to study the effect of the ligands on subunit-subunit interactions in EGF receptor (EGFR) homodimers and EGFR/ErbB2 heterodimers. In luciferase fragment complementation imaging studies, amphiregulin (AREG) functioned as a partial agonist, inducing only about half as much total dimerization as the other three ligands. However, unlike the other ligands, AREG showed biphasic kinetics for dimer formation, suggesting that its path for EGF receptor activation involves binding to both monomers and preformed dimers. EGF, TGF alpha, and betacellulin (BTC) appear to mainly stimulate receptor activation through binding to and dimerization of receptor monomers. In radioligand binding assays, EGF and TGF alpha exhibited increased affinity for EGFR/ErbB2 heterodimers compared with EGFR homodimers. By contrast, BTC and AREG showed a similar affinity for both dimers. Thus, EGF and TGF alpha are biased agonists, whereas BTC and AREG are balanced agonists with respect to selectivity of dimer formation. These data suggest that the differences in biological response to different EGF receptor ligands may result from partial agonism for dimer formation, differences in the kinetic pathway utilized to generate activated receptor dimers, and biases in the formation of heterodimers versus homodimers.	[Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			National Institutes of Health receptor affinity [R01GM099695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099695] Funding Source: NIH RePORTER	National Institutes of Health receptor affinity(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health receptor affinity. Grant R01GM099695 (to L. J. P.).	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Haslekas C, 2005, MOL BIOL CELL, V16, P5832, DOI 10.1091/mbc.E05-05-0456; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li Y, 2012, J BIOL CHEM, V287, P31116, DOI 10.1074/jbc.M112.373647; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; SCHUH SM, 1994, MOL BIOL CELL, V5, P739, DOI 10.1091/mbc.5.7.739; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Streicher KL, 2007, MOL CANCER RES, V5, P847, DOI 10.1158/1541-7786.MCR-06-0427; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	36	68	71	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26178	26188		10.1074/jbc.M114.586826	http://dx.doi.org/10.1074/jbc.M114.586826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086039	Green Published, hybrid			2022-12-25	WOS:000342128800014
J	Xu, HM; Tsang, KS; Wang, YH; Chan, JCN; Xu, G; Gao, WQ				Xu, Huiming; Tsang, Kam Sze; Wang, Yonghui; Chan, Juliana C. N.; Xu, Gang; Gao, Wei-Qiang			Unfolded Protein Response Is Required for the Definitive Endodermal Specification of Mouse Embryonic Stem Cells via Smad2 and beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; PRIMITIVE STREAK; DIFFERENTIATION; WNT; INDUCTION; GROWTH; FATE; MAINTENANCE	Tremendous efforts have been made to elucidate the molecular mechanisms that control the specification of definitive endoderm cell fate in gene knockout mouse models and ES cell (ESC) differentiation models. However, the impact of the unfolded protein response (UPR), because of the stress of the endoplasmic reticulum on endodermal specification, is not well addressed. We employed UPR-inducing agents, thapsigargin and tunicamycin, in vitro to induce endodermal differentiation of mouse ESCs. Apart from the endodermal specification of ESCs, Western blotting demonstrated the enhanced phosphorylation of Smad2 and nuclear translocation of beta-catenin in ESC-derived cells. The inclusion of the endoplasmic reticulum stress inhibitor tauroursodeoxycholic acid to the induction cultures prevented the differentiation of ESCs into definitive endodermal cells even when Activin A was supplemented. Also, the addition of the TGF-beta inhibitor SB431542 and the Wnt/beta-catenin antagonist IWP-2 negated the endodermal differentiation of ESCs mediated by thapsigargin and tunicamycin. These data suggest that the activation of the UPR appears to orchestrate the induction of the definitive endodermal cell fate of ESCs via both the Smad2 and beta-catenin signaling pathways. The prospective regulatory machinery may be helpful for directing ESCs to differentiate into definitive endodermal cells for cellular therapy in the future.	[Xu, Huiming; Wang, Yonghui; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes, Renji MedX Clin Stem Cell Res Ctr,Sch Med, Shanghai 200127, Peoples R China; [Xu, Huiming; Wang, Yonghui; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200127, Peoples R China; [Xu, Huiming; Wang, Yonghui; Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200127, Peoples R China; [Tsang, Kam Sze] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Shenzhen Res Inst, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Xu, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Rm 605, Hong Kong, Hong Kong, Peoples R China.	gangxu@cuhk.edu.hk; gao.weiqiang@sjtu.edu.cn	Chan, Juliana/B-7918-2016; Gao, Wei/GXH-0380-2022	Chan, Juliana/0000-0003-1325-1194; 	National Basic Research Program of China [2012CB967903, 2012CB966800, 2013CB945600]; National Natural Science Foundation of China [81270438, 81130038, 81372189]; Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Health Bureau Key Discipline and Specialty Foundation [J50208]; Shanghai Education Committee Key Discipline and Specialty Foundation; KC Wong Foundation	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Health Bureau Key Discipline and Specialty Foundation; Shanghai Education Committee Key Discipline and Specialty Foundation; KC Wong Foundation	This work was supported by grants from the National Basic Research Program of China (2012CB967903, 2012CB966800, and 2013CB945600), National Natural Science Foundation of China (81270438, 81130038, and 81372189), Science and Technology Commission of Shanghai Municipality (Pujiang program), Shanghai Health Bureau Key Discipline and Specialty Foundation (J50208), Shanghai Education Committee Key Discipline and Specialty Foundation, and KC Wong Foundation.	Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; CONLON FL, 1994, DEVELOPMENT, V120, P1919; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Engert S, 2013, DEVELOPMENT, V140, P3128, DOI 10.1242/dev.088765; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GARDNER RL, 1982, J EMBRYOL EXP MORPH, V68, P175; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hansson M, 2009, DEV BIOL, V330, P286, DOI 10.1016/j.ydbio.2009.03.026; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kim Peter T W, 2012, Results Probl Cell Differ, V55, P303, DOI 10.1007/978-3-642-30406-4_17; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lewis SL, 2006, DEV DYNAM, V235, P2315, DOI 10.1002/dvdy.20846; Li FM, 2011, J CELL BIOCHEM, V112, P1022, DOI 10.1002/jcb.22962; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu Y, 2004, DEV BIOL, V270, P411, DOI 10.1016/j.ydbio.2004.03.017; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Reimold AM, 2000, GENE DEV, V14, P152; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Taylor-Weiner H, 2013, STEM CELLS, V31, P2084, DOI 10.1002/stem.1453; Toivonen S, 2013, EXP CELL RES, V319, P2535, DOI 10.1016/j.yexcr.2013.07.007; Treglia AS, 2012, HISTOL HISTOPATHOL, V27, P1, DOI 10.14670/HH-27.1; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2013, CELL TRANSPLANT, V22, P147, DOI 10.3727/096368912X653057; Yang L, 2005, J BIOL CHEM, V280, P31156, DOI 10.1074/jbc.M501069200; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	44	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26290	26301		10.1074/jbc.M114.572560	http://dx.doi.org/10.1074/jbc.M114.572560			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092289	Green Published, hybrid			2022-12-25	WOS:000342128800023
J	Hoenigl, M; Wagner, J; Raggam, RB; Prueller, F; Prattes, J; Eigl, S; Leitner, E; Honigl, K; Valentin, T; Zollner-Schwetz, I; Grisold, AJ; Krause, R				Hoenigl, Martin; Wagner, Jasmin; Raggam, Reinhard B.; Prueller, Florian; Prattes, Juergen; Eigl, Susanne; Leitner, Eva; Hoenigl, Katharina; Valentin, Thomas; Zollner-Schwetz, Ines; Grisold, Andrea J.; Krause, Robert			Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria	PLOS ONE			English	Article							ANTIFUNGAL THERAPY; EPIDEMIOLOGY; BACTEREMIA; CARE; PROCALCITONIN	Purpose: The objective of this study was to compare epidemiology, causative pathogens, outcome, and levels of laboratory markers of inflammation of community-onset (i.e. community-acquired and healthcare-associated) and hospital-acquired bloodstream infection (BSI) in South-East Austria. Methods: In this prospective cohort study, 672 patients fulfilling criteria of systemic inflammatory response syndrome with positive peripheral blood cultures (277 community-onset [192 community-acquired, 85 healthcare-associated BSI], 395 hospital-acquired) were enrolled at the Medical University of Graz, Austria from 2011 throughout 2012. Clinical, microbiological, demographic as well as outcome and laboratory data was collected. Results: Escherichia coli followed by Staphylococcus aureus were the most frequently isolated pathogens. While Streptococcus spp. and Escherichia coli were isolated more frequently in patients with community-onset BSI, Enterococcus spp., Candida spp., Pseudomonas spp., Enterobacter spp., and coagulase-negative staphylococci were isolated more frequently among those with hospital-acquired BSI. With regard to the outcome, 30-day (82/395 vs. 31/277; p = 0.001) and 90-day mortality (106/395 vs. 35/277; p<0.001) was significantly higher among patients with hospital-acquired BSI even though these patients were significantly younger. Also, hospital-acquired BSI remained a significant predictor of mortality in multivariable analysis. At the time the blood cultures were drawn, patients with community-onset BSI had significantly higher leukocyte counts, neutrophil-leucocyte ratios as well as C-reactive protein, procalcitonin, interleukin-6 and serum creatinine levels when compared to those with hospital-acquired BSI. Patients with healthcare-associated BSI presented with significantly higher PCT and creatinine levels than those with community-acquired BSI. Conclusions: Hospital-acquired BSI was associated with significantly higher 30- and 90-day mortality rates. Hospital-acquired BSI therefore poses an important target for the most aggressive strategies for prevention and infection control.	[Hoenigl, Martin; Wagner, Jasmin; Prattes, Juergen; Eigl, Susanne; Hoenigl, Katharina; Valentin, Thomas; Zollner-Schwetz, Ines; Krause, Robert] Med Univ Graz, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin; Eigl, Susanne] Med Univ Graz, Div Pulmonol, Graz, Austria; [Hoenigl, Martin] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA; [Raggam, Reinhard B.; Prueller, Florian] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Leitner, Eva; Grisold, Andrea J.] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria	Medical University of Graz; Medical University of Graz; University of California System; University of California San Diego; Medical University of Graz; Medical University of Graz	Hoenigl, M (corresponding author), Med Univ Graz, Sect Infect Dis & Trop Med, Graz, Austria.	martin.hoenigl@medunigraz.at; robert.krause@medunigraz.at	Leitner, Eva/AAG-8045-2019; Prüller, Florian J./P-5326-2014; Hoenigl, Martin/E-8802-2010; Prattes, Juergen/A-9355-2014	Leitner, Eva/0000-0001-8748-2249; Prüller, Florian J./0000-0002-3388-0089; Hoenigl, Martin/0000-0002-1653-2824; Prattes, Juergen/0000-0001-5751-9311; Grisold, Andrea/0000-0002-6937-521X	Merck; Pfizer	Merck(Merck & Company); Pfizer(Pfizer)	M. Hoenigl received a research grant from Merck and Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no conflict.	Al-Hasan MN, 2012, EUR J CLIN MICROBIOL, V31, P1163, DOI 10.1007/s10096-011-1424-6; Al-Hasan MN, 2012, CLIN MICROBIOL INFEC; Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; [Anonymous], 2009, CHEST; Arendrup MC, 2009, ANTIMICROB AGENTS CH, V53, P2704, DOI 10.1128/AAC.01411-08; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; DEKRAKER ME, 2012, CLIN MICROBIOL INFEC; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Frederiksen MS, 2007, PEDIATR INFECT DIS J, V26, P398, DOI 10.1097/01.inf.0000261112.53035.4c; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Goncalves-Pereira J, 2013, CLIN MICROBIOL INFEC, V19, P242, DOI 10.1111/j.1469-0691.2012.03776.x; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Ho KM, 2009, ANAESTH INTENS CARE, V37, P234, DOI 10.1177/0310057X0903700217; Hoenigl M, 2011, MYCOSES, V54, P454, DOI 10.1111/j.1439-0507.2010.01881.x; Hoenigl M, 2013, CLIN BIOCHEM, V46, P225, DOI 10.1016/j.clinbiochem.2012.11.004; Kollef MH, 2011, J INFECTION, V62, P130, DOI 10.1016/j.jinf.2010.12.009; Laupland KB, 2013, EPIDEMIOL INFECT, V141, P2149, DOI 10.1017/S0950268812002725; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Laupland KB, 2012, CAN J INFECT DIS MED, V23, P170, DOI 10.1155/2012/931737; Leal J, 2010, INFECT CONT HOSP EP, V31, P740, DOI 10.1086/653207; Presterl E, 2007, CLIN MICROBIOL INFEC, V13, P1072, DOI 10.1111/J.1469-0691.2007.01812.x; Raggam RB, 2014, J INTERN MED, V276, P651, DOI 10.1111/joim.12238; Rahkonen M, 2012, EUR J CLIN MICROBIOL, V31, P2639, DOI 10.1007/s10096-012-1607-9; Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV2; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Rowther FB, 2009, J CLIN MICROBIOL, V47, P2964, DOI 10.1128/JCM.00418-07; Safdar A, 2006, EUR J CLIN MICROBIOL, V25, P522, DOI 10.1007/s10096-006-0173-4; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Zirkel J, 2012, MED MYCOL, V50, P50, DOI 10.3109/13693786.2011.587211	33	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e104702	10.1371/journal.pone.0104702	http://dx.doi.org/10.1371/journal.pone.0104702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105287	Green Published, gold			2022-12-25	WOS:000343231900082
J	Leiria, LB; Dora, JM; Wajner, SM; Estivalet, AAF; Crispim, D; Maia, AL				Leiria, Leonardo B.; Dora, Jose M.; Wajner, Simone M.; Estivalet, Aline A. F.; Crispim, Daisy; Maia, Ana Luiza			The rs225017 Polymorphism in the 3 ' UTR of the Human DIO2 Gene Is Associated with Increased Insulin Resistance	PLOS ONE			English	Article							HUMAN TYPE-2 DEIODINASE; HOMEOSTASIS MODEL ASSESSMENT; THYROID-HORMONE EXCESS; IODOTHYRONINE DEIODINASE; THR92ALA POLYMORPHISM; DIABETES-MELLITUS; SKELETAL-MUSCLE; HYPOTHYROIDISM; VARIANT; SENSITIVITY	The Thr92Ala (rs225014) polymorphism in the type 2 deiodinase (DIO2) gene has been associated with insulin resistance (IR) and decreased enzyme activity in human tissues but kinetic studies failed to detect changes in the mutant enzyme, suggesting that this variant might be a marker of abnormal DIO2 expression. Thus, we aimed to investigate whether other DIO2 polymorphisms, individually or in combination with the Thr92Ala, may contribute to IR. The entire coding-region of DIO2 gene was sequenced in 12 patients with type 2 diabetes mellitus (T2DM). Potentially informative variants were evaluated in 1077 T2DM patients and 516 nondiabetic subjects. IR was evaluated using the homeostasis model assessment (HOMA-IR) index. DIO2 gene sequencing revealed no new mutation but 5 previously described single nucleotide polymorphisms (SNPs). We observed that all T2DM patients displaying high HOMA-IR index (n = 6) were homozygous for the rs225017 (T/A) polymorphism. Further analysis showed that the median fasting plasma insulin and HOMA-IR of T2DM patients carrying the T/T genotype were higher than in patients carrying the A allele (P = 0.013 and P = 0.002, respectively). These associations were magnified in the presence of the Ala92Ala genotype of the Thr92Ala polymorphism. Moreover, the rs225017 and the Thr92Ala polymorphisms were in partial linkage disequilibrium (vertical bar D'vertical bar = 0.811; r(2) = 0.365). In conclusion, the rs225017 polymorphism is associated with greater IR in T2DM and it seems to interact with the Thr92Ala polymorphism in the modulation of IR.	[Leiria, Leonardo B.; Dora, Jose M.; Wajner, Simone M.; Estivalet, Aline A. F.; Crispim, Daisy; Maia, Ana Luiza] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Crispim, D (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrine, Thyroid Sect, Porto Alegre, RS, Brazil.	dcmoreira@hcpa.ufrgs.br	Wajner, Simone/CAF-3858-2022; Maia, Ana Luiza/F-9201-2012; Wajner, S/E-7240-2013; Crispim, Daisy/R-5170-2019; Dora, Jose/AAR-4324-2020	Maia, Ana Luiza/0000-0002-4186-5532; Wajner, S/0000-0002-8942-244X; Crispim, Daisy/0000-0001-5095-9269; Barbosa Leiria, Leonardo/0000-0002-7866-1939	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundo de Incentivo a Pesquisa (FIPE), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundo de Incentivo a Pesquisa (FIPE), Brazil	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundo de Incentivo a Pesquisa (FIPE), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2012, HUM MUTAT, V33, P599, DOI 10.1002/humu.22035; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Canani LH, 2005, DIABETIC MED, V22, P1167, DOI 10.1111/j.1464-5491.2005.01622.x; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Chidakel A, 2005, THYROID, V15, P899, DOI 10.1089/thy.2005.15.899; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Coppotelli G, 2006, THYROID, V16, P625, DOI 10.1089/thy.2006.16.625; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; Dimitriadis G, 2005, HORM METAB RES, V37, P15, DOI 10.1055/s-2005-861026; DIMITRIADIS G, 1985, AM J PHYSIOL, V248, pE593, DOI 10.1152/ajpendo.1985.248.5.E593; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; DUBANIEWICZ A, 1989, BIOCHEM J, V263, P243, DOI 10.1042/bj2630243; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Estivalet AA, 2010, OBESITY SILVER SPRIN, V19, P825; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; Grarup N, 2007, J CLIN ENDOCR METAB, V92, P363, DOI 10.1210/jc.2006-1958; Grozovsky R, 2009, ENDOCRINOLOGY, V150, P1976, DOI 10.1210/en.2008-0938; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; HEDRICK PW, 1987, GENETICS, V117, P331; Heemstra KA, 2009, J CLIN ENDOCR METAB, V94, P2144, DOI 10.1210/jc.2008-2520; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; ITAGAKI Y, 1990, J CLIN ENDOCR METAB, V71, P340, DOI 10.1210/jcem-71-2-340; Kim SR, 2002, MED HYPOTHESES, V59, P660, DOI 10.1016/S0306-9877(02)00211-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; Maia AL, 2007, THYROID, V17, P199, DOI 10.1089/thy.2006.0298; Maia AL, 2011, J ENDOCRINOL, V209, P283, DOI 10.1530/JOE-10-0481; Marsili A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020832; Mentuccia D, 2005, THYROID, V15, P1223, DOI 10.1089/thy.2005.15.1223; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Mix H, 2007, NUCLEIC ACIDS RES, V35, P414, DOI 10.1093/nar/gkl1060; Nair S, 2012, THYROID, V22, P80, DOI 10.1089/thy.2010.0455; North KE, 2005, OBES RES, V13, P1877, DOI 10.1038/oby.2005.230; North KE, 2003, OBES RES, V11, P1444, DOI 10.1038/oby.2003.193; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P2880, DOI 10.1210/jc.2002-021592; Rochon C, 2003, CLIN SCI, V104, P7, DOI 10.1042/CS20020154; Ryan K, 2008, INT J BIOCHEM CELL B, V40, P2384, DOI 10.1016/j.biocel.2008.03.016; Salvatore D, 1996, J CLIN INVEST, V98, P962, DOI 10.1172/JCI118880; Seligman BGS, 2000, DIABETES CARE, V23, P1395, DOI 10.2337/diacare.23.9.1395; Steinsapir J, 2000, ENDOCRINOLOGY, V141, P1127, DOI 10.1210/en.141.3.1127; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Torrance CJ, 1997, ENDOCRINOLOGY, V138, P1204, DOI 10.1210/en.138.3.1204; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WEINSTEIN SP, 1994, DIABETES, V43, P1185, DOI 10.2337/diabetes.43.10.1185; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	50	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2014	9	8							e103960	10.1371/journal.pone.0103960	http://dx.doi.org/10.1371/journal.pone.0103960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR0CG	25105294	gold, Green Submitted, Green Published			2022-12-25	WOS:000343231900033
J	Fu, LH; Hu, KD; Hu, LY; Li, YH; Hu, LB; Yan, H; Liu, YS; Zhang, H				Fu, Liu-Hui; Hu, Kang-Di; Hu, Lan-Ying; Li, Yan-Hong; Hu, Liang-Bin; Yan, Hong; Liu, Yong-Sheng; Zhang, Hua			An Antifungal Role of Hydrogen Sulfide on the Postharvest Pathogens Aspergillus niger and Penicillium italicum	PLOS ONE			English	Article							NITRIC-OXIDE; ANTIOXIDATIVE ROLE; SPORE GERMINATION; OXIDATIVE DAMAGE; IN-VITRO; FRUIT; H2S; SENESCENCE; STRAWBERRY; DEFENSE	In this research, the antifungal role of hydrogen sulfide (H2S) on the postharvest pathogens Aspergillus niger and Penicillium italicum growing on fruits and under culture conditions on defined media was investigated. Our results show that H2S, released by sodium hydrosulfide (NaHS) effectively reduced the postharvest decay of fruits induced by A. niger and P. italicum. Furthermore, H2S inhibited spore germination, germ tube elongation, mycelial growth, and produced abnormal mycelial contractions when the fungi were grown on defined media in Petri plates. Further studies showed that H2S could cause an increase in intracellular reactive oxygen species (ROS) in A. niger. In accordance with this observation we show that enzyme activities and the expression of superoxide dismutase (SOD) and catalase (CAT) genes in A. niger treated with H2S were lower than those in control. Moreover, H2S also significantly inhibited the growth of Saccharomyces cerevisiae, Rhizopus oryzae, the human pathogen Candida albicans, and several food-borne bacteria. We also found that short time exposure of H2S showed a microbicidal role rather than just inhibiting the growth of microbes. Taken together, this study suggests the potential value of H2S in reducing postharvest loss and food spoilage caused by microbe propagation.	[Fu, Liu-Hui; Hu, Kang-Di; Hu, Lan-Ying; Li, Yan-Hong; Liu, Yong-Sheng; Zhang, Hua] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Hu, Liang-Bin] Henan Inst Sci & Technol, Sch Food Sci, Xinxiang, Peoples R China; [Yan, Hong] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Key Lab Green Chem Technol, Coll Heilongjiang Prov, Harbin, Peoples R China	Hefei University of Technology; Henan Institute of Science & Technology; Harbin University of Science & Technology	Zhang, H (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	hzhanglab@gmail.com	li, yan/GTI-4638-2022		Natural Science Foundation of China [31271803, 31301820, 31300133]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS, SEM); Natural Science Foundations of Anhui Province [11040606M85]; Anhui Provincial Education Department [2012AJZR0028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS, SEM)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundations of Anhui Province; Anhui Provincial Education Department	This work was supported by the Natural Science Foundation of China (31271803 to LYH, 31301820 to HZ, 31300133 to KDH) http://www.nsfc.gov.cn/, the Scientific Research Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS, SEM to HZ), the Natural Science Foundations of Anhui Province (11040606M85 to HZ) and the Anhui Provincial Education Department (2012AJZR0028 to HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bloem E, 2004, J EXP BOT, V55, P2305, DOI 10.1093/jxb/erh236; Bloem E, 2012, J AGR FOOD CHEM, V60, P7588, DOI 10.1021/jf301912h; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Deng Jing, 2013, Journal of Chemical and Pharmaceutical Research, V5, P443; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Gao SP, 2013, HORTSCIENCE, V48, P1385, DOI 10.21273/HORTSCI.48.11.1385; Garcia-Cela E, 2014, INT J FOOD MICROBIOL, V173, P89, DOI 10.1016/j.ijfoodmicro.2013.12.012; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Hernandez-Montiel LG, 2010, POSTHARVEST BIOL TEC, V56, P181, DOI 10.1016/j.postharvbio.2009.12.010; Haneklaus S., 2007, MINERAL NUTR PLANT D, P101; Heydari A., 2010, Journal of Biological Sciences, V10, P273; Hodges RJ, 2011, J AGR SCI, V149, P37, DOI 10.1017/S0021859610000936; Hu HL, 2014, INT J FOOD SCI TECH, V49, P399, DOI 10.1111/ijfs.12313; Hu KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085524; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Joyner-Matos J, 2010, PHYSIOL BIOCHEM ZOOL, V83, P356, DOI 10.1086/597529; Kreiner M, 2002, ENZYME MICROB TECH, V30, P346, DOI 10.1016/S0141-0229(01)00517-8; Lai TF, 2011, CURR MICROBIOL, V62, P229, DOI 10.1007/s00284-010-9695-1; Lazar EE, 2008, LETT APPL MICROBIOL, V46, P688, DOI 10.1111/j.1472-765X.2008.02373.x; Li SP, 2014, J AGR FOOD CHEM, V62, P1119, DOI 10.1021/jf4047122; Lisjak M, 2013, PLANT CELL ENVIRON, V36, P1607, DOI 10.1111/pce.12073; Liu XP, 2007, INT J FOOD MICROBIOL, V119, P223, DOI 10.1016/j.ijfoodmicro.2007.07.054; Majumdar T, 2013, J ELECTROCHEM SOC, V160, pG75, DOI 10.1149/2.026306jes; Manjunatha G, 2010, BIOTECHNOL ADV, V28, P489, DOI 10.1016/j.biotechadv.2010.03.001; MARSH R. W., 1929, JOUR POMOLOGY & HORT SCI, V7, P237; Reynolds A, 2010, COMMUN DIS INTELL, V34, P329; Savi GD, 2013, INT J FOOD SCI TECH, V48, P1834, DOI 10.1111/ijfs.12158; Senthilkumar M, 2007, CURR MICROBIOL, V55, P25, DOI 10.1007/s00284-006-0500-0; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P588, DOI 10.1128/AEM.02491-12; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tian J, 2011, FOOD CONTROL, V22, P1992, DOI 10.1016/j.foodcont.2011.05.018; Tripathi P, 2004, POSTHARVEST BIOL TEC, V32, P235, DOI 10.1016/j.postharvbio.2003.11.005; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Yu T, 2009, PHYTOPATHOLOGY, V99, P258, DOI 10.1094/PHYTO-99-3-0258; Zhang H, 2008, J INTEGR PLANT BIOL, V50, P1518, DOI 10.1111/j.1744-7909.2008.00769.x	40	50	58	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104206	10.1371/journal.pone.0104206	http://dx.doi.org/10.1371/journal.pone.0104206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101960	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993900049
J	Parhira, S; Yang, ZF; Zhu, GY; Chen, QL; Zhou, BX; Wang, YT; Liu, L; Bai, LP; Jiang, ZH				Parhira, Supawadee; Yang, Zi-Feng; Zhu, Guo-Yuan; Chen, Qiao-Lian; Zhou, Bei-Xian; Wang, Yu-Tao; Liu, Liang; Bai, Li-Ping; Jiang, Zhi-Hong			In Vitro Anti-Influenza Virus Activities of a New Lignan Glycoside from the Latex of Calotropis gigantea	PLOS ONE			English	Article							NF-KAPPA-B; A H7N9 VIRUS; INFLUENZA-VIRUS; INHIBITION; PROPAGATION; ACTIVATION; RESISTANCE; INFECTION; EXPRESSION; LEAVES	A new lignan glycoside, (+)-pinoresinol 4-O-[6"-O-vanilloyl]-beta-D-glucopyranoside (1) and two known phenolic compounds, 6'-O-vanilloyltachioside (2) and 6'-O-vanilloylisotachioside (3) were isolated from the latex of Calotropis gigantea (Asclepiadaceae). The structure of the new compound was elucidated by using spectroscopic and chemical methods. Three isolates (1-3) and one authentic compound, (+)-pinoresinol 4-O-beta-D-glucopyranoside, were screened for A/PR/8/34 (H1N1) inhibitory activity by cytopathic effect (CPE) inhibition assay on MDCK cells. Compound 1 showed inhibitory activity against A/PR/8/34 (H1N1). In sharp contrast, the other three compounds (2, 3 and (+)-pinoresinol 4-O-beta-D-glucopyranoside) did not show such activity. An analysis of structure-activity relationship between 1 and (+)-pinoresinol 4-O-beta-D-glucopyranoside revealed that the presence of a vanilloyl group in the sugar moiety of 1 is crucial for its anti-influenza virus activity. Compound 1 was further evaluated for in vitro inhibitory activities against a panel of human and avian influenza viruses by CPE inhibition assay. It showed inhibitory effect against human influenza viruses in both subtypes A and B (IC50 values around 13.4-39.8 mu M with SI values of 3.7-11.4), while had no effect on avian influenza viruses. Its antiviral activity against human influenza viruses subtype A was further confirmed by plaque reduction assay. The time course assay indicated that 1 exerts its antiviral activity at the early stage of viral replication. A mechanistic study showed that 1 efficiently inhibited influenza virus-induced activation of NF-kappa B pathway in a dose-dependent manner, but had no effect on virus-induced activation of Raf/MEK/ERK pathway. Further studies demonstrated that nuclear translocation of transcription factor NF-kappa B induced by influenza virus was significantly blocked by 1, meanwhile, nuclear export of viral ribonucleoproteins was also effectively inhibited. These findings suggest that this new lignan glycoside from Calotropis gigantea, may have therapeutic potential in influenza virus infection through inhibition of NF-kappa B pathway and viral ribonucleoproteins nuclear export.	[Parhira, Supawadee; Zhu, Guo-Yuan; Liu, Liang; Bai, Li-Ping; Jiang, Zhi-Hong] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Yang, Zi-Feng; Chen, Qiao-Lian; Zhou, Bei-Xian; Wang, Yu-Tao] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Macau University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Bai, LP (corresponding author), Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China.	lpbai@must.edu.mo; zhjiang@must.edu.mo	BAI, Li-Ping/O-5691-2016; Zhu, Guo-Yuan/AAG-7914-2019	BAI, Li-Ping/0000-0002-2806-6883; Zhu, Guo-Yuan/0000-0002-4355-894X; Parhira, Supawadee/0000-0002-2077-5888; Jiang, Zhi-Hong/0000-0002-7956-2481	Macao Science and Technology Development Fund, MSAR [063/2011/A3, 040/2012/A]	Macao Science and Technology Development Fund, MSAR	This work was financially supported by Macao Science and Technology Development Fund, MSAR (063/2011/A3 to LPB), and partly supported by Macao Science and Technology Development Fund, MSAR (040/2012/A to ZFY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053962; Bhaskara RMP, 1943, P INDIAN ACAD SCI A, VA18, P145; Silva MCC, 2010, ASIAN PAC J TROP MED, V3, P332, DOI 10.1016/S1995-7645(10)60081-8; DEYAMA T, 1983, CHEM PHARM BULL, V31, P2993; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Du J, 2012, DRUG DISCOV TODAY, V17, P1111, DOI 10.1016/j.drudis.2012.06.002; eFloras, 2013, CAL GIG; Ehrhardt C, 2007, ANTIVIR RES, V76, P38, DOI 10.1016/j.antiviral.2007.05.002; Gao GF, 2014, SCIENCE, V344, P235, DOI 10.1126/science.1254664; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; He H, 2012, BIOORG MED CHEM LETT, V22, P1582, DOI 10.1016/j.bmcl.2011.12.143; Hsieh CF, 2012, J ETHNOPHARMACOL, V143, P57, DOI 10.1016/j.jep.2012.05.061; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Jiang ZH, 2005, CHEM PHARM BULL, V53, P339, DOI 10.1248/cpb.53.339; Jiang ZH, 2002, CHEM PHARM BULL, V50, P137, DOI 10.1248/cpb.50.137; Kim M, 2012, ANTIVIR RES, V93, P253, DOI 10.1016/j.antiviral.2011.12.006; Kiyohara H, 2012, PHYTOMEDICINE, V19, P111, DOI 10.1016/j.phymed.2011.07.004; Lhinhatrakool T, 2006, J NAT PROD, V69, P1249, DOI 10.1021/np060249f; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Mazur I, 2007, CELL MICROBIOL, V9, P1683, DOI 10.1111/j.1462-5822.2007.00902.x; Parhira S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04748; Pari K, 1998, J NAT PROD, V61, P102, DOI 10.1021/np970255z; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pinto R, 2011, ANTIVIR RES, V92, P45, DOI 10.1016/j.antiviral.2011.05.009; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sriwilaijaroen N, 2012, ANTIVIR RES, V94, P139, DOI 10.1016/j.antiviral.2012.02.013; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; World Health Organization, 2013, OV EM CHAR AV INFL A; Wright PF, 2007, FIELDS VIROLOGY, V2, P1692; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yang XW, 2007, PLANTA MED, V73, P1415, DOI 10.1055/s-2007-990235; Yang ZF, 2014, FITOTERAPIA, V93, P47, DOI 10.1016/j.fitote.2013.12.011; Yingsakmongkon S, 2008, BIOL PHARM BULL, V31, P511, DOI 10.1248/bpb.31.511	36	29	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104544	10.1371/journal.pone.0104544	http://dx.doi.org/10.1371/journal.pone.0104544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102000	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900074
J	Mah, WC; Thurnherr, T; Chow, PKH; Chung, AYF; Ooi, LLPJ; Toh, HC; Teh, BT; Saunthararajah, Y; Lee, CGL				Mah, Way-Champ; Thurnherr, Thomas; Chow, Pierce K. H.; Chung, Alexander Y. F.; Ooi, London L. P. J.; Toh, Han Chong; Teh, Bin Tean; Saunthararajah, Yogen; Lee, Caroline G. L.			Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis	PLOS ONE			English	Article							DNA METHYLATION; HEPATITIS-B; CLASS DISCOVERY; BETA-CATENIN; P53 GENE; CANCER; HYPERMETHYLATION; LIVER; PATTERNS; INFLAMMATION	Hepatocellular Carcinoma (HCC) is one of the leading causes of cancer-associated mortality worldwide. However, the role of epigenetic changes such as aberrant DNA methylation in hepatocarcinogenesis remains largely unclear. In this study, we examined the methylation profiles of 59 HCC patients. Using consensus hierarchical clustering with feature selection, we identified three tumor subgroups based on their methylation profiles and correlated these subgroups with clinicopathological parameters. Interestingly, one tumor subgroup is different from the other 2 subgroups and the methylation profile of this subgroup is the most distinctly different from the non-tumorous liver tissues. Significantly, this subgroup of patients was found to be associated with poor overall as well as disease-free survival. To further understand the pathways modulated by the deregulation of methylation in HCC patients, we integrated data from both the methylation as well as the gene expression profiles of these 59 HCC patients. In these patients, while 4416 CpG sites were differentially methylated between the tumors compared to the adjacent non-tumorous tissues, only 536 of these CpG sites were associated with differences in the expression of their associated genes. Pathway analysis revealed that forty-four percent of the most significant upstream regulators of these 536 genes were involved in inflammation-related NF kappa B pathway. These data suggest that inflammation via the NF kappa B pathway play an important role in modulating gene expression of HCC patients through methylation. Overall, our analysis provides an understanding on aberrant methylation profile in HCC patients.	[Lee, Caroline G. L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Mah, Way-Champ; Teh, Bin Tean; Lee, Caroline G. L.] Natl Canc Ctr Singapore, Humphrey Oei Inst Canc Res, Div Med Sci, Singapore, Singapore; [Mah, Way-Champ; Thurnherr, Thomas; Lee, Caroline G. L.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Thurnherr, Thomas; Chow, Pierce K. H.; Teh, Bin Tean; Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore, Singapore; [Chow, Pierce K. H.; Chung, Alexander Y. F.; Ooi, London L. P. J.] Singapore Gen Hosp, Dept Surg, Singapore, Singapore; [Ooi, London L. P. J.] Natl Canc Ctr Singapore, Dept Surg Oncol, Singapore, Singapore; [Toh, Han Chong] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Saunthararajah, Yogen] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; Cleveland Clinic Foundation	Lee, CGL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	caroline_lee@nuhs.edu.sg	Lee, Caroline G/M-8918-2019; Ooi, London Lucien/AGK-1395-2022	Lee, Caroline G/0000-0002-4323-3635; Teh, Bin Tean/0000-0003-1514-1124; Chow, Pierce/0000-0003-0584-2584	National Medical Research Council (NMRC) [NMRC/1131/2007, NMRC/1238/2009]; BioMedical Research Council (BMRC) of Singapore [BMRC06/1/21/19/449]; National Cancer Centre, SINGAPORE; DUKE-NUS Graduate Medical School; Singapore Millennium Foundation (SMF); NATIONAL CANCER INSTITUTE [P50CA150964] Funding Source: NIH RePORTER	National Medical Research Council (NMRC)(National Medical Research Council, Singapore); BioMedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR)); National Cancer Centre, SINGAPORE; DUKE-NUS Graduate Medical School(National University of Singapore); Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from the National Medical Research Council (NMRC) (NMRC/1131/2007 and NMRC/1238/2009), the BioMedical Research Council (BMRC) (BMRC06/1/21/19/449) of Singapore and the Singapore Millennium Foundation (SMF), as well as block funding from the National Cancer Centre, SINGAPORE and the DUKE-NUS Graduate Medical School to A/Prof Caroline Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Archer KJ, 2010, MOL GENET GENOMICS, V283, P341, DOI 10.1007/s00438-010-0522-y; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Carlson M, LUMIHUMANALL DB ME H; Carlson M, HGUG4112A DB AGILENT; Di Bisceglie AM, 2009, HEPATOLOGY, V49, pS56, DOI 10.1002/hep.22962; Du P, LUMIHUMANIDMAPPING I; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Fukai K, 2003, CANCER RES, V63, P8674; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hiranuma C, 2004, INT J MOL MED, V13, P413; Ishizaki Y, 2004, INT J ONCOL, V24, P1077; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Lee CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-255; Lee HP, 2013, SINGAPORE CANC REGIS, P9; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah WC, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-5; Minouchi K, 2002, J HEPATOL, V37, P231, DOI 10.1016/S0168-8278(02)00144-7; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okamoto Y, 2014, GASTROENTEROLOGY, V146, P562, DOI 10.1053/j.gastro.2013.10.056; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shen J, 2013, EPIGENETICS-US, V8, P34, DOI 10.4161/epi.23062; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Shim YH, 2003, CANCER LETT, V190, P213, DOI 10.1016/S0304-3835(02)00613-4; Shitani M, 2012, TUMOR BIOL, V33, P1307, DOI 10.1007/s13277-012-0378-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055761; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563; Suzuki H, 2009, METHODS MOL BIOL, V512, P55, DOI 10.1007/978-1-60327-530-9_5; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Tao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019862; Tung EKK, 2009, INT J CANCER, V124, P1811, DOI 10.1002/ijc.24115; Um TH, 2011, J HEPATOL, V54, P939, DOI 10.1016/j.jhep.2010.08.021; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zhang YJ, 2005, CANCER LETT, V221, P135, DOI 10.1016/j.canlet.2004.08.028; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	55	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104158	10.1371/journal.pone.0104158	http://dx.doi.org/10.1371/journal.pone.0104158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093504	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200077
J	Sasse, LK; Gamer, M; Buchel, C; Brassen, S				Sasse, Laura K.; Gamer, Matthias; Buechel, Christian; Brassen, Stefanie			Selective Control of Attention Supports the Positivity Effect in Aging	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; MEDIAL PREFRONTAL CORTEX; OLDER EMOTIONAL FACES; AGE-GROUP DIFFERENCES; OWN-AGE; COGNITIVE CONTROL; NEGATIVE INFORMATION; VISUAL-ATTENTION; MEMORY; ADULTS	There is emerging evidence for a positivity effect in healthy aging, which describes an age-specific increased focus on positive compared to negative information. Life-span researchers have attributed this effect to the selective allocation of cognitive resources in the service of prioritized emotional goals. We explored the basic principles of this assumption by assessing selective attention and memory for visual stimuli, differing in emotional content and self-relevance, in young and old participants. To specifically address the impact of cognitive control, voluntary attentional selection during the presentation of multiple-item displays was analyzed and linked to participants' general ability of cognitive control. Results revealed a positivity effect in older adults' selective attention and memory, which was particularly pronounced for self-relevant stimuli. Focusing on positive and ignoring negative information was most evident in older participants with a generally higher ability to exert top-down control during visual search. Our findings highlight the role of controlled selectivity in the occurrence of a positivity effect in aging. Since the effect has been related to well-being in later life, we suggest that the ability to selectively allocate top-down control might represent a resilience factor for emotional health in aging.	[Sasse, Laura K.; Gamer, Matthias; Buechel, Christian; Brassen, Stefanie] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Sasse, LK (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	lsasse@uke.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038; Brassen, Stefanie/0000-0002-8884-7593	German research foundation (DFG) [BR2877/2-2]	German research foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German research foundation (DFG, BR2877/2-2) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2010, CORTEX, V46, P425, DOI 10.1016/j.cortex.2009.04.011; Ashley V, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-14; Brassen S, 2008, BIOL PSYCHIAT, V64, P349, DOI 10.1016/j.biopsych.2008.03.022; Brassen S, 2012, SCIENCE, V336, P612, DOI 10.1126/science.1217516; Brassen S, 2011, BIOL PSYCHIAT, V70, P131, DOI 10.1016/j.biopsych.2010.10.013; Broomfield NM, 2007, INT J GERIATR PSYCH, V22, P175, DOI 10.1002/gps.1655; Brummer L, 2014, BEHAV COGN PSYCHOTH, V42, P668, DOI 10.1017/S1352465813000453; Cabeza R., 2013, PRINCIPLES FRONTAL L; Cacioppo JT., 2011, SOCIAL NEUROSCIENCE, P249, DOI [DOI 10.1093/ACPROF:OSO/9780195316872.003.0017, 10.1093/acprof:oso/9780195316872.003.0017]; Carstensen LL, 2006, SCIENCE, V312, P1913, DOI 10.1126/science.1127488; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 1998, HEALTH PSYCHOL, V17, P494, DOI 10.1037/0278-6133.17.6.494; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Colcombe AM, 2003, ACTA PSYCHOL, V113, P205, DOI 10.1016/S0001-6918(03)00019-2; Costello MC, 2010, EXP AGING RES, V36, P249, DOI 10.1080/0361073X.2010.484719; Ebner NC, 2013, NEUROIMAGE, V78, P363, DOI 10.1016/j.neuroimage.2013.04.029; Ebner NC, 2011, COGNITION EMOTION, V25, P983, DOI 10.1080/02699931.2010.540817; Ebner NC, 2011, NEUROCASE, V17, P260, DOI 10.1080/13554794.2010.536953; Ebner NC, 2010, COGNITION EMOTION, V24, P1095, DOI 10.1080/02699930903128395; Ebner NC, 2009, EMOTION, V9, P329, DOI 10.1037/a0015179; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Germain CM, 2007, AGING NEUROPSYCHOL C, V14, P462, DOI 10.1080/13825580600611302; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guerreiro MJS, 2010, PSYCHOL BULL, V136, P975, DOI 10.1037/a0020731; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Hahn S, 2006, ACTA PSYCHOL, V123, P312, DOI 10.1016/j.actpsy.2006.01.008; Hamami A, 2011, PSYCHOL AGING, V26, P636, DOI 10.1037/a0022626; Harvey PO, 2007, J COGNITIVE NEUROSCI, V19, P351, DOI 10.1162/jocn.2007.19.2.351; He Y, 2011, SOC COGNITION, V29, P97, DOI 10.1521/soco.2011.29.1.97; Isaacowitz DM, 2008, PSYCHOL SCI, V19, P848, DOI 10.1111/j.1467-9280.2008.02167.x; Isaacowitz DM, 2006, EMOTION, V6, P511, DOI 10.1037/1528-3542.6.3.511; Isaacowitz DM, 2009, J GERONTOL B-PSYCHOL, V64, P188, DOI 10.1093/geronb/gbn036; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Katz R, 2010, AM J GERIAT PSYCHIAT, V18, P1017, DOI 10.1097/JGP.0b013e3181d695f2; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Kensinger EA, 2008, J COGNITIVE NEUROSCI, V20, P1161, DOI 10.1162/jocn.2008.20080; Kensinger EA, 2009, EUR J COGN PSYCHOL, V21, P192, DOI 10.1080/09541440801937116; Knight M, 2007, EMOTION, V7, P705, DOI 10.1037/1528-3542.7.4.705; Kryla-Lighthall N., 2009, HDB THEORIES AGING, P323; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 2008, A8 U FLOR; LAWTON MP, 1992, PSYCHOL AGING, V7, P171, DOI 10.1037/0882-7974.7.2.171; Leclerc CM, 2008, COGN AFFECT BEHAV NE, V8, P153, DOI 10.3758/CABN.8.2.153; Lee LO, 2009, PSYCHOL AGING, V24, P741, DOI 10.1037/a0016409; Lien MC, 2011, PSYCHOL AGING, V26, P188, DOI 10.1037/a0021073; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M, 2012, ANN NY ACAD SCI, V1251, P33, DOI 10.1111/j.1749-6632.2012.06471.x; Monti JM, 2010, NEUROPSYCHOLOGIA, V48, P1697, DOI 10.1016/j.neuropsychologia.2010.02.017; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Nashiro K, 2012, GERONTOLOGY, V58, P156, DOI 10.1159/000328465; Ochsner K. N., 2007, SOCIAL PSYCHOL HDB B, P39; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Opitz PC, 2012, NEUROBIOL AGING, V33, P645, DOI 10.1016/j.neurobiolaging.2010.06.004; Orgeta V, 2011, EXP AGING RES, V37, P449, DOI 10.1080/0361073X.2011.590759; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Petrican R, 2008, PSYCHOL AGING, V23, P585, DOI 10.1037/a0013176; Phillips LH, 2008, J GERONTOL B-PSYCHOL, V63, pP138, DOI 10.1093/geronb/63.3.P138; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Rhodes MG, 2012, PSYCHOL BULL, V138, P146, DOI 10.1037/a0025750; Ritchey M, 2011, NEUROPSYCHOLOGIA, V49, P640, DOI 10.1016/j.neuropsychologia.2010.09.009; Samanez-Larkin GR, 2009, PSYCHOL AGING, V24, P519, DOI 10.1037/a0016952; Sheline YI, 2006, BIOL PSYCHIAT, V60, P58, DOI 10.1016/j.biopsych.2005.09.019; Tomaszczyk JC, 2008, PSYCHON B REV, V15, P191, DOI 10.3758/PBR.15.1.191; Wangelin BC, 2012, BIOL PSYCHOL, V91, P103, DOI 10.1016/j.biopsycho.2012.05.002; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; Whiting WL, 2007, PSYCHOL AGING, V22, P223, DOI 10.1037/0882-7974.22.2.223; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471	76	30	33	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104180	10.1371/journal.pone.0104180	http://dx.doi.org/10.1371/journal.pone.0104180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093459	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200086
J	Cannon, WR				Cannon, William R.			Simulating Metabolism with Statistical Thermodynamics	PLOS ONE			English	Article								New methods are needed for large scale modeling of metabolism that predict metabolite levels and characterize the thermodynamics of individual reactions and pathways. Current approaches use either kinetic simulations, which are difficult to extend to large networks of reactions because of the need for rate constants, or flux-based methods, which have a large number of feasible solutions because they are unconstrained by the law of mass action. This report presents an alternative modeling approach based on statistical thermodynamics. The principles of this approach are demonstrated using a simple set of coupled reactions, and then the system is characterized with respect to the changes in energy, entropy, free energy, and entropy production. Finally, the physical and biochemical insights that this approach can provide for metabolism are demonstrated by application to the tricarboxylic acid (TCA) cycle of Escherichia coli. The reaction and pathway thermodynamics are evaluated and predictions are made regarding changes in concentration of TCA cycle intermediates due to 10-and 100-fold changes in the ratio of NAD+: NADH concentrations. Finally, the assumptions and caveats regarding the use of statistical thermodynamics to model non-equilibrium reactions are discussed.	Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Cannon, WR (corresponding author), Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA.	William.cannon@pnnl.gov	Cannon, William R/K-8411-2014	Cannon, William R/0000-0003-3789-7889	Scientific Discovery through Advanced Computing (SciDAC) program, Office of Advanced Scientific Computing Research (OASCR); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER) through a SciDAC award; U.S. Department of Energy [DE-AC06-76RLO]	Scientific Discovery through Advanced Computing (SciDAC) program, Office of Advanced Scientific Computing Research (OASCR); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER) through a SciDAC award; U.S. Department of Energy(United States Department of Energy (DOE))	This research was developed under the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory. Initial concepts were supported through joint funding from the Scientific Discovery through Advanced Computing (SciDAC) program, Office of Advanced Scientific Computing Research (OASCR) and the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), through a SciDAC award to W. R. Cannon. PNNL is operated by Battelle for the U.S. Department of Energy under Contract DE-AC06-76RLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty R. A., 2003, THERMODYNAMICS BIOCH; Allen MP., 1989, COMPUTER SIMULATION; Annila A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1017; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bylaska EJ, 2006, THEOR CHEM ACC, V116, P281, DOI 10.1007/s00214-005-0042-8; Cannon WR, 2010, J PHYS CHEM C, V114, P5360, DOI 10.1021/jp905049d; Davidson N., 1962, STAT MECH; De Martino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002562; Dewar R, 2003, J PHYS A-MATH GEN, V36, P631, DOI 10.1088/0305-4470/36/3/303; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Ge H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051133; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Haraldsdottir HS, 2012, BIOPHYS J, V102, P1703, DOI 10.1016/j.bpj.2012.02.032; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P32, DOI 10.1073/pnas.97.1.32; Li Xin, 2011, Database (Oxford), V2011, pbar005, DOI 10.1093/database/bar005; Liu JJ, 2010, J CHEM THEORY COMPUT, V6, P1109, DOI 10.1021/ct100025j; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P151, DOI 10.1073/pnas.8.6.151; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P147, DOI 10.1073/pnas.8.6.147; McQuarrie D. A, 2000, STAT MECH; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nightingale M.P., 1999, QUANTUM MONTE CARLO; Noor E, 2014, PLOS COMPUTATIONAL B, V10; Price MLP, 2000, J AM CHEM SOC, V122, P9455, DOI 10.1021/ja001018c; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schrodinger E., 1951, WHAT IS LIFE PHYS AS; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Smith MBK, 2000, PROTEIN ENG, V13, P413, DOI 10.1093/protein/13.6.413; van Erp TS, 2014, FRONT PHYS, V1, DOI 10.3389/fphy.2013.00036	34	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103582	10.1371/journal.pone.0103582	http://dx.doi.org/10.1371/journal.pone.0103582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089525	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700033
J	Decelle, J; Romac, S; Sasaki, E; Not, F; Mahe, F				Decelle, Johan; Romac, Sarah; Sasaki, Eriko; Not, Fabrice; Mahe, Frederic			Intracellular Diversity of the V4 and V9 Regions of the 18S rRNA in Marine Protists (Radiolarians) Assessed by High-Throughput Sequencing	PLOS ONE			English	Article							DEEP-SEA; MICROBIAL EUKARYOTES; DNA; PSEUDOGENES; ACANTHARIA; OCEAN	Metabarcoding is a powerful tool for exploring microbial diversity in the environment, but its accurate interpretation is impeded by diverse technical (e. g. PCR and sequencing errors) and biological biases (e. g. intra-individual polymorphism) that remain poorly understood. To help interpret environmental metabarcoding datasets, we investigated the intracellular diversity of the V4 and V9 regions of the 18S rRNA gene from Acantharia and Nassellaria (radiolarians) using 454 pyrosequencing. Individual cells of radiolarians were isolated, and PCRs were performed with generalist primers to amplify the V4 and V9 regions. Different denoising procedures were employed to filter the pyrosequenced raw amplicons (Acacia, AmpliconNoise, Linkage method). For each of the six isolated cells, an average of 541 V4 and 562 V9 amplicons assigned to radiolarians were obtained, from which one numerically dominant sequence and several minor variants were found. At the 97% identity, a diversity metrics commonly used in environmental surveys, up to 5 distinct OTUs were detected in a single cell. However, most amplicons grouped within a single OTU whereas other OTUs contained very few amplicons. Different analytical methods provided evidence that most minor variants forming different OTUs correspond to PCR and sequencing artifacts. Duplicate PCR and sequencing from the same DNA extract of a single cell had only 9 to 16% of unique amplicons in common, and alignment visualization of V4 and V9 amplicons showed that most minor variants contained substitutions in highly-conserved regions. We conclude that intracellular variability of the 18S rRNA in radiolarians is very limited despite its multi-copy nature and the existence of multiple nuclei in these protists. Our study recommends some technical guidelines to conservatively discard artificial amplicons from metabarcoding datasets, and thus properly assess the diversity and richness of protists in the environment.	[Decelle, Johan; Romac, Sarah; Not, Fabrice] UPMC Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Decelle, Johan; Romac, Sarah; Not, Fabrice] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Sasaki, Eriko] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Mahe, Frederic] Univ Kaiserslautern, Dept Ecol, D-67663 Kaiserslautern, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Kaiserslautern	Decelle, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France.	decelle@sb-roscoff.fr	Mahé, Frédéric/AAR-8568-2021	Mahé, Frédéric/0000-0002-2808-0984; Decelle, Johan/0000-0002-4343-8358	PhD fellowship DIPHOPE from the Region Bretagne; BioMarKs project (ERA-net Biodiversa, EU) [2008-6530]; JST-CNRS; Deutsche Forschungsgemeinschaft [DU1319/1-1]; project OCEANOMICS - French government [ANR-11-BTBR-0008]	PhD fellowship DIPHOPE from the Region Bretagne; BioMarKs project (ERA-net Biodiversa, EU); JST-CNRS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); project OCEANOMICS - French government	This work was supported by the PhD fellowship DIPHOPE from the Region Bretagne (J.D.), the BioMarKs project (2008-6530, ERA-net Biodiversa, EU), and a JST-CNRS exchange program (F.N). F. M. was supported by the Deutsche Forschungsgemeinschaft (grant #DU1319/1-1). This study was also supported by the project OCEANOMICS, that has received funding from the French government, managed by the Agence Nationale de la Recherche, under the grant agreement "Investissement d'Avenir" ANR-11-BTBR-0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander E, 2009, ENVIRON MICROBIOL, V11, P360, DOI 10.1111/j.1462-2920.2008.01777.x; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; CARON DA, 1995, J PLANKTON RES, V17, P103, DOI 10.1093/plankt/17.1.103; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Decelle J, 2012, PROTIST, V163, P435, DOI 10.1016/j.protis.2011.10.002; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gaspar JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060458; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lampitt RS, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003221; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marie D, 2010, FEMS MICROBIOL ECOL, V72, P165, DOI 10.1111/j.1574-6941.2010.00842.x; Marquez LM, 2003, MOL BIOL EVOL, V20, P1077, DOI 10.1093/molbev/msg122; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Orsi W, 2011, ISME J, V5, P1357, DOI 10.1038/ismej.2011.7; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; Sasaki E, 2013, MOL BIOL EVOL, V30, P2187, DOI 10.1093/molbev/mst103; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Suzuki Noritoshi, 2011, Plankton & Benthos Research, V6, P69; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; van Berkum P, 2003, J BACTERIOL, V185, P2988, DOI 10.1128/JB.185.10.2988-2998.2003; Weber AAT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056739; Yabuki A, 2014, ISME J, P1; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	48	47	50	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104297	10.1371/journal.pone.0104297	http://dx.doi.org/10.1371/journal.pone.0104297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090095	gold, Green Submitted, Green Published			2022-12-25	WOS:000339812700116
J	Khatun, J; Huda, MM; Hossain, MS; Presber, W; Ghosh, D; Kroeger, A; Matlashewski, G; Mondal, D				Khatun, Jahanara; Huda, M. Mamun; Hossain, Md. Shakhawat; Presber, Wolfgang; Ghosh, Debashis; Kroeger, Axel; Matlashewski, Greg; Mondal, Dinesh			Accelerated Active Case Detection of Visceral Leishmaniasis Patients in Endemic Villages of Bangladesh	PLOS ONE			English	Article							INDIA; FEASIBILITY	Background: The visceral leishmaniasis (VL) elimination program in Bangladesh is in its attack phase. The primary goal of this phase is to decrease the burden of VL as much as possible. Active case detection (ACD) by the fever camp method and an approach using past VL cases in the last 6-12 months have been found useful for detection of VL patients in the community. We aimed to explore the yield of Accelerated Active Case Detection (AACD) of non-self reporting VL as well as the factors that are associated with non-self reporting to hospitals in endemic communities of Bangladesh. Methods: Our study was conducted in the Trishal sub-district of Mymensingh, a highly VL endemic region of Bangladesh. We used a two-stage sampling strategy from 12 VL endemic unions of Trishal. Two villages from each union were selected at random. We looked for VL patients who had self-reported to the hospital and were under treatment from these villages. Then we conducted AACD for VL cases in those villages using house-to-house visit. Suspected VL cases were referred to the Trishal hospital where diagnosis and treatment of VL was done following National Guidelines for VL case management. We collected socio-demographic information from patients or a patient guardian using a structured questionnaire. Results: The total number of VL cases was 51. Nineteen of 51 (37.3%) were identified by AACD. Poverty, female gender and poor knowledge about VL were independent factors associated with non self-reporting to the hospital. Conclusion: Our primary finding is that AACD is a useful method for early detection of VL cases that would otherwise go unreported to the hospital in later stage due to poverty, poor knowledge about VL and gender inequity. We recommend that the National VL Program should consider AACD to strengthen its early VL case detection strategy.	[Khatun, Jahanara] Free Univ Berlin, Charite Med Sch, Berlin, Germany; [Khatun, Jahanara] Humboldt Univ, D-10099 Berlin, Germany; [Huda, M. Mamun; Ghosh, Debashis] Ctr Communicable Dis, Parasitol Lab, Dhaka, Bangladesh; [Hossain, Md. Shakhawat; Mondal, Dinesh] Ctr Nutr & Food Secur, Parasitol Lab, Dhaka, Bangladesh; [Presber, Wolfgang] Charite, Inst Mikrobiol, D-13353 Berlin, Germany; [Kroeger, Axel] WHO World Bank, Special Program Trop Dis Res TDR, Geneva, Switzerland; [Matlashewski, Greg] McGill Univ, Dept Microbiol & Immunol, Quebec City, PQ, Canada	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University	Mondal, D (corresponding author), Ctr Nutr & Food Secur, Parasitol Lab, Dhaka, Bangladesh.	din63d@icddrb.org	Huda, M Mamun/AAA-2152-2020	Huda, M Mamun/0000-0003-1069-3472; Kroeger, Axel/0000-0001-8438-2904	Special Programme for Research and Training in Tropical Diseases (TDR/WHO/World bank) [A60443, A60482]	Special Programme for Research and Training in Tropical Diseases (TDR/WHO/World bank)	The Special Programme for Research and Training in Tropical Diseases (TDR/WHO/World bank) provided financial support (Project ID: A60443 & A60482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 2003, AM J TROP MED HYG, V69, P624, DOI 10.4269/ajtmh.2003.69.624; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2006, INDIAN J MED RES, V123, P275; Hirve S, 2010, AM J TROP MED HYG, V83, P507, DOI 10.4269/ajtmh.2010.09-0685; Huda MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1001; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Singh SP, 2011, PLOS NEGLECT TROP D, V5, pe960, DOI DOI 10.1371/journal.pntd.0000960; *WHO, 2008, SEACD182 WHO; WHO Regional Technical Advisory Group on Kala-azar Elimination, 2005, 1 M MAN HAR 20 23 DE	11	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103678	10.1371/journal.pone.0103678	http://dx.doi.org/10.1371/journal.pone.0103678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090412	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700041
J	Madissoon, E; Tohonen, V; Vesterlund, L; Katayama, S; Unneberg, P; Inzunza, J; Hovatta, O; Kere, J				Madissoon, Elo; Tohonen, Virpi; Vesterlund, Liselotte; Katayama, Shintaro; Unneberg, Per; Inzunza, Jose; Hovatta, Outi; Kere, Juha			Differences in Gene Expression between Mouse and Human for Dynamically Regulated Genes in Early Embryo	PLOS ONE			English	Article							HUMAN MATURE OOCYTES; CANCER/TESTIS ANTIGENS; PLURIPOTENT CELLS; EXPANDING FAMILY; COPY NUMBER; PROTEIN; TRANSCRIPTOME; NANOG; IDENTIFICATION; AMPLIFICATION	Infertility is a worldwide concern that can be treated with in vitro fertilization (IVF). Improvements in IVF and infertility treatment depend largely on better understanding of the molecular mechanisms for human preimplantation development. Several large-scale studies have been conducted to identify gene expression patterns for the first five days of human development, and many functional studies utilize mouse as a model system. We have identified genes of possible importance for this time period by analyzing human microarray data and available data from online databases. We selected 70 candidate genes for human preimplantation development and investigated their expression in the early mouse development from oocyte to the 8-cell stage. Maternally loaded genes expectedly decreased in expression during development both in human and mouse. We discovered that 25 significantly upregulated genes after fertilization in human included 13 genes whose orthologs in mouse behaved differently and mimicked the expression profile of maternally expressed genes. Our findings highlight many significant differences in gene expression patterns during mouse and human preimplantation development. We also describe four cancer-testis antigen families that are also highly expressed in human embryos: PRAME, SSX, GAGE and MAGEA.	[Madissoon, Elo; Tohonen, Virpi; Vesterlund, Liselotte; Katayama, Shintaro; Inzunza, Jose; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden; [Tohonen, Virpi] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Unneberg, Per] Karolinska Inst, Sci Life Lab, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hovatta, Outi] Karolinska Univ Hosp K57, Dept Clin Sci Intervent & Technol, Karolinska Inst, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Mol Neurol Program, Res Programs Unit, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Helsinki	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden.	juha.kere@ki.se	Kere, Juha/AAX-9117-2021; Katayama, Shintaro/F-2958-2010; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Katayama, Shintaro/0000-0001-7581-5157; Kere, Juha/0000-0003-1974-0271; Vesterlund, Liselotte/0000-0003-3547-9288; Unneberg, Per/0000-0001-5735-3315; Inzunza, Jose/0000-0003-0876-6767; Madissoon, Elo/0000-0003-2405-4911	Swedish Research Council; Center for Biosciences; Karolinska Institutet Distinguished Professor Award; Karolinska Institutet funds; Svenska Lakaresallskapet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Biosciences; Karolinska Institutet Distinguished Professor Award; Karolinska Institutet funds; Svenska Lakaresallskapet	This study was supported by the Swedish Research Council, the Center for Biosciences, the Karolinska Institutet Distinguished Professor Award(JK) and by the Karolinska Institutet funds and Svenska Lakaresallskapet (VT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bai Q, 2012, STEM CELL REV REP, V8, P150, DOI 10.1007/s12015-011-9301-3; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; BRAUDE P, 1979, NATURE, V282, P102, DOI 10.1038/282102a0; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Bruce JW, 2010, J VIROL, V84, P7473, DOI 10.1128/JVI.00299-10; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016867; Chiang WF, 2011, ORAL DIS, V17, P53, DOI 10.1111/j.1601-0825.2010.01702.x; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Dade S, 2003, FEBS LETT, V555, P533, DOI 10.1016/S0014-5793(03)01341-3; Duhoux FP, 2011, LEUKEMIA RES, V35, pE114, DOI 10.1016/j.leukres.2011.02.011; EDWARDS RG, 1981, AM J OBSTET GYNECOL, V141, P408, DOI 10.1016/0002-9378(81)90603-7; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Gure AO, 1997, INT J CANCER, V72, P965, DOI 10.1002/(SICI)1097-0215(19970917)72:6<965::AID-IJC8>3.0.CO;2-N; HARLOW GM, 1982, AUST J BIOL SCI, V35, P187, DOI 10.1071/BI9820187; He K, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-41; Imoto I, 2003, CANCER RES, V63, P5691; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li XL, 2004, INT J ONCOL, V24, P257; Lin SC, 2005, J PATHOL, V206, P417, DOI 10.1002/path.1790; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sunderam S, 2013, MMWR SURVEILL SUMM, V62, P1; Tanaka M, 2009, AM J SURG PATHOL, V33, P1416, DOI 10.1097/PAS.0b013e3181a9cd6c; Taniwaki M, 2006, INT J ONCOL, V29, P567; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; Xie D, 2010, GENOME RES; Xue Z, 2013, NATURE; Yan L, 2013, NAT STRUCT MOL BIOL; Zhang P, 2007, FERTIL STERIL, V87, P677, DOI 10.1016/j.fertnstert.2006.07.1509; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755	56	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102949	10.1371/journal.pone.0102949	http://dx.doi.org/10.1371/journal.pone.0102949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089626	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700012
J	Wu, XY; Cai, H; Kallianpur, A; Gao, YT; Yang, G; Chow, WH; Li, HL; Zheng, W; Shu, XO				Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Gao, Yu-Tang; Yang, Gong; Chow, Wong-Ho; Li, Hong-Lan; Zheng, Wei; Shu, Xiao-Ou			Age at Menarche and Natural Menopause and Number of Reproductive Years in Association with Mortality: Results from a Median Follow-Up of 11.2 Years among 31,955 Naturally Menopausal Chinese Women	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE MORTALITY; ISCHEMIC-HEART-DISEASE; LUNG-CANCER; POSTMENOPAUSAL WOMEN; ADVENTIST HEALTH; NORWEGIAN WOMEN; KANGWHA COHORT; RISK; STROKE	Background: Studies conducted in Western countries suggest that early age at menarche and early age at menopause are both associated with increased total mortality, but limited data are available for Asian populations. We examined associations of age at menarche and natural menopause and duration of the reproductive span with mortality in a population-based cohort study of Chinese women. Methods: We evaluated the effects of age at menarche, age at natural menopause, and number of reproductive years on total and cause-specific mortality among 31,955 naturally menopausal Chinese women who participated in the Shanghai Women's Health Study, a population-based, prospective cohort study. Results: A total of 3,158 deaths occurred during a median follow-up of 11.2 years. Results from Cox proportional hazards models showed that younger age at menopause (<46.64 years) was associated with higher risk of total mortality (P-trend = 0.02). Younger age at menarche (<14 years) was associated with higher risk of mortality from stroke (P-trend = 0.03) and diabetes (P-trend = 0.02) but lower risk of mortality from respiratory system cancer (P-trend = 0.01). Women with a shorter reproductive span had lower risk of mortality from gynecological cancers (P-trend = 0.03). Conclusions: Our study found that menstrual characteristics are important predictors of mortality, suggesting an important role of sex hormones in biological aging.	[Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA; [Wu, Xiaoyan; Cai, Hui; Kallianpur, Asha; Yang, Gong; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Gao, Yu-Tang; Li, Hong-Lan] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Chow, Wong-Ho] NCI, Occupat Epidemiol Branch, NIH, Bethesda, MD 20892 USA	Vanderbilt University; Vanderbilt University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shu, XO (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med, Nashville, TN 37212 USA.	Xiao-ou.shu@vanderbilt.edu	Gao, Y./GWZ-3665-2022; Zheng, Wei/O-3351-2013; zhang, weihua/GXV-1334-2022; Gao, Yu/HGE-1937-2022; gao, yi/HCI-8298-2022	Zheng, Wei/0000-0003-1226-070X; 	United States National Cancer Institute at the US National Institutes of Health [R37 CA070867]; NATIONAL CANCER INSTITUTE [R37CA070867] Funding Source: NIH RePORTER	United States National Cancer Institute at the US National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the United States National Cancer Institute at the US National Institutes of Health [grant number R37 CA070867, PI: W. Zheng]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belsky J, 2010, DEV PSYCHOL, V46, P120, DOI 10.1037/a0015549; Brenner AV, 2003, J EPIDEMIOL, V13, P22, DOI 10.2188/jea.13.22; Chang HS, 2011, MENOPAUSE, V18, P1205, DOI 10.1097/gme.0b013e31821adb43; Cooper GS, 1998, ANN EPIDEMIOL, V8, P229, DOI 10.1016/S1047-2797(97)00207-X; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; DEGRAAFF J, 1978, EUR J OBSTET GYN R B, V8, P187, DOI 10.1016/0028-2243(78)90014-X; Delbari A, 2011, INT J STROKE, V6, P195, DOI 10.1111/j.1747-4949.2010.00562.x; Gaudineau A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-175; Giles LC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-341; Hong JS, 2007, MATURITAS, V56, P411, DOI 10.1016/j.maturitas.2006.11.004; Hsieh YC, 2010, INT J GERONTOL, V4, P16, DOI 10.1016/S1873-9598(10)70017-X; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Jacobsen BK, 2009, INT J EPIDEMIOL, V38, P245, DOI 10.1093/ije/dyn251; Jacobsen BK, 2007, AM J EPIDEMIOL, V166, P1431, DOI 10.1093/aje/kwm237; Jacobsen BK, 2004, STROKE, V35, P1548, DOI 10.1161/01.STR.0000131746.49082.5c; Jacobsen BK, 2003, AM J EPIDEMIOL, V157, P923, DOI 10.1093/aje/kwg066; Jacobsen BK, 1999, J CLIN EPIDEMIOL, V52, P303, DOI 10.1016/S0895-4356(98)00170-X; Kreuzer M, 2003, INT J EPIDEMIOL, V32, P263, DOI 10.1093/ije/dyg064; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Liu Y, 2005, INT J CANCER, V117, P662, DOI 10.1002/ijc.21229; Macsali F, 2011, AM J RESP CRIT CARE, V183, P8, DOI 10.1164/rccm.200912-1886OC; Matthews CE, 2003, AM J EPIDEMIOL, V158, P1114, DOI 10.1093/aje/kwg255; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Mueller NT, 2012, ANN EPIDEMIOL, V22, P717, DOI 10.1016/j.annepidem.2012.08.002; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Schouw YTvd, 1996, LANCET, V347, P714; Seow A, 2009, CANCER EPIDEM BIOMAR, V18, P821, DOI 10.1158/1055-9965.EPI-08-0892; SLEE VN, 1978, ANN INTERN MED, V88, P424, DOI 10.7326/0003-4819-88-3-424; SNOWDON DA, 1989, AM J PUBLIC HEALTH, V79, P709, DOI 10.2105/AJPH.79.6.709; Tamakoshi K, 2011, EUR J EPIDEMIOL, V26, P771, DOI 10.1007/s10654-011-9623-0; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; Yang L, 2009, STROKE, V40, P1050, DOI 10.1161/STROKEAHA.108.531913; Yi SW, 2009, STROKE, V40, P3428, DOI 10.1161/STROKEAHA.109.555144; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	35	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103673	10.1371/journal.pone.0103673	http://dx.doi.org/10.1371/journal.pone.0103673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090234	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700040
J	Sponholz, C; Schelenz, C; Reinhart, K; Schirmer, U; Stehr, SN				Sponholz, Christoph; Schelenz, Christoph; Reinhart, Konrad; Schirmer, Uwe; Stehr, Sebastian N.			Catecholamine and Volume Therapy for Cardiac Surgery in Germany - Results from a Postal Survey	PLOS ONE			English	Article							HYDROXYETHYL STARCH; VASOPRESSOR USE; INTENSIVE-CARE; EPINEPHRINE; GUIDELINES; MILRINONE; PERFUSION; OUTCOMES; SOCIETY	Background: Management of cardiac surgery patients is a very standardized procedure in respective local institutions. Yet only very limited evidence exists concerning optimal indication, safety and efficacy of hemodynamic monitoring catecholamine and fluid therapy. Methods: Between April and May 2013, all 81 German anaesthesia departments involved in cardiac surgery care were asked to participate in a questionnaire addressing the institutional specific current practice in hemodynamic monitoring, catecholamine and volume therapy. Results: 51 (63%) questionnaires were completed and returned. All participating centers used basic hemodynamic monitoring (i.e. invasive arterial blood pressure and central venous pressure), supplemented by transesophageal echocardiography. Pulmonary arterial catheter and calibrated trend monitoring devices were also routinely available. In contrast, non-calibrated trend monitoring and esophageal doppler ultrasound devices were not commonly in use. Cerebral oximetry is increasingly emerging, but lacks clear indications. The majority of patients undergoing cardiac surgery, especially in university hospitals, required catecholamines during perioperative care, In case of low cardiac output syndrome, dobutamine (32%), epinephrine (30%) or phosphodiesterase inhibitors (8%) were first choice. In case of hypotension following vasoplegia, norepinephrine (96%) represented the most common catecholamine. 88% of the participating centers reported regular use of colloid fluids, with hydroxyethyl starches (HES) being first choice (64%). Conclusions: Choice of hemodynamic monitoring is homogenous throughout German centers treating cardiac surgery patients. Norepinephrine is the first line catecholamine in cases of decrease in peripheral vascular resistance. However, catecholamine choice for low cardiac output syndrome varies considerably. HES was the primary colloid used for fluid resuscitation. After conduct of this survey, HES use was restricted by European regulatory authorities in critically ill patients and should only be considered as second-line fluid in surgical patients without renal impairment or severe coagulopathy. Large clinical studies addressing catecholamine and fluid therapy in cardiac surgery patients are lacking.	[Sponholz, Christoph; Schelenz, Christoph; Reinhart, Konrad; Stehr, Sebastian N.] Univ Hosp Jena, Dept Anesthesiol & Crit Care Med, Jena, Germany; [Reinhart, Konrad; Stehr, Sebastian N.] Univ Hosp Jena, CSCC, Integrated Res & Treatment Ctr, Jena, Germany; [Schirmer, Uwe] Ruhr Univ Bochum, Inst Anasthesiol, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Ruhr University Bochum	Sponholz, C (corresponding author), Univ Hosp Jena, Dept Anesthesiol & Crit Care Med, Jena, Germany.	christoph.sponholz@med.uni-jena.de	Sponholz, Christoph/I-3585-2019	Sponholz, Christoph/0000-0002-1746-7024	German Federal Ministry of Education and Research (BMBF) [FKZ: 01EO1002]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF), FKZ: 01EO1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawaf E, 2006, J CARDIOTHOR VASC AN, V20, P353, DOI 10.1053/j.jvca.2006.02.012; Bangert K, 2005, ANASTH INTENSIV NOTF, V40, P291, DOI 10.1055/s-2005-861349; Barron ME, 2004, ARCH SURG-CHICAGO, V139, P552, DOI 10.1001/archsurg.139.5.552; Bastien O, 2005, CRIT CARE, V9, P241, DOI 10.1186/cc3482; Bayer O, 2013, CRIT CARE MED, V41, P2532, DOI 10.1097/CCM.0b013e3182978fb6; Butterworth J F 4th, 1992, J Cardiothorac Vasc Anesth, V6, P535, DOI 10.1016/1053-0770(92)90095-O; Carl M, 2007, THORAC CARDIOV SURG, V55, P130, DOI 10.1055/s-2007-964939; Carl M, 2010, Z HERZ THORAX GEFASS, V24, P294, DOI [DOI 10.1007/S00398-010-0790-1, 10.1007/s00398-010-0790-1.]; De Backer D, 2003, CRIT CARE MED, V31, P1659, DOI 10.1097/01.CCM.0000063045.77339.B6; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ekbal NJ, 2013, CHEST, V143, P1799, DOI 10.1378/chest.12-1849; Ferguson-Myrthil N, 2012, CARDIOL REV, V20, P153, DOI 10.1097/CRD.0b013e31824e2294; Funkat AK, 2012, THORAC CARDIOV SURG, V60, P371, DOI 10.1055/s-0032-1326724; Gillies M, 2005, CRIT CARE, V9, P266, DOI 10.1186/cc3024; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Kastrup M, 2007, ACTA ANAESTH SCAND, V51, P347, DOI 10.1111/j.1399-6576.2006.01190.x; Kastrup M, 2013, ACTA ANAESTH SCAND, V57, P206, DOI 10.1111/aas.12009; Lampard JG, 2013, ANN EMERG MED, V61, P351, DOI 10.1016/j.annemergmed.2012.08.028; Lequeux PY, 2010, EUR J ANAESTH, V27, P295, DOI 10.1097/EJA.0b013e3283315ad0; Levy B, 2011, CRIT CARE MED, V39, P450, DOI 10.1097/CCM.0b013e3181ffe0eb; Lobato EB, 2000, J CARDIOTHOR VASC AN, V14, P374, DOI 10.1053/jcan.2000.7921; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; MeierHellmann A, 1997, CRIT CARE MED, V25, P399, DOI 10.1097/00003246-199703000-00005; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; ROYSTER RL, 1993, ANESTH ANALG, V77, P662; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Weis F, 2006, ANAESTHESIA, V61, P938, DOI 10.1111/j.1365-2044.2006.04779.x; Werner C, 2013, ANASTH INTENSIV NOTF, V48, P437, DOI 10.1055/s-0033-1352487; Williams JB, 2011, J CARDIAC SURG, V26, P572, DOI 10.1111/j.1540-8191.2011.01301.x; Zheng F, 2013, ANESTH ANALG, V116, P663, DOI 10.1213/ANE.0b013e318277a255	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103996	10.1371/journal.pone.0103996	http://dx.doi.org/10.1371/journal.pone.0103996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084362	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800116
J	Dalal, K; Roshan-Moniri, M; Sharma, A; Li, HF; Ban, FQ; Hessein, M; Hsing, M; Singh, K; LeBlanc, E; Dehm, S; Guns, EST; Cherkasov, A; Rennie, PS				Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hessein, Mohamed; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Dehm, Scott; Guns, Emma S. Tomlinson; Cherkasov, Artem; Rennie, Paul S.			Selectively Targeting the DNA-binding Domain of the Androgen Receptor as a Prospective Therapy for Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3 BF3 SITE; CASTRATION-RESISTANT; STRUCTURAL BASIS; GENE-EXPRESSION; ACTIVATION; ANTAGONISTS; INHIBITION; IDENTIFICATION; ANTIANDROGEN; SUPPRESSION	The androgen receptor (AR) is a transcription factor that has a pivotal role in the occurrence and progression of prostate cancer. The AR is activated by androgens that bind to its ligand-binding domain (LBD), causing the transcription factor to enter the nucleus and interact with genes via its conserved DNA-binding domain (DBD). Treatment for prostate cancer involves reducing androgen production or using anti-androgen drugs to block the interaction of hormones with the AR-LBD. Eventually the disease changes into a castration-resistant form of PCa where LBD mutations render anti-androgens ineffective or where constitutively active AR splice variants, lacking the LBD, become overexpressed. Recently, we identified a surfaced exposed pocket on the AR-DBD as an alternative drug-target site for AR inhibition. Here, we demonstrate that small molecules designed to selectively bind the pocket effectively block transcriptional activity of full-length and splice variant AR forms at low to sub-micromolar concentrations. The inhibition is lost when residues involved in drug interactions are mutated. Furthermore, the compounds did not impede nuclear localization of the AR and blocked interactions with chromatin, indicating the interference of DNA binding with the nuclear form of the transcription factor. Finally, we demonstrate the inhibition of gene expression and tumor volume in mouse xenografts. Our results indicate that the AR-DBD has a surface site that can be targeted to inhibit all forms of the AR, including enzalutamide-resistant and constitutively active splice variants and thus may serve as a potential avenue for the treatment of recurrent and metastatic prostate cancer.	[Dalal, Kush; Roshan-Moniri, Mani; Sharma, Aishwariya; Li, Huifang; Ban, Fuqiang; Hessein, Mohamed; Hsing, Michael; Singh, Kriti; LeBlanc, Eric; Guns, Emma S. Tomlinson; Cherkasov, Artem; Rennie, Paul S.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Dehm, Scott] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities	Dalal, K (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.	kdalal@prostatecentre.com	Cherkasov, Artem/A-2134-2012		National Institutes of Health [R01CA174777-01]; Canadian Institutes of Health Research; Genome BC; Prostate Cancer Canada; Canada Safeway Grant [SP2013-02]; American Cancer Society [RSG-031-01-TBE]; MSFHR; Prostate Cancer Foundation BC; NATIONAL CANCER INSTITUTE [R01CA174777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome BC; Prostate Cancer Canada; Canada Safeway Grant; American Cancer Society(American Cancer Society); MSFHR(Michael Smith Foundation for Health Research); Prostate Cancer Foundation BC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA174777-01 (to the S. D. laboratory). This work was also supported by Canadian Institutes of Health Research, Genome BC, Prostate Cancer Canada with generous support from Canada Safeway Grant SP2013-02, and American Cancer Society Research Scholar Grant RSG-031-01-TBE (to the S. D. laboratory).; Supported by Canadian Institutes of Health Research and MSFHR fellowships. To whom correspondence should be addressed: Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, British Columbia V6H 3Z6, Canada. Tel.: 604-875-4818; Fax: 604-875-5654; E-mail: kdalal@prostatecentre.com.; Supported by a Prostate Cancer Foundation BC grant-in-aid award.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Caboni L, 2013, MED RES REV, V33, P1081, DOI 10.1002/med.21275; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Cheng H, 2006, CANCER RES, V66, P10613, DOI 10.1158/0008-5472.CAN-06-0028; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Duke CB, 2011, J MED CHEM, V54, P3973, DOI 10.1021/jm2000097; Ellinger-Ziegelbauer H, 2009, TOXICOL SCI, V110, P341, DOI 10.1093/toxsci/kfp103; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Ferraldeschi R, 2013, ANNU REV MED, V64, P1, DOI 10.1146/annurev-med-121211-091605; Green SM, 2012, MOL CELL ENDOCRINOL, V360, P3, DOI 10.1016/j.mce.2011.09.046; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Lack NA, 2011, J MED CHEM, V54, P8563, DOI 10.1021/jm201098n; Lallous N, 2013, INT J MOL SCI, V14, P12496, DOI 10.3390/ijms140612496; Lamont KR, 2010, ADV CANCER RES, V107, P137, DOI 10.1016/S0065-230X(10)07005-3; Li HF, 2014, J MED CHEM, V57, P6458, DOI 10.1021/jm500802j; Li HF, 2013, J CHEM INF MODEL, V53, P123, DOI 10.1021/ci300514v; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Lim MY, 2014, ACS CHEM BIOL, V9, P692, DOI 10.1021/cb400759d; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; Miyake H, 2000, CANCER RES, V60, P2547; Munuganti RSN, 2013, J MED CHEM, V56, P1136, DOI 10.1021/jm3015712; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Nyquist MD, 2013, P NATL ACAD SCI USA, V110, P17492, DOI 10.1073/pnas.1308587110; Nyquist MD, 2013, HORM CANCER-US, V4, P61, DOI 10.1007/s12672-013-0131-4; Rathkopf D, 2013, CANCER J, V19, P43, DOI 10.1097/PPO.0b013e318282635a; Saad F, 2014, UROL ONCOL-SEMIN ORI, V32, P70, DOI 10.1016/j.urolonc.2013.01.005; Salvati ME, 2005, BIOORG MED CHEM LETT, V15, P389, DOI 10.1016/j.bmcl.2004.10.051; Sato N, 1996, J STEROID BIOCHEM, V58, P139, DOI 10.1016/0960-0760(96)00018-0; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Snoek R, 1998, PROSTATE, V36, P256; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Zhang KX, 2009, CANCER GENE THER, V16, P820, DOI 10.1038/cgt.2009.28	48	85	92	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26417	26429		10.1074/jbc.M114.553818	http://dx.doi.org/10.1074/jbc.M114.553818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086042	Green Published, hybrid			2022-12-25	WOS:000342128800033
J	Alwahsh, SM; Xu, M; Schultze, FC; Wilting, J; Mihm, S; Raddatz, D; Ramadori, G				Alwahsh, Salamah Mohammad; Xu, Min; Schultze, Frank Christian; Wilting, Joerg; Mihm, Sabine; Raddatz, Dirk; Ramadori, Giuliano			Combination of Alcohol and Fructose Exacerbates Metabolic Imbalance in Terms of Hepatic Damage, Dyslipidemia, and Insulin Resistance in Rats	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SERUM ALANINE AMINOTRANSFERASE; FAST-FOOD CONSUMPTION; ETHANOL ELIMINATION; WEIGHT-GAIN; CORN SYRUP; MICE; DIET; RISK; CARBOHYDRATE	Although both alcohol and fructose are particularly steatogenic, their long-term effect in the development of a metabolic syndrome has not been studied in vivo. Consumption of fructose generally leads to obesity, whereas ethanol can induce liver damage in the absence of overweight. Here, Sprague-Dawley rats were fed ad libitum for 28 days on five diets: chow (control), liquid Lieber-DeCarli (LDC) diet, LDC +30%J of ethanol (L-Et) or fructose (L-Fr), and LDC combined with 30%J ethanol and 30%J fructose (L-EF). Body weight (BW) and liver weight (LW) were measured. Blood and liver samples were harvested and subjected to biochemical tests, histopathological examinations, and RT-PCR. Alcohol-containing diets substantially reduced the food intake and BW (<= 3rd week), whereas fructose-fed animals had higher LW than controls ( P < 0.05). Additionally, leukocytes, plasma AST and leptin levels were the highest in the fructose-administered rats. Compared to the chow and LDC diets, the L-EF diet significantly elevated blood glucose, insulin, and total-cholesterol levels (also vs. the L-Et group). The albumin and Quick-test levels were the lowest, whereas ALT activity was the highest in the L-EF group. Moreover, the L-EF diet aggravated plasma triglyceride and reduced HDL-cholesterol levels more than 2.7-fold compared to the sum of the effects of the L-Et and L-Fr diets. The decreased hepatic insulin clearance in the L-EF group vs. control and LDC groups was reflected by a significantly decreased C-peptide: insulin ratio. All diets except the control caused hepatosteatosis, as evidenced by Nile red and H&E staining. Hepatic transcription of insulin receptor substrate-1/2 was mainly suppressed by the L-Fr and L-EF diets. The L-EF diet did not enhance the mitochondrial beta-oxidation of fatty acids (Cpt1 alpha and Ppar-alpha expressions) compared to the L-Et or L-Fr diet. Together, our data provide evidence for the coaction of ethanol and fructose with a high-fat-diet on dyslipidemia and insulin resistance-accompanied liver damage.	[Alwahsh, Salamah Mohammad; Schultze, Frank Christian; Mihm, Sabine; Raddatz, Dirk; Ramadori, Giuliano] Univ Med Ctr Goettingen, Dept Gastroenterol & Endocrinol, Gottingen, Germany; [Xu, Min] Univ Med Ctr Goettingen, Dept Gen Visceral & Pediat Surg, Gottingen, Germany; [Wilting, Joerg] Univ Med Ctr Goettingen, Inst Anat & Cell Biol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Alwahsh, SM (corresponding author), Univ Med Ctr Goettingen, Dept Gastroenterol & Endocrinol, Gottingen, Germany.	alwahsh.salamah@gmail.com			UMG	UMG	This study was financed by UMG budget resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adias TC, 2013, INT J GEN MED, V6, P489, DOI 10.2147/IJGM.S43472; Ahmad S, 2014, SHOCK, V41, P337, DOI 10.1097/SHK.0000000000000107; Akash MSH, 2013, CURR DIABETES REV, V9, P387, DOI 10.2174/15733998113099990069; Alwahsh SM, 2014, WORLD J GASTROENTERO, V20, P1807, DOI 10.3748/wjg.v20.i7.1807; Berman PAM, 2003, S AFR J SCI, V99, P47; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Bykov I, 2007, CLIN IMMUNOL, V124, P213, DOI 10.1016/j.clim.2007.05.008; Cha JC, 2011, MOL MED REP, V4, P1053, DOI 10.3892/mmr.2011.562; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Collison KS, 2010, OBESITY, V18, P1122, DOI 10.1038/oby.2009.502; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; DIEHL AM, 1988, GASTROENTEROLOGY, V95, P1056, DOI 10.1016/0016-5085(88)90183-7; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Drewnowski A, 2005, J NUTR, V135, P900, DOI 10.1093/jn/135.4.900; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Fiebig R, 1998, J NUTR, V128, P810, DOI 10.1093/jn/128.5.810; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; Hirsova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070599; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Kechagias S, 2008, GUT, V57, P649, DOI 10.1136/gut.2007.131797; Kerr WC, 2005, ALCOHOL CLIN EXP RES, V29, P2015, DOI 10.1097/01.alc.0000187596.92804.bd; Lisander B, 2006, ALCOHOL ALCOHOLISM, V41, P39, DOI 10.1093/alcalc/agh188; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; Malik IA, 2012, HISTOCHEM CELL BIOL, V137, P279, DOI 10.1007/s00418-011-0899-7; Malik VS, 2006, AM J CLIN NUTR, V84, P274; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; Pravdova E, 2009, Endocr Regul, V43, P117; Raddatz D, 2007, Z GASTROENTEROL, V45, P51, DOI 10.1055/s-2006-927394; Rejitha S, 2012, BRIT J NUTR, V108, P1256, DOI 10.1017/S0007114511006568; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Rouault TA, 2003, ALCOHOL, V30, P103, DOI 10.1016/S0741-8329(03)00102-2; Ryan MC, 2007, DIABETES CARE, V30, P1075, DOI 10.2337/dc06-2169; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Shimomura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-104; Shulga N, 2014, J CELL SCI, V127, P896, DOI 10.1242/jcs.140764; Strbak V, 1998, METABOLISM, V47, P1269, DOI 10.1016/S0026-0495(98)90335-3; Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008; Thirunavukkarasu V, 2004, EXP DIABESITY RES, V5, P195, DOI 10.1080/15438600490486778; Van de Wiel A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/862504; Wei XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095399; Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526; Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017; Zhong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091308; Zhu Z, 2014, ALCOHOL CLIN EXP RES; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	57	55	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104220	10.1371/journal.pone.0104220	http://dx.doi.org/10.1371/journal.pone.0104220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101998	Green Published, gold			2022-12-25	WOS:000339993900050
J	Camargos, HS; Moreira, RA; Mendanha, SA; Fernandes, KS; Dorta, ML; Alonso, A				Camargos, Heverton Silva; Moreira, Rodrigo Alves; Mendanha, Sebastiao Antonio; Fernandes, Kelly Souza; Dorta, Miriam Leandro; Alonso, Antonio			Terpenes Increase the Lipid Dynamics in the Leishmania Plasma Membrane at Concentrations Similar to Their IC50 Values	PLOS ONE			English	Article							SPIN-LABELED LIPIDS; STRATUM-CORNEUM; CANCER CHEMOPREVENTION; ERYTHROCYTE-MEMBRANE; PROTEIN DYNAMICS; MILTEFOSINE; AMAZONENSIS; COMPONENTS; MONOTERPENES; BREAST	Although many terpenes have shown antitumor, antibacterial, antifungal, and antiparasitic activity, the mechanism of action is not well established. Electron paramagnetic resonance (EPR) spectroscopy of the spin-labeled 5-doxyl stearic acid revealed remarkable fluidity increases in the plasma membrane of terpene-treated Leishmania amazonensis promastigotes. For an antiproliferative activity assay using 5x10(6) parasites/mL, the sesquiterpene nerolidol and the monoterpenes(+)-limonene, alpha-terpineol and 1,8-cineole inhibited the growth of the parasites with IC50 values of 0.008, 0.549, 0.678 and 4.697 mM, respectively. The IC50 values of these terpenes increased as the parasite concentration used in the cytotoxicity assay increased, and this behavior was examined using a theoretical treatment of the experimental data. Cytotoxicity tests with the same parasite concentration as in the EPR experiments revealed a correlation between the IC50 values of the terpenes and the concentrations at which they altered the membrane fluidity. In addition, the terpenes induced small amounts of cell lysis (4-9%) at their respective IC50 values. For assays with high cell concentrations (2 x 10(9) parasites/mL), the incorporation of terpene into the cell membrane was very fast, and the IC50 values observed for 24 h and 5 min-incubation periods were not significantly different. Taken together, these results suggest that terpene cytotoxicity is associated with the attack on the plasma membrane of the parasite. The in vitro cytotoxicity of nerolidol was similar to that of miltefosine, and nerolidol has high hydrophobicity; thus, nerolidol might be used in drug delivery systems, such as lipid nanoparticles to treat leishmaniasis.	[Camargos, Heverton Silva; Moreira, Rodrigo Alves; Mendanha, Sebastiao Antonio; Fernandes, Kelly Souza; Alonso, Antonio] Univ Fed Goias, Inst Fis, Goiania, Go, Brazil; [Camargos, Heverton Silva] Fundacao Univ Fed Tocantins, Palmas, TO, Brazil; [Dorta, Miriam Leandro] Univ Fed Goias, Dept Imunol & Patol Geral, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal do Tocantins (UFT); Universidade Federal de Goias	Alonso, A (corresponding author), Univ Fed Goias, Inst Fis, Goiania, Go, Brazil.	alonso@ufg.br	Mendanha, Sebastião A/E-4523-2013; Alonso, Antonio/I-8969-2012	Mendanha, Sebastião A/0000-0002-9545-5248; Alonso, Antonio/0000-0003-4768-6372	Brazilian research funding agency CNPq; Brazilian research funding agency CAPES; Brazilian research funding agency FAPEG; CAPES; CNPq	Brazilian research funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian research funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian research funding agency FAPEG; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by grants from the Brazilian research funding agencies CNPq, CAPES and FAPEG. Rodrigo A. Moreira, Sebastiao Antonio Mendanha and Kelly Souza Fernandes are recipients of fellowships from CAPES. Antonio Alonso is the recipient of a research grant from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 1997, BBA-BIOMEMBRANES, V1323, P75, DOI 10.1016/S0005-2736(96)00177-0; Alonso L, 2012, INT J PHARMACEUT, V434, P391, DOI 10.1016/j.ijpharm.2012.06.006; Arruda DC, 2005, ANTIMICROB AGENTS CH, V49, P1679, DOI 10.1128/AAC.49.5.1679-1687.2005; Arruda DC, 2009, BIOMED PHARMACOTHER, V63, P643, DOI 10.1016/j.biopha.2009.02.004; Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Camargos HS, 2013, QUIM NOVA, V36, P815, DOI 10.1590/S0100-40422013000600013; Camargos HS, 2010, LIPIDS, V45, P419, DOI 10.1007/s11745-010-3407-2; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Crowell PL, 1999, J NUTR, V129, p775S, DOI 10.1093/jn/129.3.775S; Desoti VC, 2012, MAR DRUGS, V10, P1631, DOI 10.3390/md10081631; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; dos Anjos JLV, 2007, INT J PHARMACEUT, V345, P81, DOI 10.1016/j.ijpharm.2007.05.041; dos Santos AO, 2013, MEM I OSWALDO CRUZ, V108, P59, DOI 10.1590/S0074-02762013000100010; Gould MN, 1997, ENVIRON HEALTH PERSP, V105, P977, DOI 10.2307/3433313; Greay SJ, 2010, CANCER CHEMOTH PHARM, V65, P877, DOI 10.1007/s00280-009-1093-7; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Laxmi Y, 2007, CANCER LETT, V257, P216, DOI 10.1016/j.canlet.2007.07.020; Maciel-Rezende CM, 2013, BIOORGAN MED CHEM, V21, P3114, DOI 10.1016/j.bmc.2013.03.045; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Mendanha SA, 2013, TOXICOL IN VITRO, V27, P323, DOI 10.1016/j.tiv.2012.08.022; Miguel DC, 2007, J ANTIMICROB CHEMOTH, V60, P526, DOI 10.1093/jac/dkm219; Moreira RA, 2014, ANTIMICROB AGENTS CH, V58, P3021, DOI 10.1128/AAC.01332-13; Moreira RA, 2013, J PHARM SCI-US, V102, P1661, DOI 10.1002/jps.23496; Olagnier D, 2007, BIOORG MED CHEM LETT, V17, P6075, DOI 10.1016/j.bmcl.2007.09.056; Oliva B, 2003, LETT APPL MICROBIOL, V37, P185, DOI 10.1046/j.1472-765X.2003.01375.x; de Oliveira MAP, 2010, REV INST MED TROP SP, V52, P83, DOI 10.1590/S0036-46652010000200004; Rabi T, 2009, BREAST CANCER RES TR, V115, P223, DOI 10.1007/s10549-008-0118-y; Sharma M, 2013, J MED CHEM, V56, P4374, DOI 10.1021/jm400053v; Thoppil RJ, 2011, WORLD J HEPATOL, V3, P228, DOI 10.4254/wjh.v3.i9.228; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Anjos JLV, 2011, COLLOID SURFACE B, V88, P463, DOI 10.1016/j.colsurfb.2011.07.030; Dos Anjos JLV, 2008, INT J PHARMACEUT, V350, P103, DOI 10.1016/j.ijpharm.2007.08.024; dos Anjos JLV, 2007, EUR J PHARM BIOPHARM, V67, P406, DOI 10.1016/j.ejpb.2007.02.004; Wu CS, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/818261; Yang HJ, 2010, CURR DRUG TARGETS, V11, P733, DOI 10.2174/138945010791170842	37	49	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104429	10.1371/journal.pone.0104429	http://dx.doi.org/10.1371/journal.pone.0104429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101672	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900062
J	Mu, XW; Pan, C; Zheng, SY; Alhamdi, Y; Sun, BW; Shi, QK; Wang, X; Sun, ZW; Toh, C; Wang, GZ				Mu, Xinwei; Pan, Chen; Zheng, Shuyun; Alhamdi, Yasir; Sun, Bingwei; Shi, Qiankun; Wang, Xiang; Sun, Zhiwei; Toh, Chenghock; Wang, Guozheng			Protective Effects of Carbon Monoxide-Releasing Molecule-2 on the Barrier Function of Intestinal Epithelial Cells	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; HEME OXYGENASE; KAPPA-B; RAT; SEPSIS; MICE; INDUCTION; INCREASE; SYSTEM; TRANSLOCATION	Objective: To investigate the protective effects and mechanisms of carbon monoxide-releasing molecule-2 (CORM-2) on barrier function of intestinal epithelial cells. Materials and Methods: After pre-incubation with CORM-2 for 1 hour, cultured intestinal epithelial IEC-6 cells were stimulated with 50 mg/ml lipopolysaccharides (LPS). Cytokines levels in culture medium were detected using ELISA kits. Trans-epithelial electrical resistance (TER) of IEC-6 cell monolayers in Transwells were measured with a Millipore electric resistance system (ERS-2; Millipore) and calculated as Omega/cm(2) at different time points after LPS treatment. The permeability changes were also measured using FITC-dextran. The levels of tight junction (TJ) proteins (occludin and ZO-1) and myosin light chain (MLC) phosphorylation were detected using Western blotting with specific antibodies. The subsequent structural changes of TJ were visualized using transmission electron microscopy (TEM). Results: CORM-2 significantly reduced LPS-induced secretion of TNF-alpha and IL-1 beta. The LPS-induced decrease of TER and increase of permeability to FITC-dextran were inhibited by CORM-2 in a concentration dependent manner (P < 0.05). LPS-induced reduction of tight junction proteins and increase of MLC phosphorylation were also attenuated. In LPS-treated cells, TEM showed diminished electron-dense material and interruption of TJ and desmosomes between the apical lateral margins of adjoining cells, which were prevented by CORM-2 treatment. Conclusions: The present study demonstrates that CORM-2, as a novel CO-releasing molecule, has ability to protect the barrier function of LPS-stimulated intestinal epithelial cells. Inhibition of inflammatory cytokines release, restoration of TJ proteins and suppression of MLC phosphorylation are among the protective effects of CORM-2.	[Mu, Xinwei; Zheng, Shuyun; Shi, Qiankun; Wang, Xiang] Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, Nanjiang, Jiangsu, Peoples R China; [Pan, Chen] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Crit Care Med, Nanjiang, Jiangsu, Peoples R China; [Alhamdi, Yasir; Toh, Chenghock; Wang, Guozheng] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Sun, Bingwei] Jiangsu Univ, Affiliated Hosp, Dept Burn & Plast Surg, Zhenjiang, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; University of Liverpool; Jiangsu University	Zheng, SY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, Nanjiang, Jiangsu, Peoples R China.	syzheng915@163.com			National Natural Science Foundation of China [81171786, 81272148, 81071546]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal0/default.htm), No. 81171786, 81272148 and No. 81071546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Al-Sadi RM, 2007, J IMMUNOL, V178, P4641, DOI 10.4049/jimmunol.178.7.4641; ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012; Becker JC, 2003, BIOCHEM BIOPH RES CO, V312, P507, DOI 10.1016/j.bbrc.2003.10.146; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Bogatcheva NV, 2011, J CELL PHYSIOL, V226, P3132, DOI 10.1002/jcp.22669; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; de Plaen IG, 2002, IMMUNOLOGY, V106, P577, DOI 10.1046/j.1365-2567.2002.01453.x; Donato RP, 2011, METHODS MOL BIOL, V763, P115, DOI 10.1007/978-1-61779-191-8_8; Fei DS, 2012, TRANSL RES, V159, P99, DOI 10.1016/j.trsl.2011.10.009; Foresti R, 2004, BRIT J PHARMACOL, V142, P453, DOI 10.1038/sj.bjp.0705825; Garcia-Arnandis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024591; GOSCHE JR, 1990, ARCH SURG-CHICAGO, V125, P1573; Guo Y, 2007, PHARM RES-DORDR, V24, P1824, DOI 10.1007/s11095-007-9309-1; Hervera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043693; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Ince C, 2004, CRIT CARE MED, V32, P1963, DOI 10.1097/01.CCM.0000139617.88704.B9; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Katada K, 2010, INFLAMMATION, V33, P92, DOI 10.1007/s10753-009-9162-y; Kimura H, 1997, J CELL PHYSIOL, V171, P284, DOI 10.1002/(SICI)1097-4652(199706)171:3<284::AID-JCP6>3.0.CO;2-K; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; MADARA JL, 1987, AM J PHYSIOL, V253, pC171, DOI 10.1152/ajpcell.1987.253.1.C171; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Scharte M, 2000, BIOCHEM BIOPH RES CO, V267, P423, DOI 10.1006/bbrc.1999.1936; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Steidle J, 2011, AM J PHYSIOL-GASTR L, V300, pG207, DOI 10.1152/ajpgi.00407.2010; Sun BW, 2008, INT J BIOL SCI, V4, P270; Sun BW, 2008, INT J BIOL SCI, V4, P176; Takasuka H, 2011, J PHARMACOL EXP THER, V337, P293, DOI 10.1124/jpet.110.175216; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Tsoyi K, 2009, MOL PHARMACOL, V76, P173, DOI 10.1124/mol.109.055137; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Wei YW, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-42; Willis D, 2000, J PATHOL, V190, P627; Xiao WD, 2011, MOL CELL NEUROSCI, V46, P527, DOI 10.1016/j.mcn.2010.12.007; Yuhan R, 1997, GASTROENTEROLOGY, V113, P1873, DOI 10.1016/S0016-5085(97)70006-4	41	13	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104032	10.1371/journal.pone.0104032	http://dx.doi.org/10.1371/journal.pone.0104032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101775	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900031
J	Zhao, YH; Ye, XR; Su, YT; Sun, LF; She, FF; Wu, YK				Zhao, Yanhe; Ye, Xianren; Su, Yintao; Sun, Lifang; She, Feifei; Wu, Yunkun			Crystal Structure Confirmation of JHP933 as a Nucleotidyltransferase Superfamily Protein from Helicobacter pylori Strain J99	PLOS ONE			English	Article							PLASTICITY REGION; GENE; CLASSIFICATION; IDENTIFICATION; VIRULENCE; FAMILIES; GENOME; ISLAND	Helicobacter pylori is a well-known pathogen involved in the development of peptic ulcer, gastric adenocarcinoma and other forms of gastric cancer. Recently, there has been more considerable interest in strain-specific genes located in plasticity regions with great genetic variability. However, little is known about many of these genes. Studies suggested that certain genes in this region may play key roles in the pathogenesis of H. pylori-associated gastroduodenal diseases. JHP933, a conserved putative protein of unknown function, is encoded by the gene in plasticity region of H. pylori strain J99. Here we have determined the structure of JHP933. Our work demonstrates that JHP933 is a nucleotidyltransferase superfamily protein with a characteristic alpha beta alpha beta alpha beta alpha topology. A superposition demonstrates overall structural homology of the JHP933 N-terminal fragment with lincosamide antibiotic adenylyltransferase LinA and identifies a possible substrate-binding cleft of JHP933. Furthermore, through structural comparison with LinA and LinB, we pinpoint conservative active site residues which may contribute to divalent ion coordination and substrate binding.	[Zhao, Yanhe; Su, Yintao; Sun, Lifang; Wu, Yunkun] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Ye, Xianren; She, Feifei] Fujian Med Univ, Sch Basic Med Sci, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Fujian Medical University	She, FF (corresponding author), Fujian Med Univ, Sch Basic Med Sci, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Fujian, Peoples R China.	shefeifei@yeah.net; wuyk@fjirsm.ac.cn			National Nature Science Foundation of China [31270790, 81271784]; Fujian Province [2012Y0070]; Nature Science Foundation of Fujian Province [2013J01151, 2012J01130]; Fujian Medical University [09ZD018]; National Thousand Talents Program of China; Scientific Research Starting Foundation for Returned Overseas Chinese Scholars of State Human Resource Ministry of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province; Nature Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fujian Medical University; National Thousand Talents Program of China; Scientific Research Starting Foundation for Returned Overseas Chinese Scholars of State Human Resource Ministry of China	The National Nature Science Foundation of China (31270790, 81271784), Key Project of Fujian Province (2012Y0070), the Nature Science Foundation of Fujian Province (2013J01151, 2012J01130), Key Project of Science Research in Fujian Medical University (09ZD018), National Thousand Talents Program of China, and Scientific Research Starting Foundation for Returned Overseas Chinese Scholars of State Human Resource Ministry of China for support on this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Blaser MJ, 1997, LANCET, V349, P1020, DOI 10.1016/S0140-6736(96)09133-7; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; de Jonge R, 2004, FEMS IMMUNOL MED MIC, V41, P161, DOI 10.1016/j.femsim.2004.03.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Gonzalez E, 2014, J GASTROENTEROL, V49, P594, DOI 10.1007/s00535-014-0938-y; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Morar M, 2009, STRUCTURE, V17, P1649, DOI 10.1016/j.str.2009.10.013; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rogozin IB, 2003, J MOL BIOL, V326, P1449, DOI 10.1016/S0022-2836(03)00055-X; Salih BA, 2007, INFECT GENET EVOL, V7, P509, DOI 10.1016/j.meegid.2007.03.002; Santos A, 2003, J CLIN MICROBIOL, V41, P1651, DOI 10.1128/JCM.41.4.1651-1655.2003; Toro C, 2001, Rev Esp Quimioter, V14, P172; Wand G, 1998, ANTIMICROB AGENTS CH, V42, P1952, DOI 10.1128/AAC.42.8.1952; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	27	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104609	10.1371/journal.pone.0104609	http://dx.doi.org/10.1371/journal.pone.0104609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101777	gold, Green Submitted, Green Published			2022-12-25	WOS:000339993900079
J	Claes, JM; Partridge, JC; Hart, NS; Garza-Gisholt, E; Ho, HC; Mallefet, J; Collin, SP				Claes, Julien M.; Partridge, Julian C.; Hart, Nathan S.; Garza-Gisholt, Eduardo; Ho, Hsuan-Ching; Mallefet, Jerome; Collin, Shaun P.			Photon Hunting in the Twilight Zone: Visual Features of Mesopelagic Bioluminescent Sharks	PLOS ONE			English	Article							GANGLION-CELL TOPOGRAPHY; SPATIAL RESOLVING POWER; RETINAL SPECIALIZATIONS; EYES; PIGMENTS; PHOTORECEPTOR; LUMINESCENCE; FISHES; VISION; LAYER	The mesopelagic zone is a visual scene continuum in which organisms have developed various strategies to optimize photon capture. Here, we used light microscopy, stereology-assisted retinal topographic mapping, spectrophotometry and microspectrophotometry to investigate the visual ecology of deep-sea bioluminescent sharks [four etmopterid species (Etmopterus lucifer, E. splendidus, E. spinax and Trigonognathus kabeyai) and one dalatiid species (Squaliolus aliae)]. We highlighted a novel structure, a translucent area present in the upper eye orbit of Etmopteridae, which might be part of a reference system for counterillumination adjustment or acts as a spectral filter for camouflage breaking, as well as several ocular specialisations such as aphakic gaps and semicircular tapeta previously unknown in elasmobranchs. All species showed pure rod hexagonal mosaics with a high topographic diversity. Retinal specialisations, formed by shallow cell density gradients, may aid in prey detection and reflect lifestyle differences; pelagic species display areae centrales while benthopelagic and benthic species display wide and narrow horizontal streaks, respectively. One species (E. lucifer) displays two areae within its horizontal streak that likely allows detection of conspecifics' elongated bioluminescent flank markings. Ganglion cell topography reveals less variation with all species showing a temporal area for acute frontal binocular vision. This area is dorsally extended in T. kabeyai, allowing this species to adjust the strike of its peculiar jaws in the ventro-frontal visual field. Etmopterus lucifer showed an additional nasal area matching a high rod density area. Peak spectral sensitivities of the rod visual pigments (lambda(max)) fall within the range 484-491 nm, allowing these sharks to detect a high proportion of photons present in their habitat. Comparisons with previously published data reveal ocular differences between bioluminescent and non-bioluminescent deep-sea sharks. In particular, bioluminescent sharks possess higher rod densities, which might provide them with improved temporal resolution particularly useful for bioluminescent communication during social interactions.	[Claes, Julien M.; Mallefet, Jerome] Catholic Univ Louvain, Earth & Life Inst, Marine Biol Lab, Louvain La Neuve, Belgium; [Partridge, Julian C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Partridge, Julian C.; Hart, Nathan S.; Garza-Gisholt, Eduardo; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Neuroecol Grp, Crawley, WA, Australia; [Partridge, Julian C.; Hart, Nathan S.; Garza-Gisholt, Eduardo; Collin, Shaun P.] Univ Western Australia, UWA Oceans Inst, Crawley, WA, Australia; [Ho, Hsuan-Ching] Natl Museum Marine Biol, Checheng, Taiwan; [Ho, Hsuan-Ching] Aquarium, Checheng, Taiwan; [Ho, Hsuan-Ching] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Shoufeng, Taiwan	Universite Catholique Louvain; University of Bristol; University of Western Australia; University of Western Australia; National Museum of Marine Biology & Aquarium; National Dong Hwa University	Claes, JM (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Marine Biol Lab, Louvain La Neuve, Belgium.	julien.m.claes@uclouvain.be	Hart, Nathan S/B-8564-2011; Partridge, Julian C/F-2097-2014; Collin, Shaun/K-8827-2012	Hart, Nathan S/0000-0002-7289-9399; Partridge, Julian C/0000-0003-3788-2900; Collin, Shaun/0000-0001-6236-0771; mallefet, jerome/0000-0003-0918-3491; Garza-Gisholt, Eduardo/0000-0002-2353-6612	Fonds National de la Recherche Scientifique (FNRS, Belgium) through a Fonds de la Recherche Fondamentale Collective grant [FRFC - 2.4525.12]; Australian Research Council [DP110103294]; Western Australian State Government; National Museum of Marine Biology and Aquarium	Fonds National de la Recherche Scientifique (FNRS, Belgium) through a Fonds de la Recherche Fondamentale Collective grant(Fonds de la Recherche Scientifique - FNRS); Australian Research Council(Australian Research Council); Western Australian State Government; National Museum of Marine Biology and Aquarium	Financial support (specimen collection, open access fee) was provided by the Fonds National de la Recherche Scientifique (FNRS, Belgium) (http://www.fnrs.be) through a Fonds de la Recherche Fondamentale Collective grant (FRFC - 2.4525.12) and travel grants to JMC (postdoctoral researcher at FNRS) and JM (research associate at FNRS). Part of the research (data collection and analysis) was supported by an Australian Research Council (http://www.arc.gov.au) grant (DP110103294) to SPC, NSH and others, the Western Australian State Government (http://wa.gov.au) to SPC, and the National Museum of Marine Biology and Aquarium (http://www.nmmba.gov.tw/english/index.aspx) to HCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Bernal D, 2005, NATURE, V437, P1349, DOI 10.1038/nature04007; Bozzano A, 2000, BRAIN BEHAV EVOLUT, V55, P191, DOI 10.1159/000006652; Bozzano A, 2001, J FISH BIOL, V59, P1258, DOI 10.1006/jfbi.2001.1737; Claes JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04328; Claes JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01308; Claes JM, 2012, J EXP BIOL, V215, P1691, DOI 10.1242/jeb.066704; Claes JM, 2011, J EXP MAR BIOL ECOL, V406, P1, DOI 10.1016/j.jembe.2011.05.033; Claes JM, 2010, J EXP MAR BIOL ECOL, V388, P28, DOI 10.1016/j.jembe.2010.03.009; Claes JM, 2010, J EXP BIOL, V213, P1852, DOI 10.1242/jeb.041947; Claes JM, 2009, ZOOLOGY, V112, P433, DOI 10.1016/j.zool.2009.02.003; Claes JM, 2009, J EXP BIOL, V212, P3684, DOI 10.1242/jeb.034363; Coimbra JP, 2006, BRAIN BEHAV EVOLUT, V68, P15, DOI 10.1159/000092310; Coimbra JP, 2013, J COMP NEUROL, V521, P2042, DOI 10.1002/cne.23271; Collin S.P., 1999, P509; Collin SP, 2008, CLIN EXP OPTOM, V91, P85, DOI 10.1111/j.1444-0938.2007.00228.x; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P269, DOI 10.1159/000116594; Collin SP, 1996, J FISH BIOL, V49, P157, DOI 10.1111/j.1095-8649.1996.tb06073.x; CORNWALL MC, 1989, J GEN PHYSIOL, V94, P633, DOI 10.1085/jgp.94.4.633; Crescitelli F, 1991, J EXP ZOOL         S, V5, P66, DOI DOI 10.1002/JEZ.1402560510; CURCIO CA, 1987, VISION RES, V27, P9, DOI 10.1016/0042-6989(87)90137-4; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P256; DENTON EJ, 1957, J MAR BIOL ASSOC UK, V36, P651, DOI 10.1017/S0025315400025911; DOUGLAS RH, 1995, J COMP PHYSIOL A, V177, P111; DOUGLAS RH, 1992, J MAR BIOL ASSOC UK, V72, P93, DOI 10.1017/S0025315400048815; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; Douglas Ronald H., 2003, P323, DOI 10.1007/978-0-387-22628-6_17; Dun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078087; Ebert DA, 2013, SHARKS WORLD, P256; Fritsches KA, 2005, CURR BIOL, V15, P55, DOI 10.1016/j.cub.2004.12.064; Fritsches KA, 2003, MAR FRESHWATER RES, V54, P333, DOI 10.1071/MF02126; Garza-Gisholt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093485; Glaser EM, 1998, J MICROSC-OXFORD, V192, P163, DOI 10.1046/j.1365-2818.1998.00417.x; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; GRUBER SH, 1975, COPEIA, P378; Hart Nathan S., 2006, P337; Hart NS, 2012, J COMP NEUROL, V520, P1246, DOI 10.1002/cne.22784; Hart NS, 2011, NATURWISSENSCHAFTEN, V98, P193, DOI 10.1007/s00114-010-0758-8; Heidler S, 2006, ELASMOKOP, V10, P2; HERRING PJ, 1983, PROC R SOC SER B-BIO, V220, P183, DOI 10.1098/rspb.1983.0095; HERRING PJ, 1982, OCEANOGR MAR BIOL, V20, P415; Johnsen S. N., 2012, OPTICS LIFE BIOL GUI; Johnsen S, 2014, ANNU REV MAR SCI, V6, P369, DOI 10.1146/annurev-marine-010213-135018; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Land M.F., 1981, HDB SENSORY PHYSL; Land MF, 2002, ANIMAL EYES; Landgren E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0039; Lisney TJ, 2008, BRAIN BEHAV EVOLUT, V72, P59, DOI 10.1159/000146082; Lisney TJ, 2007, BRAIN BEHAV EVOLUT, V69, P266, DOI 10.1159/000100036; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; Litherland L, 2009, VISUAL NEUROSCI, V26, P397, DOI 10.1017/S0952523809990150; LOCKET NA, 1985, PROC R SOC SER B-BIO, V224, P7, DOI 10.1098/rspb.1985.0018; MACNICHOL EF, 1986, VISION RES, V26, P1543, DOI 10.1016/0042-6989(86)90174-4; Marshall N. B., 1954, ASPECTS DEEP SEA BIO; MCNULTY JA, 1976, J MORPHOL, V150, P579; MOCHIZUKI K, 1990, JPN J ICHTHYOL, V36, P385, DOI 10.1007/BF02905456; Munk O., 1980, HVIRVELDYROJET BYGNI; MUNTZ WRA, 1976, J MAR BIOL ASSOC UK, V56, P963, DOI 10.1017/S0025315400021019; MUNZ FW, 1958, J GEN PHYSIOL, V42, P445, DOI 10.1085/jgp.42.2.445; Musick JA, 2004, CRC MAR BIOL SER, P33; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Neiva J, 2006, J MAR BIOL ASSOC UK, V86, P835, DOI 10.1017/S0025315406013762; Newman AS, 2013, BRAIN BEHAV EVOLUT, V82, P237, DOI 10.1159/000355370; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; REIF WE, 1985, ACTA ZOOL-STOCKHOLM, V66, P111, DOI 10.1111/j.1463-6395.1985.tb00829.x; Renwart M, 2013, J EXP MAR BIOL ECOL, V448, P214, DOI 10.1016/j.jembe.2013.07.010; Schieber NL, 2012, J MORPHOL, V273, P423, DOI 10.1002/jmor.11033; SEIGEL JA, 1978, COPEIA, P602; Shimomura O, 2012, BIOLUMINESCENCE CHEM; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Stone J, 1981, WHOLE MOUNT HDB GUID; Straube N, 2010, MOL PHYLOGENET EVOL, V56, P905, DOI 10.1016/j.ympev.2010.04.042; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Warrant E, 2000, PHILOS T ROY SOC B, V355, P1155, DOI 10.1098/rstb.2000.0658; Warrant E, 1992, NONLINEAR VISION, P391; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Warrant Eric J., 2003, P303, DOI 10.1007/978-0-387-22628-6_16; Wetherbee Bradley M., 2000, Pacific Science, V54, P389; Yano K, 2003, ICHTHYOL RES, V50, P251, DOI 10.1007/s10228-003-0165-7; Yano K, 2007, ICHTHYOL RES, V54, P388, DOI 10.1007/s10228-007-0414-2; YOUNG RE, 1979, MAR BIOL, V51, P371, DOI 10.1007/BF00389215; YOUNG RE, 1980, DEEP-SEA RES, V27, P671, DOI 10.1016/0198-0149(80)90022-9; YOUNG RE, 1973, PAC SCI, V27, P1	88	16	16	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104213	10.1371/journal.pone.0104213	http://dx.doi.org/10.1371/journal.pone.0104213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099504	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100052
J	Arnold, WH; Heidt, BA; Kuntz, S; Naumova, EA				Arnold, Wolfgang H.; Heidt, Bastian A.; Kuntz, Sebastian; Naumova, Ella A.			Effects of Fluoridated Milk on Root Dentin Remineralization	PLOS ONE			English	Article							CARIES; ENAMEL; BIOFILM	Background: The prevalence of root caries is increasing with greater life expectancy and number of retained teeth. Therefore, new preventive strategies should be developed to reduce the prevalence of root caries. The aim of this study was to investigate the effects of fluoridated milk on the remineralization of root dentin and to compare these effects to those of sodium fluoride (NaF) application without milk. Methods: Thirty extracted human molars were divided into 6 groups, and the root cementum was removed from each tooth. The dentin surface was demineralized and then incubated with one of the following six solutions: Sodium chloride NaCl, artificial saliva, milk, milk+2.5 ppm fluoride, milk+10 ppm fluoride and artificial saliva+10 ppm fluoride. Serial sections were cut through the lesions and investigated with polarized light microscopy and quantitative morphometry, scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). The data were statistically evaluated using a one-way ANOVA for multiple comparisons. Results: The depth of the lesion decreased with increasing fluoride concentration and was the smallest after incubation with artificial saliva+10 ppm fluoride. SEM analysis revealed a clearly demarcated superficial remineralized zone after incubation with milk+2.5 ppm fluoride, milk+10 ppm fluoride and artificial saliva+10 ppm fluoride. Ca content in this zone increased with increasing fluoride content and was highest after artificial saliva+10 ppm fluoride incubation. In the artificial saliva+10 ppm fluoride group, an additional crystalline layer was present on top of the lesion that contained elevated levels of F and Ca. Conclusion: Incubation of root dentin with fluoridated milk showed a clear effect on root dentin remineralization, and incubation with NaF dissolved in artificial saliva demonstrated a stronger effect.	[Arnold, Wolfgang H.; Heidt, Bastian A.; Kuntz, Sebastian; Naumova, Ella A.] Univ Witten Herdecke, Sch Dent, Fac Hlth, Dept Biol & Mat Sci Dent, Witten, Germany	Witten Herdecke University	Arnold, WH (corresponding author), Univ Witten Herdecke, Sch Dent, Fac Hlth, Dept Biol & Mat Sci Dent, Witten, Germany.	wolfgang.arnold@uni-wh.de			Witten/Herdecke University	Witten/Herdecke University	This study was funded by Witten/Herdecke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold WH, 2003, ANN ANAT, V185, P419, DOI 10.1016/S0940-9602(03)80099-7; Arnold WH, 2003, ARCH ORAL BIOL, V48, P467, DOI 10.1016/S0003-9969(03)00087-6; Arnold Wolfgang H, 2007, J Prosthodont, V16, P445, DOI 10.1111/j.1532-849X.2007.00220.x; Arnold WH, 2007, ARCH ORAL BIOL, V52, P591, DOI 10.1016/j.archoralbio.2006.11.008; Arnold Wolfgang H., 2006, Biomedical Papers (Olomouc), V150, P63; BANOCZY J, 1985, J ROY SOC HEALTH, V105, P99, DOI 10.1177/146642408510500304; Darling A. I., 1956, BRIT DENT J, V101, P289; Engstrom K, 2006, CLIN ORAL INVEST, V10, P249, DOI 10.1007/s00784-006-0053-4; Espelid I, 2009, EUR ARCH PAEDIATR DE, V10, P149, DOI 10.1007/BF03262676; Fejerskov O, 1997, COMMUNITY DENT ORAL, V25, P5, DOI 10.1111/j.1600-0528.1997.tb00894.x; Giacaman RA, 2012, CARIES RES, V46, P460, DOI 10.1159/000339428; Gokalp S, 2012, COMMUNITY DENT HLTH, V29, P233, DOI 10.1922/CDH_2733Gokalp06; Itthagarun A, 2011, J DENT, V39, P817, DOI 10.1016/j.jdent.2011.08.016; Ivancakova R, 2005, SPEC CARE DENT, V25, P118, DOI 10.1111/j.1754-4505.2005.tb01421.x; Ivanova K, 1995, Adv Dent Res, V9, P120; Marinho VCC, 2009, EUR ARCH PAEDIATR DE, V10, P183, DOI 10.1007/BF03262681; Maslak EE, 2005, CARIES RES, V38, P377; Naumova EA, 2012, J DENT, V40, P750, DOI 10.1016/j.jdent.2012.05.006; Naumova EA, 2012, ARCH ORAL BIOL, V57, P870, DOI 10.1016/j.archoralbio.2012.01.011; Naumova EA, 2010, CENT EUR J MED, V5, P375, DOI 10.2478/s11536-010-0002-0; Neuhaus Klaus, 2005, Schweiz Monatsschr Zahnmed, V115, P1019; NYVAD B, 1982, INT DENT J, V32, P312; Pakhomov G N, 1995, Adv Dent Res, V9, P110; Ravald N, 2012, J CLIN PERIODONTOL, V39, P73, DOI 10.1111/j.1600-051X.2011.01811.x; Riley JC, 2005, COMMUNITY DENT HLTH, V22, P141; Ritter AV, 2010, COMMUNITY DENT ORAL, V38, P383, DOI 10.1111/j.1600-0528.2010.00551.x; Sanchez-Garcia S, 2011, COMMUNITY DENT ORAL, V39, P44, DOI 10.1111/j.1600-0528.2010.00569.x; Silverstone L M, 1968, Br Dent J, V125, P145; Silverstone L M, 1967, Caries Res, V1, P260; Silverstone L M, 1973, Oral Sci Rev, V3, P100; STEPHEN KW, 1984, COMMUNITY DENT ORAL, V12, P223, DOI 10.1111/j.1600-0528.1984.tb01444.x; Sugihara Naoki, 2010, Bull Tokyo Dent Coll, V51, P23; Walls A W G, 2012, Adv Dent Res, V24, P36, DOI 10.1177/0022034512453590; Yeung CA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003876.pub2; Zimmer Stefan, 2003, Oral Health Prev Dent, V1, P45	35	12	12	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104327	10.1371/journal.pone.0104327	http://dx.doi.org/10.1371/journal.pone.0104327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093506	Green Submitted, gold, Green Published			2022-12-25	WOS:000341357200095
J	Petri, RM; Mapiye, C; Dugan, MER; McAllister, TA				Petri, Renee M.; Mapiye, Cletos; Dugan, Mike E. R.; McAllister, Tim A.			Subcutaneous Adipose Fatty Acid Profiles and Related Rumen Bacterial Populations of Steers Fed Red Clover or Grass Hay Diets Containing Flax or Sunflower-Seed	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FORAGE CONSERVATION METHOD; LIPID-METABOLISM; FEEDING FLAXSEED; VACCENIC ACID; LINSEED OIL; RUMINAL BIOHYDROGENATION; EXTRUDED SEEDS; ROLLED SEEDS; CANCER-CELLS	Steers were fed 70:30 forage:concentrate diets for 205 days, with either grass hay (GH) or red clover silage (RC), and either sunflower-seed (SS) or flaxseed (FS), providing 5.4% oil in the diets. Compared to diets containing SS, FS diets had elevated (P<0.05) subcutaneous trans (t)-18:1 isomers, conjugated linoleic acids and n-6 polyunsaturated fatty acid (PUFA). Forage and oilseed type influenced total n-3 PUFA, especially alpha-linolenic acid (ALA) and total non-conjugated diene biohydrogenation (BH) in subcutaneous fat with proportions being greater (P<0.05) for FS or GH as compared to SS or RC. Of the 25 bacterial genera impacted by diet, 19 correlated with fatty acids (FA) profile. Clostridium were most abundant when levels of conjugated linolenic acids, and n-3 PUFA's were found to be the lowest in subcutaneous fat, suggestive of their role in BH. Anerophaga, Fibrobacter, Guggenheimella, Paludibacter and Pseudozobellia were more abundant in the rumen when the levels of VA in subcutaneous fat were low. This study clearly shows the impact of oilseeds and forage source on the deposition of subcutaneous FA in beef cattle. Significant correlations between rumen bacterial genera and the levels of specific FA in subcutaneous fat maybe indicative of their role in determining the FA profile of adipose tissue. However, despite numerous correlations, the dynamics of rumen bacteria in the BH of unsaturated fatty acid and synthesis of PUFA and FA tissue profiles require further experimentation to determine if these correlations are consistent over a range of diets of differing composition. Present results demonstrate that in order to achieve targeted FA profiles in beef, a multifactorial approach will be required that takes into consideration not only the PUFA profile of the diet, but also the non-oil fraction of the diet, type and level of feed processing, and the role of rumen microbes in the BH of unsaturated fatty acid.	[Petri, Renee M.; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Mapiye, Cletos; Dugan, Mike E. R.] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Mapiye, Cletos] Univ Stellenbosch, Fac AgriSci, Dept Anim Sci, Matieland, Western Cape, South Africa	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Stellenbosch University	McAllister, TA (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca	Petri, Renee Maxine/J-6102-2019; Mapiye, Cletos/K-9309-2016; McAllister, Tim A./R-9201-2017	Petri, Renee Maxine/0000-0002-8209-8261; Mapiye, Cletos/0000-0002-1474-8648; McAllister, Tim A./0000-0002-8266-6513	Alberta Meat and Livestock Agency (ALMA); NSERC through ALMA	Alberta Meat and Livestock Agency (ALMA); NSERC through ALMA	This work was financed by the Alberta Meat and Livestock Agency (ALMA). Dr. C. Mapiye acknowledges the receipt of NSERC Fellowships funded through ALMA (alma.alberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuGhazaleh AA, 2007, ANIM FEED SCI TECH, V136, P11, DOI 10.1016/j.anifeedsci.2006.08.020; AbuGhazaleh AA, 2002, J DAIRY SCI, V85, P2266, DOI 10.3168/jds.S0022-0302(02)74306-3; Aldai N, 2009, CAN J ANIM SCI, V89, P315, DOI 10.4141/CJAS08126; [Anonymous], 1993, GUIDE CARE USE EXPT; Basarab JA, 2007, CAN J ANIM SCI, V87, P71, DOI 10.4141/A06-048; Bernard L, 2009, J DAIRY SCI, V92, P6083, DOI 10.3168/jds.2009-2048; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; BRETHOUR JR, 1992, J ANIM SCI, V70, P1039, DOI 10.2527/1992.7041039x; Chow TT, 2004, ANIM FEED SCI TECH, V117, P1, DOI 10.1016/j.anifeedsci.2004.08.008; Crumb D. J., 2011, International Journal of Applied Research in Natural Products, V4, P12; Cruz-Hernandez C, 2004, J AOAC INT, V87, P545; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Doreau M, 2009, ANIM FEED SCI TECH, V150, P187, DOI 10.1016/j.anifeedsci.2008.09.004; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; Doreau M, 2009, LIPIDS, V44, P53, DOI 10.1007/s11745-008-3250-x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dugan MER, 2008, CAN J ANIM SCI, V88, P591, DOI 10.4141/CJAS08024; Field CJ, 2009, APPL PHYSIOL NUTR ME, V34, P979, DOI 10.1139/H09-079; Geay Y, 2001, REPROD NUTR DEV, V41, P1, DOI 10.1051/rnd:2001108; Gomez-Cortes P, 2009, J DAIRY SCI, V92, P4122, DOI 10.3168/jds.2008-1909; Gunstone F. D., 1994, LIPID HDB, P101; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P2428, DOI 10.3168/jds.2012-6043; HARFOOT CG, 1973, J SCI FOOD AGR, V24, P961, DOI 10.1002/jsfa.2740240814; He ML, 2012, J ANIM SCI, V90, P592, DOI 10.2527/jas.2011-4281; Hegarty RS, 2004, AUST J EXP AGR, V44, P458, DOI 10.1071/EA02148; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; HOBSON PN, 1965, J GEN MICROBIOL, V38, P167, DOI 10.1099/00221287-38-2-167; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Jacobs AAA, 2011, J DAIRY SCI, V94, P874, DOI 10.3168/jds.2010-3511; Jaudszus A, 2012, BBA-MOL CELL BIOL L, V1821, P1316, DOI 10.1016/j.bbalip.2012.06.010; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; Jeronimo E, 2011, EUR J LIPID SCI TECH, V113, P924, DOI 10.1002/ejlt.201000398; Juarez M, 2011, MEAT SCI, V88, P434, DOI 10.1016/j.meatsci.2011.01.023; Khan NA, 2009, ANIM FEED SCI TECH, V154, P183, DOI 10.1016/j.anifeedsci.2009.09.005; Kim CM, 2009, ASIAN AUSTRAL J ANIM, V22, P1151, DOI 10.5713/ajas.2009.90096; Kong YH, 2010, APPL ENVIRON MICROB, V76, P6933, DOI 10.1128/AEM.00217-10; Kramer JKG, 2008, LIPIDS, V43, P259, DOI 10.1007/s11745-007-3143-4; Lee MRF, 2009, MEAT SCI, V81, P738, DOI 10.1016/j.meatsci.2008.11.016; Lee MRF, 2003, ANIM SCI, V76, P491, DOI 10.1017/S1357729800058719; Lee YJ, 2011, J NUTR, V141, P1445, DOI 10.3945/jn.111.138396; Lock AL, 2002, ANIM SCI, V74, P163, DOI 10.1017/S1357729800052334; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Mapiye C, 2013, MEAT SCI, V95, P98, DOI 10.1016/j.meatsci.2013.03.033; Mapiye C, 2013, LIVEST SCI, V151, P11, DOI 10.1016/j.livsci.2012.10.021; Mapiye C, 2013, CANADIAN J ANIMAL SC, V93, P1; Marin ALM, 2012, J DAIRY SCI, V95, P1942, DOI 10.3168/jds.2011-4303; McKain N, 2010, MICROBIOL-SGM, V156, P579, DOI 10.1099/mic.0.036442-0; McNeill S, 2012, MEAT SCI, V92, P166, DOI 10.1016/j.meatsci.2012.03.014; Narvaez N, 2013, J SCI FOOD AGR, V93, P45, DOI 10.1002/jsfa.5725; Nassu RT, 2011, MEAT SCI, V89, P469, DOI 10.1016/j.meatsci.2011.05.016; Noci F, 2007, J ANIM SCI, V85, P1062, DOI 10.2527/jas.2006-105; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Petri RM, 2012, J APPL MICROBIOL, V112, P1152, DOI 10.1111/j.1365-2672.2012.05295.x; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Raes K, 2004, ANIM FEED SCI TECH, V113, P199, DOI 10.1016/j.anifeedsci.2003.09.001; Raes K, 2003, REPROD NUTR DEV, V43, P331, DOI 10.1051/rnd:2003029; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; RUSSELL JB, 1979, APPL ENVIRON MICROB, V37, P531, DOI 10.1128/AEM.37.3.531-536.1979; Salter AM, 2014, ANIMAL IN PRESS, DOI [10.1017/S1751731111002023, DOI 10.1017/S1751731111002023]; Sarnklong C, 2010, ASIAN AUSTRAL J ANIM, V23, P680, DOI 10.5713/ajas.2010.80619; SAS, 2009, US GUID, VVersion 9.2 ed.; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scollan ND, 2005, EAAP PUBLIC, P151; Shingfield K. J., 2008, ADV EXPT MED BIOL; Shingfield KJ, 2005, J DAIRY RES, V72, P349, DOI 10.1017/S0022029905000919; Sofi F, 2010, NUTR METAB CARDIOVAS, V20, P117, DOI 10.1016/j.numecd.2009.03.004; Van Ranst G, 2011, ANIMAL, V5, P512, DOI 10.1017/S1751731110002028; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wongtangtintharn S, 2004, J NUTR SCI VITAMINOL, V50, P137, DOI 10.3177/jnsv.50.137; Yang ZH, 2000, CANCER RES, V60, P505; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173	74	29	33	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104167	10.1371/journal.pone.0104167	http://dx.doi.org/10.1371/journal.pone.0104167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093808	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200081
J	Horsak, M; Chytry, M				Horsak, Michal; Chytry, Milan			Unimodal Latitudinal Pattern of Land-Snail Species Richness across Northern Eurasian Lowlands	PLOS ONE			English	Article							PLANT DIVERSITY; GLOBAL PATTERNS; GRADIENT; CLIMATE; ENERGY; SCALE; WATER; HABITAT; PRODUCTIVITY; NESTEDNESS	Large-scale patterns of species richness and their causes are still poorly understood for most terrestrial invertebrates, although invertebrates can add important insights into the mechanisms that generate regional and global biodiversity patterns. Here we explore the general plausibility of the climate-based "water-energy dynamics'' hypothesis using the latitudinal pattern of land-snail species richness across extensive topographically homogeneous lowlands of northern Eurasia. We established a 1480-km long latitudinal transect across the Western Siberian Plain (Russia) from the Russia-Kazakhstan border (54.5 degrees N) to the Arctic Ocean (67.5 degrees N), crossing eight latitudinal vegetation zones: steppe, forest-steppe, subtaiga, southern, middle and northern taiga, forest-tundra, and tundra. We sampled snails in forests and open habitats each half-degree of latitude and used generalized linear models to relate snail species richness to climatic variables and soil calcium content measured in situ. Contrary to the classical prediction of latitudinal biodiversity decrease, we found a striking unimodal pattern of snail species richness peaking in the subtaiga and southern-taiga zones between 57 and 59 degrees N. The main south-to-north interchange of the two principal diversity constraints, i.e. drought stress vs. cold stress, explained most of the variance in the latitudinal diversity pattern. Water balance, calculated as annual precipitation minus potential evapotranspiration, was a single variable that could explain 81.7% of the variance in species richness. Our data suggest that the "water-energy dynamics'' hypothesis can apply not only at the global scale but also at subcontinental scales of higher latitudes, as water availability was found to be the primary limiting factor also in this extratropical region with summer-warm and dry climate. A narrow zone with a sharp south-to-north switch in the two main diversity constraints seems to constitute the dominant and general pattern of terrestrial diversity across a large part of northern Eurasia, resulting in a subcontinental diversity hotspot of various taxa in this zone.	[Horsak, Michal; Chytry, Milan] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic	Masaryk University Brno	Horsak, M (corresponding author), Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic.	horsak@sci.muni.cz	Chytrý, Milan/J-4954-2012	Chytrý, Milan/0000-0002-8122-3075; Horsak, Michal/0000-0003-2742-2740	Czech Science Foundation [P504/11/0454]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was funded by the Czech Science Foundation (P504/11/0454). The funders oversaw the collection of data and preparation of the manuscript, but had no role in the study design, data analysis, or decision to publish.	Ansart A, 2003, ACTA OECOL, V24, P95, DOI 10.1016/S1146-609X(03)00045-6; Bannister JR, 2012, AUSTRAL ECOL, V37, P500, DOI 10.1111/j.1442-9993.2011.02312.x; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Cameron RAD, 1991, P 10 INT MAL C, P437; Cameron RAD, 2010, MALACOLOGIA, V53, P77, DOI 10.4002/040.053.0105; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Chown SL, 1998, ECOGRAPHY, V21, P342, DOI 10.1111/j.1600-0587.1998.tb00399.x; Churkina G, 1999, GLOBAL CHANGE BIOL, V5, P46, DOI 10.1046/j.1365-2486.1999.00006.x; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Ehlers J, 2004, QUATERNARY GLACIAT 3; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Hausdorf B, 2003, OECOLOGIA, V135, P102, DOI 10.1007/s00442-002-1142-y; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Horsak M, 2006, J BIOGEOGR, V33, P98, DOI 10.1111/j.1365-2699.2005.01359.x; Horsak M., 2013, MOLLUSCS CZECH SLOVA, DOI DOI 10.1016/j.yqres.2014.01.015; Horsak M, 2008, J BIOGEOGR, V35, P1215, DOI 10.1111/j.1365-2699.2007.01856.x; Horsak M, 2013, POLAR BIOL, V36, P185, DOI 10.1007/s00300-012-1249-5; Horsak Michal, 2003, Malacologica Bohemoslovaca, V2, P11; Hylander K, 2005, OIKOS, V108, P351, DOI 10.1111/j.0030-1299.2005.13400.x; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; Jurickova L, 2008, EUR J SOIL BIOL, V44, P172, DOI 10.1016/j.ejsobi.2007.07.001; Kerney MP, 1983, LANDSCHNECKEN NORDUN; Lennon JJ, 2000, J ANIM ECOL, V69, P581, DOI 10.1046/j.1365-2656.2000.00418.x; Lozek V., 1964, QUARTARMOLLUSKEN TSC; Malyshev LI, 1993, FRAGM FLOR GEOBOT S, V2, P331; Martin K, 2004, J BIOGEOGR, V31, P531, DOI 10.1046/j.1365-2699.2003.01005.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Nekola J. C., 2009, TENTACLE, V17, P26; Nekola Jeffrey C., 2005, Records of the Western Australian Museum Supplement, V68, P39; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; O'Brien EM, 1998, ECOGRAPHY, V21, P495, DOI 10.1111/j.1600-0587.1998.tb00441.x; Pilsbry H. A., 1948, LAND MOLLUSCA N AM 2, V2; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; R Core Team, 2021, R LANG ENV STAT COMP; Riddle WA, 1983, MOLLUSCA, V6, P431; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Schamp B, 2010, J ANIM ECOL, V79, P803, DOI 10.1111/j.1365-2656.2010.01685.x; Skillen EL, 2000, ENVIRON ENTOMOL, V29, P460, DOI 10.1603/0046-225X-29.3.460; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sysoev A., 2009, LAND SNAILS RUSSIA A; Trabucco A, 2008, AGR ECOSYST ENVIRON, V126, P81, DOI 10.1016/j.agee.2008.01.015; von Humboldt A, 1808, ANSICHTEN NATUR WISS; Walter H, 1974, VEGETATION OSTEUROPA; WAREBORN I, 1969, OIKOS, V20, P461, DOI 10.2307/3543209; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Zbiral J, 1995, ANAL PLANT MAT UNIFI	59	9	11	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104035	10.1371/journal.pone.0104035	http://dx.doi.org/10.1371/journal.pone.0104035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090628	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700086
J	Liu, T; Choi, H; Zhou, R; Chen, IW				Liu, Ting; Choi, Hoon; Zhou, Rong; Chen, I-Wei			Quantitative Evaluation of the Reticuloendothelial System Function with Dynamic MRI	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; HEPATOCELLULAR-CARCINOMA; BACTERIAL-INFECTIONS; LIVER; MACROPHAGES; DEPLETION; BLOOD; RELAXIVITY; SEVERITY; BLOCKADE	Purpose: To evaluate the reticuloendothelial system (RES) function by real-time imaging blood clearance as well as hepatic uptake of superparamagnetic iron oxide nanoparticle (SPIO) using dynamic magnetic resonance imaging (MRI) with two-compartment pharmacokinetic modeling. Materials and Methods: Kinetics of blood clearance and hepatic accumulation were recorded in young adult male 01b74 athymic nude mice by dynamic T2* weighted MRI after the injection of different doses of SPIO nanoparticles (0.5, 3 or 10 mg Fe/kg). Association parameter, K-in, dissociation parameter, K-out, and elimination constant, K-e, derived from dynamic data with two-compartment model, were used to describe active binding to Kupffer cells and extrahepatic clearance. The clodrosome and liposome were utilized to deplete macrophages and block the RES function to evaluate the capability of the kinetic parameters for investigation of macrophage function and density. Results: The two-compartment model provided a good description for all data and showed a low sum squared residual for all mice (0.27 +/- 0.03). A lower K-in, a lower K-out and a lower K-e were found after clodrosome treatment, whereas a lower K-in, a higher K-out and a lower K-e were observed after liposome treatment in comparison to saline treatment (P<0.005). Conclusion: Dynamic SPIO-enhanced MR imaging with two-compartment modeling can provide information on RES function on both a cell number and receptor function level.	[Liu, Ting; Zhou, Rong] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Choi, Hoon; Chen, I-Wei] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Liu, T (corresponding author), Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.	tingliu20072008@yahoo.com		Chen, I-Wei/0000-0002-4045-4467	NCATS NIH HHS [UL1TR000003] Funding Source: Medline; NCI NIH HHS [R21 CA198563, R01 CA211337] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Asanuma T, 2010, GUT, V59, P258, DOI 10.1136/gut.2009.176651; BAAS J, 1995, EUR SURG RES, V27, P137, DOI 10.1159/000129392; BIOZZI G, 1958, J LAB CLIN MED, V51, P230; BOLOGNESI M, 1987, EUR J NUCL MED, V13, P254; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bruns OT, 2009, NAT NANOTECHNOL, V4, P193, DOI [10.1038/nnano.2008.405, 10.1038/NNANO.2008.405]; CAPRONLAUDEREAU M, 1987, EUR SURG RES, V19, P388, DOI 10.1159/000128727; FRASER CC, 1995, BLOOD, V86, P183, DOI 10.1182/blood.V86.1.183.bloodjournal861183; GOMEZ F, 1994, NEW ENGL J MED, V331, P1122, DOI 10.1056/NEJM199410273311704; HAMAZAKI K, 1994, RES EXP MED, V194, P237, DOI 10.1007/BF02576385; HOEFS J, 1995, DIGEST DIS SCI, V40, P552, DOI 10.1007/BF02064368; HOEFS JC, 1995, HEPATOLOGY, V22, P1113, DOI 10.1016/0270-9139(95)90617-7; HUET PM, 1976, GASTROENTEROLOGY, V70, P74; Imai Y, 2000, HEPATOLOGY, V32, P205, DOI 10.1053/jhep.2000.9113; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; MANIFOLD IH, 1983, LANCET, V2, P431; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011; Navasa M, 2004, LIVER INT, V24, P277, DOI 10.1111/j.1478-3231.2004.0934.x; Nishie A, 2012, J MAGN RESON IMAGING, V36, P664, DOI 10.1002/jmri.23691; PAIN JA, 1987, BRIT J SURG, V74, P1091, DOI 10.1002/bjs.1800741207; PROFFITT RT, 1983, SCIENCE, V220, P502, DOI 10.1126/science.6836294; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Ross J R, 2004, Health Technol Assess, V8, P1; Schindl MJ, 2006, ANN SURG, V243, P507, DOI 10.1097/01.sla.0000205826.62911.a7; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; SOUHAMI RL, 1981, BIOCHIM BIOPHYS ACTA, V674, P354, DOI 10.1016/0304-4165(81)90366-4; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tanimoto A, 2002, RADIOLOGY, V222, P661, DOI 10.1148/radiol.2223010690; Tromsdorf UI, 2007, NANO LETT, V7, P2422, DOI 10.1021/nl071099b; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wade J, 2003, J HOSP INFECT, V53, P144, DOI 10.1053/jhin.2002.1363; Ward J, 2000, RADIOLOGY, V216, P154, DOI 10.1148/radiology.216.1.r00jl24154; WAXMAN AD, 1982, SEMIN NUCL MED, V12, P75, DOI 10.1016/S0001-2998(82)80030-5; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	37	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103576	10.1371/journal.pone.0103576	http://dx.doi.org/10.1371/journal.pone.0103576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090653	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700032
J	Webster, CI; Burrell, M; Olsson, LL; Fowler, SB; Digby, S; Sandercock, A; Snijder, A; Tebbe, J; Haupts, U; Grudzinska, J; Jermutus, L; Andersson, C				Webster, Carl I.; Burrell, Matthew; Olsson, Lise-Lotte; Fowler, Susan B.; Digby, Sarah; Sandercock, Alan; Snijder, Arjan; Tebbe, Jan; Haupts, Ulrich; Grudzinska, Joanna; Jermutus, Lutz; Andersson, Christin			Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer's Disease	PLOS ONE			English	Article							BRAIN A-BETA; AMYLOID-BETA; NEUTRAL ENDOPEPTIDASE; NATRIURETIC PEPTIDE; SUBSTRATE; THERMOLYSIN; METABOLISM; INHIBITOR; ENZYME; METALLOENDOPEPTIDASE	Neprilysin is a transmembrane zinc metallopeptidase that degrades a wide range of peptide substrates. It has received attention as a potential therapy for Alzheimer's disease due to its ability to degrade the peptide amyloid beta. However, its broad range of peptide substrates has the potential to limit its therapeutic use due to degradation of additional peptides substrates that tightly regulate many physiological processes. We sought to generate a soluble version of the ectodomain of neprilysin with improved activity and specificity towards amyloid beta as a potential therapeutic for Alzheimer's disease. Extensive amino acid substitutions were performed at positions surrounding the active site and inner surface of the enzyme and variants screened for activity on amyloid beta 1-40, 1-42 and a variety of other physiologically relevant peptides. We identified several mutations that modulated and improved both enzyme selectivity and intrinsic activity. Neprilysin variant G399V/G714K displayed an approximately 20-fold improved activity on amyloid beta 1-40 and up to a 3,200-fold reduction in activity on other peptides. Along with the altered peptide substrate specificity, the mutant enzyme produced a markedly altered series of amyloid beta cleavage products compared to the wild-type enzyme. Crystallisation of the mutant enzyme revealed that the amino acid substitutions result in alteration of the shape and size of the pocket containing the active site compared to the wild-type enzyme. The mutant enzyme offers the potential for the more efficient degradation of amyloid beta in vivo as a therapeutic for the treatment of Alzheimer's disease.	[Webster, Carl I.; Burrell, Matthew; Fowler, Susan B.; Digby, Sarah; Sandercock, Alan; Jermutus, Lutz] MedImmune, Antibody Discovery & Prot Engn, Cambridge, England; [Olsson, Lise-Lotte; Snijder, Arjan] AstraZeneca R&D, Discovery Sci, Molndal, Sweden; [Tebbe, Jan; Haupts, Ulrich; Grudzinska, Joanna] Bayer HealthCare, Global Drug Discovery Global Biol, D-52425 Cologne, Germany; [Andersson, Christin] AstraZeneca R&D, CNS& P iMed, Sodertalje, Sweden	AstraZeneca; Medimmune; AstraZeneca; Bayer AG; Bayer Healthcare Pharmaceuticals; AstraZeneca	Webster, CI (corresponding author), MedImmune, Antibody Discovery & Prot Engn, Cambridge, England.	websterc@medimmune.com	Jermutus, Lutz/AAU-2047-2020	Snijder, Arjan/0000-0003-2829-3098	AstraZeneca; MedImmune; Bayer HealthCare AG	AstraZeneca(AstraZeneca); MedImmune(AstraZenecaMedimmune); Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	All work was funded by AstraZeneca and MedImmune (a wholly owned subsidiary of AstraZeneca). The funders or Bayer HealthCare AG provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012793; Bricogne G., 2010, BUSTER; DeLano WL, 2002, PYMOL USERS MANUAL; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Glossop MS, 2011, BIOORG MED CHEM LETT, V21, P3404, DOI 10.1016/j.bmcl.2011.03.109; Hausrath AC, 2002, ACTA CRYSTALLOGR D, V58, P1002, DOI 10.1107/S090744490200584X; Henderson SJ, 2014, BRAIN, V137, P553, DOI 10.1093/brain/awt308; HOLLAND DR, 1992, BIOCHEMISTRY-US, V31, P11310, DOI 10.1021/bi00161a008; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kadonosono T, 2008, PROTEIN ENG DES SEL, V21, P507, DOI 10.1093/protein/gzn026; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; KENNY AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1503; KERR MA, 1974, BIOCHEM J, V137, P489, DOI 10.1042/bj1370489; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V27, P30; Li WD, 2010, METAB BRAIN DIS, V25, P277, DOI 10.1007/s11011-010-9207-9; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Marr RA, 2003, J NEUROSCI, V23, P1992; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; MATTHEWS BW, 1974, J BIOL CHEM, V249, P8030; McCord LA, 2013, P NATL ACAD SCI USA, V110, P13827, DOI 10.1073/pnas.1304575110; Medeiros MD, 1996, NEUROCHEM RES, V21, P1125, DOI 10.1007/BF02532423; Mouri A, 2006, BEHAV BRAIN RES, V168, P83, DOI 10.1016/j.bbr.2005.10.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagatomo Y, 1996, BIOCHEM BIOPH RES CO, V223, P539, DOI 10.1006/bbrc.1996.0930; Newell AJ, 2003, NEUROSCI LETT, V350, P178, DOI 10.1016/S0304-3940(03)00902-9; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Oefner C, 2007, ACTA CRYSTALLOGR D, V63, P975, DOI 10.1107/S0907444907036281; Pope D, 2014, J CHEM INF MODEL, V54, P1157, DOI 10.1021/ci500015m; POZSGAY M, 1986, BIOCHEMISTRY-US, V25, P1292, DOI 10.1021/bi00354a015; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Sexton T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032343; SEYMOUR AA, 1990, J CARDIOVASC PHARM, V16, P163, DOI 10.1097/00005344-199007000-00022; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tiraboschi G, 1999, PROTEIN ENG, V12, P141, DOI 10.1093/protein/12.2.141; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Walker JR, 2013, J NEUROSCI, V33, P2457, DOI 10.1523/JNEUROSCI.3407-12.2013; WEBB RL, 1989, J CARDIOVASC PHARM, V14, P285, DOI 10.1097/00005344-198908000-00015	48	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104001	10.1371/journal.pone.0104001	http://dx.doi.org/10.1371/journal.pone.0104001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089527	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700077
J	Erlejman, AG; De Leo, SA; Mazaira, GI; Molinari, AM; Camisay, MF; Fontana, V; Cox, MB; Piwien-Pilipuk, G; Galigniana, MD				Erlejman, Alejandra G.; De Leo, Sonia A.; Mazaira, Gisela I.; Molinari, Alejandro M.; Camisay, Mar-A Fernanda; Fontana, Vanina; Cox, Marc B.; Piwien-Pilipuk, Graciela; Galigniana, Mario D.			NF-kappa B Transcriptional Activity Is Modulated by FK506-binding Proteins FKBP51 and FKBP52 A ROLE FOR PEPTIDYL-PROLYL ISOMERASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HSP90-BINDING IMMUNOPHILIN FKBP52; GLUCOCORTICOID-RECEPTOR; NUCLEAR TRANSLOCATION; MOLECULAR CHAPERONES; DYNEIN INTERACTION; STEROID-RECEPTORS; EXPRESSION; ACTIVATION; DOMAIN	Hsp90 binding immunophilins FKBP51 and FKBP52 modulate steroid receptor trafficking and hormone-dependent biological responses. With the purpose to expand this model to other nuclear factors that are also subject to nuclear-cytoplasmic shuttling, we analyzed whether these immunophilins modulate NF-kappa B signaling. It is demonstrated that FKBP51 impairs both the nuclear translocation rate of NF-kappa B and its transcriptional activity. The inhibitory action of FKBP51 requires neither the peptidylprolyl-isomerase activity of the immunophilin nor its association with Hsp90. The TPR domain of FKBP51 is essential. On the other hand, FKBP52 favors the nuclear retention time of RelA, its association to a DNA consensus binding sequence, and NF-kappa B transcriptional activity, the latter effect being strongly dependent on the peptidylprolyl-isomerase activity and also on the TPR domain of FKBP52, but its interaction with Hsp90 is not required. In unstimulated cells, FKBP51 forms endogenous complexes with cytoplasmic RelA. Upon cell stimulation with phorbol ester, the NF-kappa B soluble complex exchanges FKBP51 for FKBP52, and the NF-kappa B biological effect is triggered. Importantly, FKBP52 is functionally recruited to the promoter region of NF-kappa B target genes, whereas FKBP51 is released. Competition assays demonstrated that both immunophilins antagonize one another, and binding assays with purified proteins suggest that the association of RelA and immunophilins could be direct. These observations suggest that the biological action of NF-kappa B in different cell types could be positively regulated by a high FKBP52/FKBP51 expression ratio by favoring NF-kappa B nuclear retention, recruitment to the promoter regions of target genes, and transcriptional activity.	[Fontana, Vanina; Galigniana, Mario D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Fontana, Vanina; Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Quim Biol Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Piwien-Pilipuk, Graciela] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Arquitectura Nucl, RA-1033 Buenos Aires, DF, Argentina; [Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Receptores Nucl, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Galigniana, MD (corresponding author), IBYME CONICET, Vuelta Obligado 2490,Rm 304,C1428ADN, Buenos Aires, DF, Argentina.	mgaligniana@conicet.gov.ar	Erlejman, Alejandra/AAV-5947-2020	Erlejman, Alejandra/0000-0003-3769-4790; Cox, Marc/0000-0001-7854-2676; GALIGNIANA, MARIO/0000-0002-9130-8574	National Institutes of Health [5 G12 RR008124, 8 G12 MD007592]; Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina [PICT-2010-1170, PICT-2011-1715, PICT-2010-2215, PICT-2012-2612]; University of Buenos Aires [UBACYT-2011/14-GC, UBACYT 2011/13-IJ, UBACYT 2013/15-IF]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina(ANPCyT); University of Buenos Aires(University of Buenos Aires); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR008124 (Border Biomedical Research Center from the National Center for Research Resources) and 8 G12 MD007592 (National Institute on Minority Health and Health Disparities (to M. B. C.). This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica de Argentina Grants PICT-2010-1170 and PICT-2011-1715 (to M. D. G.), PICT-2010-2215 (to A. G. E.), and PICT-2012-2612 (to G. P.-P.) and University of Buenos Aires Grants UBACYT-2011/14-GC (to M. D. G.), UBACYT 2011/13-IJ, and UBACYT 2013/15-IF (to A. G. E.).	Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Ciechanover A, 2001, BIOCHIMIE, V83, P341, DOI 10.1016/S0300-9084(01)01239-1; Cioffi DL, 2011, CURR OPIN PHARMACOL, V11, P308, DOI 10.1016/j.coph.2011.03.013; Cluning C, 2013, MOL ENDOCRINOL, V27, P1020, DOI 10.1210/me.2012-1023; Colo GP, 2008, ONCOGENE, V27, P2430, DOI 10.1038/sj.onc.1210900; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Erlejman AG, 2008, ARCH BIOCHEM BIOPHYS, V476, P186, DOI 10.1016/j.abb.2008.01.024; Erlejman AG, 2014, BBA-GENE REGUL MECH, V1839, P71, DOI 10.1016/j.bbagrm.2013.12.006; Fabre C, 2012, CLIN CANCER RES, V18, P4669, DOI 10.1158/1078-0432.CCR-12-0779; Fontana V, 2012, J MOL HISTOL, V43, P487, DOI 10.1007/s10735-012-9429-8; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Fujisawa K, 2000, PLACENTA, V21, P354, DOI 10.1053/plac.1999.0494; Gaali S, 2011, CURR MED CHEM, V18, P5355, DOI 10.2174/092986711798194342; GALAT A, 1993, EUR J BIOCHEM, V216, P689, DOI 10.1111/j.1432-1033.1993.tb18189.x; Galigniana MD, 2012, CHEM BIOL, V19, P662, DOI 10.1016/j.chembiol.2012.06.001; Galigniana MD, 2010, NUCLEUS-PHILA, V1, P299, DOI 10.4161/nucl.1.4.11743; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Galigniana MD, 2001, J BIOL CHEM, V276, P14884, DOI 10.1074/jbc.M010809200; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; HOHMANN HP, 1991, MOL CELL BIOL, V11, P259, DOI 10.1128/MCB.11.1.259; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Klenke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065280; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li YF, 2012, HUM REPROD, V27, P2096, DOI 10.1093/humrep/des110; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Mackenzie GG, 2006, J NEUROCHEM, V99, P402, DOI 10.1111/j.1471-4159.2006.04005.x; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Nelson G, 2002, J CELL SCI, V115, P1137; Nissinen L, 2014, BBA-GEN SUBJECTS, V1840, P2571, DOI 10.1016/j.bbagen.2014.03.007; Oeckinghaus A., 2009, COLD SPRING HARB PER, V1; Oh J, 2012, J IMMUNOL, V189, P5561, DOI 10.4049/jimmunol.1103415; Oshimo Y, 2004, INT J CANCER, V112, P1003, DOI 10.1002/ijc.20521; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Pilipuk GP, 2007, BIOCHEMISTRY-US, V46, P1389, DOI 10.1021/bi0621819; Quinta HR, 2012, BRIT J PHARMACOL, V166, P637, DOI 10.1111/j.1476-5381.2011.01783.x; Quinta HR, 2010, J NEUROCHEM, V115, P716, DOI 10.1111/j.1471-4159.2010.06970.x; Raghuram N, 2013, J CELL BIOL, V203, P57, DOI 10.1083/jcb.201305159; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017; Romano S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.109; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salem K, 2013, EXP HEMATOL, V41, P209, DOI 10.1016/j.exphem.2012.10.002; Sanchez ER, 2012, BBA-MOL CELL RES, V1823, P722, DOI 10.1016/j.bbamcr.2011.11.006; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schif B, 2013, ONCOTARGET, V4, P35, DOI 10.18632/oncotarget.774; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sivils JC, 2011, CURR OPIN PHARMACOL, V11, P314, DOI 10.1016/j.coph.2011.03.010; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Susperreguy S, 2011, EXP CELL RES, V317, P706, DOI 10.1016/j.yexcr.2010.11.008; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tsukihara S, 2004, AM J REPROD IMMUNOL, V52, P218, DOI 10.1111/j.1600-0897.2004.00209.x; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yura S, 1998, J CLIN ENDOCR METAB, V83, P3609, DOI 10.1210/jc.83.10.3609; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395	80	68	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26263	26276		10.1074/jbc.M114.582882	http://dx.doi.org/10.1074/jbc.M114.582882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25104352	Green Published, hybrid			2022-12-25	WOS:000342128800021
J	Gong, XC; Chen, HL; Chen, T; Qu, HB				Gong, Xingchu; Chen, Huali; Chen, Teng; Qu, Haibin			Unit Operation Optimization for the Manufacturing of Botanical Injections Using a Design Space Approach: A Case Study of Water Precipitation	PLOS ONE			English	Article							MICROWAVE-ASSISTED EXTRACTION; PANAX-GINSENG; QUALITY; GINSENOSIDES; FORMULATION; CHROMATOGRAPHY; FLAVONOIDS; SEPARATION; STRATEGY; PRODUCT	Quality by design (QbD) concept is a paradigm for the improvement of botanical injection quality control. In this work, water precipitation process for the manufacturing of Xueshuantong injection, a botanical injection made from Notoginseng Radix et Rhizoma, was optimized using a design space approach as a sample. Saponin recovery and total saponin purity (TSP) in supernatant were identified as the critical quality attributes (CQAs) of water precipitation using a risk assessment for all the processes of Xueshuantong injection. An Ishikawa diagram and experiments of fractional factorial design were applied to determine critical process parameters (CPPs). Dry matter content of concentrated extract (DMCC), amount of water added (AWA), and stirring speed (SS) were identified as CPPs. Box-Behnken designed experiments were carried out to develop models between CPPs and process CQAs. Determination coefficients were higher than 0.86 for all the models. High TSP in supernatant can be obtained when DMCC is low and SS is high. Saponin recoveries decreased as DMCC increased. Incomplete collection of supernatant was the main reason for the loss of saponins. Design space was calculated using a Monte-Carlo simulation method with acceptable probability of 0.90. Recommended normal operation region are located in DMCC of 0.38-0.41 g/g, AWA of 3.7-4.9 g/g, and SS of 280-350 rpm, with a probability more than 0.919 to attain CQA criteria. Verification experiment results showed that operating DMCC, SS, and AWA within design space can attain CQA criteria with high probability.	[Gong, Xingchu; Chen, Huali; Chen, Teng; Qu, Haibin] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Qu, HB (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	quhb@zju.edu.cn			National S&T Major Project of China [2012ZX09101201-003]; Research Fund for the Doctoral Program of Higher Education of China [20110101120149]	National S&T Major Project of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National S&T Major Project of China (2012ZX09101201-003) and Research Fund for the Doctoral Program of Higher Education of China (20110101120149). Haibin Qu received the first fund. The website is http://www.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Xingchu Gong received the second fund. The website is http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm. Fund were used to buy materials, chemicals, and pay labor costs.	Bhambure R, 2013, BIOTECHNOL PROGR, V29, P403, DOI 10.1002/btpr.1705; Charoo NA, 2012, INT J PHARMACEUT, V423, P167, DOI 10.1016/j.ijpharm.2011.12.024; Chen X, 2007, CHINA PHARM, V18, P41; Chinese Pharmacopoeia Commission, 2011, ZHUSH XUESH DONGG; Debrus B, 2011, ANAL CHIM ACTA, V691, P33, DOI 10.1016/j.aca.2011.02.035; Duan MH, 2013, SEP PURIF TECHNOL, V107, P26, DOI 10.1016/j.seppur.2013.01.003; Gong XC, 2013, SEP PURIF TECHNOL, V107, P273, DOI 10.1016/j.seppur.2013.01.029; Gui QF, 2013, NEURAL REGEN RES, V8, P792, DOI 10.3969/j.issn.1673-5374.2013.09.003; HAN BH, 1982, PLANTA MED, V44, P146, DOI 10.1055/s-2007-971425; Ingvarsson PT, 2013, PHARM RES; Kim SJ, 2007, SEP PURIF TECHNOL, V56, P401, DOI 10.1016/j.seppur.2007.06.014; Korakianiti E, 2011, PHARM RES-DORDR, V28, P1465, DOI 10.1007/s11095-010-0315-3; Li RY, 2012, IND ENG CHEM RES, V51, P8141, DOI 10.1021/ie300945p; [李晓海 Li Xiaohai], 2012, [中国新药杂志, Chinese Journal New Drugs], V21, P1362; Looby M, 2011, BIOTECHNOL PROGR, V27, P1718, DOI 10.1002/btpr.672; Lourenco V, 2012, EUR J PHARM BIOPHARM, V81, P438, DOI 10.1016/j.ejpb.2012.03.003; Martins PF, 2012, SEP PURIF TECHNOL, V98, P464, DOI 10.1016/j.seppur.2012.08.009; Mbinze JK, 2012, J CHROMATOGR A, V1263, P113, DOI 10.1016/j.chroma.2012.09.038; Mockus LN, 2011, PHARM DEV TECHNOL, V16, P549, DOI 10.3109/10837450.2011.611138; Nistor I, 2011, J PHARMACEUT BIOMED, V56, P30, DOI 10.1016/j.jpba.2011.04.027; Nistor I, 2013, J PHARMACEUT BIOMED, V74, P273, DOI 10.1016/j.jpba.2012.10.015; Popovich DG, 2004, PHYTOCHEMISTRY, V65, P337, DOI 10.1016/j.phytochem.2003.11.020; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Rozet E, 2012, ANAL CHEM, V84, P106, DOI 10.1021/ac202664s; Wang YT, 2008, FOOD CHEM, V110, P161, DOI 10.1016/j.foodchem.2008.01.028; Xiao WH, 2008, SEP PURIF TECHNOL, V62, P614, DOI 10.1016/j.seppur.2008.03.025; Xiao XH, 2009, SEP PURIF TECHNOL, V68, P250, DOI 10.1016/j.seppur.2009.05.011; Xu XM, 2012, INT J PHARMACEUT, V434, P349, DOI 10.1016/j.ijpharm.2012.06.002; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8; Zheng XZ, 2009, SEP PURIF TECHNOL, V70, P34, DOI 10.1016/j.seppur.2009.08.008	31	12	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104493	10.1371/journal.pone.0104493	http://dx.doi.org/10.1371/journal.pone.0104493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101624	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900069
J	Hudson, CD; Huxley, JN; Green, MJ				Hudson, Christopher D.; Huxley, Jonathan N.; Green, Martin J.			Using Simulation to Interpret a Discrete Time Survival Model in a Complex Biological System: Fertility and Lameness in Dairy Cows	PLOS ONE			English	Article							TO-CONCEPTION INTERVAL; REPRODUCTIVE-PERFORMANCE; BODY CONDITION; ODDS RATIO; MILK; CLAW; LESIONS; HEALTH; IMPACT; CATTLE	The ever-growing volume of data routinely collected and stored in everyday life presents researchers with a number of opportunities to gain insight and make predictions. This study aimed to demonstrate the usefulness in a specific clinical context of a simulation-based technique called probabilistic sensitivity analysis (PSA) in interpreting the results of a discrete time survival model based on a large dataset of routinely collected dairy herd management data. Data from 12,515 dairy cows (from 39 herds) were used to construct a multilevel discrete time survival model in which the outcome was the probability of a cow becoming pregnant during a given two day period of risk, and presence or absence of a recorded lameness event during various time frames relative to the risk period amongst the potential explanatory variables. A separate simulation model was then constructed to evaluate the wider clinical implications of the model results (i.e. the potential for a herd's incidence rate of lameness to influence its overall reproductive performance) using PSA. Although the discrete time survival analysis revealed some relatively large associations between lameness events and risk of pregnancy (for example, occurrence of a lameness case within 14 days of a risk period was associated with a 25% reduction in the risk of the cow becoming pregnant during that risk period), PSA revealed that, when viewed in the context of a realistic clinical situation, a herd's lameness incidence rate is highly unlikely to influence its overall reproductive performance to a meaningful extent in the vast majority of situations. Construction of a simulation model within a PSA framework proved to be a very useful additional step to aid contextualisation of the results from a discrete time survival model, especially where the research is designed to guide on-farm management decisions at population (i.e. herd) rather than individual level.	[Hudson, Christopher D.; Huxley, Jonathan N.; Green, Martin J.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England	University of Nottingham	Hudson, CD (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Loughborough, Leics, England.	chris.hudson@nottingham.ac.uk	Huxley, Jonathan N/B-7406-2011; Green, Martin/F-7066-2011; Hudson, Chris/G-5561-2011	Huxley, Jonathan N/0000-0002-1149-2480; Green, Martin/0000-0002-6408-6443; Hudson, Chris/0000-0003-4777-062X				Alawneh JI, 2011, J DAIRY SCI, V94, P5487, DOI 10.3168/jds.2011-4395; Anderson K, 2006, ANN INTERN MED, V144, P397, DOI 10.7326/0003-4819-144-6-200603210-00006; Andronis L, 2009, HEALTH TECHNOL ASSES, V13, P1; Bahonar AR, 2009, J ANIM VET ADV, V8, P747; Barker ZE, 2010, J DAIRY SCI, V93, P932, DOI 10.3168/jds.2009-2309; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Bicalho RC, 2007, J DAIRY SCI, V90, P4586, DOI 10.3168/jds.2007-0297; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Browne W., 2009, MCMC ESTIMATION MLWI; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Esslemont RJ, 2002, 5 DAISY U READ; Evans GE, 2009, 2009 WRI WORLD C COM, V4, P379; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Hernandez J, 2001, J AM VET MED ASSOC, V218, P1611, DOI 10.2460/javma.2001.218.1611; Hernandez JA, 2005, JAVMA-J AM VET MED A, V227, P1284, DOI 10.2460/javma.2005.227.1284; Hudson CD, 2012, J DAIRY SCI, V95, P3683, DOI 10.3168/jds.2011-4629; Huxley JN, 2013, LIVEST SCI, V156, P64, DOI 10.1016/j.livsci.2013.06.012; LeBlanc S, 2007, ADV DAIRY TECHNOL, V19, P201; Loeffler SH, 1999, J DAIRY SCI, V82, P2589, DOI 10.3168/jds.S0022-0302(99)75514-1; Machado VS, 2010, J DAIRY SCI, V93, P4071, DOI 10.3168/jds.2010-3177; Melendez P, 2003, THERIOGENOLOGY, V59, P927, DOI 10.1016/S0093-691X(02)01152-4; Peake KA, 2011, VET REC, V168, DOI 10.1136/vr.c6180; R Core Development Team, 2010, R LANG ENV STAT COMP; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rasbash J, 2010, MLWIN VERSION 2 2; SINGER JD, 1993, J EDUC STAT, V18, P155, DOI 10.2307/1165085; Sogstad AM, 2006, J DAIRY SCI, V89, P2519, DOI 10.3168/jds.S0022-0302(06)72327-X; Steele F, 2003, LIFETIME DATA ANAL, V9, P155, DOI 10.1023/A:1022930918859; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Yang M., 2003, MODELLING SURVIVAL D; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	31	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e103426	10.1371/journal.pone.0103426	http://dx.doi.org/10.1371/journal.pone.0103426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101997	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900018
J	Rundell, EA; Banta, LM; Ward, DV; Watts, CD; Birren, B; Esteban, DJ				Rundell, Ethan A.; Banta, Lois M.; Ward, Doyle V.; Watts, Corey D.; Birren, Bruce; Esteban, David J.			16S rRNA Gene Survey of Microbial Communities in Winogradsky Columns	PLOS ONE			English	Article							RARE BIOSPHERE; SP-NOV; BODY HABITATS; DIVERSITY; BACTERIAL; SEDIMENT; METAGENOMICS; SEQUENCES; ARCHAEAL; DEPTH	A Winogradsky column is a clear glass or plastic column filled with enriched sediment. Over time, microbial communities in the sediment grow in a stratified ecosystem with an oxic top layer and anoxic sub-surface layers. Winogradsky columns have been used extensively to demonstrate microbial nutrient cycling and metabolic diversity in undergraduate microbiology labs. In this study, we used high-throughput 16s rRNA gene sequencing to investigate the microbial diversity of Winogradsky columns. Specifically, we tested the impact of sediment source, supplemental cellulose source, and depth within the column, on microbial community structure. We found that the Winogradsky columns were highly diverse communities but are dominated by three phyla: Proteobacteria, Bacteroidetes, and Firmicutes. The community is structured by a founding population dependent on the source of sediment used to prepare the columns and is differentiated by depth within the column. Numerous biomarkers were identified distinguishing sample depth, including Cyanobacteria, Alphaproteobacteria, and Betaproteobacteria as biomarkers of the soil-water interface, and Clostridia as a biomarker of the deepest depth. Supplemental cellulose source impacted community structure but less strongly than depth and sediment source. In columns dominated by Firmicutes, the family Peptococcaceae was the most abundant sulfate reducer, while in columns abundant in Proteobacteria, several Deltaproteobacteria families, including Desulfobacteraceae, were found, showing that different taxonomic groups carry out sulfur cycling in different columns. This study brings this historical method for enrichment culture of chemolithotrophs and other soil bacteria into the modern era of microbiology and demonstrates the potential of the Winogradsky column as a model system for investigating the effect of environmental variables on soil microbial communities.	[Rundell, Ethan A.; Esteban, David J.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA; [Banta, Lois M.; Watts, Corey D.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Ward, Doyle V.; Birren, Bruce] Broad Inst, Genome Sequencing Ctr, Cambridge, MA USA	Vassar College; Williams College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Esteban, DJ (corresponding author), Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA.	daesteban@vassar.edu			Vassar College; Williams College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007640] Funding Source: NIH RePORTER	Vassar College; Williams College; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Vassar College start-up funds to DJE and Williams College divisional research funds to CDW and LMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banta LM, 2012, CBE-LIFE SCI EDUC, V11, P203, DOI 10.1187/cbe.11-12-0105; Bayer EA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P578, DOI 10.1007/0-387-30742-7_19; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Bowen JL, 2009, ISME J, V3, P924, DOI 10.1038/ismej.2009.44; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlton PJ, 1997, J MICROBIOL METH, V30, P161, DOI 10.1016/S0167-7012(97)00051-1; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; de Sousa ML, 2012, ENVIRON ENG SCI, V29, P180, DOI 10.1089/ees.2010.0259; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dworkin M, 2012, FEMS MICROBIOL REV, V36, P364, DOI 10.1111/j.1574-6976.2011.00299.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Guhathakurta H, 2007, ISME J, V1, P545, DOI 10.1038/ismej.2007.61; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; JANSSEN PH, 1991, INT J SYST BACTERIOL, V41, P26, DOI 10.1099/00207713-41-1-26; Jurkowski Anne, 2007, CBE Life Sci Educ, V6, P260, DOI 10.1187/cbe.07-09-0075; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Llobet-Brossa E, 2002, AQUAT MICROB ECOL, V29, P211, DOI 10.3354/ame029211; Loss RA, 2013, RENEW ENERG, V50, P648, DOI 10.1016/j.renene.2012.07.011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludemann H, 2000, APPL ENVIRON MICROB, V66, P754, DOI 10.1128/AEM.66.2.754-762.2000; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P1029, DOI 10.1128/AEM.41.4.1029-1039.1981; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mussmann M, 2005, ENVIRON MICROBIOL, V7, P405, DOI 10.1111/j.1462-2920.2005.00708.x; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; NEUTZLING O, 1984, ARCH MICROBIOL, V137, P256, DOI 10.1007/BF00414554; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Postgate J.R., 1959, J SCI FOOD AGR, V10, P669; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; Rogan B, 2005, AM BIOL TEACH, V67, P348, DOI 10.1662/0002-7685(2005)067[0348:ETSNCU]2.0.CO;2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Shivaji S, 2011, RES MICROBIOL, V162, P191, DOI 10.1016/j.resmic.2010.09.020; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Teske A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P784, DOI 10.1007/0-387-30746-x_27; van Niel C.B, 1971, METHODS ENZYMOLOGY A, P3, DOI DOI 10.1016/S0076-6879(71)23077-9; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winogradsky S, 1888, BEITRAGE MORPHOLOGIE, V1; Winogradsky S.N., 1887, BOT ZEITUNG, V45, P489; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Xiong JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050507; Youssef NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012414; Zhou JZ, 2004, APPL ENVIRON MICROB, V70, P1723, DOI 10.1128/AEM.70.3.1723-1734.2004	57	21	21	10	167	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104134	10.1371/journal.pone.0104134	http://dx.doi.org/10.1371/journal.pone.0104134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101630	Green Published, gold, Green Submitted			2022-12-25	WOS:000339993900045
J	Yusuf, I; Stern, J; McCaughtry, TM; Gallagher, S; Sun, H; Gao, C; Tedder, T; Carlesso, G; Carter, L; Herbst, R; Wang, Y				Yusuf, Isharat; Stern, Jessica; McCaughtry, Tom M.; Gallagher, Sandra; Sun, Hong; Gao, Changshou; Tedder, Thomas; Carlesso, Gianluca; Carter, Laura; Herbst, Ronald; Wang, Yue			Germinal Center B Cell Depletion Diminishes CD4(+) Follicular T Helper Cells in Autoimmune Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY IMMUNE-RESPONSE; NZB/W F-1 MICE; MURINE LUPUS; MYASTHENIA-GRAVIS; SJOGRENS-SYNDROME; CHEMOKINE CXCL13; DENDRITIC CELLS; FH CELLS; IN-SITU	Background: Continuous support from follicular CD4(+) T helper (Tfh) cells drives germinal center (GC) responses, which last for several weeks to produce high affinity memory B cells and plasma cells. In autoimmune Sle1 and NZB/W F1 mice, elevated numbers of Tfh cells persist, promoting the expansion of self-reactive B cells. Expansion of circulating Tfh like cells have also been described in several autoimmune diseases. Although, the signals required for Tfh differentiation have now been well described, the mechanisms that sustain the maintenance of fully differentiated Tfh are less understood. Recent data demonstrate a role for GC B cells for Tfh maintenance after protein immunization. Methods and Finding: Given the pathogenic role Tfh play in autoimmune disease, we explored whether B cells are required for maintenance of autoreactive Tfh. Our data suggest that the number of mature autoreactive Tfh cells is controlled by GC B cells. Depletion of B cells in Sle1 autoimmune mice leads to a dramatic reduction in Tfh cells. In NZB/W F1 autoimmune mice, similar to the SRBC immunization model, GC B cells support the maintenance of mature Tfh, which is dependent mainly on ICOS. The CD28-associated pathway is dispensable for Tfh maintenance in SRBC immunized mice, but is required in the spontaneous NZB/W F1 model. Conclusion: These data suggest that mature Tfh cells require signals from GC B cells to sustain their optimal numbers and function in both autoimmune and immunization models. Thus, immunotherapies targeting B cells in autoimmune disease may affect pathogenic Tfh cells.	[Yusuf, Isharat; Stern, Jessica; McCaughtry, Tom M.; Gallagher, Sandra; Sun, Hong; Carlesso, Gianluca; Carter, Laura; Herbst, Ronald; Wang, Yue] Medimmune LLC, Dept Resp Inflammat & Autoimmun Res, Gaithersburg, MD 20878 USA; [Gao, Changshou] Medimmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Tedder, Thomas] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; Duke University	Wang, Y (corresponding author), Medimmune LLC, Dept Resp Inflammat & Autoimmun Res, Gaithersburg, MD 20878 USA.	wangy@medimmune.com			MedImmune	MedImmune(AstraZenecaMedimmune)	MedImmune is the funder of this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bekar KW, 2010, ARTHRITIS RHEUM-US, V62, P2443, DOI 10.1002/art.27515; Bluml S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3906; Boulianne B, 2013, J IMMUNOL, V191, P4521, DOI 10.4049/jimmunol.1300769; Browning JL, 1997, J IMMUNOL, V159, P3288; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Chakera A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948218; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Gilliland LK, 1996, TISSUE ANTIGENS, V47, P1, DOI 10.1111/j.1399-0039.1996.tb02509.x; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hamaguchi Y, 2006, J EXP MED, V203, P743, DOI 10.1084/jem.20052283; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HAN SH, 1995, J IMMUNOL, V155, P556; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Herbst R, 2010, J PHARMACOL EXP THER, V335, P213, DOI 10.1124/jpet.110.168062; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; King C, 2012, TRENDS IMMUNOL, V33, P59, DOI 10.1016/j.it.2011.11.006; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Linterman MA, 2012, IMMUNOL REV, V247, P143, DOI 10.1111/j.1600-065X.2012.01121.x; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Mohan C, 1998, J CLIN INVEST, V101, P1362; MOHAN C, 1995, J IMMUNOL, V154, P1470; Monk NJ, 2003, NAT MED, V9, P1275, DOI 10.1038/nm931; Morel L, 1997, J IMMUNOL, V158, P6019; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murphy G, 2013, LANCET, V382, P809, DOI 10.1016/S0140-6736(13)60889-2; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ramiscal RR, 2013, IMMUNOL REV, V252, P146, DOI 10.1111/imr.12031; Rosenblum MD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003504; Saito R, 2005, J NEUROIMMUNOL, V170, P172, DOI 10.1016/j.jneuroim.2005.09.001; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; Shi XY, 2007, ARTHRITIS RHEUM-US, V56, P3057, DOI 10.1002/art.22825; Shinall SM, 2000, J IMMUNOL, V164, P5729, DOI 10.4049/jimmunol.164.11.5729; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; STEURER W, 1995, J IMMUNOL, V155, P1165; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Terrier B, 2012, J RHEUMATOL, V39, P1819, DOI 10.3899/jrheum.120468; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vuyyuru R, 2009, J IMMUNOL, V183, P5716, DOI 10.4049/jimmunol.0804215; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Wang XB, 2003, ARTHRITIS RHEUM, V48, P495, DOI 10.1002/art.10929; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Whitmire JK, 2009, J IMMUNOL, V182, P1868, DOI 10.4049/jimmunol.0802501; Wong CK, 2010, J CLIN IMMUNOL, V30, P45, DOI 10.1007/s10875-009-9325-5; Xu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079858; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Yazawa N, 2005, P NATL ACAD SCI USA, V102, P15178, DOI 10.1073/pnas.0505539102; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	88	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e102791	10.1371/journal.pone.0102791	http://dx.doi.org/10.1371/journal.pone.0102791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101629	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900005
J	Ashfaq, M; Hebert, PDN; Mirza, MS; Khan, AM; Mansoor, S; Shah, GS; Zafar, Y				Ashfaq, Muhammad; Hebert, Paul D. N.; Mirza, M. Sajjad; Khan, Arif M.; Mansoor, Shahid; Shah, Ghulam S.; Zafar, Yusuf			DNA Barcoding of Bemisia tabaci Complex (Hemiptera: Aleyrodidae) Reveals Southerly Expansion of the Dominant Whitefly Species on Cotton in Pakistan	PLOS ONE			English	Article							LEAF CURL DISEASE; GENETIC DIFFERENTIATION; GENNADIUS HEMIPTERA; DIVERSITY; POPULATION; STERNORRHYNCHA; BIOTYPES; VIRUS; CHINA; IDENTIFICATION	Background: Although whiteflies (Bemisia tabaci complex) are an important pest of cotton in Pakistan, its taxonomic diversity is poorly understood. As DNA barcoding is an effective tool for resolving species complexes and analyzing species distributions, we used this approach to analyze genetic diversity in the B. tabaci complex and map the distribution of B. tabaci lineages in cotton growing areas of Pakistan. Methods/Principal Findings:Sequence diversity in the DNA barcode region (mtCOI-5') was examined in 593 whiteflies from Pakistan to determine the number of whitefly species and their distributions in the cotton-growing areas of Punjab and Sindh provinces. These new records were integrated with another 173 barcode sequences for B. tabaci, most from India, to better understand regional whitefly diversity. The Barcode Index Number (BIN) System assigned the 766 sequences to 15 BINs, including nine from Pakistan. Representative specimens of each Pakistan BIN were analyzed for mtCOI-3' to allow their assignment to one of the putative species in the B. tabaci complex recognized on the basis of sequence variation in this gene region. This analysis revealed the presence of Asia II 1, Middle East-Asia Minor 1, Asia 1, Asia II 5, Asia II 7, and a new lineage "Pakistan". The first two taxa were found in both Punjab and Sindh, but Asia 1 was only detected in Sindh, while Asia II 5, Asia II 7 and "Pakistan" were only present in Punjab. The haplotype networks showed that most haplotypes of Asia II 1, a species implicated in transmission of the cotton leaf curl virus, occurred in both India and Pakistan. Conclusions: DNA barcodes successfully discriminated cryptic species in B. tabaci complex. The dominant haplotypes in the B. tabaci complex were shared by India and Pakistan. Asia II 1 was previously restricted to Punjab, but is now the dominant lineage in southern Sindh; its southward spread may have serious implications for cotton plantations in this region.	[Ashfaq, Muhammad; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mirza, M. Sajjad; Khan, Arif M.; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Shah, Ghulam S.] Agr Res Inst, Entomol Sect, Tandojam, Pakistan; [Zafar, Yusuf] Pakistan Atom Energy Commiss, Agri & Biotech Div, Islamabad, Pakistan	University of Guelph; Pakistan Institute of Engineering & Applied Science; Pakistan Atomic Energy Commission	Ashfaq, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	mashfaq@uoguelph.ca	zafar, YUSUF/F-5154-2015; Hebert, Paul DN/C-4161-2013; Ashfaq, Muhammad/J-4723-2019	Hebert, Paul DN/0000-0002-3081-6700; Ashfaq, Muhammad/0000-0003-1351-4126; Mansoor, Shahid/0000-0001-7418-1826	Higher Education Commission of Pakistan [20-1403/R D/09]; IDRC [106106-001]; Government of Canada through Genome Canada; Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); IDRC; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project	This research was enabled by grant HEC No. 20-1403/R& D/09, Sequencing DNA Barcodes of Economically Important Insect Species from Pakistan, from the Higher Education Commission of Pakistan. It was also supported by grant 106106-001, Engaging Developing Nations in iBOL, from IDRC. Sequence analysis was made possible by a grant from the Government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life (iBOL) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2012, J APPL ENTOMOL, V136, P510, DOI 10.1111/j.1439-0418.2011.01673.x; Ahmed MZ, 2011, PEST MANAG SCI, V67, P307, DOI 10.1002/ps.2067; Ahmed MZ, 2010, J PEST SCI, V83, P135, DOI 10.1007/s10340-009-0279-4; Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baker R, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3162; Blaxter M, 2004, P ROY SOC B-BIOL SCI, V271, pS189, DOI 10.1098/rsbl.2003.0130; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Boykin LM, 2012, INVERTEBR SYST, V26, P506, DOI 10.1071/IS12025; Briski E, 2011, BIOL INVASIONS, V13, P1325, DOI 10.1007/s10530-010-9892-7; Brown JK, 2005, ANN ENTOMOL SOC AM, V98, P827, DOI 10.1603/0013-8746(2005)098[0827:GDOWBT]2.0.CO;2; Chowda-Reddy RV, 2012, J INTEGR AGR, V11, P235, DOI 10.1016/S2095-3119(12)60008-2; Chu D, 2012, J ECON ENTOMOL, V105, P930, DOI 10.1603/EC10373; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; De Barro P, 2013, GLOBAL BEMISIA DATAS, DOI [10.4225/08/50EB54B6F1042, DOI 10.4225/08/50EB54B6F1042]; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2012, J INTEGR AGR, V11, P187, DOI 10.1016/S2095-3119(12)60003-3; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Erlandson M, 2003, CAN ENTOMOL, V135, P71; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farooq J, 2014, CAN J PLANT PROT, V2, P9; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Fu YX, 1997, GENETICS, V147, P915; Gao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036622; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Guo XJ, 2012, J INTEGR AGR, V11, P206, DOI 10.1016/S2095-3119(12)60005-7; Hameed S, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue6-fulltext-5; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hu J, 2011, PLOS ONE, V6; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones YL, 2013, J FOOD PROTECT, V76, P144, DOI 10.4315/0362-028X.JFP-12-168; Kauserud H, 2008, BOTANY, V86, P1326, DOI 10.1139/B08-102; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Legg JP, 2002, MOL ECOL, V11, P1219, DOI 10.1046/j.1365-294X.2002.01514.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisha VS, 2003, J ECON ENTOMOL, V96, P322, DOI 10.1603/0022-0493-96.2.322; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mugerwa H, 2012, ECOL EVOL, V2, P2749, DOI 10.1002/ece3.379; Muniz Y, 2011, ENVIRON ENTOMOL, V40, P989, DOI 10.1603/EN11129; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Panhwar GR, 2011, PAKISTAN COTTON, V55, P1; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rabello AR, 2008, GENET MOL BIOL, V31, P585, DOI 10.1590/S1415-47572008000300029; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reitz SR, 2007, SCIENCE, V318, P1733, DOI 10.1126/science.1152124; Rekha AR, 2005, ENTOMOL EXP APPL, V117, P221, DOI 10.1111/j.1570-7458.2005.00352.x; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Schloss Patrick D, 2011, Appl Environ Microbiol, V77, P3219, DOI 10.1128/AEM.02810-10; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tay WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050550; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang P, 2010, INSECT SCI, V17, P508, DOI 10.1111/j.1744-7917.2010.01353.x; Webb JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038063; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhou X, 2011, J N AM BENTHOL SOC, V30, P131, DOI 10.1899/10-010.1	84	54	56	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104485	10.1371/journal.pone.0104485	http://dx.doi.org/10.1371/journal.pone.0104485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099936	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100075
J	Dai, DW; Lu, Q; Huang, QH; Yang, PF; Hong, B; Xu, Y; Zhao, WY; Liu, JM; Li, Q				Dai, Dongwei; Lu, Qiong; Huang, Qinghai; Yang, Pengfei; Hong, Bo; Xu, Yi; Zhao, Wenyuan; Liu, Jianmin; Li, Qiang			Serum miRNA Signature in Moyamoya Disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNA; FUTURE PERSPECTIVES; DOWN-REGULATION; IVY SIGN; CANCER; GENE; RNF213; CELLS; ANGIOGENESIS	Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive stenosis of the intracranial internal carotid arteries and their proximal branches. However, the etiology of this rare disease remains unknown. Serum microRNA (miRNA) profiles have been screened to identify novel biomarkers of prognostic values. Here, we identified serum miRNAs that might play an important role in the pathogenesis of MMD. A genome-wide miRNA array analysis of two pooled serum samples from patients with MMD and controls revealed 94 differentially expressed serum miRNAs, including 50 upregulated and 44 downregulated miRNAs. In an independent MMD cohort, real-time PCR confirmed that miR-106b, miR-130a and miR-126 were significantly upregulated while miR-125a-3p was significantly downregulated in serum. GO analysis showed that the differentially expressed serum miRNAs were enriched in metabolic processes, transcription and signal transduction. Pathway analysis showed that the most enriched pathway was mTOR signaling pathway with 16 potential, functional targets. Finally, we found that 16 and 13 aberrant serum miRNAs coordinately inhibited RNF213 and BRCC3 protein expression at the posttranscriptional level, respectively, resulting in defective angiogenesis and MMD pathogenesis. To our knowledge, this is the first study to identify a serum miRNA signature in MMD. Modulation of the mechanism underlying the role of serum miRNAs in MMD is a potential therapeutic strategy and warrants further investigations.	[Dai, Dongwei; Huang, Qinghai; Yang, Pengfei; Hong, Bo; Xu, Yi; Zhao, Wenyuan; Liu, Jianmin; Li, Qiang] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Lu, Qiong] Second Mil Med Univ, Changhai Hosp, Dept Lab Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Zhao, WY (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	chstroke@126.com; chstroke@163.com; lqeimm@126.com	Li, Qiang/T-3538-2019		National Science Foundation of China [ISIS : 81271271, 81171093, 81101906]; "1255" Discipline Construction Project of Changhai Hospital [CH125520105]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "1255" Discipline Construction Project of Changhai Hospital	This paper was financially supported by National Science Foundation of China (ISIS : 81271271, 81171093 and 81101906) and "1255" Discipline Construction Project of Changhai Hospital (CH125520105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai J, 2012, ONCOTARGETS THER, V5, P213, DOI 10.2147/OTT.S36017; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Chen J, 2013, CNS NEUROSCI THER, V19, P638, DOI 10.1111/cns.12130; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Dai DW, 2013, NEURORADIOLOGY, V55, P1431, DOI 10.1007/s00234-013-1291-1; Dai DW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-478; Duan L, 2012, STROKE, V43, P56, DOI 10.1161/STROKEAHA.111.621300; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kanehisa Minoru, 2013, Methods Mol Biol, V939, P263, DOI 10.1007/978-1-62703-107-3_17; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang HS, 2010, J NEUROL NEUROSUR PS, V81, P673, DOI 10.1136/jnnp.2009.191817; Kim YJ, 2013, EUR J NEUROL, V20, P1311, DOI 10.1111/ene.12202; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kossorotoff M, 2012, CEREBROVASC DIS, V33, P76, DOI 10.1159/000333424; Kraemer M, 2008, STROKE, V39, P3193, DOI 10.1161/STROKEAHA.107.513408; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Li H, 2010, CEREBROVASC DIS, V30, P618, DOI 10.1159/000319893; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Liu ZH, 2012, CELL PHYSIOL BIOCHEM, V29, P851, DOI 10.1159/000258197; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Lu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068986; Maeda M, 1999, AM J NEURORADIOL, V20, P1836; Miskinyte S, 2011, AM J HUM GENET, V88, P718, DOI 10.1016/j.ajhg.2011.04.017; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Mori N, 2009, AM J NEURORADIOL, V30, P930, DOI 10.3174/ajnr.A1504; Roder C, 2010, ACTA NEUROCHIR, P1; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang XM, 2013, GENE, V526, P437, DOI 10.1016/j.gene.2013.05.083; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wang YY, 2012, J NEURO-ONCOL, V106, P217, DOI 10.1007/s11060-011-0679-1; Weinberg DG, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS1151; Wu WH, 2011, AM J HYPERTENS, V24, P1087, DOI 10.1038/ajh.2011.116; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930; Yun TJ, 2013, INVEST RADIOL, V48, P795, DOI 10.1097/RLI.0b013e3182981137; Zhao CJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021768, 10.1371/journal.pone.0023925]	56	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e102382	10.1371/journal.pone.0102382	http://dx.doi.org/10.1371/journal.pone.0102382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093848	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200010
J	Davidson, AE; Cheong, SS; Hysi, PG; Venturini, C; Plagnol, V; Ruddle, JB; Ali, H; Carnt, N; Gardner, JC; Hassan, H; Gade, E; Kearns, L; Jelsig, AM; Restori, M; Webb, TR; Laws, D; Cosgrove, M; Hertz, JM; Russell-Eggitt, I; Pilz, DT; Hammond, CJ; Tuft, SJ; Hardcastle, AJ				Davidson, Alice E.; Cheong, Sek-Shir; Hysi, Pirro G.; Venturini, Cristina; Plagnol, Vincent; Ruddle, Jonathan B.; Ali, Hala; Carnt, Nicole; Gardner, Jessica C.; Hassan, Hala; Gade, Else; Kearns, Lisa; Jelsig, Anne Marie; Restori, Marie; Webb, Tom R.; Laws, David; Cosgrove, Michael; Hertz, Jens M.; Russell-Eggitt, Isabelle; Pilz, Daniela T.; Hammond, Christopher J.; Tuft, Stephen J.; Hardcastle, Alison J.			Association of CHRDL1 Mutations and Variants with X-linked Megalocornea, Neuhauser Syndrome and Central Corneal Thickness	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; GENOME-WIDE ASSOCIATION; MENTAL-RETARDATION SYNDROME; CUL4B GENE; CHROMOSOME; LTBP2; DIFFERENTIATION; HYPOGONADISM; BUPHTHALMOS; POPULATION	We describe novel CHRDL1 mutations in ten families with X-linked megalocornea (MGC1). Our mutation-positive cohort enabled us to establish ultrasonography as a reliable clinical diagnostic tool to distinguish between MGC1 and primary congenital glaucoma (PCG). Megalocornea is also a feature of Neuhauser or megalocornea-mental retardation (MMR) syndrome, a rare condition of unknown etiology. In a male patient diagnosed with MMR, we performed targeted and whole exome sequencing (WES) and identified a novel missense mutation in CHRDL1 that accounts for his MGC1 phenotype but not his non-ocular features. This finding suggests that MMR syndrome, in some cases, may be di- or multigenic. MGC1 patients have reduced central corneal thickness (CCT); however no X-linked loci have been associated with CCT, possibly because the majority of genome-wide association studies (GWAS) overlook the X-chromosome. We therefore explored whether variants on the X-chromosome are associated with CCT. We found rs149956316, in intron 6 of CHRDL1, to be the most significantly associated single nucleotide polymorphism (SNP) (p=6.81x10(-6)) on the X-chromosome. However, this association was not replicated in a smaller subset of whole genome sequenced samples. This study highlights the importance of including X-chromosome SNP data in GWAS to identify potential loci associated with quantitative traits or disease risk.	[Davidson, Alice E.; Cheong, Sek-Shir; Ali, Hala; Carnt, Nicole; Gardner, Jessica C.; Hassan, Hala; Webb, Tom R.; Tuft, Stephen J.; Hardcastle, Alison J.] UCL Inst Ophthalmol, London, England; [Hysi, Pirro G.; Venturini, Cristina; Hammond, Christopher J.] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Plagnol, Vincent] UCL Genet Inst, London, England; [Ruddle, Jonathan B.; Kearns, Lisa] Univ Melbourne, Ctr Eye Res, Dept Ophthalmol, Melbourne, Vic, Australia; [Carnt, Nicole; Hassan, Hala; Restori, Marie; Tuft, Stephen J.] Moorfields Eye Hosp, London, England; [Gade, Else] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark; [Jelsig, Anne Marie; Hertz, Jens M.] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Laws, David] Singleton Hosp, Dept Ophthalmol, Swansea SA2 8QA, W Glam, Wales; [Cosgrove, Michael] Singleton Hosp, Dept Women & Child Hlth, Swansea SA2 8QA, W Glam, Wales; [Russell-Eggitt, Isabelle] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Melbourne; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Singleton Hospital; Singleton Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cardiff University	Hardcastle, AJ (corresponding author), UCL Inst Ophthalmol, London, England.	a.hardcastle@ucl.ac.uk	Webb, Tom/GMW-5311-2022; Hertz, Jens Michael/H-6269-2014; Jelsig, Anne Marie/AAR-2372-2020; Carnt, Nicole/T-1585-2017; Webb, Tom/C-6237-2011	Hertz, Jens Michael/0000-0003-0087-4739; Carnt, Nicole/0000-0002-5376-0885; Webb, Tom/0000-0001-5998-8226; Venturini, Cristina/0000-0002-4769-7912; Hammond, Christopher/0000-0002-3227-2620; Hardcastle, Alison/0000-0002-0038-6770; Plagnol, Vincent/0000-0002-5597-9215; Cheong, Sek-Shir/0000-0002-2218-7852; Hysi, Pirro/0000-0001-5752-2510	National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Moorfields Special Trustees; Moorfields Eye Charity; Lanvern foundation; Rosetrees Trust; Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant [1023911]; National Institute for Health Research [SRF/01/010] Funding Source: researchfish; Rosetrees Trust [M311] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Moorfields Special Trustees; Moorfields Eye Charity; Lanvern foundation; Rosetrees Trust(Rosetrees Trust); Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	This work was supported by the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology; Moorfields Special Trustees; Moorfields Eye Charity; the Lanvern foundation; and Rosetrees Trust. CERA receives Operational Infrastructure Support from the Victorian Government. Funding support was provided by an Australian National Health and Medical Research Council (NHMRC) Centres of Research Excellence Grant 1023911 (2012-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Abu-Amero KK, 2011, MOL VIS, V17, P2911; Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Badura-Stronka M, 2010, CLIN GENET, V77, P141, DOI 10.1111/j.1399-0004.2009.01331.x; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; CAMERON JA, 1993, CORNEA, V12, P54, DOI 10.1097/00003226-199301000-00009; CHEN JD, 1989, HUM GENET, V83, P292, DOI 10.1007/BF00285176; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dimasi DP, 2010, BRIT J OPHTHALMOL, V94, P971, DOI 10.1136/bjo.2009.162735; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Gao WL, 2013, MOL MED REP, V7, P1143, DOI 10.3892/mmr.2013.1310; Gao XY, 2013, INVEST OPHTH VIS SCI, V54, P2435, DOI 10.1167/iovs.13-11692; Gutierrez-Amavizca BE, 2013, GENET COUNSEL, V24, P185; Han J, 2013, OPHTHALMIC GENETICS; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hoehn R, 2012, HUM GENET, V131, P1783, DOI 10.1007/s00439-012-1201-3; Isidor B, 2010, AM J MED GENET A, V152A, P175, DOI 10.1002/ajmg.a.33152; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; KUPFER C, 1979, AM J OPHTHALMOL, V88, P424, DOI 10.1016/0002-9394(79)90643-3; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; MEIRE FM, 1991, OPHTHALMIC PAED GEN, V12, P153, DOI 10.3109/13816819109029398; MEIRE FM, 1994, DOC OPHTHALMOL, V87, P6; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; NEUHAUSER G, 1975, Z KINDERHEILKD, V120, P1, DOI 10.1007/BF00443795; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; Piton A, 2013, AM J HUMAN GENETICS; Piva F, 2009, BIOINFORMATICS, V25, P1211, DOI 10.1093/bioinformatics/btp124; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; RUD ERIK, 1960, ACTA OPHTHALMOL, V38, P606; SARFARAZI M, 1995, GENOMICS, V30, P171, DOI 10.1006/geno.1995.9888; Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486; Stoilov IR, 2002, INVEST OPHTHALMOL VI, V2002; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; Webb TR, 2012, AM J HUM GENET, V90, P247, DOI 10.1016/j.ajhg.2011.12.019; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104163	10.1371/journal.pone.0104163	http://dx.doi.org/10.1371/journal.pone.0104163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093588	Green Published, gold			2022-12-25	WOS:000341357200078
J	Dillon, S; McEvoy, R; Baldwin, DS; Rees, GN; Parsons, Y; Southerton, S				Dillon, Shannon; McEvoy, Rachel; Baldwin, Darren S.; Rees, Gavin N.; Parsons, Yvonne; Southerton, Simon			Characterisation of Adaptive Genetic Diversity in Environmentally Contrasted Populations of Eucalyptus camaldulensis Dehnh. (River Red Gum)	PLOS ONE			English	Article							SECONDARY CELL-WALL; PINE PINUS-TAEDA; CLIMATE-CHANGE; LOCAL ADAPTATION; EVOLUTIONARY RESPONSES; ASSOCIATION GENETICS; CANDIDATE GENES; ABSCISIC-ACID; SELECTION; FOREST	As an increasing number of ecosystems face departures from long standing environmental conditions under climate change, our understanding of the capacity of species to adapt will become important for directing conservation and management of biodiversity. Insights into the potential for genetic adaptation might be gained by assessing genomic signatures of adaptation to historic or prevailing environmental conditions. The river red gum (Eucalyptus camaldulensis Dehnh.) is a widespread Australian eucalypt inhabiting riverine and floodplain habitats which spans strong environmental gradients. We investigated the effects of adaptation to environment on population level genetic diversity of E. camaldulensis, examining SNP variation in candidate gene loci sampled across 20 climatically diverse populations approximating the species natural distribution. Genetic differentiation among populations was high (F-ST = 17%), exceeding previous estimates based on neutral markers. Complementary statistical approaches identified 6 SNP loci in four genes (COMT, Dehydrin, ERECTA and PIP2) which, after accounting for demographic effects, exhibited higher than expected levels of genetic differentiation among populations and whose allelic variation was associated with local environment. While this study employs but a small proportion of available diversity in the eucalyptus genome, it draws our attention to the potential for application of wide spread eucalypt species to test adaptive hypotheses.	[Dillon, Shannon; Southerton, Simon] CSIRO Agr Flagship, Canberra, ACT, Australia; [McEvoy, Rachel; Parsons, Yvonne] La Trobe Univ, Dept Genet, Bundoora, Vic, Australia; [Baldwin, Darren S.; Rees, Gavin N.] Murray Darling Freshwater Res Ctr, Wodonga, Vic, Australia; [Baldwin, Darren S.; Rees, Gavin N.] CSIRO Land & Water Flagship, Wodonga, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); La Trobe University; Murray Darling Basin Authority; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dillon, S (corresponding author), CSIRO Agr Flagship, Canberra, ACT, Australia.	Shannon.Dillon@csiro.au	Rees, Gavin/U-5653-2019; Rees, Gavin/E-6869-2011; Baldwin, Darren S/H-2257-2011	Rees, Gavin/0000-0002-5270-8559; Rees, Gavin/0000-0002-5270-8559; Dillon, shannon/0000-0003-2277-9724	Department of Environment, Water, Heritage and the Arts Commonwealth Environmental Research Facilities Significant Project [13282]; CSIRO's Transformational Biology Catalytic Platform	Department of Environment, Water, Heritage and the Arts Commonwealth Environmental Research Facilities Significant Project; CSIRO's Transformational Biology Catalytic Platform	This project was funded by the Department of Environment, Water, Heritage and the Arts Commonwealth Environmental Research Facilities Significant Project funding (http://www.environment.gov.au/node/13282), and CSIRO's Transformational Biology Catalytic Platform (http://www.csiro.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Allen C. D., 2009, Unasylva (English ed.), V60, P43; Allen RJ, 1985, AUSTRALASIAN SUMMER; Audigeos D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-202; Awe J. O., 1976, Australian Forestry, V39, P201; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bradbury D, 2013, MOL ECOL, V22, P5112, DOI 10.1111/mec.12463; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bragg JG, 2014, NEW PHYTOL; Brooker M. I. H., 1999, FILED GUIDE EUCALYPT; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Butcher PA, 2009, TREE GENET GENOMES, V5, P189, DOI 10.1007/s11295-008-0169-6; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Cunningham SC, 2009, ECOSYSTEMS, V12, P207, DOI 10.1007/s10021-008-9218-0; Cunningham SC, 2010, AUSTRAL ECOL, V35, P348, DOI 10.1111/j.1442-9993.2009.02043.x; DAVIDSON NJ, 1989, AUST J ECOL, V14, P139, DOI 10.1111/j.1442-9993.1989.tb01423.x; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; Dillon SK, 2013, TREE GENET GENOMES, V9, P1447, DOI 10.1007/s11295-013-0650-8; Dillon SK, 2012, NEW PHYTOL, V195, P596, DOI 10.1111/j.1469-8137.2012.04200.x; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Eckert AJ, 2009, GENETICS, V182, P1289, DOI 10.1534/genetics.109.102350; El-Lakany MH, 1980, ALEXANDRIA J AGR RES, V28, P309; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2005, EVOLUTIONARY BIOINFO, V1; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; GIBSON A, 1995, AUST J PLANT PHYSIOL, V22, P453, DOI 10.1071/PP9950453; GIBSON A, 1991, AUST J PLANT PHYSIOL, V18, P153, DOI 10.1071/PP9910153; Gibson A, 1994, RELATIONSHIPS SITE C; Gonzalez-Martinez SC, 2008, HEREDITY, V101, P19, DOI 10.1038/hdy.2008.21; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GRUNWALD C, 1983, SILVAE GENET, V32, P165; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanna P, 2012, FOREST ECOL MANAG, V274, P91, DOI 10.1016/j.foreco.2012.02.009; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hao GP, 2009, J INTEGR PLANT BIOL, V51, P175, DOI 10.1111/j.1744-7909.2008.00786.x; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Hubick K. T., 1993, Stable isotopes and plant carbon-water relations., P311; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; JAMES SA, 1995, AUST J BOT, V43, P415, DOI 10.1071/BT9950415; Jeffreys H., 1961, THEORY PROBABILITY; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kaldenhoff R, 2006, ACTA PHYSIOL, V187, P169, DOI 10.1111/j.1748-1716.2006.01563.x; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kulheim C, 2011, NEW PHYTOL, V191, P1041, DOI 10.1111/j.1469-8137.2011.03769.x; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Lemcoff JH, 2002, FLORA, V197, P134, DOI 10.1078/0367-2530-00023; Li LG, 2006, CRIT REV PLANT SCI, V25, P215, DOI 10.1080/07352680600611519; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; McDonald MW, 2009, AUST SYST BOT, V22, P257, DOI 10.1071/SB09005; Millar CI, 2012, CAN J FOREST RES, V42, P749, DOI [10.1139/X2012-031, 10.1139/x2012-031]; MORESHET S, 1981, AUST J BOT, V29, P97, DOI 10.1071/BT9810097; Mosca E, 2014, NEW PHYTOL, V201, P180, DOI 10.1111/nph.12476; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Orsini L, 2013, MOL ECOL, V22, P5983, DOI 10.1111/mec.12561; OTEGBEYE GO, 1985, SILVAE GENET, V34, P121; Paccard A, 2013, J EVOLUTION BIOL, V26, P2331, DOI 10.1111/jeb.12220; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petherick L, 2013, QUATERNARY SCI REV, V74, P58, DOI 10.1016/j.quascirev.2012.12.012; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rorat T, 2007, CELL MOL BIOL LETT, V12, P148, DOI 10.2478/s11658-006-0044-0; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schaberg PG, 2008, FOREST ECOL MANAG, V256, P855, DOI 10.1016/j.foreco.2008.06.038; Schueler S, 2013, BIODIVERS CONSERV, V22, P1151, DOI 10.1007/s10531-012-0313-3; SESBOU A, 1978, ANN SCI FOREST, V35, P237, DOI 10.1051/forest/19780401; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; Thumma BR, 2012, BMC GENOMIC IN PRESS; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; Wachowiak W, 2009, TREE GENET GENOMES, V5, P117, DOI 10.1007/s11295-008-0188-3; Ward D, 2012, ANN BOT-LONDON, V109, P247, DOI 10.1093/aob/mcr276; Wen L, 2009, ECOHYDROLOGY, V2, P143, DOI 10.1002/eco.46; Xia H, 2010, MOL ECOL, V19, P4144, DOI 10.1111/j.1365-294X.2010.04762.x	101	33	34	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103515	10.1371/journal.pone.0103515	http://dx.doi.org/10.1371/journal.pone.0103515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093589	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200024
J	Ido, N; Lee, K; Iwabuchi, K; Izumiya, H; Uchida, I; Kusumoto, M; Iwata, T; Ohnishi, M; Akiba, M				Ido, Noriko; Lee, Ken-ichi; Iwabuchi, Kaori; Izumiya, Hidemasa; Uchida, Ikuo; Kusumoto, Masahiro; Iwata, Taketoshi; Ohnishi, Makoto; Akiba, Masato			Characteristics of Salmonella enterica Serovar 4,[5], 12: i:- as a Monophasic Variant of Serovar Typhimurium	PLOS ONE			English	Article							FLAGELLAR PHASE VARIATION; MOLECULAR CHARACTERIZATION; PHENOTYPIC CHARACTERISTICS; SEROTYPE TYPHIMURIUM; DNA; PLASMID; STRAIN	Salmonella enterica subspecies enterica serovar 4,[5], 12: i:-(S. 4,[5] 12: i:-) is believed to be a monophasic variant of S. enterica serovar Typhimurium (S. Typhimurium). This study was conducted to corroborate this hypothesis and to identify the molecular and phenotypic characteristics of the S. 4,[5] 12: i:-isolates in Japan. A total of 51 S. 4,[5] 12: i:-isolates derived from humans, cattle, swine, chickens, birds, meat (pork), and river water in 15 prefectures in Japan between 2000 and 2010 were analyzed. All the S. 4,[5], 12: i:-isolates were identified as S. Typhimurium by two different polymerase chain reactions (PCR) for identification of S. Typhimurium. Of the 51 S. 4,[5], 12: i:-isolates, 39 (76.5%) harbored a 94-kb virulence plasmid, which is known to be specific for S. Typhimurium. These data suggest that the S. 4,[5], 12: i:-isolates are monophasic variants of S. Typhimurium. The flagellar phase variation is induced by three adjacent genes (fljA, fljB, and hin) in the chromosome. The results of PCR mapping of this region and comparative genomic hybridization analysis suggested that the deletion of the fljAB operon and its flanking region was the major genetic basis of the monophasic phenotype of S. 4,[5], 12: i:-. The fljAB operon and hin gene were detectable in eight of the S. 4,[5], 12: i:-isolates with common amino acid substitutions of A46T in FljA and R140L in Hin. The introduction of these mutations into S. Typhimurium isolates led to the loss of selectability of isolates expressing the phase 2 H antigen. These data suggested that a point mutation was the genetic basis, at least in part, of the S. 4,[5], 12: i:-isolates. The results of phenotypic analysis suggested that the S. 4,[5], 12: i:-isolates in Japan consist of multiple distinct clones. This is the first detailed characterization of the S. 4,[5], 12: i:-isolates derived from various sources across Japan.	[Ido, Noriko] Iwate Prefecture Cent Livestock Hyg Serv Ctr, Takizawa, Iwate, Japan; [Lee, Ken-ichi; Kusumoto, Masahiro; Iwata, Taketoshi; Akiba, Masato] Natl Agr & Food Res Org, Bacterial & Parasit Dis Res Div, Natl Inst Anim Hlth, Ibaraki, Japan; [Iwabuchi, Kaori] Res Inst Environm Sci & Publ Hlth Iwate Prefectur, Takizawa, Iwate, Japan; [Izumiya, Hidemasa; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Uchida, Ikuo] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Infectious Diseases (NIID); National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University	Akiba, M (corresponding author), Natl Agr & Food Res Org, Bacterial & Parasit Dis Res Div, Natl Inst Anim Hlth, Ibaraki, Japan.	akiba@affrc.go.jp	Lee, Ken-ichi/E-9423-2010	Lee, Ken-ichi/0000-0002-4765-0989	Ministry of Agriculture, Forestry and Fisheries of Japan [24-7304]; Ministry of Health, Labour, and Welfare of Japan [H24-Shokuhin-Ippan-008]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid from the Ministry of Agriculture, Forestry and Fisheries of Japan (Research project for ensuring food safety from farm to table 24-7304), and the Ministry of Health, Labour, and Welfare of Japan (H24-Shokuhin-Ippan-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba M, 2011, J MICROBIOL METH, V85, P9, DOI 10.1016/j.mimet.2011.02.002; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Burnens AP, 1997, MICROBIOL-UK, V143, P1539, DOI 10.1099/00221287-143-5-1539; Centers for Disease Control and Prevention, 2008, SALM SURV ANN SUMM; Clinical and Laboratory Standards Institute, 2008, M31A3 CLIN LAB STAND; de la Torre E, 2003, J CLIN MICROBIOL, V41, P2395, DOI 10.1128/JCM.41.6.2395-2400.2003; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; Edwards PR, 1986, EDWARDS WINGS IDENTI; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; FENG JA, 1994, SCIENCE, V263, P348, DOI 10.1126/science.8278807; Gallati C, 2013, FOODBORNE PATHOG DIS, V10, P549, DOI 10.1089/fpd.2012.1407; Garaizar J, 2002, J CLIN MICROBIOL, V40, P2074, DOI 10.1128/JCM.40.6.2074-2078.2002; Grimont P. A. D., 2000, Salmonella in domestic animals., P1, DOI 10.1079/9780851992617.0001; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Ido N, 2011, J VET MED SCI, V73, P241, DOI 10.1292/jvms.10-0140; IINO T, 1969, BACTERIOL REV, V33, P454, DOI 10.1128/MMBR.33.4.454-475.1969; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Majtan V, 2011, CURR MICROBIOL, V63, P491, DOI 10.1007/s00284-011-0010-6; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mossong J, 2007, Euro Surveill, V12, pE11; Namimatsu T, 2006, J VET MED SCI, V68, P187, DOI 10.1292/jvms.68.187; National Institute of Infectious Diseases, 2014, INFECT AGENTS SURVEI; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; SIMON M, 1980, SCIENCE, V209, P1370, DOI 10.1126/science.6251543; STOCKER BAD, 1949, J HYG-CAMBRIDGE, V47, P398, DOI 10.1017/S002217240001473X; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Takahashi Toshio, 2006, Kansenshogaku Zasshi, V80, P185; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Zamperini K, 2007, AVIAN DIS, V51, P958, DOI 10.1637/7944-021507-REGR.1	35	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104380	10.1371/journal.pone.0104380	http://dx.doi.org/10.1371/journal.pone.0104380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093666	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200106
J	Kiuchi, K; Kitamura, S; Taoka, T; Yasuno, F; Tanimura, M; Matsuoka, K; Ikawa, D; Toritsuka, M; Hashimoto, K; Makinodan, M; Kosaka, J; Morikawa, M; Kichikawa, K; Kishimoto, T				Kiuchi, Kuniaki; Kitamura, Soichiro; Taoka, Toshiaki; Yasuno, Fumihiko; Tanimura, Masami; Matsuoka, Kiwamu; Ikawa, Daisuke; Toritsuka, Michihiro; Hashimoto, Kazumichi; Makinodan, Manabu; Kosaka, Jun; Morikawa, Masayuki; Kichikawa, Kimihiko; Kishimoto, Toshifumi			Gray and White Matter Changes in Subjective Cognitive Impairment, Amnestic Mild Cognitive Impairment and Alzheimer's Disease: A Voxel-Based Analysis Study	PLOS ONE			English	Article							GLOBAL DETERIORATION SCALE; MEMORY IMPAIRMENT; HYPOTHETICAL MODEL; DYNAMIC BIOMARKERS; DEMENTIA; DECLINE; SCHIZOPHRENIA; ABNORMALITIES; ASSOCIATION; MARKERS	Subjective cognitive impairment may be a very early at-risk period of the continuum of dementia. However, it is difficult to discriminate at-risk states from normal aging. Thus, detection of the early pathological changes in the subjective cognitive impairment period is needed. To elucidate these changes, we employed diffusion tensor imaging and volumetry analysis, and compared subjective cognitive impairment with normal, mild cognitive impairment and Alzheimer's disease. The subjects in this study were 39 Alzheimer's disease, 43 mild cognitive impairment, 28 subjective cognitive impairment and 41 normal controls. There were no statistically significant differences between the normal control and subjective cognitive impairment groups in all measures. Alzheimer's disease and mild cognitive impairment had the same extent of brain atrophy and diffusion changes. These results are consistent with the hypothetical model of the dynamic biomarkers of Alzheimer's disease.	[Kiuchi, Kuniaki; Kitamura, Soichiro; Yasuno, Fumihiko; Matsuoka, Kiwamu; Ikawa, Daisuke; Toritsuka, Michihiro; Hashimoto, Kazumichi; Makinodan, Manabu; Kosaka, Jun; Morikawa, Masayuki; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Kashihara, Nara 634, Japan; [Kiuchi, Kuniaki; Kitamura, Soichiro; Yasuno, Fumihiko; Matsuoka, Kiwamu; Kishimoto, Toshifumi] Nara Med Univ, Med Ctr Dementia, Kashihara, Nara 634, Japan; [Kiuchi, Kuniaki] Sakai City Mental Hlth Ctr, Sakai, Osaka, Japan; [Kitamura, Soichiro] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Taoka, Toshiaki; Kichikawa, Kimihiko] Nara Med Univ, Dept Radiol, Kashihara, Nara 634, Japan; [Tanimura, Masami] Doshisha Univ, Fac Psychol, Kyoto 602, Japan; [Morikawa, Masayuki] Mie Prefectural Mental Care Ctr, Tsu, Mie, Japan	Nara Medical University; Nara Medical University; National Institutes for Quantum Science & Technology; Nara Medical University; Doshisha University	Kiuchi, K (corresponding author), Nara Med Univ, Dept Psychiat, Kashihara, Nara 634, Japan.	kuniaki@naramed-u.ac.jp	Taoka, Toshiaki/A-1637-2016	Taoka, Toshiaki/0000-0001-9227-0240; Kiuchi, Kuniaki/0000-0003-3305-5270	JSPS KAKENHI [22791138]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 22791138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Cummings JL, 2007, NEUROLOGY, V69, P1622, DOI 10.1212/01.wnl.0000295996.54210.69; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Galeone F, 2011, INT J GERIATR PSYCH, V26, P695, DOI 10.1002/gps.2583; Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Grambaite R, 2010, J INT NEUROPSYCH SOC, V16, P58, DOI 10.1017/S1355617709990932; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Harwood DG, 2000, NEUROPSY NEUROPSY BE, V13, P83; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Kamagata K, 2013, MAGN RESON IMAGING, V31, P1501, DOI 10.1016/j.mri.2013.06.009; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Kubicki M, 2002, NEUROIMAGE, V17, P1711, DOI 10.1006/nimg.2002.1296; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Luis CA, 2003, NEUROLOGY, V61, P438, DOI 10.1212/01.WNL.0000080366.90234.7F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moonis M, 2005, NEUROLOGY, V65, P323, DOI 10.1212/01.wnl.0000171397.32851.bc; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P661; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Selnes P, 2013, J ALZHEIMERS DIS, V33, P723, DOI 10.3233/JAD-2012-121603; Selnes Per, 2012, Alzheimers Dement, V8, pS112, DOI 10.1016/j.jalz.2011.07.001; Snitz BE, 2013, NEUROLOGY, V80, P1378, DOI 10.1212/WNL.0b013e31828c2fc8; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Stewart R, 2011, BRIT J PSYCHIAT, V198, P199, DOI 10.1192/bjp.bp.110.078683; Striepens N, 2010, DEMENT GERIATR COGN, V29, P75, DOI 10.1159/000264630; van Norden AGW, 2008, NEUROLOGY, V71, P1152, DOI 10.1212/01.wnl.0000327564.44819.49; Vogel A, 2005, INT J GERIATR PSYCH, V20, P238, DOI 10.1002/gps.1272; Wang Y, 2012, BBA-MOL BASIS DIS, V1822, P423, DOI 10.1016/j.bbadis.2011.08.002; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Wolkin A, 1998, AM J PSYCHIAT, V155, P1064, DOI 10.1176/ajp.155.8.1064	44	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104007	10.1371/journal.pone.0104007	http://dx.doi.org/10.1371/journal.pone.0104007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093415	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200058
J	Pfortmueller, CA; Schankath, AC; Mordasini, P; Koetter, J; Wiest, R; Exadaktylos, AK; Puig, S				Pfortmueller, Carmen A.; Schankath, Adrian C.; Mordasini, Pasquale; Koetter, Jana; Wiest, Roland; Exadaktylos, Aristomenis K.; Puig, Stefan			Radiological Findings of Sexual Intercourse Related Emergency Department Admissions: A First Overview	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; SUBARACHNOID HEMORRHAGE; MEDICOLEGAL POSTMORTEM; HEADACHE; AMNESIA; RISK	Objectives: Sexuality is an essential aspect of human function, well-being and quality of life. Many people have sex without complications. However, there are some people who need to seek emergency medical help for related health problems. The aim of this study was to present a first overview of patients who received a radiological examination related to sexual intercourse based emergency department admission. Methods: Our centralized electronic patient record database was reviewed for patients who had been admitted to our emergency department with an emergency after sexual intercourse between 2000 and 2011. The database was scanned for the standardized key words 'sexual intercourse' or 'coitus' retrospectively. For all patients identified in the electronic patient record database the radiological examinations were searched for manually in our Radiology Information System, and reviewed by three independent radiologists. Results: One hundred and twenty nine out of 445 (29,0%) patients received a radiological examination after immediate emergency department admission related to sexual intercourse. Fifty two out of 129 (40.3%) patients had positive radiological findings while 77 (59.7%) did not. Eighty point seven percent (n=42) of the radiological findings were a sexual intercourse-associated pathology and 19.2% (n=10) were considered to be incidental findings. Age and male sex positively correlated with radiological imaging workup (p<0.001, respectively p<0.037). The most common sexual intercourse-associated pathology was headache attributed to cerebrovascular insult (n=21, 40.3%) followed by epididymitis (n=7, 16.6%) and obstructive uropathy (n=5, 11.6%). Of the patients with headache attributed to non-traumatic intracranial hemorrhage, subarachnoid hemorrhage (n=14, 66.6%) was the most common, followed by intracerebral bleeding (n=4, 19.0%) and one subdural hemorrhage. Conclusions: Pathological findings are manifold. Cerebral imaging is the most common type of radiological imaging performed. Further prospective and standardized studies should be performed to better evaluate the significance of radiological imaging in this patient collective with the aim to gain better knowledge on what patients profit from what type of radiological imaging when presenting with a sexual intercourse related emergency. Advances in Knowledge: The present study provides a first overview on radiological findings of sexual intercourse related emergency department admissions.	[Pfortmueller, Carmen A.] Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria; [Schankath, Adrian C.; Puig, Stefan] Univ Hosp Bern, Univ Inst Diagnost Intervent & Pediat Radiol, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Schankath, Adrian C.; Mordasini, Pasquale; Koetter, Jana; Wiest, Roland; Exadaktylos, Aristomenis K.; Puig, Stefan] Univ Bern, Bern, Switzerland; [Mordasini, Pasquale; Wiest, Roland] Univ Hosp Bern, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.; Koetter, Jana; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Univ Dept Emergency Med, CH-3010 Bern, Switzerland	Medical University of Vienna; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Pfortmueller, CA (corresponding author), Med Univ Vienna, Dept Gen Anaesthesiol Intens Care & Pain Manageme, Vienna, Austria.	cpfortmueller@gmail.com	Mordasini, Pasquale/H-8321-2015	Pfortmueller, Carmen/0000-0003-0326-2770				Backes D, 2012, STROKE, V43, P2115, DOI 10.1161/STROKEAHA.112.658880; Banerjee A, 1996, POSTGRAD MED J, V72, P653, DOI 10.1136/pgmj.72.853.653; Becker K, 2004, ARCH NEUROL-CHICAGO, V61, P1114, DOI 10.1001/archneur.61.7.1114; Brazzelli M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007424.pub2; Chen XJ, 2009, INDIAN J MED RES, V130, P681; DINNING TAR, 1953, LANCET, V265, P799; Drory Y, 2002, EUR HEART J SUPPL, V4, pH13, DOI 10.1016/S1520-765X(02)90047-7; Eke N, 2002, BJU INT, V89, P273, DOI 10.1046/j.1464-4096.2001.01458.x; Evans RW, 2001, HEADACHE, V41, P512, DOI 10.1046/j.1526-4610.2001.01091.x; Fann JR, 2000, J NEUROL NEUROSUR PS, V69, P768, DOI 10.1136/jnnp.69.6.768; Hu CM, 2010, J CLIN NEUROSCI, V17, P1349, DOI 10.1016/j.jocn.2010.01.052; Ifergan J, 2012, Diagn Interv Imaging, V93, P509, DOI 10.1016/j.diii.2012.03.010; Johansen TEB, 2004, WORLD J UROL, V22, P392, DOI 10.1007/s00345-004-0414-z; Kriz K, 1970, Cesk Neurol, V33, P162; Larner AJ, 2008, J SEX MED, V5, P284, DOI 10.1111/j.1743-6109.2007.00654.x; Lee J, 2000, J TRAUMA, V49, P351, DOI 10.1097/00005373-200008000-00029; Lee SJ, 2008, EUR J NEUROL, V15, pE101, DOI 10.1111/j.1468-1331.2008.02322.x; Lee S, 2006, J KOREAN MED SCI, V21, P995, DOI 10.3346/jkms.2006.21.6.995; Maloy K, 2011, J EMERG MED, V41, P257, DOI 10.1016/j.jemermed.2008.02.048; Masters WH., 1966, HUMAN SEXUAL RESPONS; Morris-Stiff Gareth, 2008, J Med Case Rep, V2, P6, DOI 10.1186/1752-1947-2-6; Parzeller M, 1999, Z KARDIOL, V88, P44, DOI 10.1007/s003920050262; Pfortmueller Carmen A, 2012, EMERGENCY MED J; PORTER M, 1981, ARCH NEUROL-CHICAGO, V38, P710, DOI 10.1001/archneur.1981.00510110070011; Portunato, 2012, AM J FOREN MED PATH, V33, P90; Provenzale JM, 2010, EMERG RADIOL, V17, P403, DOI 10.1007/s10140-010-0882-y; Reynolds MR, 2011, J NEUROSURG, V114, P969, DOI 10.3171/2010.4.JNS09975; Scholes D, 2005, ANN INTERN MED, V142, P20, DOI 10.7326/0003-4819-142-1-200501040-00008; Stuckey SL, 2007, AM J ROENTGENOL, V189, P913, DOI 10.2214/AJR.07.2424; Valenca MM, 2004, HEADACHE, V44, P244, DOI 10.1111/j.1526-4610.2004.04054.x; Wagenlehner FME, 2011, UROLOGE, V50, P1248, DOI 10.1007/s00120-011-2616-5; Wilson L, 2006, UROL RES, V34, P225, DOI 10.1007/s00240-006-0039-3	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104170	10.1371/journal.pone.0104170	http://dx.doi.org/10.1371/journal.pone.0104170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093844	Green Published, gold			2022-12-25	WOS:000341357200082
J	Klinker, H; Haas, C; Harrer, N; Becker, PB; Mueller-Planitz, F				Klinker, Henrike; Haas, Caroline; Harrer, Nadine; Becker, Peter B.; Mueller-Planitz, Felix			Rapid Purification of Recombinant Histones	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; NUCLEOSOME CORE PARTICLES; ISWI; RECONSTITUTION; PROTEINS; DNA	The development of methods to assemble nucleosomes from recombinant histones decades ago has transformed chromatin research. Nevertheless, nucleosome reconstitution remains time consuming to this day, not least because the four individual histones must be purified first. Here, we present a streamlined purification protocol of recombinant histones from bacteria. We termed this method "rapid histone purification'' (RHP) as it circumvents isolation of inclusion bodies and thereby cuts out the most time-consuming step of traditional purification protocols. Instead of inclusion body isolation, whole cell extracts are prepared under strongly denaturing conditions that directly solubilize inclusion bodies. By ion exchange chromatography, the histones are purified from the extracts. The protocol has been successfully applied to all four canonical Drosophila and human histones. RHP histones and histones that were purified from isolated inclusion bodies had similar purities. The different purification strategies also did not impact the quality of octamers reconstituted from these histones. We expect that the RHP protocol can be readily applied to the purification of canonical histones from other species as well as the numerous histone variants.	[Klinker, Henrike; Harrer, Nadine; Becker, Peter B.; Mueller-Planitz, Felix] Univ Munich, Adolf Butenandt Inst, Mol Biol Unit, Munich, Germany; [Klinker, Henrike; Becker, Peter B.] Ctr Integrated Prot Sci, Munich, Germany; [Haas, Caroline] Univ Munich, Dept Biochem, Munich, Germany; [Haas, Caroline] Univ Munich, Gene Ctr, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Mueller-Planitz, F (corresponding author), Univ Munich, Adolf Butenandt Inst, Mol Biol Unit, Marchioninistr 15, Munich, Germany.	Felix.Mueller-Planitz@med.uni-muenchen.de	Mueller-Planitz, Felix/P-8461-2014	Mueller-Planitz, Felix/0000-0001-8273-6473; Becker, Peter/0000-0001-7186-0372	Deutsche Forschungsgemeinschaft [MU3613/1-1, SFB 1064 TP A7, SFB594 TP A6]; Ernst Schering Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst Schering Foundation	This work was supported by the Deutsche Forschungsgemeinschaft [MU3613/1-1 and SFB 1064 TP A7 to FMP; SFB594 TP A6 to PBB]. CH was supported by the Ernst Schering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Klinker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088411; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1999, METH MOL B, V119, P1; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Shim Y, 2012, ANAL BIOCHEM, V427, P190, DOI 10.1016/j.ab.2012.05.006; STARK GR, 1960, J BIOL CHEM, V235, P3177; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Vary JC, 2004, METHOD ENZYMOL, V375, P88; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322	17	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104029	10.1371/journal.pone.0104029	http://dx.doi.org/10.1371/journal.pone.0104029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090252	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700084
J	Sheng, BB; Zheng, ZJ; Lv, M; Zhang, HW; Qin, T; Gao, C; Ma, CQ; Xu, P				Sheng, Binbin; Zheng, Zhaojuan; Lv, Min; Zhang, Haiwei; Qin, Tong; Gao, Chao; Ma, Cuiqing; Xu, Ping			Efficient Production of (R)-2-Hydroxy-4-Phenylbutyric Acid by Using a Coupled Reconstructed D-Lactate Dehydrogenase and Formate Dehydrogenase System	PLOS ONE			English	Article							ENZYME ACE INHIBITORS; ETHYL 2-OXO-4-PHENYLBUTYRATE; ENANTIOSELECTIVE REDUCTION; ASYMMETRIC REDUCTION; KINETIC RESOLUTION; CARBOXYLIC-ACIDS; INTERMEDIATE; COLI	Background: (R)-2-Hydroxy-4-phenylbutyric acid [(R)-HPBA] is a key precursor for the production of angiotensin-converting enzyme inhibitors. However, the product yield and concentration of reported (R)-HPBA synthetic processes remain unsatisfactory. Methodology/Principal Findings: The Y52L/F299Y mutant of NAD-dependent D-lactate dehydrogenase (D-nLDH) in Lactobacillus bulgaricus ATCC 11842 was found to have high bio-reduction activity toward 2-oxo-4-phenylbutyric acid (OPBA). The mutant D-nLDH Y52L/F299Y was then coexpressed with formate dehydrogenase in Escherichia coli BL21 (DE3) to construct a novel biocatalyst E. coli DF. Thus, a novel bio-reduction process utilizing whole cells of E. coli DF as the biocatalyst and formate as the co-substrate for cofactor regeneration was developed for the production of (R)-HPBA from OPBA. The biocatalysis conditions were then optimized. Conclusions/Significance: Under the optimum conditions, 73.4 mM OPBA was reduced to 71.8 mM (R)-HPBA in 90 min. Given its high product enantiomeric excess (>99%) and productivity (47.9 mM h(-1)), the constructed coupling biocatalysis system is a promising alternative for (R)-HPBA production.	[Sheng, Binbin; Lv, Min; Zhang, Haiwei; Qin, Tong; Gao, Chao; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zheng, Zhaojuan] Nanjing Forestry Univ, Coll Chem Engn, Nanjing, Jiangsu, Peoples R China	Shandong University; Nanjing Forestry University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	jieerbu@sdu.edu.cn		Gao, Chao/0000-0002-5205-0670; Xu, Ping/0000-0002-4418-9680; Ma, Cuiqing/0000-0002-7468-1027	National Natural Science Foundation of China [31270856, 31170052, 31270090, J1103515]; Independent Innovation Foundation of Shandong University [2012GN017]; Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province [BS2013SW025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University; Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province	This work was supported by the National Natural Science Foundation of China (31270856, 31170052, 31270090 and J1103515), the Independent Innovation Foundation of Shandong University (2012GN017) and the Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province (BS2013SW025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YL, 2005, BIOTECHNOL BIOENG, V92, P137, DOI 10.1002/bit.20582; Bai YL, 2007, ENZYME MICROB TECH, V40, P940, DOI 10.1016/j.enzmictec.2006.07.035; de Lacerda PSB, 2006, TETRAHEDRON-ASYMMETR, V17, P1186, DOI 10.1016/j.tetasy.2006.04.008; Chen B, 2010, CHEM COMMUN, V46, P2754, DOI 10.1039/b925402a; Chen Y, 2008, ADV SYNTH CATAL, V350, P426, DOI 10.1002/adsc.200700420; de Lacerda PSB, 2006, BIOCHEM ENG J, V28, P299, DOI 10.1016/j.bej.2006.01.003; Frohlich P, 2011, ORG BIOMOL CHEM, V9, P7941, DOI 10.1039/c1ob06064c; Gao C, 2013, BIORESOURCE TECHNOL, V137, P111, DOI 10.1016/j.biortech.2013.02.115; He CM, 2008, TETRAHEDRON-ASYMMETR, V19, P1347, DOI 10.1016/j.tetasy.2008.05.003; Huang Y, 2010, CURR ORG CHEM, V14, P1447, DOI 10.2174/138527210791616795; IWASAKI G, 1989, CHEM PHARM BULL, V37, P280; KALARITIS P, 1990, J ORG CHEM, V55, P812, DOI 10.1021/jo00290a007; Larissegger-Schnell B, 2006, TETRAHEDRON, V62, P2912, DOI 10.1016/j.tet.2006.01.007; Lin WQ, 2001, TETRAHEDRON-ASYMMETR, V12, P1583, DOI 10.1016/S0957-4166(01)00285-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Nakamura K, 2003, TETRAHEDRON-ASYMMETR, V14, P2659, DOI 10.1016/S0957-4166(03)00526-3; Ni Y, 2013, J BIOTECHNOL, V168, P493, DOI 10.1016/j.jbiotec.2013.09.021; SCHMIDT E, 1992, J BIOTECHNOL, V24, P315, DOI 10.1016/0168-1656(92)90040-G; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; Shen ND, 2012, ORG LETT, V14, P1982, DOI 10.1021/ol300397d; Shi YG, 2009, BIOCATAL BIOTRANSFOR, V27, P211, DOI 10.1080/10242420902808333; Shi YG, 2009, J CHEM TECHNOL BIOT, V84, P681, DOI 10.1002/jctb.2099; Singhvi M, 2013, BIORESOURCE TECHNOL, V146, P736, DOI 10.1016/j.biortech.2013.07.057; Su YN, 2012, CHINESE J CATAL, V33, P1650, DOI 10.1016/S1872-2067(11)60436-1; Wang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02643; Yu SH, 2014, BIOTECHNOL LETT, V36, P627, DOI 10.1007/s10529-013-1404-2; Yun H, 2005, BIOTECHNOL PROGR, V21, P366, DOI 10.1021/bp049694w; Zhang W, 2009, PROCESS BIOCHEM, V44, P1270, DOI 10.1016/j.procbio.2009.07.011; Zheng ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03401; Zheng ZJ, 2012, APPL ENVIRON MICROB, V78, P3480, DOI 10.1128/AEM.00058-12; Zheng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019030	31	12	13	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104204	10.1371/journal.pone.0104204	http://dx.doi.org/10.1371/journal.pone.0104204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089519	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700110
J	Hu, Y; Yin, KL; Ma, X; Xia, HF				Hu, Yi; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei			Anti-PABPC1 Co-Immunoprecipitation for Examining the miRNAs Directly Targeting the 3 '-UTR of EED mRNA	PLOS ONE			English	Article							TRANSLATIONAL REPRESSION; BINDING PROTEINS; GW182; ARGONAUTE; REQUIRES; DEGRADATION; DEADENYLASE; COMPLEXES; TNRC6C; SITES	MicroRNAs (miRNAs) are small, noncoding RNA molecules that regulate post-transcriptional gene expression by base pairing with partially complementary sequences within target messenger RNAs (mRNAs). Although the target genes and the precise biological functions of individual miRNAs remain largely unknown, miRNAs have been implicated in diverse biological processes, including both normal and pathological states. As a single stranded mRNA can be directly targeted by multiple miRNAs, and as the target sites may exist in the 3'-untranslated region (UTR), 5'-UTR, or the coding regions, it is essential to develop an effective method to identify the full-scale miRNA regulatory pattern of each particular gene. In this study, we employed a biochemical approach to identify the miRNA profiles that regulate the expression of embryonic ectoderm development (EED) protein by using anti-PABPC1 ribonucleoprotein (RNP) co-immunoprecipitation (Co-IP). The full length EED mRNA was subcloned into an expression vector and transiently transfected into a Flag-PABPC1 stable expression cell line. Subsequent to cross-linking and an anti-Hag Co-IP, the miRNAs that directly targeted EED were identified. We found that the best time point to distinguish the positive miRNAs from the background was 18 hours after the plasmid transfection. As expected, the miRNAs that directly target EED were found to interact with EED mRNA through the miRNA-induced silencing complex (miRISC). Meanwhile, the EED mRNA was bound by Flag-PABPC1. This method depends on the integrity of the miRISC complex and achieves greater efficiency when ultraviolet irradiation is used for the process of cross-linking. By using anti-PABPC1 RIP, we identified EED to be a new target gene of miR-16; a finding further confirmed using a dual-luciferase assay. In summary, our data indicate that anti-PABPC1 RIP is a validated and direct biochemical method to provide data about specific miRNA-mRNA interactions, as well as global miRNA patterns regulating the mRNAs.	[Hu, Yi; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China; [Hu, Yi; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Hu, Yi] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Microbiology, CAS	Xia, HF (corresponding author), Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China.	genetic@263.net.cn; hongfeixia@126.com		Hu, Yi/0000-0002-5432-1438	Natural Science Foundation of China [81370720, 81301446]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from Natural Science Foundation of China (No. 81370720, No. 81301446). http://www.nsfc.gov.cn/Portal0/default166.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; ILYIN YV, 1969, J MOL BIOL, V41, P299, DOI 10.1016/0022-2836(69)90395-7; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; Song PP, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.045; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	34	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103695	10.1371/journal.pone.0103695	http://dx.doi.org/10.1371/journal.pone.0103695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084349	gold, Green Submitted, Green Published			2022-12-25	WOS:000339819800066
J	Cai-McRae, X; Zhong, H; Karantza, V				Cai-McRae, X.; Zhong, H.; Karantza, V.			Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways	ONCOGENE			English	Article							TRANSCRIPTION FACTOR NRF2; BINDING PROTEIN P62; BREAST-CANCER; BETA-CATENIN; TRASTUZUMAB RESISTANCE; IN-SITU; AUTOPHAGY; PTEN; KINASE; P62/SQSTM1	Previous studies have shown that increased levels of the adaptor protein Sequestosome 1/p62 are observed in human breast cancers and significantly correlate with HER2 overexpression. However, the role of p62 in the pathophysiology of HER2-induced mammary tumorigenesis has not yet been investigated. In this study, we report that p62 facilitates HER2-mediated cell survival in both two-dimensional and three-dimensional cell culture and that HER2-induced cellular transformation requires p62, as well as NRF2, which is known to become stabilized by its release from Kelch-like ECH-associated protein 1 (KEAP1) via p62-KEAP1 interaction. In agreement with these results, genetic ablation of p62 delays HER2-induced mammary tumorigenesis in tumor cell allografts in nude mice, and in MMTV-Neu transgenic mice. We also report that ablation of p62 impairs AKT and beta-catenin activation in association with PTEN (phosphatase and tensin homolog deleted on chromosome ten) accumulation, both in vitro and in vivo. Further in vivo studies suggest that loss of p62 also impairs NF-kappa B and NRF2 activation. Collectively, our results provide compelling evidence that p62 contributes to HER2-induced mammary tumorigenesis through multiple signaling pathways, including the PTEN/phosphoinositide-3-kinase/AKT axis, WNT/beta-catenin signaling, the NF-kappa B pathway and the NRF2-KEAP1 axis, and offer novel insights into the potential role of p62 in the regulation of the tumor suppressor PTEN.	[Cai-McRae, X.; Karantza, V.] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Cai-McRae, X.; Zhong, H.; Karantza, V.] Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Med Med Oncol, New Brunswick, NJ 08903 USA; [Zhong, H.] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ USA; [Karantza, V.] Rutgers Robert Wood Johnson Med Sch, Dept Internal Med, Div Med Oncol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Karantza, V (corresponding author), Rutgers State Univ, Rutgers Canc Inst New Jersey, Dept Med Med Oncol, 195 Little Albany St,Rm 3550, New Brunswick, NJ 08903 USA.	karantzav@gmail.com						Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Chang MA, 2014, PROSTATE, V74, P149, DOI 10.1002/pros.22737; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Depowski PL, 2001, MODERN PATHOL, V14, P672, DOI 10.1038/modpathol.3880371; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Joung I, 2005, BIOCHEM BIOPH RES CO, V334, P654, DOI 10.1016/j.bbrc.2005.06.138; Karantza-Wadsworth V, 2008, METHOD ENZYMOL, V446, P61, DOI 10.1016/S0076-6879(08)01604-2; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LIU E, 1992, ONCOGENE, V7, P1027; Lozy F, 2014, AUTOPHAGY, V10, P662, DOI 10.4161/auto.27867; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Ozes ON, 1999, NATURE, V401, P82; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park K, 2006, HISTOPATHOLOGY, V48, P702, DOI 10.1111/j.1365-2559.2006.02403.x; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Schade B, 2013, CANCER RES, V73, P4474, DOI 10.1158/0008-5472.CAN-12-3925; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0	50	26	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 4	2015	34	23					2968	2977		10.1038/onc.2014.244	http://dx.doi.org/10.1038/onc.2014.244			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CK3EX	25088198	Bronze			2022-12-25	WOS:000356100500003
J	Thorne, MAS; Kagoshima, H; Clark, MS; Marshall, CJ; Wharton, DA				Thorne, Michael A. S.; Kagoshima, Hiroshi; Clark, Melody S.; Marshall, Craig J.; Wharton, David A.			Molecular Analysis of the Cold Tolerant Antarctic Nematode, Panagrolaimus davidi	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; RIBONUCLEIC-ACID POPULATIONS; CRYOPROTECTIVE DEHYDRATION; DEVELOPMENTAL BIOCHEMISTRY; COTTONSEED EMBRYOGENESIS; CAENORHABDITIS-ELEGANS; LEA PROTEIN; C-ELEGANS; SURVIVAL; TREHALOSE	Isolated and established in culture from the Antarctic in 1988, the nematode Panagrolaimus davidi has proven to be an idel model for the study of adaptation to the cold. Not only is it the best-documented example of an organism surviving intracellular freezing but it is also able to undergo cryoprotective dehydration. As part of an ongoing effort to develop a molecular understanding of this remarkable organism, we have assembled both a transcriptome and a set of genomic scaffolds. We provide an overview of the transcriptome and a survey of genes involved in temperature stress. We also explore, in silico, the possibility that P. davidi will be susceptible to an environmental RNAi response, important for further functional studies.	[Thorne, Michael A. S.; Clark, Melody S.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Kagoshima, Hiroshi] Res Org Informat & Syst, Transdisciplinary Res Intergrat Ctr, Tokyo, Japan; [Kagoshima, Hiroshi] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Marshall, Craig J.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Wharton, David A.] Univ Otago, Dept Zool, Dunedin, New Zealand	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Research Organization of Information & Systems (ROIS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Otago; University of Otago	Thorne, MAS (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	mior@bas.ac.uk	Marshall, Craig J./C-6668-2009; Clark, Melody S/D-7371-2014	Marshall, Craig J./0000-0003-4186-0368; Clark, Melody S/0000-0002-3442-3824; Thorne, Michael/0000-0001-7759-612X; Wharton, David/0000-0001-6369-4984	NERC core funding; Japan Society [23510239]; Transdisciplinary Research Integration Center (TRIC); Research Organisation of Information and Systems (ROIS); Departments of Zoology and Biochemistry at the University of Otago; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	NERC core funding; Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Transdisciplinary Research Integration Center (TRIC); Research Organisation of Information and Systems (ROIS); Departments of Zoology and Biochemistry at the University of Otago; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	MAST and MSC were supported by NERC core funding to the British Antarctic Survey. HK was supported by grant-in-aid for scientific research (No. 23510239) from the Japan Society for the Promotion of Science. Further support came from the Transdisciplinary Research Integration Center (TRIC), the Research Organisation of Information and Systems (ROIS), and the Departments of Zoology and Biochemistry at the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahrndorff S, 2009, J INSECT PHYSIOL, V55, P210, DOI 10.1016/j.jinsphys.2008.11.010; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; BRENNER S, 1974, GENETICS, V77, P71; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Clark MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-328; Clark MS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-475; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; GALAU GA, 1981, BIOCHEMISTRY-US, V20, P4169, DOI 10.1021/bi00517a034; Goldstein Paul, 1996, Cytobios, V85, P81; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Hooper D. J., 1986, Laboratory methods for work with plant and soil nematodes., P5; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunault G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-221; Jaspard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036968; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kayukawa T, 2007, INSECT BIOCHEM MOLEC, V37, P1160, DOI 10.1016/j.ibmb.2007.07.007; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Lewis SC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-15; Li S, 2012, P NATL ACAD SCI USA, V109, P20859, DOI 10.1073/pnas.1214893109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Raymond MR, 2014, ANTARCT SCI, V26, P15, DOI 10.1017/S0954102013000230; Raymond MR, 2013, J COMP PHYSIOL B, V183, P181, DOI 10.1007/s00360-012-0697-0; Ring RA, 1998, CRYOLETTERS, V19, P275; SALT R. W., 1957, CANADIAN ENT, V89, P491; SALT RW, 1962, NATURE, V193, P1207, DOI 10.1038/1931207a0; SALT RW, 1959, NATURE, V184, P1426, DOI 10.1038/1841426a0; Shannon AJ, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-58; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Spieth J, 2006, OVERVIEW GENE STRUCT; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thorne MAS, 2011, INSECT MOL BIOL, V20, P303, DOI 10.1111/j.1365-2583.2010.01062.x; TIMM RW, 1971, P HELM SOC WASH, V38, P42; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tunnacliffe A, 2005, HYDROBIOLOGIA, V546, P315, DOI 10.1007/s10750-005-4239-6; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tyson Trevor, 2012, BMC Research Notes, V5, P68, DOI 10.1186/1756-0500-5-68; Walters KR, 2009, P NATL ACAD SCI USA, V106, P20210, DOI 10.1073/pnas.0909872106; WHARTON DA, 1995, J EXP BIOL, V198, P1381; WHARTON DA, 1989, NEW ZEAL J ZOOL, V16, P467, DOI 10.1080/03014223.1989.10422914; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; Wharton DA, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P182, DOI 10.1079/9781845936877.0182; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Wise Michael J, 2002, Bioinformatics, V18 Suppl 1, pS38; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	63	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104526	10.1371/journal.pone.0104526	http://dx.doi.org/10.1371/journal.pone.0104526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098249	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339995100081
J	Lo Sciuto, A; Fernandez-Pinar, R; Bertuccini, L; Iosi, F; Superti, F; Imperi, F				Lo Sciuto, Alessandra; Fernandez-Pinar, Regina; Bertuccini, Lucia; Iosi, Francesca; Superti, Fabiana; Imperi, Francesco			The Periplasmic Protein TolB as a Potential Drug Target in Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-ENVELOPE; PAL PROTEINS; RESISTANCE; INFECTION; VIRULENCE; PATHOGENESIS; ORGANIZATION; LIPOPROTEIN; INVOLVEMENT	The Gram-negative bacterium Pseudomonas aeruginosa is one of the most dreaded pathogens in the hospital setting, and represents a prototype of multi-drug resistant "superbug'' for which effective therapeutic options are very limited. The identification and characterization of new cellular functions that are essential for P. aeruginosa viability and/or virulence could drive the development of anti-Pseudomonas compounds with novel mechanisms of action. In this study we investigated whether TolB, the periplasmic component of the Tol-Pal trans-envelope protein complex of Gram-negative bacteria, represents a potential drug target in P. aeruginosa. By combining conditional mutagenesis with the analysis of specific pathogenicity-related phenotypes, we demonstrated that TolB is essential for P. aeruginosa growth, both in laboratory and clinical strains, and that TolB-depleted P. aeruginosa cells are strongly defective in cell-envelope integrity, resistance to human serum and several antibiotics, as well as in the ability to cause infection and persist in an insect model of P. aeruginosa infection. The essentiality of TolB for P. aeruginosa growth, resistance and pathogenicity highlights the potential of TolB as a novel molecular target for anti-P. aeruginosa drug discovery.	[Lo Sciuto, Alessandra; Fernandez-Pinar, Regina; Imperi, Francesco] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Bertuccini, Lucia; Iosi, Francesca; Superti, Fabiana] Natl Inst Hlth, Dept Technol & Hlth, Ultrastruct Infect Pathol Sect, Rome, Italy; [Imperi, Francesco] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, I-00185 Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Fondazione Cenci Bolognetti; Sapienza University Rome	Imperi, F (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	francesco.imperi@uniroma1.it	BERTUCCINI, LUCIA/F-2102-2015; IOSI, FRANCESCA/F-2106-2015; Superti, Fabiana/F-2100-2015; Bertuccini, Lucia/AAI-6683-2021; Imperi, Francesco/AAA-3671-2021	IOSI, FRANCESCA/0000-0002-5929-6833; Superti, Fabiana/0000-0003-4909-7598; Bertuccini, Lucia/0000-0002-4278-2376; 	Fundacion Alfonso Martin Escudero (Spain); Pasteur Institute-Cenci Bolognetti Foundation	Fundacion Alfonso Martin Escudero (Spain); Pasteur Institute-Cenci Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	Regina Fernandez-Pinar is supported by a Post-doc fellowship from the Fundacion Alfonso Martin Escudero (Spain). The work on essential periplasmic proteins in Francesco Imperi's laboratory is supported by a grant from the Pasteur Institute-Cenci Bolognetti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; BERNSTEIN A, 1972, J BACTERIOL, V112, P74, DOI 10.1128/JB.112.1.74-83.1972; Bertuccini L, 2014, DIGEST LIVER DIS, V46, P496, DOI 10.1016/j.dld.2014.02.009; Bowe F, 1998, INFECT IMMUN, V66, P3372, DOI 10.1128/IAI.66.7.3372-3377.1998; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Bulitta JB, 2010, ANTIMICROB AGENTS CH, V54, P2051, DOI 10.1128/AAC.00881-09; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Heilpern AJ, 2000, J BACTERIOL, V182, P1739, DOI 10.1128/JB.182.6.1739-1747.2000; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Lazzaroni JC, 2002, BIOCHIMIE, V84, P391, DOI 10.1016/S0300-9084(02)01419-0; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liss L, 1987, FOCUS, V9, P13; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; Massai F, 2011, BIOSENS BIOELECTRON, V26, P3444, DOI 10.1016/j.bios.2011.01.022; Mdluli KE, 2006, ANTIMICROB AGENTS CH, V50, P2178, DOI 10.1128/AAC.00140-06; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rossolini GM, 2005, CLIN MICROBIOL INFEC, V11, P17, DOI 10.1111/j.1469-0691.2005.01161.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skurnik D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003582; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; Vaara M, 2013, J ANTIMICROB CHEMOTH, V68, P1213, DOI 10.1093/jac/dkt039; WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10	41	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103784	10.1371/journal.pone.0103784	http://dx.doi.org/10.1371/journal.pone.0103784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093328	Green Submitted, Green Published, gold			2022-12-25	WOS:000341357200030
J	Alsheikh-Ali, AA; Omar, MI; Raal, FJ; Rashed, W; Hamoui, O; Kane, A; Alami, M; Abreu, P; Mashhoud, WM				Alsheikh-Ali, Alawi A.; Omar, Mohamed I.; Raal, Frederick J.; Rashed, Wafa; Hamoui, Omar; Kane, Abdoul; Alami, Mohamed; Abreu, Paula; Mashhoud, Walid M.			Cardiovascular Risk Factor Burden in Africa and the Middle East: The Africa Middle East Cardiovascular Epidemiological (ACE) Study	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; DISEASE PREVENTION; GULF REGISTRY; MYOCARDIAL-INFARCTION; LOW-INCOME; HEALTH; OBESITY; INTERVENTION; DETERMINANTS; INTERHEART	Background: Increased urbanization in the developing world parallels a rising burden of chronic diseases. Developing countries account for similar to 80% of global cardiovascular (CV) deaths, but contribute a paucity of systematic epidemiological data on CV risk factors. Objective: To estimate the prevalence of CV risk factors in rural and urban cohorts attending general practice clinics in the Africa and Middle East (AfME) region. Methods: In a cross-sectional epidemiological study, the presence of CV risk factors (hypertension, diabetes mellitus (diabetes), dyslipidemia, obesity, smoking and abdominal obesity) were evaluated in stable adult outpatients attending general practice primary care clinics. A rural population was defined as isolated (>50 km or lack of easy access to commuter transportation) from urban centers. Results: 4,378 outpatients were systematically recruited from 94 clinics across 14 AfME countries. Mean age was 46 +/- 14 years and 52% of outpatients were female. A high prevalence of dyslipidemia (70%) and abdominal obesity (68%) were observed, followed by hypertension (43%) and diabetes (25%). The vast majority of outpatients (92%) had at least one modifiable CV risk factor, many (74%) had more than one, and half (53%) had 3 or more. These findings were observed in both genders and across urban and rural centers. Among outpatients with pre-existing hypertension or dyslipidemia, many were not at their target blood pressure or LDL-cholesterol goals. Conclusion: Cardiovascular risk factors are highly prevalent among relatively young, stable outpatients attending general practice clinics across AfME. The findings support opportunistic screening for CV risk factors whenever outpatients visit a general practitioner and provide an opportunity for early identification and management of CV risk factors, including lifestyle interventions.	[Alsheikh-Ali, Alawi A.] Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates; [Omar, Mohamed I.] Pfizer AfME, Dubai Media City, Dubai, U Arab Emirates; [Raal, Frederick J.] Johannesburg Hosp, Fac Hlth Sci, Dept Med, Johannesburg, South Africa; [Rashed, Wafa] Mubarak Kabeer Hosp, Al Jabriya, Kuwait; [Hamoui, Omar] Clemenceau Med Ctr, Beirut, Lebanon; [Kane, Abdoul] Hop Gen Grand Yoff, Dakar, Senegal; [Alami, Mohamed] Mohammed V Univ, Rabat, Morocco; [Abreu, Paula] Pfizer Inc, New York, NY USA; [Mashhoud, Walid M.] Pfizer Saudi Arabia, Jeddah, Saudi Arabia	Pfizer; University of Witwatersrand; Mohammed V University in Rabat; Pfizer; Pfizer; Pfizer - Saudi Arabia	Alsheikh-Ali, AA (corresponding author), Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates.	aalsheikhali@alum.mit.edu	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938; ALAMI, MOHAMED/0000-0003-1960-6769	Pfizer	Pfizer(Pfizer)	This study was sponsored by Pfizer. Additional editorial support was provided by Steph Milsom at PHASE II International, Esher, Surrey, UK, and funded by Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Although Pfizer does not deposit clinical trial data into a publicly available resource, Pfizer makes every effort to provide access to clinical data via a data transfer agreement for researchers and investigators who wish to utilize the data to address medically relevant hypotheses. The authors, three of whom are employees at Pfizer, were involved in all aspects of the study design and implementation and we have stated the roles of each of the authors in the 'Additional Information - Author Contributions' section of the online form. All authors have contributed significantly to this work, and meet requirements for authorship in compliance with the International Committee of Medical Journal Editors guidelines. All listed authors have seen and approved the revised version submitted.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agarwal DP, 2001, IJHG, V1, P233; Ajlouni K, 1998, INT J OBESITY, V22, P624, DOI 10.1038/sj.ijo.0800637; Al-Kaabba A., 2012, OJEMD, V2, P89, DOI [10.4236/ojemd.2012.24014, DOI 10.4236/OJEMD.2012.24014]; Alarouj M, 2013, INT J CLIN PRACT, V67, P89, DOI 10.1111/ijcp.12064; Alsheikh-Ali AA, 2009, EUR J HEART FAIL, V11, P1135, DOI 10.1093/eurjhf/hfp151; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Awad HH, 2011, AM J CARDIOL, V108, P1252, DOI 10.1016/j.amjcard.2011.06.040; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Brockerhoff MP, 2000, POPUL BULL, V55, P3; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Chadha SL, 1998, CURR SCI INDIA, V74, P1069; Del Brutto OH, 2013, ENVIRON HEALTH PREV, V18, P422, DOI 10.1007/s12199-013-0344-8; Fuster V, 2007, CIRCULATION, V116, P1966, DOI 10.1161/CIRCULATIONAHA.107.733444; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gehani AA, 2012, EUR J PREV CARD 1102; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2001, NIH PUBLICATION, V01-3670; Health of Populations in Transition (HoPiT), 2004, CAM BURD DIAB CAMBOD; Hollar D, 2010, AM J PUBLIC HEALTH, V100, P646, DOI 10.2105/AJPH.2009.165746; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Diabetes Federation, 2005, IDF CONS WORLDW DEF; Levenson James W, 2002, Prev Cardiol, V5, P188, DOI 10.1111/j.1520-037X.2002.00564.x; Okello E, 2013, CARDIOVASC J AFR, V24, P80, DOI [10.5830/CVJA-2013-004, 10.5830/cvja-2013-004]; Opie LH, 2005, CIRCULATION, V112, P3536, DOI 10.1161/CIRCULATIONAHA.105.597765; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Reddy KS, 2002, PUBLIC HEALTH NUTR, V5, P231, DOI 10.1079/PHN2001298; Schernthaner G, 2008, DIABETES CARE, V31, pS297, DOI 10.2337/dc08-s270; Selvarajah S, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-10; Stern R, 2010, PREV CHRONIC DIS, V7; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Strasser R, 2003, FAM PRACT, V20, P457, DOI 10.1093/fampra/cmg422; van Drenth BB, 2000, INT J QUAL HEALTH C, V12, P319, DOI 10.1093/intqhc/12.4.319; World Health Organization, 2006, COUNTR COOP STRAT WH; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700; Zubaid M, 2009, ACTA CARDIOL, V64, P439, DOI 10.2143/AC.64.4.2041607	39	77	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102830	10.1371/journal.pone.0102830	http://dx.doi.org/10.1371/journal.pone.0102830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090638	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700010
J	Baidya, M; Genovez, M; Torres, M; Chao, MY				Baidya, Melvin; Genovez, Marx; Torres, Marissa; Chao, Michael Y.			Dopamine Modulation of Avoidance Behavior in Caenorhabditis elegans Requires the NMDA Receptor NMR-1	PLOS ONE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; ASH NEURONS; PLASTICITY; RESPONSES; CURRENTS; POTENTIATION; SENSITIVITY; SUBUNIT; PATHWAY	The nematode C. elegans utilizes a relatively simple neural circuit to mediate avoidance responses to noxious stimuli such as the volatile odorant octanol. This avoidance behavior is modulated by dopamine. cat-2 mutant animals that are deficient in dopamine biosynthesis have an increased response latency to octanol compared to wild type animals, and this defect can be fully restored with the application of exogenous dopamine. Because this avoidance behavior is mediated by glutamatergic signaling between sensory neurons and premotor interneurons, we investigated the genetic interactions between dopaminergic signaling and ionotropic glutamate receptors. cat-2 mutant animals lacking either the GLR-1 or GLR-2 AMPA/kainate receptors displayed an increased response latency to octanol, which could be restored via exogenous dopamine. However, whereas cat-2 mutant animals lacking the NMR-1 NMDA receptor had increased response latency to octanol they were insensitive to exogenous dopamine. Mutants that lacked both AMPA/kainate and NMDA receptors were also insensitive to exogenous dopamine. Our results indicate that dopamine modulation of octanol avoidance requires NMR-1, consistent with NMR-1 as a potential downstream signaling target for dopamine.	[Baidya, Melvin; Genovez, Marx; Torres, Marissa; Chao, Michael Y.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	California State University System; California State University San Bernardino	Chao, MY (corresponding author), Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.	mchao@csusb.edu			National Institute of General Medical Science [1SC3GM089597]; College of Natural Sciences, California State University San Bernardino; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM089597] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); College of Natural Sciences, California State University San Bernardino; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institute of General Medical Science (1SC3GM089597) and the College of Natural Sciences, California State University San Bernardino. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cepeda C, 2009, FRONT NEUROSCI, P41; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chao MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-45; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase Daniel L, 2007, WormBook, P1; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chergui K, 1999, NEUROPHARMACOLOGY, V38, P223, DOI 10.1016/S0028-3908(98)00187-7; CULOTTI JG, 1978, GENETICS, V90, P243; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Hapiak V, 2013, J NEUROSCI, V33, P14107, DOI 10.1523/JNEUROSCI.1324-13.2013; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hart AC, 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1]; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hutter H, 2003, DEVELOPMENT, V130, P5307, DOI 10.1242/dev.00727; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lints R, 1999, DEVELOPMENT, V126, P5819; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Mills H, 2012, EMBO J, V31, P667, DOI 10.1038/emboj.2011.422; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Rios M, 1999, J NEUROSCI, V19, P3519; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Stiernagle Theresa, 2006, WormBook, P1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Zhuo M, 2000, Prog Brain Res, V129, P101	50	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102958	10.1371/journal.pone.0102958	http://dx.doi.org/10.1371/journal.pone.0102958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089710	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700013
J	Dong, YF; Tian, H; Wang, W; Zhang, XN; Liu, JX; Ru, SG				Dong, Yifei; Tian, Hua; Wang, Wei; Zhang, Xiaona; Liu, Jinxiang; Ru, Shaoguo			Disruption of the Thyroid System by the Thyroid-Disrupting Compound Aroclor 1254 in Juvenile Japanese Flounder (Paralichthys olivaceus)	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; I IODOTHYRONINE DEIODINASE; POLYCHLORINATED-BIPHENYLS; HORMONE LEVELS; ONCORHYNCHUS-KISUTCH; FISH DEVELOPMENT; TELEOST FISH; COHO SALMON; PERCHLORATE; METAMORPHOSIS	Polychlorinated biphenyls (PCBs) are a group of persistent organochlorine compounds that have the potential to disrupt the homeostasis of thyroid hormones (THs) in fish, particularly juveniles. In this study, thyroid histology, plasma TH levels, and iodothyronine deiodinase (IDs, including ID1, ID2, and ID3) gene expression patterns were examined in juvenile Japanese flounder (Paralichthys olivaceus) following 25- and 50-day waterborne exposure to environmentally relevant concentrations of a commercial PCB mixture, Aroclor 1254 (10, 100, and 1000 ng/L) with two-thirds of the test solutions renewed daily. The results showed that exposure to Aroclor 1254 for 50 d increased follicular cell height, colloid depletion, and hyperplasia. In particular, hypothyroidism, which was induced by the administration of 1000 ng/L Aroclor 1254, significantly decreased plasma TT4, TT3, and FT3 levels. Profiles of the changes in mRNA expression levels of IDs were observed in the liver and kidney after 25 and 50 d PCB exposure, which might be associated with a reduction in plasma THs levels. The expression level of ID2 mRNA in the liver exhibited a dose-dependent increase, indicating that this ID isotype might serve as sensitive and stable indicator for thyroid-disrupting chemical (TDC) exposure. Overall, our study confirmed that environmentally relevant concentrations of Aroclor 1254 cause significant thyroid disruption, with juvenile Japanese flounder being suitable candidates for use in TDC studies.	[Dong, Yifei; Tian, Hua; Wang, Wei; Zhang, Xiaona; Liu, Jinxiang; Ru, Shaoguo] Ocean Univ China, Marine Life Sci Coll, Qingdao, Shandong, Peoples R China	Ocean University of China	Ru, SG (corresponding author), Ocean Univ China, Marine Life Sci Coll, Qingdao, Shandong, Peoples R China.	rusg@ouc.edu.cn	Tian, Hua/GPP-4477-2022		National Natural Science Foundation of China [31202001]; Natural Science Foundation of Shandong Province [ZR2012CQ010]; Marine Public Scientific Research Funding Project [2012418012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Marine Public Scientific Research Funding Project	This work was supported by the National Natural Science Foundation of China (31202001) www.nsfc.gov.cn, Natural Science Foundation of Shandong Province (ZR2012CQ010) www.sdnsf.gov.cn, and Marine Public Scientific Research Funding Project (2012418012) www.soa.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BA, 2000, COMP BIOCHEM PHYS C, V127, P367, DOI 10.1016/S0742-8413(00)00164-X; Besselink HT, 1996, ENVIRON POLLUT, V92, P267, DOI 10.1016/0269-7491(95)00116-6; Blanton ML, 2007, CRIT REV TOXICOL, V37, P97, DOI 10.1080/10408440601123529; Bradford CM, 2005, ENVIRON SCI TECHNOL, V39, P5190, DOI 10.1021/es0484505; Brown SB, 2004, ENVIRON TOXICOL CHEM, V23, P1680, DOI 10.1897/03-242; Brown SB, 2004, AQUAT TOXICOL, V67, P75, DOI 10.1016/j.aquatox.2003.12.002; Brown SB, 2002, AQUAT TOXICOL, V59, P139, DOI 10.1016/S0166-445X(01)00246-6; Castells P, 2008, CHEMOSPHERE, V70, P1552, DOI 10.1016/j.chemosphere.2007.08.034; Coimbra AM, 2005, COMP BIOCHEM PHYS C, V141, P8, DOI 10.1016/j.cca.2005.04.006; Crane HM, 2005, ENVIRON HEALTH PERSP, V113, P396, DOI 10.1289/ehp.7333; Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165, DOI 10.1007/BF00182342; Drezner Z, 2010, COMMUN STAT-SIMUL C, V39, P693, DOI 10.1080/03610911003615816; Eales JG, 1999, AM SOC TEST MATER, V1364, P136, DOI 10.1520/STP15801S; EALES JG, 1993, REV FISH BIOL FISHER, V3, P299, DOI 10.1007/BF00043383; FOK P, 1990, FISH PHYSIOL BIOCHEM, V8, P281, DOI 10.1007/BF00003423; FOLMAR LC, 1982, AQUAT TOXICOL, V2, P291, DOI 10.1016/0166-445X(82)90017-0; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; HIGGS DA, 1977, GEN COMP ENDOCR, V32, P29, DOI 10.1016/0016-6480(77)90080-6; INUI Y, 1989, GEN COMP ENDOCR, V74, P406, DOI 10.1016/S0016-6480(89)80038-3; INUI Y, 1985, GEN COMP ENDOCR, V60, P450, DOI 10.1016/0016-6480(85)90080-2; Iwanowicz LR, 2009, AQUAT TOXICOL, V93, P70, DOI 10.1016/j.aquatox.2009.03.008; Jugan ML, 2010, BIOCHEM PHARMACOL, V79, P939, DOI 10.1016/j.bcp.2009.11.006; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; LEATHERLAND JF, 1978, J FISH RES BOARD CAN, V35, P1285, DOI 10.1139/f78-202; Leroy KD, 2006, COMP BIOCHEM PHYS C, V144, P263, DOI 10.1016/j.cbpc.2006.09.005; Leung AM, 2010, BEST PRACT RES CL EN, V24, P133, DOI 10.1016/j.beem.2009.08.009; Li W, 2009, AQUAT TOXICOL, V94, P87, DOI 10.1016/j.aquatox.2009.06.002; Liu FJ, 2006, ENVIRON SCI TECHNOL, V40, P3429, DOI 10.1021/es052538g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MIWA S, 1992, J EXP ZOOL, V261, P424, DOI 10.1002/jez.1402610409; MIWA S, 1991, J EXP ZOOL, V259, P222, DOI 10.1002/jez.1402590211; MORENO M, 1994, FEBS LETT, V344, P143, DOI 10.1016/0014-5793(94)00365-3; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; Okada N, 2005, FISHERIES SCI, V71, P107, DOI 10.1111/j.1444-2906.2005.00937.x; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Palace VP, 2001, CHEMOSPHERE, V45, P185, DOI 10.1016/S0045-6535(00)00577-4; Picard-Aitken M, 2007, AQUAT TOXICOL, V83, P200, DOI 10.1016/j.aquatox.2007.04.004; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Schmidt F, 2012, AQUAT TOXICOL, V109, P47, DOI 10.1016/j.aquatox.2011.11.004; Schnitzler JG, 2011, AQUAT TOXICOL, V105, P438, DOI 10.1016/j.aquatox.2011.07.019; Sprovieri M, 2007, CHEMOSPHERE, V67, P998, DOI 10.1016/j.chemosphere.2006.10.055; Tian H, 2010, AQUAT TOXICOL, V98, P67, DOI 10.1016/j.aquatox.2010.01.011; Van der Geyten S, 1998, FISH PHYSIOL BIOCHEM, V19, P135, DOI 10.1023/A:1007790527748; Van der Geyten S, 2005, J ENDOCRINOL, V184, P467, DOI 10.1677/joe.1.05986; Van der Geyten S, 2001, GEN COMP ENDOCR, V124, P333, DOI 10.1006/gcen.2001.7722; Yamano K, 2005, JARQ-JPN AGR RES Q, V39, P161, DOI 10.6090/jarq.39.161; YAMANO K, 1991, GEN COMP ENDOCR, V81, P464, DOI 10.1016/0016-6480(91)90174-5; Zhang XN, 2013, GEN COMP ENDOCR, V193, P158, DOI 10.1016/j.ygcen.2013.08.003; Zhang ZL, 2003, CHEMOSPHERE, V52, P1423, DOI 10.1016/S0045-6535(03)00478-8	50	23	24	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104196	10.1371/journal.pone.0104196	http://dx.doi.org/10.1371/journal.pone.0104196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090620	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700108
J	Ghimire, R; Norton, JB; Stahl, PD; Norton, U				Ghimire, Rajan; Norton, Jay B.; Stahl, Peter D.; Norton, Urszula			Soil Microbial Substrate Properties and Microbial Community Responses under Irrigated Organic and Reduced-Tillage Crop and Forage Production Systems	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ENZYME-ACTIVITIES; CARBON; NITROGEN; BIOMASS; AGROECOSYSTEMS; MANAGEMENT; BACTERIAL; TURNOVER; IMPACT	Changes in soil microbiotic properties such as microbial biomass and community structure in response to alternative management systems are driven by microbial substrate quality and substrate utilization. We evaluated irrigated crop and forage production in two separate four-year experiments for differences in microbial substrate quality, microbial biomass and community structure, and microbial substrate utilization under conventional, organic, and reduced-tillage management systems. The six different management systems were imposed on fields previously under long-term, intensively tilled maize production. Soils under crop and forage production responded to conversion from monocropping to crop rotation, as well as to the three different management systems, but in different ways. Under crop production, four years of organic management resulted in the highest soil organic C (SOC) and microbial biomass concentrations, while under forage production, reduced-tillage management most effectively increased SOC and microbial biomass. There were significant increases in relative abundance of bacteria, fungi, and protozoa, with two-to 36-fold increases in biomarker phospholipid fatty acids (PLFAs). Under crop production, dissolved organic C (DOC) content was higher under organic management than under reduced-tillage and conventional management. Perennial legume crops and organic soil amendments in the organic crop rotation system apparently favored greater soil microbial substrate availability, as well as more microbial biomass compared with other management systems that had fewer legume crops in rotation and synthetic fertilizer applications. Among the forage production management systems with equivalent crop rotations, reduced-tillage management had higher microbial substrate availability and greater microbial biomass than other management systems. Combined crop rotation, tillage management, soil amendments, and legume crops in rotations considerably influenced soil microbiotic properties. More research will expand our understanding of combined effects of these alternatives on feedbacks between soil microbiotic properties and SOC accrual.	[Ghimire, Rajan; Norton, Jay B.; Stahl, Peter D.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Norton, Urszula] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Norton, JB (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA.	jnorton4@uwyo.edu	Norton, Urszula/AAX-6303-2021; Ghimire, Rajan/D-6947-2011; Ghimire, Rajan/AAF-6487-2020	Ghimire, Rajan/0000-0002-6962-6066	USDA National Institute of Food and Agriculture [2009-55618-05097]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Agricultural Prosperity for Small and Medium-Sized Farms Competitive Grant no. 2009-55618-05097 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V., 2010, Diversity, V2, P910; Acosta-Martinez V, 2007, APPL SOIL ECOL, V37, P41, DOI 10.1016/j.apsoil.2007.03.009; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Berthrong ST, 2013, MICROB ECOL, V66, P158, DOI 10.1007/s00248-013-0225-0; Blake G. R., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P377; Blanco-Canqui H, 2007, SOIL SCI SOC AM J, V71, P1770, DOI 10.2136/sssaj2007.0048; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buyer JS, 2002, CAN J MICROBIOL, V48, P955, DOI [10.1139/w02-095, 10.1139/W02-095]; Carpenter-Boggs L, 2003, SOIL TILL RES, V71, P15, DOI 10.1016/S0167-1987(02)00158-7; Delate K, 2004, AGRON J, V96, P1288, DOI 10.2134/agronj2004.1288; DEVOS P, 1985, INT J SYST BACTERIOL, V35, P169, DOI 10.1099/00207713-35-2-169; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fliessbach A, 2007, AGR ECOSYST ENVIRON, V118, P273, DOI 10.1016/j.agee.2006.05.022; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Gardner W. H., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P493; Gee G.W., 1986, METHODS SOIL ANAL PA, P383, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Ghimire R, 2014, PLANT SOIL, V374, P173, DOI 10.1007/s11104-013-1854-2; Ghimire R, 2013, RENEW AGR FOOD SYST, V28, P183, DOI 10.1017/S1742170512000208; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; JENKINSON DS, 1989, SOIL BIOL BIOCHEM, V21, P535, DOI 10.1016/0038-0717(89)90127-2; Kandeler E, 1999, BIOL FERT SOILS, V28, P343, DOI 10.1007/s003740050502; KRALL J M, 1991, Journal of Agronomic Education, V20, P120; Liebig M, 2006, RENEW AGR FOOD SYST, V21, P36, DOI 10.1079/RAF2005124; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; Minoshima H, 2007, SOIL SCI SOC AM J, V71, P952, DOI 10.2136/sssaj2006.0174; Ngosong C, 2010, APPL SOIL ECOL, V46, P134, DOI 10.1016/j.apsoil.2010.07.004; Nie M, 2013, ECOL LETT, V16, P234, DOI 10.1111/ele.12034; Norton JB, 2012, SOIL SCI SOC AM J, V76, P505, DOI 10.2136/sssaj2011.0284; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Shannon CE., 1949, MATH THEORY COMMUNIC; Sherrod LA, 2002, SOIL SCI SOC AM J, V66, P299, DOI 10.2136/sssaj2002.0299; Shi YC, 2012, APPL SOIL ECOL, V62, P14, DOI 10.1016/j.apsoil.2012.07.004; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Soil Survey Staff, 2013, WEB SOIL SURV; Stahl PD, 1999, BIOL FERT SOILS, V29, P92, DOI 10.1007/s003740050530; Stout J.D., 1980, Advances in Microbial Ecology, V4, P1; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Thomas G. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P475; Western Regional Climate Center, 2013, HIST CLIM INF	44	52	54	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103901	10.1371/journal.pone.0103901	http://dx.doi.org/10.1371/journal.pone.0103901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090235	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700062
J	White, SA; Buscaino, A; Sanchez-Pulido, L; Ponting, CP; Nowicki, MW; Allshire, RC				White, Sharon A.; Buscaino, Alessia; Sanchez-Pulido, Luis; Ponting, Chris P.; Nowicki, Matthew W.; Allshire, Robin C.			The RFTS Domain of Raf2 Is Required for Cul4 Interaction and Heterochromatin Integrity in Fission Yeast	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; HISTONE MODIFICATION; CENTROMERE FUNCTION; RNA INTERFERENCE; UBIQUITIN LIGASE; CHROMATIN; METHYLATION; COMPLEX	Centromeric heterochromatin assembly in fission yeast is critical for faithful chromosome segregation at mitosis. Its assembly requires a concerted pathway of events whereby the RNA interference (RNAi) pathway guides H3K9 methylation to target sequences. H3K9 methylation, a hallmark of heterochromatin structure, is mediated by the single histone methyltransferase Clr4 (equivalent to metazoan Suv3-9), a component of the CLRC complex. Loss of or defects in CLRC components disrupts heterochromatin formation due to loss of H3K9 methylation, thus an intact, fully functional CLRC complex is required for heterochromatin integrity. Despite its importance, little is known about the contribution of the CLRC component Raf2 to H3K9 methylation and heterochromatin assembly. We demonstrate that Raf2 is concentrated at centromeres and contrary to other analyses, we find that loss of Raf2 does not affect CENP-A(Cnp1) localisation or recruitment to centromeres. Our sequence alignments show that Raf2 contains a Replication Foci Targeting Sequence (RFTS) domain homologous to the RFTS domain of the human DNA methyltransferase DNMT1. We show that the Raf2 RFTS domain is required for centromeric heterochromatin formation as its mutation disrupts H3K9 methylation but not the processing of centromeric transcripts into small interfering RNAs (siRNAs) by the RNAi pathway. Analysis of biochemical interactions demonstrates that the RFTS domain mediates an interaction between Raf2 and the CLRC component Cul4. We conclude that the RFTS domain of Raf2 is a protein interaction module that plays an important role in heterochromatin formation at centromeres.	[White, Sharon A.; Nowicki, Matthew W.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [White, Sharon A.; Nowicki, Matthew W.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Buscaino, Alessia] Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury, Kent, England; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford, England	University of Edinburgh; University of Edinburgh; University of Kent; University of Oxford	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Buscaino, Alessia/AAK-2976-2020; Ponting, Chris/AAV-2621-2021	Buscaino, Alessia/0000-0002-1704-3168; Ponting, Chris/0000-0003-0202-7816; Allshire, Robin/0000-0002-8005-3625; Sanchez Pulido, Luis/0000-0002-2300-8502	Wellcome Trust [065061, 095021, 092076]; European Commission Network of Excellence EpiGeneSys [HEALTH-F4-2010-257082]; MRC; Medical Research Council [MC_UU_12021/1, MC_U137761446] Funding Source: researchfish; MRC [MC_UU_12021/1, MC_U137761446] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission Network of Excellence EpiGeneSys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust supported the work of R. C. A. (065061 and 095021) along with funding from the European Commission Network of Excellence EpiGeneSys (HEALTH-F4-2010-257082). The Wellcome Trust Centre for Cell Biology is supported by core funding from the Wellcome Trust (092076). RCA is a Wellcome Trust Principal Research Fellow. LSP and CPP were funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buscaino A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002499; Debeauchamp JL, 2008, MOL CELL BIOL; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Ekwall K, 1996, J CELL SCI, V109, P2637; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gonzalez M, 2013, P NATL ACAD SCI USA, V110, P606, DOI 10.1073/pnas.1214874110; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kuscu C, 2014, P NATL ACAD SCI USA, V111, P1795, DOI 10.1073/pnas.1313096111; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Margot JB, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-7; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Tullu MS, 2010, EUR J PEDIATR, V169, P629, DOI 10.1007/s00431-009-1083-0; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104161	10.1371/journal.pone.0104161	http://dx.doi.org/10.1371/journal.pone.0104161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090107	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700105
J	Mohamad, KY; Kaltenboeck, B; Rahman, KS; Magnino, S; Sachse, K; Rodolakis, A				Mohamad, Khalil Yousef; Kaltenboeck, Bernhard; Rahman, Kh. Shamsur; Magnino, Simone; Sachse, Konrad; Rodolakis, Annie			Host Adaptation of Chlamydia pecorum towards Low Virulence Evident in Co-Evolution of the ompA, incA, and ORF663 Loci	PLOS ONE			English	Article							CHLAMYDOPHILA-PECORUM; INFECTIONS; SEQUENCE; DIVERSITY; PSITTACI; SHEEP; IDENTIFICATION; PREVALENCE; STRAINS; CATTLE	Chlamydia (C.) pecorum, an obligate intracellular bacterium, may cause severe diseases in ruminants, swine and koalas, although asymtomatic infections are the norm. Recently, we identified genetic polymorphisms in the ompA, incA and ORF663 genes that potentially differentiate between high-virulence C. pecorum isolates from diseased animals and low-virulence isolates from asymptomatic animals. Here we expand these findings by including additional ruminant, swine, and koala strains. Coding tandem repeats (CTRs) at the tncA locus encoded a variable number of repeats of APA or AGA amino acid motifs. Addition of any non-APA/AGA repeat motif, such as APEVPA, APAVPA, APE, or APAPE, associated with low-virulence (P<10(-4)), as did a high number of amino acids in all incA CTRs (P=0.0028). In ORF663, high numbers of 15-mer CTRs correlated with low virulence (P=0.0001). Correction for ompA phylogram position in ORF663 and incA abolished the correlation between genetic changes and virulence, demonstrating co-evolution of ompA, incA, and ORF663 towards low virulence. Pairwise divergence of ompA,incA, and ORF663 among isolates from healthy animals was significantly higher than among strains isolated from diseased animals (P <= 10(-5)), confirming the longer evolutionary path traversed by low-virulence trains. All three markers combined identified 43 unique strains and 4 pairs of identical strains among all 57 isolates tested, demonstrating the suitability of these markers for epidemiological investigations.	[Mohamad, Khalil Yousef; Rodolakis, Annie] INRA, UR1282, Infectiol Anim & Sante Publ, F-37380 Nouzilly, France; [Kaltenboeck, Bernhard; Rahman, Kh. Shamsur] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Rahman, Kh. Shamsur; Magnino, Simone] Ist Zooprofilat Speriment Lombardia Romagna, Natl Reference Lab Anim Chlamydioses, Sezione Diagnost Pavia, Pavia, Italy; [Sachse, Konrad] Friedrich Loeffler Inst Jena, OIE & Natl Reference Lab Chalmdio, Jena, Germany	INRAE; Auburn University System; Auburn University; Friedrich Loeffler Institute	Mohamad, KY (corresponding author), INRA, UR1282, Infectiol Anim & Sante Publ, F-37380 Nouzilly, France.	khalilyoussef@hotmail.com	Rahman, Kh Shamsur/M-2419-2019; Sachse, Konrad/GWC-4999-2022	Rahman, Kh Shamsur/0000-0001-7243-8501; Sachse, Konrad/0000-0003-1230-1786	French Institut National de la Recherche Agronomique; Auburn University	French Institut National de la Recherche Agronomique; Auburn University	The study was funded by the French Institut National de la Recherche Agronomique, and current funding by Auburn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Coil DA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-218; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Di Francesco A, 2013, VET ITAL, V49, P119; Gao X, 2007, J CLIN MICROBIOL, V45, P1185, DOI 10.1128/JCM.02076-06; Godin AC, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-39; Greco G, 2008, THERIOGENOLOGY, V69, P1061, DOI 10.1016/j.theriogenology.2008.01.018; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Jackson Michael, 1999, Veterinary Microbiology, V65, P255, DOI 10.1016/S0378-1135(98)00302-2; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Jelocnik M, 2013, J CLIN MICROBIOL, V51, P2625, DOI 10.1128/JCM.00992-13; KALTENBOECK B, 1992, AM J VET RES, V53, P1482; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; Kaltenboeck B, 2009, VET MICROBIOL, V135, P175, DOI 10.1016/j.vetmic.2008.09.036; Kauffold J, 2006, THERIOGENOLOGY, V65, P1750, DOI 10.1016/j.theriogenology.2005.10.010; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; Laroucau K, 2008, INFECT GENET EVOL, V8, P171, DOI 10.1016/j.meegid.2007.12.002; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; Mohamad KY, 2010, VET MICROBIOL, V143, P424, DOI 10.1016/j.vetmic.2009.11.017; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; Mohamad KY, 2008, INFECT GENET EVOL, V8, P764, DOI 10.1016/j.meegid.2008.06.009; Mohamad KY, 2008, VET RES, V39, DOI 10.1051/vetres:2008032; Mojica S, 2011, J BACTERIOL, V193, P3690, DOI 10.1128/JB.00454-11; NORTON WL, 1967, ARTHRITIS RHEUM, V10, P1, DOI 10.1002/art.1780100102; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Polkinghorne A, 2014, COMMUNICATION; Poudel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044961; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; RODOLAKIS A, 1976, Annales de Recherches Veterinaires, V7, P195; RODOLAKIS A, 1989, RES VET SCI, V46, P34, DOI 10.1016/S0034-5288(18)31113-5; Sachse K, 2000, INFECT IMMUN, V68, P680, DOI 10.1128/IAI.68.2.680-687.2000; Sachse K, 2009, VET MICROBIOL, V135, P22, DOI 10.1016/j.vetmic.2008.09.041; Sait M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-23; Salinas J, 1996, COMP IMMUNOL MICROB, V19, P155, DOI 10.1016/0147-9571(95)00029-1; STORZ J, 1971, ANN NY ACAD SCI, V176, P162, DOI 10.1111/j.1749-6632.1971.tb35002.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Duynhoven YTHP, 1998, CLIN INFECT DIS, V26, P314, DOI 10.1086/516291; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Warren K, 2005, J ZOO WILDLIFE MED, V36, P100, DOI 10.1638/02-067; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	43	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103615	10.1371/journal.pone.0103615	http://dx.doi.org/10.1371/journal.pone.0103615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084532	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800058
J	Welsby, I; Hutin, D; Gueydan, C; Kruys, V; Rongvaux, A; Leo, O				Welsby, Iain; Hutin, David; Gueydan, Cyril; Kruys, Veronique; Rongvaux, Anthony; Leo, Oberdan			PARP12, an Interferon-stimulated Gene Involved in the Control of Protein Translation and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; STRESS GRANULE FORMATION; POLY(ADP-RIBOSE) POLYMERASE; MESSENGER-RNA; ADP-RIBOSYLATION; HUMAN-CELLS; AUTOPHAGY; FAMILY; DOMAIN; VIRUS	Transcriptome analyses have recently identified PARP12, a member of a large family of ADP-ribosyl transferases, as an interferon-induced gene (ISG), whose function remains incompletely characterized. We demonstrate herein that PARP12 is a genuine ISG, whose expressed protein displays at least two distinct subcellular locations and related functions. Upon ectopic expression or exposure to oxidative stress, PARP12 is recruited to stress-granules (SGs), known sites of mRNA translational arrest. Accordingly, PARP12 was found to block mRNA translation, possibly upon association to the translational machinery. Both the N-terminal domain (containing an RNA-binding domain characterized by the presence of five CCCH-type Zn-fingers) and integrity of the catalytic domain are required for this suppressive function. In contrast, stimulation with LPS leads to the localization of PARP12 to p62/SQSTM1 (an adaptor protein involved in innate signaling and autophagy) containing structures, unrelated to SGs. Deletion of the N-terminal domain promotes the association of the protein to p62/SQSTM1, suggesting that the RNA-binding domain is responsible for the subcellular localization of PARP12. Association to p62/ SQSTM1 was found to correlate with increased NF-kappa B signaling, suggesting a role for PARP12 in inflammation. Collectively, these observations suggest that PARP12 can alternate between two distinct subcellular compartments associated to two distinct cellular functions. The present work therefore identifies PARP12 as an ISG with a potential role in cellular defenses against viral infections.	[Welsby, Iain; Hutin, David; Leo, Oberdan] Univ Libre Bruxelles, Lab Immunobiol, B-6041 Gosselies, Belgium; [Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Lab Biol Mol Gene, B-6041 Gosselies, Belgium; [Welsby, Iain; Leo, Oberdan] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Gosselies, Belgium; [Kruys, Veronique] CMMI, B-6041 Gosselies, Belgium; [Rongvaux, Anthony] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Yale University	Leo, O (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Lab Immunobiol, B-6041 Gosselies, Belgium.	oleo@ulb.ac.be	Kruys, Veronique I/N-6613-2018	Gueydan, Cyril/0000-0003-3097-7667; Welsby, Iain/0000-0003-3034-8326; Kruys, Veronique/0000-0002-3144-5403	Belgian Program in Interuniversity Poles of Attraction initiated by Science Policy Programming, Belgium; Research Concerted Action; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agronomie" (F.R.I.A.) of the "Federation Wallonie Bruxelles"; Fonds David et Alice Van Buuren; Walloon Region	Belgian Program in Interuniversity Poles of Attraction initiated by Science Policy Programming, Belgium; Research Concerted Action; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agronomie" (F.R.I.A.) of the "Federation Wallonie Bruxelles"(Fonds de la Recherche Scientifique - FNRS); Fonds David et Alice Van Buuren; Walloon Region	This work was supported by the Belgian Program in Interuniversity Poles of Attraction initiated by Science Policy Programming, Belgium, the Research Concerted Action and the "Fonds pour la formation a la Recherche dans l'Industrie et l'Agronomie" (F.R.I.A.) of the "Federation Wallonie Bruxelles," the "Fonds David et Alice Van Buuren," and the Walloon Region.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13; Barreau C, 2006, BIOCHEM BIOPH RES CO, V347, P723, DOI 10.1016/j.bbrc.2006.06.177; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Coller J, 2002, METHODS, V26, P142, DOI 10.1016/S1046-2023(02)00016-6; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ferreyra GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088756; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gu TL, 2010, LEUKEMIA, V24, P861, DOI 10.1038/leu.2009.293; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Johansson HE, 1997, SEMIN VIROL, V8, P176, DOI 10.1006/smvy.1997.0120; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Kleine H, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-28; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Leung AKL, 2014, J CELL BIOL, V205, P613, DOI 10.1083/jcb.201402114; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Loseva O, 2010, J BIOL CHEM, V285, P8054, DOI 10.1074/jbc.M109.077834; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Morello LG, 2011, NUCLEIC ACIDS RES, V39, P648, DOI 10.1093/nar/gkq758; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Rolli V, 1997, BIOCHEMISTRY-US, V36, P12147, DOI 10.1021/bi971055p; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	62	63	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26642	26657		10.1074/jbc.M114.589515	http://dx.doi.org/10.1074/jbc.M114.589515			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086041	Green Published, hybrid			2022-12-25	WOS:000342128800054
J	Kanazawa, T; Nakagami, G; Minematsu, T; Yamane, T; Huang, LJ; Mugita, Y; Noguchi, H; Mori, T; Sanada, H				Kanazawa, Toshiki; Nakagami, Gojiro; Minematsu, Takeo; Yamane, Takumi; Huang, Lijuan; Mugita, Yuko; Noguchi, Hiroshi; Mori, Taketoshi; Sanada, Hiromi			Biological Responses of Three-Dimensional Cultured Fibroblasts by Sustained Compressive Loading Include Apoptosis and Survival Activity	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR-CLONING; HYALURONIC-ACID; STRESS; STRAIN; CELLS; PROTEOGLYCANS; ACTIVATION; EXPRESSION; PREVENTS	Pressure ulcers are characterized by chronicity, which results in delayed wound healing due to pressure. Early intervention for preventing delayed healing due to pressure requires a prediction method. However, no study has reported the prediction of delayed healing due to pressure. Therefore, this study focused on biological response-based molecular markers for the establishment of an assessment technology to predict delayed healing due to pressure. We tested the hypothesis that sustained compressive loading applied to three dimensional cultured fibroblasts leads to upregulation of heat shock proteins (HSPs), CD44, hyaluronan synthase 2 (HAS2), and cyclooxygenase 2 (COX2) along with apoptosis via disruption of adhesion. First, sustained compressive loading was applied to fibroblast-seeded collagen sponges. Following this, collagen sponge samples and culture supernatants were collected for apoptosis and proliferation assays, gene expression analysis, immunocytochemistry, and quantification of secreted substances induced by upregulation of mRNA and protein level. Compared to the control, the compressed samples demonstrated that apoptosis was induced in a time- and load-dependent manner; vinculin and stress fiber were scarce; HSP90 alpha, CD44, HAS2, and COX2 expression was upregulated; and the concentrations of HSP90 alpha, hyaluronan (HA), and prostaglandin E-2 (PGE(2)) were increased. In addition, the gene expression of antiapoptotic Bcl2 was significantly increased in the compressed samples compared to the control. These results suggest that compressive loading induces not only apoptosis but also survival activity. These observations support that HSP90 alpha, HA, and, PGE(2) could be potential molecular markers for prediction of delayed wound healing due to pressure.	[Kanazawa, Toshiki; Nakagami, Gojiro; Minematsu, Takeo; Yamane, Takumi; Huang, Lijuan; Mugita, Yuko; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Yamane, Takumi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture; University of Tokyo	Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Yamane, Takumi/N-7442-2019; Nakagami, Gojiro/V-9093-2019; Noguchi, Hiroshi/GQI-0676-2022; Mori, Taketoshi/E-3849-2016	Nakagami, Gojiro/0000-0002-9650-2464; Noguchi, Hiroshi/0000-0002-5303-5210; Mori, Taketoshi/0000-0002-7208-6435; Minematsu, Takeo/0000-0001-5859-7290; Mugita, Yuko/0000-0003-4964-7107	JSPS (Japan Society for the Promotion of Science) [23249088]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (A) from JSPS (Japan Society for the Promotion of Science) (No. 23249088). JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; Bunek J, 2011, ORAL DIS, V17, P355, DOI 10.1111/j.1601-0825.2010.01763.x; Cheng TL, 2004, EXP CELL RES, V295, P497, DOI 10.1016/j.yexcr.2004.02.002; Coleman PJ, 1998, J PHYSIOL-LONDON, V509, P695, DOI 10.1111/j.1469-7793.1998.695bm.x; Crockett RJ, 2010, MOL BIOL REP, V37, P2629, DOI 10.1007/s11033-009-9788-8; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; de Araujo RMS, 2007, J PERIODONTAL RES, V42, P15, DOI 10.1111/j.1600-0765.2006.00906.x; Demiot C, 2011, J INVEST DERMATOL, V131, P2316, DOI 10.1038/jid.2011.211; European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel, 2009, PREV TREATM PRESS UL; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Falcone SJ, 2006, J BIOMED MATER RES A, V76A, P721, DOI 10.1002/jbm.a.30623; Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x; Gilmore AP, 2009, CURR OPIN CELL BIOL, V21, P654, DOI 10.1016/j.ceb.2009.05.009; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gorman AM, 1999, FEBS LETT, V445, P98, DOI 10.1016/S0014-5793(99)00094-0; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Henke C, 1996, AM J PATHOL, V149, P1639; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Inoue H, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3042266; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, BIOCHEM BIOPH RES CO, V222, P816, DOI 10.1006/bbrc.1996.0827; Kreger ST, 2009, MATRIX BIOL, V28, P336, DOI 10.1016/j.matbio.2009.05.001; Lee RT, 2001, J BIOL CHEM, V276, P13847, DOI 10.1074/jbc.M010556200; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Martel H, 2001, CONNECT TISSUE RES, V42, P235, DOI 10.3109/03008200109016838; Mascarenhas MM, 2004, AM J RESP CELL MOL, V30, P51, DOI 10.1165/rcmb.2002-0167OC; Minematsu T, 2013, WOUND REPAIR REGEN, V21, P329, DOI 10.1111/wrr.12017; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Mitsuhashi M, 2011, INFLAMM RES, V60, P187, DOI 10.1007/s00011-010-0253-x; Moseley R, 2004, BRIT J DERMATOL, V150, P401, DOI 10.1111/j.1365-2133.2004.05845.x; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; O'Loughlin A, 2013, DIABETES, V62, P2588, DOI 10.2337/db12-1822; Odashima M, 2007, DIGEST DIS SCI, V52, P3087, DOI 10.1007/s10620-007-9795-3; Okuwa Mayumi, 2005, J Tissue Viability, V15, P3; Reno F, 2003, WOUND REPAIR REGEN, V11, P331, DOI 10.1046/j.1524-475X.2003.11504.x; Rigano R, 2007, ANN NY ACAD SCI, V1107, P1, DOI 10.1196/annals.1381.001; Roehlecke C, 2000, HISTOCHEM CELL BIOL, V114, P283; Sae-Sia W, 2007, ARCH PHYS MED REHAB, V88, P1673, DOI 10.1016/j.apmr.2007.07.037; Sato Miwa, 2006, Int Wound J, V3, P355, DOI 10.1111/j.1742-481X.2006.00267.x; Schnaider T, 1999, LIFE SCI, V65, P2417, DOI 10.1016/S0024-3205(99)00508-1; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sugama Junko, 2002, J Tissue Viability, V12, P148; Swain I, 2005, PRESSURE ULCER RESEARCH: CURRENT AND FUTURE PERSPECTIVES, P51, DOI 10.1007/3-540-28804-X_5; Takemura M, 2005, MOL HUM REPROD, V11, P659, DOI 10.1093/molehr/gah229; Tong M, 2013, WOUND REPAIR REGEN, V21, P329; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; VanGilder C, 2009, J NURS CARE QUAL, V24, P127, DOI 10.1097/01.NCQ.0000347449.83052.1a; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wang JHC, 2008, INT REV CEL MOL BIO, V271, P301, DOI 10.1016/S1937-6448(08)01207-0; Wild T, 2010, NUTRITION, V26, P862, DOI 10.1016/j.nut.2010.05.008; Xin XJ, 2004, J BIOMAT SCI-POLYM E, V15, P1223, DOI 10.1163/1568562041753025; Yip CP, 2007, BIO-MED MATER ENG, V17, P109	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104676	10.1371/journal.pone.0104676	http://dx.doi.org/10.1371/journal.pone.0104676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102054	gold, Green Published, Green Submitted			2022-12-25	WOS:000339993900083
J	Renaud, HJ; Cui, YJ; Lu, H; Zhong, XB; Klaassen, CD				Renaud, Helen J.; Cui, Yue Julia; Lu, Hong; Zhong, Xiao-bo; Klaassen, Curtis D.			Ontogeny of Hepatic Energy Metabolism Genes in Mice as Revealed by RNA-Sequencing	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; FATTY-ACID OXIDATION; MULTISTAGE ANALYSIS; LIVER; EXPRESSION; INSULIN; ELOVL3; RESISTANCE; INDUCTION; PGC-1	The liver plays a central role in metabolic homeostasis by coordinating synthesis, storage, breakdown, and redistribution of nutrients. Hepatic energy metabolism is dynamically regulated throughout different life stages due to different demands for energy during growth and development. However, changes in gene expression patterns throughout ontogeny for factors important in hepatic energy metabolism are not well understood. We performed detailed transcript analysis of energy metabolism genes during various stages of liver development in mice. Livers from male C57BL/6J mice were collected at twelve ages, including perinatal and postnatal time points (n = 3/age). The mRNA was quantified by RNA-Sequencing, with transcript abundance estimated by Cufflinks. One thousand sixty energy metabolism genes were examined; 794 were above detection, of which 627 were significantly changed during at least one developmental age compared to adult liver. Two-way hierarchical clustering revealed three major clusters dependent on age: GD17.5-Day 5 (perinatal-enriched), Day 10-Day 20 (pre-weaning-enriched), and Day 25-Day 60 (adolescence/adulthood-enriched). Clustering analysis of cumulative mRNA expression values for individual pathways of energy metabolism revealed three patterns of enrichment: glycolysis, ketogenesis, and glycogenesis were all perinatally-enriched; glycogenolysis was the only pathway enriched during pre-weaning ages; whereas lipid droplet metabolism, cholesterol and bile acid metabolism, gluconeogenesis, and lipid metabolism were all enriched in adolescence/adulthood. This study reveals novel findings such as the divergent expression of the fatty acid beta-oxidation enzymes Acyl-CoA oxidase 1 and Carnitine palmitoyltransferase 1a, indicating a switch from mitochondrial to peroxisomal beta-oxidation after weaning; as well as the dynamic ontogeny of genes implicated in obesity such as Stearoyl-CoA desaturase 1 and Elongation of very long chain fatty acids-like 3. These data shed new light on the ontogeny of homeostatic regulation of hepatic energy metabolism, which could ultimately provide new therapeutic targets for metabolic diseases.	[Renaud, Helen J.; Cui, Yue Julia] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA; [Lu, Hong] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT USA; [Klaassen, Curtis D.] Univ Kansas, Coll Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Connecticut; University of Kansas	Klaassen, CD (corresponding author), Univ Kansas, Coll Med, Kansas City, KS 66160 USA.	curtisklaassenphd@gmail.com			NIH [R01 ES019487]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by NIH R01 ES019487 awarded to CDK, HL, and XZ. HJR is supported by a Canadian Institutes of Health Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; CAVENDER CP, 1995, AM J PHYSIOL-ENDOC M, V269, pE331, DOI 10.1152/ajpendo.1995.269.2.E331; DECAUX JF, 1988, J BIOL CHEM, V263, P3284; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huyghe S, 2001, BIOCHEM J, V353, P673, DOI 10.1042/0264-6021:3530673; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Jorgensen JA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1159, DOI 10.1152/ajpendo.00213.2007; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006; Louet JF, 2001, BIOCHEM SOC T, V29, P310, DOI 10.1042/0300-5127:0290310; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Neuschwander-Tetri BA, 2007, CURR OPIN GASTROEN, V23, P193, DOI 10.1097/MOG.0b013e32801421a9; Panadero M, 2000, BIOCHIMIE, V82, P723, DOI 10.1016/S0300-9084(00)01147-0; Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088584; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; SERRA D, 1993, ARCH BIOCHEM BIOPHYS, V301, P445, DOI 10.1006/abbi.1993.1169; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Sommerfeld A, 2011, MOL CELL ENDOCRINOL, V332, P21, DOI 10.1016/j.mce.2010.11.020; THUMELIN S, 1994, BIOCHEM J, V300, P583, DOI 10.1042/bj3000583; Yubero P, 2004, ENDOCRINOLOGY, V145, P4268, DOI 10.1210/en.2004-0099; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; ZAMMIT VA, 1994, TRENDS BIOCHEM SCI, V19, P313, DOI 10.1016/0968-0004(94)90068-X; Zammit VA, 1996, BIOCHEM J, V314, P1, DOI 10.1042/bj3140001; Zhang X, 2013, J DIABETES	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104560	10.1371/journal.pone.0104560	http://dx.doi.org/10.1371/journal.pone.0104560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25102070	Green Published, Green Submitted, gold			2022-12-25	WOS:000339993900075
J	Brenner, P; Alexanderson, K; Bjorkenstam, C; Hillert, J; Jokinen, J; Mittendorfer-Rutz, E; Tinghog, P				Brenner, Philip; Alexanderson, Kristina; Bjorkenstam, Charlotte; Hillert, Jan; Jokinen, Jussi; Mittendorfer-Rutz, Ellenor; Tinghog, Petter			Psychiatric Diagnoses, Medication and Risk for Disability Pension in Multiple Sclerosis Patients; a Population-Based Register Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL COMORBIDITY; MOOD DISORDER; DEPRESSION; MS; PERSONALITY; SYMPTOMS; ILLNESS; COSTS	Background: Psychiatric comorbidity is common among multiple sclerosis (MS) patients. The majority of MS patients of working ages are on disability pension. The aims of this study were to chart the prevalences of psychiatric diagnoses and medications among MS patients of working ages, and to investigate their association with the risk for future disability pension. Methods: This nationwide, population-based prospective cohort study includes 10,750 MS patients and 5,553,141 non-MS individuals who in 2005 were aged 17-64 years. Psychiatric diagnoses and medications were identified using nationwide registers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated adjusting for socio-demographics. Furthermore, a survival analysis with five-year follow-up was performed among the 4,571 MS patients not on disability pension in 2005, with psychiatric diagnoses and medication as risk factors, and disability pension as the outcome. Results: Among MS patients, 35% had been prescribed psychiatric medication compared to 10% of non-MS individuals, adjusted OR 3.72 (95% CI 3.57 to 3.88). Ten percent of MS patients had received a psychiatric diagnosis, compared to 5.7% of non-MS individuals, OR 1.82 (95% CI 1.71 to 1.94). Serotonin reuptake inhibitors (SSRIs), were the most commonly prescribed drugs (17%) among MS patients, while depression (4.8%) was the most common psychiatric diagnosis. In the survival analysis, MS patients with any psychiatric diagnosis had a hazard ratio (HR) of 1.83 (95% CI 1.53 to 2.18) for disability pension compared to other MS patients. MS patients with any psychiatric drug prescription had a HR for disability pension of 2.09 (95% CI 1.84 to 2.33). Conclusion: Psychiatric diagnoses and medications are common among MS patients and adversely affect risk for disability pension. This highlights the importance of correct diagnosis and management of psychiatric comorbidity, in a clinical as well as in a societal perspective.	[Brenner, Philip; Jokinen, Jussi] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden; [Alexanderson, Kristina; Bjorkenstam, Charlotte; Mittendorfer-Rutz, Ellenor; Tinghog, Petter] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Hillert, Jan] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Neuro, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Brenner, P (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Clin Neurosci, Div Psychiat, Stockholm, Sweden.	philip.brenner@ki.se	Brenner, Philip/AAL-6328-2020	Brenner, Philip/0000-0001-5266-6144	Biogen Idec; Swedish Council for Working Life and Social Research [2007-1762]	Biogen Idec(Biogen); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was financially supported by Biogen Idec and the Swedish Council for Working Life and Social Research (grant number 2007-1762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Amato MP, 2002, J NEUROL, V249, P152, DOI 10.1007/PL00007858; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Bombardier CH, 2004, MULT SCLER, V10, P35, DOI 10.1191/1352458504ms989oa; Bronnum-Hansen H, 2005, J NEUROL NEUROSUR PS, V76, P1457, DOI 10.1136/jnnp.2004.056747; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Edwards LJ, 2004, MULT SCLER, V10, P575, DOI 10.1191/1352458504ms1087oa; Fruehwald S, 2001, ACTA NEUROL SCAND, V104, P257, DOI 10.1034/j.1600-0404.2001.00022.x; Ghaffar O, 2007, CURR OPIN PSYCHIATR, V20, P278; Greenblatt DJ, 2012, EXPERT OPIN PHARMACO, V13, P879, DOI 10.1517/14656566.2012.667074; HOLM S, 1979, SCAND J STAT, V6, P65; JOFFE RT, 1987, ARCH NEUROL-CHICAGO, V44, P376, DOI 10.1001/archneur.1987.00520160018007; Kennedy J, 2006, NEUROEPIDEMIOLOGY, V26, P162, DOI 10.1159/000091658; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; Lunde HMB, 2013, ACTA NEUROL SCAND, V127, P24, DOI 10.1111/ane.12046; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; Marrie RA, 2009, MULT SCLER, V15, P385, DOI 10.1177/1352458508099477; Marrie RA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-16; Mohr DC, 2006, MULT SCLER J, V12, P204, DOI 10.1191/135248506ms1265oa; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; National Institute for Health and Care Excellence, 2011, GEN ANX DIS PAN DIS; Patten SB, 2005, NEUROLOGY, V65, P1123, DOI 10.1212/01.wnl.0000178998.95293.29; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Patten SB, 2012, INT J PSYCHIAT MED, V43, P51, DOI 10.2190/PM.43.1.d; Pfleger CCH, 2010, MULT SCLER, V16, P121, DOI 10.1177/1352458509352196; Riise T, 2011, MULT SCLER J, V17, P780, DOI 10.1177/1352458510397686; Sadovnick AD, 1996, NEUROLOGY, V46, P628, DOI 10.1212/WNL.46.3.628; Shakespeare D T, 2001, Cochrane Database Syst Rev, pCD001332, DOI 10.1002/14651858.CD001332; Social Insurance Agency, 2012, SOC INS FIG; Statistics Sweden, 2003, RIK IND ARSB REG IND; Tinghog P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-117; Tinghog P, 2013, MULT SCLER J, V19, P1923, DOI 10.1177/1352458513488234; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2004, INT STAT CLASS DIS R, V1; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2013, ATC CLASS IND DDDS	39	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104165	10.1371/journal.pone.0104165	http://dx.doi.org/10.1371/journal.pone.0104165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO5BW	25093730	Green Submitted, gold, Green Published			2022-12-25	WOS:000341357200080
J	Li, ZL; Zhang, YT; Yu, DF; Zhang, N; Lin, JX; Zhang, JW; Tang, JH; Wang, JF; Mu, CS				Li, Zhuolin; Zhang, Yuting; Yu, Dafu; Zhang, Na; Lin, Jixiang; Zhang, Jinwei; Tang, Jiahong; Wang, Junfeng; Mu, Chunsheng			The Influence of Precipitation Regimes and Elevated CO2 on Photosynthesis and Biomass Accumulation and Partitioning in Seedlings of the Rhizomatous Perennial Grass Leymus chinensis	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; USE EFFICIENCY; WATER-STRESS; C-4 GRASSES; GROWTH; TEMPERATURE; RESPONSES; DROUGHT; PRODUCTIVITY; PLANTS	Leymus chinensis is a dominant, rhizomatous perennial C-3 species in the grasslands of Songnen Plain of Northern China, and its productivity has decreased year by year. To determine how productivity of this species responds to different precipitation regimes, elevated CO2 and their interaction in future, we measured photosynthetic parameters, along with the accumulation and partitioning of biomass. Plants were subjected to combinations of three precipitation gradients (normal precipitation, versus normal +/- 40%) and two CO2 levels (380 +/- 20 mu mol mol(-1),760 +/- 20 mu mol mol(-1)) in controlled-environment chambers. The net photosynthetic rate, and above-ground and total biomass increased due to both elevated CO2 and increasing precipitation, but not significantly so when precipitation increased from the normal to high level under CO2 enrichment. Water use efficiency and the ratio of root: total biomass increased significantly when precipitation was low, but decreased when it was high under CO2 enrichment. Moreover, high precipitation at the elevated level of CO2 increased the ratio between stem biomass and total biomass. The effect of elevated CO2 on photosynthesis and biomass accumulation was higher at the low level of precipitation than with normal or high precipitation. The results suggest that at ambient CO2 levels, the net photosynthetic rate and biomass of L. chinensis increase with precipitation, but those measures are not further affected by additional precipitation when CO2 is elevated. Furthermore, CO2 may partly compensate for the negative effect of low precipitation on the growth and development of L. chinensis.	[Li, Zhuolin; Zhang, Yuting; Yu, Dafu; Zhang, Na; Zhang, Jinwei; Tang, Jiahong; Wang, Junfeng; Mu, Chunsheng] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Lin, Jixiang] Northeast Forestry Univ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Alkali Soil Nat Environm Sci Ctr, Harbin, Peoples R China	Northeast Normal University - China; Northeast Forestry University - China	Mu, CS (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China.	mucs821@gmail.com			National Natural Science Foundation of China [31172259, 31370432, 31270464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The paper was supported by the National Natural Science Foundation of China (grant No. 31172259 and 31370432). Moreover, this paper was supported by the National Natural Science Foundation of China (grant No. 31270464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Arnone JA, 2000, NEW PHYTOL, V147, P73, DOI 10.1046/j.1469-8137.2000.00685.x; Atwell BJ, 2007, FUNCT PLANT BIOL, V34, P1137, DOI 10.1071/FP06338; Baez S, 2013, OECOLOGIA, V172, P1117, DOI 10.1007/s00442-012-2552-0; Bhattacharya N, 2006, PLANT CELL ENVIRON, V13, P933; Cheng WG, 2009, AGR FOREST METEOROL, V149, P51, DOI 10.1016/j.agrformet.2008.07.006; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Erice G, 2007, PLANT SCI, V172, P903, DOI 10.1016/j.plantsci.2006.12.013; Fay PA, 2012, J PLANT ECOL, V5, P366, DOI 10.1093/jpe/rts007; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Gao SuHua, 2004, Pratacultural Science, V21, P23; Gavito ME, 2001, J EXP BOT, V52, P1913, DOI 10.1093/jexbot/52.362.1913; Hill PW, 2007, NEW PHYTOL, V173, P766, DOI 10.1111/j.1469-8137.2007.01966.x; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; [马红媛 Hongyuan Ma], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P181; Huang ZeHao, 2002, Grassland of China, V24, P55; Jackson RB, 1995, J BIOGEOGR, V22, P221, DOI 10.2307/2845914; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; Kakani VG, 2007, ENVIRON EXP BOT, V61, P281, DOI 10.1016/j.envexpbot.2007.06.002; Kinmonth-Schultz H, 2011, FUNCT PLANT BIOL, V38, P797, DOI 10.1071/FP11060; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Li XinZhou, 2004, Ganhanqu Yanjiu (Arid Zone Research), V21, P97; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Milchunas DG, 2005, GLOBAL CHANGE BIOL, V11, P1837, DOI 10.1111/j.1365-2486.2005.001009.x; Mishra RS, 1999, J AGRON CROP SCI, V182, P223, DOI 10.1046/j.1439-037x.1999.00294.x; Morgan JA, 2001, GLOBAL CHANGE BIOL, V7, P451, DOI 10.1046/j.1365-2486.2001.00415.x; Morgan JA, 2001, PROCEEDINGS OF THE XIX INTERNATIONAL GRASSLAND CONGRESS, P973; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Ottman MJ, 2001, NEW PHYTOL, V150, P261, DOI 10.1046/j.1469-8137.2001.00110.x; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Ping Xiao-Yan, 2010, Chinese Journal of Plant Ecology, V34, P100, DOI 10.3773/j.issn.1005-264x.2010.01.013; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2001, OECOLOGIA, V129, P1, DOI 10.1007/s004420100736; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Rao LE, 2010, OECOLOGIA, V162, P1035, DOI 10.1007/s00442-009-1516-5; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; TOLLEY LC, 1984, CAN J BOT, V62, P2135, DOI 10.1139/b84-291; Volder A, 2004, NEW PHYTOL, V162, P397, DOI 10.1111/j.1469-8137.2004.01025.x; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wang Hui, 2012, Chinese Journal of Plant Ecology, V36, P597, DOI 10.3724/SP.J.1258.2012.00597; Wang YH, 2007, CLIMATIC CHANGE, V82, P437, DOI 10.1007/s10584-006-9145-z; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Xu ZZ, 2007, PLANT SOIL, V301, P87, DOI 10.1007/s11104-007-9424-0; Xu ZZ, 2013, J PLANT GROWTH REGUL, V32, P692, DOI 10.1007/s00344-013-9337-5; Xu ZZ, 2005, PLANT SOIL, V269, P131, DOI 10.1007/s11104-004-0397-y; Zhou G, 2002, J VEG SCI, V13, P361, DOI 10.1111/j.1654-1103.2002.tb02060.x; Ziska LH, 2007, WEED SCI, V55, P288, DOI 10.1614/WS-06-190	53	21	25	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103633	10.1371/journal.pone.0103633	http://dx.doi.org/10.1371/journal.pone.0103633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093814	gold, Green Submitted, Green Published			2022-12-25	WOS:000341357200027
J	Lin, JL; Wheeldon, I				Lin, Jyun-Liang; Wheeldon, Ian			Dual N- and C-Terminal Helices Are Required for Endoplasmic Reticulum and Lipid Droplet Association of Alcohol Acetyltransferases in Saccharomyces cerevisiae	PLOS ONE			English	Article							ESCHERICHIA-COLI; ISOAMYL ACETATE; TRIACYLGLYCEROL SYNTHESIS; ESTER PRODUCTION; FLAVOR PROFILES; ETHYL-ACETATE; YEAST; PROTEIN; EXPRESSION; SEQUENCE	In the yeast Saccharomyces cerevisiae two alcohol acetyltransferases (AATases), Atf1 and Atf2, condense short chain alcohols with acetyl-CoA to produce volatile acetate esters. Such esters are, in large part, responsible for the distinctive flavors and aromas of fermented beverages including beer, wine, and sake. Atf1 and Atf2 localize to the endoplasmic reticulum (ER) and Atf1 is known to localize to lipid droplets (LDs). The mechanism and function of these localizations are unknown. Here, we investigate potential mechanisms of Atf1 and Atf2 membrane association. Segments of the N- and C-terminal domains of Atf1 (residues 24-41 and 508-525, respectively) are predicted to be amphipathic helices. Truncations of these helices revealed that the terminal domains are essential for ER and LD association. Moreover, mutations of the basic or hydrophobic residues in the N-terminal helix and hydrophobic residues in the C-terminal helix disrupted ER association and subsequent sorting from the ER to LDs. Similar amphipathic helices are found at both ends of Atf2, enabling ER and LD association. As was the case with Atf1, mutations to the N- and C-terminal helices of Atf2 prevented membrane association. Sequence comparison of the AATases from Saccharomyces, non-Saccharomyces yeast (K. lactis and P. anomala) and fruits species (C. melo and S. lycopersicum) showed that only AATases from Saccharomyces evolved terminal amphipathic helices. Heterologous expression of these orthologs in S. cerevisiae revealed that the absence of terminal amphipathic helices eliminates LD association. Combined, the results of this study suggest a common mechanism of membrane association for AATases via dual N- and C-terminal amphipathic helices.	[Lin, Jyun-Liang; Wheeldon, Ian] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wheeldon, I (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.	iwheeldon@engr.ucr.edu		Wheeldon, Ian/0000-0002-3492-7539	Bourns College of Engineering at the University of California, Riverside	Bourns College of Engineering at the University of California, Riverside	This study was supported by the Bourns College of Engineering at the University of California, Riverside. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Aharoni A, 2000, PLANT CELL, V12, P647, DOI 10.1105/tpc.12.5.647; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Bouvet S, 2013, J CELL SCI, V126, P4794, DOI 10.1242/jcs.134254; Cauet G, 1999, EUR J BIOCHEM, V261, P317, DOI 10.1046/j.1432-1327.1999.00282.x; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Connerth M, 2009, METHODS MOL BIOL, V579, P359, DOI 10.1007/978-1-60761-322-0_18; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fujii T, 1997, APPL ENVIRON MICROB, V63, P910, DOI 10.1128/AEM.63.3.910-915.1997; FUJII T, 1994, APPL ENVIRON MICROB, V60, P2786, DOI 10.1128/AEM.60.8.2786-2792.1994; Fujiwara D, 1999, YEAST, V15, P1183, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1183::AID-YEA444>3.0.CO;2-J; Galaz S, 2013, FEBS J, V280, P1344, DOI 10.1111/febs.12127; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Horton CE, 2006, ENZYME MICROB TECH, V38, P937, DOI 10.1016/j.enzmictec.2005.08.025; Horton CE, 2003, J IND MICROBIOL BIOT, V30, P427, DOI 10.1007/s10295-003-0070-0; HOWARD D, 1976, J I BREWING, V82, P70, DOI 10.1002/j.2050-0416.1976.tb03728.x; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Lilly M, 2000, APPL ENVIRON MICROB, V66, P744, DOI 10.1128/AEM.66.2.744-753.2000; Lilly M, 2006, YEAST, V23, P641, DOI 10.1002/yea.1382; MALCORPS P, 1992, EUR J BIOCHEM, V210, P1015, DOI 10.1111/j.1432-1033.1992.tb17507.x; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Mason AB, 2000, YEAST, V16, P1287, DOI 10.1002/1097-0061(200010)16:14<1287::AID-YEA613>3.0.CO;2-I; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Nagasawa N, 1998, BIOSCI BIOTECH BIOCH, V62, P1852, DOI 10.1271/bbb.62.1852; Ohsaki Y, 2014, CHEM BIOL, V21, P86, DOI 10.1016/j.chembiol.2013.08.009; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Plata C, 2005, WORLD J MICROB BIOT, V21, P115, DOI 10.1007/s11274-004-2780-5; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; Saerens SMG, 2008, APPL ENVIRON MICROB, V74, P454, DOI 10.1128/AEM.01616-07; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Singh R, 2008, BIOPROC BIOSYST ENG, V31, P299, DOI 10.1007/s00449-007-0159-3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURSTON PA, 1982, J I BREWING, V88, P90, DOI 10.1002/j.2050-0416.1982.tb04078.x; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Vadali RV, 2004, METAB ENG, V6, P294, DOI 10.1016/j.ymben.2004.02.006; Van Laere SDM, 2008, APPL MICROBIOL BIOT, V78, P783, DOI 10.1007/s00253-008-1366-9; Verstrepen KJ, 2004, YEAST, V21, P367, DOI 10.1002/yea.1100; Verstrepen KJ, 2003, APPL ENVIRON MICROB, V69, P5228, DOI 10.1128/AEM.69.9.5228-5237.2003; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; YOSHIOKA K, 1981, AGR BIOL CHEM TOKYO, V45, P2183, DOI 10.1080/00021369.1981.10864861; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	58	22	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104141	10.1371/journal.pone.0104141	http://dx.doi.org/10.1371/journal.pone.0104141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093817	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200072
J	Vensko, SP; Stone, EA				Vensko, Steven P., II; Stone, Eric A.			No Evidence for a Global Male-Specific Lethal Complex-Mediated Dosage Compensation Contribution to the Demasculinization of the Drosophila melanogaster X Chromosome	PLOS ONE			English	Article							BIASED GENE-EXPRESSION; MSL COMPLEX; CHROMATIN-STRUCTURE; TARGET GENES; INACTIVATION; TRANSCRIPTION; SPERMATOGENESIS; ACETYLATION; GERMLINE; REVEALS	In Drosophila melanogaster males, the expression of X-linked genes is regulated by mechanisms that operate on a chromosomal scale. One such mechanism, male-specific lethal complex-dependent X-linked dosage compensation, is thought to broadly enhance the expression of male X-linked genes through two-fold transcriptional upregulation. The evolutionary consequences of this form of dosage compensation are not well understood, particularly with regard to genes more highly expressed in males. It has been observed the X chromosome arrangement of these male-biased genes is non-random, consistent with what one might expect if there is a selective advantage for male-biased genes to avoid dosage compensation. Separately, it has been noted that the male-specific lethal complex and its dosage compensation mechanism appear absent in some male tissues, thus providing a control for the selection hypothesis. Here we utilized publicly available datasets to reassess the arrangement of X-linked male-biased expressed genes after accounting for expression in tissues not dosage compensated by the male-specific lethal complex. Our results do not corroborate previous observations supporting organismal-wide detrimental effects by dosage compensation on X-linked male-biased expressed genes. We instead find no evidence that dosage compensation has played a role in the arrangement of dosage compensated male-biased genes on the X chromosome.	[Vensko, Steven P., II; Stone, Eric A.] N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Vensko, SP (corresponding author), N Carolina State Univ, Genet Program, Raleigh, NC 27695 USA.	spvensko@ncsu.edu	Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	US National Institiutes of Health [RO1-GM70806]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070806] Funding Source: NIH RePORTER	US National Institiutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by RO1-GM70806 from the US National Institiutes of Health - SPV, EAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BACHILLER D, 1986, DEV BIOL, V118, P379, DOI 10.1016/0012-1606(86)90007-2; Bachtrog D, 2010, CURR BIOL, V20, P1476, DOI 10.1016/j.cub.2010.06.076; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Deng XX, 2006, GENETICS, V174, P1859, DOI 10.1534/genetics.106.064568; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gnad F, 2006, BIOINFORMATICS, V22, P2577, DOI 10.1093/bioinformatics/btl422; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Kind J, 2007, GENE DEV, V21, P2030, DOI 10.1101/gad.430807; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Meiklejohn CD, 2012, GENOME BIOL EVOL, V4, P895; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Meisel RP, 2009, GENOME BIOL EVOL, V1, P176, DOI 10.1093/gbe/evp018; Mikhaylova LM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-50; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Sass GL, 2003, P NATL ACAD SCI USA, V100, P8287, DOI 10.1073/pnas.1332749100; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Vibranovski MD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-49; Vibranovski MD, 2009, GENOME RES, V19, P897, DOI 10.1101/gr.088609.108; Vicoso B, 2009, J MOL EVOL, V68, P576, DOI 10.1007/s00239-009-9235-4; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103659	10.1371/journal.pone.0103659	http://dx.doi.org/10.1371/journal.pone.0103659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093841	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200028
J	Adamski, MG; Gumann, P; Baird, AE				Adamski, Mateusz G.; Gumann, Patryk; Baird, Alison E.			A Method for Quantitative Analysis of Standard and High-Throughput qPCR Expression Data Based on Input Sample Quantity	PLOS ONE			English	Article							REAL-TIME PCR; NEXT-GENERATION QPCR; GENE-EXPRESSION; HOUSEKEEPING GENES; BETA-ACTIN; RNA EXPRESSION; GAPDH	Over the past decade rapid advances have occurred in the understanding of RNA expression and its regulation. Quantitative polymerase chain reactions (qPCR) have become the gold standard for quantifying gene expression. Microfluidic next generation, high throughput qPCR now permits the detection of transcript copy number in thousands of reactions simultaneously, dramatically increasing the sensitivity over standard qPCR. Here we present a gene expression analysis method applicable to both standard polymerase chain reactions (qPCR) and high throughput qPCR. This technique is adjusted to the input sample quantity (e. g., the number of cells) and is independent of control gene expression. It is efficiency-corrected and with the use of a universal reference sample (commercial complementary DNA (cDNA)) permits the normalization of results between different batches and between different instruments - regardless of potential differences in transcript amplification efficiency. Modifications of the input quantity method include (1) the achievement of absolute quantification and (2) a non-efficiency corrected analysis. When compared to other commonly used algorithms the input quantity method proved to be valid. This method is of particular value for clinical studies of whole blood and circulating leukocytes where cell counts are readily available.	[Adamski, Mateusz G.; Baird, Alison E.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Adamski, Mateusz G.] UJCM, Krakow, Poland; [Gumann, Patryk] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Gumann, Patryk] Univ Waterloo, Inst Quantum Comp, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Jagiellonian University; Collegium Medicum Jagiellonian University; Harvard University; University of Waterloo	Baird, AE (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	alison.baird@downstate.edu	Adamski, Mateusz G/K-7634-2016; Adamski, Mateusz/F-6274-2015	Adamski, Mateusz/0000-0002-8340-2181	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [R01-EB010087]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010087] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [R01-EB010087 to A.E.B.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski MG, 2013, J BIOMOL SCREEN, V18, P1008, DOI 10.1177/1087057113489882; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang TJ, 1998, ONCOL REP, V5, P469; Devonshire AS, 2013, METHODS, V59, P89, DOI 10.1016/j.ymeth.2012.07.021; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Lin JT, 2012, DEV GENES EVOL, V222, P369, DOI 10.1007/s00427-012-0420-x; Liu ML, 2011, BIOTECHNOL PROGR, V27, P1407, DOI 10.1002/btpr.666; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nishimura M, 2008, BIOCHEM BIOPH RES CO, V367, P603, DOI 10.1016/j.bbrc.2008.01.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sikand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047510; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	15	31	33	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103917	10.1371/journal.pone.0103917	http://dx.doi.org/10.1371/journal.pone.0103917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090612	gold, Green Published, Green Submitted			2022-12-25	WOS:000339812700064
J	Liu, L; Sun, TY; Liu, ZL; Chen, XR; Zhao, LL; Qu, GQ; Li, QJ				Liu, Liang; Sun, Tingyi; Liu, Zilong; Chen, Xiaorui; Zhao, Lili; Qu, Guoqiang; Li, Qingjie			Traumatic Brain Injury Dysregulates MicroRNAs to Modulate Cell Signaling in Rat Hippocampus	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; AMYLOID PRECURSOR PROTEIN; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; POSTTRANSCRIPTIONAL REGULATION; LEWY BODIES; EXPRESSION; GENDER; CASK	Traumatic brain injury (TBI) is a common cause for cognitive and communication problems, but the molecular and cellular mechanisms are not well understood. Epigenetic modifications, such as microRNA (miRNA) dysregulation, may underlie altered gene expression in the brain, especially hippocampus that plays a major role in spatial learning and memory and is vulnerable to TBI. To advance our understanding of miRNA in pathophysiological processes of TBI, we carried out a time-course microarray analysis of microRNA expression profile in rat ipsilateral hippocampus and examined histological changes, apoptosis and synapse ultrastructure of hippocampus post moderate TBI. We found that 10 out of 156 reliably detected miRNAs were significantly and consistently altered from one hour to seven days after injury. Bioinformatic and gene ontology analyses revealed 107 putative target genes, as well as several biological processes that might be initiated by those dysregulated miRNAs. Among those differentially expressed microRNAs, miR-144, miR-153 and miR-340-5p were confirmed to be elevated at all five time points after TBI by quantitative RT-PCR. Western blots showed three of the predicated target proteins, calcium/calmodulin-dependent serine protein kinase (CASK), nuclear factor erythroid 2-related factor 2 (NRF2) and alpha-synuclein (SNCA), were concurrently down-regulated, suggesting that miR-144, miR-153 and miR-340-5p may play important roles collaboratively in the pathogenesis of TBI-induced cognitive and memory impairments. These microRNAs might serve as potential targets for progress assessment and intervention against TBI to mitigate secondary damage to the brain.	[Liu, Liang; Sun, Tingyi; Liu, Zilong; Chen, Xiaorui; Zhao, Lili; Qu, Guoqiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China; [Liu, Liang] China Univ Polit Sci & Law, Minist Educ, Key Lab Evidence Sci, Beijing, Peoples R China; [Li, Qingjie] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	Huazhong University of Science & Technology; China University of Political Science & Law; University of Texas System; University of Texas Medical Branch Galveston	Liu, ZL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China.	lzlongfy@gmail.com; quli@utmb.edu		Li, Qingjie/0000-0003-1405-7000	National Natural Science Foundation of China [81102304]; Ministry of Education of China [20090142120054]; Foundation of Huazhong University of Science and Technology [20100573]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Foundation of Huazhong University of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (grant number: 81102304) (http://www.nsfc.gov.cn/), Doctoral Fund of Ministry of Education of China (grant number: 20090142120054) (http://www.cutech.edu.cn/cn/index.htm), and Foundation of Huazhong University of Science and Technology (grant number: 20100573) (http://kfy.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Baba M, 1998, AM J PATHOL, V152, P879; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Cabin DE, 2002, J NEUROSCI, V22, P8797; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carasatorre Mariana, 2013, Curr Top Behav Neurosci, V15, P73, DOI 10.1007/7854_2012_229; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chen KY, 2011, MOL CELL NEUROSCI, V48, P171, DOI 10.1016/j.mcn.2011.07.009; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Hata Y, 1996, J NEUROSCI, V16, P2488; Hsu LJ, 1998, J NEUROCHEM, V71, P338; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li XH, 2012, NEUROSCI LETT, V514, P46, DOI 10.1016/j.neulet.2012.02.054; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Patuzzo C, 2012, BALK J MED GENET, V15, P51, DOI 10.2478/v10034-012-0019-6; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rau CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-181; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Xu JZ, 2011, INT J CANCER, V129, P2527, DOI 10.1002/ijc.25917; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhang Y, 2011, J CELL BIOCHEM, V112, P2435, DOI 10.1002/jcb.23168	66	66	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103948	10.1371/journal.pone.0103948	http://dx.doi.org/10.1371/journal.pone.0103948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089700	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700068
J	Zhang, ZJ; Elser, JJ; Cease, AJ; Zhang, XM; Yu, Q; Han, XG; Zhang, GM				Zhang, Zijia; Elser, James J.; Cease, Arianne J.; Zhang, Ximei; Yu, Qiang; Han, Xingguo; Zhang, Guangming			Grasshoppers Regulate N:P Stoichiometric Homeostasis by Changing Phosphorus Contents in Their Frass	PLOS ONE			English	Article							BIOLOGICAL STOICHIOMETRY; NITROGEN; PLANT; HERBIVORE; GROWTH; LIMITATION; TEMPERATE; NUTRIENTS; LOCUSTS; RATIOS	Nitrogen (N) and phosphorus (P) are important limiting nutrients for plant production and consumer performance in a variety of ecosystems. As a result, the N: P stoichiometry of herbivores has received increased attention in ecology. However, the mechanisms by which herbivores maintain N: P stoichiometric homeostasis are poorly understood. Here, using a field manipulation experiment we show that the grasshopper Oedaleus asiaticus maintains strong N: P stoichiometric homeostasis regardless of whether grasshoppers were reared at low or high density. Grasshoppers maintained homeostasis by increasing P excretion when eating plants with higher P contents. However, while grasshoppers also maintained constant body N contents, we found no changes in N excretion in response to changing plant N content over the range measured. These results suggest that O. asiaticus maintains P homeostasis primarily by changing P absorption and excretion rates, but that other mechanisms may be more important for regulating N homeostasis. Our findings improve our understanding of consumer-driven P recycling and may help in understanding the factors affecting plant-herbivore interactions and ecosystem processes in grasslands.	[Zhang, Zijia; Han, Xingguo; Zhang, Guangming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Zijia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Elser, James J.; Cease, Arianne J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Cease, Arianne J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Zhang, Ximei; Yu, Qiang; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Yu, Qiang] Colorado State Univ, Grad Degree Program Ecol, Dept Biol, Ft Collins, CO 80523 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Arizona State University; Arizona State University-Tempe; University of Sydney; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Colorado State University	Zhang, GM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zhanggm@ibcas.ac.cn	Elser, James J/AAL-6199-2020; Elser, James/A-7082-2008; Han, Xingguo/K-7552-2016; zhang, zijia/F-9425-2017; Yu, Qiang/E-2097-2011; Cease, Arianne/F-9954-2014	Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; Han, Xingguo/0000-0002-1836-975X; zhang, zijia/0000-0002-0812-2171; Yu, Qiang/0000-0002-5480-0623; Cease, Arianne/0000-0002-4778-0775	National Natural Science Foundation of China [30870407, 31270483]; National Science Foundation [DEB-0618193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	Funding for this work came from the National Natural Science Foundation of China (30870407 and 31270483, http://www.nsfc.gov.cn/). JJE and AC were supported by a National Science Foundation grant (DEB-0618193, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; [Anonymous], 2012, PERSPECT PLANT ECOL, DOI [DOI 10.1038/NCOMMS3934, DOI 10.1016/j.ppees.2011.08.002]; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Branson DH, 2006, BIOSCIENCE, V56, P743, DOI 10.1641/0006-3568(2006)56[743:SMOIHI]2.0.CO;2; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Cease AJ, 2010, J INSECT PHYSIOL, V56, P926, DOI 10.1016/j.jinsphys.2010.05.020; Chapman R. F., 1990, BIOL GRASSHOPPERS; Chen YL, 2007, IMPORTANT GRASSHOPPE; Chen YL, 1992, RES GRASSLAND ECOSYS, V4, P141; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Han X. G., 1999, INTRO BIOGEOCHEMISTR; Harrison J. F., 1995, NITROGEN METABOLISM, P119; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; [蒋湘 Jiang Xiang], 2003, [草地学报, Acta agrestia sinica], V11, P75; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; Kagata H, 2011, AGR FOREST ENTOMOL, V13, P143, DOI 10.1111/j.1461-9563.2010.00502.x; Kay AD, 2006, FUNCT ECOL, V20, P1037, DOI 10.1111/j.1365-2435.2006.01187.x; Li Hongchang, 1987, Acta Ecologica Sinica, V7, P331; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Meng ZP, 2006, CHINA PLANT PROTECTI, V26, P35; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; PETERS TM, 1977, ANNU REV ENTOMOL, V22, P431, DOI 10.1146/annurev.en.22.010177.002243; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Simpson SJ, 2001, ECOLOGY, V82, P422; Simpson SJ, 2012, NATURE NUTR UNIFYING; Stearns S.C., 1992, pi; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tao LL, 2012, GLOBAL CHANGE BIOL, V18, P1843, DOI 10.1111/j.1365-2486.2012.02645.x; TRUMPER S, 1993, J INSECT PHYSIOL, V39, P857, DOI 10.1016/0022-1910(93)90118-B; Uvarov B. P., 1977, GRASSHOPPERS LOCUSTS, V2; White T. C. R., 1993, INADEQUATE ENV NITRO; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; ZANOTTO FP, 1993, PHYSIOL ENTOMOL, V18, P425, DOI 10.1111/j.1365-3032.1993.tb00617.x; ZHANG GM, 2007, THESIS CHINESE ACAD; Zhang GM, 2011, OECOLOGIA, V166, P253, DOI 10.1007/s00442-011-1904-5; Zhang LX, 2003, ACTA BOT SIN, V45, P1009	47	24	24	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103697	10.1371/journal.pone.0103697	http://dx.doi.org/10.1371/journal.pone.0103697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089521	Green Published, Green Submitted, gold			2022-12-25	WOS:000339812700044
J	Lazzari, E; Korczeniewska, J; Gabhann, JN; Smith, S; Barnes, BJ; Jefferies, CA				Lazzari, Elisa; Korczeniewska, Justyna; Gabhann, Joan Ni; Smith, Siobhan; Barnes, Betsy J.; Jefferies, Caroline A.			TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms	PLOS ONE			English	Article							GENE-EXPRESSION; CRYSTAL-STRUCTURE; FAMILY PROTEINS; RISK HAPLOTYPE; I INTERFERON; BLOOD-CELLS; TRANSACTIVATION; DEGRADATION; UBIQUITIN; VARIANTS	IRF5 is a member of the Interferon Regulatory Factor (IRF) family of transcription factors activated downstream of the Toll-Like receptors (TLRs). Polymorphisms in IRF5 have been shown to be associated with the autoimmune disease Systemic Lupus Erythematosus (SLE) and other autoimmune conditions, suggesting a central role for IRF5 in the regulation of the immune response. Four different IRF5 isoforms originate due to alternative splicing and to the presence or absence of a 30 nucleotide insertion in IRF5 exon 6. Since the polymorphic region disturbs a PEST domain, a region associated with protein degradation, we hypothesized that the isoforms bearing the insertion might have increased stability, thus explaining the association of individual IRF5 isoforms with SLE. As the E3 ubiquitin ligase TRIpartite Motif 21 (TRIM21) has been shown to regulate the stability and hence activity of members of the IRF family, we investigated whether IRF5 is subjected to regulation by TRIM21 and whether dysregulation of this mechanism could explain the association of IRF5 with SLE. Our results show that IRF5 is degraded following TLR7 activation and that TRIM21 is involved in this process. Comparison of the individual IRF5 variants demonstrates that isoforms generated by alternative splicing are resistant to TRIM21-mediated degradation following TLR7 stimulation, thus providing a functional link between isoforms expression and stability/activity which contributes to explain the association of IRF5 with SLE.	[Lazzari, Elisa; Gabhann, Joan Ni; Smith, Siobhan; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Inst Res, Mol & Cellular Therapeut, Dublin 2, Ireland; [Korczeniewska, Justyna; Barnes, Betsy J.] Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, Newark, NJ USA; [Korczeniewska, Justyna; Barnes, Betsy J.] Rutgers Biomed & Hlth Sci, New Jersey Med School Canc Ctr, Newark, NJ USA	Royal College of Surgeons - Ireland; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jefferies, CA (corresponding author), Royal Coll Surgeons Ireland, Inst Res, Mol & Cellular Therapeut, Dublin 2, Ireland.	cjefferies@rcsi.ie	Lazzari, Elisa/K-7804-2016; Lazzari, Elisa/AAE-6437-2019; Jefferies, Caroline/AAI-1543-2021; Lazzari, Elisa/O-6394-2019	Lazzari, Elisa/0000-0001-5299-7525; Jefferies, Caroline/0000-0002-8879-6722; Lazzari, Elisa/0000-0001-5299-7525; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952	Health Research Board [HRB/RP/2008/234]; Arthritis Foundation; Alliance for Lupus Research	Health Research Board; Arthritis Foundation; Alliance for Lupus Research	This work was supported by Health Research Board grant number HRB/RP/2008/234 (www.hrb.ie), the Arthritis Foundation (www.arthritis.org), and the Alliance for Lupus Research (www.lupusresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MM, 2013, J VIROLOGY; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hellquist A, 2009, J RHEUMATOL, V36, P1631, DOI 10.3899/jrheum.081160; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Korczeniewska J, 2013, MOL CELL BIOL, V33, P1124, DOI 10.1128/MCB.00802-12; Kozyrev SV, 2007, ARTHRITIS RHEUM, V56, P1234, DOI 10.1002/art.22497; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Niewold TB, 2012, ANN RHEUMATIC DIS; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Niida M, 2010, MOL IMMUNOL, V47, P2378, DOI 10.1016/j.molimm.2010.05.004; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Santiago-Raber ML, 2009, J AUTOIMMUN, V33, P231, DOI 10.1016/j.jaut.2009.10.001; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Smith S, 2012, ARTHRITIS RHEUM-US, V64, P1601, DOI 10.1002/art.33494; Stacey KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034041; Stone RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054487; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492	48	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103609	10.1371/journal.pone.0103609	http://dx.doi.org/10.1371/journal.pone.0103609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084355	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800056
J	Sellier, C; Hwang, VJ; Dandekar, R; Durbin-Johnson, B; Charlet-Berguerand, N; Ander, BP; Sharp, FR; Angkustsiri, K; Simon, TJ; Tassone, F				Sellier, Chantal; Hwang, Vicki J.; Dandekar, Ravi; Durbin-Johnson, Blythe; Charlet-Berguerand, Nicolas; Ander, Bradley P.; Sharp, Frank R.; Angkustsiri, Kathleen; Simon, Tony J.; Tassone, Flora			Decreased DGCR8 Expression and miRNA Dysregulation in Individuals with 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							CARDIO-FACIAL-SYNDROME; SYNDROME CRITICAL REGION; HIPPOCAMPAL VOLUME REDUCTION; DIGEORGE-SYNDROME; CHROMOSOME 22Q11; MONOZYGOTIC TWINS; MOUSE MODEL; NEUROPSYCHIATRIC DISORDERS; VELOCARDIOFACIAL SYNDROME; MYOCARDIAL-INFARCTION	Deletion of the 1.5-3 Mb region of chromosome 22 at locus 11.2 gives rise to the chromosome 22q11.2 deletion syndrome (22q11DS), also known as DiGeorge and Velocardiofacial Syndromes. It is the most common micro-deletion disorder in humans and one of the most common multiple malformation syndromes. The syndrome is characterized by a broad phenotype, whose characterization has expanded considerably within the last decade and includes many associated findings such as craniofacial anomalies (40%), conotruncal defects of the heart (CHD; 70-80%), hypocalcemia (20-60%), and a range of neurocognitive anomalies with high risk of schizophrenia, all with a broad phenotypic variability. These phenotypic features are believed to be the result of a change in the copy number or dosage of the genes located in the deleted region. Despite this relatively clear genetic etiology, very little is known about which genes modulate phenotypic variations in humans or if they are due to combinatorial effects of reduced dosage of multiple genes acting in concert. Here, we report on decreased expression levels of genes within the deletion region of chromosome 22, including DGCR8, in peripheral leukocytes derived from individuals with 22q11DS compared to healthy controls. Furthermore, we found dysregulated miRNA expression in individuals with 22q11DS, including miR-150, miR-194 and miR-185. We postulate this to be related to DGCR8 haploinsufficiency as DGCR8 regulates miRNA biogenesis. Importantly we demonstrate that the level of some miRNAs correlates with brain measures, CHD and thyroid abnormalities, suggesting that the dysregulated miRNAs may contribute to these phenotypes and/or represent relevant blood biomarkers of the disease in individuals with 22q11DS.	[Sellier, Chantal; Charlet-Berguerand, Nicolas] Univ Strasbourg, Inst Genet & Mol & Cellular Biol, Strasbourg, France; [Hwang, Vicki J.; Dandekar, Ravi; Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95820 USA; [Durbin-Johnson, Blythe] UC Davis Med Ctr, Dept Publ Hlth Sci, Sacramento, CA USA; [Ander, Bradley P.; Sharp, Frank R.; Angkustsiri, Kathleen; Simon, Tony J.; Tassone, Flora] UC Davis Med Ctr, MIND Inst, Sacramento, CA USA; [Ander, Bradley P.; Sharp, Frank R.] UC Davis Med Ctr, Dept Neurol, Sacramento, CA USA; [Angkustsiri, Kathleen] UC Davis Med Ctr, Dept Pediat, Sacramento, CA USA; [Simon, Tony J.] UC Davis Med Ctr, Dept Psychiat, Sacramento, CA USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tassone, F (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95820 USA.	ftassone@ucdavis.edu	Charlet-Berguerand, Nicolas/I-6727-2016; Charlet-Berguerand, Nicolas/GZM-6636-2022	Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Charlet-Berguerand, Nicolas/0000-0002-4423-4920	National Institutes of Health [R01HD042974, UL1TR000002]; Matteo's Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Matteo's Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health (Grant #R01HD042974 and UL1TR000002) and by Matteo's Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkustsiri K G-JB, 2014, J AUTISM DE IN PRESS; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; De Smedt B, 2007, J INTELL DISABIL RES, V51, P666, DOI 10.1111/j.1365-2788.2007.00955.x; Debbane M, 2006, NEUROPSYCHOLOGIA, V44, P2360, DOI 10.1016/j.neuropsychologia.2006.05.006; DeBoer T, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-54; Demczuk S, 1996, HUM MOL GENET, V5, P633, DOI 10.1093/hmg/5.5.633; Duijff SN, 2012, BRIT J PSYCHIAT, V200, P462, DOI 10.1192/bjp.bp.111.097139; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eliez S, 2001, AM J PSYCHIAT, V158, P447, DOI 10.1176/appi.ajp.158.3.447; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Fryer A, 1996, J MED GENET, V33, P173, DOI 10.1136/jmg.33.2.173; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; GOODSHIP J, 1995, J MED GENET, V32, P746, DOI 10.1136/jmg.32.9.746; Gothelf D, 2007, AM J PSYCHIAT, V164, P663, DOI 10.1176/appi.ajp.164.4.663; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; Hatchwell E, 1996, J MED GENET, V33, P261, DOI 10.1136/jmg.33.3.261; HEISTERKAMP N, 1995, GENOMICS, V29, P451, DOI 10.1006/geno.1995.9982; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kates WR, 2006, J AM ACAD CHILD PSY, V45, P587, DOI 10.1097/01.chi.0000205704.33077.4a; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lindsay EA, 1997, CYTOGENET CELL GENET, V79, P243, DOI 10.1159/000134736; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; Meechan DW, 2006, MOL CELL NEUROSCI, V33, P412, DOI 10.1016/j.mcn.2006.09.001; Mellios Nikolaos, 2012, Front Psychiatry, V3, P39, DOI 10.3389/fpsyt.2012.00039; Michaelovsky E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-122; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; ODonnell H, 1997, AM J HUM GENET, V60, P1544; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rutter M., 2003, SOCIAL COMMUNICATION; Schumann CM, 2007, HIPPOCAMPUS, V17, P486, DOI 10.1002/hipo.20282; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Sivagnanasundaram S, 2007, BRAIN RES, V1139, P48, DOI 10.1016/j.brainres.2007.01.014; Stappert L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059011, 10.1371/annotation/b03fbc42-8f70-4873-9cce-854e48249a13]; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Swanson JM., 1995, SNAP 4 SCALE; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; van Amelsvoort T, 2004, SCHIZOPHR RES, V70, P223, DOI 10.1016/j.schres.2003.10.004; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; Voelckel MA, 2004, ANN GENET-PARIS, V47, P235, DOI 10.1016/j.anngen.2004.04.002; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Westholm JO, 2011, BIOCHIMIE, V93, P1897, DOI 10.1016/j.biochi.2011.06.017; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Woelk CH, 2011, INT REV NEUROBIOL, V101, P41, DOI 10.1016/B978-0-12-387718-5.00003-1; Xu B, 2012, NEUROBIOL DIS, V46, P291, DOI 10.1016/j.nbd.2012.02.016; Yamagishi H, 1998, AM J MED GENET, V78, P319, DOI 10.1002/(SICI)1096-8628(19980724)78:4<319::AID-AJMG3>3.0.CO;2-G; Zhang ZP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-124	80	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103884	10.1371/journal.pone.0103884	http://dx.doi.org/10.1371/journal.pone.0103884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084529	gold, Green Published			2022-12-25	WOS:000339819800098
J	Wu, HY; Huang, JJ; Lu, H; Li, GD; Huang, QS				Wu, Hongyu; Huang, Jinjiang; Lu, Hairong; Li, Guodong; Huang, Qingshan			GMEnzy: A Genetically Modified Enzybiotic Database	PLOS ONE			English	Article							BACTERIOPHAGE ENDOLYSINS; ANTI-INFECTIVES; PSI-BLAST; ENZYMES; LYSINS; AGENTS	GMEs are genetically modified enzybiotics created through molecular engineering approaches to deal with the increasing problem of antibiotic resistance prevalence. We present a fully manually curated database, GMEnzy, which focuses on GMEs and their design strategies, production and purification methods, and biological activity data. GMEnzy collects and integrates all available GMEs and their related information into one web based database. Currently GMEnzy holds 186 GMEs from published literature. The GMEnzy interface is easy to use, and allows users to rapidly retrieve data according to desired search criteria. GMEnzy's construction will increase the efficiency and convenience of improving these bioactive proteins for specific requirements, and will expand the arsenal available for researches to control drug-resistant pathogens. This database will prove valuable for researchers interested in genetically modified enzybiotics studies. GMEnzy is freely available on the Web at http://biotechlab.fudan.edu.cn/database/gmenzy/.	[Wu, Hongyu; Huang, Jinjiang; Lu, Hairong; Huang, Qingshan] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai, Peoples R China; [Li, Guodong; Huang, Qingshan] Shanghai Engn Res Ctr, Ind Microorganisms, Shanghai, Peoples R China; [Li, Guodong; Huang, Qingshan] Shanghai High Tech United Bio Technol R&D Co Ltd, Shanghai, Peoples R China	Fudan University	Huang, QS (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai, Peoples R China.	qshuang@fudan.edu.cn			National Major Scientific and Technological Special Project of China for "Significant New Drugs Development" [2013ZX09102057]; China Spark Program [2012GA6900035]; Shanghai Science and Technology Innovation Action Plan of China [12DE1940500]	National Major Scientific and Technological Special Project of China for "Significant New Drugs Development"; China Spark Program; Shanghai Science and Technology Innovation Action Plan of China	This work was supported in part by the National Major Scientific and Technological Special Project of China for "Significant New Drugs Development" (grant 2013ZX09102057, http://www.most.gov.cn/), the China Spark Program (grant 2012GA6900035, http://www.most.gov.cn/) and the Shanghai Science and Technology Innovation Action Plan (2012) of China (Grant 12DE1940500, http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Borysowaski J, 2010, ENZYBIOTICS ANTIBIOT, P199; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; Diez-Martinez R, 2013, ANTIMICROB AGENTS CH; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Hammami R, 2010, DRUG DISCOV TODAY, V15, P540, DOI 10.1016/j.drudis.2010.05.002; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hojckova K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-53; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Moellering RC, 2011, INT J ANTIMICROB AG, V37, P2, DOI 10.1016/j.ijantimicag.2010.08.018; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Rodriguez-Rubio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064671; Rodriguez-Rubio L, 2013, CRIT REV MICROBIOL, V39, P427, DOI 10.3109/1040841X.2012.723675; Saravanan Sanjeev Rajagopalan, 2013, Bacteriophage, V3, pe26564; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]; Schmelcher M, 2010, APPL ENVIRON MICROB, V76, P5745, DOI 10.1128/AEM.00801-10; Szweda P, 2012, APPL MICROBIOL BIOT, V96, P1157, DOI 10.1007/s00253-012-4484-3; Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313; Veiga-Crespo P, 2007, J PHARM SCI-US, V96, P1917, DOI 10.1002/jps.20853; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Wu HY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-54; Yang H, 2013, ANTIMICROB AGENTS CH; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	31	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103687	10.1371/journal.pone.0103687	http://dx.doi.org/10.1371/journal.pone.0103687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084271	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800065
J	Yang, S; Wang, X; Cui, L; Ding, X; Niu, LL; Yang, FQ; Wang, C; Wang, CC; Lou, JZ				Yang, Shang; Wang, Xi; Cui, Lei; Ding, Xiang; Niu, Lili; Yang, Fuquan; Wang, Chao; Wang, Chih-chen; Lou, Jizhong			Compact Conformations of Human Protein Disulfide Isomerase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ACTIVE-SITES; BINDING SITE; B DOMAIN; OXIDATION; PATHWAY; REGION; A'	Protein disulfide isomerase (PDI) composed of four thioredoxin-like domains a, b, b', and a', is a key enzyme catalyzing oxidative protein folding in the endoplasmic reticulum. Large scale molecular dynamics simulations starting from the crystal structures of human PDI (hPDI) in the oxidized and reduced states were performed. The results indicate that hPDI adopts more compact conformations in solution than in the crystal structures, which are stabilized primarily by inter-domain interactions, including the salt bridges between domains a and b' observed for the first time. A prominent feature of the compact conformations is that the two catalytic domains a and a' can locate close enough for intra-molecular electron transfer, which was confirmed by the characterization of an intermediate with a disulfide between the two domains. Mutations, which disrupt the inter-domain interactions, lead to decreased reductase activity of hPDI. Our molecular dynamics simulations and biochemical experiments reveal the intrinsic conformational dynamics of hPDI and its biological impact.	[Yang, Shang; Wang, Xi; Cui, Lei; Wang, Chao; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Cui, Lei; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100080, Peoples R China; [Ding, Xiang; Niu, Lili; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China; [Yang, Shang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, CC (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	chihwang@sun5.ibp.ac.cn; jlou@ibp.ac.cn	Wang, Chao/AGP-7000-2022	Yang, Shang/0000-0001-6671-7571; Wang, Chao/0000-0002-3048-8559	National Major Basic Research Program of China [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31070827, 31222022, 31370758]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Basic Research Program of China (2011CB910303 and 2012CB911002) http://www.most.gov.cn, and the National Natural Science Foundation of China (31070827, 31222022 and 31370758) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NT, 2013, BIOCHEM J, V450, P321, DOI 10.1042/BJ20121635; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Cheng H, 2010, CELL STRESS CHAPERON, V15, P415, DOI 10.1007/s12192-009-0157-2; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1999, J BIOMOL NMR, V13, P357, DOI 10.1023/A:1008341820489; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTINEZGALISTEO E, 1993, BIOCHIMIE, V75, P803, DOI 10.1016/0300-9084(93)90131-B; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	29	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103472	10.1371/journal.pone.0103472	http://dx.doi.org/10.1371/journal.pone.0103472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084354	gold, Green Published, Green Submitted			2022-12-25	WOS:000339819800046
J	Vidaurre, S; Fitzpatrick, C; Burzio, VA; Briones, M; Villota, C; Villegas, J; Echenique, J; Oliveira-Cruz, L; Araya, M; Borgna, V; Socias, T; Lopez, C; Avila, R; Burzio, LO				Vidaurre, Soledad; Fitzpatrick, Christopher; Burzio, Veronica A.; Briones, Macarena; Villota, Claudio; Villegas, Jaime; Echenique, Javiera; Oliveira-Cruz, Luciana; Araya, Mariela; Borgna, Vincenzo; Socias, Teresa; Lopez, Constanza; Avila, Rodolfo; Burzio, Luis O.			Down-regulation of the Antisense Mitochondrial Non-coding RNAs (ncRNAs) Is a Unique Vulnerability of Cancer Cells and a Potential Target for Cancer Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; REPLICATION SLIPPAGE; DNA-POLYMERASES; APOPTOSIS; SURVIVIN; EXPRESSION; PROTEIN; COMPLEX; IMPORT; IAP	Hallmarks of cancer are fundamental principles involved in cancer progression. We propose an additional generalized hallmark of malignant transformation corresponding to the differential expression of a family of mitochondrial ncRNAs (ncmtRNAs) that comprises sense and antisense members, all of which contain stem-loop structures. Normal proliferating cells express sense (SncmtRNA) and antisense (ASncmtRNA) transcripts. In contrast, the ASncmtRNAs are down-regulated in tumor cells regardless of tissue of origin. Here we show that knockdown of the low copy number of the ASncmtRNAs in several tumor cell lines induces cell death by apoptosis without affecting the viability of normal cells. In addition, knockdown of ASncmtRNAs potentiates apoptotic cell death by inhibiting survivin expression, a member of the inhibitor of apoptosis (IAP) family. Down-regulation of survivin is at the translational level and is probably mediated by microRNAs generated by dicing of the double-stranded stem of the ASncmtRNAs, as suggested by evidence presented here, in which the ASncmtRNAs are bound to Dicer and knockdown of the ASncmtRNAs reduces reporter luciferase activity in a vector carrying the 3'-UTR of survivin mRNA. Taken together, down-regulation of the ASncmtRNAs constitutes a vulnerability or Achilles' heel of cancer cells, suggesting that the ASncmtRNAs are promising targets for cancer therapy.	[Vidaurre, Soledad; Fitzpatrick, Christopher; Burzio, Veronica A.; Briones, Macarena; Villota, Claudio; Villegas, Jaime; Echenique, Javiera; Oliveira-Cruz, Luciana; Araya, Mariela; Borgna, Vincenzo; Socias, Teresa; Lopez, Constanza; Avila, Rodolfo; Burzio, Luis O.] Andes Biotechnol SA, Santiago 7780272, Chile; [Fitzpatrick, Christopher; Burzio, Veronica A.; Villota, Claudio; Villegas, Jaime; Oliveira-Cruz, Luciana; Burzio, Luis O.] Fdn Ciencia Vida, Santiago 7780272, Chile; [Fitzpatrick, Christopher; Burzio, Veronica A.; Briones, Macarena; Villota, Claudio; Villegas, Jaime; Burzio, Luis O.] Univ Andres Bello, Fac Ciencias Biol, Santiago 8370134, Chile; [Borgna, Vincenzo] Univ Andres Bello, Fac Med, Santiago 8370134, Chile; [Vidaurre, Soledad] Univ Bernardo OHiggins, Dept Ciencias Quim & Biol, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad  Bernardo O'Higgins	Burzio, VA (corresponding author), Andes Biotechnol SA, Zanartu 1482, Santiago 7780272, Chile.	vburzio@gmail.com; lburzio@gmail.com	Borgna, Vincenzo/AAZ-8414-2020; Oliveira-Cruz, Luciana/N-7756-2014; Fitzpatrick, Christopher/AAU-1679-2020; Villegas, Jaime/AAW-5938-2020	Fitzpatrick, Christopher/0000-0002-5598-8111; Villegas, Jaime/0000-0002-9556-4655	Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondo Nacional de Ciencia y Tecnologia (Fondecyt)) [1110835, 1140345]; Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondecyt) [11090060, 1085210]; Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile [Fondef-D04I1338, CCTE-PFB16]; Universidad Andres Bello, Chile [DI-34-09/R, DI-31-09/R, DI-28-09/R4, DI-06-09/R]	Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondo Nacional de Ciencia y Tecnologia (Fondecyt))(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad Andres Bello, Chile	This work was supported by Comision Nacional de Ciencia y Tecnologia (Conicyt), Chile (Fondo Nacional de Ciencia y Tecnologia (Fondecyt) 1110835 and 1140345 (to V. A. B.), Fondecyt 11090060 (to C. V.), Fondecyt 1085210 (to J. V.), Fondef-D04I1338 (to J. V.), and CCTE-PFB16), and Universidad Andres Bello, Chile (DI-34-09/R, DI-31-09/R, DI-28-09/R4, and DI-06-09/R).	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Benoit MPMH, 2013, NUCLEIC ACIDS RES, V41, P4241, DOI 10.1093/nar/gkt086; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; Canceill D, 1996, P NATL ACAD SCI USA, V93, P6647, DOI 10.1073/pnas.93.13.6647; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; Dias N, 2002, MOL CANCER THER, V1, P347; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GLICKMAN BW, 1984, P NATL ACAD SCI-BIOL, V81, P512, DOI 10.1073/pnas.81.2.512; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Houston MA, 2011, INT J CELL BIOL, V2011; Hu DQ, 2010, J BIOL CHEM, V285, P18326, DOI 10.1074/jbc.M109.083170; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Ji XH, 2008, CURR TOP MICROBIOL, V320, P99; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mahata B, 2005, J BIOL CHEM, V280, P5141, DOI 10.1074/jbc.C400572200; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Rodriguez OC, 2012, CELL CYCLE, V11, P4436, DOI 10.4161/cc.22778; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Sambri I, 2011, J BIOL CHEM, V286, P43690, DOI 10.1074/jbc.M111.290437; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Viguera E, 2001, J MOL BIOL, V312, P323, DOI 10.1006/jmbi.2001.4943; Villegas J, 2007, NUCLEIC ACIDS RES, V35, P7336, DOI 10.1093/nar/gkm863; Villota C, 2012, J BIOL CHEM, V287, P21303, DOI 10.1074/jbc.M111.326694; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	73	47	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					27182	27198		10.1074/jbc.M114.558841	http://dx.doi.org/10.1074/jbc.M114.558841			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25100722	Green Published, hybrid			2022-12-25	WOS:000342853900043
J	Daudi, S; Eng, KH; Mhawech-Fauceglia, P; Morrison, C; Miliotto, A; Beck, A; Matsuzaki, J; Tsuji, T; Groman, A; Gnjatic, S; Spagnoli, G; Lele, S; Odunsi, K				Daudi, Sayeema; Eng, Kevin H.; Mhawech-Fauceglia, Paulette; Morrison, Carl; Miliotto, Anthony; Beck, Amy; Matsuzaki, Junko; Tsuji, Takemasa; Groman, Adrienne; Gnjatic, Sacha; Spagnoli, Guillo; Lele, Shashikant; Odunsi, Kunle			Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; GENE-EXPRESSION; PHASE-II; MELANOMA; NY-ESO-1; GAUGE; BAGE; IMMUNOTHERAPY	The MAGE cancer-testis antigens (CTA) are attractive candidates for immunotherapy. The aim of this study was to determine the frequency of expression, humoral immunity and prognostic significance of MAGE CTA in human epithelial ovarian cancer (EOC). mRNA or protein expression frequencies were determined for MAGE-A1, -A3, -A4, -A10 and -C1 (CT7) in tissue samples obtained from 400 patients with EOC. The presence of autologous antibodies against the MAGE antigens was determined from 285 serum samples. The relationships between MAGE expression, humoral immunity to MAGE antigens, and clinico-pathologic characteristics were studied. The individual frequencies of expression were as follows: A1: 15% (42/281), A3: 36% (131/390), A4: 47% (186/399), A10: 52% (204/395), C1: 16% (42/267). Strong concordant expression was noted with MAGE-A1:-A4, MAGE-A1:-C1 and MAGE-A4:-A10 (p<0.0005). Expression of MAGE-A1 or -A10 antigens resulted in poor progression free survival (PFS) (OR 1.44, CI 1.01-2.04, p = 0.044 and OR 1.3, CI 1.03-1.64, p = 0.03, respectively); whereas, MAGE-C1 expression was associated with improved PFS (OR 0.62, CI 0.42-0.92, p = 0.016). The improved PFS observed for MAGE-C1 expression, was diminished by co-expression of MAGE-A1 or -A10. Spontaneous humoral immunity to the MAGE antigens was present in 9% (27/285) of patients, and this predicted poor overall survival (log-rank test p = 0.0137). These findings indicate that MAGE-A1, MAGE-A4, MAGE-A3, and MAGE-A10 are priority attractive targets for polyvalent immunotherapy in ovarian cancer patients.	[Daudi, Sayeema; Miliotto, Anthony; Lele, Shashikant; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Eng, Kevin H.; Groman, Adrienne] Roswell Pk Canc Inst, Dept Biostatisticsm, Buffalo, NY 14263 USA; [Mhawech-Fauceglia, Paulette] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Morrison, Carl] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Miliotto, Anthony; Beck, Amy; Matsuzaki, Junko; Tsuji, Takemasa; Odunsi, Kunle] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Matsuzaki, Junko; Tsuji, Takemasa; Odunsi, Kunle] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Gnjatic, Sacha] Mt Sinai Hosp, Dept Med, New York, NY 10029 USA; [Spagnoli, Guillo] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Southern California; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Icahn School of Medicine at Mount Sinai; University of Basel	Odunsi, K (corresponding author), Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA.	kunle.odunsi@roswellpark.org		Matsuzaki, Junko/0000-0002-2555-1234; Gnjatic, Sacha/0000-0001-5643-9520; Tsuji, Takemasa/0000-0001-7563-2211; Eng, Kevin/0000-0001-5636-0812	Cancer Research Institute Ovarian Cancer Working Group Grant; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; National Institutes of Health [5T32 CA 108456, R01CA158318-01A1]; Roswell Park Cancer Institute-University of Pittsburg Cancer Institute [P50CA159981-01A1]; NATIONAL CANCER INSTITUTE [R01CA158318, P50CA159981, T32CA108456, P30CA016056] Funding Source: NIH RePORTER	Cancer Research Institute Ovarian Cancer Working Group Grant; Cancer Vaccine Collaborative Grant of the Cancer Research Institute; Ludwig Institute for Cancer Research; Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Cancer Institute-University of Pittsburg Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Cancer Research Institute Ovarian Cancer Working Group Grant, Cancer Vaccine Collaborative Grant of the Cancer Research Institute and Ludwig Institute for Cancer Research, Anna-Maria Kellen Clinical Investigator Award of the Cancer Research Institute (to Kunle Odunsi), National Institutes of Health 5T32 CA 108456, National Institutes of Health R01CA158318-01A1 and Roswell Park Cancer Institute-University of Pittsburg Cancer Institute Ovarian Cancer Specialized Program of Research Excellence National Institutes of Health P50CA159981-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Valeria C C, 2008, Cancer Immun, V8, P2; [Anonymous], 1971, INT FEDERATION GYNEC, P1; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; COX DR, 1972, J R STAT SOC B, V34, P187; CREASMAN WT, 1989, GYNECOL ONCOL, V35, P129, DOI 10.1016/0090-8258(89)90028-0; Gillespie AM, 1998, BRIT J CANCER, V78, P816, DOI 10.1038/bjc.1998.585; Gjerstorff M, 2009, AM J PATHOL, V175, P314, DOI 10.2353/ajpath.2009.080893; Gnjatic Sacha, 2009, V520, P11, DOI 10.1007/978-1-60327-811-9_2; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Jang SJ, 2001, CANCER RES, V61, P7959; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim J, 2006, INT J CANCER, V118, P2269, DOI 10.1002/ijc.21656; Kondo T, 2007, CLIN CANCER RES, V13, P4713, DOI 10.1158/1078-0432.CCR-07-0618; Kruit WHJ, 2013, J CLIN ONCOL, V31, P2413, DOI 10.1200/JCO.2012.43.7111; Landry C, 2000, INT J CANCER, V86, P835, DOI 10.1002/(SICI)1097-0215(20000615)86:6<835::AID-IJC12>3.0.CO;2-N; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Odunsi K, 2003, CANCER RES, V63, P6076; Odunsi K, 2007, P NATL ACAD SCI USA, V104, P12837, DOI 10.1073/pnas.0703342104; Odunsi K, 2014, CANCER IMMUNOL RES, V2, P37, DOI 10.1158/2326-6066.CIR-13-0126; Odunsi K, 2012, P NATL ACAD SCI USA, V109, P5797, DOI 10.1073/pnas.1117208109; Okabayashi K, 2012, CANCER SCI, V103, P1617, DOI 10.1111/j.1349-7006.2012.02355.x; Otte M, 2001, CANCER RES, V61, P6682; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; PATARD JJ, 1995, INT J CANCER, V64, P60, DOI 10.1002/ijc.2910640112; Picard V, 2007, INT J CANCER, V120, P2170, DOI 10.1002/ijc.22282; Russo V, 1996, INT J CANCER, V67, P457, DOI 10.1002/(SICI)1097-0215(19960729)67:3<457::AID-IJC24>3.0.CO;2-3; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Schultz-Thater E, 2011, INT J CANCER, V129, P1137, DOI 10.1002/ijc.25777; Serov S, 1973, INT HISTOLOGICAL CLA, P51; Shimizu Y, 1998, CANCER-AM CANCER SOC, V82, P893, DOI 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vansteenkiste J, 2013, J CLIN ONCOL, V31, P2396, DOI 10.1200/JCO.2012.43.7103; Yakirevich E, 2003, CLIN CANCER RES, V9, P6453; Zhang SQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-163	43	52	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104099	10.1371/journal.pone.0104099	http://dx.doi.org/10.1371/journal.pone.0104099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101620	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900037
J	Kust, N; Rybalkina, E; Mertsalov, I; Savchenko, E; Revishchin, A; Pavlova, G				Kust, Nadezda; Rybalkina, Ekaterina; Mertsalov, Ilya; Savchenko, Ekaterina; Revishchin, Alexander; Pavlova, Gali			Functional Analysis of Drosophila HSP70 Promoter with Different HSE Numbers in Human Cells	PLOS ONE			English	Article							HEAT-SHOCK GENE; EMBRYONIC STEM-CELLS; TRANSGENE EXPRESSION; IMMUNE-RESPONSE; TRANSCRIPTION; VIRUS; TRANSACTIVATOR; PROTEINS; VECTORS; BRAIN	The activation of genetic constructs including the Drosophila hsp70 promoter with four and eight HSE sequences in the regulatory region has been described in human cells. The promoter was shown to be induced at lower temperatures compared to the human hsp70 promoter. The promoter activity increased after a 60-min heat shock already at 38 degrees C in human cells. The promoter activation was observed 24 h after heat shock for the constructs with eight HSEs, while those with four HSEs required 48 h. After transplantation of in vitro heat-shocked transfected cells, the promoter activity could be maintained for 3 days with a gradual decline. The promoter activation was confirmed in vivo without preliminary heat shock in mouse ischemic brain foci. Controlled expression of the Gdnf gene under a Drosophila hsp70 promoter was demonstrated. This promoter with four and eight HSE sequences in the regulatory region can be proposed as a regulated promoter in genetic therapeutic systems.	[Kust, Nadezda; Mertsalov, Ilya; Revishchin, Alexander; Pavlova, Gali] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Savchenko, Ekaterina; Revishchin, Alexander; Pavlova, Gali] Inst Med & Cell Transplantat, Moscow, Russia; [Kust, Nadezda; Rybalkina, Ekaterina; Savchenko, Ekaterina; Revishchin, Alexander; Pavlova, Gali] Ltd Apto Pharm, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Pavlova, G (corresponding author), Russian Acad Sci, Inst Gene Biol, Moscow, Russia.	lkorochkin@mail.ru	Rybalkina, Ekaterina/B-6860-2019; Revishchin, Alexander/AAO-4863-2020; Pavlova, Galina/AAO-4691-2020	Pavlova, Galina/0000-0002-6885-6601; Mertsalov, Ilya/0000-0001-9175-0592; Revishchin, Alexandr/0000-0002-6007-6440	Russian Foundation for Basic Research [13-04-40200H, 13-00-40200K]; Program "Molecular and Cell Biology"; Ministry of Science and Education of the Russian Federation [16.552.11.7067]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program "Molecular and Cell Biology"; Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Foundation for Basic Research (project nos. 13-04-40200H, 13-00-40200K) and Program "Molecular and Cell Biology". Experiments were performed using the equipment of the IGB RAS facilities supported by the Ministry of Science and Education of the Russian Federation (grants 16.552.11.7067). The authors express appreciation to Vladimir E. Babiy for administration and funding. Authors N. Kust, E. Rybalkina, A. Revishchin, E. Savchenko and G. Pavlova are employed by Ltd Apto-pharm who provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Andreeva L E, 2008, Genetika, V44, P992; BIENZ M, 1987, ADV GENET, V24, P31, DOI 10.1016/S0065-2660(08)60006-1; CORCES V, 1984, J BIOL CHEM, V259, P4812; CORCES V, 1981, P NATL ACAD SCI-BIOL, V78, P7038, DOI 10.1073/pnas.78.11.7038; DIENEL GA, 1986, J CEREBR BLOOD F MET, V6, P505, DOI 10.1038/jcbfm.1986.86; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Fernandes M., 1994, BIOL HEAT SHOCK PROT, P375; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; KENNEDY PGE, 1985, NEUROSCI LETT, V61, P321, DOI 10.1016/0304-3940(85)90484-7; Korochkin L. I., 2000, Genetika, V36, P1436; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Pavlova GV, 2005, B EXP BIOL MED+, V139, P514, DOI 10.1007/s10517-005-0333-z; PELHAM HRB, 1982, EMBO J, V1, P1473, DOI 10.1002/j.1460-2075.1982.tb01340.x; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; SCHLESINGER MJ, 1986, J CELL BIOL, V103, P321, DOI 10.1083/jcb.103.2.321; SCHWEINFEST CW, 1988, GENE, V71, P207, DOI 10.1016/0378-1119(88)90093-5; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; WEI R, 1986, NUCLEIC ACIDS RES, V14, P8183, DOI 10.1093/nar/14.20.8183; Wilkerson DC, 2007, CELL STRESS CHAPERON, V12, P283, DOI 10.1379/CSC-250.1; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; Xiong WD, 2006, J VIROL, V80, P27, DOI 10.1128/JVI.80.1.27-37.2006	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e101994	10.1371/journal.pone.0101994	http://dx.doi.org/10.1371/journal.pone.0101994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101947	Green Submitted, Green Published, gold			2022-12-25	WOS:000339993900001
J	Daigle, CL; Banerjee, D; Montgomery, RA; Biswas, S; Siegford, JM				Daigle, Courtney L.; Banerjee, Debasmit; Montgomery, Robert A.; Biswas, Subir; Siegford, Janice M.			Moving GIS Research Indoors: Spatiotemporal Analysis of Agricultural Animals	PLOS ONE			English	Article							LAYING HENS; BEHAVIOR; WELFARE; PREDICT	A proof of concept applying wildlife ecology techniques to animal welfare science in intensive agricultural environments was conducted using non-cage laying hens. Studies of wildlife ecology regularly use Geographic Information Systems (GIS) to assess wild animal movement and behavior within environments with relatively unlimited space and finite resources. However, rather than depicting landscapes, a GIS could be developed in animal production environments to provide insight into animal behavior as an indicator of animal welfare. We developed a GIS-based approach for studying agricultural animal behavior in an environment with finite space and unlimited resources. Concurrent data from wireless body-worn location tracking sensor and video-recording systems, which depicted spatially-explicit behavior of hens (135 hens/room) in two identical indoor enclosures, were collected. The spatial configuration of specific hen behaviors, variation in home range patterns, and variation in home range overlap show that individual hens respond to the same environment differently. Such information could catalyze management practice adjustments (e.g., modifying feeder design and/or location). Genetically similar hens exhibited diverse behavioral and spatial patterns via a proof of concept approach enabling detailed examinations of individual non-cage laying hen behavior and welfare.	[Daigle, Courtney L.; Siegford, Janice M.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Banerjee, Debasmit; Biswas, Subir] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Montgomery, Robert A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Siegford, JM (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	siegford@msu.edu	, Janice/ABA-3975-2020; Siegford, Janice/AAH-1838-2020; Montgomery, Robert A./C-5541-2019	, Janice/0000-0002-1000-3147; Siegford, Janice/0000-0002-1000-3147; Montgomery, Robert A./0000-0001-5894-0589	United States Department of Agriculture; Agricultural and Food Research Initiative Award [2009-65120-05752]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural and Food Research Initiative Award	Funding came from the United States Department of Agriculture, Agricultural and Food Research Initiative Award #2009-65120-05752 to Dr. Janice Siegford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee D, 2012, BODY SENSOR NETWORKS, P107; Boddugari K, 2001, J DAIRY SCI, V84, P873, DOI [10.3168/jds.S0022-0302(01)74545-6, 10.3168/jds.S0022-0302(01)70210-X]; Browne WJ, 2011, APPL ANIM BEHAV SCI, V134, P152, DOI 10.1016/j.applanim.2011.07.004; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Cloutier S, 2000, BEHAVIOUR, V137, P705, DOI 10.1163/156853900502303; Daigle CL, 2012, POULTRY SCI, V91, P2415, DOI 10.3382/ps.2012-02300; Daigle CL, 2014, BEHAV PROCESS, V103, P58, DOI 10.1016/j.beproc.2013.11.002; Dawkins MS, 2003, ZOOLOGY, V106, P383, DOI 10.1078/0944-2006-00122; DUNCAN IJH, 1972, ANIM BEHAV, V20, P444, DOI 10.1016/S0003-3472(72)80007-1; DUNCAN IJH, 1972, ANIM BEHAV, V20, P68, DOI 10.1016/S0003-3472(72)80174-X; Duncan IJH, 1993, ALTERNATIVE HOUSING, V7, P69; Farris CA, 2010, ECOL APPL, V20, P1598, DOI 10.1890/09-1535.1; FASS, 2010, GUID CAR US AGR AN R, V3rd; Fraser D, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-S1-S1; GENTLE MJ, 1990, APPL ANIM BEHAV SCI, V27, P149, DOI 10.1016/0168-1591(90)90014-5; Gitzen RA, 2003, WILDLIFE SOC B, V31, P823; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; HESTER PY, 1994, POULTRY SCI, V73, P904, DOI 10.3382/ps.0730904; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Kernohan B, 2001, RADIOTRACKING ANIMAL; Kristensen HH, 2000, APPL ANIM BEHAV SCI, V68, P307, DOI 10.1016/S0168-1591(00)00110-6; Kuenzel WJ, 2007, POULTRY SCI, V86, P1273, DOI 10.1093/ps/86.6.1273; Lee HJ, 2011, J R SOC INTERFACE, V8, P489, DOI 10.1098/rsif.2010.0268; Mishra A, 2005, POULTRY SCI, V84, P979, DOI 10.1093/ps/84.7.979; Nicol CJ, 2011, ANIM BEHAV, V82, P255, DOI 10.1016/j.anbehav.2011.04.022; NICOL CJ, 1989, APPL ANIM BEHAV SCI, V22, P75, DOI 10.1016/0168-1591(89)90081-6; O'Connor EA, 2011, APPL ANIM BEHAV SCI, V135, P293, DOI 10.1016/j.applanim.2011.09.011; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1; WILLIAMS NS, 1984, PHARMACOL BIOCHEM BE, V20, P681, DOI 10.1016/0091-3057(84)90184-9; Zimmerman PH, 2000, APPL ANIM BEHAV SCI, V69, P265, DOI 10.1016/S0168-1591(00)00136-2	32	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104002	10.1371/journal.pone.0104002	http://dx.doi.org/10.1371/journal.pone.0104002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098421	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100043
J	Lee, SM; Yang, S; Cha, RH; Kim, M; An, JN; Paik, JH; Kim, DK; Kang, SW; Lim, CS; Kim, YS; Lee, JP				Lee, Su Mi; Yang, SeungHee; Cha, Ran-Hui; Kim, Myounghee; An, Jung Nam; Paik, Jin Ho; Kim, Dong Ki; Kang, Shin-Wook; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo			Circulating TNF Receptors Are Significant Prognostic Biomarkers for Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KIDNEY; EXPRESSION; ALPHA; PREDICT; DAMAGE; RISK; INFLAMMATION; PROGRESSION; DISEASE	Idiopathic membranous nephropathy (iMN) is a common cause of nephrotic syndrome in adults. A biomarker to accurately indicate the severity of iMN and predict long-term prognosis is insufficient. Here, we evaluated the clinical significance of circulating tumor necrosis factor receptors (cTNFRs) as prognostic biomarkers of iMN with nephrotic syndrome. A total of 113 patients with biopsy-proven iMN and 43 healthy volunteers were enrolled in this study. Ninety patients with iMN had nephrotic range proteinuria. Levels of cTNFRs were measured by using serum samples collected at the time of initial diagnosis. Levels of cTNFRs were higher in the patients with nephrotic syndrome than in those with subnephrotic range proteinuria or in the healthy volunteers (P for trend <0.001). Estimated glomerular filtration rate and proteinuria tended to worsen as the cTNFRs levels increased. Having a cTNFR1 level within the highest tertile was a significant risk factor for renal progression after adjustment, in comparison with the other tertiles (hazard ratio [HR], 3.39, 95% confidence interval [95% CI], 48-7.78; P=0.004). The cTNFR2 level within the highest tertile also significantly increased the risk of renal progression (HR, 3.29; 95% CI, 1.43-7.54- P=0.005) Renal tubular TNFRs expression was associated with cTNFRs level. However, the cTNFRs levels were not associated with autoantibody against phospholipase A(2) receptor reactivity/levels or treatment response. This study demonstrated that cTNFRs levels at he time of initial diagnosis could predict renal progression in patients with	[Lee, Su Mi; Yang, SeungHee; An, Jung Nam; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Lee, Su Mi] Dong A Univ, Dept Internal Med, Pusan, South Korea; [Yang, SeungHee; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Cha, Ran-Hui] Natl Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Myounghee] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Songnam, South Korea; [An, Jung Nam; Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Brain Korea 21, Seoul 120749, South Korea; [Kang, Shin-Wook] Yonsei Univ, Dept Internal Med, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University Hospital; Dong A University; Seoul National University (SNU); National Medical Center - Korea; Eulji University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Yonsei University; Yonsei University	Lee, JP (corresponding author), Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea.	nephrolee@gmail.com	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A070001]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was funded by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A070001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lamki RS, 2001, LAB INVEST, V81, P1503, DOI 10.1038/labinvest.3780364; BAUD L, 1995, MINER ELECTROL METAB, V21, P336; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BERTANI T, 1989, AM J PATHOL, V134, P419; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x; DAMICO G, 1995, AM J KIDNEY DIS, V26, P124, DOI 10.1016/0272-6386(95)90165-5; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; EHRENREICH T, 1976, NEW ENGL J MED, V295, P741, DOI 10.1056/NEJM197609302951401; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; FATTORI E, 1994, BLOOD, V83, P2570; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; HASEGAWA G, 1991, KIDNEY INT, V40, P1007, DOI 10.1038/ki.1991.308; Hasegawa M, 2009, NEPHRON CLIN PRACT, V113, pC222, DOI 10.1159/000235242; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hofstra JM, 2012, J AM SOC NEPHROL, V23, P1735, DOI 10.1681/ASN.2012030242; HONKANEN E, 1992, NEPHROL DIAL TRANSPL, V7, P35; Idasiak-Piechocka I, 2010, NEPHROL DIAL TRANSPL, V25, P3948, DOI 10.1093/ndt/gfq310; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lan HY, 1998, NEPHROL DIAL TRANSPL, V13, P7, DOI 10.1093/ndt/13.1.7; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen I, 2011, BIOCHEM BIOPH RES CO, V415, P330, DOI 10.1016/j.bbrc.2011.10.056; MAGIL AB, 1995, AM J KIDNEY DIS, V25, P375, DOI 10.1016/0272-6386(95)90097-7; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Oh YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062151; PEI Y, 1992, KIDNEY INT, V42, P960, DOI 10.1038/ki.1992.374; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Rivera F, 2004, KIDNEY INT, V66, P898, DOI 10.1111/j.1523-1755.2004.00833.x; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Sprangers B, 2012, AM J NEPHROL, V36, P78, DOI 10.1159/000339628; Takahashi K, 1998, J IMMUNOL, V161, P2629; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Waldman M, 2009, NAT REV NEPHROL, V5, P469, DOI 10.1038/nrneph.2009.101; Wu TF, 2007, ARTHRITIS RHEUM-US, V56, P949, DOI 10.1002/art.22556; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P557, DOI 10.1007/s10157-012-0593-7; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764	44	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104354	10.1371/journal.pone.0104354	http://dx.doi.org/10.1371/journal.pone.0104354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098821	Green Published, gold, Green Submitted			2022-12-25	WOS:000339995100066
J	Okinami, T; Imamura, M; Nishikawa, N; Negoro, H; Sugino, Y; Yoshimura, K; Kanematsu, A; Hashitani, H; Ogawa, O				Okinami, Takeshi; Imamura, Masaaki; Nishikawa, Nobuyuki; Negoro, Hiromitsu; Sugino, Yoshio; Yoshimura, Koji; Kanematsu, Akihiro; Hashitani, Hikaru; Ogawa, Osamu			Altered Detrusor Gap Junction Communications Induce Storage Symptoms in Bladder Inflammation: A Mouse Cyclophosphamide-Induced Model of Cystitis	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; OVERACTIVE BLADDER; SMOOTH-MUSCLE; CONNEXIN EXPRESSION; INCONTINENCE; INVOLVEMENT; GENERATION; CELLS; MEN	Lower urinary tract symptoms (LUTS) include storage, voiding and post-micturition symptoms, featuring many urological diseases. Storage symptoms are the most frequent among these and associated with overactive bladder and non-bacterial bladder inflammation such as interstitial cystitis/bladder pain syndrome (IC/BPS). Gap junction, a key regulator of hyperactive conditions in the bladder, has been reported to be involved in pathological bladder inflammation. Here we report involvement of gap junction in the etiology of storage symptoms in bladder inflammation. In this study, cyclophosphamide-induced cystitis was adapted as a model of bladder inflammation. Cyclophosphamide-treated mice showed typical storage symptoms including increased urinary frequency and reduced bladder capacity, with concurrent up-regulation of connexin 43 (GJA1), one of the major gap junction proteins in the bladder. In isometric tension study, bladder smooth muscle strips taken from the treated mice showed more pronounced spontaneous contraction than controls, which was attenuated by carbenoxolone, a gap junction inhibitor. In voiding behavior studies, the storage symptoms in the treated mice characterized by frequent voiding were alleviated by 18 alpha-glycyrrhetinic acid, another gap junction inhibitor. These results demonstrate that cyclophosphamide-induced mouse model of cystitis shows clinical storage symptoms related with bladder inflammation and that gap junction in the bladder may be a key molecule of these storage symptoms. Therefore, gap junction in the bladder might be an alternative therapeutic target for storage symptoms in bladder inflammation.	[Okinami, Takeshi; Imamura, Masaaki; Nishikawa, Nobuyuki; Negoro, Hiromitsu; Sugino, Yoshio; Yoshimura, Koji; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Kanematsu, Akihiro] Hyogo Coll Med, Dept Urol, Nishinomiya, Hyogo 6638501, Japan; [Nishikawa, Nobuyuki; Hashitani, Hikaru] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Physiol, Nagoya, Aichi, Japan	Kyoto University; Hyogo College of Medicine; Nagoya City University	Ogawa, O (corresponding author), Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan.	ogawao@kuhp.kyoto-u.ac.jp	Hashitani, Hikaru/AAI-3350-2020; Negoro, Hiromitsu/AAW-3261-2021	Negoro, Hiromitsu/0000-0003-1144-2755	Suzuki Urological Foundation;  [25462511];  [23-4448]	Suzuki Urological Foundation; ; 	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) No. 25462511 (YK), Grant-in-Aid for JSPS Fellows No. 23-4448 (TO) (http://www.jsps.go.jp/index.html), and Suzuki Urological Foundation (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Andersson KE, 2004, LANCET NEUROL, V3, P46, DOI 10.1016/S1474-4422(03)00622-7; Andersson KE, 1999, BJU INT, V84, P923; Apostolidis A, 2008, EUR UROL, V53, P1245, DOI 10.1016/j.eururo.2008.02.037; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Charrua A, 2007, J UROLOGY, V177, P1537, DOI 10.1016/j.juro.2006.11.046; Comperat E, 2006, EUR UROL, V50, P1058, DOI 10.1016/j.eururo.2006.01.025; Coyne KS, 2008, BJU INT, V101, P1388, DOI 10.1111/j.1464-410X.2008.07601.x; Coyne KS, 2013, NEUROUROL URODYNAM, V32, P230, DOI 10.1002/nau.22295; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Efimov IR, 2004, ANAT REC PART A, V280A, P952, DOI 10.1002/ar.a.20108; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Fry CH, 2007, NEUROUROL URODYNAM, V26, P914, DOI 10.1002/nau.20483; Ganz ML, 2010, UROLOGY, V75, P533, DOI [10.1016/j.urology.2009.06.096, 10.1016/j.urology.2009.08.003]; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Hashitani H, 2004, J PHYSIOL-LONDON, V559, P567, DOI 10.1113/jphysiol.2004.065136; Hashitani H, 2004, BRIT J PHARMACOL, V141, P183, DOI 10.1038/sj.bjp.0705602; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heinrich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020792; Hu TW, 2000, AM J MANAG CARE, V6, pS591; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Imamura M, 2013, J CELL PHYSIOL, V228, P1819, DOI 10.1002/jcp.24333; Imamura M, 2009, AM J PHYSIOL-RENAL, V297, pF46, DOI 10.1152/ajprenal.90207.2008; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Johnson MH, 2013, J UROLOGY, V189, P1268, DOI 10.1016/j.juro.2012.10.070; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Li LK, 2007, AM J PHYSIOL-CELL PH, V293, pC1627, DOI 10.1152/ajpcell.00122.2007; McCarthy CJ, 2009, J UROLOGY, V181, P1459, DOI 10.1016/j.juro.2008.10.139; Negoro H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02152; Negoro H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1812; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Ouslander JG, 2004, NEW ENGL J MED, V350, P786, DOI 10.1056/NEJMra032662; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Saban Marcia R., 2011, BMC Physiology, V11, P16, DOI 10.1186/1472-6793-11-16; Sui G, 2013, AM J PHYSL RENAL PHY; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Takeda Y, 2005, AM J PHYSIOL-GASTR L, V288, pG832, DOI 10.1152/ajpgi.00389.2004; Tincello DG, 2005, EUR J OBSTET GYN R B, V118, P91, DOI 10.1016/j.ejogrb.2004.06.012	40	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104216	10.1371/journal.pone.0104216	http://dx.doi.org/10.1371/journal.pone.0104216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099633	gold, Green Published, Green Submitted			2022-12-25	WOS:000339995100053
J	Singh, P; Jayaramaiah, RH; Sarate, P; Thulasiram, HV; Kulkarni, MJ; Giri, AP				Singh, Priyanka; Jayaramaiah, Ramesha H.; Sarate, Priya; Thulasiram, Hirekodathakallu V.; Kulkarni, Mahesh J.; Giri, Ashok P.			Insecticidal Potential of Defense Metabolites from Ocimum kilimandscharicum against Helicoverpa armigera	PLOS ONE			English	Article							PLANT; AMYLASES; PEST	Genus Ocimum contains a reservoir of diverse secondary metabolites, which are known for their defense and medicinal value. However, the defense-related metabolites from this genus have not been studied in depth. To gain deeper insight into inducible defense metabolites, we examined the overall biochemical and metabolic changes in Ocimum kilimandscharicum that occurred in response to the feeding of Helicoverpa armigera larvae. Metabolic analysis revealed that the primary and secondary metabolism of local and systemic tissues in O. kilimandscharicum was severely affected following larval infestation. Moreover, levels of specific secondary metabolites like camphor, limonene and beta-caryophyllene (known to be involved in defense) significantly increased in leaves upon insect attack. Choice assays conducted by exposing H. armigera larvae on O. kilimandscharicum and tomato leaves, demonstrated that O. kilimandscharicum significantly deters larval feeding. Further, when larvae were fed on O. kilimandscharicum leaves, average body weight decreased and mortality the larvae increased. Larvae fed on artificial diet supplemented with O. kilimandscharicum leaf extract, camphor, limonene and beta-caryophyllene showed growth retardation, increased mortality rates and pupal deformities. Digestive enzymes of H. armigera - namely, amylase, protease and lipase- showed variable patterns after feeding on O. kilimandscharicum, which implies striving of the larvae to attain required nutrition for growth, development and metamorphosis. Evidently, selected metabolites from O. kilimandscharicum possess significant insecticidal activity.	[Singh, Priyanka; Jayaramaiah, Ramesha H.; Sarate, Priya; Giri, Ashok P.] CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India; [Singh, Priyanka; Thulasiram, Hirekodathakallu V.] CSIR, Natl Chem Lab, Div Organ Chem, Chem Biol Unit, Pune, Maharashtra, India; [Thulasiram, Hirekodathakallu V.] CSIR, Inst Genom & Integrat Biol, New Delhi 110001, India; [Kulkarni, Mahesh J.] CSIR, Natl Chem Lab, Div Biochem Sci, Prote Facil, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Giri, AP (corresponding author), CSIR, Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India.	ap.giri@ncl.res.in	Jayaramaiah, Ramesha H./AAR-7246-2020; Kulkarni, Mahesh J/G-1473-2010	Jayaramaiah, Ramesha H./0000-0003-4237-9664; 	CSIR, New Delhi [BSC0124]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work is financially supported by CSIR, New Delhi sponsored network project (BSC0124). The funders had no role in study design, data and analysis, decision to publish, or preparation of the manuscript.	Bekele J, 2001, PHYTOCHEMISTRY, V57, P385, DOI 10.1016/S0031-9422(01)00067-X; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BHARGAVA KP, 1981, INDIAN J MED RES, V73, P443; BROCK FM, 1982, APPL ENVIRON MICROB, V44, P561, DOI 10.1128/AEM.44.3.561-569.1982; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Devi PU, 2000, RADIAT RES, V154, P455, DOI 10.1667/0033-7587(2000)154[0455:RPBTOF]2.0.CO;2; Dinant S, 2012, SIGNALING COMMUNICAT, V6, P89; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Furch ACU, 2008, PLANT SIGNAL BEHAV, V3, P858, DOI 10.4161/psb.3.10.6040; Gendo JO, 2008, J STORED PROD RES, V44, P328, DOI 10.1016/j.jspr.2008.02.009; Hakkim FL, 2008, J MED PLANTS RES, V2, P250; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Harborne JB, 2001, SECONDARY METABOLITE; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; JEMBERE B, 1995, B ENTOMOL RES, V85, P361, DOI 10.1017/S0007485300036099; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Kamaraj C, 2008, PARASITOL RES, V103, P1361, DOI 10.1007/s00436-008-1142-x; Karthikeyan K, 1999, PHARM BIOL, V37, P285, DOI 10.1076/phbi.37.4.285.5801; Khan A, 2010, NAT PROD COMMUN, V5, P345; Khan M.R., 2010, J SCI RES, V2, P158, DOI DOI 10.3329/JSR.V2IL.2769; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kotkar HM, 2009, J INSECT PHYSIOL, V55, P663, DOI 10.1016/j.jinsphys.2009.05.004; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Liska A., 2010, 10 INT WORK C STOR P, P716, DOI DOI 10.5073/JKA.2010.425.093; Maor R, 2005, CURR OPIN MICROBIOL, V8, P399, DOI 10.1016/j.mib.2005.06.008; Nagarkatti S, 1974, COMMONWEALTH I BIOL, V17, P169; Prakash P, 2005, Indian J Physiol Pharmacol, V49, P125; Qiantai L, 1998, P 7 INT C STOR PROD, V1, P836; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rozman V, 2007, J STORED PROD RES, V43, P349, DOI 10.1016/j.jspr.2006.09.001; Sarate PJ, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4201; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Tamhane VA, 2005, BBA-GEN SUBJECTS, V1722, P156, DOI 10.1016/j.bbagen.2004.12.017; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; ZOLLNER N., 1962, ZEIT GES EXPTL MED, V135, P545, DOI 10.1007/BF02045455	41	22	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104377	10.1371/journal.pone.0104377	http://dx.doi.org/10.1371/journal.pone.0104377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098951	Green Submitted, Green Published, gold			2022-12-25	WOS:000339995100067
J	Zhang, LZ; Liu, RH; Niu, W				Zhang, Lizhen; Liu, Ruihai; Niu, Wei			Phytochemical and Antiproliferative Activity of Proso Millet	PLOS ONE			English	Article							CELLULAR ANTIOXIDANT ACTIVITY; ANTI PROLIFERATIVE ACTIVITIES; PROTEIN; CAROTENOIDS; PHENOLICS; PROFILES; MAIZE; FOODS; ASSAY	The phytochemical content, antioxidant activity and antiproliferative properties of three diverse varieties of proso millet are reported. The free phenolic content ranged from 27.48 (Gumi 20) to 151.14 (Mi2504-6) mg gallic acid equiv/100 g DW. The bound phenolic content ranged from 55.95 (Gumi20) to 305.81 (Mi2504-6) mg gallic acid equiv/100 g DW. The percentage contribution of bound phenolic to the total phenolic content of genotype samples analyzed ranged between 62.08% and 67.05%. Ferulic acid and chlorogenic acid are the predominant phenolic acid found in bound fraction. Caffeic acid and p-coumaric acid were also detected. Syringic acid was detected only in the free fraction. The antioxidant activity was assessed using the hydrophilic peroxyl radical scavenging capacity (PSC) assay. The PSC antioxidant activity of the free fraction ranged from 57.68 (Mi2504-6) to 147.32 (Gumi20) mu mol of vitamin C equiv/100 g DW. The PSC antioxidant activity of the bound fraction ranged from 95.38 (Mizao 52) to 136.48 (Gumi 20) mu mol of vitamin C equiv/100 g DW. The cellular antioxidant activity (CAA) of the extract was assessed using the HepG2 model. CAA value ranged from 2.51 to 6.10 mu mol equiv quercetin/100 g DW. Antiproliferative activities were also studied in vitro against MDA human breast cancer and HepG2 human liver cancer cells. Results exhibited a differential and possible selective antiproliferative property of the proso millet. These results may be used to direct the consumption of proso millet with improved health properties.	[Zhang, Lizhen] Shanxi Univ, Coll Life Sci, Taiyuan, Peoples R China; [Liu, Ruihai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Niu, Wei] Shanxi Acad Agr Sci, Taiyuan, Peoples R China	Shanxi University; Cornell University; Shanxi Agricultural University	Liu, RH (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	RL23@cornell.edu	Liu, Rui Hai/AAE-4865-2019; Liu, Rui Hai/C-2865-2008	Liu, Rui Hai/0000-0002-7018-7929; 				Adom KK, 2005, J AGR FOOD CHEM, V53, P6572, DOI 10.1021/jf048318o; Adom KK, 2003, J AGR FOOD CHEM, V51, P7825, DOI 10.1021/jf030404l; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Asharani VT, 2010, INT J FOOD PROP, V13, P41, DOI 10.1080/10942910802163105; Birgit J, 2011, NUTR CANC, V63, P611; Chandrasekara A, 2011, J AGR FOOD CHEM, V59, P428, DOI 10.1021/jf103896z; Chandrasekara A, 2010, J AGR FOOD CHEM, V58, P6706, DOI 10.1021/jf100868b; Denery-Papini S, 1999, J CEREAL SCI, V30, P121, DOI 10.1006/jcrs.1999.0268; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hu XY, 2009, J GENET GENOMICS, V36, P491, DOI 10.1016/S1673-8527(08)60139-3; Hulshof PJM, 2007, J FOOD COMPOS ANAL, V20, P655, DOI 10.1016/j.jfca.2006.04.014; Kalinova J, 2006, PLANT FOOD HUM NUTR, V61, P45, DOI 10.1007/s11130-006-0013-9; Kampa M, 2004, BREAST CANCER RES, V6, pR63, DOI 10.1186/bcr752; Kean EG, 2011, J CEREAL SCI, V54, P450, DOI 10.1016/j.jcs.2011.08.010; Kimura M, 2007, FOOD CHEM, V100, P1734, DOI 10.1016/j.foodchem.2005.10.020; Kumari SK, 1998, PLANT FOOD HUM NUTR, V53, P47, DOI 10.1023/A:1008083020810; Liu CS, 2004, J AGR FOOD CHEM, V52, P4330, DOI 10.1021/jf040028k; Liu M, 2002, J AGR FOOD CHEM, V50, P2926, DOI 10.1021/jf0111209; MCDONOUGH CM, 1985, CEREAL FOOD WORLD, V30, P550; Neelam Chaturvedi, 2011, Journal of Applied Pharmaceutical Science, V1, P6; Nishizawa N, 2002, BIOSCI BIOTECH BIOCH, V66, P92, DOI 10.1271/bbb.66.92; NISHIZAWA N, 1995, BIOSCI BIOTECH BIOCH, V59, P333, DOI 10.1271/bbb.59.333; Okarter N, 2010, FOOD CHEM, V119, P249, DOI 10.1016/j.foodchem.2009.06.021; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Sun J, 2008, J AGR FOOD CHEM, V56, P11661, DOI 10.1021/jf8021223; Wang L., 2005, J PLANT GENET RESOUR, V6, P471; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Xu BJ, 2012, FOOD CHEM, V134, P1287, DOI 10.1016/j.foodchem.2012.02.212; YANEZ GA, 1991, J CEREAL SCI, V13, P299, DOI 10.1016/S0733-5210(09)80008-8; Yang J, 2004, J AGR FOOD CHEM, V52, P6787, DOI 10.1021/jf0307144; Yang J, 2009, FOOD CHEM, V116, P332, DOI 10.1016/j.foodchem.2009.02.021	34	57	58	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104058	10.1371/journal.pone.0104058	http://dx.doi.org/10.1371/journal.pone.0104058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25098952	Green Published, Green Submitted, gold			2022-12-25	WOS:000339995100047
J	Bockor, VV; Barisic, D; Horvat, T; Maglica, Z; Vojta, A; Zoldos, V				Bockor, Vedrana Vicic; Barisic, Darko; Horvat, Tomislav; Maglica, Zeljka; Vojta, Aleksandar; Zoldos, Vlatka			Inhibition of DNA Methylation Alters Chromatin Organization, Nuclear Positioning and Activity of 45S rDNA Loci in Cycling Cells of Q. robur	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; RIBOSOMAL-RNA GENES; NUCLEOLAR DOMINANCE; WHEAT; RYE; HETEROCHROMATIN; EXPRESSION; PROTEINS; NORS; ARABIDOPSIS	Around 2200 copies of genes encoding ribosomal RNA (rRNA) in pedunculate oak, Quercus robur, are organized into two rDNA loci, the major (NOR-1) and the minor (NOR-2) locus. We present the first cytogenetic evidence indicating that the NOR-1 represents the active nucleolar organizer responsible for rRNA synthesis, while the NOR-2 probably stays transcriptionally silent and does not participate in the formation of the nucleolus in Q. robur, which is a situation resembling the well-known phenomenon of nucleolar dominance. rDNA chromatin topology analyses in cycling root tip cells by light and electron microscopy revealed the minor locus to be highly condensed and located away from the nucleolus, while the major locus was consistently associated with the nucleolus and often exhibited different levels of condensation. In addition, silver precipitation was confined exclusively to the NOR-1 locus. Also, NOR-2 was highly methylated at cytosines and rDNA chromatin was marked with histone modifications characteristic for repressive state. After treatment of the root cells with the methylation inhibitor 5-aza-2'-deoxycytidine, we observed an increase in the total level of rRNA transcripts and a decrease in DNA methylation level at the NOR-2 locus. Also, NOR-2 sites relocalized with respect to the nuclear periphery/nucleolus, however, the relocation did not affect the contribution of this locus to nucleolar formation, nor did it affect rDNA chromatin decondensation, strongly suggesting that NOR-2 has lost the function of rRNA synthesis and nucleolar organization.	[Bockor, Vedrana Vicic; Horvat, Tomislav; Vojta, Aleksandar; Zoldos, Vlatka] Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia; [Barisic, Darko] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Maglica, Zeljka] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of Zagreb; Friedrich Miescher Institute for Biomedical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Zoldos, V (corresponding author), Univ Zagreb, Fac Sci, Dept Mol Biol, Zagreb 41000, Croatia.	vzoldos@biol.pmf.hr	Maglica, Željka/S-7423-2018; Vojta, Aleksandar/S-2086-2017	Maglica, Željka/0000-0002-6438-861X; Vojta, Aleksandar/0000-0002-4627-1821	Croatian Ministry of Science, Education and Sport [119-1191196-1224]; AUF PCSI Grant; FP7 RegPot Integra-Life grant [315997]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); AUF PCSI Grant; FP7 RegPot Integra-Life grant	The work was supported by the Croatian Ministry of Science, Education and Sport Grant (grant no. 119-1191196-1224), AUF PCSI Grant, and FP7 RegPot Integra-Life grant (grant no. 315997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado L, 1997, CHROMOSOME RES, V5, P445, DOI 10.1023/A:1018460828720; Bauer N, 2009, MOL GENET GENOMICS, V281, P207, DOI 10.1007/s00438-008-0404-8; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Canty A RB, 2013, BOOTSTRAP R S PLUS F; Caperta AD, 2002, J CELL SCI, V115, P2839; Caperta AD, 2007, PROTOPLASMA, V232, P55, DOI 10.1007/s00709-007-0277-4; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; CLSI, 2008, DEFINING ESTABLISHIN, VEP28-A3c; Davison AC, 1997, BOOTSTRAP METHODS TH; Dousset T, 2000, MOL BIOL CELL, V11, P2705, DOI 10.1091/mbc.11.8.2705; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Gonzalez IL, 1997, CHROMOSOMA, V105, P431, DOI 10.1007/s004120050204; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; Harrell FE., 2021, HMISC HARRELL MISCEL; Harrell FE DC, 1982, BIOMETRIKA, V69; Heitz E., 1931, PLANTA, V15, P495, DOI [10.1007/BF01909065, DOI 10.1007/BF01909065]; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kalmarova M, 2007, J STRUCT BIOL, V160, P49, DOI 10.1016/j.jsb.2007.06.012; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; LEITCH AR, 1992, J CELL SCI, V101, P751; Manickavelu A, 2007, COLLOID SURFACE B, V54, P254, DOI 10.1016/j.colsurfb.2006.10.024; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; McKeown PC, 2009, CHROMOSOMA, V118, P11, DOI 10.1007/s00412-008-0184-2; MELESE T, 1995, CURR OPIN CELL BIOL, V7, P319, DOI 10.1016/0955-0674(95)80085-9; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Pikaard C, 2007, NAT CELL BIOL, V9, P19, DOI 10.1038/ncb0107-19; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontvianne F, 2013, GENE DEV, V27, P1545, DOI 10.1101/gad.221648.113; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; Preuss SB, 2008, MOL CELL, V32, P673, DOI 10.1016/j.molcel.2008.11.009; Probst AV, 2004, PLANT CELL, V16, P1021, DOI 10.1105/tpc.018754; R Core t, 2013, LANG ENV STAT COMP; Raska I, 2004, PROG MOL SUBCELL BIO, V35, P23; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; RAWLINS DJ, 1990, J MICROSC-OXFORD, V157, P83, DOI 10.1111/j.1365-2818.1990.tb02949.x; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; Santos AP, 2011, OMICS, V15, P839, DOI 10.1089/omi.2011.0095; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PJ, 2011, PROTEIN REV, V15, P43, DOI 10.1007/978-1-4614-0514-6_3; Silva M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003824; Sirri V, 2000, MICRON, V31, P121, DOI 10.1016/S0968-4328(99)00068-2; TORRESRUIZ RA, 1994, PLANT MOL BIOL, V26, P1167, DOI 10.1007/BF00040697; Tucker S, 2010, CURR OPIN CELL BIOL, V22, P351, DOI 10.1016/j.ceb.2010.03.009; Veiseth SV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001325; Vicic V, 2013, TREE GENET GENOMES, V9, P1247, DOI 10.1007/s11295-013-0632-x; VIEIRA R, 1990, GENOME, V33, P707, DOI 10.1139/g90-106; WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66; Zoldos V, 1999, THEOR APPL GENET, V99, P969, DOI 10.1007/s001220051404	57	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103954	10.1371/journal.pone.0103954	http://dx.doi.org/10.1371/journal.pone.0103954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093501	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200050
J	Sinha, A; Rae, R				Sinha, Amit; Rae, Robbie			A Functional Genomic Screen for Evolutionarily Conserved Genes Required for Lifespan and Immunity in Germline-Deficient C. elegans	PLOS ONE			English	Article							LAMPREYS LAMPETRA-FLUVIATILIS; CAENORHABDITIS-ELEGANS; PRISTIONCHUS-PACIFICUS; TRANSCRIPTION FACTOR; LONGEVITY; METABOLISM; EXPRESSION; PATHWAY; SYSTEM; SEX	The reproductive system regulates lifespan in insects, nematodes and vertebrates. In Caenorhabditis elegans removal of germline increases lifespan by 60% which is dependent upon insulin signaling, nuclear hormone signaling, autophagy and fat metabolism and their microRNA-regulators. Germline-deficient C. elegans are also more resistant to various bacterial pathogens but the underlying molecular mechanisms are largely unknown. Firstly, we demonstrate that previously identified genes that regulate the extended lifespan of germline-deficient C. elegans (daf-2, daf-16, daf-12, tcer-1, mir-7.1 and nhr-80) are also essential for resistance to the pathogenic bacterium Xenorhabdus nematophila. We then use a novel unbiased approach combining laser cell ablation, whole genome microarrays, RNAi screening and exposure to X. nematophila to generate a comprehensive genome-wide catalog of genes potentially required for increased lifespan and innate immunity in germline-deficient C. elegans. We find 3,440 genes to be upregulated in C. elegans germline-deficient animals in a gonad dependent manner, which are significantly enriched for genes involved in insulin signaling, fatty acid desaturation, translation elongation and proteasome complex function. Using RNAi against a subset of 150 candidate genes selected from the microarray results, we show that the upregulated genes such as transcription factor DAF-16/FOXO, the PTEN homolog lipid phosphatase DAF-18 and several components of the proteasome complex (rpn-6.1, rpn-7, rpn-9, rpn-10, rpt-6, pbs-3 and pbs-6) are essential for both lifespan and immunity of germline deficient animals. We also identify a novel role for genes including par-5 and T12G3.6 in both lifespan-extension and increased survival on X. nematophila. From an evolutionary perspective, most of the genes differentially expressed in germline deficient C. elegans also show a conserved expression pattern in germline deficient Pristionchus pacificus, a nematode species that diverged from C. elegans 250-400 MYA.	[Sinha, Amit; Rae, Robbie] Max Planck Inst Dev Biol, Dept Evolutionary Biol, Tubingen, Germany	Max Planck Society	Rae, R (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England.	r.g.rae@ljmu.ac.uk	Sinha, Amit/H-5116-2019	Sinha, Amit/0000-0003-1849-710X	Max Planck Society; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors declare that no conflict of interest exists.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Drace K, 2008, APPL ENVIRON MICROB, V74, P4509, DOI 10.1128/AEM.00336-08; DRORI D, 1976, EXP GERONTOL, V11, P25, DOI 10.1016/0531-5565(76)90007-3; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Ghazi A, 2013, GENESIS, V51, P1, DOI 10.1002/dvg.22345; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; HAMILTON JB, 1965, J GERONTOL, V20, P96, DOI 10.1093/geronj/20.1.96; HAMILTON JB, 1969, J GERONTOL, V24, P395, DOI 10.1093/geronj/24.4.395; Hatle JD, 2008, EXP GERONTOL, V43, P900, DOI 10.1016/j.exger.2008.08.005; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Jia KL, 2002, DEVELOPMENT, V129, P221; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim KW, 2010, P NATL ACAD SCI USA, V107, P17445, DOI 10.1073/pnas.1012611107; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; KIME DE, 1987, GEN COMP ENDOCR, V68, P189, DOI 10.1016/0016-6480(87)90028-1; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; LARSEN LO, 1974, GEN COMP ENDOCR, V24, P305, DOI 10.1016/0016-6480(74)90184-1; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Rae R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002864; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; ROBERTSON OH, 1961, FED PROC, V20, P29; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shen YD, 2012, SCIENCE, V338, P1472, DOI 10.1126/science.1228967; Sinha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044255; Sinha A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-254; SMITH JM, 1958, J EXP BIOL, V35, P832; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; TeKippe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011777; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525	64	16	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e101970	10.1371/journal.pone.0101970	http://dx.doi.org/10.1371/journal.pone.0101970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093668	Green Published, Green Submitted, gold			2022-12-25	WOS:000341357200007
J	Cao, Y; Rathmell, JC; Macintyre, AN				Cao, Yilin; Rathmell, Jeffrey C.; Macintyre, Andrew N.			Metabolic Reprogramming towards Aerobic Glycolysis Correlates with Greater Proliferative Ability and Resistance to Metabolic Inhibition in CD8 versus CD4 T Cells	PLOS ONE			English	Article							EFFECTOR FUNCTION; PYRUVATE-KINASE; CONCANAVALIN-A; GLUCOSE; LYMPHOCYTES; ACTIVATION; INTERLEUKIN-2; REQUIREMENTS; MECHANISMS; EXPRESSION	T lymphocytes (T cells) undergo metabolic reprogramming after activation to provide energy and biosynthetic materials for growth, proliferation and differentiation. Distinct T cell subsets, however, adopt metabolic programs specific to support their needs. As CD4 T cells coordinate adaptive immune responses while CD8 T cells become cytotoxic effectors, we compared activation-induced proliferation and metabolic reprogramming of these subsets. Resting CD4 and CD8 T cells were metabolically similar and used a predominantly oxidative metabolism. Following activation CD8 T cells proliferated more rapidly. Stimulation led both CD4 and CD8 T cells to sharply increase glucose metabolism and adopt aerobic glycolysis as a primary metabolic program. Activated CD4 T cells, however, remained more oxidative and had greater maximal respiratory capacity than activated CD8 T cells. CD4 T cells were also associated with greater levels of ROS and increased mitochondrial content, irrespective of the activation context. CD8 cells were better able, however, to oxidize glutamine as an alternative fuel source. The more glycolytic metabolism of activated CD8 T cells correlated with increased capacity for growth and proliferation, along with reduced sensitivity of cell growth to metabolic inhibition. These specific metabolic programs may promote greater growth and proliferation of CD8 T cells and enhance survival in diverse nutrient conditions.	[Cao, Yilin; Rathmell, Jeffrey C.; Macintyre, Andrew N.] Duke Univ, Sarah W Stedman Ctr Nutr & Metab, Dept Pharmacol & Canc Biol, Dept Immunol, Durham, NC 27708 USA	Duke University	Rathmell, JC (corresponding author), Duke Univ, Sarah W Stedman Ctr Nutr & Metab, Dept Pharmacol & Canc Biol, Dept Immunol, Durham, NC 27708 USA.	jeff.rathmell@duke.edu; a.n.macintyre@duke.edu		Macintyre, Andrew/0000-0002-5297-0207	American Asthma Foundation; Leukemia Lymphoma Society; Colitis Foundation of America [284879]; American Asthma Foundation [R01AI063345, R01HL108006, R56AI102074]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI102074, R01AI063345] Funding Source: NIH RePORTER	American Asthma Foundation; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Colitis Foundation of America; American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Asthma Foundation (JCR), the Leukemia Lymphoma Society (JCR), the Crohn's and Colitis Foundation of America (284879, ANM), and the American Asthma Foundation (JCR), R01AI063345 (JCR), R01HL108006 (JCR), R56AI102074 (JCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell SB, 2000, IMMUNOLOGY, V99, P394, DOI 10.1046/j.1365-2567.2000.00971.x; CHAKRABARTI R, 1994, J IMMUNOL, V152, P2660; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Croft M, 2009, IMMUNOL REV, V229, P173, DOI 10.1111/j.1600-065X.2009.00766.x; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; Dreau D, 1998, IMMUNOPHARMACOLOGY, V39, P201, DOI 10.1016/S0162-3109(98)00016-2; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; KEAST D, 1991, INT J BIOCHEM, V23, P823, DOI 10.1016/0020-711X(91)90066-V; Lee HW, 2002, J IMMUNOL, V169, P4882, DOI 10.4049/jimmunol.169.9.4882; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macintyre AN, 2014, CELL METAB IN PRESS; Macintyre AN, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-5; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MARJANOVIC S, 1988, BIOCHIM BIOPHYS ACTA, V970, P1, DOI 10.1016/0167-4889(88)90215-7; MARJANOVIC S, 1990, BIOCHIM BIOPHYS ACTA, V1087, P1, DOI 10.1016/0167-4781(90)90113-G; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; MILLER ES, 1994, J NEUROIMMUNOL, V52, P165, DOI 10.1016/0165-5728(94)90110-4; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; OROURKE AM, 1989, BIOCHIM BIOPHYS ACTA, V1010, P342, DOI 10.1016/0167-4889(89)90059-1; Ostroukhova M, 2012, AM J PHYSIOL-LUNG C, V302, pL300, DOI 10.1152/ajplung.00221.2011; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu XJ, 2012, SEMIN IMMUNOL, V24, P429, DOI 10.1016/j.smim.2012.12.005; Zhao YX, 2008, METHOD ENZYMOL, V442, P439, DOI [10.1016/S0076-0879(08)01422-5, 10.1016/S0076-6879(08)01422-5]	47	84	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104104	10.1371/journal.pone.0104104	http://dx.doi.org/10.1371/journal.pone.0104104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090630	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700097
J	Laht, M; Karkman, A; Voolaid, V; Ritz, C; Tenson, T; Virta, M; Kisand, V				Laht, Mailis; Karkman, Antti; Voolaid, Veiko; Ritz, Christian; Tenson, Tanel; Virta, Marko; Kisand, Veljo			Abundances of Tetracycline, Sulphonamide and Beta-Lactam Antibiotic Resistance Genes in Conventional Wastewater Treatment Plants (WWTPs) with Different Waste Load	PLOS ONE			English	Article							SEWAGE-TREATMENT PLANTS; ACTIVATED-SLUDGE; SURFACE-WATER; BACTERIA; ENVIRONMENT; FATE; PREVALENCE; DRINKING; EFFLUENT; HOTSPOTS	Antibiotics and antibiotic resistant bacteria enter wastewater treatment plants (WWTPs), an environment where resistance genes can potentially spread and exchange between microbes. Several antibiotic resistance genes (ARGs) were quantified using qPCR in three WWTPs of decreasing capacity located in Helsinki, Tallinn, and Tartu, respectively: sulphonamide resistance genes (sul1 and sul2), tetracycline resistance genes (tetM and tetC), and resistance genes for extended spectrum beta-lactams (bla(oxa-58), bla(shv-34), and bla(ctx-m-32)). To avoid inconsistencies among qPCR assays we normalised the ARG abundances with 16S rRNA gene abundances while assessing if the respective genes increased or decreased during treatment. ARGs were detected in most samples; sul1, sul2, and tetM were detected in all samples. Statistically significant differences (adjusted p<0.01) between the inflow and effluent were detected in only four cases. Effluent values for bla(oxa-58) and tetC decreased in the two larger plants while tetM decreased in the medium-sized plant. Only bla(shv-34) increased in the effluent from the medium-sized plant. In all other cases the purification process caused no significant change in the relative abundance of resistance genes, while the raw abundances fell by several orders of magnitude. Standard water quality variables (biological oxygen demand, total phosphorus and nitrogen, etc.) were weakly related or unrelated to the relative abundance of resistance genes. Based on our results we conclude that there is neither considerable enrichment nor purification of antibiotic resistance genes in studied conventional WWTPs.	[Laht, Mailis; Voolaid, Veiko; Tenson, Tanel; Kisand, Veljo] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Karkman, Antti; Virta, Marko] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Ritz, Christian] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Tartu; University of Helsinki; University of Copenhagen	Kisand, V (corresponding author), Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia.	kisand@ut.ee	Karkman, Antti/HFZ-8618-2022; Kisand, Veljo/H-2466-2012; Tenson, Tanel/I-6431-2015; Virta, Marko/B-4292-2010; Karkman, Antti/AAW-9096-2021; Ritz, Christian/P-6159-2014	Kisand, Veljo/0000-0002-5535-1639; Tenson, Tanel/0000-0002-0260-3601; Virta, Marko/0000-0001-5981-7566; Karkman, Antti/0000-0003-0983-3319; Ritz, Christian/0000-0002-5095-0624	Academy of Finland; EnSTe graduate school; European Regional Development Fund through the Centre of Excellence in Chemical Biology in Estonia; COST Action [TD0803]	Academy of Finland(Academy of Finland); EnSTe graduate school; European Regional Development Fund through the Centre of Excellence in Chemical Biology in Estonia; COST Action(European Cooperation in Science and Technology (COST))	The research was funded by the Academy of Finland and EnSTe graduate school, and the European Regional Development Fund through the Centre of Excellence in Chemical Biology in Estonia. Additional funding was provided by COST Action TD0803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bates D., 2013, LME4 LINEAR MIXED EF; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Borjesson S, 2010, J WATER HEALTH, V8, P247, DOI 10.2166/wh.2009.159; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007; Chang XS, 2010, ENVIRON POLLUT, V158, P1444, DOI 10.1016/j.envpol.2009.12.034; Clara M, 2005, WATER RES, V39, P97, DOI 10.1016/j.watres.2004.08.036; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Figueira V, 2011, WATER RES, V45, P5599, DOI 10.1016/j.watres.2011.08.021; Gao P, 2012, SCI TOTAL ENVIRON, V421, P173, DOI 10.1016/j.scitotenv.2012.01.061; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Duong HA, 2008, CHEMOSPHERE, V72, P968, DOI 10.1016/j.chemosphere.2008.03.009; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jury KL, 2011, CRIT REV ENV SCI TEC, V41, P243, DOI 10.1080/10643380902772589; Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129; Kim S, 2007, J TOXICOL ENV HEAL B, V10, P559, DOI 10.1080/15287390600975137; Koivunen J, 2003, WATER RES, V37, P690, DOI 10.1016/S0043-1354(02)00305-6; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08; Le-Minh N, 2010, WATER RES, V44, P4295, DOI 10.1016/j.watres.2010.06.020; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Li D, 2011, WATER RES, V45, P6063, DOI 10.1016/j.watres.2011.09.002; Lillenberg M, 2011, RESIDUES SOME PHARM; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Liu MM, 2012, ENVIRON SCI TECHNOL, V46, P7551, DOI 10.1021/es301145m; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Luczkiewicz A, 2010, WATER RES, V44, P5089, DOI 10.1016/j.watres.2010.08.007; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; Moura A, 2010, RES MICROBIOL, V161, P58, DOI 10.1016/j.resmic.2009.11.004; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Nolvak H, 2013, SCI TOTAL ENVIRON, V461, P636, DOI 10.1016/j.scitotenv.2013.05.052; Novo A, 2013, WATER RES, V47, P1875, DOI 10.1016/j.watres.2013.01.010; Novo A, 2010, APPL MICROBIOL BIOT, V87, P1157, DOI 10.1007/s00253-010-2583-6; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s; Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0; Tamminen M, 2011, ENVIRON SCI TECHNOL, V45, P386, DOI 10.1021/es102725n; Toleman MA, 2006, J ANTIMICROB CHEMOTH, V58, P1, DOI 10.1093/jac/dkl204; West BM, 2011, WATER AIR SOIL POLL, V217, P473, DOI 10.1007/s11270-010-0602-y; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x	59	113	118	7	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103705	10.1371/journal.pone.0103705	http://dx.doi.org/10.1371/journal.pone.0103705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084517	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800068
J	Ling, HH; Beaule, C; Chiang, CK; Tian, RJ; Figeys, D; Cheng, HYM				Ling, Harrod H.; Beaule, Christian; Chiang, Cheng-Kang; Tian, Ruijun; Figeys, Daniel; Cheng, Hai-Ying M.			Time-of-Day- and Light-Dependent Expression of Ubiquitin Protein Ligase E3 Component N-Recognin 4 (UBR4) in the Suprachiasmatic Nucleus Circadian Clock	PLOS ONE			English	Article							GENE-EXPRESSION; DEGRADATION; RHYTHM; VASOPRESSIN; MOUSE; CRYPTOCHROME; OSCILLATION; PROTEASOME; PATHWAYS; REVEALS	Circadian rhythms of behavior and physiology are driven by the biological clock that operates endogenously but can also be entrained to the light-dark cycle of the environment. In mammals, the master circadian pacemaker is located in the suprachiasmatic nucleus (SCN), which is composed of individual cellular oscillators that are driven by a set of core clock genes interacting in transcriptional/translational feedback loops. Light signals can trigger molecular events in the SCN that ultimately impact on the phase of expression of core clock genes to reset the master pacemaker. While transcriptional regulation has received much attention in the field of circadian biology in the past, other mechanisms including targeted protein degradation likely contribute to the clock timing and entrainment process. In the present study, proteome-wide screens of the murine SCN led to the identification of ubiquitin protein ligase E3 component N-recognin 4 (UBR4), a novel E3 ubiquitin ligase component of the N-end rule pathway, as a time-of-day-dependent and light-inducible protein. The spatial and temporal expression pattern of UBR4 in the SCN was subsequently characterized by immunofluorescence microscopy. UBR4 is expressed across the entire rostrocaudal extent of the SCN in a time-of-day-dependent fashion. UBR4 is localized exclusively to arginine vasopressin (AVP)-expressing neurons of the SCN shell. Upon photic stimulation in the early subjective night, the number of UBR4-expressing cells within the SCN increases. This study is the first to identify a novel E3 ubiquitin ligase component, UBR4, in the murine SCN and to implicate the N-end rule degradation pathway as a potential player in regulating core clock mechanisms and photic entrainment.	[Ling, Harrod H.; Cheng, Hai-Ying M.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Beaule, Christian; Chiang, Cheng-Kang; Tian, Ruijun; Figeys, Daniel; Cheng, Hai-Ying M.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Beaule, Christian; Chiang, Cheng-Kang; Tian, Ruijun; Figeys, Daniel; Cheng, Hai-Ying M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Toronto; University Toronto Mississauga; University of Ottawa; University of Ottawa	Cheng, HYM (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	haiying.cheng@utoronto.ca	Chiang, Cheng-Kang/AAQ-7472-2021; Tian, Ruijun/J-3019-2014	Tian, Ruijun/0000-0001-9521-5124; Figeys, Daniel/0000-0002-5373-7546; Cheng, Hai-Ying Mary/0000-0002-9292-7406	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institute of Health Research (CIHR)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada to HYMC and DF, and the Canadian Institute of Health Research (CIHR) to HYMC and DF. HYMC is a Canada Research Chair (CRC) Tier 2 in Molecular Genetics of Biological Clocks. DF is a CRC Tier 1 in Proteomics and Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Arike L, 2014, METHODS MOL BIOL, V1156, P213, DOI 10.1007/978-1-4939-0685-7_14; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Haas AL, 1997, FASEB J, V11, P1257; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ishihama Y, 2005, NAT BIOTECHNOL, V23, P617, DOI 10.1038/nbt1086; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lee YJ, 2011, AM J PHYSIOL-RENAL, V301, pF883, DOI 10.1152/ajprenal.00117.2011; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Ohsaki K, 2008, J BIOCHEM, V144, P609, DOI 10.1093/jb/mvn112; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tian RJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007252; van der Veen Daan R, 2008, J Circadian Rhythms, V6, P5, DOI 10.1186/1740-3391-6-5; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; YOUNG WS, 1993, ENDOCRINOLOGY, V133, P585, DOI 10.1210/en.133.2.585	41	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103103	10.1371/journal.pone.0103103	http://dx.doi.org/10.1371/journal.pone.0103103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084275	Green Published, Green Submitted, gold			2022-12-25	WOS:000339819800015
J	Sandrock, C; Tanadini, M; Tanadini, LG; Fauser-Misslin, A; Potts, SG; Neumann, P				Sandrock, Christoph; Tanadini, Matteo; Tanadini, Lorenzo G.; Fauser-Misslin, Aline; Potts, Simon G.; Neumann, Peter			Impact of Chronic Neonicotinoid Exposure on Honeybee Colony Performance and Queen Supersedure	PLOS ONE			English	Article							NOSEMA-CERANAE MICROSPORIDIA; APIS-MELLIFERA; COLLAPSE DISORDER; PESTICIDE EXPOSURE; GENE-EXPRESSION; BEE; INSECTICIDES; TOXICITY; DECLINES; LOSSES	Background: Honeybees provide economically and ecologically vital pollination services to crops and wild plants. During the last decade elevated colony losses have been documented in Europe and North America. Despite growing consensus on the involvement of multiple causal factors, the underlying interactions impacting on honeybee health and colony failure are not fully resolved. Parasites and pathogens are among the main candidates, but sublethal exposure to widespread agricultural pesticides may also affect bees. Methodology/Principal Findings: To investigate effects of sublethal dietary neonicotinoid exposure on honeybee colony performance, a fully crossed experimental design was implemented using 24 colonies, including sister-queens from two different strains, and experimental in-hive pollen feeding with or without environmentally relevant concentrations of thiamethoxam and clothianidin. Honeybee colonies chronically exposed to both neonicotinoids over two brood cycles exhibited decreased performance in the short-term resulting in declining numbers of adult bees (-28%) and brood (-13%), as well as a reduction in honey production (-29%) and pollen collections (-19%), but colonies recovered in the medium-term and overwintered successfully. However, significantly decelerated growth of neonicotinoid-exposed colonies during the following spring was associated with queen failure, revealing previously undocumented long-term impacts of neonicotinoids: queen supersedure was observed for 60% of the neonicotinoid-exposed colonies within a one year period, but not for control colonies. Linked to this, neonicotinoid exposure was significantly associated with a reduced propensity to swarm during the next spring. Both short-term and long-term effects of neonicotinoids on colony performance were significantly influenced by the honeybees' genetic background. Conclusions/Significance: Sublethal neonicotinoid exposure did not provoke increased winter losses. Yet, significant detrimental short and long-term impacts on colony performance and queen fate suggest that neonicotinoids may contribute to colony weakening in a complex manner. Further, we highlight the importance of the genetic basis of neonicotinoid susceptibility in honeybees which can vary substantially.	[Sandrock, Christoph; Fauser-Misslin, Aline; Neumann, Peter] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Tanadini, Matteo] Swiss Fed Inst Technol, Zurich, Switzerland; [Tanadini, Lorenzo G.] Univ Zurich, Inst Social & Prevent Med, Div Biostat, CH-8006 Zurich, Switzerland; [Fauser-Misslin, Aline; Neumann, Peter] Univ Bern, Vetsuisse Fac, Inst Bee Hlth, Bern, Switzerland; [Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; University of Reading	Sandrock, C (corresponding author), Agroscope, Swiss Bee Res Ctr, Bern, Switzerland.	ch.sandrock@gmail.com	Neumann, Peter/C-9964-2015; Potts, Simon/ABF-9221-2020; Potts, Simon G/C-7250-2008; Tanadini, Lorenzo/E-7290-2015	Neumann, Peter/0000-0001-5163-5215; Potts, Simon/0000-0002-2045-980X; Potts, Simon G/0000-0002-2045-980X; Tanadini, Lorenzo/0000-0003-4337-0637; Sandrock, Christoph/0000-0002-2054-2216	European Union [244090]	European Union(European Commission)	This research received funding from the European Union Framework 7 under grant agreement no. 244090 (CP-FP) STEP (Status and Trends in European Pollinators, www.STEP-project.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bendahou N, 1999, ECOTOX ENVIRON SAFE, V44, P147, DOI 10.1006/eesa.1999.1812; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Brodschneider R, 2010, J APICULT RES, V49, P23, DOI 10.3896/IBRA.1.49.1.04; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; BUTLER C. G., 1957, INSECTES SOCIAUX, V4, P211, DOI 10.1007/BF02222154; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chauzat MP, 2010, J APICULT RES, V49, P113, DOI 10.3896/IBRA.1.49.1.22; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Cressey D, 2013, NATURE, V496, P408, DOI 10.1038/496408a; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; DeGrandi-Hoffman Gloria, 2013, Insects, V4, P71, DOI 10.3390/insects4010071; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Elzen PJ, 2003, SOUTHWEST ENTOMOL, V28, P255; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laurino D, 2013, B INSECTOL, V66, P119; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Laycock I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079872; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lu CS, 2014, B INSECTOL, V67, P125; Lu CS, 2012, B INSECTOL, V65, P99; Maienfisch P, 2001, PEST MANAG SCI, V57, P906, DOI 10.1002/ps.365; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mason R., 2013, J ENV IMMUNOLOGY TOX, V1, P3, DOI DOI 10.7178/JEIT.1; MASSON C, 1993, APIDOLOGIE, V24, P169, DOI 10.1051/apido:19930302; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Garrido PM, 2013, J INSECT PHYSIOL, V59, P113, DOI 10.1016/j.jinsphys.2012.10.019; Moritz R.F.A., 1992, BEES SUPERORGANISMS; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2000, APIDOLOGIE, V31, P67, DOI 10.1051/apido:2000107; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Osborne JL, 2012, NATURE, V491, P43, DOI 10.1038/nature11637; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 1997, INSECT SOC, V44, P311, DOI 10.1007/s000400050053; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, AGR FOREST ENTOMOL, V16, P119, DOI 10.1111/afe.12041; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Skerl MIS, 2010, APIDOLOGIE, V41, P73, DOI 10.1051/apido/2009051; Stokstad E, 2013, SCIENCE, V340, P674, DOI [10.1126/science.340.6133.674, 10.1126/science.340.6133.675]; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Tennekes H.A., 2011, J ENV ANAL TOXICOL, V01, DOI [10.4172/2161-0525, DOI 10.4172/2161-0525.S4-001, 10.4172/2161-0525.s4-001]; Tennekes HA, 2013, TOXICOLOGY, V309, P39, DOI 10.1016/j.tox.2013.04.007; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Tremolada P, 2010, B ENVIRON CONTAM TOX, V85, P229, DOI 10.1007/s00128-010-0066-1; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	137	140	145	9	487	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103592	10.1371/journal.pone.0103592	http://dx.doi.org/10.1371/journal.pone.0103592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084279	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000339819800055
J	Luo, JH; Warmlander, SKTS; Graslund, A; Abrahams, JP				Luo, Jinghui; Warmlander, Sebastian K. T. S.; Graslund, Astrid; Abrahams, Jan Pieter			Non-chaperone Proteins Can Inhibit Aggregation and Cytotoxicity of Alzheimer Amyloid beta Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid- (AB); Protein Aggregation; Protein-Protein Interaction; Spectroscopy; Aggregates; Fibrillation; Toxicity	HUMAN SERUM-ALBUMIN; A-BETA; ALPHA-SYNUCLEIN; TOXICITY; DISEASE; FIBRILLIZATION; STABILIZATION; FIBRILLATION; AFFINITY; BINDING	Background: A amyloid formation is associated with Alzheimer disease. Results: Non-chaperone proteins prevent amyloid formation and reduce the cytotoxicity of the A peptide. Conclusion: Non-chaperone proteins may affect the onset and development of Alzheimer disease by interfering with A peptide aggregation. Significance: Non-chaperone proteins can function as a chaperone protein to regulate the pathway of the A fibrillation in proteostasis providing a new strategy in the treatment of Alzheimer disease. Many factors are known to influence the oligomerization, fibrillation, and amyloid formation of the A peptide that is associated with Alzheimer disease. Other proteins that are present when A peptides deposit in vivo are likely to have an effect on these aggregation processes. To separate specific versus broad spectrum effects of proteins on A aggregation, we tested a series of proteins not reported to have chaperone activity: catalase, pyruvate kinase, albumin, lysozyme, -lactalbumin, and -lactoglobulin. All tested proteins suppressed the fibrillation of Alzheimer A(1-40) peptide at substoichiometric ratios, albeit some more effectively than others. All proteins bound non-specifically to A, stabilized its random coils, and reduced its cytotoxicity. Surprisingly, pyruvate kinase and catalase were at least as effective as known chaperones in inhibiting A aggregation. We propose general mechanisms for the broad-spectrum inhibition A fibrillation by proteins. The mechanisms we discuss are significant for prognostics and perhaps even for prevention and treatment of Alzheimer disease.	[Luo, Jinghui; Abrahams, Jan Pieter] Leiden Univ, Leiden Inst Chem, Gorlaeus Lab, NL-2300 RA Leiden, Netherlands; [Warmlander, Sebastian K. T. S.; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Leiden University; Leiden University - Excl LUMC; Stockholm University	Abrahams, JP (corresponding author), Leiden Univ, Leiden Inst Chem, Gorlaeus Lab, NL-2300 RA Leiden, Netherlands.	Abrahams@chem.leidenuniv.nl	Abrahams, Jan Pieter/AAE-4319-2020; Abrahams, Jan Pieter/G-7287-2016	Abrahams, Jan Pieter/0000-0001-8216-1868; Abrahams, Jan Pieter/0000-0001-8216-1868; Luo, Jinghui/0000-0002-7014-8153				Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Divsalar A, 2012, J DAIRY RES, V79, P209, DOI 10.1017/S0022029912000167; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Luo JH, 2014, BIOMACROMOLECULES, V15, P1985, DOI 10.1021/bm401874j; Luo JH, 2014, CHEM-EUR J, V20, P2410, DOI 10.1002/chem.201304253; Luo JH, 2013, CHEM-EUR J, V19, P17338, DOI 10.1002/chem.201301535; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Luo JH, 2013, ACS CHEM NEUROSCI, V4, P454, DOI 10.1021/cn300170x; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Milton NGN, 1999, BIOCHEM J, V344, P293, DOI 10.1042/0264-6021:3440293; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; VANDAEL H, 1992, BIOPHYS CHEM, V42, P235, DOI 10.1016/0301-4622(92)80015-W; Wilhelmus MMM, 2006, ACTA NEUROPATHOL, V111, P139, DOI 10.1007/s00401-005-0030-z; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Yamamoto K, 2014, GERIATR GERONTOL INT, V14, P716, DOI 10.1111/ggi.12147; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	46	42	43	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2014	289	40					27766	27775		10.1074/jbc.M114.574947	http://dx.doi.org/10.1074/jbc.M114.574947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MH	25100721	Green Published, hybrid			2022-12-25	WOS:000342852800034
J	Overkamp, KE; Gasper, R; Kock, K; Herrmann, C; Hofmann, E; Frankenberg-Dinkel, N				Overkamp, Kristina E.; Gasper, Raphael; Kock, Klaus; Herrmann, Christian; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole			Insights into the Biosynthesis and Assembly of Cryptophycean Phycobiliproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIN-BINDING-PROTEIN; AMINO-ACID-SEQUENCE; FERREDOXIN OXIDOREDUCTASE; ALPHA-SUBUNIT; CHROMOPHORE ATTACHMENT; RADICAL MECHANISM; CRYSTAL-STRUCTURE; PIERIS-BRASSICAE; BETA-PHYCOCYANIN; CPCS-I	Phycobiliproteins are employed by cyanobacteria, red algae, glaucophytes, and cryptophytes for light-harvesting and consist of apoproteins covalently associated with open-chain tetrapyrrole chromophores. Although the majority of organisms assemble the individual phycobiliproteins into larger aggregates called phycobilisomes, members of the cryptophytes use a single type of phycobiliprotein that is localized in the thylakoid lumen. The cryptophyte Guillardia theta (Gt) uses phycoerythrin PE545 utilizing the uncommon chromophore 15,16-dihydro-biliverdin (DHBV) in addition to phycoerythrobilin (PEB). Both the biosynthesis and the attachment of chromophores to the apophycobiliprotein have not yet been investigated for cryptophytes. In this study, we identified and characterized enzymes involved in PEB biosynthesis. In addition, we present the first in-depth biochemical characterization of a eukaryotic phycobiliprotein lyase (GtCPES). Plastid-encoded HO (GtHo) was shown to convert heme into biliverdin IX alpha providing the substrate with a putative nucleus-encoded DHBV: ferredoxin oxidoreductase (GtPEBA). A PEB: ferredoxin oxidoreductase (GtPEBB) was found to convert DHBV to PEB, which is the substrate for the phycobiliprotein lyase GtCPES. The x-ray structure of GtCPES was solved at 2.0 angstrom revealing 10-stranded beta-barrel with a modified lipocalin fold. GtCPES is an S-type lyase specific for binding of phycobilins with reduced C15=C16 double bonds (DHBV and PEB). Site-directed mutagenesis identified residues Glu-136 and Arg-146 involved in phycobilin binding. Based on the crystal structure, a model for the interaction of GtCPES with the apophycobiliprotein CpeB is proposed and discussed.	[Overkamp, Kristina E.; Gasper, Raphael; Hofmann, Eckhard; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Kock, Klaus; Herrmann, Christian] Ruhr Univ Bochum, Fac Chem & Biochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	Hofmann, Eckhard/GPF-5024-2022; Frankenberg-Dinkel, Nicole/C-1058-2011	Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Hofmann, Eckhard/0000-0003-4874-372X	Studienstiftung des Deutschen Volkes e.V.; Deutsche Forschungsgemeinschaft	Studienstiftung des Deutschen Volkes e.V.; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by a Ph.D. scholarship from the Studienstiftung des Deutschen Volkes e.V.; Supported by a grant from the Deutsche Forschungsgemeinschaft.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Busch AWU, 2011, BIOCHEM J, V439, P257, DOI 10.1042/BJ20110814; Busch AWU, 2011, BIOCHEM J, V433, P469, DOI 10.1042/BJ20101642; Chen YR, 2012, P NATL ACAD SCI USA, V109, P8310, DOI 10.1073/pnas.1201744109; Colyer C, 2005, ANAL BIOANAL CHEM, V382, P559, DOI 10.1007/s00216-004-3020-4; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Doust AB, 2004, J MOL BIOL, V344, P135, DOI 10.1016/j.jmb.2004.09.044; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Falk H., 1989, CHEM LINEAR OLIGOPYR, P401; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; GANTT E, 1971, J CELL BIOL, V48, P280, DOI 10.1083/jcb.48.2.280; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1977, J BIOL CHEM, V252, P32; Glazer AN, 1995, PHOTOSYNTH RES, V46, P93, DOI 10.1007/BF00020420; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; Gould SB, 2007, J BIOL CHEM, V282, P30295, DOI 10.1074/jbc.M701869200; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; Gould SB, 2006, J MOL EVOL, V62, P674, DOI 10.1007/s00239-005-0099-y; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hagiwara Y, 2006, P NATL ACAD SCI USA, V103, P27, DOI 10.1073/pnas.0507266103; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; HILL DRA, 1989, PHYCOLOGIA, V28, P455, DOI 10.2216/i0031-8884-28-4-455.1; Hoef-Emden K, 2008, J PHYCOL, V44, P985, DOI 10.1111/j.1529-8817.2008.00530.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KROIS D, 1993, J CHEM SOC PERK T 2, P1351, DOI 10.1039/p29930001351; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; MacColl R., 1987, PHYCOBILIPROTEINS; North A. C., 1990, BIOCHEM SOC SYMP, V57, P35; Overkamp K. E., 2014, PORPHYRIN HDB, P187; Samsonoff WA, 2001, ARCH MICROBIOL, V176, P400, DOI 10.1007/s002030100346; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; SNYDER SH, 1988, J BIOL CHEM, V263, P13971; Stoebe B, 2002, PROTOPLASMA, V219, P123, DOI 10.1007/s007090200013; SUTER F, 1988, BIOL CHEM H-S, V369, P497, DOI 10.1515/bchm3.1988.369.1.497; Terry M., 2002, HEME CHLOROPHYLL BIL, P273; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tu SL, 2007, BIOCHEMISTRY-US, V46, P1484, DOI 10.1021/bi062038f; Tu SL, 2004, J AM CHEM SOC, V126, P8682, DOI 10.1021/ja049280z; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Velankar S, 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [10.1093/nar/gkq985, 10.1093/nar/gkp916]; WAGNIERE G, 1976, J AM CHEM SOC, V98, P7806, DOI 10.1021/ja00440a056; WELLER JP, 1980, CHEM BER-RECL, V113, P1603, DOI 10.1002/cber.19801130439; Wiethaus J, 2010, J BIOL CHEM, V285, P37561, DOI 10.1074/jbc.M110.172619; Wilk KE, 1999, P NATL ACAD SCI USA, V96, P8901, DOI 10.1073/pnas.96.16.8901; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	76	24	26	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2014	289	39					26691	26707		10.1074/jbc.M114.591131	http://dx.doi.org/10.1074/jbc.M114.591131			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AQ5MS	25096577	hybrid, Green Published			2022-12-25	WOS:000342853900003
J	Kobayashi, D; Hirayama, M; Komohara, Y; Mizuguchi, S; Morifuji, MW; Ihn, H; Takeya, M; Kuramochi, A; Araki, N				Kobayashi, Daiki; Hirayama, Mio; Komohara, Yoshihiro; Mizuguchi, Souhei; Morifuji, Masayo Wilson; Ihn, Hironobu; Takeya, Motohiro; Kuramochi, Akira; Araki, Norie			Translationally Controlled Tumor Protein Is a Novel Biological Target for Neurofibromatosis Type 1-associated Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DIFFERENTIATION; SCHWANN-CELLS; MOUSE MODEL; TCTP; GROWTH; NF1; ARTEMISININ; CANCER; PROLIFERATION; MICROTUBULES	Neurofibromatosis type 1 (NF1) is an autosomal dominant disease that predisposes individuals to develop benign neurofibromas and malignant peripheral nerve sheath tumors (MPNSTs). Due to the lack of information on the molecular mechanism of NF1-associated tumor pathogenesis or biomarkers/therapeutic targets, an effective treatment for NF1 tumors has not been established. In this study, the novel NF1-associated protein, translationally controlled tumor protein (TCTP), was identified by integrated proteomics and found to be up-regulated via activated MAPK/PI3K-AKT signaling in response to growth factors in NF1-deficient Schwann cells. Immunohistochemical analysis of NF1-associated tumors revealed that the TCTP expression level correlated with tumorigenicity. In NF1-deficient MPNST cells, TCTP protein but not mRNA was down-regulated by NF1 GTPase-activating protein-related domain or MAPK/PI3K inhibitors, and this correlated with suppression of mammalian target of rapamycin (mTOR) signaling. mTOR inhibition by rapamycin also down-regulated TCTP protein expression, whereas knockdown or overexpression of TCTP suppressed or activated mTOR signaling, respectively, and affected cell viability. These results suggest that a positive feedback loop between TCTP and mTOR contributes to NF1-associated tumor formation. Last, the anti-tumor effect of artesunate, which binds to and degrades TCTP, was evaluated. Artesunate significantly suppressed the viability of MPNST cells but not normal Schwann cells, and the TCTP level inversely correlated with artesunate sensitivity. Moreover, combinational use of artesunate and rapamycin enhanced the cytotoxic effect on MPNST cells. These findings suggest that TCTP is functionally implicated in the progression of NF1-associated tumors and could serve as a biological target for their therapy.	[Kobayashi, Daiki; Hirayama, Mio; Mizuguchi, Souhei; Morifuji, Masayo Wilson; Araki, Norie] Kumamoto Univ, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan; [Ihn, Hironobu] Kumamoto Univ, Fac Life Sci, Dept Dermatol & Plast Surg, Kumamoto 8608556, Japan; [Kuramochi, Akira] Saitama Med Univ, Dept Dermatol, Saitama 3500495, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Saitama Medical University	Araki, N (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Tumor Genet & Biol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	nori@gpo.kumamoto-u.ac.jp		Kobayashi, Daiki/0000-0003-4131-5220	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan/Japan Society for the Promotion of Science (JSPS) [25293312, 22390281, 25640068, 24700981, 26830097]; Centers of Excellence Project B of Kumamoto University for proteomic research and education; Grants-in-Aid for Scientific Research [26830079, 25293312, 14F04099] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan/Japan Society for the Promotion of Science (JSPS); Centers of Excellence Project B of Kumamoto University for proteomic research and education; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (to N. A.); by Grant-in-Aid for Scientific Research (B) 25293312 and 22390281 (to N. A.), Grant-in-Aid for Exploratory Research 25640068 (to N. A.), and Grant-in-Aid for Young Scientists (B) 24700981 and 26830097 (to D. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan/Japan Society for the Promotion of Science (JSPS); and by the Centers of Excellence Project B of Kumamoto University for proteomic research and education (to N. A.).	Berdelle N, 2011, MOL CANCER THER, V10, P2224, DOI 10.1158/1535-7163.MCT-11-0534; Bhisutthibhan J, 1998, J BIOL CHEM, V273, P16192, DOI 10.1074/jbc.273.26.16192; BOHM H, 1989, BIOCHEM INT, V19, P277; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Bottillo I, 2009, J PATHOL, V217, P693, DOI 10.1002/path.2494; Burgess A, 2008, ONCOGENE, V27, P5554, DOI 10.1038/onc.2008.167; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chae J, 2006, ARCH PHARM RES, V29, P50, DOI 10.1007/BF02977468; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gachet Y, 1999, J CELL SCI, V112, P1257; Hirayama M, 2013, MOL CELL PROTEOMICS, V12, P1377, DOI 10.1074/mcp.M112.024802; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Kim DK, 2012, DIABETOLOGIA, V55, P1205, DOI 10.1007/s00125-012-2467-7; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Patrakitkomjorn S, 2008, J BIOL CHEM, V283, P9399, DOI 10.1074/jbc.M708206200; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sherman LS, 2000, J BIOL CHEM, V275, P30740, DOI 10.1074/jbc.M001702200; STEPHENS K, 1987, Genomics, V1, P353, DOI 10.1016/0888-7543(87)90037-1; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tsai MJ, 2014, ENDOCRINOLOGY, V155, P392, DOI 10.1210/en.2013-1663; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Watabe K, 2003, NEUROPATHOLOGY, V23, P68, DOI 10.1046/j.1440-1789.2003.00478.x; YENOFSKY R, 1982, P NATL ACAD SCI-BIOL, V79, P5876, DOI 10.1073/pnas.79.19.5876; Yunoue S, 2003, J BIOL CHEM, V278, P26958, DOI 10.1074/jbc.M209413200	38	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26314	26326		10.1074/jbc.M114.568253	http://dx.doi.org/10.1074/jbc.M114.568253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25092287	hybrid, Green Published			2022-12-25	WOS:000342128800025
J	Wu, Y; Schellinger, JN; Huang, CL; Rodan, AR				Wu, Yipin; Schellinger, Jeffrey N.; Huang, Chou-Long; Rodan, Aylin R.			Hypotonicity Stimulates Potassium Flux through the WNK-SPAK/OSR1 Kinase Cascade and the Ncc69 Sodium-Potassium-2-Chloride Cotransporter in the Drosophila Renal Tubule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-CL; BASOLATERAL ION-TRANSPORT; REGULATED ANION CHANNEL; CELL-VOLUME REGULATION; ALANINE-RICH KINASE; MALPIGHIAN TUBULES; PROTEIN-KINASES; BLOOD-PRESSURE; WNK KINASES; NA+-K+-2CL(-) COTRANSPORTER	The ability to osmoregulate is fundamental to life. Adult Drosophila melanogaster maintain hemolymph osmolarity within a narrow range. Osmolarity modulates transepithelial ion and water flux in the Malpighian (renal) tubules of the fly, which are in direct contact with hemolymph in vivo, but the mechanisms causing increased transepithelial flux in response to hypotonicity are unknown. Fly renal tubules secrete a KCl-rich fluid. We have previously demonstrated a requirement for Ncc69, the fly sodium-potassium-2-chloride cotransporter (NKCC), in tubule K+ secretion. Mammalian NKCCs are regulated by a kinase cascade consisting of the with-no-lysine (WNK) and Ste20-related proline/alanine-rich (SPAK)/oxidative stress response (OSR1) kinases. Here, we show that decreasing Drosophila WNK activity causes a reduction in K+ flux. Similarly, knocking down the SPAK/OSR1 homolog fray also decreases K+ flux. We demonstrate that a hierarchical WNK-Fray signaling cascade regulates K+ flux through Ncc69, because (i) a constitutively active Fray mutant rescues the wnk knockdown phenotype, (ii) Fray directly phosphorylates Ncc69 in vitro, and (iii) the effect of wnk and fray knockdown is abolished in Ncc69 mutants. The stimulatory effect of hypotonicity on K+ flux is absent in wnk, fray, or Ncc69 mutant tubules, suggesting that the Drosophila WNK-SPAK/OSR1-NKCC cascade is an essential molecular pathway for osmoregulation, through its effect on transepithelial ion flux and fluid generation by the renal tubule.	[Wu, Yipin; Schellinger, Jeffrey N.; Huang, Chou-Long; Rodan, Aylin R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rodan, AR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	aylin.rodan@utsouthwestern.edu		Rodan, Aylin/0000-0001-9202-2378	National Institutes of Health, NIDDK [DK091316, DK007257, DK59530, DK079328]; American Society of Nephrology Gottschalk Award; National Institutes of Health [2P40OD010949-10A1]; National Institutes of Health, NIGMS [R01-GM084947]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007257, R01DK059530, K08DK091316, P30DK079328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology Gottschalk Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK091316 (to A. R. R.), DK007257 (institutional T32), DK59530 (to C. L. H.), and DK079328 (University of Texas Southwestern O'Brien Center P30). This work was also supported by the American Society of Nephrology Gottschalk Award (to A. R. R.). The Drosophila Genomics Resource Center is supported by National Institutes of Health Grant 2P40OD010949-10A1, and the TRiP project at Harvard Medical School is supported by National Institutes of Health, NIGMS, Grant R01-GM084947.	Albers MA, 2004, J EXP BIOL, V207, P2313, DOI 10.1242/jeb.01024; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blumenthal EM, 2005, AM J PHYSIOL-CELL PH, V289, pC1261, DOI 10.1152/ajpcell.00026.2005; Blumenthal EM, 2003, AM J PHYSIOL-CELL PH, V284, pC718, DOI 10.1152/ajpcell.00359.2002; BRADLEY TJ, 1987, ANNU REV ENTOMOL, V32, P439, DOI 10.1146/annurev.en.32.010187.002255; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Cheng CJ, 2012, AM J PHYSIOL-RENAL, V303, pF667, DOI 10.1152/ajprenal.00290.2012; Chien LT, 2007, J GEN PHYSIOL, V130, P513, DOI 10.1085/jgp.200709795; Chien LT, 2008, J GEN PHYSIOL, V132, P537, DOI 10.1085/jgp.200810065; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; DELLASEGA M, 1973, AM J PHYSIOL, V224, P1288, DOI 10.1152/ajplegacy.1973.224.6.1288; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOW JAT, 1994, J EXP BIOL, V197, P421; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; GUPTA BL, 1980, J EXP BIOL, V88, P21; Hisamoto N, 2008, EMBO REP, V9, P70, DOI 10.1038/sj.embor.7401128; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ianowski JP, 2004, J EXP BIOL, V207, P2599, DOI 10.1242/jeb.01058; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Larsen EH, 2014, COMPR PHYSIOL, V4, P405, DOI 10.1002/cphy.c130004; Leader J. P., 1997, J INSECT PHYSL, V44, P39; Leiserson WM, 2011, GLIA, V59, P320, DOI 10.1002/glia.21103; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Linton SM, 1999, J EXP BIOL, V202, P1561; Liu W, 2011, AM J PHYSIOL-RENAL, V301, pF1088, DOI 10.1152/ajprenal.00347.2011; LYTLE C, 1992, AM J PHYSIOL, V262, pC1009, DOI 10.1152/ajpcell.1992.262.4.C1009; MADDRELL SHP, 1993, J EXP BIOL, V177, P273; Messerli MA, 2008, ANAL BIOANAL CHEM, V390, P1355, DOI 10.1007/s00216-007-1804-z; Miyazaki H, 2007, AM J PHYSIOL-RENAL, V292, pF1411, DOI 10.1152/ajprenal.00244.2006; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; Naito S, 2011, CLIN EXP NEPHROL, V15, P195, DOI 10.1007/s10157-010-0378-9; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; O'Donnell MJ, 1998, AM J PHYSIOL-REG I, V274, pR1039, DOI 10.1152/ajpregu.1998.274.4.R1039; ODONNELL MJ, 1995, J EXP BIOL, V198, P1647; ODonnell MJ, 1996, J EXP BIOL, V199, P1163; Ohta A, 2009, HUM MOL GENET, V18, P3978, DOI 10.1093/hmg/ddp344; Pacheco-Alvarez D, 2012, CELL PHYSIOL BIOCHEM, V29, P291, DOI 10.1159/000337610; Pacheco-Alvarez D, 2011, CELL PHYSIOL BIOCHEM, V28, P1123, DOI 10.1159/000335848; Pech V, 2012, AM J PHYSIOL-RENAL, V303, pF45, DOI 10.1152/ajprenal.00030.2012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILLIPS J, 1981, AM J PHYSIOL, V241, pR241, DOI 10.1152/ajpregu.1981.241.5.R241; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Ponce-Coria J, 2012, AM J PHYSIOL-CELL PH, V303, pC1198, DOI 10.1152/ajpcell.00284.2012; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Rheault MR, 2001, J EXP BIOL, V204, P2289; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rodan AR, 2012, AM J PHYSIOL-CELL PH, V303, pC883, DOI 10.1152/ajpcell.00201.2012; Rosay P, 1997, J CELL SCI, V110, P1683; Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055301; Serysheva E, 2013, EMBO REP, V14, P718, DOI 10.1038/embor.2013.88; Spring JH, 2009, J EXP BIOL, V212, P358, DOI 10.1242/jeb.024794; Stotz SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046865; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Takahashi D, 2014, BIOSCIENCE REP, V34, P195, DOI 10.1042/BSR20140047; te Velde J. H., 1988, J EVOLUTION BIOL, V2, P139; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wall SM, 2001, AM J PHYSIOL-RENAL, V280, pF913, DOI 10.1152/ajprenal.2001.280.5.F913; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yamamoto Y, 2008, BIOCHEM BIOPH RES CO, V366, P212, DOI 10.1016/j.bbrc.2007.11.128; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zhou B, 2010, J AM SOC NEPHROL, V21, P82, DOI 10.1681/ASN.2008121275	85	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2014	289	38					26131	26142		10.1074/jbc.M114.577767	http://dx.doi.org/10.1074/jbc.M114.577767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AP5OP	25086033	hybrid, Green Published			2022-12-25	WOS:000342128800010
J	Choi, Y; Lee, K; Ryu, J; Kim, HG; Jeong, AY; Woo, RS; Lee, JH; Hyun, JW; Hahn, S; Kim, JH; Kim, HS				Choi, Yoori; Lee, Kihwan; Ryu, Junghwa; Kim, Hyoun Geun; Jeong, A. Young; Woo, Ran-Sook; Lee, Jun-Ho; Hyun, Jin Won; Hahn, Seokyung; Kim, Joung-Hun; Kim, Hye-Sun			Neuritin Attenuates Cognitive Function Impairments in Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; SYNAPTIC FAILURE; NEURONS BORN; IN-VIVO; CPG15; GROWTH; MICE; MEMORY	Neuritin, also known as CPG15, is a neurotrophic factor that was initially discovered in a screen to identify genes involved in activity-dependent synaptic plasticity. Neuritin plays multiple roles in the process of neural development and synaptic plasticity, although its binding receptor(s) and downstream signaling effectors remain unclear. In this study, we found that the cortical and hippocampal expression of neuritin is reduced in the brains of Alzheimer's disease (AD) patients and demonstrated that viral-mediated expression of neuritin in the dentate gyrus of 13-month-old Tg2576 mice, an AD animal model, attenuated a deficit in learning and memory as assessed by a Morris water maze test. We also found that neuritin restored the reduction in dendritic spine density and the maturity of individual spines in primary hippocampal neuron cultures prepared from Tg2576 mice. It was also shown that viral-mediated expression of neuritin in the dentate gyrus of 7-week-old Sprague-Dawley rats increased neurogenesis in the hippocampus. Taken together, our results demonstrate that neuritin restores the reduction in dendritic spine density and the maturity of individual spines in primary hippocampal neurons from Tg2576 neurons, and also attenuates cognitive function deficits in Tg2576 mouse model of AD, suggesting that neuritin possesses a therapeutic potential for AD.	[Choi, Yoori; Lee, Kihwan; Ryu, Junghwa; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Lee, Kihwan] Seoul Natl Univ, Dent Res Inst, Natl Res Lab Pain, Seoul, South Korea; [Lee, Kihwan] Seoul Natl Univ, Sch Dent, Dept Neurobiol & Physiol, Seoul, South Korea; [Kim, Hyoun Geun; Jeong, A. Young; Kim, Joung-Hun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Woo, Ran-Sook] Eulji Univ, Sch Med, Dept Anat & Neurosci, Taejon, South Korea; [Lee, Jun-Ho] Daejeon Univ, Dept Emergency Med Technol, Taejon, South Korea; [Hyun, Jin Won] Jeju Natl Univ, Sch Med, Dept Biochem, Cheju, South Korea; [Hahn, Seokyung] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Eulji University; Daejeon University; Jeju National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, JH (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	joungkim@postech.ac.kr; hyisun@snu.ac.kr	Ryu, Junghwa/K-4034-2015	Hahn, Seokyung/0000-0002-4684-4917	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea [A111230, A111284]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0021866]; Seoul National University Bundang Hospital Research Fund [02-2009-025]	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Seoul National University Bundang Hospital Research Fund	This study was financially supported by grants from the Korea Healthcare Technology R&D Project (A111230) of Ministry for Health, Welfare and Family Affairs of the Republic of Korea (A111284), by the National Research Foundation of Korea (NRF)funded by the Ministry of Education, Science and Technology, grant number 2011-0021866, and in part by Seoul National University Bundang Hospital Research Fund (02-2009-025). Thank you again for the opportunity to resubmit our manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Chandler D, 2010, AM J MED GENET B, V153B, P428, DOI 10.1002/ajmg.b.30996; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fujino T, 2003, MOL CELL NEUROSCI, V24, P538, DOI 10.1016/S1044-7431(03)00230-6; Fujino T, 2008, J COMP NEUROL, V507, P1831, DOI 10.1002/cne.21649; Gan L, 2008, NEUROBIOL DIS, V29, P71, DOI 10.1016/j.nbd.2007.08.002; Han Y, 2007, J NEUROTRAUM, V24, P722, DOI 10.1089/neu.2006.0174; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jurgensen S, 2010, J MOL NEUROSCI, V40, P221, DOI 10.1007/s12031-009-9237-0; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Kolecki R, 2008, ACTA NEUROPATHOL, V116, P419, DOI 10.1007/s00401-008-0380-4; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; Maruszak A, 2014, J ALZHEIMERS DIS, V38, P11, DOI 10.3233/JAD-131004; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nedivi E, 2001, J COMP NEUROL, V435, P464, DOI 10.1002/cne.1044; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Putz U, 2005, NAT NEUROSCI, V8, P322, DOI 10.1038/nn1407; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Son H, 2012, P NATL ACAD SCI USA, V109, P11378, DOI 10.1073/pnas.1201191109; Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010	45	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2014	9	8							e104121	10.1371/journal.pone.0104121	http://dx.doi.org/10.1371/journal.pone.0104121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SB	25101829	Green Submitted, gold, Green Published			2022-12-25	WOS:000339993900040
J	Trajman, A; Pinto, M; de Souza, R; Freitas, M; Torrens, A; Lima, J; Barreira, D; Perkins, MD; Boehme, CC; Ginnard, J; Jefferson, C; Pantoja, A; Kik, SV; Chedore, P; Denkinger, CM; Pai, M				Trajman, Anete; Pinto, Marcia; de Souza Junior, Ruy; Freitas, Marianna; Torrens, Ana; Lima, Josue; Barreira, Draurio; Perkins, Mark D.; Boehme, Catharina C.; Ginnard, Janet; Jefferson, Carole; Pantoja, Andrea; Kik, Sandra V.; Chedore, Pamela; Denkinger, Claudia M.; Pai, Madhukar		TB Diagnostics Market Anal Consort	Market Assessment of Tuberculosis Diagnostics in Brazil in 2012	PLOS ONE			English	Article								Background: Improved diagnostics for the diagnosis of tuberculosis (TB) are urgently needed. However, test developers and investors require market size data to support new product development. This study assessed the served available market for TB diagnostics in Brazil in 2012 and the market segmentation in the public and private sectors. Methods: Data were collected on test volumes done in the public and private sectors for the diagnosis of latent and active TB, drug susceptibility testing and treatment follow-up. Tests included were tuberculin skin tests, interferon-gamma releases assays, smear microscopy, solid and liquid cultures, nucleic acid amplification tests and phenotypic drug susceptibility tests. The data were collected by means of an electronic survey via the Brazilian State laboratories and from sales information provided by manufacturers. Test costs for the public sector were calculated using a components approach, while costs for the private sector were based on prices paid by patients. The overall market value (expenditure) for the entire country was calculated using the public sector test costs. Results: During 2012, an estimated total of 2.4 million TB diagnostic tests were done in Brazil, resulting in an estimated overall market value of USD 17.2 million. The public sector accounted for 91% of the test volumes and 88% of the market value. Smear microscopy was the most commonly test (n = 1.3 million; 55% of total) at an estimated value of USD 3.7 million. Culture overall (n = 302,761) represented 13% of test volumes and 40% (USD 6.9 million) of the market value. On average, USD 208 was spent on TB diagnostics for every notified TB patient in Brazil, in 2012. Conclusion: The TB diagnostics market value in Brazil in 2012 was over USD 17 million. These study results will help test developers to understand the current and potential market for replacement or add-on diagnostic technologies.	[Trajman, Anete] Univ Fed Rio de Janeiro, Internal Med Grad Program, Rio De Janeiro, Brazil; [Trajman, Anete] McGill Univ, Montreal, PQ, Canada; [Pinto, Marcia] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [de Souza Junior, Ruy; Freitas, Marianna; Torrens, Ana; Lima, Josue; Barreira, Draurio] Natl TB Program, Brasilia, DF, Brazil; [Perkins, Mark D.; Boehme, Catharina C.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Ginnard, Janet] UNITAID, Geneva, Switzerland; [Kik, Sandra V.; Chedore, Pamela; Denkinger, Claudia M.; Pai, Madhukar] McGill Int TB Ctr, Montreal, PQ, Canada; [Kik, Sandra V.; Denkinger, Claudia M.; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada	Universidade Federal do Rio de Janeiro; McGill University; Fundacao Oswaldo Cruz; Foundation For Innovative New Diagnostics; McGill University	Kik, SV (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.	sandra.kik@mail.mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Bill and Melinda Gates Foundation [OPP1061487]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation (grant OPP1061487). No writing assistance was used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MAN REC CONTR TUB BR; Brazilian Ministry of Health, 2013, DATASUS SIST INF AMB; Cobelens F, 2012, J INFECT DIS, V205, pS191, DOI 10.1093/infdis/jis188; Telles MAD, 2012, J BRAS PNEUMOL, V38, P766, DOI 10.1590/S1806-37132012000600013; Drummond MF., 2005, METHODS EC EVALUATIO, V3 rd ed, P1; Pai M, 2013, EXPERT REV MOL DIAGN, V13, P311, DOI [10.1586/erm.13.16, 10.1586/ERM.13.16]; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; UNITAID, 2013, TUB DIAGN TECHN MARK, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, GLOB TUB REP 2013 WH; WHO, 2013, STATE SCI ENDOCRINE, p[1, 5]; World Bank, 2012, WORLD BANK DAT OFF E; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1	13	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2014	9	8							e104105	10.1371/journal.pone.0104105	http://dx.doi.org/10.1371/journal.pone.0104105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6SM	25099237	Green Published, gold			2022-12-25	WOS:000339995100050
J	Hong, CS; Muller, L; Boyiadzis, M; Whiteside, TL				Hong, Chang Sook; Muller, Laurent; Boyiadzis, Michael; Whiteside, Theresa L.			Isolation and Characterization of CD34+Blast-Derived Exosomes in Acute Myeloid Leukemia	PLOS ONE			English	Article							CELL-LINE; PROGENITOR CELLS; T-CELL; MICROVESICLES; PHENOTYPE; APOPTOSIS; KASUMI-1; PLASMA	Exosomes are membrane-bound vesicles found in all biological fluids. AML patients' plasma collected at diagnosis contains elevated exosome levels relative to normal donor (ND) plasma. The molecular profile of AML exosomes changes in the course of therapy and may serve as a measure of disease progression or response to therapy. However, plasma contains a mix of exosomes derived from various cell types. To be able to utilize blast-derived exosomes as biomarkers for AML, we have developed an immunoaffinity-based capture method utilizing magnetic microbeads coated with anti-CD34 antibody (Ab). This Ab is specific for CD34, a unique marker of AML blasts. The capture procedure was developed using CD34+ exosomes derived from Kasumi-1 AML cell culture supernatants. The capture capacity of CD34microbeads was shown to linearly correlate with the input exosomes. A 10 uL aliquot of CD34 microbeads was able to capture all of CD34+ exosomes present in 100-1,000 uL of AML plasma. The levels of immunocaptured CD34+ exosomes correlated with the percentages of CD34+ blasts in the AML patients' peripheral blood. The immunocaptured exosomes had a typical cup-shaped morphology by transmission electron microscopy, and their molecular cargo was similar to that of parental blasts. These exosomes were biologically-active. Upon co-incubation with natural killer (NK) cells, captured blast-derived exosomes down-regulated surface NKG2D expression, while non-captured exosomes reduced expression levels of NKp46. Our data provide a proof-of-principle that blast-derived exosomes can be quantitatively recovered from AML patients' plasma, their molecular profile recapitulates that of autologous blasts and they retain the ability to mediate immune suppression. These data suggest that immunocaptured blast-derived exosomes might be useful in diagnosis and/or prognosis of AML in the future.	[Hong, Chang Sook; Muller, Laurent; Boyiadzis, Michael; Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Muller, Laurent] Univ Hosp, Dept Otolaryngol & Head & Neck Surg, Basel, Switzerland; [Boyiadzis, Michael] Univ Pittsburgh, Sch Med, Div Hematol Oncol, Pittsburgh, PA USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whiteside, TL (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu			National Institutes of Health, USA [PO1-CA109688, R01-CA168628]; NATIONAL CANCER INSTITUTE [R01CA168628] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health, USA grants PO1-CA109688 and R01-CA168628 to TLW (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen M, 2012, SEMIN THROMB HEMOST, V38, P102, DOI 10.1055/s-0031-1300956; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; ASOU H, 1991, BLOOD, V77, P2031; Blair A, 1998, BLOOD, V92, P4325, DOI 10.1182/blood.V92.11.4325; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Hong CS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00160; Horton SJ, 2012, HAEMATOL-HEMATOL J, V97, P966, DOI 10.3324/haematol.2011.054734; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Martinez-Lorenzo MJ, 2004, EXP CELL RES, V295, P315, DOI 10.1016/j.yexcr.2003.12.024; Mathivanan S, 2010, MOL CELL PROTEOMICS, V9, P197, DOI 10.1074/mcp.M900152-MCP200; Muller L, 2014, UNPUB; Oyan AM, 2005, CYTOM PART B-CLIN CY, V64B, P18, DOI 10.1002/cyto.b.20044; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Szczepanski MJ, 2011, HAEMATOL-HEMATOL J, V96, P1302, DOI 10.3324/haematol.2010.039743; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Teague RM, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-13; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Stijn A, 2003, HAEMATOLOGICA, V88, P497; Whiteside TL, 2014, CANCER IMMUNOL IMMUN, V63, P67, DOI 10.1007/s00262-013-1490-y; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Zhang HG, 2012, BIOTECH HISTOCHEM, V87, P161, DOI 10.3109/10520291003659042	27	125	135	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103310	10.1371/journal.pone.0103310	http://dx.doi.org/10.1371/journal.pone.0103310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093329	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000341357200021
J	Kim, AJ; Lim, HJ; Ro, H; Ko, KP; Han, SY; Chang, JH; Lee, HH; Chung, W; Jung, JY				Kim, Ae Jin; Lim, Hye Jin; Ro, Han; Ko, Kwang-Pil; Han, Song Yi; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ANTIPLATELET THERAPY; BENEFITS; OUTCOMES; PREVALENCE; ACTIVATION; IMPACT; HEART; RISK	Background: Chronic kidney disease (CKD) is a major risk factor for the development of cardiovascular disease (CVD). Previous trials have investigated the effects of low-dose aspirin on CVD prevention in patients with diabetes; however, patients with CKD were not examined. The role of aspirin in diabetics is controversial, and the available literature is contradictory. Therefore, we studied whether low-dose aspirin would be beneficial for patients with CKD, a group that is at high risk for CVD. Method: From a total of 25340 patients with CKD, 1884 recipients of low-dose aspirin (100 mg/day) were paired 1: 1 with non-recipients for analysis using propensity score matching. The primary endpoint was the development of atherosclerotic CVD, including coronary arterial disease, stroke, and peripheral arterial disease. Secondary endpoints included death from any cause, bleeding events, doubling of serum creatinine, and renal death. Results: The incidence of a primary endpoint of any atherosclerotic CVD was significantly higher in the aspirin users than in the non-users (P<0.001). Secondary endpoints, including all-cause mortality and composite bleeding events, were not significantly different between the aspirin users and the non-users. However, the doubling of serum creatinine levels (P=0.001) and renal death (P=0.042) were significantly associated with the use of aspirin. Conclusion: These results suggest that the use of low-dose aspirin in patients with CKD may have harmful consequences related to the development of CVD and renal progression.	[Kim, Ae Jin; Lim, Hye Jin; Ro, Han; Han, Song Yi; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Inchon, South Korea; [Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Inchon, South Korea; [Ko, Kwang-Pil] Gachon Univ, Sch Med, Dept Prevent Med, Inchon, South Korea	Gachon University; Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Inchon, South Korea.	jyjung@gachon.ac.kr			Chong Kun Dang Pharmaceutical Corp. in Korea	Chong Kun Dang Pharmaceutical Corp. in Korea	This study was supported by Chong Kun Dang Pharmaceutical Corp. in Korea. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeseun GA, 2012, AM J NEPHROL, V36, P342, DOI 10.1159/000342794; Angiolillo DJ, 2010, J AM COLL CARDIOL, V55, P1139, DOI 10.1016/j.jacc.2009.10.043; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Briasoulis A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0340-4; Calonge N, 2009, ANN INTERN MED, V150, P396; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Debella YT, 2011, CLIN J AM SOC NEPHRO, V6, P1385, DOI 10.2215/CJN.10271110; Dreisbach AW, 2009, CLIN PHARMACOL THER, V86, P553, DOI 10.1038/clpt.2009.163; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ethier J, 2007, AM J KIDNEY DIS, V50, P602, DOI 10.1053/j.ajkd.2007.07.007; Gremmel T, 2013, NEPHROL DIAL TRANSPL, V28, P2116, DOI 10.1093/ndt/gft103; Jardine MJ, 2010, J AM COLL CARDIOL, V56, P956, DOI 10.1016/j.jacc.2010.02.068; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; Mezzano D, 1996, THROMB HAEMOSTASIS, V76, P312; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680, DOI DOI 10.1136/BMJ.F5680; Nolin TD, 2009, J AM SOC NEPHROL, V20, P2269, DOI 10.1681/ASN.2009010082; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Palmer SC, 2012, ANN INTERN MED, V157, P263, DOI 10.7326/0003-4819-157-4-201208210-00007; Palmer SC, 2012, ANN INTERN MED, V156, P445, DOI 10.7326/0003-4819-156-6-201203200-00007; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Sciahbasi Alessandro, 2010, Prev Cardiol, V13, P18, DOI 10.1111/j.1751-7141.2009.00050.x; Shen L, 2012, EXP THER MED, V3, P530, DOI 10.3892/etm.2011.432; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Washam JB, 2008, ADV CHRONIC KIDNEY D, V15, P370, DOI 10.1053/j.ackd.2008.07.006; Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308; Weigert AL, 1998, AM J MED SCI, V316, P94, DOI 10.1097/00000441-199808000-00005	30	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104179	10.1371/journal.pone.0104179	http://dx.doi.org/10.1371/journal.pone.0104179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093403	gold, Green Submitted, Green Published			2022-12-25	WOS:000341357200085
J	Martinez, AA; Zaldivar, YY; De Castillo, Z; Ortiz, AY; Mendoza, Y; Cristina, J; Pascale, JM				Martinez, Alexander A.; Zaldivar, Yamitzel Y.; De Castillo, Zoila; Ortiz, Alma Y.; Mendoza, Yaxelis; Cristina, Juan; Pascale, Juan M.		CSS-NAT Grp	High Diversity of Hepatitis B Virus Genotypes in Panamanian Blood Donors: A Molecular Analysis of New Variants	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CENTRAL-AMERICA; HBV; EPIDEMIOLOGY; RECOMBINANT; TIME	Hepatitis B Virus (HBV) is an infectious agent that causes more than half of the cases of liver disease and cancer in the world. Globally there are around 250 million people chronically infected with this virus. Despite 16% of the cases of liver disease in Central America are caused by HBV, the information regarding its genetic diversity, genotypes and circulation is scarce. The purpose of this study was to evaluate the genetic variability of the HBV genotypes from HBV-DNA positive samples obtained from screening blood donors at the Social Security System of Panama and to estimate its possible origin. From 59,696 blood donors tested for HBV infection during 2010-2012, there were 74 HBV-DNA positive subjects. Analysis of the partial PreS2-S region of 27 sequences shows that 21% of the infections were caused by genotype A, 3% by genotype D and 76% by genotype F. In addition, we were able to confirm circulation of six sub-genotypes A1, A2, A3, D4, F3, F1 and a proposed new sub-genotype denominated F5pan. We found a confinement of sub-genotypes F1 and F5pan to the western area of Panama. The tMRCA analysis suggests a simultaneous circulation of previously described sub-genotypes rather than recent introductions of the Panamanian sub-genotypes in the country. Moreover, these results highlight the need of more intensive research of the HBV strains circulating in the region at the molecular level. In conclusion, Panama has a high HBV genotype diversity that includes a new proposed sub-genotype, an elevated number of PreCore-Core mutations, and confinement of these variants in a specific geographical location.	[Martinez, Alexander A.; Zaldivar, Yamitzel Y.; Ortiz, Alma Y.; Mendoza, Yaxelis; Pascale, Juan M.] Gorgas Mem Inst Hlth Studies, Panama City, Panama; [Martinez, Alexander A.; Mendoza, Yaxelis] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, AP, India; [Martinez, Alexander A.; Mendoza, Yaxelis] INDICASAT AIP Clayton, City Of Knowledge, Panama; [De Castillo, Zoila; CSS-NAT Grp] Complejo Hosp Dr Arnulfo Arias Madrid, Panama City, Panama; [Cristina, Juan] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay	Instituto Conmemorativo Gorgas de Estudios de la Salud; Acharya Nagarjuna University; Universidad de la Republica, Uruguay	Pascale, JM (corresponding author), Gorgas Mem Inst Hlth Studies, Panama City, Panama.	jpascale@gorgas.gob.pa	Martinez, Alexander A/F-9601-2012; Martínez, Alexander/HHC-2101-2022	Martinez, Alexander A/0000-0002-7816-3040; 	Secretaria Nacional de Ciencia y Tecnologia (SENACYT)PANAMA [FID09-050]; Instituto Panameno para formacion de recursos Humanos (IFARHU) PANAMA	Secretaria Nacional de Ciencia y Tecnologia (SENACYT)PANAMA; Instituto Panameno para formacion de recursos Humanos (IFARHU) PANAMA	This study was supported by the Secretaria Nacional de Ciencia y Tecnologia (SENACYT)PANAMA, grant FID09-050. AAM was supported by a fellowship of the Instituto Panameno para formacion de recursos Humanos (IFARHU) PANAMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Mora MV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-244; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; ArauzRuiz P, 1997, J INFECT DIS, V176, P851, DOI 10.1086/516507; ArauzRuiz P, 1997, J MED VIROL, V51, P305, DOI 10.1002/(SICI)1096-9071(199704)51:4&lt;305::AID-JMV8&gt;3.0.CO;2-9; Martinez AA, 2013, MEM I OSWALDO CRUZ, V108, P541, DOI 10.1590/S0074-02762013000500002; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bouckaert R, 2013, ANTIVIR THER, V18, P497, DOI 10.3851/IMP2656; Conte E, 2013, ACTUALIZACION INFORM; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fassio E, 2010, ETIOLOGY HEPATOCELLU; Fujisaki S, 2011, J CLIN MICROBIOL, V49, P1017, DOI 10.1128/JCM.02149-10; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; GUNTHER S, 1995, J VIROL, V69, P5437; Hayer J, 2013, NUCLEIC ACIDS RES, V41, pD566, DOI 10.1093/nar/gks1022; Huy TTT, 2006, ARCH VIROL, V151, P589, DOI 10.1007/s00705-005-0671-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kato H, 2005, WORLD J GASTROENTERO, V11, P6295, DOI 10.3748/wjg.v11.i40.6295; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Laufer N, 2010, SEX TRANSM DIS, V37, P342, DOI 10.1097/OLQ.0b013e3181d73c0d; Leon B, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-60; Liu Y, 2007, J CLIN MICROBIOL, V45, P553, DOI 10.1128/JCM.00709-06; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Pinho JRR, 2013, ANTIVIR THER, V18, P425, DOI 10.3851/IMP2590; Sa MS, 2007, BRAZ J INFECT DIS, V11, P395, DOI 10.1590/S1413-86702007000400004; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Shi YH, 2012, JPN J INFECT DIS, V65, P476, DOI 10.7883/yoken.65.476; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010; Trinks J, 2008, J VIRAL HEPATITIS, V15, P827, DOI 10.1111/j.1365-2893.2008.00997.x	36	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103545	10.1371/journal.pone.0103545	http://dx.doi.org/10.1371/journal.pone.0103545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093674	gold, Green Submitted, Green Published			2022-12-25	WOS:000341357200025
J	Wilflingseder, J; Sunzenauer, J; Toronyi, E; Heinzel, A; Kainz, A; Mayer, B; Perco, P; Telkes, G; Langer, RM; Oberbauer, R				Wilflingseder, Julia; Sunzenauer, Judith; Toronyi, Eva; Heinzel, Andreas; Kainz, Alexander; Mayer, Bernd; Perco, Paul; Telkes, Gabor; Langer, Robert M.; Oberbauer, Rainer			Molecular Pathogenesis of Post-Transplant Acute Kidney Injury: Assessment of Whole-Genome mRNA and MiRNA Profiles	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; ISCHEMIA-REPERFUSION INJURY; GENE-EXPRESSION PATTERNS; ALLOGRAFT; HYPOXIA; TRANSPLANTATION; IDENTIFICATION; PERMEABILITY; ASSOCIATION; MECHANISMS	Acute kidney injury (AKI) affects roughly 25% of all recipients of deceased donor organs. The prevention of post-transplant AKI is still an unmet clinical need. We prospectively collected zero-hour, indication as well as protocol kidney biopsies from 166 allografts between 2011 and 2013. In this cohort eight cases with AKI and ten matched allografts without pathology serving as control group were identified with a follow-up biopsy within the first twelve days after engraftment. For this set the zero-hour and follow-up biopsies were subjected to genome wide microRNA and mRNA profiling and analysis, followed by validation in independent expression profiles of 42 AKI and 21 protocol biopsies for strictly controlling the false discovery rate. Follow-up biopsies of AKI allografts compared to time-matched protocol biopsies, further baseline adjustment for zero-hour biopsy expression level and validation in independent datasets, revealed a molecular AKI signature holding 20 mRNAs and two miRNAs (miR-182-5p and miR-21-3p). Next to several established biomarkers such as lipocalin-2 also novel candidates of interest were identified in the signature. In further experimental evaluation the elevated transcript expression level of the secretory leukocyte peptidase inhibitor (SLPI) in AKI allografts was confirmed in plasma and urine on the protein level (p<0.001 and p=0.003, respectively). miR-182-5p was identified as a molecular regulator of post-transplant AKI, strongly correlated with global gene expression changes during AKI. In summary, we identified an AKI-specific molecular signature providing the ground for novel biomarkers and target candidates such as SLPI and miR-182-5p in addressing AKI.	[Wilflingseder, Julia; Kainz, Alexander; Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol & Dialysis, Vienna, Austria; [Wilflingseder, Julia; Sunzenauer, Judith; Kainz, Alexander; Oberbauer, Rainer] KH Elisabethinen, Dept Nephrol & Transplantat, Linz, Austria; [Toronyi, Eva; Telkes, Gabor; Langer, Robert M.] Semmelweis Univ, Dept Transplantat & Surg, H-1085 Budapest, Hungary; [Heinzel, Andreas; Mayer, Bernd; Perco, Paul] Emergentec Biodev GmbH, Vienna, Austria	Medical University of Vienna; Ordensklinikum Linz Elisabethinen; Semmelweis University; Emergentec Biodevelopment GmbH	Oberbauer, R (corresponding author), Med Univ Vienna, Dept Nephrol & Dialysis, Vienna, Austria.	rainer.oberbauer@meduniwien.ac.at	Perco, Paul/U-2489-2019; Kainz, Alexander/AAM-7296-2021	Perco, Paul/0000-0003-2087-5691; Telkes Dr., Gabor/0000-0002-1551-5029; Wilflingseder, Julia/0000-0002-0230-9349	Austrian Science Fund [FWF P-21436, P-25726]; European Union, grant MC-IOF [328613]; Austrian Science Fund (FWF) [P 25726] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); European Union, grant MC-IOF; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants from the Austrian Science Fund (FWF P-21436 and P-25726) and the European Union, grant MC-IOF#328613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis M, 2012, AM J TRANSPLANT, V12, P2608, DOI 10.1111/j.1600-6143.2012.04245.x; [Anonymous], 2011, SRTR ANN REPORT 2011; Bolstad B, 2005, BIOINFORMATICS COMPU; Cavaille-Coll M, 2013, AM J TRANSPLANT, V13, P1134, DOI 10.1111/ajt.12210; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cohen B, 2005, NEPHROL DIAL TRANSPL, V20, P34, DOI 10.1093/ndt/gfh506; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Famulski KS, 2012, J AM SOC NEPHROL, V23, P948, DOI 10.1681/ASN.2011090887; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hauser P, 2004, LAB INVEST, V84, P353, DOI 10.1038/labinvest.3700037; HE L, 2004, NAT REV GENET, V5, P522; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jayaram D, 2012, CLIN TRANSPLANT, V26, pE536, DOI 10.1111/ctr.12029; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Legendre C, 2013, TRANSPL INT; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McDonald R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S6; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mueller TF, 2008, AM J TRANSPLANT, V8, P78, DOI 10.1111/j.1600-6143.2007.02032.x; OGAWA S, 1992, AM J PHYSIOL, V262, pC546, DOI 10.1152/ajpcell.1992.262.3.C546; OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540; Ohlsson S, 2001, MEDIAT INFLAMM, V10, P347, DOI 10.1080/09629350120102389; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Peng XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070442; Perco P, 2009, TRANSPLANTATION, V87, P290, DOI 10.1097/TP.0b013e318191b4c0; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Rosin DL, 2011, J AM SOC NEPHROL, V22, P416, DOI 10.1681/ASN.2010040430; Shao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084131; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Szeto CC, 2010, CLIN J AM SOC NEPHRO, V5, P2329, DOI 10.2215/CJN.01910310; Tso PL, 2012, AM J TRANSPLANT, V12, P1091, DOI 10.1111/j.1600-6143.2011.03956.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wilflingseder J, 2013, TRANSPLANTATION, V95, P835, DOI 10.1097/TP.0b013e318280b385; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	50	55	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e104164	10.1371/journal.pone.0104164	http://dx.doi.org/10.1371/journal.pone.0104164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093671	Green Published, gold, Green Submitted			2022-12-25	WOS:000341357200079
J	Coomans, D; Vandenbossche, J; Homble, K; Van den Bussche, E; Soetens, E; Deroost, N				Coomans, Daphne; Vandenbossche, Jochen; Homble, Koen; Van den Bussche, Eva; Soetens, Eric; Deroost, Natacha			Does Consolidation of Visuospatial Sequence Knowledge Depend on Eye Movements?	PLOS ONE			English	Article							RESPONSE SELECTION; TIME-COURSE; IMPLICIT; SLEEP; DISSOCIATION; MEMORY; STIMULUS	In the current study, we assessed whether visuospatial sequence knowledge is retained over 24 hours and whether this retention is dependent on the occurrence of eye movements. Participants performed two sessions of a serial reaction time (SRT) task in which they had to manually react to the identity of a target letter pair presented in one of four locations around a fixation cross. When the letter pair 'XO' was presented, a left response had to be given, when the letter pair 'OX' was presented, a right response was required. In the Eye Movements (EM) condition, eye movements were necessary to perform the task since the fixation cross and the target were separated by at least 9 degrees visual angle. In the No Eye Movements (NEM) condition, on the other hand, eye movements were minimized by keeping the distance from the fixation cross to the target below 1 degrees visual angle and by limiting the stimulus presentation to 100 ms. Since the target identity changed randomly in both conditions, no manual response sequence was present in the task. However, target location was structured according to a deterministic sequence in both the EM and NEM condition. Learning of the target location sequence was determined at the end of the first session and 24 hours after initial learning. Results indicated that the sequence learning effect in the SRT task diminished, yet remained significant, over the 24 hour interval in both conditions. Importantly, the difference in eye movements had no impact on the transfer of sequence knowledge. These results suggest that the retention of visuospatial sequence knowledge occurs alike, irrespective of whether this knowledge is supported by eye movements or not.	[Coomans, Daphne; Vandenbossche, Jochen; Homble, Koen; Van den Bussche, Eva; Soetens, Eric; Deroost, Natacha] Vrije Univ Brussel, Dept Expt & Appl Psychol, B-1200 Brussels, Belgium	Vrije Universiteit Brussel	Coomans, D (corresponding author), Vrije Univ Brussel, Dept Expt & Appl Psychol, B-1200 Brussels, Belgium.	Daphne.Coomans@vub.ac.be	Van den Bussche, Eva/AFU-0195-2022; Van den Bussche, Eva/E-7977-2010; Deroost, Natacha/E-1738-2013	Van den Bussche, Eva/0000-0003-1894-9380; Deroost, Natacha/0000-0001-8633-9547	Research Foundation - Flanders [FWOTM506]	Research Foundation - Flanders(FWO)	The first author, Daphne Coomans, is a research fellow of the Research Foundation - Flanders (grant FWOTM506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052805; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Clegg BA, 1998, TRENDS COGN SCI, V2, P275, DOI 10.1016/S1364-6613(98)01202-9; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Cohen DA, 2007, EXP BRAIN RES, V177, P440, DOI 10.1007/s00221-006-0701-6; Coomans D, 2012, EXP PSYCHOL, V59, P279, DOI 10.1027/1618-3169/a000155; Coomans D, 2011, CONSCIOUS COGN, V20, P1460, DOI 10.1016/j.concog.2011.06.009; Deroost N, 2006, PSYCHOL RES-PSYCH FO, V70, P88, DOI 10.1007/s00426-004-0196-3; Deroost N, 2006, Q J EXP PSYCHOL, V59, P449, DOI 10.1080/17470210500462684; Deroost N, 2006, EXP PSYCHOL, V53, P16, DOI 10.1027/1618-3169.53.1.16; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Genzel L, 2012, PSYCHONEUROENDOCRINO, V37, P987, DOI 10.1016/j.psyneuen.2011.11.006; Hallgato E, 2013, CORTEX, V49, P1073, DOI 10.1016/j.cortex.2012.01.002; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Nattkemper D, 1997, PSYCHOL RES-PSYCH FO, V60, P98, DOI 10.1007/BF00419683; Nemeth D, 2009, NEUROREPORT, V20, P1654, DOI 10.1097/WNR.0b013e328333ba08; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Press DZ, 2005, COGNITIVE BRAIN RES, V25, P375, DOI 10.1016/j.cogbrainres.2005.05.010; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Remillard G, 2011, PSYCHOL RES-PSYCH FO, V75, P307, DOI 10.1007/s00426-010-0309-0; Remillard G, 2009, J EXP PSYCHOL LEARN, V35, P528, DOI 10.1037/a0014646; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Schneider W., 2002, E PRIME USERS GUIDE; Schwarb H, 2010, MEM COGNITION, V38, P677, DOI 10.3758/MC.38.6.677; Schwarb H, 2009, BRAIN RES, V1247, P114, DOI 10.1016/j.brainres.2008.09.097; Song S, 2008, EXP BRAIN RES, V189, P145, DOI 10.1007/s00221-008-1411-z; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Witt K, 2010, NEUROSCIENCE, V171, P227, DOI 10.1016/j.neuroscience.2010.07.062; Ziessler M, 2001, J EXP PSYCHOL LEARN, V27, P595, DOI 10.1037/0278-7393.27.3.595; Ziessler M, 1998, J EXP PSYCHOL LEARN, V24, P962, DOI 10.1037/0278-7393.24.4.962	39	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103421	10.1371/journal.pone.0103421	http://dx.doi.org/10.1371/journal.pone.0103421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089701	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700024
J	Pustina, D; Doucet, G; Evans, J; Sharan, A; Sperling, M; Skidmore, C; Tracy, J				Pustina, Dorian; Doucet, Gaelle; Evans, James; Sharan, Ashwini; Sperling, Michael; Skidmore, Christopher; Tracy, Joseph			Distinct Types of White Matter Changes Are Observed after Anterior Temporal Lobectomy in Epilepsy	PLOS ONE			English	Article							LOBE EPILEPSY; UNCINATE FASCICULUS; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; LANGUAGE NETWORKS; DIFFUSION; ABNORMALITIES; MEMORY; MRI; ASYMMETRY	Anterior temporal lobectomy (ATL) is commonly adopted to control medically intractable temporal lobe epilepsy (TLE). Depending on the side of resection, the degree to which Wallerian degeneration and adaptive plasticity occur after ATL has important implications for understanding cognitive and clinical outcome. We obtained diffusion tensor imaging from 24 TLE patients (12 left) before and after surgery, and 12 matched controls at comparable time intervals. Voxel-based analyses were performed on fractional anisotropy (FA) before and after surgery. Areas with postoperative FA increase were further investigated to distinguish between genuine plasticity and processes related to the degeneration of crossing fibers. Before surgery, both patient groups showed bilateral reduced FA in numerous tracts, but left TLE patients showed more extensive effects, including language tracts in the contralateral hemisphere (superior longitudinal fasciculus and uncinate). After surgery, FA decreased ipsilaterally in both ATL groups, affecting the fornix, uncinate, stria terminalis, and corpus callosum. FA increased ipsilaterally along the superior corona radiata in both left and right ATL groups, exceeding normal FA values. In these clusters, the mode of anisotropy increased as well, confirming fiber degeneration in an area with crossing fibers. In left ATL patients, pre-existing low FA values in right superior longitudinal and uncinate fasciculi normalized after surgery, while MO values did not change. Preoperative verbal fluency correlated with FA values in all areas that later increased FA in left TLE patients, but postoperative verbal fluency correlated only with FA of the right superior longitudinal fasciculus. Our results demonstrate that genuine reorganization occurs in non-dominant language tracts after dominant hemisphere resection, a process that may help implement the inter-hemispheric shift of language activation found in fMRI studies. The results indicate that left TLE patients, despite showing more initial white matter damage, have the potential for greater adaptive changes postoperatively than right TLE patients.	[Pustina, Dorian; Doucet, Gaelle; Sperling, Michael; Skidmore, Christopher; Tracy, Joseph] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Doucet, Gaelle; Evans, James; Sharan, Ashwini] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Tracy, J (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	joseph.tracy@jefferson.edu	Doucet, Gaelle/H-9367-2019	Doucet, Gaelle/0000-0003-4120-0474; Skidmore, Christopher/0000-0002-9939-4307	National Institute for Neurological Disorders and Stroke (NINDS) [R21 NS056071-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056071] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by the National Institute for Neurological Disorders and Stroke (NINDS) [grant number R21 NS056071-01A1] to Dr. Joseph I. Tracy. The remaining funding was provided by other sources of internal organizational support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi ME, 2009, AM J NEURORADIOL, V30, P1740, DOI 10.3174/ajnr.A1650; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; Cao Y, 2005, IEEE T MED IMAGING, V24, P1216, DOI 10.1109/TMI.2005.853923; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Concha L, 2007, EPILEPSIA, V48, P931, DOI 10.1111/j.1528-1167.2007.01006.x; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Faber J, 2013, EPILEPSIA; Govindan RM, 2008, EPILEPSY RES, V80, P30, DOI 10.1016/j.eplepsyres.2008.03.011; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Haberling IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052315; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Holland SK, 2001, NEUROIMAGE, V14, P837, DOI 10.1006/nimg.2001.0875; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Keller SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046791; Keller SS, 2011, J NEUROIMAGING OFFIC; Kemmotsu N, 2011, EPILEPSIA, V52, P2257, DOI 10.1111/j.1528-1167.2011.03278.x; Kim JH, 2010, J KOREAN NEUROSURG S, V47, P17, DOI 10.3340/jkns.2010.47.1.17; Knake S, 2009, EPILEPTIC DISORD, V11, P244, DOI 10.1684/epd.2009.0272; Liacu D, 2012, J MAGN RESON IMAGING, V36, P561, DOI 10.1002/jmri.23678; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Liu M, 2013, NEUROIMAGE; Liu M, 2012, NEUROIMAGE-CLIN, V1, P99, DOI 10.1016/j.nicl.2012.09.010; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mandl RCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00817; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Mao LY, 2011, SEIZURE-EUR J EPILEP, V20, P741, DOI 10.1016/j.seizure.2011.07.002; McDonald CR, 2010, NEUROLOGY, V75, P1631, DOI 10.1212/WNL.0b013e3181fb44db; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Mori S, 2010, MRI ATLAS HUMAN WHIT; Morrell F, 1999, Adv Neurol, V81, P11; Nguyen D, 2011, EPILEPSY RES; Noppeney U, 2005, BRAIN, V128, P1377, DOI 10.1093/brain/awh414; Nucifora PGP, 2005, NEUROREPORT, V16, P791, DOI 10.1097/00001756-200505310-00002; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Oguz KK, 2012, AJNR AM J NEURORADIO; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Reich DS, 2007, NEUROIMAGE, V38, P271, DOI 10.1016/j.neuroimage.2007.07.049; Reijmer YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044074; Rodrigo S, 2007, EUR RADIOL, V17, P1663, DOI 10.1007/s00330-006-0558-x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Schoene-Bake JC, 2009, NEUROIMAGE, V46, P569, DOI 10.1016/j.neuroimage.2009.03.013; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shon YM, 2010, EPILEPSIA, V51, P529, DOI 10.1111/j.1528-1167.2009.02327.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; SPERLING MR, 1992, NEUROLOGY, V42, P416, DOI 10.1212/WNL.42.2.416; Spreen O., 1977, NEUROSENSORY CTR COM; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Teipel SJ, 2014, J ALZHEIMERS DIS JAD; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tracy JI, 2007, EPILEPSIA, V48, P2327; Voets NL, 2009, HUM BRAIN MAPP, V30, P4070, DOI 10.1002/hbm.20830; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Winston GP, 2014, NEUROIMAGE-CLIN, V4, P190, DOI 10.1016/j.nicl.2013.12.004; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Wong SWH, 2009, NEUROLOGY, V73, P518, DOI 10.1212/WNL.0b013e3181b2a48e; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175	74	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104211	10.1371/journal.pone.0104211	http://dx.doi.org/10.1371/journal.pone.0104211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089698	Green Submitted, gold, Green Published			2022-12-25	WOS:000339812700112
J	Silva, JN; Godoy, MG; Gutarra, MLE; Freire, DMG				Silva, Jaqueline N.; Godoy, Mateus G.; Gutarra, Melissa L. E.; Freire, Denise M. G.			Impact of Extraction Parameters on the Recovery of Lipolytic Activity from Fermented Babassu Cake	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; PENICILLIUM-SIMPLICISSIMUM; LIPASE PRODUCTION; STRAIN; PURIFICATION; CULTIVATION; BIODIESEL; ENZYMES	Enzyme extraction from solid matrix is as important step in solid-state fermentation to obtain soluble enzymes for further immobilization and application in biocatalysis. A method for the recovery of a pool of lipases from Penicillium simplicissimum produced by solid-state fermentation was developed. For lipase recovery different extraction solution was used and phosphate buffer containing Tween 80 and NaCl showed the best results, yielding lipase activity of 85.7 U/g and 65.7 U/g, respectively. The parameters with great impacts on enzyme extraction detected by the Plackett-Burman analysis were studied by Central Composite Rotatable experimental designs where a quadratic model was built showing maximum predicted lipase activity (160 U/g) at 25 degrees C, Tween 80 0.5% (w/v), pH 8.0 and extraction solution 7 mL/g, maintaining constant buffer molarity of 0.1 M and 200 rpm. After the optimization process a 2.5 fold increase in lipase activity in the crude extract was obtained, comparing the intial value (64 U/g) with the experimental design (160 U/g), thus improving the overall productivity of the process.	[Godoy, Mateus G.; Freire, Denise M. G.] Univ Fed Rio de Janeiro, Inst Quim, Dept Engn Bioquim, BR-20001 Rio De Janeiro, Brazil; [Silva, Jaqueline N.; Gutarra, Melissa L. E.] Univ Fed Rio de Janeiro, Escola Quim, Dept Engn Bioquim, BR-20001 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Gutarra, MLE (corresponding author), Univ Fed Rio de Janeiro, Escola Quim, Dept Engn Bioquim, BR-20001 Rio De Janeiro, Brazil.	gutarra@gmail.com	de Godoy, Mateus Gomes/D-9977-2015; FREIRE, Denise Maria/D-8699-2014; Gutarra, Melissa/J-5706-2015	de Godoy, Mateus Gomes/0000-0003-2209-7993; FREIRE, Denise Maria/0000-0002-8298-5936; Gutarra, Melissa/0000-0003-2480-7223	PETROBRAS; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)	PETROBRAS(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was financially supported by the PETROBRAS and the Brazilian governmental funding agencies CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikat K, 2000, PROCESS BIOCHEM, V35, P907, DOI 10.1016/S0032-9592(99)00148-X; Castilho LR, 2000, BIORESOURCE TECHNOL, V71, P45, DOI 10.1016/S0960-8524(99)00058-9; Salum TFC, 2010, PROCESS BIOCHEM, V45, P1348, DOI 10.1016/j.procbio.2010.05.004; Cunha AG, 2009, APPL BIOCHEM BIOTECH, V156, P563, DOI 10.1007/s12010-008-8425-7; De Oliveira D, 2004, APPL BIOCHEM BIOTECH, V113, P771, DOI 10.1385/ABAB:115:1-3:0771; Diaz AB, 2007, ENZYME MICROB TECH, V41, P302, DOI 10.1016/j.enzmictec.2007.02.006; Estrada Gutarra Melissa Limoeiro, 2009, Biotechnology Journal, V4, P1450, DOI 10.1002/biot.200800298; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Godoy MG, 2011, J IND MICROBIOL BIOT, V38, P945, DOI 10.1007/s10295-010-0865-8; Godoy MG, 2009, ENZYME MICROB TECH, V44, P317, DOI 10.1016/j.enzmictec.2009.01.002; Gutarra MLE, 2009, BIORESOURCE TECHNOL, V100, P5249, DOI 10.1016/j.biortech.2008.08.050; Gutarra MLE, 2005, APPL BIOCHEM BIOTECH, V121, P105, DOI 10.1385/ABAB:121:1-3:0105; Heck JX, 2005, PROCESS BIOCHEM, V40, P2891, DOI 10.1016/j.procbio.2005.01.006; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Johri S, 2001, BIOORGAN MED CHEM, V9, P269, DOI 10.1016/S0968-0896(00)00240-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2010, J MOL CATAL B-ENZYM, V66, P43, DOI 10.1016/j.molcatb.2010.05.004; Mahadik ND, 2002, PROCESS BIOCHEM, V38, P715, DOI 10.1016/S0032-9592(02)00194-2; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Mitchell David A, 2002, Biotechnol Annu Rev, V8, P183, DOI 10.1016/S1387-2656(02)08009-2; Palomo JM, 2003, BIOMACROMOLECULES, V4, P204, DOI 10.1021/bm020071l; Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6; Valente AM, 2010, CIENCIA TECNOL ALIME, V30, P483, DOI 10.1590/S0101-20612010000200028; Vardanega R, 2010, FOOD BIOPROCESS TECH, V3, P461, DOI 10.1007/s11947-009-0224-9; Viniegra-Gonzalez G, 2003, BIOCHEM ENG J, V13, P157, DOI 10.1016/S1369-703X(02)00128-6; Zeng GM, 2006, ENZYME MICROB TECH, V39, P1451, DOI 10.1016/j.enzmictec.2006.03.035	26	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103176	10.1371/journal.pone.0103176	http://dx.doi.org/10.1371/journal.pone.0103176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090644	gold, Green Submitted, Green Published			2022-12-25	WOS:000339812700021
J	Starkhammar, M; Larsson, O; Georen, SK; Leino, M; Dahlen, SE; Adner, M; Cardell, LO				Starkhammar, Magnus; Larsson, Olivia; Georen, Susanna Kumlien; Leino, Marina; Dahlen, Sven-Erik; Adner, Mikael; Cardell, Lars-Olaf			Toll-Like Receptor Ligands LPS and Poly (I:C) Exacerbate Airway Hyperresponsiveness in a Model of Airway Allergy in Mice, Independently of Inflammation	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; SMOOTH-MUSCLE; MOUSE MODEL; BRONCHIAL HYPERRESPONSIVENESS; RESPIRATORY-INFECTIONS; FUNCTIONAL PLASTICITY; INNATE IMMUNITY; RESPONSES; TOLL-LIKE-RECEPTOR-4; RHINOVIRUS	It is well-established that bacterial and viral infections have an exacerbating effect on allergic asthma, particularly aggravating respiratory symptoms, such as airway hyperresponsiveness (AHR). The mechanism by which these infections alter AHR is unclear, but some studies suggest that Toll-like receptors (TLRs) play a role. In this study, we investigated the impact of TLR3 and TLR4 ligands on AHR and airway inflammation in a model of pre-established allergic inflammation. Female BALB/c mice were sensitised and challenged intranasally (i.n.) with either PBS or ovalbumin (OVA) and subsequently i.n. challenged with poly (I:C) (TLR3) or LPS (TLR4) for four consecutive days. The response to methacholine was measured in vivo; cellular and inflammatory mediators were measured in blood, lung tissue and broncheoalveolar lavage fluid (BALF). OVA challenge resulted in an increase in AHR to methacholine, as well as increased airway eosinophilia and TH2 cytokine production. Subsequent challenge with TLR agonists resulted in a significant increase in AHR, but decreased TLR-specific cellular inflammation and production of immune mediators. Particularly evident was a decline in LPS-induced neutrophilia and neutrophil-associated cytokines following LPS and poly (I:C) treatment. The present data indicates that TLRs may play a pivotal role in AHR in response to microbial infection in allergic lung inflammation. These data also demonstrate that aggravated AHR occurs in the absence of an exacerbation in airway inflammation and that allergic inflammation impedes a subsequent inflammatory response to TLRs. These results may parallel clinical signs of microbial asthma exacerbation, including an extended duration of illness and increased respiratory symptoms.	[Starkhammar, Magnus; Larsson, Olivia; Georen, Susanna Kumlien; Leino, Marina; Cardell, Lars-Olaf] Karolinska Inst, CLINTEC, Div ENT Dis, Stockholm, Sweden; [Starkhammar, Magnus; Georen, Susanna Kumlien; Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Cardell, LO (corresponding author), Karolinska Inst, CLINTEC, Div ENT Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255				Adner M, 2013, EUR J PHARMACOL, V718, P544, DOI 10.1016/j.ejphar.2013.09.004; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bachar O, 2006, AM J PHYSIOL-LUNG C, V291, pL322, DOI 10.1152/ajplung.00141.2006; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Bjornsson E, 1996, SCAND J INFECT DIS, V28, P63, DOI 10.3109/00365549609027152; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Delayre-Orthez C, 2005, INT ARCH ALLERGY IMM, V138, P298, DOI 10.1159/000088867; Denkers EY, 2003, CHEM IMMUNOL, V83, P95; Duechs MJ, 2011, PULM PHARMACOL THER, V24, P203, DOI 10.1016/j.pupt.2010.12.009; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Habibzay M, 2012, MUCOSAL IMMUNOL, V5, P524, DOI 10.1038/mi.2012.28; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hollingsworth JW, 2005, AM J RESP CRIT CARE, V171, P806, DOI 10.1164/rccm.200407-953OC; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Krawczyk CM, 2007, J IMMUNOL, V178, P4080, DOI 10.4049/jimmunol.178.7.4080; Kurai D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00293; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Luxameechanporn T, 2005, ARCH OTOLARYNGOL, V131, P1001, DOI 10.1001/archotol.131.11.1001; Martin RJ, 2001, AM J RESP CELL MOL, V24, P577, DOI 10.1165/ajrcmb.24.5.4315; Micillo E, 2000, ALLERGY, V55, P42; Morishima H, 2008, INT ARCH ALLERGY IMM, V145, P163, DOI 10.1159/000108141; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Rochlitzer S, 2014, CLIN SCI, V126, P55, DOI 10.1042/CS20130174; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Simpson JL, 2008, PAEDIATR RESPIR REV, V9, P263, DOI 10.1016/j.prrv.2008.05.007; Starkhammar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032110; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Swedin L, 2009, EUR RESPIR J, V34, P200, DOI 10.1183/09031936.00030908; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Wos M, 2008, AM J RESP CRIT CARE, V177, P1082, DOI 10.1164/rccm.200607-973OC	45	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104114	10.1371/journal.pone.0104114	http://dx.doi.org/10.1371/journal.pone.0104114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089623	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700100
J	Zhang, Y; Hu, YF; Li, HW; Jin, CW				Zhang, Yi; Hu, Yunfei; Li, Hongwei; Jin, Changwen			Structural Basis for TatA Oligomerization: An NMR Study of Escherichia coli TatA Dimeric Structure	PLOS ONE			English	Article							PROTEIN-TRANSPORT SYSTEM; TWIN-ARGININE TRANSLOCASE; BACILLUS-SUBTILIS; DIPOLAR COUPLINGS; CHEMICAL-SHIFT; COMPONENT; MEMBRANE; COMPLEX; FORM; IDENTIFICATION	Many proteins are transported across lipid membranes by protein translocation systems in living cells. The twin-arginine transport (Tat) system identified in bacteria and plant chloroplasts is a unique system that transports proteins across membranes in their fully-folded states. Up to date, the detailed molecular mechanism of this process remains largely unclear. The Escherichia coli Tat system consists of three essential transmembrane proteins: TatA, TatB and TatC. Among them, TatB and TatC form a tight complex and function in substrate recognition. The major component TatA contains a single transmembrane helix followed by an amphipathic helix, and is suggested to form the translocation pore via self-oligomerization. Since the TatA oligomer has to accommodate substrate proteins of various sizes and shapes, the process of its assembly stands essential for understanding the translocation mechanism. A structure model of TatA oligomer was recently proposed based on NMR and EPR observations, revealing contacts between the transmembrane helices from adjacent subunits. Herein we report the construction and stabilization of a dimeric TatA, as well as the structure determination by solution NMR spectroscopy. In addition to more extensive inter-subunit contacts between the transmembrane helices, we were also able to observe interactions between neighbouring amphipathic helices. The side-by-side packing of the amphipathic helices extends the solvent-exposed hydrophilic surface of the protein, which might be favourable for interactions with substrate proteins. The dimeric TatA structure offers more detailed information of TatA oligomeric interface and provides new insights on Tat translocation mechanism.	[Zhang, Yi; Hu, Yunfei; Li, Hongwei; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Zhang, Yi; Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Hu, Yunfei; Li, Hongwei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University	Hu, YF (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	yunfei@pku.edu.cn; changwen@pku.edu.cn	Zhang, Yi/J-7181-2019	Zhang, Yi/0000-0001-8170-9983	National Natural Science Foundation of China [31070649]; China Ministry of Science and Technology [2010IM030700]; China Postdoctoral Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Ministry of Science and Technology(Ministry of Science and Technology, China); China Postdoctoral Foundation(China Postdoctoral Science Foundation)	This work is supported by National Natural Science Foundation of China Grant 31070649 and the Grant for Innovative Methods 2010IM030700 from China Ministry of Science and Technology (to C.J.). Y.H. acknowledges a special support from China Postdoctoral Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Barrett CML, 2003, FEBS LETT, V537, P42, DOI 10.1016/S0014-5793(03)00068-1; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Chan CS, 2011, BBA-BIOMEMBRANES, V1808, P2289, DOI 10.1016/j.bbamem.2011.05.024; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hicks MG, 2005, J BACTERIOL, V187, P2920, DOI 10.1128/JB.187.8.2920-2925.2005; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2002, J BACTERIOL, V184, P5871, DOI 10.1128/JB.184.21.5871-5879.2002; Lorieau J, 2008, J AM CHEM SOC, V130, P7536, DOI 10.1021/ja801729f; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Patel R, 2014, BIOCH BIOPH IN PRESS; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Walther TH, 2013, CELL, V152, P316, DOI 10.1016/j.cell.2012.12.017; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Warren G, 2009, J MOL BIOL, V388, P122, DOI 10.1016/j.jmb.2009.02.060; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	38	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103157	10.1371/journal.pone.0103157	http://dx.doi.org/10.1371/journal.pone.0103157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090434	Green Submitted, Green Published, gold			2022-12-25	WOS:000339812700019
J	Penumutchu, SR; Chou, RH; Yu, C				Penumutchu, Srinivasa R.; Chou, Ruey-Hwang; Yu, Chin			Structural Insights into Calcium-Bound S100P and the V Domain of the RAGE Complex	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROTEIN-PROTEIN INTERACTIONS; PANCREATIC-CANCER GROWTH; CELL-SURFACE RECEPTOR; LARGER PROTEINS; SEQUENTIAL ASSIGNMENT; IMPROVED SENSITIVITY; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH	The S100P protein is a member of the S100 family of calcium-binding proteins and possesses both intracellular and extracellular functions. Extracellular S100P binds to the cell surface receptor for advanced glycation end products (RAGE) and activates its downstream signaling cascade to meditate tumor growth, drug resistance and metastasis. Preventing the formation of this S100P-RAGE complex is an effective strategy to treat various disease conditions. Despite its importance, the detailed structural characterization of the S100P-RAGE complex has not yet been reported. In this study, we report that S100P preferentially binds to the V domain of RAGE. Furthermore, we characterized the interactions between the RAGE V domain and Ca2+-bound S100P using various biophysical techniques, including isothermal titration calorimetry (ITC), fluorescence spectroscopy, multidimensional NMR spectroscopy, functional assays and site-directed mutagenesis. The entropy-driven binding between the V domain of RAGE and Ca+2-bound S100P was found to lie in the micromolar range (K-d of similar to 6 mu M). NMR data-driven HADDOCK modeling revealed the putative sites that interact to yield a proposed heterotetrameric model of the S100P-RAGE V domain complex. Our study on the spatial structural information of the proposed protein-protein complex has pharmaceutical relevance and will significantly contribute toward drug development for the prevention of RAGE-related multifarious diseases.	[Penumutchu, Srinivasa R.; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Yu, Chin] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Xiamen University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.	cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013; Penumutchu, Srinivasa/U-4699-2018	Chou, Ruey-Hwang/0000-0002-2297-2180; Penumutchu, Srinivasa/0000-0002-3608-1442	National Science Council (NSC), Taiwan [NSC 100-2113-M-007-012-MY3]; China Medical University, Taiwan [CMU101-N2-04]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	The authors acknowledge financial support from the National Science Council (NSC), Taiwan (Grant number NSC 100-2113-M-007-012-MY3 to Chin Yu), and from China Medical University, Taiwan (Grant number CMU101-N2-04 to Ruey-Hwang Chou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt Y, 2007, CHEMMEDCHEM, V2, P1648, DOI 10.1002/cmdc.200700096; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Arumugam T, 2013, MOL CANCER THER, V12, P654, DOI 10.1158/1535-7163.MCT-12-0771; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Gospodarska E, 2011, BBA-PROTEINS PROTEOM, V1814, P592, DOI 10.1016/j.bbapap.2011.02.011; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; Gribenko AV, 2002, PROTEIN SCI, V11, P1367, DOI 10.1110/ps.0202202; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Heil A, 2011, J BIOL CHEM, V286, P7227, DOI 10.1074/jbc.M110.135095; Heizmann C. W., 2007, V45, P93; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Hung KW, 2012, J BIOMOL NMR, V54, P211, DOI 10.1007/s10858-012-9661-2; Hunter CA, 2003, CHEM BIOL, V10, P1023, DOI 10.1016/j.chembiol.2003.10.009; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KNELLER DG, 1993, J CELL BIOCHEM, P254; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LANE AN, 1994, METHOD ENZYMOL, V239, P596; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Markowitz J, 2004, J MED CHEM, V47, P5085, DOI 10.1021/jm0497038; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Penumutchu SR, 2013, BIOMOL NMR ASSIGN, V7, P5, DOI 10.1007/s12104-012-9365-2; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; RAMAN CS, 1995, BIOCHEMISTRY-US, V34, P5831, DOI 10.1021/bi00017a015; Rehbein G, 2008, INT J MOL MED, V22, P69; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tutar Y, 2006, PROTEIN PEPTIDE LETT, V13, P307, DOI 10.2174/092986606775338380; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wafer LN, 2013, BIOCHEMISTRY-US, V52, P5844, DOI 10.1021/bi400788s; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Zhang HM, 2003, J MOL BIOL, V325, P785, DOI 10.1016/S0022-2836(02)01278-0; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	88	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103947	10.1371/journal.pone.0103947	http://dx.doi.org/10.1371/journal.pone.0103947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084534	Green Submitted, Green Published, gold			2022-12-25	WOS:000339819800108
J	Sun, C; VanRaden, PM; Cole, JB; O'Connell, JR				Sun, Chuanyu; VanRaden, Paul M.; Cole, John B.; O'Connell, Jeffrey R.			Improvement of Prediction Ability for Genomic Selection of Dairy Cattle by Including Dominance Effects	PLOS ONE			English	Article							BREEDING VALUE PREDICTION; MILK-PRODUCTION TRAITS; VARIANCE; INFORMATION; PEDIGREE; VALUES; YIELD; REGRESSION; HEALTH; PLANT	Dominance may be an important source of non-additive genetic variance for many traits of dairy cattle. However, nearly all prediction models for dairy cattle have included only additive effects because of the limited number of cows with both genotypes and phenotypes. The role of dominance in the Holstein and Jersey breeds was investigated for eight traits: milk, fat, and protein yields; productive life; daughter pregnancy rate; somatic cell score; fat percent and protein percent. Additive and dominance variance components were estimated and then used to estimate additive and dominance effects of single nucleotide polymorphisms (SNPs). The predictive abilities of three models with both additive and dominance effects and a model with additive effects only were assessed using ten-fold cross-validation. One procedure estimated dominance values, and another estimated dominance deviations; calculation of the dominance relationship matrix was different for the two methods. The third approach enlarged the dataset by including cows with genotype probabilities derived using genotyped ancestors. For yield traits, dominance variance accounted for 5 and 7% of total variance for Holsteins and Jerseys, respectively; using dominance deviations resulted in smaller dominance and larger additive variance estimates. For non-yield traits, dominance variances were very small for both breeds. For yield traits, including additive and dominance effects fit the data better than including only additive effects; average correlations between estimated genetic effects and phenotypes showed that prediction accuracy increased when both effects rather than just additive effects were included. No corresponding gains in prediction ability were found for non-yield traits. Including cows with derived genotype probabilities from genotyped ancestors did not improve prediction accuracy. The largest additive effects were located on chromosome 14 near DGAT1 for yield traits for both breeds; those SNPs also showed the largest dominance effects for fat yield (both breeds) as well as for Holstein milk yield.	[Sun, Chuanyu] Natl Assoc Anim Breeders, Columbia, MO USA; [VanRaden, Paul M.; Cole, John B.] USDA, Agr Res Serv, Anim Genom & Improvement Lab, Beltsville, MD USA; [O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore	Sun, C (corresponding author), Natl Assoc Anim Breeders, Columbia, MO USA.	Chuanyu.Sun@ars.usda.gov	Cole, John B./J-8571-2014	Cole, John B./0000-0003-1242-4401	National Association of Animal Breeders, United States of America; Animal Improvement Programs Laboratory of Agricultural research service in the United States Department of Agriculture; ARS [ARS-0423282] Funding Source: Federal RePORTER	National Association of Animal Breeders, United States of America; Animal Improvement Programs Laboratory of Agricultural research service in the United States Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was performed in the project funded regularly by National Association of Animal Breeders, United States of America (http://www.naab-css.org/) and Animal Improvement Programs Laboratory of Agricultural research service in the United States Department of Agriculture (http://aipl.arsusda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL MS, 2002, P 7 WORLD C GEN APPL, V31, P123; Boysen TJ, 2013, GENETICS, V193, P431, DOI 10.1534/genetics.112.144535; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; *CTR BIOINF COMP B, 2013, BOS TAUR ASS; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Duangjinda M, 2001, J ANIM SCI, V79, P2997; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Freyer G, 2003, J DAIRY SCI, V86, P999, DOI 10.3168/jds.S0022-0302(03)73683-2; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gengler N, 1998, J ANIM SCI, V76, P2515; Gengler N, 1997, J ANIM SCI, V75, P2885; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HOESCHELE I, 1991, J DAIRY SCI, V74, P1743, DOI 10.3168/jds.S0022-0302(91)78337-9; *INT CORP, 2013, 630813061 INT CORP; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Misztal I, 1997, J DAIRY SCI, V80, P965, DOI 10.3168/jds.S0022-0302(97)76021-1; O'Connell J., 2013, MMAP USER GUIDE; OCONNELL JR, 2008, 58 ANN M AM SOC HUM; *R COR TEAM, 2012, R 2 15 1 WIND 32 64; Spelman RJ, 1996, GENETICS, V144, P1799; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Sun C, 2013, J DAIRY SCI, V96, P8014, DOI 10.3168/jds.2013-6969; Van Tassell CP, 2000, J DAIRY SCI, V83, P1873, DOI 10.3168/jds.S0022-0302(00)75059-4; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden P.M., 2011, FINDHAP F90; VANRADEN RM, 2006, P 8 WORLD C GEN APPL; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-5	38	57	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103934	10.1371/journal.pone.0103934	http://dx.doi.org/10.1371/journal.pone.0103934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084281	Green Published, gold, Green Submitted			2022-12-25	WOS:000339819800105
J	Zhao, Y; Zhou, W; Xue, LY; Zhang, WM; Zhan, QM				Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin			Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; DUCT EPITHELIAL-CELLS; ACETYLCHOLINE-RECEPTOR; CANDIDATE ONCOGENE; STEM-LIKE; KINASE-C; POPULATION; CARCINOMA; PATHWAY; CATENIN	Cigarette smoking is an established risk factor for esophageal cancers. Yes-associated protein 1 (YAP1), the key transcription factor of the mammalian Hippo pathway, has been reported to be an oncogenic factor for many cancers. In this study, we find nicotine administration can induce nuclear translocation and activation of YAP1 in ESCC. Consistently, we observed nuclear translocation and activation of YAP1 by knockdown of CHRNA3, which is a negative regulator of nicotine signaling in bronchial and esophageal cancer cells. Nicotine administration or CHRNA3 depletion substantially increased proliferation and migration in esophageal cancer cells. Interestingly, we find that YAP1 physically interacts with nAChRs, and nAChRs-signaling dissociates YAP1 from its negative regulatory complex composed with alpha-catenin, beta-catenin and 14-3-3 in the cytoplasm, leading to upregulation and nuclear translocation of YAP1. This process likely requires PKC activation, as PKC specific inhibitor Enzastaurin can block nicotine induced YAP1 activation. In addition, we find nicotine signaling also inhibits the interaction of YAP1 with P63, which contributes to the inhibitory effect of nicotine on apoptosis. Using immunohistochemistry analysis we observed upregulation of YAP1 in a significant portion of esophageal cancer samples. Consistently, we have found a significant association between YAP1 upregulation and cigarette smoking in the clinical esophageal cancer samples. Together, these findings suggest that the nicotine activated nAChRs signaling pathway which further activates YAP1 plays an important role in the development of esophageal cancer, and this mechanism may be of a general significance for the carcinogenesis of smoking related cancers.	[Zhao, Yue; Zhou, Wei; Zhang, Weimin; Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhao, Yue; Zhou, Wei; Xue, Liyan; Zhang, Weimin; Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Liyan] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn			973 National Key Fundamental Research Program of China [2009CB521801]; National Natural Science Foundation of China [81021061]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by the funds from the 973 National Key Fundamental Research Program of China (2009CB521801) and the National Natural Science Foundation of China (81021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029915; Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; An Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047919; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Brown EN, 2003, AM J PHYSIOL-GASTR L, V285, pG37, DOI 10.1152/ajpgi.00053.2003; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Chen CL, 2013, J CLIN INVEST, V123, P2832, DOI 10.1172/JCI65859; Chernyavsky AI, 2007, EXP CELL RES, V313, P3542, DOI 10.1016/j.yexcr.2007.07.011; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Densham RM, 2009, MOL CELL BIOL, V29, P6380, DOI 10.1128/MCB.00116-09; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; He JQ, 2000, J PHYSIOL-LONDON, V524, P807, DOI 10.1111/j.1469-7793.2000.00807.x; Hirata N, 2010, BIOCHEM BIOPH RES CO, V403, P138, DOI 10.1016/j.bbrc.2010.10.134; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Krais AM, 2011, CARCINOGENESIS, V32, P1388, DOI 10.1093/carcin/bgr090; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nallet-Staub F, 2013, J INVEST DERMATOL; Onoda N, 2001, HEAD NECK-J SCI SPEC, V23, P860, DOI 10.1002/hed.1125; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rosenberg MM, 2008, MOL CELL NEUROSCI, V38, P138, DOI 10.1016/j.mcn.2008.02.006; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Takeuchi H, 2010, J DENT RES, V89, P34, DOI 10.1177/0022034509353403; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yamada K, 2010, CELL PHYSIOL BIOCHEM, V26, P247, DOI 10.1159/000320524; Yeo MK, 2012, ANTICANCER RES, V32, P3835; Yu CC, 2013, TOXICOL APPL PHARM, V266, P459, DOI 10.1016/j.taap.2012.11.023; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051967; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	41	56	56	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e90836	10.1371/journal.pone.0090836	http://dx.doi.org/10.1371/journal.pone.0090836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	25093675	Green Published, gold, Green Submitted			2022-12-25	WOS:000332845300031
J	Wu, JN; Yan, SZ; Zhao, JL; Ye, YY				Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying			Barbs Facilitate the Helical Penetration of Honeybee (Apis mellifera ligustica) Stingers	PLOS ONE			English	Article							OVIPOSITOR; HYMENOPTERA; INSECTA; WASPS	The stinger is a very small and efficient device that allows honeybees to perform two main physiological activities: repelling enemies and laying eggs for reproduction. In this study, we explored the specific characteristics of stinger penetration, where we focused on its movements and the effects of it microstructure. The stingers of Italian honeybees (Apis mellifera ligustica) were grouped and fixed onto four types of cubic substrates, before pressing into different substrates. The morphological characteristics of the stinger cross-sections were analyzed before and after penetration by microscopy. Our findings suggest that the honeybee stinger undergoes helical and clockwise rotation during penetration. We also found that the helical penetration of the stinger is associated directly with the spiral distribution of the barbs, thereby confirming that stinger penetration involves an advanced microstructure rather than a simple needle-like apparatus. These results provide new insights into the mechanism of honeybee stinger penetration.	[Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying] Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China	Tsinghua University	Yan, SZ (corresponding author), Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China.	yansz@mail.tsinghua.edu.cn	Zhao, Jieliang/B-1872-2016; Yan, Shaoze/M-1707-2015; yan, shaoze/X-5768-2019; Yu, GH/H-4968-2013	Zhao, Jieliang/0000-0001-6879-0537; Yan, Shaoze/0000-0003-2578-6831; Yu, GH/0000-0002-5699-779X	Research Project of the State Key Laboratory of Tribology [SKLT11B03]	Research Project of the State Key Laboratory of Tribology	This work was funded by the Research Project of the State Key Laboratory of Tribology under Contract no. SKLT11B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2008, SENSOR ACTUAT A-PHYS, V143, P20, DOI 10.1016/j.sna.2007.06.007; Brown PE, 1998, J INSECT PHYSIOL, V44, P1017, DOI 10.1016/S0022-1910(98)00072-9; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; Dade H.A., 1994, ANATOMY DISSECTION H; Duan JJ, 2000, J INSECT BEHAV, V13, P175, DOI 10.1023/A:1007780029320; Frasson L, 2010, P I MECH ENG H, V224, P775, DOI 10.1243/09544119JEIM663; Gao Y, 2007, J SPACECRAFT ROCKETS, V44, P703, DOI 10.2514/1.23025; Izumi H, 2011, SENSOR ACTUAT A-PHYS, V165, P115, DOI 10.1016/j.sna.2010.02.010; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; Kong XQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011910; Rahman MH, 1998, ZOOL SCR, V27, P333, DOI 10.1111/j.1463-6409.1998.tb00465.x; Robbins CR., 2002, CHEM PHYS BEHAV HUMA, V4th ed.; Schilthuizen M, 1998, SYST ENTOMOL, V23, P253, DOI 10.1046/j.1365-3113.1998.00049.x; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J., 2008, BUZZ BEES BIOL SUPER; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; Visscher PK, 1996, LANCET, V348, P301, DOI 10.1016/S0140-6736(96)01367-0; Winston M. L. L., 1991, BIOL HONEY BEE; WU E, 1994, EXP MECH, V34, P93, DOI 10.1007/BF02325705	22	35	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103823	10.1371/journal.pone.0103823	http://dx.doi.org/10.1371/journal.pone.0103823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25137372	Green Published, gold, Green Submitted			2022-12-25	WOS:000339812700058
J	Johnson, SN; Lopaticki, G; Hartley, SE				Johnson, Scott N.; Lopaticki, Goran; Hartley, Susan E.			Elevated Atmospheric CO2 Triggers Compensatory Feeding by Root Herbivores on a C-3 but Not a C-4 Grass	PLOS ONE			English	Article							RISING CO2; CARBON; PERFORMANCE; NITROGEN; GROWTH	Predicted increases in atmospheric carbon dioxide (CO2) concentrations often reduce nutritional quality for herbivores by increasing the C:N ratio of plant tissue. This frequently triggers compensatory feeding by aboveground herbivores, whereby they consume more shoot material in an attempt to meet their nutritional needs. Little, however, is known about how root herbivores respond to such changes. Grasslands are particularly vulnerable to root herbivores, which can collectively exceed the mass of mammals grazing aboveground. Here we provide novel evidence for compensatory feeding by a grass root herbivore, Sericesthis nigrolineata, under elevated atmospheric CO2 (600 mmol mol(-1)) on a C-3 (Microlaena stipoides) but not a C-4 (Cymbopogon refractus) grass species. At ambient CO2 (400 mu mol mol(-1)) M. stipoides roots were 44% higher in nitrogen (N) and 7% lower in carbon (C) concentrations than C. refractus, with insects performing better on M. stipoides. Elevated CO2 decreased N and increased C: N in M. stipoides roots, but had no impact on C. refractus roots. Root-feeders displayed compensatory feeding on M. stipoides at elevated CO2, consuming 118% more tissue than at ambient atmospheric CO2. Despite this, root feeder biomass remained depressed by 24%. These results suggest that compensatory feeding under elevated atmospheric CO2 may make some grass species particularly vulnerable to attack, potentially leading to future shifts in the community composition of grasslands.	[Johnson, Scott N.; Lopaticki, Goran] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Hartley, Susan E.] Univ York, Dept Biol, York Environm Sustainabil Inst, York YO10 5DD, N Yorkshire, England	Western Sydney University; University of York - UK	Johnson, SN (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	Scott.Johnson@uws.edu.au	Johnson, Scott/HDN-6310-2022; Johnson, Scott N/B-2268-2012; Gemmell, Neil/C-6774-2009	Johnson, Scott/0000-0002-8388-8345; Rosengrave, Patrice/0000-0001-8421-3094; Gemmell, Neil/0000-0003-0671-3637; Carne, Alan/0000-0003-3665-1940; Hartley, Sue/0000-0002-5117-687X; Kleffmann, Torsten/0000-0001-9305-5980	Hawkesbury Institute for the Environment	Hawkesbury Institute for the Environment	The authors are grateful to the Hawkesbury Institute for the Environment for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Barbehenn RV, 2004, OECOLOGIA, V140, P86, DOI 10.1007/s00442-004-1572-9; Barbehenn RV, 2004, OECOLOGIA, V140, P96, DOI 10.1007/s00442-004-1555-x; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Barton CVM, 2010, AGR FOREST METEOROL, V150, P941, DOI 10.1016/j.agrformet.2010.03.001; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; BRITTON EB, 1978, AUST J ZOOL, P1; CASWELL H, 1973, AM NAT, V107, P465, DOI 10.1086/282851; Dawson LA, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P3, DOI 10.1079/9781845934613.0003; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Frew A, 2013, FOREST ECOL MANAG, V306, P275, DOI 10.1016/j.foreco.2013.06.051; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Johnson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079479; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, OECOLOGIA, V162, P209, DOI 10.1007/s00442-009-1428-4; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MURRAY PJ, 1992, ANN APPL BIOL, V121, P715, DOI 10.1111/j.1744-7348.1992.tb03480.x; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Salt DT, 1996, OIKOS, V77, P326, DOI 10.2307/3546072; Scheirs J, 2001, ECOLOGY, V82, P410, DOI 10.1890/0012-9658(2001)082[0410:ATOTCC]2.0.CO;2; Seastedt TR, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P54, DOI 10.1079/9781845934613.0054; Simpson S.J., 1990, P111; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Trumper K, 2009, UNEP RAPID RESPONSE; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WILLIAMS RE, 1968, J RANGE MANAGE, V21, P355, DOI 10.2307/3896081	30	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90251	10.1371/journal.pone.0090251	http://dx.doi.org/10.1371/journal.pone.0090251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651855	Green Published, Green Submitted, gold			2022-12-25	WOS:000333352800012
J	Ser, G; Robertson, A; Sheikh, A				Ser, Gloria; Robertson, Ann; Sheikh, Aziz			A Qualitative Exploration of Workarounds Related to the Implementation of National Electronic Health Records in Early Adopter Mental Health Hospitals	PLOS ONE			English	Article							UNINTENDED CONSEQUENCES; INFORMATION-TECHNOLOGY; MEDICAL-RECORDS; SECONDARY CARE; ORDER ENTRY; COMMUNICATION; INTEGRATION; PHYSICIANS; SYSTEMS; ERRORS	Aims: To investigate the perceptions and reported practices of mental health hospital staff using national hospital electronic health records (EHRs) in order to inform future implementations, particularly in acute mental health settings. Methods: Thematic analysis of interviews with a wide range of clinical, information technology (IT), managerial and other staff at two early adopter mental health National Health Service (NHS) hospitals in London, UK, implementing national EHRs. Results: We analysed 33 interviews. We first sought out examples of workarounds, such as delayed data entry, entering data in wrong places and individuals using the EHR while logged in as a colleague, then identified possible reasons for the reported workarounds. Our analysis identified four main categories of factors contributing to workarounds (i.e., operational, cultural, organisational and technical). Operational factors included poor system integration with existing workflows and the system not meeting users' perceived needs. Cultural factors involved users' competence with IT and resistance to change. Organisational factors referred to insufficient organisational resources and training, while technical factors included inadequate local technical infrastructure. Many of these factors, such as integrating the EHR system with day-to-day operational processes, staff training and adequate local IT infrastructure, were likely to apply to system implementations in various settings, but we also identified factors that related particularly to implementing EHRs in mental health hospitals, for example: EHR system incompatibility with IT systems used by mental health-related sectors, notably social services; the EHR system lacking specific, mental health functionalities and options; and clinicians feeling unable to use computers while attending to distressed psychiatric patients. Conclusions: A better conceptual model of reasons for workarounds should help with designing, and supporting the implementation and adoption of, EHRs for use in hospital mental health settings.	[Ser, Gloria; Robertson, Ann; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Otegui, Javier/B-3973-2012	Sheikh, Aziz/0000-0001-7022-3056; Braak, Kyle/0000-0002-3696-3496; Russell, Laura/0000-0002-1920-5298; Otegui, Javier/0000-0002-8997-3559; Bloom, David/0000-0003-1273-1807; Doring, Markus/0000-0001-7757-1889; Desmet, Peter/0000-0002-8442-8025	NHS CFH Evaluation Programme [NHS CFHEP 005]; Commonwealth Fund; private independent foundation based in New York City	NHS CFH Evaluation Programme; Commonwealth Fund; private independent foundation based in New York City	This study involved the secondary analysis of a sub-set of data previously collected in an independent research programme commissioned by NHS. This report draws on a sub-set of data that were gathered in independent research commissioned by the NHS CFH Evaluation Programme (NHS CFHEP 005). It was undertaken as a post-graduate dissertation research project. Aziz Sheikh has a Harkness Fellowship in Health Policy and Practice and is supported by The Commonwealth Fund, a private independent foundation based in New York City. The funders of the initial, commissioned study and The Commonwealth Fund had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	[Anonymous], 2004, INT J EDUC MANAG, DOI DOI 10.1108/09513540410522234; Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Burt CW, 2005, HEALTH AFFAIR, V24, P1334, DOI 10.1377/hlthaff.24.5.1334; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; Campbell EM, 2009, J GEN INTERN MED, V24, P21, DOI 10.1007/s11606-008-0857-9; Cresswell KM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-15; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Department of Health, 2007, MENT HLTH ACT; Detmer DE, 2009, QUAL HEALTH CARE, V9, P181; Ferneley EH, 2006, EUR J INFORM SYST, V15, P345, DOI 10.1057/palgrave.ejis.3000629; Forum: Qualitative Social Research, 2005, SEC AN QUAL DAT; GASSER L, 1986, ACM T INFORM SYST, V4, P205, DOI 10.1145/214427.214429; Harrison MI, 2007, J AM MED INFORM ASSN, V14, P542, DOI 10.1197/jamia.M2384; Hayes N., 2000, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V9, P435, DOI 10.1023/A:1008795025075; Heaton J, 2004, REWORKING QUALITATIV; Huckvale C, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038497; Kobayashi M, 2005, CHI LATE BREAKING RE, P1561, DOI DOI 10.1145/1056808.1056966; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; Linder Jeffrey A, 2006, AMIA Annu Symp Proc, P499; Makoul G, 2001, J AM MED INFORM ASSN, V8, P610, DOI 10.1136/jamia.2001.0080610; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Patton M. Q., 1990, QUALITATIVE EVALUATI; Poelmans S., 1999, SIGGROUP Bulletin, V20, P11; Robertson A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4564; Robertson A, 2011, J ROY SOC MED, V104, P434, DOI 10.1258/jrsm.2011.11k039; Rouf E, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-13; Safadi H, 2010, INT C INF SYS P; Saleem JJ, 2009, INT J MED INFORM, V78, P618, DOI 10.1016/j.ijmedinf.2009.04.001; Salomon RM, 2010, J AM MED INFORM ASSN, V17, P54, DOI 10.1197/jamia.M3341; Sartorius N, 2007, LANCET, V370, P810, DOI 10.1016/S0140-6736(07)61245-8; Sheikh A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6054; Sobreperez P, 2008, INT FED INFO PROC, V287, P179; Stewart RF, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-3; Stockdale SE, 2011, BMJ QUAL SAF, V20, P941, DOI 10.1136/bmjqs.2010.050450; Strauss AL, 1998, BASICS QUALITATIVE R, V2nd; Ventres W, 2006, ANN FAM MED, V4, P124, DOI 10.1370/afm.425; Vestal K, 2008, NURSE LEAD, V6, P8, DOI 10.1016/j.mnl.2008.06.008; Wachter R., 2008, UNDERSTANDING PATIEN	41	102	104	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e77669	10.1371/journal.pone.0077669	http://dx.doi.org/10.1371/journal.pone.0077669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25099149	Green Submitted, gold, Green Published			2022-12-25	WOS:000330236000001
J	Lopez, DC; Zhu-Salzman, K; Ek-Ramos, MJ; Sword, GA				Castillo Lopez, Diana; Zhu-Salzman, Keyan; Julissa Ek-Ramos, Maria; Sword, Gregory A.			The Entomopathogenic Fungal Endophytes Purpureocillium lilacinum (Formerly Paecilomyces lilacinus) and Beauveria bassiana Negatively Affect Cotton Aphid Reproduction under Both Greenhouse and Field Conditions	PLOS ONE			English	Article							VERTICILLIUM-LECANII; PERENNIAL RYEGRASS; THOM SAMSON; SEED; PLANT; ASCOMYCOTA; RESISTANCE; GRASSES; DISEASE; COLONIZATION	The effects of two entomopathogenic fungal endophytes, Beauveria bassiana and Purpureocillium lilacinum (formerly Paecilomyces lilacinus), were assessed on the reproduction of cotton aphid, Aphis gossypii Glover (Homoptera:Aphididae), through in planta feeding trials. In replicate greenhouse and field trials, cotton plants (Gossypium hirsutum) were inoculated as seed treatments with two concentrations of B. bassiana or P. lilacinum conidia. Positive colonization of cotton by the endophytes was confirmed through potato dextrose agar (PDA) media plating and PCR analysis. Inoculation and colonization of cotton by either B. bassiana or P. lilacinum negatively affected aphid reproduction over periods of seven and 14 days in a series of greenhouse trials. Field trials were conducted in the summers of 2012 and 2013 in which cotton plants inoculated as seed treatments with B. bassiana and P. lilacinum were exposed to cotton aphids for 14 days. There was a significant overall effect of endophyte treatment on the number of cotton aphids per plant. Plants inoculated with B. bassiana had significantly lower numbers of aphids across both years. The number of aphids on plants inoculated with P. lilacinum exhibited a similar, but non-significant, reduction in numbers relative to control plants. We also tested the pathogenicity of both P. lilacinum and B. bassiana strains used in the experiments against cotton aphids in a survival experiment where 60% and 57% of treated aphids, respectively, died from infection over seven days versus 10% mortality among control insects. Our results demonstrate (i) the successful establishment of P. lilacinum and B. bassiana as endophytes in cotton via seed inoculation, (ii) subsequent negative effects of the presence of both target endophytes on cotton aphid reproduction using whole plant assays, and (iii) that the P. lilacinum strain used is both endophytic and pathogenic to cotton aphids. Our results illustrate the potential of using these endophytes for the biological control of aphids and other herbivores under greenhouse and field conditions.	[Castillo Lopez, Diana; Zhu-Salzman, Keyan; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Julissa Ek-Ramos, Maria] Autonomous Univ Nuevo Leon, Dept Immunol & Microbiol, San Nicolas De Los Garza, Nuevo Leon, Mexico	Texas A&M University System; Texas A&M University College Station; Universidad Autonoma de Nuevo Leon	Lopez, DC (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	dianacastillo8@tamu.edu	Ramos, Maria Julissa Ek/W-1017-2018; Potts, Brad M/C-6489-2013	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Potts, Brad M/0000-0001-6244-289X; Costa e Silva, Joao/0000-0003-1422-9554	Cotton Incorporated Grant; Good Neighbor Scholarship	Cotton Incorporated Grant; Good Neighbor Scholarship	The work was supported by Cotton Incorporated Grant and Good Neighbor Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akello J, 2008, CROP PROT, V27, P1437, DOI 10.1016/j.cropro.2008.07.003; Akello J, 2012, BIOL CONTROL, V61, P215, DOI 10.1016/j.biocontrol.2012.02.007; Atkins SD, 2005, FEMS MICROBIOL ECOL, V51, P257, DOI 10.1016/j.femsec.2004.09.002; Ball OJP, 1997, J CHEM ECOL, V23, P1419, DOI 10.1023/B:JOEC.0000006473.26175.19; Ball OJP, 1997, J ECON ENTOMOL, V90, P1382, DOI 10.1093/jee/90.5.1382; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Biswas C, 2012, BIOCONTROL, V57, P565, DOI 10.1007/s10526-011-9424-0; Brownbridge M, 2012, BIOL CONTROL, V61, P194, DOI 10.1016/j.biocontrol.2012.01.002; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; Carriere Y, 1998, J ECON ENTOMOL, V91, P324, DOI 10.1093/jee/91.1.324; Carrión Gloria, 2012, Rev. mex. fitopatol, V30, P86; Chaudhary KK, 2012, S ASIAN J EXP BIOL, V1, P36; CLAY K, 1993, ECOLOGY, V74, P1767, DOI 10.2307/1939935; Clay K, 1996, RES POPUL ECOL, V38, P191, DOI 10.1007/BF02515727; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dugassa-Gobena D., 1996, MITTEILUNGEN BIOL BU, V321, P299; Ek-Ramos MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066049; Fiedler Z, 2007, BIOCONTROL, V52, P547, DOI 10.1007/s10526-006-9052-2; Gange AC, 2012, OECOLOGIA, V168, P1023, DOI 10.1007/s00442-011-2151-5; Gassmann AJ, 2009, PEST MANAG SCI, V65, P1174, DOI 10.1002/ps.1844; GINDIN G, 1994, PHYTOPARASITICA, V22, P189, DOI 10.1007/BF02980318; Godfrey L. D., 1997, 1997 Proceedings Beltwide Cotton Conferences, New Orleans, LA, USA, January 6-10, 1997: Volume 2., P1048; Godfrey L.D., 2000, CALIF AGR, V54, P32, DOI [10.3733/ca.v054n06p26, DOI 10.3733/CA.V054N06P26]; Gould F, 1995, WEED TECHNOL, V9, P830, DOI 10.1017/S0890037X00024301; GRAFTONCARDWELL EE, 1991, J ECON ENTOMOL, V84, P741, DOI 10.1093/jee/84.3.741; Gurulingappa P, 2011, CROP PROT, V30, P349, DOI 10.1016/j.cropro.2010.11.017; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Imoulan A, 2011, WORLD J MICROB BIOT, V27, P2619, DOI 10.1007/s11274-011-0735-1; Jaber LR, 2010, ECOL ENTOMOL, V35, P25, DOI 10.1111/j.1365-2311.2009.01152.x; Jung H.S., 2006, KOREAN J MYCOL, V34, P112; KERNS DL, 1992, J ECON ENTOMOL, V85, P1, DOI 10.1093/jee/85.1.1; Khan MR, 2012, TURK J BIOL, V36, P161, DOI 10.3906/biy-1008-72; Kiewnick S, 2011, PHYTOPATHOLOGY, V101, P105, DOI 10.1094/PHYTO-03-10-0090; King EG, 1987, 40 ANN C REP COTT IN; LATCH GCM, 1993, AGR ECOSYST ENVIRON, V44, P143, DOI 10.1016/0167-8809(93)90043-O; Luangsa-Ard J, 2011, FEMS MICROBIOL LETT, V321, P141, DOI 10.1111/j.1574-6968.2011.02322.x; Marti GA, 2006, MYCOPATHOLOGIA, V162, P369, DOI 10.1007/s11046-006-0072-3; Martinuz A, 2012, BIOL CONTROL, V62, DOI 10.1016/j.biocontrol.2012.05.006; McGee PA, 2002, AUST J EXP AGR, V42, P995, DOI 10.1071/EA01124; Munawar Fazal, 2011, Annals of Plant Protection Sciences, V19, P168; O'Brien PJ, 1990, INSECT ACAR TESTS, V15, P254; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Posada FJ, 2005, MYCOLOGIA, V97, P1208; Posada F, 2007, MYCOL RES, V111, P748, DOI 10.1016/j.mycres.2007.03.006; Powell WA, 2009, J ENTOMOL SCI, V44, P391, DOI 10.18474/0749-8004-44.4.391; Price PW, 2011, INSECT ECOLOGY, P121; Raja Kannan, 2012, Journal of Agricultural Science (Toronto), V4, P119; Rao N. B. V. C., 2012, Insect Environment, V17, P151; Raps A, 1998, OECOLOGIA, V114, P541, DOI 10.1007/s004420050478; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Reddy Narasimha P., 2009, Journal of Asia-Pacific Entomology, V12, P221, DOI 10.1016/j.aspen.2009.06.001; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saari S, 2010, MICROB ECOL, V60, P928, DOI 10.1007/s00248-010-9749-8; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011395; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036810; Swati Sharma, 2012, Indian Journal of Nematology, V42, P1; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vicari M, 2002, ECOLOGY, V83, P2452, DOI 10.1890/0012-9658(2002)083[2452:CEOFAM]2.0.CO;2; Wang LD, 2007, PEST MANAG SCI, V63, P381, DOI 10.1002/ps.1359; Waqas Wakil, 2012, African Journal of Biotechnology, V11, P821; Young C, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P660	69	130	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2014	9	8							e103891	10.1371/journal.pone.0103891	http://dx.doi.org/10.1371/journal.pone.0103891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5BW	25093505	gold, Green Published, Green Submitted			2022-12-25	WOS:000341357200041
J	Silva, JCE; Potts, BM; Lopez, GA				Costa e Silva, Joao; Potts, Brad M.; Lopez, Gustavo A.			Heterosis May Result in Selection Favouring the Products of Long-Distance Pollen Dispersal in Eucalyptus	PLOS ONE			English	Article							GLOBULUS SSP GLOBULUS; SPATIAL GENETIC-STRUCTURE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; LOCAL ADAPTATION; POPULATION DIFFERENTIATION; ENVIRONMENT INTERACTION; RECIPROCAL HYBRIDS; SEED DISPERSAL; WOOD DENSITY	Using native trees from near the northern and southern extremities of the relatively continuous eastern distribution of Eucalyptus globulus in Tasmania, we compared the progenies derived from natural open-pollination (OP) with those generated from within-region and long-distance outcrossing. Controlled outcrossing amongst eight parents - with four parents from each of the northern and southern regions - was undertaken using a diallel mating scheme. The progeny were planted in two field trials located within the species native range in southern Tasmania, and their survival and diameter growth were monitored over a 13-year-period. The survival and growth performances of all controlled cross types exceeded those of the OP progenies, consistent with inbreeding depression due to a combination of selfing and bi-parental inbreeding. The poorer survival of the northern regional (female(N)male(N)) outcrosses compared with the local southern regional outcrosses (female(S)male(S)) indicated differential selection against the former. Despite this mal-adaptation of the non-local female(N)male(N) crosses at both southern sites, the survival of the inter-regional hybrids (male(N)male(S) and female(S)male(N)) was never significantly different from that of the local female(S)male(S) crosses. Significant site-dependent heterosis was detected for the growth of the surviving long-distance hybrids. This was expressed as mid-parent heterosis, particularly at the more northern planting site. Heterosis increased with age, while the difference between the regional female(N)male(N) and female(S)male(S) crosses remained insignificant at any age at either site. Nevertheless, the results for growth suggest that the fitness of individuals derived from long-distance crossing may be better at the more northern of the planting sites. Our results demonstrate the potential for early-age assessments of pollen dispersal to underestimate realised gene flow, with local inbreeding under natural open-pollination resulting in selection favouring the products of longer-distance pollinations. Indeed, heterosis derived from long-distance pollinations may be sufficient to counter local mal-adaptation, at least in the first generation.	[Costa e Silva, Joao] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal; [Potts, Brad M.; Lopez, Gustavo A.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Potts, Brad M.; Lopez, Gustavo A.] Univ Tasmania, Natl Ctr Future Forest Ind, Hobart, Tas, Australia	Universidade de Lisboa; University of Tasmania; University of Tasmania	Silva, JCE (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal.	jces@isa.utl.pt	Ramos, Maria Julissa Ek/W-1017-2018; Potts, Brad M/C-6489-2013	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Potts, Brad M/0000-0001-6244-289X; Costa e Silva, Joao/0000-0003-1422-9554	University of Tasmania; Instituto Nacional de Tecnologia Agropecuaria; Argentina Government; Australian Research Council Linkage [LP0884001]; Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal) through the Ciencia initiative	University of Tasmania; Instituto Nacional de Tecnologia Agropecuaria; Argentina Government; Australian Research Council Linkage(Australian Research Council); Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal) through the Ciencia initiative	The trials studied were established as part of the genetic research undertaken by the CRC for Sustainable Production Forestry, and as part of the PhD studies of Gustavo Lopez. This PhD was supported by the University of Tasmania, the Instituto Nacional de Tecnologia Agropecuaria, and the Argentina Government. Trial measurements and data collation were supported by the CRC for Sustainable Production Forestry, as well as an Australian Research Council Linkage grant (LP0884001) partnered by the Southern Tree Breeding Association Inc. and SeedEnergy Pty. Ltd. The financial support given to Joao Costa e Silva by Fundacao para a Ciencia e Tecnologia (Lisboa, Portugal), through the Ciencia 2007 initiative, is gratefully acknowledged and provided the opportunity to complete this long-term study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Barbour RC, 2003, AUST J BOT, V51, P429, DOI 10.1071/BT03016; Barlow R., 1981, Animal Breeding Abstracts, V49, P715; Barton NH, 2004, EVOLUTION, V58, P2111; Berens DG, 2013, OIKOS, V122, P1616, DOI 10.1111/j.1600-0706.2013.00515.x; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Breslow N, 2004, LECT NOTES STAT, V179, P1; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Buschbom J, 2011, J HERED, V102, P464, DOI 10.1093/jhered/esr023; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V305, P129, DOI 10.1016/j.foreco.2013.05.037; Campbell DR, 2010, AM J BOT, V97, P925, DOI 10.3732/ajb.0900387; Campbell DR, 2001, EVOLUTION, V55, P669, DOI 10.1554/0014-3820(2001)055[0669:GBEIAT]2.0.CO;2; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Silva JCE, 2011, HEREDITY, V107, P50, DOI 10.1038/hdy.2010.154; Silva JCE, 2006, TREE GENET GENOMES, V2, P61, DOI 10.1007/s11295-005-0025-x; Silva JCE, 2012, TREE GENET GENOMES, V8, P249, DOI 10.1007/s11295-011-0437-8; Silva JCE, 2009, TREE GENET GENOMES, V5, P291, DOI 10.1007/s11295-008-0174-9; Cox D.R., 1970, ANAL BINARY DATA, V2; Dungey HS, 2001, FOREST ECOL MANAG, V148, P243, DOI 10.1016/S0378-1127(00)00539-9; Dutkowski GW, 2012, TREE GENET GENOMES, V8, P757, DOI 10.1007/s11295-011-0461-8; Dutkowski GW, 1999, AUST J BOT, V47, P237, DOI 10.1071/BT97114; Dutkowski GW, 2002, CAN J FOREST RES, V32, P2201, DOI 10.1139/X02-111; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; Epperson B. K., 1992, New Forests, V6, P257, DOI 10.1007/BF00120648; Eyles A, 2013, FOREST ECOL MANAG, V304, P49, DOI 10.1016/j.foreco.2013.04.033; Fenster CB, 2000, EVOLUTION, V54, P1157, DOI 10.1111/j.0014-3820.2000.tb00551.x; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; Forrest CN, 2011, ANN BOT-LONDON, V108, P185, DOI 10.1093/aob/mcr100; Freeman JS, 2007, ANN FOREST SCI, V64, P639, DOI 10.1051/forest:2007042; Fritz RS, 2006, EVOLUTION, V60, P1215, DOI 10.1111/j.0014-3820.2006.tb01200.x; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour A.R., 2009, ASREML USER GUIDE RE; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goto S, 2011, RESTOR ECOL, V19, P243, DOI 10.1111/j.1526-100X.2009.00568.x; GOVINDARAJU DR, 1989, BIOL J LINN SOC, V37, P345, DOI 10.1111/j.1095-8312.1989.tb01910.x; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; HAASE P, 1993, J BIOGEOGR, V20, P79, DOI 10.2307/2845741; Hamilton MG, 2013, HEREDITY, V110, P372, DOI 10.1038/hdy.2012.106; Hamilton MG, 2011, AUST J BOT, V59, P170, DOI 10.1071/BT10313; Hampe A., 2013, P ROYAL SOC B, V280, P1764; Hamrick J. L., 2000, Forest conservation genetics: principles and practice, P81, DOI 10.1079/9780851995045.0081; Hansen TF, 2013, EVOLUTION, V67, P3501, DOI 10.1111/evo.12214; Hardner CM, 1997, EVOLUTION, V51, P103, DOI 10.1111/j.1558-5646.1997.tb02392.x; HARDNER CM, 1995, SILVAE GENET, V44, P46; Hardner CM, 1998, EVOLUTION, V52, P614, DOI [10.2307/2411096, 10.1111/j.1558-5646.1998.tb01660.x]; Harfouche A, 2000, CAN J FOREST RES, V30, P10, DOI 10.1139/cjfr-30-1-10; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hingston A. B., 1998, Tasforests, V10, P125; Hingston AB, 2005, AUSTRAL ECOL, V30, P319, DOI 10.1111/j.1442-9993.2005.01476.x; Hingston AB, 2004, AUSTRAL ECOL, V29, P624, DOI 10.1111/j.1442-9993.2004.01397.x; Hingston AB, 2004, AUST J BOT, V52, P371, DOI 10.1071/BT03018; Hingston AB, 2004, AUST J BOT, V52, P353, DOI 10.1071/BT03002; Hirao AS, 2010, ANN BOT-LONDON, V105, P637, DOI 10.1093/aob/mcq018; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; Isagi Y, 2007, J ECOL, V95, P983, DOI 10.1111/j.1365-2745.2007.01272.x; Jones RC, 2013, ECOL EVOL, V3, P1, DOI 10.1002/ece3.421; Jones RC, 2011, TREE GENET GENOMES, V7, P1209, DOI 10.1007/s11295-011-0407-1; Jones TH, 2007, MOL ECOL, V16, P697, DOI 10.1111/j.1365-294X.2006.03180.x; Robledo-Arnuncio JJ, 2011, NEW PHYTOL, V190, P222, DOI 10.1111/j.1469-8137.2010.03588.x; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kimball S, 2008, J ECOL, V96, P1306, DOI 10.1111/j.1365-2745.2008.01432.x; KOMENDER P, 1989, LIVEST PROD SCI, V21, P101, DOI 10.1016/0301-6226(89)90042-0; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Larcombe MJ, 2013, BIOL INVASIONS, V15, P2763, DOI 10.1007/s10530-013-0492-1; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Levin D. A., 1974, EVOL BIOL, V7, P139, DOI DOI 10.1007/978-1-4615-6944-2_5; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lopez GA, 2000, HEREDITY, V85, P242, DOI 10.1046/j.1365-2540.2000.00739.x; Lopez GA, 2003, CAN J FOREST RES, V33, P2108, DOI [10.1139/x03-132, 10.1139/X03-132]; Lynch Michael, 1998; Martin B, 1989, P IUFRO C BREED TROP, P79; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; Mehta CR, 1992, J COMPUTATIONAL GRAP, V1, P21, DOI DOI 10.2307/1390598; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; Nikles DG, 1992, ACIAR P, P101; O'Reilly-Wapstra JM, 2005, J CHEM ECOL, V31, P357, DOI 10.1007/s10886-005-1346-9; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; O'Reilly-Wapstra JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058416; O'Reilly-Wapstra JM, 2011, TREE GENET GENOMES, V7, P485, DOI 10.1007/s11295-010-0350-6; Ozawa H, 2013, J HERED, V104, P465, DOI 10.1093/jhered/est022; POTTS BM, 1988, EVOLUTION, V42, P1245, DOI 10.1111/j.1558-5646.1988.tb04184.x; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Robertson AW, 2011, INT J PLANT SCI, V172, P191, DOI 10.1086/657678; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Silva JCE, 2004, THEOR APPL GENET, V108, P1113, DOI 10.1007/s00122-003-1524-5; Silva JCE, 2001, CAN J FOREST RES, V31, P1887, DOI 10.1139/cjfr-31-11-1887; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010018; Silva JCE, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010019; Skabo S, 1998, AUST J BOT, V46, P583, DOI 10.1071/BT97056; Slavov GT, 2002, ECOLOGICAL AGRONOMIC, P106; Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372; Stackpole DJ, 2010, TREE GENET GENOMES, V6, P179, DOI 10.1007/s11295-009-0239-4; Steane DA, 2006, TREE GENET GENOMES, V2, P30, DOI 10.1007/s11295-005-0028-7; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Stringer JK, 2006, THESIS U QUEENSLAND; Stringer JK, 2011, J AGR BIOL ENVIR ST, V16, P269, DOI 10.1007/s13253-010-0051-5; Su G, 2009, J DAIRY SCI, V92, P2204, DOI 10.3168/jds.2008-1499; Taylor SJ, 2009, EVOLUTION, V63, P2581, DOI 10.1111/j.1558-5646.2009.00742.x; Vaillancourt R. E., 1995, Forest Genetics, V2, P11; Volker PW, 2008, TREE GENET GENOMES, V4, P445, DOI 10.1007/s11295-007-0122-0; Volker PW, 2002, THEISI U TASMANIA; WADDINGTON KD, 1983, AM NAT, V122, P147, DOI 10.1086/284124; Wallis IR, 2011, PERSPECT PLANT ECOL, V13, P305, DOI 10.1016/j.ppees.2011.05.005; Waser N.M., 1983, P341; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; White T. L., 2007, FOREST GENETICS; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; Yeoh SH, 2012, TREE GENET GENOMES, V8, P695, DOI 10.1007/s11295-011-0457-4; Yu H, 2010, MOL ECOL, V19, P4441, DOI 10.1111/j.1365-294X.2010.04777.x	124	130	135	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e93811	10.1371/journal.pone.0093811	http://dx.doi.org/10.1371/journal.pone.0093811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	25093505	Green Published, Green Submitted, gold			2022-12-25	WOS:000335227400008
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24941042	gold, Green Published, Green Submitted			2022-12-25	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon R. T., 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/NCLIMATE1958, 10.1038/nclimate1958]; R Core Team, 2021, R LANG ENV STAT COMP; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24941042	Green Published, gold, Green Accepted			2022-12-25	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	Bertin, Aline/T-5005-2017; Malausa, Thibaut/X-1614-2018; Strugnell, Jan M/P-9921-2016; Botton, Marcos/I-1731-2016; 刘, 芳延/AAO-8535-2021; Moltschaniwskyj, Natalie/AAB-7236-2019; León, Rafael I/N-6510-2014; van den Bosch, Frank C./ABH-3801-2020; Pecl, Gretta/D-7267-2011; Dodds, Richard/D-7772-2016; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Persinoti, Gabriela/C-5933-2016; Sujii, Edison/H-7715-2015; Aidar, Marcos Pereira Marinho/B-2212-2013; Benzeval, Michaela/J-3163-2015; Sujii, Edison Ryoiti/H-7715-2015; Inskip, Hazel/L-5467-2018; Apparecida Desiderio, Janete/F-5848-2012; Silva-Rocha, Rafael/H-4929-2012; Deary, Ian/C-6297-2009	Bertin, Aline/0000-0003-4232-4241; Malausa, Thibaut/0000-0003-1681-7958; Botton, Marcos/0000-0002-0554-3157; 刘, 芳延/0000-0002-5155-1916; León, Rafael I/0000-0003-3197-4185; van den Bosch, Frank C./0000-0003-3236-2068; Pecl, Gretta/0000-0003-0192-4339; R. Silva, Rogerio/0000-0002-0599-2155; Jagger, Carol/0000-0002-6377-9926; Der, Geoff/0000-0002-8677-073X; Strugnell, Jan/0000-0003-2994-637X; Gale, Catharine/0000-0002-3361-8638; Dodds, Richard/0000-0003-4968-7678; Vucicevic, Katarina/0000-0001-9676-5785; Wong, Joshua/0000-0001-8268-5610; Souza, Silvia/0000-0001-6293-7665; Dennison, Elaine/0000-0002-3048-4961; N. Silva, Roberto/0000-0002-8992-7130; Cooper, Cyrus/0000-0003-3510-0709; Wong, Jason/0000-0002-8167-540X; Pacheco da Silva, Vitor/0000-0002-8420-1779; timbo, renata/0000-0003-1989-7412; Aihie Sayer, Avan/0000-0003-1283-6457; De Vivo, Immaculata/0000-0002-7185-7402; Leimar, Olof/0000-0001-8621-6977; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Persinoti, Gabriela/0000-0002-0975-7283; Sujii, Edison/0000-0002-0702-0181; Germain, Jean-Francois/0000-0001-7927-6031; Gan, Victor/0000-0002-6966-2729; Paveley, Neil/0000-0002-1709-4563; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Benzeval, Michaela/0000-0002-0372-2098; Robinson, Sian/0000-0003-1766-7269; Favati, Anna/0000-0002-6435-011X; Cooper, Rachel/0000-0003-3370-5720; Sujii, Edison Ryoiti/0000-0001-7602-8999; Inskip, Hazel/0000-0001-8897-1749; Fernandes, Odair/0000-0003-3489-4754; Lye, David/0000-0003-0324-0205; Tilling, Kate/0000-0002-1010-8926; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Ramos, Jorge E/0000-0002-8690-761X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Apparecida Desiderio, Janete/0000-0001-7723-3070; Silva-Rocha, Rafael/0000-0001-6319-631X; Lawlor, Debbie A/0000-0002-6793-2262; Deary, Ian/0000-0002-1733-263X; Choo, Robin/0000-0002-3240-3029; Semmens, Jayson/0000-0003-1742-6692	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	60	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24941042	Green Published, gold, Green Submitted			2022-12-25	WOS:000343943100017
